<SEC-DOCUMENT>0001047469-14-001653.txt : 20140303
<SEC-HEADER>0001047469-14-001653.hdr.sgml : 20140303
<ACCEPTANCE-DATETIME>20140303113618
ACCESSION NUMBER:		0001047469-14-001653
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20131231
FILED AS OF DATE:		20140303
DATE AS OF CHANGE:		20140303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15006
		FILM NUMBER:		14658945

	BUSINESS ADDRESS:	
		STREET 1:		119 FOURTH AVE
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		7814330771

	MAIL ADDRESS:	
		STREET 1:		119 FOURTH AVE
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494-2725

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>a2218459z10-k.htm
<DESCRIPTION>10-K
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#13ZDF47701_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><div
style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT SIZE=2><B>Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>FORM 10-K  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>(Mark&nbsp;one)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2><FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> ANNUAL REPORT PURSUANT TO SECTION&nbsp;13 OR 15(D) OF THE SECURITIES EXCHANGE&nbsp;ACT OF&nbsp;1934</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2><B> For the fiscal year ended December&nbsp;31, 2013</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2><B> or</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2><FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> TRANSITION REPORT PURSUANT TO SECTION&nbsp;13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF&nbsp;1934</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> Commission File Number&nbsp;000-15006  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>CELLDEX THERAPEUTICS,&nbsp;INC.<BR>  </B></FONT><FONT SIZE=2>(Exact name of registrant as specified in its charter) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>Delaware</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> 13-3191702</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>(I.R.S. Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>Perryville III Building, 53 Frontage Road, Suite&nbsp;200, Hampton, New Jersey 08827</B></FONT><FONT SIZE=2><BR>
(Address of principal executive offices) (Zip Code) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Registrant's
telephone number, including area code: </FONT><FONT SIZE=2><B>(908)&nbsp;200-7500</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Securities
registered pursuant to Section&nbsp;12(b) of the Act: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="41%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="41%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Title of Class: </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name of Each Exchange on Which Registered: </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Common Stock, par value $.001</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>NASDAQ Global Market</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Securities
registered pursuant to Section&nbsp;12(g) of the Act: </FONT><FONT SIZE=2><B>None</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&nbsp;405 of the Securities
Act.&nbsp;Yes&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the
Act.&nbsp;Yes&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant: (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12&nbsp;months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing requirements for the
past 90&nbsp;days.&nbsp;Yes&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to
be submitted and posted pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T (&sect;232.405 of this chapter) during the preceding 12&nbsp;months (or for such shorter period that the
registrant was required to submit and post such files).&nbsp;Yes&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark if disclosure of delinquent filers pursuant to Item&nbsp;405 of Regulation&nbsp;S-K (&sect;229.405 of this Chapter) is not
contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part&nbsp;III of this Form&nbsp;10-K
or any amendment to this Form&nbsp;10-K.&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See
definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule&nbsp;12b-2 of the Exchange Act. (Check one): </FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="134pt" style="font-family:times;"></TD>
<TD WIDTH="4%" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="4%" style="font-family:times;"></TD>
<TD WIDTH="144pt" style="font-family:times;"></TD>
<TD WIDTH="4%" style="font-family:times;"></TD>
<TD WIDTH="163pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Large&nbsp;accelerated&nbsp;filer&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Accelerated&nbsp;filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Non-accelerated&nbsp;filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT><BR></FONT> <FONT SIZE=1>(Do not check if a<BR>
smaller reporting company)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Smaller Reporting Company&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate
by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the
Act).&nbsp;Yes&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The aggregate market value of the registrant's common stock held by non-affiliates as of June&nbsp;30, 2013 was $1.3&nbsp;billion. Exclusion of shares held by
any person should not be construed to indicate that such person possesses the power, direct or indirect, to direct or cause the actions of the management or policies of the registrant, or that such
person is controlled by or under common control with the registrant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of shares of common stock outstanding at February&nbsp;19, 2014 was 89,251,747 shares. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>DOCUMENTS INCORPORATED BY REFERENCE</B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Portions
of the definitive Proxy Statement for our 2014 Annual Meeting of Stockholders are incorporated by reference into Part&nbsp;III of this Report. </FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p>
 <P style="font-family:times;"><FONT SIZE=2><div
style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=382505,FOLIO='blank',FILE='DISK104:[13ZDF1.13ZDF47701]BA47701A.;6',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_bg47701_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="bg47701_celldex_therapeutics,_inc._ann__cel02571"> </A>
<A NAME="toc_bg47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  CELLDEX THERAPEUTICS,&nbsp;INC.<BR>  ANNUAL REPORT ON FORM 10-K<BR>  YEAR ENDED DECEMBER 31, 2013    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="bg47701_table_of_contents"> </A>
<A NAME="toc_bg47701_2"> </A></FONT> <FONT SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="75pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Part&nbsp;I</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;1.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Business</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;1A.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk Factors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;1B.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unresolved Staff Comments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;2.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Properties</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;3.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Legal Proceedings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;4.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mine Safety Disclosures</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Part&nbsp;II</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;5.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>36</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;6.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Selected Financial Data</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>37</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;7.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Management's Discussion and Analysis of Financial Condition and Results of Operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;7A.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Quantitative and Qualitative Disclosures About Market Risk</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>57</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;8.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial Statements and Supplementary Data</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;9.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>86</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;9A.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Controls and Procedures</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>86</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;9B.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Information</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Part&nbsp;III</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;10.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Directors, Executive Officers and Corporate Governance</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;11.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Executive Compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;12.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;13.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Certain Relationships and Related Transactions, and Director Independence</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;14.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Principal Accountant Fees and Services</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>88</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Part&nbsp;IV</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Item&nbsp;15.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exhibits, Financial Statement Schedules</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>89</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2> Signatures</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>94</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>i</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=404702,FOLIO='i',FILE='DISK104:[13ZDF1.13ZDF47701]BG47701A.;10',USER='HYUNG',CD='26-FEB-2014;11:40' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_da47701_1_2"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Annual Report on Form&nbsp;10-K contains
forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 under Section&nbsp;27A of the Securities Act of 1933, as amended, and
Section&nbsp;21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations,
assumptions, estimates, intentions and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual
results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than
statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "will," "can,"
"anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "seek," "estimate," "continue," "plan," "point to," "project," "predict," "could," "intend," "target,"
"potential" and other similar words and expressions of the future. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include,
but are not limited to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to successfully complete research and further development, including animal, preclinical and clinical studies,
and, if we obtain regulatory approval, commercialization of rindopepimut (also referred to as CDX-110), glembatumumab vedotin (also referred to as CDX-011), and other drug candidates and the growth of
the markets for those drug candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to raise sufficient capital to fund our clinical studies and to meet our long-term liquidity needs, on terms
acceptable to us, or at all. If we are unable to raise the funds necessary to meet our long-term liquidity needs, we may have to delay or discontinue the development of one or more programs,
discontinue or delay on-going or anticipated clinical trials, license out programs earlier than expected, raise funds at significant discount or on other unfavorable terms, if at all, or sell all or
part of our business; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to manage multiple clinical trials for a variety of drug candidates at different stages of development,
including ACT IV and ReACT for rindopepimut and METRIC for glembatumumab vedotin; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the cost, timing, scope and results of ongoing safety and efficacy trials of rindopepimut, glembatumumab vedotin, and
other preclinical and clinical testing; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to fund and complete the development and, if we obtain regulatory approval, to commercialize rindopepimut in
North America ourselves; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to negotiate strategic partnerships, where appropriate, for our programs, which may include rindopepimut
outside of North America, glembatumumab vedotin and varlilumab (also referred to as CDX-1127); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to develop technological capabilities, including identification of novel and clinically important targets,
exploiting our existing technology platforms to develop new product candidates and expand our focus to broader markets for our existing targeted immunotherapeutics; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to adapt our proprietary antibody-targeted technology, or APC Targeting Technology&#153;, to develop
new, safe and effective therapeutics for oncology and infectious disease indications; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>ii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=757868,FOLIO='ii',FILE='DISK104:[13ZDF1.13ZDF47701]DA47701A.;5',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<A NAME="page_da47701_1_3"> </A>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the availability, cost, delivery and quality of clinical and commercial grade materials produced by our own manufacturing
facility or supplied by contract manufacturers, suppliers and partners, who may be the sole source of supply; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the availability, cost, delivery and quality of clinical management services provided by our clinical research
organization partners; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the timing, cost and uncertainty of obtaining regulatory approvals for our drug candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to develop and commercialize products before competitors that are superior to the alternatives developed by
such competitors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our ability to protect our intellectual property rights and our ability to avoid intellectual property litigation, which
can be costly and divert management time and attention; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the factors listed under "Risk Factors" in this Annual Report on Form&nbsp;10-K. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which
speak only as of the date of this report or the date of the document incorporated by reference into this report. We have
no obligation, and expressly disclaim any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise. We have
expressed our expectations, beliefs and projections in good faith and we believe they have a reasonable basis. However, we cannot assure you that our expectations, beliefs or projections will result
or be achieved or accomplished. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>iii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=4,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=552098,FOLIO='iii',FILE='DISK104:[13ZDF1.13ZDF47701]DA47701A.;5',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dc47701_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc47701_part_i"> </A>
<A NAME="toc_dc47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PART I    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="dc47701_item_1._business"> </A>
<A NAME="toc_dc47701_2"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Overview  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Celldex Therapeutics,&nbsp;Inc., which we refer to as "Celldex," "we," "us," "our" or the "Company," is a biopharmaceutical company
focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. Our drug candidates are derived from a broad
set of complementary technologies which have the ability to utilize the human immune system and enable the creation of therapeutic agents. We are using these technologies to develop targeted
immunotherapeutics comprised of antibodies, adjuvants and monotherapies and antibody-drug conjugates that treat cancers and other diseases that induce undesirable activity by the body's own proteins
or cells. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
lead drug candidates include rindopepimut (also referred to as CDX-110) and glembatumumab vedotin (also referred to as CDX-011). Rindopepimut is a targeted immunotherapeutic in a
pivotal Phase&nbsp;3 study for the treatment of front-line glioblastoma and a Phase&nbsp;2 study for the treatment of recurrent glioblastoma. Glembatumumab vedotin is a targeted antibody-drug
conjugate in a randomized study for the treatment of triple negative breast cancer designed to obtain accelerated approval. We also have a number of earlier stage drug candidates in clinical
development, including varlilumab (also referred to as CDX-1127), a fully human therapeutic monoclonal antibody for cancer indications, CDX-301, an immune cell mobilizing agent and dendritic cell
growth factor and CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells, or APC, for cancer indications. Our drug candidates address market opportunities for which we believe
current therapies are inadequate or non-existent. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are building a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for patients with unmet medical needs. Our program assets provide us with
the strategic options to either retain full economic rights to our innovative therapies or seek favorable economic terms through advantageous commercial partnerships. This approach allows us to
maximize the overall value of our technology and product portfolio while best ensuring the expeditious development of each individual product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table includes the programs that we currently believe are significant to our business: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:67%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"120%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="120%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="247pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:62pt;"><FONT SIZE=1><B>Product (generic)

<!-- COMMAND=ADD_SCROPPEDRULE,62pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Indication/Field </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Partner </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Status </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>CLINICAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rindopepimut</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Front-line glioblastoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;3</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Glembatumumab vedotin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Metastatic breast cancer and melanoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;2b</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rindopepimut</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Recurrent glioblastoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;2</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Varlilumab</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Lymphoma/leukemia and solid tumors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-301</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Cancer, autoimmune disease and transplant</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-1401</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Multiple solid tumors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>PRECLINICAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Ovarian and renal cancer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Preclinical</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
future success depends upon many factors, including our ability, and that of any licensees and collaborators that we may have, to successfully develop, obtain regulatory approval for
and commercialize our drug candidates. We have had no commercial revenues from sales of our drug candidates and we have had a history of operating losses. It is possible that we may not be able to
successfully develop, obtain regulatory approval for or commercialize our drug candidates, and we are subject to a number of risks that you should be aware of before investing in us. These risks are
described more fully in "Item&nbsp;1A. Risk Factors." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=5,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=904979,FOLIO='1',FILE='DISK104:[13ZDF1.13ZDF47701]DC47701A.;18',USER='HYUNG',CD='26-FEB-2014;11:33' -->
<A NAME="page_dc47701_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are incorporated in Delaware. Our website is located at </FONT><FONT SIZE=2><I>http://www.celldex.com.</I></FONT><FONT SIZE=2> On our website, investors can obtain, free of charge, a
copy of our Annual Report on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q, Current Reports on Form&nbsp;8-K, and other reports filed or furnished pursuant to Section&nbsp;13(a) or 15(d)
of the Exchange Act of 1934, as amended, as soon as reasonably practicable after we file such material electronically with, or furnish it to, the Securities and Exchange Commission, or SEC. None of
the information posted on our website is incorporated by reference into this Annual Report. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Clinical Development Programs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Rindopepimut  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rindopepimut is an immunotherapeutic that targets the tumor-specific molecule epidermal growth factor receptor variant III, or
EGFRvIII. EGFRvIII is a mutated form of the epidermal growth factor receptor, or EGFR, that is only expressed in cancer cells and not in normal tissue and can directly contribute to cancer cell
growth. EGFRvIII is expressed in approximately 30% of glioblastoma multiforme, or GBM, tumors, the most common and aggressive form of brain cancer. Rindopepimut is composed of the EGFRvIII peptide
linked to a carrier protein called Keyhole Limpet Hemocyanin, or KLH, and administered together with the adjuvant GM-CSF. The Food and Drug Administration, or FDA, and the European Medicines Agency,
or EMA, have both granted orphan drug designation for rindopepimut for the treatment of EGFRvIII expressing GBM. The FDA has also granted Fast Track designation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;2a study of rindopepimut referred to as ACTIVATE was led by collaborating investigators at the Brain Center at Duke Comprehensive Cancer Center in Durham, North Carolina
and at M.D. Anderson Cancer Center in Houston, Texas and enrolled 18 evaluable GBM patients. An extension of the Phase&nbsp;2a study referred to as ACT II evaluated 22 additional GBM patients
treated in combination with the current standard of care, maintenance temozolomide, or TMZ, at the same two institutions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;2b study of rindopepimut referred to as ACT III combined rindopepimut with standard of care, TMZ, in patients with newly diagnosed GBM. The ACT III study provided for a
multi-center, non-randomized dataset for rindopepimut in 65 patients at over 30 sites throughout the United States. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2013, we announced the four- and five-year survival data from the 105 patients enrolled in the three Phase&nbsp;2 rindopepimut clinical studies (ACTIVATE, ACT II and ACT
III)&nbsp;in EGFRvIII-positive GBM. Across these three Phase&nbsp;2 studies of rindopepimut, survival data remains consistent and suggests a continuing survival benefit in comparison to
independent control datasets (see chart below) at the median and at all other time points evaluated. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc47701_phase_2_frontline_long__dc402294"> </A>
<A NAME="toc_dc47701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Phase&nbsp;2 Frontline Long-term Overall Survival Assessments    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Median, Years<BR>
(95% CI) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>3-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>4-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>5-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Phase&nbsp;2 rindopepimut studies (n=105)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.1 (1.8, 2.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Matched historical control (n=17)(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3 (0.9, 1.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><I>(1)</I></FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I>Patients treated at M.D. Anderson contemporaneously to ACTIVATE, matched for major eligibility requirements, including
EGFRvIII-positive GBM, gross total resection and no disease progression through chemoradiation treatment.</I></FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
pooled overall long-term survival results continue to be consistent with the ACT III Phase&nbsp;2 study (18% for 4-years and 14% for 5-years). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=6,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=752043,FOLIO='2',FILE='DISK104:[13ZDF1.13ZDF47701]DC47701A.;18',USER='HYUNG',CD='26-FEB-2014;11:33' -->
<A NAME="page_dc47701_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2011, we initiated ACT IV, a pivotal, randomized, double-blind, controlled Phase&nbsp;3 study of rindopepimut in patients with surgically resected, EGFRvIII-positive GBM.
Patients are randomized after the completion of surgery and standard chemoradiation treatment. The treatment regimen includes a rindopepimut priming phase post-radiation followed by an adjuvant TMZ
phase and a rindopepimut maintenance therapy phase. Patients are treated until disease progression or intolerance to therapy. The primary objective of the study is to determine whether rindopepimut
plus adjuvant GM-CSF improves the overall survival of patients with newly diagnosed EGFRvIII-positive GBM after Gross Total Resection, or GTR, when compared to treatment with TMZ and a control
injection of KLH. KLH is a component of rindopepimut and was selected due to its ability to generate a similar injection site reaction to that observed with rindopepimut. ACT IV is enrolling patients
at over 200 centers worldwide to recruit approximately 374 patients with GTR to be included in the primary analysis. Based on current projections, we anticipate completion of enrollment in mid-2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2011, we also initiated ReACT, a Phase&nbsp;2 study of rindopepimut in combination with Avastin&reg; in patients with recurrent EGFRvIII-positive GBM. ReACT was
initially planned to enroll approximately 95 patients in a first or second relapse of GBM following receipt of standard therapy at approximately 25 sites across the United States. In August 2013, we
announced the addition of an expansion cohort of approximately 75 patients to better characterize the potential activity of rindopepimut in this refractory patient population. This decision was based
on early evidence of anti-tumor activity, including stable disease, tumor shrinkage and investigator-reported response. As amended, the ReACT study will now enroll approximately 170 patients across
three groups. Approximately 70 patients who have yet to receive Avastin will be randomized to receive either rindopepimut and Avastin or a control injection of KLH and Avastin in a blinded fashion.
Another 100 patients, including the expansion cohort of 75 patients, who are refractory to Avastin having received Avastin in either the frontline or recurrent setting with subsequent progression will
receive rindopepimut plus Avastin in a single treatment arm. Study endpoints include 6&nbsp;month progression free survival rate, objective response rate, or ORR, overall survival and safety and
tolerability. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2013, we reported interim data from our ongoing Phase&nbsp;2 ReACT study. Rindopepimut plus Avastin was very well tolerated (dosing up to 13+ months) and the results
demonstrated promising signs of clinical activity in advanced patient populations, including evidence of anti-tumor activity (tumor shrinkage, objective response and stable disease). Strong immune
response correlated with improved outcome. In Avastin-na&iuml;ve patients treated with both rindopepimut and Avastin, a strong survival trend has also been seen to date versus the control
group (see chart below). </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2><B> Interim ReACT Overall Survival and Progression-free Survival in Avastin-Na&iuml;ve Recurrent GBM  </B></FONT></P>

</UL>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="114pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Rindopepimut&nbsp;&amp;<BR>
Avastin (n=20) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Control&nbsp;&amp; Avastin<BR>
(n=20) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Overall survival</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12.0&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7.9&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Hazard ratio&nbsp;= .43<BR>
(0.13, 1.44); p=0.16</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Progression-free survival</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p align=center style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>3.7&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p align=center style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2.0&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>
Hazard ratio&nbsp;= .74<BR>
(0.34, 1.61); p=0.47</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
Avastin-refractory patients treated with both rindopepimut and Avastin, a median progression-free survival, or PFS, of 1.9&nbsp;months and an overall survival, or OS, of
5.6&nbsp;months was observed. The median overall survival of 5.6&nbsp;months is noteworthy in these heavily pre-treated, refractory EGFRvIII-positive patients. A review of the literature assessing
survival in recurrent patients who are Avastin-experienced across eight independent studies suggests a weighted-average survival of 3.6&nbsp;months (range of 2.6 to 5.8&nbsp;months) in all-comers.
It is important to note that these eight studies do not necessarily meet the strict definition of refractory applied in the ReACT study and that these studies included EGFRvIII-negative patients who
tend to perform better. Progression-free survival </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=7,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=261601,FOLIO='3',FILE='DISK104:[13ZDF1.13ZDF47701]DC47701A.;18',USER='HYUNG',CD='26-FEB-2014;11:33' -->
<A NAME="page_dc47701_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2>results
in this refractory population may be more consistent with the profile of an immunotherapy candidate where progression-free survival does not always correlate directly with an overall survival
benefit. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enrollment
in ReACT is expected to be completed in late 2014 with data anticipated by year-end 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Glembatumumab Vedotin  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Glembatumumab vedotin is an antibody-drug conjugate, or ADC, that consists of a fully-human monoclonal antibody, CR011, linked to a
potent cell-killing drug, monomethyl-auristatin E, or MMAE. The CR011 antibody specifically targets glycoprotein NMB, referred to as gpNMB, that is over-expressed in a variety of cancers including
breast cancer and melanoma. The ADC technology, comprised of MMAE and a stable linker system for attaching it to CR011, was licensed from Seattle Genetics,&nbsp;Inc. and is the same as that used in
the marketed product Adcetris&reg;. The ADC is designed to be stable in the bloodstream. Following intravenous administration, glembatumumab vedotin targets and binds to gpNMB and upon
internalization into the targeted cell, glembatumumab vedotin is designed to release MMAE from CR011 to produce a cell-killing effect. The FDA has granted Fast Track designation to glembatumumab
vedotin for the treatment of advanced, refractory/resistant gpNMB-expressing breast cancer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment of Breast Cancer:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Phase 1/2 study of glembatumumab vedotin administered intravenously once every three weeks evaluated
patients with
locally advanced or metastatic breast cancer who had received prior therapy (median of seven prior regimens). The study began with a bridging phase to confirm the maximum tolerated dose, or MTD, and
then expanded into a Phase&nbsp;2 open-label, multi-center study. The study confirmed the safety of glembatumumab vedotin at the pre-defined maximum dose level (1.88 mg/kg) in 6 patients. An
additional 28 patients were enrolled in an expanded Phase&nbsp;2 cohort (for a total of 34 treated patients at 1.88 mg/kg, the Phase&nbsp;2 dose) to evaluate the PFS rate at 12&nbsp;weeks. The
1.88 mg/kg dose was well tolerated in this patient population with the most common adverse events of rash, alopecia, and fatigue. The primary activity endpoint, which called for at least 5 of 25 (20%)
patients in the Phase&nbsp;2 study portion to be progression-free at 12&nbsp;weeks, was met as 9 of 26 (35%) evaluable patients were progression-free at 12&nbsp;weeks. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
all patients treated at the maximum dose level, tumor shrinkage was seen in 62% (16/26) and median PFS was 9.1&nbsp;weeks. A subset of 10 patients had "triple negative disease," a
more aggressive breast cancer subtype that carries a high risk of relapse and reduced survival as well as limited therapeutic options due to lack of over-expression of HER2/neu, estrogen and
progesterone receptors. In these patients, 78% (7/9) had some tumor shrinkage, 12-week PFS rate was 70% (7/10), and median PFS was 17.9&nbsp;weeks. Tumor samples from a subset of patients across all
dose groups were analyzed for gpNMB expression. The tumor samples from most patients showed evidence of stromal and/or tumor cell expression of gpNMB. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2012, we announced final results from the EMERGE study, a randomized, multi-center Phase&nbsp;2b study of glembatumumab vedotin in 122 patients with heavily pre-treated,
advanced, gpNMB
positive breast cancer. Patients were randomized (2:1) to receive either glembatumumab vedotin or single-agent Investigator's Choice, or IC, chemotherapy. Patients randomized to receive IC were
allowed to cross over to receive glembatumumab vedotin following disease progression. Activity endpoints included response rate, PFS and OS. The final results, as shown below, suggested that
glembatumumab vedotin induces significant response rates compared to currently available therapies in patient subsets with advanced, refractory breast cancers with gpNMB over-expression (expression in
greater than 25% of tumor cells) and in patients with triple negative breast cancer. The OS and PFS of patients treated with glembatumumab vedotin was also observed to be greatest in patients with
triple negative breast cancer who also over-express gpNMB and all patients with gpNMB over-expression. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=8,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=259447,FOLIO='4',FILE='DISK104:[13ZDF1.13ZDF47701]DC47701A.;18',USER='HYUNG',CD='26-FEB-2014;11:33' -->
<A NAME="page_dc47701_1_5"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc47701_emerge__overall_respon__dc402196"> </A>
<A NAME="toc_dc47701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  EMERGE: Overall Response Rate and Disease Control Data    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>gpNMB Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Triple Negative<BR>
and gpNMB<BR>
Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=25) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=8) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=12) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=4) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Response</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Disease Control Rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <P style="font-family:times;"><FONT SIZE=2><I>Responses per RECIST 1.1; IC&nbsp;= Investigator's Choice; glembatumumab vedotin arm includes 15 patients who crossed over to receive glembatumumab vedotin treatment after
progression on IC. Analysis of best response excludes patients who discontinued from study without evaluable post-baseline radiographic imaging (n=15 for glembatumumab vedotin arm; n=5 for IC
arm).</I></FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc47701_emerge__progression_free_survi__eme02633"> </A>
<A NAME="toc_dc47701_5"> </A>
<BR></FONT><FONT SIZE=2><B>  EMERGE: Progression Free Survival (PFS) and Overall Survival (OS) Data    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>gpNMB<BR>
Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Triple Negative<BR>
and gpNMB<BR>
Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Median PFS (months)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>p=0.14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><FONT SIZE=2>p=0.008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Median OS (months)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
10.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
5.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
10.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
5.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>p=0.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><FONT SIZE=2>p=0.003<BR></FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <P style="font-family:times;"><FONT SIZE=2><I>When cross over patients are removed, median OS in patients with gpNMB over-expression is 10.0&nbsp;months for glembatumumab vedotin vs 5.2&nbsp;months for IC (p=0.05) and
median OS in triple negative patients with gpNMB over-expression is 10.0&nbsp;months for glembatumumab vedotin vs 5.2&nbsp;months for IC
(p=0.009).</I></FONT></P>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2013, we initiated METRIC, a randomized, controlled study of glembatumumab vedotin in patients with triple negative breast cancer that over-express gpNMB designed to obtain
accelerated approval. METRIC will be conducted in approximately 100 sites, primarily across the United States with additional sites in Canada and Australia and will enroll approximately 300 patients. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment of Metastatic Melanoma:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Phase 1/2 open-label, multi-center, dose escalation study evaluated the safety, tolerability and
pharmacokinetics of glembatumumab vedotin in 117 patients with un-resectable Stage&nbsp;III or Stage&nbsp;IV melanoma who had failed no more than one prior line of cytotoxic therapy. The MTD was
determined to be 1.88 mg/kg administered intravenously once every three weeks. The study achieved its primary activity objective with an ORR in the Phase&nbsp;2 cohort of 15% (5/34). Median PFS was
3.9&nbsp;months. Glembatumumab vedotin was generally well tolerated, with the most frequent treatment-related adverse events being rash, fatigue, hair loss, pruritus, diarrhea and neuropathy. In the
subset of patients with tumor biopsies, high levels of tumor expression of gpNMB appeared to correlate with favorable outcome. In the seven patients whose tumors were found to express high amounts of
gpNMB, and who were treated at the maximum tolerated doses across all dosing schedules, median PFS was 4.9&nbsp;months. The development of rash, which may be associated with the presence of gpNMB in
the skin also seemed to correlate with greater PFS. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is currently exploring conducting additional clinical studies in indications known to express gpNMB. Phase&nbsp;2 studies in melanoma and squamous cell lung cancer are
expected to initiate in the second half of 2014. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=9,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=673959,FOLIO='5',FILE='DISK104:[13ZDF1.13ZDF47701]DC47701A.;18',USER='HYUNG',CD='26-FEB-2014;11:33' -->
<A NAME="page_dc47701_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2><I> Varlilumab  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Varlilumab is a human monoclonal antibody that targets CD27, a potentially important target for immunotherapy of various cancers. We
have entered into license agreements with the University of Southampton, UK for intellectual property related to uses of anti-CD27 antibodies and with Medarex (now a subsidiary of the Bristol-Myers
Squibb Company) for access to the UltiMab technology to develop and commercialize human antibodies to CD27. In July 2013, the United States Patent and Trademark Office issued a patent to the
University of Southampton, that we have exclusive license to under our license agreement, which broadly supports varlilumab. The patent includes 18 claims covering various methods of treating cancer
using agonistic anti-human CD27 antibodies and relates, among other things, directly to our CD27 antibody program and therapeutic uses of varlilumab. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CD27
acts downstream from CD40 and may provide a novel way to regulate the immune responses. CD27 is a co-stimulatory molecule on T cells and is over-expressed in certain lymphomas and
leukemias. varlilumab is an agonist antibody designed to have two potential therapeutic mechanisms. Varlilumab has been shown to activate immune cells that can target and eliminate cancerous cells in
tumor-bearing mice and to directly kill or inhibit the growth of CD27 expressing lymphomas and leukemias </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> and </FONT><FONT SIZE=2><I>in
vivo</I></FONT><FONT SIZE=2>. Both mechanisms have been seen even at low doses in appropriate preclinical models. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2013, we announced data from our ongoing open label, dose-escalating Phase&nbsp;1 study of varlilumab in patients with selected malignant solid tumors or hematologic
cancers at multiple clinical sites in the United States. The Phase&nbsp;1 study is designed to test five escalating doses of varlilumab to determine a Phase&nbsp;2 dose for further development
based on safety, tolerability, potential activity and immunogenicity. The results suggest a favorable safety profile with no evidence of immune related toxicities. Clear biologic activity and
promising signs of clinical activity were demonstrated in an advanced, refractory patient population including a complete response in Hodgkin disease, two additional patients with significant tumor
shrinkage and eight patients with stable disease or better (PFS range of 3.0 to 14+ months). No maximum tolerated dose was reached to date and immune monitoring data in patients confirmed varlilumab's
mechanism of action. Expansion cohorts have been enrolling in metastatic melanoma and renal cell carcinoma and are planned in hematologic indications with initial data anticipated in mid-2014. We
intend to initiate new studies of varlilumab in combination with various agents in 2014. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> CDX-301  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-301 is a FMS-like tyrosine kinase 3 ligand, or Flt3L, stem cell mobilizer and dendritic cell growth factor. We licensed CDX-301
from Amgen&nbsp;Inc. in March 2009. CDX-301 is a potent hematopoietic cytokine that stimulates the expansion and differentiation of hematopoietic progenitor and stem cells. CDX-301 has demonstrated
a unique capacity to increase the number of circulating dendritic cells in both laboratory and clinical studies. In addition, CDX-301 has shown impressive results in models of cancer, infectious
diseases and inflammatory/autoimmune diseases. We believe CDX-301 may hold significant opportunity for synergistic development in combination with other proprietary molecules in our portfolio. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=10,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=595569,FOLIO='6',FILE='DISK104:[13ZDF1.13ZDF47701]DC47701A.;18',USER='HYUNG',CD='26-FEB-2014;11:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de47701_1_7"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2013, we announced final results from our dose-escalating Phase&nbsp;1 study of CDX-301 in 30 healthy subjects in collaboration with Rockefeller University. The
Phase&nbsp;1 study evaluated seven different dosing regimens of CDX-301 to determine the appropriate dose for further development based on safety, tolerability, and biological activity. The data
from the study were consistent with previous clinical experience and demonstrated that CDX-301 was well-tolerated and can effectively mobilize hematopoietic stem cell populations in healthy
volunteers. In December 2013, we announced data from a preclinical combination study of CDX-301and Mozobil&reg; (Plerixafor injection, formerly AMD3100) demonstrating that the combination of
these agents significantly increases hematopoietic stem cell mobilization in mice. The data demonstrate a novel potent cell mobilization regimen combining CDX-301 and Mozobil&reg;, which may
have significant potential for use in autologous and allogeneic hematopoietic stem cell transplantation. Based on the safety profile and the clinical and preclinical data to date, we plan to initiate
a pilot clinical study of CDX-301 as a single-agent and in combination with Mozobil in the transplant setting in the first half of 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> CDX-1401  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-1401, developed from our APC Targeting Technology, is a fusion protein consisting of a fully human monoclonal antibody with
specificity for the dendritic cell receptor, DEC-205, linked to the NY-ESO-1 tumor antigen. In humans, NY-ESO-1 has been detected in 20&nbsp;-&nbsp;30% of all melanoma, lung, esophageal, liver,
gastric, prostate, ovarian and bladder cancers, thus representing a broad opportunity. This product is intended to selectively deliver the NY-ESO-1 antigen to dendritic cells for generating robust
immune responses against cancer cells expressing NY-ESO-1. We are developing CDX-1401 for the treatment of malignant melanoma and a variety of solid tumors which express the proprietary cancer antigen
NY-ESO-1, which we licensed from the Ludwig Institute for Cancer Research in 2006. Preclinical studies have shown that CDX-1401 is effective for activation of human T cell responses against NY-ESO-1. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;1 study evaluated three different doses of CDX-1401 in combination with toll-like receptor agonists poly-ICLC or Hiltonol&#153; and/or R848 or resiquimod. In
total, the study enrolled 45&nbsp;patients with advanced malignancies that had progressed after any available curative and/or salvage therapies. 60% of patients had confirmed NY-ESO expression in
archived tumor sample. Thirteen patients maintained stable disease for up to 13.4&nbsp;months with a median of 6.7&nbsp;months. Treatment was well-tolerated and there were no dose limiting
toxicities. Humoral responses were elicited in both NY-ESO-1 positive and negative patients. NY-ESO-1-specific T cell responses were absent or low at baseline, but increased post-vaccination in 53% of
evaluable patients, including both CD4 and/or CD8&nbsp;T cell responses. Robust immune responses were observed with CDX-1401 with resiquimod and Poly&nbsp;ICLC alone and in combination. The study
has identified a well-tolerated and immunogenic regimen to take forward into the future studies. We are planning a collaborative Phase&nbsp;2 study of CDX-1401 in combination with CDX-301 in
malignant melanoma. This study will be conducted by the Cancer Immunotherapy Trials Network under a cooperative research and development agreement, or CRADA, with the Cancer Therapy Evaluation Program
of the National Cancer Institute. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> CDX-1135  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-1135 is a molecule that inhibits a part of the human immune system called the complement system. The complement system is a series
of proteins that are important initiators of the body's acute inflammatory response against disease, infection and injury. Excessive complement activation also plays a role in some persistent
inflammatory conditions. CDX-1135 is a soluble form of naturally occurring Complement Receptor 1 that has been shown to inhibit the activation of the complement cascade in animal models and in human
clinical trials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dense
Deposit Disease, or DDD, is a rare and devastating disease that is caused by uncontrolled activation of the alternative pathway of complement and leads to progressive kidney damage
in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=11,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=76101,FOLIO='7',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<A NAME="page_de47701_1_8"> </A>

<P style="font-family:times;"><FONT SIZE=2>children.
There is currently no treatment for patients with DDD and about half progress to end-stage renal disease within ten years. Because DDD recurs in virtually all patients who receive a kidney
transplant, transplantation is often not a viable option for these patients. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
July 2013, we initiated a pilot study of CDX-1135 in patients with DDD. Enrollment in the pilot study has been extremely difficult due to the overall rareness of patients with DDD
(300-500 in the U.S.) further compounded by the need to enroll patients at a very specific point in their disease course. The study sought to enroll patients, particularly children, with enough kidney
deterioration to be able to demonstrate clinical benefit/improvement but not so much disease burden that the kidneys were
beyond salvaging. While we have been tracking a number of patients for potential enrollment, some patients progressed too quickly and others never progressed at all. To date, only one patient has been
enrolled. While this patient demonstrated initial evidence of clinical improvement, the effect was not sustained. The results from this one patient combined with our experience using this agent in the
compassionate use setting have not provided the conclusive results necessary for a feasible approval path in this disease. Due to these challenges, we have decided to close the study in DDD and focus
resources on our growing immuno-oncology pipeline at this time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Preclinical Programs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> CDX-014  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-014 is a fully-human monoclonal ADC that targets TIM-1, a molecule that is highly expressed on renal and ovarian cancers with
minimal expression in normal tissues. The antibody is linked to MMAE using Seattle Genetics' proprietary technology. The ADC is designed to be stable in the bloodstream, but to release MMAE upon
internalization into TIM-1-expressing tumor cells, resulting in a targeted cell-killing effect. CDX-014 has shown potent activity in preclinical models of ovarian and renal cancer. We have conducted
preclinical proof-of-concept studies to optimize the drug candidate and plan to manufacture CDX-014 at our Fall River facility in 2014 prior to initiating IND-enabling toxicology studies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Development Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Immunotherapy Platform:  </I></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe there is untapped potential in immunotherapy that can be captured through the right combination and/or sequence of
therapeutic agents. Immunotherapy approaches have encountered difficulties when following standard drug development. The mechanisms
of action are complex, activity is generally not dependent on highest tolerated dose and patient response is highly variable. Our understanding of the immune system, cancer's effect on immune mediated
mechanisms, and the impact of conventional therapies on the immune system provides a new rationale for combining therapies that may lead to significant clinical responses. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
intent is to leverage this knowledge and the availability of good, tested products that may not be sufficiently effective to be commercialized as a monotherapy, but which we believe
may be very effective in combination approaches. Our goal is to design and develop targeted products that maximize the efficacy of immunotherapy regimens through combinations of therapeutic agents in
significant and growing markets. We establish governmental and corporate alliances to fund development when appropriate and intend to commercialize our products either through our own direct selling
efforts or, for products which we cannot develop ourselves through to commercialization, through corporate partners. This approach allows us to maximize the overall value of our technology and product
portfolios while best ensuring the expeditious development of each individual product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Factors
that may significantly harm our commercial success, and ultimately the market price of our common stock, include but are not limited to, announcements of technological
innovations or new commercial products by our competitors, disclosure of unsuccessful results of clinical testing or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=12,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=128323,FOLIO='8',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<A NAME="page_de47701_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2>regulatory
proceedings and governmental approvals, adverse developments in patent or other proprietary rights, public concern about the safety of products developed by us and general economic and
market conditions. See "Item&nbsp;1A. Risk Factors." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Partnerships  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may enter into co-development and commercialization partnerships for any of our programs where appropriate, including rindopepimut
for commercialization outside of North America, glembatumumab vedotin and varlilumab. In the past, we have entered into collaborative partnership agreements with pharmaceutical and other companies and
organizations that provided financial and other resources, including capabilities in research, development, manufacturing, and sales and marketing, to support our research and development programs and
may enter into more of them in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Partnership
agreements may terminate without benefit to us if the underlying products are not fully developed. If we fail to meet our obligations under these agreements, they could
terminate and we might need to enter into relationships with other collaborators and to spend additional time, money, and other valuable resources in the process. We cannot predict whether our
collaborators will continue their development efforts or, if they do, whether their efforts will achieve success. Many of our collaborators face the same kinds of risks and uncertainties in their
business that we face. A delay or setback to a partner will, at a minimum, delay the commercialization of any affected products, and may ultimately prevent it. Moreover, any partner could breach its
agreement with us or otherwise not use best efforts to promote our products. A partner may choose to pursue alternative technologies or products that compete with our technologies or products. In
either case, if a partner failed to successfully develop one of our products, we would need to find another partner. Our ability to do so would depend upon our legal right to do so at the time and
whether the product remained commercially viable. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> TopoTarget A/S (TopoTarget)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our agreement with TopoTarget, we could receive up to $6.0&nbsp;million in either potential commercial milestone payments
related to future net sales of Belinostat or 10% of any sublicense income received by TopoTarget. We have no financial and operational responsibility for the clinical development of Belinostat under
our agreement with TopoTarget. In February 2010, TopoTarget entered into a co-development and commercialization agreement for Belinostat with Spectrum Pharmaceuticals,&nbsp;Inc. In February 2010 and
February 2014, we received $3.0&nbsp;million and $1.0&nbsp;million from TopoTarget, respectively. There are $2.0&nbsp;million in potential payments remaining under our agreement with TopoTarget. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Research Collaboration and License Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into license agreements whereby we have received licenses or options to license technology, specified patents and/or
patent applications. These license and collaboration agreements generally provide for royalty payments equal to specified percentages of product sales, annual license maintenance fees, continuing
patent prosecution costs and potential future milestone payments to third parties upon the achievement of certain development, regulatory and/or commercial milestones. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Medarex,&nbsp;Inc., a subsidiary of Bristol-Myers Squibb (Medarex)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We and Medarex have entered into an assignment and license agreement, as amended, that provides for the assignment of certain patent
and other intellectual property rights and a license to certain Medarex technology related to the Company's APC Targeting Technology&#153; and an anti-mannose receptor product. Under the terms
of the agreement, we may be required to pay royalties in the low-single digits on any net product sale of a Licensed Royalty-Bearing Product or Anti-Mannose </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=13,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=545907,FOLIO='9',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<A NAME="page_de47701_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2>Product
to Medarex until the later of (i)&nbsp;the expiration of the last to expire applicable patent and (ii)&nbsp;the tenth anniversary of the first commercial sale of such licensed product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
and Medarex have also entered into a research and commercialization agreement, as amended, that provides us with certain rights to obtain exclusive commercial licenses to proprietary
monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform for generating antibodies until December 2015. Under the terms of the agreement, we may be
required to pay milestones of up to $7.0&nbsp;million upon obtaining first approval for commercial sale in a first indication of a product containing a licensed antibody and royalty payments in the
low-to-mid single digits on any net product sales to Medarex with respect to the development of any products containing such licensed antibodies until the later of (i)&nbsp;the expiration of the
last to expire applicable patent and (ii)&nbsp;the tenth anniversary of the first commercial sale of such licensed product. In September 2010, we exercised an option under our agreement, whereby we
licensed from Medarex access to the UltiMab technology to develop and commercialize human antibodies to CD27, including varlilumab. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Rockefeller University (Rockefeller)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2005, we and Rockefeller entered into a license agreement for the exclusive worldwide rights to human DEC-205 receptor,
with the right to sublicense the technology. The license grant is exclusive except that Rockefeller may use and permit other nonprofit organizations to use the human DEC-205 receptor patent rights for
educational and research purposes. We may be required to pay milestones of up to $3.9&nbsp;million upon obtaining first approval for commercial sale in a first indication of a product targeting the
licensed receptor and royalty payments in the low-to-mid single digits on any net product sales to Rockefeller with respect to development and commercialization of the human DEC-205 receptor. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Duke University Brain Tumor Cancer Center (Duke)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In September 2006, we and Duke entered into a license agreement that gave us access and reference to the clinical data generated by
Duke and its collaborators in order for us to generate our own filing with the FDA relating to rindopepimut. We may be required to pay milestones of up to $0.7&nbsp;million upon obtaining first
approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Duke with respect to development and commercialization of rindopepimut. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Ludwig Institute for Cancer Research (Ludwig)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2006, we and Ludwig entered into an agreement for the nonexclusive rights to certain cancer tumor targets for use in
combination with our APC Targeting Technology. We may be required to pay milestones of up to $1.0&nbsp;million upon obtaining first approval for commercial sale in a first indication and royalty
payments in the low-single digits on any net product sales to Ludwig with respect to development and commercialization of the technology licensed from Ludwig. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Alteris Therapeutics,&nbsp;Inc. (Alteris)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2005, we completed the acquisition of the assets of Alteris, including the EGFRvIII molecule. We may be required to pay
Alteris up to $5.0&nbsp;million upon obtaining the first approval for commercial sale of a product containing EGFRvIII, including rindopepimut. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> University of Southampton, UK (Southampton)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2008, we entered into a license agreement with Southampton to develop human antibodies towards CD27, a potentially
important target for immunotherapy of various cancers. We may be required to pay milestones of up to approximately $1.4&nbsp;million upon obtaining first approval for </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=14,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=682931,FOLIO='10',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<A NAME="page_de47701_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2>commercial
sale in a first indication and royalty payments in the low-single digits on any net product sales to Southampton with respect to development and commercialization of varlilumab. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Amgen&nbsp;Inc. (Amgen)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March 2009, we entered into a license agreement with Amgen to acquire the exclusive rights to CDX-301 and CD40 ligand, or CD40L.
CDX-301 and CD40L are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. We may be required to pay milestones of up to
$1.0&nbsp;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Amgen with respect to development
and commercialization of the technology licensed from Amgen, including CDX-301. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Amgen Fremont (formerly Abgenix)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with our acquisition of CuraGen Corporation in 2009, we assumed the license agreement between CuraGen and Amgen Fremont
(successor in-interest to Abgenix) to develop fully-human monoclonal antibody therapeutics. In May 2009, an amendment to the license agreement was entered into related to CuraGen's exclusive rights to
develop and commercialize glembatumumab vedotin, CDX-014 and 10 other licensed antigens. Under the amendment, CuraGen and Amgen Fremont agreed to modify the terms of their existing cross-license of
antigens whereby our amended license is fully paid-up and royalty-free. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Seattle Genetics,&nbsp;Inc. (Seattle Genetics)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with our acquisition of CuraGen, we assumed the license agreement between CuraGen and Seattle Genetics whereby CuraGen
acquired the rights to proprietary ADC technology, with the right to sublicense, for use with its proprietary antibodies for the potential
treatment of cancer. Under the terms of the agreement, we have the responsibility of using commercially reasonable efforts to develop, commercialize and market such treatment. In furtherance of these
responsibilities, technical assistance from Seattle Genetics is available to us as necessary. In February 2014, we paid $2.5 million in milestones to Seattle Genetics as a result of the METRIC
initiation. We may be required to pay milestones of up to $5.0&nbsp;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the mid-single digits on
any net product sales to Seattle Genetics with respect to development and commercialization of the ADC technology, including glembatumumab vedotin and CDX-014. The term of the agreement varies country
to country and may be until the later of the expiration of the last relevant patent or the 10<SUP>th</SUP>&nbsp;anniversary of the first commercial sale. The agreement allows Celldex to terminate
with prior written notice, with both parties being able to terminate the agreement for an uncured material breach or insolvency of the other party. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Competition  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The biotechnology and pharmaceutical industries are intensely competitive and subject to rapid and significant technological change.
Many of the products that we are attempting to develop and commercialize will be competing with existing therapies. In addition, a number of companies are pursuing the development of pharmaceuticals
that target the same diseases and conditions that we are targeting. We face competition from pharmaceutical and biotechnology companies both in the United States and abroad. Our competitors may
utilize discovery technologies and techniques or partner with collaborators in order to develop products more rapidly or successfully than us or our collaborators are able to do. Many of our
competitors, particularly large pharmaceutical companies, have substantially greater financial, technical and human resources than we do. In addition, academic institutions, government agencies and
other public and private organizations conducting research may seek patent protection with respect to potentially competitive products or technologies and may establish exclusive collaborative or
licensing relationships with our competitors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=15,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=656038,FOLIO='11',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<A NAME="page_de47701_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
face intense competition in our development activities. We face competition from many companies in the United States and abroad, including a number of large pharmaceutical companies,
firms specialized in the development and production of vaccines, adjuvants and vaccine and immunotherapeutic delivery systems and major universities and research institutions. The competitors of which
we are aware that have initiated a Phase&nbsp;3 study or have obtained marketing approval for a potentially competitive drug to rindopepimut for treatment of glioblastoma and/or glembatumumab
vedotin for treatment of breast cancer include Arbor Pharmaceutics,&nbsp;Inc., AstraZeneca&nbsp;PLC, Bayer, Celgene Corporation, Eisai&nbsp;Inc., Eli Lilly and Company, Medigene AG, Northwest
Biotherapeutics,&nbsp;Inc., Pfizer&nbsp;Inc., and Roche. Many other companies are developing or commercializing products in areas that we have targeted for product development. Some of these
products use therapeutic approaches that may compete directly with our drug candidates. Most of our competitors possess substantially greater financial, technical and human resources than we possess.
In addition, many of our competitors have
significantly greater experience than we have in conducting preclinical and nonclinical testing and human clinical trials of drug candidates, scaling up manufacturing operations and obtaining
regulatory approvals of drugs and manufacturing facilities. Accordingly, our competitors may succeed in obtaining regulatory approval for drugs more rapidly than we do. If we obtain regulatory
approval and launch commercial sales of our drug candidates, we also will compete with respect to manufacturing efficiency and sales and marketing capabilities, areas in which we currently have
limited experience. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also face competition from pharmaceutical and biotechnology companies, academic institutions, government agencies and private research organizations in recruiting and retaining highly
qualified scientific personnel and consultants and in the development and acquisition of technologies. Moreover, technology controlled by third parties that may be advantageous to our business may be
acquired or licensed by our competitors, thereby preventing us from obtaining technology on commercially reasonable terms, if at all. We will also compete for the services of third parties that may
have already developed or acquired internal biotechnology capabilities or made commercial arrangements with other biopharmaceutical companies to target the diseases on which we have focused both in
the U.S. and outside of the U.S. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
competitive position will also depend upon our ability to attract and retain qualified personnel, obtain patent protection or otherwise develop proprietary products or processes and
secure sufficient capital resources for the often lengthy period between technological conception and commercial sales. We will require substantial capital resources to complete development of some or
all of our products, obtain the necessary regulatory approvals and successfully manufacture and market our products. In order to secure capital resources, we anticipate having to sell additional
capital stock, which would dilute existing stockholders. We may also attempt to obtain funds through research grants and agreements with commercial collaborators. However, these types of fundings are
uncertain because they are at the discretion of the organizations and companies that control the funds. As a result, we may not receive any funds from grants or collaborations. Alternatively, we may
borrow funds from commercial lenders, likely at high interest rates, which would increase the risk of any investment in us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Manufacturing  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have limited experience in commercial manufacturing. We rely on contract manufacturing organizations, or CMOs, to manufacture drug
substance and drug product for our late-stage clinical studies of rindopepimut and glembatumumab vedotin as well as for future commercial supplies. We also rely on CMOs for filling, packaging, storage
and shipping of drug product. In order for us to establish our own commercial manufacturing facility, we would require substantial additional funds and would need to hire and retain significant
additional personnel and comply with the extensive current Good Manufacturing Practices, or cGMP, regulations applicable to such a facility. The commercial manufacturing facility would also need to be
licensed for the production of our drug candidates by the FDA. For our most advanced programs, we are working with CMOs under established manufacturing </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=16,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1018818,FOLIO='12',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<A NAME="page_de47701_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2>arrangements
that comply with the FDA's requirements and other regulatory standards, although there is no assurance that the manufacturing will be successful. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
currently use rindopepimut drug product that was manufactured by Pfizer and Jubilant Hollister Stier, in the ACT IV and ReACT clinical studies. In 2013, we established a relationship
with SAFC, a division of the Sigma Aldrich Corporation, to manufacture rindopepimut for late stage development and commercial supply. We rely on Biosyn and Ambiopharm for supplying suitable quantities
of cGMP starting materials for the manufacture of rindopepimut. We also rely on Sanofi to supply suitable quantities of commercial quality GM-CSF which is co-administered with rindopepimut. Any
manufacturing failures or delays by our rindopepimut contract manufacturers or suppliers of critical materials could cause delays in the ACT IV and ReACT studies and/or the commercial launch of
rindopepimut. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
date, we have utilized contract manufacturing organizations for the manufacture of clinical trial supplies of glembatumumab vedotin. In 2013, we established a relationship with Lonza,
AG to manufacture the CR-011 antibody and Piramal Healthcare UK&nbsp;Ltd. to conjugate the CR-011 antibody and stable linker with the MMAE toxin. We rely on SAFC for sourcing of suitable quantities
of vcMMAE. Any manufacturing failures or delays by our glembatumumab vedotin contract manufacturers or suppliers of materials could cause delays in the METRIC study and/or the commercial launch of
glembatumumab vedotin. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have established our own cGMP manufacturing facility in Fall River, Massachusetts, to produce clinical materials for our current and planned Phase&nbsp;1 and Phase&nbsp;2 clinical
trials. Our Fall River manufacturing facility has up to 1000L bioreactor capacity and is able to manufacture in compliance with FDA regulations, allowing us to distribute potential products to
clinical sites in the US for early clinical trials. We manufacture clinical materials of varlilumab, CDX-1401, and CDX-301 in our Fall River facility for our current and planned Phase&nbsp;1 and
Phase&nbsp;2 clinical trials. The products are filled and packaged at CMOs. Any manufacturing failures or compliance issues at contract manufacturers could cause delays in our Phase&nbsp;1 and
Phase&nbsp;2 clinical studies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
manufacturing processes for our drug candidates and immunotherapeutic delivery systems utilize known technologies. We believe that the products we currently have under development
can be scaled up to permit manufacture in commercial quantities. However, there can be no assurance that we will not encounter difficulties in scaling up the manufacturing processes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
we believe that there is currently sufficient capacity worldwide for the production of our potential products through contract manufacturers, establishing long-term relationships
with contract manufacturers and securing multiple sources for the necessary quantities of clinical and commercial materials required can be a challenge. Qualifying the initial source of clinical and
ultimately
commercial material is a time consuming and expensive process due to the highly regulated nature of the pharmaceutical/biotech industry. These costs are hopefully mitigated in the economies of scale
realized in commercial manufacture and product sale. The key difficulty in qualifying more than one source for each product is the duplicated time and expense in doing so without the potential to
mitigate these costs if the secondary source is never utilized. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use
of third party manufacturers limits our control over and ability to monitor the manufacturing process. As a result, we may not be able to detect a variety of problems that may arise
and may face additional costs in the process of interfacing with and monitoring the progress of our contract manufacturers. If third party manufacturers fail to meet our manufacturing needs in an
acceptable manner, we would face delays and additional costs while we develop internal manufacturing capabilities or find alternative third party manufacturers. It may not be possible to have multiple
third party manufacturers ready to supply us with needed material at all or without incurring significant costs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=17,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=455004,FOLIO='13',FILE='DISK104:[13ZDF1.13ZDF47701]DE47701A.;17',USER='LPALLES',CD='26-FEB-2014;16:44' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg47701_1_14"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><B> Marketing  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have retained, and in the future intend to retain, marketing rights to some of our drug candidates and immunotherapeutic delivery
systems in selected geographic areas and for specified indications. We may seek marketing and distribution agreements and/or co-promotion agreements for the distribution of our products in these
geographic areas and for these indications. We believe that these arrangements could enable us to generate greater financial return than might be obtained from early stage licensing and collaboration
agreements for these products. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
currently have limited marketing and sales staff and limited experience relating to marketing and distribution of commercial products. We plan to continue to expand our marketing
staff in 2014 with a focus on commercial planning efforts for rindopepimut and glembatumumab vedotin. We plan to fund and complete the development and, if we obtain regulatory approval, to
commercialize rindopepimut in North America ourselves. If we obtain regulatory approval, we will be required to recruit an experienced marketing and sales staff, develop a supporting distribution
capability and incur significant additional expenditures. There can be no assurance that we will be able to establish a successful marketing and sales force. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
some of our drug candidates, we may choose to enter into strategic partnerships to develop, sell, market and distribute our products. Under the terms of future partnership
agreements, we may rely on the efforts of our collaborators for the distribution, sale and marketing of our products. There can be no assurance that our collaborators will develop and market our drug
candidates incorporating our technologies, or, if marketed, that such efforts will be successful. The failure of our collaborators to successfully market products would harm our business. Any delay in
the marketing or distribution of our products, whether it results from problems with internal capabilities or with a collaborative relationship, could harm the value of an investment in us. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> Patents, Licenses and Proprietary Rights  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In general, our intellectual property strategy is to protect our technology by filing patent applications and obtaining patent rights
covering our own technology, both in the United States and in foreign countries that we consider important to our business. In addition, we have acquired and will seek to acquire as needed or desired,
exclusive rights of others through assignment or license to complement our portfolio of patent rights. We also rely on trade secrets, unpatented know-how and technological expertise and innovation to
develop and maintain our competitive position. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Patents  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The successful development and marketing of products by us will depend in part on our ability to create and maintain intellectual
property, including patent rights. We are the owner or exclusive licensee to proprietary patent positions in the areas of vaccine technologies, antibody technologies and complement inhibitor
technology. Although we continue to pursue patent protection for our products, no assurance can be given that any pending application will issue as a patent, that any issued patent will have a scope
that will be of commercial benefit, or that we will be able to successfully enforce our patent position against infringers. We routinely review our patent portfolio and adjust our strategies for
prosecution and maintenance of individual cases according to a number of factors including program priorities, stage of development, and patent term. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
own or license rights under more than 300 granted patents and national and regional patent applications in the U.S. and in major international territories covering inventions relating
to our business. The key patents and patent applications owned by us or licensed to us that we consider important to our business include the following (the indicated and estimated patent expiry dates
do not </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=18,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=436359,FOLIO='14',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<A NAME="page_dg47701_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2>include
any possible Patent Term Extensions or Supplementary Protection Certificates, if these may be secured in due course):</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>We have licensed rights from Duke University under an issued European patent, a patent application in the U.S. and patents
and patent applications in other major international territories relating to uses of rindopepimut. If and where issued and maintained to full term in a form which covers commercial use of
rindopepimut, the filings could potentially provide patent protection for the relevant use in the relevant territories to 2026. We also have patent applications in the U.S. and major international
territories relating to methods of manufacture and formulation of rindopepimut, which, if issued in a form which covers manufacture and/or formulation of rindopepimut and maintained to full term in
due course, would have estimated patent expiry dates in 2030. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Our patent portfolio for glembatumumab vedotin includes an issued patent in Europe and pending patent applications in the
U.S. and Japan. If and where issued and maintained to full term in due course, these would have estimated patent expiry dates in 2025. In addition, patent rights relating to the toxin and conjugation
technology used in glembatumumab vedotin have been licensed from Seattle Genetics. The patent rights from Seattle Genetics include issued patents and pending applications in Australia, Canada, Europe,
the U.S. and Japan which include composition of matter claims relating to the toxin and conjugation technology. If maintained to full term in due course, the main Seattle Genetics patent rights would
have estimated patent expiry dates ranging from 2023 in Europe to 2026 in the U.S. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>We have licensed rights from the University of Southampton under issued U.S. and European patents and under pending patent
applications in Japan and Canada relating to the technology used in varlilumab. If and where issued and maintained to full term in due course, these would have estimated patent expiry dates in 2027.
We have filed further patent applications in the U.S. and major international territories which, if issued and maintained to full term in due course, would have estimated patent expiry dates in 2031. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Patents for the technology used in CDX-301 have current expiration dates that range from 2016 in the major European
territories to 2020 in the US. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>We have issued U.S. patents relating to the technology used in CDX-1401 which have estimated patent expiry dates in at
least 2028 (not including increases of term due to Patent Term Adjustment). We have a corresponding issued European patent and pending patent applications in other international territories relating
to the technology used in CDX-1401 which, if and where issued and maintained to full term in due course, would have estimated patent expiry dates in 2028. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Our patent portfolio for CDX-014 includes rights under an issued U.S. patent and further pending patent applications in
the U.S., Europe and Japan. If issued and maintained to full term in due course, these filings would have estimated patent expiry dates in at least 2024 (not including increases of term due to Patent
Term Adjustment in the U.S.). In addition, patent rights relating to toxin and conjugation technology have been licensed from Seattle Genetics. The patent rights from Seattle Genetics include issued
patents and pending patent applications in Australia, Canada, Europe, the U.S. and Japan which include composition of matter claims relating to the toxin and conjugation technology. If maintained to
full term in due course, the main Seattle Genetics patent rights would have estimated patent expiry dates ranging from 2023 in Europe to 2026 in the U.S. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
can be no assurance that patent applications owned by or licensed to us will result in granted patents or that, if granted, the resultant patents will afford protection against
competitors with similar technology. It is also possible that third parties may obtain patents or other proprietary rights that may be necessary or useful to us. In cases where third parties are first
to invent a particular </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=19,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=359740,FOLIO='15',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<A NAME="page_dg47701_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2>product
or technology, it is possible that those parties will obtain patents that will be sufficiently broad to prevent us from using important technology or from further developing or commercializing
important drug candidates and immunotherapeutic systems. If licenses from third parties are necessary but cannot be obtained, commercialization of the covered products might be delayed or prevented.
Even if these licenses can be obtained, they would probably require us to pay ongoing royalties and other costs, which could be substantial. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
a patent has a statutory presumption of validity in the United States, the issuance of a patent is not conclusive as to validity or as to the enforceable scope of the patent
claims. The validity or enforceability of a patent after its issuance by the Patent and Trademark Office can be challenged in litigation. As a business that uses a substantial amount of intellectual
property, we face a heightened risk of intellectual property litigation. If the outcome of the litigation is adverse to the owner of the patent, third parties may then be able to use the invention
covered by the patent without authorization or payment. There can be no assurance that our issued patents or any patents subsequently issued to or licensed by us will not be successfully challenged in
the future. In addition, there can be no assurance that our patents will not be infringed or that the coverage of our patents will not be successfully avoided by competitors through design innovation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are aware that others, including universities and companies, have filed patent applications and have been granted patents in the United States and other countries which claim subject
matter potentially useful or necessary to the commercialization of our products. The ultimate scope and validity of existing or future patents which have been or may be granted to third parties, and
the availability and
cost of acquiring rights in those patents necessary to the manufacture, use or sale of our products presently cannot be determined by us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Third
parties may have or may obtain valid and enforceable patents or proprietary rights that could block us from developing products using our technology,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>certain patents and applications in the United States and Europe owned by Sanofi-Aventis, which relate to antibody-antigen
conjugates and methods of their use for eliciting an immune response against the antigen; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>certain patents and applications in the United States and foreign countries covering particular antigens and antigenic
fragments targeted by our current drug candidates, including CDX-1401; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>certain patents and pending applications related to particular receptors and other molecules on dendritic cells and
macrophages that may be useful for generating monoclonal antibodies and can be employed in our APC Targeting Technology; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>two United States patents and related foreign patents and applications covering methods of diagnosing gliomas by detecting
the presence of the EGFRvIII (tumor specific splice variant) protein; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a United States patent relating to certain uses of GM-CSF; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a United States patent owned by Genentech,&nbsp;Inc., relating to the production of recombinant antibodies in host
cells; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>a United States patent owned by GlaxoSmithKline&nbsp;plc related to methods of culturing cells under certain conditions;
and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>certain patents held by third parties relating to antibody expression in particular types of host cells. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the patents referred to in the previous paragraphs, there may be other patent applications and issued patents belonging to competitors that may require us to alter our
drug candidates and immunotherapeutic delivery systems, pay licensing fees or cease some of our activities. If our drug candidates conflict with patents that have been or may be granted to
competitors, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=20,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1047234,FOLIO='16',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<A NAME="page_dg47701_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2>universities
or others, the patent owners could bring legal action against us claiming damages and seeking to enjoin manufacturing and marketing of the patented products. If any of these actions is
successful, in addition to any potential liability for damages, we could be required to obtain a license in order to continue to manufacture or market the affected products. There can be no assurance
that we would prevail in any such action or that any license required under any such third party patent would be made available on acceptable terms or at all. We believe that there may be significant
litigation in the biotechnology industry regarding patent and other intellectual property rights. If we become involved in that litigation, we could consume substantial resources. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Licenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into several significant license agreements relating to technologies that are being developed by us. In general, these
institutions have granted us an exclusive worldwide license (with right to sublicense) to make, use and sell products embodying the licensed technology, subject to the reservation by the licensor of a
non-exclusive right to use the technologies for non-commercial research purposes. Generally, the term of each license is through the expiration of the last of the patents issued with respect to the
technologies covered by the license. We have generally agreed to use reasonable efforts to develop and commercialize licensed products and to achieve specified milestones and pay license fees,
milestone payments and royalties based on the net sales of the licensed products or to pay a percentage of sublicense income. If we breach our obligations, the licensor has the right to terminate the
license, and, in some cases, convert the license to a non-exclusive license. Generally, we control and are responsible for the cost of defending the patent rights of the technologies that we license. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Proprietary Rights  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We also rely on unpatented technology, trade secrets and confidential information, and no assurance can be given that others will not
independently develop substantially equivalent information and techniques or otherwise gain access to our know-how and information, or that we can meaningfully protect our rights in such unpatented
technology, trade secrets and information. We require each of our employees, consultants and advisors to execute a confidentiality agreement at the commencement of an employment or consulting
relationship with us. The agreements generally provide that all inventions conceived by the individual in the course of employment or in providing services to us and all confidential information
developed by, or made known to, the individual during the term of the relationship shall be the exclusive property of us and shall be kept confidential and not disclosed to third parties except in
limited specified circumstances. There can be no assurance, however, that these agreements will provide meaningful protection for our information in the event of unauthorized use or disclosure of such
confidential information. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Government Regulation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our activities and products are significantly regulated by a number of governmental entities, including the FDA in the United States
and by comparable authorities in other countries. These entities regulate, among other things, the manufacture, testing, safety, effectiveness, labeling, documentation, advertising and sale of our
products. We must obtain regulatory approval for a product in all of these areas before we can commercialize the product. Product development within this regulatory framework takes a number of years
and involves the expenditure of substantial resources. Many products that initially appear promising ultimately do not reach the market because they are found to be unsafe or ineffective when tested.
Our inability to commercialize a product would impair our ability to earn future revenues. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=21,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=973843,FOLIO='17',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<A NAME="page_dg47701_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2><I> FDA Approval Process  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States, immunotherapeutics for human use are subject to FDA approval as "biologics" under the Public Health Service Act
or as "drugs" under the Federal
Food, Drug and Cosmetic Act. The steps required before a new product can be commercialized include: preclinical studies in animals, clinical trials in humans to determine safety and efficacy and FDA
approval of the product for commercial sale. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Data
obtained at any stage of testing is susceptible to varying interpretations, which could delay, limit or prevent regulatory approval. Moreover, during the regulatory process, new or
changed drug approval policies may cause unanticipated delays or rejection of our product. We may not obtain necessary regulatory approvals within a reasonable period of time, if at all, or avoid
delays or other problems in testing our products. Moreover, even if we received regulatory approval for a product, the approval may require limitations on use, which could restrict the size of the
potential market for the product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA provides that human clinical trials may begin thirty (30)&nbsp;days after receipt and review of an IND application, unless the FDA requests additional information or changes to
the study protocol within that period. An IND must be sponsored and filed for each of our proposed products. Authorization to conduct a clinical trial in no way assures that the FDA will ultimately
approve the product. Clinical trials are generally conducted in three sequential phases. In a Phase&nbsp;1 trial, the product is given to a small number of healthy volunteers to test for safety
(adverse effects). Phase&nbsp;2 trials are conducted on a limited group of the target patient population; safety, optimal dosage and efficacy are studied. A Phase&nbsp;3 trial is performed in a
large patient population, generally over a wide geographic area to provide evidence for the safety and efficacy of the product. The FDA has ongoing oversight over all these trials and can order a
temporary or permanent discontinuation if warranted. Such an action could materially harm us. Clinical trials are critical to the success of our products but are subject to unforeseen and
uncontrollable delay, including delay in enrollment of patients. Any delay in clinical trials could delay our commercialization of a product. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
product's safety and effectiveness in one clinical trial is not necessarily indicative of its safety and effectiveness in another clinical trial. Moreover, we may not discover all
potential problems with a product even after completing clinical trials on it. Some of our products and technologies have undergone only preclinical testing. As a result, we do not know whether they
are safe or effective for humans. Also, regulatory authorities may decide, contrary to our findings, that a product is unsafe or not as effective in actual use as its clinical trial results indicated.
This could prevent the product's widespread use, require its withdrawal from the market or expose us to liability. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
results of the clinical trials, nonclinical testing, and all supporting manufacturing data are submitted to the FDA for approval. A Biologics License Application (BLA) is submitted
for a biologic product; a New Drug Application (NDA) for a drug product. The interval between IND filing and BLA/NDA filing is usually at least several years due to the length of the clinical trials,
and the BLA/NDA review process can take over a year. During this time the FDA may request further testing or additional trials or may turn down the application. Even with approval, the FDA frequently
requires post-marketing safety studies (known as Phase&nbsp;4 trials) to be performed. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA requires that the manufacturing facility that produces a licensed product meet specified standards, undergo an inspection and obtain an establishment license prior to commercial
marketing. Subsequent discovery of previously unknown problems with a product or its manufacturing process may
result in restrictions on the product or the manufacturer, including withdrawal of the product from the market. Failure to comply with the applicable regulatory requirements can result in fines,
suspensions of regulatory approvals, product recalls, operating restrictions and criminal prosecution. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=22,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=473238,FOLIO='18',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<A NAME="page_dg47701_1_19"> </A>

<P style="font-family:times;"><FONT SIZE=2><I> Expedited Review and Approval  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The FDA has various programs, including breakthrough therapy, fast track, priority review, and accelerated approval, that are intended
to expedite or simplify the process for reviewing products, and/or provide for approval on the basis of surrogate endpoints. Generally, products that may be eligible for these programs are those for
serious or life-threatening conditions, those with the potential to address unmet medical needs, and those that offer meaningful benefits over existing treatments, however, these programs do not
affect the standards for approval. These expedited review programs apply to the combination of the product and the specific indication for which it is being studied. As a condition of approval, the
FDA may require that a sponsor of a product receiving accelerated approval perform post-marketing clinical trials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Orphan Drug  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Orphan Drug Act, the FDA may grant orphan drug designation to products intended to treat a rare disease or condition, which
is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable
expectation that the cost of developing and making available in the United States a product for this type of disease or condition will be recovered from sales in the United States for that product. If
a product that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which
means that the FDA may not approve any other applications to market the same product for the same indication, except in very limited circumstances, for seven years. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Post Approval  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory standards is not maintained or if problems
occur after the product reaches the market. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are
subject to further FDA review and approval. In addition, the FDA may require testing and surveillance programs to monitor the effect of approved products that have been commercialized, and the FDA has
the power to prevent or limit further marketing of a product based on the results of these post-marketing programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Foreign Regulation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to regulations in the United States, we will be subject to a variety of foreign regulations governing clinical trials,
manufacture, and commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we must obtain approval of a product by the comparable regulatory authorities
of foreign countries before we can commence clinical trials or marketing of the product in those countries. The approval process varies from country to country and the time may be longer or shorter
than that required for FDA approval. Approval by the FDA does not ensure approval by the regulatory bodies of other countries. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the European Union regulatory system, we will submit most of our marketing authorization applications under the centralized procedure. The centralized procedure is compulsory for
medicines produced by biotechnology, or are for the treatment of cancer, or officially designated as 'orphan medicines', provides for the grant of a single marketing authorization that is valid for
all European Union member states. As in the United States, we may apply for designation of our products as orphan drug for the treatment of a specific indication in the European Union before the
application for marketing authorization is made. Orphan drugs in Europe enjoy economic and marketing benefits, including a 10-year market exclusivity period for the approved indication, but not for
the same product, unless another applicant can show that its product is safer, more effective or otherwise clinically superior to the orphan-designated product. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=23,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=591856,FOLIO='19',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<A NAME="page_dg47701_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
collaborators are also subject to all of the above-described regulations in connection with the commercialization of products utilizing our technology. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Other Regulatory Processes  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to a variety of financial disclosure and securities trading regulations as a public company in the U.S., including laws
relating to the oversight activities of the SEC and the regulations of the NASDAQ Global Market, on which our shares are traded. We are also subject to regulation under other federal laws and
regulation under state and local laws, including laws relating to occupational safety, laboratory practices, environmental regulations, and hazardous substance control. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Employees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2013, we employed 129 employees (120 full-time, 2 part-time and 7 interns), 18 of whom have Ph.D. and/or M.D.
degrees. Of these employees, 106 were engaged in or directly support research and development activities. We believe that our employee relations are good. We believe that our future success will
depend in large part on our ability to attract and retain experienced and skilled employees.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="dg47701_item_1a._risk_factors"> </A>
<A NAME="toc_dg47701_1"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;1A.&nbsp;&nbsp;&nbsp;&nbsp;RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should consider carefully these risk factors together with all of the information included or incorporated by reference in this
Annual Report in addition to our financial statements and the notes to our financial statements. This section includes forward-looking statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following is a discussion of the risk factors that we believe are material to us at this time. These risks and uncertainties are not the only ones facing us and there may be
additional matters that we are unaware of or that we currently consider immaterial. All of these could adversely affect our business, results of operations, financial condition and cash flows. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Risks Related to our Business  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We currently have no product revenue and will need to raise capital to operate our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To date, we have generated no product revenue and cannot predict when and if we will generate product revenue. We had an accumulated
deficit of $345.7&nbsp;million as of December&nbsp;31, 2013. Until, and unless, we complete clinical trials and further development, and receive approval from the FDA and other regulatory
authorities, for our product candidates, we cannot sell our drugs and will not have product revenue. We expect to spend substantial funds to continue the research, development and testing of our
products that are in the preclinical and clinical testing stages of development and to prepare to commercialize products in anticipation of FDA approval. Therefore, for the foreseeable future, we will
have to fund all of our operations and development expenditures from cash on hand, equity or debt financings, licensing fees and grants. Additional financing will be required to meet our long term
liquidity needs. If we do not succeed in raising additional funds on acceptable terms, we might not be able to complete planned preclinical and clinical trials or obtain approval of any product
candidates from the FDA and other regulatory authorities. In addition, we could be forced to discontinue product development, reduce or forego sales and marketing efforts, forego attractive business
opportunities or curtail operations. Any additional sources of financing could involve the issuance of our equity securities, which would have a dilutive effect on our stockholders. No assurance can
be given that additional financing will be available to us when needed on acceptable terms, or at all. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot be certain that we will achieve or sustain profitability in the future. Failure to achieve profitability could diminish our ability to sustain operations, pay dividends on our
common stock, obtain additional required funds and make required payments on our present or future indebtedness. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=24,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=230051,FOLIO='20',FILE='DISK104:[13ZDF1.13ZDF47701]DG47701A.;12',USER='DPERRY',CD='25-FEB-2014;17:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di47701_1_21"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We expect to incur future losses and we may never become profitable.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have incurred operating losses of $81.4&nbsp;million, $58.1&nbsp;million and $43.4&nbsp;million during 2013, 2012 and 2011,
respectively, and expect to incur an operating loss in 2014. We believe that operating losses will continue in and beyond 2014 because we are planning to incur significant costs associated with the
clinical development, manufacturing of commercial supply and building a commercial organization to prepare for the potential launch of rindopepimut and glembatumumab vedotin. In addition, we are
planning to incur significant costs in the clinical development of varlilumab, CDX-301 and CDX-1401. Our net losses have had and will continue to have an adverse effect on, among other things, our
stockholders' equity, total assets and working capital. We expect that losses will fluctuate from quarter to quarter and year to year, and that such fluctuations may be substantial. We cannot predict
when we will become profitable, if at all. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Our long term success depends heavily on our ability to fund and complete the research and development activities for and to commercialize our program assets, including our
lead drug candidates, rindopepimut and glembatumumab vedotin.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are building a commercial organization to allow us the strategic option to retain the full commercial benefits of our program assets
or to seek favorable economic terms through advantageous commercial partnerships. We plan to commercialize our lead drug candidate rindopepimut ourselves in North America. We may enter into
co-development and commercialization partnerships for any of our programs where appropriate, including rindopepimut for commercialization outside of North America, glembatumumab vedotin and
varlilumab. We must allocate a significant portion of our time, personnel and financial resources to the development of rindopepimut and glembatumumab vedotin. We initiated ACT IV, our pivotal
Phase&nbsp;3 clinical trial of rindopepimut, in December 2011. We anticipate ACT IV to cost over $70&nbsp;million during its duration. We initiated METRIC, a randomized, controlled study of
glembatumumab vedotin designed to obtain accelerated
approval, in December 2013. The study is expected to include up to 100 sites and will enroll approximately 300 patients. We anticipate METRIC to cost over $30&nbsp;million during its duration. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
management team lacks significant experience in completing Phase&nbsp;3 clinical trials and bringing a drug through commercialization. If we face delays, difficulties or
unanticipated costs in completing the development of rindopepimut or glembatumumab vedotin, we will need substantial additional financing. Further, even if we complete the development of rindopepimut
or glembatumumab vedotin and gain marketing approvals from the FDA and comparable foreign regulatory authorities in a timely manner, we cannot be sure that rindopepimut or glembatumumab vedotin will
be commercially successful in the pharmaceutical market. If the results of clinical trials, the anticipated or actual timing of marketing approvals, or the market acceptance of rindopepimut or
glembatumumab vedotin, if approved, do not meet the expectations of investors or public market analysts, the market price of our common stock would likely decline. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We will need additional capital to fund our operations, including the development, manufacture and potential commercialization of our drug candidates. If we do not have or
cannot raise additional capital when needed, we may be unable to develop and ultimately commercialize our drug candidates successfully.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We expect to incur significant costs as we develop our drug candidates. In particular, the continuing development and commercialization
of rindopepimut, glembatumumab vedotin and our other drug candidates requires additional capital beyond our current resources. As of December&nbsp;31, 2013, we had cash, cash equivalents and
marketable securities of $303.0&nbsp;million. We may take further steps to raise additional capital to fund our long-term liquidity needs. Our capital raising activities may include, but may not be
limited to, one or more of the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>licensing of drug candidates with existing or new collaborative partners; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=25,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=369521,FOLIO='21',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_22"> </A>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>possible business combinations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>issuance of debt; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>issuance of common stock or other securities via private placements or public offerings. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
we may continue to seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and our negotiating
position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that we will be able to enter into further collaborative relationships. Additional equity
financing may be dilutive to our stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate as a business; and
licensing or strategic collaborations may result in royalties or other terms which reduce our economic potential from products under development. If we are unable to raise the funds necessary to meet
our long-term liquidity needs, we may have to delay or discontinue the development of one or more programs, discontinue or delay on-going or anticipated clinical trials, license out programs earlier
than expected, raise funds at significant discount or on other unfavorable terms, if at all, or sell all or part of our business. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We may be unable to manage multiple late stage clinical trials for a variety of product candidates simultaneously.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As our current clinical trials progress, we may need to manage multiple late stage clinical trials simultaneously in order to continue
developing all of our current products. Our management team does not have significant experience in completing late stage clinical trials and the management of late stage clinical trials is more
complex and time consuming than early stage trials. Typically, early stage trials involve several hundred patients in no more than 10-30 clinical sites. Late stage (Phase&nbsp;3) trials may involve
up to several thousand patients in up to several hundred clinical sites and may require facilities in several countries. Therefore, the project management required to supervise and control such an
extensive program is substantially larger than early stage programs. As the need for these resources is not known until some months before the trials begin, it is necessary to recruit large numbers of
experienced and talented individuals very quickly. If the labor market does not allow this team to be recruited quickly, the sponsor is faced with a decision to delay the program or to initiate it
with inadequate management resources. This may result in recruitment of inappropriate patients, inadequate monitoring of clinical investigators and inappropriate handling of data or data analysis.
Consequently it is possible that conclusions of efficacy or safety may not be acceptable to permit filing of a BLA or NDA for any one of the above reasons or a combination of several. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We rely on third parties to plan, conduct and monitor our clinical tests, and their failure to perform as required would interfere with our product development.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We rely on third parties to conduct a significant portion of our clinical development activities. These activities include clinical
patient recruitment and observation, clinical trial monitoring, clinical data management and analysis, safety monitoring and project management. We conduct project management and medical and safety
monitoring in-house for some of our programs and rely on third parties for the remainder of our clinical development activities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
significant third parties who we currently rely on for clinical development activities include Novella Clinical, a Quintiles company, for our ACT IV study and PPD
Development,&nbsp;LLC for our METRIC study. If Novella or PPD Development is unable to perform in a quality and timely manner, and at a feasible cost, ACT IV or METRIC will face delays. Further, if
any of these third parties fails to perform as we expect or if their work fails to meet regulatory standards, our testing could be delayed, cancelled or rendered ineffective. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=26,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=325995,FOLIO='22',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2><B><I> We may enter into collaboration agreements for the licensing, development and ultimate commercialization of some of our drug candidates including, where appropriate, for our
lead drug candidates. In such cases, we will depend greatly on our third-party collaborators to license, develop and commercialize such drug candidates, and they may not meet our expectations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may enter into co-development and commercialization partnerships for certain products, including rindopepimut for commercialization
outside of North America, glembatumumab vedotin and varlilumab. The process of identifying collaborators and negotiating collaboration agreements for the licensing, development and ultimate
commercialization of some of our drug candidates may cause delays and increased costs. We may not be able to enter into collaboration agreements on terms favorable to us. Furthermore some of those
agreements may give substantial responsibility over our drug candidates to the collaborator. Some collaborators may be unable or unwilling to devote sufficient resources to develop our drug candidates
as their agreements require. They often face business risks similar to ours, and this could interfere with their efforts. Also, collaborators may choose to devote their resources to products that
compete with ours. If a collaborator does not successfully develop any one of our products, we will need to find another collaborator to do so. The success of our search for a new collaborator will
depend on our legal right to do so at the time and whether the product remains commercially viable. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we enter into collaboration agreements for one or more of our lead drug candidates, the success of such drug candidates will depend in great part upon our and our collaborators'
success in promoting them as superior to other treatment alternatives. We believe that our drug candidates can be proven to offer disease prevention and treatment with notable advantages over drugs in
terms of patient compliance and effectiveness. However, there can be no assurance that we will be able to prove these advantages or that the advantages will be sufficient to support the successful
commercialization of our drug candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We may face delays, difficulties or unanticipated costs in establishing sales, distribution and manufacturing capabilities for our commercially ready products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are in the process of building a commercial organization which we believe will provide us with the strategic options to either
retain full economic rights to our drug candidates or seek favorable economic terms through advantageous commercial partnerships. As a result, we may have full responsibility for commercialization of
these products if and when they are approved for sale. We currently lack the marketing, sales and distribution capabilities that we will need to carry out this strategy. To market any of our products
directly, we must develop a substantial marketing and sales force with technical expertise and a supporting distribution capability. We have little expertise in this area, and we may not succeed. We
may find it necessary to enter into strategic partnerships on uncertain but potentially unfavorable terms to sell, market and distribute our products when they are approved for sale. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Some
of our products are difficult to manufacture, especially in large quantities, and we have not yet developed commercial scale manufacturing processes for any of our products. We do
not currently plan to develop internal manufacturing capabilities to produce any of our products at commercial scale if they are approved for sale. To the extent that we choose to market and
distribute these products ourselves, this strategy will make us dependent on other companies to produce our products in adequate quantities, in compliance with regulatory requirements, and at a
competitive cost. We may not find third parties capable of meeting those manufacturing needs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Our drug candidates are subject to extensive regulatory scrutiny.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of our drug candidates are at various stages of development and commercialization and our activities and drug candidates are
significantly regulated by a number of governmental entities, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=27,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1020637,FOLIO='23',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2>including
the FDA in the United States and by comparable authorities in other countries. These entities regulate, among other things, the manufacture, testing, safety, effectiveness, labeling,
documentation, advertising and sale of drugs and drug candidates. We or our partners must obtain regulatory approval for a drug candidate in all of these areas before we can commercialize the drug
candidate. Product development within this regulatory framework takes a number of years and involves the expenditure of substantial resources. This process typically requires extensive preclinical and
clinical testing, which may take longer or cost more than we anticipate, and may prove unsuccessful due to numerous factors. Many drug candidates that initially appear promising ultimately do not
reach the market because they are found to be unsafe or ineffective when tested. Companies in the pharmaceutical, biotechnology and immunotherapeutic drug industries have suffered significant setbacks
in advanced clinical trials, even after obtaining promising results in earlier trials. Our inability to commercialize a drug candidate would impair our ability to earn future revenues. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> If our products do not pass required tests for safety and effectiveness, we will not be able to derive commercial revenue from them.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to succeed, we will need to derive commercial revenue from the products we have under development. The FDA has not approved
our lead drug candidates, rindopepimut or glembatumumab vedotin, or any of our other products for sale to date. Our drug candidates are in various stages of preclinical and clinical testing.
Preclinical tests are performed at an early stage of a product's development and provide information about a product's safety and effectiveness on laboratory animals. Preclinical tests can last years.
If a product passes its preclinical tests satisfactorily, and we determine that further development is warranted, we would file an IND application for the product with the FDA, and if the FDA gives
its approval we would begin Phase&nbsp;1 clinical tests. Phase&nbsp;1 testing generally lasts between 6 and 24&nbsp;months. If Phase&nbsp;1 test results are satisfactory and the FDA gives its
approval, we can begin Phase&nbsp;2 clinical tests. Phase&nbsp;2 testing generally lasts between 6 and 36&nbsp;months. If Phase&nbsp;2 test results are satisfactory and the FDA gives its
approval, we can begin Phase&nbsp;3 pivotal studies. Phase&nbsp;3 studies generally last between 12 and 48&nbsp;months. Once clinical testing is completed and a new drug application is filed
with the FDA, it may take more than a year to receive FDA approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
all cases we must show that a pharmaceutical product is both safe and effective before the FDA, or drug approval agencies of other countries where we intend to sell the product, will
approve it for sale. Our research and testing programs must comply with drug approval requirements both in the United States and in other countries, since we are developing our lead products with the
intention to, or could later decide to, commercialize them both in the U.S. and abroad. A product may fail for safety or effectiveness at any stage of the testing process. A major risk we face is the
possibility that none of our products under development will come through the testing process to final approval for sale, with the result that we cannot derive any commercial revenue from them after
investing significant amounts of capital in multiple stages of preclinical and clinical testing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Product testing is critical to the success of our products but subject to delay or cancellation if we have difficulty enrolling patients.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As our portfolio of potential products moves from preclinical testing to clinical testing, and then through progressively larger and
more complex clinical trials, we will need to enroll an increasing number of patients with the appropriate characteristics. At times we have experienced difficulty enrolling patients and we may
experience more difficulty as the scale of our clinical testing program increases. The factors that affect our ability to enroll patients are largely uncontrollable and include principally the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the nature of the clinical test; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the size of the patient population; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=28,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=810085,FOLIO='24',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_25"> </A>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>patients' willingness to receive a placebo or less effective treatment on the control arm of a clinical study; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the distance between patients and clinical test sites; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the eligibility criteria for the trial. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we cannot enroll patients as needed, our costs may increase or we may be forced to delay or terminate testing for a product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We may have delays in completing our clinical trials and we may not complete them at all.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have not completed the clinical trials necessary to obtain FDA approval to market rindopepimut, glembatumumab vedotin or any of our
other products in development. We initiated a Phase&nbsp;3 study of rindopepimut in December 2011 and a study designed for accelerated approval for glembatumumab vedotin in December 2013 but we have
not initiated Phase&nbsp;3 studies for any of our other products in development. Our management lacks significant experience in completing Phase&nbsp;3 trials and bringing a drug through
commercialization. Our rindopepimut Phase&nbsp;3 trial, glembatumumab vedotin accelerated approval study and clinical trials for other products in development may be delayed or terminated as a
result of many factors, including the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>difficulty in enrolling patients in our clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>patients failing to complete clinical trials due to dissatisfaction with the treatment, side effects or other reasons; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>failure by regulators to authorize us to commence a clinical trial; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>suspension or termination by regulators of clinical research for many reasons, including concerns about patient safety or
failure of our contract manufacturers to comply with cGMP requirements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>delays or failure to obtain clinical supply for our products necessary to conduct clinical trials from contract
manufacturers, including commercial grade clinical supply for our Phase&nbsp;3 clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>treatment candidates demonstrating a lack of efficacy during clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>inability to continue to fund clinical trials or to find a partner to fund the clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>competition with ongoing clinical trials and scheduling conflicts with participating clinicians; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>delays in completing data collection and analysis for clinical trials. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
delay or failure to complete clinical trials and obtain FDA approval for our drug candidates could have a material adverse effect on our cost to develop and commercialize, and our
ability to generate revenue from, a particular drug candidate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Any delay in obtaining regulatory approval would have an adverse impact on our ability to earn future revenues.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is possible that none of the drug candidates that we develop will obtain the regulatory approvals necessary for us to begin
commercializing them. The time required to obtain FDA and other approvals is unpredictable but often can take years following the commencement of clinical trials, depending upon the nature of the drug
candidate. Any analysis we perform of data from clinical activities is subject to confirmation and interpretation by regulatory authorities, which could delay, limit or prevent regulatory approval.
Any delay or failure in obtaining required approvals could have a material adverse effect on our ability to generate revenues from the particular drug candidate including, but not limited </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=29,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=609233,FOLIO='25',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_26"> </A>

<P style="font-family:times;"><FONT SIZE=2>to,
loss of patent term during the approval period. Furthermore, if we, or our partners, do not reach the market with our products before our competitors offer products for the same or similar uses,
or if we, or our partners, are not effective in marketing our products, our revenues from product sales, if any, will be reduced. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
face intense competition in our development activities. We face competition from many companies in the United States and abroad, including a number of large pharmaceutical companies,
firms specialized in the development and production of vaccines, adjuvants and vaccine and immunotherapeutic delivery systems and major universities and research institutions. The competitors of which
we are aware that have initiated a Phase&nbsp;3 study or have obtained marketing approval for a potentially competitive drug to rindopepimut for treatment of glioblastoma and/or glembatumumab
vedotin for treatment of breast cancer include Arbor Pharmaceutics,&nbsp;Inc., AstraZeneca&nbsp;PLC, Bayer, Celgene Corporation, Eisai&nbsp;Inc., Eli Lilly and Company, Medigene AG, Northwest
Biotherapeutics,&nbsp;Inc., Pfizer&nbsp;Inc., and Roche. Most of our competitors have substantially greater resources, more extensive experience in conducting preclinical studies and clinical
testing and obtaining regulatory approvals for their products, greater operating experience, greater research and development and marketing capabilities and greater production capabilities than those
of ours. These companies might succeed in obtaining regulatory approval for competitive products more rapidly than we can for our products, especially if we experience any delay in obtaining required
regulatory approvals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Failure to comply with applicable regulatory requirements would adversely impact our operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even after receiving regulatory approval, our products would be subject to extensive regulatory requirements, and our failure to comply
with applicable regulatory requirements will adversely impact our operations. In the United States, the FDA requires that the manufacturing facility that produces a product meet specified standards,
undergo an inspection and obtain an establishment license prior to commercial marketing. Subsequent discovery of previously unknown problems with a product or its manufacturing process may result in
restrictions on the product or the manufacturer, including withdrawal of the product from the market. Failure to comply with the applicable regulatory requirements can result in fines, suspensions of
regulatory approvals, product recalls, operating restrictions and criminal prosecution. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We depend greatly on the intellectual capabilities and experience of our key executives and scientists and the loss of any of them could affect our ability to develop our
products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The loss of Anthony S. Marucci, our President and Chief Executive Officer, or other key members of our staff, including Avery W.
Catlin, our Chief Financial Officer, Dr.&nbsp;Thomas Davis, our Chief Medical Officer, Dr.&nbsp;Tibor Keler, our Chief Scientific Officer or Dr.&nbsp;Ronald Pepin, our Chief Business Officer,
could harm us. We entered into employment agreements with Messrs.&nbsp;Marucci, Catlin, Davis, Keler and Pepin although an employment agreement as a practical matter does not guarantee retention of
an employee. We also depend on our scientific and clinical collaborators and advisors, all of whom have outside commitments that may limit their availability to us. In addition, we believe that our
future success will depend in large part upon our ability to attract and retain highly skilled scientific, managerial and marketing personnel, particularly as we expand our activities in clinical
trials, the regulatory approval process and sales and manufacturing. We routinely enter into consulting agreements with our scientific and clinical collaborators and advisors, key opinion leaders and
heads of academic departments in the ordinary course of our business. We also enter into contractual agreements with physicians and institutions who recruit patients into our clinical trials on our
behalf in the ordinary course of our business. Notwithstanding these arrangements, we face significant competition for this type of personnel from other companies, research and academic institutions,
government entities and other organizations. We cannot predict our success in hiring or retaining the personnel we require for continued growth. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=30,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=282303,FOLIO='26',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_27"> </A>

<P style="font-family:times;"><FONT SIZE=2><B><I> We rely on contract manufacturers over whom we have limited control. Should the cost, delivery and quality of clinical and commercial grade materials supplied by contract
manufacturers vary to our disadvantage, our business operations could suffer significant harm.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have limited experience in commercial manufacturing. We rely on contract manufacturing organizations, or CMOs, to manufacture drug
substance and drug product for our late-stage clinical studies of rindopepimut and glembatumumab vedotin as well as for future commercial supplies. We also rely on CMOs for filling, packaging, storage
and shipping of drug product. In order for us to establish our own commercial manufacturing facility, we would require substantial additional funds and would need to hire and retain significant
additional personnel and comply with the extensive cGMP regulations applicable to such a facility. The commercial manufacturing facility would also need to be licensed for the production of our drug
candidates by the FDA. For our most advanced programs, we are working with CMOs under established manufacturing arrangements that comply with the FDA's requirements and other regulatory standards,
although there is no assurance that the manufacturing will be successful. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
currently use rindopepimut drug product that was manufactured by Pfizer and Jubilant Hollister Stier, in the ACT IV and ReACT clinical studies. In 2013, we established a relationship
with SAFC, a division of the Sigma Aldrich Corporation, to manufacture rindopepimut for late stage development and commercial supply. We rely on Biosyn and Ambiopharm for supplying suitable quantities
of cGMP starting materials for the manufacture of rindopepimut. We also rely on Sanofi to supply suitable quantities of commercial quality GM-CSF which is co-administered with rindopepimut. Any
manufacturing failures or delays by our rindopepimut contract manufacturers or suppliers of critical materials could cause delays in the ACT IV and ReACT studies and/or the commercial launch of
rindopepimut. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
date, we have utilized contract manufacturing organizations for the manufacture of clinical trial supplies of glembatumumab vedotin. In 2013, we established a relationship with Lonza,
AG to manufacture the CR-011 antibody and Piramal Healthcare UK&nbsp;Ltd. to conjugate the CR-011 antibody and stable linker with the MMAE toxin. We rely on SAFC for sourcing of suitable quantities
of vcMMAE. Any manufacturing failures or delays by our glembatumumab vedotin contract manufacturers or suppliers of materials could cause delays in the METRIC study and/or the commercial launch of
glembatumumab vedotin. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have established our own cGMP manufacturing facility in Fall River, Massachusetts, to produce clinical materials for our current and planned Phase&nbsp;1 and Phase&nbsp;2 clinical
trials. Our Fall River manufacturing facility has up to 1000L bioreactor capacity and is able to manufacture in compliance with FDA and EMEA regulations, allowing us to distribute potential products
to clinical sites in both the US and EU for early clinical trials. We manufacture clinical materials of varlilumab, CDX-1401, and CDX-301 in our Fall River facility for our current and planned
Phase&nbsp;1 and Phase&nbsp;2 clinical trials. The products are filled and packaged at CMOs. Any manufacturing failures or compliance issues at contract manufacturers could cause delays in our
Phase&nbsp;1 and Phase&nbsp;2 clinical studies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
manufacturing processes for our drug candidates and immunotherapeutic delivery systems utilize known technologies. We believe that the products we currently have under development
can be scaled up to permit manufacture in commercial quantities. However, there can be no assurance that we will not encounter difficulties in scaling up the manufacturing processes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
leading drug candidates require specialized manufacturing capabilities and processes. We may face difficulty in securing commitments from U.S. and foreign contract manufacturers as
these manufacturers could be unwilling or unable to accommodate our needs. Relying on foreign manufacturers involves peculiar and increased risks, including the risk relating to the difficulty foreign
manufacturers may face in complying with cGMP requirements as a result of language barriers, lack of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=31,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=481160,FOLIO='27',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_28"> </A>

<P style="font-family:times;"><FONT SIZE=2>familiarity
with cGMP or the FDA regulatory process or other causes, economic or political instability in or affecting the home countries of our foreign manufacturers, shipping delays, potential
changes in foreign regulatory laws governing the sales of our product supplies, fluctuations in foreign currency exchange rates and the imposition or application of trade restrictions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
can be no assurances that contract manufacturers will be able to meet our timetable and requirements. Further, contract manufacturers must operate in compliance with cGMP and
failure to do so could result in, among other things, the disruption of product supplies. As noted above, non-U.S. contract manufacturers may face special challenges in complying with cGMP
requirements, and although we are not currently dependent on non-U.S. collaborators or contract manufacturers, we may choose or be required to rely on non-U.S. sources in the future as we seek to
develop stable supplies of increasing quantities of materials for ongoing clinical trials of larger scale. Our dependence upon third parties for the manufacture of our products may adversely affect
our profit margins and our ability to develop and deliver products on a timely and competitive basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Other factors could affect the demand for and sales of any products that we may commercialize in the future.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In general, other factors that could affect the demand for and sales and profitability of our products include, but are not limited
to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the timing of regulatory approval, if any, of competitive products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>our or any other of our partners' pricing decisions, as applicable, including a decision to increase or decrease the price
of a product, and the pricing decisions of our competitors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>government and third-party payer reimbursement and coverage decisions that affect the utilization of our products and
competing products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>negative safety or efficacy data from new clinical studies conducted either in the U.S. or internationally by any party
could cause the sales of our products to decrease or a product to be recalled; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the degree of patent protection afforded our products by patents granted to or licensed by us and by the outcome of
litigation involving our or any of our licensor's patents; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the outcome of litigation involving patents of other companies concerning our products or processes related to production
and formulation of those products or uses of those products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the increasing use and development of alternate therapies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the rate of market penetration by competing products; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the termination of, or change in, existing arrangements with our partners. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of these factors could have a material adverse effect on the sales of any products that we may commercialize in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We face the risk of product liability claims, which could exceed our insurance coverage, and produce recalls, each of which could deplete our cash resources.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a participant in the pharmaceutical, biotechnology and immunotherapeutic drug industries, we are exposed to the risk of product
liability claims alleging that
use of our drug candidates caused an injury or harm. These claims can arise at any point in the development, testing, manufacture, marketing or sale of our drug candidates and may be made directly by
patients involved in clinical trials of our products, by consumers or healthcare providers or by individuals, organizations or companies selling our products. Product liability claims can be expensive
to defend, even if the drug or drug candidate did not actually cause the alleged injury or harm. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=32,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=236478,FOLIO='28',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance
covering product liability claims becomes increasingly expensive as a drug candidate moves through the development pipeline to commercialization. Under our license agreements,
we are required to maintain clinical trial liability insurance coverage up to $15&nbsp;million. However, there can be no assurance that such insurance coverage is or will continue to be adequate or
available to us at a cost acceptable to us or at all. We may choose or find it necessary under our collaborative agreements to increase our insurance coverage in the future. We may not be able to
secure greater or broader product liability insurance coverage on acceptable terms or at reasonable costs when needed. Any liability for damages resulting from a product liability claim could exceed
the amount of our coverage, require us to pay a substantial monetary award from our own cash resources and have a material adverse effect on our business, financial condition and results of
operations. Moreover, a product recall, if required, could generate substantial negative publicity about our products and business and inhibit or prevent commercialization of other products and drug
candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, some of our licensing and other agreements with third parties require or might require us to maintain product liability insurance. If we cannot maintain acceptable amounts
of coverage on commercially reasonable terms in accordance with the terms set forth in these agreements, the corresponding agreements would be subject to termination, which could have a material
adverse impact on our operations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because we rely on third parties to develop our products, we must share trade secrets with them. We seek to protect our proprietary
technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, collaborative research agreements, consulting agreements or other similar agreements
with our collaborators, advisors, employees and consultants prior to beginning research or disclosing proprietary information. These agreements typically restrict the ability of our collaborators,
advisors, employees and consultants to publish data potentially relating to our trade secrets. Our academic collaborators typically have rights to publish data, provided that we are notified in
advance and may delay publication for a specified time in order to secure our intellectual property rights arising from the collaboration. In other cases, publication rights are controlled exclusively
by us, although in some cases we may share these rights
with other parties. We also conduct joint research and development programs which may require us to share trade secrets under the terms of research and development partnership or similar agreements.
Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of these agreements, independent development or publication of information
including our trade secrets in cases where we do not have proprietary or otherwise protected rights at the time of publication. A competitor's discovery of our trade secrets would impair our
competitive position. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We may not be able to successfully integrate newly-acquired technology with our existing technology or to modify our technologies to create new immunotherapeutic drugs  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As part of our acquisition of technology assets from entities such as Amgen, we have acquired access to Fms-like tyrosine kinase 3
ligand, or Flt3L, which may improve the immunogenicity of our immunotherapeutic drugs. If we are able to integrate these licensed assets with our immunotherapy technologies, we believe these assets
will give our immunotherapeutic drugs a competitive advantage. However, if we are unable to successfully integrate licensed assets, or other technologies which we have acquired or may acquire in the
future, with our existing technologies and potential products currently under development, we may be unable to realize any benefit from our acquisition of these assets, or other technologies which we
have acquired or may acquire in the future and may face the loss of our investment of financial resources and time in the integration process. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=33,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=217889,FOLIO='29',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<A NAME="page_di47701_1_30"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that our immunotherapy technology portfolio may offer opportunities to develop immunotherapeutic drugs that treat a variety of oncology, inflammatory and infectious diseases
by stimulating a patient's immune system against those disease organisms. If our immunotherapy technology portfolio cannot be used to create effective immunotherapeutic drugs against a variety of
disease organisms, we may lose all or portions of our investment in development efforts for new drug candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We license technology from other companies to develop products, and those companies could influence research and development or restrict our use of it.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Companies that license technologies to us that we use in our research and development programs may require us to achieve milestones or
devote minimum amounts of resources to develop products using those technologies. They may also require us to make significant royalty and milestone payments, including a percentage of any
sublicensing income, as well as payments to reimburse them for patent costs. The number and variety of our research and development programs
require us to establish priorities and to allocate available resources among competing programs. From time to time we may choose to slow down or cease our efforts on particular products. If in doing
so we fail to fully perform our obligations under a license, the licensor can terminate the licenses or permit our competitors to use the technology. Moreover, we may lose our right to market and sell
any products based on the licensed technology. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> We have many competitors in our field and they may develop technologies that make ours obsolete.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biotechnology, pharmaceuticals and therapeutics are rapidly evolving fields in which scientific and technological developments are
expected to continue at a rapid pace. We have many competitors in the U.S. and abroad. The competitors of which we are aware that have initiated a Phase&nbsp;3 study or have obtained marketing
approval for a potentially competitive drug to rindopepimut for treatment of glioblastoma and/or glembatumumab vedotin for treatment of breast cancer include Arbor Pharmaceutics,&nbsp;Inc.,
AstraZeneca&nbsp;PLC, Bayer, Celgene Corporation, Eisai&nbsp;Inc., Eli Lilly and Company, Medigene AG, Northwest Biotherapeutics,&nbsp;Inc., Pfizer&nbsp;Inc., and Roche. Our success depends
upon our ability to develop and maintain a competitive position in the product categories and technologies on which we focus. Many of our competitors have greater capabilities, experience and
financial resources than we do. Competition is intense and is expected to increase as new products enter the market and new technologies become available. Our competitors may:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>develop technologies and products that are more effective than ours, making ours obsolete or otherwise noncompetitive; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>obtain regulatory approval for products more rapidly or effectively than us; and </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=34,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=999337,FOLIO='30',FILE='DISK104:[13ZDF1.13ZDF47701]DI47701A.;9',USER='BGARDNE',CD='25-FEB-2014;17:01' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk47701_1_31"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>obtain patent protection or other intellectual property rights that would block our ability to develop competitive
products. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B><I> We rely on patents, patent applications and other intellectual property protections to protect our technology and trade secrets; which are expensive and may not provide
sufficient protection.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our success depends in part on our ability to obtain and maintain patent protection for technologies that we use. Biotechnology patents
involve complex legal, scientific and factual questions and are highly uncertain. To date, there is no consistent policy regarding the breadth of claims allowed in biotechnology patents, particularly
in regard to patents for technologies for human uses like those we use in our business. We cannot predict whether the patents we seek will issue. If they do issue, a competitor may challenge them and
limit their scope. Moreover, our patents may not afford effective protection against competitors with similar technology. A successful challenge to any one of our patents could result in a third
party's ability to use the technology covered by the patent. We also face the risk that others will infringe, avoid or circumvent our patents. Technology that we license from others is subject to
similar risks and this could harm our ability to use that technology. If we, or a company that licenses technology to us, were not the first creator of an invention that we use, our use of the
underlying product or technology will face restrictions, including elimination. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we must defend against suits brought against us or prosecute suits against others involving intellectual property rights, we will incur substantial costs. In addition to any potential
liability for significant monetary damages, a decision against us may require us to obtain licenses to patents or other intellectual property rights of others on potentially unfavorable terms. If
those licenses from third parties are necessary but we cannot acquire them, we would attempt to design around the relevant
technology, which would cause higher development costs and delays, and may ultimately prove impracticable. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Our business requires us to use hazardous materials, which increases our exposure to dangerous and costly accidents.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our research and development activities involve the use of hazardous chemicals, biological materials and radioactive compounds.
Although we believe that our safety procedures for handling and disposing of hazardous materials comply with the standards prescribed by applicable laws and regulations, we cannot completely eliminate
the risk of accidental contamination or injury from these materials. In the event of an accident, an injured party will likely sue us for any resulting damages with potentially significant liability.
The ongoing cost of complying with environmental laws and regulations is significant and may increase in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Health care reform and restrictions on reimbursement may limit our returns on potential products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because our strategy ultimately depends on the commercial success of our products, we assume, among other things, that end users of our
products will be able to pay for them. In the United States and other countries, in most cases, the volume of sales of products like those we are developing depends on the availability of
reimbursement from third-party payors, including national health care agencies, private health insurance plans and health maintenance organizations. Third-party payors increasingly challenge the
prices charged for medical products and services. Accordingly, if we succeed in bringing products to market, and reimbursement is not available or is insufficient, we could be prevented from
successfully commercializing our potential products. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
health care industry in the United States and in Europe is undergoing fundamental changes as a result of political, economic and regulatory influences. Reforms proposed from time to
time include mandated basic health care benefits, controls on health care spending, the establishment of governmental controls over the cost of therapies, creation of large medical services and
products </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=35,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=673172,FOLIO='31',FILE='DISK104:[13ZDF1.13ZDF47701]DK47701A.;8',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<A NAME="page_dk47701_1_32"> </A>

<P style="font-family:times;"><FONT SIZE=2>purchasing
groups and fundamental changes to the health care delivery system. We anticipate ongoing review and assessment of health care delivery systems and methods of payment in the United States
and other countries. We cannot predict whether any particular reform initiatives will result or, if
adopted, what their impact on us will be. However, we expect that adoption of any reform proposed will impair our ability to market products at acceptable prices and that uncertainty concerning future
government regulation of consumer healthcare purchasing and insurance may result in difficulties for drug development companies, like us, in raising capital. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Changes in laws affecting the health care industry could adversely affect our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the U.S., there have been numerous proposals considered at the federal and state levels to reform the health care industry and its
cost, and it is likely that federal and state legislatures and health agencies will continue to focus on health care reform in the future. While additional health care reform may increase the number
of patients who have insurance coverage for our products, it may also include cost containment measures that adversely affect reimbursement for our products. Congress has also considered legislation
to change the Medicare reimbursement system for outpatient drugs, increase the amount of rebates that manufacturers pay for coverage of their drugs by Medicaid programs and facilitate the importation
of lower-cost prescription drugs that are marketed outside the U.S. Some states are also considering legislation that would control the prices of drugs, and state Medicaid programs are increasingly
requesting manufacturers to pay supplemental rebates and requiring prior authorization by the state program for use of any drug for which supplemental rebates are not being paid. Managed care
organizations continue to seek price discounts and, in some cases, to impose restrictions on the coverage of particular drugs. Government efforts to reduce Medicaid expenses may lead to increased use
of managed care organizations by Medicaid programs. This may result in managed care organizations influencing prescription decisions for a larger segment of the population and a corresponding
constraint on prices and reimbursement for our products. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
and our collaborators and partners operate in a highly regulated industry. As a result, governmental actions may adversely affect our business, operations or financial condition,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to
health care availability, method of delivery and payment for health care products and services; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>changes in the FDA and foreign regulatory approval processes that may delay or prevent the approval of new products and
result in lost market opportunity; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>changes in FDA and foreign regulations that may require additional safety monitoring, labeling changes, restrictions on
product distribution or use, or other measures after the introduction of our products to market, which could increase our costs of doing business, adversely affect the future permitted uses of
approved products, or otherwise adversely affect the market for our products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>new laws, regulations and judicial decisions affecting pricing or marketing practices; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>changes in the tax laws relating to our operations. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
enactment in the U.S. of health care reform, possible legislation which could ease the entry of competing follow-on biologics in the marketplace, new legislation or implementation of
existing statutory provisions on importation of lower-cost competing drugs from other jurisdictions, and legislation on comparative effectiveness research are examples of previously enacted and
possible future changes in laws that could adversely affect our business. In addition, the Food and Drug Administration Amendments Act of 2007 included new authorization for the FDA to require
post-market safety monitoring, along with an expanded clinical trials registry and clinical trials results database, and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=36,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=680189,FOLIO='32',FILE='DISK104:[13ZDF1.13ZDF47701]DK47701A.;8',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<A NAME="page_dk47701_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2>expanded
authority for the FDA to impose civil monetary penalties on companies that fail to meet certain commitments. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> If physicians, patients and third-party payors do not accept any future drugs that we may develop, we may be unable to generate significant revenue, if any.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even if our drug candidates as well as any drug candidates that we may develop or acquire in the future obtain regulatory approval,
they may not gain market acceptance among physicians, patients and health care payors. Physicians may elect not to recommend these drugs for a variety of reasons
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>timing of market introduction of competitive drugs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>lower demonstrated clinical safety and efficacy compared to other drugs; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>lack of cost-effectiveness; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>lack of availability of reimbursement from third-party payors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>convenience and ease of administration; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>prevalence and severity of adverse side effects; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>other potential advantages of alternative treatment methods; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>ineffective marketing and distribution support. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any drugs that we are developing fail to achieve market acceptance, we would not be able to generate sufficient revenue from product sales to maintain or grow our business. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Risks Related to our Capital Stock  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Our history of losses and uncertainty of future profitability make our common stock a highly speculative investment.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have had no commercial revenue to date from sales of our drug candidates. We had an accumulated deficit of $345.7&nbsp;million as
of December&nbsp;31, 2013. We expect to spend substantial funds to continue the research and development testing of our products candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
anticipation of FDA approval of these products, we will need to make substantial investments to establish sales, marketing, quality control, regulatory compliance capabilities and
commercial manufacturing alliances. These investments will increase if and when any of these products receive FDA approval. We cannot predict how quickly our lead products will progress through the
regulatory approval process. As a result, we may continue to lose money for several years. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot be certain that we will achieve or sustain profitability in the future. Failure to achieve profitability could diminish our ability to sustain operations, pay dividends on our
common stock, obtain additional required funds and make required payments on our present or future indebtedness. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Our share price has been and could remain volatile.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The market price of our common stock has historically experienced and may continue to experience significant volatility. From January
2013 through December 2013, the market price of our common stock has fluctuated from a high of $38.84 per share in the fourth quarter of 2013, to a low of $6.81 per share in the first quarter of 2013.
Our progress in developing and commercializing our products, the impact of government regulations on our products and industry, the potential sale of a large volume of our common stock by
stockholders, our quarterly operating results, changes in general conditions in the economy or the financial markets and other developments affecting us or our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=37,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=146310,FOLIO='33',FILE='DISK104:[13ZDF1.13ZDF47701]DK47701A.;8',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<A NAME="page_dk47701_1_34"> </A>

<P style="font-family:times;"><FONT SIZE=2>competitors
could cause the market price of our common stock to fluctuate substantially with significant market losses. If our stockholders sell a substantial number of shares of common stock,
especially if those sales are made during a short period of time, those sales could adversely affect the market price of our common stock and could impair our ability to raise capital. In addition, in
recent years, the stock market has experienced significant price and volume fluctuations. This volatility has affected the market prices of securities issued by many companies for reasons unrelated to
their operating performance and may adversely affect the price of our common stock. In addition, we could be subject to a securities class action litigation as a result of volatility in the price of
our stock, which could result in substantial costs and diversion of management's attention and resources and could harm our stock price, business, prospects, results of operations and financial
condition. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> Our ability to use our net operating loss carryforwards will be subject to limitation and, under certain circumstances, may be eliminated.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Utilization of our net operating loss and research and development credit carryforwards may be subject to substantial annual limitation
due to ownership change limitations that have occurred previously or that could occur in the future provided by Section&nbsp;382 of the Internal Revenue Code of 1986, or Section&nbsp;382, as well
as similar state provisions. In general, an ownership change, as defined by Section&nbsp;382, results from transactions increasing the ownership of certain shareholders or public groups in the stock
of a corporation by more than 50&nbsp;percentage points over a three-year period. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2007, June 2009 and in December 2009, we experienced a change in ownership as defined by Section&nbsp;382 of the Internal Revenue Code. Historically, we have raised capital
through the issuance of capital stock on several occasions which, combined with shareholders' subsequent disposition of those shares, has resulted in three changes of control, as defined by
Section&nbsp;382. As a result of the ownership change in October 2007, utilization of our Federal net operating loss carryforwards is subject to an annual limitation. Any unused annual limitation
may be carried over to later years, and the amount of the limitation may, under certain circumstances, be subject to adjustment if the fair value of the our net assets are determined to be below or in
excess of the tax basis of such assets at the time of the ownership change, and such unrealized loss or gain is recognized during the five-year period after the ownership change. Subsequent ownership
changes, as defined in Section&nbsp;382, could further limit the amount of net operating loss carryforwards and research and development credits that can be utilized annually to offset future
taxable income. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not undertaken a study to assess whether an ownership change or multiple ownership changes has occurred for (i)&nbsp;AVANT or CuraGen prior to our acquisitions, (ii)&nbsp;the
Company on the state level, (iii)&nbsp;the Company since October 2012, or (iv)&nbsp;research and development credits. If, based on such a study, we were to determine that there has been an
ownership change at any time since its formation,
utilization of net operating loss or tax credit carryforwards would be subject to an annual limitation under Section&nbsp;382. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Refer
to Note&nbsp;15, "Income Taxes," in the accompanying notes to the consolidated financial statements for additional discussion on income taxes.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="dk47701_item_1b._unresolved_staff_comments"> </A>
<A NAME="toc_dk47701_1"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;1B.&nbsp;&nbsp;&nbsp;&nbsp;UNRESOLVED STAFF COMMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=38,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=608934,FOLIO='34',FILE='DISK104:[13ZDF1.13ZDF47701]DK47701A.;8',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<A NAME="page_dk47701_1_35"> </A>
<BR>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="dk47701_item_2._properties"> </A>
<A NAME="toc_dk47701_2"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;PROPERTIES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2013, our significant leased properties are described below. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="210pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="106pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:64pt;"><FONT SIZE=1><B>Property Location

<!-- COMMAND=ADD_SCROPPEDRULE,64pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Approximate<BR>
Square Feet </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Use </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Lease Expiration Date </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Hampton, New Jersey</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Headquarters, Office and Laboratory</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>April 2019(1)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Needham, Massachusetts</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Office and Laboratory</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>April 2017(2)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fall River, Massachusetts</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Manufacturing Facility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>December 2017(3)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Branford, Connecticut</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Office</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>January 2018(4)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Lease
includes two renewal options of five years each.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Lease
includes one renewal option of five years.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Lease
includes two renewal options of five years each. Lease also includes provision for early termination in December 2015 upon prior notice of one year.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Lease
includes one renewal option of five years. Lease also includes provision for early termination with 12&nbsp;months notice. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><A
NAME="dk47701_item_3._legal_proceedings"> </A>
<A NAME="toc_dk47701_3"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;LEGAL PROCEEDINGS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are not currently a party to any material legal proceedings.  </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A
NAME="dk47701_item_4._mine_safety_disclosures"> </A>
<A NAME="toc_dk47701_4"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;MINE SAFETY DISCLOSURES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=39,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=264119,FOLIO='35',FILE='DISK104:[13ZDF1.13ZDF47701]DK47701A.;8',USER='JDUTRA',CD='25-FEB-2014;16:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm47701_1_36"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm47701_part_ii"> </A>
<A NAME="toc_dm47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PART II    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A
NAME="dm47701_item_5._market_for_registrant___ite04666"> </A>
<A NAME="toc_dm47701_2"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our common stock currently trades on the Nasdaq Global Market (NASDAQ) under the symbol "CLDX". The following table sets forth for the
periods indicated the high and low sale prices per share for our common stock, as reported by NASDAQ. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:46pt;"><FONT SIZE=1><B>Fiscal Period

<!-- COMMAND=ADD_SCROPPEDRULE,46pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>High </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Low </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Year Ended December&nbsp;31, 2012</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>First Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.66</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.65</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Second Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.88</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Third Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4.46</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fourth Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.02</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Year Ended December&nbsp;31, 2013</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>First Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12.49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.81</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Second Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16.48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Third Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>37.98</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fourth Quarter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38.84</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of February&nbsp;19, 2014, there were approximately 412 shareholders of record of our common stock. On February&nbsp;19, 2014 the closing price of our common stock, as reported by
NASDAQ, was $27.48 per share. We have not paid any dividends on our common stock since our inception and do not intend to pay any dividends in the foreseeable future. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> Equity Compensation Plan Information  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information as of December&nbsp;31, 2013 regarding shares of our common stock that may be issued under
our existing equity compensation plans, including our 2008 Stock Option and Incentive Plan (the "2008 Plan") and our 2004 Employee Stock Purchase Plan (the "2004 ESPP Plan"). </FONT></P>
 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="121pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="92pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="131pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity Compensation Plan Information </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities<BR>
to be issued upon exercise<BR>
of outstanding options<BR>
and rights(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted Average<BR>
exercise price of<BR>
outstanding options<BR>
and rights </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities<BR>
remaining available for<BR>
future issuance under equity<BR>
compensation plan<BR>
(excluding securities<BR>
referenced in column (a)) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans approved by security holders(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,770,544</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8.17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,267,066</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Does
not include any Restricted Stock as such shares are already reflected in our outstanding shares.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of the 2008 Plan, 2004 ESPP Plan, Celldex Research's 2005 Equity Incentive Plan and CuraGen's 2007 Stock Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Does
not include purchase rights accruing under the 2004 ESPP Plan because the purchase price (and therefore the number of shares to be purchased) will not
be determined until the end of the purchase period.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
shares available for future issuance under the 2008 Plan and the 2004 ESPP Plan.  </FONT></DD></DL>
 </DIV>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=40,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=613029,FOLIO='36',FILE='DISK104:[13ZDF1.13ZDF47701]DM47701A.;15',USER='BGARDNE',CD='25-FEB-2014;17:13' -->
<A NAME="page_dm47701_1_37"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm47701_celldex_theapeutics,_inc.,_nas__cel02591"> </A>
<A NAME="toc_dm47701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  CELLDEX THEAPEUTICS,&nbsp;INC., NASDAQ MARKET INDEX&#151;U.S. AND<BR>  PEER GROUP INDICES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The graph below compares the cumulative total stockholder return on the common stock for the period from December&nbsp;31, 2008
through December&nbsp;31, 2013, with the cumulative return on (i)&nbsp;NASDAQ Market Index&#151;U.S. Companies, (ii)&nbsp;NASDAQ Pharmaceutical Index, (iii)&nbsp;NASDAQ US Benchmark TR
Index, and (iv)&nbsp;NASDAQ Pharmaceutical (Subsector) Index. As a result of a change in the total return data made available to us through our vendor provider, our performance graphs going forward
will be using comparable indices provided by NASDAQ OMX Global Indexes. Specifically, we will use the NASDAQ US Benchmark TR Index going forward instead of the NASDAQ Stock Market (U.S.) Index and the
NASDAQ Pharmaceutical (Subsector) Index instead of the NASDAQ Pharmaceutical Stock Index. The comparison assumes investment of $100 on December&nbsp;31, 2008 in our common stock and in each of the
indices and, in each case, assumes reinvestment of all dividends. The points on the graph are as of December&nbsp;31 of the year indicated. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g621270.jpg" ALT="GRAPHIC" WIDTH="477" HEIGHT="339">
  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2008 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2009 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2010 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Celldex Therapeutics,&nbsp;Inc.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>59</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>306</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>NASDAQ Stock Market (U.S.) Index</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>144</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>170</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>171</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>202</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>282</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>NASDAQ Pharmaceutical Stock Index</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>112</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>122</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>130</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>173</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>286</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>NASDAQ US Benchmark TR Index</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>129</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>152</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>152</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>177</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>237</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>NASDAQ Pharmaceutical (Subsector) Index</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>119</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>122</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>143</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>164</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>222</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><A
NAME="dm47701_item_6._selected_financial_data"> </A>
<A NAME="toc_dm47701_4"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;SELECTED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following selected consolidated financial data are derived from our financial statements. The consolidated statement of operations
data for the years ended December&nbsp;31, 2013, 2012 and 2011 and the consolidated balance sheet data as of December&nbsp;31, 2013 and 2012 have been derived from our audited consolidated
financial statements included elsewhere in this Annual Report on Form&nbsp;10-K. This data should be read in conjunction with our audited consolidated financial statements and related notes which
are included elsewhere in this Annual Report on Form&nbsp;10-K, and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in Item&nbsp;7 below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=41,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=170077,FOLIO='37',FILE='DISK104:[13ZDF1.13ZDF47701]DM47701A.;15',USER='BGARDNE',CD='25-FEB-2014;17:13' -->
<A NAME="page_dm47701_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
October&nbsp;1, 2009, our acquisition of CuraGen became effective. The CuraGen acquisition was accounted for using the acquisition method of accounting and was treated as our
acquisition of CuraGen. Accordingly, the financial information presented below for periods prior to October&nbsp;1, 2009 reflects the financial position and the results of operations of us alone,
and for periods from October&nbsp;1, 2009 forward the combined financial position and combined results of operations of us and CuraGen. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> CONSOLIDATED STATEMENTS OF OPERATIONS DATA<BR>
(In thousands, except per share amounts)  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2010 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2009 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>REVENUE:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Development and Licensing Agreements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>146</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>110</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40,187</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,662</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Contracts and Grants</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,617</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>281</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>220</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,802</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Royalties</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,119</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,386</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,716</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,111</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,202</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,265</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>46,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,180</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OPERATING EXPENSE:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and Development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>67,401</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>47,398</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,439</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>27,650</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26,169</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Royalty</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,119</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,397</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Operating Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,818</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,106</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,106</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,464</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Operating Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>85,553</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>69,279</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>52,664</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>53,248</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>52,030</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,442</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(43,399</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(6,455</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(36,850</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Investment and Other Income, Net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>530</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>396</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,259</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>248</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(927</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,576</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,796</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,337</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(452</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss Before Income Taxes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,533</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(37,054</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income Tax Benefit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>529</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,533</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(36,525</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and Diluted Net Loss Per Common Share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.02</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.02</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.84</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Used in Calculating Basic and Diluted Net Loss Per Common Share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,777</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>57,713</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>39,501</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,823</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B> CONSOLIDATED BALANCE SHEET DATA<BR>
(In thousands)  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2010 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2009 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Working Capital</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>284,839</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67,429</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40,386</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>42,739</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>69,569</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>347,095</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>125,541</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>97,994</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>109,943</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>140,364</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Long Term Liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,950</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,082</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,974</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,480</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52,190</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated Deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(345,679</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(264,129</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(205,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(160,207</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(157,674</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Stockholders' Equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>319,795</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95,774</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68,722</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75,255</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>73,767</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=42,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=70908,FOLIO='38',FILE='DISK104:[13ZDF1.13ZDF47701]DM47701A.;15',USER='BGARDNE',CD='25-FEB-2014;17:13' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do47701_1_39"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="do47701_item_7._management_s_discussio__ite03668"> </A>
<A NAME="toc_do47701_1"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> OVERVIEW  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the
treatment of cancer and other difficult-to-treat diseases. Our drug candidates are derived from a broad set of complementary technologies which have the ability to utilize the human immune system and
enable the creation of therapeutic agents. We are using these technologies to develop targeted immunotherapeutics comprised of antibodies, adjuvants and monotherapies and antibody-drug conjugates that
prevent or treat cancer and other diseases that modify undesirable activity by the body's own proteins or cells. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
lead drug candidates include rindopepimut (also referred to as CDX-110) and glembatumumab vedotin (also referred to as CDX-011). Rindopepimut is a targeted immunotherapeutic in a
pivotal Phase&nbsp;3 study for the treatment of front-line glioblastoma and a Phase&nbsp;2 study for the treatment of recurrent glioblastoma. Glembatumumab vedotin is a targeted antibody-drug
conjugate in a randomized study for the treatment of triple negative breast cancer designed to obtain accelerated approval . We also have a number of earlier stage drug candidates in clinical
development, including varlilumab (also referred to as CDX-1127), a fully human therapeutic monoclonal antibody for cancer indications,
CDX-301, an immune cell mobilizing agent and dendritic cell growth factor and CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells, or APC, for cancer indications. Our drug
candidates address market opportunities for which we believe current therapies are inadequate or non-existent. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are building a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for patients with unmet medical needs. Our program assets provide us with
the strategic options to either retain full economic rights to our innovative therapies or seek favorable economic terms through advantageous commercial partnerships. This approach allows us to
maximize the overall value of our technology and product portfolio while best ensuring the expeditious development of each individual product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table includes the programs that we currently believe are significant to our business: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:67%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"120%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="120%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="247pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="37pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:62pt;"><FONT SIZE=1><B>Product (generic)

<!-- COMMAND=ADD_SCROPPEDRULE,62pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Indication/Field </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Partner </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Status </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>CLINICAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rindopepimut</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Front-line glioblastoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;3</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Glembatumumab vedotin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Metastatic breast cancer and melanoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;2b</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rindopepimut</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Recurrent glioblastoma</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;2</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Varlilumab</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Lymphoma/leukemia and solid tumors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-301</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Cancer, autoimmune disease and transplant</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-1401</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Multiple solid tumors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>PRECLINICAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Ovarian and renal cancer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Preclinical</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
expenditures that will be necessary to execute our business plan are subject to numerous uncertainties. Completion of clinical trials may take several years or more, and the length
of time generally varies substantially according to the type, complexity, novelty and intended use of a product candidate. It is not unusual for the clinical development of these types of product
candidates to each take five years or more, and for total development costs to exceed $100&nbsp;million for each product </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=43,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=727044,FOLIO='39',FILE='DISK104:[13ZDF1.13ZDF47701]DO47701A.;16',USER='BGARDNE',CD='25-FEB-2014;17:25' -->
<A NAME="page_do47701_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2>candidate.
Our estimates that clinical trials of the type we generally conduct are typically completed over the following timelines: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:51pt;"><FONT SIZE=1><B>Clinical Phase

<!-- COMMAND=ADD_SCROPPEDRULE,51pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated<BR>
Completion<BR>
Period </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Phase&nbsp;1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1&nbsp;-&nbsp;2 Years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Phase&nbsp;2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1&nbsp;-&nbsp;5 Years</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Phase&nbsp;3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1&nbsp;-&nbsp;5 Years</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
duration and the cost of clinical trials may vary significantly over the life of a project as a result of differences arising during the clinical trial protocol, including, among
others, the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the number of patients that ultimately participate in the trial; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the duration of patient follow-up that seems appropriate in view of results; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the number of clinical sites included in the trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the length of time required to enroll suitable patient subjects; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>the efficacy and safety profile of the product candidate. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
test potential product candidates in numerous preclinical studies for safety, toxicology and immunogenicity. We may then conduct multiple clinical trials for each product candidate.
As we obtain results from trials, we may elect to discontinue or delay clinical trials for certain product candidates in order to focus our resources on more promising product candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
element of our business strategy is to pursue the research and development of a broad portfolio of product candidates. This is intended to allow us to diversify the risks associated
with our research and development expenditures. As a result, we believe our future capital requirements and our future financial success are not substantially dependent on any one product candidate.
To the extent we are unable to maintain a broad range of product candidates, our dependence on the success of one or a few product candidates increases. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulatory
approval is required before we can market our product candidates as therapeutic products. In order to proceed to subsequent clinical trial stages and to ultimately achieve
regulatory approval, the regulatory agency must conclude that our clinical data is safe and effective. Historically, the results from preclinical testing and early clinical trials (through
Phase&nbsp;2) have often not been predictive of results obtained in later clinical trials. A number of new drugs and biologics have shown promising results in early clinical trials, but subsequently
failed to establish sufficient safety and efficacy data to obtain necessary regulatory approvals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
our business strategy includes the option of entering into collaborative arrangements with third parties to complete the development and commercialization of our product
candidates. In the event that third parties take over the clinical trial process for one of our product candidates, the estimated completion date would largely be under control of that third party
rather than us. We cannot forecast with any degree of certainty which proprietary products, if any, will be subject to future collaborative arrangements, in whole or in part, and how such arrangements
would affect our development plan or capital requirements. Our programs may also benefit from subsidies, grants, contracts or government or agency-sponsored studies that could reduce our development
costs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result of the uncertainties discussed above, among others, it is difficult to accurately estimate the duration and completion costs of our research and development projects or when,
if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product. Our inability to complete our research and development projects in a timely manner or our
failure to enter into collaborative agreements, when appropriate, could significantly increase our capital requirements and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=44,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=354862,FOLIO='40',FILE='DISK104:[13ZDF1.13ZDF47701]DO47701A.;16',USER='BGARDNE',CD='25-FEB-2014;17:25' -->
<A NAME="page_do47701_1_41"> </A>

<P style="font-family:times;"><FONT SIZE=2>could
adversely impact our liquidity. These uncertainties could force us to seek additional, external sources of financing from time to time in order to continue with our business strategy. Our
inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the past five years through December&nbsp;31, 2013, we incurred an aggregate of $201.1&nbsp;million in research and development expenses. The following table indicates the
amount incurred for each of our significant research programs and for other identified research and development activities during the years ended December&nbsp;31, 2013, 2012 and 2011. The amounts
disclosed in the following table reflect direct research and development costs, license fees associated with the underlying technology and an allocation of indirect research and development costs to
each program. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rindopepimut</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38,149</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,004</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,366</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Glembatumumab vedotin</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,284</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,325</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,917</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Varlilumab</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,376</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,965</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-301</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>532</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,482</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,112</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-1401</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>612</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,032</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,464</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>937</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,071</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>481</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CDX-1135</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,405</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,109</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,524</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Programs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,106</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,355</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,610</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total R&amp;D Expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67,401</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47,398</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32,439</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B> Clinical Development Programs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Rindopepimut  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rindopepimut is an immunotherapeutic that targets the tumor-specific molecule epidermal growth factor receptor variant III, or
EGFRvIII. EGFRvIII is a mutated form of the epidermal growth factor receptor, or EGFR, that is only expressed in cancer cells and not in normal tissue and can directly contribute to cancer cell
growth. EGFRvIII is expressed in approximately 30% of glioblastoma multiforme, or GBM, tumors, the most common and aggressive form of brain cancer. Rindopepimut is composed of the EGFRvIII peptide
linked to a carrier protein called Keyhole Limpet Hemocyanin, or KLH, and administered together with the adjuvant GM-CSF. The Food and Drug Administration, or FDA, and the European Medicines Agency,
or EMA, have both granted orphan drug designation for rindopepimut for the treatment of EGFRvIII expressing GBM. The FDA has also granted Fast Track designation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;2a study of rindopepimut referred to as ACTIVATE was led by collaborating investigators at the Brain Center at Duke Comprehensive Cancer Center in Durham, North Carolina
and at M.D. Anderson Cancer Center in Houston, Texas and enrolled 18 evaluable GBM patients. An extension of the Phase&nbsp;2a study referred to as ACT II evaluated 22 additional GBM patients
treated in combination with the current standard of care, maintenance temozolomide, or TMZ, at the same two institutions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;2b study of rindopepimut referred to as ACT III combined rindopepimut with standard of care, TMZ, in patients with newly diagnosed GBM. The ACT III study provided for a
multi-center, non-randomized dataset for rindopepimut in 65 patients at over 30 sites throughout the United States. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2013, we announced the four- and five-year survival data from the 105 patients enrolled in the three Phase&nbsp;2 rindopepimut clinical studies (ACTIVATE, ACT II and ACT
III)&nbsp;in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=45,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=206565,FOLIO='41',FILE='DISK104:[13ZDF1.13ZDF47701]DO47701A.;16',USER='BGARDNE',CD='25-FEB-2014;17:25' -->
<A NAME="page_do47701_1_42"> </A>

<P style="font-family:times;"><FONT SIZE=2>EGFRvIII-positive
GBM. Across these three Phase&nbsp;2 studies of rindopepimut, survival data remains consistent and suggests a continuing survival benefit in comparison to independent control
datasets (see chart below) at the median and at all other time points evaluated. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do47701_phase_2_frontline_long__do402306"> </A>
<A NAME="toc_do47701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Phase&nbsp;2 Frontline Long-term Overall Survival Assessments    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Median, Years<BR>
(95% CI) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>3-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>4-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>5-year<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Phase&nbsp;2 rindopepimut studies (n=105)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.1 (1.8, 2.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Matched historical control (n=17)(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3 (0.9, 1.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><I>(1)</I></FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I>Patients treated at M.D. Anderson contemporaneously to ACTIVATE, matched for major eligibility requirements, including
EGFRvIII-positive GBM, gross total resection and no disease progression through chemoradiation treatment.</I></FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
pooled overall long-term survival results continue to be consistent with the ACT III Phase&nbsp;2 study (18% for 4-years and 14% for 5-years). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2011, we initiated ACT IV, a pivotal, randomized, double-blind, controlled Phase&nbsp;3 study of rindopepimut in patients with surgically resected, EGFRvIII-positive GBM.
Patients are randomized after the completion of surgery and standard chemoradiation treatment. The treatment regimen includes a rindopepimut priming phase post-radiation followed by an adjuvant TMZ
phase and a rindopepimut maintenance therapy phase. Patients are treated until disease progression or intolerance to therapy. The primary objective of the study is to determine whether rindopepimut
plus adjuvant GM-CSF improves the overall survival of patients with newly diagnosed EGFRvIII-positive GBM after Gross Total Resection, or GTR, when compared to treatment with TMZ and a control
injection of KLH. KLH is a component of rindopepimut and was selected due to its ability to generate a similar injection site reaction to that observed with rindopepimut. ACT IV is enrolling patients
at over 200 centers worldwide to recruit approximately 374 patients with GTR to be included in the primary analysis. Based on current projections, we anticipate completion of enrollment in mid-2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2011, we also initiated ReACT, a Phase&nbsp;2 study of rindopepimut in combination with Avastin&reg; in patients with recurrent EGFRvIII-positive GBM. ReACT was
initially planned to enroll approximately 95 patients in a first or second relapse of GBM following receipt of standard therapy at approximately 25 sites across the United States. In August 2013, we
announced the addition of an expansion cohort of approximately 75 patients to better characterize the potential activity of rindopepimut in this refractory patient population. This decision was based
on early evidence of anti-tumor activity, including stable disease, tumor shrinkage and investigator-reported response. As amended, the ReACT study will now enroll approximately 170 patients across
three groups. Approximately 70 patients who have yet to receive Avastin will be randomized to receive either rindopepimut and Avastin or a control injection of KLH and Avastin in a blinded fashion.
Another 100 patients, including the expansion cohort of 75 patients, who are refractory to Avastin having received Avastin in either the frontline or recurrent setting with subsequent progression will
receive rindopepimut plus Avastin in a single treatment arm. Study endpoints include 6&nbsp;month progression free survival rate, objective response rate, or ORR, overall survival and safety and
tolerability. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2013, we reported interim data from our ongoing Phase&nbsp;2 ReACT study. Rindopepimut plus Avastin was very well tolerated (dosing up to 13+ months) and the results
demonstrated promising signs of clinical activity in advanced patient populations, including evidence of anti-tumor activity (tumor shrinkage, objective response and stable disease). Strong immune
response correlated with improved outcome. In Avastin-na&iuml;ve patients treated with both rindopepimut and Avastin, a strong survival trend has also been seen to date versus the control
group (see chart below). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=46,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=54879,FOLIO='42',FILE='DISK104:[13ZDF1.13ZDF47701]DO47701A.;16',USER='BGARDNE',CD='25-FEB-2014;17:25' -->
<A NAME="page_do47701_1_43"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do47701_interim_react_overall_survival__int03852"> </A>
<A NAME="toc_do47701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Interim ReACT Overall Survival and Progression-free Survival in Avastin-Na&iuml;ve Recurrent GBM    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="114pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Rindopepimut&nbsp;&amp;<BR>
Avastin (n=20) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Control&nbsp;&amp; Avastin<BR>
(n=20) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Overall survival</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12.0&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7.9&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Hazard ratio&nbsp;= .43<BR>
(0.13, 1.44); p=0.16</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Progression-free survival</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p align=center style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>3.7&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p align=center style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2.0&nbsp;months</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>
Hazard ratio&nbsp;= .74<BR>
(0.34, 1.61); p=0.47</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
Avastin-refractory patients treated with both rindopepimut and Avastin, a median progression-free survival, or PFS, of 1.9&nbsp;months and an overall survival, or OS, of
5.6&nbsp;months was observed. The median overall survival of 5.6&nbsp;months is noteworthy in these heavily pre-treated, refractory EGFRvIII-positive patients. A review of the literature assessing
survival in recurrent patients who are Avastin-experienced across eight independent studies suggests a weighted-average survival of 3.6&nbsp;months (range of 2.6 to 5.8&nbsp;months) in all-comers.
It is important to note that these eight studies do not necessarily meet the strict definition of refractory applied in the ReACT study and that these studies included EGFRvIII-negative patients who
tend to perform better. Progression-free survival results in this refractory population may be more consistent with the profile of an immunotherapy candidate where progression-free survival does not
always correlate directly with an overall survival benefit. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enrollment
in ReACT is expected to be completed in late 2014 with data anticipated by year-end 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Glembatumumab Vedotin  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Glembatumumab vedotin is an antibody-drug conjugate, or ADC, that consists of a fully-human monoclonal antibody, CR011, linked to a
potent cell-killing drug, monomethyl-auristatin E, or MMAE. The CR011 antibody specifically targets glycoprotein NMB, referred to as gpNMB, that is over-expressed in a variety of cancers including
breast cancer and melanoma. The ADC technology, comprised of MMAE and a stable linker system for attaching it to CR011, was licensed from Seattle Genetics,&nbsp;Inc. and is the same as that used in
the marketed product Adcetris&reg;. The ADC is designed to be stable in the bloodstream. Following intravenous administration, glembatumumab vedotin targets and binds to gpNMB and upon
internalization into the targeted cell, glembatumumab vedotin is designed to release MMAE from CR011 to produce a cell-killing effect. The FDA has granted Fast Track designation to glembatumumab
vedotin for the treatment of advanced, refractory/resistant gpNMB-expressing breast cancer. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment of Breast Cancer:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Phase 1/2 study of glembatumumab vedotin administered intravenously once every three weeks evaluated
patients with
locally advanced or metastatic breast cancer who had received prior therapy (median of seven prior regimens). The study began with a bridging phase to confirm the maximum tolerated dose, or MTD, and
then expanded into a Phase&nbsp;2 open-label, multi-center study. The study confirmed the safety of glembatumumab vedotin at the pre-defined maximum dose level (1.88 mg/kg) in 6 patients. An
additional 28 patients were enrolled in an expanded Phase&nbsp;2 cohort (for a total of 34 treated patients at 1.88 mg/kg, the Phase&nbsp;2 dose) to evaluate the PFS rate at 12&nbsp;weeks. The
1.88 mg/kg dose was well tolerated in this patient population with the most common adverse events of rash, alopecia, and fatigue. The primary activity endpoint, which called for at least 5 of 25 (20%)
patients in the Phase&nbsp;2 study portion to be progression-free at 12&nbsp;weeks, was met as 9 of 26 (35%) evaluable patients were progression-free at 12&nbsp;weeks. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
all patients treated at the maximum dose level, tumor shrinkage was seen in 62% (16/26) and median PFS was 9.1&nbsp;weeks. A subset of 10 patients had "triple negative disease," a
more aggressive breast cancer subtype that carries a high risk of relapse and reduced survival as well as limited </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=47,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=38932,FOLIO='43',FILE='DISK104:[13ZDF1.13ZDF47701]DO47701A.;16',USER='BGARDNE',CD='25-FEB-2014;17:25' -->
<A NAME="page_do47701_1_44"> </A>

<P style="font-family:times;"><FONT SIZE=2>therapeutic
options due to lack of over-expression of HER2/neu, estrogen and progesterone receptors. In these patients, 78% (7/9) had some tumor shrinkage, 12-week PFS rate was 70% (7/10), and median
PFS was 17.9&nbsp;weeks. Tumor samples from a subset of patients across all dose groups were analyzed for gpNMB expression. The tumor samples from most patients showed evidence of stromal and/or
tumor cell expression of gpNMB. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2012, we announced final results from the EMERGE study, a randomized, multi-center Phase&nbsp;2b study of glembatumumab vedotin in 122 patients with heavily pre-treated,
advanced, gpNMB positive breast cancer. Patients were randomized (2:1) to receive either glembatumumab vedotin or single-agent Investigator's Choice, or IC, chemotherapy. Patients randomized to
receive IC were allowed to cross over to receive glembatumumab vedotin following disease progression. Activity endpoints included response rate, PFS and OS. The final results, as shown below,
suggested that glembatumumab vedotin induces significant response rates compared to currently available therapies in patient subsets with advanced, refractory breast cancers with gpNMB over-expression
(expression in greater than 25% of tumor cells) and in patients with triple negative breast cancer. The OS and PFS of patients treated with glembatumumab vedotin was also observed to be greatest in
patients with triple negative breast cancer who also over-express gpNMB and all patients with gpNMB over-expression. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do47701_emerge__overall_respon__do402208"> </A>
<A NAME="toc_do47701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  EMERGE: Overall Response Rate and Disease Control Data    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>gpNMB Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Triple Negative and<BR>
gpNMB Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=25) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=8) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=12) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(n=4) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Response</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Disease Control Rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <P style="font-family:times;"><FONT SIZE=2><I>Responses per RECIST 1.1; IC&nbsp;= Investigator's Choice; glembatumumab vedotin arm includes 15 patients who crossed over to receive glembatumumab vedotin treatment after
progression on IC. Analysis of best response excludes patients who discontinued from study without evaluable post-baseline radiographic imaging (n=15 for glembatumumab vedotin arm; n=5 for IC
arm).</I></FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do47701_emerge__progression_free_survi__eme02633"> </A>
<A NAME="toc_do47701_5"> </A>
<BR></FONT><FONT SIZE=2><B>  EMERGE: Progression Free Survival (PFS) and Overall Survival (OS) Data    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>gpNMB<BR>
Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Triple Negative<BR>
and gpNMB<BR>
Over-Expression </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>glembatumumab<BR>
vedotin </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>IC </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Median PFS (months)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>p=0.14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>p=0.008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Median OS (months)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
10.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
5.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
10.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
5.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>p=0.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>p=0.003<BR></FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <P style="font-family:times;"><FONT SIZE=2><I>When cross over patients are removed, median OS in patients with gpNMB over-expression is 10.0&nbsp;months for glembatumumab vedotin vs 5.2&nbsp;months for IC (p=0.05) and
median OS in triple negative patients with gpNMB over-expression is 10.0&nbsp;months for glembatumumab vedotin vs 5.2&nbsp;months for IC
(p=0.009).</I></FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=48,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=219909,FOLIO='44',FILE='DISK104:[13ZDF1.13ZDF47701]DO47701A.;16',USER='BGARDNE',CD='25-FEB-2014;17:25' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq47701_1_45"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2013, we initiated METRIC, a randomized, controlled study of glembatumumab vedotin in patients with triple negative breast cancer that over-express gpNMB designed to obtain
accelerated approval. METRIC will be conducted in approximately 100 sites, primarily across the United States with additional sites in Canada and Australia and will enroll approximately 300 patients. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment of Metastatic Melanoma:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Phase 1/2 open-label, multi-center, dose escalation study evaluated the safety, tolerability and
pharmacokinetics of glembatumumab vedotin in 117 patients with un-resectable Stage&nbsp;III or Stage&nbsp;IV melanoma who had failed no more than one prior line of cytotoxic therapy. The MTD was
determined to be 1.88 mg/kg administered intravenously once every three weeks. The study achieved its primary activity objective with an ORR in the Phase&nbsp;2 cohort of 15% (5/34). Median PFS was
3.9&nbsp;months. Glembatumumab vedotin was generally well tolerated, with the most frequent treatment-related adverse events being rash, fatigue, hair loss, pruritus, diarrhea and neuropathy. In the
subset of patients with tumor biopsies, high levels of tumor expression of gpNMB appeared to correlate with favorable outcome. In the seven patients whose tumors were found to express high amounts of
gpNMB, and who were treated at the maximum tolerated doses across all dosing schedules, median PFS was 4.9&nbsp;months. The development of rash, which may be associated with the presence of gpNMB in
the skin also seemed to correlate with greater PFS. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is currently exploring conducting additional clinical studies in indications known to express gpNMB. Phase&nbsp;2 studies in melanoma and squamous cell lung cancer are
expected to initiate in the second half of 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Varlilumab  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Varlilumab is a human monoclonal antibody that targets CD27, a potentially important target for immunotherapy of various cancers. We
have entered into license agreements with the University of Southampton, UK for intellectual property related to uses of anti-CD27 antibodies and with Medarex (now a subsidiary of the Bristol-Myers
Squibb Company) for access to the UltiMab technology to develop and commercialize human antibodies to CD27. In July 2013, the United States Patent and Trademark Office issued a patent to the
University of Southampton, that we have exclusive license to under our license agreement, which broadly supports varlilumab. The patent includes 18 claims covering various methods of treating cancer
using agonistic anti-human CD27 antibodies and relates, among other things, directly to our CD27 antibody program and therapeutic uses of varlilumab. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CD27
acts downstream from CD40 and may provide a novel way to regulate the immune responses. CD27 is a co-stimulatory molecule on T cells and is over-expressed in certain lymphomas and
leukemias. Varlilumab is an agonist antibody designed to have two potential therapeutic mechanisms. Varlilumab has been shown to activate immune cells that can target and eliminate cancerous cells in
tumor-bearing mice and to directly kill or inhibit the growth of CD27 expressing lymphomas and leukemias </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> and </FONT><FONT SIZE=2><I>in
vivo</I></FONT><FONT SIZE=2>. Both mechanisms have been seen even at low doses in appropriate preclinical models. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2013, we announced data from our ongoing open label, dose-escalating Phase&nbsp;1 study of varlilumab in patients with selected malignant solid tumors or hematologic
cancers at multiple clinical sites in the United States. The Phase&nbsp;1 study is designed to test five escalating doses of varlilumab to determine a Phase&nbsp;2 dose for further development
based on safety, tolerability, potential activity and immunogenicity. The results suggest a favorable safety profile with no evidence of immune related toxicities. Clear biologic activity and
promising signs of clinical activity were demonstrated in an advanced, refractory patient population including a complete response in Hodgkin disease, two additional patients with significant tumor
shrinkage and eight patients with stable disease or better (PFS range of 3.0 to 14+ months). No maximum tolerated dose was reached to date and immune monitoring data in patients confirmed varlilumab's
mechanism of action. Expansion cohorts have been enrolling in metastatic melanoma and renal cell carcinoma and are planned in hematologic indications </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=1,SEQ=49,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=960979,FOLIO='45',FILE='DISK104:[13ZDF1.13ZDF47701]DQ47701A.;12',USER='LPALLES',CD='26-FEB-2014;16:42' -->
<A NAME="page_dq47701_1_46"> </A>

<P style="font-family:times;"><FONT SIZE=2>with
initial data anticipated in mid-2014. We intend to initiate new studies of varlilumab in combination with various agents in 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> CDX-301  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-301 is a FMS-like tyrosine kinase 3 ligand, or Flt3L, stem cell mobilizer and dendritic cell growth factor. We licensed CDX-301
from Amgen&nbsp;Inc. in March 2009. CDX-301 is a potent hematopoietic cytokine that stimulates the expansion and differentiation of hematopoietic progenitor and stem cells. CDX-301 has demonstrated
a unique capacity to increase the number of circulating dendritic cells in both laboratory and clinical studies. In addition, CDX-301 has shown impressive results in models of cancer, infectious
diseases and inflammatory/autoimmune diseases. We believe CDX-301 may hold significant opportunity for synergistic development in combination with other proprietary molecules in our portfolio. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2013, we announced final results from our dose-escalating Phase&nbsp;1 study of CDX-301 in 30 healthy subjects in collaboration with Rockefeller University. The
Phase&nbsp;1 study evaluated seven different dosing regimens of CDX-301 to determine the appropriate dose for further development based on safety, tolerability, and biological activity. The data
from the study were consistent with previous clinical experience and demonstrated that CDX-301 was well-tolerated and can effectively mobilize hematopoietic stem cell populations in healthy
volunteers. In December 2013, we announced data from a preclinical combination study of CDX-301and Mozobil&reg; (Plerixafor injection, formerly AMD3100) demonstrating that the combination of
these agents significantly increases hematopoietic stem cell mobilization in mice. The data demonstrate a novel potent cell mobilization regimen combining CDX-301 and Mozobil&reg;, which may
have significant potential for use in autologous and allogeneic hematopoietic stem cell transplantation. Based on the safety profile and the clinical and preclinical data to date, we plan to initiate
a pilot clinical study of CDX-301 as a single-agent and in combination with Mozobil in the transplant setting in the first half of 2014. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> CDX-1401  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-1401, developed from our APC Targeting Technology, is a fusion protein consisting of a fully human monoclonal antibody with
specificity for the dendritic cell receptor, DEC-205, linked to the NY-ESO-1 tumor antigen. In humans, NY-ESO-1 has been detected in 20&nbsp;-&nbsp;30% of all melanoma, lung, esophageal, liver,
gastric, prostate, ovarian and bladder cancers, thus representing a broad opportunity. This product is intended to selectively deliver the NY-ESO-1 antigen to dendritic cells for generating robust
immune responses against cancer cells expressing NY-ESO-1. We are developing CDX-1401 for the treatment of malignant melanoma and a variety of solid tumors which express the proprietary cancer antigen
NY-ESO-1, which we licensed from the Ludwig Institute for Cancer Research in 2006. Preclinical studies have shown that CDX-1401 is effective for activation of human T&nbsp;cell responses against
NY-ESO-1. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;1 study evaluated three different doses of CDX-1401 in combination with toll-like receptor agonists poly-ICLC or Hiltonol&#153; and/or R848 or resiquimod. In
total, the study enrolled
45&nbsp;patients with advanced malignancies that had progressed after any available curative and/or salvage therapies. 60% of patients had confirmed NY-ESO expression in archived tumor sample.
Thirteen patients maintained stable disease for up to 13.4&nbsp;months with a median of 6.7&nbsp;months. Treatment was well-tolerated and there were no dose limiting toxicities. Humoral responses
were elicited in both NY-ESO-1 positive and negative patients. NY-ESO-1-specific T cell responses were absent or low at baseline, but increased post-vaccination in 53% of evaluable patients, including
both CD4 and/or CD8&nbsp;T cell responses. Robust immune responses were observed with CDX-1401 with resiquimod and Poly ICLC alone and in combination. The study has identified a well-tolerated and
immunogenic regimen to take forward into the future studies. We are planning a collaborative Phase&nbsp;2 study of CDX-1401 in combination with CDX-301 in malignant melanoma. This study will be
conducted by the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=50,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=844796,FOLIO='46',FILE='DISK104:[13ZDF1.13ZDF47701]DQ47701A.;12',USER='LPALLES',CD='26-FEB-2014;16:42' -->
<A NAME="page_dq47701_1_47"> </A>

<P style="font-family:times;"><FONT SIZE=2>Cancer
Immunotherapy Trials Network under a cooperative research and development agreement, or CRADA, with the Cancer Therapy Evaluation Program of the National Cancer Institute. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> CDX-1135  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-1135 is a molecule that inhibits a part of the human immune system called the complement system. The complement system is a series
of proteins that are important initiators of the body's acute inflammatory response against disease, infection and injury. Excessive complement activation also plays a role in some persistent
inflammatory conditions. CDX-1135 is a soluble form of naturally occurring Complement Receptor 1 that has been shown to inhibit the activation of the complement cascade in animal models and in human
clinical trials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dense
Deposit Disease, or DDD, is a rare and devastating disease that is caused by uncontrolled activation of the alternative pathway of complement and leads to progressive kidney damage
in children. There is currently no treatment for patients with DDD and about half progress to end-stage renal disease within ten years. Because DDD recurs in virtually all patients who receive a
kidney transplant, transplantation is often not a viable option for these patients. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
July 2013, we initiated a pilot study of CDX-1135 in patients with DDD. Enrollment in the pilot study has been extremely difficult due to the overall rareness of patients with DDD
(300-500 in the U.S.) further compounded by the need to enroll patients at a very specific point in their disease course. The study sought to enroll patients, particularly children, with enough kidney
deterioration to be able to demonstrate clinical benefit/improvement but not so much disease burden that the kidneys were beyond salvaging. While we have been tracking a number of patients for
potential enrollment, some patients progressed too quickly and others never progressed at all. To date, only one patient has been
enrolled. While this patient demonstrated initial evidence of clinical improvement, the effect was not sustained. The results from this one patient combined with our experience using this agent in the
compassionate use setting have not provided the conclusive results necessary for a feasible approval path in this disease. Due to these challenges, we have decided to close the study in DDD and focus
resources on our growing immuno-oncology pipeline at this time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> Preclinical Programs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> CDX-014  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CDX-014 is a fully-human monoclonal ADC that targets TIM-1, a molecule that is highly expressed on renal and ovarian cancers with
minimal expression in normal tissues. The antibody is linked to MMAE using Seattle Genetics' proprietary technology. The ADC is designed to be stable in the bloodstream, but to release MMAE upon
internalization into TIM-1-expressing tumor cells, resulting in a targeted cell-killing effect. CDX-014 has shown potent activity in preclinical models of ovarian and renal cancer. We have conducted
preclinical proof-of-concept studies to optimize the drug candidate and plan to manufacture CDX-014 at our Fall River facility in 2014 prior to initiating IND-enabling toxicology studies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> CRITICAL ACCOUNTING POLICIES AND ESTIMATES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our significant accounting policies are described in Note&nbsp;2 to the consolidated financial statements included in Item&nbsp;8
of this Form&nbsp;10-K. We believe our most critical accounting policies include accounting for business combinations, revenue recognition, impairment of long-lived assets, research and development
expenses and stock-based compensation expense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our consolidated financial statements.
We evaluate our estimates and judgments on an on-going basis. We base our estimates on historical experience and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=51,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=56920,FOLIO='47',FILE='DISK104:[13ZDF1.13ZDF47701]DQ47701A.;12',USER='LPALLES',CD='26-FEB-2014;16:42' -->
<A NAME="page_dq47701_1_48"> </A>

<P style="font-family:times;"><FONT SIZE=2>on
assumptions that we believe to be reasonable under the circumstances. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not
readily apparent from other sources. Actual results may vary from what we anticipate and different assumptions or estimates about the future could materially change our reported results. We believe
the following accounting policies are the most critical to us in that they are important to the portrayal of our financial statements and they require our most difficult, subjective or complex
judgments in the preparation of our consolidated financial statements: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Business Combinations  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We account for business combinations under the acquisition method of accounting. We record the fair value of the consideration
transferred to acquire a business to the tangible assets and identifiable intangible assets acquired and liabilities assumed on the basis of their fair values at the date of acquisition. We assess the
fair value of assets, including intangible assets such as IPR&amp;D, using a variety of methods including present-value models. Each asset is measured at fair value from the perspective of a market
participant. The method used to estimate the fair values of IPR&amp;D assets incorporates significant assumptions regarding the estimates a market participant would make in order to evaluate an asset,
including a market participant's assumptions regarding the probability of completing IPR&amp;D projects, which would require obtaining regulatory approval for marketing of the associated drug candidate; a
market participant's estimates regarding the timing of and the expected costs to complete IPR&amp;D projects; a market participant's estimates of future cash flows from potential product sales; and the
appropriate discount rates for a market participant. Transaction costs and restructuring costs associated with the transaction are expensed as incurred. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IPR&amp;D
assets acquired in a business combination initially are recorded at fair value and accounted for as indefinite-lived intangible assets. These assets are maintained on our
consolidated balance sheets until either the project underlying them is completed or the assets become impaired. If a project is completed, the carrying value of the related intangible asset is
amortized over the remaining estimated life of the asset beginning in the period in which the project is completed. If a project becomes impaired or is abandoned, the carrying value of the related
intangible asset is written down to its fair value and an impairment charge is taken in the period in which the impairment occurs. IPR&amp;D assets are tested for impairment on an annual basis during the
third quarter, or earlier if impairment indicators are present. We performed an annual impairment test of the IPR&amp;D assets as of July&nbsp;1, 2013 and concluded that the IPR&amp;D assets were not
impaired. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible
assets acquired in a business combination with a finite life are recorded at fair value and amortized over the greater of economic consumption or on a straight-line basis over
their estimated useful life. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
difference between the purchase price and the fair value of assets acquired and liabilities assumed in a business combination is recorded to goodwill. Goodwill is evaluated for
impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. We performed an annual impairment test of the goodwill asset as of July&nbsp;1, 2013 and
concluded that the goodwill asset was not impaired. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Revenue Recognition  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or
services have been rendered; the seller's price to the buyer is fixed or determinable; and collectability is reasonably assured. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have entered into and in the future may enter into biopharmaceutical product development agreements with collaborative partners for the research and development of therapeutic drug
products. The terms of the agreements may include nonrefundable signing and licensing fees, funding for </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=52,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=139891,FOLIO='48',FILE='DISK104:[13ZDF1.13ZDF47701]DQ47701A.;12',USER='LPALLES',CD='26-FEB-2014;16:42' -->
<A NAME="page_dq47701_1_49"> </A>

<P style="font-family:times;"><FONT SIZE=2>research,
development and manufacturing, milestone payments and royalties on any product sales derived from collaborations. These multiple element arrangements are analyzed to determine whether the
deliverables can be separated or whether they must be accounted for as a single unit of accounting. In accounting for these transactions, we allocate revenue to the various elements based on their
relative fair value. The fair value of a revenue generating element can be based on current selling prices offered by us or another party for current products or our best estimate of a selling price
for future products. Revenue allocated to an individual element is recognized when all other revenue recognition criteria are met for that element. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
collaborative and other agreements may contain milestone payments. Revenues from milestones, if they are considered substantive, are recognized upon successful accomplishment of
the milestones. Determining whether a milestone is substantive involves judgment, including an assessment of our involvement in achieving the milestones and whether the amount of the payment is
commensurate to our performance. If not considered substantive, milestones are initially deferred and recognized over the remaining performance obligation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments
received to fund certain research activities are recognized as revenue in the period in which the research activities are performed. Revenue from contracts and grants is
recognized as the services are performed and recorded as effort is expended on the contracted work and billed to the government or our contractual partner. Payments received in advance that are
related to future performance are deferred and recognized as revenue when the research projects are performed. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Product
royalty revenue consists of payments received from licensees for a portion of sales proceeds from products that utilize our licensed technologies and are recognized when the
amount of and basis for such royalty payments are reported to us in accurate and appropriate form and in accordance with the related license agreement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Impairment of Long-Lived Assets  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We evaluate the recoverability of our long-lived assets, including property and equipment, and intangible assets when circumstances
indicate that an event of impairment may have occurred. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual
disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the assets, the assets are written-down to their estimated fair values. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development costs, including internal and contract research costs, are expensed as incurred. Research and development
expenses consist mainly of clinical trial costs, manufacturing of clinical material, toxicology and other studies, personnel costs, depreciation, license fees and funding of outside research. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical
trial expenses include expenses associated with clinical research organizations (CRO). The invoicing from CROs for services rendered can lag several months. We accrue the cost
of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, and project management costs. We maintain regular communication with our CROs to
gauge the reasonableness of our estimates. Differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period
in which they become known. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=53,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=178444,FOLIO='49',FILE='DISK104:[13ZDF1.13ZDF47701]DQ47701A.;12',USER='LPALLES',CD='26-FEB-2014;16:42' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ds47701_1_50"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Stock-Based Compensation Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We record stock-based compensation expense for all stock-based awards made to employees and directors based on the estimated fair
values of the stock-based awards expected to vest at the grant date and is adjusted, if necessary, to reflect actual forfeitures. Compensation expense for all stock-based awards to employees and
directors is recognized using the straight-line method over the term of vesting or performance. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
record stock-based compensation expense for stock options granted to non-employees based on the fair value of the stock options which is re-measured over the vesting term resulting in
periodic adjustments to stock-based compensation expense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> RESULTS OF OPERATIONS  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I> Year Ended December&nbsp;31, 2013 compared with Year Ended December&nbsp;31, 2012  </I></B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
$ </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
% </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Development and Licensing Agreements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>146</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Contracts and Grants</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,617</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>281</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,336</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>475</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Royalties</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,441</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (78</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,111</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,202</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7,091</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (63</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Expense:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and Development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>67,401</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>47,398</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>42</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Royalty</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,441</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (78</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and Administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,805</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,789</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>48</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amortization of Acquired Intangible Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(77</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Operating Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>85,553</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>69,279</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,274</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,442</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,365</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Investment and Other Income, Net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>530</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>289</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(927</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,576</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,427</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>38</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><I> Net Loss  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $22.4&nbsp;million increase in net loss for the year ended December&nbsp;31, 2013 compared to the year ended
December&nbsp;31, 2012 was primarily the result of an increase in research and development and general and administrative expenses. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Revenue  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $1.3&nbsp;million increase in contracts and grants revenue for the year ended December&nbsp;31, 2013 compared to the year ended
December&nbsp;31, 2012 was primarily related to our Rockefeller University agreement pursuant to which we perform research and development services for Rockefeller. The agreement includes an
approved project plan for the development services of $4.8&nbsp;million and a term of three years. The $8.4&nbsp;million decrease in product royalty revenue for the year ended December&nbsp;31, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=54,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=999276,FOLIO='50',FILE='DISK104:[13ZDF1.13ZDF47701]DS47701A.;7',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<A NAME="page_ds47701_1_51"> </A>

<P style="font-family:times;"><FONT SIZE=2>2013
compared to the year ended December&nbsp;31, 2012 was related to our retained interests in Rotarix&reg; net royalties which were not sold to Paul Royalty Fund II,&nbsp;L.P., or PRF,
and which is equal to the amount payable to Cincinnati Children's Hospital Medical Center, or CCH, and recognized in royalty expense by us. Our agreement with GlaxoSmithKline&nbsp;plc, or Glaxo,
terminated automatically upon the expiration of the last relevant patent right covered by the Glaxo agreement. We do not expect any more Rotarix royalty revenue. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Research and Development Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses consist primarily of (i)&nbsp;personnel expenses, (ii)&nbsp;laboratory supply expenses relating
to the development of our technology, (iii)&nbsp;facility expenses, and (iv)&nbsp;product development expenses associated with our drug candidates as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
$ </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
% </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Personnel</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,040</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,575</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>27</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Laboratory Supplies</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,247</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,062</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,185</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>57</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Facility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,526</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,457</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,343</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24,426</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,917</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Personnel
expenses primarily include salary, benefits, stock-based compensation and payroll taxes. The $3.6&nbsp;million increase in personnel expenses for the year ended
December&nbsp;31, 2013 compared to the year
ended December&nbsp;31, 2012 was primarily due to higher stock-based compensation of $1.2&nbsp;million and increased headcount. We expect personnel expenses to increase over the next twelve months
as we plan to continue to increase our headcount, primarily to support our rindopepimut and glembatumumab vedotin programs. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Laboratory
supply expenses include laboratory materials and supplies, services, and other related expenses incurred in the development of our technology. The $1.2&nbsp;million increase
in laboratory supply expenses for the year ended December&nbsp;31, 2013 compared to the year ended December&nbsp;31, 2012 was primarily due to higher manufacturing supply purchases. We expect
supply expenses to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Facility
expenses include depreciation, amortization, utilities, rent, maintenance, and other related expenses incurred at our facilities. The $0.1&nbsp;million increase in facility
expenses for the year ended December&nbsp;31, 2013 compared to the year ended December&nbsp;31, 2012 was primarily due to higher utility and maintenance expenses. We expect facility expenses to
increase over the next twelve months primarily related to the amortization of leasehold improvements made at our headquarters facility in Hampton, New Jersey. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Product
development expenses include clinical investigator site fees, external trial monitoring costs, data accumulation costs, contracted research and outside clinical drug product
manufacturing. The $14.9&nbsp;million increase in product development expenses for the year ended December&nbsp;31, 2013 compared to the year ended December&nbsp;31, 2012 was primarily the
result of an increase in clinical trial costs and contract manufacturing of $9.0&nbsp;million and $5.6&nbsp;million, respectively, primarily related to our rindopepimut and glembatumumab vedotin
programs. We expect product development expenses to increase over the next twelve months primarily due to the increase in clinical trial and contract manufacturing expenses related to our rindopepimut
and glembatumumab vedotin programs, although there may be fluctuations on a quarterly basis. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=55,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=601926,FOLIO='51',FILE='DISK104:[13ZDF1.13ZDF47701]DS47701A.;7',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<A NAME="page_ds47701_1_52"> </A>

<P style="font-family:times;"><FONT SIZE=2><I> Royalty Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Royalty expenses include product royalty and sublicense royalty fees on our out-licensed programs. The $8.4&nbsp;million decrease in
royalty expenses for the year ended December&nbsp;31, 2013 compared to the year ended December&nbsp;31, 2012 was due to a decrease in Rotarix related royalty fees. Our retained interests in
Rotarix net royalties which were not sold to PRF are recorded as product royalty revenue and a corresponding amount that is payable to CCH is recorded as
royalty expense. The Glaxo agreement terminated automatically upon the expiration of the last relevant patent right covered by the Glaxo agreement. We do not expect any more Rotarix royalty expense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> General and Administrative Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $4.8&nbsp;million increase in general and administrative expenses for the year ended December&nbsp;31, 2013 compared to the
year ended December&nbsp;31, 2012 was primarily due to higher stock-based compensation of $1.0&nbsp;million, increased headcount and rindopepimut-related commercialization planning costs. We
expect general and administrative expense to increase over the next twelve months primarily due to increased commercial planning efforts for rindopepimut and glembatumumab vedotin, although there may
be fluctuations on a quarterly basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Amortization Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.1&nbsp;million decrease in amortization expenses for the year ended December&nbsp;31, 2013 compared to the year ended
December&nbsp;31, 2012 was due to certain intangible assets becoming fully amortized during 2012. We expect amortization expense of acquired intangible assets to remain relatively consistent over
the next twelve months. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Investment and Other Income, Net  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.3&nbsp;million increase in investment and other income, net for the year ended December&nbsp;31, 2013 compared to the year
ended December&nbsp;31, 2012 was primarily due to higher levels of cash and investment balances compared to prior year and us recognizing $0.2&nbsp;million and $0.1&nbsp;million in other income
related to our sale of New Jersey tax benefits during the years ended December&nbsp;31, 2013 and 2012, respectively. We anticipate investment income to increase over the next twelve months due to
higher cash and investment balances resulting from our underwritten public offering in December 2013. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Interest Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.6&nbsp;million decrease in interest expense for the year ended December&nbsp;31, 2013 compared to the year ended
December&nbsp;31, 2012 was primarily due to our election in May 2013 to prepay the Term Loan in full, pursuant to the terms of our loan agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=56,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=589368,FOLIO='52',FILE='DISK104:[13ZDF1.13ZDF47701]DS47701A.;7',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<A NAME="page_ds47701_1_53"> </A>

<P style="font-family:times;"><FONT SIZE=2><B><I> Year Ended December&nbsp;31, 2012 compared with Year Ended December&nbsp;31, 2011  </I></B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
$ </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
% </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Development and Licensing Agreements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>146</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>110</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Contracts and Grants</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>281</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>245</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>681</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Royalties</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,119</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,656</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,202</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,265</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Expense:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and Development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>47,398</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,439</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,959</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>46</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Royalty</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,119</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,656</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and Administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,193</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>823</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amortization of Acquired Intangible Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,913</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(823</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (43</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Operating Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>69,279</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>52,664</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,615</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(43,399</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,678</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Investment and Other Income, Net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>530</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>396</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>134</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,576</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,796</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(220</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> (12</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,324</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><I> Net Loss  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $14.3&nbsp;million increase in net loss for the year ended December&nbsp;31, 2012 compared to the year ended
December&nbsp;31, 2011 was primarily the result of an increase in research and development and general and administrative expenses, partially offset by a decrease in amortization expense on acquired
intangible assets. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Revenue  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.2&nbsp;million increase in contracts and grants revenue for the year ended December&nbsp;31, 2012 compared to the year ended
December&nbsp;31, 2011 was due to an APC Targeting Technology-based HIV vaccine being funded through a Small Business Innovation Research, or SBIR, grant in collaboration with Rockefeller
University. The $1.7&nbsp;million increase in product royalty revenue for the year ended December&nbsp;31, 2012 compared to the year ended December&nbsp;31, 2011 was related to our retained
interests in Rotarix net royalties which were not sold to PRF and which is equal to the amount payable to CCH and recognized in royalty expense by us. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=57,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=238672,FOLIO='53',FILE='DISK104:[13ZDF1.13ZDF47701]DS47701A.;7',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_du47701_1_54"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><I> Research and Development Expense  </I></FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
$ </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase/<BR>
(Decrease)<BR>
% </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Personnel</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,715</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Laboratory Supplies</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,062</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,920</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>142</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Facility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,457</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,674</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(217</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2> (5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24,426</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,044</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,382</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>143</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
$0.8&nbsp;million increase in personnel expenses for the year ended December&nbsp;31, 2012 compared to the year ended December&nbsp;31, 2011 was primarily due to higher
headcount. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
$0.1&nbsp;million increase in laboratory supply expenses for the year ended December&nbsp;31, 2012 compared to the year ended December&nbsp;31, 2011 was primarily due to higher
manufacturing supply purchases. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
$0.2&nbsp;million decrease in facility expenses for the year ended December&nbsp;31, 2012 compared to the year ended December&nbsp;31, 2011 was primarily due to lower
depreciation and amortization expenses. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
$14.4&nbsp;million increase in product development expenses for the year ended December&nbsp;31, 2012 compared to the year ended December&nbsp;31, 2011 was primarily the result
of an increase in clinical trial costs of $14.3&nbsp;million primarily due to our rindopepimut program. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Royalty Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $1.7&nbsp;million increase in royalty expenses for the year ended December&nbsp;31, 2012 compared to the year ended
December&nbsp;31, 2011 was primarily due to an increase in Rotarix related royalty fees. Our retained interests in Rotarix net royalties which were not sold to PRF are recorded as product royalty
revenue and a corresponding amount that is payable to CCH is recorded as royalty expense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> General and Administrative Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.8&nbsp;million increase in general and administrative expenses for the year ended December&nbsp;31, 2012 compared to the
year ended December&nbsp;31, 2011 was primarily due to higher headcount and rindopepimut-related commercialization expenses. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Amortization Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.8&nbsp;million decrease in amortization expenses for the year ended December&nbsp;31, 2012 compared to the year ended
December&nbsp;31, 2011 was due to certain intangible assets becoming fully amortized during 2011. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Investment and Other Income, Net  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.1&nbsp;million increase in investment and other income, net for the year ended December&nbsp;31, 2012 compared to the year
ended December&nbsp;31, 2011 was primarily due to us recognizing $0.1&nbsp;million in other income related to our sale of New Jersey tax benefits. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Interest Expense  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $0.2&nbsp;million decrease in interest expense for the year ended December&nbsp;31, 2012 compared to the year ended
December&nbsp;31, 2011 was due to a decrease in our Term Loan balance. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=58,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=891285,FOLIO='54',FILE='DISK104:[13ZDF1.13ZDF47701]DU47701A.;11',USER='HYUNG',CD='26-FEB-2014;11:34' -->
<A NAME="page_du47701_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2><B> LIQUIDITY AND CAPITAL RESOURCES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our cash equivalents are highly liquid investments with a maturity of three months or less at the date of purchase and consist
primarily of investments in money market mutual funds with commercial banks and financial institutions. We maintain cash balances with financial institutions in excess of insured limits. We do not
anticipate any losses with respect to such cash balances. We invest our excess cash balances in marketable securities including municipal bond
securities, U.S. government agency securities, and high-grade corporate bonds that meet high credit quality standards, as specified in our investment policy. Our investment policy seeks to manage
these assets to achieve our goals of preserving principal and maintaining adequate liquidity. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
use of our cash flows for operations has primarily consisted of salaries and wages for our employees, facility and facility-related costs for our offices, laboratories and
manufacturing facility, fees paid in connection with preclinical studies, clinical studies, contract manufacturing, laboratory supplies and services, consulting, legal and other professional fees. To
date, the primary sources of cash flows from operations have been payments received from our collaborative partners and from government entities. The timing of any new collaboration agreements,
government contracts or grants and any payments under these agreements, contracts or grants cannot be easily predicted and may vary significantly from quarter to quarter. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2013, our principal sources of liquidity consisted of cash, cash equivalents and marketable securities of $303.0&nbsp;million. We incurred a loss of
$81.6&nbsp;million for the year ended December&nbsp;31, 2013. Net cash used in operations for the year ended December&nbsp;31, 2013 was $67.7&nbsp;million. We believe that the cash, cash
equivalents and marketable securities at December&nbsp;31, 2013 are sufficient to meet estimated working capital requirements and fund planned operations for more than the next two years. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the next twelve months, we may take further steps to raise additional capital to fund our long-term liquidity needs. Our capital raising activities may include, but may not be
limited to, one or more of the following: the licensing of technology programs with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common
stock or other securities via private placements or public offerings. While we may continue to seek capital through a number of means, there can be no assurance that additional financing will be
available on acceptable terms, if at all, and our negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that we will be able to enter
into further collaborative relationships. Additional equity financing may be dilutive to our stockholders; debt financing, if available, may involve significant cash payment obligations and covenants
that restrict our ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce our economic potential from products under
development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Operating Activities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities was $67.7&nbsp;million for the year ended December&nbsp;31, 2013 compared to
$49.8&nbsp;million for the year ended December&nbsp;31, 2012. The increase in net cash used in operating activities was primarily due to an increase in net loss of $22.4&nbsp;million. We expect
that cash used in operating activities will increase over the next twelve months primarily related to costs incurred on our rindopepimut and glembatumumab vedotin programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have incurred and will continue to incur significant costs in the area of research and development, including preclinical and clinical trials, as our drug candidates are developed. We
plan to spend significant amounts to progress our current drug candidates through the clinical trial and commercialization processes as well as to develop additional drug candidates. As our drug
candidates progress through the clinical trial process, we may be obligated to make significant milestone payments. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=59,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=218135,FOLIO='55',FILE='DISK104:[13ZDF1.13ZDF47701]DU47701A.;11',USER='HYUNG',CD='26-FEB-2014;11:34' -->
<A NAME="page_du47701_1_56"> </A>

<P style="font-family:times;"><FONT SIZE=2><I> Investing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities was $77.4&nbsp;million for the year ended December&nbsp;31, 2013 compared to
$17.0&nbsp;million for the year ended December&nbsp;31, 2012. The increase in net cash used in investing activities was primarily due to net purchases of marketable securities for the year ended
December&nbsp;31, 2013 of $73.2&nbsp;million as compared to $16.9&nbsp;million for the year ended December&nbsp;31, 2012. We expect that cash used in investing activities will increase over
the next twelve months as we purchase more marketable securities with the funds raised in December 2013. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Financing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities was $289.6&nbsp;million for the year ended December&nbsp;31, 2013 compared to
$79.8&nbsp;million for the year ended December&nbsp;31, 2012. Net proceeds from stock issuances, including stock issued pursuant to employee benefit plans, were $301.1&nbsp;million during the
year ended December&nbsp;31, 2013 compared to $83.8&nbsp;million for the year ended December&nbsp;31, 2012. We paid $11.0&nbsp;million and $4.0&nbsp;million in principal payments on our Term
Loan during the years ended December&nbsp;31, 2013 and 2012, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
May 2013, pursuant to the terms of our Loan Agreement, we elected to prepay our Term Loan in full and paid $8.8&nbsp;million in principal and $0.7&nbsp;million in interest,
prepayment and final payment fees. The Term Loan would have otherwise matured in December 2014. By prepaying the term loan in May 2013, we saved approximately $0.5&nbsp;million in interest costs
(net of prepayment fees) which would have been payable over the remaining term of the loan. Our obligations under the Loan Agreement had been secured by a first priority security interest in
substantially all of its assets, other than its intellectual property. In connection with the repayment of the Term Loan and the termination of the Loan Agreement, those security interests were
released. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Equity Offerings  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In April 2010, we filed a shelf registration statement with the Securities and Exchange Commission to register for sale any combination
of the types of securities described in the shelf registration statement up to a dollar amount of $150&nbsp;million. The shelf registration went effective on April&nbsp;22, 2010. In December 2012,
we filed a new shelf registration statement with the Securities and Exchange Commission to register for sale any combination of the types of securities described in the new shelf registration
statement up to a dollar amount of $200&nbsp;million. The new shelf registration went effective on January&nbsp;16, 2013. In December 2013, we filed a new automatic shelf registration statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the years ended December&nbsp;31, 2013, 2012 and 2011, we issued 21,613,483, 12,075,000 and 11,500,000 shares of our common stock in underwritten public offerings resulting in
net proceeds to us of $278.6&nbsp;million, $43.5&nbsp;million and $33.7&nbsp;million, after deducting underwriting fees and offering expenses, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the years ended December&nbsp;31, 2013, 2012 and 2011, we issued 2,433,608, 8,003,290 and 575,000 shares of our common stock under our controlled equity offering sales agreement
with Cantor Fitzgerald&nbsp;&amp;&nbsp;Co., as amended, resulting in net proceeds to us of $17.1&nbsp;million, $40.1&nbsp;million and $2.2&nbsp;million, after deducting commission and offering
expenses, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> AGGREGATE CONTRACTUAL OBLIGATIONS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into license agreements whereby we have received licenses or options to license technology, specified patents and/or
patent applications. These license and collaboration agreements generally provide for royalty payments equal to specified percentages of product sales, annual license maintenance fees, continuing
patent prosecution costs and potential future milestone payments to third parties upon the achievement of certain development, regulatory and/or commercial milestones. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=60,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=1012104,FOLIO='56',FILE='DISK104:[13ZDF1.13ZDF47701]DU47701A.;11',USER='HYUNG',CD='26-FEB-2014;11:34' -->
<A NAME="page_du47701_1_57"> </A>

<P style="font-family:times;"><FONT SIZE=2>Because
the achievement of these milestones had not occurred as of December&nbsp;31, 2013, such contingencies have not been recorded in our financial statements. We expect to incur approximately
$3.8&nbsp;million of license and milestone payments in 2014. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes our contractual obligations (not including contingent royalty and milestone payments as described above) at December&nbsp;31, 2013 and the effect such
obligations and commercial commitments are expected to have on our liquidity and cash flow in future years. These obligations, commitments and supporting arrangements represent expected payments based
on current operating forecasts, which are subject to change: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2015&nbsp;-&nbsp;2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017&nbsp;-&nbsp;2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Thereafter </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Contractual obligations:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating lease obligations(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,876</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,666</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,777</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,266</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>167</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other contractual obligations(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,550</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,550</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total contractual obligations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,426</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,216</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,777</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,266</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>167</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Such
amounts primarily consist of payments for our facility leases and do not assume the exercise of renewal terms or early termination provisions.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>We
enter into agreements in the normal course of business with contract research organizations for clinical trials, contract manufacturing organizations,
vendors for preclinical research studies and other services and products for operating purposes. We have included obligations in the table above if the contracts are not cancelable at any time by us,
generally upon 30&nbsp;days prior written notice to the vendor.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B> RECENT ACCOUNTING PRONOUNCEMENTS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Refer to Note&nbsp;2, "Summary of Significant Accounting Policies," in the accompanying notes to the consolidated financial
statements for a discussion of recent accounting pronouncements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> OFF-BALANCE SHEET ARRANGEMENTS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="du47701_item_7a._quantitative_and_qual__ite02669"> </A>
<A NAME="toc_du47701_1"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;7A.&nbsp;&nbsp;&nbsp;&nbsp;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We own financial instruments that are sensitive to market risk as part of our investment portfolio. Our investment portfolio is used to
preserve our capital until it is used to fund operations, including our research and development activities. None of these market-risk sensitive instruments are held for trading purposes. We invest
our cash primarily in money market mutual funds. These investments are evaluated quarterly to determine the fair value of the portfolio. From time to time, we invest our excess cash balances in
marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds that meet high credit quality standards, as specified in our investment
policy. Our investment policy seeks to manage these assets to achieve our goals of preserving principal and maintaining adequate liquidity. Because of the short-term nature of these investments, we do
not believe we have material exposure due to market risk. The impact to our financial position and results of operations from likely changes in interest rates is not material. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not utilize derivative financial instruments. The carrying amounts reflected in the consolidated balance sheet of cash and cash equivalents, accounts receivables and accounts
payable approximates fair value at December&nbsp;31, 2013 due to the short-term maturities of these instruments. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>57</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=61,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=598032,FOLIO='57',FILE='DISK104:[13ZDF1.13ZDF47701]DU47701A.;11',USER='HYUNG',CD='26-FEB-2014;11:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fa47701_1_58"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fa47701_item_8._financial_statements_and_supplementary_data"> </A>
<A NAME="toc_fa47701_1"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="fa47701_report_of_independent___fa402281"> </A>
<A NAME="toc_fa47701_2"> </A></FONT> <FONT SIZE=2><B>  REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>To
the Board of Directors and Stockholders of Celldex Therapeutics,&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations and comprehensive loss, of stockholders' equity, and of cash flows,
present fairly, in all material respects, the financial position of Celldex Therapeutics,&nbsp;Inc. and its subsidiaries at December&nbsp;31, 2013 and December&nbsp;31, 2012, and the results of
their operations and their cash flows for each of the three years in the period ended December&nbsp;31, 2013 in conformity with accounting principles generally accepted in the United States of
America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&nbsp;31, 2013, based on criteria established in </FONT> <FONT SIZE=2><I>Internal
Control&#151;Integrated Framework (1992)</I></FONT><FONT SIZE=2> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The
Company's management is responsible for these financial statements, for maintaining effective internal control over
financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control over Financial Reporting
appearing under Item&nbsp;9A. Our responsibility is to express opinions on these financial statements and on the Company's internal control over financial reporting based on our integrated audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and
significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of
internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the
assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures
that (i)&nbsp;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)&nbsp;provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)&nbsp;provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>/s/
PricewaterhouseCoopers&nbsp;LLP </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Boston,
Massachusetts<BR>
March&nbsp;3, 2014 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>58</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=62,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=399662,FOLIO='58',FILE='DISK104:[13ZDF1.13ZDF47701]FA47701A.;8',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fc47701_1_59"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="fc47701_celldex_therapeutics,_inc._con__cel03928"> </A>
<A NAME="toc_fc47701_1"> </A></FONT> <FONT SIZE=2><B><BR>  CELLDEX THERAPEUTICS,&nbsp;INC.    <BR>    <BR>    CONSOLIDATED BALANCE SHEETS    <BR>    <BR>    (In thousands, except share and per share amounts)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>ASSETS</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current Assets:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and Cash Equivalents</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>169,402</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24,897</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable Securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>133,581</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>59,065</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts and Other Receivables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>489</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>44</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prepaid and Other Current Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,717</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,108</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Current Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>305,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>85,114</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and Equipment, Net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,973</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Intangible Assets, Net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,833</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>148</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>424</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Goodwill</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,965</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,965</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>347,095</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>125,541</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>LIABILITIES AND STOCKHOLDERS' EQUITY</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current Liabilities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts Payable</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,243</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>745</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued Expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,179</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,960</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current Portion of Long-Term Liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>388</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current Portion of Term Loan</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,592</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Current Liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,685</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term Loan, less Current Portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,746</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Long-Term Liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,336</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>27,300</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>29,767</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Commitments and Contingent Liabilities (Notes&nbsp;14 and 16)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stockholders' Equity:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at December&nbsp;31, 2013 and 2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,246,832 and 64,359,513 Shares Issued and Outstanding at December&nbsp;31, 2013 and 2012,
respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>89</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Additional Paid-In Capital</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>662,717</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>357,094</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated Other Comprehensive Income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,668</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,745</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated Deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(345,679</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(264,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Stockholders' Equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>319,795</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>95,774</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Liabilities and Stockholders' Equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>347,095</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>125,541</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>59</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=63,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=941900,FOLIO='59',FILE='DISK104:[13ZDF1.13ZDF47701]FC47701A.;7',USER='HYUNG',CD='26-FEB-2014;11:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fe47701_1_60"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="fe47701_celldex_therapeutics,_inc._con__cel04980"> </A>
<A NAME="toc_fe47701_1"> </A></FONT> <FONT SIZE=2><B><BR>  CELLDEX THERAPEUTICS,&nbsp;INC.    <BR>    <BR>    CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS    <BR>    <BR>    (In thousands, except per share amounts)    <BR>
</B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>REVENUE:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Development and Licensing Agreements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>146</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>110</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Contracts and Grants</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,617</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>281</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Product Royalties</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,119</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,111</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,202</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,265</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>OPERATING EXPENSE:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and Development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>67,401</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>47,398</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,439</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Royalty</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,775</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,119</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and Administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,805</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,193</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amortization of Acquired Intangible Assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,913</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Operating Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>85,553</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>69,279</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>52,664</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,442</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(43,399</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Investment and Other Income, Net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>530</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>396</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest Expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(927</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,576</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,796</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and Diluted Net Loss Per Common Share (See Note&nbsp;2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.02</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.02</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Used in Calculating Basic and Diluted Net Loss per Share (See Note&nbsp;2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,777</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>57,713</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>39,501</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>COMPREHENSIVE LOSS:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Comprehensive Income (Loss):</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign Currency Translation Adjustments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unrealized (Loss) Gain on Marketable Securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>91</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(90</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Comprehensive Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,627</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,030</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,898</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>60</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=64,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=941328,FOLIO='60',FILE='DISK104:[13ZDF1.13ZDF47701]FE47701A.;6',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fg47701_1_61"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>CELLDEX THERAPEUTICS,&nbsp;INC.<BR>
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY<BR>
(In thousands, except share amounts)  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Common<BR>
Stock<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Common<BR>
Stock Par<BR>
Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Additional<BR>
Paid-In<BR>
Capital </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Other<BR>
Comprehensive<BR>
Income </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
Stockholders'<BR>
Equity </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Balance at December&nbsp;31, 2010</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 32,055,382</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>32</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>232,679</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>2,751</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(160,207</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>75,255</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued under Stock Option and Employee Stock Purchase Plans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80,254</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>173</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>173</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued in Connection with Cantor Agreement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>575,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,154</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,155</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued in Underwritten Offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,500,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33,684</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33,695</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-Based Compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign Currency Translation Adjustments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unrealized Losses on Marketable Securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(90</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(90</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Balance at December&nbsp;31, 2011</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 44,210,636</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>44</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>271,032</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>2,652</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(205,006</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>68,722</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued under Stock Option and Employee Stock Purchase Plans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>70,587</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>163</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>163</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued in Connection with Cantor Agreement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,003,290</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40,130</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40,138</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued in Underwritten Offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,075,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>43,471</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>43,483</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-Based Compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,298</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,298</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign Currency Translation Adjustments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unrealized Gains on Marketable Securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>91</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>91</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Balance at December&nbsp;31, 2012</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 64,359,513</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>64</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>357,094</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>2,745</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(264,129</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>95,774</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued under Stock Option and Employee Stock Purchase Plans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>840,228</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,402</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,403</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued in Connection with Cantor Agreement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,433,608</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,132</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,134</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Issued in Underwritten Offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,613,483</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>278,541</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>278,563</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-Based Compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,548</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,548</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign Currency Translation Adjustments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unrealized Losses on Marketable Securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Balance at December&nbsp;31, 2013</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 89,246,832</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>89</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>662,717</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>2,668</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(345,679</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2><B>$</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>319,795</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>The
accompanying notes are an integral part of the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>61</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=65,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=934000,FOLIO='61',FILE='DISK104:[13ZDF1.13ZDF47701]FG47701A.;9',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fi47701_1_62"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="fi47701_celldex_therapeutics,_inc._con__cel02991"> </A>
<A NAME="toc_fi47701_1"> </A></FONT> <FONT SIZE=2><B><BR>  CELLDEX THERAPEUTICS,&nbsp;INC.    <BR>    <BR>    CONSOLIDATED STATEMENTS OF CASH FLOWS    <BR>    <BR>    (In thousands)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Cash Flows From Operating Activities:</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Loss</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adjustments to Reconcile Net Loss to Cash Used in Operating
Activities:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Depreciation and Amortization</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,932</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,047</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,248</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amortization of Intangible Assets</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,090</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,913</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amortization and Premium of Marketable Securities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,366</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(660</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Realized (Gain) Loss on Sales and Maturities of Marketable Securities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gain on Sale or Disposal of Assets</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stock-Based Compensation Expense&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,548</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,298</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-Cash Interest Expense</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>97</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>226</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>307</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Changes in Operating Assets and Liabilities:</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts and Other Receivables</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(445</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>126</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>154</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prepaid and Other Current Assets</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(706</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>241</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Assets</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>276</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(95</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts Payable and Accrued Expenses</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,236</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,762</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,076</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Liabilities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,317</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>594</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(138</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Cash Used in Operating Activities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(67,669</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(49,782</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(35,658</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Cash Flows From Investing Activities:</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sales and Maturities of Marketable Securities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>38,894</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>52,360</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>51,003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Purchases of Marketable Securities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(112,118</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(69,255</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(52,717</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition of Property and Equipment&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(303</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(509</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from Sale or Disposal of Assets</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>218</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>68</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Cash Used in Investing Activities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(77,422</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16,980</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,155</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Cash Flows From Financing Activities:</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Proceeds from Stock Issuances</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>295,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>83,784</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>36,023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from Issuance of Stock from Employee Benefit Plans</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,403</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>(Payments) Issuance of Term Loan</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11,029</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,971</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Payment of Convertible Subordinated Debt</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(12,503</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Payment of Other Liabilities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(472</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(86</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Cash Provided by Financing Activities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>289,599</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,758</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>28,434</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Effect of Exchange Rate Changes on Cash and Cash Equivalents</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Increase (Decrease) in Cash and Cash Equivalents</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>144,505</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,998</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,388</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and Cash Equivalents at Beginning of Period</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24,897</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,899</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,287</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and Cash Equivalents at End of Period</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>169,402</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24,897</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,899</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="TOP" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Supplemental Disclosure of Cash Flow Information</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash Paid for Interest</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,209</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,384</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,560</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"> <FONT SIZE=2>
The accompanying notes are an integral part of the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>62</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=66,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=528180,FOLIO='62',FILE='DISK104:[13ZDF1.13ZDF47701]FI47701A.;10',USER='HYUNG',CD='26-FEB-2014;11:35' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fk47701_1_63"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="fk47701_celldex_therapeutics,_inc._not__cel02700"> </A>
<A NAME="toc_fk47701_1"> </A></FONT> <FONT SIZE=2><B><BR>  CELLDEX THERAPEUTICS,&nbsp;INC.    <BR>    <BR>    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (1) NATURE OF BUSINESS AND OVERVIEW  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Celldex Therapeutics,&nbsp;Inc. (the "Company" or "Celldex") is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for
the treatment of cancer and other difficult-to-treat diseases. The Company's lead drug candidates include rindopepimut (also referred to as CDX-110) and glembatumumab vedotin (also referred to as
CDX-011). Rindopepimut is a targeted immunotherapeutic in a pivotal Phase&nbsp;3 study for the treatment of front-line glioblastoma and a Phase&nbsp;2 study for the treatment of recurrent
glioblastoma. Glembatumumab vedotin is an antibody-drug conjugate in a randomized study in patients with triple negative breast cancer that over-express gpNMB designed to obtain accelerated approval.
The Company has a number of earlier stage candidates in clinical development, including varlilumab (also referred to as CDX-1127), a fully human therapeutic monoclonal antibody in a Phase&nbsp;1
study for cancer indications, CDX-301, an immune cell mobilizing agent and dendritic cell growth factor and CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells for cancer
indications. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2013, the Company had cash, cash equivalents and marketable securities of $303.0&nbsp;million. The Company incurred a loss of $81.6&nbsp;million for the year
ended December&nbsp;31, 2013. Net cash used in operations for the year ended December&nbsp;31, 2013 was $67.7&nbsp;million. The Company believes that the cash, cash equivalents and marketable
securities at December&nbsp;31, 2013 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the next twelve months, the Company may take further steps to raise additional capital to meet its long-term liquidity needs. These capital raising activities may include, but may
not be limited to, one or more of the following: the licensing of technology programs with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of
common stock or other securities via private placements or public offerings. While the Company continues to seek capital through a number of means, there can be no assurance that additional financing
will be available on acceptable terms, if at all, and the Company's negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the
Company will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to the Company's stockholders; debt financing, if available, may involve
significant cash payment obligations and covenants that restrict the Company's ability to operate as a business; and licensing or strategic
collaborations may result in royalties or other terms which reduce the Company's economic potential from products under development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Basis of Presentation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The accompanying consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary. All
intercompany balances and transactions have been eliminated in consolidation. The Company operates in one segment, which is the business of development, manufacturing and commercialization of novel
therapeutics for human health care. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Use of Estimates  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United
States of America (U.S.&nbsp;GAAP) requires management to make </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>63</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=67,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=890888,FOLIO='63',FILE='DISK104:[13ZDF1.13ZDF47701]FK47701A.;8',USER='BGARDNE',CD='25-FEB-2014;17:38' -->
<A NAME="page_fk47701_1_64"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>estimates
and use assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Cash and Cash Equivalents  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company considers all highly liquid investments purchased with a maturity date of 90&nbsp;days or less at the date of purchase to
be cash equivalents. Cash equivalents consist principally of money market funds and debt securities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Marketable Securities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company invests its excess cash balances in marketable securities including municipal bond securities, U.S. government agency
securities, and high-grade corporate bonds. The Company classifies all of its marketable securities as current assets on the consolidated balance sheets because they are available-for-sale and
available to fund current operations. Marketable securities are stated at fair value with their unrealized gains and losses included as a component of accumulated other comprehensive income (loss),
which is a separate component of stockholders' equity, until such gains and losses are realized. If a decline in the fair value is considered other-than-temporary, based on available evidence, the
unrealized loss is transferred from other comprehensive income (loss) to the consolidated statements of operations. Realized gains and losses are determined on the specific identification method and
are included in investment and other income, net. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Concentration of Credit Risk and of Significant Customers and Suppliers  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash
equivalents, marketable securities and accounts receivable. The Company invests its cash, cash equivalents and marketable securities in debt instruments and interest bearing accounts at major
financial institutions in excess of insured limits. The
Company mitigates credit risk by limiting the investment type and maturity to securities that preserve capital, maintain liquidity and have a high credit quality. The Company has not historically
experienced credit losses from its accounts receivable and therefore has not established an allowance for doubtful accounts. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue
from Glaxo represented 57%, 96% and 98% for the years ended December&nbsp;31, 2013, 2012 and 2011 and of total Company revenue, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company relies on contract manufacturing organizations (CMO) to manufacture drug substance and drug product for its late-stage clinical studies of rindopepimut and glembatumumab
vedotin as well as for future commercial supplies. The Company also relies on CMOs for supply of raw materials as well as filling, packaging, storage and shipping of drug product. These clinical
studies would be adversely affected by a significant interruption in the supply of rindopepimut and glembatumumab vedotin. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Fair Value Measurements  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has certain assets and liabilities that are measured at fair value in the financial statements. The Company seeks to
maximize the use of observable inputs (market data obtained from </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>64</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=68,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=337616,FOLIO='64',FILE='DISK104:[13ZDF1.13ZDF47701]FK47701A.;8',USER='BGARDNE',CD='25-FEB-2014;17:38' -->
<A NAME="page_fk47701_1_65"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>sources
independent from the Company) and to minimize the use of unobservable inputs (the Company's assumptions about how market participants would price assets and liabilities) when measuring the
fair value of its assets and liabilities. These assets and liabilities are classified into one of three levels of the following fair value hierarchy as defined by U.S.&nbsp;GAAP: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;1:
Observable inputs such as quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;2:
Observable inputs other than Level&nbsp;1 prices, such as quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or
liabilities in markets that are not active. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;3:
Unobservable inputs based on the Company's assessment of the assumptions that market participants would use in pricing the asset or liability. </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2><I> Property and Equipment  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment is stated at cost and depreciated over the estimated useful lives of the related assets using the straight-line
method. Laboratory equipment and office furniture and equipment are depreciated over five years and computer equipment is depreciated over three years. Manufacturing equipment is amortized over seven
to ten years. Leasehold improvements are amortized over the shorter of the estimated useful life or the non-cancelable term of the related lease, including any renewals that are reasonably assured of
occurring. Property and equipment under construction is classified as construction in progress and is depreciated or amortized only after the asset is placed in service. Expenditures for maintenance
and repairs are charged to expense whereas the costs of significant improvements which extend the life of the underlying asset are capitalized. Upon retirement or sale, the cost of assets disposed of
and the related accumulated depreciation are eliminated and any resulting gain or loss is reflected in the Company's consolidated statements of operations and comprehensive loss. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
treatment of costs to construct property and equipment depends on the nature of the costs and the stage of construction. Costs incurred in the project planning, design, construction
and installation phases are capitalized as part of the cost of the asset. The Company stops capitalizing these costs when the asset is substantially complete and ready for its intended use. For
manufacturing property and equipment, the Company also capitalizes the cost of validating these assets for the underlying manufacturing process. The Company completes the capitalization of validation
costs when the asset is substantially complete and ready for its intended use. Costs capitalized include incremental labor and fringe benefits, and direct consultancy services. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Business Combinations  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company records the fair value of the consideration transferred to acquire a business to the tangible assets and identifiable
intangible assets acquired and liabilities assumed on the basis of their fair values at the date of acquisition. The Company assesses the fair value of assets, including intangible assets such as
in-process research and development (IPR&amp;D), using a variety of methods including present value models. Each asset is measured at fair value from the perspective of a market </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>65</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=69,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=442054,FOLIO='65',FILE='DISK104:[13ZDF1.13ZDF47701]FK47701A.;8',USER='BGARDNE',CD='25-FEB-2014;17:38' -->
<A NAME="page_fk47701_1_66"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>participant.
The method used to estimate the fair values of IPR&amp;D assets incorporates significant assumptions regarding the estimates a market participant would make in order to evaluate an asset,
including a market participant's assumptions regarding the probability of completing IPR&amp;D projects, which would require obtaining regulatory approval for marketing of the associated drug candidate; a
market participant's estimates regarding the timing of and the expected costs to complete IPR&amp;D projects; a market participant's estimates of future cash flows from potential product sales; and the
appropriate discount rates for a market participant. Transaction costs and restructuring costs associated with the transaction are expensed as incurred. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the acquisition of CuraGen Corporation ("CuraGen") in October 2009, the Company assumed CuraGen's $12.5&nbsp;million in 4% convertible subordinated debt due
February&nbsp;15, 2011 (the "Convertible Subordinated Debt"). In February 2011, the Company paid $12.8&nbsp;million and satisfied all the outstanding principal and accrued interest related to the
Convertible Subordinated Debt. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Intangible Assets  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IPR&amp;D assets acquired in a business combination initially are recorded at fair value and accounted for as indefinite-lived intangible
assets. These assets are maintained on the Company's consolidated balance sheets until either the project underlying them is completed or the assets become impaired. If a project is completed, the
carrying value of the related intangible asset is amortized over the remaining estimated life of the asset beginning in the period in which the project is completed. If a project becomes impaired or
is abandoned, the carrying value of the related intangible asset is written down to its fair value and an impairment charge is taken in the period in which the impairment occurs. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2013, the Company adopted a new U.S.&nbsp;GAAP accounting standard which amended guidance applicable to annual impairment tests of indefinite-lived intangible assets. The
amended guidance added an optional qualitative assessment for determining whether an indefinite-lived intangible asset is impaired. Prior to this guidance, companies were required to perform an annual
impairment test that included a calculation of the fair value of the asset and a comparison of that fair value with its carrying value. If the carrying value exceeded the fair value, an impairment was
recorded. The amended guidance allows a company the option to perform a qualitative assessment, considering both negative and positive evidence, regarding the potential impairment of the
indefinite-lived intangible asset. If, based on the qualitative analysis, the company determines that it is more likely than not that the fair value of such an asset exceeds its carrying value, the
company would be permitted to conclude that the indefinite-lived intangible asset was not impaired without a quantitative calculation of the fair value of the asset. Otherwise, the company would
perform the quantitative calculation of the fair value and the comparison with the carrying value. The Company's adoption of this new standard did not have a material effect on its operating results
or financial position. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IPR&amp;D
assets are tested for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. As part of the annual impairment test of the IPR&amp;D
assets as of July&nbsp;1, 2013, the Company bypassed the optional qualitative assessment and performed a calculation of the fair value of the asset. The Company concluded that the IPR&amp;D assets were
not impaired. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>66</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=70,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=427970,FOLIO='66',FILE='DISK104:[13ZDF1.13ZDF47701]FK47701A.;8',USER='BGARDNE',CD='25-FEB-2014;17:38' -->
<A NAME="page_fk47701_1_67"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible
assets acquired in a business combination with a finite life are recorded at fair value and amortized over the greater of economic consumption or on a straight-line basis over
their estimated useful life. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Goodwill  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The difference between the purchase price and the fair value of assets acquired and liabilities assumed in a business combination is
allocated to goodwill. Goodwill is evaluated for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. The Company has the option to assess
qualitative factors to determine if it is more likely than not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment test required under
U.S.&nbsp;GAAP. As part of its annual impairment test of the goodwill asset as of July&nbsp;1, 2013, the Company bypassed the optional qualitative assessment and performed the two-step impairment
test. The Company concluded that the goodwill asset was not impaired. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Impairment of Long-Lived Assets  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company evaluates the recoverability of its long-lived assets, including property and equipment, and intangible assets when
circumstances indicate that an event of impairment may have occurred. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and
its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the assets, the assets are written-down to their estimated fair values. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Revenue Recognition  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company recognizes revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has
occurred or services have been rendered; the seller's price to the buyer is fixed or determinable; and collectability is reasonably assured. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has entered into and in the future may enter into biopharmaceutical product development agreements with collaborative partners for the research and development of therapeutic
drug products. The terms of the agreements may include nonrefundable signing and licensing fees, funding for research, development and manufacturing, milestone payments and royalties on any product
sales derived from collaborations. These multiple element arrangements are analyzed to determine whether the deliverables can be separated or whether they must be accounted for as a single unit of
accounting. In accounting for these transactions, the Company allocates revenue to the various elements based on their relative fair value. The fair value of a revenue generating element can be based
on current selling prices offered by the Company or another party for current products or the Company's best estimate of a selling price for future products. Revenue allocated to an individual element
is recognized when all other revenue recognition criteria are met for that element. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
collaborative and other agreements may contain milestone payments. Revenues from milestones, if they are considered substantive, are recognized upon successful accomplishment of
the milestones. Determining whether a milestone is substantive involves judgment, including an assessment of the Company's involvement in achieving the milestones and whether the amount of the payment
is </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>67</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=71,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=178557,FOLIO='67',FILE='DISK104:[13ZDF1.13ZDF47701]FK47701A.;8',USER='BGARDNE',CD='25-FEB-2014;17:38' -->
<A NAME="page_fk47701_1_68"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>commensurate
to the Company's performance. If not considered substantive, milestones are initially deferred and recognized over the remaining performance obligation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments
received to fund certain research activities are recognized as revenue in the period in which the research activities are performed. Revenue from contracts and grants is
recognized as the services are performed and recorded as effort is expended on the contracted work and billed to the government or the Company's contractual partner. Payments received in advance that
are related to future performance are deferred and recognized as revenue when the research projects are performed. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Product
royalty revenue consists of payments received from licensees for a portion of sales proceeds from products that utilize the Company's licensed technologies and are recognized
when the amount of and basis for such royalty payments are reported to the Company in accurate and appropriate form and in accordance with the related license agreement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development costs, including internal and contract research costs, are expensed as incurred. Research and development
expenses consist mainly of clinical trial costs, manufacturing of clinical material, toxicology and other studies, personnel costs, depreciation, license fees and funding of outside research. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical
trial expenses include expenses associated with clinical research organizations (CRO). The invoicing from CROs for services rendered can lag several months. We accrue the cost
of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, and project management costs. We maintain regular communication with our CROs to
gauge the reasonableness of our estimates. Differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period
in which they become known. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Patent Costs  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patent costs are expensed as incurred. Certain patent costs are reimbursed by the Company's product development and licensing partners.
Any reimbursed patent costs are recorded as product development and licensing agreement revenues in the Company's financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Stock-Based Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company records stock-based compensation expense for all stock-based awards made to employees and directors based on the estimated
fair values of the stock-based awards expected to vest at the grant date and is adjusted, if necessary, to reflect actual forfeitures. Compensation expense for all stock-based awards to employees and
directors is recognized using the straight-line method over the term of vesting or performance. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>68</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=72,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=467811,FOLIO='68',FILE='DISK104:[13ZDF1.13ZDF47701]FK47701A.;8',USER='BGARDNE',CD='25-FEB-2014;17:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fm47701_1_69"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company records stock-based compensation expense for stock options granted to non-employees based on the fair value of the stock options which is re-measured over the vesting term
resulting in periodic adjustments to stock-based compensation expense. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Foreign Currency Translation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains and losses resulting from foreign currency translation are included in other comprehensive income (loss). At
December&nbsp;31, 2013 and December&nbsp;31, 2012, accumulated other comprehensive income includes a net unrealized gain related to foreign currency translation of $2.6&nbsp;million. In 2011,
the Company's foreign subsidiary voluntarily liquidated in order to consolidate the Company's foreign operations into Celldex Therapeutics,&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Income Taxes  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company uses the asset and liability method to account for income taxes, including the recognition of deferred tax assets and
deferred tax liabilities for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax basis. Quarterly, the Company reviews its
deferred tax assets for recovery. A valuation allowance is established when the Company believes that it is more likely than not that its deferred tax assets will not be realized. Changes in valuation
allowances from period to period are included in the Company's tax provision in the period of change. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company records uncertain tax positions in the financial statements only if it is more likely than not that the uncertain tax position will be sustained upon examination by the
taxing authorities. The Company records interest and penalties related to uncertain tax positions in income tax expense. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Comprehensive Loss  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive loss is comprised of net loss and certain changes in stockholders' equity that are excluded from net loss. The Company
includes foreign currency translation adjustments and unrealized gains and losses on marketable securities in other comprehensive loss. The consolidated statements of operations and comprehensive loss
reflect total comprehensive loss for the years ended December&nbsp;31, 2013, 2012 and 2011. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2013, the Company adopted a new U.S.&nbsp;GAAP accounting standard which requires the Company to separately disclose, on a prospective basis, the change in each component of
other comprehensive income (loss) relating to reclassification adjustments and current period other comprehensive income (loss). As the new guidance relates to presentation only, the adoption did not
have a material impact on the Company's results of operations or financial position. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Net Loss Per Share  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding
restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional
weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>69</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=73,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=411802,FOLIO='69',FILE='DISK104:[13ZDF1.13ZDF47701]FM47701A.;15',USER='LPALLES',CD='28-FEB-2014;10:19' -->
<A NAME="page_fm47701_1_70"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>have
not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stock options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,770,544</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,349,810</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,459,034</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Restricted stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,776,544</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,355,810</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,465,034</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><I> Recent Accounting Pronouncements  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard
setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet
effective will not have a material impact on the Company's financial position or results of operations upon adoption. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (3) COMPREHENSIVE LOSS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The changes in accumulated other comprehensive income (loss) by component for the year ended December&nbsp;31, 2013 are summarized below. No amounts were reclassified out of
accumulated other comprehensive income during the years ended December&nbsp;31, 2013, 2012 and 2011. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Unrealized Gain<BR>
(Loss) on<BR>
Marketable<BR>
Securities, net of tax </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Foreign<BR>
Currency Items </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Balance at December&nbsp;31, 2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>156</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,589</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,745</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other comprehensive income (loss) before reclassifications</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(77</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amounts reclassified from other comprehensive income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net current-period other comprehensive income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(77</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Balance at December&nbsp;31, 2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>82</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,586</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,668</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B> (4) FAIR VALUE MEASUREMENTS  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following tables set forth the Company's financial assets subject to fair value measurements: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;3 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Money market funds and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>148,549</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>148,549</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable securities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>133,581</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>133,581</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>282,130</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>282,130</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>70</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=74,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=817346,FOLIO='70',FILE='DISK104:[13ZDF1.13ZDF47701]FM47701A.;15',USER='LPALLES',CD='28-FEB-2014;10:19' -->
<A NAME="page_fm47701_1_71"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (4) FAIR VALUE MEASUREMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;3 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Money market funds and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,688</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,688</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable securities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>59,065</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>59,065</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>77,753</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,688</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>59,065</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
have been no transfers of assets or liabilities between the fair value measurement classifications. The Company's financial instruments consist mainly of cash and cash equivalents,
marketable securities, short-term accounts receivable and accounts payable. The Company values its marketable securities utilizing independent pricing services which normally derive security prices
from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. At each balance sheet date, observable market inputs may include
trade information, broker or dealer quotes, bids, offers or a combination of these data sources. Short-term accounts receivable and accounts payable are reflected in the accompanying consolidated
financial statements at cost, which approximates fair value due to the short-term nature of these instruments. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (5) MARKETABLE SECURITIES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A summary of marketable securities is shown below: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amortized<BR>
Cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gross<BR>
Unrealized<BR>
Gains </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gross<BR>
Unrealized<BR>
Losses </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair<BR>
Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>December&nbsp;31, 2013</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>U.S. government and municipal obligations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing in one year or less</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55,531</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55,554</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing after one year through three years&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>18,234</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>56</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>18,286</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total U.S. government and municipal obligations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>73,765</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>83</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>73,840</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Corporate debt securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing in one year or less</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>38,973</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>38,973</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing after one year through three years&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,761</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,768</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total corporate debt securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>59,734</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>59,741</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>133,499</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>104</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>133,581</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>71</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=75,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=71986,FOLIO='71',FILE='DISK104:[13ZDF1.13ZDF47701]FM47701A.;15',USER='LPALLES',CD='28-FEB-2014;10:19' -->
<A NAME="page_fm47701_1_72"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (5) MARKETABLE SECURITIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amortized<BR>
Cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gross<BR>
Unrealized<BR>
Gains </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gross<BR>
Unrealized<BR>
Losses </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair<BR>
Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>December&nbsp;31, 2012</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>U.S. government and municipal obligations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing in one year or less</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,566</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>28</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,594</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing after one year through three years</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,797</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>99</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,895</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total U.S. government and municipal obligations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>35,363</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>127</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>35,489</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Corporate debt securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing in one year or less</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,353</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,372</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Maturing after one year through three years</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,193</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,204</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total corporate debt securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,546</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,576</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>58,909</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>164</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>59,065</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
marketable securities held by the Company were high investment grade and there were no marketable securities that the Company considered to be other-than-temporarily impaired as of
December&nbsp;31, 2013. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (6) PROPERTY AND EQUIPMENT, NET  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment include the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Laboratory Equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,699</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,164</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Manufacturing Equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,130</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,055</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Office Furniture and Equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,386</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,264</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Leasehold Improvements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,493</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,932</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Construction in Progress</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>257</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>115</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Property and Equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,965</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,530</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less Accumulated Depreciation and Amortization</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11,992</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(12,325</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,973</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation
and amortization expense related to property and equipment was $1.9&nbsp;million, $2.0&nbsp;million and $2.2&nbsp;million for the years ended December&nbsp;31, 2013,
2012 and 2011, respectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>72</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=76,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=272108,FOLIO='72',FILE='DISK104:[13ZDF1.13ZDF47701]FM47701A.;15',USER='LPALLES',CD='28-FEB-2014;10:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fo47701_1_73"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (7) INTANGIBLE ASSETS AND GOODWILL  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net of accumulated amortization, and goodwill are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=10 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated<BR>
Life </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Amortization </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Net </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Amortization </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Net </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=17 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Intangible Assets:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>IPR&amp;D</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Indefinite</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amgen Amendment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,812</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,688</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,915</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,585</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Core Technology</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,296</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>332</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,296</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(848</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>448</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Intangible Assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>27,596</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,776</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22,820</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>27,596</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,763</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,833</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Goodwill</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Indefinite</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,965</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,965</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,965</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,965</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
IPR&amp;D intangible asset was recorded in connection with the acquisition of CuraGen and relates to the development of glembatumumab vedotin. At the date of acquisition and at
December&nbsp;31, 2013, glembatumumab vedotin had not yet reached technological feasibility nor did it have any alternative future use. Glembatumumab vedotin is in a randomized, accelerated approval
study in patients with triple negative breast cancer that over-express gpNMB. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization
expense for intangible assets was $1.0&nbsp;million, $1.1&nbsp;million and $1.9&nbsp;million for the years ended December&nbsp;31, 2013, 2012 and 2011, respectively.
The estimated future amortization expense of intangible assets for the years ended December&nbsp;31, 2014, 2015, 2016, 2017 and 2018 is $1.0&nbsp;million, $1.0&nbsp;million, $1.0&nbsp;million,
$0.9&nbsp;million and $0.9&nbsp;million, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (8) ACCRUED EXPENSES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses include the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued Royalty and License Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,776</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued Payroll and Employee Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,515</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>925</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued Research and Development Contract Costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,840</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,569</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued Professional Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>556</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>317</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Accrued Expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>373</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,179</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,960</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>73</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=77,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=958806,FOLIO='73',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_74"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (9) OTHER LONG-TERM LIABILITIES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities include the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred Rent</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>419</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>434</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Deferred Tax Liability related to IPR&amp;D</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred Income from Sale of Tax Benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,630</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred Revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,168</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loan Payable</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>472</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,878</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,724</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less Current Portion</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(388</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Long-Term Portion</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,950</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,336</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2013, 2012 and 2011, the Company received approval from the New Jersey Economic Development Authority and agreed to sell New Jersey tax benefits worth $0.8&nbsp;million,
$0.8&nbsp;million and $0.6&nbsp;million to an independent third party for $0.8&nbsp;million, $0.7&nbsp;million and $0.5&nbsp;million, respectively. Under the agreement, the Company must
maintain a base of operations in New Jersey for five years or the tax benefits must be paid back on a pro-rata basis based on the number of years completed. During the years ended December&nbsp;31,
2013 and 2012, the Company recorded $0.2&nbsp;million and $0.1&nbsp;million to other income related to the sale of these tax benefits, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
September 2013, the Company entered into an agreement with Rockefeller University pursuant to which the Company will perform research and development services for Rockefeller. The
agreement includes an approved project plan for the development services of $4.8&nbsp;million and a term of three years. The agreement included an upfront payment of $1.3&nbsp;million which is
being recognized as revenue over the term of the agreement. The Company will bill Rockefeller quarterly for actual time and direct costs incurred and record those amounts to revenue in the quarter the
services are performed. The Company recorded $1.4&nbsp;million in revenue related to the Rockefeller agreement during the year ended December&nbsp;31, 2013. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (10) TERM LOAN  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2010, the Company entered into a loan and security agreement with MidCap Financial,&nbsp;LLC pursuant to which the Company borrowed $10.0&nbsp;million under a term loan
from MidCap. In March 2011, the Company amended the loan agreement and borrowed an additional $5.0&nbsp;million from General Electric Capital Corporation to increase the amount owed under the term
loan to $15.0&nbsp;million. In March 2012, the Company amended the loan agreement to extend the maturity date from December 2013 to December 2014. In May 2013, the Company elected to prepay the
outstanding principal under the term loan in full, pursuant to the terms of its loan agreement, as amended, and paid $8.8&nbsp;million in principal and $0.7&nbsp;million in interest, prepayment
and final payment fees. The Company's obligations under the loan agreement had been collateralized by a first priority security interest in substantially all of its assets, other than its intellectual
property. In connection with the repayment of the term loan and the termination of the loan agreement, those security interests </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>74</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=2,SEQ=78,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=654121,FOLIO='74',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_75"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (10) TERM LOAN (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>were
released. Interest expense on the term loan was $0.8&nbsp;million, $1.5&nbsp;million and $1.6&nbsp;million for the years ended December&nbsp;31, 2013, 2012 and 2011, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (11) STOCKHOLDERS' EQUITY  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Common Stock  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In April 2010, the Company filed a shelf registration statement with the Securities and Exchange Commission to register for sale any
combination of the types of securities described in the shelf registration statement up to a dollar amount of $150&nbsp;million. The shelf registration went effective on April&nbsp;22, 2010. In
December 2012, the Company filed a new shelf registration statement with the Securities and Exchange Commission to register for sale any combination of the types of securities described in the new
shelf registration statement up to a dollar amount of $200&nbsp;million. The new shelf registration went effective on January&nbsp;16, 2013. In December 2013, the Company filed a new automatic
shelf registration statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the years ended December&nbsp;31, 2013, 2012 and 2011, Company issued 21,613,483, 12,075,000 and 11,500,000 shares of its common stock in underwritten public offerings resulting
in net proceeds to the Company of $278.6&nbsp;million, $43.5&nbsp;million and $33.7&nbsp;million, after deducting underwriting fees and offering expenses, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the years ended December&nbsp;31, 2013, 2012 and 2011, Company issued 2,433,608, 8,003,290 and 575,000 shares of its common stock under our controlled equity offering sales
agreement with Cantor Fitzgerald&nbsp;&amp;&nbsp;Co., as amended, resulting in net proceeds to the Company of $17.1&nbsp;million, $40.1&nbsp;million and $2.2&nbsp;million, after deducting
commission and offering expenses, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Convertible Preferred Stock  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2013, the Company had authorized 3,000,000 shares of preferred stock all of which have been designated
Class&nbsp;C Preferred Stock including 350,000 shares which have been designated Series&nbsp;C-1&nbsp;Junior Participating Cumulative Preferred Stock (the "Series&nbsp;C-1 Preferred Stock"). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Shareholder Rights Plan  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company's Board has adopted a Shareholder Rights Plan, as set forth in the Shareholder Rights Agreement, as amended, between the
Company and Computershare Trust Company, N.A., as Rights Agent (the "Rights Agreement"). Pursuant to the terms of the Rights Agreement, the Board declared a dividend distribution of one Preferred
Stock Purchase Right (a "Right") for each outstanding share of the Company's common stock. Each Right, which expires in November 2014, entitles their holder to purchase from the Company one
ten-thousandth of a share (a "Unit") of Series&nbsp;C-1 Preferred Stock at a cash exercise price of $35.00 per Unit, subject to adjustment. The Rights will trade separately from the common stock and
will become exercisable only when a person or group has acquired 15% or more of the outstanding common stock or upon the commencement by a person or group of a tender offer that would result in such
person or group acquiring 15% or more of the outstanding common stock other than as a result of repurchases of stock by the Company or certain inadvertent actions by a shareholder. In the event a
person or group acquires 15% or more of the outstanding common stock each holder of a Right (except for any such person or group) would be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>75</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=3,SEQ=79,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=115983,FOLIO='75',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_76"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (11) STOCKHOLDERS' EQUITY (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>entitled
to receive upon exercise sufficient Units of Series&nbsp;C-1 Preferred Stock to equal a value of two times the exercise price of the Right. In the event the Company is acquired in a merger
or other business combination transaction or if 50% or more of the Company's assets or earning power is sold, each holder of a Right (except for any such person or group described above) would receive
upon exercise common stock of the acquiring company with a value equal to two times the exercise price of the Right. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (12) STOCK-BASED COMPENSATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has the following stock-based compensation plans: the 2004 Employee Stock Purchase Plan (the "2004 ESPP Plan"), the 2008 Stock Option and Incentive Plan (the "2008 Plan"),
Celldex Research's 2005 Equity Incentive Plan (the "Celldex Research 2005 Plan") and CuraGen 2007 Stock Plan (the "CuraGen 2007 Plan"). There are no shares available for future grant under the Celldex
Research 2005 Plan and CuraGen 2007 Plan. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Employee Stock Purchase Plan  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2013, a total of 200,000 shares of common stock are reserved for issuance under the 2004 ESPP Plan. Under the
2004 ESPP Plan, each participating employee may purchase shares of common stock through payroll deductions at a purchase price equal to 85% of the lower of the fair market value of the common stock at
either the beginning of the offering period or the applicable exercise date. During the years ended December&nbsp;31, 2013 and 2012, the Company issued 11,823 and 5,935 shares under the 2004 ESPP
Plan, respectively. At December&nbsp;31, 2013, 164,124 shares were available for issuance under the 2004 ESPP Plan. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Employee Stock Option and Incentive Plan  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2008 Plan permits the granting of incentive stock options (intended to qualify as such under Section&nbsp;422A of the Internal
Revenue Code of 1986, as amended), non-qualified stock options, stock appreciation rights, performance share units, restricted stock and other awards of restricted stock in lieu of cash bonuses to
employees, consultants and non-employee directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2013, the 2008 Plan allowed for a maximum of 7,400,000 shares of common stock to be issued for grants of Stock Options and other Awards made prior to
March&nbsp;7, 2018 and grants of Incentive Stock Options made prior to October&nbsp;20, 2017. The Company's board of directors determines the term of each option, option price, and number of
shares for which each option is granted and the rate at which each option vests. Options generally vest over a period not to exceed four years. The term of each option cannot exceed ten years (five
years for options granted to holders of more than 10% of the voting stock of the Company) and the exercise price of stock options cannot be less than the fair market value of the common stock at the
date of grant (110% of fair market value for incentive stock options granted to holders of more than 10% of the voting stock of the Company). Vesting of all employee and non-employee director stock
option awards is accelerated upon a change in control as defined in the 2008 Plan. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>76</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=80,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=656200,FOLIO='76',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_77"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (12) STOCK-BASED COMPENSATION (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
summary of stock option activity for the year ended December&nbsp;31, 2013 is as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Exercise<BR>
Price<BR>
Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Remaining<BR>
Contractual<BR>
Term (In Years) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Options Outstanding at December&nbsp;31, 2012</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,349,810</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.98</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Granted</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,252,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16.44</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercised</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(816,405</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.53</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Canceled</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(14,861</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.97</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Options Outstanding at December&nbsp;31, 2013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,770,544</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Options Vested and Expected to Vest at December&nbsp;31, 2013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,712,596</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Options Exercisable at December&nbsp;31, 2013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,297,190</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares Available for Grant under the 2008 Plan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,102,942</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
total intrinsic value of stock options exercised during the years ended December&nbsp;31, 2013, 2012 and 2011 was $10.0&nbsp;million, $0.2&nbsp;million and
$0.03&nbsp;million, respectively. The weighted average grant-date fair value of stock options granted during the years ended December&nbsp;31, 2013, 2012 and 2011 was $10.51, $3.67 and $1.83,
respectively. The total fair value of stock options vested during the years ended December&nbsp;31, 2013, 2012 and 2011 was $2.4&nbsp;million, $2.1&nbsp;million and $2.6&nbsp;million,
respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
aggregate intrinsic value of stock options outstanding at December&nbsp;31, 2013 was $92.6&nbsp;million. The aggregate intrinsic value of stock options vested and expected to
vest at December&nbsp;31, 2013 was $91.9&nbsp;million. As of December&nbsp;31, 2013, total compensation cost related to non-vested employee and non-employee director stock options not yet
recognized was approximately $14.4&nbsp;million, net of estimated forfeitures, which is expected to be recognized as expense over a weighted average period of 2.8&nbsp;years. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Restricted Stock  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A summary of restricted stock activity under the 2008 Plan for the year ended December&nbsp;31, 2013 is as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Grant Date<BR>
Fair Value<BR>
(per share) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding and unvested at December&nbsp;31, 2012</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Granted</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vested</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(12,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Canceled</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding and unvested at December&nbsp;31, 2013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>77</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=81,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=736465,FOLIO='77',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_78"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (12) STOCK-BASED COMPENSATION (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Valuation and Expenses Information  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense for the years ended December&nbsp;31, 2013, 2012 and 2011 was recorded as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,640</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,415</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,412</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,908</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>883</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>930</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stock-based compensation expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,548</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,298</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,342</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
fair values of employee stock options granted during the years ended December&nbsp;31, 2013, 2012 and 2011 were valued using the Black-Scholes option-pricing model with the
following assumptions: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, 2011 </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected stock price volatility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>71&nbsp;-&nbsp;72%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70&nbsp;-&nbsp;72%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68&nbsp;-&nbsp;70%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected option term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.0 Years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.0 Years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.0 Years</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2&nbsp;-&nbsp;2.1%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.9&nbsp;-&nbsp;1.4%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.4&nbsp;-&nbsp;2.9%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividend yield</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>None</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>None</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>None</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company estimates expected term based on historical exercise patterns. The Company uses its historical stock price volatility consistent with the expected term of grant as the basis
for its expected volatility assumption. The risk-free interest rate is based upon the yield of U.S. Treasury securities consistent with the expected term of the option. The dividend yield assumption
is based on the Company's history of zero dividend payouts and expectation that no dividends will be paid in the foreseeable future. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (13) REVENUE  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 1997, the Company licensed its oral rotavirus strain to GlaxoSmithKline&nbsp;plc (Glaxo) and Glaxo assumed responsibility for all subsequent clinical trials and all other
development activities. The Company's licensed-in the rotavirus strain that was used to develop Glaxo's Rotarix rotavirus vaccine in 1995 and owed a license fee of 30% to Cincinnati Children's
Hospital Medical Center (CCH) on net royalties received from Glaxo. In May 2005, the Company entered into an agreement whereby an affiliate of Paul Royalty Fund II,&nbsp;L.P. (PRF) purchased a 70%
interest in the net royalties the Company received on worldwide sales of Rotarix. In December 2012, the Glaxo agreement expired automatically upon the expiration of the last relevant patent right
covered by the Glaxo agreement. The Company's retained interests in Rotarix net royalties which were not sold to PRF are recorded as product royalty revenue and a corresponding amount that is payable
to CCH is recorded as royalty expense. Product royalty revenue and royalty expense related to the Company's retained interest in Rotarix was $2.3&nbsp;million, $10.8&nbsp;million and
$9.1&nbsp;million for the years ended December&nbsp;31, 2013, 2012 and 2011, respectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>78</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=82,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=41130,FOLIO='78',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_79"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (14) COLLABORATION AGREEMENTS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into license agreements whereby the Company has received licenses or options to license technology, specified patents or patent applications. The Company's
licensing and development collaboration agreements generally provide for royalty payments equal to specified percentages of product sales, annual license maintenance fees, continuing patent
prosecution costs and potential future milestone payments to third parties upon the achievement of certain developmental, regulatory and/or commercial milestones. Nonrefundable license fee expense was
$0.7&nbsp;million, $0.7&nbsp;million and $1.4&nbsp;million for the years ended December&nbsp;31, 2013, 2012 and 2011, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Medarex,&nbsp;Inc., a subsidiary of Bristol-Myers Squibb (Medarex)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and Medarex have entered into an assignment and license agreement, as amended, that provides for the assignment of certain
patent and other intellectual property rights and a license to certain Medarex technology related to the Company's APC Targeting Technology&#153; and an anti-mannose receptor product. Under the
terms of the agreement, the Company may be required to pay royalties in the low-single digits on any net product sale of a Licensed Royalty-Bearing Product or Anti-Mannose Product to Medarex until the
later of (i)&nbsp;the expiration of the last to expire applicable patent and (ii)&nbsp;the tenth anniversary of the first commercial sale of such licensed product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and Medarex have also entered into a research and commercialization agreement, as amended, that provides the Company with certain rights to obtain exclusive commercial
licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform for generating antibodies until December 2015. Under the terms of the
agreement, the Company may be required to pay milestones of up to $7.0&nbsp;million upon obtaining first approval for commercial sale in a first indication of a product containing a licensed
antibody and royalty payments in the low-to-mid single digits on any net product sales to Medarex with respect to the development of any products containing such licensed antibodies until the later of
(i)&nbsp;the expiration of the last to expire
applicable patent and (ii)&nbsp;the tenth anniversary of the first commercial sale of such licensed product. In September 2010, the Company exercised an option under the agreement, whereby it
licensed from Medarex access to the UltiMab technology to develop and commercialize human antibodies to CD27, including varlilumab. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Rockefeller University (Rockefeller)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2005, the Company and Rockefeller entered into a license agreement for the exclusive worldwide rights to human DEC-205
receptor, with the right to sublicense the technology. The license grant is exclusive except that Rockefeller may use and permit other nonprofit organizations to use the human DEC-205 receptor patent
rights for educational and research purposes. The Company may be required to pay milestones of up to $3.9&nbsp;million upon obtaining first approval for commercial sale in a first indication of a
product targeting the licensed receptor and royalty payments in the low-to-mid single digits on any net product sales to Rockefeller with respect to development and commercialization of the human
DEC-205 receptor. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Duke University Brain Tumor Cancer Center (Duke)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In September 2006, the Company and Duke entered into a license agreement that gave the Company access and reference to the clinical
data generated by Duke and its collaborators in order for the Company to generate its own filing with the FDA relating to rindopepimut. The Company may be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>79</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=7,SEQ=83,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=894764,FOLIO='79',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_80"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (14) COLLABORATION AGREEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>required
to pay milestone of up to $0.7&nbsp;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to
Duke with respect to development and commercialization of rindopepimut. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Ludwig Institute for Cancer Research (Ludwig)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2006, the Company and Ludwig entered into an agreement for the nonexclusive rights to certain cancer tumor targets for use
in combination with the Company's APC Targeting Technology. The Company may be required to pay milestones of up to $1.0&nbsp;million upon obtaining first approval for commercial sale in a first
indication and royalty payments in the low-single digits on any net product sales to Ludwig with respect to development and commercialization of the technology licensed from Ludwig. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Alteris Therapeutics,&nbsp;Inc. (Alteris)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2005, the Company completed the acquisition of the assets of Alteris, including the EGFRvIII molecule. The Company may be
required to pay Alteris up to $5.0&nbsp;million upon obtaining the first approval for commercial sale of a product containing EGFRvIII, including rindopepimut. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> University of Southampton, UK (Southampton)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2008, the Company entered into a license agreement with Southampton to develop human antibodies towards CD27, a potentially
important target for immunotherapy of various cancers. The Company may be required to pay milestones of up to approximately $1.4&nbsp;million upon obtaining first approval for commercial sale in a
first indication and royalty payments in the low-single digits on any net product sales to Southampton with respect to development and commercialization of varlilumab. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Amgen&nbsp;Inc. (Amgen)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March 2009, the Company entered into a license agreement with Amgen to acquire the exclusive rights to CDX-301 and CD40 ligand
(CD40L). CDX-301 and CD40L are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. The Company may be required to pay milestones of up to
$1.0&nbsp;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single
digits on any net product sales to Amgen with respect to development and commercialization of the technology licensed from Amgen, including CDX-301. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Seattle Genetics,&nbsp;Inc. (Seattle Genetics)  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with the CuraGen acquisition, the Company assumed the license agreement between CuraGen and Seattle Genetics whereby
CuraGen acquired the rights to proprietary antibody-drug conjugate (ADC) technology for use with the Company's proprietary antibodies for the potential treatment of cancer. In February 2014, the
Company paid $2.5&nbsp;million in milestones to Seattle Genetics as a result of the METRIC initiation. The Company may be required to pay milestones of up to $5.0&nbsp;million upon obtaining first
approval for commercial sale in a first indication and royalty payments </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>80</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=84,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=429512,FOLIO='80',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<A NAME="page_fo47701_1_81"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (14) COLLABORATION AGREEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>in
the mid-single digits on any net product sales to Seattle Genetics with respect to development and commercialization of the ADC technology, including glembatumumab vedotin and CDX-014. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (15) INCOME TAXES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The components of income tax expense attributable to continuing operations consist of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax benefit (provision):</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Federal</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,962</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,394</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,204</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>State</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,920</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,237</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,131</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>84</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expiration of Net Operating Losses and Research&nbsp;&amp; Development Tax Credits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(126</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,426</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(411</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>35,756</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred tax valuation allowance</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(35,756</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(19,008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate of 34% follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2011 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pre-tax loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(81,550</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,123</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss at Statutory Rates</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(27,727</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(20,102</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,213</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and Development Credits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,261</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,736</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>State Taxes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,920</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,237</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,131</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>708</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>661</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expiration of Net Operating Losses and Research&nbsp;&amp; Development Tax Credits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>126</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,426</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>411</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Change in Valuation Allowance</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>35,756</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax (benefit) provision</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred
tax assets and liabilities are recognized based on temporary differences between the financial reporting and tax basis of assets and liabilities using future expected enacted
rates. A valuation allowance is recorded against deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>81</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=85,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=213207,FOLIO='81',FILE='DISK104:[13ZDF1.13ZDF47701]FO47701A.;12',USER='LPALLES',CD='26-FEB-2014;15:22' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fs47701_1_82"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (15) INCOME TAXES (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The principal components of the deferred tax assets and liabilities at December&nbsp;31, 2013 and 2012, respectively, are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gross Deferred Tax Assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Operating Loss Carryforwards</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>79,558</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67,728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Credit Carryforwards</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,582</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,692</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred Expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61,370</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>43,226</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stock-based Compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,926</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,264</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fixed Assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,638</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,156</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued Expenses and Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>623</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>241</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>172,697</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>137,307</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gross Deferred Tax Liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Acquired Intangibles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,115</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,481</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>IPR&amp;D Intangibles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(8,776</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,142</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Deferred Tax Assets and Liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>163,921</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>128,165</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred Tax Assets Valuation Allowance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(168,582</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(132,826</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net Deferred Tax Asset (Liability)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT"  VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,661</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
net deferred tax liability of $4.7&nbsp;million at December&nbsp;31, 2013 and 2012 relates to the temporary differences associated with the IPR&amp;D intangible assets acquired in
the CuraGen acquisition, which are not deductible for tax purposes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2013, the Company had the following federal net operating loss ("NOL") carryforwards:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Prior to the merger of the Company and AVANT, $33.0&nbsp;million was generated by the Company which expire at various
dates starting in 2023 and going through 2028; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Prior to the merger of the Company and AVANT, $101.2&nbsp;million, net of expirations and utilization, was generated by
AVANT which expire at various dates starting in 2018 and going through 2028. During the years ended, December&nbsp;31, 2013 and 2012, NOLs of $0 and $16.4&nbsp;million expired, respectively; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Following the merger of the Company and AVANT, $131.7&nbsp;million was generated by the combined company which expire at
various dates starting in 2028 and going through 2033; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Prior to its acquisition by the Company, $518.3&nbsp;million was generated by CuraGen. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2013, the Company has an additional $6.0&nbsp;million of federal and state net operating losses not reflected above, that are attributable to stock option
exercises which will be recorded as an increase in additional paid in capital on the consolidated balance sheet once they are "realized" in accordance with ASC 718. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>82</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=86,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=43641,FOLIO='82',FILE='DISK104:[13ZDF1.13ZDF47701]FS47701A.;11',USER='DPERRY',CD='25-FEB-2014;17:42' -->
<A NAME="page_fs47701_1_83"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (15) INCOME TAXES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, an ownership change, as defined by Section&nbsp;382 of the Internal Revenue Code, results from transactions increasing the ownership of certain shareholders or public
groups in the stock of a corporation by more than 50&nbsp;percentage points over a three-year period. Such ownership changes can significantly limit the amount of NOLs that may be utilized in future
periods. The Company currently expects that it is remote that the CuraGen NOLs may be utilized and, as such, no related asset has been recorded for such losses. The Company has not completed an
analysis of losses generated by AVANT, however, the Company believes it is remote that $60.8&nbsp;million of the AVANT NOLs may be utilized in future periods and there may be substantial limitations
on the Company's ability to use the remaining NOLs of $40.4&nbsp;million. Following the merger of the Company and AVANT, the Company experienced changes in ownership as defined by Section&nbsp;382
in June 2009 and December 2009. Further, prior to the AVANT merger, the Company as a stand alone company experienced a change in ownership in October 2007. As a result of the ownership change in
October 2007, utilization of the Company's NOLs prior to October 2007 is subject to an annual limitation of $4.5&nbsp;million on $28.3&nbsp;million of NOLs generated before that date. As a result
of the ownership changes in June 2009 and December 2009, there is an annual limitation amount of $6.0&nbsp;million on $67.7&nbsp;million NOLs. Any unused annual limitation may be carried over to
later years, and the amount of the limitation may, under certain circumstances, be subject to adjustment if the fair value of the Company's net assets are determined to be below or in excess of the
tax basis of such assets at the time of the ownership change, and such unrealized loss or gain is recognized during the five-year period after the ownership change. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similar
to the AVANT and CuraGen NOL carryforwards above, the Company believes that it is not more likely than not that federal and state research and development ("R&amp;D") credits of
$20.8&nbsp;million and $14.4&nbsp;million, respectively, will be utilized in the future periods. Further, the Company's ability to use the state NOLs of approximately $108.3&nbsp;million and the
remaining federal and state R&amp;D credit carryforwards of approximately $19.4&nbsp;million and $9.3&nbsp;million, respectively, may be substantially limited. These state NOLs and federal and state
credits expire at various dates starting in 2016 going through 2033. The Company has not yet completed a study of these credits to substantiate the amounts. Until a study is completed, no amounts are
being presented as an uncertain tax position. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequent
ownership changes, as defined in Section&nbsp;382, could further limit the amount of net operating loss carryforwards and research and development credits that can be
utilized annually to offset future taxable income. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company applies the authoritative guidance on account for and disclosure of uncertainty in income tax positions which requires the Company to determine whether an income tax position
of the Company is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income
tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements is reduced to the largest benefit that has a greater than fifty perfect likelihood of
being realized upon the ultimate settlement with the relevant taxing authority. At December&nbsp;31, 2013 and 2012, we had no unrecognized tax benefits. A full valuation allowance has been provided
against our deferred tax assets and liabilities and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the
consolidated balance sheet or statement of operations if an adjustment were required. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>83</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=87,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=81093,FOLIO='83',FILE='DISK104:[13ZDF1.13ZDF47701]FS47701A.;11',USER='DPERRY',CD='25-FEB-2014;17:42' -->
<A NAME="page_fs47701_1_84"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (15) INCOME TAXES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Massachusetts,
New Jersey and Connecticut are the three states in which the Company primarily operates or has operated and has income tax nexus. The Company is not currently under
examination by any other jurisdictions for any tax year. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has evaluated the positive and negative evidence bearing upon the realizability of its net deferred tax assets, which are comprised principally of net operating loss
carryforwards, capitalized R&amp;D expenditures and R&amp;D tax credit carryforwards. The Company has determined that it is more likely than not that it will not recognize the benefits of federal and state
deferred tax assets and, as a result, a full valuation allowance was maintained at December&nbsp;31, 2013 against the Company's net deferred tax assets. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
American Taxpayer Relief Act of 2012 was enacted on January&nbsp;2, 2013 under which the federal research and development credit was retroactively extended for amounts paid or
incurred after December&nbsp;31, 2011 through December&nbsp;31, 2013. The effects of the change in the tax law were recognized in the first quarter of 2013, which is the quarter in which the law
was enacted. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B> (16) COMMITMENTS AND CONTINGENCIES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has facility and equipment leases that expire at various dates through 2019. Certain of these facility leases contain renewal options, early termination provisions, and
provisions that escalate the base rent payments and require the Company to pay common area maintenance costs ("CAM") during the lease term. The following obligations for base rent and CAM costs under
facility and other non-cancelable operating leases as of December&nbsp;31, 2013 do not include the exercise of renewal terms or early termination provisions (in thousands): </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,666</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,863</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,914</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,765</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>501</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thereafter</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>167</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total minimum lease payments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,876</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.1pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR style="font-size:1.5pt;" bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-family:times;">


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->


&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
<TD COLSPAN=2 ALIGN="RIGHT" style="line-height:0pt;font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
<TD style="line-height:0pt;font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's total rent and CAM expense for all facility leases was $2.7&nbsp;million, $2.5&nbsp;million and $2.5&nbsp;million for the years ended December&nbsp;31, 2013, 2012
and 2011, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (17) RETIREMENT SAVINGS PLAN  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company maintains a 401(k) Plan which is available to substantially all employees. Under the terms of the 401(k) Plan, participants may elect to contribute up to 15% of their
compensation, or the statutory prescribed limits. The Company may make 50% matching contributions on up to 4% of a participant's annual salary. Benefit expense for the 401(k) Plan was
$0.3&nbsp;million, $0.2&nbsp;million and $0.2&nbsp;million for the years ended December&nbsp;31, 2013, 2012 and 2011, respectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>84</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=88,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=450281,FOLIO='84',FILE='DISK104:[13ZDF1.13ZDF47701]FS47701A.;11',USER='DPERRY',CD='25-FEB-2014;17:42' -->
<A NAME="page_fs47701_1_85"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CELLDEX THERAPEUTICS,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B> (18) SELECTED QUARTERLY FINANCIAL DATA (Unaudited)  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:17pt;"><FONT SIZE=1><B>2013

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q1 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q2 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q3 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q4 2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands, except per share amounts)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,414</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>97</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>980</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>620</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(17,332</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(19,016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(23,140</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,062</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and diluted net loss per common share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:17pt;"><FONT SIZE=1><B>2012

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q1 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q2 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q3 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Q4 2012 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(In thousands, except per share amounts)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,433</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,113</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  style="font-family:times;"><FONT SIZE=2>$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,647</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(13,516</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(13,773</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,027</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16,807</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and diluted net loss per common share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>85</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=89,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=7719,FOLIO='85',FILE='DISK104:[13ZDF1.13ZDF47701]FS47701A.;11',USER='DPERRY',CD='25-FEB-2014;17:42' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fu47701_1_86"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_9._changes_in_and_disagre__ite03576"> </A>
<A NAME="toc_fu47701_1"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_9a._controls_and_procedures"> </A>
<A NAME="toc_fu47701_2"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;9A.&nbsp;&nbsp;&nbsp;&nbsp;CONTROLS AND PROCEDURES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Evaluation of Disclosure Controls and Procedures  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2013, we evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the
effectiveness of our disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). Based on that
evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December&nbsp;31,
2013. Our disclosure controls and procedures are
designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within
time periods specified by the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as
appropriate to allow timely decisions regarding required disclosure. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I> Management's Annual Report on Internal Control Over Financial Reporting  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Internal control
over financial reporting is defined in Rules&nbsp;13a-15(f) and 15d-15(f) under the Exchange Act as the process designed by, or under the supervision of, our Chief Executive Officer and Chief
Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of
our financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures
that:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of assets; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with the authorizations of management and directors; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use or disposition
of assets that could have a material effect on our financial statements. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of
our internal control over financial reporting based on the framework provided in </FONT><FONT SIZE=2><I>Internal Control&#151;Integrated Framework (1992)</I></FONT><FONT SIZE=2> issued by the
Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of
December&nbsp;31, 2013. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>86</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=90,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=851252,FOLIO='86',FILE='DISK104:[13ZDF1.13ZDF47701]FU47701A.;7',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<A NAME="page_fu47701_1_87"> </A>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
effectiveness of our internal control over financial reporting as of December&nbsp;31, 2013 has been audited by PricewaterhouseCoopers&nbsp;LLP, an independent registered public
accounting firm, as stated in their report, which is included herein. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> Changes in Internal Control Over Financial Reporting  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There were no changes in our internal control over financial reporting during the three months ended December&nbsp;31, 2013 that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_9b._other_information"> </A>
<A NAME="toc_fu47701_3"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;9B.&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_part_iii"> </A>
<A NAME="toc_fu47701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  PART III    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_10._directors,_executive___ite02336"> </A>
<A NAME="toc_fu47701_5"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by this Item&nbsp;10 will be included in the definitive Proxy Statement for our 2014 Annual Meeting of
Stockholders, or the 2014 Proxy Statement, under "Information Regarding the Current Directors and Executive Officers of Celldex Therapeutic,&nbsp;Inc.," "Section&nbsp;16(a) Beneficial Ownership
Reporting Compliance," "Code of Business Conduct and Ethics" and "The Board of Directors and Its Committees" and is incorporated herein by reference. If the 2014 Proxy Statement is not filed with the
SEC within 120&nbsp;days after the end of our most recent fiscal year, we will provide such information by means of an amendment to this Annual Report on Form&nbsp;10-K. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_11._executive_compensation"> </A>
<A NAME="toc_fu47701_6"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;11.&nbsp;&nbsp;&nbsp;&nbsp;EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by this Item&nbsp;11 will be included in the 2014 Proxy Statement under "Executive Compensation," and
"Compensation Committee Interlocks and Insider Participation," and is incorporated herein by reference. If the 2014 Proxy Statement is not filed with the SEC within 120&nbsp;days after the end of
our most recent fiscal year, we will provide such information by means of an amendment to this Annual Report on Form&nbsp;10-K.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_12._security_ownership_of__ite04004"> </A>
<A NAME="toc_fu47701_7"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;12.&nbsp;&nbsp;&nbsp;&nbsp;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by this Item&nbsp;12 will be included in the 2014 Proxy Statement under "Security Ownership of Certain
Beneficial Owners and Management" and "Equity Compensation Plan Information" and is incorporated herein by reference. If the 2014 Proxy Statement is not filed with the SEC within 120&nbsp;days after
the end of our most recent fiscal year, we will provide such information by means of an amendment to this Annual Report on Form&nbsp;10-K.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_13._certain_relationships__ite03067"> </A>
<A NAME="toc_fu47701_8"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by this Item&nbsp;13 will be included in the 2014 Proxy Statement under "Election of Directors" and
"Approval of Related Person Transactions and Transactions with Related Persons" and is incorporated herein by reference. If the 2014 Proxy Statement is not filed with the SEC within 120&nbsp;days
after the end of our most recent fiscal year, we will provide such information by means of an amendment to this Annual Report on Form&nbsp;10-K. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>87</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=91,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=965840,FOLIO='87',FILE='DISK104:[13ZDF1.13ZDF47701]FU47701A.;7',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<A NAME="page_fu47701_1_88"> </A>
<BR>

<P style="font-family:times;"><FONT SIZE=2><A
NAME="fu47701_item_14._principal_accounting_fees_and_services"> </A>
<A NAME="toc_fu47701_9"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;14.&nbsp;&nbsp;&nbsp;&nbsp;PRINCIPAL ACCOUNTING FEES AND SERVICES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by this Item&nbsp;14 will be included in the 2014 Proxy Statement under "Independent Registered Public
Accounting Firm" and is incorporated herein by reference. If the 2014 Proxy Statement is not filed with the SEC within 120&nbsp;days after the end of our most recent fiscal year, we will provide
such information by means of an amendment to this Annual Report on Form&nbsp;10-K. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>88</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=92,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=767884,FOLIO='88',FILE='DISK104:[13ZDF1.13ZDF47701]FU47701A.;7',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ja47701_1_89"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ja47701_part_iv"> </A>
<A NAME="toc_ja47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PART IV    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A
NAME="ja47701_item_15._exhibits,_financial_statement_schedules"> </A>
<A NAME="toc_ja47701_2"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;15.&nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS, FINANCIAL STATEMENT SCHEDULES    <BR>    </B></FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(A)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
following documents are filed as part of this Form&nbsp;10-K:
<BR><BR></FONT>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><I>(1)</I></FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I>Financial Statements:</I></FONT></DD></DL>
</DD></DL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Financial Statements and Supplementary Data are included in Part&nbsp;II Item&nbsp;8 of this report.  </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><I>(2)</I></FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I>Financial Statement Schedules:</I></FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schedules
are omitted since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required
is included in the Consolidated Financial Statements or Notes thereto.  </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><I>(3)</I></FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I>Exhibits:</I></FONT></DD></DL>
</UL>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Incorporated by Reference to </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Description </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Form and<BR>
SEC File No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SEC<BR>
Filing Date </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><FONT SIZE=2><I> Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Agreement and Plan of Merger, dated as of October&nbsp;19, 2007, by and among AVANT, Celldex Merger Corporation, and Celldex Therapeutics,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10/22/07</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>2.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Agreement and Plan of Merger, dated as of May&nbsp;28, 2009, by and among Celldex Therapeutics,&nbsp;Inc., CuraGen Corporation and Cottrell Merger Sub,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>2.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>5/29/09</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><BR><FONT SIZE=2><I> Articles of Incorporation and By-Laws</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-4<BR>
(333-59215)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7/16/98</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Certificate of Amendment of Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>S-4<BR>
(333-59215)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>7/16/98</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Second Certificate of Amendment of Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>S-4<BR>
(333-59215)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>7/16/98</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Third Certificate of Amendment of Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>5/10/02</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Fourth Certificate of Amendment of Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/11/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Fifth Certificate of Amendment of Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/11/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Sixth Certificate of Amendment of Third Restated Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>11/10/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amended and Restated By-Laws as of March&nbsp;14, 2007</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/18/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><BR><FONT SIZE=2><I> Instruments Defining the Rights of Security Holders</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Specimen of Common Stock Certificate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-3<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12/21/12</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>89</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=93,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=485761,FOLIO='89',FILE='DISK104:[13ZDF1.13ZDF47701]JA47701A.;9',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<A NAME="page_ja47701_1_90"> </A>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Incorporated by Reference to </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Description </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Form and<BR>
SEC File No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SEC<BR>
Filing Date </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Shareholder Rights Agreement dated November&nbsp;5, 2004</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8-A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/8/04</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>4.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amendment No.&nbsp;1 to Shareholder Rights Agreement dated October&nbsp;19, 2007</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-A/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10/22/07</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>4.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amendment No.&nbsp;2 to Shareholder Rights Agreement dated March&nbsp;7, 2008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-A/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/7/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>4.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Certificate of Designations, Preferences and Rights of a Series of Preferred Stock classifying and designating the Series&nbsp;C-1&nbsp;Junior Participating Cumulative Preferred Stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>11/8/04</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><BR><FONT SIZE=2><I> Material Contracts&#151;Leases</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Commercial Lease Agreement of May&nbsp;1, 1996 between the Company and Fourth Avenue Ventures Limited Partnership</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10-Q/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10.11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8/23/96</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Extension of Lease Agreement of May&nbsp;1, 1997 between the Company and DIV Needham 53&nbsp;LLC (successor in interest to Fourth Avenue Ventures Limited Partnership) dated as of August&nbsp;23, 2001</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/27/02</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>First Amendment to Lease by and between the Company and DIV Needham 53&nbsp;LLC dated November&nbsp;29, 2005</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.40</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/16/06</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Lease Agreement, by and between the Company and the Massachusetts Development Finance Agency, dated as of December&nbsp;22, 2003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>4/30/04</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>First Amendment to Lease between Massachusetts Development Finance Agency and the Company dated March&nbsp;17, 2005</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Second Amendment to Lease by and between the Company and the Massachusetts Development Finance Agency dated as of November&nbsp;4, 2005</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/16/06</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Third Amendment to Lease between Massachusetts Development Finance Agency and the Company dated December&nbsp;20, 2006</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Fifth Amendment to Lease between Massachusetts Development Finance Agency and the Company dated October&nbsp;3, 2008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Sixth Amendment to Lease between Massachusetts Development Finance Agency and the Company dated August&nbsp;20, 2009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Seventh Amendment to Lease by and between the Company and the Massachusetts Development Finance Agency dated as of June&nbsp;22, 2010</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8/5/10</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>90</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=94,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=813390,FOLIO='90',FILE='DISK104:[13ZDF1.13ZDF47701]JA47701A.;9',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<A NAME="page_ja47701_1_91"> </A>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Incorporated by Reference to </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Description </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Form and<BR>
SEC File No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SEC<BR>
Filing Date </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Lease Agreement dated as of May&nbsp;1, 2013 by and between Crown Perryville,&nbsp;LLC and the Company.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5/03/13</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><BR><FONT SIZE=2><I> Material Contracts&#151;License, Collaboration, Supply and Distribution Agreements</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*10.12</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>License Agreement dated as of November&nbsp;1, 2005 by and between The Rockefeller University and the Company</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>S-4<BR>
(333-148291)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1/18/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>License Agreement dated September&nbsp;1, 2006 by and between Duke University and the Company</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>S-4<BR>
(333-148291)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>1/18/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amendment to License Agreement between Duke University and the Company dated April&nbsp;2, 2008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.15</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>License Agreement between Duke University, The Johns Hopkins University and the Company dated December&nbsp;31, 2003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amendment to License Agreement between Duke University, The Johns Hopkins University and the Company dated April&nbsp;2, 2008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Assignment and License Agreement, as amended, dated April&nbsp;6, 2004 by and among Medarex,&nbsp;Inc., GenPharm International,&nbsp;Inc. and the Company</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>S-4<BR>
(333-148291)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>1/18/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Research and Commercialization Agreement, as amended, dated as of April&nbsp;6, 2004 by and among Medarex,&nbsp;Inc., GenPharm International,&nbsp;Inc. and the Company</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>S-4<BR>
(333-148291)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>1/18/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Supply Agreement dated August&nbsp;18, 2006 by and between the Company and Biosyn</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>S-4<BR>
(333-148291)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>1/18/08</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Research Collaboration and Commercialization Agreement effective October&nbsp;20, 2006 between the Company and the Ludwig Institute for Cancer Research</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.45</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/2/09</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Exclusive Patent and Know-How License Agreement dated as of November&nbsp;5, 2008 between the Company and the University of Southampton</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.47</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/2/09</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>License and Assignment Agreement, between Amgen&nbsp;Inc. and the Company dated March&nbsp;16, 2009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Collaboration Agreement dated June&nbsp;18, 2004 between Seattle Genetics and CuraGen</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/12/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Second Restated Collaboration Agreement dated April&nbsp;12, 2004 and amended October&nbsp;19, 2004 between Abgenix&nbsp;Inc. and CuraGen</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.28</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/12/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amgen Letter Agreement, by and between CuraGen and Amgen Fremont,&nbsp;Inc. dated May&nbsp;2, 2009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/12/10</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>91</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=95,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=917017,FOLIO='91',FILE='DISK104:[13ZDF1.13ZDF47701]JA47701A.;9',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<A NAME="page_ja47701_1_92"> </A>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Incorporated by Reference to </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Description </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Form and<BR>
SEC File No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SEC<BR>
Filing Date </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*10.26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Transfer and Termination Agreement, dated as of April&nbsp;21, 2008 by and between TopoTarget A/S and CuraGen</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3/12/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>*10.27</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>License Agreement between Medarex and Company dated September&nbsp;17, 2010</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q/A<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/23/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.28</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Master Services Agreement dated March&nbsp;29, 2010 by and between the Company and Prologue Research International,&nbsp;Inc. (Prologue)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>11/3/11</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amendment to Master Services Agreement dated July&nbsp;6, 2011 by and between the Company and Novella Clinical&nbsp;Inc. (formerly known as Prologue)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>11/3/11</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Master Services Agreement dated May&nbsp;6, 2013 by and between the Company and PPD Development,&nbsp;LLC</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-Q<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8/6/13</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><BR><FONT SIZE=2><I> Material Contracts&#151;Stock Purchase, Financing and Credit Agreements</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.31</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Sales Agreement, dated January&nbsp;6, 2011, between Celldex Therapeutics,&nbsp;Inc. and Cantor Fitzgerald&nbsp;&amp;&nbsp;Co.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10.1.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1/6/11</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Amendment No.&nbsp;1 to Sales Agreement, dated January&nbsp;6, 2011, between Celldex Therapeutics,&nbsp;Inc. and Cantor Fitzgerald&nbsp;&amp;&nbsp;Co., dated September&nbsp;20, 2012</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>9/24/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=9 style="font-family:times;"><BR><FONT SIZE=2><I> Material Contracts&#151;Management Contracts and Compensatory Plans</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#134;10.33</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>2008 Stock Option and Incentive Plan, as amended and restated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6/14/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>2004 Employee Stock Purchase Plan, as amended and restated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>6/13/13</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.35</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Employment Agreement, dated as of January&nbsp;1, 2013, by and between the Company and Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/21/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.36</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Employment Agreement, dated as of January&nbsp;1, 2013, by and between the Company and Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/21/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Employment Agreement, dated as of January&nbsp;1, 2013, by and between the Company and Thomas Davis, MD</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/21/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.38</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Employment Agreement, dated as of January&nbsp;1, 2013, by and between the Company and Tibor Keler, Ph.D.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/21/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.39</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Employment Agreement, dated as of January&nbsp;1, 2013, by and between the Company and Ronald A. Pepin, Ph.D.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>12/21/12</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.40</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Form of Stock Option Agreement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>8-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>1/25/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>CuraGen 2007 Stock Incentive Plan, amended and restated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/12/10</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>&#134;10.42</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Form of Restricted Stock Award</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10-K<BR>
(000-15006)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>10.42</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>3/12/10</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>92</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=96,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=627039,FOLIO='92',FILE='DISK104:[13ZDF1.13ZDF47701]JA47701A.;9',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<A NAME="page_ja47701_1_93"> </A>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Incorporated by Reference to </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Description </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Form and<BR>
SEC File No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
No. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SEC<BR>
Filing Date </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21.0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>List of Subsidiaries</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Filed herewith</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>23.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Consent of PricewaterhouseCoopers&nbsp;LLP, an Independent Registered Public Accounting Firm</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Filed herewith</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>31.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Certification of President and Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Filed herewith</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>31.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Certification of Senior Vice President and Chief Financial Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Filed herewith</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Section&nbsp;1350 Certifications</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Furnished herewith</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>+101</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>XBRL Instance Document</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>+102</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>XBRL Taxonomy Extension Schema Document</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>+103</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>XBRL Taxonomy Extension Calculation Linkbase Document</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>+104</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>XBRL Taxonomy Extension Definition Linkbase Document</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>+105</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>XBRL Taxonomy Extension Label Linkbase Document</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>+106</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>XBRL Taxonomy Extension Presentation Linkbase Document</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Confidential
treatment has been requested for certain provisions of this Exhibit pursuant to Rule&nbsp;24b-2 promulgated under the Securities Exchange Act
of 1934, as amended.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#134;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Indicates
a management contract or compensation plan, contract or arrangement.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>+</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
XBRL information is being furnished and not filed for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended, and is not
incorporated by reference into any registration statement under the Securities Act of 1933, as amended.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>93</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=97,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=872092,FOLIO='93',FILE='DISK104:[13ZDF1.13ZDF47701]JA47701A.;9',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_jc47701_1_94"> </A>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="jc47701_signatures"> </A>
<A NAME="toc_jc47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SIGNATURES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="45%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><B> CELLDEX THERAPEUTICS,&nbsp;INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p align=center style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>/s/&nbsp;ANTHONY S. MARUCCI<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Date</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I> President and Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the
dates indicated. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="218pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:34pt;"><FONT SIZE=1><B>Signature

<!-- COMMAND=ADD_SCROPPEDRULE,34pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:17pt;"><FONT SIZE=1><B>Title

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:17pt;"><FONT SIZE=1><B>Date


<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>/s/&nbsp;ANTHONY S. MARUCCI<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Anthony S. Marucci</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>President, Chief Executive Officer, and Director<BR>
(Principal Executive Officer)</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;AVERY W. CATLIN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Avery W. Catlin</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Senior Vice President, Chief Financial Officer and Treasurer<BR>
(Principal Financial and Accounting Officer)</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;LARRY ELLBERGER<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Larry Ellberger</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Director, Chairman of the Board of Directors</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;HERBERT J. CONRAD<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Herbert J. Conrad</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;GEORGE O. ELSTON<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> George O. Elston</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;HARRY H. PENNER, JR.<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Harry H. Penner, Jr.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;TIMOTHY M. SHANNON, M.D.<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Timothy M. Shannon, M.D.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;KAREN L. SHOOS<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Karen L. Shoos</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;3, 2014</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>94</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=98,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1",CHK=207589,FOLIO='94',FILE='DISK104:[13ZDF1.13ZDF47701]JC47701A.;8',USER='HYUNG',CD='26-FEB-2014;11:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="13ZDF47701_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_bg47701_1">CELLDEX THERAPEUTICS, INC. ANNUAL REPORT ON FORM 10-K YEAR ENDED DECEMBER 31, 2013</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_bg47701_2">TABLE OF CONTENTS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc47701_1">PART I</A></FONT><BR>
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc47701_2">Item 1. BUSINESS</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc47701_3">Phase 2 Frontline Long-term Overall Survival Assessments</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc47701_4">EMERGE: Overall Response Rate and Disease Control Data</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc47701_5">EMERGE: Progression Free Survival (PFS) and Overall Survival (OS) Data</A></FONT><BR>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dg47701_1">Item 1A. RISK FACTORS</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk47701_1">Item 1B. UNRESOLVED STAFF COMMENTS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk47701_2">Item 2. PROPERTIES</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk47701_3">Item 3. LEGAL PROCEEDINGS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk47701_4">Item 4. MINE SAFETY DISCLOSURES</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm47701_1">PART II</A></FONT><BR>
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm47701_2">Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm47701_3">CELLDEX THEAPEUTICS, INC., NASDAQ MARKET INDEX&#151;U.S. AND PEER GROUP INDICES</A></FONT><BR>
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm47701_4">Item 6. SELECTED FINANCIAL DATA</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do47701_1">Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do47701_2">Phase 2 Frontline Long-term Overall Survival Assessments</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do47701_3">Interim ReACT Overall Survival and Progression-free Survival in Avastin-Na&iuml;ve Recurrent GBM</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do47701_4">EMERGE: Overall Response Rate and Disease Control Data</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do47701_5">EMERGE: Progression Free Survival (PFS) and Overall Survival (OS) Data</A></FONT><BR>

<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_du47701_1">Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fa47701_1">Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fa47701_2">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fc47701_1">CELLDEX THERAPEUTICS, INC. CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share amounts)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fe47701_1">CELLDEX THERAPEUTICS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except per share amounts)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fi47701_1">CELLDEX THERAPEUTICS, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fk47701_1">CELLDEX THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</A></FONT><BR>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_1">Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_2">Item 9A. CONTROLS AND PROCEDURES</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_3">Item 9B. OTHER INFORMATION</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_4">PART III</A></FONT><BR>
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_5">Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_6">Item 11. EXECUTIVE COMPENSATION</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_7">Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_8">Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_fu47701_9">Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ja47701_1">PART IV</A></FONT><BR>
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ja47701_2">Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_jc47701_1">SIGNATURES</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.0
<SEQUENCE>2
<FILENAME>a2218459zex-21_0.htm
<DESCRIPTION>EX-21.0
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#13ZDF47701_2">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="ke47701_exhibit_21.0"> </A>
<A NAME="toc_ke47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Exhibit&nbsp;21.0    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ke47701_list_of_subsidiaries"> </A>
<A NAME="toc_ke47701_2"> </A></FONT> <FONT SIZE=2><B>  LIST OF SUBSIDIARIES    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="103pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:21pt;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>State of Incorporation </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Celldex Research Corporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Delaware</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="2",CHK=673554,FOLIO='blank',FILE='DISK104:[13ZDF1.13ZDF47701]KE47701A.;4',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="13ZDF47701_2">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ke47701_1">Exhibit 21.0</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ke47701_2">LIST OF SUBSIDIARIES</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="2" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>a2218459zex-23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#13ZDF47701_3">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="kg47701_exhibit_23.1"> </A>
<A NAME="toc_kg47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Exhibit&nbsp;23.1    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="kg47701_consent_of_independent__kg402321"> </A>
<A NAME="toc_kg47701_2"> </A></FONT> <FONT SIZE=2><B>  CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We hereby consent to the incorporation by reference in the Registration Statements on Form&nbsp;S-8 (Nos.&nbsp;333-182142,
333-189336, 333-151728, 333-117602 and 333-162423) and on Form&nbsp;S-3 (No.&nbsp;333-192640) of Celldex Therapeutics,&nbsp;Inc. of our report dated March&nbsp;3, 2014 relating to the
financial statements and the effectiveness of internal control over financial reporting, which appears in this Form&nbsp;10-K. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>/s/
PricewaterhouseCoopers&nbsp;LLP </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Boston,
Massachusetts<BR>
March&nbsp;3, 2014 </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="3",CHK=92790,FOLIO='blank',FILE='DISK104:[13ZDF1.13ZDF47701]KG47701A.;4',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="13ZDF47701_3">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_kg47701_1">Exhibit 23.1</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_kg47701_2">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="3" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>a2218459zex-31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#13ZDF47701_4">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="ki47701_exhibit_31.1"> </A>
<A NAME="toc_ki47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Exhibit&nbsp;31.1    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ki47701_certification"> </A>
<A NAME="toc_ki47701_2"> </A></FONT> <FONT SIZE=2><B>  CERTIFICATION    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>I,
Anthony S. Marucci, certify that: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this annual report on Form&nbsp;10-K of Celldex Therapeutics,&nbsp;Inc.; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules&nbsp;13a-15(f) and 15d-15(f)) for the registrant and have: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;Evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;Disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial
reporting; and </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant's ability to record, process, summarize and report financial information; and </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial
reporting. </FONT></P>

</UL>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="47%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="38%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Date: March&nbsp;3, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>/s/&nbsp;ANTHONY S. MARUCCI<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Name:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Title:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> President and Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="4",CHK=10359,FOLIO='blank',FILE='DISK104:[13ZDF1.13ZDF47701]KI47701A.;4',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="13ZDF47701_4">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ki47701_1">Exhibit 31.1</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ki47701_2">CERTIFICATION</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="4" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>a2218459zex-31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#13ZDF47701_5">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="kk47701_exhibit_31.2"> </A>
<A NAME="toc_kk47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Exhibit&nbsp;31.2    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> CERTIFICATION  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>I,
Avery W. Catlin, certify that: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this annual report on Form&nbsp;10-K of Celldex Therapeutics,&nbsp;Inc.; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules&nbsp;13a-15(f) and 15d-15(f)) for the registrant and have: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared; </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;Evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;Disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial
reporting; and </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant's ability to record, process, summarize and report financial information; and </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial
reporting. </FONT></P>

</UL>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="47%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="38%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Date: March&nbsp;3, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>/s/&nbsp;AVERY W. CATLIN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Name:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Avery W. Catlin</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Title:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> Senior Vice President and<BR>
Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="5",CHK=655390,FOLIO='blank',FILE='DISK104:[13ZDF1.13ZDF47701]KK47701A.;6',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="13ZDF47701_5">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_kk47701_1">Exhibit 31.2</A></FONT><BR>
</UL>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="5" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>a2218459zex-32.htm
<DESCRIPTION>EX-32
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#13ZDF47701_6">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="km47701_exhibit_32"> </A>
<A NAME="toc_km47701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Exhibit&nbsp;32    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="km47701_certification_of_chief_executi__cer05925"> </A>
<A NAME="toc_km47701_2"> </A></FONT> <FONT SIZE=2><B>  CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND<BR>  CHIEF FINANCIAL OFFICER PURSUANT TO<BR>  18 U.S.C. SECTION&nbsp;1350, AS ADOPTED PURSUANT TO<BR>  SECTION&nbsp;906 OF THE SARBANES-OXLEY ACT
OF&nbsp;2002    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the
Sarbanes-Oxley Act of 2002, in his capacity as an officer of Celldex Therapeutics,&nbsp;Inc. (the "Company"), that, to his knowledge, the Annual Report of the Company on Form&nbsp;10-K for the
period ended December&nbsp;31, 2013 (the "Form&nbsp;10-K"), fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &sect;78m
or 78o(d)) and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company. This written statement is
being furnished to the Securities and Exchange Commission as an exhibit to the Form&nbsp;10-K. A signed original of this statement has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff upon request. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="47%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="38%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Date: March&nbsp;3, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>/s/&nbsp;ANTHONY S. MARUCCI<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Name:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Anthony S. Marucci</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Title:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> President and Chief Executive Officer</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> Date: March&nbsp;3, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;AVERY W. CATLIN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Name:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Avery W. Catlin</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Title:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> Senior Vice President and<BR>
Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
certification shall be not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange
Act. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="6",CHK=45850,FOLIO='blank',FILE='DISK104:[13ZDF1.13ZDF47701]KM47701A.;4',USER='JDUTRA',CD='25-FEB-2014;16:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="13ZDF47701_6">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_km47701_1">Exhibit 32</A></FONT><BR>
</UL>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_km47701_2">CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=HYUNG,SEQ=,EFW="2218459",CP="CELLDEX THERAPEUTICS, INC.",DN="6" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>cldx-20131231.xml
<DESCRIPTION>EX-101.INS
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<!--Generated by IRIS Proton Version 4.0.2.8-->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cldx="http://www.celldextherapeutics.com/20131231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31">
  <link:schemaRef xlink:type="simple" xlink:href="cldx-20131231.xsd" />
  <xbrli:context id="I2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_USGovernmentAndMunicipalObligationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">cldx:USGovernmentAndMunicipalObligationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2010_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2011_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2010_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2011_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2010_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2011_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2010_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2011_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013Q2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013SO">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-02-19</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ControlledEquityOfferingProgramAmendedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ControlledEquityOfferingProgramAmendedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_SalesMember_CustomerConcentrationRiskMember_GlaxoSmithKlinePlcMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">cldx:GlaxoSmithKlinePlcMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_SalesMember_CustomerConcentrationRiskMember_GlaxoSmithKlinePlcMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">cldx:GlaxoSmithKlinePlcMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_SalesMember_CustomerConcentrationRiskMember_GlaxoSmithKlinePlcMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">cldx:GlaxoSmithKlinePlcMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_LaboratoryEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:LaboratoryEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ManufacturingEquipmentMember_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:ManufacturingEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ManufacturingEquipmentMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:ManufacturingEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2009Q4_M1031_CuraGenCorporationMember_ConvertibleSubordinatedDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-10-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011Q1_M02_CuraGenCorporationMember_ConvertibleSubordinatedDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleSubordinatedDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-02-01</xbrli:startDate>
      <xbrli:endDate>2011-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_AccumulatedNetUnrealizedInvestmentGainLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_AccumulatedTranslationAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_AccumulatedNetUnrealizedInvestmentGainLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_AccumulatedTranslationAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_AccumulatedNetUnrealizedInvestmentGainLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_AccumulatedTranslationAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_FairValueMeasurementsRecurringMember_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_CorporateDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_USGovernmentAndMunicipalObligationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">cldx:USGovernmentAndMunicipalObligationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_CorporateDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_LaboratoryEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:LaboratoryEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_ManufacturingEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:ManufacturingEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LaboratoryEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:LaboratoryEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_ManufacturingEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cldx:ManufacturingEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_InProcessResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InProcessResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_AmgenAmendmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:AmgenAmendmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_CoreTechnologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:CoreTechnologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_AmgenAmendmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:AmgenAmendmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_CoreTechnologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:CoreTechnologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_AmgenAmendmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:AmgenAmendmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_CoreTechnologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:CoreTechnologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011Q1_M01">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012Q1_M01">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q1_M01">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q3_M09_ProductDevelopmentAndLicensingAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:ProductDevelopmentAndLicensingAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-09-01</xbrli:startDate>
      <xbrli:endDate>2013-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ProductDevelopmentAndLicensingAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:ProductDevelopmentAndLicensingAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q2_M05_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-05-01</xbrli:startDate>
      <xbrli:endDate>2013-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2010Q2_M0430">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-04-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_ControlledEquityOfferingProgramAmendedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ControlledEquityOfferingProgramAmendedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_ControlledEquityOfferingProgramAmendedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ControlledEquityOfferingProgramAmendedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_InternalRevenueServiceIRSMember_AVANTMember_PriorToMergerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:AVANTMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:StatusOfMergerAndAcquisitionAxis">cldx:PriorToMergerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_SeriesCPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q4_M12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-12-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_CumulativePreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CumulativePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ShareholderRightsPlanMember_CumulativePreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ShareholderRightsPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CumulativePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_ShareholderRightsPlanMember_CumulativePreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ShareholderRightsPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CumulativePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ShareholderRightsPlanMember_CumulativePreferredStockMember_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ShareholderRightsPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CumulativePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ShareholderRightsPlanMember_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ShareholderRightsPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ShareholderRightsPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:StockIssuedByTypeOfProgramAxis">cldx:ShareholderRightsPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D1995_LicenseAgreementsMember_CincinnatiChildrensHospitalMedicalCenterMember_RotarixRotavirusVaccineMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:CincinnatiChildrensHospitalMedicalCenterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:RotarixRotavirusVaccineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>1995-01-01</xbrli:startDate>
      <xbrli:endDate>1995-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2005Q2_M05_RoyaltyAgreementMember_PRFAgreementMember_RotarixRotavirusVaccineMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:RoyaltyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:PRFAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:RotarixRotavirusVaccineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2005-05-01</xbrli:startDate>
      <xbrli:endDate>2005-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_GlaxoSmithKlinePlcMember_RotarixRotavirusVaccineMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:GlaxoSmithKlinePlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:RotarixRotavirusVaccineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_GlaxoSmithKlinePlcMember_RotarixRotavirusVaccineMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:GlaxoSmithKlinePlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:RotarixRotavirusVaccineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_GlaxoSmithKlinePlcMember_RotarixRotavirusVaccineMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:GlaxoSmithKlinePlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:RotarixRotavirusVaccineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_LicenseAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_LicenseAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_LicenseAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_LicenseAgreementsMember_MedarexIncMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:MedarexIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_MedarexIncMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:MedarexIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_RockefellerUniversityMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:RockefellerUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_DukeUniversityBrainTumorCancerCenterMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:DukeUniversityBrainTumorCancerCenterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_LudwigInstituteForCancerResearchMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:LudwigInstituteForCancerResearchMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_AlterisTherapeuticsIncMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:AlterisTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_UniversityOfSouthamptonUKMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:UniversityOfSouthamptonUKMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_AmgenIncMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:AmgenIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_LicenseAgreementsMember_SeattleGeneticIncMember_CuraGenCorporationMember_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:SeattleGeneticIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_PriorToMergerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:StatusOfMergerAndAcquisitionAxis">cldx:PriorToMergerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_InternalRevenueServiceIRSMember_AVANTMember_PriorToMergerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:AVANTMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:StatusOfMergerAndAcquisitionAxis">cldx:PriorToMergerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_AVANTMember_PriorToMergerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:AVANTMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:StatusOfMergerAndAcquisitionAxis">cldx:PriorToMergerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_AVANTMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:AVANTMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_CuraGenCorporationMember_PriorToAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:StatusOfMergerAndAcquisitionAxis">cldx:PriorToAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_OwnershipChangeInOctober2007Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:OwnershipChangeAxis">cldx:OwnershipChangeInOctober2007Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_ResearchMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_StateAndLocalJurisdictionMember_ResearchMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_StateAndLocalJurisdictionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_InternalRevenueServiceIRSMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_InternalRevenueServiceIRSMember_OwnershipChangesInJune2009AndDecember2009Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="cldx:OwnershipChangeAxis">cldx:OwnershipChangesInJune2009AndDecember2009Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012Q1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012Q2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-04-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012Q3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012Q4">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-10-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-04-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2013-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013Q4">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-10-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_EmployeeStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_EmployeeStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_EmployeeStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_StockOptionAndIncentivePlan2008Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cldx:StockOptionAndIncentivePlan2008Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_StockOptionAndIncentivePlan2008Member_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cldx:StockOptionAndIncentivePlan2008Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_StockOptionAndIncentivePlan2008Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cldx:StockOptionAndIncentivePlan2008Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2012_RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_RestrictedStockMember_SBC">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2012_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2013_GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cldx:CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2013_CuraGenCorporationMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2010Q4_M12_MidCapFinancialLLCMember_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:DebtInstrumentLenderAxis">cldx:MidCapFinancialLLCMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-12-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2011Q1_M03_GeneralElectricCapitalCorporationMember_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cldx:DebtInstrumentLenderAxis">cldx:GeneralElectricCapitalCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-03-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2011Q1_M0331_SecuredDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2014Q1_2M_CuraGenCorporationMember_SeattleGeneticIncMember_SubsequentEventMember_LicenseAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744218</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:SeattleGeneticIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cldx:LicenseAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Item">
    <xbrli:measure>cldx:item</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Segment">
    <xbrli:measure>cldx:segment</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USDPerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="USDPerUnit">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>cldx:unit</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag1" decimals="-3" contextRef="I2012" unitRef="USD">24897000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost id="Tag2" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">15566000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AccountsAndOtherReceivablesNetCurrent id="Tag3" decimals="-3" contextRef="I2012" unitRef="USD">44000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Tag4" decimals="-3" contextRef="I2012" unitRef="USD">1108000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent id="Tag5" decimals="-3" contextRef="I2012" unitRef="USD">85114000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="Tag6" decimals="-3" contextRef="I2013" unitRef="USD">305189000</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet id="Tag7" decimals="-3" contextRef="I2012" unitRef="USD">7205000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Tag8" decimals="-3" contextRef="I2012" unitRef="USD">23833000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:OtherAssetsNoncurrent id="Tag9" decimals="-3" contextRef="I2012" unitRef="USD">424000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Goodwill id="Tag10" decimals="-3" contextRef="I2012" unitRef="USD">8965000</us-gaap:Goodwill>
  <us-gaap:Assets id="Tag11" decimals="-3" contextRef="I2012" unitRef="USD">125541000</us-gaap:Assets>
  <us-gaap:Assets id="Tag12" decimals="-3" contextRef="I2013" unitRef="USD">347095000</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="Tag13" decimals="-3" contextRef="I2012" unitRef="USD">745000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Tag14" decimals="-3" contextRef="I2012" unitRef="USD">10960000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="Tag15" decimals="-3" contextRef="I2012" unitRef="USD">388000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:SecuredDebtCurrent id="Tag16" decimals="-3" contextRef="I2012" unitRef="USD">5592000</us-gaap:SecuredDebtCurrent>
  <us-gaap:LiabilitiesCurrent id="Tag17" decimals="-3" contextRef="I2012" unitRef="USD">17685000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="Tag18" decimals="-3" contextRef="I2013" unitRef="USD">20350000</us-gaap:LiabilitiesCurrent>
  <us-gaap:SecuredLongTermDebt id="Tag19" decimals="-3" contextRef="I2012" unitRef="USD">5746000</us-gaap:SecuredLongTermDebt>
  <us-gaap:OtherLiabilitiesNoncurrent id="Tag20" decimals="-3" contextRef="I2012" unitRef="USD">6336000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:Liabilities id="Tag21" decimals="-3" contextRef="I2012" unitRef="USD">29767000</us-gaap:Liabilities>
  <us-gaap:CommonStockValue id="Tag22" decimals="-3" contextRef="I2012" unitRef="USD">64000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="Tag23" decimals="-3" contextRef="I2012" unitRef="USD">357094000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag24" decimals="-3" contextRef="I2012" unitRef="USD">2745000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Tag25" decimals="-3" contextRef="I2012" unitRef="USD">-264129000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="Tag26" decimals="-3" contextRef="I2012" unitRef="USD">95774000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Tag27" decimals="-3" contextRef="I2012" unitRef="USD">125541000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag28" decimals="-3" contextRef="I2013" unitRef="USD">319795000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Tag29" decimals="-3" contextRef="I2013" unitRef="USD">347095000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Tag30" decimals="INF" contextRef="I2013" unitRef="USDPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Tag31" decimals="INF" contextRef="I2012" unitRef="USDPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Tag32" decimals="INF" contextRef="I2013" unitRef="Shares">3000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="Tag33" decimals="INF" contextRef="I2012" unitRef="Shares">3000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Tag34" decimals="INF" contextRef="I2013" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued id="Tag35" decimals="INF" contextRef="I2012" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Tag36" decimals="INF" contextRef="I2013" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="Tag37" decimals="INF" contextRef="I2012" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Tag38" decimals="INF" contextRef="I2013" unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Tag39" decimals="INF" contextRef="I2012" unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Tag40" decimals="INF" contextRef="I2013" unitRef="Shares">297000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="Tag41" decimals="INF" contextRef="I2012" unitRef="Shares">297000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Tag42" decimals="INF" contextRef="I2012" unitRef="Shares">64359513</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="Tag43" decimals="INF" contextRef="I2013" unitRef="Shares">89246832</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="Tag44" decimals="INF" contextRef="I2013" unitRef="Shares">89246832</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="Tag45" decimals="INF" contextRef="I2012" unitRef="Shares">64359513</us-gaap:CommonStockSharesOutstanding>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements id="Tag46" decimals="-3" contextRef="D2012" unitRef="USD">146000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements id="Tag47" decimals="-3" contextRef="D2011" unitRef="USD">110000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromContractsAndGrants id="Tag48" decimals="-3" contextRef="D2012" unitRef="USD">281000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants id="Tag49" decimals="-3" contextRef="D2011" unitRef="USD">36000</cldx:RevenueFromContractsAndGrants>
  <us-gaap:RoyaltyRevenue id="Tag50" decimals="-3" contextRef="D2012" unitRef="USD">10775000</us-gaap:RoyaltyRevenue>
  <us-gaap:RoyaltyRevenue id="Tag51" decimals="-3" contextRef="D2011" unitRef="USD">9119000</us-gaap:RoyaltyRevenue>
  <us-gaap:Revenues id="Tag52" decimals="-3" contextRef="D2012" unitRef="USD">11202000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag53" decimals="-3" contextRef="D2011" unitRef="USD">9265000</us-gaap:Revenues>
  <us-gaap:RoyaltyRevenue id="Tag54" decimals="-3" contextRef="D2013" unitRef="USD">2334000</us-gaap:RoyaltyRevenue>
  <us-gaap:Revenues id="Tag55" decimals="-3" contextRef="D2013" unitRef="USD">4111000</us-gaap:Revenues>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag56" decimals="-3" contextRef="D2012" unitRef="USD">47398000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag57" decimals="-3" contextRef="D2011" unitRef="USD">32439000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RoyaltyExpense id="Tag58" decimals="-3" contextRef="D2012" unitRef="USD">10775000</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense id="Tag59" decimals="-3" contextRef="D2011" unitRef="USD">9119000</us-gaap:RoyaltyExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag60" decimals="-3" contextRef="D2012" unitRef="USD">10016000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag61" decimals="-3" contextRef="D2011" unitRef="USD">9193000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:AmortizationOfIntangibleAssets id="Tag62" decimals="-3" contextRef="D2012" unitRef="USD">1090000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets id="Tag63" decimals="-3" contextRef="D2011" unitRef="USD">1913000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:CostsAndExpenses id="Tag64" decimals="-3" contextRef="D2012" unitRef="USD">69279000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses id="Tag65" decimals="-3" contextRef="D2011" unitRef="USD">52664000</us-gaap:CostsAndExpenses>
  <us-gaap:RoyaltyExpense id="Tag66" decimals="-3" contextRef="D2013" unitRef="USD">2334000</us-gaap:RoyaltyExpense>
  <us-gaap:CostsAndExpenses id="Tag67" decimals="-3" contextRef="D2013" unitRef="USD">85553000</us-gaap:CostsAndExpenses>
  <us-gaap:OperatingIncomeLoss id="Tag68" decimals="-3" contextRef="D2012" unitRef="USD">-58077000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Tag69" decimals="-3" contextRef="D2011" unitRef="USD">-43399000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Tag70" decimals="-3" contextRef="D2013" unitRef="USD">-81442000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestAndOtherIncome id="Tag71" decimals="-3" contextRef="D2012" unitRef="USD">530000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome id="Tag72" decimals="-3" contextRef="D2011" unitRef="USD">396000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestExpense id="Tag73" decimals="-3" contextRef="D2012" unitRef="USD">1576000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="Tag74" decimals="-3" contextRef="D2011" unitRef="USD">1796000</us-gaap:InterestExpense>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag75" decimals="-3" contextRef="D2012" unitRef="USD">-59123000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag76" decimals="-3" contextRef="D2011" unitRef="USD">-44799000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag77" decimals="-3" contextRef="D2013" unitRef="USD">-81550000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag78" decimals="2" contextRef="D2012" unitRef="USDPerShare">-1.02</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag79" decimals="2" contextRef="D2011" unitRef="USDPerShare">-1.13</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag80" decimals="-3" contextRef="D2012" unitRef="Shares">57713000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag81" decimals="-3" contextRef="D2011" unitRef="Shares">39501000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:DepreciationDepletionAndAmortization id="Tag82" decimals="-3" contextRef="D2012" unitRef="USD">2047000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Tag83" decimals="-3" contextRef="D2011" unitRef="USD">2248000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent id="Tag84" decimals="-3" contextRef="D2012" unitRef="USD">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent id="Tag85" decimals="-3" contextRef="D2011" unitRef="USD">-9000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Tag86" decimals="-3" contextRef="D2012" unitRef="USD">91000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Tag87" decimals="-3" contextRef="D2011" unitRef="USD">-90000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag88" decimals="-3" contextRef="D2012" unitRef="USD">-59030000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag89" decimals="-3" contextRef="D2011" unitRef="USD">-44898000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag90" decimals="-3" contextRef="D2013" unitRef="USD">-81627000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="Tag91" decimals="-3" contextRef="D2012" unitRef="USD">660000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="Tag92" decimals="-3" contextRef="D2011" unitRef="USD">-17000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:MarketableSecuritiesGainLoss id="Tag93" decimals="-3" contextRef="D2012" unitRef="USD">6000</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MarketableSecuritiesGainLoss id="Tag94" decimals="-3" contextRef="D2011" unitRef="USD">-5000</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="Tag95" decimals="-3" contextRef="D2012" unitRef="USD">74000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="Tag96" decimals="-3" contextRef="D2011" unitRef="USD">58000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:ShareBasedCompensation id="Tag97" decimals="-3" contextRef="D2012" unitRef="USD">2298000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="Tag98" decimals="-3" contextRef="D2011" unitRef="USD">2342000</us-gaap:ShareBasedCompensation>
  <us-gaap:AmortizationOfDebtDiscountPremium id="Tag99" decimals="-3" contextRef="D2012" unitRef="USD">226000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium id="Tag100" decimals="-3" contextRef="D2011" unitRef="USD">307000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="Tag101" decimals="-3" contextRef="D2012" unitRef="USD">-126000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="Tag102" decimals="-3" contextRef="D2011" unitRef="USD">-154000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Tag103" decimals="-3" contextRef="D2012" unitRef="USD">-33000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Tag104" decimals="-3" contextRef="D2011" unitRef="USD">-241000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="Tag105" decimals="-3" contextRef="D2012" unitRef="USD">95000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="Tag106" decimals="-3" contextRef="D2011" unitRef="USD">-34000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Tag107" decimals="-3" contextRef="D2012" unitRef="USD">3762000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Tag108" decimals="-3" contextRef="D2011" unitRef="USD">2076000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="Tag109" decimals="-3" contextRef="D2012" unitRef="USD">594000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="Tag110" decimals="-3" contextRef="D2011" unitRef="USD">-138000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="Tag111" decimals="-3" contextRef="D2012" unitRef="USD">-49782000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="Tag112" decimals="-3" contextRef="D2011" unitRef="USD">-35658000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="Tag113" decimals="-3" contextRef="D2013" unitRef="USD">-67669000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="Tag114" decimals="-3" contextRef="D2012" unitRef="USD">52360000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="Tag115" decimals="-3" contextRef="D2011" unitRef="USD">51003000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="Tag116" decimals="-3" contextRef="D2012" unitRef="USD">69255000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="Tag117" decimals="-3" contextRef="D2011" unitRef="USD">52717000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag118" decimals="-3" contextRef="D2012" unitRef="USD">303000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag119" decimals="-3" contextRef="D2011" unitRef="USD">509000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfProductiveAssets id="Tag120" decimals="-3" contextRef="D2012" unitRef="USD">218000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <us-gaap:ProceedsFromSaleOfProductiveAssets id="Tag121" decimals="-3" contextRef="D2011" unitRef="USD">68000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="Tag122" decimals="-3" contextRef="D2012" unitRef="USD">-16980000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="Tag123" decimals="-3" contextRef="D2011" unitRef="USD">-2155000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="Tag124" decimals="-3" contextRef="D2013" unitRef="USD">-77422000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag125" decimals="-3" contextRef="D2012" unitRef="USD">83784000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag126" decimals="-3" contextRef="D2011" unitRef="USD">36023000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromStockPlans id="Tag127" decimals="-3" contextRef="D2013" unitRef="USD">5403000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="Tag128" decimals="-3" contextRef="D2013" unitRef="USD">-11029000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="Tag129" decimals="-3" contextRef="D2012" unitRef="USD">-3971000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="Tag130" decimals="-3" contextRef="D2011" unitRef="USD">5000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:RepaymentsOfConvertibleDebt id="Tag131" decimals="-3" contextRef="D2011" unitRef="USD">12503000</us-gaap:RepaymentsOfConvertibleDebt>
  <us-gaap:RepaymentsOfOtherLongTermDebt id="Tag132" decimals="-3" contextRef="D2011" unitRef="USD">86000</us-gaap:RepaymentsOfOtherLongTermDebt>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="Tag133" decimals="-3" contextRef="D2011" unitRef="USD">28434000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:RepaymentsOfOtherLongTermDebt id="Tag134" decimals="-3" contextRef="D2012" unitRef="USD">55000</us-gaap:RepaymentsOfOtherLongTermDebt>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="Tag135" decimals="-3" contextRef="D2012" unitRef="USD">79758000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="Tag136" decimals="-3" contextRef="D2013" unitRef="USD">289599000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations id="Tag137" decimals="-3" contextRef="D2012" unitRef="USD">2000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations id="Tag138" decimals="-3" contextRef="D2011" unitRef="USD">-9000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInContinuingOperations id="Tag139" decimals="-3" contextRef="D2012" unitRef="USD">12998000</us-gaap:NetCashProvidedByUsedInContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInContinuingOperations id="Tag140" decimals="-3" contextRef="D2011" unitRef="USD">-9388000</us-gaap:NetCashProvidedByUsedInContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInContinuingOperations id="Tag141" decimals="-3" contextRef="D2013" unitRef="USD">144505000</us-gaap:NetCashProvidedByUsedInContinuingOperations>
  <us-gaap:InterestPaid id="Tag142" decimals="-3" contextRef="D2012" unitRef="USD">1384000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="Tag143" decimals="-3" contextRef="D2011" unitRef="USD">1560000</us-gaap:InterestPaid>
  <us-gaap:StockholdersEquity id="Tag144" decimals="-3" contextRef="I2010_CommonStockMember" unitRef="USD">32000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag145" decimals="-3" contextRef="I2011_CommonStockMember" unitRef="USD">44000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag146" decimals="-3" contextRef="I2012_CommonStockMember" unitRef="USD">64000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag147" decimals="-3" contextRef="I2013_CommonStockMember" unitRef="USD">89000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesIssued id="Tag148" decimals="INF" contextRef="I2010_CommonStockMember" unitRef="Shares">32055382</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="Tag149" decimals="INF" contextRef="I2011_CommonStockMember" unitRef="Shares">44210636</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="Tag150" decimals="INF" contextRef="I2012_CommonStockMember" unitRef="Shares">64359513</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="Tag151" decimals="INF" contextRef="I2013_CommonStockMember" unitRef="Shares">89246832</us-gaap:CommonStockSharesIssued>
  <us-gaap:StockholdersEquity id="Tag152" decimals="-3" contextRef="I2010_AdditionalPaidInCapitalMember" unitRef="USD">232679000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag153" decimals="-3" contextRef="I2011_AdditionalPaidInCapitalMember" unitRef="USD">271032000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag154" decimals="-3" contextRef="I2012_AdditionalPaidInCapitalMember" unitRef="USD">357094000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag155" decimals="-3" contextRef="I2013_AdditionalPaidInCapitalMember" unitRef="USD">662717000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag156" decimals="-3" contextRef="I2010_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">2751000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag157" decimals="-3" contextRef="I2011_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">2652000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag158" decimals="-3" contextRef="I2012_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">2745000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag159" decimals="-3" contextRef="I2013_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">2668000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag160" decimals="-3" contextRef="I2010_RetainedEarningsMember" unitRef="USD">-160207000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag161" decimals="-3" contextRef="I2011_RetainedEarningsMember" unitRef="USD">-205006000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag162" decimals="-3" contextRef="I2012_RetainedEarningsMember" unitRef="USD">-264129000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag163" decimals="-3" contextRef="I2013_RetainedEarningsMember" unitRef="USD">-345679000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag164" decimals="-3" contextRef="I2010" unitRef="USD">75255000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag165" decimals="-3" contextRef="I2011" unitRef="USD">68722000</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Tag166" decimals="INF" contextRef="D2011_CommonStockMember" unitRef="Shares">80254</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Tag167" decimals="INF" contextRef="D2012_CommonStockMember" unitRef="Shares">70587</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="Tag168" decimals="INF" contextRef="D2011_CommonStockMember" unitRef="Shares">575000</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="Tag169" decimals="INF" contextRef="D2012_CommonStockMember" unitRef="Shares">8003290</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="Tag170" decimals="INF" contextRef="D2013_CommonStockMember" unitRef="Shares">2433608</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag171" decimals="INF" contextRef="D2011_CommonStockMember" unitRef="Shares">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag172" decimals="INF" contextRef="D2012_CommonStockMember" unitRef="Shares">12075000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag173" decimals="INF" contextRef="D2013_CommonStockMember" unitRef="Shares">21613483</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag174" decimals="-3" contextRef="D2011_CommonStockMember" unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag175" decimals="-3" contextRef="D2012_CommonStockMember" unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag176" decimals="-3" contextRef="D2013_CommonStockMember" unitRef="USD">2000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag177" decimals="-3" contextRef="D2011_CommonStockMember" unitRef="USD">11000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag178" decimals="-3" contextRef="D2012_CommonStockMember" unitRef="USD">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag179" decimals="-3" contextRef="D2013_CommonStockMember" unitRef="USD">22000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag180" decimals="-3" contextRef="D2011_AdditionalPaidInCapitalMember" unitRef="USD">173000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag181" decimals="-3" contextRef="D2012_AdditionalPaidInCapitalMember" unitRef="USD">163000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag182" decimals="-3" contextRef="D2011_AdditionalPaidInCapitalMember" unitRef="USD">2154000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag183" decimals="-3" contextRef="D2012_AdditionalPaidInCapitalMember" unitRef="USD">40130000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag184" decimals="-3" contextRef="D2013_AdditionalPaidInCapitalMember" unitRef="USD">17132000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag185" decimals="-3" contextRef="D2011_AdditionalPaidInCapitalMember" unitRef="USD">33684000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag186" decimals="-3" contextRef="D2012_AdditionalPaidInCapitalMember" unitRef="USD">43471000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Tag187" decimals="-3" contextRef="D2011_AdditionalPaidInCapitalMember" unitRef="USD">2342000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Tag188" decimals="-3" contextRef="D2012_AdditionalPaidInCapitalMember" unitRef="USD">2298000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent id="Tag189" decimals="-3" contextRef="D2011_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-9000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent id="Tag190" decimals="-3" contextRef="D2012_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Tag191" decimals="-3" contextRef="D2011_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-90000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Tag192" decimals="-3" contextRef="D2012_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">91000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag193" decimals="-3" contextRef="D2011_RetainedEarningsMember" unitRef="USD">-44799000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag194" decimals="-3" contextRef="D2012_RetainedEarningsMember" unitRef="USD">-59123000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag195" decimals="-3" contextRef="D2011" unitRef="USD">173000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag196" decimals="-3" contextRef="D2011" unitRef="USD">2155000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag197" decimals="-3" contextRef="D2011" unitRef="USD">33695000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Tag198" decimals="-3" contextRef="D2011" unitRef="USD">2342000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag199" decimals="-3" contextRef="D2012" unitRef="USD">163000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag200" decimals="-3" contextRef="D2012" unitRef="USD">40138000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag201" decimals="-3" contextRef="D2012" unitRef="USD">43483000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Tag202" decimals="-3" contextRef="D2012" unitRef="USD">2298000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag203" decimals="-3" contextRef="D2013" unitRef="USD">17134000</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Tag204" decimals="-3" contextRef="D2013_AdditionalPaidInCapitalMember" unitRef="USD">4548000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent id="Tag205" decimals="-3" contextRef="D2013_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Tag206" decimals="-3" contextRef="D2013_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-74000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag207" decimals="-3" contextRef="D2013_RetainedEarningsMember" unitRef="USD">-81550000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:BasisOfAccounting id="Tag208" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(1) NATURE OF BUSINESS AND OVERVIEW&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Celldex Therapeutics,&amp;#160;Inc. (the "Company" or "Celldex") is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's lead drug candidates include rindopepimut (also referred to as CDX-110) and glembatumumab vedotin (also referred to as CDX-011). Rindopepimut is a targeted immunotherapeutic in a pivotal Phase&amp;#160;3 study for the treatment of front-line glioblastoma and a Phase&amp;#160;2 study for the treatment of recurrent glioblastoma. Glembatumumab vedotin is an antibody-drug conjugate in a randomized study in patients with triple negative breast cancer that over-express gpNMB designed to obtain accelerated approval. The Company has a number of earlier stage candidates in clinical development, including varlilumab (also referred to as CDX-1127), a fully human therapeutic monoclonal antibody in a Phase&amp;#160;1 study for cancer indications, CDX-301, an immune cell mobilizing agent and dendritic cell growth factor and CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells for cancer indications.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;At December&amp;#160;31, 2013, the Company had cash, cash equivalents and marketable securities of $303.0&amp;#160;million. The Company incurred a loss of $81.6&amp;#160;million for the year ended December&amp;#160;31, 2013. Net cash used in operations for the year ended December&amp;#160;31, 2013 was $67.7&amp;#160;million. The Company believes that the cash, cash equivalents and marketable securities at December&amp;#160;31, 2013 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;During the next twelve months, the Company may take further steps to raise additional capital to meet its long-term liquidity needs. These capital raising activities may include, but may not be limited to, one or more of the following: the licensing of technology programs with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While the Company continues to seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and the Company's negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the Company will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to the Company's stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict the Company's ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce the Company's economic potential from products under development.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Tag209" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The accompanying consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation. The Company operates in one segment, which is the business of development, manufacturing and commercialization of novel therapeutics for human health care.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S.&amp;#160;GAAP) requires management to make estimates and use assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company considers all highly liquid investments purchased with a maturity date of 90&amp;#160;days or less at the date of purchase to be cash equivalents. Cash equivalents consist principally of money market funds and debt securities.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Marketable Securities&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company invests its excess cash balances in marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds. The Company classifies all of its marketable securities as current assets on the consolidated balance sheets because they are available-for-sale and available to fund current operations. Marketable securities are stated at fair value with their unrealized gains and losses included as a component of accumulated other comprehensive income (loss), which is a separate component of stockholders' equity, until such gains and losses are realized. If a decline in the fair value is considered other-than-temporary, based on available evidence, the unrealized loss is transferred from other comprehensive income (loss) to the consolidated statements of operations. Realized gains and losses are determined on the specific identification method and are included in investment and other income, net.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Concentration of Credit Risk and of Significant Customers and Suppliers&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, marketable securities and accounts receivable. The Company invests its cash, cash equivalents and marketable securities in debt instruments and interest bearing accounts at major financial institutions in excess of insured limits. The Company mitigates credit risk by limiting the investment type and maturity to securities that preserve capital, maintain liquidity and have a high credit quality. The Company has not historically experienced credit losses from its accounts receivable and therefore has not established an allowance for doubtful accounts.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Revenue from Glaxo represented 57%, 96% and 98% for the years ended December&amp;#160;31, 2013, 2012 and 2011 and of total Company revenue, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company relies on contract manufacturing organizations (CMO) to manufacture drug substance and drug product for its late-stage clinical studies of rindopepimut and glembatumumab vedotin as well as for future commercial supplies. The Company also relies on CMOs for supply of raw materials as well as filling, packaging, storage and shipping of drug product. These clinical studies would be adversely affected by a significant interruption in the supply of rindopepimut and glembatumumab vedotin.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has certain assets and liabilities that are measured at fair value in the financial statements. The Company seeks to maximize the use of observable inputs (market data obtained from sources independent from the Company) and to minimize the use of unobservable inputs (the Company's assumptions about how market participants would price assets and liabilities) when measuring the fair value of its assets and liabilities. These assets and liabilities are classified into one of three levels of the following fair value hierarchy as defined by U.S.&amp;#160;GAAP:&lt;/font&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li style="list-style: none;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Level&amp;#160;1: Observable inputs such as quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Level&amp;#160;2: Observable inputs other than Level&amp;#160;1 prices, such as quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Level&amp;#160;3: Unobservable inputs based on the Company's assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/font&gt;&lt;/p&gt;&lt;/li&gt;&lt;/ul&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Property and equipment is stated at cost and depreciated over the estimated useful lives of the related assets using the straight-line method. Laboratory equipment and office furniture and equipment are depreciated over five years and computer equipment is depreciated over three years. Manufacturing equipment is amortized over seven to ten years. Leasehold improvements are amortized over the shorter of the estimated useful life or the non-cancelable term of the related lease, including any renewals that are reasonably assured of occurring. Property and equipment under construction is classified as construction in progress and is depreciated or amortized only after the asset is placed in service. Expenditures for maintenance and repairs are charged to expense whereas the costs of significant improvements which extend the life of the underlying asset are capitalized. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are eliminated and any resulting gain or loss is reflected in the Company's consolidated statements of operations and comprehensive loss.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The treatment of costs to construct property and equipment depends on the nature of the costs and the stage of construction. Costs incurred in the project planning, design, construction and installation phases are capitalized as part of the cost of the asset. The Company stops capitalizing these costs when the asset is substantially complete and ready for its intended use. For manufacturing property and equipment, the Company also capitalizes the cost of validating these assets for the underlying manufacturing process. The Company completes the capitalization of validation costs when the asset is substantially complete and ready for its intended use. Costs capitalized include incremental labor and fringe benefits, and direct consultancy services.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Business Combinations&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records the fair value of the consideration transferred to acquire a business to the tangible assets and identifiable intangible assets acquired and liabilities assumed on the basis of their fair values at the date of acquisition. The Company assesses the fair value of assets, including intangible assets such as in-process research and development (IPR&amp;amp;D), using a variety of methods including present value models. Each asset is measured at fair value from the perspective of a market participant. The method used to estimate the fair values of IPR&amp;amp;D assets incorporates significant assumptions regarding the estimates a market participant would make in order to evaluate an asset, including a market participant's assumptions regarding the probability of completing IPR&amp;amp;D projects, which would require obtaining regulatory approval for marketing of the associated drug candidate; a market participant's estimates regarding the timing of and the expected costs to complete IPR&amp;amp;D projects; a market participant's estimates of future cash flows from potential product sales; and the appropriate discount rates for a market participant. Transaction costs and restructuring costs associated with the transaction are expensed as incurred.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In connection with the acquisition of CuraGen Corporation ("CuraGen") in October 2009, the Company assumed CuraGen's $12.5&amp;#160;million in 4% convertible subordinated debt due February&amp;#160;15, 2011 (the "Convertible Subordinated Debt"). In February 2011, the Company paid $12.8&amp;#160;million and satisfied all the outstanding principal and accrued interest related to the Convertible Subordinated Debt.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Intangible Assets&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;IPR&amp;amp;D assets acquired in a business combination initially are recorded at fair value and accounted for as indefinite-lived intangible assets. These assets are maintained on the Company's consolidated balance sheets until either the project underlying them is completed or the assets become impaired. If a project is completed, the carrying value of the related intangible asset is amortized over the remaining estimated life of the asset beginning in the period in which the project is completed. If a project becomes impaired or is abandoned, the carrying value of the related intangible asset is written down to its fair value and an impairment charge is taken in the period in which the impairment occurs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In January 2013, the Company adopted a new U.S.&amp;#160;GAAP accounting standard which amended guidance applicable to annual impairment tests of indefinite-lived intangible assets. The amended guidance added an optional qualitative assessment for determining whether an indefinite-lived intangible asset is impaired. Prior to this guidance, companies were required to perform an annual impairment test that included a calculation of the fair value of the asset and a comparison of that fair value with its carrying value. If the carrying value exceeded the fair value, an impairment was recorded. The amended guidance allows a company the option to perform a qualitative assessment, considering both negative and positive evidence, regarding the potential impairment of the indefinite-lived intangible asset. If, based on the qualitative analysis, the company determines that it is more likely than not that the fair value of such an asset exceeds its carrying value, the company would be permitted to conclude that the indefinite-lived intangible asset was not impaired without a quantitative calculation of the fair value of the asset. Otherwise, the company would perform the quantitative calculation of the fair value and the comparison with the carrying value. The Company's adoption of this new standard did not have a material effect on its operating results or financial position.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;IPR&amp;amp;D assets are tested for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. As part of the annual impairment test of the IPR&amp;amp;D assets as of July&amp;#160;1, 2013, the Company bypassed the optional qualitative assessment and performed a calculation of the fair value of the asset. The Company concluded that the IPR&amp;amp;D assets were not impaired.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets acquired in a business combination with a finite life are recorded at fair value and amortized over the greater of economic consumption or on a straight-line basis over their estimated useful life.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The difference between the purchase price and the fair value of assets acquired and liabilities assumed in a business combination is allocated to goodwill. Goodwill is evaluated for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. The Company has the option to assess qualitative factors to determine if it is more likely than not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment test required under U.S.&amp;#160;GAAP. As part of its annual impairment test of the goodwill asset as of July&amp;#160;1, 2013, the Company bypassed the optional qualitative assessment and performed the two-step impairment test. The Company concluded that the goodwill asset was not impaired.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Impairment of Long-Lived Assets&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company evaluates the recoverability of its long-lived assets, including property and equipment, and intangible assets when circumstances indicate that an event of impairment may have occurred. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the assets, the assets are written-down to their estimated fair values.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company recognizes revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the seller's price to the buyer is fixed or determinable; and collectability is reasonably assured.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has entered into and in the future may enter into biopharmaceutical product development agreements with collaborative partners for the research and development of therapeutic drug products. The terms of the agreements may include nonrefundable signing and licensing fees, funding for research, development and manufacturing, milestone payments and royalties on any product sales derived from collaborations. These multiple element arrangements are analyzed to determine whether the deliverables can be separated or whether they must be accounted for as a single unit of accounting. In accounting for these transactions, the Company allocates revenue to the various elements based on their relative fair value. The fair value of a revenue generating element can be based on current selling prices offered by the Company or another party for current products or the Company's best estimate of a selling price for future products. Revenue allocated to an individual element is recognized when all other revenue recognition criteria are met for that element.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;These collaborative and other agreements may contain milestone payments. Revenues from milestones, if they are considered substantive, are recognized upon successful accomplishment of the milestones. Determining whether a milestone is substantive involves judgment, including an assessment of the Company's involvement in achieving the milestones and whether the amount of the payment is commensurate to the Company's performance. If not considered substantive, milestones are initially deferred and recognized over the remaining performance obligation.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Payments received to fund certain research activities are recognized as revenue in the period in which the research activities are performed. Revenue from contracts and grants is recognized as the services are performed and recorded as effort is expended on the contracted work and billed to the government or the Company's contractual partner. Payments received in advance that are related to future performance are deferred and recognized as revenue when the research projects are performed.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Product royalty revenue consists of payments received from licensees for a portion of sales proceeds from products that utilize the Company's licensed technologies and are recognized when the amount of and basis for such royalty payments are reported to the Company in accurate and appropriate form and in accordance with the related license agreement.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Research and Development Expenses&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Research and development costs, including internal and contract research costs, are expensed as incurred. Research and development expenses consist mainly of clinical trial costs, manufacturing of clinical material, toxicology and other studies, personnel costs, depreciation, license fees and funding of outside research.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Clinical trial expenses include expenses associated with clinical research organizations (CRO). The invoicing from CROs for services rendered can lag several months. We accrue the cost of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, and project management costs. We maintain regular communication with our CROs to gauge the reasonableness of our estimates. Differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period in which they become known.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Patent Costs&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Patent costs are expensed as incurred. Certain patent costs are reimbursed by the Company's product development and licensing partners. Any reimbursed patent costs are recorded as product development and licensing agreement revenues in the Company's financial statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records stock-based compensation expense for all stock-based awards made to employees and directors based on the estimated fair values of the stock-based awards expected to vest at the grant date and is adjusted, if necessary, to reflect actual forfeitures. Compensation expense for all stock-based awards to employees and directors is recognized using the straight-line method over the term of vesting or performance.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records stock-based compensation expense for stock options granted to non-employees based on the fair value of the stock options which is re-measured over the vesting term resulting in periodic adjustments to stock-based compensation expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Foreign Currency Translation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net unrealized gains and losses resulting from foreign currency translation are included in other comprehensive income (loss). At December&amp;#160;31, 2013 and December&amp;#160;31, 2012, accumulated other comprehensive income includes a net unrealized gain related to foreign currency translation of $2.6&amp;#160;million. In 2011, the Company's foreign subsidiary voluntarily liquidated in order to consolidate the Company's foreign operations into Celldex Therapeutics,&amp;#160;Inc.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company uses the asset and liability method to account for income taxes, including the recognition of deferred tax assets and deferred tax liabilities for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax basis. Quarterly, the Company reviews its deferred tax assets for recovery. A valuation allowance is established when the Company believes that it is more likely than not that its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records uncertain tax positions in the financial statements only if it is more likely than not that the uncertain tax position will be sustained upon examination by the taxing authorities. The Company records interest and penalties related to uncertain tax positions in income tax expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Comprehensive Loss&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Comprehensive loss is comprised of net loss and certain changes in stockholders' equity that are excluded from net loss. The Company includes foreign currency translation adjustments and unrealized gains and losses on marketable securities in other comprehensive loss. The consolidated statements of operations and comprehensive loss reflect total comprehensive loss for the years ended December&amp;#160;31, 2013, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In January 2013, the Company adopted a new U.S.&amp;#160;GAAP accounting standard which requires the Company to separately disclose, on a prospective basis, the change in each component of other comprehensive income (loss) relating to reclassification adjustments and current period other comprehensive income (loss). As the new guidance relates to presentation only, the adoption did not have a material impact on the Company's results of operations or financial position.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Net Loss Per Share&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended December&amp;#160;31,&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,770,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,349,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,459,034&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Restricted stock&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,776,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,355,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,465,034&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company's financial position or results of operations upon adoption.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:ComprehensiveIncomeNoteTextBlock id="Tag210" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(3) COMPREHENSIVE LOSS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The changes in accumulated other comprehensive income (loss) by component for the year ended December&amp;#160;31, 2013 are summarized below. No amounts were reclassified out of accumulated other comprehensive income during the years ended December&amp;#160;31, 2013, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="96"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="73"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Unrealized Gain&lt;br /&gt;
(Loss) on&lt;br /&gt;
Marketable&lt;br /&gt;
Securities, net of tax&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Foreign&lt;br /&gt;
Currency Items&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Balance at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;156&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,589&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,745&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(74&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(77&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Amounts reclassified from other comprehensive income&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net current-period other comprehensive income&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(74&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(77&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Balance at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;82&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,586&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,668&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="Tag211" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(4) FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The following tables set forth the Company's financial assets subject to fair value measurements:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="36"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;As of&lt;br /&gt;
December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;1&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;2&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;3&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;148,549&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;148,549&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;133,581&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;133,581&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;282,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;282,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;br /&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="36"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;As of&lt;br /&gt;
December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;1&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;2&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;3&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;18,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;18,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;77,753&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;18,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;There have been no transfers of assets or liabilities between the fair value measurement classifications. The Company's financial instruments consist mainly of cash and cash equivalents, marketable securities, short-term accounts receivable and accounts payable. The Company values its marketable securities utilizing independent pricing services which normally derive security prices from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. At each balance sheet date, observable market inputs may include trade information, broker or dealer quotes, bids, offers or a combination of these data sources. Short-term accounts receivable and accounts payable are reflected in the accompanying consolidated financial statements at cost, which approximates fair value due to the short-term nature of these instruments.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock id="Tag212" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(5) MARKETABLE SECURITIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;A summary of marketable securities is shown below:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Amortized&lt;br /&gt;
Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Gains&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Losses&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Fair&lt;br /&gt;
Value&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;55,531&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;55,554&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;18,234&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;56&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;18,286&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;73,765&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;83&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(8&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;73,840&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;38,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;9&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(9&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;38,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;20,761&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;12&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(5&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;20,768&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;59,734&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;21&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(14&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;59,741&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;133,499&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;104&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(22&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;133,581&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;br /&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="49"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Amortized&lt;br /&gt;
Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Gains&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Losses&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Fair&lt;br /&gt;
Value&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;15,566&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;28&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;15,594&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,797&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;99&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,895&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total U.S. government and municipal obligations&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,363&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;127&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,489&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;17,353&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;23&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;17,372&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;6,193&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;14&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;6,204&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;23,546&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;37&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(7&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;23,576&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;58,909&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;164&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(8&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The marketable securities held by the Company were high investment grade and there were no marketable securities that the Company considered to be other-than-temporarily impaired as of December&amp;#160;31, 2013.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="Tag213" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(6) PROPERTY AND EQUIPMENT, NET&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Property and equipment include the following:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Laboratory Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,699&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,164&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Manufacturing Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,055&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Office Furniture and Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,386&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,264&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Leasehold Improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;14,493&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;12,932&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Construction in Progress&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;257&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;115&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total Property and Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;21,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,530&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Less Accumulated Depreciation and Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(11,992&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(12,325&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;9,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;7,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Depreciation and amortization expense related to property and equipment was $1.9&amp;#160;million, $2.0&amp;#160;million and $2.2&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock id="Tag214" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(7) INTANGIBLE ASSETS AND GOODWILL&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets, net of accumulated amortization, and goodwill are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 54%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"150%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="150%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="58" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="61"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="61"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="10" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
Life&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Accumulated&lt;br /&gt;
Amortization&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Accumulated&lt;br /&gt;
Amortization&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="17" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Intangible Assets:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;Indefinite&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Amgen Amendment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;16&amp;#160;years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;14,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(3,812&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;10,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;14,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(2,915&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,585&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Core Technology&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11&amp;#160;years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,296&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(964&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;332&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,296&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(848&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;448&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total Intangible Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;27,596&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;22,820&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;27,596&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(3,763&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;23,833&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;Indefinite&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The IPR&amp;amp;D intangible asset was recorded in connection with the acquisition of CuraGen and relates to the development of glembatumumab vedotin. At the date of acquisition and at December&amp;#160;31, 2013, glembatumumab vedotin had not yet reached technological feasibility nor did it have any alternative future use. Glembatumumab vedotin is in a randomized, accelerated approval study in patients with triple negative breast cancer that over-express gpNMB.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amortization expense for intangible assets was $1.0&amp;#160;million, $1.1&amp;#160;million and $1.9&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively. The estimated future amortization expense of intangible assets for the years ended December&amp;#160;31, 2014, 2015, 2016, 2017 and 2018 is $1.0&amp;#160;million, $1.0&amp;#160;million, $1.0&amp;#160;million, $0.9&amp;#160;million and $0.9&amp;#160;million, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock id="Tag215" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(8) ACCRUED EXPENSES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Accrued expenses include the following:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 543px;" border="0" cellspacing="0" cellpadding="0" width="543"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Royalty and License Fees&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;250&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Payroll and Employee Benefits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,515&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;925&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Research and Development Contract Costs&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,840&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7,569&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Professional Fees&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;556&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;317&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other Accrued Expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,018&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;373&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;17,179&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;10,960&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
  <us-gaap:OtherLiabilitiesDisclosureTextBlock id="Tag216" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(9) OTHER LONG-TERM LIABILITIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other long-term liabilities include the following:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred Rent&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;419&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;434&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net Deferred Tax Liability related to IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred Income from Sale of Tax Benefits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,630&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,118&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred Revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,168&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Loan Payable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;472&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;39&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7,878&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,724&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Less Current Portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(928&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(388&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Long-Term Portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,950&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,336&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In January 2013, 2012 and 2011, the Company received approval from the New Jersey Economic Development Authority and agreed to sell New Jersey tax benefits worth $0.8&amp;#160;million, $0.8&amp;#160;million and $0.6&amp;#160;million to an independent third party for $0.8&amp;#160;million, $0.7&amp;#160;million and $0.5&amp;#160;million, respectively. Under the agreement, the Company must maintain a base of operations in New Jersey for five years or the tax benefits must be paid back on a pro-rata basis based on the number of years completed. During the years ended December&amp;#160;31, 2013 and 2012, the Company recorded $0.2&amp;#160;million and $0.1&amp;#160;million to other income related to the sale of these tax benefits, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In September 2013, the Company entered into an agreement with Rockefeller University pursuant to which the Company will perform research and development services for Rockefeller. The agreement includes an approved project plan for the development services of $4.8&amp;#160;million and a term of three years. The agreement included an upfront payment of $1.3&amp;#160;million which is being recognized as revenue over the term of the agreement. The Company will bill Rockefeller quarterly for actual time and direct costs incurred and record those amounts to revenue in the quarter the services are performed. The Company recorded $1.4&amp;#160;million in revenue related to the Rockefeller agreement during the year ended December&amp;#160;31, 2013.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
  <us-gaap:LongTermDebtTextBlock id="Tag217" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(10) TERM LOAN&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In December 2010, the Company entered into a loan and security agreement with MidCap Financial,&amp;#160;LLC pursuant to which the Company borrowed $10.0&amp;#160;million under a term loan from MidCap. In March 2011, the Company amended the loan agreement and borrowed an additional $5.0&amp;#160;million from General Electric Capital Corporation to increase the amount owed under the term loan to $15.0&amp;#160;million. In March 2012, the Company amended the loan agreement to extend the maturity date from December 2013 to December 2014. In May 2013, the Company elected to prepay the outstanding principal under the term loan in full, pursuant to the terms of its loan agreement, as amended, and paid $8.8&amp;#160;million in principal and $0.7&amp;#160;million in interest, prepayment and final payment fees. The Company's obligations under the loan agreement had been collateralized by a first priority security interest in substantially all of its assets, other than its intellectual property. In connection with the repayment of the term loan and the termination of the loan agreement, those security interests were released. Interest expense on the term loan was $0.8&amp;#160;million, $1.5&amp;#160;million and $1.6&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="Tag218" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(11) STOCKHOLDERS' EQUITY&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In April 2010, the Company filed a shelf registration statement with the Securities and Exchange Commission to register for sale any combination of the types of securities described in the shelf registration statement up to a dollar amount of $150&amp;#160;million. The shelf registration went effective on April&amp;#160;22, 2010. In December 2012, the Company filed a new shelf registration statement with the Securities and Exchange Commission to register for sale any combination of the types of securities described in the new shelf registration statement up to a dollar amount of $200&amp;#160;million. The new shelf registration went effective on January&amp;#160;16, 2013. In December 2013, the Company filed a new automatic shelf registration statement.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;During the years ended December&amp;#160;31, 2013, 2012 and 2011, Company issued 21,613,483, 12,075,000 and 11,500,000 shares of its common stock in underwritten public offerings resulting in net proceeds to the Company of $278.6&amp;#160;million, $43.5&amp;#160;million and $33.7&amp;#160;million, after deducting underwriting fees and offering expenses, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;During the years ended December&amp;#160;31, 2013, 2012 and 2011, Company issued 2,433,608, 8,003,290 and 575,000 shares of its common stock under our controlled equity offering sales agreement with Cantor Fitzgerald&amp;#160;&amp;amp;&amp;#160;Co., as amended, resulting in net proceeds to the Company of $17.1&amp;#160;million, $40.1&amp;#160;million and $2.2&amp;#160;million, after deducting commission and offering expenses, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Convertible Preferred Stock&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;At December&amp;#160;31, 2013, the Company had authorized 3,000,000 shares of preferred stock all of which have been designated Class&amp;#160;C Preferred Stock including 350,000 shares which have been designated Series&amp;#160;C-1&amp;#160;Junior Participating Cumulative Preferred Stock (the "Series&amp;#160;C-1 Preferred Stock").&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Shareholder Rights Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company's Board has adopted a Shareholder Rights Plan, as set forth in the Shareholder Rights Agreement, as amended, between the Company and Computershare Trust Company, N.A., as Rights Agent (the "Rights Agreement"). Pursuant to the terms of the Rights Agreement, the Board declared a dividend distribution of one Preferred Stock Purchase Right (a "Right") for each outstanding share of the Company's common stock. Each Right, which expires in November 2014, entitles their holder to purchase from the Company one ten-thousandth of a share (a "Unit") of Series&amp;#160;C-1 Preferred Stock at a cash exercise price of $35.00 per Unit, subject to adjustment. The Rights will trade separately from the common stock and will become exercisable only when a person or group has acquired 15% or more of the outstanding common stock or upon the commencement by a person or group of a tender offer that would result in such person or group acquiring 15% or more of the outstanding common stock other than as a result of repurchases of stock by the Company or certain inadvertent actions by a shareholder. In the event a person or group acquires 15% or more of the outstanding common stock each holder of a Right (except for any such person or group) would be entitled to receive upon exercise sufficient Units of Series&amp;#160;C-1 Preferred Stock to equal a value of two times the exercise price of the Right. In the event the Company is acquired in a merger or other business combination transaction or if 50% or more of the Company's assets or earning power is sold, each holder of a Right (except for any such person or group described above) would receive upon exercise common stock of the acquiring company with a value equal to two times the exercise price of the Right.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Tag219" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(12) STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has the following stock-based compensation plans: the 2004 Employee Stock Purchase Plan (the "2004 ESPP Plan"), the 2008 Stock Option and Incentive Plan (the "2008 Plan"), Celldex Research's 2005 Equity Incentive Plan (the "Celldex Research 2005 Plan") and CuraGen 2007 Stock Plan (the "CuraGen 2007 Plan"). There are no shares available for future grant under the Celldex Research 2005 Plan and CuraGen 2007 Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Employee Stock Purchase Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;At December&amp;#160;31, 2013, a total of 200,000 shares of common stock are reserved for issuance under the 2004 ESPP Plan. Under the 2004 ESPP Plan, each participating employee may purchase shares of common stock through payroll deductions at a purchase price equal to 85% of the lower of the fair market value of the common stock at either the beginning of the offering period or the applicable exercise date. During the years ended December&amp;#160;31, 2013 and 2012, the Company issued 11,823 and 5,935 shares under the 2004 ESPP Plan, respectively. At December&amp;#160;31, 2013, 164,124 shares were available for issuance under the 2004 ESPP Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Employee Stock Option and Incentive Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The 2008 Plan permits the granting of incentive stock options (intended to qualify as such under Section&amp;#160;422A of the Internal Revenue Code of 1986, as amended), non-qualified stock options, stock appreciation rights, performance share units, restricted stock and other awards of restricted stock in lieu of cash bonuses to employees, consultants and non-employee directors.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;At December&amp;#160;31, 2013, the 2008 Plan allowed for a maximum of 7,400,000 shares of common stock to be issued for grants of Stock Options and other Awards made prior to March&amp;#160;7, 2018 and grants of Incentive Stock Options made prior to October&amp;#160;20, 2017. The Company's board of directors determines the term of each option, option price, and number of shares for which each option is granted and the rate at which each option vests. Options generally vest over a period not to exceed four years. The term of each option cannot exceed ten years (five years for options granted to holders of more than 10% of the voting stock of the Company) and the exercise price of stock options cannot be less than the fair market value of the common stock at the date of grant (110% of fair market value for incentive stock options granted to holders of more than 10% of the voting stock of the Company). Vesting of all employee and non-employee director stock option awards is accelerated upon a change in control as defined in the 2008 Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;A summary of stock option activity for the year ended December&amp;#160;31, 2013 is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="47"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="74"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Exercise&lt;br /&gt;
Price&lt;br /&gt;
Per Share&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Remaining&lt;br /&gt;
Contractual&lt;br /&gt;
Term (In Years)&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Outstanding at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,349,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5.98&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,252,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;16.44&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(816,405&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6.53&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Canceled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(14,861&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6.97&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Outstanding at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,770,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8.17&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Vested and Expected to Vest at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,712,596&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8.12&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Exercisable at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,297,190&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6.30&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5.6&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Shares Available for Grant under the 2008 Plan&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,102,942&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The total intrinsic value of stock options exercised during the years ended December&amp;#160;31, 2013, 2012 and 2011 was $10.0&amp;#160;million, $0.2&amp;#160;million and $0.03&amp;#160;million, respectively. The weighted average grant-date fair value of stock options granted during the years ended December&amp;#160;31, 2013, 2012 and 2011 was $10.51, $3.67 and $1.83, respectively. The total fair value of stock options vested during the years ended December&amp;#160;31, 2013, 2012 and 2011 was $2.4&amp;#160;million, $2.1&amp;#160;million and $2.6&amp;#160;million, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The aggregate intrinsic value of stock options outstanding at December&amp;#160;31, 2013 was $92.6&amp;#160;million. The aggregate intrinsic value of stock options vested and expected to vest at December&amp;#160;31, 2013 was $91.9&amp;#160;million. As of December&amp;#160;31, 2013, total compensation cost related to non-vested employee and non-employee director stock options not yet recognized was approximately $14.4&amp;#160;million, net of estimated forfeitures, which is expected to be recognized as expense over a weighted average period of 2.8&amp;#160;years.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Restricted Stock&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;A summary of restricted stock activity under the 2008 Plan for the year ended December&amp;#160;31, 2013 is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="44"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="54"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Grant Date&lt;br /&gt;
Fair Value&lt;br /&gt;
(per share)&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Outstanding and unvested at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4.50&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;12,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;15.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(12,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;9.85&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Canceled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Outstanding and unvested at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;15.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Valuation and Expenses Information&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock-based compensation expense for the years ended December&amp;#160;31, 2013, 2012 and 2011 was recorded as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Research and development&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,640&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,415&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,412&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,908&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;883&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;930&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,548&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,298&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,342&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The fair values of employee stock options granted during the years ended December&amp;#160;31, 2013, 2012 and 2011 were valued using the Black-Scholes option-pricing model with the following assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88" align="center"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88" align="center"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88" align="center"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#160;31, 2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expected stock price volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;71&amp;#160;-&amp;#160;72%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;70&amp;#160;-&amp;#160;72%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;68&amp;#160;-&amp;#160;70%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expected option term&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;6.0 Years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;6.0 Years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;6.0 Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;1.2&amp;#160;-&amp;#160;2.1%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;0.9&amp;#160;-&amp;#160;1.4%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;1.4&amp;#160;-&amp;#160;2.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;None&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;None&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;None&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company estimates expected term based on historical exercise patterns. The Company uses its historical stock price volatility consistent with the expected term of grant as the basis for its expected volatility assumption. The risk-free interest rate is based upon the yield of U.S. Treasury securities consistent with the expected term of the option. The dividend yield assumption is based on the Company's history of zero dividend payouts and expectation that no dividends will be paid in the foreseeable future.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <cldx:SignificantRevenueArrangementsDisclosureTextBlock id="Tag220" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(13) REVENUE&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In 1997, the Company licensed its oral rotavirus strain to GlaxoSmithKline&amp;#160;plc (Glaxo) and Glaxo assumed responsibility for all subsequent clinical trials and all other development activities. The Company's licensed-in the rotavirus strain that was used to develop Glaxo's Rotarix rotavirus vaccine in 1995 and owed a license fee of 30% to Cincinnati Children's Hospital Medical Center (CCH) on net royalties received from Glaxo. In May 2005, the Company entered into an agreement whereby an affiliate of Paul Royalty Fund II,&amp;#160;L.P. (PRF) purchased a 70% interest in the net royalties the Company received on worldwide sales of Rotarix. In December 2012, the Glaxo agreement expired automatically upon the expiration of the last relevant patent right covered by the Glaxo agreement. The Company's retained interests in Rotarix net royalties which were not sold to PRF are recorded as product royalty revenue and a corresponding amount that is payable to CCH is recorded as royalty expense. Product royalty revenue and royalty expense related to the Company's retained interest in Rotarix was $2.3&amp;#160;million, $10.8&amp;#160;million and $9.1&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</cldx:SignificantRevenueArrangementsDisclosureTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="Tag221" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(15) INCOME TAXES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The components of income tax expense attributable to continuing operations consist of the following:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended December&amp;#160;31,&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Income tax benefit (provision):&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Federal&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;30,962&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,394&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;16,204&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;State&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;4,920&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;4,237&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Foreign&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;84&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Expiration of Net Operating Losses and Research&amp;#160;&amp;amp; Development Tax Credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(126&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1,426&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(411&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,756&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;22,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,008&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred tax valuation allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(35,756&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(22,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(19,008&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;A reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate of 34% follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Pre-tax loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(81,550&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(59,123&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(44,799&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Loss at Statutory Rates&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(27,727&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(20,102&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(15,213&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Research and Development Credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3,261&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1,736&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;State Taxes&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4,920&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4,237&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;26&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;708&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expiration of Net Operating Losses and Research&amp;#160;&amp;amp; Development Tax Credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;126&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,426&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;411&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Change in Valuation Allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,756&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;22,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,008&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Income tax (benefit) provision&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Deferred tax assets and liabilities are recognized based on temporary differences between the financial reporting and tax basis of assets and liabilities using future expected enacted rates. A valuation allowance is recorded against deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The principal components of the deferred tax assets and liabilities at December&amp;#160;31, 2013 and 2012, respectively, are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Gross Deferred Tax Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Net Operating Loss Carryforwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;79,558&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;67,728&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Tax Credit Carryforwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;25,582&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;20,692&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Deferred Expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;61,370&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;43,226&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Stock-based Compensation&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,926&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,264&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Fixed Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,638&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,156&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Accrued Expenses and Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;623&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;241&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;172,697&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;137,307&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Gross Deferred Tax Liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Other Acquired Intangibles&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,115&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,481&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;IPR&amp;amp;D Intangibles&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(8,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(9,142&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total Deferred Tax Assets and Liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;163,921&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;128,165&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Deferred Tax Assets Valuation Allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(168,582&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(132,826&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net Deferred Tax Asset (Liability)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The net deferred tax liability of $4.7&amp;#160;million at December&amp;#160;31, 2013 and 2012 relates to the temporary differences associated with the IPR&amp;amp;D intangible assets acquired in the CuraGen acquisition, which are not deductible for tax purposes.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;As of December&amp;#160;31, 2013, the Company had the following federal net operating loss ("NOL") carryforwards:&lt;/font&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li style="list-style: none;"&gt;
&lt;dl compact="compact"&gt;
&lt;dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"&gt;&lt;font size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/dt&gt;
&lt;dd style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;Prior to the merger of the Company and AVANT, $33.0&amp;#160;million was generated by the Company which expire at various dates starting in 2023 and going through 2028;&lt;/font&gt; &lt;font size="2"&gt;&lt;br /&gt;
&lt;br /&gt;&lt;/font&gt;&lt;/dd&gt;
&lt;dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"&gt;&lt;font size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/dt&gt;
&lt;dd style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;Prior to the merger of the Company and AVANT, $101.2&amp;#160;million, net of expirations and utilization, was generated by AVANT which expire at various dates starting in 2018 and going through 2028. During the years ended, December&amp;#160;31, 2013 and 2012, NOLs of $0 and $16.4&amp;#160;million expired, respectively;&lt;/font&gt; &lt;font size="2"&gt;&lt;br /&gt;
&lt;br /&gt;&lt;/font&gt;&lt;/dd&gt;
&lt;dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"&gt;&lt;font size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/dt&gt;
&lt;dd style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;Following the merger of the Company and AVANT, $131.7&amp;#160;million was generated by the combined company which expire at various dates starting in 2028 and going through 2033; and&lt;/font&gt; &lt;font size="2"&gt;&lt;br /&gt;
&lt;br /&gt;&lt;/font&gt;&lt;/dd&gt;
&lt;dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"&gt;&lt;font size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/dt&gt;
&lt;dd style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;Prior to its acquisition by the Company, $518.3&amp;#160;million was generated by CuraGen.&lt;/font&gt;&lt;/dd&gt;&lt;/dl&gt;&lt;/li&gt;&lt;/ul&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;As of December&amp;#160;31, 2013, the Company has an additional $6.0&amp;#160;million of federal and state net operating losses not reflected above, that are attributable to stock option exercises which will be recorded as an increase in additional paid in capital on the consolidated balance sheet once they are "realized" in accordance with ASC 718.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In general, an ownership change, as defined by Section&amp;#160;382 of the Internal Revenue Code, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50&amp;#160;percentage points over a three-year period. Such ownership changes can significantly limit the amount of NOLs that may be utilized in future periods. The Company currently expects that it is remote that the CuraGen NOLs may be utilized and, as such, no related asset has been recorded for such losses. The Company has not completed an analysis of losses generated by AVANT, however, the Company believes it is remote that $60.8&amp;#160;million of the AVANT NOLs may be utilized in future periods and there may be substantial limitations on the Company's ability to use the remaining NOLs of $40.4&amp;#160;million. Following the merger of the Company and AVANT, the Company experienced changes in ownership as defined by Section&amp;#160;382 in June 2009 and December 2009. Further, prior to the AVANT merger, the Company as a stand alone company experienced a change in ownership in October 2007. As a result of the ownership change in October 2007, utilization of the Company's NOLs prior to October 2007 is subject to an annual limitation of $4.5&amp;#160;million on $28.3&amp;#160;million of NOLs generated before that date. As a result of the ownership changes in June 2009 and December 2009, there is an annual limitation amount of $6.0&amp;#160;million on $67.7&amp;#160;million NOLs. Any unused annual limitation may be carried over to later years, and the amount of the limitation may, under certain circumstances, be subject to adjustment if the fair value of the Company's net assets are determined to be below or in excess of the tax basis of such assets at the time of the ownership change, and such unrealized loss or gain is recognized during the five-year period after the ownership change.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Similar to the AVANT and CuraGen NOL carryforwards above, the Company believes that it is not more likely than not that federal and state research and development ("R&amp;amp;D") credits of $20.8&amp;#160;million and $14.4&amp;#160;million, respectively, will be utilized in the future periods. Further, the Company's ability to use the state NOLs of approximately $108.3&amp;#160;million and the remaining federal and state R&amp;amp;D credit carryforwards of approximately $19.4&amp;#160;million and $9.3&amp;#160;million, respectively, may be substantially limited. These state NOLs and federal and state credits expire at various dates starting in 2016 going through 2033. The Company has not yet completed a study of these credits to substantiate the amounts. Until a study is completed, no amounts are being presented as an uncertain tax position.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Subsequent ownership changes, as defined in Section&amp;#160;382, could further limit the amount of net operating loss carryforwards and research and development credits that can be utilized annually to offset future taxable income.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company applies the authoritative guidance on account for and disclosure of uncertainty in income tax positions which requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements is reduced to the largest benefit that has a greater than fifty perfect likelihood of being realized upon the ultimate settlement with the relevant taxing authority. At December&amp;#160;31, 2013 and 2012, we had no unrecognized tax benefits. A full valuation allowance has been provided against our deferred tax assets and liabilities and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the consolidated balance sheet or statement of operations if an adjustment were required.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Massachusetts, New Jersey and Connecticut are the three states in which the Company primarily operates or has operated and has income tax nexus. The Company is not currently under examination by any other jurisdictions for any tax year.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has evaluated the positive and negative evidence bearing upon the realizability of its net deferred tax assets, which are comprised principally of net operating loss carryforwards, capitalized R&amp;amp;D expenditures and R&amp;amp;D tax credit carryforwards. The Company has determined that it is more likely than not that it will not recognize the benefits of federal and state deferred tax assets and, as a result, a full valuation allowance was maintained at December&amp;#160;31, 2013 against the Company's net deferred tax assets.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The American Taxpayer Relief Act of 2012 was enacted on January&amp;#160;2, 2013 under which the federal research and development credit was retroactively extended for amounts paid or incurred after December&amp;#160;31, 2011 through December&amp;#160;31, 2013. The effects of the change in the tax law were recognized in the first quarter of 2013, which is the quarter in which the law was enacted.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Tag222" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(16) COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has facility and equipment leases that expire at various dates through 2019. Certain of these facility leases contain renewal options, early termination provisions, and provisions that escalate the base rent payments and require the Company to pay common area maintenance costs ("CAM") during the lease term. The following obligations for base rent and CAM costs under facility and other non-cancelable operating leases as of December&amp;#160;31, 2013 do not include the exercise of renewal terms or early termination provisions (in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,666&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2015&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,863&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,914&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,765&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;501&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;167&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total minimum lease payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;10,876&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company's total rent and CAM expense for all facility leases was $2.7&amp;#160;million, $2.5&amp;#160;million and $2.5&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock id="Tag223" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(17) RETIREMENT SAVINGS PLAN&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company maintains a 401(k) Plan which is available to substantially all employees. Under the terms of the 401(k) Plan, participants may elect to contribute up to 15% of their compensation, or the statutory prescribed limits. The Company may make 50% matching contributions on up to 4% of a participant's annual salary. Benefit expense for the 401(k) Plan was $0.3&amp;#160;million, $0.2&amp;#160;million and $0.2&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:QuarterlyFinancialInformationTextBlock id="Tag224" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(18) SELECTED QUARTERLY FINANCIAL DATA (Unaudited)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 611px;" border="0" cellspacing="0" cellpadding="0" width="611"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" nowrap="nowrap" align="left"&gt;
&lt;div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"&gt;&lt;font size="1"&gt;&lt;b&gt;2013 &lt;!-- COMMAND=ADD_SCROPPEDRULE,17pt --&gt;&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q1 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q2 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q3 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q4 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands, except per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,414&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;97&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;980&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;620&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(17,332&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(19,016&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(23,140&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(22,062&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Basic and diluted net loss per common share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.24&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;br /&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 609px;" border="0" cellspacing="0" cellpadding="0" width="609"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" nowrap="nowrap" align="left"&gt;
&lt;div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"&gt;&lt;font size="1"&gt;&lt;b&gt;2012 &lt;!-- COMMAND=ADD_SCROPPEDRULE,17pt --&gt;&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q1 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q2 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q3 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q4 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands, except per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,433&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,009&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,113&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,647&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(13,516&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(13,773&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(15,027&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(16,807&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Basic and diluted net loss per common share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.25&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <dei:EntityRegistrantName id="Tag225" contextRef="D2013">Celldex Therapeutics, Inc.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="Tag226" contextRef="D2013">0000744218</dei:EntityCentralIndexKey>
  <dei:DocumentType id="Tag227" contextRef="D2013">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate id="Tag228" contextRef="D2013">2013-12-31</dei:DocumentPeriodEndDate>
  <dei:AmendmentFlag id="Tag229" contextRef="D2013">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="Tag230" contextRef="D2013">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityWellKnownSeasonedIssuer id="Tag231" contextRef="D2013">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityVoluntaryFilers id="Tag232" contextRef="D2013">No</dei:EntityVoluntaryFilers>
  <dei:EntityCurrentReportingStatus id="Tag233" contextRef="D2013">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory id="Tag234" contextRef="D2013">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityPublicFloat id="Tag235" decimals="-8" contextRef="I2013Q2" unitRef="USD">1300000000</dei:EntityPublicFloat>
  <dei:EntityCommonStockSharesOutstanding id="Tag236" decimals="INF" contextRef="I2013SO" unitRef="Shares">89251747</dei:EntityCommonStockSharesOutstanding>
  <dei:DocumentFiscalYearFocus id="Tag237" contextRef="D2013">2013</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="Tag238" contextRef="D2013">FY</dei:DocumentFiscalPeriodFocus>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="Tag239" decimals="-3" contextRef="D2013" unitRef="USD">1366000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="Tag240" decimals="-3" contextRef="D2013" unitRef="USD">21000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="Tag241" decimals="-3" contextRef="D2013" unitRef="USD">-276000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="Tag242" decimals="-3" contextRef="D2013" unitRef="USD">112118000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag243" decimals="-3" contextRef="D2013" unitRef="USD">4219000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:RepaymentsOfOtherLongTermDebt id="Tag244" decimals="-3" contextRef="D2013" unitRef="USD">472000</us-gaap:RepaymentsOfOtherLongTermDebt>
  <us-gaap:InterestPaid id="Tag245" decimals="-3" contextRef="D2013" unitRef="USD">1209000</us-gaap:InterestPaid>
  <us-gaap:InvestmentsAndCash id="Tag246" decimals="-5" contextRef="I2013" unitRef="USD">303000000</us-gaap:InvestmentsAndCash>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag247" decimals="INF" contextRef="D2013_ControlledEquityOfferingProgramAmendedMember" unitRef="Shares">2433608</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="Tag248" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The accompanying consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation. The Company operates in one segment, which is the business of development, manufacturing and commercialization of novel therapeutics for human health care.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:UseOfEstimates id="Tag249" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S.&amp;#160;GAAP) requires management to make estimates and use assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="Tag250" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company considers all highly liquid investments purchased with a maturity date of 90&amp;#160;days or less at the date of purchase to be cash equivalents. Cash equivalents consist principally of money market funds and debt securities.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:MarketableSecuritiesPolicy id="Tag251" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Marketable Securities&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company invests its excess cash balances in marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds. The Company classifies all of its marketable securities as current assets on the consolidated balance sheets because they are available-for-sale and available to fund current operations. Marketable securities are stated at fair value with their unrealized gains and losses included as a component of accumulated other comprehensive income (loss), which is a separate component of stockholders' equity, until such gains and losses are realized. If a decline in the fair value is considered other-than-temporary, based on available evidence, the unrealized loss is transferred from other comprehensive income (loss) to the consolidated statements of operations. Realized gains and losses are determined on the specific identification method and are included in investment and other income, net.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
  <us-gaap:ConcentrationRiskCreditRisk id="Tag252" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Concentration of Credit Risk and of Significant Customers and Suppliers&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, marketable securities and accounts receivable. The Company invests its cash, cash equivalents and marketable securities in debt instruments and interest bearing accounts at major financial institutions in excess of insured limits. The Company mitigates credit risk by limiting the investment type and maturity to securities that preserve capital, maintain liquidity and have a high credit quality. The Company has not historically experienced credit losses from its accounts receivable and therefore has not established an allowance for doubtful accounts.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Revenue from Glaxo represented 57%, 96% and 98% for the years ended December&amp;#160;31, 2013, 2012 and 2011 and of total Company revenue, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company relies on contract manufacturing organizations (CMO) to manufacture drug substance and drug product for its late-stage clinical studies of rindopepimut and glembatumumab vedotin as well as for future commercial supplies. The Company also relies on CMOs for supply of raw materials as well as filling, packaging, storage and shipping of drug product. These clinical studies would be adversely affected by a significant interruption in the supply of rindopepimut and glembatumumab vedotin.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock id="Tag253" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has certain assets and liabilities that are measured at fair value in the financial statements. The Company seeks to maximize the use of observable inputs (market data obtained from sources independent from the Company) and to minimize the use of unobservable inputs (the Company's assumptions about how market participants would price assets and liabilities) when measuring the fair value of its assets and liabilities. These assets and liabilities are classified into one of three levels of the following fair value hierarchy as defined by U.S.&amp;#160;GAAP:&lt;/font&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li style="list-style: none;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Level&amp;#160;1: Observable inputs such as quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Level&amp;#160;2: Observable inputs other than Level&amp;#160;1 prices, such as quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Level&amp;#160;3: Unobservable inputs based on the Company's assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/font&gt;&lt;/p&gt;&lt;/li&gt;&lt;/ul&gt;
&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="Tag254" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Property and equipment is stated at cost and depreciated over the estimated useful lives of the related assets using the straight-line method. Laboratory equipment and office furniture and equipment are depreciated over five years and computer equipment is depreciated over three years. Manufacturing equipment is amortized over seven to ten years. Leasehold improvements are amortized over the shorter of the estimated useful life or the non-cancelable term of the related lease, including any renewals that are reasonably assured of occurring. Property and equipment under construction is classified as construction in progress and is depreciated or amortized only after the asset is placed in service. Expenditures for maintenance and repairs are charged to expense whereas the costs of significant improvements which extend the life of the underlying asset are capitalized. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are eliminated and any resulting gain or loss is reflected in the Company's consolidated statements of operations and comprehensive loss.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The treatment of costs to construct property and equipment depends on the nature of the costs and the stage of construction. Costs incurred in the project planning, design, construction and installation phases are capitalized as part of the cost of the asset. The Company stops capitalizing these costs when the asset is substantially complete and ready for its intended use. For manufacturing property and equipment, the Company also capitalizes the cost of validating these assets for the underlying manufacturing process. The Company completes the capitalization of validation costs when the asset is substantially complete and ready for its intended use. Costs capitalized include incremental labor and fringe benefits, and direct consultancy services.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:BusinessCombinationsPolicy id="Tag255" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Business Combinations&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records the fair value of the consideration transferred to acquire a business to the tangible assets and identifiable intangible assets acquired and liabilities assumed on the basis of their fair values at the date of acquisition. The Company assesses the fair value of assets, including intangible assets such as in-process research and development (IPR&amp;amp;D), using a variety of methods including present value models. Each asset is measured at fair value from the perspective of a market participant. The method used to estimate the fair values of IPR&amp;amp;D assets incorporates significant assumptions regarding the estimates a market participant would make in order to evaluate an asset, including a market participant's assumptions regarding the probability of completing IPR&amp;amp;D projects, which would require obtaining regulatory approval for marketing of the associated drug candidate; a market participant's estimates regarding the timing of and the expected costs to complete IPR&amp;amp;D projects; a market participant's estimates of future cash flows from potential product sales; and the appropriate discount rates for a market participant. Transaction costs and restructuring costs associated with the transaction are expensed as incurred.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In connection with the acquisition of CuraGen Corporation ("CuraGen") in October 2009, the Company assumed CuraGen's $12.5&amp;#160;million in 4% convertible subordinated debt due February&amp;#160;15, 2011 (the "Convertible Subordinated Debt"). In February 2011, the Company paid $12.8&amp;#160;million and satisfied all the outstanding principal and accrued interest related to the Convertible Subordinated Debt.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
  <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy id="Tag256" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Intangible Assets&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;IPR&amp;amp;D assets acquired in a business combination initially are recorded at fair value and accounted for as indefinite-lived intangible assets. These assets are maintained on the Company's consolidated balance sheets until either the project underlying them is completed or the assets become impaired. If a project is completed, the carrying value of the related intangible asset is amortized over the remaining estimated life of the asset beginning in the period in which the project is completed. If a project becomes impaired or is abandoned, the carrying value of the related intangible asset is written down to its fair value and an impairment charge is taken in the period in which the impairment occurs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In January 2013, the Company adopted a new U.S.&amp;#160;GAAP accounting standard which amended guidance applicable to annual impairment tests of indefinite-lived intangible assets. The amended guidance added an optional qualitative assessment for determining whether an indefinite-lived intangible asset is impaired. Prior to this guidance, companies were required to perform an annual impairment test that included a calculation of the fair value of the asset and a comparison of that fair value with its carrying value. If the carrying value exceeded the fair value, an impairment was recorded. The amended guidance allows a company the option to perform a qualitative assessment, considering both negative and positive evidence, regarding the potential impairment of the indefinite-lived intangible asset. If, based on the qualitative analysis, the company determines that it is more likely than not that the fair value of such an asset exceeds its carrying value, the company would be permitted to conclude that the indefinite-lived intangible asset was not impaired without a quantitative calculation of the fair value of the asset. Otherwise, the company would perform the quantitative calculation of the fair value and the comparison with the carrying value. The Company's adoption of this new standard did not have a material effect on its operating results or financial position.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;IPR&amp;amp;D assets are tested for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. As part of the annual impairment test of the IPR&amp;amp;D assets as of July&amp;#160;1, 2013, the Company bypassed the optional qualitative assessment and performed a calculation of the fair value of the asset. The Company concluded that the IPR&amp;amp;D assets were not impaired.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets acquired in a business combination with a finite life are recorded at fair value and amortized over the greater of economic consumption or on a straight-line basis over their estimated useful life.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy id="Tag257" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The difference between the purchase price and the fair value of assets acquired and liabilities assumed in a business combination is allocated to goodwill. Goodwill is evaluated for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. The Company has the option to assess qualitative factors to determine if it is more likely than not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment test required under U.S.&amp;#160;GAAP. As part of its annual impairment test of the goodwill asset as of July&amp;#160;1, 2013, the Company bypassed the optional qualitative assessment and performed the two-step impairment test. The Company concluded that the goodwill asset was not impaired.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock id="Tag258" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Impairment of Long-Lived Assets&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company evaluates the recoverability of its long-lived assets, including property and equipment, and intangible assets when circumstances indicate that an event of impairment may have occurred. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the assets, the assets are written-down to their estimated fair values.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="Tag259" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company recognizes revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the seller's price to the buyer is fixed or determinable; and collectability is reasonably assured.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has entered into and in the future may enter into biopharmaceutical product development agreements with collaborative partners for the research and development of therapeutic drug products. The terms of the agreements may include nonrefundable signing and licensing fees, funding for research, development and manufacturing, milestone payments and royalties on any product sales derived from collaborations. These multiple element arrangements are analyzed to determine whether the deliverables can be separated or whether they must be accounted for as a single unit of accounting. In accounting for these transactions, the Company allocates revenue to the various elements based on their relative fair value. The fair value of a revenue generating element can be based on current selling prices offered by the Company or another party for current products or the Company's best estimate of a selling price for future products. Revenue allocated to an individual element is recognized when all other revenue recognition criteria are met for that element.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;These collaborative and other agreements may contain milestone payments. Revenues from milestones, if they are considered substantive, are recognized upon successful accomplishment of the milestones. Determining whether a milestone is substantive involves judgment, including an assessment of the Company's involvement in achieving the milestones and whether the amount of the payment is commensurate to the Company's performance. If not considered substantive, milestones are initially deferred and recognized over the remaining performance obligation.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Payments received to fund certain research activities are recognized as revenue in the period in which the research activities are performed. Revenue from contracts and grants is recognized as the services are performed and recorded as effort is expended on the contracted work and billed to the government or the Company's contractual partner. Payments received in advance that are related to future performance are deferred and recognized as revenue when the research projects are performed.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Product royalty revenue consists of payments received from licensees for a portion of sales proceeds from products that utilize the Company's licensed technologies and are recognized when the amount of and basis for such royalty payments are reported to the Company in accurate and appropriate form and in accordance with the related license agreement.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy id="Tag260" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Research and Development Expenses&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Research and development costs, including internal and contract research costs, are expensed as incurred. Research and development expenses consist mainly of clinical trial costs, manufacturing of clinical material, toxicology and other studies, personnel costs, depreciation, license fees and funding of outside research.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Clinical trial expenses include expenses associated with clinical research organizations (CRO). The invoicing from CROs for services rendered can lag several months. We accrue the cost of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, and project management costs. We maintain regular communication with our CROs to gauge the reasonableness of our estimates. Differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period in which they become known.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <cldx:PatentCostsPolicyTextBlock id="Tag261" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Patent Costs&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Patent costs are expensed as incurred. Certain patent costs are reimbursed by the Company's product development and licensing partners. Any reimbursed patent costs are recorded as product development and licensing agreement revenues in the Company's financial statements.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</cldx:PatentCostsPolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="Tag262" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records stock-based compensation expense for all stock-based awards made to employees and directors based on the estimated fair values of the stock-based awards expected to vest at the grant date and is adjusted, if necessary, to reflect actual forfeitures. Compensation expense for all stock-based awards to employees and directors is recognized using the straight-line method over the term of vesting or performance.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records stock-based compensation expense for stock options granted to non-employees based on the fair value of the stock options which is re-measured over the vesting term resulting in periodic adjustments to stock-based compensation expense.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock id="Tag263" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Foreign Currency Translation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net unrealized gains and losses resulting from foreign currency translation are included in other comprehensive income (loss). At December&amp;#160;31, 2013 and December&amp;#160;31, 2012, accumulated other comprehensive income includes a net unrealized gain related to foreign currency translation of $2.6&amp;#160;million. In 2011, the Company's foreign subsidiary voluntarily liquidated in order to consolidate the Company's foreign operations into Celldex Therapeutics,&amp;#160;Inc.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock id="Tag264" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company uses the asset and liability method to account for income taxes, including the recognition of deferred tax assets and deferred tax liabilities for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax basis. Quarterly, the Company reviews its deferred tax assets for recovery. A valuation allowance is established when the Company believes that it is more likely than not that its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company records uncertain tax positions in the financial statements only if it is more likely than not that the uncertain tax position will be sustained upon examination by the taxing authorities. The Company records interest and penalties related to uncertain tax positions in income tax expense.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock id="Tag265" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Comprehensive Loss&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Comprehensive loss is comprised of net loss and certain changes in stockholders' equity that are excluded from net loss. The Company includes foreign currency translation adjustments and unrealized gains and losses on marketable securities in other comprehensive loss. The consolidated statements of operations and comprehensive loss reflect total comprehensive loss for the years ended December&amp;#160;31, 2013, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In January 2013, the Company adopted a new U.S.&amp;#160;GAAP accounting standard which requires the Company to separately disclose, on a prospective basis, the change in each component of other comprehensive income (loss) relating to reclassification adjustments and current period other comprehensive income (loss). As the new guidance relates to presentation only, the adoption did not have a material impact on the Company's results of operations or financial position.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:EarningsPerSharePolicyTextBlock id="Tag266" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Net Loss Per Share&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended December&amp;#160;31,&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,770,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,349,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,459,034&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Restricted stock&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,776,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,355,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,465,034&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Tag267" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company's financial position or results of operations upon adoption.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NumberOfOperatingSegments id="Tag268" decimals="INF" contextRef="D2013" unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
  <us-gaap:ConcentrationRiskPercentage1 id="Tag269" decimals="2" contextRef="D2012_SalesMember_CustomerConcentrationRiskMember_GlaxoSmithKlinePlcMember" unitRef="Pure">0.96</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Tag270" decimals="2" contextRef="D2011_SalesMember_CustomerConcentrationRiskMember_GlaxoSmithKlinePlcMember" unitRef="Pure">0.98</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Tag271" decimals="2" contextRef="D2013_SalesMember_CustomerConcentrationRiskMember_GlaxoSmithKlinePlcMember" unitRef="Pure">0.57</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Tag272" contextRef="D2013_FurnitureAndFixturesMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Tag273" contextRef="D2013_LaboratoryEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Tag274" contextRef="D2013_ComputerEquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Tag275" contextRef="D2013_ManufacturingEquipmentMember_MinimumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Tag276" contextRef="D2013_ManufacturingEquipmentMember_MaximumMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="Tag277" decimals="-5" contextRef="I2013" unitRef="USD">2600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="Tag278" decimals="-5" contextRef="I2012" unitRef="USD">2600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock id="Tag279" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 591px;" border="0" cellspacing="0" cellpadding="0" width="591"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended December&amp;#160;31,&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,770,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,349,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,459,034&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Restricted stock&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,776,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,355,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,465,034&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag280" decimals="INF" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">5349810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag281" decimals="INF" contextRef="D2012_RestrictedStockMember" unitRef="Shares">6000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag282" decimals="INF" contextRef="D2012" unitRef="Shares">5355810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag283" decimals="INF" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">4459034</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag284" decimals="INF" contextRef="D2011_RestrictedStockMember" unitRef="Shares">6000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag285" decimals="INF" contextRef="D2011" unitRef="Shares">4465034</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag286" decimals="INF" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">5770544</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag287" decimals="INF" contextRef="D2013_RestrictedStockMember" unitRef="Shares">6000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag288" decimals="INF" contextRef="D2013" unitRef="Shares">5776544</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ConvertibleSubordinatedDebt id="Tag289" decimals="-5" contextRef="I2009Q4_M1031_CuraGenCorporationMember_ConvertibleSubordinatedDebtMember" unitRef="USD">12500000</us-gaap:ConvertibleSubordinatedDebt>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Tag290" decimals="INF" contextRef="I2009Q4_M1031_CuraGenCorporationMember_ConvertibleSubordinatedDebtMember" unitRef="Pure">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:RepaymentsOfDebt id="Tag291" decimals="-5" contextRef="D2011Q1_M02_CuraGenCorporationMember_ConvertibleSubordinatedDebtMember" unitRef="USD">12800000</us-gaap:RepaymentsOfDebt>
  <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock id="Tag292" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 675px;" border="0" cellspacing="0" cellpadding="0" width="675"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="96"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="73"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Unrealized Gain&lt;br /&gt;
(Loss) on&lt;br /&gt;
Marketable&lt;br /&gt;
Securities, net of tax&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Foreign&lt;br /&gt;
Currency Items&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Balance at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;156&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,589&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,745&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(74&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(77&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Amounts reclassified from other comprehensive income&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net current-period other comprehensive income&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(74&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(77&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Balance at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;82&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,586&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,668&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock id="Tag293" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left;" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="36"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;As of&lt;br /&gt;
December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;1&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;2&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;3&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;148,549&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;148,549&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;133,581&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;133,581&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;282,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;282,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;br /&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left;" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="36"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;As of&lt;br /&gt;
December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;1&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;2&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Level&amp;#160;3&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;18,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;18,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;77,753&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;18,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
  <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock id="Tag294" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 655px;" border="0" cellspacing="0" cellpadding="0" width="655"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Amortized&lt;br /&gt;
Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Gains&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Losses&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Fair&lt;br /&gt;
Value&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;55,531&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;55,554&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;18,234&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;56&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;18,286&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;73,765&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;83&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(8&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;73,840&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;38,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;9&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(9&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;38,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;20,761&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;12&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(5&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;20,768&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;59,734&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;21&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(14&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;59,741&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;133,499&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;104&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(22&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;133,581&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;br /&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 661px;" border="0" cellspacing="0" cellpadding="0" width="661"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="49"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="51"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Amortized&lt;br /&gt;
Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Gains&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Gross&lt;br /&gt;
Unrealized&lt;br /&gt;
Losses&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Fair&lt;br /&gt;
Value&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;15,566&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;28&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;15,594&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,797&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;99&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,895&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total U.S. government and municipal obligations&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,363&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;127&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,489&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;17,353&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;23&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;17,372&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"&gt;&lt;font size="2"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;6,193&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;14&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;6,204&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"&gt;&lt;font size="2"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;23,546&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;37&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(7&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;23,576&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;58,909&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;164&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(8&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;59,065&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="Tag295" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 621px;" border="0" cellspacing="0" cellpadding="0" width="621"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Laboratory Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,699&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,164&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Manufacturing Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,055&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Office Furniture and Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,386&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,264&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Leasehold Improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;14,493&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;12,932&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Construction in Progress&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;257&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;115&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total Property and Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;21,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,530&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Less Accumulated Depreciation and Amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(11,992&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(12,325&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;9,973&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;7,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock id="Tag296" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 54%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 682px;" border="0" cellspacing="0" cellpadding="0" width="682"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="58" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="61"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="61"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="10" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
Life&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Accumulated&lt;br /&gt;
Amortization&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Accumulated&lt;br /&gt;
Amortization&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="17" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Intangible Assets:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;Indefinite&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,800&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Amgen Amendment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;16&amp;#160;years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;14,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(3,812&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;10,688&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;14,500&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(2,915&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,585&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Core Technology&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11&amp;#160;years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,296&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(964&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;332&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,296&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(848&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;448&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total Intangible Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;27,596&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;22,820&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;27,596&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(3,763&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;23,833&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;Indefinite&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8,965&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag297" decimals="-3" contextRef="I2012_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD">156000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag298" decimals="-3" contextRef="I2012_AccumulatedTranslationAdjustmentMember" unitRef="USD">2589000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag299" decimals="-3" contextRef="I2013" unitRef="USD">2668000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag300" decimals="-3" contextRef="I2013_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD">82000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag301" decimals="-3" contextRef="I2013_AccumulatedTranslationAdjustmentMember" unitRef="USD">2586000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="Tag302" decimals="-3" contextRef="D2013" unitRef="USD">-77000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="Tag303" decimals="-3" contextRef="D2013_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD">-74000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="Tag304" decimals="-3" contextRef="D2013_AccumulatedTranslationAdjustmentMember" unitRef="USD">-3000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:AmortizationOfIntangibleAssets id="Tag305" decimals="-3" contextRef="D2013" unitRef="USD">1013000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag306" decimals="-3" contextRef="D2013" unitRef="USD">-77000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag307" decimals="-3" contextRef="D2013_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD">-74000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag308" decimals="-3" contextRef="D2013_AccumulatedTranslationAdjustmentMember" unitRef="USD">-3000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Tag309" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_FairValueInputsLevel1Member" unitRef="USD">18688000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Tag310" decimals="-3" contextRef="I2013_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD">148549000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Tag311" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD">18688000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Tag312" decimals="-3" contextRef="I2013_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member" unitRef="USD">148549000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:AvailableForSaleSecurities id="Tag313" decimals="-3" contextRef="I2013_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD">133581000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="Tag314" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD">59065000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="Tag315" decimals="-3" contextRef="I2013_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member" unitRef="USD">133581000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="Tag316" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member" unitRef="USD">59065000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AssetsFairValueDisclosure id="Tag317" decimals="-3" contextRef="I2013_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD">282130000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure id="Tag318" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD">77753000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure id="Tag320" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_FairValueInputsLevel1Member" unitRef="USD">18688000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure id="Tag321" decimals="-3" contextRef="I2013_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member" unitRef="USD">282130000</us-gaap:AssetsFairValueDisclosure>
  <cldx:FairValueAssetsAmountTransfersBetweenMeasurementLevels id="Tag322" decimals="-3" contextRef="I2013" unitRef="USD">0</cldx:FairValueAssetsAmountTransfersBetweenMeasurementLevels>
  <us-gaap:AssetsFairValueDisclosure id="Tag323" decimals="-3" contextRef="I2012_FairValueMeasurementsRecurringMember_FairValueInputsLevel2Member" unitRef="USD">59065000</us-gaap:AssetsFairValueDisclosure>
  <cldx:FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels id="Tag324" decimals="-3" contextRef="I2013" unitRef="USD">0</cldx:FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost id="Tag325" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">17353000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost id="Tag326" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">55531000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost id="Tag327" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">38973000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost id="Tag328" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">19797000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost id="Tag329" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">6193000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost id="Tag330" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">18234000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost id="Tag331" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">20761000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="Tag332" decimals="-3" contextRef="I2012" unitRef="USD">58909000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="Tag333" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">35363000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="Tag334" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">23546000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="Tag335" decimals="-3" contextRef="I2013" unitRef="USD">133499000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="Tag336" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">73765000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="Tag337" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">59734000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain id="Tag338" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">28000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain id="Tag339" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">23000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain id="Tag340" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">27000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain id="Tag341" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">9000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain id="Tag342" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">99000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain id="Tag343" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">14000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain id="Tag344" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">56000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag345" decimals="-3" contextRef="I2012_LaboratoryEquipmentMember" unitRef="USD">3164000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag346" decimals="-3" contextRef="D2013_AdditionalPaidInCapitalMember" unitRef="USD">5402000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain id="Tag347" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">12000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="Tag348" decimals="-3" contextRef="I2012" unitRef="USD">164000</cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="Tag349" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">127000</cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="Tag350" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">37000</cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="Tag351" decimals="-3" contextRef="I2013" unitRef="USD">104000</cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="Tag352" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">83000</cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="Tag353" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">21000</cldx:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses id="Tag354" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">4000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses id="Tag355" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">4000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses id="Tag356" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">9000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses id="Tag357" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">1000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses id="Tag358" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">3000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses id="Tag359" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">4000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses id="Tag360" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">5000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="Tag361" decimals="-3" contextRef="I2012" unitRef="USD">8000</cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="Tag362" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">1000</cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="Tag363" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">7000</cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="Tag364" decimals="-3" contextRef="I2013" unitRef="USD">22000</cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="Tag365" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">8000</cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="Tag366" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">14000</cldx:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="Tag367" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">55554000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="Tag368" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">38973000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="Tag369" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">15594000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="Tag370" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">17372000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue id="Tag371" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">18286000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue id="Tag372" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">20768000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue id="Tag373" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">19895000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue id="Tag374" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">6204000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Tag375" decimals="-3" contextRef="I2012" unitRef="USD">59065000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Tag376" decimals="-3" contextRef="I2013_USGovernmentAndMunicipalObligationsMember" unitRef="USD">73840000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Tag377" decimals="-3" contextRef="I2013_CorporateDebtSecuritiesMember" unitRef="USD">59741000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Tag378" decimals="-3" contextRef="I2012_USGovernmentAndMunicipalObligationsMember" unitRef="USD">35489000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Tag379" decimals="-3" contextRef="I2012_CorporateDebtSecuritiesMember" unitRef="USD">23576000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Tag380" decimals="-3" contextRef="I2013" unitRef="USD">133581000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <cldx:AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired id="Tag381" decimals="-3" contextRef="I2013" unitRef="USD">0</cldx:AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag382" decimals="-3" contextRef="I2012_ManufacturingEquipmentMember" unitRef="USD">2055000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag383" decimals="-3" contextRef="I2012_FurnitureAndFixturesMember" unitRef="USD">1264000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag384" decimals="-3" contextRef="I2012_LeaseholdImprovementsMember" unitRef="USD">12932000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag385" decimals="-3" contextRef="I2012_ConstructionInProgressMember" unitRef="USD">115000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag386" decimals="-3" contextRef="I2012" unitRef="USD">19530000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag387" decimals="-3" contextRef="I2013_LaboratoryEquipmentMember" unitRef="USD">3699000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag388" decimals="-3" contextRef="I2013_ManufacturingEquipmentMember" unitRef="USD">2130000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag389" decimals="-3" contextRef="I2013_FurnitureAndFixturesMember" unitRef="USD">1386000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag390" decimals="-3" contextRef="I2013_LeaseholdImprovementsMember" unitRef="USD">14493000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag391" decimals="-3" contextRef="I2013_ConstructionInProgressMember" unitRef="USD">257000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Tag392" decimals="-3" contextRef="I2012" unitRef="USD">12325000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentGross id="Tag393" decimals="-3" contextRef="I2013" unitRef="USD">21965000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Tag394" decimals="-3" contextRef="I2013" unitRef="USD">11992000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet id="Tag395" decimals="-3" contextRef="I2013" unitRef="USD">9973000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:DepreciationDepletionAndAmortization id="Tag396" decimals="-3" contextRef="D2013" unitRef="USD">1932000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:Goodwill id="Tag397" decimals="-3" contextRef="I2013" unitRef="USD">8965000</us-gaap:Goodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="Tag398" decimals="-3" contextRef="I2012_InProcessResearchAndDevelopmentMember" unitRef="USD">11800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="Tag399" decimals="-3" contextRef="I2013_InProcessResearchAndDevelopmentMember" unitRef="USD">11800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="Tag400" contextRef="D2013_AmgenAmendmentMember">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="Tag401" contextRef="D2013_CoreTechnologyMember">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Tag402" decimals="-3" contextRef="I2013_AmgenAmendmentMember" unitRef="USD">14500000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Tag403" decimals="-3" contextRef="I2013_CoreTechnologyMember" unitRef="USD">1296000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Tag404" decimals="-3" contextRef="I2012_AmgenAmendmentMember" unitRef="USD">14500000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="Tag405" decimals="-3" contextRef="I2012_CoreTechnologyMember" unitRef="USD">1296000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Tag406" decimals="-3" contextRef="I2012" unitRef="USD">3763000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Tag407" decimals="-3" contextRef="I2013" unitRef="USD">4776000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Tag408" decimals="-3" contextRef="I2013_AmgenAmendmentMember" unitRef="USD">3812000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Tag409" decimals="-3" contextRef="I2013_CoreTechnologyMember" unitRef="USD">964000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Tag410" decimals="-3" contextRef="I2012_AmgenAmendmentMember" unitRef="USD">2915000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Tag411" decimals="-3" contextRef="I2012_CoreTechnologyMember" unitRef="USD">848000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="Tag412" decimals="-3" contextRef="I2013_AmgenAmendmentMember" unitRef="USD">10688000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="Tag413" decimals="-3" contextRef="I2013_CoreTechnologyMember" unitRef="USD">332000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="Tag414" decimals="-3" contextRef="I2012_AmgenAmendmentMember" unitRef="USD">11585000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="Tag415" decimals="-3" contextRef="I2012_CoreTechnologyMember" unitRef="USD">448000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Tag416" decimals="-3" contextRef="I2012" unitRef="USD">27596000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Tag417" decimals="-3" contextRef="I2013" unitRef="USD">27596000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Tag418" decimals="-3" contextRef="I2013" unitRef="USD">22820000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="Tag419" decimals="-5" contextRef="I2013" unitRef="USD">1000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="Tag420" decimals="-5" contextRef="I2013" unitRef="USD">1000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree id="Tag421" decimals="-5" contextRef="I2013" unitRef="USD">1000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour id="Tag422" decimals="-5" contextRef="I2013" unitRef="USD">900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive id="Tag423" decimals="-5" contextRef="I2013" unitRef="USD">900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <cldx:AccruedRoyaltyAndLicenseFeesCurrent id="Tag424" decimals="-3" contextRef="I2012" unitRef="USD">1776000</cldx:AccruedRoyaltyAndLicenseFeesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="Tag425" decimals="-3" contextRef="I2012" unitRef="USD">925000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <cldx:AccruedResearchAndDevelopmentContractCostsCurrent id="Tag426" decimals="-3" contextRef="I2012" unitRef="USD">7569000</cldx:AccruedResearchAndDevelopmentContractCostsCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent id="Tag427" decimals="-3" contextRef="I2012" unitRef="USD">317000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="Tag428" decimals="-3" contextRef="I2012" unitRef="USD">373000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <cldx:AccruedRoyaltyAndLicenseFeesCurrent id="Tag429" decimals="-3" contextRef="I2013" unitRef="USD">250000</cldx:AccruedRoyaltyAndLicenseFeesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="Tag430" decimals="-3" contextRef="I2013" unitRef="USD">3515000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <cldx:AccruedResearchAndDevelopmentContractCostsCurrent id="Tag431" decimals="-3" contextRef="I2013" unitRef="USD">11840000</cldx:AccruedResearchAndDevelopmentContractCostsCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent id="Tag432" decimals="-3" contextRef="I2013" unitRef="USD">556000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="Tag433" decimals="-3" contextRef="I2013" unitRef="USD">1018000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Tag434" decimals="-3" contextRef="I2013" unitRef="USD">17179000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:DeferredRentCredit id="Tag435" decimals="-3" contextRef="I2013" unitRef="USD">419000</us-gaap:DeferredRentCredit>
  <us-gaap:DeferredRentCredit id="Tag436" decimals="-3" contextRef="I2012" unitRef="USD">434000</us-gaap:DeferredRentCredit>
  <us-gaap:DeferredTaxLiabilities id="Tag437" decimals="-3" contextRef="I2012" unitRef="USD">4661000</us-gaap:DeferredTaxLiabilities>
  <cldx:DeferredIncomeFromSaleOfTaxBenefits id="Tag438" decimals="-3" contextRef="I2012" unitRef="USD">1118000</cldx:DeferredIncomeFromSaleOfTaxBenefits>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag439" decimals="-3" contextRef="D2013" unitRef="USD">5403000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:LoansPayable id="Tag440" decimals="-3" contextRef="I2012" unitRef="USD">472000</us-gaap:LoansPayable>
  <us-gaap:OtherSundryLiabilities id="Tag441" decimals="-3" contextRef="I2012" unitRef="USD">39000</us-gaap:OtherSundryLiabilities>
  <us-gaap:OtherLiabilities id="Tag442" decimals="-3" contextRef="I2012" unitRef="USD">6724000</us-gaap:OtherLiabilities>
  <us-gaap:DeferredTaxLiabilities id="Tag443" decimals="-3" contextRef="I2013" unitRef="USD">4661000</us-gaap:DeferredTaxLiabilities>
  <cldx:DeferredIncomeFromSaleOfTaxBenefits id="Tag444" decimals="-3" contextRef="I2013" unitRef="USD">1630000</cldx:DeferredIncomeFromSaleOfTaxBenefits>
  <us-gaap:DeferredRevenue id="Tag445" decimals="-3" contextRef="I2013" unitRef="USD">1168000</us-gaap:DeferredRevenue>
  <us-gaap:OtherLiabilities id="Tag446" decimals="-3" contextRef="I2013" unitRef="USD">7878000</us-gaap:OtherLiabilities>
  <us-gaap:OtherLiabilitiesCurrent id="Tag447" decimals="-3" contextRef="I2013" unitRef="USD">928000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="Tag448" decimals="-3" contextRef="I2013" unitRef="USD">6950000</us-gaap:OtherLiabilitiesNoncurrent>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold id="Tag449" decimals="-5" contextRef="D2011Q1_M01" unitRef="USD">600000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold id="Tag450" decimals="-5" contextRef="D2012Q1_M01" unitRef="USD">800000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold id="Tag451" decimals="-5" contextRef="D2013Q1_M01" unitRef="USD">800000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <cldx:ValueAtWhichTaxBenefitsSold id="Tag452" decimals="-5" contextRef="D2012Q1_M01" unitRef="USD">700000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:ValueAtWhichTaxBenefitsSold id="Tag453" decimals="-5" contextRef="D2011Q1_M01" unitRef="USD">500000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:ValueAtWhichTaxBenefitsSold id="Tag454" decimals="-5" contextRef="D2013Q1_M01" unitRef="USD">800000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:PeriodForWhichBaseOfOperationsMustBeMaintained id="Tag455" contextRef="D2013">P5Y</cldx:PeriodForWhichBaseOfOperationsMustBeMaintained>
  <us-gaap:GainLossOnSaleOfOtherAssets id="Tag456" decimals="-5" contextRef="D2012" unitRef="USD">100000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:GainLossOnSaleOfOtherAssets id="Tag457" decimals="-5" contextRef="D2013" unitRef="USD">200000</us-gaap:GainLossOnSaleOfOtherAssets>
  <cldx:CollaborativeArrangementEstimatedCostForDevelopmentServices id="Tag458" decimals="-5" contextRef="D2013Q3_M09_ProductDevelopmentAndLicensingAgreementMember" unitRef="USD">4800000</cldx:CollaborativeArrangementEstimatedCostForDevelopmentServices>
  <cldx:CollaborativeArrangementAgreementTerm id="Tag459" contextRef="D2013Q3_M09_ProductDevelopmentAndLicensingAgreementMember">P3Y</cldx:CollaborativeArrangementAgreementTerm>
  <cldx:CollaborativeArrangementUpfrontPaymentAmount id="Tag460" decimals="-5" contextRef="D2013Q3_M09_ProductDevelopmentAndLicensingAgreementMember" unitRef="USD">1300000</cldx:CollaborativeArrangementUpfrontPaymentAmount>
  <cldx:RevenueFromContractsAndGrants id="Tag461" decimals="-5" contextRef="D2013_ProductDevelopmentAndLicensingAgreementMember" unitRef="USD">1400000</cldx:RevenueFromContractsAndGrants>
  <cldx:RepaymentOfLongTermDebtPrincipalAmount id="Tag462" decimals="-5" contextRef="D2013Q2_M05_SecuredDebtMember" unitRef="USD">8800000</cldx:RepaymentOfLongTermDebtPrincipalAmount>
  <cldx:DebtInstrumentInterestAndPrepaymentFees id="Tag463" decimals="-5" contextRef="D2013Q2_M05_SecuredDebtMember" unitRef="USD">700000</cldx:DebtInstrumentInterestAndPrepaymentFees>
  <us-gaap:InterestExpenseLongTermDebt id="Tag464" decimals="-5" contextRef="D2012_SecuredDebtMember" unitRef="USD">1500000</us-gaap:InterestExpenseLongTermDebt>
  <us-gaap:InterestExpenseLongTermDebt id="Tag465" decimals="-5" contextRef="D2011_SecuredDebtMember" unitRef="USD">1600000</us-gaap:InterestExpenseLongTermDebt>
  <us-gaap:InterestExpenseLongTermDebt id="Tag466" decimals="-5" contextRef="D2013_SecuredDebtMember" unitRef="USD">800000</us-gaap:InterestExpenseLongTermDebt>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock id="Tag467" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 565px;" border="0" cellspacing="0" cellpadding="0" width="565"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Royalty and License Fees&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;250&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Payroll and Employee Benefits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,515&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;925&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Research and Development Contract Costs&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;11,840&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7,569&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Accrued Professional Fees&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;556&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;317&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other Accrued Expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,018&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;373&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;17,179&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;10,960&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <cldx:ScheduleOfOtherLongTermLiabilitiesTableTextBlock id="Tag468" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 593px;" border="0" cellspacing="0" cellpadding="0" width="593"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred Rent&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;419&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;434&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net Deferred Tax Liability related to IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred Income from Sale of Tax Benefits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,630&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,118&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred Revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,168&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Loan Payable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;472&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;39&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7,878&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,724&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Less Current Portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(928&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(388&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Long-Term Portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,950&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,336&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</cldx:ScheduleOfOtherLongTermLiabilitiesTableTextBlock>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="Tag469" decimals="-3" contextRef="I2013" unitRef="USD">79558000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <cldx:ShelfRegistrationStatementAmount id="Tag470" decimals="-6" contextRef="I2010Q2_M0430" unitRef="USD">150000000</cldx:ShelfRegistrationStatementAmount>
  <cldx:ShelfRegistrationStatementAmount id="Tag471" decimals="-6" contextRef="I2012" unitRef="USD">200000000</cldx:ShelfRegistrationStatementAmount>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag472" decimals="INF" contextRef="D2012_ControlledEquityOfferingProgramAmendedMember" unitRef="Shares">8003290</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag473" decimals="INF" contextRef="D2011_ControlledEquityOfferingProgramAmendedMember" unitRef="Shares">575000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag474" decimals="-5" contextRef="D2011_ControlledEquityOfferingProgramAmendedMember" unitRef="USD">2200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <cldx:OperatingLossCarryforwardsExpired id="Tag475" decimals="-5" contextRef="D2013_InternalRevenueServiceIRSMember_AVANTMember_PriorToMergerMember" unitRef="USD">0</cldx:OperatingLossCarryforwardsExpired>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch id="Tag476" decimals="-3" contextRef="D2013" unitRef="USD">3261000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="Tag477" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="Tag478" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="Tag479" decimals="3" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="Tag480" decimals="3" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag481" decimals="INF" contextRef="D2012" unitRef="Shares">12075000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag482" decimals="INF" contextRef="D2013" unitRef="Shares">21613483</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:AccountsAndOtherReceivablesNetCurrent id="Tag483" decimals="-3" contextRef="I2013" unitRef="USD">489000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag484" decimals="-5" contextRef="D2012_ControlledEquityOfferingProgramAmendedMember" unitRef="USD">40100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag485" decimals="-5" contextRef="D2013_ControlledEquityOfferingProgramAmendedMember" unitRef="USD">17100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag486" decimals="INF" contextRef="D2011" unitRef="Shares">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards id="Tag487" decimals="-3" contextRef="I2013" unitRef="USD">25582000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense id="Tag488" decimals="-3" contextRef="I2013" unitRef="USD">61370000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Tag489" decimals="-3" contextRef="I2013" unitRef="USD">1717000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:OtherAssetsNoncurrent id="Tag490" decimals="-3" contextRef="I2013" unitRef="USD">148000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:PreferredStockSharesAuthorized id="Tag491" decimals="INF" contextRef="I2013_SeriesCPreferredStockMember" unitRef="Shares">3000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:AccountsPayableCurrent id="Tag492" decimals="-3" contextRef="I2013" unitRef="USD">2243000</us-gaap:AccountsPayableCurrent>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag493" decimals="INF" contextRef="D2013Q4_M12" unitRef="Shares">7813483</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost id="Tag494" decimals="-3" contextRef="I2013" unitRef="USD">3926000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment id="Tag495" decimals="-3" contextRef="I2013" unitRef="USD">1638000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
  <us-gaap:PreferredStockSharesAuthorized id="Tag496" decimals="INF" contextRef="I2013_CumulativePreferredStockMember" unitRef="Shares">350000</us-gaap:PreferredStockSharesAuthorized>
  <cldx:ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare id="Tag497" decimals="INF" contextRef="D2013_ShareholderRightsPlanMember_CumulativePreferredStockMember" unitRef="Item">1</cldx:ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Tag498" decimals="INF" contextRef="I2013_ShareholderRightsPlanMember_CumulativePreferredStockMember" unitRef="Shares">0.0001</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <cldx:ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired id="Tag499" decimals="2" contextRef="D2013_ShareholderRightsPlanMember_CumulativePreferredStockMember_MinimumMember" unitRef="Pure">0.15</cldx:ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired>
  <cldx:ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender id="Tag500" decimals="2" contextRef="D2013_ShareholderRightsPlanMember_CumulativePreferredStockMember_MinimumMember" unitRef="Pure">0.15</cldx:ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender>
  <cldx:NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired id="Tag501" decimals="INF" contextRef="D2013_ShareholderRightsPlanMember_CumulativePreferredStockMember" unitRef="Item">2</cldx:NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired>
  <cldx:ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany id="Tag502" decimals="2" contextRef="D2013_ShareholderRightsPlanMember_MinimumMember" unitRef="Pure">0.50</cldx:ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany>
  <cldx:NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany id="Tag503" decimals="INF" contextRef="D2013_ShareholderRightsPlanMember" unitRef="Item">2</cldx:NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany>
  <cldx:PercentageOfLicenseFeeDueOnNetRoyaltiesReceived id="Tag504" decimals="INF" contextRef="D1995_LicenseAgreementsMember_CincinnatiChildrensHospitalMedicalCenterMember_RotarixRotavirusVaccineMember" unitRef="Pure">0.30</cldx:PercentageOfLicenseFeeDueOnNetRoyaltiesReceived>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther id="Tag505" decimals="-3" contextRef="I2013" unitRef="USD">623000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <cldx:PercentageOfInterestInNetRoyaltiesSold id="Tag506" decimals="INF" contextRef="D2005Q2_M05_RoyaltyAgreementMember_PRFAgreementMember_RotarixRotavirusVaccineMember" unitRef="Pure">0.70</cldx:PercentageOfInterestInNetRoyaltiesSold>
  <us-gaap:RoyaltyExpense id="Tag507" decimals="-5" contextRef="D2011_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_GlaxoSmithKlinePlcMember_RotarixRotavirusVaccineMember" unitRef="USD">9100000</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense id="Tag508" decimals="-5" contextRef="D2012_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_GlaxoSmithKlinePlcMember_RotarixRotavirusVaccineMember" unitRef="USD">10800000</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense id="Tag509" decimals="-5" contextRef="D2013_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_GlaxoSmithKlinePlcMember_RotarixRotavirusVaccineMember" unitRef="USD">2300000</us-gaap:RoyaltyExpense>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock id="Tag510" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;b&gt;(14) COLLABORATION AGREEMENTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company has entered into license agreements whereby the Company has received licenses or options to license technology, specified patents or patent applications. The Company's licensing and development collaboration agreements generally provide for royalty payments equal to specified percentages of product sales, annual license maintenance fees, continuing patent prosecution costs and potential future milestone payments to third parties upon the achievement of certain developmental, regulatory and/or commercial milestones. Nonrefundable license fee expense was $0.7&amp;#160;million, $0.7&amp;#160;million and $1.4&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Medarex,&amp;#160;Inc., a subsidiary of Bristol-Myers Squibb (Medarex)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company and Medarex have entered into an assignment and license agreement, as amended, that provides for the assignment of certain patent and other intellectual property rights and a license to certain Medarex technology related to the Company's APC Targeting Technology&amp;#8482; and an anti-mannose receptor product. Under the terms of the agreement, the Company may be required to pay royalties in the low-single digits on any net product sale of a Licensed Royalty-Bearing Product or Anti-Mannose Product to Medarex until the later of (i)&amp;#160;the expiration of the last to expire applicable patent and (ii)&amp;#160;the tenth anniversary of the first commercial sale of such licensed product.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;The Company and Medarex have also entered into a research and commercialization agreement, as amended, that provides the Company with certain rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform for generating antibodies until December 2015. Under the terms of the agreement, the Company may be required to pay milestones of up to $7.0&amp;#160;million upon obtaining first approval for commercial sale in a first indication of a product containing a licensed antibody and royalty payments in the low-to-mid single digits on any net product sales to Medarex with respect to the development of any products containing such licensed antibodies until the later of (i)&amp;#160;the expiration of the last to expire applicable patent and (ii)&amp;#160;the tenth anniversary of the first commercial sale of such licensed product. In September 2010, the Company exercised an option under the agreement, whereby it licensed from Medarex access to the UltiMab technology to develop and commercialize human antibodies to CD27, including varlilumab.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Rockefeller University (Rockefeller)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In November 2005, the Company and Rockefeller entered into a license agreement for the exclusive worldwide rights to human DEC-205 receptor, with the right to sublicense the technology. The license grant is exclusive except that Rockefeller may use and permit other nonprofit organizations to use the human DEC-205 receptor patent rights for educational and research purposes. The Company may be required to pay milestones of up to $3.9&amp;#160;million upon obtaining first approval for commercial sale in a first indication of a product targeting the licensed receptor and royalty payments in the low-to-mid single digits on any net product sales to Rockefeller with respect to development and commercialization of the human DEC-205 receptor.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Duke University Brain Tumor Cancer Center (Duke)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In September 2006, the Company and Duke entered into a license agreement that gave the Company access and reference to the clinical data generated by Duke and its collaborators in order for the Company to generate its own filing with the FDA relating to rindopepimut. The Company may be required to pay milestone of up to $0.7&amp;#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Duke with respect to development and commercialization of rindopepimut.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Ludwig Institute for Cancer Research (Ludwig)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In October 2006, the Company and Ludwig entered into an agreement for the nonexclusive rights to certain cancer tumor targets for use in combination with the Company's APC Targeting Technology. The Company may be required to pay milestones of up to $1.0&amp;#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Ludwig with respect to development and commercialization of the technology licensed from Ludwig.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Alteris Therapeutics,&amp;#160;Inc. (Alteris)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In October 2005, the Company completed the acquisition of the assets of Alteris, including the EGFRvIII molecule. The Company may be required to pay Alteris up to $5.0&amp;#160;million upon obtaining the first approval for commercial sale of a product containing EGFRvIII, including rindopepimut.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;University of Southampton, UK (Southampton)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In November 2008, the Company entered into a license agreement with Southampton to develop human antibodies towards CD27, a potentially important target for immunotherapy of various cancers. The Company may be required to pay milestones of up to approximately $1.4&amp;#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Southampton with respect to development and commercialization of varlilumab.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Amgen&amp;#160;Inc. (Amgen)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In March 2009, the Company entered into a license agreement with Amgen to acquire the exclusive rights to CDX-301 and CD40 ligand (CD40L). CDX-301 and CD40L are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. The Company may be required to pay milestones of up to $1.0&amp;#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Amgen with respect to development and commercialization of the technology licensed from Amgen, including CDX-301.&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;i&gt;Seattle Genetics,&amp;#160;Inc. (Seattle Genetics)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In connection with the CuraGen acquisition, the Company assumed the license agreement between CuraGen and Seattle Genetics whereby CuraGen acquired the rights to proprietary antibody-drug conjugate (ADC) technology for use with the Company's proprietary antibodies for the potential treatment of cancer. In February 2014, the Company paid $2.5&amp;#160;million in milestones to Seattle Genetics as a result of the METRIC initiation. The Company may be required to pay milestones of up to $5.0&amp;#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the mid-single digits on any net product sales to Seattle Genetics with respect to development and commercialization of the ADC technology, including glembatumumab vedotin and CDX-014.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <cldx:NonRefundableLicenseFee id="Tag511" decimals="-5" contextRef="D2012_LicenseAgreementsMember" unitRef="USD">700000</cldx:NonRefundableLicenseFee>
  <cldx:NonRefundableLicenseFee id="Tag512" decimals="-5" contextRef="D2011_LicenseAgreementsMember" unitRef="USD">1400000</cldx:NonRefundableLicenseFee>
  <cldx:NonRefundableLicenseFee id="Tag513" decimals="-5" contextRef="D2013_LicenseAgreementsMember" unitRef="USD">700000</cldx:NonRefundableLicenseFee>
  <cldx:CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct id="Tag514" contextRef="D2013_LicenseAgreementsMember_MedarexIncMember_MaximumMember">P10Y</cldx:CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag515" decimals="-5" contextRef="I2013_LicenseAgreementsMember_MedarexIncMember_MaximumMember" unitRef="USD">7000000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag516" decimals="-5" contextRef="I2013_LicenseAgreementsMember_RockefellerUniversityMember_MaximumMember" unitRef="USD">3900000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag517" decimals="-5" contextRef="I2013_LicenseAgreementsMember_DukeUniversityBrainTumorCancerCenterMember_MaximumMember" unitRef="USD">700000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag518" decimals="-5" contextRef="I2013_LicenseAgreementsMember_LudwigInstituteForCancerResearchMember_MaximumMember" unitRef="USD">1000000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag519" decimals="-5" contextRef="I2013_LicenseAgreementsMember_AlterisTherapeuticsIncMember_MaximumMember" unitRef="USD">5000000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag520" decimals="-5" contextRef="I2013_LicenseAgreementsMember_UniversityOfSouthamptonUKMember_MaximumMember" unitRef="USD">1400000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag521" decimals="-5" contextRef="I2013_LicenseAgreementsMember_AmgenIncMember_MaximumMember" unitRef="USD">1000000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <us-gaap:Liabilities id="Tag522" decimals="-3" contextRef="I2013" unitRef="USD">27300000</us-gaap:Liabilities>
  <us-gaap:CommonStockValue id="Tag523" decimals="-3" contextRef="I2013" unitRef="USD">89000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="Tag524" decimals="-3" contextRef="I2013" unitRef="USD">662717000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Tag525" decimals="-3" contextRef="I2013" unitRef="USD">-345679000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <cldx:CollaborativeArrangementTotalPotentialMilestonePayments id="Tag526" decimals="-5" contextRef="I2013_LicenseAgreementsMember_SeattleGeneticIncMember_CuraGenCorporationMember_MaximumMember" unitRef="USD">5000000</cldx:CollaborativeArrangementTotalPotentialMilestonePayments>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock id="Tag527" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 703px;" border="0" cellspacing="0" cellpadding="0" width="703"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended December&amp;#160;31,&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Income tax benefit (provision):&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Federal&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;30,962&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,394&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;16,204&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;State&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;4,920&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;4,237&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Foreign&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;84&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Expiration of Net Operating Losses and Research&amp;#160;&amp;amp; Development Tax Credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(126&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1,426&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(411&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,756&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;22,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,008&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Deferred tax valuation allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(35,756&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(22,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(19,008&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock id="Tag528" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 685px;" border="0" cellspacing="0" cellpadding="0" width="685"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Pre-tax loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(81,550&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(59,123&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(44,799&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Loss at Statutory Rates&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(27,727&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(20,102&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(15,213&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Research and Development Credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3,261&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(1,736&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;State Taxes&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4,920&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(4,237&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(3,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;26&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;708&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expiration of Net Operating Losses and Research&amp;#160;&amp;amp; Development Tax Credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;126&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,426&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;411&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Change in Valuation Allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;35,756&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;22,205&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;19,008&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Income tax (benefit) provision&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="Tag529" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 649px;" border="0" cellspacing="0" cellpadding="0" width="649"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="64"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;December&amp;#160;31,&lt;br /&gt;
2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="5" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Gross Deferred Tax Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Net Operating Loss Carryforwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;79,558&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;67,728&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Tax Credit Carryforwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;25,582&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;20,692&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Deferred Expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;61,370&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;43,226&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Stock-based Compensation&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,926&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,264&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Fixed Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,638&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,156&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Accrued Expenses and Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;623&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;241&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;172,697&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;137,307&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Gross Deferred Tax Liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Other Acquired Intangibles&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,115&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,481&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;IPR&amp;amp;D Intangibles&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(8,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(9,142&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Total Deferred Tax Assets and Liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;163,921&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;128,165&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"&gt;&lt;font size="2"&gt;Deferred Tax Assets Valuation Allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(168,582&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(132,826&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net Deferred Tax Asset (Liability)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(4,661&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations id="Tag530" decimals="-3" contextRef="D2012" unitRef="USD">-19394000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
  <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations id="Tag531" decimals="-3" contextRef="D2011" unitRef="USD">-16204000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
  <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations id="Tag532" decimals="-3" contextRef="D2013" unitRef="USD">-30962000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
  <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations id="Tag533" decimals="-3" contextRef="D2012" unitRef="USD">-4237000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
  <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations id="Tag534" decimals="-3" contextRef="D2011" unitRef="USD">-3131000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
  <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations id="Tag535" decimals="-3" contextRef="D2013" unitRef="USD">-4920000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
  <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations id="Tag536" decimals="-3" contextRef="D2011" unitRef="USD">-84000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
  <cldx:ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits id="Tag537" decimals="-3" contextRef="D2012" unitRef="USD">1426000</cldx:ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits>
  <cldx:ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits id="Tag538" decimals="-3" contextRef="D2011" unitRef="USD">411000</cldx:ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits>
  <cldx:ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits id="Tag539" decimals="-3" contextRef="D2013" unitRef="USD">126000</cldx:ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits>
  <cldx:IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance id="Tag540" decimals="-3" contextRef="D2012" unitRef="USD">-22205000</cldx:IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance>
  <cldx:IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance id="Tag541" decimals="-3" contextRef="D2011" unitRef="USD">-19008000</cldx:IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance>
  <cldx:IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance id="Tag542" decimals="-3" contextRef="D2013" unitRef="USD">-35756000</cldx:IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="Tag543" decimals="-3" contextRef="D2012" unitRef="USD">-22205000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="Tag544" decimals="-3" contextRef="D2011" unitRef="USD">-19008000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="Tag545" decimals="-3" contextRef="D2013" unitRef="USD">-35756000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:IncomeTaxExpenseBenefit id="Tag546" decimals="-3" contextRef="D2013" unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Tag547" decimals="INF" contextRef="D2013" unitRef="Pure">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate id="Tag548" decimals="-3" contextRef="D2012" unitRef="USD">-20102000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate id="Tag549" decimals="-3" contextRef="D2011" unitRef="USD">-15213000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate id="Tag550" decimals="-3" contextRef="D2013" unitRef="USD">-27727000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch id="Tag551" decimals="-3" contextRef="D2011" unitRef="USD">1736000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="Tag552" decimals="-3" contextRef="I2013" unitRef="USD">167000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes id="Tag553" decimals="-3" contextRef="D2012" unitRef="USD">-4237000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes id="Tag554" decimals="-3" contextRef="D2011" unitRef="USD">-3131000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes id="Tag555" decimals="-3" contextRef="D2013" unitRef="USD">-4920000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationOtherAdjustments id="Tag556" decimals="-3" contextRef="D2012" unitRef="USD">708000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
  <us-gaap:IncomeTaxReconciliationOtherAdjustments id="Tag557" decimals="-3" contextRef="D2011" unitRef="USD">661000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
  <us-gaap:IncomeTaxReconciliationOtherAdjustments id="Tag558" decimals="-3" contextRef="D2013" unitRef="USD">26000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
  <cldx:IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits id="Tag559" decimals="-3" contextRef="D2012" unitRef="USD">1426000</cldx:IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits>
  <cldx:IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits id="Tag560" decimals="-3" contextRef="D2011" unitRef="USD">411000</cldx:IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits>
  <cldx:IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits id="Tag561" decimals="-3" contextRef="D2013" unitRef="USD">126000</cldx:IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Tag562" decimals="-3" contextRef="D2012" unitRef="USD">22205000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Tag563" decimals="-3" contextRef="D2011" unitRef="USD">19008000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Tag564" decimals="-3" contextRef="D2013" unitRef="USD">35756000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="Tag565" decimals="-3" contextRef="I2012" unitRef="USD">67728000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards id="Tag566" decimals="-3" contextRef="I2012" unitRef="USD">20692000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense id="Tag567" decimals="-3" contextRef="I2012" unitRef="USD">43226000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements id="Tag568" decimals="-3" contextRef="D2013" unitRef="USD">160000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromContractsAndGrants id="Tag569" decimals="-3" contextRef="D2013" unitRef="USD">1617000</cldx:RevenueFromContractsAndGrants>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag570" decimals="-3" contextRef="D2013" unitRef="USD">67401000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost id="Tag571" decimals="-3" contextRef="I2012" unitRef="USD">3264000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag572" decimals="-3" contextRef="D2013" unitRef="USD">14805000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment id="Tag573" decimals="-3" contextRef="I2012" unitRef="USD">2156000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther id="Tag574" decimals="-3" contextRef="I2012" unitRef="USD">241000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <us-gaap:InterestAndOtherIncome id="Tag575" decimals="-3" contextRef="D2013" unitRef="USD">819000</us-gaap:InterestAndOtherIncome>
  <us-gaap:DeferredTaxAssetsGross id="Tag576" decimals="-3" contextRef="I2012" unitRef="USD">137307000</us-gaap:DeferredTaxAssetsGross>
  <cldx:DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets id="Tag577" decimals="-3" contextRef="I2012" unitRef="USD">4481000</cldx:DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets>
  <cldx:DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets id="Tag578" decimals="-3" contextRef="I2013" unitRef="USD">4115000</cldx:DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets>
  <cldx:DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets id="Tag579" decimals="-3" contextRef="I2012" unitRef="USD">4661000</cldx:DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets>
  <cldx:DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets id="Tag580" decimals="-3" contextRef="I2013" unitRef="USD">4661000</cldx:DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets>
  <us-gaap:DeferredIncomeTaxLiabilities id="Tag581" decimals="-3" contextRef="I2012" unitRef="USD">9142000</us-gaap:DeferredIncomeTaxLiabilities>
  <us-gaap:DeferredIncomeTaxLiabilities id="Tag582" decimals="-3" contextRef="I2013" unitRef="USD">8776000</us-gaap:DeferredIncomeTaxLiabilities>
  <cldx:DeferredTaxAssetsLiabilitiesGross id="Tag583" decimals="-3" contextRef="I2012" unitRef="USD">128165000</cldx:DeferredTaxAssetsLiabilitiesGross>
  <cldx:DeferredTaxAssetsLiabilitiesGross id="Tag584" decimals="-3" contextRef="I2013" unitRef="USD">163921000</cldx:DeferredTaxAssetsLiabilitiesGross>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="Tag585" decimals="-3" contextRef="I2012" unitRef="USD">132826000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="Tag586" decimals="-3" contextRef="I2013" unitRef="USD">168582000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:OperatingLossCarryforwards id="Tag587" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_PriorToMergerMember" unitRef="USD">33000000</us-gaap:OperatingLossCarryforwards>
  <cldx:OperatingLossCarryforwardsExpired id="Tag588" decimals="-5" contextRef="D2012_InternalRevenueServiceIRSMember_AVANTMember_PriorToMergerMember" unitRef="USD">16400000</cldx:OperatingLossCarryforwardsExpired>
  <cldx:OperatingLossCarryforwardsNetOfExpirationsAndUtilization id="Tag589" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_AVANTMember_PriorToMergerMember" unitRef="USD">101200000</cldx:OperatingLossCarryforwardsNetOfExpirationsAndUtilization>
  <us-gaap:OperatingLossCarryforwards id="Tag590" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_AVANTMember" unitRef="USD">131700000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards id="Tag591" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_CuraGenCorporationMember_PriorToAcquisitionMember" unitRef="USD">518300000</us-gaap:OperatingLossCarryforwards>
  <cldx:OperatingLossCarryforwardsRemotelyLikelyToBeUtilized id="Tag592" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_AVANTMember" unitRef="USD">60800000</cldx:OperatingLossCarryforwardsRemotelyLikelyToBeUtilized>
  <cldx:OperatingLossCarryforwardsWithLimitationsOnUse id="Tag593" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_AVANTMember" unitRef="USD">40400000</cldx:OperatingLossCarryforwardsWithLimitationsOnUse>
  <us-gaap:OperatingLossCarryforwards id="Tag594" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_OwnershipChangeInOctober2007Member" unitRef="USD">28300000</us-gaap:OperatingLossCarryforwards>
  <cldx:OperatingLossCarryforwardsAnnualLimitationAmount id="Tag595" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_OwnershipChangeInOctober2007Member" unitRef="USD">4500000</cldx:OperatingLossCarryforwardsAnnualLimitationAmount>
  <us-gaap:TaxCreditCarryforwardAmount id="Tag596" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_ResearchMember" unitRef="USD">20800000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount id="Tag597" decimals="-5" contextRef="I2013_StateAndLocalJurisdictionMember_ResearchMember" unitRef="USD">14400000</us-gaap:TaxCreditCarryforwardAmount>
  <cldx:TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse id="Tag598" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_ResearchMember" unitRef="USD">19400000</cldx:TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse>
  <cldx:TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse id="Tag599" decimals="-5" contextRef="I2013_StateAndLocalJurisdictionMember_ResearchMember" unitRef="USD">9300000</cldx:TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse>
  <cldx:TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse id="Tag600" decimals="-5" contextRef="I2013_StateAndLocalJurisdictionMember" unitRef="USD">108300000</cldx:TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse>
  <cldx:PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange id="Tag601" contextRef="D2013_InternalRevenueServiceIRSMember">P5Y</cldx:PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange>
  <us-gaap:NumberOfStatesInWhichEntityOperates id="Tag602" decimals="INF" contextRef="I2013" unitRef="Item">3</us-gaap:NumberOfStatesInWhichEntityOperates>
  <us-gaap:OperatingLossCarryforwards id="Tag603" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_OwnershipChangesInJune2009AndDecember2009Member" unitRef="USD">67700000</us-gaap:OperatingLossCarryforwards>
  <cldx:OperatingLossCarryforwardsAnnualLimitationAmount id="Tag604" decimals="-5" contextRef="I2013_InternalRevenueServiceIRSMember_OwnershipChangesInJune2009AndDecember2009Member" unitRef="USD">6000000</cldx:OperatingLossCarryforwardsAnnualLimitationAmount>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="Tag605" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;The following obligations for base rent and CAM costs under facility and other non-cancelable operating leases as of December&amp;#160;31, 2013 do not include the exercise of renewal terms or early termination provisions (in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"&gt;

&lt;tr style="padding:0;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="45"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,666&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2015&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,863&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,914&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;1,765&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;501&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;167&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total minimum lease payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;10,876&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="Tag606" decimals="-3" contextRef="I2013" unitRef="USD">2666000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="Tag607" decimals="-3" contextRef="I2013" unitRef="USD">2863000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="Tag608" decimals="-3" contextRef="I2013" unitRef="USD">2914000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="Tag609" decimals="-3" contextRef="I2013" unitRef="USD">1765000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="Tag610" decimals="-3" contextRef="I2013" unitRef="USD">501000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="Tag611" decimals="-3" contextRef="I2013" unitRef="USD">10876000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesRentExpenseNet id="Tag612" decimals="-5" contextRef="D2011" unitRef="USD">2500000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="Tag613" decimals="-5" contextRef="D2012" unitRef="USD">2500000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="Tag614" decimals="-5" contextRef="D2013" unitRef="USD">2700000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent id="Tag615" decimals="2" contextRef="D2013" unitRef="Pure">0.15</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
  <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch id="Tag616" decimals="2" contextRef="D2013" unitRef="Pure">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
  <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent id="Tag617" decimals="2" contextRef="D2013" unitRef="Pure">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
  <us-gaap:DefinedContributionPlanCostRecognized id="Tag618" decimals="-5" contextRef="D2012" unitRef="USD">200000</us-gaap:DefinedContributionPlanCostRecognized>
  <us-gaap:DefinedContributionPlanCostRecognized id="Tag619" decimals="-5" contextRef="D2011" unitRef="USD">200000</us-gaap:DefinedContributionPlanCostRecognized>
  <us-gaap:DefinedContributionPlanCostRecognized id="Tag620" decimals="-5" contextRef="D2013" unitRef="USD">300000</us-gaap:DefinedContributionPlanCostRecognized>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock id="Tag621" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 629px;" border="0" cellspacing="0" cellpadding="0" width="629"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" nowrap="nowrap" align="left"&gt;
&lt;div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"&gt;&lt;font size="1"&gt;&lt;b&gt;2013 &lt;!-- COMMAND=ADD_SCROPPEDRULE,17pt --&gt;&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q1 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q2 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q3 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q4 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands, except per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,414&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;97&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;980&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;620&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(17,332&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(19,016&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(23,140&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(22,062&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Basic and diluted net loss per common share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.24&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.29&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;br /&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_TABLEWIDTH,"100%" --&gt;&lt;/font&gt;&lt;/p&gt;
&lt;!-- User-specified TAGGED TABLE --&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 631px;" border="0" cellspacing="0" cellpadding="0" width="631"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="50"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" nowrap="nowrap" align="left"&gt;
&lt;div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"&gt;&lt;font size="1"&gt;&lt;b&gt;2012 &lt;!-- COMMAND=ADD_SCROPPEDRULE,17pt --&gt;&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q1 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q2 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q3 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Q4 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="11" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands, except per share amounts)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,433&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;2,009&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,113&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;3,647&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(13,516&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(13,773&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(15,027&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(16,807&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Basic and diluted net loss per common share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.23&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.25&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" align="right"&gt;&lt;font size="2"&gt;(0.27&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:Revenues id="Tag622" decimals="-3" contextRef="D2012Q1" unitRef="USD">2433000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag623" decimals="-3" contextRef="D2012Q2" unitRef="USD">2009000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag624" decimals="-3" contextRef="D2012Q3" unitRef="USD">3113000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag625" decimals="-3" contextRef="D2012Q4" unitRef="USD">3647000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag626" decimals="-3" contextRef="D2013Q1" unitRef="USD">2414000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag627" decimals="-3" contextRef="D2013Q2" unitRef="USD">97000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag628" decimals="-3" contextRef="D2013Q3" unitRef="USD">980000</us-gaap:Revenues>
  <us-gaap:Revenues id="Tag629" decimals="-3" contextRef="D2013Q4" unitRef="USD">620000</us-gaap:Revenues>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag630" decimals="-3" contextRef="D2012Q1" unitRef="USD">-13516000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag631" decimals="-3" contextRef="D2012Q2" unitRef="USD">-13773000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag632" decimals="-3" contextRef="D2012Q3" unitRef="USD">-15027000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag633" decimals="-3" contextRef="D2012Q4" unitRef="USD">-16807000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag634" decimals="-3" contextRef="D2013Q1" unitRef="USD">-17332000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag635" decimals="-3" contextRef="D2013Q2" unitRef="USD">-19016000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag636" decimals="-3" contextRef="D2013Q3" unitRef="USD">-23140000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Tag637" decimals="-3" contextRef="D2013Q4" unitRef="USD">-22062000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag638" decimals="2" contextRef="D2012Q1" unitRef="USDPerShare">-0.27</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag639" decimals="2" contextRef="D2012Q2" unitRef="USDPerShare">-0.23</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag640" decimals="2" contextRef="D2012Q3" unitRef="USDPerShare">-0.25</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag641" decimals="2" contextRef="D2012Q4" unitRef="USDPerShare">-0.27</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag642" decimals="2" contextRef="D2013Q1" unitRef="USDPerShare">-0.23</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag643" decimals="2" contextRef="D2013Q2" unitRef="USDPerShare">-0.24</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag644" decimals="2" contextRef="D2013Q3" unitRef="USDPerShare">-0.29</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag645" decimals="2" contextRef="D2013Q4" unitRef="USDPerShare">-0.27</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="Tag646" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 643px;" border="0" cellspacing="0" cellpadding="0" width="643"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="55"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="47"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="74"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Exercise&lt;br /&gt;
Price&lt;br /&gt;
Per Share&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Remaining&lt;br /&gt;
Contractual&lt;br /&gt;
Term (In Years)&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Outstanding at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,349,810&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5.98&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,252,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;16.44&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(816,405&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6.53&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Canceled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(14,861&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6.97&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Outstanding at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,770,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8.17&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Vested and Expected to Vest at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5,712,596&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;8.12&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;7.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Options Exercisable at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;3,297,190&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6.30&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;5.6&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Shares Available for Grant under the 2008 Plan&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,102,942&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock id="Tag647" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 579px;" border="0" cellspacing="0" cellpadding="0" width="579"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="44"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="54"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
Average&lt;br /&gt;
Grant Date&lt;br /&gt;
Fair Value&lt;br /&gt;
(per share)&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Outstanding and unvested at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4.50&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;12,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;15.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;(12,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;9.85&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Canceled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Outstanding and unvested at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;6,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;15.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="Tag648" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 585px;" border="0" cellspacing="0" cellpadding="0" width="585"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="7" align="right"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="39"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;" colspan="8" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Research and development&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,640&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,415&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,412&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;1,908&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;883&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;930&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;4,548&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,298&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="right"&gt;&lt;font size="2"&gt;2,342&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --&gt;&lt;/font&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right"&gt;&amp;#8203;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#8203;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff"&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&lt;!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --&gt;&lt;!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" --&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="Tag649" contextRef="D2013">&lt;div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;"&gt;
&lt;p style="FONT-FAMILY: times;"&gt;&amp;#160;&lt;/p&gt;
&lt;div align="center"&gt;
&lt;table style="text-align:left;TEXT-ALIGN: left; WIDTH: 601px;" border="0" cellspacing="0" cellpadding="0" width="601"&gt;

&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"&gt;&lt;!-- TABLE COLUMN WIDTHS SET --&gt;
&lt;td style="FONT-FAMILY: times;" align="left"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88" align="center"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88" align="center"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="12"&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" width="88" align="center"&gt;&lt;/td&gt;&lt;!-- TABLE COLUMN WIDTHS END --&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom"&gt;
&lt;th style="FONT-FAMILY: times;" align="left"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#160;31, 2013&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#160;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;
&lt;th style="FONT-FAMILY: times;"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/th&gt;
&lt;th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"&gt;&lt;font size="1"&gt;&lt;b&gt;Year Ended&lt;br /&gt;
December&amp;#160;31, 2011&lt;/b&gt;&lt;/font&gt;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expected stock price volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;71&amp;#160;-&amp;#160;72%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;70&amp;#160;-&amp;#160;72%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;68&amp;#160;-&amp;#160;70%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expected option term&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;6.0 Years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;6.0 Years&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;6.0 Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;1.2&amp;#160;-&amp;#160;2.1%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;0.9&amp;#160;-&amp;#160;1.4%&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;1.4&amp;#160;-&amp;#160;2.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white"&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;
&lt;p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"&gt;&lt;font size="2"&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;None&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;None&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom"&gt;&lt;font size="2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="FONT-FAMILY: times;" valign="bottom" align="center"&gt;&lt;font size="2"&gt;None&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;!-- end of user-specified TAGGED TABLE --&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="Tag650" decimals="INF" contextRef="I2013_EmployeeStockMember" unitRef="Shares">200000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent id="Tag651" decimals="2" contextRef="D2013_EmployeeStockMember" unitRef="Pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Tag652" decimals="INF" contextRef="D2012_EmployeeStockMember" unitRef="Shares">5935</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Tag653" decimals="INF" contextRef="D2013_EmployeeStockMember" unitRef="Shares">11823</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="Tag654" decimals="INF" contextRef="I2013_EmployeeStockMember" unitRef="Shares">164124</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Tag655" decimals="INF" contextRef="I2013_StockOptionAndIncentivePlan2008Member" unitRef="Shares">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Tag656" contextRef="D2013_StockOptionAndIncentivePlan2008Member_MaximumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm id="Tag657" contextRef="D2013_StockOptionAndIncentivePlan2008Member_MaximumMember">P10Y</cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm>
  <cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock id="Tag658" contextRef="D2013_StockOptionAndIncentivePlan2008Member">P5Y</cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Tag659" decimals="INF" contextRef="I2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">5349810</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Tag660" decimals="INF" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">5770544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Tag661" decimals="INF" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Shares">1252000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Tag662" decimals="INF" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Shares">816405</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="Tag663" decimals="INF" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Shares">14861</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="Tag664" decimals="INF" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">5712596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="Tag665" decimals="INF" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">3297190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="Tag666" decimals="INF" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Shares">2102942</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Tag667" decimals="2" contextRef="I2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USDPerShare">5.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Tag668" decimals="2" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USDPerShare">8.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Tag669" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USDPerShare">16.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="Tag670" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USDPerShare">6.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="Tag671" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USDPerShare">6.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice id="Tag672" decimals="2" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USDPerShare">8.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="Tag673" decimals="2" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USDPerShare">6.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Tag674" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 id="Tag675" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="Tag676" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Tag677" decimals="-5" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USD">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Tag678" decimals="-4" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USD">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Tag679" decimals="-5" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USD">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Tag680" decimals="2" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USDPerShare">3.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Tag681" decimals="2" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USDPerShare">1.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Tag682" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USDPerShare">10.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="Tag683" decimals="-5" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USD">2100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="Tag684" decimals="-5" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USD">2600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="Tag685" decimals="-5" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="USD">2400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="Tag686" decimals="-5" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USD">92600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue id="Tag687" decimals="-5" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USD">91900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions id="Tag688" decimals="-5" contextRef="I2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="USD">14400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Tag689" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Tag690" decimals="INF" contextRef="I2012_RestrictedStockMember" unitRef="Shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Tag691" decimals="INF" contextRef="I2013_RestrictedStockMember" unitRef="Shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag692" decimals="INF" contextRef="D2013_RestrictedStockMember_SBC" unitRef="Shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="Tag693" decimals="INF" contextRef="D2013_RestrictedStockMember_SBC" unitRef="Shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="Tag694" decimals="2" contextRef="I2012_RestrictedStockMember" unitRef="USDPerShare">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="Tag695" decimals="2" contextRef="I2013_RestrictedStockMember" unitRef="USDPerShare">15.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Tag696" decimals="2" contextRef="D2013_RestrictedStockMember_SBC" unitRef="USDPerShare">15.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="Tag697" decimals="2" contextRef="D2013_RestrictedStockMember_SBC" unitRef="USDPerShare">9.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag698" decimals="-3" contextRef="D2012_ResearchAndDevelopmentExpenseMember" unitRef="USD">1415000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag699" decimals="-3" contextRef="D2012_GeneralAndAdministrativeExpenseMember" unitRef="USD">883000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag700" decimals="-3" contextRef="D2012" unitRef="USD">2298000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag701" decimals="-3" contextRef="D2011_ResearchAndDevelopmentExpenseMember" unitRef="USD">1412000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag702" decimals="-3" contextRef="D2011_GeneralAndAdministrativeExpenseMember" unitRef="USD">930000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag703" decimals="-3" contextRef="D2011" unitRef="USD">2342000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag704" decimals="-3" contextRef="D2013_ResearchAndDevelopmentExpenseMember" unitRef="USD">2640000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag705" decimals="-3" contextRef="D2013_GeneralAndAdministrativeExpenseMember" unitRef="USD">1908000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag706" decimals="-3" contextRef="D2013" unitRef="USD">4548000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="Tag707" decimals="2" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="Tag708" decimals="2" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="Tag709" decimals="2" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="Tag710" decimals="2" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Tag711" decimals="2" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Tag712" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Tag713" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Tag714" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="Tag715" decimals="3" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="Tag716" decimals="3" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Tag717" decimals="2" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="Tag718" decimals="3" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="Tag719" decimals="3" contextRef="D2012_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Tag720" decimals="2" contextRef="D2011_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC" unitRef="Pure">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock id="Tag721" decimals="2" contextRef="I2013_StockOptionAndIncentivePlan2008Member" unitRef="Pure">0.10</cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock>
  <us-gaap:DeferredTaxAssetsGross id="Tag722" decimals="-3" contextRef="I2013" unitRef="USD">172697000</us-gaap:DeferredTaxAssetsGross>
  <cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock id="Tag723" decimals="2" contextRef="D2013_StockOptionAndIncentivePlan2008Member" unitRef="Pure">1.10</cldx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock>
  <us-gaap:CommitmentsAndContingencies id="Tag724" xsi:nil="true" contextRef="I2012" unitRef="USD" />
  <us-gaap:CommitmentsAndContingencies id="Tag725" xsi:nil="true" contextRef="I2013" unitRef="USD" />
  <us-gaap:PreferredStockValue id="Tag726" xsi:nil="true" contextRef="I2012" unitRef="USD" />
  <us-gaap:PreferredStockValue id="Tag727" xsi:nil="true" contextRef="I2013" unitRef="USD" />
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="Tag728" decimals="INF" contextRef="D2013_CommonStockMember" unitRef="Shares">840228</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag729" decimals="-3" contextRef="D2013_AdditionalPaidInCapitalMember" unitRef="USD">278541000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag730" decimals="-3" contextRef="D2013" unitRef="USD">278563000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Tag731" decimals="-3" contextRef="D2013" unitRef="USD">4548000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent id="Tag732" decimals="-3" contextRef="D2013" unitRef="USD">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Tag733" decimals="-3" contextRef="D2013" unitRef="USD">-74000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:InterestExpense id="Tag734" decimals="-3" contextRef="D2013" unitRef="USD">927000</us-gaap:InterestExpense>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="Tag735" decimals="2" contextRef="I2013_ShareholderRightsPlanMember_CumulativePreferredStockMember" unitRef="USDPerUnit">35.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Tag736" contextRef="D2013_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_SBC">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag737" decimals="-3" contextRef="I2013" unitRef="USD">169402000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag738" decimals="-3" contextRef="I2011" unitRef="USD">11899000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag739" decimals="-3" contextRef="I2010" unitRef="USD">21287000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="Tag740" decimals="INF" contextRef="I2013_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:UnrecognizedTaxBenefits id="Tag741" decimals="-3" contextRef="I2013" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
  <cldx:DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized id="Tag742" decimals="-5" contextRef="I2013_CuraGenCorporationMember" unitRef="USD">0</cldx:DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag743" decimals="2" contextRef="D2013" unitRef="USDPerShare">-1.02</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag744" decimals="-3" contextRef="D2013" unitRef="Shares">79777000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ShareBasedCompensation id="Tag745" decimals="-3" contextRef="D2013" unitRef="USD">4548000</us-gaap:ShareBasedCompensation>
  <us-gaap:AmortizationOfDebtDiscountPremium id="Tag746" decimals="-3" contextRef="D2013" unitRef="USD">97000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="Tag747" decimals="-3" contextRef="D2013" unitRef="USD">445000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Tag748" decimals="-3" contextRef="D2013" unitRef="USD">706000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Tag749" decimals="-3" contextRef="D2013" unitRef="USD">7236000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="Tag750" decimals="-3" contextRef="D2013" unitRef="USD">1317000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="Tag751" decimals="-3" contextRef="D2013" unitRef="USD">38894000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleOfProductiveAssets id="Tag752" decimals="-3" contextRef="D2013" unitRef="USD">21000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag753" decimals="-3" contextRef="D2013" unitRef="USD">295697000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations id="Tag754" decimals="-3" contextRef="D2013" unitRef="USD">-3000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="Tag755" decimals="-3" contextRef="D2013" unitRef="USD">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="Tag756" decimals="-3" contextRef="D2012" unitRef="USD">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="Tag757" decimals="-3" contextRef="D2011" unitRef="USD">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="Tag758" decimals="-3" contextRef="D2013_CommonStockMember" unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:ProceedsFromIssuanceOfDebt id="Tag759" decimals="-5" contextRef="D2010Q4_M12_MidCapFinancialLLCMember_SecuredDebtMember" unitRef="USD">10000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:ProceedsFromIssuanceOfDebt id="Tag760" decimals="-5" contextRef="D2011Q1_M03_GeneralElectricCapitalCorporationMember_SecuredDebtMember" unitRef="USD">5000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:SecuredDebt id="Tag761" decimals="-5" contextRef="I2011Q1_M0331_SecuredDebtMember" unitRef="USD">15000000</us-gaap:SecuredDebt>
  <cldx:ExpectedDividendPayableInForeseeableFuture id="Tag762" decimals="-3" contextRef="I2013" unitRef="USD">0</cldx:ExpectedDividendPayableInForeseeableFuture>
  <us-gaap:OperatingLossCarryforwards id="Tag763" decimals="-5" contextRef="I2013" unitRef="USD">6000000</us-gaap:OperatingLossCarryforwards>
  <cldx:CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric decimals="-5" contextRef="D2014Q1_2M_CuraGenCorporationMember_SeattleGeneticIncMember_SubsequentEventMember_LicenseAgreementsMember" unitRef="USD">2500000</cldx:CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cldx-20131231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--Generated by IRIS XBRL Generation Engine-->
<xsd:schema elementFormDefault="qualified" attributeFormDefault="unqualified" targetNamespace="http://www.celldextherapeutics.com/20131231" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:cldx="http://www.celldextherapeutics.com/20131231" xmlns:us-roles="http://fasb.org/us-roles/2013-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20131231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20131231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20131231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20131231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/BalanceSheet" id="BalanceSheet">
        <link:definition>0010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/BalanceSheetParenthetical" id="BalanceSheetParenthetical">
        <link:definition>0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementOfIncome" id="StatementOfIncome">
        <link:definition>0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementOfIncomeCalc2" id="StatementOfIncomeCalc2">
        <link:definition>0021 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity" id="StatementOfStockholdersEquity">
        <link:definition>0030 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/CashFlows" id="CashFlows">
        <link:definition>0040 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverview" id="DisclosureNatureOfBusinessAndOverview">
        <link:definition>1010 - Disclosure - NATURE OF BUSINESS AND OVERVIEW</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>1020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLoss" id="DisclosureComprehensiveLoss">
        <link:definition>1030 - Disclosure - COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>1040 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities" id="DisclosureMarketableSecurities">
        <link:definition>1050 - Disclosure - MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNet" id="DisclosurePropertyAndEquipmentNet">
        <link:definition>1060 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill" id="DisclosureIntangibleAssetsAndGoodwill">
        <link:definition>1070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpenses" id="DisclosureAccruedExpenses">
        <link:definition>1080 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities" id="DisclosureOtherLongTermLiabilities">
        <link:definition>1090 - Disclosure - OTHER LONG-TERM LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureTermLoan" id="DisclosureTermLoan">
        <link:definition>1100 - Disclosure - TERM LOAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
        <link:definition>1110 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation" id="DisclosureStockBasedCompensation">
        <link:definition>1120 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenue" id="DisclosureRevenue">
        <link:definition>1130 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreements" id="DisclosureCollaborationAgreements">
        <link:definition>1140 - Disclosure - COLLABORATION AGREEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>1150 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>1160 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlan" id="DisclosureRetirementSavingsPlan">
        <link:definition>1170 - Disclosure - RETIREMENT SAVINGS PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialData" id="DisclosureSelectedQuarterlyFinancialData">
        <link:definition>1180 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>3020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossTables" id="DisclosureComprehensiveLossTables">
        <link:definition>3030 - Disclosure - COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>3040 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables" id="DisclosureMarketableSecuritiesTables">
        <link:definition>3050 - Disclosure - MARKETABLE SECURITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetTables" id="DisclosurePropertyAndEquipmentNetTables">
        <link:definition>3060 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables" id="DisclosureIntangibleAssetsAndGoodwillTables">
        <link:definition>3070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesTables" id="DisclosureAccruedExpensesTables">
        <link:definition>3080 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables" id="DisclosureOtherLongTermLiabilitiesTables">
        <link:definition>3090 - Disclosure - OTHER LONG-TERM LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables" id="DisclosureStockBasedCompensationTables">
        <link:definition>3120 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>3150 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>3160 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataTables" id="DisclosureSelectedQuarterlyFinancialDataTables">
        <link:definition>3180 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverviewDetails" id="DisclosureNatureOfBusinessAndOverviewDetails">
        <link:definition>4010 - Disclosure - NATURE OF BUSINESS AND OVERVIEW (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>4020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2" id="DisclosureSummaryOfSignificantAccountingPoliciesDetails2">
        <link:definition>4021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3" id="DisclosureSummaryOfSignificantAccountingPoliciesDetails3">
        <link:definition>4022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4" id="DisclosureSummaryOfSignificantAccountingPoliciesDetails4">
        <link:definition>4023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails" id="DisclosureComprehensiveLossDetails">
        <link:definition>4030 - Disclosure - COMPREHENSIVE LOSS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" id="DisclosureFairValueMeasurementsDetails">
        <link:definition>4040 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" id="DisclosureMarketableSecuritiesDetails">
        <link:definition>4050 - Disclosure - MARKETABLE SECURITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetailsCalc2" id="DisclosureMarketableSecuritiesDetailsCalc2">
        <link:definition>4051 - Disclosure - MARKETABLE SECURITIES (Details) (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails" id="DisclosurePropertyAndEquipmentNetDetails">
        <link:definition>4060 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" id="DisclosureIntangibleAssetsAndGoodwillDetails">
        <link:definition>4070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetailsCalc2" id="DisclosureIntangibleAssetsAndGoodwillDetailsCalc2">
        <link:definition>4071 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details) (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesDetails" id="DisclosureAccruedExpensesDetails">
        <link:definition>4080 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" id="DisclosureOtherLongTermLiabilitiesDetails">
        <link:definition>4090 - Disclosure - OTHER LONG-TERM LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails2" id="DisclosureOtherLongTermLiabilitiesDetails2">
        <link:definition>4091 - Disclosure - OTHER LONG-TERM LIABILITIES (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetailsCalc2" id="DisclosureOtherLongTermLiabilitiesDetailsCalc2">
        <link:definition>4092 - Disclosure - OTHER LONG-TERM LIABILITIES (Details) (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureTermLoanDetails" id="DisclosureTermLoanDetails">
        <link:definition>4100 - Disclosure - TERM LOAN (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" id="DisclosureStockholdersEquityDetails">
        <link:definition>4110 - Disclosure - STOCKHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails" id="DisclosureStockBasedCompensationDetails">
        <link:definition>4120 - Disclosure - STOCK-BASED COMPENSATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails2" id="DisclosureStockBasedCompensationDetails2">
        <link:definition>4121 - Disclosure - STOCK-BASED COMPENSATION (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" id="DisclosureRevenueDetails">
        <link:definition>4130 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreementsDetails" id="DisclosureCollaborationAgreementsDetails">
        <link:definition>4140 - Disclosure - COLLABORATION AGREEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails" id="DisclosureIncomeTaxesDetails">
        <link:definition>4150 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails2" id="DisclosureIncomeTaxesDetails2">
        <link:definition>4151 - Disclosure - INCOME TAXES (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetailsCalc2" id="DisclosureIncomeTaxesDetailsCalc2">
        <link:definition>4152 - Disclosure - INCOME TAXES (Details) (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails" id="DisclosureCommitmentsAndContingenciesDetails">
        <link:definition>4160 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlanDetails" id="DisclosureRetirementSavingsPlanDetails">
        <link:definition>4170 - Disclosure - RETIREMENT SAVINGS PLAN (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataDetails" id="DisclosureSelectedQuarterlyFinancialDataDetails">
        <link:definition>4180 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureBusinessCombinations" id="DisclosureBusinessCombinations">
        <link:definition>8000 - Disclosure - BUSINESS COMBINATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantRevenueArrangements" id="DisclosureSignificantRevenueArrangements">
        <link:definition>8010 - Disclosure - SIGNIFICANT REVENUE ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRockefellerUniversityDetails" id="DisclosureRockefellerUniversityDetails">
        <link:definition>8020 - Disclosure - Rockefeller University (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRockefellerUniversity" id="DisclosureRockefellerUniversity">
        <link:definition>8030 - Disclosure - Rockefeller University</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails2" id="DisclosureCommitmentsAndContingenciesDetails2">
        <link:definition>8040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare" id="DisclosureNetLossPerShare">
        <link:definition>8050 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables" id="DisclosureNetLossPerShareTables">
        <link:definition>8060 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" id="DisclosureNetLossPerShareDetails">
        <link:definition>8070 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3" id="DisclosureOtherLongTermLiabilitiesDetails3">
        <link:definition>8080 - Disclosure - OTHER LONG-TERM LIABILITIES (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-roles-2013-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:element name="RindopepimutMember" id="cldx_RindopepimutMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PRFAgreementMember" id="cldx_PRFAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RotarixRotavirusVaccineMember" id="cldx_RotarixRotavirusVaccineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AmountReceivedForRightToParticipateInCollaborativeArrangement" id="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" id="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" id="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfInterestInNetRoyaltiesSold" id="cldx_PercentageOfInterestInNetRoyaltiesSold" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" id="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" id="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionAndIncentivePlan2008Member" id="cldx_StockOptionAndIncentivePlan2008Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" id="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" id="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" id="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" id="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LicenseAgreementsMember" id="cldx_LicenseAgreementsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MedarexIncMember" id="cldx_MedarexIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RockefellerUniversityMember" id="cldx_RockefellerUniversityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ProductDevelopmentAndLicensingAgreementMember" id="cldx_ProductDevelopmentAndLicensingAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DukeUniversityBrainTumorCancerCenterMember" id="cldx_DukeUniversityBrainTumorCancerCenterMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NatureOfBusinessAndOverviewLineItems" id="cldx_NatureOfBusinessAndOverviewLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PatentCostsPolicyTextBlock" id="cldx_PatentCostsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OtherIncomePolicyTextBlock" id="cldx_OtherIncomePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BasisOfPresentationAbstract" id="cldx_BasisOfPresentationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GlaxoSmithKlinePlcMember" id="cldx_GlaxoSmithKlinePlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PfizerIncMember" id="cldx_PfizerIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LaboratoryEquipmentMember" id="cldx_LaboratoryEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ManufacturingEquipmentMember" id="cldx_ManufacturingEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CuraGenCorporationMember" id="cldx_CuraGenCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" id="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AccruedRoyaltyAndLicenseFeesCurrent" id="cldx_AccruedRoyaltyAndLicenseFeesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AccruedResearchAndDevelopmentContractCostsCurrent" id="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DebtInstrumentAmortizationPeriod" id="cldx_DebtInstrumentAmortizationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="cldx_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RevenueFromProductDevelopmentAndLicensingAgreements" id="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="RevenueFromContractsAndGrants" id="cldx_RevenueFromContractsAndGrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="SignificantRevenueArrangementsDisclosureAbstract" id="cldx_SignificantRevenueArrangementsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SignificantRevenueArrangementsDisclosureTextBlock" id="cldx_SignificantRevenueArrangementsDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementDisclosureAbstract" id="cldx_CollaborativeArrangementDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WorkingCapital" id="cldx_WorkingCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" id="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AmgenAmendmentMember" id="cldx_AmgenAmendmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CoreTechnologyMember" id="cldx_CoreTechnologyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentLenderDomain" id="cldx_DebtInstrumentLenderDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MidCapFinancialLLCMember" id="cldx_MidCapFinancialLLCMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedByTypeOfProgramDomain" id="cldx_StockIssuedByTypeOfProgramDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ControlledEquityOfferingProgramMember" id="cldx_ControlledEquityOfferingProgramMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ControlledEquityOfferingProgramAmendedMember" id="cldx_ControlledEquityOfferingProgramAmendedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareholderRightsPlanMember" id="cldx_ShareholderRightsPlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GeneralElectricCapitalCorporationMember" id="cldx_GeneralElectricCapitalCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" id="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfOtherLongTermLiabilitiesTableTextBlock" id="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredIncomeFromSaleOfTaxBenefits" id="cldx_DeferredIncomeFromSaleOfTaxBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ValueOfTaxBenefitsAgreedToBeSold" id="cldx_ValueOfTaxBenefitsAgreedToBeSold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="PeriodForWhichBaseOfOperationsMustBeMaintained" id="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentLenderAxis" id="cldx_DebtInstrumentLenderAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedByTypeOfProgramAxis" id="cldx_StockIssuedByTypeOfProgramAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentInterestOnlyPeriodOfExtension" id="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" id="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" id="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentPaymentFeePayableOnRepayment" id="cldx_DebtInstrumentPaymentFeePayableOnRepayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" id="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" id="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NoticePeriodForTerminationOfAgreement" id="cldx_NoticePeriodForTerminationOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" id="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" id="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockholdersEquityTable" id="cldx_StockholdersEquityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockholdersEquityLineItems" id="cldx_StockholdersEquityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="USGovernmentAndMunicipalObligationsMember" id="cldx_USGovernmentAndMunicipalObligationsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" id="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="FixedRateOfCommissionOnSaleOfStock" id="cldx_FixedRateOfCommissionOnSaleOfStock" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" id="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfNatureOfBusinessAndOverviewTable" id="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" id="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShelfRegistrationStatementAmount" id="cldx_ShelfRegistrationStatementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" id="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" id="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" id="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" id="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" id="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LudwigInstituteForCancerResearchMember" id="cldx_LudwigInstituteForCancerResearchMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AlterisTherapeuticsIncMember" id="cldx_AlterisTherapeuticsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ThomasJeffersonUniversityMember" id="cldx_ThomasJeffersonUniversityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="UniversityOfSouthamptonUKMember" id="cldx_UniversityOfSouthamptonUKMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AmgenIncMember" id="cldx_AmgenIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SeattleGeneticIncMember" id="cldx_SeattleGeneticIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NonRefundableLicenseFee" id="cldx_NonRefundableLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" id="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementTotalPotentialMilestonePayments" id="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeArrangementAgreementTerm" id="cldx_CollaborativeArrangementAgreementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementNumberOfAgreements" id="cldx_CollaborativeArrangementNumberOfAgreements" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" id="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" id="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" id="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DeferredTaxAssetsLiabilitiesGross" id="cldx_DeferredTaxAssetsLiabilitiesGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" id="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeArrangementMilestonePaymentsReceived" id="cldx_CollaborativeArrangementMilestonePaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="AVANTMember" id="cldx_AVANTMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLossAndTaxCreditCarryforwardsLineItems" id="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLossCarryforwardsAnnualLimitationAmount" id="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="OperatingLossCarryforwardsExpired" id="cldx_OperatingLossCarryforwardsExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="OperatingLossCarryforwardsNetOfExpirationsAndUtilization" id="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="OperatingLossCarryforwardsWithLimitationsOnUse" id="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" id="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="OwnershipChangeAxis" id="cldx_OwnershipChangeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OwnershipChangeDomain" id="cldx_OwnershipChangeDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OwnershipChangeInOctober2007Member" id="cldx_OwnershipChangeInOctober2007Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OwnershipChangesInJune2009AndDecember2009Member" id="cldx_OwnershipChangesInJune2009AndDecember2009Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" id="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PriorToAcquisitionMember" id="cldx_PriorToAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PriorToMergerMember" id="cldx_PriorToMergerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StatusOfMergerAndAcquisitionAxis" id="cldx_StatusOfMergerAndAcquisitionAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StatusOfMergerAndAcquisitionDomain" id="cldx_StatusOfMergerAndAcquisitionDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" id="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="OperatingLossAndTaxCreditCarryforwardsTable" id="cldx_OperatingLossAndTaxCreditCarryforwardsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" id="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RoyaltyAgreementMember" id="cldx_RoyaltyAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CincinnatiChildrensHospitalMedicalCenterMember" id="cldx_CincinnatiChildrensHospitalMedicalCenterMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DukeUniversityAndThomasJeffersonUniversityMember" id="cldx_DukeUniversityAndThomasJeffersonUniversityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommonStockSharesAvailableForSale" id="cldx_CommonStockSharesAvailableForSale" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" id="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" id="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ValueAtWhichTaxBenefitsSold" id="cldx_ValueAtWhichTaxBenefitsSold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="FairValueAssetsAmountTransfersBetweenMeasurementLevels" id="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" id="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" id="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" id="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccumulatedOtherComprehensiveIncomeLossRollForward" id="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLeasesTermOfLease" id="cldx_OperatingLeasesTermOfLease" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLeasesPeriodOfRenewalOptions" id="cldx_OperatingLeasesPeriodOfRenewalOptions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLeasesCommencementPeriodOfRentalObligations" id="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLeasesNumberOfRenewalOptions" id="cldx_OperatingLeasesNumberOfRenewalOptions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="RepaymentOfLongTermDebtPrincipalAmount" id="cldx_RepaymentOfLongTermDebtPrincipalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentInterestAndPrepaymentFees" id="cldx_DebtInstrumentInterestAndPrepaymentFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" id="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" id="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" id="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementNumberOfAntiHIVAntibodies" id="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementEstimatedCostForDevelopmentServices" id="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementUpfrontPaymentAmount" id="cldx_CollaborativeArrangementUpfrontPaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" id="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" id="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" id="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" abstract="false" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" type="xbrli:monetaryItemType" />
  <xsd:element name="ExpectedDividendPayableInForeseeableFuture" id="cldx_ExpectedDividendPayableInForeseeableFuture" abstract="false" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" type="xbrli:monetaryItemType" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>cldx-20131231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--Generated by IRIS XBRL Generation Engine-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetailsCalc2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxesDetailsCalc2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity" xlink:type="simple" xlink:href="cldx-20131231.xsd#StatementOfStockholdersEquity" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureAccruedExpensesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails3" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureComprehensiveLossDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/CashFlows" xlink:type="simple" xlink:href="cldx-20131231.xsd#CashFlows" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/StatementOfIncome" xlink:type="simple" xlink:href="cldx-20131231.xsd#StatementOfIncome" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/StatementOfIncomeCalc2" xlink:type="simple" xlink:href="cldx-20131231.xsd#StatementOfIncomeCalc2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/BalanceSheet" xlink:type="simple" xlink:href="cldx-20131231.xsd#BalanceSheet" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetailsCalc2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureMarketableSecuritiesDetailsCalc2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetailsCalc2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIntangibleAssetsAndGoodwillDetailsCalc2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIntangibleAssetsAndGoodwillDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureMarketableSecuritiesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureFairValueMeasurementsDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCommitmentsAndContingenciesDetails" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:label="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:title="IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="calculation: cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="calculation: cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="calculation: cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:label="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="calculation: cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" order="4" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsLiabilitiesGross" xlink:label="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:title="DeferredTaxAssetsLiabilitiesGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:title="calculation: us-gaap_DeferredTaxLiabilities to cldx_DeferredTaxAssetsLiabilitiesGross" order="1" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:to="us-gaap_DeferredTaxAssetsGross" xlink:title="calculation: cldx_DeferredTaxAssetsLiabilitiesGross to us-gaap_DeferredTaxAssetsGross" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="calculation: us-gaap_DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:label="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:title="DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:title="calculation: us-gaap_DeferredIncomeTaxLiabilities to cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:title="IncomeTaxReconciliationTaxCreditsResearch" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="2" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:title="DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:title="calculation: us-gaap_DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="2" weight="1" use="optional" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" xlink:title="calculation: cldx_DeferredTaxAssetsLiabilitiesGross to us-gaap_DeferredIncomeTaxLiabilities" order="2" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:label="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:title="calculation: us-gaap_DeferredIncomeTaxLiabilities to cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="calculation: us-gaap_DeferredTaxLiabilities to us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:title="DeferredTaxAssetsTaxDeferredExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:title="calculation: us-gaap_DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:title="IncomeTaxReconciliationOtherAdjustments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to us-gaap_IncomeTaxReconciliationOtherAdjustments" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="calculation: us-gaap_DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:label="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" order="5" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:title="DeferredTaxAssetsPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:title="calculation: us-gaap_DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="5" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="calculation: us-gaap_IncomeTaxExpenseBenefit to us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="calculation: us-gaap_DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="6" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="StockholdersEquityPeriodIncreaseDecrease" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="calculation: us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="StockIssuedDuringPeriodValueOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodValueOther" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="calculation: us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodSharesOther" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="calculation: us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="5" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="6" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="calculation: us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="7" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="calculation: us-gaap_PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: us-gaap_PropertyPlantAndEquipmentNet to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:label="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:title="AccruedRoyaltyAndLicenseFeesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:title="calculation: us-gaap_AccruedLiabilitiesCurrent to cldx_AccruedRoyaltyAndLicenseFeesCurrent" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: us-gaap_AccruedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:label="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:title="AccruedResearchAndDevelopmentContractCostsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:title="calculation: us-gaap_AccruedLiabilitiesCurrent to cldx_AccruedResearchAndDevelopmentContractCostsCurrent" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" xlink:title="calculation: us-gaap_AccruedLiabilitiesCurrent to us-gaap_AccruedProfessionalFeesCurrent" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="calculation: us-gaap_AccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent" order="5" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" xlink:title="LoansPayable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="calculation: us-gaap_LoansPayable to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="calculation: us-gaap_LoansPayable to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="calculation: us-gaap_LoansPayable to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="calculation: us-gaap_LoansPayable to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="calculation: us-gaap_LoansPayable to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="5" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="calculation: us-gaap_LoansPayable to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" order="6" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="calculation: us-gaap_OtherComprehensiveIncomeLossNetOfTax to us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:title="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:title="calculation: us-gaap_OtherComprehensiveIncomeLossNetOfTax to us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" order="2" weight="-1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/CashFlows">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:title="NetCashProvidedByUsedInContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInContinuingOperations to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1" use="optional" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInContinuingOperations to us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap_PaymentsToAcquireMarketableSecurities" order="2" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:title="ProceedsFromStockPlans" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromStockPlans" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromStockPlans" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_AmortizationOfIntangibleAssets" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" weight="-1" use="optional" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInContinuingOperations to us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:title="ProceedsFromIssuanceOfLongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="4" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap_ProceedsFromSaleOfProductiveAssets" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:title="RepaymentsOfConvertibleDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_RepaymentsOfConvertibleDebt" order="4" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:title="EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInContinuingOperations to us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" xlink:title="MarketableSecuritiesGainLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_MarketableSecuritiesGainLoss" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_MarketableSecuritiesGainLoss" order="5" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:title="RepaymentsOfOtherLongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_RepaymentsOfOtherLongTermDebt" order="5" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:title="GainLossOnSaleOfPropertyPlantEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="6" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ShareBasedCompensation" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_ShareBasedCompensation" order="7" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="AmortizationOfDebtDiscountPremium" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_AmortizationOfDebtDiscountPremium" order="8" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="IncreaseDecreaseInAccountsAndOtherReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="9" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="11" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="12" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="13" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/StatementOfIncome">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="calculation: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="Revenues" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" xlink:title="calculation: us-gaap_OperatingIncomeLoss to us-gaap_Revenues" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:title="RevenueFromProductDevelopmentAndLicensingAgreements" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:title="calculation: us-gaap_Revenues to cldx_RevenueFromProductDevelopmentAndLicensingAgreements" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="calculation: us-gaap_CostsAndExpenses to us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants" xlink:title="RevenueFromContractsAndGrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="cldx_RevenueFromContractsAndGrants" xlink:title="calculation: us-gaap_Revenues to cldx_RevenueFromContractsAndGrants" order="2" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" xlink:title="calculation: us-gaap_OperatingIncomeLoss to us-gaap_CostsAndExpenses" order="2" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" xlink:title="RoyaltyExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_RoyaltyExpense" xlink:title="calculation: us-gaap_CostsAndExpenses to us-gaap_RoyaltyExpense" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_InterestAndOtherIncome" xlink:title="calculation: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_InterestAndOtherIncome" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:title="RoyaltyRevenue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RoyaltyRevenue" xlink:title="calculation: us-gaap_Revenues to us-gaap_RoyaltyRevenue" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:title="calculation: us-gaap_CostsAndExpenses to us-gaap_GeneralAndAdministrativeExpense" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xlink:title="InterestExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_InterestExpense" xlink:title="calculation: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_InterestExpense" order="3" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:title="calculation: us-gaap_CostsAndExpenses to us-gaap_AmortizationOfIntangibleAssets" order="4" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/StatementOfIncomeCalc2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="calculation: us-gaap_ComprehensiveIncomeNetOfTax to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="calculation: us-gaap_ComprehensiveIncomeNetOfTax to us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="calculation: us-gaap_ComprehensiveIncomeNetOfTax to us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="3" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" xlink:title="OtherLiabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_OtherLiabilitiesCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_OtherLiabilitiesNoncurrent" order="2" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" xlink:title="OtherLiabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit" xlink:title="DeferredRentCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DeferredRentCredit" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_DeferredRentCredit" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_DeferredTaxLiabilities" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:title="DeferredIncomeFromSaleOfTaxBenefits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:title="calculation: us-gaap_OtherLiabilities to cldx_DeferredIncomeFromSaleOfTaxBenefits" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:title="DeferredRevenue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DeferredRevenue" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_DeferredRevenue" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" xlink:title="LoansPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_LoansPayable" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_LoansPayable" order="5" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherSundryLiabilities" xlink:label="us-gaap_OtherSundryLiabilities" xlink:title="OtherSundryLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherSundryLiabilities" xlink:title="calculation: us-gaap_OtherLiabilities to us-gaap_OtherSundryLiabilities" order="6" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/BalanceSheet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" xlink:title="calculation: us-gaap_Assets to us-gaap_AssetsCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: us-gaap_AssetsCurrent to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:title="Liabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" xlink:title="calculation: us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_Liabilities" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="calculation: us-gaap_Liabilities to us-gaap_LiabilitiesCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" xlink:title="calculation: us-gaap_LiabilitiesCurrent to us-gaap_AccountsPayableCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" xlink:title="calculation: us-gaap_StockholdersEquity to us-gaap_PreferredStockValue" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="calculation: us-gaap_AssetsCurrent to us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="calculation: us-gaap_Assets to us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="calculation: us-gaap_LiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredLongTermDebt" xlink:label="us-gaap_SecuredLongTermDebt" xlink:title="SecuredLongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_SecuredLongTermDebt" xlink:title="calculation: us-gaap_Liabilities to us-gaap_SecuredLongTermDebt" order="2" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:title="calculation: us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_StockholdersEquity" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" xlink:title="calculation: us-gaap_StockholdersEquity to us-gaap_CommonStockValue" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:title="calculation: us-gaap_AssetsCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="calculation: us-gaap_Assets to us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:title="calculation: us-gaap_LiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="calculation: us-gaap_Liabilities to us-gaap_OtherLiabilitiesNoncurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="AdditionalPaidInCapitalCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="calculation: us-gaap_StockholdersEquity to us-gaap_AdditionalPaidInCapitalCommonStock" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: us-gaap_AssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" xlink:title="calculation: us-gaap_Assets to us-gaap_OtherAssetsNoncurrent" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="us-gaap_SecuredDebtCurrent" xlink:title="SecuredDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_SecuredDebtCurrent" xlink:title="calculation: us-gaap_LiabilitiesCurrent to us-gaap_SecuredDebtCurrent" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="calculation: us-gaap_StockholdersEquity to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" xlink:title="calculation: us-gaap_Assets to us-gaap_Goodwill" order="5" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="calculation: us-gaap_StockholdersEquity to us-gaap_RetainedEarningsAccumulatedDeficit" order="5" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="calculation: cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent to cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="calculation: cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent to cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" order="3" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" order="3" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="calculation: cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" order="3" weight="-1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="calculation: us-gaap_IntangibleAssetsNetExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="IntangibleAssetsGrossExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="calculation: us-gaap_IntangibleAssetsGrossExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="calculation: us-gaap_IntangibleAssetsNetExcludingGoodwill to us-gaap_FiniteLivedIntangibleAssetsNet" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="calculation: us-gaap_IntangibleAssetsGrossExcludingGoodwill to us-gaap_FiniteLivedIntangibleAssetsGross" order="2" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="calculation: us-gaap_FiniteLivedIntangibleAssetsNet to us-gaap_FiniteLivedIntangibleAssetsGross" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="IntangibleAssetsGrossExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="calculation: us-gaap_IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="calculation: us-gaap_FiniteLivedIntangibleAssetsNet to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" weight="-1" use="optional" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="calculation: us-gaap_IntangibleAssetsNetExcludingGoodwill to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" weight="-1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="calculation: cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments to cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="calculation: cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments to cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="calculation: cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="calculation: cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="calculation: us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" order="2" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="CashAndCashEquivalentsFairValueDisclosure" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="calculation: us-gaap_AssetsFairValueDisclosure to us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:title="AvailableForSaleSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AvailableForSaleSecurities" xlink:title="calculation: us-gaap_AssetsFairValueDisclosure to us-gaap_AvailableForSaleSecurities" order="2" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="OperatingLeasesFutureMinimumPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="calculation: us-gaap_OperatingLeasesFutureMinimumPaymentsDue to us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="1" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="calculation: us-gaap_OperatingLeasesFutureMinimumPaymentsDue to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="calculation: us-gaap_OperatingLeasesFutureMinimumPaymentsDue to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="3" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="calculation: us-gaap_OperatingLeasesFutureMinimumPaymentsDue to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="calculation: us-gaap_OperatingLeasesFutureMinimumPaymentsDue to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="5" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="calculation: us-gaap_OperatingLeasesFutureMinimumPaymentsDue to us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="6" weight="1" use="optional" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cldx-20131231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--Generated by IRIS XBRL Generation Engine-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RindopepimutMember" xlink:label="cldx_RindopepimutMember" xlink:title="RindopepimutMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RindopepimutMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RindopepimutMember" xml:lang="en-US" id="label_cldx_RindopepimutMember">Rindopepimut [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RindopepimutMember" xlink:to="label_cldx_RindopepimutMember" xlink:title="label: RindopepimutMember to label_cldx_RindopepimutMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RindopepimutMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RindopepimutMember" xml:lang="en-US" id="label_cldx_RindopepimutMember_1">Rindopepimut</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RindopepimutMember" xlink:to="label_cldx_RindopepimutMember_1" xlink:title="label: RindopepimutMember to label_cldx_RindopepimutMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RindopepimutMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RindopepimutMember" xml:lang="en-US" id="label_cldx_RindopepimutMember_2">Represents the information related to Rindopepimut.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RindopepimutMember" xlink:to="label_cldx_RindopepimutMember_2" xlink:title="label: RindopepimutMember to label_cldx_RindopepimutMember" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PRFAgreementMember" xlink:label="cldx_PRFAgreementMember" xlink:title="PRFAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PRFAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PRFAgreementMember" xml:lang="en-US" id="label_cldx_PRFAgreementMember">PRF Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PRFAgreementMember" xlink:to="label_cldx_PRFAgreementMember" xlink:title="label: PRFAgreementMember to label_cldx_PRFAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PRFAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PRFAgreementMember" xml:lang="en-US" id="label_cldx_PRFAgreementMember_1">PRF</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PRFAgreementMember" xlink:to="label_cldx_PRFAgreementMember_1" xlink:title="label: PRFAgreementMember to label_cldx_PRFAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PRFAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PRFAgreementMember" xml:lang="en-US" id="label_cldx_PRFAgreementMember_2">Details pertaining to the agreement with Paul Royalty Fund II, L.P. (PRF).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PRFAgreementMember" xlink:to="label_cldx_PRFAgreementMember_2" xlink:title="label: PRFAgreementMember to label_cldx_PRFAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RotarixRotavirusVaccineMember" xlink:label="cldx_RotarixRotavirusVaccineMember" xlink:title="RotarixRotavirusVaccineMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RotarixRotavirusVaccineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RotarixRotavirusVaccineMember" xml:lang="en-US" id="label_cldx_RotarixRotavirusVaccineMember">Rotarix Rotavirus Vaccine [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RotarixRotavirusVaccineMember" xlink:to="label_cldx_RotarixRotavirusVaccineMember" xlink:title="label: RotarixRotavirusVaccineMember to label_cldx_RotarixRotavirusVaccineMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RotarixRotavirusVaccineMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RotarixRotavirusVaccineMember" xml:lang="en-US" id="label_cldx_RotarixRotavirusVaccineMember_1">Rotarix</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RotarixRotavirusVaccineMember" xlink:to="label_cldx_RotarixRotavirusVaccineMember_1" xlink:title="label: RotarixRotavirusVaccineMember to label_cldx_RotarixRotavirusVaccineMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RotarixRotavirusVaccineMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RotarixRotavirusVaccineMember" xml:lang="en-US" id="label_cldx_RotarixRotavirusVaccineMember_2">Represents the information related to the product Rotarix rotavirus vaccine.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RotarixRotavirusVaccineMember" xlink:to="label_cldx_RotarixRotavirusVaccineMember_2" xlink:title="label: RotarixRotavirusVaccineMember to label_cldx_RotarixRotavirusVaccineMember" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:label="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:title="AmountReceivedForRightToParticipateInCollaborativeArrangement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xml:lang="en-US" id="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement">Amount Received for Right to Participate in Collaborative Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:to="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:title="label: AmountReceivedForRightToParticipateInCollaborativeArrangement to label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xml:lang="en-US" id="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement_1">Upfront fee received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:to="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement_1" xlink:title="label: AmountReceivedForRightToParticipateInCollaborativeArrangement to label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xml:lang="en-US" id="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement_2">Represents the amount received by the entity for the right to participate in a collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:to="label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement_2" xlink:title="label: AmountReceivedForRightToParticipateInCollaborativeArrangement to label_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:label="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:title="StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xml:lang="en-US" id="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement">Stock Issued During Period Value Issued for Collaborative Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:to="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:title="label: StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement to label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xml:lang="en-US" id="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement_1">Equity investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:to="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement_1" xlink:title="label: StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement to label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xml:lang="en-US" id="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement_2">Represents the value of stock sold as an equity investment to obtain the right to participate in a collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:to="label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement_2" xlink:title="label: StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement to label_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:label="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:title="PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xml:lang="en-US" id="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived">Percentage of License Fee Due on Net Royalties Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:to="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:title="label: PercentageOfLicenseFeeDueOnNetRoyaltiesReceived to label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xml:lang="en-US" id="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived_1">Percentage of license fee payable on net royalties received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:to="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived_1" xlink:title="label: PercentageOfLicenseFeeDueOnNetRoyaltiesReceived to label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xml:lang="en-US" id="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived_2">Percentage of license fee payable to third party on net royalties received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:to="label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived_2" xlink:title="label: PercentageOfLicenseFeeDueOnNetRoyaltiesReceived to label_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:label="cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:title="PercentageOfInterestInNetRoyaltiesSold" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PercentageOfInterestInNetRoyaltiesSold" xml:lang="en-US" id="label_cldx_PercentageOfInterestInNetRoyaltiesSold">Percentage of Interest in Net Royalties Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:to="label_cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:title="label: PercentageOfInterestInNetRoyaltiesSold to label_cldx_PercentageOfInterestInNetRoyaltiesSold" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PercentageOfInterestInNetRoyaltiesSold_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PercentageOfInterestInNetRoyaltiesSold" xml:lang="en-US" id="label_cldx_PercentageOfInterestInNetRoyaltiesSold_1">Percentage of interest in net royalties sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:to="label_cldx_PercentageOfInterestInNetRoyaltiesSold_1" xlink:title="label: PercentageOfInterestInNetRoyaltiesSold to label_cldx_PercentageOfInterestInNetRoyaltiesSold" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PercentageOfInterestInNetRoyaltiesSold_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PercentageOfInterestInNetRoyaltiesSold" xml:lang="en-US" id="label_cldx_PercentageOfInterestInNetRoyaltiesSold_2">Represents the percentage of interest in net royalties sold.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:to="label_cldx_PercentageOfInterestInNetRoyaltiesSold_2" xlink:title="label: PercentageOfInterestInNetRoyaltiesSold to label_cldx_PercentageOfInterestInNetRoyaltiesSold" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:label="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:title="PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xml:lang="en-US" id="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances">Period for Right to Negotiate for Extension of Agreement Term under Certain Circumstances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:to="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:title="label: PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances to label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xml:lang="en-US" id="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances_1">Period for right to negotiate to extend the agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:to="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances_1" xlink:title="label: PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances to label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xml:lang="en-US" id="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances_2">Represents the period for right to negotiate for extension of the agreement term under certain circumstances.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:to="label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances_2" xlink:title="label: PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances to label_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:label="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:title="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xml:lang="en-US" id="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany">Number of Multiples Class of Warrant or Right Condition on Exercise of Rights of Exercise Price Holder Can Receive in Common Stock Value of Acquiring Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:to="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:title="label: NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany to label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xml:lang="en-US" id="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany_1">Number of multiples of the exercise price that the Right holder has a right to receive in value of the acquiring company's common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:to="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany_1" xlink:title="label: NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany to label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xml:lang="en-US" id="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany_2">Represents the number of multiples of the exercise price that the right holder has the right to receive in value of the acquiring entity's common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:to="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany_2" xlink:title="label: NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany to label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockOptionAndIncentivePlan2008Member" xlink:label="cldx_StockOptionAndIncentivePlan2008Member" xlink:title="StockOptionAndIncentivePlan2008Member" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockOptionAndIncentivePlan2008Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StockOptionAndIncentivePlan2008Member" xml:lang="en-US" id="label_cldx_StockOptionAndIncentivePlan2008Member">Stock Option and Incentive Plan 2008 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockOptionAndIncentivePlan2008Member" xlink:to="label_cldx_StockOptionAndIncentivePlan2008Member" xlink:title="label: StockOptionAndIncentivePlan2008Member to label_cldx_StockOptionAndIncentivePlan2008Member" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockOptionAndIncentivePlan2008Member_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_StockOptionAndIncentivePlan2008Member" xml:lang="en-US" id="label_cldx_StockOptionAndIncentivePlan2008Member_1">2008 Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockOptionAndIncentivePlan2008Member" xlink:to="label_cldx_StockOptionAndIncentivePlan2008Member_1" xlink:title="label: StockOptionAndIncentivePlan2008Member to label_cldx_StockOptionAndIncentivePlan2008Member" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockOptionAndIncentivePlan2008Member_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StockOptionAndIncentivePlan2008Member" xml:lang="en-US" id="label_cldx_StockOptionAndIncentivePlan2008Member_2">Represents information pertaining to the 2008 Stock Option and Incentive Plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockOptionAndIncentivePlan2008Member" xlink:to="label_cldx_StockOptionAndIncentivePlan2008Member_2" xlink:title="label: StockOptionAndIncentivePlan2008Member to label_cldx_StockOptionAndIncentivePlan2008Member" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" xlink:title="AmendmentDescription" />
    <link:label xlink:type="resource" xlink:label="label_dei_AmendmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_AmendmentDescription" xml:lang="en-US" id="label_dei_AmendmentDescription">Amendment Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="label_dei_AmendmentDescription" xlink:title="label: AmendmentDescription to label_dei_AmendmentDescription" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm">Terms of options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm_1">The period of time, from the grant date until the time at which the share-based option award expires.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm_2">Share Based Compensation, Arrangements by Share Based Payment, Award, Options, Expiration Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm_2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="label_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_AmendmentFlag" xml:lang="en-US" id="label_dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag" xlink:title="label: AmendmentFlag to label_dei_AmendmentFlag" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock">Share Based Compensation Arrangements by Share Based Payment Award, Options, Expiration Term for Holders of More than Ten Percent of Voting Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock_1">Terms of options granted to the holders of more than 10% of the voting stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock_2">Represents the term of options granted to the holders of more than 10 percent of voting stock of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock_2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock">Threshold percentage of voting stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock_1">Represents the threshold percentage of voting stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock_2">Share Based Compensation, Arrangements by Share Based Payment, Award, Options, Threshold Percentage of Voting Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock_2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock">Share Based Compensation Arrangements by Share Based Payment Award, Options, Exercise Price as Percentage of Fair Market Value for Holders of More than Ten Percent of Voting Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock_1">Exercise price as a percentage of fair market value for options granted to the holders of more than 10% of the voting stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock_2">Represents the exercise price as a percentage of the fair market for options granted to the holders of than 10 percent of voting stock of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:to="label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock_2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock to label_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LicenseAgreementsMember" xlink:label="cldx_LicenseAgreementsMember" xlink:title="LicenseAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_LicenseAgreementsMember" xml:lang="en-US" id="label_cldx_LicenseAgreementsMember">License Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LicenseAgreementsMember" xlink:to="label_cldx_LicenseAgreementsMember" xlink:title="label: LicenseAgreementsMember to label_cldx_LicenseAgreementsMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LicenseAgreementsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_LicenseAgreementsMember" xml:lang="en-US" id="label_cldx_LicenseAgreementsMember_1">License agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LicenseAgreementsMember" xlink:to="label_cldx_LicenseAgreementsMember_1" xlink:title="label: LicenseAgreementsMember to label_cldx_LicenseAgreementsMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LicenseAgreementsMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_LicenseAgreementsMember" xml:lang="en-US" id="label_cldx_LicenseAgreementsMember_2">Details pertaining to the license agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LicenseAgreementsMember" xlink:to="label_cldx_LicenseAgreementsMember_2" xlink:title="label: LicenseAgreementsMember to label_cldx_LicenseAgreementsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_MedarexIncMember" xlink:label="cldx_MedarexIncMember" xlink:title="MedarexIncMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_MedarexIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_MedarexIncMember" xml:lang="en-US" id="label_cldx_MedarexIncMember">Medarex Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_MedarexIncMember" xlink:to="label_cldx_MedarexIncMember" xlink:title="label: MedarexIncMember to label_cldx_MedarexIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_MedarexIncMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_MedarexIncMember" xml:lang="en-US" id="label_cldx_MedarexIncMember_1">Medarex</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_MedarexIncMember" xlink:to="label_cldx_MedarexIncMember_1" xlink:title="label: MedarexIncMember to label_cldx_MedarexIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_MedarexIncMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_MedarexIncMember" xml:lang="en-US" id="label_cldx_MedarexIncMember_2">Represents information related to Medarex, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_MedarexIncMember" xlink:to="label_cldx_MedarexIncMember_2" xlink:title="label: MedarexIncMember to label_cldx_MedarexIncMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RockefellerUniversityMember" xlink:label="cldx_RockefellerUniversityMember" xlink:title="RockefellerUniversityMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RockefellerUniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RockefellerUniversityMember" xml:lang="en-US" id="label_cldx_RockefellerUniversityMember">Rockefeller University [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RockefellerUniversityMember" xlink:to="label_cldx_RockefellerUniversityMember" xlink:title="label: RockefellerUniversityMember to label_cldx_RockefellerUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RockefellerUniversityMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RockefellerUniversityMember" xml:lang="en-US" id="label_cldx_RockefellerUniversityMember_1">Rockefeller</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RockefellerUniversityMember" xlink:to="label_cldx_RockefellerUniversityMember_1" xlink:title="label: RockefellerUniversityMember to label_cldx_RockefellerUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RockefellerUniversityMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RockefellerUniversityMember" xml:lang="en-US" id="label_cldx_RockefellerUniversityMember_2">Represents information related to Rockefeller University.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RockefellerUniversityMember" xlink:to="label_cldx_RockefellerUniversityMember_2" xlink:title="label: RockefellerUniversityMember to label_cldx_RockefellerUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RockefellerUniversityMember_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_cldx_RockefellerUniversityMember" xml:lang="en-US" id="label_cldx_RockefellerUniversityMember_3">Rockefeller University</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RockefellerUniversityMember" xlink:to="label_cldx_RockefellerUniversityMember_3" xlink:title="label: RockefellerUniversityMember to label_cldx_RockefellerUniversityMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:label="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="ProductDevelopmentAndLicensingAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ProductDevelopmentAndLicensingAgreementMember" xml:lang="en-US" id="label_cldx_ProductDevelopmentAndLicensingAgreementMember">Product Development and Licensing Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:to="label_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="label: ProductDevelopmentAndLicensingAgreementMember to label_cldx_ProductDevelopmentAndLicensingAgreementMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ProductDevelopmentAndLicensingAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ProductDevelopmentAndLicensingAgreementMember" xml:lang="en-US" id="label_cldx_ProductDevelopmentAndLicensingAgreementMember_1">Arrangement under which the entity provides product development services, which may include manufacturing, in return for compensation and/or royalties as agreed between the parties.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:to="label_cldx_ProductDevelopmentAndLicensingAgreementMember_1" xlink:title="label: ProductDevelopmentAndLicensingAgreementMember to label_cldx_ProductDevelopmentAndLicensingAgreementMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ProductDevelopmentAndLicensingAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ProductDevelopmentAndLicensingAgreementMember" xml:lang="en-US" id="label_cldx_ProductDevelopmentAndLicensingAgreementMember_2">Rockefeller Development Services Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:to="label_cldx_ProductDevelopmentAndLicensingAgreementMember_2" xlink:title="label: ProductDevelopmentAndLicensingAgreementMember to label_cldx_ProductDevelopmentAndLicensingAgreementMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:label="cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:title="DukeUniversityBrainTumorCancerCenterMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DukeUniversityBrainTumorCancerCenterMember" xml:lang="en-US" id="label_cldx_DukeUniversityBrainTumorCancerCenterMember">Duke University Brain Tumor Cancer Center [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:to="label_cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:title="label: DukeUniversityBrainTumorCancerCenterMember to label_cldx_DukeUniversityBrainTumorCancerCenterMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DukeUniversityBrainTumorCancerCenterMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DukeUniversityBrainTumorCancerCenterMember" xml:lang="en-US" id="label_cldx_DukeUniversityBrainTumorCancerCenterMember_1">Duke</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:to="label_cldx_DukeUniversityBrainTumorCancerCenterMember_1" xlink:title="label: DukeUniversityBrainTumorCancerCenterMember to label_cldx_DukeUniversityBrainTumorCancerCenterMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DukeUniversityBrainTumorCancerCenterMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DukeUniversityBrainTumorCancerCenterMember" xml:lang="en-US" id="label_cldx_DukeUniversityBrainTumorCancerCenterMember_2">Represents information related to Duke University Brain Tumor Cancer Center.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:to="label_cldx_DukeUniversityBrainTumorCancerCenterMember_2" xlink:title="label: DukeUniversityBrainTumorCancerCenterMember to label_cldx_DukeUniversityBrainTumorCancerCenterMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NatureOfBusinessAndOverviewLineItems" xlink:label="cldx_NatureOfBusinessAndOverviewLineItems" xlink:title="NatureOfBusinessAndOverviewLineItems" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NatureOfBusinessAndOverviewLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_NatureOfBusinessAndOverviewLineItems" xml:lang="en-US" id="label_cldx_NatureOfBusinessAndOverviewLineItems">Nature of Business and Overview [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="label_cldx_NatureOfBusinessAndOverviewLineItems" xlink:title="label: NatureOfBusinessAndOverviewLineItems to label_cldx_NatureOfBusinessAndOverviewLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NatureOfBusinessAndOverviewLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_NatureOfBusinessAndOverviewLineItems" xml:lang="en-US" id="label_cldx_NatureOfBusinessAndOverviewLineItems_1">NATURE OF BUSINESS AND OVERVIEW</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="label_cldx_NatureOfBusinessAndOverviewLineItems_1" xlink:title="label: NatureOfBusinessAndOverviewLineItems to label_cldx_NatureOfBusinessAndOverviewLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PatentCostsPolicyTextBlock" xlink:label="cldx_PatentCostsPolicyTextBlock" xlink:title="PatentCostsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PatentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PatentCostsPolicyTextBlock" xml:lang="en-US" id="label_cldx_PatentCostsPolicyTextBlock">Patent Costs Policy [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PatentCostsPolicyTextBlock" xlink:to="label_cldx_PatentCostsPolicyTextBlock" xlink:title="label: PatentCostsPolicyTextBlock to label_cldx_PatentCostsPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PatentCostsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PatentCostsPolicyTextBlock" xml:lang="en-US" id="label_cldx_PatentCostsPolicyTextBlock_1">Patent Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PatentCostsPolicyTextBlock" xlink:to="label_cldx_PatentCostsPolicyTextBlock_1" xlink:title="label: PatentCostsPolicyTextBlock to label_cldx_PatentCostsPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PatentCostsPolicyTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PatentCostsPolicyTextBlock" xml:lang="en-US" id="label_cldx_PatentCostsPolicyTextBlock_2">Disclosure of accounting policy for patent costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PatentCostsPolicyTextBlock" xlink:to="label_cldx_PatentCostsPolicyTextBlock_2" xlink:title="label: PatentCostsPolicyTextBlock to label_cldx_PatentCostsPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AreaOfRealEstateProperty" xml:lang="en-US" id="label_us-gaap_AreaOfRealEstateProperty">Area of office space (in square feet)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="label_us-gaap_AreaOfRealEstateProperty" xlink:title="label: AreaOfRealEstateProperty to label_us-gaap_AreaOfRealEstateProperty" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AreaOfRealEstateProperty_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AreaOfRealEstateProperty" xml:lang="en-US" id="label_us-gaap_AreaOfRealEstateProperty_1">Area of Real Estate Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="label_us-gaap_AreaOfRealEstateProperty_1" xlink:title="label: AreaOfRealEstateProperty to label_us-gaap_AreaOfRealEstateProperty" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OtherIncomePolicyTextBlock" xlink:label="cldx_OtherIncomePolicyTextBlock" xlink:title="OtherIncomePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OtherIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OtherIncomePolicyTextBlock" xml:lang="en-US" id="label_cldx_OtherIncomePolicyTextBlock">Other Income [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OtherIncomePolicyTextBlock" xlink:to="label_cldx_OtherIncomePolicyTextBlock" xlink:title="label: OtherIncomePolicyTextBlock to label_cldx_OtherIncomePolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OtherIncomePolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OtherIncomePolicyTextBlock" xml:lang="en-US" id="label_cldx_OtherIncomePolicyTextBlock_1">Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OtherIncomePolicyTextBlock" xlink:to="label_cldx_OtherIncomePolicyTextBlock_1" xlink:title="label: OtherIncomePolicyTextBlock to label_cldx_OtherIncomePolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OtherIncomePolicyTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OtherIncomePolicyTextBlock" xml:lang="en-US" id="label_cldx_OtherIncomePolicyTextBlock_2">Disclosure of accounting policy for recognition of income due to transactions that are not part of on-going operations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OtherIncomePolicyTextBlock" xlink:to="label_cldx_OtherIncomePolicyTextBlock_2" xlink:title="label: OtherIncomePolicyTextBlock to label_cldx_OtherIncomePolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_BasisOfPresentationAbstract" xlink:label="cldx_BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_cldx_BasisOfPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_BasisOfPresentationAbstract" xml:lang="en-US" id="label_cldx_BasisOfPresentationAbstract">Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BasisOfPresentationAbstract" xlink:to="label_cldx_BasisOfPresentationAbstract" xlink:title="label: BasisOfPresentationAbstract to label_cldx_BasisOfPresentationAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_BasisOfPresentationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_BasisOfPresentationAbstract" xml:lang="en-US" id="label_cldx_BasisOfPresentationAbstract_1">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BasisOfPresentationAbstract" xlink:to="label_cldx_BasisOfPresentationAbstract_1" xlink:title="label: BasisOfPresentationAbstract to label_cldx_BasisOfPresentationAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GlaxoSmithKlinePlcMember" xlink:label="cldx_GlaxoSmithKlinePlcMember" xlink:title="GlaxoSmithKlinePlcMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_GlaxoSmithKlinePlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_GlaxoSmithKlinePlcMember" xml:lang="en-US" id="label_cldx_GlaxoSmithKlinePlcMember">Glaxo</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GlaxoSmithKlinePlcMember" xlink:to="label_cldx_GlaxoSmithKlinePlcMember" xlink:title="label: GlaxoSmithKlinePlcMember to label_cldx_GlaxoSmithKlinePlcMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_GlaxoSmithKlinePlcMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_GlaxoSmithKlinePlcMember" xml:lang="en-US" id="label_cldx_GlaxoSmithKlinePlcMember_1">Represents information related to Glaxo SmithKline plc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GlaxoSmithKlinePlcMember" xlink:to="label_cldx_GlaxoSmithKlinePlcMember_1" xlink:title="label: GlaxoSmithKlinePlcMember to label_cldx_GlaxoSmithKlinePlcMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_GlaxoSmithKlinePlcMember_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_GlaxoSmithKlinePlcMember" xml:lang="en-US" id="label_cldx_GlaxoSmithKlinePlcMember_2">Glaxo Smith Kline Plc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GlaxoSmithKlinePlcMember" xlink:to="label_cldx_GlaxoSmithKlinePlcMember_2" xlink:title="label: GlaxoSmithKlinePlcMember to label_cldx_GlaxoSmithKlinePlcMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PfizerIncMember" xlink:label="cldx_PfizerIncMember" xlink:title="PfizerIncMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PfizerIncMember" xml:lang="en-US" id="label_cldx_PfizerIncMember">Pfizer Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PfizerIncMember" xlink:to="label_cldx_PfizerIncMember" xlink:title="label: PfizerIncMember to label_cldx_PfizerIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PfizerIncMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PfizerIncMember" xml:lang="en-US" id="label_cldx_PfizerIncMember_1">Pfizer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PfizerIncMember" xlink:to="label_cldx_PfizerIncMember_1" xlink:title="label: PfizerIncMember to label_cldx_PfizerIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PfizerIncMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PfizerIncMember" xml:lang="en-US" id="label_cldx_PfizerIncMember_2">Represents information related to Pfizer Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PfizerIncMember" xlink:to="label_cldx_PfizerIncMember_2" xlink:title="label: PfizerIncMember to label_cldx_PfizerIncMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LaboratoryEquipmentMember" xlink:label="cldx_LaboratoryEquipmentMember" xlink:title="LaboratoryEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_LaboratoryEquipmentMember" xml:lang="en-US" id="label_cldx_LaboratoryEquipmentMember">Laboratory Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LaboratoryEquipmentMember" xlink:to="label_cldx_LaboratoryEquipmentMember" xlink:title="label: LaboratoryEquipmentMember to label_cldx_LaboratoryEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LaboratoryEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_LaboratoryEquipmentMember" xml:lang="en-US" id="label_cldx_LaboratoryEquipmentMember_1">Laboratory equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LaboratoryEquipmentMember" xlink:to="label_cldx_LaboratoryEquipmentMember_1" xlink:title="label: LaboratoryEquipmentMember to label_cldx_LaboratoryEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LaboratoryEquipmentMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_LaboratoryEquipmentMember" xml:lang="en-US" id="label_cldx_LaboratoryEquipmentMember_2">Details pertaining to laboratory equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LaboratoryEquipmentMember" xlink:to="label_cldx_LaboratoryEquipmentMember_2" xlink:title="label: LaboratoryEquipmentMember to label_cldx_LaboratoryEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LaboratoryEquipmentMember_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_cldx_LaboratoryEquipmentMember" xml:lang="en-US" id="label_cldx_LaboratoryEquipmentMember_3">Laboratory Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LaboratoryEquipmentMember" xlink:to="label_cldx_LaboratoryEquipmentMember_3" xlink:title="label: LaboratoryEquipmentMember to label_cldx_LaboratoryEquipmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ManufacturingEquipmentMember" xlink:label="cldx_ManufacturingEquipmentMember" xlink:title="ManufacturingEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ManufacturingEquipmentMember" xml:lang="en-US" id="label_cldx_ManufacturingEquipmentMember">Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ManufacturingEquipmentMember" xlink:to="label_cldx_ManufacturingEquipmentMember" xlink:title="label: ManufacturingEquipmentMember to label_cldx_ManufacturingEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ManufacturingEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ManufacturingEquipmentMember" xml:lang="en-US" id="label_cldx_ManufacturingEquipmentMember_1">Manufacturing equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ManufacturingEquipmentMember" xlink:to="label_cldx_ManufacturingEquipmentMember_1" xlink:title="label: ManufacturingEquipmentMember to label_cldx_ManufacturingEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ManufacturingEquipmentMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ManufacturingEquipmentMember" xml:lang="en-US" id="label_cldx_ManufacturingEquipmentMember_2">Details pertaining to manufacturing equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ManufacturingEquipmentMember" xlink:to="label_cldx_ManufacturingEquipmentMember_2" xlink:title="label: ManufacturingEquipmentMember to label_cldx_ManufacturingEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ManufacturingEquipmentMember_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_cldx_ManufacturingEquipmentMember" xml:lang="en-US" id="label_cldx_ManufacturingEquipmentMember_3">Manufacturing Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ManufacturingEquipmentMember" xlink:to="label_cldx_ManufacturingEquipmentMember_3" xlink:title="label: ManufacturingEquipmentMember to label_cldx_ManufacturingEquipmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="label_dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate" xlink:title="label: CurrentFiscalYearEndDate to label_dei_CurrentFiscalYearEndDate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AwardTypeAxis" xml:lang="en-US" id="label_us-gaap_AwardTypeAxis">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="label_us-gaap_AwardTypeAxis" xlink:title="label: AwardTypeAxis to label_us-gaap_AwardTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CuraGenCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CuraGenCorporationMember" xml:lang="en-US" id="label_cldx_CuraGenCorporationMember">Cura Gen Corporation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CuraGenCorporationMember" xlink:to="label_cldx_CuraGenCorporationMember" xlink:title="label: CuraGenCorporationMember to label_cldx_CuraGenCorporationMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CuraGenCorporationMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CuraGenCorporationMember" xml:lang="en-US" id="label_cldx_CuraGenCorporationMember_1">CuraGen</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CuraGenCorporationMember" xlink:to="label_cldx_CuraGenCorporationMember_1" xlink:title="label: CuraGenCorporationMember to label_cldx_CuraGenCorporationMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CuraGenCorporationMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CuraGenCorporationMember" xml:lang="en-US" id="label_cldx_CuraGenCorporationMember_2">Represents information pertaining to CuraGen Corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CuraGenCorporationMember" xlink:to="label_cldx_CuraGenCorporationMember_2" xlink:title="label: CuraGenCorporationMember to label_cldx_CuraGenCorporationMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:label="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:title="DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xml:lang="en-US" id="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock">Debt Instrument, Principal Amount Denomination for Conversion into Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:to="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:title="label: DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock to label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xml:lang="en-US" id="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock_1">Principal amount of notes used for debt instrument conversion ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:to="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock_1" xlink:title="label: DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock to label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xml:lang="en-US" id="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock_2">The principal amount of notes used as denominator for purposes of computing the conversion ratio of convertible debt.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:to="label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock_2" xlink:title="label: DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock to label_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:label="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:title="AccruedRoyaltyAndLicenseFeesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" xml:lang="en-US" id="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent">Accrued Royalty and License Fees Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:to="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:title="label: AccruedRoyaltyAndLicenseFeesCurrent to label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" xml:lang="en-US" id="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent_1">Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties and licenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:to="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent_1" xlink:title="label: AccruedRoyaltyAndLicenseFeesCurrent to label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" xml:lang="en-US" id="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent_2">Accrued Royalty and License Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:to="label_cldx_AccruedRoyaltyAndLicenseFeesCurrent_2" xlink:title="label: AccruedRoyaltyAndLicenseFeesCurrent to label_cldx_AccruedRoyaltyAndLicenseFeesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:label="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:title="AccruedResearchAndDevelopmentContractCostsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xml:lang="en-US" id="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent">Accrued Research and Development Contract Costs, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:to="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:title="label: AccruedResearchAndDevelopmentContractCostsCurrent to label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xml:lang="en-US" id="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent_1">Accrued Research and Development Contract Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:to="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent_1" xlink:title="label: AccruedResearchAndDevelopmentContractCostsCurrent to label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xml:lang="en-US" id="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent_2">Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development contract costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:to="label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent_2" xlink:title="label: AccruedResearchAndDevelopmentContractCostsCurrent to label_cldx_AccruedResearchAndDevelopmentContractCostsCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentAmortizationPeriod" xlink:label="cldx_DebtInstrumentAmortizationPeriod" xlink:title="DebtInstrumentAmortizationPeriod" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentAmortizationPeriod" xml:lang="en-US" id="label_cldx_DebtInstrumentAmortizationPeriod">Debt Instrument, Amortization Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentAmortizationPeriod" xlink:to="label_cldx_DebtInstrumentAmortizationPeriod" xlink:title="label: DebtInstrumentAmortizationPeriod to label_cldx_DebtInstrumentAmortizationPeriod" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentAmortizationPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentAmortizationPeriod" xml:lang="en-US" id="label_cldx_DebtInstrumentAmortizationPeriod_1">Amortization period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentAmortizationPeriod" xlink:to="label_cldx_DebtInstrumentAmortizationPeriod_1" xlink:title="label: DebtInstrumentAmortizationPeriod to label_cldx_DebtInstrumentAmortizationPeriod" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentAmortizationPeriod_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentAmortizationPeriod" xml:lang="en-US" id="label_cldx_DebtInstrumentAmortizationPeriod_2">Represents the amortization period of the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentAmortizationPeriod" xlink:to="label_cldx_DebtInstrumentAmortizationPeriod_2" xlink:title="label: DebtInstrumentAmortizationPeriod to label_cldx_DebtInstrumentAmortizationPeriod" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DocumentAndEntityInformationAbstract" xlink:label="cldx_DocumentAndEntityInformationAbstract" xlink:title="DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DocumentAndEntityInformationAbstract" xml:lang="en-US" id="label_cldx_DocumentAndEntityInformationAbstract">Document and Entity Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="label_cldx_DocumentAndEntityInformationAbstract" xlink:title="label: DocumentAndEntityInformationAbstract to label_cldx_DocumentAndEntityInformationAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:title="RevenueFromProductDevelopmentAndLicensingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xml:lang="en-US" id="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements">Product Development and Licensing Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:to="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:title="label: RevenueFromProductDevelopmentAndLicensingAgreements to label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xml:lang="en-US" id="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_1">Revenue from Product Development and Licensing Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:to="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_1" xlink:title="label: RevenueFromProductDevelopmentAndLicensingAgreements to label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xml:lang="en-US" id="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_2">This element represents revenue from product development and licensing agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:to="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_2" xlink:title="label: RevenueFromProductDevelopmentAndLicensingAgreements to label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xml:lang="en-US" id="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_3">Revenue related to the Rockefeller agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:to="label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements_3" xlink:title="label: RevenueFromProductDevelopmentAndLicensingAgreements to label_cldx_RevenueFromProductDevelopmentAndLicensingAgreements" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants" xlink:title="RevenueFromContractsAndGrants" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromContractsAndGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RevenueFromContractsAndGrants" xml:lang="en-US" id="label_cldx_RevenueFromContractsAndGrants">Contracts and Grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromContractsAndGrants" xlink:to="label_cldx_RevenueFromContractsAndGrants" xlink:title="label: RevenueFromContractsAndGrants to label_cldx_RevenueFromContractsAndGrants" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromContractsAndGrants_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RevenueFromContractsAndGrants" xml:lang="en-US" id="label_cldx_RevenueFromContractsAndGrants_1">Revenue from Contracts and Grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromContractsAndGrants" xlink:to="label_cldx_RevenueFromContractsAndGrants_1" xlink:title="label: RevenueFromContractsAndGrants to label_cldx_RevenueFromContractsAndGrants" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromContractsAndGrants_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RevenueFromContractsAndGrants" xml:lang="en-US" id="label_cldx_RevenueFromContractsAndGrants_2">This element represents revenue earned during the period arising from products sold or services provided under the terms of a contract. Also include revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromContractsAndGrants" xlink:to="label_cldx_RevenueFromContractsAndGrants_2" xlink:title="label: RevenueFromContractsAndGrants to label_cldx_RevenueFromContractsAndGrants" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RevenueFromContractsAndGrants_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_cldx_RevenueFromContractsAndGrants" xml:lang="en-US" id="label_cldx_RevenueFromContractsAndGrants_3">Revenue related to the Rockefeller agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromContractsAndGrants" xlink:to="label_cldx_RevenueFromContractsAndGrants_3" xlink:title="label: RevenueFromContractsAndGrants to label_cldx_RevenueFromContractsAndGrants" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:title="SignificantRevenueArrangementsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_SignificantRevenueArrangementsDisclosureAbstract" xml:lang="en-US" id="label_cldx_SignificantRevenueArrangementsDisclosureAbstract">REVENUE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:to="label_cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:title="label: SignificantRevenueArrangementsDisclosureAbstract to label_cldx_SignificantRevenueArrangementsDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:title="SignificantRevenueArrangementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" xml:lang="en-US" id="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock">Significant Revenue Arrangements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:to="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:title="label: SignificantRevenueArrangementsDisclosureTextBlock to label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" xml:lang="en-US" id="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock_1">This element may be used to capture the complete disclosure pertaining to an entity's significant revenue contracts and arrangements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:to="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock_1" xlink:title="label: SignificantRevenueArrangementsDisclosureTextBlock to label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" xml:lang="en-US" id="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock_2">REVENUE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:to="label_cldx_SignificantRevenueArrangementsDisclosureTextBlock_2" xlink:title="label: SignificantRevenueArrangementsDisclosureTextBlock to label_cldx_SignificantRevenueArrangementsDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementDisclosureAbstract" xlink:label="cldx_CollaborativeArrangementDisclosureAbstract" xlink:title="CollaborativeArrangementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementDisclosureAbstract" xml:lang="en-US" id="label_cldx_CollaborativeArrangementDisclosureAbstract">COLLABORATION AGREEMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementDisclosureAbstract" xlink:to="label_cldx_CollaborativeArrangementDisclosureAbstract" xlink:title="label: CollaborativeArrangementDisclosureAbstract to label_cldx_CollaborativeArrangementDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentPeriodEndDate" xml:lang="en-US" id="label_dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to label_dei_DocumentPeriodEndDate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_WorkingCapital" xlink:label="cldx_WorkingCapital" xlink:title="WorkingCapital" />
    <link:label xlink:type="resource" xlink:label="label_cldx_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_WorkingCapital" xml:lang="en-US" id="label_cldx_WorkingCapital">Working Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_WorkingCapital" xlink:to="label_cldx_WorkingCapital" xlink:title="label: WorkingCapital to label_cldx_WorkingCapital" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_WorkingCapital_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_WorkingCapital" xml:lang="en-US" id="label_cldx_WorkingCapital_1">Working capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_WorkingCapital" xlink:to="label_cldx_WorkingCapital_1" xlink:title="label: WorkingCapital to label_cldx_WorkingCapital" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_WorkingCapital_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_WorkingCapital" xml:lang="en-US" id="label_cldx_WorkingCapital_2">Represents the working capital of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_WorkingCapital" xlink:to="label_cldx_WorkingCapital_2" xlink:title="label: WorkingCapital to label_cldx_WorkingCapital" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xml:lang="en-US" id="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable">Finite Lived and Indefinite Lived Intangible Assets by Major Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xml:lang="en-US" id="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_1">Disclosure of the carrying value of purchased amortizable finite-lived intangible assets, including disclosure of the carrying value of indefinite-lived intangible assets not subject to amortization, excluding goodwill, in total and by major class.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_1" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmgenAmendmentMember" xlink:label="cldx_AmgenAmendmentMember" xlink:title="AmgenAmendmentMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmgenAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AmgenAmendmentMember" xml:lang="en-US" id="label_cldx_AmgenAmendmentMember">Amgen Amendment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenAmendmentMember" xlink:to="label_cldx_AmgenAmendmentMember" xlink:title="label: AmgenAmendmentMember to label_cldx_AmgenAmendmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmgenAmendmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AmgenAmendmentMember" xml:lang="en-US" id="label_cldx_AmgenAmendmentMember_1">Amgen Amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenAmendmentMember" xlink:to="label_cldx_AmgenAmendmentMember_1" xlink:title="label: AmgenAmendmentMember to label_cldx_AmgenAmendmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmgenAmendmentMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AmgenAmendmentMember" xml:lang="en-US" id="label_cldx_AmgenAmendmentMember_2">Represents information pertaining to an amendment to the license agreement, Amgen Amendment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenAmendmentMember" xlink:to="label_cldx_AmgenAmendmentMember_2" xlink:title="label: AmgenAmendmentMember to label_cldx_AmgenAmendmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CoreTechnologyMember" xlink:label="cldx_CoreTechnologyMember" xlink:title="CoreTechnologyMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CoreTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CoreTechnologyMember" xml:lang="en-US" id="label_cldx_CoreTechnologyMember">Core Technology [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CoreTechnologyMember" xlink:to="label_cldx_CoreTechnologyMember" xlink:title="label: CoreTechnologyMember to label_cldx_CoreTechnologyMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CoreTechnologyMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CoreTechnologyMember" xml:lang="en-US" id="label_cldx_CoreTechnologyMember_1">Core Technology</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CoreTechnologyMember" xlink:to="label_cldx_CoreTechnologyMember_1" xlink:title="label: CoreTechnologyMember to label_cldx_CoreTechnologyMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CoreTechnologyMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CoreTechnologyMember" xml:lang="en-US" id="label_cldx_CoreTechnologyMember_2">Represents information pertaining to the core technology of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CoreTechnologyMember" xlink:to="label_cldx_CoreTechnologyMember_2" xlink:title="label: CoreTechnologyMember to label_cldx_CoreTechnologyMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderDomain" xlink:label="cldx_DebtInstrumentLenderDomain" xlink:title="DebtInstrumentLenderDomain" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentLenderDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentLenderDomain" xml:lang="en-US" id="label_cldx_DebtInstrumentLenderDomain">Identification of the lender, who may be a single entity (for example, a bank, pension fund or venture capital firm) or a group of entities which participate in the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentLenderDomain" xlink:to="label_cldx_DebtInstrumentLenderDomain" xlink:title="label: DebtInstrumentLenderDomain to label_cldx_DebtInstrumentLenderDomain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentLenderDomain_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentLenderDomain" xml:lang="en-US" id="label_cldx_DebtInstrumentLenderDomain_1">Debt Instrument, Lender [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentLenderDomain" xlink:to="label_cldx_DebtInstrumentLenderDomain_1" xlink:title="label: DebtInstrumentLenderDomain to label_cldx_DebtInstrumentLenderDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_MidCapFinancialLLCMember" xlink:label="cldx_MidCapFinancialLLCMember" xlink:title="MidCapFinancialLLCMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_MidCapFinancialLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_MidCapFinancialLLCMember" xml:lang="en-US" id="label_cldx_MidCapFinancialLLCMember">MidCap Financial LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_MidCapFinancialLLCMember" xlink:to="label_cldx_MidCapFinancialLLCMember" xlink:title="label: MidCapFinancialLLCMember to label_cldx_MidCapFinancialLLCMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_MidCapFinancialLLCMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_MidCapFinancialLLCMember" xml:lang="en-US" id="label_cldx_MidCapFinancialLLCMember_1">MidCap</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_MidCapFinancialLLCMember" xlink:to="label_cldx_MidCapFinancialLLCMember_1" xlink:title="label: MidCapFinancialLLCMember to label_cldx_MidCapFinancialLLCMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_MidCapFinancialLLCMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_MidCapFinancialLLCMember" xml:lang="en-US" id="label_cldx_MidCapFinancialLLCMember_2">Represents information pertaining to MidCap Financial, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_MidCapFinancialLLCMember" xlink:to="label_cldx_MidCapFinancialLLCMember_2" xlink:title="label: MidCapFinancialLLCMember to label_cldx_MidCapFinancialLLCMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramDomain" xlink:label="cldx_StockIssuedByTypeOfProgramDomain" xlink:title="StockIssuedByTypeOfProgramDomain" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedByTypeOfProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StockIssuedByTypeOfProgramDomain" xml:lang="en-US" id="label_cldx_StockIssuedByTypeOfProgramDomain">Stock Issued by Type of Program [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedByTypeOfProgramDomain" xlink:to="label_cldx_StockIssuedByTypeOfProgramDomain" xlink:title="label: StockIssuedByTypeOfProgramDomain to label_cldx_StockIssuedByTypeOfProgramDomain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedByTypeOfProgramDomain_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StockIssuedByTypeOfProgramDomain" xml:lang="en-US" id="label_cldx_StockIssuedByTypeOfProgramDomain_1">A group of different programs or plans under which stock of the entity is issued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedByTypeOfProgramDomain" xlink:to="label_cldx_StockIssuedByTypeOfProgramDomain_1" xlink:title="label: StockIssuedByTypeOfProgramDomain to label_cldx_StockIssuedByTypeOfProgramDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ControlledEquityOfferingProgramMember" xlink:label="cldx_ControlledEquityOfferingProgramMember" xlink:title="ControlledEquityOfferingProgramMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ControlledEquityOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ControlledEquityOfferingProgramMember" xml:lang="en-US" id="label_cldx_ControlledEquityOfferingProgramMember">Controlled Equity Offering Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ControlledEquityOfferingProgramMember" xlink:to="label_cldx_ControlledEquityOfferingProgramMember" xlink:title="label: ControlledEquityOfferingProgramMember to label_cldx_ControlledEquityOfferingProgramMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ControlledEquityOfferingProgramMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ControlledEquityOfferingProgramMember" xml:lang="en-US" id="label_cldx_ControlledEquityOfferingProgramMember_1">Cantor Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ControlledEquityOfferingProgramMember" xlink:to="label_cldx_ControlledEquityOfferingProgramMember_1" xlink:title="label: ControlledEquityOfferingProgramMember to label_cldx_ControlledEquityOfferingProgramMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ControlledEquityOfferingProgramMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ControlledEquityOfferingProgramMember" xml:lang="en-US" id="label_cldx_ControlledEquityOfferingProgramMember_2">Represents the Controlled Equity Offering Program of the entity through which shares of common stock may be publicly offered and sold through Cantor Fitzgerald and Co. ("Cantor") in privately negotiated and/or at-the-market transactions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ControlledEquityOfferingProgramMember" xlink:to="label_cldx_ControlledEquityOfferingProgramMember_2" xlink:title="label: ControlledEquityOfferingProgramMember to label_cldx_ControlledEquityOfferingProgramMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ControlledEquityOfferingProgramAmendedMember" xlink:label="cldx_ControlledEquityOfferingProgramAmendedMember" xlink:title="ControlledEquityOfferingProgramAmendedMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ControlledEquityOfferingProgramAmendedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ControlledEquityOfferingProgramAmendedMember" xml:lang="en-US" id="label_cldx_ControlledEquityOfferingProgramAmendedMember">Controlled Equity Offering Program Amended [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ControlledEquityOfferingProgramAmendedMember" xlink:to="label_cldx_ControlledEquityOfferingProgramAmendedMember" xlink:title="label: ControlledEquityOfferingProgramAmendedMember to label_cldx_ControlledEquityOfferingProgramAmendedMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ControlledEquityOfferingProgramAmendedMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ControlledEquityOfferingProgramAmendedMember" xml:lang="en-US" id="label_cldx_ControlledEquityOfferingProgramAmendedMember_1">Represents the Controlled Equity Offering Program of the entity, as amended, through which shares of common stock may be publicly offered and sold through Cantor Fitzgerald and Co. ("Cantor") in privately negotiated and/or at-the-market transactions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ControlledEquityOfferingProgramAmendedMember" xlink:to="label_cldx_ControlledEquityOfferingProgramAmendedMember_1" xlink:title="label: ControlledEquityOfferingProgramAmendedMember to label_cldx_ControlledEquityOfferingProgramAmendedMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ControlledEquityOfferingProgramAmendedMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ControlledEquityOfferingProgramAmendedMember" xml:lang="en-US" id="label_cldx_ControlledEquityOfferingProgramAmendedMember_2">Cantor Amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ControlledEquityOfferingProgramAmendedMember" xlink:to="label_cldx_ControlledEquityOfferingProgramAmendedMember_2" xlink:title="label: ControlledEquityOfferingProgramAmendedMember to label_cldx_ControlledEquityOfferingProgramAmendedMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareholderRightsPlanMember" xlink:label="cldx_ShareholderRightsPlanMember" xlink:title="ShareholderRightsPlanMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareholderRightsPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShareholderRightsPlanMember" xml:lang="en-US" id="label_cldx_ShareholderRightsPlanMember">Shareholder Rights Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareholderRightsPlanMember" xlink:to="label_cldx_ShareholderRightsPlanMember" xlink:title="label: ShareholderRightsPlanMember to label_cldx_ShareholderRightsPlanMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareholderRightsPlanMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ShareholderRightsPlanMember" xml:lang="en-US" id="label_cldx_ShareholderRightsPlanMember_1">Represents the Shareholder Rights Plan of the entity through which rights issued by the entity entitle recipients to obtain shares of preferred stock of the entity or common stock of an acquiring company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareholderRightsPlanMember" xlink:to="label_cldx_ShareholderRightsPlanMember_1" xlink:title="label: ShareholderRightsPlanMember to label_cldx_ShareholderRightsPlanMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareholderRightsPlanMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShareholderRightsPlanMember" xml:lang="en-US" id="label_cldx_ShareholderRightsPlanMember_2">Shareholder Rights Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareholderRightsPlanMember" xlink:to="label_cldx_ShareholderRightsPlanMember_2" xlink:title="label: ShareholderRightsPlanMember to label_cldx_ShareholderRightsPlanMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GeneralElectricCapitalCorporationMember" xlink:label="cldx_GeneralElectricCapitalCorporationMember" xlink:title="GeneralElectricCapitalCorporationMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_GeneralElectricCapitalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_GeneralElectricCapitalCorporationMember" xml:lang="en-US" id="label_cldx_GeneralElectricCapitalCorporationMember">General Electric Capital Corporation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GeneralElectricCapitalCorporationMember" xlink:to="label_cldx_GeneralElectricCapitalCorporationMember" xlink:title="label: GeneralElectricCapitalCorporationMember to label_cldx_GeneralElectricCapitalCorporationMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_GeneralElectricCapitalCorporationMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_GeneralElectricCapitalCorporationMember" xml:lang="en-US" id="label_cldx_GeneralElectricCapitalCorporationMember_1">GECC</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GeneralElectricCapitalCorporationMember" xlink:to="label_cldx_GeneralElectricCapitalCorporationMember_1" xlink:title="label: GeneralElectricCapitalCorporationMember to label_cldx_GeneralElectricCapitalCorporationMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_GeneralElectricCapitalCorporationMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_GeneralElectricCapitalCorporationMember" xml:lang="en-US" id="label_cldx_GeneralElectricCapitalCorporationMember_2">Represents information pertaining to General Electric Capital Corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GeneralElectricCapitalCorporationMember" xlink:to="label_cldx_GeneralElectricCapitalCorporationMember_2" xlink:title="label: GeneralElectricCapitalCorporationMember to label_cldx_GeneralElectricCapitalCorporationMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xml:lang="en-US" id="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems">Finite Lived and Indefinite Lived Intangible Assets by Major Class [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xml:lang="en-US" id="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_1">Intangible Assets and Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_1" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to label_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US" id="label_us-gaap_ArrangementsAndNonarrangementTransactionsMember">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="label_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to label_us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:title="ScheduleOfOtherLongTermLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xml:lang="en-US" id="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock">Tabular disclosure of other long-term liabilities, not separately disclosed on the balance sheet.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:to="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:title="label: ScheduleOfOtherLongTermLiabilitiesTableTextBlock to label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xml:lang="en-US" id="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_1">Schedule of Other Long Term Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:to="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_1" xlink:title="label: ScheduleOfOtherLongTermLiabilitiesTableTextBlock to label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xml:lang="en-US" id="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_2">Schedule of Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:to="label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_2" xlink:title="label: ScheduleOfOtherLongTermLiabilitiesTableTextBlock to label_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:title="DeferredIncomeFromSaleOfTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DeferredIncomeFromSaleOfTaxBenefits" xml:lang="en-US" id="label_cldx_DeferredIncomeFromSaleOfTaxBenefits">Deferred Income from Sale of Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:to="label_cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:title="label: DeferredIncomeFromSaleOfTaxBenefits to label_cldx_DeferredIncomeFromSaleOfTaxBenefits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredIncomeFromSaleOfTaxBenefits_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DeferredIncomeFromSaleOfTaxBenefits" xml:lang="en-US" id="label_cldx_DeferredIncomeFromSaleOfTaxBenefits_1">Deferred Income from Sale of Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:to="label_cldx_DeferredIncomeFromSaleOfTaxBenefits_1" xlink:title="label: DeferredIncomeFromSaleOfTaxBenefits to label_cldx_DeferredIncomeFromSaleOfTaxBenefits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredIncomeFromSaleOfTaxBenefits_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DeferredIncomeFromSaleOfTaxBenefits" xml:lang="en-US" id="label_cldx_DeferredIncomeFromSaleOfTaxBenefits_2">Represents the deferred income from the sale of tax benefit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:to="label_cldx_DeferredIncomeFromSaleOfTaxBenefits_2" xlink:title="label: DeferredIncomeFromSaleOfTaxBenefits to label_cldx_DeferredIncomeFromSaleOfTaxBenefits" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:title="ValueOfTaxBenefitsAgreedToBeSold" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ValueOfTaxBenefitsAgreedToBeSold" xml:lang="en-US" id="label_cldx_ValueOfTaxBenefitsAgreedToBeSold">Amount at which New Jersey tax benefit agreed to be sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:to="label_cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:title="label: ValueOfTaxBenefitsAgreedToBeSold to label_cldx_ValueOfTaxBenefitsAgreedToBeSold" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ValueOfTaxBenefitsAgreedToBeSold_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ValueOfTaxBenefitsAgreedToBeSold" xml:lang="en-US" id="label_cldx_ValueOfTaxBenefitsAgreedToBeSold_1">Represents the value of tax benefits agreed to be sold by the entity during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:to="label_cldx_ValueOfTaxBenefitsAgreedToBeSold_1" xlink:title="label: ValueOfTaxBenefitsAgreedToBeSold to label_cldx_ValueOfTaxBenefitsAgreedToBeSold" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ValueOfTaxBenefitsAgreedToBeSold_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ValueOfTaxBenefitsAgreedToBeSold" xml:lang="en-US" id="label_cldx_ValueOfTaxBenefitsAgreedToBeSold_2">Value of Tax Benefits Agreed to be Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:to="label_cldx_ValueOfTaxBenefitsAgreedToBeSold_2" xlink:title="label: ValueOfTaxBenefitsAgreedToBeSold to label_cldx_ValueOfTaxBenefitsAgreedToBeSold" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:title="PeriodForWhichBaseOfOperationsMustBeMaintained" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xml:lang="en-US" id="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained">Period for which base of operations must be maintained</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:to="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:title="label: PeriodForWhichBaseOfOperationsMustBeMaintained to label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xml:lang="en-US" id="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_1">Represents period for which base of operations must be maintained in New Jersey.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:to="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_1" xlink:title="label: PeriodForWhichBaseOfOperationsMustBeMaintained to label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xml:lang="en-US" id="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_2">Period for which Base of Operations Must be Maintained</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:to="label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_2" xlink:title="label: PeriodForWhichBaseOfOperationsMustBeMaintained to label_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderAxis" xlink:label="cldx_DebtInstrumentLenderAxis" xlink:title="DebtInstrumentLenderAxis" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentLenderAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentLenderAxis" xml:lang="en-US" id="label_cldx_DebtInstrumentLenderAxis">Debt Instrument, Lender [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentLenderAxis" xlink:to="label_cldx_DebtInstrumentLenderAxis" xlink:title="label: DebtInstrumentLenderAxis to label_cldx_DebtInstrumentLenderAxis" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentLenderAxis_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentLenderAxis" xml:lang="en-US" id="label_cldx_DebtInstrumentLenderAxis_1">The information pertaining to the debt instrument by lender.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentLenderAxis" xlink:to="label_cldx_DebtInstrumentLenderAxis_1" xlink:title="label: DebtInstrumentLenderAxis to label_cldx_DebtInstrumentLenderAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramAxis" xlink:label="cldx_StockIssuedByTypeOfProgramAxis" xlink:title="StockIssuedByTypeOfProgramAxis" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedByTypeOfProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StockIssuedByTypeOfProgramAxis" xml:lang="en-US" id="label_cldx_StockIssuedByTypeOfProgramAxis">Stock Issued by Type of Program [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedByTypeOfProgramAxis" xlink:to="label_cldx_StockIssuedByTypeOfProgramAxis" xlink:title="label: StockIssuedByTypeOfProgramAxis to label_cldx_StockIssuedByTypeOfProgramAxis" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockIssuedByTypeOfProgramAxis_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StockIssuedByTypeOfProgramAxis" xml:lang="en-US" id="label_cldx_StockIssuedByTypeOfProgramAxis_1">A categorization of various plans or programs under which stock of the entity is issued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedByTypeOfProgramAxis" xlink:to="label_cldx_StockIssuedByTypeOfProgramAxis_1" xlink:title="label: StockIssuedByTypeOfProgramAxis to label_cldx_StockIssuedByTypeOfProgramAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:label="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:title="DebtInstrumentInterestOnlyPeriodOfExtension" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xml:lang="en-US" id="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension">Debt Instrument, Interest Only Period of Extension</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:to="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:title="label: DebtInstrumentInterestOnlyPeriodOfExtension to label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xml:lang="en-US" id="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension_1">Extension of interest-only period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:to="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension_1" xlink:title="label: DebtInstrumentInterestOnlyPeriodOfExtension to label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xml:lang="en-US" id="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension_2">The period of extension of interest-only period which was extended through exercise of an option for extension by the entity during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:to="label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension_2" xlink:title="label: DebtInstrumentInterestOnlyPeriodOfExtension to label_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:label="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xml:lang="en-US" id="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt">Upfront fee due upon repayment of the Term Loan in full</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:to="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="label: DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt to label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xml:lang="en-US" id="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt_1">Represents the upfront fee due upon amendment to extend the maturity period of the Term loan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:to="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt_1" xlink:title="label: DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt to label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xml:lang="en-US" id="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt_2">Debt Instrument, UpFront Fee Due upon Repayment for Extension of Maturity Period of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:to="label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt_2" xlink:title="label: DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt to label_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:label="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xml:lang="en-US" id="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt">Debt Instrument, Additional Fee Due on Repayment for Extension of Maturity Period of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:to="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="label: DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt to label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xml:lang="en-US" id="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt_1">Additional Final Payment Fee due upon repayment of the Term Loan in full</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:to="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt_1" xlink:title="label: DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt to label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xml:lang="en-US" id="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt_2">Represents the additional fee due upon repayment of the Term Loan for the extension of the maturity period of debt.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:to="label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt_2" xlink:title="label: DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt to label_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:label="cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:title="DebtInstrumentPaymentFeePayableOnRepayment" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xml:lang="en-US" id="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment">Debt Instrument, Payment Fee Payable on Repayment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:to="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:title="label: DebtInstrumentPaymentFeePayableOnRepayment to label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xml:lang="en-US" id="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment_1">Original Payment Fee payable upon repayment of term loan in full</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:to="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment_1" xlink:title="label: DebtInstrumentPaymentFeePayableOnRepayment to label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xml:lang="en-US" id="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment_2">Represents the original payment fee to be paid upon repayment of the Term Loan in full.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:to="label_cldx_DebtInstrumentPaymentFeePayableOnRepayment_2" xlink:title="label: DebtInstrumentPaymentFeePayableOnRepayment to label_cldx_DebtInstrumentPaymentFeePayableOnRepayment" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:label="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:title="DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xml:lang="en-US" id="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments">Debt Instrument, Number of Equal Consecutive Monthly Installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:to="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:title="label: DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments to label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xml:lang="en-US" id="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments_1">Number of equal consecutive monthly installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:to="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments_1" xlink:title="label: DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments to label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xml:lang="en-US" id="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments_2">Represents the number of equal consecutive monthly installments over which the loan is to be paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:to="label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments_2" xlink:title="label: DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments to label_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:label="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:title="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xml:lang="en-US" id="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree">Debt Instrument, Covenant Rate of Prepayment Premium in Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:to="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:title="label: DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree to label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xml:lang="en-US" id="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree_1">Rate of prepayment premium in year three (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:to="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree_1" xlink:title="label: DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree to label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xml:lang="en-US" id="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree_2">Represents the percentage of prepayment premium of the Term Loan to be paid in year three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:to="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree_2" xlink:title="label: DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree to label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NoticePeriodForTerminationOfAgreement" xlink:label="cldx_NoticePeriodForTerminationOfAgreement" xlink:title="NoticePeriodForTerminationOfAgreement" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NoticePeriodForTerminationOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_NoticePeriodForTerminationOfAgreement" xml:lang="en-US" id="label_cldx_NoticePeriodForTerminationOfAgreement">Notice Period for Termination of Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NoticePeriodForTerminationOfAgreement" xlink:to="label_cldx_NoticePeriodForTerminationOfAgreement" xlink:title="label: NoticePeriodForTerminationOfAgreement to label_cldx_NoticePeriodForTerminationOfAgreement" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NoticePeriodForTerminationOfAgreement_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_NoticePeriodForTerminationOfAgreement" xml:lang="en-US" id="label_cldx_NoticePeriodForTerminationOfAgreement_1">Notice period for termination of agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NoticePeriodForTerminationOfAgreement" xlink:to="label_cldx_NoticePeriodForTerminationOfAgreement_1" xlink:title="label: NoticePeriodForTerminationOfAgreement to label_cldx_NoticePeriodForTerminationOfAgreement" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NoticePeriodForTerminationOfAgreement_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_NoticePeriodForTerminationOfAgreement" xml:lang="en-US" id="label_cldx_NoticePeriodForTerminationOfAgreement_2">Represents notice period for termination of agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NoticePeriodForTerminationOfAgreement" xlink:to="label_cldx_NoticePeriodForTerminationOfAgreement_2" xlink:title="label: NoticePeriodForTerminationOfAgreement to label_cldx_NoticePeriodForTerminationOfAgreement" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:label="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:title="CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xml:lang="en-US" id="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter">Common Stock Exercise of Full over Allotment Option to Purchase Additional Shares by Underwriter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:to="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:title="label: CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter to label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xml:lang="en-US" id="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter_1">Shares issued on exercise of over-allotment option by underwriters (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:to="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter_1" xlink:title="label: CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter to label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xml:lang="en-US" id="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter_2">Represents the purchase of additional common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:to="label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter_2" xlink:title="label: CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter to label_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">Share Based Compensation Arrangement by Share Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xml:lang="en-US" id="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_1">Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to label_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockholdersEquityTable" xlink:label="cldx_StockholdersEquityTable" xlink:title="StockholdersEquityTable" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StockholdersEquityTable" xml:lang="en-US" id="label_cldx_StockholdersEquityTable">Stockholders Equity [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityTable" xlink:to="label_cldx_StockholdersEquityTable" xlink:title="label: StockholdersEquityTable to label_cldx_StockholdersEquityTable" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockholdersEquityTable_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StockholdersEquityTable" xml:lang="en-US" id="label_cldx_StockholdersEquityTable_1">Disclosure of information pertaining to changes in stockholders' equity during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityTable" xlink:to="label_cldx_StockholdersEquityTable_1" xlink:title="label: StockholdersEquityTable to label_cldx_StockholdersEquityTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockholdersEquityLineItems" xlink:label="cldx_StockholdersEquityLineItems" xlink:title="StockholdersEquityLineItems" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StockholdersEquityLineItems" xml:lang="en-US" id="label_cldx_StockholdersEquityLineItems">Stockholders Equity [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="label_cldx_StockholdersEquityLineItems" xlink:title="label: StockholdersEquityLineItems to label_cldx_StockholdersEquityLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockholdersEquityLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_StockholdersEquityLineItems" xml:lang="en-US" id="label_cldx_StockholdersEquityLineItems_1">Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="label_cldx_StockholdersEquityLineItems_1" xlink:title="label: StockholdersEquityLineItems to label_cldx_StockholdersEquityLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StockholdersEquityLineItems_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StockholdersEquityLineItems" xml:lang="en-US" id="label_cldx_StockholdersEquityLineItems_2">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="label_cldx_StockholdersEquityLineItems_2" xlink:title="label: StockholdersEquityLineItems to label_cldx_StockholdersEquityLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_USGovernmentAndMunicipalObligationsMember" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember" xlink:title="USGovernmentAndMunicipalObligationsMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_USGovernmentAndMunicipalObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_USGovernmentAndMunicipalObligationsMember" xml:lang="en-US" id="label_cldx_USGovernmentAndMunicipalObligationsMember">Represents securities issued by US government agencies and municipal governments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_USGovernmentAndMunicipalObligationsMember" xlink:to="label_cldx_USGovernmentAndMunicipalObligationsMember" xlink:title="label: USGovernmentAndMunicipalObligationsMember to label_cldx_USGovernmentAndMunicipalObligationsMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_USGovernmentAndMunicipalObligationsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_USGovernmentAndMunicipalObligationsMember" xml:lang="en-US" id="label_cldx_USGovernmentAndMunicipalObligationsMember_1">U.S. government and municipal obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_USGovernmentAndMunicipalObligationsMember" xlink:to="label_cldx_USGovernmentAndMunicipalObligationsMember_1" xlink:title="label: USGovernmentAndMunicipalObligationsMember to label_cldx_USGovernmentAndMunicipalObligationsMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_USGovernmentAndMunicipalObligationsMember_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_USGovernmentAndMunicipalObligationsMember" xml:lang="en-US" id="label_cldx_USGovernmentAndMunicipalObligationsMember_2">US Government and Municipal Obligations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_USGovernmentAndMunicipalObligationsMember" xlink:to="label_cldx_USGovernmentAndMunicipalObligationsMember_2" xlink:title="label: USGovernmentAndMunicipalObligationsMember to label_cldx_USGovernmentAndMunicipalObligationsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost">Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_1">Available For Sale Securities, Debt Maturities after One Through Three Years, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_2">Maturing after one year through three years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_2" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain">Available For Sale Securities, Debt Maturities within One Year Gross Unrealized Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_1">Maturing in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_2">Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_2" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain">Available For Sale Securities, Debt Maturities after One Through Three Years, Gross Unrealized Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_1">Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature after one year and through three years from the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_2">Maturing after one year through three years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_2" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract">Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_1">Available For Sale Securities, Gross Unrealized Losses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_1" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses">Maturing in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_1">Represents the gross unrealized losses on securities, at a point in time, which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_2">Available For Sale Securities, Debt Maturities within One Year, Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_2" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses">Maturing after one year through three years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses_1">Represents the gross unrealized losses on securities, at a point in time, which are expected to mature after one year and through three years from the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses_2">Available For Sale Securities, Debt Maturities after One Through Three Years, Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses_2" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">Available For Sale Securities, Debt Maturities after One Through Three Years, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_1">Maturing after one year through three years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_2">Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_2" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue to label_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FixedRateOfCommissionOnSaleOfStock" xlink:label="cldx_FixedRateOfCommissionOnSaleOfStock" xlink:title="FixedRateOfCommissionOnSaleOfStock" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FixedRateOfCommissionOnSaleOfStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_FixedRateOfCommissionOnSaleOfStock" xml:lang="en-US" id="label_cldx_FixedRateOfCommissionOnSaleOfStock">Fixed Rate of Commission on Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FixedRateOfCommissionOnSaleOfStock" xlink:to="label_cldx_FixedRateOfCommissionOnSaleOfStock" xlink:title="label: FixedRateOfCommissionOnSaleOfStock to label_cldx_FixedRateOfCommissionOnSaleOfStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FixedRateOfCommissionOnSaleOfStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_FixedRateOfCommissionOnSaleOfStock" xml:lang="en-US" id="label_cldx_FixedRateOfCommissionOnSaleOfStock_1">Fixed commission rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FixedRateOfCommissionOnSaleOfStock" xlink:to="label_cldx_FixedRateOfCommissionOnSaleOfStock_1" xlink:title="label: FixedRateOfCommissionOnSaleOfStock to label_cldx_FixedRateOfCommissionOnSaleOfStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FixedRateOfCommissionOnSaleOfStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_FixedRateOfCommissionOnSaleOfStock" xml:lang="en-US" id="label_cldx_FixedRateOfCommissionOnSaleOfStock_2">Represents the fixed commission rate expressed as a percentage of the gross sales price per share of common stock sold by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FixedRateOfCommissionOnSaleOfStock" xlink:to="label_cldx_FixedRateOfCommissionOnSaleOfStock_2" xlink:title="label: FixedRateOfCommissionOnSaleOfStock to label_cldx_FixedRateOfCommissionOnSaleOfStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:label="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:title="CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xml:lang="en-US" id="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice">Aggregate offering price of additional shares which the entity can issue as per amended agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:to="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:title="label: CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice to label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xml:lang="en-US" id="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice_1">Represents the aggregate offering price of additional shares which the entity can issue as per amended agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:to="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice_1" xlink:title="label: CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice to label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xml:lang="en-US" id="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice_2">Common Stock Issuance of Additional Shares Aggregate Offering Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:to="label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice_2" xlink:title="label: CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice to label_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:label="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:title="ScheduleOfNatureOfBusinessAndOverviewTable" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xml:lang="en-US" id="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable">Schedule of Nature of Business and Overview [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:to="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:title="label: ScheduleOfNatureOfBusinessAndOverviewTable to label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xml:lang="en-US" id="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable_1">Schedule detailing quantitative information concerning the nature of business and overview of the same.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:to="label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable_1" xlink:title="label: ScheduleOfNatureOfBusinessAndOverviewTable to label_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xml:lang="en-US" id="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">Employee Consultant and Non Employee Director Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:to="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="label: EmployeeConsultantAndNonEmployeeDirectorStockOptionMember to label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xml:lang="en-US" id="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_1">An arrangement whereby an employee, consultant or non-employee director is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the holder pays the strike value in cash to the issuing entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize recipients, in addition to other compensation and other benefits, if any.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:to="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_1" xlink:title="label: EmployeeConsultantAndNonEmployeeDirectorStockOptionMember to label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xml:lang="en-US" id="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_2">Stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:to="label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_2" xlink:title="label: EmployeeConsultantAndNonEmployeeDirectorStockOptionMember to label_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShelfRegistrationStatementAmount" xlink:label="cldx_ShelfRegistrationStatementAmount" xlink:title="ShelfRegistrationStatementAmount" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShelfRegistrationStatementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ShelfRegistrationStatementAmount" xml:lang="en-US" id="label_cldx_ShelfRegistrationStatementAmount">Shelf Registration Statement Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShelfRegistrationStatementAmount" xlink:to="label_cldx_ShelfRegistrationStatementAmount" xlink:title="label: ShelfRegistrationStatementAmount to label_cldx_ShelfRegistrationStatementAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShelfRegistrationStatementAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ShelfRegistrationStatementAmount" xml:lang="en-US" id="label_cldx_ShelfRegistrationStatementAmount_1">Maximum value of securities for which the entity filed a shelf registration statement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShelfRegistrationStatementAmount" xlink:to="label_cldx_ShelfRegistrationStatementAmount_1" xlink:title="label: ShelfRegistrationStatementAmount to label_cldx_ShelfRegistrationStatementAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ShelfRegistrationStatementAmount_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ShelfRegistrationStatementAmount" xml:lang="en-US" id="label_cldx_ShelfRegistrationStatementAmount_2">Represents the maximum value of securities for which the entity filed a shelf registration statement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShelfRegistrationStatementAmount" xlink:to="label_cldx_ShelfRegistrationStatementAmount_2" xlink:title="label: ShelfRegistrationStatementAmount to label_cldx_ShelfRegistrationStatementAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:label="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:title="ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare">Class of Warrant or Right, Number of Rights Per Common Stock Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:to="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:title="label: ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare to label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare_1">Number of preferred stock purchase rights for each outstanding share of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:to="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare_1" xlink:title="label: ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare to label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare_2">Represents the number of rights that were distributed for each outstanding share of common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:to="label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare_2" xlink:title="label: ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare to label_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:label="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired">Class of Warrant or Right Condition on Exercise of Rights Percentage of Common Stock Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired_1">Percentage of common stock to be acquired for rights to be exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired_1" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired_2">Represents the percentage of the entity's outstanding common stock that must be acquired for rights to become exercisable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired_2" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:label="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender">Class of Warrant or Right Condition on Exercise of Rights Percentage of Common Stock Acquired through Tender</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender_1">Percentage of common stock to be acquired in a tender offer for rights to be exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender_1" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender_2">Represents the percentage of the entity's outstanding common stock that must be acquired in a tender offer for rights to become exercisable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender_2" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:label="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:title="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xml:lang="en-US" id="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired">Represents the number of multiples of the exercise price that the right holder has the right to receive in value, if 15 percent or more of the outstanding common stock is acquired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:to="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:title="label: NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired to label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xml:lang="en-US" id="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired_1">Number of Multiples Class of Warrant or Right Condition on Exercise of Rights of Exercise Price Holder Can Receive in Value if Fifteen Percent or More of Common Stock is Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:to="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired_1" xlink:title="label: NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired to label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xml:lang="en-US" id="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired_2">Number of multiples of the exercise price that the Right holder has right to receive in value if 15% or more of the outstanding common stock is acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:to="label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired_2" xlink:title="label: NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired to label_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:label="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany">Class of Warrant or Right Condition on Exercise of Rights Percentage of Assets or Earning Power Sold for Holder Right to Receive Common Stock of Acquiring Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany_1">Percentage of assets or earning power sold allowing the Right holder a right to receive common stock of the acquiring company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany_1" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xml:lang="en-US" id="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany_2">Represents the percentage of assets or earning power sold which would allow the right holder the right to receive the common stock of the acquiring entity with a value that is twice the right's exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:to="label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany_2" xlink:title="label: ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany to label_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LudwigInstituteForCancerResearchMember" xlink:label="cldx_LudwigInstituteForCancerResearchMember" xlink:title="LudwigInstituteForCancerResearchMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LudwigInstituteForCancerResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_LudwigInstituteForCancerResearchMember" xml:lang="en-US" id="label_cldx_LudwigInstituteForCancerResearchMember">Ludwig Institute for Cancer Research [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LudwigInstituteForCancerResearchMember" xlink:to="label_cldx_LudwigInstituteForCancerResearchMember" xlink:title="label: LudwigInstituteForCancerResearchMember to label_cldx_LudwigInstituteForCancerResearchMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LudwigInstituteForCancerResearchMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_LudwigInstituteForCancerResearchMember" xml:lang="en-US" id="label_cldx_LudwigInstituteForCancerResearchMember_1">Ludwig</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LudwigInstituteForCancerResearchMember" xlink:to="label_cldx_LudwigInstituteForCancerResearchMember_1" xlink:title="label: LudwigInstituteForCancerResearchMember to label_cldx_LudwigInstituteForCancerResearchMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_LudwigInstituteForCancerResearchMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_LudwigInstituteForCancerResearchMember" xml:lang="en-US" id="label_cldx_LudwigInstituteForCancerResearchMember_2">Represents information related to Ludwig Institute for Cancer Research.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LudwigInstituteForCancerResearchMember" xlink:to="label_cldx_LudwigInstituteForCancerResearchMember_2" xlink:title="label: LudwigInstituteForCancerResearchMember to label_cldx_LudwigInstituteForCancerResearchMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AlterisTherapeuticsIncMember" xlink:label="cldx_AlterisTherapeuticsIncMember" xlink:title="AlterisTherapeuticsIncMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AlterisTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AlterisTherapeuticsIncMember" xml:lang="en-US" id="label_cldx_AlterisTherapeuticsIncMember">Represents information related to Alteris Therapeutics, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AlterisTherapeuticsIncMember" xlink:to="label_cldx_AlterisTherapeuticsIncMember" xlink:title="label: AlterisTherapeuticsIncMember to label_cldx_AlterisTherapeuticsIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AlterisTherapeuticsIncMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AlterisTherapeuticsIncMember" xml:lang="en-US" id="label_cldx_AlterisTherapeuticsIncMember_1">Alteris Therapeutics Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AlterisTherapeuticsIncMember" xlink:to="label_cldx_AlterisTherapeuticsIncMember_1" xlink:title="label: AlterisTherapeuticsIncMember to label_cldx_AlterisTherapeuticsIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AlterisTherapeuticsIncMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AlterisTherapeuticsIncMember" xml:lang="en-US" id="label_cldx_AlterisTherapeuticsIncMember_2">Alteris</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AlterisTherapeuticsIncMember" xlink:to="label_cldx_AlterisTherapeuticsIncMember_2" xlink:title="label: AlterisTherapeuticsIncMember to label_cldx_AlterisTherapeuticsIncMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ThomasJeffersonUniversityMember" xlink:label="cldx_ThomasJeffersonUniversityMember" xlink:title="ThomasJeffersonUniversityMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ThomasJeffersonUniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ThomasJeffersonUniversityMember" xml:lang="en-US" id="label_cldx_ThomasJeffersonUniversityMember">TJU</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ThomasJeffersonUniversityMember" xlink:to="label_cldx_ThomasJeffersonUniversityMember" xlink:title="label: ThomasJeffersonUniversityMember to label_cldx_ThomasJeffersonUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ThomasJeffersonUniversityMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ThomasJeffersonUniversityMember" xml:lang="en-US" id="label_cldx_ThomasJeffersonUniversityMember_1">Represents information related to Thomas Jefferson University.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ThomasJeffersonUniversityMember" xlink:to="label_cldx_ThomasJeffersonUniversityMember_1" xlink:title="label: ThomasJeffersonUniversityMember to label_cldx_ThomasJeffersonUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ThomasJeffersonUniversityMember_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ThomasJeffersonUniversityMember" xml:lang="en-US" id="label_cldx_ThomasJeffersonUniversityMember_2">Thomas Jefferson University [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ThomasJeffersonUniversityMember" xlink:to="label_cldx_ThomasJeffersonUniversityMember_2" xlink:title="label: ThomasJeffersonUniversityMember to label_cldx_ThomasJeffersonUniversityMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_UniversityOfSouthamptonUKMember" xlink:label="cldx_UniversityOfSouthamptonUKMember" xlink:title="UniversityOfSouthamptonUKMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_UniversityOfSouthamptonUKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_UniversityOfSouthamptonUKMember" xml:lang="en-US" id="label_cldx_UniversityOfSouthamptonUKMember">University of Southampton UK [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_UniversityOfSouthamptonUKMember" xlink:to="label_cldx_UniversityOfSouthamptonUKMember" xlink:title="label: UniversityOfSouthamptonUKMember to label_cldx_UniversityOfSouthamptonUKMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_UniversityOfSouthamptonUKMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_UniversityOfSouthamptonUKMember" xml:lang="en-US" id="label_cldx_UniversityOfSouthamptonUKMember_1">Southampton</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_UniversityOfSouthamptonUKMember" xlink:to="label_cldx_UniversityOfSouthamptonUKMember_1" xlink:title="label: UniversityOfSouthamptonUKMember to label_cldx_UniversityOfSouthamptonUKMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_UniversityOfSouthamptonUKMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_UniversityOfSouthamptonUKMember" xml:lang="en-US" id="label_cldx_UniversityOfSouthamptonUKMember_2">Represents information related to University of Southampton, UK.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_UniversityOfSouthamptonUKMember" xlink:to="label_cldx_UniversityOfSouthamptonUKMember_2" xlink:title="label: UniversityOfSouthamptonUKMember to label_cldx_UniversityOfSouthamptonUKMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmgenIncMember" xlink:label="cldx_AmgenIncMember" xlink:title="AmgenIncMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmgenIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AmgenIncMember" xml:lang="en-US" id="label_cldx_AmgenIncMember">Amgen Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenIncMember" xlink:to="label_cldx_AmgenIncMember" xlink:title="label: AmgenIncMember to label_cldx_AmgenIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmgenIncMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AmgenIncMember" xml:lang="en-US" id="label_cldx_AmgenIncMember_1">Amgen</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenIncMember" xlink:to="label_cldx_AmgenIncMember_1" xlink:title="label: AmgenIncMember to label_cldx_AmgenIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AmgenIncMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AmgenIncMember" xml:lang="en-US" id="label_cldx_AmgenIncMember_2">Represents information related to Amgen Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenIncMember" xlink:to="label_cldx_AmgenIncMember_2" xlink:title="label: AmgenIncMember to label_cldx_AmgenIncMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SeattleGeneticIncMember" xlink:label="cldx_SeattleGeneticIncMember" xlink:title="SeattleGeneticIncMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SeattleGeneticIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_SeattleGeneticIncMember" xml:lang="en-US" id="label_cldx_SeattleGeneticIncMember">Represents information related to Seattle Genetics, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SeattleGeneticIncMember" xlink:to="label_cldx_SeattleGeneticIncMember" xlink:title="label: SeattleGeneticIncMember to label_cldx_SeattleGeneticIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SeattleGeneticIncMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_SeattleGeneticIncMember" xml:lang="en-US" id="label_cldx_SeattleGeneticIncMember_1">Seattle Genetic Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SeattleGeneticIncMember" xlink:to="label_cldx_SeattleGeneticIncMember_1" xlink:title="label: SeattleGeneticIncMember to label_cldx_SeattleGeneticIncMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_SeattleGeneticIncMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_SeattleGeneticIncMember" xml:lang="en-US" id="label_cldx_SeattleGeneticIncMember_2">Seattle Genetics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SeattleGeneticIncMember" xlink:to="label_cldx_SeattleGeneticIncMember_2" xlink:title="label: SeattleGeneticIncMember to label_cldx_SeattleGeneticIncMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityWellKnownSeasonedIssuer" xml:lang="en-US" id="label_dei_EntityWellKnownSeasonedIssuer">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="label_dei_EntityWellKnownSeasonedIssuer" xlink:title="label: EntityWellKnownSeasonedIssuer to label_dei_EntityWellKnownSeasonedIssuer" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NonRefundableLicenseFee" xlink:label="cldx_NonRefundableLicenseFee" xlink:title="NonRefundableLicenseFee" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NonRefundableLicenseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_NonRefundableLicenseFee" xml:lang="en-US" id="label_cldx_NonRefundableLicenseFee">Non Refundable License Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NonRefundableLicenseFee" xlink:to="label_cldx_NonRefundableLicenseFee" xlink:title="label: NonRefundableLicenseFee to label_cldx_NonRefundableLicenseFee" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NonRefundableLicenseFee_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_NonRefundableLicenseFee" xml:lang="en-US" id="label_cldx_NonRefundableLicenseFee_1">Nonrefundable license fee expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NonRefundableLicenseFee" xlink:to="label_cldx_NonRefundableLicenseFee_1" xlink:title="label: NonRefundableLicenseFee to label_cldx_NonRefundableLicenseFee" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_NonRefundableLicenseFee_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_NonRefundableLicenseFee" xml:lang="en-US" id="label_cldx_NonRefundableLicenseFee_2">Represents the amount of nonrefundable license fee expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NonRefundableLicenseFee" xlink:to="label_cldx_NonRefundableLicenseFee_2" xlink:title="label: NonRefundableLicenseFee to label_cldx_NonRefundableLicenseFee" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityVoluntaryFilers" xml:lang="en-US" id="label_dei_EntityVoluntaryFilers">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="label_dei_EntityVoluntaryFilers" xlink:title="label: EntityVoluntaryFilers to label_dei_EntityVoluntaryFilers" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:label="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:title="CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xml:lang="en-US" id="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct">Collaborative Arrangement Royalty Payment Period from First Commercial Sale of Licensed Product</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:to="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:title="label: CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct to label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xml:lang="en-US" id="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct_1">Period from the first commercial sale of licensed product for royalty payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:to="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct_1" xlink:title="label: CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct to label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xml:lang="en-US" id="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct_2">Represents the period from the first commercial sale of licensed product for royalty payment under the collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:to="label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct_2" xlink:title="label: CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct to label_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCurrentReportingStatus" xml:lang="en-US" id="label_dei_EntityCurrentReportingStatus">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="label_dei_EntityCurrentReportingStatus" xlink:title="label: EntityCurrentReportingStatus to label_dei_EntityCurrentReportingStatus" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:label="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:title="CollaborativeArrangementTotalPotentialMilestonePayments" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xml:lang="en-US" id="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments">Collaborative Arrangement, Total Potential Milestone Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:to="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:title="label: CollaborativeArrangementTotalPotentialMilestonePayments to label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xml:lang="en-US" id="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments_1">Milestone payment due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:to="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments_1" xlink:title="label: CollaborativeArrangementTotalPotentialMilestonePayments to label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xml:lang="en-US" id="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments_2">Represents the total amount of potential milestone payments to be made by the entity based on terms of the collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:to="label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments_2" xlink:title="label: CollaborativeArrangementTotalPotentialMilestonePayments to label_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityFilerCategory" xml:lang="en-US" id="label_dei_EntityFilerCategory">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="label_dei_EntityFilerCategory" xlink:title="label: EntityFilerCategory to label_dei_EntityFilerCategory" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="cldx_CollaborativeArrangementAgreementTerm" xlink:title="CollaborativeArrangementAgreementTerm" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementAgreementTerm" xml:lang="en-US" id="label_cldx_CollaborativeArrangementAgreementTerm">Term of the agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementAgreementTerm" xlink:to="label_cldx_CollaborativeArrangementAgreementTerm" xlink:title="label: CollaborativeArrangementAgreementTerm to label_cldx_CollaborativeArrangementAgreementTerm" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementAgreementTerm_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementAgreementTerm" xml:lang="en-US" id="label_cldx_CollaborativeArrangementAgreementTerm_1">Represents the term of the collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementAgreementTerm" xlink:to="label_cldx_CollaborativeArrangementAgreementTerm_1" xlink:title="label: CollaborativeArrangementAgreementTerm to label_cldx_CollaborativeArrangementAgreementTerm" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementAgreementTerm_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementAgreementTerm" xml:lang="en-US" id="label_cldx_CollaborativeArrangementAgreementTerm_2">Collaborative Arrangement Agreement Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementAgreementTerm" xlink:to="label_cldx_CollaborativeArrangementAgreementTerm_2" xlink:title="label: CollaborativeArrangementAgreementTerm to label_cldx_CollaborativeArrangementAgreementTerm" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityPublicFloat" xml:lang="en-US" id="label_dei_EntityPublicFloat">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="label_dei_EntityPublicFloat" xlink:title="label: EntityPublicFloat to label_dei_EntityPublicFloat" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementNumberOfAgreements" xlink:label="cldx_CollaborativeArrangementNumberOfAgreements" xlink:title="CollaborativeArrangementNumberOfAgreements" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementNumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementNumberOfAgreements" xml:lang="en-US" id="label_cldx_CollaborativeArrangementNumberOfAgreements">Collaborative Arrangement, Number of Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementNumberOfAgreements" xlink:to="label_cldx_CollaborativeArrangementNumberOfAgreements" xlink:title="label: CollaborativeArrangementNumberOfAgreements to label_cldx_CollaborativeArrangementNumberOfAgreements" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementNumberOfAgreements_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementNumberOfAgreements" xml:lang="en-US" id="label_cldx_CollaborativeArrangementNumberOfAgreements_1">Number of exclusive license agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementNumberOfAgreements" xlink:to="label_cldx_CollaborativeArrangementNumberOfAgreements_1" xlink:title="label: CollaborativeArrangementNumberOfAgreements to label_cldx_CollaborativeArrangementNumberOfAgreements" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementNumberOfAgreements_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementNumberOfAgreements" xml:lang="en-US" id="label_cldx_CollaborativeArrangementNumberOfAgreements_2">Represents the number of exclusive license agreements under the collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementNumberOfAgreements" xlink:to="label_cldx_CollaborativeArrangementNumberOfAgreements_2" xlink:title="label: CollaborativeArrangementNumberOfAgreements to label_cldx_CollaborativeArrangementNumberOfAgreements" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityRegistrantName" xml:lang="en-US" id="label_dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to label_dei_EntityRegistrantName" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:label="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" />
    <link:label xlink:type="resource" xlink:label="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xml:lang="en-US" id="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits">Income Tax Reconciliation Expiration of Net Operating Losses and Research and Development Tax Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:to="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="label: IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits to label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xml:lang="en-US" id="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_1">Expiration of Net Operating Losses and Research &amp; Development Tax Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:to="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_1" xlink:title="label: IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits to label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xml:lang="en-US" id="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_2">The portion of the difference between total income tax expense or benefit as reported in the Income Statement and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to expiration of net operating losses and research and development tax credits under enacted tax laws during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:to="label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_2" xlink:title="label: IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits to label_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCentralIndexKey" xml:lang="en-US" id="label_dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to label_dei_EntityCentralIndexKey" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:label="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:title="DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xml:lang="en-US" id="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets">Amount of deferred tax liability attributable to taxable temporary differences from other acquired intangible assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:to="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:title="label: DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets to label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xml:lang="en-US" id="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets_1">Deferred Tax Liabilities, Other Acquired Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:to="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets_1" xlink:title="label: DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets to label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xml:lang="en-US" id="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets_2">Other Acquired Intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:to="label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets_2" xlink:title="label: DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets to label_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:label="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:title="DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xml:lang="en-US" id="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense">Deferred Tax Liabilities, Deferred License Costs and Other Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:to="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:title="label: DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense to label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xml:lang="en-US" id="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense_1">Deferred License Costs and Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:to="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense_1" xlink:title="label: DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense to label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xml:lang="en-US" id="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense_2">Amount of deferred tax liability attributable to taxable temporary differences from license costs and other items that are not separately disclosed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:to="label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense_2" xlink:title="label: DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense to label_cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsLiabilitiesGross" xlink:label="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:title="DeferredTaxAssetsLiabilitiesGross" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DeferredTaxAssetsLiabilitiesGross" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsLiabilitiesGross">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:to="label_cldx_DeferredTaxAssetsLiabilitiesGross" xlink:title="label: DeferredTaxAssetsLiabilitiesGross to label_cldx_DeferredTaxAssetsLiabilitiesGross" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsLiabilitiesGross_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DeferredTaxAssetsLiabilitiesGross" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsLiabilitiesGross_1">Deferred Tax Assets (Liabilities) Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:to="label_cldx_DeferredTaxAssetsLiabilitiesGross_1" xlink:title="label: DeferredTaxAssetsLiabilitiesGross to label_cldx_DeferredTaxAssetsLiabilitiesGross" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsLiabilitiesGross_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_cldx_DeferredTaxAssetsLiabilitiesGross" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsLiabilitiesGross_2">Total Deferred Tax Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:to="label_cldx_DeferredTaxAssetsLiabilitiesGross_2" xlink:title="label: DeferredTaxAssetsLiabilitiesGross to label_cldx_DeferredTaxAssetsLiabilitiesGross" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:label="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets">Amount of deferred tax liability attributable to taxable temporary differences from in-process research and development intangible assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:to="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets to label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets_1">Deferred Tax Assets in Process Research and Development Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:to="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets_1" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets to label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets_2">IPR&amp;D Intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:to="label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets_2" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets to label_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US" id="label_dei_EntityCommonStockSharesOutstanding">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="label_dei_EntityCommonStockSharesOutstanding" xlink:title="label: EntityCommonStockSharesOutstanding to label_dei_EntityCommonStockSharesOutstanding" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:label="cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:title="CollaborativeArrangementMilestonePaymentsReceived" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementMilestonePaymentsReceived" xml:lang="en-US" id="label_cldx_CollaborativeArrangementMilestonePaymentsReceived">Collaborative Arrangement Milestone Payments Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:to="label_cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:title="label: CollaborativeArrangementMilestonePaymentsReceived to label_cldx_CollaborativeArrangementMilestonePaymentsReceived" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementMilestonePaymentsReceived_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementMilestonePaymentsReceived" xml:lang="en-US" id="label_cldx_CollaborativeArrangementMilestonePaymentsReceived_1">Other income related to milestone payment received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:to="label_cldx_CollaborativeArrangementMilestonePaymentsReceived_1" xlink:title="label: CollaborativeArrangementMilestonePaymentsReceived to label_cldx_CollaborativeArrangementMilestonePaymentsReceived" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementMilestonePaymentsReceived_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementMilestonePaymentsReceived" xml:lang="en-US" id="label_cldx_CollaborativeArrangementMilestonePaymentsReceived_2">Represents the payment received towards potential commercial milestone payments related to future net sales of Belinostat.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:to="label_cldx_CollaborativeArrangementMilestonePaymentsReceived_2" xlink:title="label: CollaborativeArrangementMilestonePaymentsReceived to label_cldx_CollaborativeArrangementMilestonePaymentsReceived" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AVANTMember" xlink:label="cldx_AVANTMember" xlink:title="AVANTMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AVANTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AVANTMember" xml:lang="en-US" id="label_cldx_AVANTMember">AVANT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AVANTMember" xlink:to="label_cldx_AVANTMember" xlink:title="label: AVANTMember to label_cldx_AVANTMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AVANTMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AVANTMember" xml:lang="en-US" id="label_cldx_AVANTMember_1">AVANT [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AVANTMember" xlink:to="label_cldx_AVANTMember_1" xlink:title="label: AVANTMember to label_cldx_AVANTMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AVANTMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AVANTMember" xml:lang="en-US" id="label_cldx_AVANTMember_2">Represents information pertaining to AVANT Immunotherapeutics, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AVANTMember" xlink:to="label_cldx_AVANTMember_2" xlink:title="label: AVANTMember to label_cldx_AVANTMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:label="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:title="OperatingLossAndTaxCreditCarryforwardsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xml:lang="en-US" id="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems">Net operating loss and tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:title="label: OperatingLossAndTaxCreditCarryforwardsLineItems to label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xml:lang="en-US" id="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems_1">Operating Loss and Tax Credit Carryforwards [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems_1" xlink:title="label: OperatingLossAndTaxCreditCarryforwardsLineItems to label_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:label="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:title="OperatingLossCarryforwardsAnnualLimitationAmount" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount">Represents the annual limitation on operating loss carryforwards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:to="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:title="label: OperatingLossCarryforwardsAnnualLimitationAmount to label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount_1">Operating Loss Carryforwards Annual Limitation Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:to="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount_1" xlink:title="label: OperatingLossCarryforwardsAnnualLimitationAmount to label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount_2">Annual limitation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:to="label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount_2" xlink:title="label: OperatingLossCarryforwardsAnnualLimitationAmount to label_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsExpired" xlink:label="cldx_OperatingLossCarryforwardsExpired" xlink:title="OperatingLossCarryforwardsExpired" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsExpired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossCarryforwardsExpired" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsExpired">Operating Loss Carryforwards Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsExpired" xlink:to="label_cldx_OperatingLossCarryforwardsExpired" xlink:title="label: OperatingLossCarryforwardsExpired to label_cldx_OperatingLossCarryforwardsExpired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsExpired_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLossCarryforwardsExpired" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsExpired_1">Represents the operating loss carryforwards that were expired during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsExpired" xlink:to="label_cldx_OperatingLossCarryforwardsExpired_1" xlink:title="label: OperatingLossCarryforwardsExpired to label_cldx_OperatingLossCarryforwardsExpired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsExpired_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLossCarryforwardsExpired" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsExpired_2">NOLs expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsExpired" xlink:to="label_cldx_OperatingLossCarryforwardsExpired_2" xlink:title="label: OperatingLossCarryforwardsExpired to label_cldx_OperatingLossCarryforwardsExpired" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:label="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:title="OperatingLossCarryforwardsNetOfExpirationsAndUtilization" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization">Operating Loss Carryforwards Net of Expirations and Utilization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:to="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:title="label: OperatingLossCarryforwardsNetOfExpirationsAndUtilization to label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization_1">The sum of domestic, foreign and state and local operating loss carryforwards, net of expirations and utilization but before tax effects, available to reduce future taxable income under enacted tax laws.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:to="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization_1" xlink:title="label: OperatingLossCarryforwardsNetOfExpirationsAndUtilization to label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization_2">NOL, net of expirations and utilization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:to="label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization_2" xlink:title="label: OperatingLossCarryforwardsNetOfExpirationsAndUtilization to label_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:label="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:title="OperatingLossCarryforwardsWithLimitationsOnUse" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse">Operating Loss Carryforwards with Limitations on Use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:to="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:title="label: OperatingLossCarryforwardsWithLimitationsOnUse to label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse_1">Represents the operating loss carryforwards with limitations on use.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:to="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse_1" xlink:title="label: OperatingLossCarryforwardsWithLimitationsOnUse to label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse_2">Loss carryforwards with limitations on use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:to="label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse_2" xlink:title="label: OperatingLossCarryforwardsWithLimitationsOnUse to label_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:label="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:title="OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized">Operating Loss Carryforwards Remotely Likely to be Utilized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:to="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:title="label: OperatingLossCarryforwardsRemotelyLikelyToBeUtilized to label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized_1">Represents the operating loss carryforwards that are remotely likely to be utilized in future periods.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:to="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized_1" xlink:title="label: OperatingLossCarryforwardsRemotelyLikelyToBeUtilized to label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xml:lang="en-US" id="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized_2">Loss carryforwards remotely likely to be utilized in future periods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:to="label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized_2" xlink:title="label: OperatingLossCarryforwardsRemotelyLikelyToBeUtilized to label_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeAxis" xlink:label="cldx_OwnershipChangeAxis" xlink:title="OwnershipChangeAxis" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OwnershipChangeAxis" xml:lang="en-US" id="label_cldx_OwnershipChangeAxis">Ownership Change [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeAxis" xlink:to="label_cldx_OwnershipChangeAxis" xlink:title="label: OwnershipChangeAxis to label_cldx_OwnershipChangeAxis" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeAxis_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OwnershipChangeAxis" xml:lang="en-US" id="label_cldx_OwnershipChangeAxis_1">Details pertaining to transactions that result in ownership change as defined by Section 382 of the Internal Revenue Code.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeAxis" xlink:to="label_cldx_OwnershipChangeAxis_1" xlink:title="label: OwnershipChangeAxis to label_cldx_OwnershipChangeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeDomain" xlink:label="cldx_OwnershipChangeDomain" xlink:title="OwnershipChangeDomain" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OwnershipChangeDomain" xml:lang="en-US" id="label_cldx_OwnershipChangeDomain">Transactions that result in ownership change as defined by Section 382 of the Internal Revenue Code.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeDomain" xlink:to="label_cldx_OwnershipChangeDomain" xlink:title="label: OwnershipChangeDomain to label_cldx_OwnershipChangeDomain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeDomain_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OwnershipChangeDomain" xml:lang="en-US" id="label_cldx_OwnershipChangeDomain_1">Ownership Change [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeDomain" xlink:to="label_cldx_OwnershipChangeDomain_1" xlink:title="label: OwnershipChangeDomain to label_cldx_OwnershipChangeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeInOctober2007Member" xlink:label="cldx_OwnershipChangeInOctober2007Member" xlink:title="OwnershipChangeInOctober2007Member" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeInOctober2007Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OwnershipChangeInOctober2007Member" xml:lang="en-US" id="label_cldx_OwnershipChangeInOctober2007Member">Ownership Change in October2007 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeInOctober2007Member" xlink:to="label_cldx_OwnershipChangeInOctober2007Member" xlink:title="label: OwnershipChangeInOctober2007Member to label_cldx_OwnershipChangeInOctober2007Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeInOctober2007Member_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OwnershipChangeInOctober2007Member" xml:lang="en-US" id="label_cldx_OwnershipChangeInOctober2007Member_1">Details pertaining to ownership change in October 2007.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeInOctober2007Member" xlink:to="label_cldx_OwnershipChangeInOctober2007Member_1" xlink:title="label: OwnershipChangeInOctober2007Member to label_cldx_OwnershipChangeInOctober2007Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangeInOctober2007Member_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OwnershipChangeInOctober2007Member" xml:lang="en-US" id="label_cldx_OwnershipChangeInOctober2007Member_2">Ownership change in October 2007</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangeInOctober2007Member" xlink:to="label_cldx_OwnershipChangeInOctober2007Member_2" xlink:title="label: OwnershipChangeInOctober2007Member to label_cldx_OwnershipChangeInOctober2007Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:label="cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:title="OwnershipChangesInJune2009AndDecember2009Member" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OwnershipChangesInJune2009AndDecember2009Member" xml:lang="en-US" id="label_cldx_OwnershipChangesInJune2009AndDecember2009Member">Ownership Changes in June 2009 and December 2009 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:to="label_cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:title="label: OwnershipChangesInJune2009AndDecember2009Member to label_cldx_OwnershipChangesInJune2009AndDecember2009Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangesInJune2009AndDecember2009Member_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OwnershipChangesInJune2009AndDecember2009Member" xml:lang="en-US" id="label_cldx_OwnershipChangesInJune2009AndDecember2009Member_1">Details pertaining to ownership changes June 2009 and December 2009.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:to="label_cldx_OwnershipChangesInJune2009AndDecember2009Member_1" xlink:title="label: OwnershipChangesInJune2009AndDecember2009Member to label_cldx_OwnershipChangesInJune2009AndDecember2009Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OwnershipChangesInJune2009AndDecember2009Member_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OwnershipChangesInJune2009AndDecember2009Member" xml:lang="en-US" id="label_cldx_OwnershipChangesInJune2009AndDecember2009Member_2">Ownership changes in June 2009 and December 2009</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:to="label_cldx_OwnershipChangesInJune2009AndDecember2009Member_2" xlink:title="label: OwnershipChangesInJune2009AndDecember2009Member to label_cldx_OwnershipChangesInJune2009AndDecember2009Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:label="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:title="PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xml:lang="en-US" id="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange">Period of Recognition of Unrealized Gain (loss) after Ownership Change</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:to="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:title="label: PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange to label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xml:lang="en-US" id="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange_1">Represents the period of recognition of unrealized gain (loss) after ownership change.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:to="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange_1" xlink:title="label: PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange to label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xml:lang="en-US" id="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange_2">Period of recognition of unrealized loss or gain after the ownership change</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:to="label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange_2" xlink:title="label: PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange to label_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PriorToAcquisitionMember" xlink:label="cldx_PriorToAcquisitionMember" xlink:title="PriorToAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PriorToAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PriorToAcquisitionMember" xml:lang="en-US" id="label_cldx_PriorToAcquisitionMember">Prior to Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PriorToAcquisitionMember" xlink:to="label_cldx_PriorToAcquisitionMember" xlink:title="label: PriorToAcquisitionMember to label_cldx_PriorToAcquisitionMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PriorToAcquisitionMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PriorToAcquisitionMember" xml:lang="en-US" id="label_cldx_PriorToAcquisitionMember_1">Details prior to acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PriorToAcquisitionMember" xlink:to="label_cldx_PriorToAcquisitionMember_1" xlink:title="label: PriorToAcquisitionMember to label_cldx_PriorToAcquisitionMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PriorToAcquisitionMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PriorToAcquisitionMember" xml:lang="en-US" id="label_cldx_PriorToAcquisitionMember_2">Prior to acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PriorToAcquisitionMember" xlink:to="label_cldx_PriorToAcquisitionMember_2" xlink:title="label: PriorToAcquisitionMember to label_cldx_PriorToAcquisitionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PriorToMergerMember" xlink:label="cldx_PriorToMergerMember" xlink:title="PriorToMergerMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PriorToMergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_PriorToMergerMember" xml:lang="en-US" id="label_cldx_PriorToMergerMember">Prior to Merger [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PriorToMergerMember" xlink:to="label_cldx_PriorToMergerMember" xlink:title="label: PriorToMergerMember to label_cldx_PriorToMergerMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PriorToMergerMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_PriorToMergerMember" xml:lang="en-US" id="label_cldx_PriorToMergerMember_1">Details prior to merger.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PriorToMergerMember" xlink:to="label_cldx_PriorToMergerMember_1" xlink:title="label: PriorToMergerMember to label_cldx_PriorToMergerMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_PriorToMergerMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_PriorToMergerMember" xml:lang="en-US" id="label_cldx_PriorToMergerMember_2">Prior to merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PriorToMergerMember" xlink:to="label_cldx_PriorToMergerMember_2" xlink:title="label: PriorToMergerMember to label_cldx_PriorToMergerMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionAxis" xlink:label="cldx_StatusOfMergerAndAcquisitionAxis" xlink:title="StatusOfMergerAndAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StatusOfMergerAndAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StatusOfMergerAndAcquisitionAxis" xml:lang="en-US" id="label_cldx_StatusOfMergerAndAcquisitionAxis">Status of Merger and Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StatusOfMergerAndAcquisitionAxis" xlink:to="label_cldx_StatusOfMergerAndAcquisitionAxis" xlink:title="label: StatusOfMergerAndAcquisitionAxis to label_cldx_StatusOfMergerAndAcquisitionAxis" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StatusOfMergerAndAcquisitionAxis_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StatusOfMergerAndAcquisitionAxis" xml:lang="en-US" id="label_cldx_StatusOfMergerAndAcquisitionAxis_1">Information pertaining to status of merger and acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StatusOfMergerAndAcquisitionAxis" xlink:to="label_cldx_StatusOfMergerAndAcquisitionAxis_1" xlink:title="label: StatusOfMergerAndAcquisitionAxis to label_cldx_StatusOfMergerAndAcquisitionAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionDomain" xlink:label="cldx_StatusOfMergerAndAcquisitionDomain" xlink:title="StatusOfMergerAndAcquisitionDomain" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StatusOfMergerAndAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_StatusOfMergerAndAcquisitionDomain" xml:lang="en-US" id="label_cldx_StatusOfMergerAndAcquisitionDomain">Status of Merger and Acquisition [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StatusOfMergerAndAcquisitionDomain" xlink:to="label_cldx_StatusOfMergerAndAcquisitionDomain" xlink:title="label: StatusOfMergerAndAcquisitionDomain to label_cldx_StatusOfMergerAndAcquisitionDomain" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_StatusOfMergerAndAcquisitionDomain_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_StatusOfMergerAndAcquisitionDomain" xml:lang="en-US" id="label_cldx_StatusOfMergerAndAcquisitionDomain_1">Details of status of merger and acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StatusOfMergerAndAcquisitionDomain" xlink:to="label_cldx_StatusOfMergerAndAcquisitionDomain_1" xlink:title="label: StatusOfMergerAndAcquisitionDomain to label_cldx_StatusOfMergerAndAcquisitionDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentFiscalYearFocus" xml:lang="en-US" id="label_dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to label_dei_DocumentFiscalYearFocus" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:label="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:title="TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" />
    <link:label xlink:type="resource" xlink:label="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xml:lang="en-US" id="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse">Tax Credit Carryforward Amount with Substantial Limitations on Use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:to="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:title="label: TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse to label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xml:lang="en-US" id="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse_1">The amount of the tax credit carryforward, with substantial limitations on use before tax effects, available to reduce future taxable income under enacted tax laws.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:to="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse_1" xlink:title="label: TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse to label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xml:lang="en-US" id="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse_2">Tax credit carryforwards with substantial limitations on use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:to="label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse_2" xlink:title="label: TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse to label_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="label_dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to label_dei_DocumentFiscalPeriodFocus" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:label="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:title="OperatingLossAndTaxCreditCarryforwardsTable" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xml:lang="en-US" id="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable">Operating Loss and Tax Credit Carryforwards [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:title="label: OperatingLossAndTaxCreditCarryforwardsTable to label_cldx_OperatingLossAndTaxCreditCarryforwardsTable" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xml:lang="en-US" id="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable_1">Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss and tax credit carryforwards, including an assessment of the likelihood of utilization.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="label_cldx_OperatingLossAndTaxCreditCarryforwardsTable_1" xlink:title="label: OperatingLossAndTaxCreditCarryforwardsTable to label_cldx_OperatingLossAndTaxCreditCarryforwardsTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:label="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:title="CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xml:lang="en-US" id="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember">Collaborative Arrangement for Development and Commercialization of Product [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:to="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:title="label: CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember to label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xml:lang="en-US" id="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_1">Collaboration arrangement for development and commercialization of oral rotavirus strain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:to="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_1" xlink:title="label: CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember to label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xml:lang="en-US" id="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_2">Details pertaining to collaboration arrangement for development and commercialization of product.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:to="label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember_2" xlink:title="label: CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember to label_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RoyaltyAgreementMember" xlink:label="cldx_RoyaltyAgreementMember" xlink:title="RoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RoyaltyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RoyaltyAgreementMember" xml:lang="en-US" id="label_cldx_RoyaltyAgreementMember">Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RoyaltyAgreementMember" xlink:to="label_cldx_RoyaltyAgreementMember" xlink:title="label: RoyaltyAgreementMember to label_cldx_RoyaltyAgreementMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RoyaltyAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RoyaltyAgreementMember" xml:lang="en-US" id="label_cldx_RoyaltyAgreementMember_1">Royalty Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RoyaltyAgreementMember" xlink:to="label_cldx_RoyaltyAgreementMember_1" xlink:title="label: RoyaltyAgreementMember to label_cldx_RoyaltyAgreementMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RoyaltyAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RoyaltyAgreementMember" xml:lang="en-US" id="label_cldx_RoyaltyAgreementMember_2">Details pertaining to royalty agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RoyaltyAgreementMember" xlink:to="label_cldx_RoyaltyAgreementMember_2" xlink:title="label: RoyaltyAgreementMember to label_cldx_RoyaltyAgreementMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:label="cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:title="CincinnatiChildrensHospitalMedicalCenterMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xml:lang="en-US" id="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember">Cincinnati Children's Hospital Medical Center</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:to="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:title="label: CincinnatiChildrensHospitalMedicalCenterMember to label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xml:lang="en-US" id="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember_1">Represents information related to Cincinnati Children's Hospital Medical Center.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:to="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember_1" xlink:title="label: CincinnatiChildrensHospitalMedicalCenterMember to label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xml:lang="en-US" id="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember_2">Cincinnati Children's Hospital Medical Center [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:to="label_cldx_CincinnatiChildrensHospitalMedicalCenterMember_2" xlink:title="label: CincinnatiChildrensHospitalMedicalCenterMember to label_cldx_CincinnatiChildrensHospitalMedicalCenterMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:label="cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:title="DukeUniversityAndThomasJeffersonUniversityMember" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xml:lang="en-US" id="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember">Represents information related to Duke University and Thomas Jefferson University.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:to="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:title="label: DukeUniversityAndThomasJeffersonUniversityMember to label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xml:lang="en-US" id="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember_1">Duke University and Thomas Jefferson University [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:to="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember_1" xlink:title="label: DukeUniversityAndThomasJeffersonUniversityMember to label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xml:lang="en-US" id="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember_2">Duke University and Thomas Jefferson University</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:to="label_cldx_DukeUniversityAndThomasJeffersonUniversityMember_2" xlink:title="label: DukeUniversityAndThomasJeffersonUniversityMember to label_cldx_DukeUniversityAndThomasJeffersonUniversityMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockSharesAvailableForSale" xlink:label="cldx_CommonStockSharesAvailableForSale" xlink:title="CommonStockSharesAvailableForSale" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockSharesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CommonStockSharesAvailableForSale" xml:lang="en-US" id="label_cldx_CommonStockSharesAvailableForSale">Common stock available for sale (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockSharesAvailableForSale" xlink:to="label_cldx_CommonStockSharesAvailableForSale" xlink:title="label: CommonStockSharesAvailableForSale to label_cldx_CommonStockSharesAvailableForSale" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockSharesAvailableForSale_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CommonStockSharesAvailableForSale" xml:lang="en-US" id="label_cldx_CommonStockSharesAvailableForSale_1">Common Stock Shares Available For Sale</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockSharesAvailableForSale" xlink:to="label_cldx_CommonStockSharesAvailableForSale_1" xlink:title="label: CommonStockSharesAvailableForSale to label_cldx_CommonStockSharesAvailableForSale" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockSharesAvailableForSale_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CommonStockSharesAvailableForSale" xml:lang="en-US" id="label_cldx_CommonStockSharesAvailableForSale_2">Represents the common stock available for sale.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockSharesAvailableForSale" xlink:to="label_cldx_CommonStockSharesAvailableForSale_2" xlink:title="label: CommonStockSharesAvailableForSale to label_cldx_CommonStockSharesAvailableForSale" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:label="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xml:lang="en-US" id="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits">Expiration of Net Operating Losses and Research and Development Tax Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:to="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="label: ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits to label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xml:lang="en-US" id="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_1">Reflects the amounts of net operating losses and research and development tax credits expired during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:to="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_1" xlink:title="label: ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits to label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xml:lang="en-US" id="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_2">Expiration of Net Operating Losses and Research &amp; Development Tax Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:to="label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits_2" xlink:title="label: ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits to label_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:label="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:title="CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xml:lang="en-US" id="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters">Common Stock Available For Sale Lock up Period to be Waived by Underwriters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:to="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:title="label: CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters to label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xml:lang="en-US" id="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters_1">Lock-up period to be waived by underwriters</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:to="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters_1" xlink:title="label: CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters to label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xml:lang="en-US" id="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters_2">Represents the lock-up period to be waived by underwriters for remaining aggregate offering price available to the entity for the issuance of common stock as per the amended agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:to="label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters_2" xlink:title="label: CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters to label_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ValueAtWhichTaxBenefitsSold" xlink:label="cldx_ValueAtWhichTaxBenefitsSold" xlink:title="ValueAtWhichTaxBenefitsSold" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ValueAtWhichTaxBenefitsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ValueAtWhichTaxBenefitsSold" xml:lang="en-US" id="label_cldx_ValueAtWhichTaxBenefitsSold">Represents the value at which tax benefit sold by the entity during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueAtWhichTaxBenefitsSold" xlink:to="label_cldx_ValueAtWhichTaxBenefitsSold" xlink:title="label: ValueAtWhichTaxBenefitsSold to label_cldx_ValueAtWhichTaxBenefitsSold" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ValueAtWhichTaxBenefitsSold_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ValueAtWhichTaxBenefitsSold" xml:lang="en-US" id="label_cldx_ValueAtWhichTaxBenefitsSold_1">Value at which Tax Benefits Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueAtWhichTaxBenefitsSold" xlink:to="label_cldx_ValueAtWhichTaxBenefitsSold_1" xlink:title="label: ValueAtWhichTaxBenefitsSold to label_cldx_ValueAtWhichTaxBenefitsSold" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ValueAtWhichTaxBenefitsSold_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ValueAtWhichTaxBenefitsSold" xml:lang="en-US" id="label_cldx_ValueAtWhichTaxBenefitsSold_2">Amount of sale of New Jersey tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueAtWhichTaxBenefitsSold" xlink:to="label_cldx_ValueAtWhichTaxBenefitsSold_2" xlink:title="label: ValueAtWhichTaxBenefitsSold to label_cldx_ValueAtWhichTaxBenefitsSold" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:title="FairValueAssetsAmountTransfersBetweenMeasurementLevels" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xml:lang="en-US" id="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels">Assets transferred between the fair value measurement classifications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:to="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:title="label: FairValueAssetsAmountTransfersBetweenMeasurementLevels to label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xml:lang="en-US" id="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_1">Represents the amount of transfer of assets measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:to="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_1" xlink:title="label: FairValueAssetsAmountTransfersBetweenMeasurementLevels to label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xml:lang="en-US" id="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_2">Fair Value Assets Amount Transfers between Measurement Levels</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:to="label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_2" xlink:title="label: FairValueAssetsAmountTransfersBetweenMeasurementLevels to label_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:title="FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xml:lang="en-US" id="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels">Fair Value Liabilities Amount Transfers between Measurement Levels</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:to="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:title="label: FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels to label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xml:lang="en-US" id="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_1">Liabilities transferred between the fair value measurement classifications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:to="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_1" xlink:title="label: FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels to label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xml:lang="en-US" id="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_2">Represents the amount of transfer of liabilities measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:to="label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_2" xlink:title="label: FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels to label_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:title="AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired">Marketable securities considered to be other-than-temporarily impaired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:to="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:title="label: AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired to label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_1">Represents the amount of investment in debt and equity securities considered to be other-than-temporarily impaired, categorized neither as held-to-maturity nor trading.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:to="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_1" xlink:title="label: AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired to label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_2">Available For Sale Securities, Considered to be Other than Temporarily Impaired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:to="label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_2" xlink:title="label: AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired to label_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentType" xml:lang="en-US" id="label_dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="label_dei_DocumentType" xlink:title="label: DocumentType to label_dei_DocumentType" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:label="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:title="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xml:lang="en-US" id="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour">Debt Instrument, Covenant Rate of Prepayment Premium in Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:to="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:title="label: DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour to label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xml:lang="en-US" id="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour_1">Rate of prepayment premium in year four (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:to="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour_1" xlink:title="label: DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour to label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xml:lang="en-US" id="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour_2">Represents the percentage of prepayment premium on the term loan to be paid in year four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:to="label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour_2" xlink:title="label: DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour to label_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US" id="label_us-gaap_AccountingPoliciesAbstract">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="label_us-gaap_AccountingPoliciesAbstract" xlink:title="label: AccountingPoliciesAbstract to label_us-gaap_AccountingPoliciesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:title="AccumulatedOtherComprehensiveIncomeLossRollForward" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xml:lang="en-US" id="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossRollForward to label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xml:lang="en-US" id="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_1">Changes in accumulated other comprehensive income (loss) by component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_1" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossRollForward to label_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesTermOfLease" xlink:label="cldx_OperatingLeasesTermOfLease" xlink:title="OperatingLeasesTermOfLease" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesTermOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLeasesTermOfLease" xml:lang="en-US" id="label_cldx_OperatingLeasesTermOfLease">Operating Leases Term of Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesTermOfLease" xlink:to="label_cldx_OperatingLeasesTermOfLease" xlink:title="label: OperatingLeasesTermOfLease to label_cldx_OperatingLeasesTermOfLease" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesTermOfLease_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLeasesTermOfLease" xml:lang="en-US" id="label_cldx_OperatingLeasesTermOfLease_1">Term of lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesTermOfLease" xlink:to="label_cldx_OperatingLeasesTermOfLease_1" xlink:title="label: OperatingLeasesTermOfLease to label_cldx_OperatingLeasesTermOfLease" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesTermOfLease_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLeasesTermOfLease" xml:lang="en-US" id="label_cldx_OperatingLeasesTermOfLease_2">Represents the term of lease under the lease agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesTermOfLease" xlink:to="label_cldx_OperatingLeasesTermOfLease_2" xlink:title="label: OperatingLeasesTermOfLease to label_cldx_OperatingLeasesTermOfLease" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:label="cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:title="OperatingLeasesPeriodOfRenewalOptions" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLeasesPeriodOfRenewalOptions" xml:lang="en-US" id="label_cldx_OperatingLeasesPeriodOfRenewalOptions">Operating Leases Period of Renewal Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:to="label_cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:title="label: OperatingLeasesPeriodOfRenewalOptions to label_cldx_OperatingLeasesPeriodOfRenewalOptions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesPeriodOfRenewalOptions_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLeasesPeriodOfRenewalOptions" xml:lang="en-US" id="label_cldx_OperatingLeasesPeriodOfRenewalOptions_1">Period of each renewal option</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:to="label_cldx_OperatingLeasesPeriodOfRenewalOptions_1" xlink:title="label: OperatingLeasesPeriodOfRenewalOptions to label_cldx_OperatingLeasesPeriodOfRenewalOptions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesPeriodOfRenewalOptions_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLeasesPeriodOfRenewalOptions" xml:lang="en-US" id="label_cldx_OperatingLeasesPeriodOfRenewalOptions_2">Represents the period of each renewal option under the lease agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:to="label_cldx_OperatingLeasesPeriodOfRenewalOptions_2" xlink:title="label: OperatingLeasesPeriodOfRenewalOptions to label_cldx_OperatingLeasesPeriodOfRenewalOptions" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:label="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:title="OperatingLeasesCommencementPeriodOfRentalObligations" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xml:lang="en-US" id="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations">Operating Leases Commencement Period of Rental Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:to="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:title="label: OperatingLeasesCommencementPeriodOfRentalObligations to label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xml:lang="en-US" id="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations_1">Period from the lease commencement date after which the Company's obligation to pay rent commences</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:to="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations_1" xlink:title="label: OperatingLeasesCommencementPeriodOfRentalObligations to label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xml:lang="en-US" id="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations_2">Represents the period from the lease commencement date after which the entity's obligation to pay rent commences.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:to="label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations_2" xlink:title="label: OperatingLeasesCommencementPeriodOfRentalObligations to label_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesNumberOfRenewalOptions" xlink:label="cldx_OperatingLeasesNumberOfRenewalOptions" xlink:title="OperatingLeasesNumberOfRenewalOptions" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_OperatingLeasesNumberOfRenewalOptions" xml:lang="en-US" id="label_cldx_OperatingLeasesNumberOfRenewalOptions">Operating Leases Number of Renewal Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesNumberOfRenewalOptions" xlink:to="label_cldx_OperatingLeasesNumberOfRenewalOptions" xlink:title="label: OperatingLeasesNumberOfRenewalOptions to label_cldx_OperatingLeasesNumberOfRenewalOptions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesNumberOfRenewalOptions_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_OperatingLeasesNumberOfRenewalOptions" xml:lang="en-US" id="label_cldx_OperatingLeasesNumberOfRenewalOptions_1">Number of renewal options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesNumberOfRenewalOptions" xlink:to="label_cldx_OperatingLeasesNumberOfRenewalOptions_1" xlink:title="label: OperatingLeasesNumberOfRenewalOptions to label_cldx_OperatingLeasesNumberOfRenewalOptions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_OperatingLeasesNumberOfRenewalOptions_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_OperatingLeasesNumberOfRenewalOptions" xml:lang="en-US" id="label_cldx_OperatingLeasesNumberOfRenewalOptions_2">Represents the number of renewal options under the lease agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_OperatingLeasesNumberOfRenewalOptions" xlink:to="label_cldx_OperatingLeasesNumberOfRenewalOptions_2" xlink:title="label: OperatingLeasesNumberOfRenewalOptions to label_cldx_OperatingLeasesNumberOfRenewalOptions" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:label="cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:title="RepaymentOfLongTermDebtPrincipalAmount" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_RepaymentOfLongTermDebtPrincipalAmount" xml:lang="en-US" id="label_cldx_RepaymentOfLongTermDebtPrincipalAmount">Repayment of Long Term Debt Principal Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:to="label_cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:title="label: RepaymentOfLongTermDebtPrincipalAmount to label_cldx_RepaymentOfLongTermDebtPrincipalAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RepaymentOfLongTermDebtPrincipalAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_RepaymentOfLongTermDebtPrincipalAmount" xml:lang="en-US" id="label_cldx_RepaymentOfLongTermDebtPrincipalAmount_1">Repayment of principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:to="label_cldx_RepaymentOfLongTermDebtPrincipalAmount_1" xlink:title="label: RepaymentOfLongTermDebtPrincipalAmount to label_cldx_RepaymentOfLongTermDebtPrincipalAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_RepaymentOfLongTermDebtPrincipalAmount_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_RepaymentOfLongTermDebtPrincipalAmount" xml:lang="en-US" id="label_cldx_RepaymentOfLongTermDebtPrincipalAmount_2">Represents the amount of principal repaid by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:to="label_cldx_RepaymentOfLongTermDebtPrincipalAmount_2" xlink:title="label: RepaymentOfLongTermDebtPrincipalAmount to label_cldx_RepaymentOfLongTermDebtPrincipalAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:label="cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:title="DebtInstrumentInterestAndPrepaymentFees" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DebtInstrumentInterestAndPrepaymentFees" xml:lang="en-US" id="label_cldx_DebtInstrumentInterestAndPrepaymentFees">Represents the amount of interest, prepayment and final payment fees paid by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:to="label_cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:title="label: DebtInstrumentInterestAndPrepaymentFees to label_cldx_DebtInstrumentInterestAndPrepaymentFees" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentInterestAndPrepaymentFees_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DebtInstrumentInterestAndPrepaymentFees" xml:lang="en-US" id="label_cldx_DebtInstrumentInterestAndPrepaymentFees_1">Debt Instrument, Interest and Prepayment Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:to="label_cldx_DebtInstrumentInterestAndPrepaymentFees_1" xlink:title="label: DebtInstrumentInterestAndPrepaymentFees to label_cldx_DebtInstrumentInterestAndPrepaymentFees" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DebtInstrumentInterestAndPrepaymentFees_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DebtInstrumentInterestAndPrepaymentFees" xml:lang="en-US" id="label_cldx_DebtInstrumentInterestAndPrepaymentFees_2">Amount of interest, prepayment and final payment fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:to="label_cldx_DebtInstrumentInterestAndPrepaymentFees_2" xlink:title="label: DebtInstrumentInterestAndPrepaymentFees to label_cldx_DebtInstrumentInterestAndPrepaymentFees" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments">Available For Sale Securities, Gross Unrealized Gain Accumulated in Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_1">Amount of accumulated unrealized gain before deducting unrealized loss on investments in available-for-sale securities impacting investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_1" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_2">Gross Unrealized Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_2" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments">Available For Sale Securities, Gross Unrealized Loss Accumulated in Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_1">Amount of accumulated unrealized loss before deducting unrealized gain on investments in available-for-sale securities impacting investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_1" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_2" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xml:lang="en-US" id="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_2">Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:to="label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_2" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments to label_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:label="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:title="IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xml:lang="en-US" id="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance">Income Tax Expense (Benefit) before Change in Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:title="label: IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xml:lang="en-US" id="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance_1">Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations before the effect of the change during the period in the valuation allowance for a specified deferred tax asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance_1" xlink:title="label: IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance_2" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xml:lang="en-US" id="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance_2">Income tax benefit (provision) before valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:to="label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance_2" xlink:title="label: IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance to label_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:label="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:title="CollaborativeArrangementNumberOfAntiHIVAntibodies" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xml:lang="en-US" id="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies">Represents the number of anti-HIV antibodies which are subject to the agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:to="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:title="label: CollaborativeArrangementNumberOfAntiHIVAntibodies to label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xml:lang="en-US" id="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies_1">Collaborative Arrangement Number of Anti HIV Antibodies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:to="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies_1" xlink:title="label: CollaborativeArrangementNumberOfAntiHIVAntibodies to label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xml:lang="en-US" id="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies_2">Number of anti-HIV antibodies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:to="label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies_2" xlink:title="label: CollaborativeArrangementNumberOfAntiHIVAntibodies to label_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:label="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:title="CollaborativeArrangementEstimatedCostForDevelopmentServices" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xml:lang="en-US" id="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices">Collaborative Arrangement Estimated Cost for Development Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:to="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:title="label: CollaborativeArrangementEstimatedCostForDevelopmentServices to label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xml:lang="en-US" id="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices_1">Represents the estimated cost for the development services under the agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:to="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices_1" xlink:title="label: CollaborativeArrangementEstimatedCostForDevelopmentServices to label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xml:lang="en-US" id="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices_2">Approved project plan for the development services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:to="label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices_2" xlink:title="label: CollaborativeArrangementEstimatedCostForDevelopmentServices to label_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:label="cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:title="CollaborativeArrangementUpfrontPaymentAmount" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementUpfrontPaymentAmount" xml:lang="en-US" id="label_cldx_CollaborativeArrangementUpfrontPaymentAmount">Collaborative Arrangement Upfront Payment Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:to="label_cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:title="label: CollaborativeArrangementUpfrontPaymentAmount to label_cldx_CollaborativeArrangementUpfrontPaymentAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementUpfrontPaymentAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementUpfrontPaymentAmount" xml:lang="en-US" id="label_cldx_CollaborativeArrangementUpfrontPaymentAmount_1">Upfront payment recognized as revenue over the term of the agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:to="label_cldx_CollaborativeArrangementUpfrontPaymentAmount_1" xlink:title="label: CollaborativeArrangementUpfrontPaymentAmount to label_cldx_CollaborativeArrangementUpfrontPaymentAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementUpfrontPaymentAmount_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementUpfrontPaymentAmount" xml:lang="en-US" id="label_cldx_CollaborativeArrangementUpfrontPaymentAmount_2">Represents the amount of upfront payment for development services, which is recorded by the entity as revenue over the term of the agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:to="label_cldx_CollaborativeArrangementUpfrontPaymentAmount_2" xlink:title="label: CollaborativeArrangementUpfrontPaymentAmount to label_cldx_CollaborativeArrangementUpfrontPaymentAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:label="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:title="CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xml:lang="en-US" id="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member">Celldex Research Equity Incentive Plan 2005 and CuraGen Stock Plan 2007 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:to="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:title="label: CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member to label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xml:lang="en-US" id="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member_1">Celldex Research 2005 Plan and CuraGen 2007 Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:to="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member_1" xlink:title="label: CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member to label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xml:lang="en-US" id="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member_2">Represents information pertaining to Celldex Research's 2005 Equity Incentive Plan and CuraGen 2007 Stock Plan of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:to="label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member_2" xlink:title="label: CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member to label_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:label="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized">Deferred Tax Assets, Operating Loss Carryforwards not yet Utilized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:to="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized to label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized_1">Assets recorded for net operating losses not yet utilized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:to="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized_1" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized to label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xml:lang="en-US" id="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized_2">Represents amount of deferred tax assets attributable to deductible operating loss carryforwards not yet utilized.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:to="label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized_2" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized to label_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:label="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:title="CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xml:lang="en-US" id="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric">Collaborative Arrangement Milestone Payments Made in Connection with Initiation of Metric</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:to="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:title="label: CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric to label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xml:lang="en-US" id="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric_1">Payment made in connection with initiation of METRIC</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:to="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric_1" xlink:title="label: CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric to label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xml:lang="en-US" id="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric_2">Represents the amount of payment made in connection with the initiation of METRIC, based on the terms of the collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:to="label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric_2" xlink:title="label: CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric to label_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" use="optional" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ExpectedDividendPayableInForeseeableFuture" xlink:label="cldx_ExpectedDividendPayableInForeseeableFuture" xlink:title="ExpectedDividendPayableInForeseeableFuture" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ExpectedDividendPayableInForeseeableFuture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_cldx_ExpectedDividendPayableInForeseeableFuture" xml:lang="en-US" id="label_cldx_ExpectedDividendPayableInForeseeableFuture">Expected dividend payable in foreseeable future</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ExpectedDividendPayableInForeseeableFuture" xlink:to="label_cldx_ExpectedDividendPayableInForeseeableFuture" xlink:title="label: ExpectedDividendPayableInForeseeableFuture to label_cldx_ExpectedDividendPayableInForeseeableFuture" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ExpectedDividendPayableInForeseeableFuture_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_cldx_ExpectedDividendPayableInForeseeableFuture" xml:lang="en-US" id="label_cldx_ExpectedDividendPayableInForeseeableFuture_1">Represents the amount of expected dividend payable in foreseeable future.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ExpectedDividendPayableInForeseeableFuture" xlink:to="label_cldx_ExpectedDividendPayableInForeseeableFuture_1" xlink:title="label: ExpectedDividendPayableInForeseeableFuture to label_cldx_ExpectedDividendPayableInForeseeableFuture" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_cldx_ExpectedDividendPayableInForeseeableFuture_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_cldx_ExpectedDividendPayableInForeseeableFuture" xml:lang="en-US" id="label_cldx_ExpectedDividendPayableInForeseeableFuture_2">Expected Dividend Payable in Foreseeable Future</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ExpectedDividendPayableInForeseeableFuture" xlink:to="label_cldx_ExpectedDividendPayableInForeseeableFuture_2" xlink:title="label: ExpectedDividendPayableInForeseeableFuture to label_cldx_ExpectedDividendPayableInForeseeableFuture" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccountsAndOtherReceivablesNetCurrent" xml:lang="en-US" id="label_us-gaap_AccountsAndOtherReceivablesNetCurrent">Accounts and Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="label_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to label_us-gaap_AccountsAndOtherReceivablesNetCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsAndOtherReceivablesNetCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsAndOtherReceivablesNetCurrent" xml:lang="en-US" id="label_us-gaap_AccountsAndOtherReceivablesNetCurrent_1">Accounts and Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="label_us-gaap_AccountsAndOtherReceivablesNetCurrent_1" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to label_us-gaap_AccountsAndOtherReceivablesNetCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:title="AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xml:lang="en-US" id="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:title="label: AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock to label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xml:lang="en-US" id="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_1">ACCRUED EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_1" xlink:title="label: AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock to label_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccountsPayableCurrent" xml:lang="en-US" id="label_us-gaap_AccountsPayableCurrent">Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="label_us-gaap_AccountsPayableCurrent" xlink:title="label: AccountsPayableCurrent to label_us-gaap_AccountsPayableCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsPayableCurrent" xml:lang="en-US" id="label_us-gaap_AccountsPayableCurrent_1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="label_us-gaap_AccountsPayableCurrent_1" xlink:title="label: AccountsPayableCurrent to label_us-gaap_AccountsPayableCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xml:lang="en-US" id="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">Amortization and Premium of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="label: AccretionAmortizationOfDiscountsAndPremiumsInvestments to label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xml:lang="en-US" id="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1" xlink:title="label: AccretionAmortizationOfDiscountsAndPremiumsInvestments to label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent" xlink:title="label: AccruedLiabilitiesCurrent to label_us-gaap_AccruedLiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent_1">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent_1" xlink:title="label: AccruedLiabilitiesCurrent to label_us-gaap_AccruedLiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent_2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent_2" xlink:title="label: AccruedLiabilitiesCurrent to label_us-gaap_AccruedLiabilitiesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedProfessionalFeesCurrent">Accrued Professional Fees, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="label_us-gaap_AccruedProfessionalFeesCurrent" xlink:title="label: AccruedProfessionalFeesCurrent to label_us-gaap_AccruedProfessionalFeesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedProfessionalFeesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedProfessionalFeesCurrent_1">Accrued Professional Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="label_us-gaap_AccruedProfessionalFeesCurrent_1" xlink:title="label: AccruedProfessionalFeesCurrent to label_us-gaap_AccruedProfessionalFeesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">Less Accumulated Depreciation and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:title="AccumulatedNetUnrealizedInvestmentGainLossMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xml:lang="en-US" id="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">Unrealized Gain (Loss) on Marketable Securities, net of tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:title="label: AccumulatedNetUnrealizedInvestmentGainLossMember to label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xml:lang="en-US" id="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1">Accumulated Net Unrealized Investment Gain (Loss) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1" xlink:title="label: AccumulatedNetUnrealizedInvestmentGainLossMember to label_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">Accumulated Other Comprehensive Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1">Balance at the beginning of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2">Balance at the end of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember">Accumulated Other Comprehensive Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:title="label: AccumulatedOtherComprehensiveIncomeMember to label_us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1" xlink:title="label: AccumulatedOtherComprehensiveIncomeMember to label_us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">Net unrealized gain related to foreign currency translation included in accumulated other comprehensive income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:title="AccumulatedOtherComprehensiveIncomeLossLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">Comprehensive Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossLineItems to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossLineItems to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:title="AccumulatedOtherComprehensiveIncomeLossTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossTable to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:title="AccumulatedTranslationAdjustmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedTranslationAdjustmentMember" xml:lang="en-US" id="label_us-gaap_AccumulatedTranslationAdjustmentMember">Foreign Currency Items</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="label_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:title="label: AccumulatedTranslationAdjustmentMember to label_us-gaap_AccumulatedTranslationAdjustmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedTranslationAdjustmentMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedTranslationAdjustmentMember" xml:lang="en-US" id="label_us-gaap_AccumulatedTranslationAdjustmentMember_1">Accumulated Translation Adjustment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="label_us-gaap_AccumulatedTranslationAdjustmentMember_1" xlink:title="label: AccumulatedTranslationAdjustmentMember to label_us-gaap_AccumulatedTranslationAdjustmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="AdditionalPaidInCapitalCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalCommonStock">Additional Paid-In Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="label_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="label: AdditionalPaidInCapitalCommonStock to label_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalCommonStock_1">Additional Paid in Capital, Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="label_us-gaap_AdditionalPaidInCapitalCommonStock_1" xlink:title="label: AdditionalPaidInCapitalCommonStock to label_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalMember">Additional Paid-In Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember" xlink:title="label: AdditionalPaidInCapitalMember to label_us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalMember_1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember_1" xlink:title="label: AdditionalPaidInCapitalMember to label_us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">Adjustments to Reconcile Net Loss to Cash Used in Operating Activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">Share-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense">Total stock-based compensation expense (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="label: AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense_1">Allocated Share-based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xlink:title="label: AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US" id="label_us-gaap_AmortizationOfIntangibleAssets">Amortization of Acquired Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="label_us-gaap_AmortizationOfIntangibleAssets" xlink:title="label: AmortizationOfIntangibleAssets to label_us-gaap_AmortizationOfIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfIntangibleAssets_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US" id="label_us-gaap_AmortizationOfIntangibleAssets_1">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="label_us-gaap_AmortizationOfIntangibleAssets_1" xlink:title="label: AmortizationOfIntangibleAssets to label_us-gaap_AmortizationOfIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfIntangibleAssets_2" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US" id="label_us-gaap_AmortizationOfIntangibleAssets_2">Amortization expense for intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="label_us-gaap_AmortizationOfIntangibleAssets_2" xlink:title="label: AmortizationOfIntangibleAssets to label_us-gaap_AmortizationOfIntangibleAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfIntangibleAssets_3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US" id="label_us-gaap_AmortizationOfIntangibleAssets_3">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="label_us-gaap_AmortizationOfIntangibleAssets_3" xlink:title="label: AmortizationOfIntangibleAssets to label_us-gaap_AmortizationOfIntangibleAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="AmortizationOfDebtDiscountPremium" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US" id="label_us-gaap_AmortizationOfDebtDiscountPremium">Non-Cash Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="label_us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="label: AmortizationOfDebtDiscountPremium to label_us-gaap_AmortizationOfDebtDiscountPremium" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfDebtDiscountPremium_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US" id="label_us-gaap_AmortizationOfDebtDiscountPremium_1">Amortization of Debt Discount (Premium)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="label_us-gaap_AmortizationOfDebtDiscountPremium_1" xlink:title="label: AmortizationOfDebtDiscountPremium to label_us-gaap_AmortizationOfDebtDiscountPremium" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">Anti-dilutive securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1">Net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesNameDomain">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="label_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="label: AntidilutiveSecuritiesNameDomain to label_us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_Assets" xml:lang="en-US" id="label_us-gaap_Assets">Total Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="label_us-gaap_Assets" xlink:title="label: Assets to label_us-gaap_Assets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Assets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Assets" xml:lang="en-US" id="label_us-gaap_Assets_1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="label_us-gaap_Assets_1" xlink:title="label: Assets to label_us-gaap_Assets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract">Current Assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract" xlink:title="label: AssetsCurrentAbstract to label_us-gaap_AssetsCurrentAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract_1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract_1" xlink:title="label: AssetsCurrentAbstract to label_us-gaap_AssetsCurrentAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AssetsAbstract" xml:lang="en-US" id="label_us-gaap_AssetsAbstract">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract" xlink:title="label: AssetsAbstract to label_us-gaap_AssetsAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsAbstract" xml:lang="en-US" id="label_us-gaap_AssetsAbstract_1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract_1" xlink:title="label: AssetsAbstract to label_us-gaap_AssetsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AssetsCurrent" xml:lang="en-US" id="label_us-gaap_AssetsCurrent">Total Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent" xlink:title="label: AssetsCurrent to label_us-gaap_AssetsCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsCurrent" xml:lang="en-US" id="label_us-gaap_AssetsCurrent_1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent_1" xlink:title="label: AssetsCurrent to label_us-gaap_AssetsCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US" id="label_us-gaap_AssetsFairValueDisclosure">Total financial assets at fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="label_us-gaap_AssetsFairValueDisclosure" xlink:title="label: AssetsFairValueDisclosure to label_us-gaap_AssetsFairValueDisclosure" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsFairValueDisclosure_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US" id="label_us-gaap_AssetsFairValueDisclosure_1">Assets, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="label_us-gaap_AssetsFairValueDisclosure_1" xlink:title="label: AssetsFairValueDisclosure to label_us-gaap_AssetsFairValueDisclosure" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract">Gross Unrealized Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_1">Available-for-sale Securities, Gross Unrealized Gain [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_1" xlink:title="label: AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to label_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">Maturing in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_1">Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1">Maturing in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">Maturing in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_1">Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:title="AvailableForSaleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecurities" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecurities">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="label_us-gaap_AvailableForSaleSecurities" xlink:title="label: AvailableForSaleSecurities to label_us-gaap_AvailableForSaleSecurities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecurities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecurities" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecurities_1">Available-for-sale Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="label_us-gaap_AvailableForSaleSecurities_1" xlink:title="label: AvailableForSaleSecurities to label_us-gaap_AvailableForSaleSecurities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost">Amortized cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost_1">Available-for-sale Securities, Debt Maturities, Amortized Cost Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="label: AvailableForSaleSecuritiesDebtSecuritiesCurrent to label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1">Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1" xlink:title="label: AvailableForSaleSecuritiesDebtSecuritiesCurrent to label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2">Available-for-sale Securities, Debt Securities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2" xlink:title="label: AvailableForSaleSecuritiesDebtSecuritiesCurrent to label_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1">Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">Fair Value, rolling maturity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">Maturing in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xml:lang="en-US" id="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract">Amortized Cost, rolling maturity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:to="label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract to label_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" xlink:title="BasisOfAccounting" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_BasisOfAccounting" xml:lang="en-US" id="label_us-gaap_BasisOfAccounting">NATURE OF BUSINESS AND OVERVIEW</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="label_us-gaap_BasisOfAccounting" xlink:title="label: BasisOfAccounting to label_us-gaap_BasisOfAccounting" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BasisOfAccounting_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BasisOfAccounting" xml:lang="en-US" id="label_us-gaap_BasisOfAccounting_1">Basis of Accounting [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="label_us-gaap_BasisOfAccounting_1" xlink:title="label: BasisOfAccounting to label_us-gaap_BasisOfAccounting" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionAxis">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="label_us-gaap_BusinessAcquisitionAxis" xlink:title="label: BusinessAcquisitionAxis to label_us-gaap_BusinessAcquisitionAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_BusinessAcquisitionLineItems" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionLineItems">Acquisition of CuraGen Corporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="label_us-gaap_BusinessAcquisitionLineItems" xlink:title="label: BusinessAcquisitionLineItems to label_us-gaap_BusinessAcquisitionLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessAcquisitionLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessAcquisitionLineItems" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionLineItems_1">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="label_us-gaap_BusinessAcquisitionLineItems_1" xlink:title="label: BusinessAcquisitionLineItems to label_us-gaap_BusinessAcquisitionLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionAcquireeDomain">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="label_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="label: BusinessAcquisitionAcquireeDomain to label_us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" xlink:title="BusinessCombinationsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_BusinessCombinationsPolicy" xml:lang="en-US" id="label_us-gaap_BusinessCombinationsPolicy">Business Combinations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="label_us-gaap_BusinessCombinationsPolicy" xlink:title="label: BusinessCombinationsPolicy to label_us-gaap_BusinessCombinationsPolicy" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessCombinationsPolicy_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessCombinationsPolicy" xml:lang="en-US" id="label_us-gaap_BusinessCombinationsPolicy_1">Business Combinations Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="label_us-gaap_BusinessCombinationsPolicy_1" xlink:title="label: BusinessCombinationsPolicy to label_us-gaap_BusinessCombinationsPolicy" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CounterpartyNameAxis" xml:lang="en-US" id="label_us-gaap_CounterpartyNameAxis">Counterparty Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="label_us-gaap_CounterpartyNameAxis" xlink:title="label: CounterpartyNameAxis to label_us-gaap_CounterpartyNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1">Cash and Cash Equivalents at Beginning of Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2">Cash and Cash Equivalents at End of Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAcquiredFromAcquisition" xml:lang="en-US" id="label_us-gaap_CashAcquiredFromAcquisition">Cash Acquired in the CuraGen acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="label_us-gaap_CashAcquiredFromAcquisition" xlink:title="label: CashAcquiredFromAcquisition to label_us-gaap_CashAcquiredFromAcquisition" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAcquiredFromAcquisition_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAcquiredFromAcquisition" xml:lang="en-US" id="label_us-gaap_CashAcquiredFromAcquisition_1">Cash Acquired from Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="label_us-gaap_CashAcquiredFromAcquisition_1" xlink:title="label: CashAcquiredFromAcquisition to label_us-gaap_CashAcquiredFromAcquisition" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="CashAndCashEquivalentsFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure">Money market funds and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="label: CashAndCashEquivalentsFairValueDisclosure to label_us-gaap_CashAndCashEquivalentsFairValueDisclosure" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="label_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1" xlink:title="label: CashAndCashEquivalentsFairValueDisclosure to label_us-gaap_CashAndCashEquivalentsFairValueDisclosure" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">Supplemental Disclosure of Non-Cash Flow Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">Number of shares callable by rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">Exercise price (in dollars per unit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_1">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_1" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfStockDomain" xml:lang="en-US" id="label_us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="label_us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to label_us-gaap_ClassOfStockDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US" id="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">Collaborative Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="label: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US" id="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1">REVENUE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1" xlink:title="label: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US" id="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_2" xlink:title="label: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_3" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US" id="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_3">Other Long-Term Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_3" xlink:title="label: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to label_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:title="CollaborativeArrangementDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CollaborativeArrangementDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_CollaborativeArrangementDisclosureTextBlock">COLLABORATION AGREEMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="label_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:title="label: CollaborativeArrangementDisclosureTextBlock to label_us-gaap_CollaborativeArrangementDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CollaborativeArrangementDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CollaborativeArrangementDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_CollaborativeArrangementDisclosureTextBlock_1">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="label_us-gaap_CollaborativeArrangementDisclosureTextBlock_1" xlink:title="label: CollaborativeArrangementDisclosureTextBlock to label_us-gaap_CollaborativeArrangementDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies">Commitments and Contingent Liabilities (Notes 14 and 16)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies" xlink:title="label: CommitmentsAndContingencies to label_us-gaap_CommitmentsAndContingencies" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingencies_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies_1">Commitments and Contingencies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies_1" xlink:title="label: CommitmentsAndContingencies to label_us-gaap_CommitmentsAndContingencies" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare">Common Stock, Par Value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="label: CommonStockParOrStatedValuePerShare to label_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare_1">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xlink:title="label: CommonStockParOrStatedValuePerShare to label_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockMember" xml:lang="en-US" id="label_us-gaap_CommonStockMember">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember" xlink:title="label: CommonStockMember to label_us-gaap_CommonStockMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockMember" xml:lang="en-US" id="label_us-gaap_CommonStockMember_1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember_1" xlink:title="label: CommonStockMember to label_us-gaap_CommonStockMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CommonStockValue" xml:lang="en-US" id="label_us-gaap_CommonStockValue">Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,246,832 and 64,359,513 Shares Issued and Outstanding at December 31, 2013 and 2012, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue" xlink:title="label: CommonStockValue to label_us-gaap_CommonStockValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockValue" xml:lang="en-US" id="label_us-gaap_CommonStockValue_1">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue_1" xlink:title="label: CommonStockValue to label_us-gaap_CommonStockValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued">Common Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued" xlink:title="label: CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued_1" xlink:title="label: CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_2">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued_2" xlink:title="label: CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_3">Common stock issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued_3" xlink:title="label: CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued_4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_4">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued_4" xlink:title="label: CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized" xlink:title="label: CommonStockSharesAuthorized to label_us-gaap_CommonStockSharesAuthorized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized_1">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized_1" xlink:title="label: CommonStockSharesAuthorized to label_us-gaap_CommonStockSharesAuthorized" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US" id="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">Common stock reserved for issuance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="label: CommonStockCapitalSharesReservedForFutureIssuance to label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US" id="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1" xlink:title="label: CommonStockCapitalSharesReservedForFutureIssuance to label_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding">Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding" xlink:title="label: CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding_1">Common Stock, Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding_1" xlink:title="label: CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CompensationAndRetirementDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_CompensationAndRetirementDisclosureAbstract">RETIREMENT SAVINGS PLAN</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="label_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:title="label: CompensationAndRetirementDisclosureAbstract to label_us-gaap_CompensationAndRetirementDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US" id="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">Principal components of the deferred tax assets and liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="label: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US" id="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xlink:title="label: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to label_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="ComprehensiveIncomeNetOfTaxAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">COMPREHENSIVE LOSS:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="label: ComprehensiveIncomeNetOfTaxAbstract to label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_1">COMPREHENSIVE LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_1" xlink:title="label: ComprehensiveIncomeNetOfTaxAbstract to label_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:title="ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:title="label: ComprehensiveIncomePolicyPolicyTextBlock to label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1" xlink:title="label: ComprehensiveIncomePolicyPolicyTextBlock to label_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTax">Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="label: ComprehensiveIncomeNetOfTax to label_us-gaap_ComprehensiveIncomeNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTax_1">Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTax_1" xlink:title="label: ComprehensiveIncomeNetOfTax to label_us-gaap_ComprehensiveIncomeNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTax_2">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTax_2" xlink:title="label: ComprehensiveIncomeNetOfTax to label_us-gaap_ComprehensiveIncomeNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:title="ComprehensiveIncomeNoteTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComprehensiveIncomeNoteTextBlock" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNoteTextBlock">COMPREHENSIVE LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="label_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:title="label: ComprehensiveIncomeNoteTextBlock to label_us-gaap_ComprehensiveIncomeNoteTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNoteTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComprehensiveIncomeNoteTextBlock" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNoteTextBlock_1">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="label_us-gaap_ComprehensiveIncomeNoteTextBlock_1" xlink:title="label: ComprehensiveIncomeNoteTextBlock to label_us-gaap_ComprehensiveIncomeNoteTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComputerEquipmentMember" xml:lang="en-US" id="label_us-gaap_ComputerEquipmentMember">Computer equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="label_us-gaap_ComputerEquipmentMember" xlink:title="label: ComputerEquipmentMember to label_us-gaap_ComputerEquipmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComputerEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComputerEquipmentMember" xml:lang="en-US" id="label_us-gaap_ComputerEquipmentMember_1">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="label_us-gaap_ComputerEquipmentMember_1" xlink:title="label: ComputerEquipmentMember to label_us-gaap_ComputerEquipmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:title="ConcentrationRiskTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskTypeDomain">Concentration Risk Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="label_us-gaap_ConcentrationRiskTypeDomain" xlink:title="label: ConcentrationRiskTypeDomain to label_us-gaap_ConcentrationRiskTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskLineItems">Concentration risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="label_us-gaap_ConcentrationRiskLineItems" xlink:title="label: ConcentrationRiskLineItems to label_us-gaap_ConcentrationRiskLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskLineItems_1">Concentration Risk [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="label_us-gaap_ConcentrationRiskLineItems_1" xlink:title="label: ConcentrationRiskLineItems to label_us-gaap_ConcentrationRiskLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskBenchmarkDomain">Concentration Risk Benchmark [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="label_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:title="label: ConcentrationRiskBenchmarkDomain to label_us-gaap_ConcentrationRiskBenchmarkDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskCreditRisk">Concentration of Credit Risk and of Significant Customers and Suppliers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="label_us-gaap_ConcentrationRiskCreditRisk" xlink:title="label: ConcentrationRiskCreditRisk to label_us-gaap_ConcentrationRiskCreditRisk" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskCreditRisk_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskCreditRisk_1">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="label_us-gaap_ConcentrationRiskCreditRisk_1" xlink:title="label: ConcentrationRiskCreditRisk to label_us-gaap_ConcentrationRiskCreditRisk" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:title="ConcentrationRiskByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskByTypeAxis">Concentration Risk Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="label_us-gaap_ConcentrationRiskByTypeAxis" xlink:title="label: ConcentrationRiskByTypeAxis to label_us-gaap_ConcentrationRiskByTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskTable" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskTable">Concentration Risk [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="label_us-gaap_ConcentrationRiskTable" xlink:title="label: ConcentrationRiskTable to label_us-gaap_ConcentrationRiskTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskByBenchmarkAxis">Concentration Risk Benchmark [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="label_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:title="label: ConcentrationRiskByBenchmarkAxis to label_us-gaap_ConcentrationRiskByBenchmarkAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:title="ConcentrationRiskPercentage1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskPercentage1">Concentration risk (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="label_us-gaap_ConcentrationRiskPercentage1" xlink:title="label: ConcentrationRiskPercentage1 to label_us-gaap_ConcentrationRiskPercentage1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskPercentage1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskPercentage1_1">Concentration Risk, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="label_us-gaap_ConcentrationRiskPercentage1_1" xlink:title="label: ConcentrationRiskPercentage1 to label_us-gaap_ConcentrationRiskPercentage1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConstructionInProgressMember" xml:lang="en-US" id="label_us-gaap_ConstructionInProgressMember">Construction in Progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="label_us-gaap_ConstructionInProgressMember" xlink:title="label: ConstructionInProgressMember to label_us-gaap_ConstructionInProgressMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConstructionInProgressMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConstructionInProgressMember" xml:lang="en-US" id="label_us-gaap_ConstructionInProgressMember_1">Construction in Progress [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="label_us-gaap_ConstructionInProgressMember_1" xlink:title="label: ConstructionInProgressMember to label_us-gaap_ConstructionInProgressMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:label="us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:title="ConvertibleSubordinatedDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtCurrent" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtCurrent">Convertible Subordinated Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:title="label: ConvertibleSubordinatedDebtCurrent to label_us-gaap_ConvertibleSubordinatedDebtCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtCurrent" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtCurrent_1">Convertible Subordinated Debt, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtCurrent_1" xlink:title="label: ConvertibleSubordinatedDebtCurrent to label_us-gaap_ConvertibleSubordinatedDebtCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:label="us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:title="ConvertibleSubordinatedDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent">Convertible Subordinated Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:title="label: ConvertibleSubordinatedDebtNoncurrent to label_us-gaap_ConvertibleSubordinatedDebtNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent_1">Convertible Subordinated Debt, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtNoncurrent_1" xlink:title="label: ConvertibleSubordinatedDebtNoncurrent to label_us-gaap_ConvertibleSubordinatedDebtNoncurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="ConvertibleSubordinatedDebtMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtMember" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtMember">Convertible subordinated debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtMember" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="label: ConvertibleSubordinatedDebtMember to label_us-gaap_ConvertibleSubordinatedDebtMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtMember" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtMember_1">4% convertible subordinated debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtMember" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtMember_1" xlink:title="label: ConvertibleSubordinatedDebtMember to label_us-gaap_ConvertibleSubordinatedDebtMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebtMember_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConvertibleSubordinatedDebtMember" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebtMember_2">Convertible Subordinated Debt [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebtMember" xlink:to="label_us-gaap_ConvertibleSubordinatedDebtMember_2" xlink:title="label: ConvertibleSubordinatedDebtMember to label_us-gaap_ConvertibleSubordinatedDebtMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebt" xlink:label="us-gaap_ConvertibleSubordinatedDebt" xlink:title="ConvertibleSubordinatedDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConvertibleSubordinatedDebt" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebt">Convertible subordinate debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebt" xlink:to="label_us-gaap_ConvertibleSubordinatedDebt" xlink:title="label: ConvertibleSubordinatedDebt to label_us-gaap_ConvertibleSubordinatedDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertibleSubordinatedDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConvertibleSubordinatedDebt" xml:lang="en-US" id="label_us-gaap_ConvertibleSubordinatedDebt_1">Convertible Subordinated Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleSubordinatedDebt" xlink:to="label_us-gaap_ConvertibleSubordinatedDebt_1" xlink:title="label: ConvertibleSubordinatedDebt to label_us-gaap_ConvertibleSubordinatedDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CorporateDebtSecuritiesMember" xml:lang="en-US" id="label_us-gaap_CorporateDebtSecuritiesMember">Corporate debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="label_us-gaap_CorporateDebtSecuritiesMember" xlink:title="label: CorporateDebtSecuritiesMember to label_us-gaap_CorporateDebtSecuritiesMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CorporateDebtSecuritiesMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CorporateDebtSecuritiesMember" xml:lang="en-US" id="label_us-gaap_CorporateDebtSecuritiesMember_1">Corporate Debt Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="label_us-gaap_CorporateDebtSecuritiesMember_1" xlink:title="label: CorporateDebtSecuritiesMember to label_us-gaap_CorporateDebtSecuritiesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:label="us-gaap_CostOfReimbursableExpense" xlink:title="CostOfReimbursableExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostOfReimbursableExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CostOfReimbursableExpense" xml:lang="en-US" id="label_us-gaap_CostOfReimbursableExpense">Reimbursable costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfReimbursableExpense" xlink:to="label_us-gaap_CostOfReimbursableExpense" xlink:title="label: CostOfReimbursableExpense to label_us-gaap_CostOfReimbursableExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostOfReimbursableExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CostOfReimbursableExpense" xml:lang="en-US" id="label_us-gaap_CostOfReimbursableExpense_1">Cost of Reimbursable Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfReimbursableExpense" xlink:to="label_us-gaap_CostOfReimbursableExpense_1" xlink:title="label: CostOfReimbursableExpense to label_us-gaap_CostOfReimbursableExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CostsAndExpensesAbstract" xml:lang="en-US" id="label_us-gaap_CostsAndExpensesAbstract">OPERATING EXPENSE:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="label_us-gaap_CostsAndExpensesAbstract" xlink:title="label: CostsAndExpensesAbstract to label_us-gaap_CostsAndExpensesAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostsAndExpensesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CostsAndExpensesAbstract" xml:lang="en-US" id="label_us-gaap_CostsAndExpensesAbstract_1">Costs and Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="label_us-gaap_CostsAndExpensesAbstract_1" xlink:title="label: CostsAndExpensesAbstract to label_us-gaap_CostsAndExpensesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_CostsAndExpenses" xml:lang="en-US" id="label_us-gaap_CostsAndExpenses">Total Operating Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="label_us-gaap_CostsAndExpenses" xlink:title="label: CostsAndExpenses to label_us-gaap_CostsAndExpenses" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostsAndExpenses_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CostsAndExpenses" xml:lang="en-US" id="label_us-gaap_CostsAndExpenses_1">Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="label_us-gaap_CostsAndExpenses_1" xlink:title="label: CostsAndExpenses to label_us-gaap_CostsAndExpenses" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CumulativePreferredStockMember" xlink:label="us-gaap_CumulativePreferredStockMember" xlink:title="CumulativePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CumulativePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CumulativePreferredStockMember" xml:lang="en-US" id="label_us-gaap_CumulativePreferredStockMember">Series C-1 Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CumulativePreferredStockMember" xlink:to="label_us-gaap_CumulativePreferredStockMember" xlink:title="label: CumulativePreferredStockMember to label_us-gaap_CumulativePreferredStockMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CumulativePreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CumulativePreferredStockMember" xml:lang="en-US" id="label_us-gaap_CumulativePreferredStockMember_1">Cumulative Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CumulativePreferredStockMember" xlink:to="label_us-gaap_CumulativePreferredStockMember_1" xlink:title="label: CumulativePreferredStockMember to label_us-gaap_CumulativePreferredStockMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:title="CustomerConcentrationRiskMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US" id="label_us-gaap_CustomerConcentrationRiskMember">Customer concentration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="label_us-gaap_CustomerConcentrationRiskMember" xlink:title="label: CustomerConcentrationRiskMember to label_us-gaap_CustomerConcentrationRiskMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CustomerConcentrationRiskMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US" id="label_us-gaap_CustomerConcentrationRiskMember_1">Customer Concentration Risk [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="label_us-gaap_CustomerConcentrationRiskMember_1" xlink:title="label: CustomerConcentrationRiskMember to label_us-gaap_CustomerConcentrationRiskMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:title="DebtInstrumentDescriptionOfVariableRateBasis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xml:lang="en-US" id="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">Basis of interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:title="label: DebtInstrumentDescriptionOfVariableRateBasis to label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xml:lang="en-US" id="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1" xlink:title="label: DebtInstrumentDescriptionOfVariableRateBasis to label_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentLineItems" xml:lang="en-US" id="label_us-gaap_DebtInstrumentLineItems">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="label_us-gaap_DebtInstrumentLineItems" xlink:title="label: DebtInstrumentLineItems to label_us-gaap_DebtInstrumentLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DebtInstrumentLineItems" xml:lang="en-US" id="label_us-gaap_DebtInstrumentLineItems_1">Other Long-Term Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="label_us-gaap_DebtInstrumentLineItems_1" xlink:title="label: DebtInstrumentLineItems to label_us-gaap_DebtInstrumentLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentLineItems_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentLineItems" xml:lang="en-US" id="label_us-gaap_DebtInstrumentLineItems_2">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="label_us-gaap_DebtInstrumentLineItems_2" xlink:title="label: DebtInstrumentLineItems to label_us-gaap_DebtInstrumentLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentTable" xml:lang="en-US" id="label_us-gaap_DebtInstrumentTable">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="label_us-gaap_DebtInstrumentTable" xlink:title="label: DebtInstrumentTable to label_us-gaap_DebtInstrumentTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:title="DebtInstrumentConvertibleNumberOfEquityInstruments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">Number of shares of common stock into which debt was convertible</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:title="label: DebtInstrumentConvertibleNumberOfEquityInstruments to label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_1">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_1" xlink:title="label: DebtInstrumentConvertibleNumberOfEquityInstruments to label_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">Interest rate margin (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to label_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_DebtDisclosureAbstract">TERM LOAN</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="label_us-gaap_DebtDisclosureAbstract" xlink:title="label: DebtDisclosureAbstract to label_us-gaap_DebtDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:title="DebtInstrumentConvertibleConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentConvertibleConversionRatio1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleConversionRatio1">Rate at which debt was converted into shares of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="label_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:title="label: DebtInstrumentConvertibleConversionRatio1 to label_us-gaap_DebtInstrumentConvertibleConversionRatio1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleConversionRatio1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentConvertibleConversionRatio1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleConversionRatio1_1">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="label_us-gaap_DebtInstrumentConvertibleConversionRatio1_1" xlink:title="label: DebtInstrumentConvertibleConversionRatio1 to label_us-gaap_DebtInstrumentConvertibleConversionRatio1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentAxis" xml:lang="en-US" id="label_us-gaap_DebtInstrumentAxis">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="label_us-gaap_DebtInstrumentAxis" xlink:title="label: DebtInstrumentAxis to label_us-gaap_DebtInstrumentAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="DebtInstrumentConvertibleConversionPrice1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleConversionPrice1">Conversion price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="label: DebtInstrumentConvertibleConversionPrice1 to label_us-gaap_DebtInstrumentConvertibleConversionPrice1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1" xlink:title="label: DebtInstrumentConvertibleConversionPrice1 to label_us-gaap_DebtInstrumentConvertibleConversionPrice1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentNameDomain" xml:lang="en-US" id="label_us-gaap_DebtInstrumentNameDomain">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="label_us-gaap_DebtInstrumentNameDomain" xlink:title="label: DebtInstrumentNameDomain to label_us-gaap_DebtInstrumentNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateStatedPercentage">Fixed annual interest rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to label_us-gaap_DebtInstrumentInterestRateStatedPercentage" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1">Interest rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to label_us-gaap_DebtInstrumentInterestRateStatedPercentage" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_2">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_2" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to label_us-gaap_DebtInstrumentInterestRateStatedPercentage" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:label="us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:title="DebtInstrumentInterestRateAtPeriodEnd" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd">Interest rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:to="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:title="label: DebtInstrumentInterestRateAtPeriodEnd to label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd_1">Debt Instrument, Interest Rate at Period End</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:to="label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd_1" xlink:title="label: DebtInstrumentInterestRateAtPeriodEnd to label_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:title="DeferredTaxAssetsPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:title="label: DeferredTaxAssetsPropertyPlantAndEquipment to label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_1">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_1" xlink:title="label: DeferredTaxAssetsPropertyPlantAndEquipment to label_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US" id="label_us-gaap_DeferredIncomeTaxLiabilities">Gross Deferred Tax Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="label_us-gaap_DeferredIncomeTaxLiabilities" xlink:title="label: DeferredIncomeTaxLiabilities to label_us-gaap_DeferredIncomeTaxLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredIncomeTaxLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US" id="label_us-gaap_DeferredIncomeTaxLiabilities_1">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="label_us-gaap_DeferredIncomeTaxLiabilities_1" xlink:title="label: DeferredIncomeTaxLiabilities to label_us-gaap_DeferredIncomeTaxLiabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:title="DeferredFinanceCostsNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredFinanceCostsNet" xml:lang="en-US" id="label_us-gaap_DeferredFinanceCostsNet">Capitalized deferred financing costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="label_us-gaap_DeferredFinanceCostsNet" xlink:title="label: DeferredFinanceCostsNet to label_us-gaap_DeferredFinanceCostsNet" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:title="DeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredRevenue" xml:lang="en-US" id="label_us-gaap_DeferredRevenue">Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="label_us-gaap_DeferredRevenue" xlink:title="label: DeferredRevenue to label_us-gaap_DeferredRevenue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRevenue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredRevenue" xml:lang="en-US" id="label_us-gaap_DeferredRevenue_1">Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="label_us-gaap_DeferredRevenue_1" xlink:title="label: DeferredRevenue to label_us-gaap_DeferredRevenue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:title="DeferredRevenueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredRevenueCurrent" xml:lang="en-US" id="label_us-gaap_DeferredRevenueCurrent">Current Portion of Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="label_us-gaap_DeferredRevenueCurrent" xlink:title="label: DeferredRevenueCurrent to label_us-gaap_DeferredRevenueCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRevenueCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredRevenueCurrent" xml:lang="en-US" id="label_us-gaap_DeferredRevenueCurrent_1">Deferred Revenue, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="label_us-gaap_DeferredRevenueCurrent_1" xlink:title="label: DeferredRevenueCurrent to label_us-gaap_DeferredRevenueCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:title="DeferredTaxAssetsGrossAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsGrossAbstract" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsGrossAbstract">Gross Deferred Tax Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="label_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:title="label: DeferredTaxAssetsGrossAbstract to label_us-gaap_DeferredTaxAssetsGrossAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsGrossAbstract" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsGrossAbstract_1">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="label_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:title="label: DeferredTaxAssetsGrossAbstract to label_us-gaap_DeferredTaxAssetsGrossAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit" xlink:title="DeferredRentCredit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRentCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredRentCredit" xml:lang="en-US" id="label_us-gaap_DeferredRentCredit">Deferred Rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCredit" xlink:to="label_us-gaap_DeferredRentCredit" xlink:title="label: DeferredRentCredit to label_us-gaap_DeferredRentCredit" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRentCredit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredRentCredit" xml:lang="en-US" id="label_us-gaap_DeferredRentCredit_1">Deferred Rent Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCredit" xlink:to="label_us-gaap_DeferredRentCredit_1" xlink:title="label: DeferredRentCredit to label_us-gaap_DeferredRentCredit" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:title="DeferredRevenueNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredRevenueNoncurrent" xml:lang="en-US" id="label_us-gaap_DeferredRevenueNoncurrent">Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="label_us-gaap_DeferredRevenueNoncurrent" xlink:title="label: DeferredRevenueNoncurrent to label_us-gaap_DeferredRevenueNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredRevenueNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredRevenueNoncurrent" xml:lang="en-US" id="label_us-gaap_DeferredRevenueNoncurrent_1">Deferred Revenue, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="label_us-gaap_DeferredRevenueNoncurrent_1" xlink:title="label: DeferredRevenueNoncurrent to label_us-gaap_DeferredRevenueNoncurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsGross">Gross Deferred Tax Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="label_us-gaap_DeferredTaxAssetsGross" xlink:title="label: DeferredTaxAssetsGross to label_us-gaap_DeferredTaxAssetsGross" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsGross_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsGross_1">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="label_us-gaap_DeferredTaxAssetsGross_1" xlink:title="label: DeferredTaxAssetsGross to label_us-gaap_DeferredTaxAssetsGross" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">Stock-based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost to label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost to label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">Accrued Expenses and Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseOther to label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_1">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseOther to label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:title="DeferredTaxAssetsTaxDeferredExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense">Deferred Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:title="label: DeferredTaxAssetsTaxDeferredExpense to label_us-gaap_DeferredTaxAssetsTaxDeferredExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense_1">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpense_1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpense to label_us-gaap_DeferredTaxAssetsTaxDeferredExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">Net Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwards to label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwards to label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:title="DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">Tax Credit Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:title="label: DeferredTaxAssetsTaxCreditCarryforwards to label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1" xlink:title="label: DeferredTaxAssetsTaxCreditCarryforwards to label_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance">Deferred Tax Assets Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="label: DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance_1">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:title="label: DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxLiabilities" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilities">Net Deferred Tax Liability related to IPR&amp;D</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="label_us-gaap_DeferredTaxLiabilities" xlink:title="label: DeferredTaxLiabilities to label_us-gaap_DeferredTaxLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxLiabilities_1" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_DeferredTaxLiabilities" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilities_1">Net Deferred Tax Asset (Liability)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="label_us-gaap_DeferredTaxLiabilities_1" xlink:title="label: DeferredTaxLiabilities to label_us-gaap_DeferredTaxLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxLiabilities_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxLiabilities" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilities_2">Deferred Tax Liabilities, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="label_us-gaap_DeferredTaxLiabilities_2" xlink:title="label: DeferredTaxLiabilities to label_us-gaap_DeferredTaxLiabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:title="DeferredTaxLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxLiabilitiesAbstract" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesAbstract">Gross Deferred Tax Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="label_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:title="label: DeferredTaxLiabilitiesAbstract to label_us-gaap_DeferredTaxLiabilitiesAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxLiabilitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxLiabilitiesAbstract" xml:lang="en-US" id="label_us-gaap_DeferredTaxLiabilitiesAbstract_1">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="label_us-gaap_DeferredTaxLiabilitiesAbstract_1" xlink:title="label: DeferredTaxLiabilitiesAbstract to label_us-gaap_DeferredTaxLiabilitiesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">Maximum contribution by participants (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="label: DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent to label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1" xlink:title="label: DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent to label_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">Employer match (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatch to label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatch to label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">Maximum percentage of employees' gross pay subject to employer match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercent to label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercent to label_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" xlink:title="DefinedContributionPlanCostRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DefinedContributionPlanCostRecognized" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanCostRecognized">Benefit expense for the 401(k) Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="label_us-gaap_DefinedContributionPlanCostRecognized" xlink:title="label: DefinedContributionPlanCostRecognized to label_us-gaap_DefinedContributionPlanCostRecognized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanCostRecognized_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DefinedContributionPlanCostRecognized" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanCostRecognized_1">Defined Contribution Plan, Cost Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="label_us-gaap_DefinedContributionPlanCostRecognized_1" xlink:title="label: DefinedContributionPlanCostRecognized to label_us-gaap_DefinedContributionPlanCostRecognized" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US" id="label_us-gaap_DepreciationDepletionAndAmortization">Depreciation and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="label_us-gaap_DepreciationDepletionAndAmortization" xlink:title="label: DepreciationDepletionAndAmortization to label_us-gaap_DepreciationDepletionAndAmortization" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationDepletionAndAmortization_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US" id="label_us-gaap_DepreciationDepletionAndAmortization_1">Depreciation and amortization expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="label_us-gaap_DepreciationDepletionAndAmortization_1" xlink:title="label: DepreciationDepletionAndAmortization to label_us-gaap_DepreciationDepletionAndAmortization" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationDepletionAndAmortization_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US" id="label_us-gaap_DepreciationDepletionAndAmortization_2">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="label_us-gaap_DepreciationDepletionAndAmortization_2" xlink:title="label: DepreciationDepletionAndAmortization to label_us-gaap_DepreciationDepletionAndAmortization" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">STOCK-BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">STOCK-BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted">Basic and Diluted Net Loss Per Common Share (Note 2) (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="label: EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted_1">Earnings Per Share, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xlink:title="label: EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted_2">Basic and diluted net loss per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted_2" xlink:title="label: EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US" id="label_us-gaap_EarningsPerShareTextBlock">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="label_us-gaap_EarningsPerShareTextBlock" xlink:title="label: EarningsPerShareTextBlock to label_us-gaap_EarningsPerShareTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US" id="label_us-gaap_EarningsPerShareTextBlock_1">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="label_us-gaap_EarningsPerShareTextBlock_1" xlink:title="label: EarningsPerShareTextBlock to label_us-gaap_EarningsPerShareTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="label: EarningsPerSharePolicyTextBlock to label_us-gaap_EarningsPerSharePolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock_1">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xlink:title="label: EarningsPerSharePolicyTextBlock to label_us-gaap_EarningsPerSharePolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareBasic" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasic">Basic net (loss) income per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="label_us-gaap_EarningsPerShareBasic" xlink:title="label: EarningsPerShareBasic to label_us-gaap_EarningsPerShareBasic" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasic_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareBasic" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasic_1">Earnings Per Share, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="label_us-gaap_EarningsPerShareBasic_1" xlink:title="label: EarningsPerShareBasic to label_us-gaap_EarningsPerShareBasic" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareDiluted">Diluted net (loss) income per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="label_us-gaap_EarningsPerShareDiluted" xlink:title="label: EarningsPerShareDiluted to label_us-gaap_EarningsPerShareDiluted" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareDiluted_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareDiluted_1">Earnings Per Share, Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="label_us-gaap_EarningsPerShareDiluted_1" xlink:title="label: EarningsPerShareDiluted to label_us-gaap_EarningsPerShareDiluted" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareAbstract" xml:lang="en-US" id="label_us-gaap_EarningsPerShareAbstract">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="label_us-gaap_EarningsPerShareAbstract" xlink:title="label: EarningsPerShareAbstract to label_us-gaap_EarningsPerShareAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:title="EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xml:lang="en-US" id="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations">Effect of Exchange Rate Changes on Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:to="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:title="label: EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations to label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xml:lang="en-US" id="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_1">Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:to="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_1" xlink:title="label: EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations to label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">U.S. Statutory rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_EmployeeRelatedLiabilitiesCurrent">Accrued Payroll and Employee Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="label_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to label_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeRelatedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_EmployeeRelatedLiabilitiesCurrent_1">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="label_us-gaap_EmployeeRelatedLiabilitiesCurrent_1" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to label_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">Valuation and Expenses Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="label: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1" xlink:title="label: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember" xlink:title="EmployeeStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeStockMember" xml:lang="en-US" id="label_us-gaap_EmployeeStockMember">2004 ESPP Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="label_us-gaap_EmployeeStockMember" xlink:title="label: EmployeeStockMember to label_us-gaap_EmployeeStockMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeStockMember" xml:lang="en-US" id="label_us-gaap_EmployeeStockMember_1">Employee Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="label_us-gaap_EmployeeStockMember_1" xlink:title="label: EmployeeStockMember to label_us-gaap_EmployeeStockMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">Weighted average period over which compensation cost is expected to be recognized as expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">Total compensation cost not yet recognized (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EquityComponentDomain" xml:lang="en-US" id="label_us-gaap_EquityComponentDomain">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="label_us-gaap_EquityComponentDomain" xlink:title="label: EquityComponentDomain to label_us-gaap_EquityComponentDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US" id="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember">Fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="label: EstimateOfFairValueFairValueDisclosureMember to label_us-gaap_EstimateOfFairValueFairValueDisclosureMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US" id="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1">Estimate of Fair Value Measurement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="label_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1" xlink:title="label: EstimateOfFairValueFairValueDisclosureMember to label_us-gaap_EstimateOfFairValueFairValueDisclosureMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueByMeasurementFrequencyAxis" xml:lang="en-US" id="label_us-gaap_FairValueByMeasurementFrequencyAxis">Measurement Frequency [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="label_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:title="label: FairValueByMeasurementFrequencyAxis to label_us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US" id="label_us-gaap_FairValueByFairValueHierarchyLevelAxis">Fair Value, Hierarchy [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="label_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to label_us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementsRecurringMember">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="label_us-gaap_FairValueMeasurementsRecurringMember" xlink:title="label: FairValueMeasurementsRecurringMember to label_us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementsRecurringMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementsRecurringMember_1">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="label_us-gaap_FairValueMeasurementsRecurringMember_1" xlink:title="label: FairValueMeasurementsRecurringMember to label_us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementFrequencyDomain" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementFrequencyDomain">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="label_us-gaap_FairValueMeasurementFrequencyDomain" xlink:title="label: FairValueMeasurementFrequencyDomain to label_us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="FairValueMeasurementPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="label: FairValueMeasurementPolicyPolicyTextBlock to label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1" xlink:title="label: FairValueMeasurementPolicyPolicyTextBlock to label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">Fair value measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresAbstract">FAIR VALUE MEASUREMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="label_us-gaap_FairValueDisclosuresAbstract" xlink:title="label: FairValueDisclosuresAbstract to label_us-gaap_FairValueDisclosuresAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain">Fair Value Hierarchy [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="label: FairValueMeasurementsFairValueHierarchyDomain to label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">Schedule of financial assets subject to fair value measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="label: FairValueAssetsMeasuredOnRecurringBasisTextBlock to label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1" xlink:title="label: FairValueAssetsMeasuredOnRecurringBasisTextBlock to label_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresTextBlock">FAIR VALUE MEASUREMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="label_us-gaap_FairValueDisclosuresTextBlock" xlink:title="label: FairValueDisclosuresTextBlock to label_us-gaap_FairValueDisclosuresTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueDisclosuresTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresTextBlock_1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="label_us-gaap_FairValueDisclosuresTextBlock_1" xlink:title="label: FairValueDisclosuresTextBlock to label_us-gaap_FairValueDisclosuresTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel3Member">Level 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="label_us-gaap_FairValueInputsLevel3Member" xlink:title="label: FairValueInputsLevel3Member to label_us-gaap_FairValueInputsLevel3Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel1Member">Level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="label_us-gaap_FairValueInputsLevel1Member" xlink:title="label: FairValueInputsLevel1Member to label_us-gaap_FairValueInputsLevel1Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel1Member_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel1Member_1">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="label_us-gaap_FairValueInputsLevel1Member_1" xlink:title="label: FairValueInputsLevel1Member to label_us-gaap_FairValueInputsLevel1Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel2Member">Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="label_us-gaap_FairValueInputsLevel2Member" xlink:title="label: FairValueInputsLevel2Member to label_us-gaap_FairValueInputsLevel2Member" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel2Member_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel2Member_1">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="label_us-gaap_FairValueInputsLevel2Member_1" xlink:title="label: FairValueInputsLevel2Member to label_us-gaap_FairValueInputsLevel2Member" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="label: FederalIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" xlink:title="label: FederalIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife">Estimated Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to label_us-gaap_FiniteLivedIntangibleAssetUsefulLife" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to label_us-gaap_FiniteLivedIntangibleAssetUsefulLife" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsGross" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsGross">Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="label: FiniteLivedIntangibleAssetsGross to label_us-gaap_FiniteLivedIntangibleAssetsGross" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsGross_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsGross" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsGross_1">Finite-Lived Intangible Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsGross_1" xlink:title="label: FiniteLivedIntangibleAssetsGross to label_us-gaap_FiniteLivedIntangibleAssetsGross" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">2016</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">Estimated future amortization expense of intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="label: FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_1">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_1" xlink:title="label: FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to label_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to label_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsNet">Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="label: FiniteLivedIntangibleAssetsNet to label_us-gaap_FiniteLivedIntangibleAssetsNet" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsNet_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsNet_1">Finite-Lived Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsNet_1" xlink:title="label: FiniteLivedIntangibleAssetsNet to label_us-gaap_FiniteLivedIntangibleAssetsNet" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to label_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to label_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">Finite-lived intangible asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:title="label: FiniteLivedIntangibleAssetsNetAbstract to label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_1">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_1" xlink:title="label: FiniteLivedIntangibleAssetsNetAbstract to label_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">2014</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xml:lang="en-US" id="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to label_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">Foreign Currency Translation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="label: ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock to label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1" xlink:title="label: ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock to label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="label: ForeignIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" xlink:title="label: ForeignIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTranslationAbstract" xlink:label="us-gaap_ForeignCurrencyTranslationAbstract" xlink:title="ForeignCurrencyTranslationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTranslationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignCurrencyTranslationAbstract" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTranslationAbstract">Foreign Currency Translation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTranslationAbstract" xlink:to="label_us-gaap_ForeignCurrencyTranslationAbstract" xlink:title="label: ForeignCurrencyTranslationAbstract to label_us-gaap_ForeignCurrencyTranslationAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTranslationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyTranslationAbstract" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTranslationAbstract_1">Foreign Currency Translation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTranslationAbstract" xlink:to="label_us-gaap_ForeignCurrencyTranslationAbstract_1" xlink:title="label: ForeignCurrencyTranslationAbstract to label_us-gaap_ForeignCurrencyTranslationAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US" id="label_us-gaap_FurnitureAndFixturesMember">Office furniture and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="label_us-gaap_FurnitureAndFixturesMember" xlink:title="label: FurnitureAndFixturesMember to label_us-gaap_FurnitureAndFixturesMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FurnitureAndFixturesMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US" id="label_us-gaap_FurnitureAndFixturesMember_1">Office Furniture and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="label_us-gaap_FurnitureAndFixturesMember_1" xlink:title="label: FurnitureAndFixturesMember to label_us-gaap_FurnitureAndFixturesMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FurnitureAndFixturesMember_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US" id="label_us-gaap_FurnitureAndFixturesMember_2">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="label_us-gaap_FurnitureAndFixturesMember_2" xlink:title="label: FurnitureAndFixturesMember to label_us-gaap_FurnitureAndFixturesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xlink:title="GainLossOnDispositionOfAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_GainLossOnDispositionOfAssets" xml:lang="en-US" id="label_us-gaap_GainLossOnDispositionOfAssets">Gain on Sale of Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="label_us-gaap_GainLossOnDispositionOfAssets" xlink:title="label: GainLossOnDispositionOfAssets to label_us-gaap_GainLossOnDispositionOfAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnDispositionOfAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GainLossOnDispositionOfAssets" xml:lang="en-US" id="label_us-gaap_GainLossOnDispositionOfAssets_1">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="label_us-gaap_GainLossOnDispositionOfAssets_1" xlink:title="label: GainLossOnDispositionOfAssets to label_us-gaap_GainLossOnDispositionOfAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:title="GainLossOnSaleOfOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GainLossOnSaleOfOtherAssets" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfOtherAssets">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="label_us-gaap_GainLossOnSaleOfOtherAssets" xlink:title="label: GainLossOnSaleOfOtherAssets to label_us-gaap_GainLossOnSaleOfOtherAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfOtherAssets_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GainLossOnSaleOfOtherAssets" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfOtherAssets_1">Other income related to sale of tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="label_us-gaap_GainLossOnSaleOfOtherAssets_1" xlink:title="label: GainLossOnSaleOfOtherAssets to label_us-gaap_GainLossOnSaleOfOtherAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:title="GainLossOnSaleOfPropertyPlantEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">Gain on Sale or Disposal of Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:title="label: GainLossOnSaleOfPropertyPlantEquipment to label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1" xlink:title="label: GainLossOnSaleOfPropertyPlantEquipment to label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpense">General and Administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense" xlink:title="label: GeneralAndAdministrativeExpense to label_us-gaap_GeneralAndAdministrativeExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpense_1">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense_1" xlink:title="label: GeneralAndAdministrativeExpense to label_us-gaap_GeneralAndAdministrativeExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpenseMember">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="label_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="label: GeneralAndAdministrativeExpenseMember to label_us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpenseMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpenseMember_1">General and Administrative Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="label_us-gaap_GeneralAndAdministrativeExpenseMember_1" xlink:title="label: GeneralAndAdministrativeExpenseMember to label_us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:title="GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:title="label: GoodwillAndIntangibleAssetsIntangibleAssetsPolicy to label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1" xlink:title="label: GoodwillAndIntangibleAssetsIntangibleAssetsPolicy to label_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_Goodwill" xml:lang="en-US" id="label_us-gaap_Goodwill">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="label_us-gaap_Goodwill" xlink:title="label: Goodwill to label_us-gaap_Goodwill" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Goodwill_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Goodwill" xml:lang="en-US" id="label_us-gaap_Goodwill_1">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="label_us-gaap_Goodwill_1" xlink:title="label: Goodwill to label_us-gaap_Goodwill" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">INTANGIBLE ASSETS AND GOODWILL</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to label_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">INTANGIBLE ASSETS AND GOODWILL</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to label_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="label: GoodwillAndIntangibleAssetsGoodwillPolicy to label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xml:lang="en-US" id="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1" xlink:title="label: GoodwillAndIntangibleAssetsGoodwillPolicy to label_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">Impairment of Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_1">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:title="InProcessResearchAndDevelopmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InProcessResearchAndDevelopmentMember" xml:lang="en-US" id="label_us-gaap_InProcessResearchAndDevelopmentMember">IPR&amp;D</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="label_us-gaap_InProcessResearchAndDevelopmentMember" xlink:title="label: InProcessResearchAndDevelopmentMember to label_us-gaap_InProcessResearchAndDevelopmentMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InProcessResearchAndDevelopmentMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InProcessResearchAndDevelopmentMember" xml:lang="en-US" id="label_us-gaap_InProcessResearchAndDevelopmentMember_1">In Process Research and Development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="label_us-gaap_InProcessResearchAndDevelopmentMember_1" xlink:title="label: InProcessResearchAndDevelopmentMember to label_us-gaap_InProcessResearchAndDevelopmentMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeStatementAbstract" xml:lang="en-US" id="label_us-gaap_IncomeStatementAbstract">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="label_us-gaap_IncomeStatementAbstract" xlink:title="label: IncomeStatementAbstract to label_us-gaap_IncomeStatementAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeStatementLocationAxis" xml:lang="en-US" id="label_us-gaap_IncomeStatementLocationAxis">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="label_us-gaap_IncomeStatementLocationAxis" xlink:title="label: IncomeStatementLocationAxis to label_us-gaap_IncomeStatementLocationAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureAbstract">INCOME TAXES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="label_us-gaap_IncomeTaxDisclosureAbstract" xlink:title="label: IncomeTaxDisclosureAbstract to label_us-gaap_IncomeTaxDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxAuthorityDomain" xml:lang="en-US" id="label_us-gaap_IncomeTaxAuthorityDomain">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="label_us-gaap_IncomeTaxAuthorityDomain" xlink:title="label: IncomeTaxAuthorityDomain to label_us-gaap_IncomeTaxAuthorityDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxAuthorityAxis" xml:lang="en-US" id="label_us-gaap_IncomeTaxAuthorityAxis">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="label_us-gaap_IncomeTaxAuthorityAxis" xlink:title="label: IncomeTaxAuthorityAxis to label_us-gaap_IncomeTaxAuthorityAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureTextBlock">INCOME TAXES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="label: IncomeTaxDisclosureTextBlock to label_us-gaap_IncomeTaxDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureTextBlock_1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock_1" xlink:title="label: IncomeTaxDisclosureTextBlock to label_us-gaap_IncomeTaxDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeStatementLocationDomain" xml:lang="en-US" id="label_us-gaap_IncomeStatementLocationDomain">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="label_us-gaap_IncomeStatementLocationDomain" xlink:title="label: IncomeStatementLocationDomain to label_us-gaap_IncomeStatementLocationDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract">Income tax benefit (provision):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsAbstract to label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsAbstract to label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefit">Income tax benefit (provision)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit" xlink:title="label: IncomeTaxExpenseBenefit to label_us-gaap_IncomeTaxExpenseBenefit" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefit_1">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit_1" xlink:title="label: IncomeTaxExpenseBenefit to label_us-gaap_IncomeTaxExpenseBenefit" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">Change in Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="label: IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance to label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:title="label: IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance to label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">Reconciliation between the amount of reported income tax and the amount computed using U.S. Statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">Loss at Statutory Rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxPolicyTextBlock">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="label_us-gaap_IncomeTaxPolicyTextBlock" xlink:title="label: IncomeTaxPolicyTextBlock to label_us-gaap_IncomeTaxPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxPolicyTextBlock_1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="label_us-gaap_IncomeTaxPolicyTextBlock_1" xlink:title="label: IncomeTaxPolicyTextBlock to label_us-gaap_IncomeTaxPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">State Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="label: IncomeTaxReconciliationStateAndLocalIncomeTaxes to label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1" xlink:title="label: IncomeTaxReconciliationStateAndLocalIncomeTaxes to label_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:title="IncomeTaxReconciliationOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationOtherAdjustments" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationOtherAdjustments">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="label_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:title="label: IncomeTaxReconciliationOtherAdjustments to label_us-gaap_IncomeTaxReconciliationOtherAdjustments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationOtherAdjustments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationOtherAdjustments" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationOtherAdjustments_1">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="label_us-gaap_IncomeTaxReconciliationOtherAdjustments_1" xlink:title="label: IncomeTaxReconciliationOtherAdjustments to label_us-gaap_IncomeTaxReconciliationOtherAdjustments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:title="IncomeTaxReconciliationTaxCreditsResearch" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">Research and Development Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:title="label: IncomeTaxReconciliationTaxCreditsResearch to label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1" xlink:title="label: IncomeTaxReconciliationTaxCreditsResearch to label_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">Accounts Payable and Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="IncreaseDecreaseInAccountsAndOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">Accounts and Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="label: IncreaseDecreaseInAccountsAndOtherReceivables to label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_1">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_1" xlink:title="label: IncreaseDecreaseInAccountsAndOtherReceivables to label_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDeferredRevenue">Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="label_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:title="label: IncreaseDecreaseInDeferredRevenue to label_us-gaap_IncreaseDecreaseInDeferredRevenue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDeferredRevenue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDeferredRevenue_1">Increase (Decrease) in Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="label_us-gaap_IncreaseDecreaseInDeferredRevenue_1" xlink:title="label: IncreaseDecreaseInDeferredRevenue to label_us-gaap_IncreaseDecreaseInDeferredRevenue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">Other Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">Changes in Operating Assets and Liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets">Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to label_us-gaap_IncreaseDecreaseInOtherOperatingAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1">Increase (Decrease) in Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="label_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to label_us-gaap_IncreaseDecreaseInOtherOperatingAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">Prepaid and Other Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to label_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="label_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="label: IndefiniteLivedIntangibleAssetsByMajorClassAxis to label_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">Indefinite-lived intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="IndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="label_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="label: IndefiniteLivedIntangibleAssetsMajorClassNameDomain to label_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">Indefinite-lived intangible assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract to label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xml:lang="en-US" id="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_1">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_1" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract to label_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">Total Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="label: IntangibleAssetsNetExcludingGoodwillAbstract to label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_1">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_1" xlink:title="label: IntangibleAssetsNetExcludingGoodwillAbstract to label_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="IntangibleAssetsGrossExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill">Cost of total intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="label: IntangibleAssetsGrossExcludingGoodwill to label_us-gaap_IntangibleAssetsGrossExcludingGoodwill" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="label_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1" xlink:title="label: IntangibleAssetsGrossExcludingGoodwill to label_us-gaap_IntangibleAssetsGrossExcludingGoodwill" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsNetExcludingGoodwill">Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="label_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to label_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_1">Net total intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_1" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to label_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_2">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_2" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to label_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_3">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="label_us-gaap_IntangibleAssetsNetExcludingGoodwill_3" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to label_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xlink:title="InterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_InterestExpense" xml:lang="en-US" id="label_us-gaap_InterestExpense">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="label_us-gaap_InterestExpense" xlink:title="label: InterestExpense to label_us-gaap_InterestExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestExpense" xml:lang="en-US" id="label_us-gaap_InterestExpense_1">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="label_us-gaap_InterestExpense_1" xlink:title="label: InterestExpense to label_us-gaap_InterestExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestAndOtherIncome" xml:lang="en-US" id="label_us-gaap_InterestAndOtherIncome">Investment and Other Income, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="label_us-gaap_InterestAndOtherIncome" xlink:title="label: InterestAndOtherIncome to label_us-gaap_InterestAndOtherIncome" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestAndOtherIncome_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestAndOtherIncome" xml:lang="en-US" id="label_us-gaap_InterestAndOtherIncome_1">Interest and Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="label_us-gaap_InterestAndOtherIncome_1" xlink:title="label: InterestAndOtherIncome to label_us-gaap_InterestAndOtherIncome" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestExpenseDebt" xml:lang="en-US" id="label_us-gaap_InterestExpenseDebt">Interest expense on debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="label_us-gaap_InterestExpenseDebt" xlink:title="label: InterestExpenseDebt to label_us-gaap_InterestExpenseDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpenseDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestExpenseDebt" xml:lang="en-US" id="label_us-gaap_InterestExpenseDebt_1">Interest Expense, Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="label_us-gaap_InterestExpenseDebt_1" xlink:title="label: InterestExpenseDebt to label_us-gaap_InterestExpenseDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt" xlink:title="InterestExpenseLongTermDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpenseLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestExpenseLongTermDebt" xml:lang="en-US" id="label_us-gaap_InterestExpenseLongTermDebt">Interest expense on the term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseLongTermDebt" xlink:to="label_us-gaap_InterestExpenseLongTermDebt" xlink:title="label: InterestExpenseLongTermDebt to label_us-gaap_InterestExpenseLongTermDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpenseLongTermDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestExpenseLongTermDebt" xml:lang="en-US" id="label_us-gaap_InterestExpenseLongTermDebt_1">Interest Expense, Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseLongTermDebt" xlink:to="label_us-gaap_InterestExpenseLongTermDebt_1" xlink:title="label: InterestExpenseLongTermDebt to label_us-gaap_InterestExpenseLongTermDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:title="InterestPaid" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestPaid" xml:lang="en-US" id="label_us-gaap_InterestPaid">Cash Paid for Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="label_us-gaap_InterestPaid" xlink:title="label: InterestPaid to label_us-gaap_InterestPaid" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestPaid_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestPaid" xml:lang="en-US" id="label_us-gaap_InterestPaid_1">Interest Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="label_us-gaap_InterestPaid_1" xlink:title="label: InterestPaid to label_us-gaap_InterestPaid" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember" xlink:title="InternalRevenueServiceIRSMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InternalRevenueServiceIRSMember" xml:lang="en-US" id="label_us-gaap_InternalRevenueServiceIRSMember">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="label_us-gaap_InternalRevenueServiceIRSMember" xlink:title="label: InternalRevenueServiceIRSMember to label_us-gaap_InternalRevenueServiceIRSMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InternalRevenueServiceIRSMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InternalRevenueServiceIRSMember" xml:lang="en-US" id="label_us-gaap_InternalRevenueServiceIRSMember_1">Internal Revenue Service (IRS) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="label_us-gaap_InternalRevenueServiceIRSMember_1" xlink:title="label: InternalRevenueServiceIRSMember to label_us-gaap_InternalRevenueServiceIRSMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash" xlink:title="InvestmentsAndCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InvestmentsAndCash" xml:lang="en-US" id="label_us-gaap_InvestmentsAndCash">Cash, cash equivalents and marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="label_us-gaap_InvestmentsAndCash" xlink:title="label: InvestmentsAndCash to label_us-gaap_InvestmentsAndCash" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsAndCash_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentsAndCash" xml:lang="en-US" id="label_us-gaap_InvestmentsAndCash_1">Investments and Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="label_us-gaap_InvestmentsAndCash_1" xlink:title="label: InvestmentsAndCash to label_us-gaap_InvestmentsAndCash" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xml:lang="en-US" id="label_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">MARKETABLE SECURITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="label_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="label: InvestmentsDebtAndEquitySecuritiesAbstract to label_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">MARKETABLE SECURITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="label: InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock to label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xlink:title="label: InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock to label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US" id="label_us-gaap_LongtermDebtTypeAxis">Long-term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="label_us-gaap_LongtermDebtTypeAxis" xlink:title="label: LongtermDebtTypeAxis to label_us-gaap_LongtermDebtTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US" id="label_us-gaap_LongtermDebtTypeDomain">Long-term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="label_us-gaap_LongtermDebtTypeDomain" xlink:title="label: LongtermDebtTypeDomain to label_us-gaap_LongtermDebtTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US" id="label_us-gaap_LeaseholdImprovementsMember">Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="label_us-gaap_LeaseholdImprovementsMember" xlink:title="label: LeaseholdImprovementsMember to label_us-gaap_LeaseholdImprovementsMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseholdImprovementsMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US" id="label_us-gaap_LeaseholdImprovementsMember_1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="label_us-gaap_LeaseholdImprovementsMember_1" xlink:title="label: LeaseholdImprovementsMember to label_us-gaap_LeaseholdImprovementsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent">Total Current Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent" xlink:title="label: LiabilitiesCurrent to label_us-gaap_LiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent_1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent_1" xlink:title="label: LiabilitiesCurrent to label_us-gaap_LiabilitiesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity">Total Liabilities and Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="label: LiabilitiesAndStockholdersEquity to label_us-gaap_LiabilitiesAndStockholdersEquity" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity_1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:title="label: LiabilitiesAndStockholdersEquity to label_us-gaap_LiabilitiesAndStockholdersEquity" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract">Current Liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract" xlink:title="label: LiabilitiesCurrentAbstract to label_us-gaap_LiabilitiesCurrentAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract_1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract_1" xlink:title="label: LiabilitiesCurrentAbstract to label_us-gaap_LiabilitiesCurrentAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_Liabilities" xml:lang="en-US" id="label_us-gaap_Liabilities">Total Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="label_us-gaap_Liabilities" xlink:title="label: Liabilities to label_us-gaap_Liabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Liabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Liabilities" xml:lang="en-US" id="label_us-gaap_Liabilities_1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="label_us-gaap_Liabilities_1" xlink:title="label: Liabilities to label_us-gaap_Liabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseCosts" xlink:label="us-gaap_LicenseCosts" xlink:title="LicenseCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LicenseCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LicenseCosts" xml:lang="en-US" id="label_us-gaap_LicenseCosts">Sublicense fees paid to Duke University and Thomas Jefferson University</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseCosts" xlink:to="label_us-gaap_LicenseCosts" xlink:title="label: LicenseCosts to label_us-gaap_LicenseCosts" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LicenseCosts_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LicenseCosts" xml:lang="en-US" id="label_us-gaap_LicenseCosts_1">License Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseCosts" xlink:to="label_us-gaap_LicenseCosts_1" xlink:title="label: LicenseCosts to label_us-gaap_LicenseCosts" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" xlink:title="LoansPayableMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LoansPayableMember" xml:lang="en-US" id="label_us-gaap_LoansPayableMember">Loan Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="label_us-gaap_LoansPayableMember" xlink:title="label: LoansPayableMember to label_us-gaap_LoansPayableMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LoansPayableMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LoansPayableMember" xml:lang="en-US" id="label_us-gaap_LoansPayableMember_1">Loans Payable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="label_us-gaap_LoansPayableMember_1" xlink:title="label: LoansPayableMember to label_us-gaap_LoansPayableMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" xlink:title="LoansPayable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LoansPayable" xml:lang="en-US" id="label_us-gaap_LoansPayable">Loan Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="label_us-gaap_LoansPayable" xlink:title="label: LoansPayable to label_us-gaap_LoansPayable" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LoansPayable_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LoansPayable" xml:lang="en-US" id="label_us-gaap_LoansPayable_1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="label_us-gaap_LoansPayable_1" xlink:title="label: LoansPayable to label_us-gaap_LoansPayable" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LoansPayable_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LoansPayable" xml:lang="en-US" id="label_us-gaap_LoansPayable_2">Loans Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="label_us-gaap_LoansPayable_2" xlink:title="label: LoansPayable to label_us-gaap_LoansPayable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" xlink:title="LongTermDebtTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtTextBlock" xml:lang="en-US" id="label_us-gaap_LongTermDebtTextBlock">TERM LOAN</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="label_us-gaap_LongTermDebtTextBlock" xlink:title="label: LongTermDebtTextBlock to label_us-gaap_LongTermDebtTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtTextBlock" xml:lang="en-US" id="label_us-gaap_LongTermDebtTextBlock_1">Long-term Debt [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="label_us-gaap_LongTermDebtTextBlock_1" xlink:title="label: LongTermDebtTextBlock to label_us-gaap_LongTermDebtTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_1">Long-term Debt, Maturities, Repayments of Principal after Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">2016</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtByMaturityAbstract" xml:lang="en-US" id="label_us-gaap_LongTermDebtByMaturityAbstract">Principal amounts for the loan which the entity is obligated to repay</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="label_us-gaap_LongTermDebtByMaturityAbstract" xlink:title="label: LongTermDebtByMaturityAbstract to label_us-gaap_LongTermDebtByMaturityAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtByMaturityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_LongTermDebtByMaturityAbstract" xml:lang="en-US" id="label_us-gaap_LongTermDebtByMaturityAbstract_1">Obligations to repay principal amounts for the term loan (including Payment Fee)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="label_us-gaap_LongTermDebtByMaturityAbstract_1" xlink:title="label: LongTermDebtByMaturityAbstract to label_us-gaap_LongTermDebtByMaturityAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtByMaturityAbstract_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtByMaturityAbstract" xml:lang="en-US" id="label_us-gaap_LongTermDebtByMaturityAbstract_2">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="label_us-gaap_LongTermDebtByMaturityAbstract_2" xlink:title="label: LongTermDebtByMaturityAbstract to label_us-gaap_LongTermDebtByMaturityAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">2014</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xml:lang="en-US" id="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to label_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:title="MajorTypesOfDebtAndEquitySecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xml:lang="en-US" id="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis">Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:title="label: MajorTypesOfDebtAndEquitySecuritiesAxis to label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:title="MajorTypesOfDebtAndEquitySecuritiesDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xml:lang="en-US" id="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain">Major Types of Debt and Equity Securities [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:title="label: MajorTypesOfDebtAndEquitySecuritiesDomain to label_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MajorCustomersAxis" xml:lang="en-US" id="label_us-gaap_MajorCustomersAxis">Customer [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="label_us-gaap_MajorCustomersAxis" xlink:title="label: MajorCustomersAxis to label_us-gaap_MajorCustomersAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:title="MarketableSecuritiesPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MarketableSecuritiesPolicy" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesPolicy">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="label_us-gaap_MarketableSecuritiesPolicy" xlink:title="label: MarketableSecuritiesPolicy to label_us-gaap_MarketableSecuritiesPolicy" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesPolicy_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MarketableSecuritiesPolicy" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesPolicy_1">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="label_us-gaap_MarketableSecuritiesPolicy_1" xlink:title="label: MarketableSecuritiesPolicy to label_us-gaap_MarketableSecuritiesPolicy" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" xlink:title="MarketableSecuritiesGainLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_MarketableSecuritiesGainLoss" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesGainLoss">Realized (Gain) Loss on Sales and Maturities of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="label_us-gaap_MarketableSecuritiesGainLoss" xlink:title="label: MarketableSecuritiesGainLoss to label_us-gaap_MarketableSecuritiesGainLoss" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesGainLoss_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MarketableSecuritiesGainLoss" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesGainLoss_1">Marketable Securities, Gain (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="label_us-gaap_MarketableSecuritiesGainLoss_1" xlink:title="label: MarketableSecuritiesGainLoss to label_us-gaap_MarketableSecuritiesGainLoss" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MaximumMember" xml:lang="en-US" id="label_us-gaap_MaximumMember">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="label_us-gaap_MaximumMember" xlink:title="label: MaximumMember to label_us-gaap_MaximumMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MaximumMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MaximumMember" xml:lang="en-US" id="label_us-gaap_MaximumMember_1">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="label_us-gaap_MaximumMember_1" xlink:title="label: MaximumMember to label_us-gaap_MaximumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MinimumMember" xml:lang="en-US" id="label_us-gaap_MinimumMember">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="label_us-gaap_MinimumMember" xlink:title="label: MinimumMember to label_us-gaap_MinimumMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MinimumMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MinimumMember" xml:lang="en-US" id="label_us-gaap_MinimumMember_1">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="label_us-gaap_MinimumMember_1" xlink:title="label: MinimumMember to label_us-gaap_MinimumMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NameOfMajorCustomerDomain" xml:lang="en-US" id="label_us-gaap_NameOfMajorCustomerDomain">Customer [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="label_us-gaap_NameOfMajorCustomerDomain" xlink:title="label: NameOfMajorCustomerDomain to label_us-gaap_NameOfMajorCustomerDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">Cash Flows From Financing Activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">Cash Flows From Operating Activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:title="NetCashProvidedByUsedInContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInContinuingOperations">Net Increase (Decrease) in Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:title="label: NetCashProvidedByUsedInContinuingOperations to label_us-gaap_NetCashProvidedByUsedInContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInContinuingOperations_1">Net Cash Provided by (Used in) Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInContinuingOperations_1" xlink:title="label: NetCashProvidedByUsedInContinuingOperations to label_us-gaap_NetCashProvidedByUsedInContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">Net Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1">Net Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2">Net (loss) income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3">Pre-tax loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">Net Cash Used in Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1">Net cash used in operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">Net Cash Provided by Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">Net Cash Used in Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">Cash Flows From Investing Activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NumberOfStatesInWhichEntityOperates" xml:lang="en-US" id="label_us-gaap_NumberOfStatesInWhichEntityOperates">Number of states in which the entity primarily operates or has operated and has income tax nexus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="label_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:title="label: NumberOfStatesInWhichEntityOperates to label_us-gaap_NumberOfStatesInWhichEntityOperates" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NumberOfStatesInWhichEntityOperates_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NumberOfStatesInWhichEntityOperates" xml:lang="en-US" id="label_us-gaap_NumberOfStatesInWhichEntityOperates_1">Number of States in which Entity Operates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="label_us-gaap_NumberOfStatesInWhichEntityOperates_1" xlink:title="label: NumberOfStatesInWhichEntityOperates to label_us-gaap_NumberOfStatesInWhichEntityOperates" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NumberOfOperatingSegments" xml:lang="en-US" id="label_us-gaap_NumberOfOperatingSegments">Number of operating segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="label_us-gaap_NumberOfOperatingSegments" xlink:title="label: NumberOfOperatingSegments to label_us-gaap_NumberOfOperatingSegments" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NumberOfOperatingSegments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NumberOfOperatingSegments" xml:lang="en-US" id="label_us-gaap_NumberOfOperatingSegments_1">Number of Operating Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="label_us-gaap_NumberOfOperatingSegments_1" xlink:title="label: NumberOfOperatingSegments to label_us-gaap_NumberOfOperatingSegments" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueThereafter to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueThereafter to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">Obligations for base rent and CAM costs under facility and other non-cancelable operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueAbstract to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueAbstract to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInFourYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInFourYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInFiveYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1">Annual rental obligations in the fifth year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInFiveYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInFiveYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">2016</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xlink:title="OperatingLeasesRentExpenseNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesRentExpenseNet" xml:lang="en-US" id="label_us-gaap_OperatingLeasesRentExpenseNet">Total rent and CAM expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="label_us-gaap_OperatingLeasesRentExpenseNet" xlink:title="label: OperatingLeasesRentExpenseNet to label_us-gaap_OperatingLeasesRentExpenseNet" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesRentExpenseNet_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesRentExpenseNet" xml:lang="en-US" id="label_us-gaap_OperatingLeasesRentExpenseNet_1">Operating Leases, Rent Expense, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="label_us-gaap_OperatingLeasesRentExpenseNet_1" xlink:title="label: OperatingLeasesRentExpenseNet to label_us-gaap_OperatingLeasesRentExpenseNet" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">2014</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1">Annual rental obligations in the first year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OperatingIncomeLoss" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss">Operating Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="label_us-gaap_OperatingIncomeLoss" xlink:title="label: OperatingIncomeLoss to label_us-gaap_OperatingIncomeLoss" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingIncomeLoss_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingIncomeLoss" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss_1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="label_us-gaap_OperatingIncomeLoss_1" xlink:title="label: OperatingIncomeLoss to label_us-gaap_OperatingIncomeLoss" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="OperatingLeasedAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasedAssetsLineItems" xml:lang="en-US" id="label_us-gaap_OperatingLeasedAssetsLineItems">Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="label_us-gaap_OperatingLeasedAssetsLineItems" xlink:title="label: OperatingLeasedAssetsLineItems to label_us-gaap_OperatingLeasedAssetsLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasedAssetsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasedAssetsLineItems" xml:lang="en-US" id="label_us-gaap_OperatingLeasedAssetsLineItems_1">Operating Leased Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="label_us-gaap_OperatingLeasedAssetsLineItems_1" xlink:title="label: OperatingLeasedAssetsLineItems to label_us-gaap_OperatingLeasedAssetsLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">Total minimum lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDue to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1">Operating Leases, Future Minimum Payments Due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" xlink:title="label: OperatingLeasesFutureMinimumPaymentsDue to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_OperatingLossCarryforwards">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="label_us-gaap_OperatingLossCarryforwards" xlink:title="label: OperatingLossCarryforwards to label_us-gaap_OperatingLossCarryforwards" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLossCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_OperatingLossCarryforwards_1">Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="label_us-gaap_OperatingLossCarryforwards_1" xlink:title="label: OperatingLossCarryforwards to label_us-gaap_OperatingLossCarryforwards" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US" id="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">NATURE OF BUSINESS AND OVERVIEW</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax">Net current-period other comprehensive income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="label: OtherComprehensiveIncomeLossNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" xlink:title="label: OtherComprehensiveIncomeLossNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">Other comprehensive income (loss) before reclassifications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="label: OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1" xlink:title="label: OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherAssetsNoncurrent" xml:lang="en-US" id="label_us-gaap_OtherAssetsNoncurrent">Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="label_us-gaap_OtherAssetsNoncurrent" xlink:title="label: OtherAssetsNoncurrent to label_us-gaap_OtherAssetsNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherAssetsNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherAssetsNoncurrent" xml:lang="en-US" id="label_us-gaap_OtherAssetsNoncurrent_1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="label_us-gaap_OtherAssetsNoncurrent_1" xlink:title="label: OtherAssetsNoncurrent to label_us-gaap_OtherAssetsNoncurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="OtherLiabilitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherLiabilitiesDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesDisclosureAbstract">OTHER LONG-TERM LIABILITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="label_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="label: OtherLiabilitiesDisclosureAbstract to label_us-gaap_OtherLiabilitiesDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherSundryLiabilities" xlink:label="us-gaap_OtherSundryLiabilities" xlink:title="OtherSundryLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherSundryLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherSundryLiabilities" xml:lang="en-US" id="label_us-gaap_OtherSundryLiabilities">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilities" xlink:to="label_us-gaap_OtherSundryLiabilities" xlink:title="label: OtherSundryLiabilities to label_us-gaap_OtherSundryLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherSundryLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherSundryLiabilities" xml:lang="en-US" id="label_us-gaap_OtherSundryLiabilities_1">Other Sundry Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilities" xlink:to="label_us-gaap_OtherSundryLiabilities_1" xlink:title="label: OtherSundryLiabilities to label_us-gaap_OtherSundryLiabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">Unrealized (Loss) Gain on Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="label: OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax to label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1">Unrealized Gains (Losses) on Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1" xlink:title="label: OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax to label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2">Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2" xlink:title="label: OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax to label_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" xlink:title="OtherNonoperatingIncome" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherNonoperatingIncome" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncome">Other income related to IRS Qualifying Therapeutic Discovery Grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="label_us-gaap_OtherNonoperatingIncome" xlink:title="label: OtherNonoperatingIncome to label_us-gaap_OtherNonoperatingIncome" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncome_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherNonoperatingIncome" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncome_1">Other Nonoperating Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="label_us-gaap_OtherNonoperatingIncome_1" xlink:title="label: OtherNonoperatingIncome to label_us-gaap_OtherNonoperatingIncome" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherLiabilitiesNoncurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesNoncurrent">Other Long-Term Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="label_us-gaap_OtherLiabilitiesNoncurrent" xlink:title="label: OtherLiabilitiesNoncurrent to label_us-gaap_OtherLiabilitiesNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OtherLiabilitiesNoncurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesNoncurrent_1">Long-Term Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="label_us-gaap_OtherLiabilitiesNoncurrent_1" xlink:title="label: OtherLiabilitiesNoncurrent to label_us-gaap_OtherLiabilitiesNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesNoncurrent_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OtherLiabilitiesNoncurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesNoncurrent_2">Long-Term Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="label_us-gaap_OtherLiabilitiesNoncurrent_2" xlink:title="label: OtherLiabilitiesNoncurrent to label_us-gaap_OtherLiabilitiesNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesNoncurrent_3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherLiabilitiesNoncurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesNoncurrent_3">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="label_us-gaap_OtherLiabilitiesNoncurrent_3" xlink:title="label: OtherLiabilitiesNoncurrent to label_us-gaap_OtherLiabilitiesNoncurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesCurrent">Current Portion of Long-Term Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="label_us-gaap_OtherLiabilitiesCurrent" xlink:title="label: OtherLiabilitiesCurrent to label_us-gaap_OtherLiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesCurrent_1">Less Current Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="label_us-gaap_OtherLiabilitiesCurrent_1" xlink:title="label: OtherLiabilitiesCurrent to label_us-gaap_OtherLiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesCurrent_2">Other Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="label_us-gaap_OtherLiabilitiesCurrent_2" xlink:title="label: OtherLiabilitiesCurrent to label_us-gaap_OtherLiabilitiesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:title="OtherLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherLiabilitiesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesDisclosureTextBlock">OTHER LONG-TERM LIABILITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="label_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:title="label: OtherLiabilitiesDisclosureTextBlock to label_us-gaap_OtherLiabilitiesDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilitiesDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherLiabilitiesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_OtherLiabilitiesDisclosureTextBlock_1">Other Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="label_us-gaap_OtherLiabilitiesDisclosureTextBlock_1" xlink:title="label: OtherLiabilitiesDisclosureTextBlock to label_us-gaap_OtherLiabilitiesDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" xlink:title="OtherLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OtherLiabilities" xml:lang="en-US" id="label_us-gaap_OtherLiabilities">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="label_us-gaap_OtherLiabilities" xlink:title="label: OtherLiabilities to label_us-gaap_OtherLiabilities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherLiabilities" xml:lang="en-US" id="label_us-gaap_OtherLiabilities_1">Other Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="label_us-gaap_OtherLiabilities_1" xlink:title="label: OtherLiabilities to label_us-gaap_OtherLiabilities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeTaxExpense" xlink:label="us-gaap_OtherNoncashIncomeTaxExpense" xlink:title="OtherNoncashIncomeTaxExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNoncashIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherNoncashIncomeTaxExpense" xml:lang="en-US" id="label_us-gaap_OtherNoncashIncomeTaxExpense">Non-Cash Tax Benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeTaxExpense" xlink:to="label_us-gaap_OtherNoncashIncomeTaxExpense" xlink:title="label: OtherNoncashIncomeTaxExpense to label_us-gaap_OtherNoncashIncomeTaxExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNoncashIncomeTaxExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherNoncashIncomeTaxExpense" xml:lang="en-US" id="label_us-gaap_OtherNoncashIncomeTaxExpense_1">Other Noncash Income Tax Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeTaxExpense" xlink:to="label_us-gaap_OtherNoncashIncomeTaxExpense_1" xlink:title="label: OtherNoncashIncomeTaxExpense to label_us-gaap_OtherNoncashIncomeTaxExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_OtherAccruedLiabilitiesCurrent">Other Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="label_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="label: OtherAccruedLiabilitiesCurrent to label_us-gaap_OtherAccruedLiabilitiesCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherAccruedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_OtherAccruedLiabilitiesCurrent_1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="label_us-gaap_OtherAccruedLiabilitiesCurrent_1" xlink:title="label: OtherAccruedLiabilitiesCurrent to label_us-gaap_OtherAccruedLiabilitiesCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:title="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">Other Comprehensive Income (Loss):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:title="label: OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1" xlink:title="label: OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to label_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">Foreign Currency Translation Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="label: OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent to label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1" xlink:title="label: OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent to label_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProductsAndServicesDomain" xml:lang="en-US" id="label_us-gaap_ProductsAndServicesDomain">Products and Services [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="label_us-gaap_ProductsAndServicesDomain" xlink:title="label: ProductsAndServicesDomain to label_us-gaap_ProductsAndServicesDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PayablesAndAccrualsAbstract" xml:lang="en-US" id="label_us-gaap_PayablesAndAccrualsAbstract">ACCRUED EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="label_us-gaap_PayablesAndAccrualsAbstract" xlink:title="label: PayablesAndAccrualsAbstract to label_us-gaap_PayablesAndAccrualsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToAcquireMarketableSecurities" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireMarketableSecurities">Purchases of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="label_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:title="label: PaymentsToAcquireMarketableSecurities to label_us-gaap_PaymentsToAcquireMarketableSecurities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquireMarketableSecurities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToAcquireMarketableSecurities" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireMarketableSecurities_1">Payments to Acquire Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="label_us-gaap_PaymentsToAcquireMarketableSecurities_1" xlink:title="label: PaymentsToAcquireMarketableSecurities to label_us-gaap_PaymentsToAcquireMarketableSecurities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">Acquisition of Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">RETIREMENT SAVINGS PLAN</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="label: PensionAndOtherPostretirementBenefitsDisclosureTextBlock to label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" xlink:title="label: PensionAndOtherPostretirementBenefitsDisclosureTextBlock to label_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PlanNameDomain" xml:lang="en-US" id="label_us-gaap_PlanNameDomain">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="label_us-gaap_PlanNameDomain" xlink:title="label: PlanNameDomain to label_us-gaap_PlanNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PlanNameAxis" xml:lang="en-US" id="label_us-gaap_PlanNameAxis">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="label_us-gaap_PlanNameAxis" xlink:title="label: PlanNameAxis to label_us-gaap_PlanNameAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_PreferredStockParOrStatedValuePerShare">Convertible Preferred Stock, Par Value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="label_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="label: PreferredStockParOrStatedValuePerShare to label_us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_PreferredStockParOrStatedValuePerShare_1">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="label_us-gaap_PreferredStockParOrStatedValuePerShare_1" xlink:title="label: PreferredStockParOrStatedValuePerShare to label_us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PreferredStockValue" xml:lang="en-US" id="label_us-gaap_PreferredStockValue">Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at December 31, 2013 and 2012</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="label_us-gaap_PreferredStockValue" xlink:title="label: PreferredStockValue to label_us-gaap_PreferredStockValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockValue" xml:lang="en-US" id="label_us-gaap_PreferredStockValue_1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="label_us-gaap_PreferredStockValue_1" xlink:title="label: PreferredStockValue to label_us-gaap_PreferredStockValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockSharesIssued" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesIssued">Convertible Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="label_us-gaap_PreferredStockSharesIssued" xlink:title="label: PreferredStockSharesIssued to label_us-gaap_PreferredStockSharesIssued" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockSharesIssued" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesIssued_1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="label_us-gaap_PreferredStockSharesIssued_1" xlink:title="label: PreferredStockSharesIssued to label_us-gaap_PreferredStockSharesIssued" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesAuthorized">Convertible Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="label_us-gaap_PreferredStockSharesAuthorized" xlink:title="label: PreferredStockSharesAuthorized to label_us-gaap_PreferredStockSharesAuthorized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesAuthorized_1">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="label_us-gaap_PreferredStockSharesAuthorized_1" xlink:title="label: PreferredStockSharesAuthorized to label_us-gaap_PreferredStockSharesAuthorized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesAuthorized_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesAuthorized_2">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="label_us-gaap_PreferredStockSharesAuthorized_2" xlink:title="label: PreferredStockSharesAuthorized to label_us-gaap_PreferredStockSharesAuthorized" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesOutstanding">Convertible Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="label_us-gaap_PreferredStockSharesOutstanding" xlink:title="label: PreferredStockSharesOutstanding to label_us-gaap_PreferredStockSharesOutstanding" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesOutstanding_1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="label_us-gaap_PreferredStockSharesOutstanding_1" xlink:title="label: PreferredStockSharesOutstanding to label_us-gaap_PreferredStockSharesOutstanding" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">Prepaid and Other Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfDebt">Amount borrowed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="label_us-gaap_ProceedsFromIssuanceOfDebt" xlink:title="label: ProceedsFromIssuanceOfDebt to label_us-gaap_ProceedsFromIssuanceOfDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfDebt_1">Proceeds from Issuance of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="label_us-gaap_ProceedsFromIssuanceOfDebt_1" xlink:title="label: ProceedsFromIssuanceOfDebt to label_us-gaap_ProceedsFromIssuanceOfDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:title="ProceedsFromIssuanceOfLongTermDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt">(Payments) Issuance of Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:title="label: ProceedsFromIssuanceOfLongTermDebt to label_us-gaap_ProceedsFromIssuanceOfLongTermDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1">Proceeds from Issuance of Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="label_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1" xlink:title="label: ProceedsFromIssuanceOfLongTermDebt to label_us-gaap_ProceedsFromIssuanceOfLongTermDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock">Net proceeds from sale of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="label: ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1">Net Proceeds from Stock Issuances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xlink:title="label: ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2" xlink:title="label: ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">Sales and Maturities of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="label: ProceedsFromSaleAndMaturityOfMarketableSecurities to label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xlink:title="label: ProceedsFromSaleAndMaturityOfMarketableSecurities to label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromSaleOfProductiveAssets" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleOfProductiveAssets">Proceeds from Sale or Disposal of Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="label_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:title="label: ProceedsFromSaleOfProductiveAssets to label_us-gaap_ProceedsFromSaleOfProductiveAssets" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleOfProductiveAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromSaleOfProductiveAssets" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleOfProductiveAssets_1">Proceeds from Sale of Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="label_us-gaap_ProceedsFromSaleOfProductiveAssets_1" xlink:title="label: ProceedsFromSaleOfProductiveAssets to label_us-gaap_ProceedsFromSaleOfProductiveAssets" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:title="ProceedsFromStockPlans" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromStockPlans" xml:lang="en-US" id="label_us-gaap_ProceedsFromStockPlans">Proceeds from Issuance of Stock from Employee Benefit Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="label_us-gaap_ProceedsFromStockPlans" xlink:title="label: ProceedsFromStockPlans to label_us-gaap_ProceedsFromStockPlans" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromStockPlans_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromStockPlans" xml:lang="en-US" id="label_us-gaap_ProceedsFromStockPlans_1">Proceeds from Stock Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="label_us-gaap_ProceedsFromStockPlans_1" xlink:title="label: ProceedsFromStockPlans to label_us-gaap_ProceedsFromStockPlans" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProductOrServiceAxis" xml:lang="en-US" id="label_us-gaap_ProductOrServiceAxis">Products and Services [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="label_us-gaap_ProductOrServiceAxis" xlink:title="label: ProductOrServiceAxis to label_us-gaap_ProductOrServiceAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentUsefulLife">Estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to label_us-gaap_PropertyPlantAndEquipmentUsefulLife" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentUsefulLife_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentUsefulLife_1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="label_us-gaap_PropertyPlantAndEquipmentUsefulLife_1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to label_us-gaap_PropertyPlantAndEquipmentUsefulLife" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentGross">Total Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="label_us-gaap_PropertyPlantAndEquipmentGross" xlink:title="label: PropertyPlantAndEquipmentGross to label_us-gaap_PropertyPlantAndEquipmentGross" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentGross_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentGross_1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="label_us-gaap_PropertyPlantAndEquipmentGross_1" xlink:title="label: PropertyPlantAndEquipmentGross to label_us-gaap_PropertyPlantAndEquipmentGross" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet" xlink:title="label: PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_1">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet_1" xlink:title="label: PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_2">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet_2" xlink:title="label: PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentAbstract">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="label_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="label: PropertyPlantAndEquipmentAbstract to label_us-gaap_PropertyPlantAndEquipmentAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTextBlock">Schedule of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="label: PropertyPlantAndEquipmentTextBlock to label_us-gaap_PropertyPlantAndEquipmentTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xlink:title="label: PropertyPlantAndEquipmentTextBlock to label_us-gaap_PropertyPlantAndEquipmentTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTypeDomain">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to label_us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentLineItems">Property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="label_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="label: PropertyPlantAndEquipmentLineItems to label_us-gaap_PropertyPlantAndEquipmentLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentLineItems_1">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="label_us-gaap_PropertyPlantAndEquipmentLineItems_1" xlink:title="label: PropertyPlantAndEquipmentLineItems to label_us-gaap_PropertyPlantAndEquipmentLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:title="QuarterlyFinancialInformationTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_QuarterlyFinancialInformationTextBlock" xml:lang="en-US" id="label_us-gaap_QuarterlyFinancialInformationTextBlock">SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="label_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:title="label: QuarterlyFinancialInformationTextBlock to label_us-gaap_QuarterlyFinancialInformationTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_QuarterlyFinancialInformationTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_QuarterlyFinancialInformationTextBlock" xml:lang="en-US" id="label_us-gaap_QuarterlyFinancialInformationTextBlock_1">Quarterly Financial Information [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="label_us-gaap_QuarterlyFinancialInformationTextBlock_1" xlink:title="label: QuarterlyFinancialInformationTextBlock to label_us-gaap_QuarterlyFinancialInformationTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:title="QuarterlyFinancialInformationDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="label_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:title="label: QuarterlyFinancialInformationDisclosureAbstract to label_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RangeAxis" xml:lang="en-US" id="label_us-gaap_RangeAxis">Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="label_us-gaap_RangeAxis" xlink:title="label: RangeAxis to label_us-gaap_RangeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RangeMember" xml:lang="en-US" id="label_us-gaap_RangeMember">Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="label_us-gaap_RangeMember" xlink:title="label: RangeMember to label_us-gaap_RangeMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:title="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xml:lang="en-US" id="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">Amounts reclassified from other comprehensive income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:title="label: ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax to label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xml:lang="en-US" id="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1" xlink:title="label: ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax to label_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt" xlink:title="RepaymentsOfSecuredDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_RepaymentsOfSecuredDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfSecuredDebt">Payments of Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="label_us-gaap_RepaymentsOfSecuredDebt" xlink:title="label: RepaymentsOfSecuredDebt to label_us-gaap_RepaymentsOfSecuredDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfSecuredDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RepaymentsOfSecuredDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfSecuredDebt_1">Repayments of Secured Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="label_us-gaap_RepaymentsOfSecuredDebt_1" xlink:title="label: RepaymentsOfSecuredDebt to label_us-gaap_RepaymentsOfSecuredDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfSubordinatedDebt" xlink:label="us-gaap_RepaymentsOfSubordinatedDebt" xlink:title="RepaymentsOfSubordinatedDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfSubordinatedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_RepaymentsOfSubordinatedDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfSubordinatedDebt">Related Party Loan Due to Medarex</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSubordinatedDebt" xlink:to="label_us-gaap_RepaymentsOfSubordinatedDebt" xlink:title="label: RepaymentsOfSubordinatedDebt to label_us-gaap_RepaymentsOfSubordinatedDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfSubordinatedDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RepaymentsOfSubordinatedDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfSubordinatedDebt_1">Repayments of Subordinated Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSubordinatedDebt" xlink:to="label_us-gaap_RepaymentsOfSubordinatedDebt_1" xlink:title="label: RepaymentsOfSubordinatedDebt to label_us-gaap_RepaymentsOfSubordinatedDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RepaymentsOfDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfDebt">Payment of outstanding principal and accrued interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="label_us-gaap_RepaymentsOfDebt" xlink:title="label: RepaymentsOfDebt to label_us-gaap_RepaymentsOfDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RepaymentsOfDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfDebt_1">Repayments of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="label_us-gaap_RepaymentsOfDebt_1" xlink:title="label: RepaymentsOfDebt to label_us-gaap_RepaymentsOfDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:title="RepaymentsOfOtherLongTermDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_RepaymentsOfOtherLongTermDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfOtherLongTermDebt">Payment of Other Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="label_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:title="label: RepaymentsOfOtherLongTermDebt to label_us-gaap_RepaymentsOfOtherLongTermDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfOtherLongTermDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RepaymentsOfOtherLongTermDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfOtherLongTermDebt_1">Repayments of Other Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="label_us-gaap_RepaymentsOfOtherLongTermDebt_1" xlink:title="label: RepaymentsOfOtherLongTermDebt to label_us-gaap_RepaymentsOfOtherLongTermDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:title="RepaymentsOfConvertibleDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_RepaymentsOfConvertibleDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfConvertibleDebt">Payment of Convertible Subordinated Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="label_us-gaap_RepaymentsOfConvertibleDebt" xlink:title="label: RepaymentsOfConvertibleDebt to label_us-gaap_RepaymentsOfConvertibleDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepaymentsOfConvertibleDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RepaymentsOfConvertibleDebt" xml:lang="en-US" id="label_us-gaap_RepaymentsOfConvertibleDebt_1">Repayments of Convertible Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="label_us-gaap_RepaymentsOfConvertibleDebt_1" xlink:title="label: RepaymentsOfConvertibleDebt to label_us-gaap_RepaymentsOfConvertibleDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xml:lang="en-US" id="label_us-gaap_RepurchaseAgreementCounterpartyNameDomain">Counterparty Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="label_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="label: RepurchaseAgreementCounterpartyNameDomain to label_us-gaap_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense" xlink:title="label: ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense_1">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense_1" xlink:title="label: ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpenseMember">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="label_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="label: ResearchAndDevelopmentExpenseMember to label_us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpenseMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpenseMember_1">Research and Development Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="label_us-gaap_ResearchAndDevelopmentExpenseMember_1" xlink:title="label: ResearchAndDevelopmentExpenseMember to label_us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpensePolicy">Research and Development Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="label: ResearchAndDevelopmentExpensePolicy to label_us-gaap_ResearchAndDevelopmentExpensePolicy" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xlink:title="label: ResearchAndDevelopmentExpensePolicy to label_us-gaap_ResearchAndDevelopmentExpensePolicy" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember" xlink:title="ResearchMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchMember" xml:lang="en-US" id="label_us-gaap_ResearchMember">R&amp;D credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="label_us-gaap_ResearchMember" xlink:title="label: ResearchMember to label_us-gaap_ResearchMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchMember" xml:lang="en-US" id="label_us-gaap_ResearchMember_1">Research Tax Credit Carryforward [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="label_us-gaap_ResearchMember_1" xlink:title="label: ResearchMember to label_us-gaap_ResearchMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedStockMember" xml:lang="en-US" id="label_us-gaap_RestrictedStockMember">Restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="label_us-gaap_RestrictedStockMember" xlink:title="label: RestrictedStockMember to label_us-gaap_RestrictedStockMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedStockMember" xml:lang="en-US" id="label_us-gaap_RestrictedStockMember_1">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="label_us-gaap_RestrictedStockMember_1" xlink:title="label: RestrictedStockMember to label_us-gaap_RestrictedStockMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:title="RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">Restricted cash related to security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:title="label: RestrictedCashAndCashEquivalentsNoncurrent to label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1" xlink:title="label: RestrictedCashAndCashEquivalentsNoncurrent to label_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RetainedEarningsMember" xml:lang="en-US" id="label_us-gaap_RetainedEarningsMember">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember" xlink:title="label: RetainedEarningsMember to label_us-gaap_RetainedEarningsMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RetainedEarningsMember" xml:lang="en-US" id="label_us-gaap_RetainedEarningsMember_1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember_1" xlink:title="label: RetainedEarningsMember to label_us-gaap_RetainedEarningsMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="label: RetainedEarningsAccumulatedDeficit to label_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit_1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xlink:title="label: RetainedEarningsAccumulatedDeficit to label_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="us-gaap_RevenueRecognitionAbstract" xlink:title="RevenueRecognitionAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RevenueRecognitionAbstract" xml:lang="en-US" id="label_us-gaap_RevenueRecognitionAbstract">Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionAbstract" xlink:to="label_us-gaap_RevenueRecognitionAbstract" xlink:title="label: RevenueRecognitionAbstract to label_us-gaap_RevenueRecognitionAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueRecognitionAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RevenueRecognitionAbstract" xml:lang="en-US" id="label_us-gaap_RevenueRecognitionAbstract_1">Revenue Recognition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionAbstract" xlink:to="label_us-gaap_RevenueRecognitionAbstract_1" xlink:title="label: RevenueRecognitionAbstract to label_us-gaap_RevenueRecognitionAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:title="RevenueRecognitionPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_RevenueRecognitionPolicyTextBlock">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="label_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:title="label: RevenueRecognitionPolicyTextBlock to label_us-gaap_RevenueRecognitionPolicyTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueRecognitionPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_RevenueRecognitionPolicyTextBlock_1">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="label_us-gaap_RevenueRecognitionPolicyTextBlock_1" xlink:title="label: RevenueRecognitionPolicyTextBlock to label_us-gaap_RevenueRecognitionPolicyTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="Revenues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_Revenues" xml:lang="en-US" id="label_us-gaap_Revenues">Total revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="label_us-gaap_Revenues" xlink:title="label: Revenues to label_us-gaap_Revenues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Revenues_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_Revenues" xml:lang="en-US" id="label_us-gaap_Revenues_1">Total Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="label_us-gaap_Revenues_1" xlink:title="label: Revenues to label_us-gaap_Revenues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Revenues_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Revenues" xml:lang="en-US" id="label_us-gaap_Revenues_2">Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="label_us-gaap_Revenues_2" xlink:title="label: Revenues to label_us-gaap_Revenues" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RevenuesAbstract" xml:lang="en-US" id="label_us-gaap_RevenuesAbstract">REVENUE:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="label_us-gaap_RevenuesAbstract" xlink:title="label: RevenuesAbstract to label_us-gaap_RevenuesAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenuesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RevenuesAbstract" xml:lang="en-US" id="label_us-gaap_RevenuesAbstract_1">Revenues [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="label_us-gaap_RevenuesAbstract_1" xlink:title="label: RevenuesAbstract to label_us-gaap_RevenuesAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" xlink:title="RoyaltyExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RoyaltyExpense" xml:lang="en-US" id="label_us-gaap_RoyaltyExpense">Royalty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="label_us-gaap_RoyaltyExpense" xlink:title="label: RoyaltyExpense to label_us-gaap_RoyaltyExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RoyaltyExpense_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RoyaltyExpense" xml:lang="en-US" id="label_us-gaap_RoyaltyExpense_1">Product royalty expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="label_us-gaap_RoyaltyExpense_1" xlink:title="label: RoyaltyExpense to label_us-gaap_RoyaltyExpense" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RoyaltyExpense_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RoyaltyExpense" xml:lang="en-US" id="label_us-gaap_RoyaltyExpense_2">Royalty Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="label_us-gaap_RoyaltyExpense_2" xlink:title="label: RoyaltyExpense to label_us-gaap_RoyaltyExpense" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:title="RoyaltyRevenue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RoyaltyRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RoyaltyRevenue" xml:lang="en-US" id="label_us-gaap_RoyaltyRevenue">Product Royalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="label_us-gaap_RoyaltyRevenue" xlink:title="label: RoyaltyRevenue to label_us-gaap_RoyaltyRevenue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RoyaltyRevenue_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RoyaltyRevenue" xml:lang="en-US" id="label_us-gaap_RoyaltyRevenue_1">Product royalty revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="label_us-gaap_RoyaltyRevenue_1" xlink:title="label: RoyaltyRevenue to label_us-gaap_RoyaltyRevenue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RoyaltyRevenue_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RoyaltyRevenue" xml:lang="en-US" id="label_us-gaap_RoyaltyRevenue_2">Royalty Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="label_us-gaap_RoyaltyRevenue_2" xlink:title="label: RoyaltyRevenue to label_us-gaap_RoyaltyRevenue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">Fair value of stock options vested (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">Expected option term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">Purchase price as a percentage of the lower of the fair market value of the common stock at either the beginning of the offering period or the applicable exercise date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">Options Exercisable at the end of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">Options Vested and Expected to Vest at the end of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">Options Outstanding at beginning of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1">Options Outstanding at the end of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember" xlink:title="SalesMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SalesMember" xml:lang="en-US" id="label_us-gaap_SalesMember">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="label_us-gaap_SalesMember" xlink:title="label: SalesMember to label_us-gaap_SalesMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SalesMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SalesMember" xml:lang="en-US" id="label_us-gaap_SalesMember_1">Sales [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="label_us-gaap_SalesMember_1" xlink:title="label: SalesMember to label_us-gaap_SalesMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesTable to label_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">Schedule of potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:title="ScheduleOfNonvestedShareActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">Summary of restricted stock activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:title="label: ScheduleOfNonvestedShareActivityTableTextBlock to label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1" xlink:title="label: ScheduleOfNonvestedShareActivityTableTextBlock to label_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">Summary of stock option activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1">Schedule of assumptions used for the fair values of employee stock options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1">Schedule of components of income tax expense attributable to continuing operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to label_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">Schedule of principal amounts for the loan which the Company is obligated to repay</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to label_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:title="ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">Schedule of intangible assets, net of accumulated amortization, and goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:title="label: ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock to label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1" xlink:title="label: ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock to label_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">Schedule of reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">Schedule of principal components of the deferred tax assets and liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">Schedule of accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">Schedule of obligations for base rent and CAM costs under facility and other non-cancelable operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="label: ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock to label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xlink:title="label: ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock to label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:title="ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">Schedule of selected quarterly financial data (unaudited)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:title="label: ScheduleOfQuarterlyFinancialInformationTableTextBlock to label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1">Schedule of Quarterly Financial Information [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_1" xlink:title="label: ScheduleOfQuarterlyFinancialInformationTableTextBlock to label_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xml:lang="en-US" id="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesLineItems to label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xml:lang="en-US" id="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesLineItems to label_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to label_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">Summary of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock to label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock to label_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="label_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="label: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to label_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:title="ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">Summary of changes in accumulated other comprehensive income (loss) by component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:title="label: ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock to label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1" xlink:title="label: ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock to label_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="ScheduleOfOperatingLeasedAssetsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable">Schedule of Operating Leased Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="label: ScheduleOfOperatingLeasedAssetsTable to label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">Schedule of stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredLongTermDebt" xlink:label="us-gaap_SecuredLongTermDebt" xlink:title="SecuredLongTermDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SecuredLongTermDebt" xml:lang="en-US" id="label_us-gaap_SecuredLongTermDebt">Term Loan, less Current Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredLongTermDebt" xlink:to="label_us-gaap_SecuredLongTermDebt" xlink:title="label: SecuredLongTermDebt to label_us-gaap_SecuredLongTermDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredLongTermDebt_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SecuredLongTermDebt" xml:lang="en-US" id="label_us-gaap_SecuredLongTermDebt_1">Secured Long-term Debt, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredLongTermDebt" xlink:to="label_us-gaap_SecuredLongTermDebt_1" xlink:title="label: SecuredLongTermDebt to label_us-gaap_SecuredLongTermDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="us-gaap_SecuredDebtCurrent" xlink:title="SecuredDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SecuredDebtCurrent" xml:lang="en-US" id="label_us-gaap_SecuredDebtCurrent">Current Portion of Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtCurrent" xlink:to="label_us-gaap_SecuredDebtCurrent" xlink:title="label: SecuredDebtCurrent to label_us-gaap_SecuredDebtCurrent" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebtCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SecuredDebtCurrent" xml:lang="en-US" id="label_us-gaap_SecuredDebtCurrent_1">Secured Debt, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtCurrent" xlink:to="label_us-gaap_SecuredDebtCurrent_1" xlink:title="label: SecuredDebtCurrent to label_us-gaap_SecuredDebtCurrent" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember" xlink:title="SecuredDebtMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SecuredDebtMember" xml:lang="en-US" id="label_us-gaap_SecuredDebtMember">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtMember" xlink:to="label_us-gaap_SecuredDebtMember" xlink:title="label: SecuredDebtMember to label_us-gaap_SecuredDebtMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebtMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SecuredDebtMember" xml:lang="en-US" id="label_us-gaap_SecuredDebtMember_1">Secured Debt [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtMember" xlink:to="label_us-gaap_SecuredDebtMember_1" xlink:title="label: SecuredDebtMember to label_us-gaap_SecuredDebtMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebt" xlink:label="us-gaap_SecuredDebt" xlink:title="SecuredDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SecuredDebt" xml:lang="en-US" id="label_us-gaap_SecuredDebt">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="label_us-gaap_SecuredDebt" xlink:title="label: SecuredDebt to label_us-gaap_SecuredDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebt_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_SecuredDebt" xml:lang="en-US" id="label_us-gaap_SecuredDebt_1">Amount owed under the term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="label_us-gaap_SecuredDebt_1" xlink:title="label: SecuredDebt to label_us-gaap_SecuredDebt" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SecuredDebt_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SecuredDebt" xml:lang="en-US" id="label_us-gaap_SecuredDebt_2">Secured Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="label_us-gaap_SecuredDebt_2" xlink:title="label: SecuredDebt to label_us-gaap_SecuredDebt" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:title="SeriesCPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US" id="label_us-gaap_SeriesCPreferredStockMember">Class C Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="label_us-gaap_SeriesCPreferredStockMember" xlink:title="label: SeriesCPreferredStockMember to label_us-gaap_SeriesCPreferredStockMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SeriesCPreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US" id="label_us-gaap_SeriesCPreferredStockMember_1">Series C Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="label_us-gaap_SeriesCPreferredStockMember_1" xlink:title="label: SeriesCPreferredStockMember to label_us-gaap_SeriesCPreferredStockMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">Additional information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_1">Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">Canceled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1">Outstanding and unvested at the beginning of the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2">Outstanding and unvested at the end of the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">Expected stock price volatility, maximum (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">Expected stock price volatility, minimum (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">Vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensation" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensation">Stock-Based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation" xlink:title="label: ShareBasedCompensation to label_us-gaap_ShareBasedCompensation" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensation_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensation" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensation_1">Share-based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation_1" xlink:title="label: ShareBasedCompensation to label_us-gaap_ShareBasedCompensation" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">Maximum number of shares of common stock that can be purchased by each participating employee per year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">Risk-free interest rate, maximum (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">Weighted Average Grant Date Fair Value (per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">Outstanding and unvested at the beginning of the period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2">Outstanding and unvested at the end of the period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">Canceled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1">Canceled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">Risk-free interest rate, minimum (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">Exercised (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">Options Exercisable at the end of the period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1">Expected dividend yield (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">Canceled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">Vested (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">Options Exercisable at the end of the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">Shares Available for Grant under the 2008 Plan (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1">Shares available for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">Total intrinsic value of stock options exercised (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1">Expected stock price volatility (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">Maximum shares of common stock to be issued for grants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">Risk-free interest rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">Assumptions used for fair values of employee and director stock options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Weighted average grant-date fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">Options Outstanding at beginning of the period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1">Options Outstanding at the end of the period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">Aggregate intrinsic value of stock options vested and expected to vest (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">Options Outstanding at the end of the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2">Options Outstanding at beginning of the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">Options Vested and Expected to Vest at the end of the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">Aggregate intrinsic value of stock options outstanding (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">Options Vested and Expected to Vest at the end of the period (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="label_us-gaap_SignificantAccountingPoliciesTextBlock">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="label: SignificantAccountingPoliciesTextBlock to label_us-gaap_SignificantAccountingPoliciesTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="label_us-gaap_SignificantAccountingPoliciesTextBlock_1">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xlink:title="label: SignificantAccountingPoliciesTextBlock to label_us-gaap_SignificantAccountingPoliciesTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="label: StateAndLocalIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_1">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_1" xlink:title="label: StateAndLocalIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StateAndLocalJurisdictionMember" xml:lang="en-US" id="label_us-gaap_StateAndLocalJurisdictionMember">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="label_us-gaap_StateAndLocalJurisdictionMember" xlink:title="label: StateAndLocalJurisdictionMember to label_us-gaap_StateAndLocalJurisdictionMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StateAndLocalJurisdictionMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StateAndLocalJurisdictionMember" xml:lang="en-US" id="label_us-gaap_StateAndLocalJurisdictionMember_1">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="label_us-gaap_StateAndLocalJurisdictionMember_1" xlink:title="label: StateAndLocalJurisdictionMember to label_us-gaap_StateAndLocalJurisdictionMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementTable" xml:lang="en-US" id="label_us-gaap_StatementTable">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="label_us-gaap_StatementTable" xlink:title="label: StatementTable to label_us-gaap_StatementTable" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StatementLineItems" xml:lang="en-US" id="label_us-gaap_StatementLineItems">Statement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems" xlink:title="label: StatementLineItems to label_us-gaap_StatementLineItems" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementLineItems" xml:lang="en-US" id="label_us-gaap_StatementLineItems_1">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems_1" xlink:title="label: StatementLineItems to label_us-gaap_StatementLineItems" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfStockholdersEquityAbstract">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="label_us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="label: StatementOfStockholdersEquityAbstract to label_us-gaap_StatementOfStockholdersEquityAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfCashFlowsAbstract">CONSOLIDATED STATEMENTS OF CASH FLOWS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="label_us-gaap_StatementOfCashFlowsAbstract" xlink:title="label: StatementOfCashFlowsAbstract to label_us-gaap_StatementOfCashFlowsAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US" id="label_us-gaap_StatementEquityComponentsAxis">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="label_us-gaap_StatementEquityComponentsAxis" xlink:title="label: StatementEquityComponentsAxis to label_us-gaap_StatementEquityComponentsAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfFinancialPositionAbstract">CONSOLIDATED BALANCE SHEETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="label_us-gaap_StatementOfFinancialPositionAbstract" xlink:title="label: StatementOfFinancialPositionAbstract to label_us-gaap_StatementOfFinancialPositionAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="label_us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="label_us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to label_us-gaap_StatementClassOfStockAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="label: StockIssuedDuringPeriodSharesPeriodIncreaseDecrease to label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_1">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_1" xlink:title="label: StockIssuedDuringPeriodSharesPeriodIncreaseDecrease to label_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">Shares Issued in Connection with the CuraGen acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions">Shares Issued in Connection with the CuraGen acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther">Shares of common stock sold under the Cantor Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="label: StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther_1">Shares Issued in Connection with Cantor Agreement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xlink:title="label: StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther_2">Stock Issued During Period, Shares, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther_2" xlink:title="label: StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:title="StockGrantedDuringPeriodValueSharebasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xml:lang="en-US" id="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">Shares Issued to Executive Officers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:title="label: StockGrantedDuringPeriodValueSharebasedCompensation to label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xml:lang="en-US" id="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_1">Stock Granted, Value, Share-based Compensation, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_1" xlink:title="label: StockGrantedDuringPeriodValueSharebasedCompensation to label_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">Shares Issued under Stock Option and Employee Stock Purchase Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="label: StockIssuedDuringPeriodValueEmployeeStockPurchasePlan to label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1" xlink:title="label: StockIssuedDuringPeriodValueEmployeeStockPurchasePlan to label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">Exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">Shares Issued under Stock Option and Employee Stock Purchase Plans (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="label: StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans to label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1">Shares issued under the plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1" xlink:title="label: StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans to label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2" xlink:title="label: StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans to label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues">Common stock issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1">Shares Issued in Underwritten Offering (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="StockIssuedDuringPeriodValueOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueOther">Shares Issued in Connection with Cantor Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="label: StockIssuedDuringPeriodValueOther to label_us-gaap_StockIssuedDuringPeriodValueOther" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueOther_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueOther_1">Stock Issued During Period, Value, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueOther_1" xlink:title="label: StockIssuedDuringPeriodValueOther to label_us-gaap_StockIssuedDuringPeriodValueOther" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues">Shares Issued in Underwritten Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1">Net proceeds from sale of stock in an underwritten public offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_2" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_2">Amount raised from shares issued in underwritten public offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_2" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_3">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_3" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract">Stockholders' Equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract" xlink:title="label: StockholdersEquityAbstract to label_us-gaap_StockholdersEquityAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract_1">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract_1" xlink:title="label: StockholdersEquityAbstract to label_us-gaap_StockholdersEquityAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="StockholdersEquityPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="label: StockholdersEquityPeriodIncreaseDecrease to label_us-gaap_StockholdersEquityPeriodIncreaseDecrease" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease_1">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="label_us-gaap_StockholdersEquityPeriodIncreaseDecrease_1" xlink:title="label: StockholdersEquityPeriodIncreaseDecrease to label_us-gaap_StockholdersEquityPeriodIncreaseDecrease" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity">Total Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity" xlink:title="label: StockholdersEquity to label_us-gaap_StockholdersEquity" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_1" xlink:title="label: StockholdersEquity to label_us-gaap_StockholdersEquity" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_2">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_2" xlink:title="label: StockholdersEquity to label_us-gaap_StockholdersEquity" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_3">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_3" xlink:title="label: StockholdersEquity to label_us-gaap_StockholdersEquity" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_4">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_4" xlink:title="label: StockholdersEquity to label_us-gaap_StockholdersEquity" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteAbstract">STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="label_us-gaap_StockholdersEquityNoteAbstract" xlink:title="label: StockholdersEquityNoteAbstract to label_us-gaap_StockholdersEquityNoteAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock">STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SubsequentEventMember" xml:lang="en-US" id="label_us-gaap_SubsequentEventMember">Subsequent event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="label_us-gaap_SubsequentEventMember" xlink:title="label: SubsequentEventMember to label_us-gaap_SubsequentEventMember" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventMember" xml:lang="en-US" id="label_us-gaap_SubsequentEventMember_1">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="label_us-gaap_SubsequentEventMember_1" xlink:title="label: SubsequentEventMember to label_us-gaap_SubsequentEventMember" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeDomain">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="label_us-gaap_SubsequentEventTypeDomain" xlink:title="label: SubsequentEventTypeDomain to label_us-gaap_SubsequentEventTypeDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeAxis">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="label_us-gaap_SubsequentEventTypeAxis" xlink:title="label: SubsequentEventTypeAxis to label_us-gaap_SubsequentEventTypeAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US" id="label_us-gaap_SupplementalCashFlowInformationAbstract">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="label_us-gaap_SupplementalCashFlowInformationAbstract" xlink:title="label: SupplementalCashFlowInformationAbstract to label_us-gaap_SupplementalCashFlowInformationAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SupplementalCashFlowInformationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US" id="label_us-gaap_SupplementalCashFlowInformationAbstract_1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="label_us-gaap_SupplementalCashFlowInformationAbstract_1" xlink:title="label: SupplementalCashFlowInformationAbstract to label_us-gaap_SupplementalCashFlowInformationAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US" id="label_us-gaap_TaxCreditCarryforwardAmount">Tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="label_us-gaap_TaxCreditCarryforwardAmount" xlink:title="label: TaxCreditCarryforwardAmount to label_us-gaap_TaxCreditCarryforwardAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TaxCreditCarryforwardAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US" id="label_us-gaap_TaxCreditCarryforwardAmount_1">Tax Credit Carryforward, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="label_us-gaap_TaxCreditCarryforwardAmount_1" xlink:title="label: TaxCreditCarryforwardAmount to label_us-gaap_TaxCreditCarryforwardAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" xlink:title="TaxCreditCarryforwardNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TaxCreditCarryforwardNameDomain" xml:lang="en-US" id="label_us-gaap_TaxCreditCarryforwardNameDomain">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="label_us-gaap_TaxCreditCarryforwardNameDomain" xlink:title="label: TaxCreditCarryforwardNameDomain to label_us-gaap_TaxCreditCarryforwardNameDomain" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis" xlink:title="TaxCreditCarryforwardAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TaxCreditCarryforwardAxis" xml:lang="en-US" id="label_us-gaap_TaxCreditCarryforwardAxis">Tax Credit Carryforward [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="label_us-gaap_TaxCreditCarryforwardAxis" xlink:title="label: TaxCreditCarryforwardAxis to label_us-gaap_TaxCreditCarryforwardAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TypeOfArrangementAxis" xml:lang="en-US" id="label_us-gaap_TypeOfArrangementAxis">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="label_us-gaap_TypeOfArrangementAxis" xlink:title="label: TypeOfArrangementAxis to label_us-gaap_TypeOfArrangementAxis" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefits">Unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="label_us-gaap_UnrecognizedTaxBenefits" xlink:title="label: UnrecognizedTaxBenefits to label_us-gaap_UnrecognizedTaxBenefits" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefits_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefits_1">Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="label_us-gaap_UnrecognizedTaxBenefits_1" xlink:title="label: UnrecognizedTaxBenefits to label_us-gaap_UnrecognizedTaxBenefits" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_UseOfEstimates" xml:lang="en-US" id="label_us-gaap_UseOfEstimates">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates" xlink:title="label: UseOfEstimates to label_us-gaap_UseOfEstimates" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UseOfEstimates_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_UseOfEstimates" xml:lang="en-US" id="label_us-gaap_UseOfEstimates_1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates_1" xlink:title="label: UseOfEstimates to label_us-gaap_UseOfEstimates" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xml:lang="en-US" id="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">Deferred tax valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="label: ValuationAllowanceDeferredTaxAssetChangeInAmount to label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xml:lang="en-US" id="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1">Valuation Allowance, Deferred Tax Asset, Change in Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xlink:title="label: ValuationAllowanceDeferredTaxAssetChangeInAmount to label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">Shareholder Rights Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1">Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 2) (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cldx-20131231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--Generated by IRIS XBRL Generation Engine-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreementsDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCollaborationAgreementsDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockBasedCompensationDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxesTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockBasedCompensationDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureNetLossPerShareDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockBasedCompensationTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails3" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosurePropertyAndEquipmentNetTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureAccruedExpensesTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureAccruedExpensesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails4" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCommitmentsAndContingenciesTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCommitmentsAndContingenciesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSelectedQuarterlyFinancialDataDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlanDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRetirementSavingsPlanDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSelectedQuarterlyFinancialDataTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureFairValueMeasurementsTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureMarketableSecuritiesTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIntangibleAssetsAndGoodwillTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureComprehensiveLossTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCommitmentsAndContingenciesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureMarketableSecuritiesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRevenueDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureComprehensiveLossDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureTermLoanDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureTermLoanDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIntangibleAssetsAndGoodwillDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverviewDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureNatureOfBusinessAndOverviewDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockholdersEquityDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesTables" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails3" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureFairValueMeasurementsDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRockefellerUniversityDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRockefellerUniversityDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity" xlink:type="simple" xlink:href="cldx-20131231.xsd#StatementOfStockholdersEquity" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenue" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRevenue" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxes" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockBasedCompensation" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverview" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureNatureOfBusinessAndOverview" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureNetLossPerShare" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNet" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosurePropertyAndEquipmentNet" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockholdersEquity" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureAccruedExpenses" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureAccruedExpenses" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilities" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingencies" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCommitmentsAndContingencies" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlan" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRetirementSavingsPlan" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialData" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSelectedQuarterlyFinancialData" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureFairValueMeasurements" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureMarketableSecurities" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIntangibleAssetsAndGoodwill" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureTermLoan" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureTermLoan" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cldx-20131231.xsd#DocumentAndEntityInformation" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/BalanceSheetParenthetical" xlink:type="simple" xlink:href="cldx-20131231.xsd#BalanceSheetParenthetical" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLoss" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureComprehensiveLoss" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/CashFlows" xlink:type="simple" xlink:href="cldx-20131231.xsd#CashFlows" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/StatementOfIncome" xlink:type="simple" xlink:href="cldx-20131231.xsd#StatementOfIncome" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/BalanceSheet" xlink:type="simple" xlink:href="cldx-20131231.xsd#BalanceSheet" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreements" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCollaborationAgreements" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:title="DeferredTaxAssetsGrossAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:title="Presentation : us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_DeferredTaxAssetsGrossAbstract" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:title="DeferredTaxLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:label="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:title="DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" xlink:title="Presentation : us-gaap_DeferredTaxLiabilitiesAbstract to cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:title="DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:title="Presentation : us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_DeferredTaxLiabilitiesAbstract" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:label="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" xlink:title="Presentation : us-gaap_DeferredTaxLiabilitiesAbstract to cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:title="DeferredTaxAssetsTaxDeferredExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsTaxDeferredExpense" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" xlink:title="Presentation : us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_DeferredTaxLiabilities" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" xlink:title="Presentation : us-gaap_DeferredTaxLiabilitiesAbstract to us-gaap_DeferredIncomeTaxLiabilities" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsLiabilitiesGross" xlink:label="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:title="DeferredTaxAssetsLiabilitiesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="cldx_DeferredTaxAssetsLiabilitiesGross" xlink:title="Presentation : us-gaap_DeferredTaxLiabilitiesAbstract to cldx_DeferredTaxAssetsLiabilitiesGross" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:label="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:title="IncomeTaxReconciliationTaxCreditsResearch" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxReconciliationTaxCreditsResearch" use="optional" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:label="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:title="IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="Presentation : us-gaap_DeferredTaxLiabilitiesAbstract to us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:title="DeferredTaxAssetsPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:title="IncomeTaxReconciliationOtherAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxReconciliationOtherAdjustments" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_IncomeTaxExpenseBenefit" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:label="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" xlink:title="Presentation : us-gaap_DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsGross" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:title="Presentation : us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefit" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:label="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:title="DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" xlink:title="Presentation : us-gaap_DeferredTaxLiabilitiesAbstract to cldx_DeferredTaxLiabilitiesDeferredLicenseCostsAndOtherExpense" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_MedarexIncMember" xlink:label="cldx_MedarexIncMember" xlink:title="MedarexIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_MedarexIncMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_MedarexIncMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Presentation : us-gaap_BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_CuraGenCorporationMember" xlink:title="Presentation : us-gaap_BusinessAcquisitionAcquireeDomain to cldx_CuraGenCorporationMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementDisclosureAbstract" xlink:label="cldx_CollaborativeArrangementDisclosureAbstract" xlink:title="CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Presentation : cldx_CollaborativeArrangementDisclosureAbstract to us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_TypeOfArrangementAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Presentation : us-gaap_TypeOfArrangementAxis to us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LicenseAgreementsMember" xlink:label="cldx_LicenseAgreementsMember" xlink:title="LicenseAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cldx_LicenseAgreementsMember" xlink:title="Presentation : us-gaap_ArrangementsAndNonarrangementTransactionsMember to cldx_LicenseAgreementsMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="Presentation : us-gaap_CounterpartyNameAxis to us-gaap_RepurchaseAgreementCounterpartyNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NonRefundableLicenseFee" xlink:label="cldx_NonRefundableLicenseFee" xlink:title="NonRefundableLicenseFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_NonRefundableLicenseFee" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_NonRefundableLicenseFee" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:label="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:title="CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RockefellerUniversityMember" xlink:label="cldx_RockefellerUniversityMember" xlink:title="RockefellerUniversityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_RockefellerUniversityMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_RockefellerUniversityMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CounterpartyNameAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_CounterpartyNameAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:label="cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:title="DukeUniversityBrainTumorCancerCenterMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_DukeUniversityBrainTumorCancerCenterMember" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_BusinessAcquisitionAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:label="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:title="CollaborativeArrangementTotalPotentialMilestonePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementTotalPotentialMilestonePayments" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LudwigInstituteForCancerResearchMember" xlink:label="cldx_LudwigInstituteForCancerResearchMember" xlink:title="LudwigInstituteForCancerResearchMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_LudwigInstituteForCancerResearchMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_LudwigInstituteForCancerResearchMember" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_RangeAxis" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:label="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:title="CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="cldx_CollaborativeArrangementAgreementTerm" xlink:title="CollaborativeArrangementAgreementTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementAgreementTerm" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementAgreementTerm" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AlterisTherapeuticsIncMember" xlink:label="cldx_AlterisTherapeuticsIncMember" xlink:title="AlterisTherapeuticsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_AlterisTherapeuticsIncMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_AlterisTherapeuticsIncMember" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_SubsequentEventTypeAxis" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_UniversityOfSouthamptonUKMember" xlink:label="cldx_UniversityOfSouthamptonUKMember" xlink:title="UniversityOfSouthamptonUKMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_UniversityOfSouthamptonUKMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_UniversityOfSouthamptonUKMember" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmgenIncMember" xlink:label="cldx_AmgenIncMember" xlink:title="AmgenIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_AmgenIncMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_AmgenIncMember" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SeattleGeneticIncMember" xlink:label="cldx_SeattleGeneticIncMember" xlink:title="SeattleGeneticIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_SeattleGeneticIncMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_SeattleGeneticIncMember" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementNumberOfAgreements" xlink:label="cldx_CollaborativeArrangementNumberOfAgreements" xlink:title="CollaborativeArrangementNumberOfAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementNumberOfAgreements" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementNumberOfAgreements" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ThomasJeffersonUniversityMember" xlink:label="cldx_ThomasJeffersonUniversityMember" xlink:title="ThomasJeffersonUniversityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_ThomasJeffersonUniversityMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_ThomasJeffersonUniversityMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:title="Presentation : us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to us-gaap_IncomeStatementLocationAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:title="Presentation : us-gaap_IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="Presentation : us-gaap_IncomeStatementLocationDomain to us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Presentation : us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to us-gaap_AllocatedShareBasedCompensationExpense" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="Presentation : us-gaap_IncomeStatementLocationDomain to us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to us-gaap_AwardTypeAxis" use="optional" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="Presentation : us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ExpectedDividendPayableInForeseeableFuture" xlink:label="cldx_ExpectedDividendPayableInForeseeableFuture" xlink:title="ExpectedDividendPayableInForeseeableFuture" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="cldx_ExpectedDividendPayableInForeseeableFuture" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to cldx_ExpectedDividendPayableInForeseeableFuture" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to us-gaap_RangeAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_PlanNameAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:title="Presentation : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:label="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:title="CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:title="Presentation : us-gaap_PlanNameDomain to cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Presentation : cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_RestrictedStockMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember" xlink:title="EmployeeStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_EmployeeStockMember" xlink:title="Presentation : us-gaap_PlanNameDomain to us-gaap_EmployeeStockMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:title="Presentation : cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockOptionAndIncentivePlan2008Member" xlink:label="cldx_StockOptionAndIncentivePlan2008Member" xlink:title="StockOptionAndIncentivePlan2008Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="cldx_StockOptionAndIncentivePlan2008Member" xlink:title="Presentation : us-gaap_PlanNameDomain to cldx_StockOptionAndIncentivePlan2008Member" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RangeAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Presentation : cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Presentation : cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:label="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Presentation : us-gaap_EarningsPerShareAbstract to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_RestrictedStockMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:title="ScheduleOfNonvestedShareActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_BasisOfAccountingPolicyPolicyTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_UseOfEstimates" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_CashAndCashEquivalentsPolicyTextBlock" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:title="MarketableSecuritiesPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_MarketableSecuritiesPolicy" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ConcentrationRiskCreditRisk" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="FairValueMeasurementPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_FairValueMeasurementPolicyPolicyTextBlock" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" xlink:title="BusinessCombinationsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessCombinationsPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_BusinessCombinationsPolicy" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:title="GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:title="RevenueRecognitionPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_RevenueRecognitionPolicyTextBlock" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ResearchAndDevelopmentExpensePolicy" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PatentCostsPolicyTextBlock" xlink:label="cldx_PatentCostsPolicyTextBlock" xlink:title="PatentCostsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cldx_PatentCostsPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to cldx_PatentCostsPolicyTextBlock" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_IncomeTaxPolicyTextBlock" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:title="ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_EarningsPerSharePolicyTextBlock" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OtherIncomePolicyTextBlock" xlink:label="cldx_OtherIncomePolicyTextBlock" xlink:title="OtherIncomePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cldx_OtherIncomePolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to cldx_OtherIncomePolicyTextBlock" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Presentation : us-gaap_BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_CuraGenCorporationMember" xlink:title="Presentation : us-gaap_BusinessAcquisitionAcquireeDomain to cldx_CuraGenCorporationMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:title="Presentation : us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_BusinessAcquisitionAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:title="Presentation : us-gaap_DebtInstrumentAxis to us-gaap_DebtInstrumentNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="ConvertibleSubordinatedDebtMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="Presentation : us-gaap_DebtInstrumentNameDomain to us-gaap_ConvertibleSubordinatedDebtMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebt" xlink:label="us-gaap_ConvertibleSubordinatedDebt" xlink:title="ConvertibleSubordinatedDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ConvertibleSubordinatedDebt" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_ConvertibleSubordinatedDebt" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTranslationAbstract" xlink:label="us-gaap_ForeignCurrencyTranslationAbstract" xlink:title="ForeignCurrencyTranslationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ForeignCurrencyTranslationAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:title="Presentation : us-gaap_ForeignCurrencyTranslationAbstract to us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:title="Presentation : us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_DebtInstrumentAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_DebtInstrumentInterestRateStatedPercentage" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTranslationAbstract" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ForeignCurrencyTranslationAbstract" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" xlink:title="Presentation : us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_BusinessAcquisitionLineItems" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_RepaymentsOfDebt" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_RepaymentsOfDebt" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:title="DebtInstrumentConvertibleNumberOfEquityInstruments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:title="DebtInstrumentConvertibleConversionRatio1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_DebtInstrumentConvertibleConversionRatio1" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:label="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:title="DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" use="optional" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="DebtInstrumentConvertibleConversionPrice1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_DebtInstrumentConvertibleConversionPrice1" use="optional" order="8003" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_InterestExpenseDebt" xlink:title="Presentation : us-gaap_BusinessAcquisitionLineItems to us-gaap_InterestExpenseDebt" use="optional" order="8004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:label="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:title="AccruedRoyaltyAndLicenseFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="cldx_AccruedRoyaltyAndLicenseFeesCurrent" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to cldx_AccruedRoyaltyAndLicenseFeesCurrent" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:label="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:title="AccruedResearchAndDevelopmentContractCostsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="cldx_AccruedResearchAndDevelopmentContractCostsCurrent" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to cldx_AccruedResearchAndDevelopmentContractCostsCurrent" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to us-gaap_AccruedProfessionalFeesCurrent" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to us-gaap_OtherAccruedLiabilitiesCurrent" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to us-gaap_AccruedLiabilitiesCurrent" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_RestrictedStockMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="ConvertibleSubordinatedDebtMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_ConvertibleSubordinatedDebtMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="OperatingLeasesFutureMinimumPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDue" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xlink:title="OperatingLeasesRentExpenseNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesRentExpenseNet" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:title="RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:title="QuarterlyFinancialInformationDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_Revenues" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_Revenues" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_EarningsPerShareBasicAndDiluted" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_EarningsPerShareBasic" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_EarningsPerShareBasic" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_EarningsPerShareDiluted" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="Presentation : us-gaap_CompensationAndRetirementDisclosureAbstract to us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="Presentation : us-gaap_CompensationAndRetirementDisclosureAbstract to us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:title="Presentation : us-gaap_CompensationAndRetirementDisclosureAbstract to us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" xlink:title="DefinedContributionPlanCostRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" xlink:title="Presentation : us-gaap_CompensationAndRetirementDisclosureAbstract to us-gaap_DefinedContributionPlanCostRecognized" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:title="QuarterlyFinancialInformationDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:title="ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="Presentation : us-gaap_FairValueDisclosuresAbstract to us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="Presentation : us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract to us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:title="ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:title="Presentation : us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="ComprehensiveIncomeNetOfTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:title="ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="ScheduleOfOperatingLeasedAssetsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_ScheduleOfOperatingLeasedAssetsTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfOperatingLeasedAssetsTable to us-gaap_SubsequentEventTypeAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="OperatingLeasedAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_AreaOfRealEstateProperty" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfOperatingLeasedAssetsTable to us-gaap_OperatingLeasedAssetsLineItems" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesTermOfLease" xlink:label="cldx_OperatingLeasesTermOfLease" xlink:title="OperatingLeasesTermOfLease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="cldx_OperatingLeasesTermOfLease" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to cldx_OperatingLeasesTermOfLease" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:label="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:title="OperatingLeasesCommencementPeriodOfRentalObligations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to cldx_OperatingLeasesCommencementPeriodOfRentalObligations" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesNumberOfRenewalOptions" xlink:label="cldx_OperatingLeasesNumberOfRenewalOptions" xlink:title="OperatingLeasesNumberOfRenewalOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="cldx_OperatingLeasesNumberOfRenewalOptions" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to cldx_OperatingLeasesNumberOfRenewalOptions" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:label="cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:title="OperatingLeasesPeriodOfRenewalOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to cldx_OperatingLeasesPeriodOfRenewalOptions" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="Presentation : cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="Presentation : us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract to us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:title="MajorTypesOfDebtAndEquitySecuritiesAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesTable to us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:title="MajorTypesOfDebtAndEquitySecuritiesDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:title="Presentation : us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis to us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_USGovernmentAndMunicipalObligationsMember" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember" xlink:title="USGovernmentAndMunicipalObligationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="cldx_USGovernmentAndMunicipalObligationsMember" xlink:title="Presentation : us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain to cldx_USGovernmentAndMunicipalObligationsMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" xlink:title="Presentation : us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain to us-gaap_CorporateDebtSecuritiesMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesTable to us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="Presentation : cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="Presentation : cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="Presentation : us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:title="AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:title="Presentation : us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="OtherLiabilitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit" xlink:title="DeferredRentCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_DeferredRentCredit" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_DeferredRentCredit" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_DeferredTaxLiabilities" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:title="DeferredIncomeFromSaleOfTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to cldx_DeferredIncomeFromSaleOfTaxBenefits" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:title="DeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_DeferredRevenue" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_DeferredRevenue" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" xlink:title="LoansPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_LoansPayable" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_LoansPayable" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherSundryLiabilities" xlink:label="us-gaap_OtherSundryLiabilities" xlink:title="OtherSundryLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherSundryLiabilities" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_OtherSundryLiabilities" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" xlink:title="OtherLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilities" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_OtherLiabilities" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_OtherLiabilitiesCurrent" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_OtherLiabilitiesNoncurrent" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:title="ValueOfTaxBenefitsAgreedToBeSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to cldx_ValueOfTaxBenefitsAgreedToBeSold" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ValueAtWhichTaxBenefitsSold" xlink:label="cldx_ValueAtWhichTaxBenefitsSold" xlink:title="ValueAtWhichTaxBenefitsSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="cldx_ValueAtWhichTaxBenefitsSold" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to cldx_ValueAtWhichTaxBenefitsSold" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:title="PeriodForWhichBaseOfOperationsMustBeMaintained" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:title="GainLossOnSaleOfOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_GainLossOnSaleOfOtherAssets" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_TypeOfArrangementAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Presentation : us-gaap_TypeOfArrangementAxis to us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:label="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:title="CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:title="Presentation : us-gaap_ArrangementsAndNonarrangementTransactionsMember to cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="Presentation : us-gaap_CounterpartyNameAxis to us-gaap_RepurchaseAgreementCounterpartyNameDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GlaxoSmithKlinePlcMember" xlink:label="cldx_GlaxoSmithKlinePlcMember" xlink:title="GlaxoSmithKlinePlcMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_GlaxoSmithKlinePlcMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_GlaxoSmithKlinePlcMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:label="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:title="PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" xlink:title="Presentation : us-gaap_ProductOrServiceAxis to us-gaap_ProductsAndServicesDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RotarixRotavirusVaccineMember" xlink:label="cldx_RotarixRotavirusVaccineMember" xlink:title="RotarixRotavirusVaccineMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="cldx_RotarixRotavirusVaccineMember" xlink:title="Presentation : us-gaap_ProductsAndServicesDomain to cldx_RotarixRotavirusVaccineMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:title="SignificantRevenueArrangementsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Presentation : cldx_SignificantRevenueArrangementsDisclosureAbstract to us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LicenseAgreementsMember" xlink:label="cldx_LicenseAgreementsMember" xlink:title="LicenseAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cldx_LicenseAgreementsMember" xlink:title="Presentation : us-gaap_ArrangementsAndNonarrangementTransactionsMember to cldx_LicenseAgreementsMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CounterpartyNameAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_CounterpartyNameAxis" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:label="cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:title="CincinnatiChildrensHospitalMedicalCenterMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_CincinnatiChildrensHospitalMedicalCenterMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:label="cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:title="PercentageOfInterestInNetRoyaltiesSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_PercentageOfInterestInNetRoyaltiesSold" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RoyaltyAgreementMember" xlink:label="cldx_RoyaltyAgreementMember" xlink:title="RoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cldx_RoyaltyAgreementMember" xlink:title="Presentation : us-gaap_ArrangementsAndNonarrangementTransactionsMember to cldx_RoyaltyAgreementMember" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PRFAgreementMember" xlink:label="cldx_PRFAgreementMember" xlink:title="PRFAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_PRFAgreementMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_PRFAgreementMember" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" xlink:title="RoyaltyExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RoyaltyExpense" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to us-gaap_RoyaltyExpense" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ProductOrServiceAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_ProductOrServiceAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_SubsequentEventTypeAxis" use="optional" order="4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PfizerIncMember" xlink:label="cldx_PfizerIncMember" xlink:title="PfizerIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_PfizerIncMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_PfizerIncMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:label="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:title="PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RindopepimutMember" xlink:label="cldx_RindopepimutMember" xlink:title="RindopepimutMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="cldx_RindopepimutMember" xlink:title="Presentation : us-gaap_ProductsAndServicesDomain to cldx_RindopepimutMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:label="cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:title="DukeUniversityAndThomasJeffersonUniversityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:title="Presentation : us-gaap_RepurchaseAgreementCounterpartyNameDomain to cldx_DukeUniversityAndThomasJeffersonUniversityMember" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:label="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:title="AmountReceivedForRightToParticipateInCollaborativeArrangement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:label="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:title="StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" use="optional" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:label="us-gaap_CostOfReimbursableExpense" xlink:title="CostOfReimbursableExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CostOfReimbursableExpense" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to us-gaap_CostOfReimbursableExpense" use="optional" order="8003" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseCosts" xlink:label="us-gaap_LicenseCosts" xlink:title="LicenseCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_LicenseCosts" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to us-gaap_LicenseCosts" use="optional" order="8004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Presentation : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:title="AccumulatedNetUnrealizedInvestmentGainLossMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:title="AccumulatedOtherComprehensiveIncomeLossTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Presentation : us-gaap_AccumulatedOtherComprehensiveIncomeLossTable to us-gaap_StatementEquityComponentsAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:title="AccumulatedOtherComprehensiveIncomeLossLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:title="AccumulatedOtherComprehensiveIncomeLossRollForward" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:title="Presentation : us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems to cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="Presentation : cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="ComprehensiveIncomeNetOfTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:title="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:title="AccumulatedTranslationAdjustmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_AccumulatedTranslationAdjustmentMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:title="Presentation : us-gaap_AccumulatedOtherComprehensiveIncomeLossTable to us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="Presentation : cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Presentation : cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to us-gaap_OtherComprehensiveIncomeLossNetOfTax" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:title="Presentation : cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureTermLoanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" xlink:title="Presentation : us-gaap_LongtermDebtTypeAxis to us-gaap_LongtermDebtTypeDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember" xlink:title="SecuredDebtMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SecuredDebtMember" xlink:title="Presentation : us-gaap_LongtermDebtTypeDomain to us-gaap_SecuredDebtMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" xlink:title="Presentation : us-gaap_DebtDisclosureAbstract to us-gaap_DebtInstrumentTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderAxis" xlink:label="cldx_DebtInstrumentLenderAxis" xlink:title="DebtInstrumentLenderAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderDomain" xlink:label="cldx_DebtInstrumentLenderDomain" xlink:title="DebtInstrumentLenderDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DebtInstrumentLenderAxis" xlink:to="cldx_DebtInstrumentLenderDomain" xlink:title="Presentation : cldx_DebtInstrumentLenderAxis to cldx_DebtInstrumentLenderDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_MidCapFinancialLLCMember" xlink:label="cldx_MidCapFinancialLLCMember" xlink:title="MidCapFinancialLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DebtInstrumentLenderDomain" xlink:to="cldx_MidCapFinancialLLCMember" xlink:title="Presentation : cldx_DebtInstrumentLenderDomain to cldx_MidCapFinancialLLCMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_ProceedsFromIssuanceOfDebt" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="cldx_DebtInstrumentLenderAxis" xlink:title="Presentation : us-gaap_DebtInstrumentTable to cldx_DebtInstrumentLenderAxis" use="optional" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_LongtermDebtTypeAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GeneralElectricCapitalCorporationMember" xlink:label="cldx_GeneralElectricCapitalCorporationMember" xlink:title="GeneralElectricCapitalCorporationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DebtInstrumentLenderDomain" xlink:to="cldx_GeneralElectricCapitalCorporationMember" xlink:title="Presentation : cldx_DebtInstrumentLenderDomain to cldx_GeneralElectricCapitalCorporationMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebt" xlink:label="us-gaap_SecuredDebt" xlink:title="SecuredDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SecuredDebt" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_SecuredDebt" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:label="cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:title="RepaymentOfLongTermDebtPrincipalAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_RepaymentOfLongTermDebtPrincipalAmount" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_RangeAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:label="cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:title="DebtInstrumentInterestAndPrepaymentFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentInterestAndPrepaymentFees" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_DebtInstrumentLineItems" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt" xlink:title="InterestExpenseLongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_InterestExpenseLongTermDebt" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:label="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:label="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" use="optional" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:label="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:title="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" use="optional" order="8003" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:label="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:title="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" use="optional" order="8004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:label="cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:title="DebtInstrumentPaymentFeePayableOnRepayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentPaymentFeePayableOnRepayment" use="optional" order="8005" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:label="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:title="DebtInstrumentInterestOnlyPeriodOfExtension" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentInterestOnlyPeriodOfExtension" use="optional" order="8006" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:label="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:title="DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" use="optional" order="8007" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtByMaturityAbstract" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_LongTermDebtByMaturityAbstract" use="optional" order="8008" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:title="DebtInstrumentDescriptionOfVariableRateBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" use="optional" order="8009" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:title="Presentation : us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract to cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="IndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="Presentation : us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:title="InProcessResearchAndDevelopmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" xlink:title="Presentation : us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_InProcessResearchAndDevelopmentMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmgenAmendmentMember" xlink:label="cldx_AmgenAmendmentMember" xlink:title="AmgenAmendmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="cldx_AmgenAmendmentMember" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain to cldx_AmgenAmendmentMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_Goodwill" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to us-gaap_Goodwill" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="Presentation : us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="IntangibleAssetsGrossExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="Presentation : us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract to us-gaap_IntangibleAssetsGrossExcludingGoodwill" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CoreTechnologyMember" xlink:label="cldx_CoreTechnologyMember" xlink:title="CoreTechnologyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="cldx_CoreTechnologyMember" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain to cldx_CoreTechnologyMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsGross" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="Presentation : us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract to us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to us-gaap_RangeAxis" order="3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to us-gaap_FiniteLivedIntangibleAssetsNetAbstract" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsNet" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to us-gaap_AmortizationOfIntangibleAssets" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="Presentation : us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="Presentation : cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverviewDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:label="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:title="ScheduleOfNatureOfBusinessAndOverviewTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to cldx_ScheduleOfNatureOfBusinessAndOverviewTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : cldx_ScheduleOfNatureOfBusinessAndOverviewTable to us-gaap_SubsequentEventTypeAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NatureOfBusinessAndOverviewLineItems" xlink:label="cldx_NatureOfBusinessAndOverviewLineItems" xlink:title="NatureOfBusinessAndOverviewLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash" xlink:title="InvestmentsAndCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="us-gaap_InvestmentsAndCash" xlink:title="Presentation : cldx_NatureOfBusinessAndOverviewLineItems to us-gaap_InvestmentsAndCash" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:to="cldx_NatureOfBusinessAndOverviewLineItems" xlink:title="Presentation : cldx_ScheduleOfNatureOfBusinessAndOverviewTable to cldx_NatureOfBusinessAndOverviewLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : cldx_NatureOfBusinessAndOverviewLineItems to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="Presentation : cldx_NatureOfBusinessAndOverviewLineItems to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_WorkingCapital" xlink:label="cldx_WorkingCapital" xlink:title="WorkingCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="cldx_WorkingCapital" xlink:title="Presentation : cldx_NatureOfBusinessAndOverviewLineItems to cldx_WorkingCapital" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockholdersEquityTable" xlink:label="cldx_StockholdersEquityTable" xlink:title="StockholdersEquityTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="cldx_StockholdersEquityTable" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to cldx_StockholdersEquityTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramAxis" xlink:label="cldx_StockIssuedByTypeOfProgramAxis" xlink:title="StockIssuedByTypeOfProgramAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable" xlink:to="cldx_StockIssuedByTypeOfProgramAxis" xlink:title="Presentation : cldx_StockholdersEquityTable to cldx_StockIssuedByTypeOfProgramAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramDomain" xlink:label="cldx_StockIssuedByTypeOfProgramDomain" xlink:title="StockIssuedByTypeOfProgramDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockIssuedByTypeOfProgramAxis" xlink:to="cldx_StockIssuedByTypeOfProgramDomain" xlink:title="Presentation : cldx_StockIssuedByTypeOfProgramAxis to cldx_StockIssuedByTypeOfProgramDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ControlledEquityOfferingProgramMember" xlink:label="cldx_ControlledEquityOfferingProgramMember" xlink:title="ControlledEquityOfferingProgramMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockIssuedByTypeOfProgramDomain" xlink:to="cldx_ControlledEquityOfferingProgramMember" xlink:title="Presentation : cldx_StockIssuedByTypeOfProgramDomain to cldx_ControlledEquityOfferingProgramMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="Presentation : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:title="SeriesCPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" xlink:title="Presentation : us-gaap_ClassOfStockDomain to us-gaap_SeriesCPreferredStockMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CumulativePreferredStockMember" xlink:label="us-gaap_CumulativePreferredStockMember" xlink:title="CumulativePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_CumulativePreferredStockMember" xlink:title="Presentation : us-gaap_SeriesCPreferredStockMember to us-gaap_CumulativePreferredStockMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockholdersEquityLineItems" xlink:label="cldx_StockholdersEquityLineItems" xlink:title="StockholdersEquityLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShelfRegistrationStatementAmount" xlink:label="cldx_ShelfRegistrationStatementAmount" xlink:title="ShelfRegistrationStatementAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_ShelfRegistrationStatementAmount" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_ShelfRegistrationStatementAmount" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:label="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:title="ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ControlledEquityOfferingProgramAmendedMember" xlink:label="cldx_ControlledEquityOfferingProgramAmendedMember" xlink:title="ControlledEquityOfferingProgramAmendedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockIssuedByTypeOfProgramDomain" xlink:to="cldx_ControlledEquityOfferingProgramAmendedMember" xlink:title="Presentation : cldx_StockIssuedByTypeOfProgramDomain to cldx_ControlledEquityOfferingProgramAmendedMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="Presentation : cldx_StockholdersEquityTable to us-gaap_StatementClassOfStockAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Presentation : cldx_StockholdersEquityLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareholderRightsPlanMember" xlink:label="cldx_ShareholderRightsPlanMember" xlink:title="ShareholderRightsPlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockIssuedByTypeOfProgramDomain" xlink:to="cldx_ShareholderRightsPlanMember" xlink:title="Presentation : cldx_StockIssuedByTypeOfProgramDomain to cldx_ShareholderRightsPlanMember" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : cldx_StockholdersEquityTable to us-gaap_RangeAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : cldx_StockholdersEquityLineItems to us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : cldx_StockholdersEquityTable to us-gaap_SubsequentEventTypeAxis" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Presentation : cldx_StockholdersEquityLineItems to us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:label="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable" xlink:to="cldx_StockholdersEquityLineItems" xlink:title="Presentation : cldx_StockholdersEquityTable to cldx_StockholdersEquityLineItems" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:label="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:title="Presentation : cldx_StockholdersEquityLineItems to us-gaap_PreferredStockSharesAuthorized" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:label="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:title="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="Presentation : cldx_StockholdersEquityLineItems to us-gaap_WarrantsAndRightsNoteDisclosureAbstract" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:label="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:label="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:title="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:label="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:title="CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockSharesAvailableForSale" xlink:label="cldx_CommonStockSharesAvailableForSale" xlink:title="CommonStockSharesAvailableForSale" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_CommonStockSharesAvailableForSale" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_CommonStockSharesAvailableForSale" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:label="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:title="CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" use="optional" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FixedRateOfCommissionOnSaleOfStock" xlink:label="cldx_FixedRateOfCommissionOnSaleOfStock" xlink:title="FixedRateOfCommissionOnSaleOfStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_FixedRateOfCommissionOnSaleOfStock" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_FixedRateOfCommissionOnSaleOfStock" use="optional" order="8003" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NoticePeriodForTerminationOfAgreement" xlink:label="cldx_NoticePeriodForTerminationOfAgreement" xlink:title="NoticePeriodForTerminationOfAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_NoticePeriodForTerminationOfAgreement" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_NoticePeriodForTerminationOfAgreement" use="optional" order="8004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:label="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:title="CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:title="Presentation : cldx_StockholdersEquityLineItems to cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" use="optional" order="8005" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:label="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:title="OperatingLossAndTaxCreditCarryforwardsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to cldx_OperatingLossAndTaxCreditCarryforwardsTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsTable to us-gaap_IncomeTaxAuthorityAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:title="Presentation : us-gaap_IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember" xlink:title="InternalRevenueServiceIRSMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" xlink:title="Presentation : us-gaap_IncomeTaxAuthorityDomain to us-gaap_InternalRevenueServiceIRSMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Presentation : us-gaap_BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_CuraGenCorporationMember" xlink:title="Presentation : us-gaap_BusinessAcquisitionAcquireeDomain to cldx_CuraGenCorporationMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionAxis" xlink:label="cldx_StatusOfMergerAndAcquisitionAxis" xlink:title="StatusOfMergerAndAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionDomain" xlink:label="cldx_StatusOfMergerAndAcquisitionDomain" xlink:title="StatusOfMergerAndAcquisitionDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StatusOfMergerAndAcquisitionAxis" xlink:to="cldx_StatusOfMergerAndAcquisitionDomain" xlink:title="Presentation : cldx_StatusOfMergerAndAcquisitionAxis to cldx_StatusOfMergerAndAcquisitionDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeAxis" xlink:label="cldx_OwnershipChangeAxis" xlink:title="OwnershipChangeAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeDomain" xlink:label="cldx_OwnershipChangeDomain" xlink:title="OwnershipChangeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OwnershipChangeAxis" xlink:to="cldx_OwnershipChangeDomain" xlink:title="Presentation : cldx_OwnershipChangeAxis to cldx_OwnershipChangeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeInOctober2007Member" xlink:label="cldx_OwnershipChangeInOctober2007Member" xlink:title="OwnershipChangeInOctober2007Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OwnershipChangeDomain" xlink:to="cldx_OwnershipChangeInOctober2007Member" xlink:title="Presentation : cldx_OwnershipChangeDomain to cldx_OwnershipChangeInOctober2007Member" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis" xlink:title="TaxCreditCarryforwardAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" xlink:title="TaxCreditCarryforwardNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" xlink:title="Presentation : us-gaap_TaxCreditCarryforwardAxis to us-gaap_TaxCreditCarryforwardNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember" xlink:title="ResearchMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" xlink:title="Presentation : us-gaap_TaxCreditCarryforwardNameDomain to us-gaap_ResearchMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:label="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:title="OperatingLossAndTaxCreditCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to us-gaap_OperatingLossCarryforwards" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:title="Presentation : us-gaap_IncomeTaxAuthorityDomain to us-gaap_StateAndLocalJurisdictionMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsTable to us-gaap_BusinessAcquisitionAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:label="cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:title="OwnershipChangesInJune2009AndDecember2009Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OwnershipChangeDomain" xlink:to="cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:title="Presentation : cldx_OwnershipChangeDomain to cldx_OwnershipChangesInJune2009AndDecember2009Member" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:label="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:title="OperatingLossCarryforwardsNetOfExpirationsAndUtilization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="cldx_StatusOfMergerAndAcquisitionAxis" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsTable to cldx_StatusOfMergerAndAcquisitionAxis" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsExpired" xlink:label="cldx_OperatingLossCarryforwardsExpired" xlink:title="OperatingLossCarryforwardsExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_OperatingLossCarryforwardsExpired" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_OperatingLossCarryforwardsExpired" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="cldx_OwnershipChangeAxis" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsTable to cldx_OwnershipChangeAxis" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:label="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:title="OperatingLossCarryforwardsWithLimitationsOnUse" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_OperatingLossCarryforwardsWithLimitationsOnUse" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsTable to us-gaap_TaxCreditCarryforwardAxis" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:label="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsTable to cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:label="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:title="OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:label="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:title="OperatingLossCarryforwardsAnnualLimitationAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_OperatingLossCarryforwardsAnnualLimitationAmount" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:label="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:title="PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to us-gaap_TaxCreditCarryforwardAmount" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:label="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:title="TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to us-gaap_NumberOfStatesInWhichEntityOperates" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" xlink:title="Presentation : cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to us-gaap_UnrecognizedTaxBenefits" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AVANTMember" xlink:label="cldx_AVANTMember" xlink:title="AVANTMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_AVANTMember" xlink:title="Presentation : us-gaap_BusinessAcquisitionAcquireeDomain to cldx_AVANTMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PriorToMergerMember" xlink:label="cldx_PriorToMergerMember" xlink:title="PriorToMergerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StatusOfMergerAndAcquisitionDomain" xlink:to="cldx_PriorToMergerMember" xlink:title="Presentation : cldx_StatusOfMergerAndAcquisitionDomain to cldx_PriorToMergerMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PriorToAcquisitionMember" xlink:label="cldx_PriorToAcquisitionMember" xlink:title="PriorToAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StatusOfMergerAndAcquisitionDomain" xlink:to="cldx_PriorToAcquisitionMember" xlink:title="Presentation : cldx_StatusOfMergerAndAcquisitionDomain to cldx_PriorToAcquisitionMember" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LaboratoryEquipmentMember" xlink:label="cldx_LaboratoryEquipmentMember" xlink:title="LaboratoryEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cldx_LaboratoryEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to cldx_LaboratoryEquipmentMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentGross" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentAbstract to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ManufacturingEquipmentMember" xlink:label="cldx_ManufacturingEquipmentMember" xlink:title="ManufacturingEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cldx_ManufacturingEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to cldx_ManufacturingEquipmentMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_FurnitureAndFixturesMember" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_LeaseholdImprovementsMember" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_DepreciationDepletionAndAmortization" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_ConstructionInProgressMember" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="OtherLiabilitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:title="ScheduleOfOtherLongTermLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_DebtInstrumentTable" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_LongtermDebtTypeAxis" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" xlink:title="Presentation : us-gaap_LongtermDebtTypeAxis to us-gaap_LongtermDebtTypeDomain" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" xlink:title="LoansPayableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" xlink:title="Presentation : us-gaap_LongtermDebtTypeDomain to us-gaap_LoansPayableMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_DebtInstrumentLineItems" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LaboratoryEquipmentMember" xlink:label="cldx_LaboratoryEquipmentMember" xlink:title="LaboratoryEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cldx_LaboratoryEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to cldx_LaboratoryEquipmentMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentUsefulLife" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_FurnitureAndFixturesMember" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_RangeAxis" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_ComputerEquipmentMember" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentLineItems" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ManufacturingEquipmentMember" xlink:label="cldx_ManufacturingEquipmentMember" xlink:title="ManufacturingEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cldx_ManufacturingEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to cldx_ManufacturingEquipmentMember" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="us-gaap_RevenueRecognitionAbstract" xlink:title="RevenueRecognitionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_RevenueRecognitionAbstract" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_RevenueRecognitionAbstract" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:label="cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:title="CollaborativeArrangementMilestonePaymentsReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueRecognitionAbstract" xlink:to="cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:title="Presentation : us-gaap_RevenueRecognitionAbstract to cldx_CollaborativeArrangementMilestonePaymentsReceived" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" xlink:title="OtherNonoperatingIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueRecognitionAbstract" xlink:to="us-gaap_OtherNonoperatingIncome" xlink:title="Presentation : us-gaap_RevenueRecognitionAbstract to us-gaap_OtherNonoperatingIncome" use="optional" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="OtherLiabilitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_DebtInstrumentTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_LongtermDebtTypeAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" xlink:title="Presentation : us-gaap_LongtermDebtTypeAxis to us-gaap_LongtermDebtTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" xlink:title="LoansPayableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" xlink:title="Presentation : us-gaap_LongtermDebtTypeDomain to us-gaap_LoansPayableMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="Presentation : us-gaap_LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentAmortizationPeriod" xlink:label="cldx_DebtInstrumentAmortizationPeriod" xlink:title="DebtInstrumentAmortizationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cldx_DebtInstrumentAmortizationPeriod" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to cldx_DebtInstrumentAmortizationPeriod" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" xlink:title="Presentation : us-gaap_DebtInstrumentTable to us-gaap_DebtInstrumentLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="Presentation : us-gaap_LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:label="us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:title="DebtInstrumentInterestRateAtPeriodEnd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_DebtInstrumentInterestRateAtPeriodEnd" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtByMaturityAbstract" xlink:title="Presentation : us-gaap_DebtInstrumentLineItems to us-gaap_LongTermDebtByMaturityAbstract" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="Presentation : us-gaap_LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="Presentation : us-gaap_LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="Presentation : us-gaap_LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="Presentation : us-gaap_LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_BasisOfPresentationAbstract" xlink:label="cldx_BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cldx_BasisOfPresentationAbstract" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to cldx_BasisOfPresentationAbstract" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_BasisOfPresentationAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" xlink:title="Presentation : cldx_BasisOfPresentationAbstract to us-gaap_NumberOfOperatingSegments" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:title="Presentation : us-gaap_ConcentrationRiskTable to us-gaap_ConcentrationRiskByBenchmarkAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:title="Presentation : us-gaap_ConcentrationRiskByBenchmarkAxis to us-gaap_ConcentrationRiskBenchmarkDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember" xlink:title="SalesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesMember" xlink:title="Presentation : us-gaap_ConcentrationRiskBenchmarkDomain to us-gaap_SalesMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:title="ConcentrationRiskByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:title="ConcentrationRiskTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:title="Presentation : us-gaap_ConcentrationRiskByTypeAxis to us-gaap_ConcentrationRiskTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:title="CustomerConcentrationRiskMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:title="Presentation : us-gaap_ConcentrationRiskTypeDomain to us-gaap_CustomerConcentrationRiskMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" xlink:title="Presentation : us-gaap_MajorCustomersAxis to us-gaap_NameOfMajorCustomerDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GlaxoSmithKlinePlcMember" xlink:label="cldx_GlaxoSmithKlinePlcMember" xlink:title="GlaxoSmithKlinePlcMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="cldx_GlaxoSmithKlinePlcMember" xlink:title="Presentation : us-gaap_NameOfMajorCustomerDomain to cldx_GlaxoSmithKlinePlcMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:title="ConcentrationRiskPercentage1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" xlink:title="Presentation : us-gaap_ConcentrationRiskLineItems to us-gaap_ConcentrationRiskPercentage1" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskTable" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ConcentrationRiskTable" use="optional" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:title="Presentation : us-gaap_ConcentrationRiskTable to us-gaap_ConcentrationRiskByTypeAxis" use="optional" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_MajorCustomersAxis" xlink:title="Presentation : us-gaap_ConcentrationRiskTable to us-gaap_MajorCustomersAxis" use="optional" order="3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskLineItems" xlink:title="Presentation : us-gaap_ConcentrationRiskTable to us-gaap_ConcentrationRiskLineItems" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PfizerIncMember" xlink:label="cldx_PfizerIncMember" xlink:title="PfizerIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="cldx_PfizerIncMember" xlink:title="Presentation : us-gaap_NameOfMajorCustomerDomain to cldx_PfizerIncMember" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="Presentation : us-gaap_FairValueDisclosuresAbstract to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueByMeasurementFrequencyAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" xlink:title="Presentation : us-gaap_FairValueByMeasurementFrequencyAxis to us-gaap_FairValueMeasurementFrequencyDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" xlink:title="Presentation : us-gaap_FairValueMeasurementFrequencyDomain to us-gaap_FairValueMeasurementsRecurringMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="Presentation : us-gaap_FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="Presentation : us-gaap_FairValueMeasurementsFairValueHierarchyDomain to us-gaap_EstimateOfFairValueFairValueDisclosureMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="CashAndCashEquivalentsFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_CashAndCashEquivalentsFairValueDisclosure" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" xlink:title="Presentation : us-gaap_FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueInputsLevel1Member" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:title="AvailableForSaleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_AvailableForSaleSecurities" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" xlink:title="Presentation : us-gaap_FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueInputsLevel2Member" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_AssetsFairValueDisclosure" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:title="FairValueAssetsAmountTransfersBetweenMeasurementLevels" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:title="FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRockefellerUniversityDetails">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementDisclosureAbstract" xlink:label="cldx_CollaborativeArrangementDisclosureAbstract" xlink:title="CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Presentation : cldx_CollaborativeArrangementDisclosureAbstract to us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_TypeOfArrangementAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Presentation : us-gaap_TypeOfArrangementAxis to us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:label="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="ProductDevelopmentAndLicensingAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="Presentation : us-gaap_ArrangementsAndNonarrangementTransactionsMember to cldx_ProductDevelopmentAndLicensingAgreementMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:label="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:title="CollaborativeArrangementNumberOfAntiHIVAntibodies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_TypeOfArrangementAxis" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Presentation : us-gaap_TypeOfArrangementAxis to us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:label="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="ProductDevelopmentAndLicensingAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="Presentation : us-gaap_ArrangementsAndNonarrangementTransactionsMember to cldx_ProductDevelopmentAndLicensingAgreementMember" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:label="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:title="CollaborativeArrangementEstimatedCostForDevelopmentServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="OtherLiabilitiesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="cldx_CollaborativeArrangementAgreementTerm" xlink:title="CollaborativeArrangementAgreementTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementAgreementTerm" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementAgreementTerm" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:label="cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:title="CollaborativeArrangementUpfrontPaymentAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_CollaborativeArrangementUpfrontPaymentAmount" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants" xlink:title="RevenueFromContractsAndGrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_RevenueFromContractsAndGrants" xlink:title="Presentation : us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to cldx_RevenueFromContractsAndGrants" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Presentation : us-gaap_StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="StatementTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:title="Presentation : us-gaap_StatementOfStockholdersEquityAbstract to us-gaap_StatementTable" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Presentation : us-gaap_StatementTable to us-gaap_StatementEquityComponentsAxis" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Presentation : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_CommonStockMember" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockholdersEquity" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="Presentation : us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan to us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="StockIssuedDuringPeriodValueOther" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Presentation : us-gaap_StockIssuedDuringPeriodValueOther to us-gaap_StockIssuedDuringPeriodSharesOther" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="StockholdersEquityPeriodIncreaseDecrease" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="Presentation : us-gaap_StockholdersEquityPeriodIncreaseDecrease to us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_AdditionalPaidInCapitalMember" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:title="Presentation : us-gaap_StatementTable to us-gaap_StatementLineItems" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesIssued" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_CommonStockSharesIssued" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_RetainedEarningsMember" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockIssuedDuringPeriodValueOther" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="90" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity_1" xlink:title="StockholdersEquity_1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity_1" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockholdersEquity" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued_2" xlink:title="CommonStockSharesIssued_2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="CommonStockSharesIssued_2" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_CommonStockSharesIssued" use="optional" order="110" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockholdersEquityPeriodIncreaseDecrease" use="optional" order="120" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="Presentation : us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_StockIssuedDuringPeriodValueAcquisitions" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="Presentation : us-gaap_StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRevenue">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:title="SignificantRevenueArrangementsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:title="SignificantRevenueArrangementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:to="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:title="Presentation : cldx_SignificantRevenueArrangementsDisclosureAbstract to cldx_SignificantRevenueArrangementsDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverview">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" xlink:title="BasisOfAccounting" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BasisOfAccounting" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_BasisOfAccounting" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" xlink:title="Presentation : us-gaap_EarningsPerShareAbstract to us-gaap_EarningsPerShareTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_SignificantAccountingPoliciesTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:title="AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:title="Presentation : us-gaap_PayablesAndAccrualsAbstract to us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:title="OtherLiabilitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:title="OtherLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:title="Presentation : us-gaap_OtherLiabilitiesDisclosureAbstract to us-gaap_OtherLiabilitiesDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlan">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="Presentation : us-gaap_CompensationAndRetirementDisclosureAbstract to us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialData">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:title="QuarterlyFinancialInformationDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:title="QuarterlyFinancialInformationTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:title="Presentation : us-gaap_QuarterlyFinancialInformationDisclosureAbstract to us-gaap_QuarterlyFinancialInformationTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:title="Presentation : us-gaap_FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="Presentation : us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract to us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="Presentation : us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureTermLoan">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" xlink:title="LongTermDebtTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtTextBlock" xlink:title="Presentation : us-gaap_DebtDisclosureAbstract to us-gaap_LongTermDebtTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DocumentAndEntityInformationAbstract" xlink:label="cldx_DocumentAndEntityInformationAbstract" xlink:title="DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityRegistrantName" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityCentralIndexKey" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_DocumentType" use="optional" order="30" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_DocumentPeriodEndDate" use="optional" order="40" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_AmendmentFlag" use="optional" order="50" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" xlink:title="AmendmentDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_AmendmentDescription" use="optional" order="60" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_CurrentFiscalYearEndDate" use="optional" order="70" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityWellKnownSeasonedIssuer" use="optional" order="80" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityVoluntaryFilers" use="optional" order="90" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityCurrentReportingStatus" use="optional" order="100" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityFilerCategory" use="optional" order="110" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityPublicFloat" use="optional" order="120" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_EntityCommonStockSharesOutstanding" use="optional" order="130" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_DocumentFiscalYearFocus" use="optional" order="140" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="Presentation : cldx_DocumentAndEntityInformationAbstract to dei_DocumentFiscalPeriodFocus" use="optional" order="150" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/BalanceSheetParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockSharesAuthorized" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockSharesIssued" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockSharesOutstanding" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockParOrStatedValuePerShare" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesAuthorized" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesIssued" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesOutstanding" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="ComprehensiveIncomeNetOfTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:title="ComprehensiveIncomeNoteTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_ComprehensiveIncomeNoteTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/CashFlows">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_DepreciationDepletionAndAmortization" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="IncreaseDecreaseInAccountsAndOtherReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:title="InterestPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" xlink:title="Presentation : us-gaap_SupplementalCashFlowInformationAbstract to us-gaap_InterestPaid" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AmortizationOfIntangibleAssets" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_PaymentsToAcquireMarketableSecurities" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans" xlink:title="ProceedsFromStockPlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromStockPlans" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOtherOperatingAssets" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:title="ProceedsFromIssuanceOfLongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromIssuanceOfLongTermDebt" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" xlink:title="MarketableSecuritiesGainLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_MarketableSecuritiesGainLoss" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_MarketableSecuritiesGainLoss" use="optional" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromSaleOfProductiveAssets" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:title="RepaymentsOfConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_RepaymentsOfConvertibleDebt" use="optional" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:title="EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:title="GainLossOnSaleOfPropertyPlantEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_GainLossOnSaleOfPropertyPlantEquipment" use="optional" order="50" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:title="RepaymentsOfOtherLongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_RepaymentsOfOtherLongTermDebt" use="optional" order="50" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:title="NetCashProvidedByUsedInContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInContinuingOperations" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_ShareBasedCompensation" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="AmortizationOfDebtDiscountPremium" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AmortizationOfDebtDiscountPremium" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue_1" xlink:title="CashAndCashEquivalentsAtCarryingValue_1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue_1" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_SupplementalCashFlowInformationAbstract" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInDeferredRevenue" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeTaxExpense" xlink:label="us-gaap_OtherNoncashIncomeTaxExpense" xlink:title="OtherNoncashIncomeTaxExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeTaxExpense" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_OtherNoncashIncomeTaxExpense" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAcquiredFromAcquisition" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_CashAcquiredFromAcquisition" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfSubordinatedDebt" xlink:label="us-gaap_RepaymentsOfSubordinatedDebt" xlink:title="RepaymentsOfSubordinatedDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfSubordinatedDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_RepaymentsOfSubordinatedDebt" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:title="StockGrantedDuringPeriodValueSharebasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:title="Presentation : us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt" xlink:title="RepaymentsOfSecuredDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfSecuredDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_RepaymentsOfSecuredDebt" use="optional" order="8010" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/StatementOfIncome">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenuesAbstract" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_RevenuesAbstract" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:title="RevenueFromProductDevelopmentAndLicensingAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:title="Presentation : us-gaap_RevenuesAbstract to cldx_RevenueFromProductDevelopmentAndLicensingAgreements" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Presentation : us-gaap_CostsAndExpensesAbstract to us-gaap_ResearchAndDevelopmentExpense" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="ComprehensiveIncomeNetOfTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:title="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="Presentation : us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants" xlink:title="RevenueFromContractsAndGrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="cldx_RevenueFromContractsAndGrants" xlink:title="Presentation : us-gaap_RevenuesAbstract to cldx_RevenueFromContractsAndGrants" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_CostsAndExpensesAbstract" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" xlink:title="RoyaltyExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" xlink:title="Presentation : us-gaap_CostsAndExpensesAbstract to us-gaap_RoyaltyExpense" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="Presentation : us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract to us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:title="RoyaltyRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RoyaltyRevenue" xlink:title="Presentation : us-gaap_RevenuesAbstract to us-gaap_RoyaltyRevenue" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:title="Presentation : us-gaap_CostsAndExpensesAbstract to us-gaap_GeneralAndAdministrativeExpense" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OperatingIncomeLoss" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="Presentation : us-gaap_ComprehensiveIncomeNetOfTaxAbstract to us-gaap_ComprehensiveIncomeNetOfTax" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" xlink:title="Presentation : us-gaap_RevenuesAbstract to us-gaap_Revenues" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:title="Presentation : us-gaap_CostsAndExpensesAbstract to us-gaap_AmortizationOfIntangibleAssets" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestAndOtherIncome" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_InterestAndOtherIncome" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" xlink:title="Presentation : us-gaap_CostsAndExpensesAbstract to us-gaap_CostsAndExpenses" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xlink:title="InterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpense" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_InterestExpense" use="optional" order="50" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_EarningsPerShareBasicAndDiluted" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_ComprehensiveIncomeNetOfTaxAbstract" use="optional" order="90" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xlink:title="GainLossOnDispositionOfAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets" xlink:title="Presentation : us-gaap_CostsAndExpensesAbstract to us-gaap_GainLossOnDispositionOfAssets" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/BalanceSheet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_AssetsAbstract" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_AssetsCurrentAbstract" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesCurrentAbstract" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccountsPayableCurrent" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_PreferredStockValue" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccruedLiabilitiesCurrent" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredLongTermDebt" xlink:label="us-gaap_SecuredLongTermDebt" xlink:title="SecuredLongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_SecuredLongTermDebt" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_SecuredLongTermDebt" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_CommonStockValue" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_AccountsAndOtherReceivablesNetCurrent" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_OtherLiabilitiesCurrent" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_OtherLiabilitiesNoncurrent" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="AdditionalPaidInCapitalCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_OtherAssetsNoncurrent" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="us-gaap_SecuredDebtCurrent" xlink:title="SecuredDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_SecuredDebtCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_SecuredDebtCurrent" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_Liabilities" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_AssetsCurrent" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Goodwill" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_Goodwill" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrent" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_CommitmentsAndContingencies" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_Assets" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_StockholdersEquity" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquity" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:title="DeferredRevenueCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_DeferredRevenueCurrent" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:title="DeferredRevenueNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_DeferredRevenueNoncurrent" use="optional" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:label="us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:title="ConvertibleSubordinatedDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_ConvertibleSubordinatedDebtCurrent" use="optional" order="8010" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:label="us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:title="ConvertibleSubordinatedDebtNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleSubordinatedDebtNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_ConvertibleSubordinatedDebtNoncurrent" use="optional" order="8010" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreements">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementDisclosureAbstract" xlink:label="cldx_CollaborativeArrangementDisclosureAbstract" xlink:title="CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:title="CollaborativeArrangementDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:title="Presentation : cldx_CollaborativeArrangementDisclosureAbstract to us-gaap_CollaborativeArrangementDisclosureTextBlock" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>cldx-20131231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--Generated by IRIS XBRL Generation Engine-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockBasedCompensationDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIncomeTaxesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockBasedCompensationDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureTermLoanDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureTermLoanDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRevenueDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreementsDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCollaborationAgreementsDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverviewDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureNatureOfBusinessAndOverviewDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureStockholdersEquityDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails3" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureIntangibleAssetsAndGoodwillDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureNetLossPerShareDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails4" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureMarketableSecuritiesDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesDetails3" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureFairValueMeasurementsDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureComprehensiveLossDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureCommitmentsAndContingenciesDetails2" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureRockefellerUniversityDetails" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureRockefellerUniversityDetails" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity" xlink:type="simple" xlink:href="cldx-20131231.xsd#StatementOfStockholdersEquity" />
  <link:roleRef roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="cldx-20131231.xsd#DisclosureOtherLongTermLiabilitiesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="Definition : loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="loc_us-gaap_IncomeStatementLocationDomain" xlink:title="Definition : loc_us-gaap_IncomeStatementLocationAxis to loc_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : loc_us-gaap_AwardTypeAxis to loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="Definition : loc_us-gaap_IncomeStatementLocationDomain to loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaap_IncomeStatementLocationAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to loc_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_1" xlink:title="IncomeStatementLocationDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_1" xlink:title="Definition : loc_us-gaap_IncomeStatementLocationAxis to loc_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="Definition : loc_us-gaap_IncomeStatementLocationDomain to loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Definition : loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to loc_us-gaap_AwardTypeAxis" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="Definition : loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MinimumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MinimumMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" use="optional" order="8001" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MaximumMember" xlink:type="arc" use="optional" order="8001" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails2">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:label="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:title="OperatingLossAndTaxCreditCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:label="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:title="OperatingLossAndTaxCreditCarryforwardsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:title="Definition : loc_us-gaap_IncomeTaxAuthorityAxis to loc_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAxis to loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionAxis" xlink:label="loc_cldx_StatusOfMergerAndAcquisitionAxis" xlink:title="StatusOfMergerAndAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionDomain" xlink:label="loc_cldx_StatusOfMergerAndAcquisitionDomain" xlink:title="StatusOfMergerAndAcquisitionDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cldx_StatusOfMergerAndAcquisitionAxis" xlink:to="loc_cldx_StatusOfMergerAndAcquisitionDomain" xlink:title="Definition : loc_cldx_StatusOfMergerAndAcquisitionAxis to loc_cldx_StatusOfMergerAndAcquisitionDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeAxis" xlink:label="loc_cldx_OwnershipChangeAxis" xlink:title="OwnershipChangeAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeDomain" xlink:label="loc_cldx_OwnershipChangeDomain" xlink:title="OwnershipChangeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cldx_OwnershipChangeAxis" xlink:to="loc_cldx_OwnershipChangeDomain" xlink:title="Definition : loc_cldx_OwnershipChangeAxis to loc_cldx_OwnershipChangeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:title="TaxCreditCarryforwardAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:title="TaxCreditCarryforwardNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:title="Definition : loc_us-gaap_TaxCreditCarryforwardAxis to loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:title="InternalRevenueServiceIRSMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:title="Definition : loc_us-gaap_IncomeTaxAuthorityDomain to loc_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="loc_cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="loc_cldx_CuraGenCorporationMember" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAcquireeDomain to loc_cldx_CuraGenCorporationMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeInOctober2007Member" xlink:label="loc_cldx_OwnershipChangeInOctober2007Member" xlink:title="OwnershipChangeInOctober2007Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OwnershipChangeDomain" xlink:to="loc_cldx_OwnershipChangeInOctober2007Member" xlink:title="Definition : loc_cldx_OwnershipChangeDomain to loc_cldx_OwnershipChangeInOctober2007Member" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember" xlink:title="ResearchMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="loc_us-gaap_ResearchMember" xlink:title="Definition : loc_us-gaap_TaxCreditCarryforwardNameDomain to loc_us-gaap_ResearchMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable to loc_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_1" xlink:title="IncomeTaxAuthorityDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_1" xlink:title="Definition : loc_us-gaap_IncomeTaxAuthorityAxis to loc_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAxis to loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StatusOfMergerAndAcquisitionDomain" xlink:label="StatusOfMergerAndAcquisitionDomain_3" xlink:title="StatusOfMergerAndAcquisitionDomain_3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cldx_StatusOfMergerAndAcquisitionAxis" xlink:to="StatusOfMergerAndAcquisitionDomain_3" xlink:title="Definition : loc_cldx_StatusOfMergerAndAcquisitionAxis to loc_cldx_StatusOfMergerAndAcquisitionDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangeDomain" xlink:label="OwnershipChangeDomain_4" xlink:title="OwnershipChangeDomain_4" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cldx_OwnershipChangeAxis" xlink:to="OwnershipChangeDomain_4" xlink:title="Definition : loc_cldx_OwnershipChangeAxis to loc_cldx_OwnershipChangeDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="TaxCreditCarryforwardNameDomain_5" xlink:title="TaxCreditCarryforwardNameDomain_5" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="TaxCreditCarryforwardNameDomain_5" xlink:title="Definition : loc_us-gaap_TaxCreditCarryforwardAxis to loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:title="Definition : loc_us-gaap_IncomeTaxAuthorityDomain to loc_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:label="loc_cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:title="OwnershipChangesInJune2009AndDecember2009Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OwnershipChangeDomain" xlink:to="loc_cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:title="Definition : loc_cldx_OwnershipChangeDomain to loc_cldx_OwnershipChangesInJune2009AndDecember2009Member" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_us-gaap_OperatingLossCarryforwards" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_us-gaap_OperatingLossCarryforwards" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="loc_us-gaap_BusinessAcquisitionAxis" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable to loc_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:label="loc_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:title="OperatingLossCarryforwardsNetOfExpirationsAndUtilization" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="loc_cldx_StatusOfMergerAndAcquisitionAxis" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable to loc_cldx_StatusOfMergerAndAcquisitionAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsExpired" xlink:label="loc_cldx_OperatingLossCarryforwardsExpired" xlink:title="OperatingLossCarryforwardsExpired" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_OperatingLossCarryforwardsExpired" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_OperatingLossCarryforwardsExpired" xlink:type="arc" use="optional" order="4" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="loc_cldx_OwnershipChangeAxis" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable to loc_cldx_OwnershipChangeAxis" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:label="loc_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:title="OperatingLossCarryforwardsWithLimitationsOnUse" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_OperatingLossCarryforwardsWithLimitationsOnUse" xlink:type="arc" use="optional" order="5" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsTable to loc_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:label="loc_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:label="loc_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:title="OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:label="loc_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:title="OperatingLossCarryforwardsAnnualLimitationAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_OperatingLossCarryforwardsAnnualLimitationAmount" xlink:type="arc" use="optional" order="8" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:label="loc_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:title="PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange" xlink:type="arc" use="optional" order="9" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:label="loc_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:title="TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse" xlink:type="arc" use="optional" order="11" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" use="optional" order="12" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits" xlink:title="Definition : loc_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems to loc_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" use="optional" order="13" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AVANTMember" xlink:label="loc_cldx_AVANTMember" xlink:title="AVANTMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="loc_cldx_AVANTMember" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAcquireeDomain to loc_cldx_AVANTMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PriorToMergerMember" xlink:label="loc_cldx_PriorToMergerMember" xlink:title="PriorToMergerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StatusOfMergerAndAcquisitionDomain" xlink:to="loc_cldx_PriorToMergerMember" xlink:title="Definition : loc_cldx_StatusOfMergerAndAcquisitionDomain to loc_cldx_PriorToMergerMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PriorToAcquisitionMember" xlink:label="loc_cldx_PriorToAcquisitionMember" xlink:title="PriorToAcquisitionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StatusOfMergerAndAcquisitionDomain" xlink:to="loc_cldx_PriorToAcquisitionMember" xlink:title="Definition : loc_cldx_StatusOfMergerAndAcquisitionDomain to loc_cldx_PriorToAcquisitionMember" xlink:type="arc" use="optional" order="8001" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : loc_us-gaap_AwardTypeAxis to loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="loc_us-gaap_PlanNameDomain" xlink:title="Definition : loc_us-gaap_PlanNameAxis to loc_us-gaap_PlanNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MaximumMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:label="loc_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:title="CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="loc_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:title="Definition : loc_us-gaap_PlanNameDomain to loc_cldx_CelldexResearchEquityIncentivePlan2005AndCuraGenStockPlan2007Member" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Definition : loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaap_PlanNameAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to loc_us-gaap_PlanNameAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : loc_us-gaap_AwardTypeAxis to loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="Definition : loc_us-gaap_PlanNameAxis to loc_us-gaap_PlanNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to loc_us-gaap_RestrictedStockMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:title="EmployeeStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:title="Definition : loc_us-gaap_PlanNameDomain to loc_us-gaap_EmployeeStockMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Definition : loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to loc_us-gaap_AwardTypeAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockOptionAndIncentivePlan2008Member" xlink:label="loc_cldx_StockOptionAndIncentivePlan2008Member" xlink:title="StockOptionAndIncentivePlan2008Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="loc_cldx_StockOptionAndIncentivePlan2008Member" xlink:title="Definition : loc_us-gaap_PlanNameDomain to loc_cldx_StockOptionAndIncentivePlan2008Member" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Definition : loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract to loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:label="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm" xlink:type="arc" use="optional" order="8" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:label="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock" xlink:type="arc" use="optional" order="9" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:label="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:label="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock" xlink:type="arc" use="optional" order="11" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" use="optional" order="12" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" use="optional" order="13" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" use="optional" order="14" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:type="arc" use="optional" order="15" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" use="optional" order="16" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" use="optional" order="17" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="Definition : loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" use="optional" order="8000" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Definition : loc_us-gaap_TypeOfArrangementAxis to loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:label="loc_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="ProductDevelopmentAndLicensingAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="Definition : loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember to loc_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_TypeOfArrangementAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_TypeOfArrangementAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:label="loc_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:title="CollaborativeArrangementEstimatedCostForDevelopmentServices" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="loc_cldx_CollaborativeArrangementAgreementTerm" xlink:title="CollaborativeArrangementAgreementTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementAgreementTerm" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementAgreementTerm" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:label="loc_cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:title="CollaborativeArrangementUpfrontPaymentAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementUpfrontPaymentAmount" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="loc_cldx_RevenueFromContractsAndGrants" xlink:title="RevenueFromContractsAndGrants" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_RevenueFromContractsAndGrants" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_RevenueFromContractsAndGrants" xlink:type="arc" order="5" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureTermLoanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_DebtInstrumentTable" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_DebtInstrumentTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="loc_us-gaap_LongtermDebtTypeDomain" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeAxis to loc_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderAxis" xlink:label="loc_cldx_DebtInstrumentLenderAxis" xlink:title="DebtInstrumentLenderAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderDomain" xlink:label="loc_cldx_DebtInstrumentLenderDomain" xlink:title="DebtInstrumentLenderDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cldx_DebtInstrumentLenderAxis" xlink:to="loc_cldx_DebtInstrumentLenderDomain" xlink:title="Definition : loc_cldx_DebtInstrumentLenderAxis to loc_cldx_DebtInstrumentLenderDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:title="SecuredDebtMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="loc_us-gaap_SecuredDebtMember" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeDomain to loc_us-gaap_SecuredDebtMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_MidCapFinancialLLCMember" xlink:label="loc_cldx_MidCapFinancialLLCMember" xlink:title="MidCapFinancialLLCMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_DebtInstrumentLenderDomain" xlink:to="loc_cldx_MidCapFinancialLLCMember" xlink:title="Definition : loc_cldx_DebtInstrumentLenderDomain to loc_cldx_MidCapFinancialLLCMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="loc_cldx_DebtInstrumentLenderAxis" xlink:title="Definition : loc_us-gaap_DebtInstrumentTable to loc_cldx_DebtInstrumentLenderAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_1" xlink:title="LongtermDebtTypeDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_1" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeAxis to loc_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentLenderDomain" xlink:label="DebtInstrumentLenderDomain_2" xlink:title="DebtInstrumentLenderDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cldx_DebtInstrumentLenderAxis" xlink:to="DebtInstrumentLenderDomain_2" xlink:title="Definition : loc_cldx_DebtInstrumentLenderAxis to loc_cldx_DebtInstrumentLenderDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GeneralElectricCapitalCorporationMember" xlink:label="loc_cldx_GeneralElectricCapitalCorporationMember" xlink:title="GeneralElectricCapitalCorporationMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_DebtInstrumentLenderDomain" xlink:to="loc_cldx_GeneralElectricCapitalCorporationMember" xlink:title="Definition : loc_cldx_DebtInstrumentLenderDomain to loc_cldx_GeneralElectricCapitalCorporationMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="loc_us-gaap_LongtermDebtTypeAxis" xlink:title="Definition : loc_us-gaap_DebtInstrumentTable to loc_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaap_SecuredDebt" xlink:title="SecuredDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_SecuredDebt" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_SecuredDebt" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_us-gaap_DebtInstrumentTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:label="loc_cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:title="RepaymentOfLongTermDebtPrincipalAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_RepaymentOfLongTermDebtPrincipalAmount" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:label="loc_cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:title="DebtInstrumentInterestAndPrepaymentFees" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentInterestAndPrepaymentFees" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="loc_us-gaap_InterestExpenseLongTermDebt" xlink:title="InterestExpenseLongTermDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_InterestExpenseLongTermDebt" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_InterestExpenseLongTermDebt" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MinimumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MinimumMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:label="loc_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentUpFrontFeeDueUponRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:type="arc" use="optional" order="8001" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:label="loc_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentAdditionalFeeDueOnRepaymentForExtensionOfMaturityPeriodOfDebt" xlink:type="arc" use="optional" order="8002" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:label="loc_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:title="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearThree" xlink:type="arc" use="optional" order="8003" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:label="loc_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:title="DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentCovenantRateOfPrepaymentPremiumInYearFour" xlink:type="arc" use="optional" order="8004" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:label="loc_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:title="DebtInstrumentPaymentFeePayableOnRepayment" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentPaymentFeePayableOnRepayment" xlink:type="arc" use="optional" order="8005" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:label="loc_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:title="DebtInstrumentInterestOnlyPeriodOfExtension" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentInterestOnlyPeriodOfExtension" xlink:type="arc" use="optional" order="8006" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:label="loc_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:title="DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentNumberOfEqualConsecutiveMonthlyInstallments" xlink:type="arc" use="optional" order="8007" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" use="optional" order="8008" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:title="DebtInstrumentDescriptionOfVariableRateBasis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" use="optional" order="8009" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Definition : loc_us-gaap_TypeOfArrangementAxis to loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CounterpartyNameAxis" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="Definition : loc_us-gaap_CounterpartyNameAxis to loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis" xlink:to="loc_us-gaap_ProductsAndServicesDomain" xlink:title="Definition : loc_us-gaap_ProductOrServiceAxis to loc_us-gaap_ProductsAndServicesDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:label="loc_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:title="CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:title="Definition : loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember to loc_cldx_CollaborativeArrangementForDevelopmentAndCommercializationOfProductMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GlaxoSmithKlinePlcMember" xlink:label="loc_cldx_GlaxoSmithKlinePlcMember" xlink:title="GlaxoSmithKlinePlcMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_GlaxoSmithKlinePlcMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_GlaxoSmithKlinePlcMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RotarixRotavirusVaccineMember" xlink:label="loc_cldx_RotarixRotavirusVaccineMember" xlink:title="RotarixRotavirusVaccineMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain" xlink:to="loc_cldx_RotarixRotavirusVaccineMember" xlink:title="Definition : loc_us-gaap_ProductsAndServicesDomain to loc_cldx_RotarixRotavirusVaccineMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_TypeOfArrangementAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_TypeOfArrangementAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_1" xlink:title="ArrangementsAndNonarrangementTransactionsMember_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_1" xlink:title="Definition : loc_us-gaap_TypeOfArrangementAxis to loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain_2" xlink:title="RepurchaseAgreementCounterpartyNameDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain_2" xlink:title="Definition : loc_us-gaap_CounterpartyNameAxis to loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_3" xlink:title="ProductsAndServicesDomain_3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_3" xlink:title="Definition : loc_us-gaap_ProductOrServiceAxis to loc_us-gaap_ProductsAndServicesDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LicenseAgreementsMember" xlink:label="loc_cldx_LicenseAgreementsMember" xlink:title="LicenseAgreementsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cldx_LicenseAgreementsMember" xlink:title="Definition : loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember to loc_cldx_LicenseAgreementsMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:label="loc_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:title="CincinnatiChildrensHospitalMedicalCenterMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_CincinnatiChildrensHospitalMedicalCenterMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:label="loc_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:title="PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_CounterpartyNameAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_CounterpartyNameAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RoyaltyAgreementMember" xlink:label="loc_cldx_RoyaltyAgreementMember" xlink:title="RoyaltyAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cldx_RoyaltyAgreementMember" xlink:title="Definition : loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember to loc_cldx_RoyaltyAgreementMember" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PRFAgreementMember" xlink:label="loc_cldx_PRFAgreementMember" xlink:title="PRFAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_PRFAgreementMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_PRFAgreementMember" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:label="loc_cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:title="PercentageOfInterestInNetRoyaltiesSold" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_PercentageOfInterestInNetRoyaltiesSold" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_ProductOrServiceAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_ProductOrServiceAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:title="RoyaltyExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_RoyaltyExpense" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_RoyaltyExpense" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeAxis to loc_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PfizerIncMember" xlink:label="loc_cldx_PfizerIncMember" xlink:title="PfizerIncMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_PfizerIncMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_PfizerIncMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RindopepimutMember" xlink:label="loc_cldx_RindopepimutMember" xlink:title="RindopepimutMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain" xlink:to="loc_cldx_RindopepimutMember" xlink:title="Definition : loc_us-gaap_ProductsAndServicesDomain to loc_cldx_RindopepimutMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeDomain to loc_us-gaap_SubsequentEventMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:label="loc_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:title="PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_PeriodForRightToNegotiateForExtensionOfAgreementTermUnderCertainCircumstances" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:label="loc_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:title="DukeUniversityAndThomasJeffersonUniversityMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_DukeUniversityAndThomasJeffersonUniversityMember" xlink:type="arc" use="optional" order="8001" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:label="loc_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:title="AmountReceivedForRightToParticipateInCollaborativeArrangement" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_AmountReceivedForRightToParticipateInCollaborativeArrangement" xlink:type="arc" use="optional" order="8001" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:label="loc_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:title="StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_StockIssuedDuringPeriodValueIssuedForCollaborativeArrangement" xlink:type="arc" use="optional" order="8002" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:label="loc_us-gaap_CostOfReimbursableExpense" xlink:title="CostOfReimbursableExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_CostOfReimbursableExpense" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_CostOfReimbursableExpense" xlink:type="arc" use="optional" order="8003" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseCosts" xlink:label="loc_us-gaap_LicenseCosts" xlink:title="LicenseCosts" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_LicenseCosts" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_LicenseCosts" xlink:type="arc" use="optional" order="8004" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAxis to loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Definition : loc_us-gaap_TypeOfArrangementAxis to loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CounterpartyNameAxis" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:title="Definition : loc_us-gaap_CounterpartyNameAxis to loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeAxis to loc_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MaximumMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="loc_cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="loc_cldx_CuraGenCorporationMember" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAcquireeDomain to loc_cldx_CuraGenCorporationMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LicenseAgreementsMember" xlink:label="loc_cldx_LicenseAgreementsMember" xlink:title="LicenseAgreementsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cldx_LicenseAgreementsMember" xlink:title="Definition : loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember to loc_cldx_LicenseAgreementsMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_MedarexIncMember" xlink:label="loc_cldx_MedarexIncMember" xlink:title="MedarexIncMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_MedarexIncMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_MedarexIncMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeDomain to loc_us-gaap_SubsequentEventMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_TypeOfArrangementAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_TypeOfArrangementAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NonRefundableLicenseFee" xlink:label="loc_cldx_NonRefundableLicenseFee" xlink:title="NonRefundableLicenseFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_NonRefundableLicenseFee" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_NonRefundableLicenseFee" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_RockefellerUniversityMember" xlink:label="loc_cldx_RockefellerUniversityMember" xlink:title="RockefellerUniversityMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_RockefellerUniversityMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_RockefellerUniversityMember" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_CounterpartyNameAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_CounterpartyNameAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:label="loc_cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:title="DukeUniversityBrainTumorCancerCenterMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_DukeUniversityBrainTumorCancerCenterMember" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:label="loc_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:title="CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_BusinessAcquisitionAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LudwigInstituteForCancerResearchMember" xlink:label="loc_cldx_LudwigInstituteForCancerResearchMember" xlink:title="LudwigInstituteForCancerResearchMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_LudwigInstituteForCancerResearchMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_LudwigInstituteForCancerResearchMember" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:label="loc_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:title="CollaborativeArrangementTotalPotentialMilestonePayments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementTotalPotentialMilestonePayments" xlink:type="arc" use="optional" order="4" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AlterisTherapeuticsIncMember" xlink:label="loc_cldx_AlterisTherapeuticsIncMember" xlink:title="AlterisTherapeuticsIncMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_AlterisTherapeuticsIncMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_AlterisTherapeuticsIncMember" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:label="loc_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:title="CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric" xlink:type="arc" use="optional" order="5" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="loc_cldx_CollaborativeArrangementAgreementTerm" xlink:title="CollaborativeArrangementAgreementTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementAgreementTerm" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementAgreementTerm" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_UniversityOfSouthamptonUKMember" xlink:label="loc_cldx_UniversityOfSouthamptonUKMember" xlink:title="UniversityOfSouthamptonUKMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_UniversityOfSouthamptonUKMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_UniversityOfSouthamptonUKMember" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmgenIncMember" xlink:label="loc_cldx_AmgenIncMember" xlink:title="AmgenIncMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_AmgenIncMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_AmgenIncMember" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_SeattleGeneticIncMember" xlink:label="loc_cldx_SeattleGeneticIncMember" xlink:title="SeattleGeneticIncMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_SeattleGeneticIncMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_SeattleGeneticIncMember" xlink:type="arc" use="optional" order="8" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementNumberOfAgreements" xlink:label="loc_cldx_CollaborativeArrangementNumberOfAgreements" xlink:title="CollaborativeArrangementNumberOfAgreements" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementNumberOfAgreements" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementNumberOfAgreements" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ThomasJeffersonUniversityMember" xlink:label="loc_cldx_ThomasJeffersonUniversityMember" xlink:title="ThomasJeffersonUniversityMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cldx_ThomasJeffersonUniversityMember" xlink:title="Definition : loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain to loc_cldx_ThomasJeffersonUniversityMember" xlink:type="arc" use="optional" order="8000" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverviewDetails">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NatureOfBusinessAndOverviewLineItems" xlink:label="loc_cldx_NatureOfBusinessAndOverviewLineItems" xlink:title="NatureOfBusinessAndOverviewLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:label="loc_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:title="ScheduleOfNatureOfBusinessAndOverviewTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="loc_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:title="Definition : loc_cldx_NatureOfBusinessAndOverviewLineItems to loc_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_ScheduleOfNatureOfBusinessAndOverviewTable" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : loc_cldx_ScheduleOfNatureOfBusinessAndOverviewTable to loc_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="loc_us-gaap_InvestmentsAndCash" xlink:title="InvestmentsAndCash" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="loc_us-gaap_InvestmentsAndCash" xlink:title="Definition : loc_cldx_NatureOfBusinessAndOverviewLineItems to loc_us-gaap_InvestmentsAndCash" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Definition : loc_cldx_NatureOfBusinessAndOverviewLineItems to loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="Definition : loc_cldx_NatureOfBusinessAndOverviewLineItems to loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeAxis to loc_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_WorkingCapital" xlink:label="loc_cldx_WorkingCapital" xlink:title="WorkingCapital" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_NatureOfBusinessAndOverviewLineItems" xlink:to="loc_cldx_WorkingCapital" xlink:title="Definition : loc_cldx_NatureOfBusinessAndOverviewLineItems to loc_cldx_WorkingCapital" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeDomain to loc_us-gaap_SubsequentEventMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_1" xlink:title="SubsequentEventTypeDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_1" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeAxis to loc_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="8001" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockholdersEquityLineItems" xlink:label="loc_cldx_StockholdersEquityLineItems" xlink:title="StockholdersEquityLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockholdersEquityTable" xlink:label="loc_cldx_StockholdersEquityTable" xlink:title="StockholdersEquityTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_StockholdersEquityTable" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_StockholdersEquityTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramAxis" xlink:label="loc_cldx_StockIssuedByTypeOfProgramAxis" xlink:title="StockIssuedByTypeOfProgramAxis" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramDomain" xlink:label="loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:title="StockIssuedByTypeOfProgramDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cldx_StockIssuedByTypeOfProgramAxis" xlink:to="loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:title="Definition : loc_cldx_StockIssuedByTypeOfProgramAxis to loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="loc_us-gaap_ClassOfStockDomain" xlink:title="Definition : loc_us-gaap_StatementClassOfStockAxis to loc_us-gaap_ClassOfStockDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MinimumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MinimumMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ControlledEquityOfferingProgramMember" xlink:label="loc_cldx_ControlledEquityOfferingProgramMember" xlink:title="ControlledEquityOfferingProgramMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:to="loc_cldx_ControlledEquityOfferingProgramMember" xlink:title="Definition : loc_cldx_StockIssuedByTypeOfProgramDomain to loc_cldx_ControlledEquityOfferingProgramMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:title="SeriesCPreferredStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_SeriesCPreferredStockMember" xlink:title="Definition : loc_us-gaap_ClassOfStockDomain to loc_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CumulativePreferredStockMember" xlink:label="loc_us-gaap_CumulativePreferredStockMember" xlink:title="CumulativePreferredStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="loc_us-gaap_CumulativePreferredStockMember" xlink:title="Definition : loc_us-gaap_SeriesCPreferredStockMember to loc_us-gaap_CumulativePreferredStockMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:label="loc_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:title="ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_StockholdersEquityTable" xlink:to="loc_cldx_StockIssuedByTypeOfProgramAxis" xlink:title="Definition : loc_cldx_StockholdersEquityTable to loc_cldx_StockIssuedByTypeOfProgramAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_1" xlink:title="RangeMember_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis" xlink:to="RangeMember_1" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_StockIssuedByTypeOfProgramDomain" xlink:label="StockIssuedByTypeOfProgramDomain_2" xlink:title="StockIssuedByTypeOfProgramDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cldx_StockIssuedByTypeOfProgramAxis" xlink:to="StockIssuedByTypeOfProgramDomain_2" xlink:title="Definition : loc_cldx_StockIssuedByTypeOfProgramAxis to loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_3" xlink:title="ClassOfStockDomain_3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_3" xlink:title="Definition : loc_us-gaap_StatementClassOfStockAxis to loc_us-gaap_ClassOfStockDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ControlledEquityOfferingProgramAmendedMember" xlink:label="loc_cldx_ControlledEquityOfferingProgramAmendedMember" xlink:title="ControlledEquityOfferingProgramAmendedMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:to="loc_cldx_ControlledEquityOfferingProgramAmendedMember" xlink:title="Definition : loc_cldx_StockIssuedByTypeOfProgramDomain to loc_cldx_ControlledEquityOfferingProgramAmendedMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShelfRegistrationStatementAmount" xlink:label="loc_cldx_ShelfRegistrationStatementAmount" xlink:title="ShelfRegistrationStatementAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_ShelfRegistrationStatementAmount" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_ShelfRegistrationStatementAmount" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_StockholdersEquityTable" xlink:to="loc_us-gaap_StatementClassOfStockAxis" xlink:title="Definition : loc_cldx_StockholdersEquityTable to loc_us-gaap_StatementClassOfStockAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ShareholderRightsPlanMember" xlink:label="loc_cldx_ShareholderRightsPlanMember" xlink:title="ShareholderRightsPlanMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockIssuedByTypeOfProgramDomain" xlink:to="loc_cldx_ShareholderRightsPlanMember" xlink:title="Definition : loc_cldx_StockIssuedByTypeOfProgramDomain to loc_cldx_ShareholderRightsPlanMember" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_StockholdersEquityTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_cldx_StockholdersEquityTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:label="loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_StockholdersEquityTable" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : loc_cldx_StockholdersEquityTable to loc_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:label="loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:label="loc_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:title="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" use="optional" order="6" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:label="loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:title="ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany" xlink:type="arc" use="optional" order="7" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:label="loc_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:title="NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:title="Definition : loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract to loc_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany" xlink:type="arc" use="optional" order="8" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeAxis to loc_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:label="loc_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:title="CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_CommonStockExerciseOfFullOverAllotmentOptionToPurchaseAdditionalSharesByUnderwriter" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MaximumMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeDomain to loc_us-gaap_SubsequentEventMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockSharesAvailableForSale" xlink:label="loc_cldx_CommonStockSharesAvailableForSale" xlink:title="CommonStockSharesAvailableForSale" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_CommonStockSharesAvailableForSale" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_CommonStockSharesAvailableForSale" xlink:type="arc" use="optional" order="8001" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:label="loc_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:title="CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_CommonStockIssuanceOfAdditionalSharesAggregateOfferingPrice" xlink:type="arc" use="optional" order="8002" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FixedRateOfCommissionOnSaleOfStock" xlink:label="loc_cldx_FixedRateOfCommissionOnSaleOfStock" xlink:title="FixedRateOfCommissionOnSaleOfStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_FixedRateOfCommissionOnSaleOfStock" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_FixedRateOfCommissionOnSaleOfStock" xlink:type="arc" use="optional" order="8003" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_NoticePeriodForTerminationOfAgreement" xlink:label="loc_cldx_NoticePeriodForTerminationOfAgreement" xlink:title="NoticePeriodForTerminationOfAgreement" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_NoticePeriodForTerminationOfAgreement" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_NoticePeriodForTerminationOfAgreement" xlink:type="arc" use="optional" order="8004" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:label="loc_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:title="CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_StockholdersEquityLineItems" xlink:to="loc_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:title="Definition : loc_cldx_StockholdersEquityLineItems to loc_cldx_CommonStockAvailableForSaleLockUpPeriodToBeWaivedByUnderwriters" xlink:type="arc" use="optional" order="8005" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAxis to loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="loc_us-gaap_DebtInstrumentNameDomain" xlink:title="Definition : loc_us-gaap_DebtInstrumentAxis to loc_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CuraGenCorporationMember" xlink:label="loc_cldx_CuraGenCorporationMember" xlink:title="CuraGenCorporationMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="loc_cldx_CuraGenCorporationMember" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionAcquireeDomain to loc_cldx_CuraGenCorporationMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="loc_us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="ConvertibleSubordinatedDebtMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="Definition : loc_us-gaap_DebtInstrumentNameDomain to loc_us-gaap_ConvertibleSubordinatedDebtMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaap_BusinessAcquisitionAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable to loc_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_1" xlink:title="DebtInstrumentNameDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_1" xlink:title="Definition : loc_us-gaap_DebtInstrumentAxis to loc_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebt" xlink:label="loc_us-gaap_ConvertibleSubordinatedDebt" xlink:title="ConvertibleSubordinatedDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_ConvertibleSubordinatedDebt" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_ConvertibleSubordinatedDebt" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaap_DebtInstrumentAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable to loc_us-gaap_DebtInstrumentAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_RepaymentsOfDebt" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_RepaymentsOfDebt" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:title="DebtInstrumentConvertibleNumberOfEquityInstruments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:title="DebtInstrumentConvertibleConversionRatio1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" use="optional" order="8001" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:label="loc_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:title="DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_cldx_DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock" xlink:type="arc" use="optional" order="8002" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="DebtInstrumentConvertibleConversionPrice1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" use="optional" order="8003" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="loc_us-gaap_InterestExpenseDebt" xlink:title="Definition : loc_us-gaap_BusinessAcquisitionLineItems to loc_us-gaap_InterestExpenseDebt" xlink:type="arc" use="optional" order="8004" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis to loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MinimumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MinimumMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LaboratoryEquipmentMember" xlink:label="loc_cldx_LaboratoryEquipmentMember" xlink:title="LaboratoryEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_cldx_LaboratoryEquipmentMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_cldx_LaboratoryEquipmentMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_1" xlink:title="PropertyPlantAndEquipmentTypeDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_1" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis to loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MaximumMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaap_FurnitureAndFixturesMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaap_ComputerEquipmentMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_us-gaap_ComputerEquipmentMember" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ManufacturingEquipmentMember" xlink:label="loc_cldx_ManufacturingEquipmentMember" xlink:title="ManufacturingEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_cldx_ManufacturingEquipmentMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_cldx_ManufacturingEquipmentMember" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:title="RevenueRecognitionAbstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_RevenueRecognitionAbstract" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:label="loc_cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:title="CollaborativeArrangementMilestonePaymentsReceived" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="loc_cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:title="Definition : loc_us-gaap_RevenueRecognitionAbstract to loc_cldx_CollaborativeArrangementMilestonePaymentsReceived" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaap_OtherNonoperatingIncome" xlink:title="OtherNonoperatingIncome" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="loc_us-gaap_OtherNonoperatingIncome" xlink:title="Definition : loc_us-gaap_RevenueRecognitionAbstract to loc_us-gaap_OtherNonoperatingIncome" xlink:type="arc" use="optional" order="8001" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:label="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="IndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="Definition : loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis to loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis to loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:title="InProcessResearchAndDevelopmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:title="Definition : loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain to loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AmgenAmendmentMember" xlink:label="loc_cldx_AmgenAmendmentMember" xlink:title="AmgenAmendmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_cldx_AmgenAmendmentMember" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain to loc_cldx_AmgenAmendmentMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="Definition : loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract to loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract to loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="IntangibleAssetsGrossExcludingGoodwill" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:title="Definition : loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract to loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:title="IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:title="Definition : loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis to loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis to loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CoreTechnologyMember" xlink:label="loc_cldx_CoreTechnologyMember" xlink:title="CoreTechnologyMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_cldx_CoreTechnologyMember" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain to loc_cldx_CoreTechnologyMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaap_Goodwill" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_us-gaap_Goodwill" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="FiniteLivedIntangibleAssetsGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:title="Definition : loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract to loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="loc_us-gaap_RangeAxis" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable to loc_us-gaap_RangeAxis" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="FiniteLivedIntangibleAssetsNet" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" use="optional" order="4" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="Definition : loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract to loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" use="optional" order="6" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:title="Definition : loc_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems to loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" xlink:title="Definition : loc_us-gaap_RangeAxis to loc_us-gaap_RangeMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MinimumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MinimumMember" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" xlink:title="Definition : loc_us-gaap_RangeMember to loc_us-gaap_MaximumMember" xlink:type="arc" use="optional" order="8001" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesNameDomain to loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_1" xlink:title="AntidilutiveSecuritiesNameDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_1" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesNameDomain to loc_us-gaap_RestrictedStockMember" xlink:type="arc" use="optional" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesNameDomain to loc_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesNameDomain to loc_us-gaap_RestrictedStockMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleSubordinatedDebtMember" xlink:label="loc_us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="ConvertibleSubordinatedDebtMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaap_ConvertibleSubordinatedDebtMember" xlink:title="Definition : loc_us-gaap_AntidilutiveSecuritiesNameDomain to loc_us-gaap_ConvertibleSubordinatedDebtMember" xlink:type="arc" use="optional" order="8000" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:title="ConcentrationRiskLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:title="ConcentrationRiskTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="loc_us-gaap_ConcentrationRiskTable" xlink:title="Definition : loc_us-gaap_ConcentrationRiskLineItems to loc_us-gaap_ConcentrationRiskTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:title="Definition : loc_us-gaap_ConcentrationRiskByBenchmarkAxis to loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:title="ConcentrationRiskByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:title="ConcentrationRiskTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:title="Definition : loc_us-gaap_ConcentrationRiskByTypeAxis to loc_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorCustomersAxis" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain" xlink:title="Definition : loc_us-gaap_MajorCustomersAxis to loc_us-gaap_NameOfMajorCustomerDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember" xlink:title="SalesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaap_SalesMember" xlink:title="Definition : loc_us-gaap_ConcentrationRiskBenchmarkDomain to loc_us-gaap_SalesMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:title="CustomerConcentrationRiskMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember" xlink:title="Definition : loc_us-gaap_ConcentrationRiskTypeDomain to loc_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_GlaxoSmithKlinePlcMember" xlink:label="loc_cldx_GlaxoSmithKlinePlcMember" xlink:title="GlaxoSmithKlinePlcMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain" xlink:to="loc_cldx_GlaxoSmithKlinePlcMember" xlink:title="Definition : loc_us-gaap_NameOfMajorCustomerDomain to loc_cldx_GlaxoSmithKlinePlcMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:title="Definition : loc_us-gaap_ConcentrationRiskTable to loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="ConcentrationRiskBenchmarkDomain_1" xlink:title="ConcentrationRiskBenchmarkDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="ConcentrationRiskBenchmarkDomain_1" xlink:title="Definition : loc_us-gaap_ConcentrationRiskByBenchmarkAxis to loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="ConcentrationRiskTypeDomain_2" xlink:title="ConcentrationRiskTypeDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="ConcentrationRiskTypeDomain_2" xlink:title="Definition : loc_us-gaap_ConcentrationRiskByTypeAxis to loc_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="NameOfMajorCustomerDomain_3" xlink:title="NameOfMajorCustomerDomain_3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorCustomersAxis" xlink:to="NameOfMajorCustomerDomain_3" xlink:title="Definition : loc_us-gaap_MajorCustomersAxis to loc_us-gaap_NameOfMajorCustomerDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:title="ConcentrationRiskPercentage1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1" xlink:title="Definition : loc_us-gaap_ConcentrationRiskLineItems to loc_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:title="Definition : loc_us-gaap_ConcentrationRiskTable to loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="loc_us-gaap_MajorCustomersAxis" xlink:title="Definition : loc_us-gaap_ConcentrationRiskTable to loc_us-gaap_MajorCustomersAxis" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_PfizerIncMember" xlink:label="loc_cldx_PfizerIncMember" xlink:title="PfizerIncMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain" xlink:to="loc_cldx_PfizerIncMember" xlink:title="Definition : loc_us-gaap_NameOfMajorCustomerDomain to loc_cldx_PfizerIncMember" xlink:type="arc" use="optional" order="8000" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis to loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_LaboratoryEquipmentMember" xlink:label="loc_cldx_LaboratoryEquipmentMember" xlink:title="LaboratoryEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_cldx_LaboratoryEquipmentMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_cldx_LaboratoryEquipmentMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ManufacturingEquipmentMember" xlink:label="loc_cldx_ManufacturingEquipmentMember" xlink:title="ManufacturingEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_cldx_ManufacturingEquipmentMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_cldx_ManufacturingEquipmentMember" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaap_FurnitureAndFixturesMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaap_LeaseholdImprovementsMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaap_ConstructionInProgressMember" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentTypeDomain to loc_us-gaap_ConstructionInProgressMember" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:title="Definition : loc_us-gaap_PropertyPlantAndEquipmentLineItems to loc_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" use="optional" order="5" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:title="MajorTypesOfDebtAndEquitySecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:title="MajorTypesOfDebtAndEquitySecuritiesDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:title="Definition : loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis to loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_USGovernmentAndMunicipalObligationsMember" xlink:label="loc_cldx_USGovernmentAndMunicipalObligationsMember" xlink:title="USGovernmentAndMunicipalObligationsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_cldx_USGovernmentAndMunicipalObligationsMember" xlink:title="Definition : loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain to loc_cldx_USGovernmentAndMunicipalObligationsMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:label="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:title="Definition : loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable to loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="MajorTypesOfDebtAndEquitySecuritiesDomain_1" xlink:title="MajorTypesOfDebtAndEquitySecuritiesDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="MajorTypesOfDebtAndEquitySecuritiesDomain_1" xlink:title="Definition : loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis to loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:title="Definition : loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain to loc_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:label="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:title="Definition : loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to loc_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:label="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract to loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:label="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:title="Definition : loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract to loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="Definition : loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to loc_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:type="arc" use="optional" order="4" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:label="loc_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:title="AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:title="Definition : loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems to loc_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:type="arc" use="optional" order="6" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails3">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_DebtInstrumentTable" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_DebtInstrumentTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="loc_us-gaap_LongtermDebtTypeDomain" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeAxis to loc_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaap_LoansPayableMember" xlink:title="LoansPayableMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="loc_us-gaap_LoansPayableMember" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeDomain to loc_us-gaap_LoansPayableMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="Definition : loc_us-gaap_LongTermDebtByMaturityAbstract to loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="loc_us-gaap_LongtermDebtTypeAxis" xlink:title="Definition : loc_us-gaap_DebtInstrumentTable to loc_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="Definition : loc_us-gaap_LongTermDebtByMaturityAbstract to loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_DebtInstrumentAmortizationPeriod" xlink:label="loc_cldx_DebtInstrumentAmortizationPeriod" xlink:title="DebtInstrumentAmortizationPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_cldx_DebtInstrumentAmortizationPeriod" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_cldx_DebtInstrumentAmortizationPeriod" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="Definition : loc_us-gaap_LongTermDebtByMaturityAbstract to loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:label="loc_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:title="DebtInstrumentInterestRateAtPeriodEnd" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_DebtInstrumentInterestRateAtPeriodEnd" xlink:type="arc" use="optional" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="Definition : loc_us-gaap_LongTermDebtByMaturityAbstract to loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="Definition : loc_us-gaap_LongTermDebtByMaturityAbstract to loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:title="Definition : loc_us-gaap_LongTermDebtByMaturityAbstract to loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" use="optional" order="6" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:title="Definition : loc_us-gaap_FairValueByMeasurementFrequencyAxis to loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="Definition : loc_us-gaap_FairValueByFairValueHierarchyLevelAxis to loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:title="Definition : loc_us-gaap_FairValueMeasurementFrequencyDomain to loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="Definition : loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain to loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain_1" xlink:title="FairValueMeasurementFrequencyDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain_1" xlink:title="Definition : loc_us-gaap_FairValueByMeasurementFrequencyAxis to loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="Definition : loc_us-gaap_FairValueByFairValueHierarchyLevelAxis to loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaap_FairValueInputsLevel1Member" xlink:title="Definition : loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain to loc_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="CashAndCashEquivalentsFairValueDisclosure" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaap_FairValueInputsLevel2Member" xlink:title="Definition : loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain to loc_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities" xlink:title="AvailableForSaleSecurities" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaap_AvailableForSaleSecurities" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to loc_us-gaap_AvailableForSaleSecurities" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaap_AssetsFairValueDisclosure" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to loc_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:label="loc_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:title="FairValueAssetsAmountTransfersBetweenMeasurementLevels" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to loc_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:type="arc" use="optional" order="5" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:label="loc_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:title="FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:title="Definition : loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to loc_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:type="arc" use="optional" order="6" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:title="AccumulatedOtherComprehensiveIncomeLossLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:title="AccumulatedOtherComprehensiveIncomeLossTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:title="Definition : loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems to loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="loc_us-gaap_EquityComponentDomain" xlink:title="Definition : loc_us-gaap_StatementEquityComponentsAxis to loc_us-gaap_EquityComponentDomain" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:title="AccumulatedNetUnrealizedInvestmentGainLossMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:title="Definition : loc_us-gaap_EquityComponentDomain to loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:label="loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:title="AccumulatedOtherComprehensiveIncomeLossRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="Definition : loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaap_StatementEquityComponentsAxis" xlink:title="Definition : loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable to loc_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_1" xlink:title="EquityComponentDomain_1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_1" xlink:title="Definition : loc_us-gaap_StatementEquityComponentsAxis to loc_us-gaap_EquityComponentDomain" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:title="AccumulatedTranslationAdjustmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:title="Definition : loc_us-gaap_EquityComponentDomain to loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" use="optional" order="2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:title="Definition : loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems to loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:title="Definition : loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Definition : loc_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward to loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" use="optional" order="3" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails2">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:title="OperatingLeasedAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="ScheduleOfOperatingLeasedAssetsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="Definition : loc_us-gaap_OperatingLeasedAssetsLineItems to loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable to loc_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="loc_us-gaap_AreaOfRealEstateProperty" xlink:title="Definition : loc_us-gaap_OperatingLeasedAssetsLineItems to loc_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" use="optional" order="2" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesTermOfLease" xlink:label="loc_cldx_OperatingLeasesTermOfLease" xlink:title="OperatingLeasesTermOfLease" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="loc_cldx_OperatingLeasesTermOfLease" xlink:title="Definition : loc_us-gaap_OperatingLeasedAssetsLineItems to loc_cldx_OperatingLeasesTermOfLease" xlink:type="arc" use="optional" order="3" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:label="loc_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:title="OperatingLeasesCommencementPeriodOfRentalObligations" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="loc_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:title="Definition : loc_us-gaap_OperatingLeasedAssetsLineItems to loc_cldx_OperatingLeasesCommencementPeriodOfRentalObligations" xlink:type="arc" use="optional" order="4" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesNumberOfRenewalOptions" xlink:label="loc_cldx_OperatingLeasesNumberOfRenewalOptions" xlink:title="OperatingLeasesNumberOfRenewalOptions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="loc_cldx_OperatingLeasesNumberOfRenewalOptions" xlink:title="Definition : loc_us-gaap_OperatingLeasedAssetsLineItems to loc_cldx_OperatingLeasesNumberOfRenewalOptions" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:label="loc_cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:title="OperatingLeasesPeriodOfRenewalOptions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="loc_cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:title="Definition : loc_us-gaap_OperatingLeasedAssetsLineItems to loc_cldx_OperatingLeasesPeriodOfRenewalOptions" xlink:type="arc" use="optional" order="8" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeAxis to loc_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" xlink:title="Definition : loc_us-gaap_SubsequentEventTypeDomain to loc_us-gaap_SubsequentEventMember" xlink:type="arc" use="optional" order="8000" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureRockefellerUniversityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" use="optional" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="Definition : loc_us-gaap_TypeOfArrangementAxis to loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:label="loc_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="ProductDevelopmentAndLicensingAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:title="Definition : loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember to loc_cldx_ProductDevelopmentAndLicensingAgreementMember" xlink:type="arc" use="optional" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaap_TypeOfArrangementAxis" xlink:title="Definition : loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to loc_us-gaap_TypeOfArrangementAxis" xlink:type="arc" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="cldx-20131231.xsd#cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:label="loc_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:title="CollaborativeArrangementNumberOfAntiHIVAntibodies" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:title="Definition : loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to loc_cldx_CollaborativeArrangementNumberOfAntiHIVAntibodies" xlink:type="arc" use="optional" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="loc_us-gaap_StatementTable" xlink:title="Definition : loc_us-gaap_StatementLineItems to loc_us-gaap_StatementTable" xlink:type="arc" use="optional" order="10" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="loc_us-gaap_EquityComponentDomain" xlink:title="Definition : loc_us-gaap_StatementEquityComponentsAxis to loc_us-gaap_EquityComponentDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Definition : loc_us-gaap_StockIssuedDuringPeriodValueNewIssues to loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="loc_us-gaap_CommonStockMember" xlink:title="Definition : loc_us-gaap_EquityComponentDomain to loc_us-gaap_CommonStockMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockholdersEquity" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_StockholdersEquity" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="Definition : loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan to loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="StockIssuedDuringPeriodValueOther" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Definition : loc_us-gaap_StockIssuedDuringPeriodValueOther to loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="StockholdersEquityPeriodIncreaseDecrease" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:title="Definition : loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease to loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" use="optional" order="10" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable" xlink:to="loc_us-gaap_StatementEquityComponentsAxis" xlink:title="Definition : loc_us-gaap_StatementTable to loc_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:title="Definition : loc_us-gaap_EquityComponentDomain to loc_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" use="optional" order="20" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="Definition : loc_us-gaap_StatementLineItems to loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_CommonStockSharesIssued" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_CommonStockSharesIssued" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:title="Definition : loc_us-gaap_EquityComponentDomain to loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" use="optional" order="30" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" use="optional" order="30" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="loc_us-gaap_RetainedEarningsMember" xlink:title="Definition : loc_us-gaap_EquityComponentDomain to loc_us-gaap_RetainedEarningsMember" xlink:type="arc" use="optional" order="40" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" use="optional" order="40" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" use="optional" order="50" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" use="optional" order="60" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" use="optional" order="70" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" use="optional" order="80" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" use="optional" order="90" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" use="optional" order="100" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="Definition : loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward to loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="Definition : loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions to loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" use="optional" order="8000" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_DebtInstrumentTable" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_DebtInstrumentTable" xlink:type="arc" use="optional" order="8000" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="loc_us-gaap_LongtermDebtTypeDomain" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeAxis to loc_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaap_LoansPayableMember" xlink:title="LoansPayableMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="loc_us-gaap_LoansPayableMember" xlink:title="Definition : loc_us-gaap_LongtermDebtTypeDomain to loc_us-gaap_LoansPayableMember" xlink:type="arc" use="optional" order="8000" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="loc_us-gaap_LongtermDebtTypeAxis" xlink:title="Definition : loc_us-gaap_DebtInstrumentTable to loc_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="Definition : loc_us-gaap_DebtInstrumentLineItems to loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" use="optional" order="8001" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g621270.jpg
<DESCRIPTION>G621270.JPG
<TEXT>
begin 644 g621270.jpg
M_]C_X``02D9)1@`!`0$!L`&P``#__@`^1$E32S$P-#I;,3-:1$8Q+C$S6D1&
M-#<W,#$N3U544%5473(V,#<W7S%?0T5,3$1%6%]+7TQ)3D4N15!3_]L`0P`!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!_\``"P@!4P'=`0$1`/_$`!X``0`!!`,!`0``
M```````````(!08'"0$"!`H#_\0`9A````8!`@(#"0H)"`8%!PP#`0(#!`4&
M!P`("1$2$R$4%QDQ45B2T=@5%A@B4UEAEIG205)7D9.7F-;7"B,X<7B!M]0D
M*3)IJ+%"5I2A\"4H,S8W8G(F)S0Y0T1'2$E5LL9HI,'_V@`(`0$``#\`W:YA
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MK&[>J=4\:LXW`F57%QA6V/V&0,;T:KU6R)VVI7HT(NVD)JO\C/R1S6_JQP5#
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MJ3BYW.0-+7"W+5J"80JMGM<J8`-)62?48FEIV0,`&>2CQVX$.:@ZO7333333
M33333333333333333333333333333333333333333333333333337111-$AU
M53E333*8ZBAS`4A"%`3&.<P\BE(0H"8YC"!2E`3&$"@(AJOQOQ@=I^0)S+A'
M[;+..\=8RQI+YF@<U9#QI.P6+\OXJKE#B,E3]TQC)MPD)QXU0I$_!VRNP]H@
M:Q9<AU.78VK'<-9X-19TWN9+BF8&3QQD.[3N-MS],M^-[/@NJR6!+SM]N%1W
M`S[W<Q:PI.!WE+QO-*-36N+R39F\Y"Q+R+FCFBY>I7.%LR$'.5:8C&]QS_$:
MQS4L?U"V6K!>[>#O.0K;<*MC_;RIM[LDMN-NK;'\-'V*ZW.OXKKDA-O5J!6H
M62:NI&VO)-BP%ZYC:^T*ZL\_6X69F3BC*=#S?C.AY@Q?86UKQYDRIP5WIEB:
M(NVJ<M7+''HR<6[.QD&[22C7)FRY2/8J49LI6+>IN(Z39M'S5PW3O\3D*/(Q
MB@/D$P`/YA'7'6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$
M](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)
M_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>
MG6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI
M%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y
M0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZ
MQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](O
MKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$](OKTZQ/Y0GI%]>G6)_*$
M](OKTZQ/Y0GI%]>G6)_*$](OKUW\?BTTTTTTUYW@.A:N.XNH[LZA7N070*"V
M!SU9NH%P"0E5%`%>@*Q4A!0R73`GQA#7RI[-\);T<4[F=RSO`&V/(V%HJLX\
M(?+^V++F7:S9=B]_R<CMFAU,>8^VR+S5PR1>:_7)?/*;F8I<_7U<?8ZQW@5<
M:?<J76+*O$T>MWO.[6,D92LFYS,EYV#[P\I8%R?DK9I?;%@#<)N<I['=8\O>
M&[MF>QW&U8'EZ9G2<:#AC$*%YH_O+VZ7+.M*I=FE$\GRN-(V`*[0;Y"NO;]@
M;=MM.NF+-T#/;#GC*.&JO>M\%'Q!M%')&.LC[IMMFW#<DQVKV'%44K8<GYB8
M4MPR:97VXW=W+T9CFFWN,5T?-58B6TJ_9U*SLH?;WPZ<&W_;ALIV]8>RJA#,
MLDU:CF=7J)KSA)Y"5ZUVVP3MWG*O%OFZSAI(,JJ_LRU<0D62ZK&0+%=V,5#L
MUT##CO?EA?)#W'.:,^4#>%NHPC*XXP/>[#`T+%$[AIKCAQ8:#3[;:8V:E8J\
M82O5B=/91\FS:SA$;4U9.H^/:(M&;%4'"[C$&WO:%E_*F!<)Y-LG$GX@R-BR
M)B+&=ZGDHFX;96<6G-6^CP-BEB1S1;:L[5:L"R$DY!FW4=.#H-P32,LH).F.
M8/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7
M(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<K
MXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O
M.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R
M=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"
MY%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE
M?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWU
MYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V
M3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`
M7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<
MKXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^
MO.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^
MR=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@
M"Y%^<KXBWUYVP^R=I\`7(OSE?$6^O.V'V3M/@"Y%^<KXBWUYVP^R=KJ?8'D4
MY#D#B6\1@@G(<@')>=KX'3$Y1*!R";::8H'((](@F*8H&`.D4P<P'85#1ZD3
M$1<6M)R4VM&QS%@K,3*C567E5&35%L>2E%6+2/9*2+\Z0NWRC1BR:G=++&;M
M&R(D13J6FFFFFFN`*`"(@``(^,?+_P"/^?;IT2\A#HAR'QAR#D//Q\P\0\].
MB7ERZ(<@\0<@Y!R\79XNS7.HT;S_`.B#NG_LX9U_PJMNFS#^B#M8_LX8*_PJ
MJ6I+Z:::::::::::::::::::::::::::::::::::::::::::::::::::::H,
M?::S+3%@KT58823GZFK&H6F#CY5@]F*VO,QY):(1GXQLX5?0RTK%JIR4:E)(
M-5'[!0CQH59L8J@U4CQJJB=PFX1403ZP#K$4(=(HI"(*@90IA('5"4P*\S?S
M0E-UG1Y#RY,[;$0*Y,ND5N8"&*N90A43%4$H)F!41!,2J"<@)F`W14$Y`()A
M.7GZ`'F',/P_W#_>`]H#Y0'M#\.HT;S_`.B#NG_LX9U_PJMNFS#^B#M8_LX8
M*_PJJ6I+Z::::::::::::::::::::::::::::::::::::::::::::PMN%W$X
M4VI8@N>>MPN1*_BS$N/XT)2U7*RK+D8L455TFC-HU:,F[R5F9J5?+MXZ#K\(
MPD9V=DW#>-B(YZ]720-?E#OE,RA3*OD7'5H@KM1+M`Q=HJ-NK$FUF:]9*[-M
M$G\3-0TJQ46:2$=(,UDEVSINJ=-0AN7,#%,4MVZ:::::\KY4$&;I8PN0!%NL
MJ(LVQWCODDD=0>Y6J:+@[ER`%$6Z!$%S*K`1,J*IC`F;XH-GSW;IBK*F=('(
MUBJ5GPYF3;+>FR6_[:?=\D8ZW+2^"`VA53*^3\H[I<%*5VSW9_;[%7"$L=ZR
M[*3]HG<6;IG\FC$T?'TM<C!$96>UC&.-,]97V]MZ_MFQILJONZ3AA+Y3H>T:
M]KV':RYVXW(FZNHT;X0A9!G6*_4<L;@LFTW!4!G6`;QIZ7DO$[?%3:5G+TG,
MV21F,BXCKVUBYYXJ&W3,;BCS'#0@=SG%?C,(8[R#*P1]JKVUXXK.T20K%4AT
MY60)07M:Q,^NV^5[B&`;'6B:$XJ]M?55G$/\=M'4'N\X3%AM-JX<NT2=MLI9
M)UX^Q!$^XD];W#I[9)^AM9288XRGIB2?*+/)=Y-8V:U*3--.EUW$RFZ3E%5E
M3O!4/0^(K:=WD9@[<?%8GPGM]NF(5]L67E)ZZ7_<C?\`&]^CGZV-;V2?0BL>
M5_;'E"#F$(R/38.X95UD.&&??KKQC\*RU0+-'Q-M2R#Q*FVUW;8WK&U79E*U
MY';[A%.%DI??)F.(E7\:7%M3!F[DHEML.DFT4_<(=!5Y&-I27;1[DZK-O,2Z
M""<F[S[WR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P
M%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.
M*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.*/YHN
MR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.*/YHNR']O3
M-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.*/YHNR']O3-/L!:
M=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.*/YHNR']O3-/L!:=\CBC
M^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.*/YHNR']O3-/L!:=\CBC^:+LA
M_;TS3[`6G?(XH_FB[(?V],T^P%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3
M[`6G?(XH_FB[(?V],T^P%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?
M(XH_FB[(?V],T^P%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_F
MB[(?V],T^P%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V
M],T^P%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P
M%IWR.*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%IWR.
M*/YHNR']O3-/L!:=\CBC^:+LA_;TS3[`6G?(XH_FB[(?V],T^P%KYC./+BG>
MKQ5<M[7.&-'8:PC4MS4<UO.Z!9]BO>OE3(.)<68AAH5S5U+%N0I$YM3QK%L7
M=]LJL?6,+6UD>=M$-*EL<<W8MX&W/E5_H>X,?#?EN%OL?I&VFS9>L^7[BI+R
M>0+J]D)9^ZH5/MML;L%9RD8;A)``6KF.(EZV4<HD5*BZL]G?6*[OF,0ZLAX6
M-VOZ::::::C]C_:IMQQ5D++^5\=87QW3LB9\<,G68;9`U>*82N0%F++N(GO@
M60;%*Z3=%,L\E6_0*A-2[EW-RZ;V8>.GJOOK>V+;=3<>6G$51V_82JN*+P=X
MI=,8UO$]!@L>V]2101;2)[12HNO-*U8#R#9NW;OC2\8\,Z00116$Z:292^F;
MVW;>;+C"$PE8\$89L&&JT>,/7<2S>+:+*XR@3PJBRL,:%H+^!<5.*-$*KK*Q
MAF$0W,P465.U%(RJ@FS$U:MF39NS9MT6K1H@DV;-FR2:#=NW03*D@@@BD4B2
M***1")I))D*FFF4I"%*4H`$;]Y_]$'=/_9PSK_A5;=-F']$':Q_9PP5_A54M
M27TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTU$W?!O!Q;L/VP96
MW/9<745KF.(`[B)K#!PFE8LAW:44+%T;&M10,191W:+U9G,?`12:2"Q6G=3B
M6>`G&QCYPC\>V8\UYRV+X6RGD"\9%K0\47B4)RERWI&@4T).^;8ZG8XUBEA?
M;Q49IFX[IQRWPCB9PZAV;0BSJ8+<Y7W:4<N6\57)9S](?!AWF9'WK;6']ZRM
M*1LG=:/<4<;3*K&)+$+'=050K;M20?IE65[K<S@2!)PSP`2(8[]5`B294.B&
MWC3333333F';V^+Q_1_7IIIJ-&\_^B#NG_LX9U_PJMNFS#^B#M8_LX8*_P`*
MJEJ2^FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFK0O%_I>-:\\M=
M\LT-5*\P+S<RDT]29-@/R$2-T`.(JNWBO(2MV+-)P]<GY)MVZAQ`NOG1S53;
MYQ>]ZV(9G&UN>-=I.S*PEN-75?5(RE/+N3%@];)Y;MJLLL#.W9"QK&/F?>/Q
MM$MC.*)++260,A2\$M-1->-M%KW"VVF1,"RC)>LV>TS)74E)S=ME;G8&T]9Y
MJ9<%>2LO-GBGK)JZ?/'8*.%79T#OW*JJKB2?2+U55V>5V$-ON+]O$#,5K%D*
M[A(B=F?=^20>3,K-J+2?<#.,ZXB\JZ=+(D[C8MT^I2.5+I$,IT>F<QAS5III
MIIK\U14*F<4BD.H!1$A5#F3(8X`(E*=0I%#)E,;D4R@)J"F`B?JS]'HC\S>S
MO?IONR3GS=!BNTY(QJYW2QF)9"=KFP7<'BJP[<W5#S(WQ=69^)B<(Y`!FX<Y
MBPG6+M+2$/DJY'M%Z<7FC'J^9,?3M:CYQ2M*5>V[WM[=7J>XZAXCS2EO96I>
M4=E^.8S=)MHV=FM:>/,C97R_9*YNLQ%`8[K-KL^.LSOL(XNJD3=0EFME9)XN
MD\B1](S!87%BC.ZRY/P]NUW*;CN\YMJP5NK42R_<IS=K8<X9JSCL]@Z)D[;T
M?;`?;_!+[>;!M?4MU:AT[M+VC<'1IYU;W\S),9#&IW[RLK.%K!`6J#VG[%MP
M%BW1[2\&YSN4)%5ZZWBED/>(F`,N->;7FN2\M3[F>ME=NG[Q*MO+/795]7F[
MU^_?-H9TQ;O'SQRDJY5C=Q(=[FV/"V%MQF%,EY,+6\EV/;)E9]#5L:=D*8,\
M:V?'=YB8)7W7K]1EJ\W!](,'3?H.Y=NJUZH5GB;=$Z2BF&]J7%;V%57:_MPK
M4[G<C&:@<!87B)5F.,LTN1:R,=C.K-'K?NAEC9TS7ZERBJGUS9RL@J!>FDJ<
MABF'/WA>N'KYP*?ZJ\Y_PNT\+UP]?.!3_57G/^%VGA>N'KYP*?ZJ\Y_PNT\+
MUP]?.!3_`%5YS_A=IX7KAZ^<"G^JO.?\+M/"]</7S@4_U5YS_A=IX7KAZ^<"
MG^JO.?\`"[3PO7#U\X%/]5><_P"%VGA>N'KYP*?ZJ\Y_PNT\+UP]?.!3_57G
M/^%VGA>N'KYP*?ZJ\Y_PNT\+UP]?.!3_`%5YS_A=IX7KAZ^<"G^JO.?\+M/"
M]</7S@4_U5YS_A=IX7KAZ^<"G^JO.?\`"[3PO7#U\X%/]5><_P"%VGA>N'KY
MP*?ZJ\Y_PNT\+UP]?.!3_57G/^%VGA>N'KYP*?ZJ\Y_PNT\+UP]?.!3_`%5Y
MS_A=IX7KAZ^<"G^JO.?\+M/"]</7S@4_U5YS_A=IX7KAZ^<"G^JO.?\`"[3P
MO7#U\X%/]5><_P"%VGA>N'KYP*?ZJ\Y_PNT\+UP]?.!3_57G/^%VGA>N'KYP
M*?ZJ\Y_PNT\+UP]?.!3_`%5YS_A=IX7KAZ^<"G^JO.?\+M/"]</7S@4_U5YS
M_A=IX7KAZ^<"G^JO.?\`"[3PO7#U\X%/]5><_P"%VGA>N'KYP*?ZJ\Y_PNT\
M+UP]?.!3_57G/^%VGA>N'KYP*?ZJ\Y_PNT\+UP]?.!3_`%5YS_A=IX7KAZ^<
M"G^JO.?\+M/"]</7S@4_U5YS_A=IX7KAZ^<"G^JO.?\`"[3PO7#U\X%/]5><
M_P"%VGA>N'KYP*?ZJ\Y_PNU^:W&`X=S9%5RYW$-&K9`H'<.G6,<W-FS<AC`0
MJCAPOC%-%!,3F*0#JJ$()S%(`](P`.)]R_&$V\8F""AJ?=JFR]]B+GN#,N4H
MW($)@Z%,W0(LN4TM!5&5EK1-)<U&K:MLDHE:1E2>Y;-^Y>HNVB'R7;^-[V5-
MX>0J3C*!W%63'TWDG)*%)C9+(..\BL[M5<1H'15R-N<M.)J]658_$6"8".63
MC,;UFON[;;\HVM13WY/D8^(?,0^K/;!ONX5VTO`F+MN^*,ZK-:/BNJ,:U%N9
M+&.<G,Y/.R"=W/6VS/0Q80)"UW*?<R5IM$@":97L[+/EB)IHBDDGG@_%\X>:
M9%%#[@DP(FF=4X]ZO.@]$B91.<W(,7"(\BE$>0`(CRY``CR#6QF$F8VQ0\5/
MP[GNR)FXUA+QCOJ7#?NF/DVB+YDXZATD@Y1Z]JX15ZIP@BNGT^@LDFH4Q"U/
M333337G=M4'S5PS=)@JV=H+-G"0B8H*(+IF263$Q!*<`.F<Q!$ABF`!$2F*8
M`$-)-;X,,0,QFR-R%NKW"6_'=@QVZQ9MUCTI#'D9><"5^P[>VNVNPV@;VWQN
MG+Y%R7"X@+(XOHEPR"O:#-*=+R\U;F-LR7*.+L22K+A\7*)Q<UQK#[Z]U,06
MF2V-IW!\M6ZYM1QPPP>^QF688LH>LT'#^V[&N.;CCZTUJ9<4^Y8PRG6+M1G\
M$BQ=0L17[1',+(VLT.%=`0S*`NV/MS>?<>[KF>2\MY6M^[V*8X;G<F9&L>>J
MK1Z-E>-M%$MV,)W"32H2=1Q;B6)J56K6.H2/H9\2X_?P@J/&$ZI8Y[[>\$X^
MVQX2QA@'%C)\QH.)J=#TNMEE7@2,R[9Q2`E6EYV2*BV+)6"<?J/)N?D2-6I'
M\S(/G9&K8BQ4$[*WH%`=H6Z<W,W,-M^=0[#&`O\`[*K=_P!$!Z(CV^,0Y^(?
M&`:XV8IE':%M8$1/_1PP5XE%"AV8JJ(>(#@'_=VCVCVZDMU1?*I^F5^_IU1?
M*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5
M^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1
M?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F
M5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU
M1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^
MF5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_I
MU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_IU1?*I^F5^_K@4R!X
MQ4_2K"(_U`!^8_W:B3D;=C5H:R.L98=KLUG[,2(]4YI=">IC"U<YA(4'.0KV
MN<];IK-,3B*J3AP[END0R18XAS%,$&-T60HG#4-7;EOGR'8LK9"OLF2(P1L*
MVX*374Y.MXB`QU:85UDZ;VC**K-R=JK.VNWK1]'K(`LN\!9)1LT7PU8L3C1,
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MA,1,K9T<[1,@%1YFOG33333333334:-Y_P#1!W3_`-G#.O\`A5;=-F']$':Q
M_9PP5_A54M27TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT$0#M$>0>4=1
M_P`Q;E\7X778P<X_D;+?YKD2M8MHL<K:LC6)8_0ZL&-;CS&7:-3`<#&E)A2.
MC")@<_=9Q()!P8..=R&Y0!<YIGW6WO$;L.FGAO&LX"V2[&Q.`B#?).3FI`1A
M6ZQ>0.Z[2DR=:BJHT?29%4A.:/N7MTM7P58DMC?#EP]5,M;K%F9%Y6IPXF8X
MBV]1#L>I')NZ"^LA7<1_5"H+F/J"KU]D2Y+E(U12:D<MU'69MH.P>&P-9IO<
M'FZ\2.Y'>?D-@".1=PEO9)I'B&"P"8<=X8K'\XRQ=BV)`XLH^!@R(2$N@F5Q
M.N5C*%8MM;66CI\8'B/);?&PED^'+PO,A0]UW)S#:1.2L[D=]42W1E*#@)WT
M#A'V''NW9HX/;<HL%5'#-:ZK(5B=C>J6@I)/?BMD)@Z548U"/?W5ZF8Q%%(<
M$TX1NL`\Q![9'0I1*?,1$3ILU'KDOQN381``'\1K]PL'QK18BPK!0!$8"F&6
M;**$Y<P3?69R4)1Q\4>@J$6VB2F[?CF+R'4$-U^YC'6W:UXFQWB]/'CW,5NM
MKR'.@O%SV4+!3(P\:+TT@]Q?19QC=K5;K<_(QK5,;2,O`D5>.WSYQ-MHZ.>E
M/(?:#DR2RG1KQ,6&'J$=;*SEV^X\MDMCQ[(NL?W*<I3MI'KV^I(23AVO',Y)
M%=!K*1IGD@I'6*/F&*\E(*MA<FECIIIIIK\U52(IG54'D1,ACG'D(]$A"B8Q
MN0`(B!2@)A``$P@'(H"/(!T[X<XP-1R6EFF_V/;7G>C;<<?8?2SOC_.S2/A,
ME,<AX]-C*!RLQ1GZ7CA]8+#BR[WZHV..E\/4FS*/)*^)@]K,@M4\FQS_`!^A
M>GA28^N#<:7ES:IN#Q#N&8.<#-L6[=+%+8+L%VSDIN:LMWIN(D*+;:9EN>Q=
M"O1LV-<@L,CML@W.I$QHRITU8IIP[K81\H_]*/%%@9RLTZ%H6VK/%\W16;(6
M<,8RVT&)D,,1>4*19MM"==<YR=6>^V+*,5@L*Q5F%VQR[K]CB,F2C6]]]+'*
M%>1.K.2004[]O^<J%N6PMC+/6,74@ZHF5J=#72NA,,?<R;9-)=OTUHB?C.N<
MA&6"#?$=PL_&E<N2L)B/?-"N7!$2K*61O/'_`,T'=.'_`/CAG7\`_DJMOX?%
MKC9@/_F@[6/'_1PP5^`?R55+Z-27YA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/
MJTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]
M6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/J
MTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6
MG,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JTYA]/YA]6G,/I_,/JT
MYA]/YA]6G,/I_,/JTYA]/YA]6@F`/+XP#Q#^$0#\/]>M54WQ9<.P<[,P3G&>
M4E5X2;E81PNB%-%!5:(DW,8NNB![*5445%6IU42F3*J*9B`9,J@B0,QC:=S^
MY<`3H47*;6\.NP#G?KE%MGN<K:P5*(@>I4=<RL;C]HY((@G,V95W,`BJB]CF
M)#<R%SKBO`6'MOL;,2]=C2(S#MNO(W7)MRDSS5UL`-TSN7LI:[K-'[J,W33(
MHY<)%680S1,AE"M$$B"8-;-SW29ZXA=IGL)<.^>>8VV_0<D[K.;.(6ZB#N(W
MKVRIFLW0MH<:_(BAD&[D)TFS_*Q^5-J`J=UQ#ET_-#/G\]MN&VC;QL<Q<GC[
M%L2WK4:[>'F[;:[#(*3F0\G7!UVR5SO]I>%/.W2W2RYE55'*P*)M@4[@AV4>
MP31:$C+OGWWQ>(3XEVYTFM95F-Q6\VPSV(MOE<QZ%9A,E).4H8SBZ9F:M;N5
MPRJ./\.P;Q.T6;(UI@96,@%RL%6U3MBI'$6&5]L^RW;-L.V^P6**HH:"Q51U
M9FQR;_(5L%9I*V>QR:TW;+]D"PS;AJ-LMECE5U7LO8[6Z=JB0K1@P:Q<3'QT
M8SJ)MW[:Z%]Q-J&'KIN#42Z31M<HYJ7&F`8XZ)A34ZS+=L9-HZ=;M>8*"EC6
M!NZRA.1$RE,8I@X';_N`S!R6W'9[?5^N+F`[C#>V8)?&]962#F4\?9\M/E5L
MLVQNX0,9%X6"=8\8.1$PC'=$2@7+$;M+VS1-#=8S98,QE[QY!VTD92">5",D
MTYF58*G69S,X^DD'<M-SC=110Z<U*R#R4`RJHB[$%%`-F6HTZJ4&N150I%;@
MZC5H-MW)#UVMQ3*%A8QL)S*F18QL>BW:MB'5.HLJ":0&574465$ZJASFN333
M3337G=IKJMG"35<K9RHBJ1NY.B#@C=<R9@17,@)TP6!%42*BD*B8*=#H=,G2
MZ0?+7MYV3<07%VY7=3F/#>"<1[7LKL*'.&E9>DY6M<)M.WD9TL6V]A3ZQ8(K
M;\QKI*-4J@EG@[O<7;+S-U]?*-+F"+X72>V]I:;E94Y!U[95NV8UQOE0F`*Z
M3=)BW<=@7=#(Y"R=O1-G*_;S'F.(C*N.K/BRYW17;_CRI;?H*OXPRW=7F%JK
MC^E,\-5"Z3'<$53Z3&2EELKJY*7M@WY8<R+`;YH+$F,,C9QNV6]Y=GRAM1[]
M\94X^J8[W30^U^%H,3`9U?8\>5ZPVO&`[/\`&3B]J%J\7'2K:]7KWL2%E<U6
M";6S9]L1V_6?:WM(P9@N\6"+M-ZHU,*2]SD$FJG`/;S8YF7N-R"O=T-&#E6O
MM+-8Y1C!.G<='/'D2U9NW<<P<+JM$<$\17:CC'*.#MR&6++9MP4;9X/;%EY@
MSC:!NKW,XJH2R,)C6]O61Y7&.,LL5+'DXNNN_63F5IFM/CV1@1"(L8RT0@DP
M+B7:EPZ<"6;:[MLL$A?-YJ#Z8V^X2D':,1Q#-]L)%)+N<75-55.-A8K<0UBH
M=@0YA*SB8EHRB8QL"3"+8LH]NV:(Y^\&;MX_*#O=^T?W^>T?IX,W;Q^4'>[]
MH_O\]H_3P9NWC\H.]W[1_?Y[1^G@S=O'Y0=[OVC^_P`]H_3P9NWC\H.]W[1_
M?Y[1^G@S=O'Y0=[OVC^_SVC]/!F[>/R@[W?M']_GM'Z>#-V\?E!WN_:/[_/:
M/T\&;MX_*#O=^T?W^>T?IX,W;Q^4'>[]H_O\]H_3P9NWC\H.]W[1_?Y[1^G@
MS=O'Y0=[OVC^_P`]H_3P9NWC\H.]W[1_?Y[1^G@S=O'Y0=[OVC^_SVC]/!F[
M>/R@[W?M']_GM'Z>#-V\?E!WN_:/[_/:/T\&;MX_*#O=^T?W^>T?IX,W;Q^4
M'>[]H_O\]H_3P9NWC\H.]W[1_?Y[1^G@S=O'Y0=[OVC^_P`]H_3P9NWC\H.]
MW[1_?Y[1^G@S=O'Y0=[OVC^_SVC]/!F[>/R@[W?M']_GM'Z>#-V\?E!WN_:/
M[_/:/T\&;MX_*#O=^T?W^>T?IX,W;Q^4'>[]H_O\]H_3P9NWC\H.]W[1_?Y[
M1^G@S=O'Y0=[OVC^_P`]H_3P9NWC\H.]W[1_?Y[1^G@S=O'Y0=[OVC^_SVC]
M!X9NW@.T<@[W0#RCQ']_GM'Z_);AI[<FZ9UE\C;VD44R"=157B0[^DTB$`.8
MF.J?<>5,A0#M$3&``#M'LU'N[8"X<F/%S,[5NIW0-9(@B4T+%\3K?M99_IE$
M2BD6!K.XV7EC+=(HE!$&G3$0Y<N>L:CA+;_:0%/#>->+#E$3G,1M,.-]6_C&
M=07Y?["GODR-N:@C`@H',P*(Q2YNCR$""(@&O0'#LS%=RC[FK9BP0P4'EW1:
MN*+Q'LPVQ!,Y>8&"+K^X&OU,'!/^DF>171Z8\@$Y2\S9ZPSPOUL;.59"R;R=
MY-S=.C"==HON*S0]BT2*@)5V#(<@Y'R-)M60D,HD06KUH[(0W2*Y*J4ARQSD
M^$3D5S,23MIF&F$8.9:0=M$WL%:W4B1BXD%W#9-Y(#(=:ZD2-5$R.9`3`JX>
M`H[$W6'YZS_G#:)L?VV8SL>8,Y9]W?X^H%5;$7FK'.<2;?XW1.Y6#H-(R+9(
M[C57TS.RS@`:0==AVKR6EG9TF4:Q64$"!K0Q'LU?;U+R2_WV0WG82V/24.Y9
MU?:O>]W^['+^<=V-?>.VDC'V_.U9R1F6[06%<:296;%U7J@T1C+A+QAUW,C.
M,F[Y![K9Q2.%AA*M15:KU/EMTN'J)4B-&U<I,!O^WLOV+&*8N0=(0C>KML_(
MT:#A%!,H5S#,V,DW635734`>N4,/&].!X?\`C5E'W#=%N`RMCAW0JNY=M&=.
MW@[C,5V<D&R;\G-@E(##F4:G)/T"-R(MG%IM"`1;(A42NI5D5118^E;9CPO,
MX;J\FY%WW6ZQ9!I4-FIJTCMFN1K/O8WH7C(F`MGTB627B8"@O(S,=9R/=IO,
M*;UI?[S(90R.VH23]^"%)ITG77X2+K=^APDMN5DQQ7L?YSONZ#<*K7G"+YI:
M<D[I<]IV!N^34!<YX]]6L@P[UF@H[`KH0<2$B_.H4A',DX2(5,+]3X9.W1%)
M!NC?=[*+=JD5!JV1XC>_E%LU0(`%(@U;I;C2(MD"```1%`B:1```*0`#EKOX
M,W;Q^4'>[]H_O\]H_74_#*V[J$.F;(.]\"J$.F82\2'?\0X%.42B)#DW(`<A
MP`1$IR&*<AN1B&*8`$)]0\6VA(F,AF:CY9I$Q[*,:JRDG(3,DJW8-4FB"DA+
MRSEY*2CTZ2)#.Y&2=NG[YP*CMZX7<K*JGJ.FFFFFFFFFFHT;S_Z(.Z?^SAG7
M_"JVZ;,/Z(.UC^SA@K_"JI:DOIIIIIIIIIIIIIIIIJ)&5M[^W?"UXDL=Y`M4
MQ%VF):Q;QZR9TZT2[=-"89)R#`Q'\9&.6:HJM52',5-8QDC"*:@%.`@&?<:Y
M&JF6J/7LB4AZXD:K:&JSR'>N8][&+KMV[UU'JF482"*#QL(.F:Y`(NB0QBE!
M0H"0Y1&^.D'D-Z!_NZ=(/(;T#_=TZ0>0WH'^[IT@\AO0/]W7/2`?QO[RF#_F
M&G,/I_,/JTYA]/YA]6L.9TSE2]O="7R+?$9U:`;RT1"J)UZ-3E)(7DVY,U9B
M5HL[8D%$%2B*ZG7@*9.T"'Y\M1UQIQ&MLF2I:5BR6.4HB4/!KSSJ:R8VAZ=`
MG;H/63$63:2=3S@KF554?$5;QZ21EUFZ+I4@""`@-Q.=]N#7[D8_&R&2,W28
M"8O<F'\:6VVMA/V`0!GU6$76RIG,/('`RYD0`!,8X`';YN_-NVN@`3'^U9E2
M&:YB]SV#.V3H:&.FF<.Q1Q3J(VL\V4Q.8&,W4?MU.0"03`<1`H<3[QKJ"AKS
MN9JV-VBW8M"8,Q<R%R4@B;F1*XY&?3D@0_0'EU[>';F`Q0,4`$.8_LEL5P]+
MJE=92G\MYR>@!1%3+&4K5-1W3`PFYDKD.\@:X1/F8P`B,6=,"B)1*/CU(2D8
M9Q+C5%)&@8THM-*B42E/7*K"Q+@W/QBH[:,TWBQC?](ZK@YC?](1UDKD']?+
MM[1$PA^?F.OP<NVK-(5W;A!JB7_:5<K)H)E^DQUC$*']XZM!QDBD(..Y"6-@
M_>#XF4**T\^,/XI6<,B_<&-S[!*"8B';V!RU$'+>[-QB^/L<0U8V&\69-)67
MKD)3JHM,Y8E89>;B84Z$)BDI6DE.*Q$M.QD0\L(@SK\21TV?6%5FD5RL7R#M
MAI6;)>O[B=X-006ME614F:?CR^6J*LU&P0SZDG6KL62`A0(Z\+(`92UW!B,S
M+)+<HJ.O+V#8M"%K)-W6/GBCNJ;4\:6G<E.-W2K5T]Q:Q9PV)(Z2(<2K'M6=
M+,+"AF4``4.Z]P']RGC'(<`C%EAZ(_L;#NZ/,G)?.&;FV'JBL(F5Q5M@4?1D
MJX:C\<K.T9ZL[,MP=B!#"@\"@5O'X&Z(]3(J$$#CI7SE@K$^^_?(RX8&WBE1
M=<V>[79:E9OXJ.28@AIJ1SG=N[T+-@W958\AR;B3M5L7F96*#(N:4)>:?=RP
ML<TB1>QL_#*,7/T_L6+.-9M8^/:MF+%DW1:,V;-!-JT:-6R1$&[5JV1*5)NV
M;HIIH-VZ12I((III)E*0A2AZM-----------80Q_N6V^Y7R'DK$N-,T8RON3
M,.N6C/*5$J5T@)^U4)T]`001M$+&OG#V*/UQ3LE^Z$@*SDDEHIZ+:305:$N&
MQYLPU3JC;+_;LLXSJM$H4TK6[U=+)?*K!5.EV)!\QC%X&VV*5EFD/6YI&2DX
MV/5BIIXR?IOI!BT.W*X=MTU+'1W<[4W&,G.:F^YG;ZXPXSL05!YEE#-&-E<9
MM+88[=,M7=7TEF&J(6(ZCMHF6$5EB29CNFY0:B*Q.EG]JZ;/6S=XS<(NFCM!
M)RV<ME4UV[ANNF55!=!9(QTED5DCD4253.9-1,Q3D,8I@$8W[S_Z(.Z?^SAG
M7_"JVZ;,/Z(.UC^SA@K_``JJ6I+Z::::::::::<P#ES$`Y^+Z?ZM>=R[:LT5
M'#MPBU;HE$ZJ[E4C=!,A0YF,=98Q$RE`.T3&,``':(@&L"7'=?MLH)S(VG-^
M-8]X0QBFC&]JC9>7`Y0Z0D"'A%9*3,H(=A4RM!,8WQ2@)NS6,!WOT2=,HGBW
M%NX',0@4!1>4G$-C90:AC<@*(V"ZEJL81(W/F"P*'3Y`(@)M<#EO>+:P*6F[
M6:U1FZHFZB6S+F&(25(7I!T%'%9Q]&6)^4>CS$R!I-,W/F7K``.D;D<=[W+:
M<YK-N$Q7B]LH!P,QQ-B->RO2)G`.1$Y_)$VN0%"!S`%R09>WXP)@/("ZZ\]\
M.+</D/+%BL<'DJOY)069UU!U:,CV=O%W)P]1AFQ%VTC$UBGEB8UDV.`I0C9`
MA3>YH(F4,J<3*FF'@+8E"06*Z*QOF0,JEM,>R<DG&&.<^9#C,?\`=`3$BJ1&
M!8PK^&:M60MCH=TD8MF/^G"[.(=<=153+)MB.!SF,<[C,!SG,8YSFSWF,3'.
M81,8YA&Y<Q,8PB8PCVB(B(]HZZ_`/P+\ME[]?68OWRT^`?@7Y;+WZ^LQ?OEI
M\`_`ORV7OU]9B_?+78NPK;@H(C*0M_GNB')`L[F?+LD#41'FH9MUET(*)E>1
M`5$!'I@0@"'Q0UW^`-M9_P"H<_\`K4RS^^^GP!MK/_4.?_6IEG]]]80W!<.;
M%=HQZ>%PZV8T2[NI^",RG+G?,E3D0=FBY4/(QI(V2L$ZV7?2#<>K9F".4<)J
M$$R"J(](PV'M(X=TKA+*C^S9<E,19'C5J>_9PL`2)=S#Z-FS3,*NA8FS*SQ!
M6R`-&K9ZQ[O;!W4B=\")#@194-;:&[9G'MDV[5!NS:-DP(F@W23;-D4BAR`I
M$DRIHID*4```*4I2@'(``-6](7BFQ(BF^LT$V5`>7<XR34[GGV]@-45%'!A[
M/$5(1_OU2>^1#N.7N-$6RP@/8!XFLRA6XB(B`"#V42C6(E'E_M`X$O+XW2Z/
M;KJ:Q7IYS"/H:;`AQ#H.++98]GT2B(]IVD,E-+\^7+X@J$-S$0Z7X=?@Y1R&
M9NLZE+14:RS;I'677CX9S(=SI$`3***R,Y)-&21$R!TC*JL03`0$3AR#EK71
MG;B7;$L%*/&%]W83.2K6T(?KJ)@\[G($VHN"ADE&*[?$T2XBH9PF8ARJI6&S
M175=`P*'(`".H#N>*1=LSOR,]KFUK'5%CG:I099+WAV^WWVS+)K**)E>,-O>
MWZ'RQD%^L!4SJ)-I:SP"IC"4%$TRE,(UE#%FY+.J0MMP&:N(UF.OO6Y.CBK:
M5@F)X?6"W!'`F5<1+ZU76RU;,-C@UDS@W!^^L\,]6;G2,JW34(<":\[3M9S6
MINY0G8V8M&-MPM0R+7*5BRGVMY,6S)T+C5R[A8['\=1F]>?SM4L6)J?1WCU/
M*+^9MBM'M+.-L2ECL+BWS;AR;Z>(S974[0^;6'<I>+AN?L3=R1XVBLAK(1.'
MH1TD;^;&LX-K1F="0;D*!`05M;>Y31"D(*LRNKS4&8L9%1D*P9Q41'LHN+CT
M$VK"-CFC=C'L6R(=%%NS9-4T6K5%(O(J:2"29"%``*4`UK9XJ6^.<V6;>6"&
M'Z^;(>[[<9;X[;]LVQ.U02?N[EG6[)F:Q$W*1Y^D4M%QHS54O5YD7H-XE&-C
M&D0_D&!IULN%\\-?8W";!-K]<Q"M8!R)EVT34[EO<KFIX149W.&XC(CDLUD[
M)$TZ=?Z<Y3>RQBP];(_,H[8U.'A&;A55T1TNM/S333333333337E?'ZMFZ4!
M!RY$C=8X-F9RINW`E2.8$&JAUVI4W*PAU3<YG+<"+'(85T@#K"_('PL']`:[
MVAP9CA;'NX?%J6-G]5@I!W0);$>]W9903[8*:24K.Y![C6PO*DUD',_'Q&WW
M+19ICCO(4_N,AVM\1)-V2+L[^-S)(8/Q!C#9=G?#TWENR[2\%4SC=2$^AEJP
M8]=;@Z]4(VJY4I.4*W(9=F\T3,Y&QE%M.18J-92>;,P.;M4X&TRT"M;&,M'O
MC]10,3YSHY,G;>\G[[[3AFZ[(<5Y%XD>&\.;O;!C"B8OVV[@I24I^UN5Q'F>
MTUV.BT\/C:K!2VF[C`=/O]6;QU-RR_IMF)CMBG[_`!E#S&Z[A,0MLKW#DVB0
M]QA+#67[/$$3[BUJUMUV5AK=#<2DP[QA7Y6/=E3>1;J%QHXJ,;[E/DD7T6DV
M2CWJ*+ILLD2S>)%\-[O+[B^\K\%?O*?!DRM[X^^CWX>^AW=WNKU[Z/<3WI?_
M`".[E]R>X?<#W0_G_=+NOW0_T?J-89VI^%=^"_MP]ZO@]_>UW@L+^X'N_P#"
M:]V_<?O95;W-]U_<K_R;[I]Q]3W=W#_HO=76]3_-]'6??];Y_NX?^*K3_6^?
M[N'_`(JM/];Y_NX?^*K3_6^?[N'_`(JM/];Y_NX?^*K3_6^?[N'_`(JM/];Y
M_NX?^*K5OVB\\4[&U=FL@7M/A[.:938UW9+.S@76Y9C/R,)#H'?2,=774V(1
M!)]^U14:PX/P4:FD%4"KIG3Z9=1:1XK^<K6HG7:ABW%</9YLP,8&2G5<JW")
M9R*OQT%)"KT**<7*=1,4AT`CJV@I)JKJI'3*"*:YBW57]R?&2M4NR0K.VG;)
M+5]<Q3+ST["[B,9""!R\R*-&&09>)67`WB,*YFO0*(*`4_80TWH5[Q%+/"MT
MY6%VLXODC("#UX=_D2_N07$R@AW)$M%V$<W*4H)E,#B>D>9@,<IAZ75$B-D/
M!'&3MDX(QFYW:ZQJ0`L4T2PCLP4J6<`<2@F!9JF0+1RR3(0#`8@'>KF,8IBO
M"=$0/CI78UOLDU$W=PK6Q+)DD4XJ*2&4<K;\[[W0<2E*8RL7+63W"`#"',R9
M(HI!$1+RZ(%*7,M6Q+Q#L6MTQJ>.N$E14D"EZ#J-K&X*"7#H%Z(&,_!F@Y.<
MH?\`3.X.?M$1-S,(C6W&2N)^W5%`++PT7JP#T1;Q'PLIM3GXNB"$.B^,/+Q`
M!2=G8'9V:J"5NXMSLI/<N)V#OQ.`"7K:WO"A4.WF(<W,TR8I]'ER'I$*<.T/
MP\PU)/#ZN_-4J*V=6^U1J8P=)>/Q@&6SE)S(/Q4Y>URJISB!Q`>9X!(!`HDY
M%$W6$K%EJV9+#9[6HP3K<,9&`:L%9:&&<BD[61RS%<T.[%Z4Y73E@J`-FLFT
M6*1)HLJV5?,ESF:IX+@`XGJ4+&I1,/L.B(U)J1%G&."[BX]=BBD)DP;K-%:X
M4Z:A#%-TC"`E6$1<)J*IJD5/5^GQ3OD-A'_:]P_[O:=/BG?(;"/^U[A_W>TZ
M?%.^0V$?]KW#_N]IT^*=\AL(_P"U[A_W>TZ?%.^0V$?]KW#_`+O:X%3BFAVB
MCL'`/*+O<.'_`/7M<=;Q3>7,$=A`A_[KK<0;_P#C7AUB[+^1-\6-Z:O:,_R.
MQ6'QDRD8CWQ.()WG@]P3;K239`BE-:R,.T;J6SK%B)UT'*S=H>759H.G*""Y
MSZB99]Z^95K9)O,=Y9VH5%VW8Q\-;*YG&;RK<\EJRR:KA9BWJ\_M8D;U5YJL
MKQ`L7#AI"N@F(JQ$F8^>(#QH!@\Q\^\0:R$3?4[$F`\P&<`(HG:X1XC`0RHE
M*)B@$WEXE.KW0-\4`4(NJD'3*!AY<]7K$[@N+!CYBK9\J[>N''@'&K11--6Y
M9$S':,;I(H]G6J/P>2SY*.[`,9,JCQVHHF4QS)E.4B2N)K;Q;]Q%X9/:OM)8
MX=W3Y5;`FT-";8<+[D\W4!O)%%4BZDOG:P)8UQ57V)3I%,54B]E1%N=50KE0
M4DA7K%0H?\H,SW!KR=YREMXVE(N&95V->ZII;;,599(3HMW3:@U^23C"DYE*
MZ66O#AXB8Q>4=TTSI!;\9PU^)C84G!=RF9-L&[85'(KM8G*N1-Y$#060%.84
M`[W5-EF41(KIDZ`&5F'\B@*A>M29H"/1U(6C[.=Z&-T4$*7MVX/L(5L!0;J)
MX^W#/'"70$#%$CN28O70'*)2B!^NZ8"4H]+XH<I#,HSBU1C=-I&1_#3C&B0<
MDVL8SW11[8@>0J#--!(`[/$!/+Y1U[.CQ>A\8<.`?_B^%4;_`)\]<=#B\\^E
MT>&_TOP&Y;J>D`?A*!O&!1\9B`(%,/:8!'MUV_UOG^[A_P"*K5#L]FXKE+K=
M@N%MF>&?7*K5(26LMFL,R[W1Q\1`UZ!CW$K-S4J^<G2;LXZ*C&CI^]=+J$20
M;-U5#F`I1'6FC8S6N)1Q&,]0_&3DH':.TAX^HW/!6Q:BY?9[AXFO53#P2RD;
M=-S-%K$6F6<BYW<<Z2D&S.1NB;>SMJ"Q:,T"GAG44X/NS_UOG^[A_P"*K3_6
M^?[N'_BJT_UOG^[A_P"*K3_6^?[N'_BJT_UOG^[A_P"*K74_A?N@IU?@W^LZ
ML_5=/X5?0ZWHCU?6='XW5]/H]/H_&Z//H]O+6QR$]V?<>*]\7N9[O^YK#W;]
MQ>Z_<CW7[D1]T_<ON_\`T[W.[N[H[A[L_P!*[DZGNG^>Z>JIIIIIIIJUXBE5
M*`L%KM<+78>+LEY<0SNX3C%@W;REF<UZ'1K\&O-O4R`O(JQ,(W0BF"CDYS-F
M"2;9,03*`:N11)-9,Z2I"J)J%$ITU"@<ARF`0,4Y#`)3$,`B!B&`2F`1`0$!
M$-?F9HU.@5L=!$S<G5]!`R9#(E!(2BD!4A**8`D)2BD4"@"0E**8%$I>7H`.
M0<@_!_>/]XCVB/E$>T?PZC1O/_H@[I_[.&=?\*K;ILP_H@[6/[.&"O\`"JI:
MDOIIH(@'C'E_7JTKA?:1CZ+/-7JW5JG1"?2Z4E9YN-@F?,H"(E(O).6Q%3CR
M^*FD)U##V%*(ZBRXWLTVS*JQ^!<=Y5W#210$A']"J;J)HJ2X*"F!7V1+D$#6
MTFXF`?\`28\\J7H`)R%/V!KS>Y^^7*`_^4)S$^V6OKF$#-:\T7S-DQ)$2_'*
M:6E"PU$CG`@/5@=O'2H(GZ1RG4Z)1-0;3L<Q--5^>=9;O.0\NW"0A9-K&VK+
M>2'A64%*.V:R+:2K]<8$CZ7`KL%E`7CEBUR0[@6*14$UN@!1CMB+:#MVQQDO
M'5[J4SEF0LU,EAGY)E(R49/Q;!ZR;/HX(Y-&LTGNJ<.^77,JR<-G;5@+$".5
MG8*F[FUL_+=I!R`%B*%<GIP`"E6?LXZOMQ``\8J34@V<@7^IH8WC^+S[![>Z
M&2WW:VKE6@R_A-+6!]++ASY]O<L3&(("(?B]W\A'GR-RY:!!9`><S/;RRCBF
M'XR%>JS5,Q0'Q@1U-O)8W,.8@!A;@/X?'V!SWO6S@1]UK1=IDIO_`$B+FR.8
MYL?Q<P%M`IQ"71'\7ERY=@\^T1];/&]%9*=:G5XA=;GSZ^0;>ZCCI#R$3=T2
M9G:O2'EX^D`^(.?(-7<W:-6B8)-6Z#9(.7)-NBF@0`#Q`!$BD*`!]`:]'(/Z
M_P"OM_YZ:ITA+Q44+(LG),(XTD_0BXXKYXV9B_DW)5#MHYD#E5(7;]P1%8Z#
M-OUCE4J2ADTC`0PA[^D7R\Q\@=H_F#F/_=KQOY..BVRCR3?-(YHD43JNG[E!
MDW3(7ES,HLZ412(4.8<S&,`!S#F/:'/`=HW<[8:<=1&?SYB=J\2,*9XQK>(*
M8F`4+T@%(L-".Y*4.MS(8H)$:&4,<HE`HFY`-@J;X<3R"8GH-,W"Y7'D)B#C
MS;CF-^Q5``(;^;L$_4ZW61*)5$Q!0TR5(>M('6<Q'E1Y;=)FE1N1W6MGF1(Q
MBLH5!O)YJRIA+#S!18Y1$I3M27&[V(@=$BRAB!!&<`DET@1$Q@*&+YK<SGW_
M`$M::R7P\\$,&C@K9\-VSM.9-E8I91<40;O6S;O20Z3T!,F0J*DKT3.1ZL`,
M`AK$\[N3H37NT,H<9C;)32-6I7<G$8F-MNJ3EJW,CUQA;/;[<,M30E,!@,DH
MDB5<Z)"@!!,8XZP[+[H^$^DJ*63N*9/99260.Z58/]WEC2AUDB@=)1)2'P82
MGQ'6JE(<I8\R/="O6"*"`]<038SN>Y_@$O*-;XCWSUV6+*P,@$A<*OC'/MQR
M#`<@*Y0DF&09BD3LE59=1XDD6+?RDLSCW3D#LY`RT:=^@?$/#EW]S]]I5KL.
MU;8[G[<=N.LK]I6LLV>QW/#>+,)X^@:NYFDL3U97(B3.OQL4@:DN&ECF(2LX
MS5DWMG?S:[EY(E%BX+LB+A;BQ;@TP-F+=/AS9G3WJ:`JT3:-0E\H9/%H<PG6
M9/\`.&:$_<B&E"%$J*K^IT!9+I)"=LMT3\AO2A<(;9A`6)G?,L5:Z;L\G-%T
MW9<B[NL@V3/4N#H@"856=<M;D<>Q!>O,==)O%4YJBV.8`0`A2$`-DT'7H&L1
M+*!KD-%0$'&H$:QT-"1S.)B6#9,.2;=G&1Z#9BU13`.1$D$$R$#L*4`U6/%X
MM------?/9Q*[/8>(QNFI?!EP[+R;/%J,95\Z<4C)%8E'D4^HVW4DDE(T';5
M&3L>(#&Y#W)2[-L>48=>A)QN-6XRPLY&&D)A!+?I5*M7:/5ZY2ZC#1]<JE1@
MHBL5BO1#=-G$P->@(]M$PD+%M$2D2:QT5&,VK!BW3(4B+5NDF4.1=5_33333
M333333337`"`B(`("(>,.?:&G,.0CS#D'/F/,.0<O'S\G+\//Q:=(H!TA,`%
M\O,.7Y_%KG4:-Y_]$'=/_9PSK_A5;=-F']$':Q_9PP5_A54M26$0#_O'E^$>
M7CY!XQ_NUB7).><-X@;]?DO)5/IQAZ/5,9B::)S#H3E$Q2,H-`Z\T^4,':5-
MHP6.;F```B(:CR[W?6>WH&4P-MZR7?H\R:IDKWD$C7"&,^KYB5%XA.WLJ$W+
MMN?)02Q=>.=5+M2,)C%`+-4;;D,F**I7S<?6,;QJ@(==2=JU.D+G93(=AE$'
M&2K$QF';-WR'JU%XB!:)E,'--0/P^F,P%MXQ^Z+=)_%DE>+(0ZBJN2-S5VC9
M&345,)0,XZW(DR\28BF)R=$8VMLNI`X`0A1,`#7IK>3@VO$3C7FX_;352(I$
M(A!U.UM<D3C5%/JB)MV\16W:8`H`*H@DBA%*A\<@$(<!#5"/NHQQ.)"O`GW<
MYE((%^)B[;MEN)@E^F05"IIS)J+58GJU2"F(*JV7J1(NB<7`%,8Q;=M&8[6C
M`2SND;),E1CYS'2*,3:LX7O!N.`2?E9/#HNRA;LG66SB#=5)%90J<41T1)8J
MANY1_GT]/>USB!W9IF&/4D<GX]J?<$+96V4$]RNX.%H.'QD4&49)(2]+DD*"
MFC0()"U2KNBQU&CW>09.6EHEP]DG2"23>WOIY7'BX4>LE4;J;G.%BUD6[\C)
M<J>\*^6\$S=4=0Y1:U3"RRH$$O1'NXK@S%(1!,YQ.JF&L8(\:^F*@J4N<MF\
MNL3I"1*A06][)`&2+V`LLI6MN0E:HN%.2;!=0#M)'I`9JY/XAIP\7W-<LZ$E
M'QE*7Y(ZR223>F[&-_LJY2<.5`!K$J.YZI4YD>572$%4!7&.CUBF(*CMJ`GZ
M%2?\2CB(3!#(X]V(9NGUQ<$1:NI?:!D^D,GARI@=T@J>_9XKON4#<IA,5\^#
MN5THEW.T.H=<IB?K&[RN-O8D^E7>&_!IF5556:'N\K1J(@K%HE`@JNTG^XM_
M(1TNHX$2I1*K95-1J`NB2`\RI:N.-RQQ\I@55E=K.UJK%42*Y0;V'*->/U9E
MS<P8F&OVFR+=<S*8`<&4'JS%*/5.7"G8.4V+?CDSR92/E-@=&%)X@4RJ,UDR
M?<.&JA.2R@)!0W;<"-Q$3=1TF[A=0A2D<$3,8VLC0V.N+LY71"P[B]G$,W,L
M<KCW&PO?K.NF@!!%-9$SV3J*2JRBG(IVJA42(DYJ%=KF$$PT;<4#;GQ(\KYW
MJ4:LYS-F@V.*]`2[NYXFV\6BMXE,,NZ?R;FI4-M#R]F"6G(=%-FK.3,H[;NG
M3Z71BEWW1K:)$=M&,-EFZ;.6(<7VV_[_`/>7BU2QT:">6#%Q*;3L:6NG/5(H
MC9Q4Y<';>2E0D8!PB$>]DI4)1S/@V4EC.!]U15"VI3@1X>N0@ODW=SO:OSL[
MDZKQ1_DRB1Z+QN=0I^Y3E0QJY=H](H&(JY;ODW!NF*A#)'*4=7_6>")M>JJ8
M)Q^8]Z0%(B5H@+'=/>*F9O'\C`M&D]X36I@JT<],XK]U`X<FZ9RD<)D$2ZOX
M.#-L4=B/OEK6<[L0A`*R2NF[;='84XSF/-4T85SEHO<AEP*D5<2"(*%11`0`
M4RCJHLN"]PQ&1R*'VB8]ESE3$AO?1+W^W)JG,`=-VNA9KC*MUY`X@)CR2B)G
MPG47-UX"NL)\D5[A8<."KG9*Q&Q_;"59@58K=>0P[3YMQR7!4JHKN)R.DEGA
MC%6.4#O#KG('1`AB@FF!,PP>RW9[62-TZ[M4VWP1&;H7K0(G!V,6(M7@J%5[
MK;F0JY3(N05*50%DS%.!RE,`@(`.LK16(\601%DH3&U!ATW"A%ETXNEUF/(L
MJ0O0(JJ1G%(E44(3XA3G`QBE^*`@'9K'.YO;%C7=CANS8)R@K:V>/[BXA%+,
MUHMG>4J4F&D#+-IIK$/)>)3[K4AG+]DT/)1H_P`Q((H%;.`,@91,\?MEW#+V
MT[";'>+'M\')T8ID6%B86V1%KR5-V^OR)8%^X?PLF$1)I%0;S489])-&TFB8
MJX,)-ZS5!1)1/JMA6FFFFFFFFH"\27?)7]@FV"RY?&%+?,LV:7AL3[:L,MC+
MGG,X[C,AKGA<68RAFC,0?."2DV<LG8E60&<1]4BIMZ@15TFU;KV!PK-C<]LO
MV_RTCF:;;W[>/N4N4IN`WFY8!5-ZM<<WW119^^KL2_`!Z%"Q<P=DHM$BV7<T
M*W8,)"8C8R.&?=-PV<Z:::::::::::::_!RH*3=90#I)BFDH?K%S=!$G0(8W
M36/S#HHEY=)4P"!BI@<2B!@#7S/\/'</ND5WFY=Q5N4S]G2N9WM548L3XBS?
MCROWS:=DK)[+`=<R(M8-HN6,-JL:/1*K5C%E[M7<:K6PF1,H;?)E.P7ZHI9.
MJ%CN[/*55W+[RY##;C%.1L[P#/-F6.,'==CLQG#&U-A*BRQCBAO$SV29(F#:
ME?4<E1\584:?2)&@8^<Y)5R8[C)RT$L4LM8GS)DW#R8VRUNJS3FJ)X>SG=]?
MZ@CCW,V_6#L6Z6F1>&"[E,B4;;)$;/9O$%4>KS6*9K#Z%H:+;R637+4W"XDB
MWEE;X@9HD0B1M%I5>[3.'7G2[[DME>WO,F2GD-*9!M=&%M=9VO-F[&#LUHJ<
M_.4B;MD2P:%(SCX^V2%:7LK:.9)D9,$Y4&;,A&J")"Q;XCFXS(C:9;;/,65E
M(]DS[C6[5N1L-^@)R&Q\:OV>KV2)G`@+P!$6+ZPQ$.5T=U[G'?L:E)/J\K;D
M4VDW&MW<)L/\7$<40./MGT31V%PSQ3:O'8^J5.AEE969F8/%3<<:GEX2G%>P
MEEL[1V_K)3"^<N:^8S@[HIF;<A2HI65F7>5OYM`/&TKM(XBLU&JF62/7<9X8
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MRCA5AU#1+DP3ZG$NV2KKE5:N!,X%RFZ35=`5!N\!=!ND4+A[S^Q.6`@9&PSQ
MWLQ@!4R+IY1IO$KFVSQ'IBL];.V$4G!1RC24<B#I^T(T3;"N4HM4FJ903UXY
M[;WPJ7%9LK"M<,C>FA<9.OS,?7KKDGA_;X,S#`V%\R<)15GDH>[F7-9%8A^H
MW>+-%)..=2C-J$2I*MFJIC%A%LVV'82VJYYJF8;36][FX2LPT;/0]@Q9D;@G
MY[7@[`SFHL[5)Y&OIAU:6M7L$/)IL92+FV<$Z4001?0_4=P2KDI=\M>W8;4J
MD1%.J\/O>#64V[=1H@G7N%MG"%30:K'ZU9LB2-Q0V!)NJK_.*(DY)G/\<Q1-
MVZR>WXCF-6A")-=J?$.:IIID133;</7<ZW(1)(H%32*5#'Z92IIE`"D3``(0
MH`!2@`!KT!Q)Z`'_`.5WB+_W\/[=(/\`SH@Z#Q)\?CX]K7$4'_XN'UNA'_G0
MAT#B3X^#Q;6N(F']7#YW0!__`$+7;PE-!\USB*_9];H?W"T\)50?-<XBOV?6
MZ']PM/"54'S7.(K]GUNA_<+7`\2C'X]H[6^(H(^+F/#ZW0>+R?\`J%KD.)30
M`[`VN<14`\@</K=#^X6GA*J#YKG$5^SZW0_N%IX2J@^:YQ%?L^MT/[A:>$JH
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M>%>.59&O1C,THO'PMGAU5U]Z(<2F@```&USB*@`````</K=#R``[`#_U"_!K
MGPE5!\USB*_9];H?W"T\)50?-<XBOV?6Z']PM/"54'S7.(K]GUNA_<+3PE5!
M\USB*_9];H?W"T\)50?-<XBOV?6Z']PM/"54'S7.(K]GUNA_<+74_$LH!"'.
M.UOB+F`A#G$I.'SNB.<P$*)A*0A:$)CG,`<B$*`F.80*4!$0#6PN&DTYJ(BY
MA)I),4I6.8R2;*9CG41+LTW[5%V1K*13Y-)[&2+<JP(OH]VDFZ9.B*M7"9%D
MCE"I::::::_)9!%RBJW<))+H+IG16063*JBLDJ04U4E4S@8BB:A#&(H0Y1*<
MAC%,`E$0'6AMEX66!]K^<+-F2KV3)UM9MFT-$X*QM?+Y9[30]ME=C\<QV+7<
M+BV)EYAXD03TB,;4BN3$TF_G*-C0@XVJTBRK+J41DLW7?8IM^O.-\EXT=15M
MK[+)F='&YIU:JA>[-7,@T_/PS,+88[*>.+HR>^Z]'L<),U^-=1B,0<(7N4'\
M+(Q,C`3$Q%/L1ON%MMR4QK1:/`V7/]'N=`O&1\DQNX>C9VO-<W+3-XS.D+;,
M\_;<R-W2L[:%<J,R,&EI82K=:(:I5^G*52/K3FB4EQ7YOXFQ50<&XRH>'L65
MQI4L=8SJD)2J97&2KIPE$UZO,4H^-;'>OUW4E).^I1!9_*RCQ[*RS]5S)2CU
MV_=.7*L/N(]M^QQE[;5EZX71E*N)S$V',LWBDNXR;?0QXVR5RAV*?AWBQXXR
M*[QLA)L6RKJ+77&+E4""RF&4@R.=N:,F)^%7P_\`=#LXV]);C-L.,LSR%DP5
MBB><6R[PX.<AQ+ZSX_@Y^P>]?)<4I$9"JS>5GI>3FW3>"L[)$\F[%T!2F1;%
M1QV7@PY2V_B+OAR<3C>7M-:-BII16',LSD5O4VT1;%N<ABQ,7C'.PJVB!;.D
M"`Q7>1.1`D$&_049J)."'46_,,^\=S:^8$LV[*=L7$&HC-0R:N0-E.77V"<O
M-H1`I>4Q-8-W`).H"QV%40,*T%0[FV;J'/\`Z&)2IE25O&B<?78,O8F&/]S:
MF;>'QE20,=-''F_+"=PP"94Z!CINEFF1'C:<Q$\8$.3I(/AOK9)V@=-9$@E$
MX)[?J#DC'&5JVPN>+[S2\D4^4("D9:Z#9H*Y5J12$.D55E/5M])Q3E(Q1`Q3
MI.S%$!Y\]7J`)F#F4""'E`"B'YPUST"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT
M"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT
M"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT
M"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT
M"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT"?BE]$/5IT
M"?BE]$/5IT"?BE]$/5IT"?BE]$/5JV[7;JC1*[+6Z[6.NU"J0+-60G+/:)B,
MKU=AF#<!,X?2TY+N6<7',VY0$Z[EX[121(4QSF*4!'7P%<3S^4F1V[[<O,<-
MO;7/.Z#LDR[=Z=MMS/NRQ[69N^9SMU<L&28J`RS-8#KU>DE6CFEVNJ#*4&O-
MDX*PVV[0\P[LL$1E[IQ<&M]Z>(,3X]P9B['^',55>-IV-\8U&!HU(J\4V*W8
MPE:K<<A%Q3!(G1*=11-LW*=TY7YNGKU1R]>&.[<+G-D;H$_%+Z(>K3H$_%+Z
M(>K3H$_%+Z(>K3H$_%+Z(>K3H$_%+Z(>K3H$_%+Z(>K3H$_%+Z(>K3H$_%+Z
M(>K7;333333333334:-Y_P#1!W3_`-G#.O\`A5;=-F']$':Q_9PP5_A54M27
MUP(`("`@`@/C`0Y@/]8#JT+SCVAY.K4E3,D4NJ9`J$PB=M+U2[UR&ME;E&RA
M#)J-Y""L#*1BG:"B9S$.FNT.4Q#&*(<A$!T_W_@"\/F0LK_(6W2#S#L$RP_Z
M(CDS89F>Z;=)!+JE1<-TO>+"NY7$:[5-<>:C13'Q45T>397FW*1,MFCMSXY^
MUT!5P+OBV[;_`"C,U4Q0QOOJQ`]Q!E9G!(E3(>+B-P6WU<S"QV!7JQ40FK[1
M"H'454*]Z?Q%D^A>,CG#``$:<17A:;R-LC)N"ONIF3!<9#;V]N48S:],59R<
MO6%13N=78.D""\0:RU`<O6Z8*(.1!5(AEY^;7^)KL#WFI,R;:=V6%,HS;U(J
MQ*.PN+&`R<U3.(EYRF*K?[WLD1!RG*9,Z4C5VYR*E,F8.D'+4YP.41`.?(1Y
M\BFYE,/+QB!3<C<OIY:Y`P#S`!Y\O_'9Y0_!S#LY@(>,!`.=------------
M----------=#J$(!A,8``H=(W_NEY"/2-R_V2@`"(F-R*`=HB`:U4;E>--P^
MMM=I-BY;,"^?,_+'<-8C;9M/K4ON1SG,2S9)1=2#]Z.-$Y:/KDJ)$PY(W6>K
M"9.L3,JH0A@-J-0YZXWV]`.IV^;7\0\,C$$IS[GS!O6E2YLW,.X9RW*+>7K.
MV'&CQ"G4:QM'"H":$RS<9)$"-C`N@!E0(6X:MP)<&Y$L<1DCB*YXW#<3C)T4
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MFX1CJ%MJQAE_<#N*/F&U8FQYAO>#2[UAF:PK@]I4!NN5I+<L3&$;`,R'L%ZJ
MM'A*Q%4.>6>W"PQ#9Y-1D$E8Y^NSLVSY]J6Z/`F*=P-(8S$17,JTV+M;2!L:
M+5O8ZT\=`HVFJK8D6+EZP2L%5G6DG7)LC!Z]8!*1;H63QTU%)<]M[SQ#X(6Z
M<.W^CAG7\`\O_95;OP\N7_?KC9@8`V@[6.PW]'#!7B*8?_PJJ7D#4E^D'D-Z
M!_NZ=(/(;T#_`'=.D'D-Z!_NZ=(/(;T#_=TZ0>0WH'^[KJ($'F/1,`CRYB4J
MA3#R\7,Q0`1#Z!'EJ`VZ+A<</7>:+EWN0VD8:R'8W7/I7\E3)3LJ(#V"0665
MZ"I5LCLC)*%(LB*%G*5)<A%B%!0A3!`29X0NY_;K$RLGPT^*/NRPL[8,7#FK
MX#W32T1O$VU+.&#0XQ-,9MLIQ3G(V-JU+KI(1TG/P%DL<K"-EC2;&-?JM"L7
M.@?A-9[_`)3.WWR[[:1<,5QN8I.-GU9S/-8W<V>R8QPK0\I&1C?>:RP+=JA"
MS[.-"STA)F2L5;'L5*XWF\>A7;;+*Q1`@I]_]%:^[+CJP/5N'G"!V[7A)STD
MBL*9Q**M!/HY0H%5!T^<W3"+9DX:G)TFQ$&'6.0<""J@D;A\;QEXA7%_B1Z%
MIX"M_538J#[LR%`XA>TFVM#-2*\UG-992J57FIY0K8Q3-V3J/AW#IT51N!4D
M@*X-40XJ.]&%/U=UX'W$&8F<E`\:-'MNU[))%03,)'02BL3EN-3AC$$Z`M2.
M#+'>D,NH0J9&QC'\1>-A:6!R$L_!PXUD*1N?N>7>Q>SBL7ADQ<D$4518I4K,
M4Q-6!EW6`)(/H:&<)KH')("FDQ!19.J-N.;B5(JA;3L*XN^/GQ1`Z,3<N&WG
M="1>-!((A(-B0;><;=Q&5*JV`[AR@L*Z"W\SU12JF.?Y0=PX88B+FY3.Z6@Q
MBQNH"7N.Q/>-&QI7PI&63C17:X8D5#OE2IK`FDB@J0106.94J1.L'LV_E&'!
MO4$J4CO%:5=X*I$CQMWP=N4I$HV*H).J<OHZT8;C';!@J10JZ<@]309';=-T
M"_<Z:BA<GPG':X0$^Y7:L>(;MA;J-T>O4/-9`3K;<Q.M*CT4'EB8Q31RMTS`
M/<[9=5?J@,MU74D.H6+&[K^4R<+3:O8\!P45F^O[C&F8K0BVMMBV\3\)DB$P
MGCP'#N+?9$R`XA'+PZBK6:3;D0Q]$D6O,A`I3%C;1H-F<,TLF\?&F8<5YEK,
M1<L49%I.1ZK/Q;":AI^D6B%M$5)14F@+A@_:NX9Z[(=LZ1*8Z1C`0WQ%"'(1
M1)4A,C=(/(;T#_=TZ0>0WH'^[IT@\AO0/]W3I!Y#>@?[NG2#R&]`_P!W3I!Y
M#>@?[NG2#R&]`_W=.D'D-Z!_NZ=(/(;T#_=TZ0>0WH'^[IT@\AO0/]W4*]V/
M$7V1['HTKW='N2QGBJ2<(I+Q5)?S!Y_*-C(NIU*'O5Q-4F\_DJSBLX$J!!A*
ML\3ZTP`=0A>9@UT&XEG$0W<F&.X;O#2NU;IK\.@PW6\29_(;9L1D3,D"S2>K
M."80)C<#DVL2R"J:T7+QK>M(J@`]THHD,!@_$O!]S_NI,$IQ3^(EGC<9`/S@
MX?;6-LQG>S[:8DT<("FYJ]BB\?O399RM&LE#J]P3=HNT!*.$S])XUZ1N@7:W
MMLV<[5MGM5]Y>V#;_BO!E?431(_0QS2HJOR,XH@1---Y9["@V-9+5(]6DD12
M3LDO*OU@3)US@X@`ZDJ`E`.0%$`[1Y`F8`YCVB/87\(^/7/2#R&]`_W=.D'D
M-Z!_NZ=(/(;T#_=TZ0>0WH'^[IT@\AO0/]W3I!Y#>@?[NG2#R&]`_P!W3I!Y
M#>@?[NG2#R&]`_W=.D'D-Z!_NZ=(/(;T#_=UVTTTTTTTUB;.U7R3=<.Y)JF'
MKO#XXRC/4^;CJ%=;%5(Z\5VOVA=H<(EY8:E*I+,K!`*.`*SFXU1,55XIT[[E
M$KLJ`A\\NV;A;[H<;%S7E6%V[;$<2R\WN$"XQ.S27<V"_;;<I-:9N;S/D9GE
M![8^]''P^$LDQ5%OE:I^W#)F/L`REEK%.H\([R!"*KV1.IX\D'BGAV[M=M=M
MC]T6"V.UX,Z63,F[Z^W3:TZN60:#M?I5*W:U[`#-W4L:9/KN(K#:%9JFWK;#
MCK*5IGE<&U>/RK9[OELA(>D+R-?E$-I.R;;O(;4=JV$L`3=J3O-CQU2T(^VW
M!NR/&LK)=)>1D;/=)B+C53'7CX=]:YV95A6+E19VTB19(.UE7)%5#1KXCNR?
M:?F?".XW-65<!8TON5:[MERPQ@[W9:^E(V*+:UC'5YE:\BS>J*!U18:3?NW\
M>()B9NZ7.LF8#]$Q<0;4.%3PZ;5M=VW66P;.L%2L[/8!PM+S$H\IJ)W<C*2.
M,JL[?OW:A'!`5=/':RSERJ)0.LNJHJH)CG,8<_\`@BN&CYE>`OJ6G_F]/!%<
M-'S*\!?4M/\`S>G@BN&CYE>`OJ6G_F]/!%<-'S*\!?4M/_-Z>"*X:/F5X"^I
M:?\`F]/!%<-'S*\!?4M/_-Z>"*X:/F5X"^I:?^;T\$5PT?,KP%]2T_\`-ZY'
MA&<-,0*4=EF!!*4.12C32"4H<@#D4!=\B]A2AV`'84H>(I0#CP17#1\RO`7U
M+3_S>N!X1/#0'Q[*<`CS\?.E)#S_`/\`:UU'A#<,T?'LGV_#_72$?\UKL7A$
M<-`@@8FRG`)#!XC$I293!V<NPQ78"'9V=@^+L\6O23A+<-Y(.BELWP<D41YB
M5*K*IE$?%S$I'Y0$>0`',0Y\@`.?8&OU/PG>'*H``IL_PLH`#S`#UUT<`'Q<
MP`TD(`/(1#GX^0CY=4MUP@.&,_%49#8]MUD173%%P,EC]E("X1$@I&1<"\67
M%=$R0BD9%43IBD(IB42#T=6]X%#A)_-S[/OU&TO_`"&H5;O_`.3(<*[=2XQ`
MY@,(PFV,^-;PTG+,3;;"0N.T,LT910BT]CF[-F38&H(2JC=K[G72-01N-71[
MO;0L@1"14(CG.Y?R>7@ZW)5-X&R>C466;M"LV<YAZY98PO+M$R-2-"J)NL7W
MZKD67.FF072KQ!T:14ZT\GW:+EWU\,,E?R4GA[6]55[1<R;X,./2*E<1Z%5W
M%JW"%9JI'641*K&Y4J=U=OFQ3J)`HV=S!P63;)IJ*""KHR^($OY-!DK'KKNC
M$^^'$UWBVYT>Y:ONRX=V`LRG7;(G1*"#V[T^PXVLAE3HI!W0\!L=9R<SDXD2
M7>J.D?&_X2?$!HSDIT=D_`)W%5]N<H""=`W1[;[V_3!$A1,)49')='3647,8
MX@5-NF@FB?D+@SQ-*/\`,E@C)M`7,GE_^2VX>MT,W.H*]LVQ;M=O^2Q603(L
ML*C.BWMICBTJ*F(0$T&_7J"NH0P&.@LX:-%>2Y;X4%5<"US[P#=\^W--N94)
M"Q7/A[V"_41J1!42+NDKAA>W9#;.FB:9%U^L29`L9LU6<D;G;JL57EUTO=!_
M)3[E(D@UT]J..;"7D5Y`9PPIE;!4E'*\P(=)\.6*74X]$2*]-$52R"C90Z*X
MH+K)HG4U/?%^W/\`D_N;2H&PY!\.G*AG!!431Q]D+%5M="4`6$P&9PMT=O$S
MI]S.2JIJMR*)';."*$(9!4"27?<*3A=Q<8\FY+9[MT80T<R=24A+O*JU;1;"
M.8HJ.7L@]D5GQ&31BS;)*N'3QPNFV;()*K+*D33.8L2(S#'\GLEMO['=4VK>
MP9OMUDGDW&,,PR\Q5("CNY:NR2T1+PS>6G9F-%:;:22`M!A4T#2JRBK0[9FL
MB^9*N-=#W(W#1W`NGE9X6O!3E>(/*=<HQ1S*3%YMM6SZ+>).S,77NCN%S2C$
M#-BQ,FX>@VIM,G"RC-OSC)`XN&ZIJM"_R=O*NZF0B9[>-:-LFS3'R+E)Z;;M
MPR,4^]^UO&R;HSR/:W?=IEPE@N[V1;I`@TG6=.J+*M22@+F8%;("F.ML^*^`
MKPE<3P#2(8;*<37J71<)2+W(&9&TQF+)TO-$33(I,OK_`)!E9NPHNU3I%7(W
MB',5%,EOC1D:Q(4B9,S*<(WAJJJ'65V78%664'FHLM3BJK*"'B%151X90X_2
M8PCKKX(KAH^97@+ZEI_YO3P17#1\RO`7U+3_`,WIX(KAH^97@+ZEI_YO3P17
M#1\RO`7U+3_S>G@BN&CYE>`OJ6G_`)O3P17#1\RO`7U+3_S>G@BN&CYE>`OJ
M6G_F]/!%<-'S*\!?4M/_`#>G@BN&CYE>`OJ6G_F]/!%<-'S*\!?4M/\`S>G@
MBN&CYE>`OJ6G_F]/!%<-'S*\!?4M/_-Z>"*X:/F5X"^I:?\`F]=3\(CAGJ$.
MF?93@$Q%"'34*-+3Y'(H42'*(=U]H&*82B'X0$=;"X:'C*]$1<#",6\9#PD<
MQB(J.:$ZIJPC8QJBQ8,FR?,>K;M&B"+=$G,>@DF0O,>6JEIIIIIIII_X_/X]
M--1HWG_T0=T_]G#.O^%5MTV8?T0=K']G#!7^%52U)?333333333333333333
M3337`E*;L,4#!Y!`!_YZZ]`O+D`"4/(0QB!Y/^@)=6C;L>T._L#Q=ZIE3N<8
M<IB'C[;6X6RLCD.9(QR':SC%^@8AC((F,4R8@)DDQ$.:9.4!\E\''A69;%TI
M=^'UM)=O'I`3=RT%A&DTB>7`I4R%,>?HD96)D%4TTDTTEBOBJI)EZLARD$Q3
M:^MP?\F;X?UVPGE?&VV13-VT"SW^FRU=C9?&>XC/LSCI!T\16ZEC<,.V[)<W
M2[=1I-0Q&%JJ7<T8$C#JO"QKV,E%0?FA3P./Y,;3=GK:PYFXA];Q/N"S:M-2
MT7C/%,E%1&3\-XGA8N>3%#(K-"U0ZK"<R7=O<6+E(]^,4U+3*QW!&N$W%G<R
M`0/U\,8YA&,VL?',VS%@Q01:L631!)LS9-FZ94D&[-J@1-NU012*5-)%NFFD
MF0I2D(!0``]FFFFFFFFFFFFFFFFFFFFFFFFFF@B`>,>7B#M\HCR`/[Q[`^G4
M.L([_-HVXS+M_P`&8:S56+ODG'**CN8AHY.508SD:T,S1F)G'UBD(]I7,G0=
M;>R,=&6F:Q[*V2,K<I(1[&8=-%'[$7,Q=1HWG_T0=T_]G#.O^%5MTV8?T0=K
M']G#!7^%52U)?33333335@0N4:%8LAWG%,-8FS_(&-82C6.[UM-M()NH"%R5
M[Z?>0_<N5V:4<X3G_>5:.YDV+QVNW]R%N[DFG7->Z+_TTTTTTTU8.0<H4/%;
M&MR5_L3:MLK=?:-C"N.'3>0<EE+WDJQLJC2*\D6/9O%$G,_8I%E&-G#DB#!N
MJN55\[:-BG7)?P"`@`AXA#F']0Z:::::::?^/SZL7'F2Z/E>!?6;'U@;66"C
M;A?Z`^D&K=^V2;V_%UWG\<7V$,G(M&:YEZY=:O/0+I9-([-PYCE5X]R\8J-W
M2U]::::::::L":RC0J[D.C8IF;$V89`R5"7FQTBMJ-I!1U/PN-?>M[]W[9R@
MS5CFZ<![]:OW2F^>-%W'NNCW"D[ZEUW/?^FFFFFFFK>MMKK]$JMENULDDH:K
MU"`FK19)==)PLC%P->C'4Q,R*R+1%PZ528QK)TZ43;-UW"A$3$1155$I#*E:
MZ_>ZK6KM4Y)*9J]O@(6T5N702<(HRD#88QK,0TBBB[1;NDDGT:]:NDTW+=!P
MF18I%D4E0,0MPZ:::::::\C_`*SN)WU34CY4&R_5LE%"))O%.I/T&JBJI%$T
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M1AYM?VX.H'?=@V`A%\!875B(-[L/5FWD3&GQG5A8QSR84W71IY1VR:BDW=2'
MN='E>+IJ.",&1%"M4L^]X?B7_."X$^S['VN].\/Q+_G!<"?9]C[7>G>'XE_S
M@N!/L^Q]KO3O#\2_YP7`GV?8^UWIWA^)?\X+@3[/L?:[T[P_$O\`G!<"?9]C
M[7>G>'XE_P`X+@3[/L?:[T[P_$O^<%P)]GV/M=Z@CAO#'$&<<0#>_'QV]S"T
M;:6>%MC:UCM*^R!>0BK''N4]T)*]'QE9/NB:D@',`9M,GE'X3DR,Z:98E3:0
MJ<1T9*=W>'XE_P`X+@3[/L?:[T[P_$O^<%P)]GV/M=Z=X?B7_."X$^S['VN]
M.\/Q+_G!<"?9]C[7>G>'XE_S@N!/L^Q]KO3O#\2_YP7`GV?8^UWIWA^)?\X+
M@3[/L?:[T[P_$O\`G!<"?9]C[7>H)[^<,<0:.I6W0]JWN86M3=QOQV.-(EO&
M;(%ZRK$V1UN)IS>O6)XNENCF_=2*K\LJUEI2O]3'GGFC4\62<A0<G?I3J+@?
MB7=$O+B"X$_V0_\`T^Q\G]KL-=N\/Q+_`)P7`GV?8^UWIWA^)?\`."X$^S['
MVN].\/Q+_G!<"?9]C[7>G>'XE_S@N!/L^Q]KO3O#\2_YP7`GV?8^UWIWA^)?
M\X+@3[/L?:[T[P_$O^<%P)]GV/M=Z!@CB7`)1\(+@3L,4?\`ZOPP>(P?A+N\
MYA_=V^3MU"#A]X5XA;_!=V6JN^'"U5C4]WN_5JYC);8XI9G3F>9;UL\,K//)
MR!MT<$#>/L]C;REBBX4&2WO=CI-M`>ZLX6-+,/9O]X?B7_."X$^S['VN].\/
MQ+_G!<"?9]C[7>G>'XE_S@N!/L^Q]KO3O#\2_P"<%P)]GV/M=Z=X?B7_`#@N
M!/L^Q]KO3O#\2_YP7`GV?8^UWIWA^)?\X+@3[/L?:[T[P_$O^<%P)]GV/M=Z
M@CF3#'$&;\0#9!'R.]S"TE:7F%M\BU<M*&R!>/BJY'MD]KQ+#'R=9)NB=$GW
M,^9S#'BWXSD,,$:&?%4:32<OT8V=W>'XE_S@N!/L^Q]KO3O#\2_YP7`GV?8^
MUWIWA^)?\X+@3[/L?:[T[P_$O^<%P)]GV/M=Z=X?B7_."X$^S['VN].\/Q+_
M`)P7`GV?8^UWIWA^)?\`."X$^S['VN].\/Q+_G!<"?9]C[7>L`;K\(<1MGM<
MW).9O?A@R<B$=O\`FI23AV>PU6'=R;$N,+4+MBTE4MV$@>.=.D.L1;/>X'Q6
MJYTUCLG9"&;J["=FW(-H^UT`3.D`;=,'<DE#"8Z8=ZRI\DSF$I!,<@?%,82$
M$1`1$I1'D$D]--------4]K$Q;)Y(2#..8M7\LHV5E'K=H@BZD5&;8C)HH^<
M)IE6=G:LTTVC8[@ZAD&Q"-TA(B4I`\TM8X"!4C4IN;B8=69?I1<0G*23*//*
M2:X"*,=&D>+H&?OU0*(I,F@+.E``1(D8-=W$W"(RC.ONI2,2F91J\=,(9=\T
M3DY!DRZLC]RTC550=O&K05TBO%D$%46PJD!P9/IE`>&TW"+R;R`:2L8M,139
MFYD(=N]:*24<S?`H#!P\C453.V;9X"*H,E5T$D7/5'!N93H&Y(>?@["BZ<0,
MQ%S2#%^ZBGJ\3(LY)%I)L3`1['.562ZZ;=^T.8I'3)8Q'3<P@59(@B`#5]--
M--=3G*F4QSF`I2E$QC"(``%*`B(B(]@```(B(]@``B/8&K=9W&IR,"O:6%FK
M[ZM-4GB[FPLYJ,=0;=&/$Y7ZR\P@Z4C4DF(I*`\44=%(U%,X.#)B4W+]75DK
M,>Q8S3V;A&4=-*QC:-E'4G'-F4HM*&`L.W9/UG";=\K(F6*$8BW66.]%4.XR
MJ]/M]#N?@V$G%PSV7C&<O-]U##1;J0:-Y*6[A3!9[[F,%EDW;_N-$05=]QHK
M=RIB"B_5D'GJKZ:::::HRMC@$)QM65IN)2L3UDK),X%629)S3J.0.*2[]M%'
M7+(.&2*A3)JNT6QVZ1RF*HJ4Q3`'9"9@Y"2D85O)1CR6A08KRL6B\9N)"*!Z
M0SB.6D&)%3NH\'::9EV*CI%#NA,AE6QCE*)@_<):+%N_=!(L1;1:CI&2<`\;
M"@P58DZQXF]5!44VAVB?\XZ(Y,D9NG\=8"$^-KM&2D;-1[.6AW[*4BY!ND[8
M2,<Z;OF#UJL4#HN6;QJHLV=-U2"!DET%5$E"CS(<P=NO=IIIIJG2\Q$P$<[F
M)R3CX>)8(BX?2<J]:QT>R0*)2F7=OGJJ#5LB4QBE%5=9-,#&*43<S``^1W9Z
MXPCX^6?3T,SBY9:.;1<DZE&#9A(N)<Q"Q2#!XNX3;/%I,RA"QR39551\)R@T
M*MT@YU`[M@T6:-%'#1LO(+.",FQU44%7BY$E7KDC9$QB*.%B(IKNERI$.H5(
MBJZH`0BAP[=W,^[?<[NMMW?W+W;W%W0CW7W)UW<_=7<W3Z_N?K_YGK^KZKK?
MYOI]/XNO5IIIIIJBL;'`2DC+0\;-Q,A+0)T$IN,923)W(PZKI,56J4JQ;KJ.
MXY1RD`J-TWJ*!UR`)T@.4!'7:+FH*>15?PTI%2[=D[?1JSR-?,I%%J^9+=1(
ML57+15<B#MHNEU+UH<Y%VZI.K<)$.4"AYY&V5B'ADK'*V*"C(!<K,Z,Y(3$:
MRAU2R!B%8&3E'3I)@<KTRJ96@D<"#HQR`@*@F+SKQ3%.4IRB!BG*!BF`>8&*
M8.8"`AV"`@/,!#L$.T.S7;33335&F;'`5TK$\_-Q$(23?H14<>7DV,81_)NN
MEW+',C/EVY7;]ST3=SLFXJ.ENB;JDC]$>7=U-0K>1CX)Y)QJ$M-)/3Q<2Y>M
M$I"418)E4D3L(]94KI^FR24(=\9L@L1JFH0SD4R&`1]9'C$'1HQ-RU!Z@U1=
M&8D61!RDS555;(.!:E-UQ&RBS==!);JP1.JBJD0PG2.4OAA[%`6$CU2!FHF:
M3C7[B*D%(B1929&,FT$H.HYX=BNX*U?MA,4'#-P*;E`3%ZU(G2#G6=------
M--?.9Q=QVA7/-LYA._DVTR^Y?*6TPM-A+YOES!C*A[;]FF);3;LD,4\\XZKM
MT7)<YO<+;+:UD'L<PP\S:6:?+AFB%N>5<+UZ#K\Y.1ROK;`\?D[-;BWV^I9"
MX@-&XD_"[INT*\6B?IL]N,GMNYXG9"Q@9W#3]9\K9WN'<ET=YNOMV7C5(YZI
M8U)7/C^SE=D9SBK?!TG9,'5/'^,\C0GNB_X@)+AQGC;Z5L+351CMYKS&E4PC
MO2<6N*R-)0_=UVCHNIY%AMKJ&W\UKCY&OU5=#"PTZ*5;.(!B_FUP686"H&Y/
M)]*A;3LTO!I78ALTGGD]PZ*\WJ6WGK(.Q98C"2V;81M/6=.2W'W8TZI(PMZ&
M0AE+ABR`(FK3H'W#35?_`$KZ::::A1Q%IC!,#LMSU*[FK#=Z[@EM6(HN238[
ML"%7MEF@G-PK;1/&[&:>/8J.;,LL2B\?C">0EYJO0DC7;?+1LW9*Y$O'LY'_
M`#Y0%9VUJ&J>2Y^1V68ZV?;@N(MMF;[CMHNU_+6(\F;9,&4BH[8MP\'APNZI
M[23QN%5KAG7<@WPD;)D?%5MKC9S*T3$E0:V'*1HIS<YJS,:([*Y2ZS=7W6'P
MT?ANPU+XM[C9+'Y0>XS)MN%"O[J::RL4C@52;=A2UY>H4AY96NWY]4CBXK6+
MG-P[W:K&#)+')A#+B%J3PY6IFU16WS+>]R][.N%-+XQLNX+)%RJ6_;:IG%I1
M,=Q=?KVV['LKB^R3F2)/*N6(^;OX26(LD4J/1RE+Y4A,_`XA*\X;/?N$)XA\
M?^T?Q\^?^V;R_@\GX.7+EV<M=M---=3\NB;F(E#HCS,`\A`.0\Q`0[0$`[0$
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MG-L[@Y[1<@5N]9#NSJOL9M3AQ9'L=DGI+%\E+K5.*RY)338B-PNQ(A*WO`3<
M0[^1%IUK4)8TC&,11.,[DNSQ]@O\Y(92V"1UDFFUTR!:[I#UY6*W-+1S*%QY
M"6.4?QF.JJ1)PNZ6J].:Q$&ZE'#B6=,UI)=9TIMTTTTTU^+DQ"(+'46!N0B2
MAC.!,D0$"E(83+B=8IT2@B`"J)E2'3+T.D<IB@(#\8B([?KKB;/>9^'Q:<,X
MQ?XBX?N]2KT*5I>=L:V[B=[Z)#(5;@Y:U;@L[P=`D0MK)G5PK\_EJ@!DF5LV
M:)3)=HBK5)U3!B[0U4L6RK;CB79YE#/^]+#&R*>@ZAL_M^R'9M*7:;V4Y'2Q
MK7&N;3W#<*\C'D/D#"4S&2%?RQ:<$Q6.$LG/&$BUL]GQ\M11M*[MF_BU5H^2
MEOVGU'A]\&&,SU2<.9IR5*;(:O%X#PGNMRSC#%^S=)<^$\&PU[S=GY]EAA.0
M3Q;&<-(0U2I;FO5')63>JRC<(FB4!\$[9;/5]Z/#WQU%8DV5;:L:P>9*OG^(
MI>**Y`1V6J+,I3]"MK5D5P"1Z!)I3MGZZ@P@'&LT=%6PS3IE5(2'8/))T[:K
MJ#,G33337SV<760VA369XG%.48C;C?MQ>2MK=RJ5&+OKS!CK'NT3:_C&U6Z4
MB9O<.G#WWK;%,YELEF0:PD-'X9BGN0+5$XT9PLG=L,U=DYNKR#>:(/!U62W.
MQ5ER/`9DWTXJRIPF:AP\LJ6R=IL]G^\8V1QWM*C*)?ML<@_E9&UO:QF#,`[F
M['EE;'<@^C+21_DU&S/9F)8O%B;05L94S&_$6X@TU,W#.SZ"R9PU,=WR^OVF
M0<D7R\U")-FC=\QD8O`+`7DY,X^1A81%R\H=&QC'LFC.U*ED(6&6G7RJKG3,
M^R'@W;ON`O!MJ<(C.8#N>"-N9\51?!HG&+"W-L?P+_,YJA9]];5&N6*/DLQ6
MZ%G&P4ZU)G:RD[&05K:2X/%(5L[4^T_333333335EV+'&/K>[(_M='I]E?)M
MP:)O+!5X&:=)M0,<X-B.9./=KD;@90Y@1*H"0&.80*`F,(\K8YQ^XM4!>G%'
MIZ]UJL.YKU8MZU8@U+178!Z42O(2"L)V`S$/#NRB)747&O6S%P41*LW.`B`_
MI'X_HL3;IZ_Q=-JL;>;4SCXZS7-A7(9E;+%'Q)"IQ3&=LC5BE-3#.,3(4D>U
MD7SE!D4I2MDT@*4`\U'QGCG&;:598YH5+H3.=E5YV::4NJP%4;2\VZ`I7,Q*
M-X".CD9"5<%*4J\B\(L\6*4H*+&``#5\:::::ILO#1-@CG41.QD=,Q3TA4WD
M9*L6LE'NB$4(J4CED]17:KD*H0BA2JI'`IR%.``8I1"S^])BSWO6&H][:@C5
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M-R*P);[7%5R%CK+:2Q2/<\66R3S-BA+3I8UO_,,`E7CL&:/\TV!(GQ=51]6Z
M])14U!R,'#OX6QI2"%@B'L6P=1DXC+("VE$9B/7;J,Y1*2;&,W?IOT7!'J!C
M(N053$2ZZ5BK5JE0$55:=7X2J5B":$80M=K<3'P,##L4A,*3*+AXELSC8YHF
M)C"FV9MD$""8PE(`F,(U[33335NV.HU6WMD&5KK4!9F;9;NENUL$+&3;9!P)
M!3Z]%"4:NTDEN@(DZU,A5.B(EZ71$0U;<IB#%$Y`Q%6F<9X^EJS`3K:SP=>D
MZ56'\%#61FNJZ9V"*AW<4M'1TXT<N%W#:69-D)!!=995)R114YC7XLR9N%VC
ME=JV6<,%%56*ZR"2J[-5=!1JLJU64(91NHLV65;JJ(F(=1!51(YC)G,47<+/
MNWW1[D;=W]R]Q=V]SH]U]Q]=W1W+W5T.O[FZ_P#GNHZSJ>M_G.AT_C:]6FFF
MFNIR%.4Q#E*<ARB4Q3`!BF*8!*8IBF`0$!`1`0$!`0$0$!`=63!XSQU69,)J
MNT.F0,P":Z(2L+5*_$R0).N7=*8/X^.;.P3<=$O7D!8"K=$.L`W(->JFX_HN
M.XMW"4"F5.D0S^5D)U[$U"N0M9C'DU+*`K*3#J/@V+!FXE))4I5)"161.\>G
M*4[E=4Q0$.DSCRA6)K&,I^E5*;9PJ'<T.TEZS!R;:*;]!-/J(UN^8.$6"/5H
MI$ZIH1%/H)IEZ/1(4`N&)B8N"CFD1"1K"(BH]$K=C&1;)M'1[)N41$J#1DS2
M0:MD2B8PE2023(`B(@7F(ZJ&FFFFK.LF/*%<7*+VV4JHV=VV;BU;NK#68.;<
M(-A.=06Z*\HP=K)("=0YQ13.5,3G,;H](QA'\G.-<>/+%5;<[HE-<VJC1SJ(
MI5F<5:!6L%1BGS<C5[&5>:4CS2=>CWC9,C=TRAW3)JX0(5%9(Z90+J[`8LP>
M'D`:-@?*-DF:CT$$@=G:(*K+HM3N0("YFZ*[A=9)`R@I)JK*J$(4ZAS&M.EX
MUQWCA*90Q]1*;14;%+N)^?2IM6@:LE.3KO\`^E34PG`Q\>23EG/_`-XDGQ7#
MU;_[1<VKVTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
MTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTUP)BE_VC`7GXN8@'/\`
M/KKUB?RA/2+Z]6*XRIC-ID:-P^ZR%26V6)FHR%_B,9N+5!HW^4HL3)MX24N<
M=3E'Q;"]JL=,NVL4^L#:.4BFDBX19KNR+G`FKZZQ/Y0GI%]>N0.0>?(Q1Y>/
MD(#X^P/%Y1[`\HZP/CK=+MOR[D6^8CQ=G7%&0LGXQ[H]_P#0J=>ZY8;74RLI
M,8.14F(2,?N'K=&*GP-7IA<J2B,/82F@951G,`+(,BRF2<>P=CCZ?-7BI1%L
ME_<@(NL2EABF%@D1GW,PR@P90[ITE(.AF'E>G6L8"+<XOG$-*HM@448.BI59
ME:JS)3<W6HZ?AW]BK:,.YL,"SD6KF9@F]A2>.(%Q+QB*IWL<A-(1S]:*6=HI
M)OTF3M1J94C=4Q:]T@\7/_N'^H/S_@_&_!SU%NK;X-G-WLKBFT_='@.S6UHY
M09.ZW"96IDC-M'CN8C:^S:.XQM+G=MG3V=F8B'8MUTDUGLE*1S)J15=ZW(I*
M/IEY@';S-XOBF[/_`(NSXO/Q!TN7,0$`YB'+0#@/(`Y]O_NFY?WCRY!_6/+G
M^#03E`!'XW9^#HFZ0_U%Y=(WT\@'ER'GXAUY)&181#!]*RCUK'1D8T<R$C(O
MW"+-BP8LD#NG;UX\<G2;-6C5LDHNY=+JIH((IG454(0AC!2X*V5FSC,EKD_$
M3IJ[/R-5G@B'[>0&%LD0#<92"E.Y3J=P2T>#IL+Q@YZMPW!PCUI"]83G<`"`
M]H?@\H"']_:`=GD'Q#^`=46+LM>G'4^QA9N*EWE5F@KEG:1;]L_<UZP##Q%@
M"$G$6JBJD5+#!6""F0CWI4'0Q<Q%O^J[E?ME5*T!@$1`.?9]`@`_U"(`!OI$
MHCR'L'MUSIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIJ&>\3;GGO<
M-#T=A@C>MEW9G(5B5F7MBE\4T/$=Z6OC&28LVS&,FV^5:Q84X]."<MEGD>O"
M*,C+GD'B<BD\`C!1E`X>&?Q#Q`?]>?O#_9[V@?\`_,:@/YA#7S_9B_DZ'%1F
M>,3BS<Y5M_5\M=1D$V-_L>^RPKUB&SGB=W3F#*!=XN98KB%6=7F%K+'NSQE%
MB(")9XD6J+FR1]YA6"4<M#V_Z`?!H<0[F(^'.WA@`B(@`;>]G_(`$>?(.6-"
MAR#Q=A2AY"E#D`3`VC[4-RV!)2^O<Z\0?.F\*/M<!'P]=ALF8ZPC06M#?MG3
MM=Y8H1WBZGP<D]E7J#A%H"<DZ4CVZ;8J@-%7!DUD(+CMAWO/=I\3MLK&%\%X
MBN^W#;'=,+8XW`Q%TCI>]9(L2Z])@"R&#)R/;1EFP+%9KI]0EY_,DG>7:5B/
M;)J!K;-9RFQ>Y0B<953A[;V58PDNQF8C'=H,[G'6*S35G@))7;XS)8MS+K&\
M+%L*^YM[%*`Q^\R/4+C"U.'LUY85%&5?5&O6&:CZXR;(X7F>'COC+"VV1H./
M+748RUR.,23N-[-NG)DRX3]PJVT:P8\;9.+?[)D$IX2+HNX*8=W6LI#=Y::B
MYYPUSM$T"0O*'O/CMJ&TO;ENDQ;N:R!?<UV^6OV-)[&T75J$B[RI)S7O1R)!
M16-(W,>49*DJ,XZOK.-UEC@0N<5&1"`(811H<FUAHZ'7SQ>(N+]N9MHN0<FK
M[O(U1FP4KV=\Z;%;=#`VMKN!D75'P?:L%OLJ=;)1*S*7K\FG#T6SEA18OF\D
M^6*S]SW;1PY153A78-D&^YIF7"WO2N$\VQ[0YI)I3+*?+:DR\PU5X#>7GG(\
MPW54MEG=V&<:Y/VQS^&,3248A7[\ZL5=KSK&]HDJ/$0S*R.J#/[,=[^.)[9U
M*T:#M%I;81Q_M9LV4+>;==D2?NUFR-`75W-[OF$^WR%DUK5YDMSKBS9C7T(Z
MF3K/(\6D]KUAMU`AJS3H&2C[B[9_Q`KCM[Q18:_5[K#42<Q?M#D\K85O^Y>?
MRQ8MQF0H#%&;C9"S4\<Y0NU7]YC*?L-]P7*3&.[%::5)2,UCI:=EZP,Q0ZRQ
MMN?[ML]XAMTP?;ML%_9SV58>Q4+*+ZSY?F]R+-)2^O;3PQ4MO%<Q@\B$5*]8
MGK\NZ%$UKGI^19UFH/C%1R8L=:<G9MC&Y`7V?[O!RG0;2\H]GMU'B9RPRF':
M@XW@6?%"^V&>>YKBK4C;+M)U)W>4LCHN,'$CL6M8*,B\IHQ)ZG8:6BS2I.5+
M):%L_</K'VZ#;SW=3LMXTR!(0.5,@1ID[%;\O=\:XTGW#PW,RUQN>1U&-_O^
M/GS>T7V'@J?$6?'B.,97)$W.J7FW8:H+E%=HXL'<)L&S3EW(FX6?:RECBX"R
MNMU^1,5H4C/-^Q.N?,=MVR[+<8[>[5/ACVQUE9R[JMTQ%EE=@>P*RD=5C+L)
MP&1U99`R5^[2<);I,*9<R1<\F8UE[U<+A<;2PR%FA3=7-OZ_EV$O6?2S-"M4
M#@":2D:I16&W[`IF]8(P:A3)I-Q&NZ/1X"QPUB<VQEMUTTTTTTTTTTTTTTTT
MTTTTTTTTTTTTTTTTTTTTTTTTTTTUQS+Y0_.'_C\`:YTTTTTTTTUQV`'+R!^$
M>8\OI$>W^\?'KG3333F'CY]GETTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
MTTTTTTTUB'+>3;%C5I".:_B#(^6SRSMXV=-<>)UE1Q!D;-TUTG4H6QV""#J'
MICF0;&9BZ$%DE`<`B`I"IA$-TV1Q$H#LSW,``F*`CW)C#Q"8`'_:R&4.8AV!
MS,4/*8OC#1O8=]V[E*TSZ+?+=KB6J5GFD6\(X@Z0+J+;)S;M)"&7$*XX(+F.
M0*2-6,5RN45D#F!RL`]<?>*ENGR2*20CLUW+J"*:8B<&F,N1Q$@")P_^<$.P
MP]H=@>/Q!X@RYB?+MIR2^F6<_@S*N)48MJR<MI'(2512:3*CIPJBJRC0KUFG
M')G+1-(KAP+ANB@"*J?07,J/5ZT(XPXG.YC%V/L+MMR5VIDU>QVJ9?W3)6JP
MPQ*31=PF,[7%8B[QDK,O:!1+;*5.W8URCD&2P;D:L8XJKZ5F9U.CVF/K+R/R
M?`HQL@JUQ>;Q((8[>3.*L:(Q#+)^2\:YREX>^6Z8<5^0I^X%Y@VJ-X*IPU-G
M;;3)C()&:\O5#9?BZY1Y>]H*8:/?8FRE<S++#K/B\YW3=/;A,16VUD3)^W[:
M/E7">)F.5[C<THA#-U?W?9:M#2YNJEB`]S1RK`X_PM7XFT0C\T-C*+B(J5OZ
M-GB4HY]!V&2&WSBM6[/N8,$UZ.QKB*!QQF?)=,PYW(MF9])YJB[18=AJ.]V1
MO</2&].0@K/BA%-\VQI"3B$ZS?29VSBZ.$F;=PC74,39=W=[FZ;N<RB]B\RN
M7=#C\Z7+"N)Z[44,'W#")+5#[?YN:AL*YZQA*P51WBXYR4M>V8WA[F^@V+,.
M,6]>)`3CNIQN,Y:6"*\[3C'9*Q]CEM<LEXQP]=QJ>+F,?<JW0<Q/F>9YW+L-
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MC)Q2-QO/+06)-I;U'"F';,>M,;)>GU#L&;9/)N:;#<X"`GZ[0Y)%]1H.\LFT
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MALL$R)8+/E3;?1,J^^JG4_'%TOE?SC?)S`*<M8*#6;%=(&L3"=N<DOK"7QW9
M'5!NB^/9N3Q]+2./I=%GKW9WW2[BJ#NEE<+8@@L=WI_>3[3:=1(/*%CE*32Z
M7+9'J^^Z_9&NDC/4ZF6NX3:CJ#VX5F*85TS<69G94E6SR'*K)KNX%37&4S)+
M0..,S,,7XZJ&+ZQ:K$PR?C-KEE.5S?D":IW#0ON]:;A*Q7YW'39@7$$A/O*K
M!P>1XUZTM@,JL6Y2<$A`SSZK-LSU_BT9).TQU#SF)L<K62];DE=L!9X;M/4V
MM,IN2J&&\B1^8):O3D9.6JL8=IL=DJ3Q?DA]/+IS+#,3[`T3#IN(?<'#*U/>
MP4>8`/BY\^S\(=O8`^00#_:#\`\P_!KG3333333333333333333333333333
M333333337`@`^,`'^L`'_GKCH$_%+V"`AV!XP'F`^+\`ASU%UYLHVJOW[N3>
M8,H3A^^?.9)VZ4C7(JN'SQTH]=.E#`]`!56=*J+J#R`!4.(\@\6I0E23(4I2
MD*!2E*4H`4.PI0`I0#Z`*``'T`&NP%*'B*`?U``:LN1QOCV7C6T-*T:G240S
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MYYV2C\S8['_0S)"V_FM4V`PEANJ+,7%7Q/C2MKQE(:XTC58"AU2&5CL<L2B5
ME06*L=$-E&E*9E$0:U1N=.`;@(@C'$#LUZ(C#N)8"OMJI!8PQY#5=DS1CF=<
MB:15XV!:1[>=/:&[!M#LHE"-09(V50]@2:I-2H)SAS2Q$RR!A<C<KRGU20DT
MIE]6:^]ET'["41E'<+&.9%*2BV,E&1D@F^6:G=)OH^-F9>/8NR+`X:,962:-
MU$V[]VFM8SW`.#)*60GI'#6*7\VV8PL8WF'N.*6ZE4(ZML7$976",BO!J/$F
M4#'.G3"&:)K%;Q3)RNT8)MVZRB1KLF,>T.P$>)SM*J4TG(.9-Z^3EJW"R1'K
MR:K2E-F';LCUBN5RYE:BJK5I)PN"BK^N*JP3LZT4H=F-*KN(,45!:JN:GC+'
MU8<T:"G:O27->I=9@W%.K5ID&$M9J_55HN+:*5V$L,K%1<G.1,.9E'RTA&L'
ML@W<.F;=5.RF>V/!:,*_K4IC6I6RMNLF7/+K*OWF!A[M#5V]Y`FWMHMTS5H^
MSL)-"NGE[/*SEA43C"H@A*3TPJU,@B\%`E[V;$>*[HVEF=PQK0+4TGY6-G)Q
MM9*96IYO,S4-%IPD1+RR$M%O$I*4BH9)*)C9!Z1=XQC4R,&JZ+0I40H=@P/B
MFR3-&G']-AD'V/;/6;;`#%,FL,DI+T>N6NL44LPG&(-?=R+H["Z3[JH0DF9Q
M#UV8<-IB,8H2$>Q7;Y$6K5=<2B,XO`PJ\RW.Q50EEHI@K)HJ1C:99QJB4@HW
M,\34CVEBGVK(Y%BF:-YN70;BFE)OR.+.+A;#Y+`SMA,5XX):(^!3JS"R%HM5
M+/LJTC%NX-&O-)D(@))K!HPS]]$I1#=TG')QKUVP(V!FY61/Q!X5P]6(!&J5
MO%6-Z_6&[&3C$*Y"46J1,"C&S4BSEYB.2AX^(;1J;"5E8]C)R3,C8K9_(LVK
MYVDLZ;(*IY-_\?G\>FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFJ5*SL+
M!D14F9>+B4W!S)H'DY!G'D64(7IG(D9XN@50Y2?',4@F,4OQA``[=47O@47_
M`*Y53ZR0G^?U'Z9WK[=H'<I2]JLA?X<F4KWC&TY3A$DY&,5@BPM7EH^,/%OI
M@CX4&MBFD%YF9@HHY>F^AJI8GIE$NY6R;J0/?`HO_7*J?62$_P`_JJQ=DK\V
M98D--Q$N=N"9G!(R482!T"JF$B9EBLW"QDBG,4P$,H!0,)3`41$HAK7SB#BF
M;7,O8ZH.447]HQY5+=#YOE[0YRDQ@Z@KATF`XZJ3ER;Y:ZRPO&]?/)5J\5"V
M5![%N)V)LU4LU?L+%_[G3D4J[SW%[VMILR;&A(W<!C!RME^<EJQCMO[Y6R#J
MQV.#M8T*5@4VKDJ+B,F&E[Y4<T;-I1;M2Y'2JJ"2L\JG'GQ,RXG^QZ0G,@1[
M3<%CMS7\;Q&.G\]?V=GA9&E.97)\ME:.K-3@WT:]>2DY9%8_#EQMAT8V(<1C
MFF-BV>*E)&):3#F,S1#;R-J]BR=7<,U_/^*9S*-OC(66JM)B+E$R,Y9&5CHJ
MN4((T(BU751DW$MC1(<AL6+5PH_6HRB%M!J$`Y;R"N!;%Q%:55LH3M&F,-9?
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MEZN87FHK'\E&3B]0L]G4R2R82-DZUZR*6M)SN)KU5G,S#&F$26F`DH(A%'\;
M)I,K+M>_^@UO</;-OD=C'*EU>XUF<;P>7+I3>]M*1N+U<HP$;9X"PV''JV16
M><I;'<1"3U>D+KE&HXKL./:@VDWR\G811IN05*G<N).(5LYS4VQ'[S,]X^).
M9OQQ'Y5Q[3;!/,*[=)6FR<789IH_<5V471=Q[A6(J%OE46#HQ';R*J-IEX]-
M[$UZ6?-:?4>(OM`O\O$M:-F>GVRMRE<M,\?(,--Q:U*C'5<ON'L=1U9DGJ[M
MO*IV.^SF<J`XQHV;P[EC?8:5;R]:D)!E)02LMD'*>\#!>$+G8:GEZVL\<,:S
M0:/?I.\6UW&Q-*ZC(V3)+$E-K#604?FDWEQG[K'A&14$VB55)-5_'MHY5T^<
M&:)XYGN(]LXC)?"U?@LXT&_3V?9G&\?CB'H=LK4Z_E8?*+B:3KEQ42-+-2I5
M<C*LV>:>N`.>4+"5FQR3.*>(0<H+6](K?3M$EZPM<F^X+&;6M(#9.MEI>?)`
MM@3JE/2R)*N2>[J,:JNR5QXNAD*#?MTU6-KH2Z%TJ;B<K*R<H:5R9RJ$(H4#
M`4Y2G`#D.F<`,4#`!DU"D4(;D(=(AR%.4>93%*8!`.^FFFFFFFFFFFFFFFFF
MFFFFFFFFFFFFFFFFFFHY[AMH^VO=A'U>+W&X8HF86%+?R4I5&]VB1DRP#^8:
M(,91S&&(NW4;G?M&S=!V!3B18C=#IE$R1!+%T>#EPPO,FP/^#GRJ[@!Y<^WD
M/ND/(>7/D(@(`/(1`0[-::[S_)KI.PYSG\HU3,N!*70'>2$[=7L%M=O-B>8[
MB:E'S#5Q&4"09AE!L>7C'4*Q2C+&\#N-:7=/9610(P%TD@WW)AP<^&'R#I;)
ML#=+E\;E5W`@`_A`/_*(=@#V!S`!Y<N?;J0VWS9#M,VI2UDGMNN`\<8@F;A'
M1T19I2EP@QSV9BXEVX?QS!ZX4<.%#M&KQTX<I(D$A.O4%0P&,4HEAE8.$E2U
MF-+7H&>,KXJMM6VCN-K$E:*6C",3VY9@RH$-3LM3+!+N8['(%?J%+?8W?RT!
M)Q<U-8VLIZVVL<"]J=(G8"T:[PBY*(D(47NYN;7B&V0+U=9=:"QFA4;Z:-R5
MDUKE:\46"R+#Y&-*K4JT32L[`S-?RJPS%#FKKN&E8N,BLHQ<QDRT=`X1UD]P
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M3G,HS4C,%E=R%@G[)&U&#A"SD]N4PQ)X9LKX(<KZ0*Q3@8N2]TX5`\E(*G5:
MMHYZ[49I@8,69[X3".8FMECX'<SDC'L1<X<T-9JXRK4/,UA^9MA#`N&86QG@
MR34"WD[1!-,#1C^./;E+54D&-PMT<A3F\R:"MT/Z)CA6RLQ3#41QN<M)ZS3L
MMN<XX2@AQG5&S/'^1;+FV>SQ?'UBL<+-PN4[O$35KM]LA(&)B\EX_&MU23CR
M/7MGMT!&V\OYT+A,QN-W]`B:QGZQL\85A:CVFU40N-J8D[N>3*AA_+>)7=J3
MM+9ZW4J\'9`RLO=)*I1D&Z52M-?9"C9314I-L'U4JW"^G*9(4VV5C<W/U[(C
M.A%Q'D>SQ>(Z')PUUQ<^QOM6Q_8X2`I-^?7F"ILY)&VGU"8C[%*C?$(X+3:X
MF0@)]H$`M#_GB;A9O<=9RA\RV'<[D')IX6R5V=)'7"K1KJ>EBTB^Y;O%++,W
M!6QO3@[8CFBUP4LC78"M5)U%QM7][-+IBC"7">S!ESA_Q.9,]0^7[7D8KZ*@
M<KXAS!68^1QE2)3*>-9K$JD`]&EX8S^N"5^Q;BG(<O5(B1R)2XEL_=RR<[DJ
M)BK%"0V195BSCQ$\(")7J,5BV];B+;8L0O:_16^1J+6\=TVFKW*X8JPI+[=\
M>6Z(N:SJT6VD)-<6GIYK378Z0E&,]>:,QL$([I]:L=OHTW<+WA3A;Y+&5]R?
MN.MEQS7@F+20P)DZ+Q=C6D&Q+/03G!Q:G98>NP391.R//<7#+NN7IG=YBQM+
MC`Y.R#7XH*35W</`14O<K[1*UE?,-?R_)6N9C)"OJX'50A6L=&N(]<V",R3V
M9(;IKN!!PG[LRLX>*>B0O-FS:(.F8B[$PA"Q/A!U9J^=Q#'.=I0QC;<I5/,6
M3*8M1*F]F[1=:A7LFTQB,!=W;M1>D0DA4;W!LY5BR@):04EJ,QDX^7C8^RVR
M!E+>JG!DJ$/0XRJS>=K5)3T%?L-9.A[;$T:NQSHETVNT1"J;6I"59VB7OKB;
MCL56)69R',UI[,!6KU.2:=64B:WC)D-'>;K$@4*FF"QB'5`A>M.FF9),ZG(.
ML,1(RJQDR&/TC%(994Q"B!144$!.;]------------------------------
M-------/%X]>5-ZR5:=WI.VJC$4C.`>IN$CM.H(!C'6[H*<4>J(4IA,IT^@4
M"F$3``#R_=)5-=--9%0BR*Q"*I*I'*HFJFH4#IJ)J$$2G(<H@8ARB)3%$!`1
M`0'7?7Y%71.!#%53,"A3&3$%""!RE`!,8@@80.4H"`B8O,``0$1Y"'/].D7L
M^,'QO]GM#M_J\O\`=KKUJ?2,7K"=(H%,8O3+S*!A,4HB'/F`"8A@`1``$2F`
M!$0'EVZ1>?+F'/Q\N8<^7EY>/73K4NT>L)R*H"0CTR]BIA*`)CV]AQ$Q0`@_
M&$3```(B'/\`%!\S=*N4&SINNLS."3M)%=)55JH8!$J;E,AS';J&`!$I%BD.
M8`$0`0`>75O(L':SANU>M'*[,W0=HH.45E6I^9@`KE-(YSH&$2&`"K`01$I@
M`.93<O5TR=GQB_&_V?C!\;^KM[?[M<&53*(`90A1$W0#F<H<S]$QNB',0YFZ
M)3&Z(=O(!'ER`1#D3D#GS.4.0<QYF`.0>4>8^+M#MUSTB@(@)@`0[1#F',`'
MQ"/DYZX*<A^?0.4W1,8H]$Q3<C$'D8H\A'D8H]A@'M`1Y"`#JDIV&!5$Y4IJ
M)4,FFLL<"23(XD2;#R<*&`JXB5-`>Q8YN1$A[%!*.O:U?LGK?NMF[;.FOQ^3
MELNBNW'JQ$%.2Z1SI#T!`0/R/\00$#<A`=>D#D'Q&*/9TNPP#\40`0-V#XA`
M0'GXN0@.N"JIFY@50AN1A(/(Y1^.``(D[!'D8`$!$H]H`(#RY"&NP"`^(0'L
MY]@_@\O]6N=-------------------------------------4693L"B:`0#R
M(:*@H<7)I>.>R!#I=#D0J)6<E'&2.!^TQE#*E,3XH%*(=(:!W-D?_P#>Z8'T
M^]J<#E]/;9^7Y^S4=%HNW#'2DJQ[C5QDK8$7S^*:1$JC'/6R8'&3F6-:&2-+
M*507P`Y?1C>4;DE.K.]08&8],BT@V:=^6:-5F4Y2#,UFR"K0R-8FRI&;*)%.
M@9(H64H%3%(2"0H%*!2\@Z(<N07##I6<AG'O@?0;Q,01[E+$1;^/.F<#F%85
MS/)61!4IB]7U8)E2$@@<3B<#%`OS(4+;?OCVKXMPE5L=XOS5;*U3-F6=<CT)
M6GS]5)D[`F>,NP6%X/*.!F?OVCKPP[E;7'WW9OQ`NO4[NX81CO(V,8"JSDC5
M,=14IDJE9%XFII'#D<K&;LW\C4<MY0BT8&TXZ;UNOY#H\OGELYQO/W_*;W&L
MY'2M;K6%9:-86:O94B\&S[ZFGD9:J9$)GR`GJI6\2L6?$:8I6"[)Q._:<R5D
M+#FS>CY:O$A5\8TV0H^8:_%[R;=FFK8V;P.*YR;L>#F&6+-C2/B7%0JR<8Q<
MV&N*.<NQ>'S6Z0'/F`,R;]AW#[1C[C)3<[3W.5<M4:E62EV+'N.ZYM_F,2I<
M.NUV^;2GW"%<"Q0V>W.[RD7N5L<1#6$CHC")9>YT4VQ,ZK[I](&PU_,3;)62
M<!M<$9BDWU\XDF"MSU>RLQ@XLV#4\*U.PX*R;9IR9R,M/)I0DE#ABBS4MS2G
M44-V>VUW"A!UN6K4H2RIXUX96W6_X8SK&R#G!DY7H-Q@2\0^0\BY0P['XCSA
M4+V]RE39F.Q?D;*^/;B3&&_:5FWS&\61+<(?%,;98!O$FLPY$?NLX62"=0EH
M&WW>5B:9RAD'`&&;?6\WU[%>^^(?S#7;!7,//U'V1MQT3>*-+ES2>?>.-W-O
MDZM%R"V-Z]*5N5C(5\_-=%BH33-A`6>5D%!<3JT5".GVN0-R5,CJ#"YHM^+*
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M7"[;D;#AJ<1:LS.26#OJ5J2E+5N"?F9"O,V7*%>>-);!LS3`JU(BX&#R3"6N
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M.V^04#.,-5F3/;KL:=[J'-PW%!N5-E`M=+<T#;9T[M%U%FW4V^FL=\][3ZXN
M*NDFZ[_CF2]T$+W&316Y&.)&6`G1&+:\R641/L5TTTTTTTTTTTTTTTTTTTTT
MTTTTTTTTTTTTTTTTTTTY!RY<NSQ<OP<O)IIKJ)2B``)2B``)0`0`0`H\N8!V
M>(>0<P\0\@\FN`33#ER(0.0\PY%*'(?*'9V#_5IU:?;\0G:("/Q2]HASY"/9
MVB',>0_@YCKQNHN-?*QZ[R/8NUXEX$C%K.6C=PK'2`,WD<#Y@HLF<[-X#"1?
ML@=-C)+@T>NVO6=0Y734]O1+TNET2]+ERZ7(.ER\7+GRY\N6@%*41$I2@(^,
M0``$>T1[1`.WM$1[?PB.@)D#GR(0.D`@;D4/C`/C`>SM`?P\_'H!2@'("E`.
M7+D```<N?/ERY>+GV\O+H!2@(B!2@(CS$0``$1[>T1Y=H]H]OC[1\NN>B4/$
M4/S!Y.C_`/Q^+_5V>+7'5DY\^@3GY>B'/L[`[>7/L#LUSR#GSY!S#GR'D',.
M?C[?I_#Y?PZ<@[>P.WES[/'R\7/^K\&G(.WL#M[![`[0\@^7^_3HE_%#\/X`
M_"'(?SAV#]'9KCJR!RY$)\41$OQ0[!'QB'9V"/(.8AY-<@`!X@`.SEV``=GD
M_J[1[/IUSIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIK%^3LP4O$3.)?7
M(+<+>:>.&+'WI8YR#D1<'#5N#I7NUK0*S97,8CU/_HG,DBU;+J<T$%5%@%,,
M.CO5P8`"/1S+R*`B/_FS;D`[`[1[>]7R`>0#R$>SGXQ`.8ZUV)[X<NV?',UN
M"A,KR==7!O8;Q4,`J;2LJV/&CJDUUQ)G85BVYVCZ>X<&L5CAHLZ\OD&O3[2D
M5*:=E(I'NXF%DE'$^JWOJPA8*Y7YY1EF.//.04/-&8DV[;@9<C(9:-:R`M"2
ML5C%S%R96PN10+(QCES&OP3!VP<N&BR*Q\UXRSG0LNN)AK3`NP+02+!>0]]N
M+,G8[2ZJ15<HM^X5[_4JTA*J=)HOUZ,6H[59EZE1V1%-P@933EA3BU93?T?&
MSK/>-Z%`9);X)R]N`R?4ZK+L:K'77%J%0HUYV]9+Q'8,I7F$K5<I]]8VR7I-
MU7OUD795#*=$NM2=3;48N*6G9`0O%LQW()8A<RN'<@UR-R%>,HT*T6*7LN-V
M=1ILSBG)RN,9Y*%M$A98V*R?(.#$#($?4:6JI?)+&?.>AJK+S1VU9<XR0XO$
MVF>?N<SMJM]<QS.85VOY;PC#VJ^X4K%PR/`;C%-R5BBK8,V[RF[KS=HI1<*Q
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M'OO%09U9G9)6M[6\V7J%A,@Y7HT9(,+'A^N^^EK@K$\_F7+%MAFUHO<<JE`U
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MS2T)`5#<9O1S_`6G,E2P30HR:2Q7G;!F"9>38TU?+^0&KFT8*E-QF7;93<)1
M^3\5SF8W=7IUFQ!!-:%3K*VMD`PD<A9/7C;G$U'WI+57!O$09VC&(J7@L7;\
MC5N>PM1[78\>4ZZ8]J*MJSQN2RSMQJ;66QEF%:,ROBRW4F;QBH[SEBVY(/)O
M'DVO*5FOS=Y2CV<U)8*J7&(?16#Z1;\S;8,E5?)\Y@[;KG1["M;#BZ+HTCCC
M.=2OT@WR:YN3S($O7<1U0UPQ99Z;&0N6;!#RB5AM&,X1_*E/99&1@KZM_&4P
M?3[O?ZLXQSD*::59Y,4JLNJZ\JDI+W#,D*TQSU>-UHPDL2!J#"VV#*=<I./L
ME3]R]X=HM,1<`7DH6N1];L=NJP<23+\7EE]BFV;*LCPEM?UC#\11Z2ADG$;^
MR6K-60[SN&@YVMI3_OM;TQEC:"I&WRW9$C\B2CV*=2D)#R+$M8"SRE;K#WWQ
M_$V3O]?D+OCK#=[AJ'CJ1VTN<MV7(:-413CD<[9"J]`L.-X*-KUU?RSK).-1
ML$U-6*3;-):AJ#3#QL'.V!.V0S]'*^X7>=;,#YI?4!EB]]E1@\HF`BTZJ4]S
M!PEUGLH9UW#6+"L<V=6.Z6>$IT33(5C%HV&8<NR>Z35LUDE682KA5E%&BG)\
M8).?;T&6H6W_`"-$5-CE?#V/=QEPNYJ-)1V%Y*ZPMKNEPI"D/4\@N;!:++"5
M"IF!C<:A'V2D&L%FJC%$\LFXG30%?K7&6QE-4>.MSC">3U'4Y?\`$F,:]#UN
M2J-A2FKSN6J![-MDJK:P.9&!@2SN2IQ)QBZW($>.(K#N3&ZC:Z32E"68Y">;
ME4Q.8A!4*4BG1+TRD.*A"GY!TRE.)$A.4IN8%.*:8G``-T"\^B'?33333333
M3333333333333333333333337`@`^/G_`'"(?\A#742AR$?C=G:',QA[0[0[
M!'D/:'X>S6AV]5&*:;TUMK#%Y:([;K>;G&2UHPY&WBZ1M%D5;9&FM5GC4H5C
M/MT8RLV"?.O(3%0BA8U21,\D&[J&5:2+Y!QO=;-&K-N@T9H)-&K9%)NV:MB`
M@W;MT"%210002Z"2***1"))))E*FFF4I"%*4H`'[@4`\O]YC#XNW\(CJ*]LV
M1[3;U#5BN6W`V/YR)I.))C!E12=QBH.JYB:?DZC-/Z5$2:#E&491R4[CZDV&
M)<(O"R5?L58B+!`O8V9:E?:LR&X<VS*N2J,Y$86;-WB=B&WOVZ]XR7(0UHLI
M;4QOJ4Q?*Y(W-W7LB.V]^8%OS0;U%V)-I?'\[=&R:5GLE@E9/P-^&AL9;H'2
M0V]UI(XJU4S1Z2?O`2L*PI,3>:]5JW6)GWT>ZU4I416<F9!J2-$K3V)IBU.N
M$_474"O6I!>+-@+(^S?;/@#./#]M>'<40]$G8_<VPH31U%REE702K4'LKW/U
MB)1&-DYM]%JRS*IP%?IR5G69*6<:77X&G'F#UF%BXIILKCL84"*8WF.CJM%M
M&.3)J<L=\;)$5!.SSEFB&,#/24D`JB)W,I#QK"/<BD*13-VJ0%*4P"88_7?8
M-L\R-&LHFY8&ITNQ8,6\0W*12<BW`P"&-F&'UJNZ?0\O'OGU0EL8Q452;)4'
MSEQ6;3!148VLD5*C',SH7A%[1MN$/5HFELL40`UN#)>2QS!\YF955,V3*FYH
MM^7<R4K*/960=VRI/'4'-/9%ZZ=NVBZ@F6!<W6ZLC)7#^V<9?4<KY$P-4K`Y
M?Q+ROR;LKNQ0SR8K;^HT:CNZQ./(";BW,W5E:YC+';?WLRRKR!))4FL6%./)
M8H5A*H^(W#RV9J+VU^&"J\A+7A]%RDS/LYNXL;*QEHBUM[ZC,TZS,[(A/X[F
M7][:)7BQ3&/Y*LR5KN1G-JL[J7GGCR07J##8'L\C+92;M'8*JS&PXZ@:]6J<
MJT>V1"*B(^I4RX8YKCH];2FRUN3L,31+]<ZDVMLO$O[4,%9)2/5F5$''1#P.
M>'GLS?0=*K4G@FN341CT[)2N)S\Q;[`\5;Q]8QW34HFT2TU8G\O?*ZZK6(L7
MQ<O6+T^L==G24"IN)J+D'D(Q<(^^B;`]G^,KQ'9'H>#ZY6K?#.^ZX1^QE;49
MC!`G/SUI8,(&O.9]>N0D'!6&U6J6K%>BHEI`U1W:K.>MQT46PS!7N)$\`XAR
MENZW35J\TUM,QAH'9KG9J=*4G8:7ALQ1T7N!QFUR/6K%`RD98:M:RX\HU8I2
MTK6Y2*6=UA@O#.Q78RLPB_RNWV`;.VUBQS:VN"ZPTG<3*5A:C.F<C9VC=C(T
MJXV'(=3GIB,;SJ47<+1`7RWVVXQUKN3*?LB%EM-DF@E1D)V47=V[&\-79+!U
MIC4('!S.NPL8A$L(DU<O.3J_-PU>@:S;Z7%TF%M$-=6-GAL<(53(-Y@%,:1<
MPTH#R,MM@;/:VX+*.^MN5QL$V<NG]OD%\`TA0+[47M$L</T9<E5&N2</4("2
M3@:824+4J?,241CZC-)"TU"$@K2^]Z-=7=3*KF)9+(TI;AT[,%H?W!/@^*",
M/&1T<=-*U7]!TH]B,C6#+L9<U)-&V)R:F4F.1[7:[6WR^=X;*:;ZU6=$+CW#
M89AH]Q3N0P7A_$>/,(X_QICFJTJDW7=5LII=GJ\!%HLX66JF,;U6QHD`JQ+S
M10C*\6DUA)LV:%;E<MXSN9_W6W>R";N;=BPMBNY6B/O-HI$+-6V.]YBC*>>)
M+&?-CX^M+V\4LR9DUB)@-=MLF_GH_FF/0?.E3*=8003#"BVPG:`XMD#=E<$U
M$T_6).-G(L07GB0BD]"C>_<:?F:J28+5;+/Q#?)]_C(N<LD++2L=!VJ5@&;Q
M&%538)^.&X?FS>`JJE):8'JCZM*FF`%A97MDN"R7N_1&.+7(M9.V3DW*LS1F
M-XQI1:F9H^0-1ZJ#B#I@P,>^>H.)CI)E2332()Q*F0I"BHHHLH)2%`H"HLL=
3154X@',ZBISJ*&YG.8QS"8?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIPAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Revenue | Customer concentration | Glaxo</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration risk</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
        <td class="nump">57.00%<span></span></td>
        <td class="nump">96.00%<span></span></td>
        <td class="nump">98.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BasisOfPresentationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_BasisOfPresentationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6404-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13531-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 18<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6351-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskPercentage1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NumberOfOperatingSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDEAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details 2) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Valuation and Expenses Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense (in dollars)</a></td>
        <td class="nump">$ 4,548<span></span></td>
        <td class="nump">$ 2,298<span></span></td>
        <td class="nump">$ 2,342<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used for fair values of employee and director stock options granted</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ExpectedDividendPayableInForeseeableFuture', window );">Expected dividend payable in foreseeable future</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock options</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used for fair values of employee and director stock options granted</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected stock price volatility, minimum (as a percent)</a></td>
        <td class="nump">71.00%<span></span></td>
        <td class="nump">70.00%<span></span></td>
        <td class="nump">68.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected stock price volatility, maximum (as a percent)</a></td>
        <td class="nump">72.00%<span></span></td>
        <td class="nump">72.00%<span></span></td>
        <td class="nump">70.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term</a></td>
        <td class="text">6 years<span></span></td>
        <td class="text">6 years<span></span></td>
        <td class="text">6 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum (as a percent)</a></td>
        <td class="nump">1.20%<span></span></td>
        <td class="nump">0.90%<span></span></td>
        <td class="nump">1.40%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum (as a percent)</a></td>
        <td class="nump">2.10%<span></span></td>
        <td class="nump">1.40%<span></span></td>
        <td class="nump">2.90%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (as a percent)</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and development</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Valuation and Expenses Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense (in dollars)</a></td>
        <td class="nump">2,640<span></span></td>
        <td class="nump">1,415<span></span></td>
        <td class="nump">1,412<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and administrative</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Valuation and Expenses Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense (in dollars)</a></td>
        <td class="nump">$ 1,908<span></span></td>
        <td class="nump">$ 883<span></span></td>
        <td class="nump">$ 930<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ExpectedDividendPayableInForeseeableFuture">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of expected dividend payable in foreseeable future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ExpectedDividendPayableInForeseeableFuture</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6IAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccruedRoyaltyAndLicenseFeesCurrent', window );">Accrued Royalty and License Fees</a></td>
        <td class="nump">$ 250<span></span></td>
        <td class="nump">$ 1,776<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued Payroll and Employee Benefits</a></td>
        <td class="nump">3,515<span></span></td>
        <td class="nump">925<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccruedResearchAndDevelopmentContractCostsCurrent', window );">Accrued Research and Development Contract Costs</a></td>
        <td class="nump">11,840<span></span></td>
        <td class="nump">7,569<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued Professional Fees</a></td>
        <td class="nump">556<span></span></td>
        <td class="nump">317<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other Accrued Expenses</a></td>
        <td class="nump">1,018<span></span></td>
        <td class="nump">373<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Expenses</a></td>
        <td class="nump">$ 17,179<span></span></td>
        <td class="nump">$ 10,960<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AccruedResearchAndDevelopmentContractCostsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development contract costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AccruedResearchAndDevelopmentContractCostsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AccruedRoyaltyAndLicenseFeesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties and licenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AccruedRoyaltyAndLicenseFeesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedProfessionalFeesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeRelatedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PayablesAndAccrualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0`.<;_,,@(``*0D```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,VLUNVD`4!>!]I;Z#-=L*
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MS"%!<BB0'!HDAP'),0/)\1XDQQ5(C@\@.<04)0B*J`*%5(%BJD!!5:"H*E!8
M%2BN"A18!8JL$D56B2*K1)%5HL@J4625*+)*%%DEBJP215:)(JM"D56AR*I0
M9%4HLBH4616*K`I%5H4BJT*15:'(JE%DU2BR:A19-8JL&D56C2*K1I%5H\BJ
M4635*+(:%%D-BJP&15:#(JM!D=6@R&I09#4HLAH460V*K#,466?_2]:4.R#$
MQ]=_CS".>:6$$-.^I7CA/PX/0U_;O+&!ZA\IY+;,Q0,\GWTJ1^Z2W`3?Q]RJ
M"73^4WBLS0RG)WT>1"$U]%2<.59`>=J8&SGG+WS1@*&A\U-3?60W'SM&RS\`
M``#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P"```+``@"7W)E;',O+G)E
M;',@H@0"**```@``````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````C)+/3L,P#,;O2+Q#Y/OJ;D@(
MH:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH
M0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B
M-!U/%`OQ['*ED3!1RF%HT9,9J&7<E.4]AK\>4"T\U<%J"`=[!ZH^^CSYLK<T
M36]X+^9]8I=.C$">$SO+=N5#9@NIS]NHFD++28,5\YS3$<G[(F,#GB;:7$_T
M_[8X<2)+B=!(X/,\WXIS0.OK@2Z?:*GXO<X\XJ>$X4UD^&'!Q0]47P```/__
M`P!02P,$%``&``@````A`(T8TZ=Y`@``,20``!H`"`%X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<R"B!`$HH``!````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````+R:RV[;,!!%]P7Z#P+WM<P94DF*R-D4!;)MTP\0+-HR8DN"R#[\
M]R7<0G&`]K8+X6X,2(:I"W/FG*&3^X<?IV/Q+4SQ,/2UL:NU*4*_'=I#OZ_-
MEZ>/[VY-$5/3M\UQZ$-MSB&:A\W;-_>?PK%)^4.Q.XRQR*OTL39=2N/[LHS;
M+IR:N!K&T.=W=L-T:E*^G/;EV&R?FWTH9;VNRNEZ#;-YM6;QV-9F>FRMFN+I
M/.9'_WOQ8;<[;,.'8?OU%/KTAV>4WX?I.78AI+QH,^U#JLU\*Y:7=ZRN<F93
M_B5._CZX<6Y1'*G(<:1"<?2.'$?O4!RQY#AB41QUY#CJ4!PGY#A.8)P;=IP;
M%,=G$E(;W:]A',^.XU&<:E$JQW0^9J_,2/YUC9[/KA58*NP^@FUDV4:PT`C"
M-H)`(UBV$2PT@K"-(-`(RJYDA:6L["Y7V.:.;00'C>#81G#0"'Y1(\Q#^8L4
MYEN_YW0/YW3/GM,]G-/9>P6WJF)#L((0M&Q%6*P(-I,M9+*PF2R0R<)FLD`F
M*YO)"IFL[#Y7V.B.S60'F>S83':8R>Q)V<-)N5J4.[%KIM!^3E/^(>_Z9'5]
M&QVPV%N%=XHM+`^%Q>XJV%26[0<+_6#9?K#0#\(&LD`@*[UT8.THN\L5MKEC
M`]E!('OV7.KA7"KL44?@J./83':0R7Y1>\YG37#\A%-[M2B54_YS6GB)<KDL
M+Z_P.V'O$`S#[FW8VI:M!0NU(&PM"-2"L+4@4`O*+AV%M>/86G!0"YX]<'DX
M<%FVI2RTE+(9J!""CFTI!RWE%[74_T@3GATJ=NU4L';H>X7.XVSHS,PI7_VC
MS^8G````__\#`%!+`P04``8`"````"$`O#OS?_<$```G$@``#P```'AL+W=O
M<FMB;V]K+GAM;)2877.B2!2&[[=J_X/%_8[RH894DJD6.Z9K$!QHS.2JBU$2
MJ4&PA&R2?[\'3,B!1FIS95KLE_/QG)<.5]]?]\G@W^B8QUEZK:C?1LH@2C?9
M-DZ?KI6`W_YSH0SR(DRW89*ET;7R%N7*]YN__[IZR8Y_?F?9GP$(I/FULBN*
MP^5PF&]VT3[,OV6'*(4KC]EQ'Q:P/#X-\\,Q"K?Y+HJ*?3+41J/)<!_&J7)2
MN#S^'XWL\3'>1/-L\[R/TN(D<HR2L(#P\UU\R)6;J\<XB=:GC`;AX>"$>XC[
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MBSA<$,MR`X?CG("FNM47;1G+7:X\>D<=GZVIL%V_D<<$;37;6V\)\\2:V`$5
M2TI\2*KJ#;[U%.U71VT!B/\'Y61F`US4"CS&&6W<'CRGCER5*%UY@(#''ZKR
MT9\!6Y7W%PYM9&]B#8E2YG#B+%@9`O%]X+L26[CN_)[9-DIE"E/[&8O$*93=
M"V!8Z*\5E+*1Q;0Q:A*;+K^C'A3>67#J+87-R(S9[4I,\:BI$IBGG2YQ<,`8
M956B$+BW?MRY]IQZOBB+QQ_P9HR>*K-7;IX1'Q(N^8&,"6=NX^X8.E6BSJ-K
MZ@08]BE&3958LUS;)C/7J^XCR,*C$FQ3#!N8;,O3F`.A4L')KV9W,&.:Q!CL
M63)^\IQR2L$9.7,6U+&:J$XQ9IJ$F4<Y.XV'\,D:!'RQ`E=%%;_`?&D27SZU
MJ56Z\<^`>-!N^T'<,@=\F1%;S+$.IDV3:.MW#=A;/R`N,'*:A%R_$.S]%,(@
MGAZ2V`YE`Q(\_)W`\0))8!PU"<<S1M2A@ZG4)"H[_:A#!:.J2:B>MZ52"F>%
M@=4[@.VSID:K,,.ZQ'#;FSHRPO3J$KWG+:J5D8DAUF6(NVU#CL?$$.L2Q'B4
M.S9C<.%XU?*!WHD6J#TFYE:7#;1W(G%[3$RO+M';?Q[`0GJCSQ*^_2,)V=0C
MJ3?Z+1'<+P39U$(&;C@L6K7N%X)AK(5,/)F&A'"_$,QC+63@[L.B%5&'V\RC
M(HP3;#<&[CPL6AKG[.8DA&(QL5$8$L;==B.'8V*?,"2@>_P&M%`X1B,<">C^
MHQ!V=*,1D`2TY#<=*6&2#8GD'L-II81!-B20^W7P:)E8:"R!7!^PA)P+_,.&
MCH9CF5WYI-6A,L;<PJ+%7'5<DT]<[T*HR6/,+BR^I(,K,L:N!8N6T/L)KB,3
M=00R]5%Y+/%Z[BAWDD*IJ*-&33J`A6E^/]%UQ#'&E,*BE4#C(?+>58$I'V-&
M8=':W_\<:52RP98$Z9FSH=S:">8,%JV`^H^(.+,);A`L0&A8&2B\3-B$R0;>
M<I0?Y6N"ZB[#CW<\-_\!``#__P,`4$L#!!0`!@`(````(0!F$7")>P4``-05
M```8````>&PO=V]R:W-H965T<R]S:&5E=#0N>&ULE%C)CJ-($+V/-/^`N-N0
M[%BV6PVH9EJ:ED:C6<X43MNHC+&`VOY^(@EL,L+EK0_59<?+X,7ZJ)Q_^ZAV
MQIMLVK+>+TPQM4U#[HMZ5>XW"_.?OY\FD6FT7;Y?Y;MZ+Q?FIVS-;\M??YF_
MU\U+NY6R,\##OEV8VZX[S"RK+;:RRMMI?9![L*SKILH[^-ALK/;0R'S5'ZIV
MEF/;@57EY=Y$#[/F'A_U>ET6,JN+UTKN.W32R%W>`?]V6Q[:H[>JN,==E3<O
MKX=)45<'</%<[LKNLW=J&E4Q^['9UTW^O(.X/X27%T??_8<S]U59-'5;K[LI
MN+.0Z'G,L15;X&DY7Y40@4J[T<CUPOPN9IGCF]9RWB?HWU*^M]KO1KNMWW]K
MRM4?Y5Y"MJ%.J@+/=?VBH#]6ZBLX;)V=?NHK\&=CK.0Z?]UU?]7OO\MRL^V@
MW#Y$I`*;K3XSV1:047`S11I%O0,"\-.H2M4:D)'\H___O5QUVX7I!E,_M%T!
M<.-9MMU3J5R:1O':=G7U'X*$(G5RX@Q./&`_V)VI$_G"#VY[L9!1'V"6=_ER
MWM3O!G0-/+,]Y*H'Q0P\'R-#'J=8+X4*])23[\I+[PNB:*$^;\O0GUMOD-)B
M@"0(B4WC!'$H(CTB5-#*:Z9]80'=$V?(!.?L0DV_KL:1HCK$*`:40'(.<2DB
M_0+A44AV#@G#$X2$X=(PKM-78&@;+7UA='+;IRM!"!3QE.'QP3TBO8G(KB$(
M>7C,XS50AQ8F9&AD&+,@$!+U/20"FUI38O58_3)B%>-90AP&3B=^/>L*3`E'
MHUO,.D+"@;#@*4>SUYN=2-!X,MWJCN$0PL$CA!68$6;/3!""A!W79?V;ZF9A
MAWR.,]T>"S'6CY`.'R&MP(PTVPT)0I"T)P2+*=7-0C@V.Y[I]M@)QMU$2"NY
MUG;A]=908#J0$=L6"4*@*\=VI_5/;R*R:PA"'C;K_>05F&6<]4&"$,QX$'HV
M3[EN]T(W9MLHT^VNX[D7&D7`XKZ?=X]FQ,=BXD`.F(L-3NQ?=3@!7&YQH>3I
M[G;IT8SY./`#<Q0\9"Z\R&:AI8.3`6#;@GG(""`6\=B1I%>$$BF-NE+]VPK:
MGV(AL'67#)@C0S$20`5B]IAMTXS:8^T\#4#IE!;`]5$5J&JZ[D2L79,!@\0C
MW_?/F*,3!`2Q$XX-W8>6$0^^$P3C1%'N2J;NYXZB1KBS)R<",4AM$@G/8_LO
MI0@_@KU.-U%&$9[KQN-3*'VE6??31X73Z?.:)^I-&K81:F2D*<K0,KK9=\\Z
M1C>[\3@1E+62K?M9H\@1UFS_)0(QR'H"_4`3F@[VH2C"#T=F0[_H2CH1X47J
M2KSNIXY21ZBS;DB$+H?0+[[/DII2A!\+AXU#1A&>%U[L%Z5@&GVU:SRHV8V1
M1=TC83`*B4!,T+];3>#/;Q9G>@N0<8!P8O+O5%+:2TK:'H\(!9%$-&Z(OB42
MH8MF&(=\2E,"\,-0VX]#4^D>W-C79)O$X#PDNSV:ONS$3)N2`7/M;><V)+L*
MH1$\)+\.2BO)/FN79,"<UNCY6%#$5V-!$5?&P@$J>A-='X<>S0K`]DDR8*X6
M0#U4;=J+;Z3952^T`$R#[WN)<,ZU.&:K,QDPPVIE8Y\2*ZMA1HR3"Q+F*+UD
M`WS[]:<_15]_^$MO,F`&YB&;[Y288Z8H&;%.-)FD:5=ZIY&_T3BHCJ3OQZS@
MUE&W1]`5^#<WR$%PIF44X<?VF0I3A.=%6FJ0/EZNX=U3)9N-3.5NUQI%_:HN
MS@0L\=.W>*F7P*5>?P-FG0QPIW;(-_)GWFS*?6OLY!J.VM,0`FCP5@X_=/6A
MO^IYKCNX3>M_W<+MJ81+)7L*X'5==\</ZM[O=!^[_!\``/__`P!02P,$%``&
M``@````A`-1E2CRB!@``]1X``!D```!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&ULG%G;CJ,X$'U?:?\!\=XAF'O4Z=&$T>R.M"NM5GMYI@E)T(00`3T]\_=;
M=CG@L@F!?4EWXN/BN*I\CA,_?_A>G:UO1=.6]65KNZNU;167O-Z7E^/6_ONO
MST^Q;;5==MEGY_I2;.T?16M_>/GYI^?WNOG:GHJBLR#"I=W:IZZ[;ARGS4]%
ME;6K^EI<8.10-U76P=OFZ+37ILCV8E)U=MAZ'3I55EYLC+!IYL2H#X<R+S[5
M^5M57#H,TA3GK`/^[:F\MK=H53XG7)4U7]^N3WE=72'$:WDNNQ\BJ&U5^>;+
M\5(WV>L9UOW=];/\%EN\,<)79=[4;7WH5A#.0:+FFA,G<2#2R_.^A!7PM%M-
M<=C:']U-Z@>V\_(L$O1/6;RWRO]6>ZK??VG*_6_EI8!L0YUX!5[K^BN'?MGS
MCV"R8\S^+"KP1V/MBT/V=N[^K-]_+<KCJ8-R![`BOK#-_L>GHLTAHQ!FQ02-
MO#X#`7BUJI*W!F0D^R[^OI?[[K2UO7`51&O/!;CU6K3=YY*'M*W\K>WJZE\$
MN9Q4'X3)(!ZPE^-LQ>+`#<+'41QD)!;X*>NRE^>F?K>@:^"9[37C/>AN(#)?
MF0?Y&5\9L.%S/O))8BJ@6RC'MY>01<_.-TAA+C$[Q"2VU6,\BDA'$'X/<8!?
M3Q*6OIPDGT1)>AJ#'4(2D6:^L%3Y@!"`S*@$IK/#P9!%9>4AB_N%B0SN$.,K
M&"U_Z12"<(,@\[EQ\-:&9?95"5FB<4-,+.KJ>IZ?:(!4!01QLA[&"3%H[?G$
M.%A+FK?6B"$&GMZ3UY,VA2#<PB7<.%A+FL$-,3XF;3WTL2AW2D;#891PBI9P
MXF`]7ZZ6+\1,Y6L*0;AQ)U-D8GH#<+">+YT;8C!?3XQ1YBD9'?8.H032,I\2
M!]-T>;'6/#O$3*5K"D&XN2"A\\D)-$V8R4Z"HMNV#&(MI2E!!,DZ#/JL4G+_
M3_-1KHET>%K==BZ"L*S:]DW[P;']2QER'5;:;:8KH7JK#%FH2[Z+H*DJ3T(H
M3R[2"L_I;>&BI,-KKU^F,4C0)+_9UN!"F`7\.)JV(5.T"HU+A-S:V(9!$'A&
M%V(4V:=!$(9WNE"SAYDU1H4G-8Z&)TB.")(48N8-@HMRS,]NL%()2*)DD`):
MWT4VX8[XA&&N$H2/CKQ(V:22&T9!@!=X2@=3;HOLPAWS"VV#[B1HLO=F.X:[
MR#($^F'OJ;:@'SA3&0*U1SEPT:QIKC&SZU#X'W3=S1WX>3C0>C)UU5'E1$78
ML46V(=`T9Z%Q+I$@S$JLJ6%*1ETEI9269AC3,L?0`XC,Z2JQDZ"I5IN$4'Y<
MTV?+,$,'(,4T9$Z"Y/E$UX]^=%#R.PK"N%8KU.;UFYA%*\L,E9.@>Q1O)L&[
M\6D0:9HXKM4*NP>%1657$Q>:A4609#4<W5#<&!F]QTISA@>L4,O5=C,/3_P+
M,@@^/+VWWJ%@DMH4A&9MD2LPTQ5,5Y4@%'UPU<#H.-45W"!(!@#EIKG"S'Y#
M55<K.])O")*F&;-8ESA&`$F<W#E_LD7.(-!T+XS4%YWAYJJQKUE;*J/<7-6/
M[WQG99H_/.B]$5\(A\BBL78BY(/>NYG#6'N2^O+?9N;O6(&F7WO,$Z<$3>V-
M20CEM\@J/+0*TG>&%$N0+%V<1+J)$8`;P9EI_,3IP7/4W,W;&V(6[3]S;T@0
M<F3K*!RD#=6%`$(WN4=1LXOI]O-0X]7TF;_F2!!2"R![@W)(:AA%<O<"?]C7
MM+1<NV>;A8=*K\JR>3B1H,G6PSCC$,IOD6UX*/=J[DQ9EB`T,VU?IV20W2NH
MYA4S>V[$,PS_]Q"$Y%SMFWA*1X>:TY1I;O&@W4R7&"DI@I`5,[:!.NH-%DQ9
M+?('#Z6?-IKVW)T$C7>1W`889QQ"^2WR"&_,(X9ZH$=(D#PU&9UVLP=QEAOF
M$E:^Y@SS.DW,>J1N$B39#:Z.B:.C=_:!O\@7!)JR,D^:$B19N4-:)"WT%CE\
MI]5\S1*F-X!`4SLUCR(2--Y'DAI_ZKT3`2TJU^;9FNNCDD]KF@3=MU,"`#N-
M!FFAW&")*K>9#<=GT=*:=NHC:+!3_7L$`81,^;V=4EQD"7"#J%,;*2^"\'8$
M[-37I(;?0_(H"&!>H.@V<L-;1KR$JXKF6*3%^=Q:>?W&;Q`9_+[;?XJWFSMW
MLV/\CDK[/(5;3_&YTP_`I>,U.Q:_9\VQO+36N3A`R/4J`DX-7EOBFZZ^BJNQ
MU[J#ZT;Q[PFNEPNX`UNO`'RHZ^[VAE^,]A?6+_\!``#__P,`4$L#!!0`!@`(
M````(0"0UZ06G00``-43```9````>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM
M;)1878^K-A!]K]3_@'C?@$T@(4IR=8FU[95:J:KZ\4R(DZ`%'`&[V?WW'3.$
MQ88:]B6[9`[C<V8&'^+MM_<\L]YX6:6BV-EDX=H6+Q)Q2HO+SO[[K^>GM6U5
M=5R<XDP4?&=_\,K^MO_YI^U=E"_5E?/:@@Q%M;.O=7W;.$Z57'D>5PMQXP5$
MSJ+,XQHNRXM3W4H>GYJ;\LRAKALX>9P6-F;8E'-RB/,Y33@3R6O.BQJ3E#R+
M:^!?7=-;]<B6)W/2Y7'Y\GI[2D1^@Q3'-$OKCR:I;>7)YL>E$&5\S$#W.UG&
MR2-W<S%(GZ=)*2IQKA>0SD&B0\VA$SJ0:;\]I:!`EMTJ^7EG?R<;1JGM[+=-
M@?Y)^;WJ_6]55W'_I4Q/OZ4%AVI#GV0'CD*\2.B/D_P*;G8&=S\W'?BCM$[\
M'+]F]9_B_BM/+]<:VNV#(BEL<_I@O$J@HI!F07V9*1$9$(!/*T_E:$!%XO?F
M[ST]U=>=[04+?^5Z!.#6D5?U<RI3VE;R6M4B_Q=!I$V%26B;9`GLVSA=T+5/
M_&`ZBX.,&H$LKN/]MA1W"Z8&UJQNL9Q!LH',#V7(H]/Z?U)!HTSR769I<H&*
M"OKSM@\\;^N\04V3%A,A)K2M#D-5Q.&!D`64:5GO"P?X=J2A%#II#YHZWHX'
M1WF3RG%`<02B41Q!+%4(&T)6JPZBR/!4&6;Z$@QSTRN?OPZ[O$V](L1`&[L2
M?Z[<(`Z3"&9"*.QAF7X3S.PE>&=#:3IF=,`>,>MF?"@)`U]5=^C'2>A[KAIG
M&(?/;HU/]0IS>.;ZS.7,3X^/O$E3$&H,(L2L&@5/A(2A/N$J@'I4T\@0,$-#
MH&HP5U^"5>Y+HA8O0@A2#\.5]O`>^N$5=77:&)Y!>Z72GE=Z>9-*/_"TIRY"
M#/(GH:<7OA^F[O)S,'"C4<)TN>Z*H\R-M//>7FFNN02KI.E:)XV8\;+A\SJ)
M8":$PAYVWOGL)7AJMT&,B?TD@ID0"GL"^_M\^@U:K[Z^6[8@G!DO"+7X08V3
M0.L>:^/C!5#)2R.;/3D$;4_=++4G+FI!XXOC[$Q#F!&B2I"V-E\"FJ#9K0B"
MC!(F(<R8194@K6V^!#1"(-#9R="R"()PA"C1+>F@QEU?ZR)KX^,E4,D#Y@OD
M)5J?_Z#;U9KYB`B"QA=O1V@2PHQ95`G2W.;7'ZUP8H1,?ME*F(0P^2H/U1HO
MA"I!&MU\"6B+$R/4MU;BK;4N'8@2I\-=".-SR$N7FT\>/5$EK_EF1!`TOGA;
M_TD(,V91ZR_=;KX$],:)$3(9:"MA$L*(":)*D)8W7P(:I-H%S:@B@J#VY6>Y
M#/6W-Q5`!Z]'K`6,]U&A3[_DPPU:WX<^WZZ:\D8M:'QQ[,`TA!DAJH0ON3%%
M-S8/40LR2L`\!@@S9E$EP$#,'R(X&AFZ@3Y$+:C]^>5K3_I!"1.B&UD;'E>'
MU/%T!0\?<EY>^(%G664EXE6>G!#XT=1]BZ<Z$9SJ-$<@3A>`0Y5;?.&_Q^4E
M+2HKXV>XU5VL8`,O\5@&+VIQ:W[J'T4-QRG-OU<X/N-PJ.`N`'P6HGY<R(.?
M[D!N_Q\```#__P,`4$L#!!0`!@`(````(0!5OS:2P@4``-X:```9````>&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;)296X^K-A2%WROU/R#>)V`@)!E-YF@2
M:]HCM5)5]?+,$"=!$T($S.7\^^[-=AAL4^.\S#E)OFS6VKXL$QZ^?98G[UW4
M35&=USZ;A;XGSGFU*\Z'M?_W7\]W2]]KVNR\RT[56:S]'Z+QOSW^_-/#1U6_
M-D<A6@\JG)NU?VS;RWT0-/E1E%DSJR[B#)_LJ[K,6GA9'X+F4HMLUWVI/`51
M&*9!F15GGRK<URXUJOV^R`6O\K=2G%LJ4HM3UH+^YEA<FFNU,G<I5V;UZ]OE
M+J_*"Y1X*4Y%^Z,KZGME?O_]<*[J[.4$OC]9DN77VMT+HWQ9Y'755/MV!N4"
M$FIZ7@6K`"H]/NP*<(!M]VJQ7_M/[)['S`\>'[H&_5.(CV;P?Z\Y5A^_U,7N
MM^(LH-LP3C@"+U7UBNCW';X%7PZ,;S]W(_!'[>W$/GL[M7]6'[^*XG!L8;CG
MX`B-W>]^<-'DT%$H,XOF6"FO3B``_GIE@5,#.I)]=O]^%+OVN/;C=#9?A#$#
MW'L13?M<8$G?R]^:MBK_):ASU!>)9)$$U,O/HUFTG+-Y.ETE($6=09ZUV>-#
M77UX,&O@FLTEPSG([J'RU1GIZ+W^GU7PB$6>L,K:7_D>N&A@?-X?TWC^$+Q#
M3W/);$PF4HGME<`&8ED^>",`O;UH:,50]/@P7+4AC-JN53?T!M3NQ<::D!$B
M41%N(HM%CRABXUO$(@RS8Z`MC=.^;M>5#3$P6+W^KRMWQ':2X#9"40^7<6\U
MPFL?6M,K2[2^;0A9=G-DN4KG81BJ]K:3!"<"_O:7^6J`(AX6E[MXA/76?]6E
MUA,S?F5J_23!;82B/KU%/<)JZ]-XJ79V0\RBZ_U=LEBD9O,5)%ZDL8%P0L9[
MH.A?W*(?8;7[,=.6Y8:8\2M3]R<);B,4]9C=@XW1OL<@K'=_I76?&.I^M)BO
M1KH_C7!"QGN@Z(?->*@?-_88@L_N`[^D^4BT];DA1OJ(EG`4,9:P@L3+>&06
M$>+@@X'HVXUTW]*=,&U$)$166,A,F5L-69EFN8JLU"K*D##,L\&<<AN3[EOJ
MTD@3+3HW$AKO)ZV-:81;$=4*YM_`BGU:,4K+J-MYHI#IH2`_OPX$-EF;=5N)
M6`QR*Z*JQ_AS5T]AV:LW#C;TN56]+6^[X>',AJCJH0DWJ$<:5P*>RJ#W^FF"
MT>=6]83`WY'`E>IMB*H>\\^]]Y26O7H]D/$4#NY(?;<ZC8ECRULIWH:HXC'\
MW,535/;B]3QFP[0=%V\+6RG>AJCB,?O<Q5-2#@]S<6A,?5N<=OJV;!+A5D2U
M@/'G;H'"$A96/V_3V)A!MD25%B81SFR(:@&3S]T"Y>1P%-)$/Q<Q,TQ3_>"]
M'8&T5G`KHIB(M%"V;_\=K89Q--?W(0G)?2C!&P,C!!P8+IGQS4HUH<7QA`FZ
M&55&PCAA1P21B;MXR?!TI)XZMBH3K9AY#\0EXV("H]5Y.D5(JR,1A_JQ2$+7
M1$B7RQ$35$@R;+X<,T&,BPG,/G<3E)10O5_6<:B?MB-;G-*RGD:X%5$G$P:@
MNP6DM3.=L3-%!(WW3UJ81+BUBFH!8]#=`H7F<!3,G0E_F`*?0PMIHH7(=@32
M=R8KHIK`.'0W0>$Y-#&R,Q$DYWHT=N,632)<(L-6?+E4+=R4TY&9T^:=OX3D
MOK1*DY$5374DLDS,1<]E%1<+&(?NHT#A.1R%D5V)(-(7QV,;ZY!(1@T0X6+@
MII2.S)2.0SVE)31^<;F<S2#_FB,=PJU5E&F$=_ON8]#1VHZ4Z!DM(9N%:81;
M$=7"30D-3P#T<$L3K7\;"=$/D(SA+#<2VH'!QPWZSO9U*3)!CQ/HU_92U`>Q
M%:=3X^75&SXJP+N"_MW^,<93A+]3:^]OX/%&]RP@Z#^`IPN7["!^S^I#<6Z\
MD]A#R7"V@/VVIN<3]**M+MUO_"]5"\\5NO\>X3F2@%_7PQG`^ZIJKR_@PD'_
M9.KQ/P```/__`P!02P,$%``&``@````A``6.H#L4`P``O@@``!D```!X;"]W
M;W)K<VAE971S+W-H965T-#@N>&ULC)9;;]HP%,??)^T[6'EOKB0!!%2%JENE
M39JF79Y-XA"K21S9IK3??L<^-#>JCI>6Y/S]]^]<L%G=OM05>692<=&LG<#U
M'<*:3.2\.:R=W[\>;N8.49HV.:U$P];.*U/.[>;SI]5)R"=5,J8).#1J[91:
MMTO/4UG):JI<T;(&(H60-=7P*`^>:B6CN5U45U[H^XE74]XXZ+"4UWB(HN`9
MNQ?9L6:-1A/)*JJ!7Y6\56]N=7:-74WET[&]R43=@L6>5UR_6E.'U-GR\=`(
M2?<5Y/T2S&CVYFT?+NQKGDFA1*%=L/,0]#+GA;?PP&FSRCED8,I.)"O6SEVP
MW"T<;[.R]?G#V4D-/A-5BM,7R?-OO&%0;&B3:<!>B"<C?<S-*UCL7:Q^L`WX
M(4G."GJL]$]Q^LKXH=30[1@2,GDM\]=[IC(H*-BX86R<,E$!`/PE-3>3`06A
M+_;_B>>Z7#M1XL:I'P4@)WNF]`,WE@[)CDJ+^B^*@K,5FH1GDPCHS_'0#>=Q
M$"?_=_&0R"9X3S7=K*0X$1@:V%.UU(Q@L`3G]S."5(SVSHCM$H!5T(7G33*;
MK[QG*%UVUFQ1LW!(IXG&BMT[BEDG\8"K@X.4AW"F[!$T[V-(LV@,&4T(MBBQ
M`V,3VPU>C`"@(D.`CS<V8@`<9AY,JX.:V4"3=JDCRD>*$1N87,]FQ&L'TNR[
M$H;CG;>HF=N^AK$_CNZ&T2!-DRX\@H)QOA[*B*=0TU:A)K50$<QZMRU6"\,S
M&UZ$?70$E8RAKALCLV@*UX^IW7V+&H0+@OEL6K-A/(V310<_PDO'>!\/F1%/
ML?JT$0LU6)0X[CN%)1M&HZ`?OQ&3N;BN/A:,>,HTV76+FG.I_.GW8H=A1([2
M?@A&4'"H7`]EQ&.HBZ,*)3CP01JD?7^P4J.XOTCZ]B(6WA=XG-9,'MB.594B
MF3B:NR"$H>S>XC6U#99P]L#],'F_@^O+OO>Z`%P?+3VP[U0>>*-(Q0JP]-T4
M!E[B!80/6K3VL-L+#1>'_5C"[P0&Q[7O@K@00K\]F"NN^^6Q^0<``/__`P!0
M2P,$%``&``@````A`$"!;LVY!```+!0``!D```!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&ULG)A=;ZLX$(;O5]K_@+AOB$,@'TIRU`38/=*NM%KMQS4E3H(*
M.`+:]/S[G6$(P0ZUT[UI`WG\XGD]'B9>??O(,^N=EU4JBK7-1F/;XD4B]FEQ
M7-M__Q4]S6VKJN-B'V>BX&O[!Z_L;YN??UI=1/E:G3BO+5`HJK5]JNOSTG&J
MY,3SN!J),R_@FX,H\[B&R_+H5.>2Q_MF4)XYD_'8=_(X+6Q26):/:(C#(4UX
M()*WG!<UB90\BVN8?W5*S]55+4\>D<OC\O7M_)2(_`P2+VF6UC\:4=O*D^7W
M8R'*^"6#N#_8-$ZNVLW%G7R>)J6HQ*$>@9Q#$[V/>>$L'%#:K/8I1("V6R4_
MK.UGMHR8;SN;56/0/RF_5+W/5G42EU_*=/];6G!P&]8)5^!%B%=$O^_Q%@QV
M[D9'S0K\45I[?HC?LOI/<?F5I\=3#<OM0408V'+_(^!5`HZ"S&CBH5(B,I@`
M_+7R%%,#'(D_FO^7=%^?UK;KC[S9V&6`6R^\JJ,4)6TK>:MJD?]+$&NE2&32
MBDQA]NWW;#3WO*D_GSVN`F0S%?^F,AE-YA[S?/-<'(JKL2F(ZWBS*L7%@MR#
MF5?G&#.9+4'YZ@]%TSGVF6'@%(H\H\K:7M@6>%'!*K]O_.EBY;S#RB0MLQU@
MO+',[*X,+@0*!^J-\'KC]J2)K!%="4P+"+*+%%:A'^EP!EP#0A@#NDYD2S=`
M^Q:AQ^0G[X8897;!$./*.N$]HQ#1`#'M1*2HW:]$C3!D>"](=S+K=)L5V1(#
MJ=P9H1`[(Q$8B=!(1#I"<@"F^OBZ([RVP=XN.M=5DG1+C,X!(Q$8B9"(>;.9
MIFPQ'BO3B"3`G?8!*7ZH&_WX<8>[4$?U^8^#5!^4=-\2`]/HO%(SP4@$1B(D
M8D8^^#[KQ]ED9*0C)">@OGW="1RD.J%LZBTQ.B>,1&`D0B+(">:[8(2:$A+!
MV+Q/2$[,9"?TN8"PZH!2D+;$Z!PP$H&1"(EH'6"^%!_E@DY#<@`;O-Y[3^\`
MPJH#MWI+=9$8G0-&(C`2H9&(B&CWRPS:S5N22`;`R_IQ`Q!6#?"4%P,Q.@.,
M1&`D0B,1$4$&N%+=E.)G4`,?-Z"A90?86"T#+:2SP(P$9B1L$8IQ-I\-;`0)
M\6>3S]\/#!NFA[="0\M&N*ZOI$(+:8V@-DV#!&:5L$7(B*?%9,@(>E"+N',)
MD3,"NZK'C:`>3&X5[GI>@C11[I@1"<Q(V"(4I;_P!EX.,@*+]FEI8-A;]8QX
MK&5H1LF9X7MJE6PAFB<N1:\\-75T9R0"B<`H5(VP)32V1UI$3@N0^1]NX"C5
M#;5D,H)T;O2)V4"L@:31K/NMX#>.ABT!2I\U:I$6D=W`;NOKN4$]6G^S^-Y=
MU2!(,\\=_G0'5S5(8$;"`<1;*-UM-`#=VEO9$FR[OFX)-6NR);<G4%,!1R.&
M>'=F)#`C88O0SPUL&M0]A:<T.!4BL`OO$60''<+0Z4+.RR/?\2RKK$2\X0&+
M"QU\=[<[_'F>X$]LY?Z6+>&'__W]$`^+\+[3#8"SFG-\Y+_'Y3$M*BOC!WC4
M>(3'*B6=]M!%+<[-6<>+J.&4IOEX@E,Y#F<,XQ'`!R'JZP4^H#OGV_P'``#_
M_P,`4$L#!!0`!@`(````(0"B!%B`@@,``-4+```9````>&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;)1678^;,!!\K]3_@'AO""00@I)4EQ#:2JU45?UX=L`D
MU@%&MG.Y^_==XT`PI)#>`Q>6\7AG=C&[^OB:9\8+9IS08FW:DZEIX"*F"2F.
M:_/7S^B#;QI<H")!&2WPVGS#W/RX>?]N=:'LF9\P%@8P%'QMGH0H`\OB\0GG
MB$]HB0MXDE*6(P&W[&CQDF&45(ORS'*F4\_*$2E,Q1"P1SAHFI(8AS0^Y[@0
MBH3A#`G(GY](R6NV/'Z$+D?L^5Q^B&E>`L6!9$2\5:2FD<?!EV-!&3IDH/O5
MGJ.XYJYN>O0YB1GE-!43H+-4HGW-2VMI`=-FE1!0(&TW&$[7YI,=1+YI;5:5
M/[\)OO#6;X.?Z.43(\E74F`P&\HD"W"@]%E"OR0R!(NMWNJH*L!W9B0X1>=,
M_*"7SY@<3P*J[8(@J2M(WD+,8S`4:":.*YEBFD$"<#5R(CL##$&OU?\+2<1I
M;<Z\B;N8SFR`&P?,140DI6G$9RYH_D>!["N5(G&N)'/(_OK<F3B^:[O>?[#`
M?E4J7L/R>"J6DE6Y%"*!-BM&+P9T'B3.2R3[V`Z`N+9'B6D,^Y=?8)0D>9(L
M:W-I&F`%AQJ_;#S77UDO4)CXBMGV,8Z.V-4(605)&W8#>Q6`:VN?J<X2]3&W
M?2Q0W4B'JK2EW^^(6J$$2X5U;MLZ<$MEIB>RNX.8ZY"P#UDL=,A>0=J2W86K
M8Z(^YI:+)GFF2Y;5GL$K-2Q=+M*D=P.[;B#L!O8JT%;AN<N.BF&,I@->I,=+
M)\&@L]4T[LV>JM&V"@+7IJ\Z9=B-(L)1Q'X4$0TA-`/@+&@;\%@AY:*U"<W2
MJ/2\SMNS51C(H\%TG1A%A*.(O4+XU4DQ]Z?RK],,0QR:$W!HM9T8;F4)[CI@
MZSMO%6;(@5%$.(K8]Q'NLG,Z1'W,K1::!PO=`]D-<S!PV`NYJ.O%[:14[X7"
M#'DQB@A'$7N%6%3=8,_N=<,0A^:$G-I:G[-A!R18=\#OM.%6052CVIZ]Z#7J
MKHUP?+L'"-N`F==[OE?/!SR&\4CF>4UBKONCU*OQ1WW8<\R.>(>SC!LQ/<O1
MQ@5GFV@S=3W-Y,>L$]_:`7QU[\2=8'L/OW,"./W[^-`)X",`<:O9`*:J$AWQ
M-\2.I.!&AE-(;3I90*,R-9>I&T'+:BPY4`'S5/7S!.,SAH%@.@%P2JFH;^0&
MS4"^^0L``/__`P!02P,$%``&``@````A`*-9'SOD`P``+@\``!D```!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&ULE%==CZLV$'VOU/^`>+\AAD!(E.3JAM6V
M5VJEJNJ]?2;@)&@!(^QL=O]]QQZ68"\UR4MV@3.',Q^>839?WZK2>:4M+UB]
M=<EL[CJTSEA>U*>M^^.?YR^QZW"1UGE:LIINW7?*W:^[7W_97%G[PL^4"@<8
M:KYUST(T:\_CV9E6*9^QAM;PY,C:*A5PV9X\WK0TS95157K^?!YY55K4+C*L
MVWLXV/%89/2)99>*U@))6EJF`O3S<]'P#[8JNX>N2MN72_,E8U4#%(>B+,2[
M(G6=*EM_/]6L30\E^/U&%FGVP:TN/M%71=8RSHYB!G0>"OWL\\I;><"TV^0%
M>"##[K3TN'6_D75"5JZWVZ@`_2SHE0_^=_B977]KB_R/HJ80;<B3S,"!L1<)
M_9[+6V#L?;)^5AGXJW5R>DPOI?B;77^GQ>DL(-TA>"0=6^?O3Y1G$%&@F?FA
M9,I8"0+@UZD*61H0D?1-_;T6N3AOW2":A<MY0`#N'"@7SX6D=)WLP@6K_D40
MZ:B0Q.](`E#?/?=G?AR2,)IF\5"1<O`I%>ENT[*K`U4#[^1-*FN0K(%9>A9`
M?,8]`Y>DS3=II$P!S2$=K[N(K#;>*X0PZS![Q*Q<I\<$.B(902QZB`?Z>I'@
M^N,BI9$N,C`4[!&B"D<YE@QN:`(@,D,!]NA(,$1QX'GDSWO'U(OVB%D,,$L=
MD=@0FC8@&6J[+X/2:.N"NWUV(I_H"O:(B55^#?T)/H/?WOZF7U,']?VX.FED
MJO,-=8A9C*K[>#:I+M+5V?,JP:8JLZ(0,QX7+#$;0HO<\A%M$CQ5<XBQ:;,A
M-&URL#W<-:21'C]_$1M91<Q2994LXG!AM)5$`\11?"/0!$+?&0JT)U:"36'&
M>_>(Z80%01@;IR49`L+5/`I[SS1A!)KK_<H46I<6^;<FB;VD`Z$V/_9)8)Y6
M#;%<+L-;V>KBC&E@#QO!!JXWD9O;G3@$V:JNXQF'Z/ID?Q[4W80^[.;V1DP0
M-/YR/+%6B*Y/-NV!OOMZ,<%6/XSCYX/1@:PZD:>KT?\_&P1(ABHGHBC1DR6(
M(*LZA$RK,R;&A+JQ41'U1Z^K0=L\Z')L@^@Y?FAF$&SW$S5HFPF=/AM$UV?,
MC3MK$%O_1`TBJ$OA6'<F=T\08HR0B32/S0ZS12O*K=O)&^O1&L+6I!\:'[!Y
MW'%"$(1?4^-->H@8$X?K"7Z]5[0]T826)7<R=I&KAP\SL[^+:]&>K.$3%]81
MXWX"ZY*Z[_4/8%MITA/],VU/1<V=DAZ!<CY;PK%H<=_!"\$:]4U]8`+V%/7O
M&?92"EO!?`;@(V/BXT)N5/VFN_L/``#__P,`4$L#!!0`!@`(````(0!B,O(*
MG`0``$H3```9````>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;)Q878^J2!!]
MWV3_`^%]Q$9%QZ@W5\CLWF1OLMGLQS-BJV2`-C0SSOS[K>H"EFZP<>_+C%BG
MRW.JJJN:WGSYR#/GG9<R%<7699.IZ_`B$<>T.&_=O_Y\>5JYCJSBXAAGHN!;
M]Y-+]\ONYY\V-U&^R@OGE0,>"KEU+U5U77N>3"X\C^5$7'D!EI,H\[B"Q_+L
MR6O)XZ-:E&>>/YT&7AZGA4L>UN4C/L3IE"8\$LE;SHN*G)0\BRO@+R_I53;>
M\N01=WE<OKY=GQ*17\'%(<W2ZE,Y=9T\67\[%Z*,#QGH_F#S.&E\JX>>^SQ-
M2B'%J9J`.X^(]C4_>\\>>-IMCBDHP+`[)3]MW:]L'?G,]78;%:"_4WZ3G<^.
MO(C;+V5Z_"TM.$0;\H09.`CQBM!O1_P*%GN]U2\J`[^7SI&?XK>L^D/<?N7I
M^5)!NA>@"(6MCY\1EPE$%-Q,_`5Z2D0&!."ODZ=8&A"1^$/]OZ7'ZK)U9\%D
ML9S.&,"=`Y?52XHN72=YDY7(_R&04M0Z\6LG<V!?V_V)OUJP13#NQ2-&2F`4
M5_%N4XJ;`U4#ORFO,=8@6X/G1AGQ:+7>DPH:T<E7]*)\@0H)^7G?!6RV\=XA
MIDF-V1/FV75:C*\CP@:!`42W4><+#_BVI"$4)ND9)'4X'0U'7*1SG)D4!R`&
MQ0'$7(=$?<ARV4(T&3-=AIT^@J%NNN%CSZU?%:\]82"-;8C_^V6%"$<1D0VA
ML8>?^?])P$5;%T+4,O1G@:&","M51E/=%EILT;!-XPR[S>0\O[N/F\+!17KD
M`V8D?4\88-#J,B,_BHAL"$U%H*NPUPV"]8@';*%'=4^8I8JXOYP;YI#,%G&1
M#:%17^K4L=V,[UQ<I$OP9\R00)BYDO#4V7!4]HWU;GHB&T)3@#/=:)CC"G"1
MJ6!E*"#,/06-];X"&T)3`"VXJ\!>/@C6F0?,W+"$J<LG"`QAH6;N55=$YN'J
MTG@S:/%=XH\5CUIE*C`VY[X&#9.@$AJ'1%:(+@4GFU%%XXV(T3SLSH!^)ZI!
M5BGDQP*)K%YT*3CO.E+LY<1H.G8'0+\=U2#:"G"\T3=*V)KO[P4K1*>/\ZY#
M_\&BHBG9E=%O2:P9I7@>>EH:(R-LS189C8<AB"X#DOD#,G"5OC?\F;%]]XQ`
M36/JR6C,0QS5UHE:#T,070;.P$XV1HJ))F8W"_WFA.=TT$CT5[TC9V,=HE:S
MMT%T]C@&'V=/0U-GWPN^;;+6C6D4$C$;1)>`<[`C`;?#`XV)IB=4:WO\&6A,
MMA%;2QF%1,P&T:7@0.Q(&:DE&I]Z-HR#T)X1J)YTBY5Q_@YK.^R(-@[&I(FL
M$)T_#L8._P<[$XW3KHZ!SM3,7-69C+>@D#56BPH;1%/A_]#05JO&&E,-JAN3
MJ:*UWE=AA>@JC'EMKR6?YFLW!_V^5(/H-<=?K,PI5]MMM62%$'^ZTJ`W_IR7
M9Q[R+)-.(M[PNH+!<;G]EJY2]G"5HNX=O-8`-QG7^,R_Q^4Y+:23\1,LG4Z6
MT!=+N@NAATI<U?OU051PAZ$^7N#.BL.;_'0"X),05?.`MRWM+=CN7P```/__
M`P!02P,$%``&``@````A``N<4%A&`P``X@H``!D```!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&ULE)9=;YLP%(;O)^T_(.[+5X`T44C5!'6;M$G3M(]K!TRP
M"AC93M/^^QWC0#&TD-XDP3Q^><]'\-G</9>%\809)[2*3-=R3`-7"4U)=8S,
M/[\?;FY-@PM4I:B@%8[,%\S-N^WG3YLS98\\QU@8H%#QR,R%J->VS9,<EXA;
MM,85W,DH*Y&`2W:T><TP2IM-96%[CA/:)2*5J136[!H-FF4DP3%-3B6NA!)A
MN$`"_/.<U+Q5*Y-KY$K$'D_U34++&B0.I"#BI1$UC3)9?SM6E*%#`7$_NSY*
M6NWF8B1?DH113C-A@9RMC(YC7MDK&Y2VFY1`!#+M!L-99-Z[Z]AU3'N[:1+T
ME^`S[_TV>$[/7QA)OY,*0[:A3K("!TH?)?HME4NPV1[M?F@J\),9*<[0J1"_
MZ/DK)L=<0+D#B$@&MDY?8LP3R"C(6%X@E1):@`'X-$HB6P,R@IZ;[S-)11Z9
MB]`*EL["!=PX8"X>B)0TC>3$!2W_*<B]2"D1[R+B@_O+?<_R;@,W".=5;.6H
M"3!&`FTWC)X-Z!IX)J^1[$%W#<IM9,I'%^M[H4*,4N1>JD3FRC0@"@[U>=J&
MKK.QGR"GR879C1E/)_8M(1,H9>/>@@U^.].0BK[IM\O0>I.P]-:J[M0":'=F
M%P,C;Q"^CL1C9+GL$,WLXB-F)0S=T?,6NFZGVV1EIQ@H5N?_]<D-L9\EXBE"
M<P^/Z:=:]L?RW<YO4RXW12:DJ',8NH-B[Q2S;)HE6"[#P!^D>*\1BR"X';94
MW"=\/PR<Q:N&%@4X[D<QW3`2UMU[[JNNJH%BX/E=A,,:S!+Q%*&Y#S_B7L)S
M':28*?>S1#Q%:.Z7NOOK.DANTFLP[B#%=!WDC#M((Q;^:MQ!?<+W@]6['22/
M\MY[<KJ#)*R[]]Q@\"]6S%0-9HEXBM!J`&_FZ]U+>*Z#%#/E?I:(IPC-/1SM
MFOWK6JC9I5=AW$,72#51Z#B#0VL_<U].'3)9;^Q7$:B10IVX)69'O,=%P8V$
MGN2XX,';KUOM1IE[3YY5@_6='''DNMW=@`FC1D?\`[$CJ;A1X`PD'4N^GIF:
M4=2%H'5SSA^H@-FB^9G#+(GAA'4L@#-*17LA']!-I]O_````__\#`%!+`P04
M``8`"````"$`68_MP8P)``#P+@``&0```'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6RLFEESXDH2A=\G8OX#P?LUEEAL$[9O7-"^3DS,\DQCV28:D`/H[=_?
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MW\+#YB7;["MRF_I)],"GNOXL0N,7@2AY!-E!TP/_.`Q>JM?5E^WIG_6WJ-J\
MO9^HNZ?4(M&P^<L/KSJNR5&2N9&7L:ZW=`'T[V"W$4.#'%E]?QJZ=.+-R^G]
M:3B>W4SO;L<.A0\^5<=3L!&2P\'ZR_%4[_XK@QQQ49W(I!6AWU;$N;F?3B>S
M^[O+12BRN1+Z;45F-^[]U)G.KKB262M"O]V57-N:NU:#?CN-JUM#\ZMI#?W^
M>FL>6A'Z[:[DVM8X-*2:*Q%_="I7M\=1`T7\\>LM<FB<R:OA`>=</=Z<L5*A
M/_Z/-JEQZ_#`_84Q)Z:;;!,/W8O;-)+SL9G>WNJT>GX\U-\&M&:2S<>/E5B!
MG;DX@YK8<AIV4_U_S72:G4+E#R'S-*0!1)/X2,O3U^?IG?,X^DI+RKJ-66",
M:T8L5828]$+6LX%O@\`&H0TB&\0V2&R0VB"S06Z#P@:E!D;D=6<X#<B_PG`A
M(PQ75BT4X!X86^ZJ")7BV<"W06"#T`:1#6(;)#9(;9#9(+=!88-2`X:[-%'!
MW3&M2/WW*35Z11;=D?31ZTQ-]Q9M#$V1;HC?F2'++J1S&(@/)``2`HF`Q$`2
M("F0#$@.I`!2ZL1PF]8S<%LL(E<N'D*&UA_JT\[:Z9VU-BQDT/B<_UU(YS\0
M'T@`)`02`8F!)$!2(!F0'$@!I-2)X3^98?A_?I2+Z,9F9<]"$O)4D240#X@/
M)``2`HF`Q$`2("F0#$@.I`!2ZL2PD'9P5U@HHDT+)1G?LX5`/"`^D`!(""0"
M$@-)@*1`,B`YD`)(J1/#0MK`7F&AB#8ME$0?A4`\(#Z0`$@()`(2`TF`I$`R
M(#F0`DBI$\-"42;KN[#S$UE$FQ9*HH]"(!X0'T@`)`02`8F!)$!2(!F0'$@!
MI-2)82'M/:^P4$2;%DHRD16GV'PN@7A`?"`!D!!(!"0&D@!)@61`<B`%D%(G
MAH6B=+O"PR;<-%&A"2^'"O%-QE-HUD7Y"G%4@"A4B!,CA3@Q1I0HQ(FI0IR8
M(<H5XL1"(4XL#61:*LH`?6;+^NI&/+`XO6_6GQ>U?.S1,^/'5$>UU94L)FB'
MI&[4"U$?TPB>.4VQY=XZ]FZ_#7#XSN2U:&QLM!QK%^MSE#I9@%HA1VF;-N?>
MW!%''*6T8M1*.$K7>C"U4HY26AEJY1RE:;FWIE;!44JK-+3,/A3%AMZ'/7U%
MSXZZSI*UB=%9$KG-,[:F2Y=BMRM6(+U[))J(H=%5T:Y51?MM(D6I2P\0A8@B
M1#&B!%&**$.4(RH0E2V2S39=%E7&%2[+HH3TE`T+\;B&+'5I9FC^677$4D5Q
MHM>B"?G?);IC:\SX*E%,RZ_/[L29F(,J4`&L'%ZD''&44'ZP)F2,N@EGG+GB
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M`/(1!8A"1!&B&%&"*$64(<H1%8A*`YF6BF+S"DME;6I8JI>KK:6`/-H-B35*
M*]]]1`&B$%&$*$:4($H198AR1`6BTD"FI:+XO,)26:L:ENKE:VLI(,\!Y",*
M$(6((D0QH@11BBA#E",J$)4&,BREJN(:2YMP\TZJD%:U*\3+JZ>0MG]2B*,"
M1*%"G!@IQ(DQHD0A3DP5XL0,4:X0)Q8*<6)I(-/2OZ1J%SL3:\_2(J[:K;OH
M4N5H96&+S*K=WG[Z'*7NVP%JA1S%-^GIV-KP1AREM&+42CA*U[)VMRE'*:T,
MM7*.TK6LK6S!44JK-+3,/A35].4K#6T0H;,DHF&B3K=447KWR*B?5.UMHEZU
M(PH118AB1`FB%%&&*$=4("I;1,LZ.6&Z?%W5[F+5WB+1D5H-!O.BK>VU;7R;
M:.S9L6I7\JIJMR=.H`)8.;Q(.5*)K?+MK54NQ"J`E9.+E%.5*)7'COUL+U,!
MK)Q?I%RHQ%9Y-K'+.170*)L]+:K@*^:3+)KU.[<HV44I1C]:3UMU]%)%\=KM
M(?);9%;N8ZLU`2?R&;%RYR@USZ-^>:NVC#GQC'S"44H^[9>WQD_&B6?D<XY2
M\D6O_,1Z^E-R8K^\V?NBC-9[_^+*7=3V]EWPHLJ]3:2U1S7,0^2WR%@%IF-K
M^0@XL;^MLG+G*'7&J%?>?C`0<^(9^82CE'S:*S^Q*W=./".?<Y22+WKE;7/$
M=Z/-O*0;63<O]5DB!X+\-%1^.[:K#F_5LMINCX-U_45\]DD:SX\=EM^D+N[G
M]+J.+L;F#W-Z!]7#G=E<%+A]1^[HR%WO$3J)O"_99W'H-+1K1C7/=>?B+H='
MZ"O:/_KX@KZN;5X,VN=PZ:O;'IW%>$X?S?3H3TB_V8':0I,Y?>6!"8OIG#Y=
MZ.'D5*]1Y%.?3?3J9RY>[*`2O<B9B]<T>(1>R\S%2Q<\0B]9YN(5"A[Q'+)6
MKOE6"SV7KH!N\IA#F]*YV'+B$=IBSL4&$H_0AI&ZL#DRZDY$WQM_K-ZJ?'5X
MV^R/@VWU2@/SMGG5=I!?+,O_G.H/JG_HJ^/Z1%\:-W^^TY?E%;WSO;VAN?!:
MUR?U'SKUJ/M6_?E/````__\#`%!+`P04``8`"````"$`0;ZO!1$$``"@#P``
M&0```'AL+W=O<FMS:&5E=',O<VAE970S."YX;6R<EUV3HC@4AN^W:O\#Q7W+
MEWQ9ZE0K?KM56U.SN]<(4:D&0A%LN__]G!!@3'!,NWTA<OKAY>2\)S$9?_O(
M4N4=E23!^40U!KJJH#S"<9*?)NH_/Y8OGJJ0*LSC,,4YFJB?B*C?IG_^,;[B
M\HV<$:H44,C)1#U753'2-!*=41:2`2Y0#O\YXC(+*[@M3QHI2A3&]4-9JIFZ
M[FA9F.0J4QB57]'`QV,2H0!'EPSE%1,I41I6D#\Y)P5IU;+H*W)96+Y=BI<(
M9P5(')(TJ3YK457)HM'FE.,R/*0P[@]C&$:M=GW3D\^2J,0$'ZL!R&DLT?Z8
M?<W70&DZCA,8`2V[4J+C1'TU1GM'U:;CNC[_)NA*;KXKY(ROJS*)]TF.H-A@
M$S7@@/$;13<Q#<'#6N_I96W`WZ42HV-X2:OO^+I&R>E<@=LV#(B.:Q1_!HA$
M4%"0&9@V58IP"@G`IY(EM#.@(.%'?;TF<76>J)8SL%W=,@!7#HA4RX1*JDIT
M(17._F.0T4@Q$;,1@6LC8IA/BUB-"%Q_B9B>;=C.$ZD,&Q6X=BI?'@>,N"X&
M7+N'GQZ'TXBXMR)/CP.F9YT*7+M4OCP.OWG8^#^&:*Q#ZH8+PBJ<CDM\56`2
M0P^0(J1+@C&BRFVKL<;HFN]WO0=-1U5>J<Q$A12AK0C,E_>I[5IC[1V:/&J8
MV3UFR#/SEJ$]384#,;`0`TLQL!(#:S&P$0/;-O`K?9-/;-<2;6+[FX`&M>P*
M"C7D"GI_SK9UHS2M6RL[8P$0[PHIE''>)VS7YK,-[C`\L;A#N`[/+/N,)?BU
MZB.VZ_(RZWN,QS.;>XS/,]L^(Y1F=X<0$M[WD9M\.2-AR7K"2$K#,GOCFV$+
M[YXQ!A:QSENA5',I$4B)A9182HF5E%A+B8V4V$J)G938/R(X.Z'LG)UTH;/@
ME_GQ_*1/351HFLXRV]/YOIPQQJM7/4NW]/J/9^:,@<].1[`^D!(+*;&4$BLI
ML982&RFQ9<3#BNRD*OM'!&<M_+)SUCZVE-*\I;ZPV,\8XM:.OIBF[L#V5W!]
MSC.6,:2V\ZX''&/XNN'TF`7/N);5?]>29QQ/=WLZ*YZQ=;//K'G&<EW:K'S.
M&X&Q[^2\Y1C/L&V0$71V'&/[AME_UYYCAD/7]V]U.(]A`_:$QY3F/;8]@Q_H
MC#'09+^;DG,I$4B)A9182HF5E%A+B8V4V#*"3=H7QW4<SHQZ-[;CF*'O>OUF
MA7,1K7VC8]D.+)@WS<%,92<?MA'-4'E"<Y2F1(GPA9YJ+)AX7;0[<+V:=)<D
MQ&?&"'9S_?@6#FAU7.L>@`-2$9[07V%Y2G*BI.@(K]('+C1AR8Y8[*;"1;TM
M/N`*CD;UUS.<A!'L1O4!P$>,J_8&7JQU9^OI3P```/__`P!02P,$%``&``@`
M```A`/7\79[T`@``G@@``!D```!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL
ME%9=;YLP%'V?M/]@^;TXD$`^%%(U0=TJ;=(T[>/9`0-6`2/;:=I_OVL<:"`=
M:?.08/OX^)Q[+[Y9WSZ7!7IB4G%1A=AU)ABQ*A8)K[(0__YU?[/`2&E:);00
M%0OQ"U/X=O/YT_HHY*/*&=,(&"H5XESK>D6(BG-64N6(FE6PD@I94@U#F1%5
M2T:39E-9$&\R"4A)>84MPTJ^AT.D*8]9).)#R2IM220KJ`;]*N>U:MG*^#UT
M)96/A_HF%F4-%'M></W2D&)4QJN'K!*2[@OP_>S.:-QR-X,+^I+'4BB1:@?H
MB!5ZZ7E)E@28-NN$@P,3=B19&N([=Q7-,=FLF_C\X>RHSIZ1RL7QB^3)-UXQ
M"#:DR21@+\2C@3XD9@HVDXO=]TT"?DB4L)0>"OU3'+\RGN4:LNV#(>-KE;Q$
M3,404*!Q/-\PQ:(``?"-2FXJ`P)"GYO?(T]T'N)IX/CSR=0%.-HSI>^YH<0H
M/B@MRK\6Y)ZH+(EW(IF!^M.ZYW@+W_6#ZRS$*FH,1E33S5J*(X*B@3-534T)
MNBM@;IU9'9W7_UD%CX;DSK"$>(D1N%"0GJ>-O_#6Y`EB&I\PVTO,`+%K$2:`
MAC8ZFR"@MQ,-H3@7_78:6FT&;+2UK%L[`=R=V&E?ZNX-Q*P/B2XA\WD'Z8F=
M?D2L`4-UG&ES`[?C;:*RM1A(5J?_]>0&L;N*B,80/?5PS/M#;<`AAM!TROS%
M(+9;BYDU13)PMFO77O</G$5CB)YN>*_.=9NZGL)[/UXJ9M-0_R#Q6XL!'9W'
M@<;=540TANBY"/HNQM4;<+]V_(4_J!V+&5-_%1&-(7KJYQ]1;\##V`<#]183
M>$WQ3!P_6/8^`[.[`7PYH(..88[LZ):+[CAKP_8#>UV63&9LQXI"H5@<S%UO
M5'2S71NZ\\Q%,YC?0GMJ+G/2+4![J&G&OE.9\4JA@J5`.7'F4!K2-A@[T*)N
M+NF]T-`8FL<<_@<PN!XA`!BE0NAV``>3[I_%YA\```#__P,`4$L#!!0`!@`(
M````(0`6&C[Q0`,``*8+```9````>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM
M;)1676^B0!1]WV3_`YGW@J.B8L2FW::[37:3S68_GD<89%)@R,Q8VW^_=[B(
MB-K"BPH>SKGG<+G<U>UKGCDO7&DABY!0=T0<7D0R%L4V)']^/]XLB*,-*V*6
MR8*'Y(UK<KO^_&FUE^I9IYP;!Q@*'9+4F'+I>3I*><ZT*TM>P#^)5#DS<*BV
MGBX59W%U49YYX]%HYN5,%`09EJH/ATP2$?$'&>UR7A@D43QC!NK7J2CU@2V/
M^M#E3#WORIM(YB50;$0FS%M%2IP\6CYM"ZG8)@/?KW3*H@-W=7!&GXM(22T3
MXP*=AX6>>PZ\P`.F]2H6X,#&[BB>A.2.+N_IG'CK51707\'WNO7;T:G<?U4B
M_BX*#FG#?;)W8"/ELX4^Q?847.R=7?U8W8&?RHEYPG:9^27WW[C8I@9NMP^.
MK+%E_/;`=02)`HT[]BU3)#,H`#Z=7-C6@$38:_6]%[%)0S*9N?Y\-*$`=S9<
MFT=A*8D3[;21^3\$T9H*2<8U"7S7)'3F3L?^?-&#Q<.**H,/S+#U2LF]`UT#
MFKIDM@?I$I@/SK".QNLUJ^#1DMQ9EI`$Q`$7&N[/R]I?S%?>"V0:U9A[Q,!G
M@QDW"`^J:4J",MHE70[YH&S!5MF&;DNYQQ-MF<EEF<D0&0L."7`WQ?N+1<.+
MRHB9MC#'"$X,`J2_00N&?FFQ^HN@HXR8'LK0;?V5+;CC.1AUE!'35O8#VF!.
M7,^&:%MP5_O8+I@W8MK:5_*>#U&VX(_R1DP/9?L":#U=[[>R!7<]=_-&3%OY
M:M[P-/;7MN"N]O&YP;P1T]:^DC>%`=M?ND)_E'@-ZB-NYTSOS"E.I9,'^ZS)
M:U!;W`^FE[N<VOG37QZGU:F\WS!C[A5E2-KRUX(?--,H#JSW1TL-ZB,.F`'.
M+;K;<=UNIPAJB_O!K(GG9+S8]_$`^4O#[9AJ'?SY=#M"3L4'#3>*D^N#X'N/
M-]A\ACC'X77:<F?!GT\X/SB^[]`[KDNX3>1<;?D7GF7:B>3.KD(4UH#F;+.F
MW8VK1:OY`[:DDFWY#Z:VHM!.QA.X=.3.(7F%>Q8>&%E6N\I&&MB/JI\I[,,<
MWO@C%\")E.9P8#>Y9L->_P<``/__`P!02P,$%``&``@````A`'G<X6%=`P``
M7@L``!D```!X;"]W;W)K<VAE971S+W-H965T-#$N>&ULE)9;;]HP%,??)^T[
M1'EO;D`H$5`5DFZ5-FF:=GDVB0-6DSBR36F__<Z)N3FPA+X08O_\S_F?X]OT
MX:TLK%<J)./5S/8=S[9HE?*,5>N9_?O7T]V];4E%JHP4O*(S^YU*^V'^^=-T
MQ\6+W%"J+%"HY,S>*%5'KBO3#2V)='A-*^C)N2B)@E>Q=F4M*,F:067A!IX7
MNB5AE:T5(G&+!L]SEM*8I]N25DJ+"%H0!?'+#:OE0:U,;Y$KB7C9UG<I+VN0
M6+&"J?=&U+;*-'I>5UR050&^W_PA20_:S<N%?,E2P27/E0-RK@[TTO/$G;B@
M-)]F#!Q@VBU!\YG]Z$?)Q';GTR8_?QC=R;/_EMSPW1?!LF^LHI!L*!,68,7Y
M"Z+/&3;!8/=B]%-3@!_"RFA.MH7ZR7=?*5MO%%1[!(;05Y2]QU2FD%"0<8(1
M*J6\@`#@URH9S@Q("'EKGCN6J<W,'H3.:.P-?,"M%97JB:&D;:5;J7CY5T/^
M7DJ+!'N1`42_[P^<X'[DC\(/J`SW*O#=0RB^,_:]R6#<&XJK;359BHDB\ZG@
M.PMF'@0N:X+SV(]`!=,SA.?U]$!><,PC#FJ&`BVAI*_ST60R=5^A#NF>66AF
M8EM'9F`2RRO$T$3BRP^%GF\RR37FI.."SZ-9J,.YV6Z3")LF0\\SO[W03#-]
MF\PLVPWQ-97`5$FZ&<,!S*#;'2",#G!68]T6NN$LW'9#?!ARJEKHM>J6=#-&
MN#!E;P\785A>9S,F]$9FJA::@=_CK!J;Q+*7B'N)I(LP_,%*N=T?PC,;BGV,
M/?1",_J%9KK\]1)Q+Y%H(FQ6KA\XIR0;YL*/F$.X;:Y5FH5FNLSU$G$OD6@B
M#!IWGN/]9R\8F^YPXQO`Z=*])^"@MLO[5@DUT^6REX@/!&ZM4*#6)Y)#]VDF
MG5)ME!`O,6>[>[<YA,WU%YPE3^\@FNDRUTO$O43211C^X'@Y]X=%#'N+B(/:
M16R?7IK1*R1P6JMTV=D;Z]Z.',%]!R.X3FA_^CZC3^J2BC5=TJ*05LJW>%?!
MN7ULU=>HA1_!]@X[?:M]Z4?+IMT]=L#UIB9K^IV(-:ND5=`<)#T'+Q%"7Y#T
MB^)U<_ZMN(*+3?-W`_=8"B>)YP"<<ZX.+W@%.]Z,Y_\```#__P,`4$L#!!0`
M!@`(````(0`CN,+2&P0``.\/```9````>&PO=V]R:W-H965T<R]S:&5E=#4Q
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M3IO=C.3+/&TPP8?6`#F3=W2<\])<FJ"T664Y9$!MUQIT6.L_;"]>ZN9FQ?SY
M-T<7<O-;(R=\B9H\^Y57",R&8:(#L,?XC:(_,QJ"E\W1VR$;@#\;+4.'Y%RT
M?^%+C/+CJ871GD%"-"\O^_012<%0D#&<&55*<0$=@/]:F=.9`88D'^QZR;/V
MM-8GKC&;6Q,;<&V/2!OF5%+7TC-I<?D?A^RK%!=QKB)PO8K8,V/JS.:+5U0F
M5Q5HMU-Q#&<QLV?N"WUQKRIP'51>36A^%8'K(/)R5V"),6_A.J@\V163CQ,;
M=C]ID\VJP1<-EA*,!*D3NC!M#X2[\>:CT\^`KR8`C#P5^4%5F!:,+8%)^[YQ
MW<G*?(>9EEZ9[1UF9HG,CC-+7>MU')'P.X)./=IT(`?"KIV.B#IB$'7EAN..
MH6L#G.GM@2EX:\_]9="Y0&')!4O*<,L9=\I,FMHPJ\4$=QRXM4`RTK]#3$61
M8(S,YR(2CA'7E60BSH`W_7"XKM3?^!XSZ`AFPHI\WDP*4S.[8=SR`#C7178\
MPG9#-A=\.1#(@5`.1#P@INB*5L7WF,%.(<7I*RE2&#9(P=Z%V/:6,_"_'X*A
M99;T3DGX2B)0$J&2B)1$_(@07(0M^_F)0N&U#M.P=\AUEY*+G('V>T9V44GX
M2B)0$J&2B#BQ8-N#+6T>\>W#81T*UL%WZGGK*"Q9-Y?:W'+FD75*PE<2@9((
M.X)^7.PA>;8&HN[AE^,;/R($`^$;_;R!%)8-M*6YQQF^X2^,A27\R=.P@[],
MQ%<2@9((E42D).)'A&`H/1E(%<8$ZM+'GU+ZDFRL5`IL.<.-M0S9R>[IUTXJ
MB4!)A$HB4A+Q(T)P$HJ"6R<?.TAAV4&IDMARYM':YH3+MB/+D#Y._NU3VY`6
M92`^E3ZJH;+M2$G`08CF>+__W#E^T.$5;XF:(]JAHB!:BL_T$#.'O/HH/U_M
M;`]*2B@QI'@$YZY[\:WC064RYG>.!_7)..X['I0IXWC@>%"MC..AXT'1`G&S
M[Q"<M^KDB/Y(FF->$:U`!T@%%@!\'1I^8N,W+:Y9-;K'+9RTV,\3'*P15,V6
M`?`!X[:[H0WT1_7-_P```/__`P!02P,$%``&``@````A`-F6A1(>!P``HR<`
M`!D```!X;"]W;W)K<VAE971S+W-H965T-3(N>&ULG)I?CZ,V%,7?*_4[(-XW
M"9"09#29:L%V6ZF5JJI_GIF$3-`F(0)F9_?;]YKK,-AD[B6=A\F$_#CQ/;;Q
M@?'C3]].1^]K7M5%>=[XP63F>_EY6^Z*\\O&__LO]6GE>W63G7?9L3SG&_][
M7OL_/?WXP^-;67VI#WG>>*!PKC?^H6DN#]-IO3WDIZR>E)?\#)_LR^J4-?"V
M>IG6ERK/=NU)I^,TG,WBZ2DKSCXJ/%1C-,K]OMCFHMR^GO)S@R)5?LP::']]
M*"[U5>VT'2-WRJHOKY=/V_)T`8GGXE@TWUM1WSMM'WY].9=5]GR$NK\%\VQ[
MU6[?#.1/Q;8JZW+?3$!NB@T=UKR>KJ>@]/2X*Z`";;M7Y?N-_SEX4-'<GSX]
MM@;]4^1O=>]OKSZ4;S]7Q>ZWXIR#V]!/N@>>R_*+1G_=Z4-P\G1PMFI[X(_*
MV^7[[/78_%F^_9(7+X<&NGL!%>G"'G;?15YOP5&0F80+K;0MC]``^.V="CTT
MP)'L6_OZ5NR:P\:/XLEB.8L"P+WGO&Y4H25];_M:-^7I7X0"(X4BH1&!5R,2
M+";S<+%<W:,2&15XO:J$DW"U"!;Q'6V9&Q5X?5>YMR`HO74%7M]%[FY*;%3@
M]5UE9%.FV$]MMXNLR9X>J_+-@[D$/5%?,CTS@P<0OO8W]DXW`CX:`-#S6N2S
M5MGX:]^#OJUAU'Y]BI?SQ^E7&&E;PR3(P.]W9C&SF72H$]J$N!)ZZ.FOENX!
MA0?:$36%(KM*833U*[T]HJ\%:5@7=/V:!`^`=M?ZR&Y9RA+B!N&8)(?(<FE_
MCQHB\7+1,5;),/3'EZQAF*Z]"N-EW.FV9B?(P%SH7'!:E[*$8`G)$HHB+`>@
MJ7T']/">?W@YNW:^/FGC@\]=E;';"PDRE!,L(9!8M?,%UCG\L1V7K(KJJP0+
M5\5R`RKONT%/`0V[+JSLUB7(+-L*X.H<S5?NK.@381#?0$0?"<+94M=@?X^T
M$%.DC2A$P(RNT]Z'IF4"7.7Z)N@A$<$Z29NA3W+-6-LM2)"YW8)V^J1(H%WA
M>A&OEX-219]91<O5?(#(/A+%LS`:((IJB^7&\O^XH4]RW%@Y798@0[F!A'%C
MN5K$PSI$GYGKX34H5?:1*(K7P^&CJ+98;N@8VUL-Z3&A8=>%P!D3R&"-NNV#
MYJ<L(5A"(D%XK2C"<@#6\/$.:-AUP%FP$V2(MJ4L(5A"LH2B",N!`"X&XRUH
M:6[9-!!E`H\('I$\HDC$-D(GJ=&S(<#<9:V:*W<Z&(B:#SPB#$+8*7E$D8AM
MA(Y<XXW`@&8;X2R+28`044+*(X)')(\H$K&-T+EKO!&8TN!WMR0/$V5`13E<
M-7E$\(CD$44BMA'0<7<8H6GW.CF8&@B9J='F.'LM20..$(8`KG/\/029VR44
M(1!%JM@VZ-`U?CQ@1+,GAG,#E.B'#>`5T;Z41P2/2!Y1)&(;H?/6>",PG3$3
M@XIP9F*PB`A81/*((A';"!VUQAN!P<P:$4OW'B.@TILQ`A$3)>>0`F>.BC`J
MB*QFLRA<.XE56LCBQFV((IMB^Z`#5\^'<7<9`<8TVP_W-L-`Y`Q!';RS#);!
MC=PIC`PR\]DM1EI,B+>H]D5)D:VQ+=$)K&<)':X#S&M]*Z*%FRT-1%I!Y;YV
M]`A>1?*((A'+B/"N@-G2=L`<&F$@R@@>$3PB>421B&V$$S#U)(G96_'P5M!\
M?P#6]FEB(-(0U)GCXQ=[6`O^?,DCBD1L*V"@CY\<H:;=0.$^JS,0:0'J$(C@
M522/*!*QC=!Y</15(L3TV%]);TP.A(@J4Z-#(()')(\H$K&-@,;TC1@Y.?19
M[LAP,F`2(D14FQHD#MO9,9LX\TOP$I)'%(G8;CA)<]QZJO_/,W##20:)@4@W
MV%`J>!7)(XI$;$-TL!L_3S`&,O.$S8IIR"*"1R2/*!*QC7`2IQX9_"/^\$;R
M7+E)RT#DR+B&4_T_+^>63O#G2QY1)&);X81..F&%-\*FFXD3`^$B&<A/SNU:
MRGPNNL\_OB/E$44BM@5WA<QP&#+CM=.+B8'0@LBY$*;DIZ+[E"B?#:B*5+'*
MU__(Z%\5QBT:[5G.HK%VL[:!J,G0(7HR..>+[L./K>`112*V%3?"I3Z;GA31
MC7"Y=A_>&8BTXAHN/ZQ6\"J21Q2)V(;<%3$CC(;TBF$@T@@^8O(JDD<4B=A&
MZ#S86SK'98D(4R24TSU;B]?.Y3`Q$&D(ZG3)*G"N*(+7D#RB2,2V`UKKVL$O
MH+`):1"MUDXIB8%(.U"'L`,!0D/R7Z/W3.GFWE9!.W!/%&Z..>752Y[FQV/M
M;<M7O=])!^'N:+<7ZW.H=X@XQ]/@`7:EP/%I]P%LD;ID+_GO6?52G&OOF.]!
M<C990JZL<),5OFG*2[LEY[EL8'-4^^<!-L/EL-$%,KCO[<NRN;[17]!MKWOZ
M#P``__\#`%!+`P04``8`"````"$`+NQ>\MD)``#O.```&0```'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6R<FUUOXL@2AN]7.O\!<3^&]A<0)5FMW9JS*^U*
M1T?GXYJ`DZ`!C#"9S/S[K785X"IWJDWF(C-)/R[7V]W5;YF)[W_]L=N.OE?'
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MUW&TKIZ7;]O3O^OWWZO-R^L)ECL#14[8W?JGK9H5S"B$B>+,15K56T@`OHYV
M&[<U8$:6/]J_WS?KT^O#.,FC;#9-#."CIZHY?=VXD./1ZJTYU;O_(V0H%`:)
M*0C\34'B)$KC;#:_)4I"4=)+%!-'\3PS61[.98*ZVFFRR]/R\?Y8OX]@[T'F
MS6'I=K*Y@\CG^4$UEQG[:,)@IER0WUR4-A;,10.K_/TQ7^3WD^^P,BMB"F06
MX]&%B3E1G@FW#"ZL[?Q@`OE>DH:)E$DGL#7\BWK.T5TD<YSQ#(H^DW"B]!`I
M1VP?F5WOPW3`DG9UZ/D[^&$,P:_S9\2M"V1@'2_,]<[ME)9!PFH$RQYN,SQ[
M!T/Q=#*+IX9/7(&,EGV0L!K!LH?R'9Z]@_G<YXNYR!Z96;O[8S.-%ZG<WT@H
M^JQ&L.SS6[)W,)_[)!?[ND!&R:T,$E8C6/8SGKT[=,+UZRZ2:[`0:X`,KD&6
MI(NYF7*B1$+1:36"J7`]0N?HU*O7P3S[V53D5B"#V8,S0*L@B!()+7N-8-G#
M03P\>P?+[&7U(H/9?YF;/)UF8NZ1T++7"):]@>-^>/HM+?,7U5D01`),.L^%
MPI((38"*<`7.W#K;9U@1&+3$K@M`,\+GN2"(RF`VFV:I,(J2([Y*L83XU7(I
MSO%NEX(^R:6(/`N#T%D*5(7L*TI"_'E2'X%1_`B7XMSO=BGHF5R*V/V%00BE
M)/%B9A:RO`GQYTE2,(H?X5*`^804=Y4LE5XKAQ!*B;U>9Q"!KQ^U(E9%N!3G
MB[>O"KHI3-@UA:GHAPKW,`!ZE3S+,&)5A$MQ)GF[%+16OL%D`V(0RML.)(MD
M@U+2N"+5J@C7X6RRHT-W/X.FRO.7YDT0YF_R*$W!`"]_>H>QYM-4*QK"U3C;
M'*X&39:ID8U&81!"-?#,*`[IDL;5U1ALYL89Y_#\T69Y_F)^BS;DP_B<_T(4
M3DGC:OZ#[3P6=C[,#-NKQ%EEI*T3A#KFD9$ZV'B_:BR-^W6R311['#V%XT4O
MC?8J*4)LEH*@BPBSZ/X1DDNB_2EC::@(5P7;I+NU!BZ-NTJJDN8>(W3>8D)T
M2<.J#(S@1[@,YYN="ADH`]V668B1QAXCY$^BG>XRC%@5X5+@3I^0XJZ2*R*-
M/4:H*Z7?<`V!K`>Z5AZ7\RES=Q]Y]>1<[]!.>T%00$Z_`^AIMIY(UYMQ.9\R
M^-AC\$8:/$$!.1BI"UTSI>+7$"Y&N/S`JO&XO9%N'WO,.98-L0_B#SM61;B8
MFTP^1O-EI1]+DR1(F>PRC%@5X1*$SP]<#X_?Q\(TBABA>=L]RFZFI%$\JN&S
M<KD(>/%YN/-$RM)W'_+<?G*U5XF3*Q9F41"$&9AIE(FE*AF01+DL"C9NHOGU
M!ER"Q^3=I;K))Y[']EC:(4$I?H(8B>%2#`M]5@Q?3W:>_J?<//&X>2QMD"!,
M?Q%'UPS0`R_CG<<QL8U4A.MPGBOL/-QK)>C4H.;Z1!B+/`N"2(>)Q,%57L8[
M0:0.K2/@.N#HD#H&;"=WE:P(L:&+!"&JB+2_GW`<OEXG0^K0$*[#8^(#UL-C
MXK%TO:3OS[.XMR@>2(K1$"Y&6'B@MOO6'?=ZQ$2S7*J/(&+5*%R",.Z`!/3B
MKM?U_X<@\1@VG^(RC%@5X1*$70_SN@1MFY5X(MJ*@B#\_"J'CQBD#@RBEH:&
M<!W"LP-+X?%JF5^1((3Y&\__$Q"@"L`8?H0)2(5KZP):6IQ-B3"K@B`4\,6G
M@`A_>MC&J@A7\"G33CVFG8C.IR#HPZU$XZH.O(\?X3H^Y=XING>WNF?)M;UI
M)[,@R)\$'E!AQ*H(E^(L\F8#3]%8>76+1JD@"(TOC42?4M*PHM2J")<!8;HR
M`K7A:%$;4V%E18H0^78F>^V2QM7\,80?X?D[4^PL0R!_M%`^_6)^"V?[(!+S
M7T1S,5[2N#\YJNS!5IT*JQYF$NU58AT2V0<2]/$ZA/V:0OBE\G40?CU0!UHR
M7P_9!Z9AWPXC5D6X%.';@2V%/MH]G#R_&**9+1U.0<2F&L(EW&39:=^R^[\=
M0A`^5<A^XS+X<2NN(BSY[":[;NG0+X<0Y-_'./]AQ*H(E_`IO\X\?CV554V0
M?QTN@Q^O@XIP$<YV!Q^MF:/ED20?A0A2UP'C*(A5HW`)PJ3U4L[0G/52)DC)
MKPPC5D6X!+A3=Q6&':R9NTJNAC1J@K#U<TVX[--+(A2Q5D6X$F'53LD,?A98
M%+129A&I.'^*#*$\;C]ZFO8]FP!5",;P(UR(\.R``+19+D`^3V0(T0.1F<N/
M!TL&9(M$-"66QH=D+YPZD'W?H?O>D"%$V>>ID1\-ED3XT\.>247X_#L?''XP
MH6MVJ[K_V4"F62L91!"Q:A0N01CTP*KN&_6L;Q`(:8N!A+H8&L*4Y#>Y=4N+
M<TG^FFE!D))?&4:LBG`)PJWUBLC1I;O[J=_P$:1*P#@*8M4H7()SS4Y)#-M/
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M.G_C7HF[O*KX^#<```#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3
M````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQ
MFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5
M]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[
M=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+
MRSPA,<Q-N(BP@E<15,8"'P'=B%76JM5F)<(T]E",(R![>S*A/D%#3=+;RHCW
M&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\
MRM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=V<OH&P-0RKM?K=7NU
MG)X!8-\'3:TL19KU_D:MD]$L@.SC,NUNM5&MN_@"_?4EF5N=3J?12F6Q1`W(
M/M:7\!O59GU[S<$;D,4WEO#USG:WVW3P!F3QS25\_TJK67?Q!A0R&D^7T-JA
M_7Y*/8=,.-LMA6\`?*.:PA<HB(8\NC2+"8_5JEB+\'TN^@#00(85C9&:)V2"
M?8CB+HY&@F+-`&\27)BQ0[Y<&M*\D/0%353;^S#!D!$+>J^>?__J^5/TZOF3
MXX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,G
MO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q
M)2<C<;X5PQ!39P4.@78)Z9X*'>"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)
MYQMAY`#W.&<=+DH-<$/S*EAX.(N#<N9B5L0=8'Q8QKN+8\>UO5D"53,+2L?V
MW9`X8NXS'"L<D)@HI.?XE)`2[>Y1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV
M:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD<E9$<XH@5#7X3
MJ[!,R,%<^$5<3RKP=$`81[TQD;)LS6T!^A:<?@-#O2IU^QZ;1RY2*#HMHWD3
M<UY$[O!I-\114H8=T#@L8C^04PA1C/:Y*H/O<3=#]#OX`<<KW7V7$L?=IQ>"
M.S1P1%H$B)Z9B1)?7B?<B=_!G$TP,54&2KI3J2,:_UW99A3JMN7PKFRWO6W8
MQ,J29_=$L5Z%^P^6Z!T\B_<)9,7R%O6N0K^KT-Y;7Z%7Y?+%U^5%*88JK1L2
MVVN;SCM:V7A/*&,#-6?DIC2]MX0-:-R'0;W.'#I)?A!+0GC4F0P,'%P@L%F#
M!%<?414.0IQ`WU[S-)%`IJ0#B1(NX;QHADMI:SST_LJ>-AOZ'&(KA\1JCX_M
M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8
MG,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z
M+_NH9IR4Q<J2(EH/&PSZ['B*U0K<6IKL&W`[BY.*[.HKV&7>>Q,O91&\\!)0
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MT#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?
M*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-
M`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2B
MS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9
M_>"A-]0A/X#:BN#[A28&80-1?<DV'D@72#LX@L;)#MI@TJ2L:=/625LMVZPO
MN-/-^9XPMI;L+/X^I['SYLQEY^3B11H[M;!C:SNVTM3@V9,I"D.3["!C'&.^
ME!4_9O'1?7#T#GPVF#$E33#!IRJ!H8<>F#R`Y+<<S=*MOP```/__`P!02P,$
M%``&``@````A`,0S?@"]"P``(&L```T```!X;"]S='EL97,N>&ULW%U[;^/&
M$?^_0+\#P6N+!*BM%V5)CN7@))O-`==KD'/1`DU1T!)EL^9#I:@[.T6_>V=V
M^9BU^%A**ZW;"#E+E';F-\^=62[)J^^?`]_XXL8;+PJG9N^\:QINN(B67O@P
M-?]\9Y^-36.3..'2\:/0G9HO[L;\_OK7O[K:)"^^^_G1=1,#2(2;J?F8).O+
M3F>S>'0#9W,>K=T0OEE%<>`D\#%^Z&S6L>LL-S@H\#O];O>B$SA>:'(*E\%"
MADC@Q$_;]=DB"M9.XMU[OI>\,%JF$2PN/SR$4>S<^P#UN6<YBXPV^[!#/O`6
M<;2)5LDYD.M$JY6W<'=13CJ3#E"ZO@JW@1TD&V,1;<-D:O;S0P;_YL-R:EZ8
M!A=Y'BT!Q._^M8V2[W[#_[S[_;MWW7]\^]W??G*7?__YF]WO?O[6[&1L"$VP
M03W-\VXM6?B:4^ZD$EQ?K:*0"#($-:&V+I_"Z&MHXW?@#"`>_NSZ:O.+\<7Q
MX4@/X2TB/XJ-!*P,\K$CH1.X_!=SQ_?N8P]_MG("SW_AA_MX@#E&^KO``S/A
MP0[G<%H^]X@FDVF,,`29!GB$RA2`2`X>K)?)^6>)3`*O83.O0_0G\&)2U,NE
MC->N7^SH\!!>N:T(G_CA?FK:-N207K>+:J4&.Q*SR;P+_$[&[&)X,LD&]L`>
M*95,\,5=NR'#@:U2E0T,[?>CFY.I4SVS*NG2-'RJ","`4ZM%#T*W)KY'-KY.
MX2<GGM".8S%&54CZ+/2*W'CG!>[&^.1^-7Z*`B=$Q=))C?VZ?$Z6(XT$A?&"
MX^Y)0_"1/6F4^5BYR9F*:N48G>].Y&5ZWB&2@VA/@"EU`];R?#^O0`=#K-'@
MR/45%,.)&X<V?##2]W<O:ZC00JC;.1#VNX9?/\3.2Z_/Q.OPGS8,V$2^MT04
M#W-6%Z;S\OSBUI[?,KX$&?J&#(H*HK8]'QV!Z.UL,E>/=#Z9J";:M^&EF.C[
M(;X4$[7AO[DRG:9A:JD"F=,S$@_[N.[Y:#*9C'L7X_%X8@UZEL64?)]ZM!<N
MW6<76SME:MI%,`0$D\%X<M$'(%UKS%B=%,$``(R&P_&P-^E;\#]+:,='H%JG
MT,IJMBI!H,FJ!($FJ[)6HJ,@\Z>1`JLJFJU*$&BR*D&@R:HCQ1EXI-VJ!($F
MJQ($FJS*%L`4QBJL5FJ.58)`DU4)`DU6559\IAEXHMVJ!($FJQ($I[9JUE;-
M;V]MMARR6YDIJX]37EC$M^?%&CSH4^^C>`FGE;)S);T!](C\V/65[ZX26">(
MO8='_)M$:_CW/DH2.`ES?;7TG(<H='QXV\E&9']K1L)I*C@C-3631V_Q!,R$
M51"N&\[B6!SRK&=A-V&-K.[(&O8O>,.FB'7@+KUML"M=SKO4+T&-J-MFP8D.
MPYQ)Z@[%2EP'K9":3W($,S6SM.0`\(G,)21'J)"Q6)66E9&,D).1#)"4D8R0
ME1%"IRRX,DTNHRV<(7UM8-L>=[M\`5"63SU!`KS$8\I!D#&[^FP<4J+1QC%M
M987\LA,;LSZ^6'5<(FG#B%TY&P:42-DP0E9&T6\RZPK$\Z4+3,\E2%[I6_CY
M?C"`$1^8X7F5!-/\A"<F^*D)Z717+FXC^1*I&\?L)[JTQ`02"%4V@Z93*<S,
M"]?W/^-<^==5/CW#BM?UU?.*[#F`C2!X4AZW-.!;6+5-W_*IF'\`7E6#^I6#
M#&>]]E\^;8-[-[;9[A#&@AVU@4_Q:<9JB.+S>]]["`.7K=F9G,R/<92XBX3M
M7F%G!JKP#"KP]%)",G@.X6]5\`<]2>OC$/ZP)E1J1-"+5O[@7-+\5?H#[M-)
MG1I,0)VZ#H]*!-#Y9PC`"#H0X+ZB5`?@GCH00$>5(0`'+1``G!JO."0.>B2;
M@0\4+('_L5A"CLFD%%@>4<JJ]`O\:Z2TA?1[D)I)O@5'+]0,'VH`',2R*L7J
M2C'$[!!IA0K@0XT*;)AUU4QYO:J<KTTA).D"AD(CD`;J-*+.*TG.!9X%@'J-
MS!36(<0I,!7IA@!PM$`@ANAIFG][%(.F&9AZ@Z8IF$(0YN`3Q@2UA#!#:L(`
M>+1$15$G](09XX1J(!!T94CB#7U=*9)BT)4C"U/T=:5(`D%7AJ26T)4B*09=
M.9*80E>*)!!`(UHR)+6$KA1),>C*D84I!KI2)(&@*T,22PR.G"([=-F4+Z*2
M]5/8&EB]%`H&RMK_U[9Z7C4NI/:JFB:@E0WGW1/O',$6K)<BK31>R>5D:Z?&
M8Q1[OT"3B5=T+6`QU8U-O`(P\1;TR-?86=^YS]"*\E-"SZN#!&S`5/"'E6S3
M:,-<N7X.P")AZ09%-$K.FOK&A?E7GB$N;C=Z2",(R+S-)P>.C`$7F'3K`4-3
M-P;TN12#\E!0GRJPH&]*AJVR6:.O4OW`;*V-N;3@E8G[@,0$N[GU28[=BU*U
M4[?$\^WM)@SE<-JXH'+F5!=L)T%+94B[I0U)!HN!A@F,XN&V*=PVJS9:*8R<
M2`"L0M/Q1LJ??A5$7."MPSA+UY5;*353XAM6JPJ[]TBN'KQ>>ZA3JLW.%K12
MZ6X.,?"B'^[OL,>A4U?\'AMH8["00J@%EO*24`SR/52Y1PH20+]>X7E+EJ:Y
M>W`$H(V6QER=E7HT/'1@J?*Z>BQOQ^OZ`#0K2G0;\]A8Z)R\1X`>V^]5PGO+
M,\7_59T`]P)ZL[5-96@W%63BA+=7>;9'?$F7X)6=89N90VL'KK4/I86&DE:B
MC=H/-S)-D\HJ5B5Z4(<,%Q;3'8G*D66-4QNK49<Y=A>R1^80X-577CHJ>^6I
M9M?1WG`7G/G;@1!)XCBV!RK+*L<HJ'=M3P,Y;]C9C>>T-NR20/DEB=(K"T>.
M[AK3\SMT2`/55X&W!*I/HRU-KT^CS<%TRMZPQD>;SU%7-E^07^L6F2IK[MTP
M/S#1XXI*6>V#^V/K$.[5IBB:G(YY9B>#2-.\[L58:O2#\1TY`>V%[Y@%^$'Q
M2TM=Y:U!#3)^56_=[%>969I6&_8*7`YU)]64!@8"R!:,21E9K[[R)=K*--@8
MG73#BOP&A7(48A-3B:DL2G<TUKS)Z'\*.=N?!CO2R/6]XM6]^?XU`^\&"G<O
M[_[6.#/>+S!-Y&MY&&7W6\^'&_C@QC3<6[C8;N#>$3-^,-T-5D<KGZTP+B@M
M2'=M:0$%/O/U<;\IP05IJBTM8,]I#4!:0@LN?6Y-"_8`I[1P-W"!RX(-06UQ
MP9"4EJC[H:3NK3([LGWS!2X46087I578$><I0@M$;DNKL",8CM("D=O2*NP(
M"`DM"YBTI578$:Q`:8&[M:65V]'"_%KH:RBI^XM2.XJ^BIM<97!16H4=15\=
M2/HJI5784?15%+DMKL*.0)7HRX(OVM(J["CF"4LR3U`9"SN*NA]*ZOYU1A4]
MOB_I\9Q*83MX1W2$"T$R.N)4"JN)7CZ0]').I;"7Z-^6I']S*H6E@!Z1R((O
MY"7*;300M6M):G?F++.L*SH,SC,R,.`Y%XNM#\\?B?#I)6P3-YX0(P)A8RQ%
MZ=%=/!ESN"='3DB,!YQ&90C=/J]])W22*'XQ<.-V3DXT^E"2W!^B*->12*$/
M'V4`_0#/>H''R!B@%ZXAT8>Q%FQ#)H\%43UX%6<;,C":HQ']#Z^W:T,&1G,R
M8E+%^DF&S(=PO<TM).92G+IE2'STPB=W*7J.J&'<5B!#Z9.[36(G]S\QI/J2
MBOF$=W+):8@I@M^R/;OM3%I_?H(;MV1*Q$J;Q`[V+3+`_[1-B!IQ%"&"IQIE
MB-QY"=P+*PMB@03"DB(1P<44.8E7&462QE^<.,1H$4+WE8]62%1<F@+5__*Y
MN*L/TWN"3T-B]_O)^P%0U-)=.5L_N<N_G)K%^S^RN\R!,Z6_^M'[$B6,Q-0L
MWG_$V_=!%$/K">GFXP9N"0=_C6WL3<U_W\Y&DYM;NW\V[L[&9];`'9Y-AK.;
MLZ$UG]W<V)-NOSO_#Z@,'QUU"<\>.N#13.P14G!Q2L^ZW/CP`*<X%38%_[DX
M-C7)!PZ?W;,+8,,FOTR(SB9_M-7U?P$``/__`P!02P,$%``&``@````A`(RY
MCJ35:P``2V`!`!0```!X;"]S:&%R9613=')I;F=S+GAM;,2=V5(<69:N[X_9
M>0<WF>H(F0')H#$KJ]H0`B55"&A`F9673H0#41E$1,4@1%[U?=^>!\AGR4?I
M)SG?O];>[MN'`%19W:>'*A'AOH<U_FO8.[[[MR\WP^QS,9T-QJ,_/=E<WWB2
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MT?WF`]MNCO6L^4&@U&EQ-9C-ISGT.\IOBN93SW:+X;!??,G.(4,^*1;S00]Z
M'8QZZ\U'PX"[L&*:#WE$K_VUN&L^]VR#_WG]XL76YIOF5^6>SN\F[:5L;JS]
M=>D;)\5T,!;_^]G[?-YZ>0<)Z9N4[`_SJ^8HSR[SX:SUSNYB.F4SV?Y@UF-#
M/Q7Y=.GXS];6-K?6MC>;(P>B_`@5UWX>C6]'V5F1SU"6?G8PFRV*:?.%9S\5
ML^9G89`?QL/%:)Y/[UC1$*5L/O;L:-S\*+P9=W):3,;3.=J;G<WS^:(U0GC<
MAL]V(>/5>-KFWV$^O2JRG5ZO8!4\U/?U+)G[9'$Q'/2R_>$XGR]Y9'=\<X.B
MGLW'O9]770EGV?%B;J:%U39?*\4DY<P^9J"UH6==.M=\/8A.]P#[/S5GWST^
M.CL^/'B_<[[W/GNW<[ASM+N7G7V_MW=^=H^M.;\>+V98*)3G\98E-1U;K74$
M\=R9S8KY[-O6U_GLVDSBKOZQ]X_%X',^+$;S%HT^YM.?BWE^,2R0S=YB.I@/
MVB((MV5Y9S;BL6QB=EKT"L;DO=:0)]-BD@_ZR<-1`GVQS;6>C^<HV/W/G$QQ
M'5-LNYEYMC.1.J]F1T5+K`[0DM'50#OR^3J?\EUT+^C#>-R_Q3MT+[3[G;C\
MPT%^,1@:%5M,*<EXDM^)<LWQ^7ZZ0*'VON`F9VW"QCE.I,:HS/@R.QR/KM;.
MB^E-EDS<'+?C/7]EG(^:S]:9<<^@Y0BKF;G*QB3-<9W>CUJN+^&>J64Q!G,)
M@$OD+OX70\'?*16RE:/QO)AEFR],:#9?M4#`L]]^_>W7YD+-#EV/<7O3V3/3
MG/E=BY/,"#":FY`A[I<%OJ(?3=C3]8W-[`1W\4,^7!1_S+97<7GZ_VC<=A;S
MZ_%T\$O1_V-V-(Z?FD<(6E-9ORR?9QB"XN8"I8LXPC:$<6M;A9HM92'UE6R]
M?7W?6MZ\7=UZ\6KUS?:63?#JQ>KVR[>K+S>W?\\25[-I(?`T'WPNABUWLM/O
MHROC$0;@!)NQ!B[;S2<##$*3+RC'XF8Q-(_CPH08@!VO416&%B@9MQ%,^M;[
MXG+0&[3LA8M;%]N;2V@)II'I,6_>ZS40%43WN@!<Y</GR[S(/4,TUWFO=):"
MF:T,1EE_/!SFTUF&<<UFPK\M);EW,(/,LZP2Z*]:2GC;!?^?>?,>E%!'%5^_
MZ0Y,<M\N.QY?MJV.1^_;1XHWSLZ!'1_WCL`:Q_O9\<G>Z<[Y`0]D.T?OL]WC
MCR>G>]_O'9T=_+"7'1Z?/1*0A.@''.1J_M414(I36A#X=.^'O:-/>RT+BD/O
M+WJR;9B%L7ESTZ;#04\*#4C=N9H6A1GY#M$@R.@%Z_]!X4L'"/'Q3\=W^;`+
MT[@RGS+]:-'RQ(&T1Q^RO;^=0-'V^D^+&1%!ST%6LHGF6GW^EMW[4(Q`ST/;
M\D[_9C"R,$PVLCG`SHV\_2]Y]/@[/="/O$T+YS3?]!T>H]J\#$$#K&@^5CUP
M.)ZUZ'B`HYN9K[6UNN5U6]N)JUA5@<&?+YL-P`9H:<_S+I\1)PC=O1\,%PHK
MXI.9)#.JLX7HYMBS+4SEHRQ8,#.?9@S*"[OYL"<_(I+<,ZLLHKWI.").-],*
M9FTKV5*^EL0O=UK9BBCRO/7&_GA:#*Y8L6']WEUVCJC/M'3`WT[_[PMG3(MG
MGT:D5(;"%V'D[$/.QGGI46B_[E>[F%7S176C='9^O/O7[X\/W^^=G@&?_OW3
MP?E/RUS:P8C$0AD8_:XLC,EZ4[*CT"BR;'[W+A_FHUX1X%69HME8]IQ$+?#^
MP7=0#QA`TF@%TVC_>B[!>PQ0"+(:L.""+`I2J/5GQQ-CN\4_-Y/A^*X@8K-O
M3A;8(4UWPI9:PO#[1S0U"WMODJ<^.IL$+HP$]A"VV\'\&FT;S<?3RIC_[@&^
M:C6?1,!;@MIY,<J.+\'I:/V#2^A\Z\%YUS`F:)RT!P]F2MJ<*5%,:>3,U1-S
M\FC=7"*V+;<;G[M';)>^XQ%'J1*M(.,18R]]IS'V=I-"CQB[]<X]UFAWY^S[
M;/_P^,>E6,CR(Z2G;F?9_G1\@YI%=[FCD&5)(%_9WFP^5BYD/.J1E:M\%I_:
MR-'I/&K8]P7Q3&_@]EV*GOK^)J72[Y0)>!`.U%[0Z`2N-X/%C5Y^E%\X+9V*
MA/>YN7$)[AF9)0_$/Y)6]`S2HP>-GDF#9!B*]X/99#P#&;&J[DR+&;T.95N*
M.,:C->/%0]!D]YJ\$3O!BB7LLOQ:@*:/3^TXL'L@GQ-R(E7&J,EC0:`'Q:CY
M4E.B'<$9HEXNT;^+A]$!42]YI"@9B)U9Y*]WNK-[S8WQ5*\H^K/L4HKZ>(%I
M4;&+(LW)FE3<'XS`"P]043,U5FD>6NY<:*/EG.L/Q\=$$G?MMM.]Z.[?$31<
M#IBBR\^OD%2T:.FYU18,W##.N>4&.Q)]X7'-E8;X9XN+\;3/9@7!WQ<7K71)
M\M[CY9=]?AY0'<LN5+YH4[))_3U<-<$A:]O[TC.US$Y94195%*MC#)(9LW_<
MD^$64Y8@LD>/L?1!8<%W%-%&(XD&ZR58H1+5W,^][^^QB:5OGBTFDZ&%P=A$
MC&-O.)XM*%.*;3FI?;DNME<6/#MG5FHMXQ$Y"8O.FD\=[9Q_.MU34N'=I[.#
MHSUR!THI'/^P=_K#P=Z/S<=7-I]G7_F*4JWI_W96%G_[%4:M9RLDP[(G`E+Y
MZ.Z)O,*3\/@3@#2N)KL8C"<$8C=YSVJ2D*;G3[-+"D$(&A*B4?J-]`*/W113
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M0HDK'6`]^]"Y66V`-5('N!CW[]:<L./1WQ=7,ANV?&+G_OC&HF)?.)].D`$K
M(UBL,I\.T+5L5/"24LH7BMWFD<WS:W1]C*2L%5_`:70'7$V./KY#Q&8$Z9`-
MSHPOYKDF2ZJC^62"\<N'-0'(("$4'2TLK8\HD4L:#I`EBIY45VLBD?4@HU+#
MJ3"OLB?)BJS.9[T[--[?(RM;KY^O,N7E8CB\RZYYVA0D5O4S2K!C;(L2\9&*
M3K;`J\V$5T'N$2"6I5!OMFH"N;U!GP/CFORP"\K>C*MRV"]:)SL+?1K]8M07
M3NSY,U?3\2VAXB4I/73=;+K$^X4-E]TCEOG@!KK#%BV9T3/QA4DTFV9WO6TO
MM]6]D%HF_7NG*KH@Z*%[8]4L2C!+<+`/GV;7J_:?65&56&T'-U5==5;6566U
MGVYO;*]O_/;KC;>?U,4"IDKHV5.&G3<\]?3-YOJK\O%2V^[4CP`9>3:6AZJ5
MKEL@HM5E9@P12<R)TH#PZG%#9+=(Z--7K]=?EW/7EWI1(+#D!B$*#)!M_&IJ
M\%Y[[:0-$)L+.FX6,J923VG6#?U!&7G%`8U#[/EV//W9N.S%(LRC946KFN#E
M`J\Z`2A),QN;9U[,+YJM58^*+_SCMABB\"@!C3P/2L=[@APDK/OMNI3<Y#B2
M_.<"O9ORO!2\F$`S#'JNMJ*\JG_UPE;B9@?DMU'(JS5<]DTVI/]I0*WLC@6#
M@8T7O!]?TFBF8R7$SS2U&XEB-;O`D>@#W)MH.QQ00(4P\_$JGM("+]+,ABJT
MJTNJ0N-;QOO6-DD'1\C)([^E6[Q#V\97T_QFYIF>X@LY;*T!'1X5MWAD2DN`
M2;>EDWPZ)^6-I2"\FUGA]&+!DF5'<<H70IQN208!+$M9^@!05CBU9:1?R(_C
MXG$JI,;XWOUOHFF?!SBL*1T*F'_$@`*JV7D>G7A+RCAD@R#EC]>*W;7QJ-S$
M\VQE(>D>`P^*GTM"SZ^GX\45:?_$>-\4Y-V,[Y`0:R,*C^2F06J&PTU%$E9?
MEA`X"GO^.1]`+<7`[CXFWI,AWC/TX-*LW'`H^PK;JJ4")?!7.'S(!^TAKD=5
MJ'R0C;4H&\4E$!"ADAR@/QA*(8F2;9C.,9E$]DR&V^R&"1G_EG,5!FGO*5E(
MJ;>V"\@&O9'W`>F_4OCK(C$MAL[SZ\$$+B2E8"DSDEZ2R=<,5?NJ#<@U,V@R
M-T0P20AE^S^:W%2O._TBA5>#9GP>2^7EN^GK@VMR]!C,B8=1N/+A0#A`%E,T
M[^'Z"5R@GW$3:@$7B%'JR_`,`3H/%C"+BXK+TT=9_Z.-E2B4+`(J0@B!,ZPT
M1K.*3TP#G)0GGL9"5B7N)AS9[?6`,A1.8]&K"3%$45X*R--#+$B`(B-#CYU1
M7!7?9C0C]>%1`I);MN_LT\>/.Z<_*30X._AP=+!_L+MS=)[M[.X>?SHZ/Z!"
M=D([U.[!WEDK2*!`\\^_K<J,^;\3=^G&B>843;=]CEZ`O3P4D#JP_]EX:.B:
M`,BU#B*`LN;!(("KAPHUQ<;$3<C054IF3),]OD7"AG=K=/)A/&>+BQDFF98\
MA!>?A:@36H0XY,+K"RX[<)B,,*99;+W.!2T+M`\/2N7/_)G4M5PKC]5];1`E
M2TW)7,^**YFSU<!["*7%1AESPUF6527OHX7`E;LM%^:.,&B$A`\U4@2%#A4<
M*UZ3_`.C];`-+1DAR:DY]X)W;F4YNM@T49.8(Q*]J_57!("XG<QR*BG6E7DP
MS"YV+QSQ8>[)T(#@0>9>7@7I"HI/+*CQ@/#3R!R?.B!YCIGI#46/<VI4ZV?K
MO_WZ86?GY#G:9'!".C@"MHK84ND;>?((0IRUX"LS]#=6G@G&(??TA3;%-C&Z
M;"B_\18ZIL0QT+,7+$&94[2_]0HA8Q+E0Q59=JU@V7LNO1Y"/IJ6T8]T+7#J
M57%?(M$.WA]B]2O8XR^9PX%ZXSX*@'BA66ZOY-(70^);XF'LBV6Q:'F"5"7Q
M6D+4)22).T;30`_XH6%V/;BZAK..B-"Z6*"FBR54PL"'JCWE,,P2TG?J:3`9
M?0OR[N=W<'X*!@1[!.P:OX\CB-OX&_,(";1?]Z1+\HE)+<!'8$/2QP+O)%:@
MD^*.^=5=B?^C]=/X*T"#^H+RK;+P553PG6($D!T52X6<Y+%*4X-Z=(<=#@/%
M+A(<8&I6F5V,<6K52E8SR7]VI0!W9/*N<(V:<_J(9$;47P/VD:;HC:<(MRBK
MP7#AYTAOR3-"_IDZYIUID$3K[EX?+C(&^T'&0_JF9A+"/BG#$@O,8$\OE_:A
M,J@Y,*7$4&M8B#5J"'S$@LN/Q5,+"^)<E;U?3RL@U8YM6',6#`,;\\&4:)NF
M/I<O9N:#155MOR+X=SXK>F/G`7_S-A]#KYL)8H$FRP@D_6R.7O5UU<_&J_2S
M92L:B<C=O;R0&!PQRRGZ)^.E`.B9A:/S.W4;SP?XNP4(H;4XT8P,AS4*K&<'
M+`DDH&2#)4QDB9(-,[.8(2W$F-F"UP!"(Z(3%C'%"1)D6`%4`#9BK:Q0VI<L
MF4=%":DLO)7CDFL,J2VS$P_20FS4XFJRD7AT:)LRMJQ:=>Z_3\(+;V)!HCN(
M<-"CEVGA<X.&\ML$H%@P&"F)@G`E9U&ZR@39U[X#Y]\JZ'S>TO)=RH4,7KF_
M78A*8O]T,/O9AZ``D`#3W07<Q4^Y;%E*F&31@WYVOP0\B.5\NO`0R.!K"0BQ
M5N"8OT<(M!O@"S2&OM4BS572RZ!53K5*S!VZ/.!U$PL,('3OS@`(@)1-YJER
MB92QLYQT7^@GKYN1U.AU#V\$ZYX!WIC!3;<O!AI2PQ5A0]@#9K%<!EI^D_\=
MYU#A#[T\F!-V"+PQ8C"],F@C`CRTP:+IAOD#H2A\P`:D5*/\80]K3LEP(CES
M#KV$K02?!0\2:CG;!(:GX,<0VXFT;$8YQRI!8%9:(#,W8QT7\`_\,["I3E[E
M(943N,:%T9),EA&.RN-/2;STV%M8?;!GIJ&RXR7!*K[9XMD4B%JIA#@R9"8B
M'&"TI3QRX.-;"XIYBO;3Q<6<E&0Y7DM5FK`@-.PYIO@PS+\H-8[9))H5RGKY
M^@^KV=M7?[#%O'WSAUJR"[>Y)&%FAZR\ZYFVZDU[&P;/_61"T(F`BNH-S0\N
M^#SQB42\\H=8$Y0&]2?NJ&-S#L3EHU"9H#MD]^/Q<YF[ZB'0H6H&"CTXY=!S
MB;&/0DQG&Q:'A@C?&@\IG1P3R,I[VP(N4>*DQ"")Z2XB(!ZDQN"/QP*7"V33
M'$^HHK`2ZE.,61>K4+*(NV4?_KX];?AHFM^R+8PO02GBE$RCO.CHBCQ1WOLY
MI[+&/R6;VHC6.2-;,)'^P)]TX[8`X$!KL[<&12]XNP^VF=&$GCD^1US01_QI
M8FG-,DP7WFN%5DE)DT4_BF@MD=@7;K##`-E'\HY0T"SQ8Z+9:(^E3=2:O+K0
M'3Z8@9!K(AWE=JD.6<)N*L-6^<PZ\Y3OPC%+[+X0H/[B605!+4@^OI`!LAS/
M8#3AG$*VXK;7VH9#`03*FJ6("27(5A!$R*'&8*`$BL^-JYJ-*D=S-LIQ[?G$
MDT`7<AP`QD4,OD@WDN>\IB(:U@10HLH`WE7>Q@4!QR6UZ:3A<V`6<;D3,-KH
M!`3)YLOX=;X<!;#[6P,-O8B)S061(E+J5<$OG<Z$(X3?YF>UP3(%FX*P:[R^
MFHZ16L(Q>@&$6Y#A*G1M]9`V[>>A9OGMU\UOL^,690TF,O(_%J2+R)Z+4N;R
ME+K`GSA179,=':DJ%?:K@*KJ9"$@5!XS><T,DQR`B&?A5WB:+#4DC1Q#2AWJ
MUG(F\A6B2L?+8W#TU/%X4C&X5`1O\8ML!JD^P(]$&BLI1&I[$X,'5>7<,J_J
MDKT:ZQO`[.#A4D`@YU87.1T'"B1GD>J!IE@T(?)'DGJ&6G!(HYO0ICUUAHE8
M#["'?9?<+.V&<("SK&7!EDC1]K?9IPX-+>.`EJ82LUIL:4)O["QUUY:Q7&UE
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MNC^E\`M!!15QM!]<GRR-PH7U>L-:10%/IRL@(MK"^`'T%#=75E]>O/:M))HB
MFF6B8`=/UVB/TE<4'1ER$34J4\@+5MV20R%:F'Y&(-:]$Y)0C96[M;8H0>4+
MN3[F`3*#21`!1(3^*OH^^F)32/7)"XH$-H\$W22W!I-2UKF]IHR*A[=7A@,Q
MQ9.Z1I+AG=':++]-Z:5."<IZ]FD"F::<?G-8)&XJ=^,9`U,SA@JJ0FJ4"I>S
M0_L0(2)OTX1*242Q0#,FJ7:]YVQ7:44+4V;`/))*[E`TU`28AL_K-DS<*PL*
M%8`R\:@J[%&SJFR.XJ>6=6I:U7-V4V\P,MK#F%)H)"[,0_9;<U22QX:AOH46
M6C!%!=F#P`-G8:27QP1\50X*D4ALVEQHAC<@A)TSG>4&K)(.K5:13PD"70^I
M'&MLQ<E$=U:HR28`5F2OP6S8"*R?XOYCQM_S!EJR<;@!1.=C:N4AU/4>$I[$
M$?B&#*N5KXIQ(2Q2H0M=D6T;DM\)$I_WO5=)"$XPWT)!S/-ZMH_(52&6)**;
MRBZ2$9);C%,NCLUJ*5%>R1*JZJ2Q?,E!@".02=2B-;,RNW5"Q)V$.:+V.*FA
M99S-`DNIZ[^,-"X5U2[%9N]1X[]=88&`5N<W,E_*/JJ\99VJ,R]7]U%M0EU)
M#!J'$5)6V4Q56R?>Q:8`R'RAXIC2+@\Y[',H']G"5#2P.J7JT-WYXSE,)YUA
MS)!\1,MR/UH'&"U+:?)=#%[>*!#8:/*N<(;\8(B%6H_$<WIZ-D'&YE'4M@2S
M-+3AS*`0A(G5DM&>JK"C!VQY7MZOBX<6I?^S\:H![!W97-A0>3REB\+U"&$S
M$8L.1FO(O:0/"YB<;DS*P]G*P<GI_\EO)G]\3T[:@4NN!K1!@4EBC8Y9I&"Q
M.VWBN9F0-[\9]PER\%"YX5^%`NCMDH@UU(U`Z\3MX0BY;2H&"[(E(;QSBH0D
M+5KM_HS,G9(,#<*8.RLW$GT+2X[U#"Q)DA.`3"5*G=(;J/9HQVL1CL"JCB6%
M@-.*AN9@^G+=>%F5$+2J&`VE[.D:J!'EUM<`RRYBUP$,"*9"*ZQV&*PX<N"^
MVB/A4.0,,;O>8&2=C!32C&V+%K8Y+-<3S""AA23C@'DM!P/L\AY6^ALZ**%6
MA,`*R59*0A@4QI6>:&R!D)[0M%MY\W[!D+=W](CY6'),6ZE:=FEG?4RTRB2X
M[+V=1A;PF'F/AFUSPA>$'&*6JK*JX-*XI:RN#'G75I'#JM@?MJ"=H06&"2G\
M04;?6D)%[S^5I4G>-N#BU5<%"U(J<\X/`HD#2S#6SN'9=F22JE,7NW0G?0"8
M[P:Q%U9:>1(^5:<UYV!Z\[$NGN!:KK<-[R>E@$GA<3C\='-K_679+*BW7_R!
MC5879>"=JZ,%?15"^U32N`-KNJ!\1$[BI:5A-\O^[^K5L_35][SZA`YF=AE?
MUNU:=&EJD]$/`'#[MJ8WU9K$")W,F^DB+ZLEZPUR1B`7!!C&P&ROXIHW`U+:
MA2R6%82!<!'U<-OB<]VSQ!:7#BK+NV-F^2&W5HD[DJ*29W!0<L*IDT+GHZOD
M&PH/!G\D/>X,M==:]5)T"!E\OC-1EG191HGV"/JV:2+G@X:G,!L+_(JK88)8
M?N#QX,\"_1$(^?L2*S>*MR@2=<F"*GT(9X*)\HXDCQ?X[D;>(9@T39&$/E8`
M5H64,))81I&$E3#C0.F+(9;(IU,+1&1_2W`<6=K<K69.@J\8V8-YB!8D*M&B
MR;M7\8[1!OP3CX3`*4F*"BI4#_DK9+?T6<#6Z4H;F[@`S-Q@;>(>10&MZP(.
MDCSL_[,;BT=B^[J3#`LK3)P`!Y,/]7&+LI;[\"!1<ZN;527/I=M*WK*(N8WQ
MFG'/P2C["SD%W6VF&[OJ>IQS$D(J1\,E3:55IC,*L%AAZHM?#L3E)CL#]U=T
MS'K(JQI%SX`:FZ4G6*TJR3HQZ!``1_%('4`PFC/T^UJC^JR%6!G>RVT8F\^N
M,"'S)66+16<M':1N.L"K#TXN\D=)4`YB('T00.7SN%<%9CHWHS+/+5$\)L!:
MF0P/(87,?Z-U=A.!L;`4#MZ,YB1X.<_B:#GX_D1.*C0`CC.A\=FI$&,-[-NZ
MX3$W)V&CCRS119-ZJ4G]8RNU%B*LOJOF5521LD^MZM'2F8WJX(_*CH)I3AT:
M-!G1>242EH19PC8/=TFJFO>^(+.KKMO`7(RIM]W"Z:K?H0YS*JB1B%T@WX-\
M%WF2[@HMO29=B-L=R>I@#$*U,@J9A05B*O\'TE9I=CCX654P>#VRXJ\QO4YB
M,<_C@IBQ5]E;AR_;W*O/6Y;;H"E%\.`M\04>-I9S/;AK.X&@G'04>4ORJ\"3
M:_LXD+DSX/$RNIX=LTV[T+-KT5$*`H$?.X,$7Z^8:+GHEW"N+M`NG+O.(3RD
MV3;!+I,$V",35QHS$+77YKV6'ZNE&7W<"J=Y3;P(O2Z8$B`FX36?I-T+L2&\
MA49:1C@&=JE[EV%$_62T4KF5^8@6Q./7ON-:D0%SA"6&0TK<6O,^V68JP0R!
M@:U<"@*`32;8@`X(Y<3C1`I']1S1$D,5=*<-D<R._V4Q%*#TNU/K_N3B;B(?
M[2Q[R%J+M4$JOM(<UEB-:+CX:U9T461JK=RL=2KO#[.L"=`>`Q!#9R2U0Y">
M0Y>'D&*5@HXHB(PU.-C2\F6/N>!>B),E@H@GI?5:02.D.L(@)#LJ"$7$[F62
MRW9[<5-2SZ&>=Y:J106LQ>D=((F(6K9OJDZD`-O97+D.:5J$KP\E:,`X228(
M[:Y`-B*+0T%Z)4=CNB;]PDA.)X9_R=;&./]_6']$GF!BK`E'=*D\G39/@B?U
M'W[N#F0W+I$)J%JE[OL]1MPUE7MJ5O"ALM0B?$0V/@S!*/,*XB7N5DN;WXYI
M4RDF)1%3&R'[4R$82YHF$+!F*V0+[[<5Y7H=HP,:$(;_'DM1VUAB\[2?!RU#
M8YU"-_>:A8/*IK(ANV+ST`*XG4=%F:F\1)'U5*(P%<J:9)=$9#N3YA&B:U*:
MOE*^I%V>\#1P,\(*:>K>8-I;W,CK(2$"P?(*<B,82MR,2H@XNYKKT,D8.T;A
M)3G%?N]#(V<)51N+1Q_+LK1&C9E!!D:L0FY'KBYT.%6I(G>KPNIE/A)KY2X[
MQ,)F:$0;6ZR""R]4V5$LT)L;)]^)[<N@E35O>SI*%E@\+G-?*`GZE#0T\$'8
MD1FZ$E<0HBHIQ38D<Y$AU;_-MX9P;RV&>WQ=L[Z5?6P':['A[A1AX*B4HIOO
M&I>I=QGH:(&T:%[[!=:&_CD9!BPK365AT56K2X^N>"`VQ\2A![G<;RWSNZ`3
M(X'6>DWP8TJF+!S-L#-LY.W(+?,D-D;M4E$VY(QBN<&EQ@[?4/4%SNL*5A&+
MMC"NLP:2N>.`VOKT8G$GV$)L//B";#!01-6*)3U/J$-;P+&H)#S<KAX_Z,G/
MF2Q23&M'Y+4VM(&5R)B&>#M(I^3?'O$'VK<AH(:6STQ3]WEYGZ)WRVCA[?.9
MAO6T=\&Q\H+#=!SG6CPC5.O!F[EM8^T<"HTB64VK98?8$FFG;5[=^!:56[H=
M#=-6J\-QET5!4*.'3/L@?UR4RI#E`2=[JU9%HRV6$YUT#=)?%<[SR3F0A:T.
MT2%!U/XCH2SQRZ"<&)41T`4S"7U`-K8SU)XK:.=V2P#7GUMF))%#![*<&!K>
MJ04"UD5QX<!`B/-%VB"FVKDB83LO&IOZ3<J2ASE#LL`'8@Q:"3MU+HYHV\2`
MX6.E%>59*+,YU9^1J:P_R2^'@#'*740TE:(&+5!YAUOZJ*&'7HW2D+(9[(AE
MT*2AE1EQ.:C^MM7QH%VV&4YG67$T4C%0H1S9$MW8->FEF&]J*9FZ-+VX\``^
M+AW)R#&?RB5."#N\SAN'""SF9<\>AI?0]0M$I.8)=+8BF<_(%E0NCL+%&6$7
MD5[&:)@HST5OF:Q_W)49@V#_#!`%NV<KC=0(%M*Z19H&,#`.3QB&?(PE@<N)
M["K]A.0[=1(;(&4$LEM':5M;RFUB^Z0,Y1,(#="0#5`BPD@+]"LM@KB7Q??/
M]&[HN]+TTP4U(1S`Z0D#QG9O:CITA9L.!5-135+Y<S$_J@/UEE*M(6TR(<2W
MX[RS[.^+?C@;Z99&[\,<.<9Z[UDE!N%=6XDP?X\VR\]ZCUU6,[H!B4O15W77
M&\\-L[">+IG1V0##,>Y*JNE"/"FX8WDO^?UE9"SWZZ:E2NZ3JB_\H@A9M>AC
M83/NS]9=Y:F3^9)#S0\*4KCGR3)KG,QP>^;'IT(?<C3&4(PL)\@`:];@.ZXL
MBGGP8*RFE0A?-E!8N>!=5+I@F;UYWEG"631U]]9UC8G%HM+O:UWE<*80(MI4
MN46Y6SL9;S&;RFWZ%'G5`-(0]>GSB:Z<L#>YT&3HY-`3R8FYEH&);\LFR#!Q
M`0)YVW!/E]CFA)70]3];IMI1KRG/,$:7T0)Y\M83VCRQ3`02FB.MOHV2PI@Q
M]?,XHTJ"/"P,`4^X_U3+G%MRD]N0.R\=;;DO8Y:[<SRYV3(N95"'(-1%Y]WI
MLJ3D6K=H9Z$^5H]3-SJ>9JRH-"@,B>%-KVB2E6N(7[G_2E7UE.<AE-0R'!XW
M56[`1]%"*S:'V3$T<K.NVC;CA!7CG:3J(;=N:$W.=^K5AS(9&$M-8?U<B!-N
MN&[1_S0%7^\3J+/GY>`'.V)J`Z18R2K/:<0&Q.3$)P*JW42!A<$!_87G19+0
M'6@:@W'U4G2V=*;PN,PA/@)/J\(9:6<87Y[1X`H%9@YSU"!<[;&8^B23-_XR
MP+F-K[P!SKU:.-;"D1'Z1'3_;#EDV@?([U20$^(D<R9<:=N-T)(EJ0BLQO"X
M\19+FD'.;CQ4XWLH=QL!;OD!KB?V2I@DE)N/4P%,ZJ=^3H^I;I]C6^29O-_9
M5&GW-!ZC"=U3K-:#&$.1_+01!@\'`$G#33;9CX8;*6(':P8;I'BM]Q%KV%3K
M&&"VU+*7T(Q+0FJ@B88"U8'C.7FP]Q@\RF$R/&B4'D0K6)[D2?^6ZU?TNI(#
M+,([4*9\I;O8E`F0K3"Z:5ZC`+#T*E_092;S6P9;=)R1US).5NL#MK^W,^C*
M%`KP>:H0@RZ37'*BP4)I0DP0H!-+&%TZ$,M$R(M;7!EEU01,:I/;9;%8$LNB
MASQEVPO>\3J[+C+[H:B6^)U@8,##N^K2?"C^#L\:\<TD=FON;O#C$Q^Z>IQ;
MQV\N%AR5PE36@+;%QQV1)?1RW1+/@Z.#]#O67%V.U3%/Y8*#W<>KU>.Z:MS2
M6L)S\SY*%C4\0^?AIB:YSG1I4,<%LLWGFAHOC8QNP)FO`P$:RW4#[@$>9BZR
M@>3N],AUI`_FM]2J=18>>X,P%^%^3[=)WBRIJDBI<9+S2AZKJ*J,L3L&U_P&
M6YA`%R1DH>Q@:,FO0Y"8@YJB?!JP+].T,K40VB]'"?J"`%_2LK'`<*E?^.MV
M>\]&Z]#M_N,0%<)5ED'ZKMU)[G#G`=`8M/YOXZ81.V34J;L+?3I,T/F#BI<U
M[E4\TXK%S_HHWA1B=%@KFR%++!]W:#N&^*%M'>EGPZ!I_7!"_4;J5""ZQ+)E
M7O;O^:F!ARBI"U:3D_VM<_;5BLV+(47VJP8>G],+;"D)T*XLO0QF\*`&H]S!
M:PM5+SW?RT[ZS0A8F<Y;Y"3<K<OEM@A,`6_Q9X3N&3RL`>W0`?[F]E","IW?
MMQV8_70KN;[/\C*M7C7,:B2*8EJ_4\@.K>$4[8R]'^ZV@`"N*VZQS@\AJ]!A
MU32$857530B0%17<);_1^D''WWX]X-K5)IOY3&0^S[^T[RV^SS22'/?@RY+1
MY@9C^S/)++]%@96$[%3PBC;57%.EV-0=?)EWENZ440\/EY4\>%W[/,ZGB!3*
M&FW4,*"3H%+6$%%I")&0#AG'!_D<),!5>;%3J*HR5MBAP\6$3(#;;]9L.;&R
M85FS8`PX3)C]NQ?%A]R5H:WM>B.`_-F@N/76BMH^/)UO6Y##`=KIJBEKI0[J
M4IZFQW9@!UFXG[0O(Y\XQX6.GNL,FL55#Y7V5,OH6HE=5S<RJ,.JX]4A\59F
M1--;FTV3X])"!LE-E;Q*^%=3U1.*H!"B&IC@,_VJF(7@Z,.;B`']:"3_6S)[
MGUQ&E[T`"OI!:ILC7)A7@HD._N)G%;@\HB2J/72/#X8%!5RHI@.;[."N)<6*
M+[G=`:9=!K#%LN3/<O^5.*55/!J(K(P;L<C-7#OR#_+PWSE*;5/W4FRKP8B*
M!`&J/$A,S5]9X7B!2T^?<I4E*9-+LY7VA063@<S.*YO5_%+YXWKJ3"-96^8\
M:#'2]<<A_RZ[:\>F:M<*E88Y6LQN-Y*X0RWE/O<$X;V_W2L1Y=U,$KHN#U&M
M*3&_I#_I1@KY<0B1V%TC19MT$5OY'1-&Q?*W[(R$T7#Y84W/2K4\VG;CYHH'
MF7CP+^ZU+&]*2]172A[K&>B-JJOLB*RP'+RTNK2-9A?=&+J4B.B%SH:((.5=
M25UL"`+L*,"%7EK#U.A'.'$9PL<4'!DWE+H@F(KFA*5;Q)E(=VUTZS/0_M2>
M%1LM?4H95)TJ)UV"K_;$%K;"MU2V=RWKY%)G0(^(O!G&.&+R:)9%VKC\]:B^
M+J&Q0QUD/&%39_JUJJ9C;QK)=SBG7J6Z3&CA-ZN:Z77%"`YFS6")#K<`N&L<
MZ1J=:78Q1W61-7RSBUGU)DM.6NN3%C$GO/WP=KC#FH=QO1:P.#(VHZ!2J`75
MNOH5NZ!;;%F-'-`=VQ0NMMI_^,6P:#'$V/^9+7#X=J$(BK.V&'!2"BW*E(V?
MI@CA]M*O())7RT7TT/;'_N,MJ.X6'C%#(":E(/?=UL`=;&UPK<MIE[17BAOE
MI6MQ0=[P6=UJ*:"U%I=H@!XN>HV__3O%/U%C]A].KZ/UILR>^46_?LEB\\O3
MAO`TO_^O__C/YD>GY-ZQ`#MEQ51'ND>T4H2+@IO/-W5F7T4QSBY9`*__UD5?
MMQ'46AJD-IX'-D&*/:>R7][.E:SBC#:8OF4'WHW5T+ZROW/V[KE4WVT@7L:^
MQ[[.+>J](/R+J$[*&MOEZXD;%3GP2A*C<+\9VN0"I<(M)U6I17UJ_N:]#/="
MO9)UN%J'DAHSVC&N%3*Z"BSY7N-Z`^[4"D=!>ZOI2U1I0J13542Z2@S'<9OV
ML<)HL;U5%.JVFF:THB5NN<?VCV8V.;^R_3Q[^*FF?)Q#E03W/#+J#,X,WE7N
M+X4!-'T('K51@(D7W9<`&1VJ1TUI=^<6>,*L<.UH.`L0/2//J),:F7CDTA+K
M_?L`R:?JNL0/X.`6N>6[$/C6%Q_+.^2:KYR5D,UNVS-!S[\TG]KWB+CY\:YA
M`;(0!Z"W5F9U!;C$M7_^V^VM'WU\5_L-0?N)YO(._M8OH#UMSGR,YMP+.^"B
M0*YTJH9GVJM\_:(Y>&NM*]O-1U9>OVY^M!.$I9H1.;&DS7($UASCO_[C_S8_
M$B1QF#Y?<]??":P=<S5?OH_(K3WM[QR<9C_L''[:RS[N[9SQFS;V:[G-,5=>
M/,\>^6B78E<-:Y8I(`O,!F$5IT)D#7>!KO06*:M3FO@0R9/>\:L6N8E4EX+Y
M2;20\5,#0MM#[LAR-S?0M@#-)^*-0TL^;XEG>+Y%T8^`\(Y[;*UW4?$;.]"R
MF]-4V@IQX+UU!S0?:NVBM:H.ZJ,0%=;@1GK+'EY2^#-C9AVO<@9I"BB6?<2<
M;K*7=[1XQ%`/N&N,3*^25/S7*&RJ;=1"#/TCH8\N:NRX`Y.+H'3!C?_$`Y98
MO9RQX\+"48U5?DZ!6A_6LP$F0IX[ZIPBU-`%273DQMH;%/N$BY3*4J"GH$<<
M#Z.QB:`-#PPR",Q3HQS%TY#**9U\>7<T3.CK6PA?W3S%'_'JJDH&1`C[Y8XT
M*//P0@%'<NP^N?G->$RD!,:&-21\+42L'2DU#$.$65UJYM1@TW9+7=I[:*OE
M"Y8+U&!0#E=-QS]CC5ERG[06_[(KM4A&7@SZ_*?UG2%A.O.-:RX/`CBFHJ0,
M@J)YS'\_89VPZZN9:AX\Y`0PN@&5B_5F3,2^6KJA,BU)XH$:CZIX\9B_G>'G
M"C_@%+RI[(V.71.U2AT2\:O=&<.6$DEOP29^$N"O>^<[[P[WLK.]W4^G!^==
M/P#P\GGVJ`>;6KY#DDQ0QF^4Z-(;18$LG<.KAG1:M][AR/P>JJ;)4?VT^=D'
M$A(M`U;!E-;CH);6XT(M[33Y/C1OOOZ##A\W/VS=O8W:5U=U)S]%T7SQHUUP
M;KH-9O*;O<S\40QO/KO20@GEV_DEB+L:(/[(27+M5Y-'^KLYP;E=E_I/[V7E
M37/`>#.!FIUJ]Z8W'UQYV_KD9?,37QT5YXG?6?[0D)LM<OD(G5:V.=G*5LN7
M?06Q6Z.U?JOW*TG]&.ZMM.!@\ZUS#$;G[K/K@OO<&B&G11RZ+1Y+HDR-]5?Z
MQ?'R:E@?7'DX]+9D6,M;R$P%2&4F,+2;8L`N.(6A8>H7D>M.:@6.NA,@Q+TM
MH+'=LF@GI\<G>Z?G/V7ZW4/];/F)D.-J=K1WWN+&J^?95SS>I"*)!D`P>6]1
M01!A$CI/XP%9-9*I>(+-;QFVY"[`O?AJ<WT?:_?S+7WLV&\/W*_='KCTZ>K:
MO@/R_92B#*TVI][%05=7WXV45*''K6V*7'QKE+AG9I*9.TG9]GV\<5$U$Q$Q
M6'MSY<T5K7`OR-NW+65<V=Q:W=YJV8@FKUI3$4[+L7BF-_9X3*MJ,*3I8J[]
MF-KF^MOR*I)5U86K7X&S;?#)5OF`82F)_E=%VP_<37UP=+YS].%`;GOG[&SO
MW'_E\\/Q\?L?#PX/6Z1[S4_)?M4;3?(=D!.OW355!N@`F[(,G]+43XI5)^`P
M$?=D#_?"*:Y^<^F'W,C1_"P1H=97"5>;WQ&\-C]*MK5C`4=+3<O#O>U7*:O:
MT=OF-SLW_-Z&?HUFU)=J-;_>Y#<`312:7ZQLK[[9;,OWUNK;S99XXT\IZ,>F
MV;OF4)N;R^9X^^I%\^&5-R]:_MK5ND6>UJLO5E^_?M7Z='OU]:OMYJ=-D3I'
M)4KJXEGJ`F9W!A">>&<W(!K,7&MJE$8E]Z@I9B0#9-<@R9*X)EM-1T^FS6@\
MV7E%NL4C]C`PVV+0Y)8EC0DH;_N?U>[!"&W]S+_*&Q38>[HU?QX91CLD/^#%
MQ9P#_:8F'H1HC6(`T0*77MLE`33<4056/Z_=.Q+Z'.C(N.=W4Z%2SJ56\<=1
MK46&TR8ZO,#B)S+V3*L>6YW>HKV/BK2B5&]K_F=^,K7E?)M,3@UZ+$][<-G@
M-ZO`/#S=3$PIEG5S'4'FZ`0_/.L.@D\JT_LOL:Q6DP;4A)^C#(1.+5FY;@2G
M*:8>*4MH[K7N+ZRXZ[=BO;)_OS9'00/1&T5`[7U7'L7(4/MS(Z6!!/-I^LD#
MGH/?>SO]M`<R^MO)WM%9QX^]O7F>/?1,B\OA=JW@1M4@\!@(5%.FIKG`R-N-
M7:=VT,\QUF%H^]ZG[7O9\QS*F`*ZC+Q[H1^3'_;V6RR7O43=J3HBF7;I`X/(
M,5#95;BY?,[I^!)LA)"B7UV+\PQQW-+>DM;_X_/O]TZSP^.C#VOG>Z<?L\.#
MG7<'A]T1^=OGV5<\WF28KR?]3=+JQ\L>RSLR=<+EIQTN3FGB]_%<TSF-*8?E
M#?$)PBJ-?Y,KY:L'WKAF>>LSDCDRRAIN&3O+%\,AH^;`A^,<).NYM^9W1I+F
MAX=P56[%F@Q.!!C;Y8R5MULM][FR_:;UF1WG/U>KZY*!FDPZ:#9X8"VVHMEH
MW)&G1)X=[2K-O!%-ANF(:N9?R*J2_-W#B=JO2*8BOA.ZDUS%K#?;#D+J`&7Z
MLAJ,+H(>Z0@5.7+L3G4G'W8J_=.!\$;2,JE,%?1/<Y=^P\RD/.E9&\$&K'ZT
M.`Y8W4S8L'24/<EU6C*L[#"OUSOM`&YY0H$K0;C:6#*5]/C@%Q."*0V:W+/.
M7Z)HC1+Q4*_=4GC!+YVH"<1Z8_BY5E*)S(&!+_.B>K_JL7"GH<R@KC?6Y0<D
MV-7[\I!#V8YR0".L'HYA=8F8H&02@@0GD3A3>&$1MTRUFD,3O=1X.M`ERO!O
M2)1NN$'TIL9T"/&9?K;1?AZ]?2<<QL..G.)733A*QCDH.:4G'SNB$_UP%P&?
M<D:%%#9'&G1OE"2JNH4OTL"*T,1N2@JSK\2RIRBP3)>+Q\D\GI.OUA',H5I"
M`X;"Z`&ERLNT2Q32.3HT?/HBT1+C6PX2]);W)"^W9&*0VXA3MZBS<OWQ)VT9
M=7-]N\)&9=OY12'YD1C870V6-XEG_,HV]&IV,'1Y=*W6G>=-CNIT3&@3[X(B
M+R.JA<,$UCPA"2MOA]8Y0N@FNZGE^[E6>B#\ER/!5@O!3I@75X;62>K"55/V
M[Y(_ZC0(W)2&G'=*^^;ZBXH8C!8';HAUNI=RX^G/84HAE];F6VC7O?3QSE%3
M"U8V-YYG2[_MT)$(A71MXD9=I>LJ0B.E!!&:E@6=:B,&Y#\.^KOY)-N/%<O5
MWWX]/-Q]0&>XSW4ZOH5;3S<W$@A.NZ5,:I!7F]K\BL]A/?`?[6H)EMWP2/%B
M1?'5UQP%S59?3JC=5%U73U^FL]M<7&Q+"#/,]G0Y![4K?KASPH5Q0VR>)X`5
M&R!+")R.D&&MF-%E++,M^1[TJ<F]+8;GGVZF<]7WTK"J]^R%@9+?2Z!`HPII
M^)526W[*V6VM,_W@19BVZ[I,(K=X[&>B7WGP7J.T#X]*7KCBMFN+:`$']/F=
M\=1:1BI8C=7O`!(#(FL(&3%TRERH54A29F[MZ9O4@C%P-;.>P=<D;IJOL>98
M=96O?.5*@]AHJG7I`/6=?:+3FS6%ICZ;5$B"\'4(D&)KZR:TVQ&8R_O7E;?.
M\==3#DFQ0@XNPHE23>*B6%UUX8!52/D/^3J1PZO[E`F95<X>XNACO6N7P]CY
M[Y`9--YUI26,6[9#]Z")W(E<D0?00G@RN-F&DL@&Z&=V6\LO+P.U7T#!(!X$
M8E=AJAO32M@MLDZQF864%8XRUN!/2$S%6%OF7>N\-ZK=;K0L/P`-SLZ/=__Z
M_?'A^[W3LV>6F3__J6TX-_FM\4<\V&%#=^#YL,.`7G+5!&Z(,F,Q5%_;%95^
M[\2M6KU##H0=GY5-#D:6O2^AG1ET<4,K7#`V/@HB(D(96-(=-""I1D$YTX]!
MFK(%1JK%CP([UX-<L"A$452^=V6+B:P&O^BJ6WZPQ>4U41BP*BW@>M0QT*UT
MK^K00]Z,3K_]NH61D[<Q,4Z-4L/X1?*I*[)C_+)H_?^7A`^N;CD9N1*]%'PG
MXY+!VJ0,EQUS0:5G=;9;Q$1'Q.&(35-B<BQDC,/`H]U'UA;H:$K^HT.&EK;&
M184.SZW-U5?<V?SB#6NFJ++Q^N7JQL:&:0'._>7&AOUIG>2E^T#BK4G<FGJ1
M9G-$\4[JR8)#3#WL&ZD"4*G:89(3C^I3!D?[C1%(>$HFH>:MUV\2BX3)>K&=
MWDIOCF=[._$\."PK?N.[%G28`(/+U>B/\JZ`N)YH,&</V*W_/H*OOMC>7GVU
M\68U>P-MMU>WWCJY7P;2WT-K]_@Z28\'FBOCA3DI_!A.N4$9)GQ:].ZNH;L$
M3ABM_<'\ERMYSOYOO]KO@/SVZ^YXO0X`OHI?FZ^39*W8M9'\[2XF+8NUN259
M"A96S"UW$;.*#[")5!WQX7Q`7Q75RIA]LG;SII=I<K3SX&E=<04YPCDNM>5N
M2Q<:^@#6"3DQ/_@08(6'9E6G&]:?WBC+R>^J&Q2Z-]>+7U#^5%*[_;(VS?\C
M[]QVX[C.?/\J!4.!VX#H\*333"9`JT7)G%`D0U)*<MDB6Q(3BB1(MFP'OM@7
M^T&">90\RCS)_/[?M]:J56M5=3=E>Y"-?6'([*I:Q^]\7##8,4@VTVAKJ/G_
M2<D%+OD0RXKG2FJLB3OJ%`U6'%!HU)`-4;Y!FX;R%(^5&>(I8,V1TDC(5+F8
M7I:OE8=]TI)#Y#T/CE=Z2(QWGWJN2SVPP68;H!EX9\\JQA'@N]"<!P]&TB=`
MT_^K<YYA&TT_YHB/X3E1`]^.'2G"#L?X]N["<:6?0O$7M;(XS$P3HFB2PHQ:
MZH_R`P<Q/X(SQ0:;OHP>;;W6I5`KEX9<F2`F*BZHO#DF/.7XPN#-:-I\9=/0
M]D.RB<77Y4J#[S((IF&;W,-I1LA#4Q\;)D:@@82$84@2)A:=F`'O);*!8X/S
M.+\3G6&'!,*&>X.@HW?XRDP/TO[#=!:>1!$,HCT\(!M3(@N2A"9E7UO`V'/'
M#OAU`4S*(4<4GP5H_C"[.25W47+_J5FN'FRAWJU;`I$&4Z/.%+';1BPZOP_W
M8C8/#RG,DM[2ZO,C,GKF-A),+=C/9KX`"_6T'%/+V\4."%Q)QK^AOL`5,HA!
M>JQ7O/'H-WJ"SSH:VSIY5IT)>2]E;>G!+"2XN-)33F/':9W1"`83_^5V.*W8
M+DAL6%=I59/*;[TWB0C&O=;'!0>-2<C<.._0#:(.!4AP0=ADA2+$B-V=AB13
MU"*U=[8B*2%2U/=HT.'@96*6($KU0P0$_7L`*.^S!<.5`+]V@`87S4@%\Z\M
M+IQK1Z-4Q]=B0OH-Q^;4`1_,AA[,\GYS`400]^<*V)'O549-R.82,`>7X.S3
M"_9I,<)ZGV++EK5D:!>A+P-_'8XMOSBJ'`VQ2W?[T-`*')%`(.GZ;VJ>!L`E
MQ08$H32*A?#J37*I'ZU78#Q)D?,A7IXW,:U9NY5KK#)6BY6*!U@9?L:I9YH4
M]4\_S^(M]!][%YT\AZJ%=9Y>ZW;-AA8/VH]=PNG*QUVR/U-FUYZ/C_&Y*OL(
MI^OX9/>@QV2X&33?%5Y>P%.-PNB64^B95RCI*VVC7I"W_V:2-TK0=I/\I9ZD
MEUB+V'K@>?[>\>&A\?JOZ!VGN?CU:>,?'5AFG]''74@4S$'B1F>`I^G;6,3B
M*%CI840,]:A1"!FVF]X!RF_\"\T`PS!^/O<P$$9Z$A:5S1^#1.RI?V5,`!(L
MYD,>@M$94./SE&;-DB;%1T-<@!?=<>';4`FSD*IPQ`VTBZF7HLDJ(6K1D9>@
M5-[Z@-B*M=;"=Z$2;+(04CM(H`U#IZDAADBK74H3M+*$[0X9`L"(%Z[<PC.C
M\W;IV9.`R/+EM1)G+*)#5*AY;5P>"`?,^CJKB;'*F`?-@Q_T.`(1G=%'+A)X
M?,+-I^*BCL[$6HI^^1\6)^]1KAG=!%H[L\(5L^95[U*[IS!(TD(@^"IWR2'I
MWG&SHMH:="2R[KF7*ZOC!B`88`IS2U#&T;B?;F[9.X\>/MMZ%*%RZ&(*Y:B_
ME@YZ_>/MAQN;VW$T3HN]=`!].0B48%F`\"`!*+\KP?DD$A+#5LZ;IC/.W@SK
M))!P*:A&@:BXEN4-$6Z;D6RTLEO+6F9-$=YC#2:Y0-S:3PW3GB3I?_YC>W-S
M'*'$S*>R2H>8`814BGDQT<:SIQAU6GLXI$YUH7QH=9WKS(]\:7*-_._61%PB
M^XUI15;-$.RBLAZBJ0$_"V)O=F?=9'E3?`$P['Q>6HR%@*'=EQ#<*`$SUR)-
M^'UW=3FW4CU9!3+O<X28A[8/_J#FY$6M@JN.VF0502IO98#("`D@#4[*K8>&
MO$>B(<KZ)55E;B6]GCS<7DR"N*QW9*AXCK$^M[MVD<@.U,')M^!2R=A/QHJN
MF9E?-VYNJ'_^XXD9N9[:AMN16CZ2\ZA0MRT-$5HD8AG%`P=B/G'E8))$F7>6
MR,VIMY7=4EEP!U2SN?.":UW&"?$E.$<TS02`TE7,37_BQ4`*M7%7[;,O%1AF
M>^!@]96.7+%\HH;URPK,QYL2CPLU5<8=/+5ZX+763$P6$;LD<9LS\T907-K\
MQ@W]ON&>3:@JI3X*7X!HP3,PRJ(CM(F(C7'=S.("M=VH*3KF5-E83S3[\Y79
MZ@(V.>D.9^[\7/M.1-9.49#?P;ZX/D`)351W@<"B[U;F`7I9!%Q#V^(;XLU]
MD?48VND0'?J%=OYM\Y9["S1/EJ3$2@=QN7,DD7Z8C'^:HD`]ASXDM$L##-9#
MT3F+9P;6^%6GD;![.8F`R*8LK_Q>%"&@>M(>+J!!%_K7!?"L8ZC"Q+%5(BFY
MR)]"!9/R]S$ZY/1#%3N^$PP%Y>N'LAM4/T*';=;RP5'L'5D^P`AI\8)H:^6C
M$X5\*`W]+RA"MU5:=T3<@ZS0"H@>'3/#Z>BOO&YA.5W<:!51/WJ*LV)[O0XI
M%WO"BEP.-,+(\_1QE;>TZGJK./#XH>`[4#8%1$9?MWX6A:LV/CA0V*D)8RM]
MZ(#4C#MRCQUC$!0ZX%^>1\D@3P!K%[B10/!SJ`1/4M-S;*"N6P`^+'N$"2#/
M1)3@D8DN]:8+ITV(DLYC-"Q,KH[U6F^C@TK94"N.Y6V0_@Q/G.BM&0DT@C>P
MA4C>?O8&'A$O\F#KV\<>"(WW66XG1)W0'?R"^GCMR2Y:D?@;</3S%K29Q0^Q
MKLT>UT7K'2_6N0J`3#]@DZ;-I))QEP!);JSM!6>'@6?=:I0ZJWM,$@Y-O$3N
ME8A\^KD?^<*D>?@]^1+&U?N`UA$"18LL]5!'5_G,7/"%>3Z0"R2/AF7<D[>U
M=:.R.#<%.5CPJZ=)(_@\V-CNW*H<CI+-8*NX70$9V'BL@AO-W'"@_#R0)[(I
MF$$/57C<0NFF-19%+1'56R$S%CY1\4^,!5&@/Y:,NPR`.EG4E3:0>&Q'-0R"
MN2252&0&:<P2ONN4\05'5B[TI3+1W_:E08\X"!=N:T:7,SC@;VXYI>($/42_
M2H=Z:]A>+D1)@#CDRI\[O'395!5_T<8\0D=H(A[%S=]BE.)0Y;>O0\%+UF"W
MVV=XBV"47\_]>(#`,C:]&!*8@+,VJR&+3BV/Z56(L-,VIV<4L0P!,I^K"_>T
M,&-J"[95CE\>BVA52]&-AB0*T&68/Y_;R,!AK`Q`4Y,EPX;G%\1IKQV?HIIP
MH:ZSK$FST`N?T/\I_T9#<WNW-:-BR9Y_,EVNKNTBF<ZKGY6;KZAC)4D)LHP`
M^]Y=P_E\!:&TW+!RP">X=]?0=#=_4STACJ7_R6-HD9ZL5]^DR?T4S%]9COOX
MVW476LL'1^>W?UM[C_=37,TB_DQ!+5_;4"@ZT\-5J_DM<XEG!/!6SRRHU[Y[
M5CU+ZT[.TA_/25TOI]['95K^U@>.0>%,S"%G`Y+;4_P^';K5$>$4@U&4YI1(
MQ^Y#9['DY#23C"Q8V2?]-RPE3.5GY!!*<"<2X6Q9\R>M%!XD>NY9!2(?FB&]
MVT(-BE2$5A>DJ.S:=U>B_;ZYY%VT@]2,5O_A1$&U<RIX9`%L*ZU7RW2@\@5T
M+RI;7[L$3&;ZJK6X^-%9]9"_SV[HPA8]X]B()2>97<1W[Y3:O)S8\..+2FY$
M>8:/6R!K4&TY-TCCS(W[UB:RYM$[;W?VW^R4L#/:H(C<4?^S$JY0]3:>/<,B
ME>TI=%>`V^G>*%]QT=Q@K/]\3M0!^OL-%4EDF7EU,?WAZAC[Y\<_T+-B]L]_
M7%^<-B/[U6TB]K]^AHS%;JX%0B&95&`ADX%*D&,E%UAU6U_XN5E\"FM3I9RL
M58.K[&6M8CPSWL"!6J'A%.N%FXL9"`7TS0P;QO7M,,(16[TY_R';\F?2Q]F@
M;`Z<U2.[3PO:GL;I%+<E8-S"&,/)3+"[G%\J<K:9?#R_.",SBX&_HQ"MQ82_
MGIT9;D[8-!L;32;?J02=U41M6P;"/#U;R@/,==CF)GV-EP*S!WF:^9794+JQ
M.D>%PYLIZ)@0:ERZ5*IR`]+A=*Z\B1_)X/VQ>8E<UNSN*@S_V\-OF]'AT<MO
M4FP$#+>!*K?T,YRM9-5VO?EJTMK9%5E8%V??J]F-1WIQ3.&(JSC$X&4(<!,#
M9$0YO+I&C$4TDV$B!?;8,8NQM0PBEDR*I[\L8`7E$W29G1LJABK).077?C&5
M$X$6M6]FH7AV9!T66Q(AI+M_MW::L^(2*Z3\QH(%3M)\=KDL1$2A]<OTPVO[
M6YELPQ))21&N6&Q5"*4UF@$9A*8811"43;X35<H'C@.*VB`'$NFS8*;BY5SM
MR>X2P*U.09@0#\'BMC>S-!\T4^)UVY0[0Y<'SW)E]8LDRB4*[>1@;V_\_.#(
M_-;-^-71SD`QO@VJ\:WZ<DDM3UK";R[L#M8%TM.&,D+7`^YEYVG?)?P(WXC*
M)K,T5QN'NHNY^)1X;BNI.D#;-P&V@Z=/XC[F]6R5B2)*:!1XY534$A/(<7'<
M21&8&/2371Y(59B7^4PBO(3,"#BZQ7NPW&QI1#AQ*-@T6=Y[A<X:H!OFRZUP
MJ0B1N#M+<J20O#Q."GPU=Q#FY+D6&W;&".+I%EPFY=RYPO654%HU6X/+.W4N
M%((HJP$)1-&ZYR1TF;>7]22"X2T7O9\JBXPQ/=G13,E(P10ROY@B1XETGOV6
M"\)20/#)J:9-\W'<B&\$54)`#3'CYL01`AJZ62+//S%S6):.HIO!NI2EA_T:
M*`+?P9G^`T0>7Y,"!HWYAOX?',1SQ*^[JXNUU[0AOFV."6]X]ZX9A:\J%7D1
M;F@_X3O@G=B*#J*($Y&D\.'2TD_T;CRT!(.Y3U.,#K4[@&);S"`;([O%B!&,
M&G-'>])BG!L$$2--#\A$8(BK;S%PF#Z.#R=D?!.59*Z0DX2S__U__\MP3OM5
ME6I\JY=*EQ'V7RN\.:!''J^`0-"&8F;'D5,0Q2D@+(9:^,9E@/K&\5.Y&X$_
M$VBP=@LN$1UR=O[!9#FMA$(>'M6>4%.H.B7_'=254'3D0L':<_1%H>)AP&)6
M/-8^J/AD^XB_<VSQN.8\OP@\6+(-`X_.O_GG/[3\`3[-U_8$TV`;KY#=XN@\
M#B"<5[U+S[$-!?LTLF=39>@I>J.YS:\>@`M"X/NHQ.A[0?+TXI8%FR89I2UN
M(K-AM,N(A9NR:Y3]#Z@G`J"$ZOR"3;^*D.C^>9&SJW>21C@MXJZM1WD[501A
M(WOL$_T<T0721>+#%>T0%#L@&'SG];L1X7714VN>A.`=HAKU!K0?4BFM_N^Z
M>RTK7NX;>E&_'K]#_3[]>.E=$:^AD)"J3\8@G&T8$F1S.4B\`.9C/.ZC7PC@
M6R*LN_;<F0=/\MQ,(_E^;-J,PXD98#&WV)JS(S2@X7QC=IXZ+(>6#H8?`7Q@
M`S`X[$\,F!0`SM)/UYA%4['*#"/OKM8^441G)<2TZXS';U`AR1"5V[E;53)(
MR!V6:8TPXSJ[>%!=CBZ9B_Q7Q==F]Y((Z^LV/[],/DX>*RAM,!&U=N8,^Z(X
M1@&C1!1,NXI'C*)GGGE/]#%XGW;@'2R,^J+X5@L]:AO[<0Z%CX`@.LS;DQ>;
M*-?H@R%5@N[F%_2/^#1]5Y&A/.^;D%OT%*LC,,I^7\J$.:DL\KU4$K7D;+22
MC%5<V#!$P-&2G%:;:^F2[_O%SF1MD[#(R-WP5D3SI*M>G`;*?IQ$P[:$Q(76
M^,PLJM)MVGD5U$%XLTD"^1;$"]'D.77H.[Q3K>D9^D:>&S#AO?[N]#ME%7I?
MT_>O.TJ>87\2Q)2K94*R45$S9;C-FF@_6@(4"<(61]C#GWO)U59>)NE7(5>P
M@2"9:,\)[N,UV<G]HO0JOYZ29F4RMDV<(U!'A>^_FPIG7LS_-LN+;CPWX]3)
MG"`>4O!1+/C'F'4STJNKX$].:=8)KM.I34+<M:#,IBP$@`BXB=8XH'Z0Z-OY
MWNF+AK$\+.5'1%*>K%^XMZ=!!9,#$$N%3:F/),.U6INZ=L)8O#]?5!CB4H'S
MP(\Q7,F,1_5B67_@6@DO7[X8LPXHOW%Z*EW`\B@S<TU@W)UC9!QM0.1,()TQ
MX%S/<9WK%V#`=F+!5I4TO(RIKLY-[2R_""P[IU/:7/?FV+@^P*EPW-Z1J&6D
M,T#@410/1_[6*E`8XOQDZ>N!P3!;%PIA/<ED%J$!*MC2T)9B1X&/B#FAR)WA
MBQ,*UZ]$(CE>T/-=K`"0H";`!*:%(<7G?K!CEH(@O>6E]?X%@2><^Q>!C^A`
MR_!:0FP"B`]<D;>QJBO"!T_@:-/K&6+YZ6U0WYM1>'A/:"KLQMRPEW4R.E74
MJM22T;)G(A_OFS!?+LWHA9U7+X\^[^[NHFI0#&1>-@P8H!QQ9^'>\RHGY;UK
MDA4D]R$9/:XO7_="5,YD+\8\QH7S<8I+]>KR8?/F#\TH^V&5H\_%,7*HM9E(
M5+OH&R$BPV*#LVP^L8HH?O8(FQYR[!(G8;311N8%JJF%AMQ/E2Q)`T:=SM7S
MW(2EZ;5YKY!-S\EU5)PJ5.'VB[&XC'#)[5J_E(CSRS&$_'R_"+$7B/169=?-
M;>"K2NZN`C*Q6M'ZLR^!%Z_L"Z2$M#D#N3XF,'GQY[6M]0V3PR8OMM<!P`\Z
MUI'^V"--N'QASQP9!C949L>R&R2'B/@H/#+4H>RT-8X\BCP8VF*@+6@51B&8
M\R)\)K6:E)KXQ%T@/TNV_A=G)GY17P1RHB*#O,3&S:E=N,>*NQS/B`G`4/8*
M<W^'LY0/5@%:KJ\J?1S3V#*VTH5H\_\CXVH_M0P=<^'3,`!GN;3D8DDOQ;QE
MC=E*/.B"R286335K9S=SZW/RU[E%/8[&+R;?Y.<J*4J2D-U11KD1?7K&D\8?
MY:Y$?&D8Q"F;H1NH=\IJ?L^7LW<W<UGH2.(@03T;'044^Q#AG5GQ(V2Q)&N;
M7:$Z!UD698A4TC0S:;S7.R='NQ/PD79(IEQ],47O5CS[WZ#AF,A6LUWWG\87
M8Q4@D$%`CD6]Y;@#\?SS&I=8X=?N/KFT.\W)^,\]%8PW:%>SZ(4^H[2$-01Z
M>;=$0KTHINI>1D=3V5%<-#7XT[+RH?QJC:0"F*3@L;JN?#M#**K:C`!\[Y+]
M3?7ZR]F9TGE*U>CXKB<J<T<^_:3Q[R.2'&"^<4W4N]O8T4;5*91_(>"^#0(Y
M8>,3?/EHM^64A%K6!=\W'F[W_+J]4<6ZI0J].EK%Y?DZB3JX^EZB437;UJ.'
M3Q[5$U*\"H-8]?;&,\)`J\J[Y7U+,^>B3BU@0WEZD1H*L]OZ6JDG5@8-8N+9
M6X(:--(\MM""IG0O1%1`@BQA"VC8VOX-%$S;K(,'#V]F:SJ/BY[N161K/'ST
MJ(IL'3UZ1AYG%;(ZVJ8@_[-GY;GHUAO$AW991\!-?;784Y]L5LUC1N3#;:Q7
MD;BCC4</-S>J)42P,AC+86H(GBA[5&>7C#8>/MFJKMW`716@>]:^_?#99GU,
MVP\WM^H-;3W<V*I`<V*-Z*6:MX&_XR&XW&W1=Q3PEZ">B+_E^9<`V,&"H`4*
MLO)6=YZ;G<JXI@!$3/77Q!4`6F?G*NPA.Y>Z^=Y]/R,K3[#9-A1S"#9OBN`6
M$/.X0>!Q8%:/D0V>?Y$^"T$DD,#^%3"CNXS[,+<;+Q.\7Z24>95PS1VFI&`$
MEF,T;\L&O#C_VPPM"NF6("VE)4K,O55%%00$R$)DN'TC66B?/C*+L->`K#A%
M>?8GG!#B2BB<V27[.KV^B:J[Z8E4WS*`]WQN"=B<''X&-1#732)"#&&_-2V#
M^H:3`KK)JY!AH(2BFI)CA[VY^1'!R-33\GV-Y$BW^+TT-8S#0MS+@8Z5I!#B
MO2=0/%XRLEV^]_+\!TAA_^++VO=V6@<<^$TY2L]YQ/+QB('EVS8$386(J%#L
MV6YJ*U&].2+SO6ZDPJ_;3RM:D$K3+QGP<0_E>MK;$@5RO5V14`^G3^??7KV=
MSH)=]WVR`M4:;3Q^^O#1TVH=1+5N4FZ@HK>"N'JJ9A17]N-2[478A@;4Q:I(
MYLPR0G7L/%IG(6:Y1=V]?\+5?EH(G;DBDDAL.6D7[842;MCM9!25>84<&/WL
MJ#OX"9$08GJ04/D2@D.0P1S\CL5!1-V2OZJ$T)(`C4W"C$[[E->YU5545&].
M6TP2)&%<)@+:<0:)$X>#9(9F]-7^P1[53TYS<E#)D/_]?_ZK6%OSPZ>+?[N]
MGI[._N.K:XB6"H%\]?M#E<Z-KI-8$JB3EVW@.7X[5ENU!]1@;.MG6CQ6=(ZD
M4%`1#:NM\_&<8@RP%7!5\DBTBN&6X5)O,:"9NX1[V%P/Q2\^7)D#Y2/%L^@_
MQ\]/_[WY-7:QL6Y9"FB"ZC63NEO96HW8N9W%HS?L!V`"JM[9JQU)S,U?:9>T
M?Q%SJ7<YU`K@84]BK`WAG`<X,/!ZX(4D'VP\SBV$?O+$Q^0,:L7S?&G"JU\&
M)JI0*6H8+)"P<L2NSDK`#??%!P*>B@W?&T#ZCVYKZ]_M/`H@::%:'KO,:A+#
ME0.,`M"/-IYF,;?U+0?ZL%326!71!5F=&NCDVZ2"M))_(N8+4D`2/&`BJ5T:
M`/Y<0IAP?8:RX5802S0%/#,)Y(Z<0TH)QA!G3T4)(1TQE45AM4+1F#0A/2EF
MF;%(I"8W/X*A6='VF%IQ&@JSAS0.Z<)7%^=";BA!Z+!.J5NM':%5Y(V0'BC!
M5PQ*3-3L["N18`)%F%/*H)/O\?&D><*5E!=:TM7=RQA<B\B%Z_9["F#<?CR_
M#L4.^+$M<8#C-Q6#V7JZ&85,I`=UW.K6@C%LP?2#!'=S]<F[5'OY,[F([4`B
M5K1S<FO1$7C;ELD$-8E,]*JX5@XPQ1.&VU"L(+N7@&]AN:RSK9FA:L\H\B$(
M&"<$K(P1"6;A*VLDL6;E%7B'(A_T+E;EFW9)IZ;?F`LB[\Z,\'UQKM@.(62K
M_!HA,>`)7B:G?-PD5Q3T`Y_HMFOZ.O5N.0P+M4$(#B9H%_EO9I]PG3A0:K[(
M:FVV<B+`W2Y-$5:JO1.X/_%@$H\MV-N*P"<@E870P[&LAV]W72J\*`P1J;%F
M*X9U7/:/ZL_"?8F3@D4U07]("9/O,8[<=#GTNQE%>$A@#MI,OK4'CSM1^@RN
MS3IWZ-UJ=:9&PO@([`C'HF0>N9D4(FT7%KA20+9`OC"?>B<G5*HV&H>U33VJ
M+O$'JO.V(='?-O>D[G9W@6;KF@F)!%^AXP'&V$\+>`OPCO>H5&NU1I[9EJ-8
M).?\,Y8UI\V0#AZ-K95)_""=!77OA*F(O.:8`!(B,XW#7(NQY(L$Q9*JWZZ2
MI62!`=3^&6LL&&5F]6W?;D?(/WH8HCL=><.UMS=CAY]VDG\H=3BO3PH5C/'\
MH&8:#EDY,UQS\P\V.ZR*&6V.#(9G($5`.!'BE;9E5&G!O=B9,RJ+%N>J5MI2
MD0==5L:"'S_)I0*MEB5Q07.5L%*H9TAC2-L.X"_15D6WC-P!VOC'H'N67R]R
M[\)R.[$`M,42X1!W8Y7K(ED^/;\YG7\2K&`_H3N\RG+V%(A5?4L-UN8K1V;1
MWJNXL=$DSH-C236A6)15MX)27'TOT@^,*=@.B3W`AA2'9)(QTA7'<7ILK77"
MNR7P^;;MHSE9$J$%AND#3"4#3#3)A$Y`684,56W*F46HG*Z-EM,LY;O'<`\U
M)F"O^MZ14S>2$?>N9@*)XAJ[F)NHJ?$<YQ8BU\-&HEHJD@9CW6@T>QX.-_KJ
MR$J<OY".Y&9MW<"#S0Z9UE=ES8A<4%;4)08I("7GA08<ED.J($D8+P"=R)8>
MMG#20YE=G(M4N?3NKW>P.T)Y2\WK(PC[#+LLCITMES,\R[B`H1'99$.%8Q[V
ML*(H/83.3#CTLAUIP?42XP6X,K),#=QX7"E'*)QY'I8)`@(5=5H];;D[*U&C
M4\<>%A;G!4Y;7FK"2)1[N+DW,-@+XR'6)%4A@4%<,`G$"8RCN7?:NA;0(39*
M*N$`(3*1P)A1X,KM!\N1J$W5+1$0XI1Q4+`ZEUR5US4G&_*],\I>4:Y6%@JX
MT#T-XDXZ-BD2.%D[\._D6O9;4BC>O[?B[(X+[-XT#21DC+E+]W_2(HKGJB!7
M"7E"R7VQ0.(]/\S1)J08P/JD)LR)NI'0IPU0*YUDC-LY!)@K3]=``JX(86NN
M)ZC83#I1U0FI/CY=P%5M)U%QN<%9BF;I&R<`6$3S8<.VL8+;.?AA*J]Y>F<_
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MYQ%VQ90YI*J,9]$K8,=K7@$#]FA!55P$P`_L"$S0R?\*?-G>['3=**X+DJC6
M/DRUR@/.HF9VOPX7TK-@D=XY)$D8@8(>BYZCG9UCPFFS9Q8I_VAI('1*$LW<
MY]4V+.<[9N,MI2*OD9[(0$62O%-UU:R1IRC$)(31D/)J<IK`POLOVG),ZG7S
MAYY$4H"\3@WA<VB<KY,3!V<$E>%O;HS!]4-&90@-GG/Q)]E`7('IGTD_=GDT
M(P%6YAYD]RR+O\X)3R5-2ACNT2\B!`($2;U+SR*?6HL#P.5M%[:Q**<`D%2M
M_5*5R41?9]9W`OKZCAF$"`E]'*&B``.>B9I4AGT77G-CN=@GVV!6_G&?FT[R
M?8\%J\N48&QN39)=J(EBC=0X4L?NH/(&^.F!CL4Y57>8[A7H'!)=UT%`7Y;Y
M(GF>_(P)P>T,(WYK.[68,X"ZQLRC7LD?PY1!%M/8JU9DH9\0!4=K!K&8``8N
M9B68&8M5B,^?3'\@'0":>R1#!S'*(#<[E9W9;*+1*0RO26VPJ#+!\ZV@:K7(
M%(]GB91AXU(2X>9*!C9Y3]&72$T5630^'SJ'FL'1.5?H,6J-GZ+Q(/E4-H3?
MYCBH'FTY9'ACM*2/M6J]#E1`=3']'AH/J4MWG_Q$'CA-HCZ]*BP=5UN/P`^V
M:XCX%$;8GH:-*91TMWIU+80VO=X]>;VS?W+<C/?5-F#_9'?_U<[^9+<OVNFQ
MBB[<XXO2<'J2$2EAR/NI(F/@L*(-%"(XOS:.8OT&@S5O2':/Q\U)8+V9A-Q7
MH(:S0`1/(X>Q8!*2ACA;.JY-\?5[=2V5DK^14*FDL]`D,<560->UKO9OQ@8W
M:*F'A3F(\PJ6T*!W;<D"?1/XB%U,).]P.B5X0Z?4QPSU7>6K,:R&V@E>%V'T
MU63\&MTQTZ!M![9"!Z363Y=WL!30MHO1&AB(R51LP<E_.A(]=,)/8LF:13-Z
M]X',SJ_VIM`]`]<:HND0:!P&.GLQ/Q-O4W:AJBIP&MQ!/&4=JS&Q1:>L>NJ,
MX/UY;NN`-("&LQ+:_>ZW=[__W6]OSW__._UW]WMW:JN*G&J`^SG%O*+RW06@
M"!F[LS8&=H_QZ(P!")(X6$6'I.,+$!5*IK0>9?PYG6A/#=3]14/IJ,R6!$Z*
MV-2'6]1A[;K0*@P^VCG9/;(B*<WQ^"VX>]P<[O6U"7ZB:E(KO;O@J!*;`#::
M[?6-T=^^\8X;3G(D^WV.O2R`]U;[57EPG6*LOH?$\L:,9#J/`":N,62C8HR-
M/1[D?Y!]#O'9)3\AM'F9$+BM;:6UW[$AJ!0I82#&CE`6W8]=LI>'REW#'4)?
M3#/=%?*3)OHT)2?QT?IO^)^[TX^24-*,)B6!PCXOT79`/)D:[5)E&G?K(MGH
MQ$]]VSP/>D8.5-IYMEGC2/2WS6TB_%F7V\U^^34`ZGAG;V=R0@N9/[X9']%8
M>N\OS<O=_3$<8;S7O!B?C)O1F\LI+>,0\*J@C-'&4UK+_)P1_KAA?+U$WS]N
M]O^\U?_S=N_/*HF="`VDW[.1T>Y"JX1@<ZEVY70F-/HN5[:/+4BFT/+WT<:3
MAUM;/0$P!(YN5/$OHTTB!;?KJ$*B3]<?5X,\GZKTLPC,&6GHDK0EAYE!5KL)
M+.96[L!J68#45M^/VWT_5O&=(SZOHAS]SJI5^IW5/]N=U3_;G54_$S#T\%'/
M>?'SDR?U1H@47:\72#32PZ?KU;JUF2JR]_C-Z]?CH[\T!R^;X]U7^[LO=R=$
MGS3CR>3@C0E'S>'!WJ[D(PJLX72FNU9=8OT^@YS(>M4SQ.E';!9>`>4ZRP*S
M&Y<*E=]R$):L2L\E!DKS5@;NG*3(01A!D;D@Y\\L/`KP/)VBUSI3)^X3>NO*
M=]M84L[!M;B0$F[4>NIHYSNZ3^V^W6GV#HXYJ*$]ML7\71XVS1A[F[>/!*Y=
M3A$YIP$D%%T;#\KO2/#^C319/;:(^G(I+\>[1\W;\=Z;'=(HQL=OG%$N6$]V
MYJTE*3A*,J=-YJ+Y9#4KS<)0D0#@Z`\[)^/G>SO0Q,F;H]T3@YKEA^&MA,RJ
MV=;"+#=W>'1PN'-T\A<3W'?^^&;W4'(\MHB=D^$#SS:(7`NQ*(7O<I;=_9/Q
M_JM=[6%\?+P3](17!P<O_K2[M[?21%4<7(IYRF\:XDM,UM^#A5*T[0.&-BG$
MY9)`Q:,W,*B=/ZO%F?!PZ$2SW3+5S1R`"ARXNJN#D^]VCH#6_5=K,+W7S=[N
M^/GNWI(;R\;WZ%`\P1_6),Y@*W031D\@Z5"?MN%]M&C2B:4QU17UJ3R@X_9]
M!)U8`-P_'?PFVXN]>8^JRY0W3J0*9(FEB[TX9Y116IPQI2(*@ACH"/F-^ECL
M0E/N*,^Q&3ZF;!F))-AD@6)(RXX2V$I)-N4R\HU*2__?2^Q8M))D[VH)H>U:
M`N:`;6@1>"[4\%<Z_%];+RT/XX2-_O^F%=]+R%[IUFY-MX)$!DL2&EO+`XGH
MF#:C^:#@OS\^@;M*:'K^YGAW?P>F+WO2P=N=H[>[.W^B<(N*L%[`KT=OCE\T
M#RH9>ZMYC4;W\;:_M#GE7+ZE+J_;_,KK)].:AS3YD%6L?)A_60F71)ZD8:N'
M^;#5PPFM@&4XOB7(&+L5%F]L0%+[SE`8;_[&9A6Q/<R\I378UTA:)J`%VPL&
M^&H']Q!(XRF78^RG-F"MC>=V]L'<8^6[L3O=3X150)PQTD)7<(6B;[L/\">O
MLEQ^-^F\A"F^ZC91OT$'9@Y-#C:-7P'%?<3HL/5FLQIECR`0EJX<N61C+!=_
MN)(PM',;&WIP;3C:(*.$Y95C??W(+3SE[P?JQ0NEFM.<5GX%@Y;!%4T0:M4K
M?'C-7V_UST-EQSG6*J:0V2)-T/S4O'936;FPKY_<>R#ONU<-M+'>/]*77"3E
MSP=H!6K\:X^>QT0[O[0^;*8H?"_[8ZIC6ZZ.9.UOFTW*=T`GJCR<$$)4?H-U
M!^`G(M-3,-`!B!B6I1BL/9N]NRO?)]0NTJ+U9^5#RQWRF`#9C&+4TJ0-PRV_
M`&/ZYNZ=VD**$?<\$70Q8AUZ?5VM(F\"U$H2(F119):-6G)DN3C1L"P>S.+`
M8O0`QC\$/QJF47[(W)"G&-G5SMFU3.EPLAP;Z<NU@&%]KYS]2T!JNZ(-VD.R
MF_0:3`[_7]>](T\8PJ9)&TF[VDTT*VC>ST,0/OX2B:%5LULH/@%LY9T67V$A
M%X1J@/[WW[31B*_DW1GMF4D`VRS,.S)A@IB@A'<H8DGO1!$HIWX9H!6DQ`T`
MM.X2-E"1]D&#PK)#?JG^1?*+*Z%%72[Z+09C#[PP3'D_8R6D,^3YMKVCT'(!
MK>L<YN(6G')K,8=.(1R_[,BVJ[>VJ]?9KN`T[7[+U;@QM94L@W4%0&DUQ/*;
MX7GV5$J@J:CYL@\J>6[`5+/L6L=NM.":)GC:RF6W3^6'*Y]Z]FD!PA7$56\)
MQ&N9(X/W5N@4Z[JE\+O`"(+\#M\<N'2SIM`FK!2>W:UX$P74**FU7.)"$].R
MLWDQPV:G[$@%EQD_R2P\40\O9UQF;EHV*4PPYEP&7-+,KP8L22]5566V)BE.
MG"A]:C!9+FV<F27#S=K>RO<$"4:VS*=8CEI=<+5B11/=-:,=%8A&U/B05E\Q
MKWP5\4#-7[ETTE:0#0DVTYZ[T2;N,=+>^?O*V_`U0;7F[2P/Z>N-C?X'NW@%
M(0[#UU(7M5C^23E[;4%<!E<+S8/+/MYH%NFVA+1$D;%67_.'%='*'U8D$."8
M$Y8`777?;!:B)CO8N^"1M&J3D3P0"UK1@#`.L&"EM?FW?Z3RC`^-PQLX^@(L
M.H'/6TVW^30'52!+;?!1.8J;58/]+A,NXUJRK528M<J=H2X.R45Y!=R\NL@Q
MN<OH<13.C(4ZRT6/KQ4S`DGAG[_*?T*!=6))@QLZ3Q>X#6.5(YS(A,Q92?1)
M]4#+E]Y<DR;81IX0=9&B8=&J@[LRI+$P#D+\\C'=]GTPWL\M-K::O:OI);43
M>XTWN:FD`D0B'!)\5P[.U^=GD^EUN;-7.Y-)^5M:1/D@`"B*V8WZ.0T\ME9/
M'@BC0[7#N&!+Y>M'LQ!!HN//]"'#IO+E%C>@DZ8C*7\LC2#6(T'G(@8'$;Q7
MLVX8@'V:*#CL<N$2S7_PW<'>BYVCXZ\;>7YP`BTUL(VO925S$UIU#<<RPH?V
MZ0R)1:OV*KQVG3](L9Q.)F@(MMNH,TPYUHG[G![/6'=N/\XN%!/T(31[9'\I
M*K<\4:P>BHYRI\`YO@1&4'R0J6:UDU2<$B0[G<W.0M)L)`PX`-)`Y23#7X5Y
M):]XU-3W:`Y$:,546J*8(6N7'\H1#ZT0M.0L&X$^/]9!/(9W$UA:?C&1S-Y,
M:,L1`Z_M#LK7(#82VR=K&\O>G."4Y18(JKP\DUVO'*DU`7Y2A#J9J<E)D$*W
M@'<,5!;E)@@\.O_PD;!XF`)F*,7K$4UJ/R%,0FS4V`P!H04(HU96'\7C92S3
MGF"817=QW.8L^WRW'E`T:*R"K\2\9&`P:`]LG!`SZ^9P#:83T*'&700<77VO
MI52;Z=E(OLA$>LO-E(<ZO/K5+ZZ]F.L$"PZ'%/HXY=A3!41AV8RH\X[-QB!-
M"\XW4*ZSG<->5VKVA<?\X3[W^HKE)SLQGL^!0DAX1F$&&LI+&0<[SFM[;3O-
ME\/8,(01LF]!7C>>JL>6=:^Y_2H_`LL9#<5ZRKU]R;4-FT^[$-E9@VM=5@-"
MQ$$7Z*<=]+&`>7(6E&M<?51NAJQ\T)YK,0)UKWF&O='+Q-K=W`P;@JGL9!MY
MB^YCF;6O("^?8^R@#DK4OZ]0WX&'[C8'>7=GB9$?Z-8H;`^``91B8EK$/:S=
M]&(&$[%@X3B07DK@+AYH8-6"X,K,M6C-<1SO3FUZ]8Y5/V!ZH$T_2^;_XG'#
MALU]]27CA*L<=Z[2^WJWTA<I]Z%K^`+>_B>LQQ]E9Q]C`J<7'7VQ0X3QH;$I
M$*2QV4K,B4=T#P#)*=NM.%*E:^>PLOSMN%0'F^7O=R!H^>L#.QR^]-6'_&*X
M6GV*E4%L^9`5C!RE^A.X3C!VX@5#_#Y!]?EY4++BU[TW,/3MEQSUT%BKG&GY
M;?13-D]@J.9[?PSE_K'2H\=G!/MBQ.,@SX<[TKM=%ST(^5C1J6[LAA:[+',5
MJ/8L('$',RIL2_=*[Q7#?6LFM`9?46I',J670DD_ZIHQ>&`YGZ&7@7`':*O6
M,OZ`GF^EI9=N+I=%LK7]G"'#`J5**G3)BF-"Y_6SL8FA5?MU((RD.'@$1+ZY
M#.GKF;%@T4JKBPA<U8ICN,97ST$:0+Y6##S9;*@1(0:K@L=--PDVSR(\4K.L
M#R`[A)V#F>,DM6L,#.L+1(&W+1P8$-6JYK))[\7%T[%&WN8<\H7@V\#5G2HC
M3MM5R0J$EBUGT1DLIZO9<2Q_>=E2^D]F^;@3V@J<S7YHCDCHLF(;:ICMVJ'0
M`4_=]!6J.;\^L5]+>.+!=K-S?'C8^W22&0B`3UGB(`2YX+E(##N,JIEK1WD4
MBT25((*B?II,;N*8T2T/#FJ)HQA&1V,`A&=T7.,S/:IN,1H@@D,TIK:0K$\D
MN@EMD<!*"*^4"I.7"+)VPTHKD,E`V7-\+J25#Z(AR!&E5#V#9A.FT'D:[;Y=
M=)KBSV:-B%S"/G&)5L<0+%.:"C^%62CHXKYNF3=Z_OG**@@8IRE7>_*1R]4`
M,<HHW,^B;P(WM?*]&$1Z;K>^3.WT5UA^*RIC$>F/NA&R2N]QTESN_^OM?D=+
M>>;E=TOUP@6F<V<^=AT+PH@7\B^\=W4<L9VZ<7*#EA1#+')PA@/S5!:PKKP1
M(*G<7=*9SLXM$QWH"#W9T::Y2NC!S-#)_6.#G_MD3@0^7RFX1?FLU*\)28F+
MPW#2*@:'"3;7Q<-\/>!D.R(&;^W]#3VLHWG:8H-67=WPYRNM*FTN'?&/YS/0
M</%>CG;>[NR3K['4GCV1,:KM>WY#<-$'+_0@3,R=+((.T5AICZI=Y1YI:`E1
M@1?-#6[:S^<W<U6%5=_!\JI?74Q_N"I_/.*CF_,JB"2Y.C:>/:L2B_:\,W/K
MSZD$[0E^+FP8K*^9?#R_.",0!>OI=U>WUU1FNU`'7ZNP,L&Z6R?#AG[/PUZI
MPZ.7Y390H3-;:NS=HJ;G$1NPQ5]B8_?6DK)$![MO9<_N#I7@#6SJ?M_G8CP,
MK:EC`\L!^7!RL+<W?GYP-#[9/=AOQJ^.=BSOE?R/UE)5'_*0SVJS6>24#;UD
MRP,;H,"9J[#\0IT*R]^\3USY:VBF5OZ<=;8J'UF/H/+'/,IQNWQ8-IRIGK?%
MH0BLJ9T(&=)A^T\.T`J2]Z^(S'J/?&$T-`>L@;L%?&2L\[JG<'2O>-!B;7(^
MA[&@UP%HA.T1<(+KKMP5P:*P2!5IC+Z]LWEU*8<A)/+3],R\&L3.=%HA*28A
M!+-`.KPK3SE1-TVEA<I^KRD$\C[=4QHK+$?"^$K-4W;;.E31U9]U?4&P%),S
M.=3)H?E*^LRMBP<J3^#HU\F*Z6EU4L[<\\H25M-[6PND&KD-V_!YBQH5:U$(
M0E]!F'*!/9]WJJA7[Z>8_;ZB0<''BN2!2O%%-8/*^12)E@((%L55()JIF:3>
MMHK-PD`1^>[9P"LN@ZTA%C$L9PQ(#SJ%F2U4C#^SJ&([9B:PZ&*K`N%>GZ+F
M<CGTRU#"_J=4M\>OJ'SO9,7+&WK/"T=G=0Y("8@%19%1\2+?5I2F7=M!L0MY
M4_-BK>5JQV7-TO*%X:$MLW9!I=7AD;"V<_[8G!"@/M1R1SME5,A_PE4=/LFJ
MGP]/8'4\R\<*<\1+F34=\:->?KP]7Q)M2Q0W@8ZQ!XP%0T:PU*EWZTR7BVGW
M:&O%%9AVV'\HE-E,P<9PO$#F/3_(IS6J6\YCU3GM_3I@X/A.QJ%E\+PD>6\9
M2SJ@L[M7^O,Z8+]T19ERPZXH(N?BM)))AY(U`P+"0.V27/;KY[+16@$_]X(A
M"D?%ZYW5Z\`VD:OXE:UMA\*<5ZI/9;5`EKP<Y[ONR-915;W]&G.(0!M))"\#
M')Z'*<IC>KZ\?$CYR3WS`Y<!AIA7"/OW8+QROGN4I,CU?HLE*,WVO[V]O?O]
M_P@```#__P,`4$L#!!0`!@`(````(0#^\QA[ZP(``%`)```8````>&PO=V]R
M:W-H965T<R]S:&5E=#,N>&ULG)9=;]HP%(;O)^T_1+YO/DD@B%`U=-TJ==(T
M[>/:)`ZQFL21;4K[[W=L4\"!LE(N(,'O>?V<8\<GL^OGMG&>"!>4=1D*7!\Y
MI"M82;M5AG[_NKN:($=(W)6X81W)T`L1Z'K^^=-LP_BCJ`F1#CAT(D.UE/W4
M\T11DQ8+E_6D@Y&*\19+N.4K3_2<X%('M8T7^G[BM9AVR#A,^7L\6%71@MRR
M8MV23AH33AHL@5_4M!>O;FWQ'KL6\\=U?U6PM@>+)6VH?-&FR&F+Z?VJ8QPO
M&\C[.1CAXM5;WQS9M[3@3+!*NF#G&=#CG%,O]<!I/BLI9*#*[G!29>@FF"X"
M'WGSF2[0'THVXN#:$37;?.6T?*`=@6K#.JD56#+VJ*3WI?H+@KVCZ#N]`C^X
M4Y(*KQOYDVV^$;JJ)2QW#!FIQ*;ERRT1!504;-PP5DX%:P``OIV6JJT!%<'/
M^G=#2UEG*$K<>.Q'`<B=)1'RCBI+Y!1K(5G[UXB"K94Q";<F$=!OQT,WG,1!
MG/S?Q3-$.L%;+/%\QMG&@5T#<XH>JST83,%9919!?4YG!BFIF!L5I$-!+6`Y
MGN9)//.>H(+%5I(?2R);L3BA&.TD'N#M&"'S0\;S;$H,.2!GSY;L;#5^;B2C
M`\G85BS.*2PTF.<0[7WE4T$9@CGVB`.`W$@275O?]8,!WYO#%AQD>#F<"AK`
M3>S9<R,9:[C(UQ];L3BGL!!A^U^.J((&B*D-D!O)R-3/'EN<'K.PDH]@J2`;
M:^S;4^=&<AKK])B%-?X(E@H:8`VV4VXD9K<%7ZZ&3^J;PQ:<:G8')\GYIU2)
M!U#AH%9&8G99F(Y/[K/S&@LOO01/B0=X@Z+D1F+P)FDX2B;1((/%H20917$:
M!WL7"PZ:UP7%T^H!WO[H-&?<5G.6S]*\`6AZHFD9/5Z1[YBO:"><AE1P>OGN
M&)XF;CJBN9&LUZUAR21T,GU9PYL+@;[ANR"N&).O-ZKG[MZ%YO\```#__P,`
M4$L#!!0`!@`(````(0!JY+;,=`4``$P6```8````>&PO=V]R:W-H965T<R]S
M:&5E=#(N>&ULE%C;CJ,X$'U?:?\!\=X!FUN(DHP&6KT[THZT6NWEF29.@CK$
M$="WO]^RRQU?Z*3)RTP''\JG+CYE:OGMK3UX+ZSK&WY<^606^AX[UGS3''<K
M_Y^_'^[FOM</U7%3'?B1K?QWUOO?UK_^LGSEW5._9VSPP,*Q7_G[83@M@J"O
M]ZRM^AD_L2.L;'G75@/\['9!?^I8M9$OM8>`AF$:M%5S]-'"HIMB@V^W3<WN
M>?W<LN.`1CIVJ`;@W^^;4_]AK:VGF&NK[NGY=%?S]@0F'IM#,[Q+H[[7UHL?
MNR/OJL<#^/U&XJK^L"U_C,RW3=WQGF^'&9@+D.C8YSS(`["T7FX:\$"$W>O8
M=N5_)XLR(GZP7LH`_=NPU][XV^OW_/6WKMG\T1P91!OR)#+PR/F3@/[8B$?P
M<C!Z^T%FX,_.V[!M]7P8_N*OO[-FMQ\@W0EX)!Q;;-[O65]#1,',C";"4LT/
M0`#^]=I&E`9$I'J3_[\VFV&_\J-TEF1A1`#N/;)^>&B$2=^KG_N!M_\A2'IT
M-D*5D0C8JW4ZH_.$).G75@)D)!V\KX9JO>SXJP=5`WOVITK4(%F`9>%9!/'Y
MW#-P2;SS7;PD7P5T#^EX64=T&;Q`!&L%*1"2^YZ&V(CR$T1\A@1`[\P1/+^=
MHWC)X1B=S4LW"H3D,F'"K])X8!&`P)@$K@='@"&(IN>)LS%"8@.2V8CR&L*B
M!D:F4Q/@E0]>ZJ2D]L8%0N8RJ23-X]!);&D":#S/-7.+%]3U=%X"[/#29C%7
M",F05Q0E<V(3+TU`DH>ICKG%*[V%EP`[O.;VM@5"8LD+HF&OEM;JA>K.;F$D
MP`XC9\\"(2I2&7$"65K+)-3^6&$2G<N0A>L5+\`VJ3BT`U$@!$E%84)&D3(!
MH&GD0K!`4*;S$F"'EU,U!4*05YYGCD*4YG)&PPLU14`PI[.2:(>6<\@*A4%>
ME,ZI$\_2!D3S2#.W\D@<?;^>2(EVJ&G#>!`5!BN>Q+I^Y')I+<?T0AJ)4-K)
M]271#BUM6-%"[<:(S7/C^"M>%]?M>`GAG4X,9=H4U%C7B"*&&%7Z<1;F#J(D
M)@)N!$FLJ]0F=Y/8$U1J,'Y6^]A5>X4!Y!GCZL55B$WO)LT7]R?W=#I[%PKS
M<0QBIQ9+M8ZUF!FAMWG=I/ED+/IND1<*@[P(:*RCP:4-"/-4GU^;FB/^$Z]?
MXRX0.PP*@A@,34Y'Q]1<CN9ZV:9W4QL@XSZ0:+_5:4#,U8(S6T&2Y%H;;6XW
MM0(R[@6)/F6*FZGV-(Q<\J4R\I'V=*Y/LD6-WM0/)-I6MT3[C-04YEK8%`3)
M)9EQU&UN-S4$BI=T4^`2YQ`6"H,;I_DH:O9Z%&D-LHD)@9ZLO!3EW"+FM@2%
M06(TBT*G&$L;D&>IUA^;FA!H@]JT4TI1UBV*NF!47A%CYC71\9&84MFY@+&)
M`L@D>KW;4X&VOU02'0%%$#'FY@ZD5&8^A]CTG`8AXIA^^;$I/FZ=1I%HO5(T
M$6-R&,?Q*L8FZG0,032#U[^(Y[AS)*XL4\2@+(\NP=9JJNO9)N?TC"](C7N%
MT8Q4]!"C3G!*QQ\-U$1$,+G(+Y%S.L;$HS+N'*FKSM1L"S1-G1(H[?6+EP%Z
M4]N0:%N;TY$VFVWC+HJ3='0=4&8PP'<TC0G5A6$E5\Q>II]@B7;HN?*L,+AW
M1/)L=/^T$'F291=R"Q,VB]NTW,JW'(YZ`RQ`A<&I0_39'=E"?'I'QN$=SK9:
MUNU8R0Z'WJOYLQC,4?A`/S_%H6%!%@45LQ_G>0G#1/D\."_`+.]4[=C/JMLU
MQ]X[L"V8#&="$CJ<!N*/@9_DR.F1#S#%DW_N86K+8+84S@"\Y7SX^"'FC><Y
M\/I_````__\#`%!+`P04``8`"````"$`:#0S;S0$``!E#P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970V,2YX;6R<EUN3HC@4Q]^W:K\#Q7L+`;E9ZM1XOVW5
MUM;L[C-B5*J!6`3;[F^_)T21')Q!MQ\:S?GES[DE)OUOGVFB?="<QRP;Z*1C
MZAK-(K:+L\-`__O'[,W7-5Z$V2Y,6$8'^A?E^K?A[[_U+RQ_YT=*"PT4,C[0
MCT5QZAD&CXXT#7F'G6@&ECW+T["`K_G!X*><AKMR4IH8EFFZ1AK&F2X5>ODS
M&FR_CR,Z8=$YI5DA17*:A`7XSX_QB=_4TN@9N33,W\^GMXBE)Y#8QDE<?)6B
MNI9&O>4A8WFX32#N3](-HYMV^:4AG\91SCC;%QV0,Z2CS9@#(S!`:=C?Q1"!
M2+N6T_U`_TYZ&U<WAOTR/__$],)KGS5^9)=Y'N\V<48AV5`F48`M8^\"7>[$
M$$PV&K-G90'^S+4=W8?GI/B+718T/AP+J+8#`8FX>KNO">41)!1D.I8CE"*6
M@`/P7TMCT1F0D/"S?%[B77$<Z+;;<3S3)H!K6\J+62PD=2TZ\X*E_TJ(7*6D
MB'45L<'[J]WJ6+Y#'/<%E>Y5!9Z5RM,N@+-E'/"L)K\<AWL5\>HB+\<!*ZMT
M!9Z5*T_'$5PGP[.:_'(<!-I(5A4J<Y=Y-A)#]DC9<I.P"(?]G%TT6,;0!?P4
MBDV!]`A(WYI-MD;5?C_K/F@[H?)=R)1BT%@<5LS'T+>\OO$!;1Y=F9%D(`L5
MXWA=E1G?&-'50GB"!Z9X8(8'YGA@@0>6>&!U&[B[9JF.K6_$S;%-;<"`7%8)
MA1PV$FI#\1ZOWEO^Q"PU?YZK>C!J(K9*C)N$XSDJ,WG`J,3T`8%]F349&U5R
MWD0<#W7$XA'CJ^XL'S&!RJR:#$K-^@&!'-XTD9J_2HEA3_P?)1:S8"NNMS]!
MU1E)!G;+:HF@E(U;B4DK,6TE9JW$O)58M!++5F+52JQ;B<VO"*6LD':EK+]>
ML8(>Z-`T5:D<"VT:(\GXY7[H6J;:M>.Z-?"1=:)841=,ZT:K2U`KS^IFV^VB
MV7/%3`A:*XNZ&4Y^:+$M%7/71K-7=7.7$*(&O:Z;";%,E+)-W1Y8[GV!**6"
M(\$+I1*T6BK?0MO,2#*R5&^69;K(L;$*V*2+"Z8`)#`)VL"G*N#9-GK%3`5<
MW\2%4P''Q#^Q"Q6P/0]59XD`!SNY4@"?.`X*<ZT`3D`L](J-`G2[7G!O(*6&
M<#)3:BA.'NT_E&(6KN7]!>698209MUQV;W!(1FD<8[L?*'^H-2881ZMMBNTH
M(3-L1^[,L?W>\V4X"VQ'^DML1_HKQ0[71M1VZQ8[7'5$RJ_I)!UB*=FZ)U]6
M5UYKY!DSI?F!CFF2<"UB9W%EL:`HU:B\38U(#PYD<*Y"XRNX997C1F6`6\XI
M/-`_POP09UQ+Z!XDS8X'+9?+>Y+\4K!3>9C:L@+N-^7'(UQG*1PHS0[`>\:*
MVQ=XL5%=D(?_`0``__\#`%!+`P04``8`"````"$`M1I\/NX"``"+"```&0``
M`'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6R45EUOFS`4?9^T_V#YO1A((6D4
M4I6@;I,V:9KV\>R``:N`D>TT[;_?-0XTD(YV+TG`QX=SSKWX9G/[5%?HD4G%
M11-ASW$Q8DTJ,MX4$?[U\_YJA9'2M,EH)1H6X6>F\.WVXX?-4<@'53*F$3`T
M*L*EUNV:$)66K*;*$2UK8"47LJ8:+F5!5"L9S;I-=45\UPU)37F#+<-:OH=#
MY#E/62+20\T:;4DDJZ@&_:KDK>K9ZO0]=#65#X?V*A5U"Q1[7G']W)%B5*?K
M+T4C)-U7X/O)NZ9IS]U=7-#7/)5"B5P[0$>LT$O/-^2&`--VDW%P8&)'DN41
MOO/6R1*3[:;+YS=G1W7V&ZE2'#])GGWE#8.PH4RF`'LA'@ST2V9NP69RL?N^
M*\!WB3*6TT.E?XCC9\:+4D.U`S!D?*VSYX2I%`(%&L</#%,J*A``GZCFIC,@
M$/K4?1]YILL(+T(G6+H+#^!HSY2^YX82H_2@M*C_6)!WHK(D_HGD&M2?UGW'
M7P5>$+[-0JRBSF!"-=UNI#@B:!IXIFJI:4%O#<R],ZMC\/HOJ^#1D-P9EHX+
M7"@HS^-VY?L;\@B9IB=,;#$W&`V8"6+7(TR`AC8YNT%`[R`:HC@7_7H9>FT&
M/-86NNY$VR5F,4;L7D%<CR'))62Y'"`C_8O_T6_`T#!GN07>)+G88J!^0[8O
M3^ZBW+V)2.80(_7PF//T3<LLX)6:KX+9%&&(:%"X\B<9QQ83^ET#N8X7#.E9
M#W8=/@>.B<MD#C'R`*_=N8=Y[08\U3XI?FPQ@_:I=+L\)WT.,9(>CJ6_+WZS
M:6IAHC&VF,&".[&XL^MS'N80(P_+L8?Y^`UXJCT<MT9L,>&I<R:-M1NO3EX>
M&!R&O]_[LFH5VZ%@S\R:R8+M6%4IE(J#.?`]>.)PU\ZB&&91=W*380%F04L+
M]HW*@C<*52R'K:ZSA)I+.TWLA19M=U+MA88IT/TL8>@S.`M=!\"Y$+J_,/-J
M^!NQ_0L``/__`P!02P,$%``&``@````A`"$3@+]J`P``A`L``!D```!X;"]W
M;W)K<VAE971S+W-H965T-3DN>&ULE);;;IM`$(;O*_4=$/<Q!YN#+>,HMI6V
M4BM550_7:UCL58!%N^LX>?O.L$`X),2YL<W.S\\WL^MAUK=/>68\4B$9+R+3
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M]]4._!1&0E-RSM0O?OE*V?&D8+L]R`@36R7/>RICJ"C8S%P/G6*>`0!\&CG#
MHP$5(4_5]X4EZA29<W_F!?;<`;EQH%+=,[0TC?@L%<__:5&546OBUB8+H*_C
M[LP-/<?SWW>Q-%&5X)XHLED+?C'@U,`S94GP##HK<&XRTQQMKF^E"CFBR1VZ
M1.;2-"`+"?OSN`F=Y=IZA)K&M68[UKA]Q:Y18`'1=M]9L("WA892=*%?WX:&
M#<7(UKAN]0)XM[#S`<@KBD5?LA]+@J"5]&#G?5BL\.+-L]-`XTUP2CJ,H6NW
M_E5UMEH#F];F\4)0*7;O*O93BEX6\)CK2X[BR'2K@^#:SJ!V6QT.==CW?=L>
MI+;3"OA\*[7]E*('#J6^'AS%'7!O4'$=#C1XZ,_'X%HQ!3ZEZ('['P%'<0?<
M'X#K<`V^=!9C<*V8`I]2],"#CX"CN`,^.,%;'=;@3N![8W"MF`*?4O3`\77=
MZ873;07%'?!P4'$=UN">[8RYM6"*>TK1XX:^>STWBI'[Y:_EV<-6K35UU?U@
M#*\%4_!3BAZ\`V_CZ^DK]0#?&72/;2VJ^>TP>*7#U)JI%"8E_1SP177UR8%)
M9;@%H>L,SD\MJILD;L&H2?8E^-<82G`HPD?5+@.)3D$//7HFR*DXTAW-,FG$
M_(P##?;P=K4=MNY<?)L.UK<XA%5C5!N`&:@D1_J#B",KI)'1%"SM60`]4.@I
M2E\H7E:3R($KF'ZJGR>8=BG,`/8,Q"GGJKF`!UOM_+SY#P``__\#`%!+`P04
M``8`"````"$`MJ?@5J0$``"V$@``&0```'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6R46%UOHS@4?5]I_P/BO8#Y""%*,IK$T]V19J75:F?VF1`G004<`6W:
M?[_7-B%<T^(T#VV(CP_GW'OM"UY^>2T+ZX753<ZKE4T<S[98E?%]7AU7]L]_
M'Q_FMM6T:;5/"UZQE?W&&OO+^O??EA=>/S4GQEH+&*IF99_:]KQPW28[L3)M
M''YF%8P<>%VF+5S61[<YURS=RTEEX?J>-W/+-*]LQ;"H[^'@AT.>,<JSYY)5
MK2*I69&VH+\YY>?FRE9F]]"5:?WT?'[(>'D&BEU>Y.V;)+6M,EM\/U:\3G<%
M^'XE89I=N>7%B+[,LYHW_-`Z0.<JH6//B9NXP+1>[G-P(,)NU>RPLK^2!?4]
MVUTO98!^Y>S2#+Y;S8E?_JCS_8^\8A!MR)/(P([S)P']OA<_P61W-/M19N#O
MVMJS0_I<M/_PRY\L/YY:2'<$CH2QQ?Z-LB:#B`*-XT>"*>,%"("_5IF+TH"(
MI*_R_R7?MZ>5'<R<*/8"`G!KQYKV,1>4MI4]-RTO_U,@TE$I$K\C"4%]-^X[
M_CPBT<S,XBI%TB!-VW2]K/G%@JJ!>S;G5-0@60#SU9G2T7O]R"IX%"1?!8OD
M`A<-Y.=E'4=DZ;Y`3+,.LU&8Q+9ZC(\1VRM"!%#0TL$/+NCM14,H=-$!)/7]
M=%PUBDE88Q!@`9MW(!BQ?0<18@@=0^*XAR`;`;8Q+5^`H6X&X0L27;_"0!K[
M$-_N+".Z-2+H%`*IA]M\/@EBTLJ&$-T41EH9;!1F+LLHC,)Y'SQE83CL^XDV
M3-%P$-[(D7A8=KKX\,,%?:T@,0FG(([T%"@,B+@9U/0;$70*@5S,QB[,ZT!,
MTE.@U?!&84*9`D_3?QW[T"&=0B#],=8_O0`$&.OVB:Y;8::B;T30*012+[J[
MMG6::TA,,M60PDRY,"+H%`*Y@`U9=V&N(3$)YR*.(EPG&X69^:J(G%CK!UM]
M'$^GVO#LMLZ1?`+[_N?URUFZ@1E6L.E`-P>WO43M1"8`'0'Z.V`/HL\-*FEZ
M'1#5%8=[:.CIP>]`J(8BO1G<`Z(&$#8B>M_`B'B:,!<341US:"B.;NF6L=YT
MH"X9Q/&_/8S2H7@ZR-Q)\"?X]J!MUE0G#8>DV)EHBY]WIIHI=I;T1=`Y4Z!.
MMN\0#WW(4%-7=V@&<9!L":$$07PG09P>(L5&H62&1@VU*-#:.III#6-#%.BZ
MCK#][>0H_6@4:Q8-<Y`<@V;57H=)"9+1^IGJP5T6C!`JWA$@/&@5]O:Q!=$S
M[[>@.BSDN'_*&#\,DJDVW%DP0N@D"[8@&N?`PIV+7[7;83;BT1,A4:!8MA)_
M%FH5MD7C)"1:-JD^?MLYL`/1-`<.#'6D6NQ0>9",>LA4'^Z28(10,@7!%D3;
MO-^":K*&.E*@]XNXLV"$4#(%01;@11Y9N*^.Y"QM)QK540=2KQ8D\;0FLT7C
M\[G>+M!P$MRJ4.E7QP?J[;ID]9%M65$T5L:?Q=$`@>+M?U7'%ALXMI#O^&X_
M`*<&Y_3(_DKK8UXU5L$.,-5S8MA(:G7NH"Y:?I;OLCO>PGF!_'J"\R$&;\V>
M`^`#Y^WU0IQLB/,.^?*__A\``/__`P!02P,$%``&``@````A`,8Q'=$2!```
M]0\``!D```!X;"]W;W)K<VAE971S+W-H965T-34N>&ULG)=;KZHX&(;O)YG_
M0+C?'!64J#M;D4,RDTPF<[A&J$H64$-QN=:_GZ^M(%2V9<V-R->G+^W;KZ?5
M]X^R4-Y137)<K553,U0%52G.\NJT5O_^*_BV4!72)%66%+A":_43$?7[YM=?
M5C=<OY$S0HT""A59J^>FN7BZ3M(S*A.BX0NJH.2(ZS)IX+4^Z>12HR1CE<I"
MMPS#T<LDKU2NX-53-/#QF*?(Q^FU1%7#16I4)`VTGYSS"VG5RG2*7)G4;]?+
MMQ27%Y`XY$7>?#)152E3+SY5N$X.!?3[PYPE::O-7I[DRSRM,<''1@,YG3?T
MN<]+?:F#TF:5Y=`#:KM2H^-:_6%Z\5+5-ROFSS\YNI'>?X6<\2VL\^RWO$)@
M-@P3'8`#QF\4C3,:@LKZ4^V`#<`?M9*A8W(MFC_Q+4+YZ=S`:,^A0[1?7O;I
M(Y*"H2"C67.JE.("&@"_2IG3S`!#D@_VO.59<UZKMJ/-7<,V`5<.B#1!3B55
M);V2!I?_<LB\2W$1ZRXR@];?RRW-6LS-N?,%%?@>:PIDYO]ORO(N`L^V*8O)
M3=&Y.<QK/VF2S:K&-P7R%[I/+@F=#:8'RJW)W)+.]I^Y#G93D1]4A6F!H00R
MY7WC.N9*?X?A3>_,EC/PC8ZQAL2N)>A84EE?#.S%0"`&0C$0B8&8!^"W:X<S
M-[J6Z.!+9PZ,OFB.#7D\GH&M%[32T`O;[N19O[8<Z5LA$+L18C84\9\1UQTB
M^Y&F#(E@A!"^$SXCXG>B$<29#[\4<\:Q67;8B[GQZ/+`<_O9\]E/9WWK.:U$
M/6\S9\L#;'5BEN_$@"\&]JW&(R]<1\C08`(33F"B,<81#!MC%ATS\`Q6IZ_G
M*:TT\(P'>IZ)`5\,[%N-OF>/<67.!Q.8<`(3C3%"PL=CS'+<,\BIOF>OYS2%
M!U[Q0,\K,>"+@7VKT?=*F&O!!":<P$03F/@U,\@OYRM>41CVVM[Z.C.%?FXY
M`Z/5K<'"2.ZDA"\E]E(BD!*AE(BD1/R*&/CL#GVFF[%\OZ&5UBHLKP\OW<=^
MQC<<SKSR6TKX4F(O)0(I$4J)B!..Q3820Q.6F_B5P,!L>DT03CYRLVDET6SQ
MH,.95V9+"5]*[*5$("5"*1%)B9@3W7`\YO'`;#CK],U^O=I26#19V(FWG%FP
M)+!L6UA@=OUBTW!=X33B]\N7IOG8(]A\V?>++=L0IE/0+S:-A5@>]LN7IE@<
M\>(7"0+7*NK`.,%]Y=<F?I0O47U".U041$GQE5Z)9N!+%^6WM:WIP5D8#DAB
MW/*V[/HDQ'>6MQN+^Y8'>QOHZ%T%N'5=DA/Z/:E/>464`AVA"8;FP@Y3\WL;
M?VGPA1V,#[B!^Q;[>X;K-8*COJ$!?,2X:5_H![H+^^8_````__\#`%!+`P04
M``8`"````"$`,8]59-D$``"%%@``&0```'AL+W=O<FMS:&5E=',O<VAE970U
M-BYX;6R<F-N2JC@4AN^G:MZ!XGYS\(1:ZJZ-B*)8-34UAVL:HU(-Q`*ZW?WV
M>X6(D@5#=&ZZ<>7C)UE_0L*:??^9Q,HGR?*(IG/5U`Q5(6E(#U%ZFJM__^5^
M&ZM*7@3I(8AI2N;J%\G5[XO??YM=:?:>GPDI%%!(\[EZ+HK+5-?S\$R2(-?H
MA:30<J19$A3P,SOI^24CP:&\*8GUGF&,]"2(4I4K3+-G-.CQ&(7$H>%'0M*"
MBV0D#@KH?WZ.+GFEEH3/R"5!]OYQ^1;2Y`(2;U$<%5^EJ*HDX=0[I30+WF(8
M]T]S$(25=OFC(9]$849S>BPTD--Y1YMCGN@3'906LT,$(V!I5S)RG*L_S.G>
M-%1],2L3]$]$KGGM6LG/]+K.HH,?I02R#3XQ!]XH?6>H=V`AN%EOW.V6#OR1
M*0=R##[BXD]ZW9#H="[`[B&,B`UL>OAR2!Y"1D%&ZPV94DACZ`#\59*(30W(
M2/"S_'^-#L5YKO9'VM`R^B;@RAO)"S=BDJH2?N0%3?[ED'F3XB*]F\@$>G]K
M[VF]\=`<CEY0@33=^L*R<-/I:^;`>$GE/B*XJ%3^3V^J09EP4>E8VJ`WM,:O
MY,;L5Z."BTIGJ%FF,>E;TA3KW*[2?2<H@L4LHU<%EA0,+K\$;(&:4_:(RG?N
MTGTF_-=$@!G`5'XPF5(,/,YA]GXN+*L_TS]AQH4WQN8,>'MG>B*QK`@VO9BL
M@P,K''!Q8(T#&QSP<&"+`SL<\'D`_MZ[;ED#L?/[BF&K#))[SS#8+F2X?455
MB62TF,B188A/LCE33R1*];*%0-UUFHAEB<]9-?N"GN-*B;64V$@)3TILI<1.
M2OA-PAJC\>Z;S(,03(>5](+IC&:F5_/>YH')/;#$`0<'5I5&?8H.14/=-@:9
MOFYCQJ+.IHV9B(S7PHS11-ZV,::HLVMCT'O#;V/0?-]W,X)Y@Y?,8[1@'@_4
MS,,!!P=6E4;=O)&8"/<)9OT$LWF"\9Y@MD\PNR<8O\F,#&3POIL1S(.M\(65
MQVC!/!ZHF8<##@ZLL(:+`VL<V."`AP-;'-CA@%\%:G-FC!;\OH6Q'O-*R-OH
MI;PQ&HYX]0UQ_!`N-V^;,V#=8],4I_122CA28B4E7"FQEA(;*>%)B:V4V$D)
M7TKLNPC!<.LEPQD]5V'_>Y@Y1EN'S9E1>?PS--2Z[&QUZJVFAE[>*][:,95<
M*;&6$ALIX4F)K93820E?2NR[",%D]GF.C_<#>"MT'T+97=AL=`:P.=-AR5)*
M.%)BU22&$]03M\F@J;>6$ALIX4F)K93820E?2NR[",%Z^#X0K.^VG-'8<G2D
MLSG39;F4<*3$JB+*CTAQPW#K;7T-]6]=;VV\?S;U5G3(].IM:`_=UML:;Z:=
MT"KVUJ_::N],D=A7!!OKX[F"C:R:(?C(OM#[$.SVL[P-&3I!YV_[!G4Y*D<<
M.;*2(ZX<6<N1C1SQY,A6CNSDB']#^'[8TQ[^EL<C5LUC2ZX]^7P*\&H=K]<D
M)#N1)8GC7`GI!ZO$#6&CO4=YE=`VIU`B@<](%'?-*10UFG&[-[7+:A[BE[WI
MLBWN]*9P_F45COL-4`2\!">R#[)3E.9*3([0-5A]L,EDO(S(?Q3T4M8UWF@!
MY;_R\@SE7@)E'D,#^$AI4?U@#[@7D!>_````__\#`%!+`P04``8`"````"$`
M<>_:#&0*``"B1```&0```'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6R4G%MO
MXDH6A=]'FO^`>$_`%VR(DAP=X[L]TFATSLPS(4Z"&G`$I-/][Z?*51CVME,K
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MN=E7HK>%3E*!I[K^(='L66X2.T\Z>\>-`O\^C)ZKE]7']O2?^C.M-J]O)R'W
M3)R1/+&[Y]]A=5R+'A5A;NTFC76]%0F(?T>[C1P:HD=6OYK/S\WSZ>UA['BW
M,W_J6`(?/57'4[R1(<>C]<?Q5._^IR!+)M4&L7401V2OV^U;>SZS9MZ`**Z.
M(C[;*-].023;G(?X;'<>?!Z>#N)?!QE\'F)J-:F(SS:5;Y_'0N\L/MN=!Y^'
M)8:14E4H<PGSW3.9J#'2#+EP=5H]WA_JSY&8QV(4'-]7<E6P[BP1^CS8U-!H
MA]]7HT^,&!GE3QFF"28&UE%,F9^/_L*ZG_P4PWRMF4`QHA=:9N:[E%F>&3D4
M9>"0;XCXAIAO2/B&E&_(^(;\O.&2FDT3*\[$.;'R:L-$]&7;H:(/.QWJ"/'Z
M9^^Y_^1>M/\<AV80]""46':)F3^C3-C#4"+J(7R/,G&7<9B221>9^3X-D_8Q
M<\ID?<R",GF789U7]!`LX;*+7.5+)!9K(I'8+*VDQ1)\->Q==TI/(%",6"7;
MJ<&Z:@F)$!(1)&)())!((9%!(H=$`8G21!`Y1;</D%/2#V,Q6%JI7)>O=(HQ
MR0F)$!(1)&)())!((9%!(E?$O+DN.-.%QQ?7ZW9KX2SXU"3MGCV]M!,A1:$P
M0$A)<R%98H%BQ.%;L?F\A$0(B0@2,2022*20R""1*\)OA'07-EO&"M)L.ZRO
MRNMFQW(NLX:H*"JV`2I*FJIHV^QJ%2C&I"(D0DA$D(@AD4`BA40&B1P2!23*
M,R%+O?D7\U'4W$1)65OB4DCN117U%WQ>*L:D*"1"2$20B"&10"*%1`:)_$Q(
M-6XL/@$*U:RF[8WE\O:2[.Y:7TQ,Z2_P6P4LI]R+R\FJLT`Q)CDA$4(B@D0,
MB002*20R2.2*4'HYHH9G"UIQW6[;]I05^>5UN[683B\U-5EIQ:T8$=1<QTJ:
M"NFZ;(4/%&,2$A(A)")(Q)!(()%"(H-$K@@]\?J4)$"?E`0P:"G]@0%B-CA5
MT^=E5Z`ADYP8"3$2823&2(*1%",91O(6D<LMKX':QB]KQM*(D!EJ29>!K[FN
MJ*/,4[79C=YS^@NV2`0:,JJK3`X#$N(H$49BC"0823&2823'2(&1THA0C:7Q
M<*TQT%;Y%-<WH/Z"72`"Z>2)Q=H@W!(C(48BC,0823"28B3#2*X1SV[N8*:W
MW+4J<(S2B%!EI04Q0%GE6%PKZ\YXY6LI2%]2Q+6?WTPO&>%8W&T**2$N*A8;
M/Q$C?,=A><2,\.935@LDC)A-;4:DC'!\GQ6&&2=F/-.<$G-K-NLLR*3'9@O+
M9D<I:0Q1U2PN!B,55$RH(8)*G%YD75[+!9:"C%,5(B&.$F$DQDB"D10C&49R
MC9P'NN_SX5,P8FI-V2`M*6'-;.LB/1566A,#9JIR,LA,]=BX"^0C.[0&0R3$
M42*,Q!A),))B),-(KI%S46Q[E]O-YI%/@6.4-(;E.Y<%C.HJ;8H!NBI7@^IZ
M&3)->H%UMCZ^+/"6&`DQ$F$DQDB"D10C&49RC6A=>]Q!!G3]00I\[1!:TJ\8
MH*JR-ZY5=9Q.-7SV0`RJ0B1L,C/671%&8HPD&$DQDF$D;Q%YK\.-HX*T^E<^
M0S-52M+L74UT.DFE77$MY_=\0DNY'->R=HU"#1FOKBJ.`0EQE`@C,482C*08
MR3"2MXB4M6L8ZF8UEWL,0[+[EX:A)<V+:V'!G8WR.JX%=3U6,P9-3.,,6V(D
MQ$B$D1@C"492C&08R36B%.MSF@C0YS01P.`TV<.<I@:G17#7:=*080XN,1)B
M),)(C)$$(RE&,HSD+=+G-+6-7UZR2B-"%F&;.TWFN=K@U&%R?5;(!1HRJHH=
M)APEPDB,D00C*48RC.08*3!2&A&JK5A2!ZS#ML3IC'5]=FL5:$BM-\)<G%V>
M,337_J4&#.*'&(DP$I-,/'&?R#))<(P4(QE&<I))3Y\4!.A)M30>A&HZS%NR
M>[PE[K8$&E*:VD)2)OI2`T9-U8$,2(2CQ#23J<<?`"<X1HJ1#",YS:3;)P4%
MNJF6QH-0346O#9FG$N?S]/(H7MVMV@I2FGJ6XS.;8JD!@V`A1B*,Q"03U^E\
M32/!,5*,9!C)228]?5(0H"?5TG@0JNDP9TE^M[JC*;]7U9"N]1;\KFRIVXV2
M0N<IPE%BFHCML<&7X!`I1C*,Y#213H\4M+V3:&D\!-5SF*-D]SA*_-NT@8:4
MGI;GL`O84K<;]82F5(2CQ"016WS5GWY--<$A4HQD&,E)(MT>*4A[-]'2>`BJ
MYS`OR>YZ2>[5UX3UFGLVBF35[O''#4L=PRCG.<*7I7V$H\0MTG@W_%NJ2=O\
MY4%2C&08R5NDMS\*TFSS-,NVN2]-JB4WDL`]3-=`ZKF'49">F[[M+9@CL;2Q
M?X21"".Q1G0JCN]T'KGA("E&,HSD-)6>7BDHT9-L:3P,U768CV0K'TD4HNVW
M=EV?K:F!A@R3<(F1$",11F*,)!A),9)A),=(@9'2B!!MY1<(!]2\#<YKWLO3
M6K7^:DA-E!MA3[(":JD!@_@A1B*,Q"P3=\XLD@3'2#&2821GF73ZI&!`)]72
M>!"JZ3`OR5$>$/%]^:UGH*&SIM</$Y3?H`&CIM!LBG"4&&62X!@I1C*,Y"B3
M`@&E\2!4TV$>DM/G(?$U6$-:T[G/"^.E!HR:J@,9D`A'B6DF"_'$@U6^.$:*
MD0PC.<VDVR<%!;JIEL:#4$VYA_2]!V].CY<T9[<*@89TL>(Y"YLM?4M-&)0+
M,1)A)*:IV'/+8]>#!`=),9)A)*>I]/1*08F>9$OC8:B^HF_)M?6;^LK=V#5V
MSJK>P%&0GKN6-^^ZA1HQ"JRB&)`(1XE9+HX]YY9(@J.D&,DPDK-<>OJE8$A/
MNJ7Q0%3C8?Z2>&]!1]L%LP0##:G?Z]VX/==:Z!Z%.H9161@E1IDD^#`I1C*,
MY"B3`@'RE1&RZ_M[1&FJ7@FA?I^_JPZOU;+:;H^C=?TA7_<@O[3:;E6OH@BL
M._%C=O&;=+8]%Z^H:+9/V@;QAHCWU6OUK]7A=;,_CK;5BP@YO?5%5@?UC@GU
MQZE^;WZ(_E2?Q+LAFO^^B7>!5.+'^--;`;_4]>G\ASCPI'V[R./_`0``__\#
M`%!+`P04``8`"````"$`2@M>YF,&``"Y(```&0```'AL+W=O<FMS:&5E=',O
M<VAE970U."YX;6R<FEUOZC@0AN]7VO\0Y?Z0.`D0JL)1H>KND?9(J]5^7*?!
M0%1"4)*6]M_OV&,@X[B.*1=M(:\GCV=LOS'N_??W<N^]\;HIJL/<9Z/0]_@A
MK];%83OW__G[Z5OJ>TV;'=;9OCKPN?_!&__[XM=?[D]5_=+L.&\]B'!HYOZN
M;8]W0=#D.UYFS:@Z\@-<V51UF;7PMMX&S;'FV5HV*O=!%(:3H,R*@X\1[FJ7
M&-5F4^3\L<I?2WYH,4C-]UD+_,VN.#;G:&7N$J[,ZI?7X[>\*H\0XKG8%^V'
M#.I[97[W8WNHZNQY#_U^9TF6GV/+-[WP99'755-MVA&$"Q"TW^=9,`L@TN)^
M74`/1-J]FF_F_@.[6R43/UC<RP3]6_!3T_G;:W;5Z;>Z6/]1'#AD&^HD*O!<
M52]"^F,M/H+&0:_UDZS`G[6WYIOL==_^59U^Y\5VUT*YQ]`CT;&[]<<C;W+(
M*(0916,1*:_V```_O;(00P,RDKW+WZ=BW>[F?CP9C:=AS$#N/?.F?2I$2-_+
M7YNV*O]#$5.A,$BD@L1`KZY'HR@=L_%D.$J`1+*#CUF;+>[KZN3!J(%[-L=,
MC$%V!Y'//4..2U\_ZRKT401Y$%'F_LSWH!<-U.=M,9U-[X,WR&FN-,N^)J**
MU5DA2@%X%T;H>9?1G/4SBA`+%%$%P;;$#R#VA2W6[FM0)!<)(8$,=4E$MF(8
M378BT0AT'8#I++W$1TC4)%T-5:QL"L((0;J,=C8AGON0@$MRIK,9O?,2-:DL
MZR24+ZI8H0)^7J-<%(0-1GN73>0O^70>G2LJ&E'&-`PO\3%_J$DDHU[>\[5!
MN@FELV=.B'4JIE&A!JDTXM7YVB#5]!8J(:94DU";9DO4F*LEL[FR*4@]A<%I
MJ\?P?!"-AN8#:FR,-@5AA%7I=D;1B.8Q[>41->;JGJ\-5I?!\M'%LP\ZJ:9<
M2:*/.B6R)<\J(=EC8E&^N<2RU5"-E<C*B99@EE!.L8C?SHE+?W?]2T-M_5@R
M%'4AQC,MZ2N#Z&J`E%2LY!W2@8KCND\)K^Z$JQ^SF0-.::N$\D%'NWQN)L=$
MJ\&*HZB;R6N2%*=-0CG%NNZ>1Y.+C+7U6CS302>FTD:B$&P&7E2S4AIS'RB@
MYB>.B309RX1"+!F*$)3-$B.HL\,PS6(<0?M>DX9:.9<R-)B\\=%`5=S9;=B7
M[$:V&AR9-CM1G#8)+;QF.0,SO.\U_6<PAB(U,M/86'!GTXEN,AVIIJ:3AOH#
MK!(A8#(V\2F)>2R0!$9?,AW92N?4'V:5R`R!A;9***=PALX2Y#9Q(O036+.O
MC\N]#8$263G[OG2=?I3S)LN)^I;3'Y!*A/6>3*?&@MMLB0)"/[N)M,^82*CU
M0O<&)(H4H,33EW(5QYQCRG>3UXCMN,['M)LOE<A\<S40,8Y90OF^9#41.L3`
M0+39B.*T22BGYC0#=>X[C&$@H@CK'./"J.5Z%3E;3*19S``@6@)Y.&/:D^%2
MAK1;H%5"$ZA9B^.*@\XP4&B;?:A"VR2$4^P"W2>T5-,)W2^T$F&AQ\SL@4KD
M,&5BS6/LE99J2I@R?6.M1.:;8P:M$IK!+WE+[.(M2F3E=/:66"SR'0\<R"-:
M0G?&&"J-(JPTBYG17.1]/YM6-)/0T2ZAVYR)12N]XOK64(F0-`F-S^%*8\XV
M!=5<QA'4Y#;Z#C%&$8).S#L;I7$!U>QFH.9H#]V:ITS?>L4V#U%SQR:AB=1L
MQC&1Z!+V53*V68GBM$DHYTUN$YO<1M\9*I&:.R&#DR)XT>WC2HE<*JWYS4"E
MT1]HI:_/I#(]R_AL(N*8H$>&%Q7^1)M0)'G)318CU70Z)XF^@"N1.2]87*N$
M\FD&XS8($_S&RSX(E<C*B7',$LHIEOK.`N[(*5K1?*:A/A@3%)T'H]FRE<B%
M5/A"A]0^&!-T$3H8]5V"$IEOKBJ.<<P2FDG0=/D<,RE:#7T_D:#(#*$X;1+*
MJ?G,0!X-_A+JR[<XQ8%.J$HGVKQ5@*@Q]X$":O[BF$B#S_2')(KP-&MF_!X%
M3I)%7VR<>%*,!ZDEK[=\Q??[QLNK5W$*','WAY=/+R?4#Y$XD]0^7\+)M3SF
M#2X7X.#XF&WYSZS>%H?&V_,-A`Q'4\A>C4?/^*:MCO+X]KEJX<A8_KF#?Q'@
M<.89CD"\J:KV_$:<J%[^Z6#Q/P```/__`P!02P,$%``&``@````A``&N9,($
M!```9Q```!@```!X;"]W;W)K<VAE971S+W-H965T,2YX;6R4F%N/JS84A=\K
M]3\@W@_$Y#:)DAP=0-,>J96J]ISVV0$GL08PPI[)S+_O-B8)WHX8\C*Y?2S6
MVML7/)NO[V7AO;%&<E%M?1),?(]5F<AY==SZ/W\\?WGR/:EHE=-"5&SK?S#I
M?]W]^LOF+)H7>6),>:!0R:U_4JI>AZ',3JRD,A`UJ^"7@VA*JN!C<PQEW3":
MMQ>511A-)HNPI+SRC<*Z&:,A#@>>L51DKR6KE!%I6$$5^)<G7LN+6IF-D2MI
M\_):?\E$68/$GA=<?;2BOE=FZ^_'2C1T7T#N=S*CV46[_>#(ESQKA!0'%8!<
M:(RZF5?A*@2EW2;GD$"7W6O88>M_(^N4+/UPMVD+]"]G9]E[[\F3./_6\/P/
M7C&H-O1)T?T_K&"98CETSO=T1_9"O.A+O\-7$RT6.FK/;4?^:KR<'>AKH?X6
MY]\9/YX4B,PAH0ZZSC]2)C.H,,@$T5PK9:(`0_#7*[D>*E`A^FYNS'-UVOK3
M13!?3J8$<&_/I'KF6M+WLE>I1/F?@4@G942B3@1>S^;W:/:PR+03@==.A$1!
M]#0G\\4#5F:="KQ>53[+$9J:M"5.J:*[32/.'HQC2"UKJF<%68.@KNT4.G:_
MME!4?<TW?5%[*=`2!LC;;K()WZ"%64?$+A'91'(A=+^T:-K[(@1S5X=0\<<=
MZHMLA\2^?^P24YM(7&)F$ZE+S*^$E0$:WL\P7%T-0Q=@VERJN[BJMJ6*#0'M
MNA)+FT@^)=(APO(.MQGO7<-;'^IR=?9D.XL-T?>^LHG$)5"Z=(BPO,/\'N]=
MP[9W@H>U0?KF"1I7B8M@]T.$Y7[QB'L-(_=HRL4&L=SC,>\BV/T08;E?/N)>
MP\@]FFRQ0>;M<C,CBRD>-N;W?CIL?8BPK.LGB=ZB.#Q=-8RLWU8!,U\-TK=&
MT)1.7`2['R(L]ZM'W&L8N4<WC@UBN4>3.G$1))(.$99[`KO/^.*W-/*/!D;<
M,?T`$9K8R1T&)QA$[`AZ*QL]?HC9^/IK9H06E;ACK`AH=B=W&">"N55?YH;8
M$?36-CZ"V0BM"&AEB8EA^O=VN^`R-W_=4\(08D?0.]SX"&8_M"+@%8BX>V:$
MIGIRAW$BN#(WQ(X`U7H@@J;MN1"A928FANEWX7;OML+)YTC:(8MV+2;!K=6V
M>[W1]1HP\MG2;(]6(Y#%6#_]0]+!%`99MA:?5M&<+&=()AV4L:/H7:\797A'
M(&:/M"*@%3/NF'Z$""U<R1W&B3!Z.X83VR,1S%[9CS!%:V;<*MI=F**%*[G#
M.!$^WY;-T="<6VIZ9'_2YL@KZ17L`,^9DV`)S6[,P=!\4*)NG_[W0L&!KGU[
M@@,]@W/&)`#X((2Z?-!'S^N_"';_`P``__\#`%!+`P04``8`"````"$`E44+
M^X4%```%%@``&0```'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RL6-F.XD84
M?8^4?[#\/G@#`Q8P:F_)2(D415F>W:8`J[$+V>ZF^^]S:[-K8<`9]4N[.9PZ
MOJ?NK;I%;;Z^UV?K#;5=A9NM[<U<VT)-B?=5<]S:?_^5?UG95M<7S;XXXP9M
M[0_4V5]W/_^TN>+VI3LAU%N@T'1;^]3WE\AQNO*$ZJ*;X0MJX)L#;NNBAX_M
MT>DN+2KV=%!]=GS7#9VZJ!J;*43M%`U\.%0E2G'Y6J.F9R(M.A<]Q-^=JDLG
MU.IRBEQ=M"^OER\EKB\@\5R=J_Z#BMI674;?C@UNB^<S^'[WYD4IM.D'0[ZN
MRA9W^-#/0,YA@9J>U\[:`:7=9E^!`S+M5HL.6_O)BW+?LYW=AD[0/Q6Z=M+_
M5G?"UU_::O];U2"8;<@3R<`SQB^$^FU/(!CL&*-SFH$_6FN/#L7KN?\37W]%
MU?'40[H7X(@8B_8?*>I*F%&0F?D+HE3B,P0`?ZVZ(J4!,U*\T^>UVO>GK1V$
ML\72#3R@6\^HZ_.*2-I6^=KUN/Z7D:BC0<3G(O"\(7)G8,`'PI,/G-]]$7Q+
MHX4GYR_'8.^\!ZS0<?#DX_Q@-O<7RQ6U>6=DR$?"\UZ$#IM6FJ6TZ(O=IL57
M"TH?)JZ[%&0A>1%HB/2P-PX)^UZ^(%%$Y(FH;.VU;4$J.BBRM]TB7&V<-RB,
MDG-BD^.KC$0P2!40V50',AW()<`!1X,MR/0GV"(JQ)8(*!;`Z#/0/`B&&)+J
M0*8#N00H'J#H/L$#48%%(Z?&#=6@8\Z!ZAORMU0IR4`9C!E(9B"YC"C>8(%\
M@C>B`H4+$SC$O0C7:N0Q(P7WS`V4P9R!9`:2RXAB#EXEF[N]U8FE0\C4@WAW
MS!`(6"")@:0&DAE(+B-*?+#.Y?C(F@]69/OE>^CD94^$U-@9$D#W'C.R=-6,
M)`-)&$P-)#.07$84.TO5SOWI)F0U9(;,6<<@VTYB(*F!9`:2RX@2'SG*2%OL
M_?@(68V/(_.Q'#@R%DC*D7#@9`8GEQ$E/MBVI\='R&I\#/$]NNW[KC?7LLV_
M]X?84H;,Y67K!UJ19'Q8P&3#4-NS<EE6L>/!&66Z'\I6#7'(GPM'"\V1((S3
MG9I0)J`EDUF%6JO(!8'*J!9(6YM<,AYK@K`-BO44<VA,BC9[B2",8U(3R@3$
MD[#6<YL+`I51+9"N-MT"ZX&*!0:-6=`[$MGVH11].0L&E`D6RX*W#+5DYH)P
M(PND>TVWP'J=8H%!8Q:T(U'B<8*<!0/*.`O6"SU8N9Y:CKFBHB:!M*CI#EA#
M4QPP")(@[>>NUF$3C[/D3!A0QEES5DQ>J.4S5U14&Z2323;8(76V!+@_5>5+
MC*'9P"*XL;.2E_$C*FN'BCL&^:MAX23DIPDIJA%*.12,&W!F0KDR4(V>-"XI
M^AM10NL=PF1M3@F30:0_#TW5]XP5/865>E-8&6<%L)-^_XWY(RUU%DA[G#X+
MK)DJL\`@6$QC3`M/ZQJ)QUGRBF+0@W8C!O+J=%=+;8)SP;BQUY'6*GG[L?KD
M_7F,//88)!5C8D(IAY3Z9`,E*%<&JIDAG52*_D%]LKZK9(:WX@?U.865>E-8
M&6<]JL\'6LHL^/_KU$#9ZJF!0P]6Z216.HF5<=:#67BDI<Z"=O#XH4HF2U0[
M(W)(KF032CDDE6UF0N2V:MRB6?3L]HG=:]2H/:($G<^=5>)7<K,$M;K;##"[
M]HK#"'Y0P'E)QY<1'.1-'+I`1+;]6]^LX!O:+S0M\!,1`^88N'1[HNM<&Q'#
M9=PM?NS#)=T-G3B(X"?V#?TYZ-\4FD?PL]4<$"\B^+D(N#-$!)=PE^*(?B_:
M8]5TUAD=8"I=VG1;=HW'/O3X0IOO,^[A^HW^>X+K5@0_I-P9;`D'C'OQ@;Q@
MN,#=_0<``/__`P!02P,$%``&``@````A`$T^#%5A%```:'0``!D```!X;"]W
M;W)K<VAE971S+W-H965T,S0N>&ULK)W;;B,YDH;O%]AW,'P_MG4^H*H&I4R2
M>5I@L9C9O7;;JK+0MF58JJ[NM]]@DA09_%D2T^BY&%=_C`@F_V0R(Y@IZ=,_
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M]]CM7K>D-ITG?09^V^]_UZ;UHT;D?`O>LC\#__U^];C]=O_C^?@_^Y_5=O?]
MZ4BG>T8CT@-;/_Y5;@\/I"B%N1G/=*2'_3,=`/W_U<M.3PU2Y/[/S]=CZGCW
M>'SZ?#V9W\P6=Y,1F5_]MCT<Y4Z'O+YZ^'$X[E_^SQB-;"@39&*#T%\;A.PS
M?:?6E_XZW_G-:'HW']`_'6D_"/IK8RQNEK/9=+Y<Y`]B;H/0WP\?R,+&H+\N
MQO`#H4NS'PW]=4%FPZ.L;!3ZZZ)DGY,13</^$/0_K/?D9CJ>+9;]M#@S%49N
M0NE_6->5GU#G/&D*FD[]7+PXC6[-=.ZOCO+^>/_ET_O^YQ4M.>1Y>+O7"]AH
M/:*`[KHP!W"Z4GYUH=`5HJ-\U6$^7Y.&=`T<Z.K^X\MLMOIT^P==D0_69H,V
M8VY1.`M]^>FP90Q$#&0,5`RJ&-0Q:&+0QJ`+P"T)=U*/!/L[U--AM'INW!L'
MO)R32"IGX5S*&(@8R!BH&%0QJ&/0Q*"-01<`)A6M>7^'5#H,K;W!1)O,IER;
MC;6A)>TT&Q?<I#B9G/0#(H!((`I(!:0&T@!I@70A84+2#>#O$%*'H8N>3M=)
MI-G\CLNT,4:3<TJ>3$Y*`A%`)!`%I`)2`VF`M$"ZD#`E:5A,R70NX)8X;=T+
MY@:Z,834<:0`4@(10"00!:0"4@-I@+1`NI`P,>AV/D`,;<W%,&2R]&(`*8$(
M(!*(`E(!J8$T0%H@74B8&)27#!!#6W,Q#`EG!I`2B``B@2@@%9`:2`.D!=*%
MA(FA2Z`P13A_F6AK+H8AX<P`4@(10"00!:0"4@-I@+1`NI`P,2C%&2"&MN9B
M&#(U=8'.<0H@)1`!1`)10"H@-9`&2`ND"PD30Z>]`]3HS;D<#DW]LN&07U9+
MA^8G*^&0MY*(E$/>L7+(.]:(&H>\8^N0=^P8XLKHC#'_HM%%0#11+)J&RABK
MJ3^"TEG1LGZZC4_F4;(HO)6[4TE$RJ,P5I1<5=[*Q:H1-1Z=B=5Z*Q>K8XA+
MJC/+`9*:1)02'!=[HY,=4IE):E$H*2#A'+V51*0\"L<\XRE5Y:W<<=6(&H_.
MQ&J]E8O5,<3UTQGE`/U,`DKQ7.S-R""FGT5>F=)9>200243*HW#,\U@_Z+'V
MCNY0&X_"6%%%VGHKY]@QQ/73>>0`_4S:R?0SB.EGD1>K'`$2B"0BY5$XYJCR
MJ;R5&W.-J/$HB+6(RH/66[E8'4-</YUZAOJ9K88;O?5T?-H]_+[9TQ)&2UPB
MOYC0EH+=:#`)+)/5(":K1:&L!DW\?!9Z_X_6@P!)BX(E5GFK0(KY,IZ6$*O&
M6$TRUF+$8[7>RLL:#HC+JI/84-:$?+1%>-+/Y+Q,/X/&)+V_ARQ@;\9:>?W*
M$2#AD#YAM`<TF:Z6HVC62&?C(RF+IK3TG@YA/(D<*V_5![]912>AQL@-HI:'
MB:Z/CCEPI76&/$!IDU`SI0T:TQ5^&N9D$=VMBY&U\KE'B4@XM.B5INU&>J`0
M"2:=C8^D+)K2*GHZA(32YA#(2BL]FM],IQ3]]+]HPM;83X.H]5W[:1T.E8NM
M,_`!8IN$G8EM4#2MHW2F&%DK/QE+1,(B-C\GB^C6+KUCJ&UT>E4J5N(,F..B
M'O49H$<-49C:=^;4;!"UOC-GU3$KKKE.]`=H;NH"IKE!T02/;N'%R%KY:5DB
M$A:QF3I91)>K](YG-3<]LE@)S4]61O-5U%GM.W-J-HA:?^#.JF-63/-Q7$)]
MZ*[81^&5E47C8$,&46G1Q%<9`I%$1X6H<LCO8]<.^8-H$+4.><?.H=Z1"Z:+
MH/Q)JB__J+*R2#\W\TO@*)ZD659EEI6P5A,ZU[_N46;%4EE655:/=5:L)LNJ
MS>JQNQ2+GVI=B0TXU:9P"]>CL4&ZUY/PDT64-A3.*K@'(!(.V=1FL;B;3:.[
MB70V/I*RB-TZ<.GQ5GKI6=Z,XJ4'(S>(6AXFBM$Q!ZZT+JI"I3^V"IG2C)T`
M@]@J!*@<&\16(4#26@6Q%*+*(;^8U`Z%JQ`<1.NLO&/G4&(5TD5:*-CYK%O?
M$.-5R*!+JU".56G#GX\EK-6E52BG1Y758Y758YT5J\FR:K-Z["[%XM>&+KT&
MG&I3J;&+P*#SIZ?0S31'SEN565;"6ETZU3D]JJP>JZP>ZZQ83995F]5C=RD6
M/]6ZH`U/]<>605,6LQE@*V6_`A5C0*5%;!DT5@&2Z*@050[YU:QVR!]$@ZAU
MR#MV#B6605V_Q8*-Y_H5JM0V#F&W#S$VE1\3R1:#M``%-^MHSZZPCG1,+KLN
M$0F'3'4\6U!]O(HR/.EL?"1ET84ZP5O9F_5H%?XOVCFIL9\&4<N#PJW[EX4R
MW0[Y*;AP)S)U)=/=EL`L25I&>PE%WP\M3SZU*1$)ATR2-!FO%J-5%$DZ&Q])
M670I28IJXK@DQL`-HM;WI<_>["::%AUSX<N#K@\_-MM-9<E4-TC?BOQL7T8[
M*\786ODY6B(2#IG9/A[=C5?3:!9*9^,C*425170!N*NK1JL&48N.';-B0NK[
M$@BI=ST'OG76Q^G+7J_A;!YIN+%69]]B\39NW"4B@4@B4H@J1#6B!E&+J&.(
MRSJL-)Y@:6Q1^.("HA*10"01*405HAI1@ZA%U#'$E1E62=(3@3A=MRA\BP%1
MB4@@DH@4H@I1C:A!U"+J&.+*Z$(H7-/.WSXFIFX*%S*+V)RQQ5OP^`6M!"*)
M2"&J$-6(&D0MHHXAKHPNA`8H8^HFIHQ!;,X`*BFWTY,ML!*()"*%J$)4(VH0
MM8@ZAK@RNFX8H(PI,Y@R!H6OP>CEF60(4(E(()*(%*(*48VH0=0BZACBRNAT
M?8`R)KMGRECD-V2+B47AU621OYD+M)*(E$/>L7+(AZ\9X@.,$_X+RP5F^1.#
MPJ>U#ODC*#WR=W9\K\5;N;NV1*0\"F-%6W>5MW*Q:H:X#,.2;KJVX7YB<]GP
M/%L4R@!(V%C!$VJ)2'D4CCEZ8%5Y*S_FL$<^YCC[O7#J,>6=&,1.O47AF`$)
MY^BM)"+E43#F993>5][*CSGLD8UY&B>JY\?<F_/',!:%8W;(CZ9$)!!)1,JC
M<,Q1]5AYJ].8&>)CCK/(#VV"T#H>3WF+F!3&*IC,I;6BC,4=JT`D72ROH?)6
MH1317G_EK5SXFL7B4L1IHY8B:WM#5[+1AJ]%_%G$,M[><%9^^"4BX9`IL^?T
M8)Z_0B*=@0^C+-)_3@4G/HCP5KHZGMY$2T;-`G.QAF62>H\E5L@@7A+#ZQ'6
M,=P`0B0<<J]')"2RO?E;H;).^L\YB8PC66F)1K.;J-2N7=]]9*Z1SO7R\P.Z
M5$`C@_@LBK=8"NL8;M8@$A:Q&3%91>6S](ZA*-'>BTK%2LPN<_34HY9N19_6
MX_.V]IW1Y<FE&Y9TTI("TAD43:_H_E!81S:]K*.?*<):13,E6G<EQE*(JJQ8
M-7/DRNAD,)Q4'UNP;4KI5XS-U"#:$'-K98&HM(C*!6<E$$ET5(@JA_SF<^T0
M;CY/A^6BO7ET<S:YJ-ZM]M<[O`E@'<];E5E6PEKI/9Q?]RBS8JDLJRJKQ_I2
M+#[A=(X83[B\VZ+)+L."9VI0M*!%2VKAK/SL+!$)AWY]6[2=^3#*^K!%,+%P
M&4>[<*76_#`R5TMGE[%:%&'8>Z]3DZ,RY0QBER>@TCJRR]-8!4A:JR"60E0Y
M%%Z>88]LW+-AN7-OSB]/B\Y?>$6659EE):S5A<LS*Y;*LJJR>JPOQ>+"QPG\
M^:)EAIFZ19>$-X[GK<JL6,):71(^IT>5U6.5U6-]*187/E4N#+[29U@Z6!1<
MG06BTJ+@LA:()#HJ1)5#P97N$-Z(9SHAQA5N\..</@X\SHEN!1MKI3?A3K?0
M*/$JO(W+24I$`I%$I!!5B&I$#:(64<<0GT[#BH49%@L6D51.A@)1B4@@DH@4
MH@I1C:A!U"+J&.+*Z(0\G'`75CB3OX?WSIE!M`'FE0%4HI5`)!$I1!6B&E&#
MJ$74,<25B6N!"\I@TC\SB,T90"5:"402D4)4(:H1-8A:1!U#7)EAU<+,E`9L
MSAC$Y@R@TCH&5@*11*0058AJ1`VB%E''$%=&IZX#KB:3Z3)E;'8<?*IY!JA$
M)!!)1`I1A:A&U"!J$74,<65T<CM`&9,+,V4L\L5Q,;/(+\JE0\$&@T/>2B)2
M#GG'RB'O6"-J'/*.K4/>L6.(*3./D_L/[3GT47C.[]#"+\P.^;6ZM(@VB?4^
MTOAN%&U'"6_@UG>)892WLF&B7*/R!BY,C6$:;V7#1%MHK3=P83H6ADL[+'V?
M8_IN$7V&PG57.*M00^.H]Y5.>=1X'.V7"^M(5BZ61*0058AJ1`VB%E%G$7UR
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M*WCF6/!8%-T`XAT%9^47T]*B2S<`TR-]E$@G!]/9%-8@:^`CJZS(E3LD>VL9
MP\?AG8&/W&1%;IVCC3R)7R;NG$'B!A"761];J[#ZFAO$UBI`I;5B:Y6Q"I#$
M6`H=*T0U.C9HU2+JF".?P,.JKSE67Q:=7X6*+*LRRTI8JTMKE3G4\\>ELGJL
MLGJLLV(U659M5H_=I5C\5`\K)^=83EIT7M(BRZK,LA+6ZM*I-H=Z_KA45H]5
M5H]U5JPFRZK-ZK&[%(N=ZL7?4A_W47A];%&X#"(J+0K6/(%(HJ-"JPI1C8X-
M6K6(.N;(!8NK7G/?&/P,87$JAWU5.XN_$&UCK<X^0_`VKO(M$0E$$I%"5"&J
M$36(6D0=0US68?7Q`NMCB\+]8$0E(H%((E*(*D0UH@91BZACB"LSK%)=8*5J
M4;#36R`J$0E$$I%"5"&J$36(6D0=0UR9N-P\7\,OL*ZTB,T98Q6@$JT$(HE(
M(:H0U8@:1"VBCB&NS+"Z4K_A$;WB:!&;,\8J0"5:"402D4)4(:H1-8A:1!U#
M7)EA9=@"RS"+Z&5<M]P6B$I$`I%$I!!5B&I$#:(64<<05T:7'_E[$0M3K81[
M$0X%SQ`<\KNRI47T`,SI)]!*HI5"JXI9\=$,JU866*U81"]ZNN,L'`I'8QWI
MSVES>K**7I86Z"A=CV<=%3I6EQRY#'$F_Z$J=X$)OD5,'6,5[,"7SI%:3NJ,
MXR^C$2Z6EU4F'6?1EK1"QRKE2%\)=WI[EZFSC)/?\S>0WIQGN1:Q/9GI7?18
MI7!6?G^CM$@_[#PI,[V+]J\%.LJT8[33J]"Q2COZ3Q=Q9<(LEZ;H!6%.N:R[
M5#9+@]CN^/0NVODOG)5?"TJ+]+/.0)CHY6>!CC++4:%C=<F1"Q/FJ9>%P31U
M:5`T8^)=/&<5SACC&,V8:)-.H*.T*'*,EBB%CE72,?B63"Y,F*9>%@:S5/I1
M)9V$\!DS@DO)6H4SQB`^8T9P*8&CM#V>=U3NN'R/U25'(XSYB2?S(S8OV_?O
MVV+[_'RX>MC_T#_?1+/NRZ<3MK\MM1BMOU)PNHJB%BH$U[IZ2K6,J:6?)^`S
MH99TM"FU]#<V\)E12[\00\N<6GH1XI8)13,5/+10-)-)1RU?9Y/U5RJR$^.A
M%OVN6:J%^J%WK5(MU`^]:Y1JH:,VJ49T!)O9@EKZI_?0LJ26_A$NM%!#JA?J
M)*D,=9'L@3I(QE^MZ3OL<11?)W?KK_1:([;0=T:0PDD=)S1CZ(L&4CXT8\S'
MUN+Q34A[^J!YPF>Q7&_HWHHME!2MBV0+93UK?6]''TIKUOKFC2WTZVI?D^.D
MP23'0D-)VNN!I.)/*7ZJXPW-K=34HHWZM:!-<3Q4VHE?ZZUW;*&M]K7>6\<6
MVN\B25*GBS:TUGH'"WUHQVJMMZBPA5ZD7>LW9Q,M<^J'WMS`%GJ5A(XZU4)O
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M42)QUW]`Y]W\4J3YC^/^C<H4^G7`_9%^X;'_YQ/]HN>6?L7E[H9V<;[M]T?W
M'S20V]-OA'[Y?P$```#__P,`4$L#!!0`!@`(````(0"8+:U:D0\``,99```9
M````>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;*R<6W/:NA;'W\_,^0Z9O)\$
M#.3B:;NG`7R_7Y]I0AJF2<@`;??^]F<)6\C2WR&BLU]*^M-_+<G6DJR+Y4]_
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MZ6Y3/;$:^+9>_V!2]X$A,KX$:VM?`\GF[&'YN/CYO,O6OYWEZOO3CJI[0E?$
M+LQ\^&>VW-[3'24W%\:$>;I?/U,!Z-^SEQ4+#;HCB[_WO[]7#[NGS^>C\?G9
MM^5V9ZV8J_.S^Y_;W?JE;A*'K8O&V&B-Z9<;7UU,K@>C(>5US'#4&M)O:SB^
M,&XFP\G5!X94MGUQZ?>T'*D\>T/Z/2W'J]:0?EM#:CI'[LEUJZ??5F^,+ZZ'
M@]O1]?%[0F[W):3?TTIXVQK2KU8)AQ1D39VS:&OJU1AIU=OP$"[T1VMZI75U
M0QXK[`^]8O(@&8HHT;R50QXF[(\V,\T`8VVGN3DB4HY7^)!'"/N#WTZ]*A_R
M8&%_G%A.'BY#$2\?E)/'R5`$BF:U&SQBV!]M.?6JW>`!P_YH+8\7T^"!POXX
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M:OX@.50]D#D0"X@-Q`'B`O&`^$`"("&0"$@,)`&2`LF`Y$`*("60"DC=)5(X
MT"CAWP@'YH8>&!1TAZK&[KX1C8[%PT%RB`<@<R`6$!N(`\0%X@'Q@01`0B`1
MD!A(`B0%D@')@11`2B`5D+I+I'B@RI'BH7\RQ1_R3+VO=EY==PVA.N9D"F0&
M9`[$`F(#<8"X0#P@/I``2`@D`A(#28"D0#(@.9`"2`FD`E)WB52E-#8_H4J9
M6J[2AHSHI].V)TI'?A#Q>I\!F0.Q@-A`'"`N$`^(#R0`$@*)@,1`$B`ID`Q(
M#J0`4@*I@-1=(M4R3:-.J&6FEFNY(=V&"V0&9`[$`F(#<8"X0#P@/I``2`@D
M`A(#28"D0#(@.9`"2`FD`E)WB52E-%L\H4J96J[2AHSHI]-PKY2&>Q`=&BZ0
M.1`+B`W$`>("\8#X0`(@(9`(2`PD`9("R8#D0`H@)9`*2-TE4BW3%/F$6F9J
MN98;,FZ6)]D<>0ID!F0.Q`)B`W&`N$`\(#Z0`$@()`(2`TF`I$`R(#F0`D@)
MI`)2=XE4I6R9\80ZW<OE2N5H+,91'(FAU8RCJX-JSI%061P)E<V14#F(7(Z$
MH<>1,/01!1P)PY`C81@ABCD2A@E'PC!%E'$D#'..A&&!J.1(&%8<"<-:0G)5
ML]447"Z[8"O>NZ?5_8^[-76^).H92(]H6:Q=+&O69&C^Q'OA.[;>S%KZ]0%-
M.;HYH%F+1M+$:ZRLL\V%BKNW$-F('$0N(@^1CRA`%"**6D1+N[RHL5!UGF.3
M@?P<2X2*&Z:(,D0YH@)1B:A"5+>H*;T<)VP]IALG/?%`&T"'@&B6;Z2`:-"D
MVR4T:"PB=<:FX"QLZ''3>>@KRR[S5C41AI9`'<.),EJPA8K?90>1*U#'U^VM
M7&.>4'%?/J)`(.%K-!C*OD*AXKZB%G5N3BQ4PI>A7F,B5-Q7BB@3J.-+O<9<
MJ+BO`E$ID/`%UU@)%?=5MZBY1CG>V(I/-]Z:9?Q3^Z5FW8BRX5G>L2TI"C`I
M#!O4N=.S5L7V6SIA>"/7VKQ5=0RM%E&'QG.T$3EHZ`J5R'$T4'H)3ZBX>Q]]
M!:@*$45H&*,J092B82941TJ?"Q4O?8&^2E15B&K)4`X=MCC4#9T/NJIF+4F*
MD0;1EADOYY1M1S;]$D>S%G54<U19+:(8$7?&,)1(LH6*NW<0N8@\1#ZB`%&(
M*$(4(TH0I8@R1#FB`E&)J$)4MZCO0<76D4ZH_6;92:K]!ADT@#FT_='`D-O^
ME.TV4T#05B>OL5F+Q@+-464ALM'0096+R$-#'U4!HA`-(U3%B!(T3%&5(<K1
ML$!5B:A"PUI2R6V?K2^=4/O-<I14^PT:TZI&I_;5'3_VP@"K?3'LGK5H3`^3
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M0'0J+B*O1?(#8:C,_'QA>*2B`J'B%14*]ZSYC$;*`"5"DQA1PM%[UYIR@;C6
M#%'>(N5:E2(5PO#(M99"Q:^U$N[9M8['2K37DHD<DFR1LQN2?S:/;)9*I4AM
MD"$6>J9LMLC"4J`91^)UHCE'0F6UB%[?Y5=L(W+0T$65A\A'PP!5(:((#6-4
M)8A2-,Q0E2,JT+!$586HE@RE"&`O/DH1<'PZN)?+B]DM8N\W'YZ6QE#I%*9:
MJEFK&E&AWO<UU_)E::ELK1P=+5^NELK3RM'7\A5HJ4*M'",M7[&6*M'*,=7R
ME6FI<JT<"RU?I9:JTLJQ_LB7W!C9KD"W._Z@,>*^`IN6LTY6FIT/E7'<E*O$
M4&K6HN[L'%664'7:)TS&N&$S2#*N)S!$X`I1`%?+M=>G&@V5::0OW'>+J=R%
MH,\7S"Q#[JN]&./&4(9-$5>(BXFU7"?<\-W[E'*%<)UIN<[[5*.A,E8MA/LC
M]ZGL\P7WJ>*^VHL9W:BSAYHK]A<CQSW;UNC&_1\-0]A[]13[W6%(BSICCBFB
M&4>=80A'G6%(B[K#$$0.&KJH\A#Y:!B@*D04H6&,J@11BH89JG)$!1J6J*H0
MU9*A'`%LDZ$;`1_T?,V>A%35#?IH&**CFK&#$11)'PU#='Q9K:_CY;*U<G2T
M?+E:*D\K1U_+5Z"E"K5RC+1\Q5JJ1"O'5,M7IJ7*M7(LM'R56JI**\?Z(U]R
M8SQMB\C`+:(6L9_#.%Y];V'*16+N/&N1/%$>*(_W.1I:?8;PC+*Y83.=O[F]
M4AZ(#A>((KE:GKU^E;K*ANZ#?D-EB!%RP_<*'G&!*'BLY3GAAN]Y3KE`>,ZT
M/.?]*N66%.B^[#=4;DG%#=\K>,T%^X++\<TVI[H/FS\;;C1;7-(SJ-WU$J.&
M*>OWE54/CKK##5!9K4H:;C2J#G*X+Y&CBX8>(A\-`U2%B"(TC%&5($K1,$-5
MCJA`PQ)5%:):,I0C@.TS=2/@@^%&LRTE576[4T55<NCA>E8]=%0SVB?3&6[H
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M1`&B$%&$*$:4($H198AR1`6B$E&%B'V2451'4]7-)Q:;KX"]+#??E]/E\_/V
M['[]DWT^\6I`+Y@></-MQ[M;DXZ_4J-4N4$)-)SH21D-Z'.0^Q,AJLV(?2AR
M?WX94@Q*V>\&0\J(?UQ22:&O3G[MM:!,>O.@+'KU+(.>Z_@Z-K_2+>RYP+%)
MGU7IX1.3OLW1PZ],^II##[\VZ9,`/?S&I$/DR&FN8[+)#:;09,9DLQ=,H=F*
MR:8GF$+3$9/-/S"%YALFFV!@"DTH3#:#P!1:HZ:R]5T]+4)3V?I2:)69RM:7
M0LO(5+:^%%HGIK+UI=!",)6M+\4R#"I;7]73?CR5K2^%-MRI;'TIM*-.9>M+
MH2US*EM?"NV)4]GZ4NB0H,F.=N$=I;.")CO.A2ET&)`BO"^%SE"135]LTIN3
M)GM5$KW1JY$F>Q<24^C=1Y.][(@I]'*CR=YFQ!1Z>]%DKRMB"KV>2&7K2Z&3
MGY1/W_70T4Z3G;Y#;W3"DTK0ET)'.$UV\`YMZ"0GE:VO%NA4'J7TV="Y:RI;
M7W="IY7I>OI2[B@?=GH22S"EE&EO"AW4-=DI2;2A\[I4<WTI="#79`<DT8;.
MY5*=]ETIG9ZDE#X;.I)KLB.2Y.WRT-/25W3?%M^7X6+S??6Z/7M>/M)C8K`_
M6[IIOL/;_&>W?J,9'WU3=[VC[^CN_WRB[R4OZ2,5`S:%?%RO=_P_+(/#%YB_
M_!\``/__`P!02P,$%``&``@````A`"LG%QB=!P``W"$``!D```!X;"]W;W)K
M<VAE971S+W-H965T,30N>&ULK)K;CN(X$(;O5]IW0-P/D(1CU,UH($=I5EJM
M]G"=AM!$#00EZ>Z9M]_?L9W8K@RD1W/3@2]5E:IRV2Z<?OC\[7P:O*5%F>67
MQZ$UF@P'Z667[[/+\^/PG[^#3\OAH*R2RSXYY9?T<?@]+8>?U[__]O">%R_E
M,4VK`2Q<RL?AL:JN[GA<[H[I.2E'^36]X,XA+\Y)A:_%\[B\%FFRKY7.I[$]
MF<S'YR2[#+D%M^AC(S\<LEWJY;O7<WJIN)$B/245_"^/V;64ULZ[/N;.2?'R
M>OVTR\]7F'C*3EGUO38Z')QW;OQ\R8ODZ82XOUG39"=MUU^(^7.V*_(R/U0C
MF!MS1VG,J_%J#$OKAWV&"%C:!T5Z>!Q^L=S8G@W'ZX<Z0?]FZ7NI?!Z4Q_P]
M+++]U^R2(ML8)S8"3WG^PD3C/4-0'A/MH!Z!/XO!/CTDKZ?JK_P]2K/G8X7A
MGB$B%IB[_^ZEY0X9A9D1=V.7G^``_@[.&2L-9"3Y5E_?LWUUQ*?E:#F;3>?+
M!<P\I6459,SF<+![+:O\_)^08EXU5FQA!5=AQ9F/9HN)8^&A?8TXP@BNTI7>
MNE.ABZO0M94H;G@.]^KX<16*R]'"FJP<%OT-O;G0P_7#SBZ$+JX?<Q:3MG86
MUP\YNQ)ZN/9U=LSKI"X[+ZF2]4.1OP\PEU$(Y35A*X/EPIZL-YZJI@)_5("H
M&6;D"[/R.(0^2JO$K'E;.];R8?R&2M\)F0V5L76)K91@I<C,>B;P31"8(#1!
M9()8`6,DH<D$BOT79()989F0,6PD4%)CA"TEI(IG`M\$@0E"$T0FB!6@A8WI
M^0O"9E8>A_A[HP"$#"9B([0P4M&(-+D@Q"<D("0D)"(D5HF6$2PZOR`CS`HF
M%=+>1$OG!!=R;J6D$6E20HA/2$!(2$A$2*P2+25P4$U)]VXD%P,F7$<N/=YP
M@C`EV1+B$>(3$A`2$A(1$JM$BPJ+??^HF+`>%2<.+LH(KXR*;H1DZ!XA/B$!
M(2$A$2&Q2K1`L3/U#Y0)ZX%RH@X?(1XA/B$!(2$A$2&Q2K2H6,^K;%VWBY()
MZU%QXN#2#I\],8:O$6J&CQ"?D("0D)"(D%@E6J#85_L'RH3U0#F96NWL(\0C
MQ"<D("0D)"(D5HD6E87FN']8M;0>ET33-C")VI7&DVC>2/D2M5(!1:%$K6(D
M4:L8:TB/CS4:2GW6K=5JA-7HH\T5[UBPE<@BW%@<3=70!6I]\Z04'JF4N*67
MN-]*2?,!16&+;MB*6BEI*]:0GB#6DI@)FHU8IUX=L]W+)H?7B*IC8COH,47G
MR?L:+3D<:<D12$T.1XY=MZOVQ'+,O#0",I:`[>:87-/63"A0:\9H:J-60)J)
M-3-Z2EA3HJ2D(W3\`FMBYRT,S$G3&XLCN_Z566=H*Y"U;*0\@1!'.YBV;33L
M?BLES0<4A11%%,4"<2?TD%G3T3]DWJ)H(7-DHU*4*C>&86L)J397GD!3#&JC
M:#O&#N"W4NQGC3TS[@?4<-BJW#`<2456RV]K:[&8ZP482X':93UG&+@/Y(Q)
M&TLG1S:2TH3NV,8,V+*#!RC:[0KH4>1+M*CC<&;63(\CD`*MF9"B2*`I3\?*
M-JS$FHJ>#=;W*!7$%EI[SLY'NI8.=?[PADDK)HZ,8IKJ$6TM(:46$T&^E!(#
M;"VGI':(4BB56M.11-S.8C8W>LQ8"G04"FN>E-3<64]XJZ7E@R.C4(RQV5I"
MJAUACR)?(#'"LYE1[P%5"2F*="N.9?R$C#45O4Y8@]4_&;P=TY+!D5$<1AA;
MK''UK&E'T*/(ET@4Q\0\+@FD0&LFI"@2"&M8?>BR,*9PK*GHV6"-F9(-?O+S
MT=V7=W=:DCBRV^UF:Q'D">2T#8Q/44`50RH5411KBEK8V!FUL&_/B%I:7SH%
M8JM+LW3:EED$O:2\7E*^D'+@^8^?&/2R%?:2BGH],;YG2\\[:T^5<KN3=][,
MJG7%9ATVHYG3M#%;@=3]22"L,4JNR)XN%?F692VLA;&D!E*B7='"7J8CJ2A,
M3U9S8]&/I41M6L\1:R^5'/W4E+1YCZJECB-U2@HI!7D"J5.2HH`JAE0JHBC6
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M]<<C_HLBQ5O,"3OR.^1Y);_`J7'S?QGK_P$``/__`P!02P,$%``&``@````A
M`/$,%BS]"```92L``!D```!X;"]W;W)K<VAE971S+W-H965T,34N>&ULK)K=
M;^,X#L#?#[C_(<C[-K&=CS9HNVC](0G8`PZ+W;WG3.(VQB1Q$+O3F?_^*$NR
M1-&3J,6\C*<_D[1(410=^?[W[X?]Z%MY;JKZ^#".;J;C47G<U-OJ^/HP_ONO
MXK?;\:AIU\?M>E\?RX?QC[(9__[X[W_=O]?GK\VN+-L16#@V#^-=VYY6DTFS
MV96'=7-3G\HCW'FISX=U"W^>7R?-Z5RNMYW283^)I]/%Y+"NCF-E874.L5&_
MO%2;,JLW;X?RV"HCYW*_;F'\S:XZ-<;:81-B[K`^?WT[_;:I#R<P\:7:5^V/
MSNAX=-BLQ.NQ/J^_[,'O[]%LO3&VNS^(^4.U.==-_=+>@+F)&BCU^6YR-P%+
MC_?;"CR081^=RY>'\5.T$LEL/'F\[P+T3U6^-\[_1\VN?F?G:OM'=2PAVC!/
M<@:^U/57*2JV$H'RA&@7W0S\]SS:EB_KMWW[9_W.R^IUU\)TS\$CZ=AJ^R,K
MFPU$%,S<Q'-I:5/O80#P[^A0R=2`B*R_=]?W:MON'L;Q[<U\.4TB$!]]*9NV
MJ*3)\6CSUK3UX7]**-*FE)%8&X&K-I(LK)$+BHE6A*M67-S<SN>SQ>T2GGY!
M<:85X:H5HSCHB6"V\Q>N9JA)D.)"*\+5/'$:-M:EUH2KT0P;*ZS1;JQP_=A8
M[[0B7,T3+X]UHK*B2[)LW:X?[\_U^PA6+LQ[<UK+.A"MP)K)+C4S?;[]+-T@
MSZ21)VGE80SZD$D-K)%OCTF\O)]\@[S>:)EG*A-CB=1(R"269C,?Y#XH?,!\
MP'T@'#"!(/21@-S^!9&05F0DC`_/!CBA\=PV$D8E\T'N@\('S`?<!\(!R&U8
MF;_`;6GE80S_7D@`+0,+LQ?R<B3M1?I8$)(34A#"".&$")>@B$#)^041D59@
M44'8>V_IFE!"R:60]")]2`C)"2D(881P0H1+4$A@@&Y(AO<>4PRD<.>Y&?&S
M(N"F(2DA&2$Y(04AC!!.B'`)\@HJ?;A74AA[I4@"%V>&;[W%W0L9US-"<D(*
M0A@AG!#A$N0H;$SACDIA[*@B[O01DA&2$U(0P@CAA`B7(*]DA^ML79>34@IC
MKQ1)X.),WYTW?;U0/WV$Y(04A#!"."'")<A1V%?#'97"V%%%9JJCD_MJ2DA&
M2$Y(00@CA!,B7(*\BJ`5#G>KD\9^&=0UWUW#D!ID*TUFT*(O/KE!5JJ@B!ED
M%;E!5E$@A/V3C8:3GZJUNI%];[NK-E^?:\@[D!G(VP1:*-U8J6X%MA&3@,^1
M1LL>I0;=]BC3*''WGW@VP^F=6RECOJ"VF)6R2R6>3[$M;J6,+8%LX>#(=L0)
MSD`0X/6DCX)J7E`4%(J[ER<]^5K*C8)",QESTYG&L5>C<[E)PYH!*3/R@B)&
M$:=(:!1U@\`NRX8CW&75GH`Y,Z;G2*$8YK]W)DF\:4B-E%7,-)J!F[UB["OF
M5DKV[[/(*X4%-<RLR@7#W$IUAA,O"04RC$,F&Y+PD*GV!85,H1@NO>=)$N',
M32,M95=Z1E%NT+)[OYDM%IZ9P@A8,XPB;M#/S`@CT)G!X9"=3'@X5-^#PJ&0
MET'D-4Q+N1E$4"Y_@X!%$\M:]>TQ6OCY5!@!:X91Q`W29J+(6YS""'1F<#AD
MOQ,>#M4=H7`HY&5'XF>'EK+3FD4$Y0:I:8VBA>='802L&481UV@&2[U/V#CQ
M7I,$4L0QD=U2>$Q4;X5BHI"7(MZ232,M9><VHRC7R*L[GC,%5604<6NK*R)+
M+VD%4L$AD7U5>$A4%X9"HI"7)G,_3;24G=\,-H%NB5B4:W1Y?@NJR"CBUI8,
M2>+5:X$T<$1D3^9$Y'.=B6KL4*`4BNT&G$8$91JIWTR[G3NGJ*"*C$IQB@12
M1&Y#KX#<OMQS=-*XX=1(_FYJ%V>T\!(A2"H+DLJU5`(C__D3BR!;+$B*!SU1
M7+.%XRX;5B?=KL2==KRR&,%6,W?[EVCJ58!42\5.3:(H-TCM-\O;I5^GC8`U
MPRCB!BDSBV7L54AA!.BV!0/\2#A4;^HNL\X`[+RXJ2%IJ!1C6WPRHVA1KA&J
M1XF_WQ16T4G#Q-LHF94R+2L?-N^%7%C%8?,XF[PV^E/%"[H6F5$HJKJ[=HJ7
MEG+J6::16[PH*J@BHU*<(H$4L=NR1PU?1*JC1?[I)O=*\0J1RF3JR=[OHJU<
M2UTK7B&V6-`3>=`3Q35;..ZRS0V/NY3V\DHA60_Z$I[XFW4J0RDC:JM.II'7
M/7FO>[E1U(7HSG\M+XR`M<R"+'.CJ"TGB5=AA!$8*'&R/W:"]KDUJIILE,.Z
M[W;7*$$9E#P92[1&"2JTE+.X&57D%`FDB'/E0\UW3)MOC61@^UR):8.AF^^+
M4EF0K5Q+75NC(4]D04_D04\4UVSAN,L^VTFW*PV&ZLI17NE&_6)$4TB5ZU4O
M"Y+*M=2UN(<\D04]D0<]45RSA>/^*]XC8OH>H1&,Q302*4691FB9*UL.*J@B
MHXJ<(H$4D=MRTL+3K9/&6X)&[H$*11E%.44%18PB3I%`"/OG]>NR>L^!??";
M@$1U[>XZTPB?N<R\+2VU4F;Z,XIRB@J*&$6<(H$0CL6'FG7Y:[NW_6N$YEI)
M.2BC4CE%!46,(DZ10`C[-]!-?V:N:3^=*.3-M?>;:6JE[%SWB@;E5*J@B%'$
M*1((X5C(3C1X&X$B0^9:(6=B4RWEH(RBG**"(D81ITA^B]9U/]UAAO)/?5NF
M/OLYE.?7,BWW^V:TJ=_D=V.PU3[>]UA]U/:<R*_:NA-#<B>&.UW+1^XD<">1
M-9O<F9EOY/P[\Q4<SP]H+%9PFCW`ERLX#Q[@MRLX/AW@=RLX@!S@R11&U)T=
M>2."[G&50XM'=:`]7,E^D-Z!K0ATAIX#>PWH#-V!SP:?!J,(@1^,.X1]4%X&
M?6!,3[/5$Z0"'>PSS,40AQ/#E3P/I!IP_K>2IWOT3A;%<&=H6/`K'U@;<AQ^
MQ@.=H3OP<@UA''(&WIXAC-V=23]?\)'C:?U:_F=]?JV.S6A?OD`R3[OSU;/Z
M3%+]T=8GV'[A4\>ZA<\;N__NX'/6$@["IS?0\;W4=6O^`!<G_0>RC_\'``#_
M_P,`4$L#!!0`!@`(````(0`$"F;!GP(``#<'```9````>&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;)156V^;,!1^G[3_8/F]."&D:5!(E:[J-FF3IFF79\<8
ML(HQLIVF_?<[!U-&EJZB+UP.G[_OW-E</^J:/$CKE&DR.H]FE,A&F%PU949_
M_KB[N*+$>=[DO#:-S.B3=/1Z^_[=YFCLO:ND]`08&I?1ROLV9<R)2FKN(M/*
M!KX4QFKNX=66S+56\KP[I&L6SV:73'/5T,"0VBD<IBB4D+=&'+1L?""QLN8>
M_'>5:MTSFQ93Z#2W]X?V0AC=`L5>U<H_=:24:)%^+AMC^;Z&N!_G"1?/W-W+
M&;U6PAIG"A\!'0N.GL>\9FL&3-M-KB`"3#NQLLCH;I[>K"G;;KK\_%+RZ$;/
MQ%7F^-&J_(MJ)"0;RH0%V!MSC]#/.9K@,#L[?=<5X)LEN2SXH?;?S?&35&7E
MH=I+"`CC2O.G6^D$)!1HHGB)3,+4X`!<B5;8&9`0_MC=CRKW%3S-HR1>KJ[F
M@"=[Z?R=0DY*Q,%YHW_WJ)XKL,0]"]Q[EL5EM%S-%A-(6/"H"_"6>[[=6',D
MT#0@Z5J.+3A/@?CEB"`4Q.X0G-$U)>"K@RH\;!=)O&$/D#K18VX"!JX#YB^"
M@>B@#&K3E1&,RIA;=.4F&,8RB\&1$YG%6V00G%&X#LZ?!Q@PR0BS>ED9(-,#
M1##4`,)Z13J`)DA#4TV71G`G/20W6))N)L8ENWP++8)/:7L+C-\HQO^4;?46
M*02?2@7+>02XD$?MCH.\6,TB"/CUSL=SIPJ]Y:0#D^3E3H")&:N^+H7@4ZE@
M&043%E688RUM*3_(NG9$F`,NH1@F<[`.^W$78SG_M2?IKALJ-GR`O=7R4G[E
MME2-([4L@'(6K2!%-FR^\.)-"U["\C(>%E;W6,$/2L)P=ODLC/'/+R#,AE_>
M]@\```#__P,`4$L#!!0`!@`(````(0!/6I("B@,``-L,```9````>&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;)1776^;,!1]G[3_@'AOP)`T3112I:NZ3=JD
M:=K'LP,FL0H8V4[3_OO=:Q/&5QKR0L+-X1P?WP^<U?UKGCDO3"HNBL@E$]]U
M6!&+A!>[R/W]Z^GFSG64ID5",U&PR'UCRKU??_RP.@KYK/:,:0<8"A6Y>ZW+
MI>>I>,]RJB:B9`7\D@J94PVW<N>I4C*:F(?RS`M\_];+*2]<R["48SA$FO*8
M/8KXD+-"6Q+),JIA_6K/2W5BR^,Q=#F5SX?R)A9Y"11;GG']9DA=)X^77W>%
MD'2;@>]7,J7QB=O<].AS'DNA1*HG0.?9A?8]+[R%!TSK5<+!`6Z[(UD:N1NR
M?`A"UUNOS`;]X>RH&M\=M1?'SY(GWWC!8+<A3YB!K1#/"/V:8`@>]GI//YD,
M_)!.PE)ZR/1/<?S"^&ZO(=TS<(3&ELG;(U,Q["C03((9,L4B@P7`U<DYE@;L
M"'TUGT>>Z'WD!L%D3OQ%.`>6+5/ZB2.EZ\0'I47^UX)(165)@HH$/BN2\'8R
MF_LA`<T+))Y=D/'W2#5=KZ0X.E`T(*E*BB5(ED`\;`B<(':#X,A=N`ZL54$6
M7M;A=+;R7F#GX@KS8#%PK3%!C?!`M%8&M?'*"$9EW%I<RH,--&7"89GP&AD$
M1RY<Z\7W#5K,M(&9#RL#9+Q!!$,.P-8[TA8T0AKJ8;PT@HUTO;DV,C4MT4S9
M[36T"&[35A'HOH;'V^'-FU\CA>"VE(WT'>!`'EWN"&[35I%F@1#_3.%!FXR7
M0G!;RD;Z#@AL7Y,71U%`YA/(V87FQ0?;&H8+0JTVFIXI9T0UA2^H(;JC9D,#
MECJCP$Q7'P;D94_5&`C^#P9L(11N>[H;KC*"S3RZ'@RZX^DT#?#MT6P5TNE^
MXRFXP]?#I3S5HZ#N1T/6\[0XXPF[=[PG1'<\V=!`GJ[J?](?`*=0LW_"F7_&
MQU4C@/1G0!4:\-&9`IB;!73'A8KNCP-2A5JU-B-G_%PU$$A_(E2AOI^@,Q+>
M]V'0[8R?0NV\G'MO8QN/KJ_`-CUT95W-56C`Q\`<F/J+"132!4O],1`,C8'9
MF5$-1\=K+-F>;UFRH88E>Y2T1ZV<R1W[Q+),.;$XX#$Q@,-3':V/L!NS2=WX
M=+FQ1UNO_@6.EB7=L>]4[GBAG(REP.F;>2GMX=3>:%%"HN%L*#0<*LW7/?R)
M8'"`\O&%D0JA3S<XP.J_)>M_````__\#`%!+`P04``8`"````"$`Y#.A,H((
M```9*```&0```'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6RLFEEOXS@,@-\7
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MYOCY3MCN?B#SYW)75TUU:"=@;LH&BGU>3]=3L+1YV)?@`0W[J"X.C^,G)\@\
M9SS=/'0!^K<LWAOE_U%SK-[3NMS_7EX*B#;,$YV!YZIZI:+9GB)0GB+MI)N!
M/^O1OCCD;Z?VK^J=%.7+L87IGH-'U+%@_STJFAU$%,Q,W#FUM*M.,`#X.SJ7
M-#4@(OFW[OA>[MOCXQA&.WHNFC8IJ:GQ:/?6M-7Y/W:R\Z17=KDR'(7R8C)?
MSCP'KF5KQ.-&X,B-N-+&C8O[7`^.7,^?K.9S?[%:PL5O*,+9SF4X<D5G,?'=
M^7+5#?N&YH)KPE%<\N:5EEP>CD+>;HBP.KLAPO&#0UQS33B*2PX-<<K2H,NJ
M*&_SS4-=O8]@J<*$-]><+GPG`!LBG5A0^@3[47Y!8E$C3]3*XQCT(84:6!1?
M-^[*>9A^A43><9GM@(PN$0H)FK74;&2"V`2)"5(3$!-D"IA"$/I(0%)_0B2H
M%1H)X<-6`!D:SW!;2`B5R`2Q"1(3I"8@)L@4H+D-R_`3W*96H)3<3``N`\NP
MSY*E$8I>I(\%(C$B"2(I(@213"5:1*#`?$)$J!585!#VWEN\)IB0=RLDO4@?
M$D1B1!)$4D0((IE*M)#``-60#&\VHAA0X<YS,>(M(^"F("$B$2(Q(@DB*2($
MD4PEFE=0UNV]HL*Z5XQX<%!FV#4RNA<2KD>(Q(@DB*2($$0RE6B.PGYD[R@5
MUAUE1)T^1")$8D021%)$""*92C2O:$NK;%VWDY(*ZUXQXL%!F3ZS-O="_?0A
M$B.2()(B0A#)5*(Y"ONJO:-46'>4$9^U<G1?#1&)$(D121!)$2&(9"K1O'*@
M][5WJY/6_1+(EV5%(%EI(H$6O50LD)1*,$H%DHI$(*F8:4CWCS8:2GZRUFI"
MF]7V6.Y>MQ7D'<@,Y*T'+11OK%BW`MN(2,"MP]&R1Z%`JQY%''G:_N/[>G6*
MI90PGV!;J912ELI\IMLB4DK8RC1;>G!H.Z($9R`(<$O11X$U+UH4&'*[NZ4N
M5B'=:VGJJU%@R*<Q[SM3=Z6//.:*("5&GF"48D0PRCAB@]!=I@V'O<NL/0%S
M8DQ;AR$7YE\ZLS*F-!124C'BR(=@2$7/F+]8*-+D^[KQ%NNU'J9$"$C+J95E
M(A2Y96=AC#D3`IUE/6BT);$/&FM@M*`QY,)!^KZ:ZZZ%#I>2:SW"*!9HR>YP
M'#.$B1"09E*,B$#<S&QNC"83`IT9/1RTE[$/!^M\M'`P9.30P@P'EY(S'=%G
M#+"X7(EB@=BT.M[*,),(`:F38D0$XF9<G!WJI?5PT(['/ARL/]+"P9"1'>9=
MB<.EY+1&&,4"L6EU?']M-!.)D)!V4HR(0-R.N_:,GC(3$@/Y09LE^X"PUDH+
M"$-&?A@%,W2XE)S8"*.8(R@[W0.!N1'6!*ND&!'=BN.@Q:*.1<\.VE`IP?BY
M#9AU95J,&'+E/A-"N>]6AT011Y[L3F*,$JR88BF"4:8IZF[3CDMQ^\[6ROHS
MS3^&Z",]63(=8W&'CHU49"45<RD/.L(?7S&QLI5:21&K*V;W;&EQAU;D`W'O
MI/5^EB,?$EI&867LPB&7<F41B3"*!1);U7IAK)M$2$@[*49$(%Z,UG-SS\N$
M!"Y&M(BHB4C7G[N@CZ6'>EZEW>L4C=BPIE>O2VNCA0FYHK))11C%'.GMT-IX
M7)E(164V/*.DIU)*M&EDV+Q9PZ7BL'D]M6@;JRSIGZID$!7SSI`CM9)A%'&D
M5C*,$JR88BF"4:8IZFY_J&-V<<?,T9U*9B4564G%7.I.);.RE5I)$:LK9O=L
MZ7&GW;"2;K=W$-H\&4\<.)I[_<U+R)%6MIBB#_,FZYU97V*AR"K0>KTTEF`B
M!-1"9F.9"$5F>>G.C!*9"8&!TD9;4B5"/[<@65^K;KTT4VF7+?N($*.((VU!
M,D4%)5@QQ8H$HTQ3U!/C0_TVS#5*#-Y)PVCEE*/6@BO2<?Q8*K*2BKG4O05I
M,Z[4ZHK$ZHK9/5MZW&F/JZ3;G07).F(MKWB3?#.BH6LC%5E)Q5SJ7MQMKIA:
M79%873&[9TN/^V?<0<!B1LL`W2Z$7$I9^1%'RIJ.,4JP8HJE"$:9IJB[_:$[
M"!??07"DOC'`*,(HQBC!*,6(8)1I2/./)J6ZG+K&=#Z!Q?'!U]Z=(;U1Y4A_
MK6`^"0BEE&@;(XQBC!*,4HP(1IF&]&@8;?KMXD*_%C%V>X[4V<8HPBC&*,$H
MQ8A@1+^YH>-B@V#^L6]HV-<.YZ)^*<+B=&I&N^J-?A\#N\OFH<?LXYVM-X.O
M=[I'RNA,_UV/>68>P!M&F$:3+P)X(3?`EP&\TAK@JP#>``WP=0#O4`:X"R<@
MQ_$9Z`^"&-S#9Z`!".B.C\]`L0&=H>M#-0&=H3/PJ=-3]P3(]!Q"U;UL,KD+
M`QZX]M:#H`_P)S]X@FG%@]WZ`;RJQAQ>>@3TE08^`Z\P`OJ"`I^)'!?.#`T+
MGN"`M2''X1$-Z`R=@7LE"..0-;@9@C!V9Z9]7.##K&O^4OR1UR_EI1F=B@,D
MYJQ[152S3[O8C[:Z0I6!+ZRJ%C[-ZOX]PB=X!;S+F]&R=:BJ5OP`%Z?]1WV;
M_P$``/__`P!02P,$%``&``@````A`&N3$`9,%P``-8D``!D```!X;"]W;W)K
M<VAE971S+W-H965T,3$N>&ULK)W;<ALYDH;O-V+?0:'[D<1#D52%[8E6G<\;
M&S.[U[)$6PI+HD.DV]UO/XD"0`#YHUF@HV]:[@]_)JH2*!R2=?CPSS]>7RY^
MW[[OGW=O'R]G5S>7%]NWA]WC\]O7CY?__E?^C\WEQ?YP__9X_[)[VWZ\_'.[
MO_SGI__^KP\_=^_?]D_;[>&"/+SM/UX^'0[?X^OK_</3]O5^?[7[OGVCDB^[
M]]?[`_WO^]?K_??W[?WC:/3Z<CV_N5E=O]X_OUU*#_%[B(_=ER_/#]MT]_#C
M=?MVD$[>MR_W!SK^_=/S][WV]OH0XN[U_OW;C^__>-B]?B<7GY]?G@]_CDXO
M+UX?XNKKV^[]_O,+G?<?L^7]@_8]_@^X?WU^>-_M=U\.5^3N6AXHGO/M]>TU
M>?KTX?&9SD"$_>)]^^7CY6^S>%C/+Z\_?1@#]'_/VY][Z]\7^Z?=S^+]^;%]
M?MM2M*F=1`M\WNV^"6GU*!`97X-U/K;`_[Q?/&Z_W/]X.?SO[F>Y??[Z=*#F
MCNB,Q(G%CW^FV_T#193<7,TCX>EA]T('0/^]>'T678,B<O_'^/?G\^/AZ>/E
M?'&UG$?KS8ST%Y^W^T/^+'Q>7CS\V!]VK_\O53/E2WJ9*R_T5WE9K*ZB]<WB
M'"<+Y83^ZD.YFF^B6;021W*B]J4RI+_*<&F=P@E#<CN>//U5AK/H:A-%R]5F
M?;K*E;*DO^<=ZUH9TM_SCI4NV/%8Z:\RW)@(GSC'6V5'?\\[TAGU1=DU1*>4
MK1X8U]FQ5]$_E.DZ++`SW97$/Y3IXFH]N[E=3#3)3/<?\8\SCU?WH)GI0J$]
M05QL,DRF%\U/]MMK>0F.5W1Z?[C_].%]]_."ADD*UO[[O1AT9[%PJZ]EV;K'
MJ_NO+FZZJH67WX2;CY?4WG39[FE$^OW3/)I_N/Z=1I$'I;GS:%Q%HA5BR!!N
M4PXR#G(."@Y*#BH.:@X:#EH..@YZ#@8+7%.LCP&G+O9W!%RX$0'7H;K3P+3`
M@D57*[1)RD'&0<Y!P4')0<5!S4'#0<M!QT'/P6`!)[IT&?X=T15N/E[2?T]T
M9Z6A:^8H6K.('R7'D`/)@.1`"B`ED`I(#:0!T@+I@/1`!ILXX:>A[.\(OW!#
M`Q(U\C&T.)Q(T>)4_(^28_R!9$!R(`60$D@%I`;2`&F!=$!Z((--G/A3,)SX
M^U=D>M`6ZC',.CQWDE!,-4F`I$`R(#F0`D@)I`)2`VF`M$`Z(#V0P29."&EU
M=48(A=H-H20+^F/U73X4'T4ZSBF0#$@.I`!2`JF`U$`:("V0#D@/9+")$U5:
M>IX15:%VHRJ)W3&!I$`R(#F0`D@)I`)2`VF`M$`Z(#V0P29.",7NV5ZIG;ZV
MA=H-H20+^F-US"6;L8ZB8\<$D@')@11`2B`5D!I(`Z0%T@'I@0PV<:)*2]8S
MHBK4;E0E6<JMJ5BS)D!2(!F0'$@!I`12`:F!-$!:(!V0'LA@$R>$8M-V1@Q'
MN1M$C99FWM'(3$6I1JNC*M/(J')$A4;&L-3(&%:(:HV,8:.1,6P1=1H9PUXC
M8S@XR`VIV#V$7^QB[\OZI4)+.Z12M31'D&H5S8;6H!"Y@T)F5'I4R!$5!MF^
MV)*X-"KMJT)4&W3"5V-4VE>+J#/(\K6:N>?8&Y7V-3C(;1ZQ_3BC>>1NA=:S
MVO>=6-M2BSG-HY#=/$=D'7JT<@\]T[Z,88ZH,,CVM7%]E4:E#[5"5!MTPE=C
M5-I7BZ@SR/*U8KF#WJBTK\%!;O.(_8G=/#*I<262.8>GYX=O=SOJ[70U>*;0
M!24O5$I#[G*H&EWEG<CR\%93R`0_5:J%,<P0Y=J7,2R,R@I%=,N;2-9HN:_0
M5^WUM;IQ?35&I<^Q15\=JGI$@V/HMH?8K]CMX8D[I5N/@9?;&R?P$LW'O/38
M/(E(FXDQ;W-LGE0A&N"L^,U9%\^,2I]SCJA`5"*J$-6(&D0MH@Y1CVA02)ZV
M&V6QI3DCRD+.IF&)EK2*-[/!DB\119:0#.>F>Z>(,H661I6CJD!4HF&%JAI1
M@X8MJCI$/1H.CLJ-LMCBG!%EN2-R^K)$2UKH6U%F5WDRDZJY64&DB#*%EHOC
M19"CJD!4HF&%JAI1@X8MJCI$/1H.CLJ-LM@%V5$6(_A\)7Y.\@W:]N`A]T].
MP"5:TA[`!'S%M^0SJ7*Z-:!,J9QN#:H"?95H6*&J1M2@88NJ#E&/AH.C<@,N
M-DAVP">&:+F?<J(LT9*V"5:48?"0*J=;*T.:UHSA@LU4&0UXXZBS'G]<B*)H
MP59PN5:8*Z90B"Z/$ZY+HQI_MV`KU@K]UL;BA-_&JUJQQ75KW-N^6._LO+YX
MD'KMZQBDB,5_T(HQ2&X/$/L[NP>$7W)R9^AT!HDBVAF:-EVQA6LRDRKGD@.4
M:958F?W^:;:9+]A)Y5IAYIH"4:D07;K"#U]%5VA1(VJ,$_O$H$V/9V&I%M"F
M1Y5>B/2ZQN.Y;EC,!JT8S]5I0%H<80/2+XKGK7I'+^ZR0*&Y66DEB%*%%F;#
MF2'*T;!`58FH0L,:50VB%@T[5/6(!L?0C?1YN_,Y[LX5$M.9N3YFK*V3(%4:
MI,J4:N%<D;S&/,A7$:0J@VJL@GS50:HFJ,8VR%<7I.J#:ARF?+F=2^SY?VD<
MIG&4K^@5BJ@'FGZV8C-<HE3VI*S0Z9DSTX9ROEDOUGQVR[7"FI2#7)=&)4;K
M#1L[*_1;&POK7/D4V7A5*[9';(U[VQ<[B,[KB]?8:U\Z2)LE6]L,6H&3\ESL
M]7EG.'],EQD#>X(>'=.2VA[3I<I"J5(Y8[I462A'7P4:EH@J-*Q1U2!JT;!#
M58]H<`S=R^Z\',4<<Q0*38WI*I-Q<N1/@WQE2C4UIH?46`356`;56`7YJH-4
M35"-;9"O+DC5!]4X3/ER.Y=(F=B7\>G=E>A"+#6C$-O#\J2!4M%XHE>4*:),
M^S*J'%4%HA(-*U35B!HT;%'5(>K1<'!4;I3/2\W0=`=15JD96IA;TR7;;B3*
MT)DNE2$-CL:0SP29-I0SP6)SNV8S2JX5]G09XKI4AC1?B^F2]8L*W=;&X,01
M-U[5FLU?K7%O^V+GUGE]\1CUVM=?QFC0"L]L*3(Q]F46O(6=RQR.,T-*-+&%
M58;.%0?YH$RK9.O,;];\YZ=<*\PU62`J%5);V!G[D:1"BQI18YQ8K;5FV936
M&%HJV,(:E1YP>HW,N;+%U:`5GBVL2/+P!CQ_N2-314YCJNR1O=P!E-+21XP(
MUMHF0Y0K9*V3"E25B"HTK%'5(&K1L$-5CVAP#-VQ4N0>[$A/S$@R5>&$5&4O
M3BYDDGF(*@U294HUM=P)J;$(JK$,JK$*\E4'J9J@&ML@7UV0J@^J<9CRY70N
MT4)G=*Y1[J:<%'+WK6LVWB5*11."'GU2A2;VK=I03C(1S<-LCL^UPK@N@ER7
M1B4FXCD;5BOT6QL+>Z1E<VSC5?'U0VO<V[[X3.SU!3.Q]G4,TI*=S*`5.!,O
M>(;LEWZ!'[VPCB%S:32PZ29/E,I"J4+V0(XH1\,"526B"@UK5#6(6C3L4-4C
M&AQ#]UKCZ:+3`SG=-<`7O0J)=;59N_+,8!*D2H-4F5*)[O/7->9!OHH@51E4
M8Q7DJPY2-4$UMD&^NB!5'U3C,.7+[5PBV1.^2EC(W)"]2E`HHFYGFGK-1MM$
MJ>Q5M$*TU+4,^1B5:4/U>\EBL;QE>Y]<2ZR5=9#OTJC$2#Z[80==H>/:F)PX
MZ,:K6O/?D(Q[VQ<,Y3+DI\/4:U_',$4;&,NE(]D$;B?@F;%?&\LQ84;#LQB+
MK($[090JY(SETM!".1H6:%@BJM"P1E6#J$7##E4]HL$Q="-]7II(//K"TD0*
M38WETO"T*@WRE2G5U%@>4F,15&,95&,5Y*L.4C5!-;9!OKH@51]4XS#ER^U<
M(H]TQE@NTT[.6"[1Z6Z3B"=?Q%5-+6Y&?+Z<2(-4F5)-=:Z0&HN@&LN@&JL@
M7W60J@FJL0WRU06I^J`:ARE?;N?R9=[.3MPL,`NGD#-'J/R:V0*D2D4CJ]X5
M9(AR]%6@JD14H6&-J@91BX8=JGI$@V/H1EKDJ,ZXC&5*R[F,59;+W'B<B(>"
M1.++H!11ABA'5"`J$56(:D0-HA91AZA'-#C(#:G(&)T14IE@<D(JD16_9`$H
M190ARA$5B$I$%:(:48.H1=0AZA$-#G)"NCPO`S3*W8V^0M1J^I).$*6(,D0Y
MH@)1B:A"5"-J$+6(.D0]HL%!;DAY2N7T1I^>2..+0X7L9]40I8@R1#FB`E&)
MJ$)4(VH0M8@Z1#VBP4%N2,_+G8A-%EMO:V0FGD0C:RS5R"03,XV,*D=4:&0,
M2XV,886HUL@8-AH9PQ91IY$Q[#4RAH.#W)">ES$0>5H>4K6CM4.JD#F"5!FZ
MCWI$;`^=&94>1')$A4'6BC5B-TF51J5]58AJ@T[X:HQ*^VH1=099OO@OA[U1
M:5^#@]SFX7OYB4$$-^WTQ)IH,?O!-8WLYE$J9Q/`;[G-T#!'5!ADA2%B/RJ6
M1J7#4"&J#3KAJS$J[:M%U!ED^8('UXQ*^QH<Y#:/V";;*Y%?2K6(BX)?5!)1
MS?HH$J6B/QJE"E&*4*,,48Z&A5%9H8`'UXQ*NZ_05VU4EB]X<,VHM*\6?76H
MZA$-CJ';'F)G:;?'Q.4B-Z+VRE`\2T5M0?<2Z^-,%*([\35*%1('8O;,\.":
M46G#'%&!J$14(:H1-8A:1!VB'M&@D#QM-\I\\S@19=PEBF>IQ*!$P3;QB]A/
M:(E2V5EF1)GV92Z"'%4%HA(-*U35B!HT;%'5(>K1<'!4;I3/VSB*.\WX("*1
MJ,)$><GR[8DRM'^4190I1#.5Z<O2O658H&&)AA6J:D0-&K:HZA#U:#@X*C?*
M?"\9?`N2>'"*!UPB49L).#RXI@R=;BT-+90I%:W<3,!!5:"O$@TK5-6(&C1L
M4=4AZM%P<%1.P,7]66<,T:/<W6DJ)*JPHLQ^[4F4RNJ=J3:DU:DQA)^HM*'\
M&7T61?PQJ%PKS)J["')=&M5XKP%;$E7HMS86)PZY\:O8@KA%]YW?D(W#O38\
M1N26!7O0BC$B;G/S77#P]27N)6'7ET*B-M.`:_X4CE)9%U.**--(_<1VN[YE
M\<JUPER!!:)2(;I.QQLYV>A:H46-J#%.[!-C!]0:0TL%M_@9E1XX>HWTN6YN
MV<9KT(KQ7-T&Y'ON7UKBBM^3>6-*9&>*E<I"J4)VIAA1CH8%JDI$%1K6J&H0
MM6C8H:I'-#B&;J3%KCE\\1K)3;:]>%7H]$\Y29`J#5)E2C7Q@T^0KR)(50;5
M6`7YJH-435"-;9"O+DC5!]4X3/ER.Q=/)(2/PYA3B"02@X8U#K/I+%$J9P96
M:8:)&5BJZ+9C,:0NH@5?0N7HNE!(I%+,,?')O32J\1Z1.1MB*W1<&Y,3CANO
M:LW<M\:][8O?(^+UQ4^EU[YTE)8;-O<,6N&9E?^6O$6$>0N%K!$\090JY`SJ
MTI>%<C0LT+!$5*%AC:H&48N&':IZ1(-CZ%YWYV4D(LQ(*#0UJ*N\A9.1@%_Q
M@WQE2C4UJ(?46`356`;56`7YJH-435"-;9"O+DC5!]4X3/ER.]=YB9@($S$*
ML1TK&T@2I7)6U-*7A3+MRZR7<S0L$)5H6*&J1M2@88NJ#E&/AH.C<J,L\AQG
MK,MD6L19ETDTM6.5*F>^5(8G)[4L4H9J?[:F&=-];5BN%?:.-<1UJ0QI5AUW
MK,QOA7YK8V%/<6Q+V7A5_&'TUKBW?;&#Z+R^<+KD0>)/)PRF-MHXN3U`)%[L
M'A"^>)(I&Z<S2#2UB94JZ_I*(T"91K)Y5K-;%IM<"\PU62`J%5)[V!G;W5=H
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M5D<O;"`7CMTG&Y3*&MM3A9R!7!I:*$?#`@U+1!4:UJAJ$+5HV*&J1S0XANZU
M)E(P=J0GKC69L;&7.2N5Q#FY(4V"5&F0*E.JJ8$\Y+B*H!K+H!JK(%]UD*H)
MJK$-\M4%J?J@&H<I7V[G$KF>,SJ73`TYG4LBD4LWR3YX2FTE5?8:6B%Q/YPQ
MY&-4I@WE6C/:W-ZP$3'7"FM='>2Z-*HQ`;EBZ^,*'=?&Y,0Q-UX5O"?+N+=]
MP4@N`W<Z2KWVI:)T>\/W;X-6X*]**YX6^[4E.6;+1L=L)%>)*NO^':6RANT,
M48Z^"E25B"HTK%'5(&K1L$-5CVAP#-V+[;P<T0IS1`I-+<E50HBZCKFR(`$9
MY"M3JJF1/*3&(JC&,JC&*LA7':1J@FIL@WQU0:H^J,9ARI?;N412Y8R17.9@
MG)%<I65.=IMD%:)*@U294DUUKI`:BZ`:RZ`:JR!?=9"J":JQ#?+5!:GZH!J'
M*5]NYQ(9'[MS_=H<(?-&3I]3J20S(20K0*E"SAPA51;*T;!`PQ)1A88UJAI$
M+1IVJ.H1#8ZA$^DU3Y"=7NV/<G<#I9#]0!6B%%&&*$=4("H158AJ1`VB%E&'
MJ$<T.,@-*<^$C2GCZ(K&N3._U+K&))E"X@DY,]=NV-X^,2J=1$T198AR1`6B
M$E&%J$;4(&H1=8AZ1(.#W`80N1Y[])CHTS(U9`\3]$5ND11P^C2@%%49HAQ1
M@:A$5"&J$36(6D0=HAZ1^!"Y.6T94OEA<?D9XM?M^]=MLGUYV5\\['Z(CX;3
MFS;HUZ$CEY\TOUN+;YJ/7UF#DKG^VCDON8WIHV7463E?;&+Q.*BOA$SHJ49/
MR?(F%@_G^4KHR.@9,T_)FFSHDL82^D#[;^,FAA\9N?)ZHE/TZA=TN#[_R_@W
MBCM6?+>D8_7Q**8O8GKTJYB^Z>CA:SHS'Z?(^@*;KE:QV!*A)]H"Q6+/@R6T
MQXG%I@9+:!,3BUT+EM`L2_7X&I"F4:K'5T+S)-7C*Z&)D.KQE="/,%2/KVGI
M5Q:JQU="/Z-0/;X2^IV$ZO&54(Z0ZO$U,24!J1Y?"67YJ!Y?":7QJ!Y?"=T7
M&6>4_L"(THV/L;C3$4OHSL98W,J()73K8BSN5<02NE6'ZO'U-+H7A^KQE=#-
M-E2/KX3NIJ%Z?"7T.%TL'@C"(Z"GZF+QS)RO9$DEOJN#GB.B$I\W>M2.+BA?
M"3W30S:^/DK/&\;B:4(\`GK4C4I\1T!/6%&)KQYZ"#$6CU&A-WH6,19/&OI*
MEE3BJX>>OJ(2G[<[\G;G+4FH1#Q-AO704YJQ>`;35[*D$M\1T$-H5.+S1H]N
MQN+A,X^W!7F3JV@VH-)+@&+QUA^TH;?\Q.*U/EA"K_&)Q7M[L(3>,T'U^,8]
M>I$$U>,KH3=%4#V^$GH5!-7C*Z$7D<;BS:-X!/2FT5B\6A1+Z%6BL7AW*);0
MNT)C\7)0+*'WY-'Y^"8<>A$>G8^OA-YT1^?C*Z%7V='Y^$KHVR!T/K[QC3[^
M0>?C*Z&O>]#Y^$KH\QUT/KX2>E\]U>/K;_1">JK'5T)OG*=Z?"7T2GFJQU="
M7YF,Q7?R,*+TL<E8?$K25T)CHEP.LCY*G]>C$I\W^@(EK0=\)?2I.[+Q]5'Z
M#&<L/K*)1T!?@*02WZA,'QZD$E\]]&W.6'Q=$+W1)SIC\0%.7PG-"]YZZ*.$
M5.+S=D?>Q-<5T5M")8FWA#Y>&HM/DZ)-2F<JOHKI*Z$>XO5&7S2-Q3<9R>;Z
MV$#[3Q^^WW_==O?O7Y_?]A<OVR^T/KT9OZCS_OQ5;,'D_QQVWVG=>GGQ>7<X
M[%['?SYM[Q^W]#G@&[%%^[+;'?3_B`I^[MZ_[9^VV\.G_P@```#__P,`4$L#
M!!0`!@`(````(0`0#O/(^`T``&U/```9````>&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;*R<V6[C.!:&[P>8=S!\WW&\91$J:52L?1T,9KEV.4IB5!P%MJNJ
M^^W[4"3-Y6=L.NB;4N7C?PZIPTTD+7WY_8_-Z^!GN]VMN[>[X?CB<CAHWU;=
MX_KM^6[XW__$O]T,![O]\NUQ^=J]M7?#/]O=\/?[?_[CRZ]N^WWWTK;[`7EX
MV]T-7_;[]V`TVJU>VLUR=]&]MV^4\M1M-\L]_;E]'NW>M^WRL3?:O(XFEY=7
MH\UR_3;D'H*MCX_NZ6F]:L-N]6/3ONVYDVW[NMQ3^7<OZ_>=]+99^;C;++??
M?[S_MNHV[^3BV_IUO?^S=SH<;%9!]OS6;9??7NF^_QC/EBOIN_\#W&_6JVVW
MZY[V%^1NQ`N*]WP[NAV1I_LOCVNZ`Q;VP;9]NAM^'0?-;#(<W7_I`_2_=?MK
MI_U_L'OI?B7;]6.Y?FLIVE1/K`:^==UW)LT>&2+C$5C'?0W\:SMX;)^6/U[W
M_^Y^I>WZ^65/U3VG.V(W%CS^&;:[%464W%Q,YLS3JGNE`M"_@\V:-0V*R/*/
M_OIK_;A_N1M.KB\F-_/Q_(KT@V_M;A^OF<_A8/5CM^\V_^>JL?#%O4R$%[H*
M+].KB_GUY73,G!PQG`I#N@I#/[N9L*.KL!M/+F:3^?7-J1RI//T-T_6\HEX)
M0[J>5=1K84?7,XM*?;0O*EW/*^JM,*3K644=4_/CK8&U0U'1GG$='UH2_>>\
MXHYE\QF?VPS&LAVP_\@"WUZ,9Y=]ZSW2\%@?X;>J&L+1IC?B':?OA^%RO[S_
MLNU^#6APH]O=O2_94#D.F%?9`WGFAS[Y49>DOLB\?&5N[H948]39=C2._+R?
MS"Z_C'Y2WU\)S8-#8RH64L$Z.G,;VB"R06R#Q`:I#3(;Y#8H;%#:H+)!;8-&
M`R.*]2'@U%K^CH`S-RS@,E0/$J@:F%K1E0II$MH@LD%L@\0&J0TR&^0V*&Q0
MVJ"R06V#1@-&=*D+_AW196[NAO3OD>8L--1G#J)K*^('R2'D0"(@,9`$2`HD
M`Y(#*8"40"H@-9!&)T;X:1S[.\+/W-"`1)5\""T.)UPT/1;_@^00?R`1D!A(
M`B0%D@')@11`2B`5D!I(HQ,C_A0,(_[NYR@Y:#-U'V89G@=.**:2+("$0"(@
M,9`$2`HD`Y(#*8"40"H@-9!&)T8(Z0'IC!`RM1E"3J9TT=KNV!H8#B(9YQ!(
M!"0&D@!)@61`<B`%D!)(!:0&TNC$B"H]/IX15:8VH\J)WC"!A$`B(#&0!$@*
M)`.2`RF`E$`J(#601B=&"-F:5W]2.]ZWF=H,(2=3NF@-<V(US(/HT#"!1$!B
M(`F0%$@&)`=2`"F!5$!J((U.C*C2(^L9465J,ZJ<S/B"DCVS+H"$0"(@,9`$
M2`HD`Y(#*8"40"H@-9!&)T8(V;KKC!CV<C.($LW4O".1FHI"B:X.JD@BI8H1
M)1(IPU0B99@ARB52AH5$RK!$5$FD#&N)E&%C(#.D;/7@W]G9ZM5JEP+-])!R
MU4R5()0JF@VU0<%:.$1*)4>%&%&BD.YK;@XPJ5))7QFB7"'=UY7IJU`JZ:M$
M5"FD^[(>U6NEDKX:`YG5PY8?>O7P5?/%-8OCRWKU_:&C<%*X'6/TE%;'8LW,
M%S'TF"NS?&"/O%211JT)I-<:1U.Z:+4V,Z,3"5^DDNYCZ5[Y2E"5(LK0,$=5
M@:A$PPI5-:+&,#2#SU8?>O`=0:9]NT.4^6*%_,DP/+"-&HKRI-^;[.MB(=#X
MYJ`*!:+NHD5Y<F-'F?O2.E6L#&6.":(4488H1U0@*A%5B&I$C4#\MLTHLS7&
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MRVNC5CDR1F%`X9@C8Q0&%`N5YBM!PQ11AH8YJ@I$)1I6J*H1-8:A$6EZ8#<C
M?7P4[N7F$XQ`)T9A+U7HI8J$ZL0H[.4K\5*E7CEF7KYR+U7AE6/IY:OR4M5>
M.3:G?)F-B^V.Z-WX1./BFREZ?V4K'?;@>WR*]U*%7JI(J$XU+I]R)5XYIEXY
M9EZ^<B]5X95CZ>6K\E+57CDVIWR9C8OMV.B-ZU-S!"V2[2690-JXOD`4"J3/
M$8AB-$Q0E2+*T#!'58&H1,,*536BQC`T(\WV8_1(G^C&?/O&Z,8<Z6=-$T`A
MH@A1C"A!E"+*$.6("D0EH@I1C:@QD!E2MD5S1DCYCHX14HZ,D`(*V;X"C9^:
M*D(4(TH0I8@R1#FB`E&)J$)4(VH,9(:4;2&<$5*^XV"$E",ZSI.;C`LV\;#X
M*10BBA#%B!)$*:(,48ZH0%0BJA#5B!H#F2&U-T-.='S<]:`=*Q8__2P/48@H
M0A0C2A"EB#)$.:("48FH0E0C:@QDAO2\78\)[GI(I+:(%A*I,XA0(K5C&$FD
M5#&B1")EF$JD##-$N43*L)!(&9:(*HF482V1,FP,9(:4K5K/Z/A\D6MT?([T
M(R*:_?N&JTH0*J1M_LSL@SVEDH-(C"A12/=E'^PIE?25(<H5TGU9VV"%4DE?
M):)*(=V7M7"OE4KZ:@QD5@];.>O5\[GG-+[^-FJ-(Z/6!-)KC2/S8&]N[7Q$
MDX-*WE$LD'8*E:`J192A88ZJ`E&)AA6J:D2-86@$GRUCC.`?'\%[N;F\%XC6
M?3(R"ZG2)D6!3ASL*97T%2-*$*6(,D0YH@)1B:A"5"-J!*)=*RJ]&>7SUKE3
M7.<*Q!9`:F-Y9A_L294ZU`H%LG8$[>8M#<6!V<W5C>4ZE@KE.O%RG4K##UUG
M4J%<YX@*=V[6R%.B886H]O+5&(9F?=I+RQ.]!M>0;+AA^Q;T^*W5IWVL)U5J
MY@L%.G&L)PWYL=[\]O+*FCIBJ5"N$T2I.S<KZ!D:YFY#J]D5TO##8I92H8I9
M(:K=N5G%;`Q#LS[M!>RGIJ`IKFL%HLE/#F@+1*%`^E8!HA@-$U2EB#(TS%%5
M("K1L$)5C:@Q#,U(L_6F/MF?Z#E\>:K/ZA2EON?0PDOU'#C4\U*%7JI(J-CP
M_G&.L9>OQ$N5>N68>?G*O52%5XZEEZ_*2U5[Y=B<\F4V+K88/Z-Q\;6[T;C$
M<EX[U*.MD;Z]J=DI%.C4G"H,^<1W?7T]MY8",;I.O%RGTO#(G`JESKU<%Z9K
MQ\Q12H4*2(6H=N<&0[)>3+,N[:V%SPW)N./`WA)@,Z\^)`,*A8J:GQRX(T0Q
M^DI0E2+*T#!'58&H1,,*536BQC`T(WW>CL,4=QP$8OM$'P^0"R]5Z*6*A.K4
MD,R+>KQ<B5>.J5>.F9>OW$M5>.58>OFJO%2U5X[-*5]FXSIO[X6]*4&=TQB2
M.3I>B0MA>%P5>JDBH3K5N'S*E7CEF'KEF'GYRKU4A5>.I9>ORDM5>^78G/)E
M-BZV*://]Y^;(_C6CM'F.#+F"$#AE"-CC@`4"Y7F*T'#%%&&ACFJ"D0E&E:H
MJA$UAJ$1Z=EYVT2]W.S&`M%C@9Q0%XA"1!&B&%&"*$64(<H1%8A*1!6B&E%C
M(#.D]IX0:[S3&_;-#?'Y"^\/`=#IB3UJ"L2ZDYJ2Y]9/>Q=*)2LE1!0ABA$E
MB%)$&:(<48&H1%0AJA$U!C)KX+Q='/:X;\U-`AF-FJLT%*(J0A0C2A"EB#)$
M.:("48FH0E0C8E^G89'@]\A#RK\VP[]RL6FWS^VB?7W=#5;=#_8EF:LK^GGY
M`?//W#Q,9@$[K:66!RES2ND'"DBYHI1^+\A.F5W25W/Z/6A(8=_3Z1=TD#*1
M7]JQ4Z@`SOPI>V?NUP&]0^JXDYN`WH)T\-N`7NUS\,F4[F_J2*'))HAH?$8;
MFDT"-GU@"DT7`9L?,(7F@X!-`)A"'Q_ZVB_L[(A0$)TQI!`Z]70CKOOX.@N^
M4O/!C!^H-;@:`VV.T8V[7-'N%]VX*X6VM^C&72FT?T4W[DJA%1_EXZI<6M)1
M/JX46K-1/JX46I11/JX4.J`+V`D01H#.Z0)VZH,I=!`7L,,?3*'SN(`=^&`*
M';A1S;A2PNDEE<W55>@W2T%$/_-!;_2CI(#]"@E3Z%='5&I7"OVLB,KF2GF@
MLCTXR[:@E(4SA4Y7J6RNSA1.J&LX;>A@-6#'=%AJ.E^E^W&ET!L6`7NEPF%#
M*>R="4RA=R0"]E($IM!+$`%[ZP%3Z#?$E(^K!/0C8<K'E4*_`J9\7"GT,U_*
MQY5";WH&[%5"+`&]\$G>7"GT1F?`WB)$&WJQD_)QI=";FS1"N%+HI3ZR<?6Y
M![)AKU]B/@M*63A3Z/59BIMK*`K'U'J=-O3F;,#>P\1\Z`5:BG6?,CJ,>/2Q
ML_?E<ULMM\_KM]W@M7VB*>RR?]%TRS^7QO_8=^_TC$M?/.OV])6S_K\O]%F[
MEEY(O[R@I[BGKMO+/RCKT>%#>?=_`0``__\#`%!+`P04``8`"````"$`G`N_
M5D()``#3,```&````'AL+W=O<FMS:&5E=',O<VAE970U+GAM;)R;;6_JN!+'
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M`P^T[+-3_70W_XVM51+/E_>WG4#_V]7O;>_W6?O2O/_SM'O\8W>L06V8)ST#
M#TWS3:._/^JWH/-RT%MU,_#7:?98/VW>]N=_-^__JG?/+V>8[A0\THZM'W^*
MNMV"HF#FAJ?:TK;9PP#@Y^RPTZ$!BFQ^=*_ON\?SR]T\SF[2/(H9X+.'NCVK
MG38YGVW?VG-S^#]"S)A"(]P8@5=CA$4W+(FR3]B(C0UXO=A(;O@J9>EGK"3&
M"KP:*QQ^G>@&.-QI`:^F\Q>TR(P1>+WX44S48HESTTVUV)PW][>GYGT&ZP?4
M;U\W>C6R-=B]S#'.B)WU:Y,.LZV-_*:M=+9@/EN(U._W+(INE]\ANK:&*9$I
MYK,>PUVF&F-BEQ%#)B./DB,(<ZVH$>1C,$L0QRH$D4<5BF$MC:^"BR"Z$Q6$
M#*%$INC"7:M8T3<$?4/2-U3O#6?0$.K]0?L'J^&[.9CJS4SBZE4BL^KF-D]Y
MFKKM5;\]_E"R"P_1;^0QS_+"[2T=($^)4JK?O&!9Q*/<&G#<A@4YW6T-4[>)
M6R4R\--*\_'DSK<*B;P3)N91FL8KZG[0B`P2RD<X$D"&Z4N@%W0X7'4GX'IN
MLBBS$G>.ELC`.*Y*$21$D)!!0OD(1PE(9Y]70G>B04&FO$0FP3R7D_Q475JO
MZB0N1)<G:7]Y:;W:7_D(1X%\J$`"\OFS@>Y$%5B16$#&%PM(X+)813PE^40$
M+<@@H7R$HX.N2,DF%UX3NA/5@>2M$AGTDK-!4L1F$RBNA()T)?K(2]?K4>`C
M'.]AR_V\][H3\9Z1;;9$QA<%2*`^:9Y&M"@001,R2"@?X0C!8-ON*^%?!QU-
M)2`[4VD@D_[CK"`;2&4`$P.DNZ#=5S0,;/?K<>!%7/]UT?/I=<"P5'+*`T:V
MN-)`J`-C>J;I7%<3&&$83TS),**\B"N)+J!ZD@1"`LLM5PJ2_TN&D$D*<4*D
MJDR[QT41,"'#)I07<270U55/@FD5`\.:K"]%0?=)PV#L+TCNK&SKU=`6841:
M1&^F]!G*MHX]PU4!YN,+*NA>-$>0-5PRA"XRD"Q:V>:Q,6+]'$:D15`'\A!E
MF\<>X@JAZZM>.`16!%9C3AB0@"_U9P8@$BZ(19+DQ2`4D/`NB2`BS7,\5I1O
M**X*NL::K@)69'T5(`>Z&W[)$$(9LE7.B4Z5`3!.$A)%PNG.<Q;14Y9TB2PE
M]I73OH"C"GR<9L?H>J\KJ^G>8QWF>O]A&4\/S%>LX4G*("A0DG`X@L3$C`B;
MD6%$>1%7"5UE]928F!RQ-O.?IYBO@#.*!!$1MB+#B/(BKB"ZVOJ\(%BC.2'2
M.\.;$+D4<MVY*"/[:L4NS6,IK+,@+#)J0=KFJQ:4%W&$X*28U)$1/EQUO<B&
M$='3E8$\B:PR"*Z5/$I79.\581LRC"@OXLKQI=J2C]26$=D=2@.9O!"QF.A5
M&0`3)VD4@]YD:Y2V]_6H\"*N#!#BGU\>7/<B43$X;1G(&Q5H!Y5:1;!%%,1;
M$;8BPXCR(JX@I+KTEQ-\6%4R1@Y-I8%,/,3)BF8*`V`\T*.*H-US8E_:[IZ`
MP'&.SX7K/S!?"`C=BP8$V<]+_?6#K:L8?"8Z/%]7$QAAF'%GNL0JPXCR(JXD
MNI3K;2&!D,#"S]DZ&)GQ4G\99*7@O"!)H#+M'A=%P(0,FU!>Q)6`E)?3R@H^
M+#,'9R[#8.R3B*ELX]7(%F%$6D3OLN01RC:./<+5@!29$S48*S9)K5SR2[&I
M1UB0]5W9UK$A8B$11J1%QIZA;.O8,UP92(496`U8$?970T&FH.3(8'Y<I`7C
M9+E4AO`NAV#I*<-6E&\HK@JDK`RH,%).,E(!E1PAE*%(\YQ$264`7"H9:15.
M]QB^MBX((1V"YPDY\"FG?<&SA/&/TL;Q7G\8/3TC=C3='$C&*PV$WF=)G!8I
MS9K5!$88QA,J,HPH+^)*\:4Z,L8ZTG_@,I#'E2J,B#`BPXCR(JX@NJ;K[9;3
MTF2,E6`_3[#!@<M`&"-I$M$T8=I-'64_*L`423N3+"1MY[$,V)E07L05@521
MTPY;\4@U.3AL&<@;%6@'=5HE$>=DM8FP$1E&E!=Q]8#A?B$H="^2.`:GK1@A
M=);E+"9IKS+`:(4A!KT'88'FX>>UKY&5?<`8XLI`*LF):V.LHB3GI#)&R#/.
MRB"H%$_B.*/!)<)69!A17L05A-25_FTT'M:3P].6@8R7^2H=?#!C"!,09,+%
MH']"ZC%I^X_-M\D4.-+QV7`5^%)5&8]5E<23TD!&"9;!TA@</2<PPC#CSG3^
MRC"BO(@KR:<JS'A883):.90&0BF2-"'YL#+M'A=%P(0,FU!>Q)6`E)<3$\6P
MS!R<MV)D,/@7@QWTTGHUM(4U<!61%M%'#?H,95O'##@J)*3,G*9"UXOL&HQL
M"J6!C`R#4MLVCXT1ZXDP(BW2Z4`?HFSSV$-<(4B1Z4^3R?!#RL&9RS"X(!8K
MN`I"-I3*$+XE$49D&%&^H;@JD,HRH,)(1<D^SC/=))8)0GA-,&9%/K@/X1`K
MTE\XK5D&7W.14YUT")YE)/,HIWT1)VG_LJ'K/JDI`^Z/U)*<S'$)M[$_/H9:
M%3S)5O1;NFH"(PSCB1491O3=<#V:<2LH!=[]Q@O!A_KT7%?U?M_.MLV;OM>=
MP@TW^R[>.2_9NN3ZQBIYOV+K:NQ]P=9B['W)UG"9=6A'P9WV[OVE?0!<*7_=
M/-=_;D[/NV,[V]=/,+3H)H<"[827TO&/<_/:W;A]:,YPF;S[]07^>:"&F[71
M#<!/37.^_*&OO=M_1[C_&P``__\#`%!+`P04``8`"````"$`+!I(,E,'``"M
M'P``&````'AL+W=O<FMS:&5E=',O<VAE970V+GAM;)Q9VV[C-A!]+]!_,/P>
M6R1U#9(L*@G;%FB!HNCE6;'E6%C;,B1EL_OW'6IHD3-R9*4OV4WF<'3FQD.)
M#Y^^'0^+KV735O7I<2E6WG)1GC;UMCJ]/"[__NOS7;Q<M%UQVA:'^E0^+K^7
M[?+3TX\_/+S5S9=V7Y;=`CR<VL?EONO.]^MUN]F7QZ)=U>?R!)9=W1R+#GYM
M7M;MN2F+;;_H>%A+SPO7QZ(Z+='#?3/'1[W;59LRKS>OQ_+4H9.F/!0=\&_W
MU;F]>#MNYK@[%LV7U_/=ICZ>P<5S=:BZ[[W3Y>*XN?_UY50WQ?,!XOXF_&)S
M\=W_,G)_K#9-W=:[;@7NUDAT''.R3M;@Z>EA6T$$.NV+IMP]+G\2][F*E^NG
MASY!_U3E6^O\?]'NZ[>?FVK[6W4J(=M0)UV!Y[K^HJ&_;O6?8/%ZM/IS7X$_
MFL6VW!6OA^[/^NV7LGK9=U#N`"+2@=UOO^=ENX&,@IN5#+2G37T``O!S<:QT
M:T!&BF_]OV_5MML_+E6X"B)/"8`OGLNV^UQIE\O%YK7MZN._"!+&%3J1QHD/
M[(U=KF0<B""\[66-C/H`\Z(KGAZ:^FT!70//;,^%[D%Q#YXOD2&/(=;W0H48
MM9.?M)?>%T310GV^/@DI'M9?(:<;@TD1DRP7`T921'9!Z`1JM[GSAS7P'4A#
M*CAI!46]7HX+1[V(<E2*$DBO0"@BNX+P*20?0Z)H@)`P%`UCFKX&0]\XZ1.2
M)3!%#)1Q2+%]<I_1["8BGT(0]O`8MPC3[#7X<0FI&9@EG#Q"XKY[[F(1!-Z0
M->1.`$$B)"M?3@"^'R7)X($PAYESF>N>O]T^>A'//R.0(@9H#%'R_-]$Y%,(
M$D5(HYC.OP;3_`O)&C=%3(3CFRA6G\PU2\]GD>7$+/WX>NJCCY#68$XZ&/SV
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MT6C:\8I5/A6(,0WO^W;4#'W7+L85(.;`#@2EK35K/FU4.+=OU*CA+RK8[QV1
MQSHCTX=O"!W#XL>XG%BE;ZM*66O%FL\:]<UE[3.Q205BD)6,1J1=\UW"2I&3
MU>J]5&O%<DC/;';4.9>\X/J>"E<,(ZE&]%V[BD*[B9A-QK5+SPF?IEVKEA/!
MC1Y'C:/,1WE'D#D$*$<*39.[0ADD-K6&N&L&&;8S1(EKR9I/'`6.$F=/3@6"
MS`$@C,*0#4)&$7X2Q:.T$Q\J"-_3)?DA.>W1[+RK6,NF!@2;Q+")VDT:<W\;
MDD]"2`DDD]9YW=^OHOLDG+784<R`L!0JCGF79`00P'@PJ<LI0'B>;5,:!/3$
M_#Z2&LW)LR2G!F3Z2,"[M[!-;.J`?BZMELB`%3.G3@(9.7-$`]"2-WL0)`HD
M'03&+C4@P\Z7@L^!`1@=4TYN<8:I/?#L>DI=ZYE#?68#H0K2$.P3>@:I=*5R
M=+)D5A9_3LRAM5+R'Y)9_4V(-X[/>C8U()/W*/+Y)X6,(D28Q,Q'3A$27MR'
MT:+T/Z2W$L42FF?86H2CY";G%T6U(#8:F?$SL47EDQ`:@I8XIWVFM4NB()*V
M<8[>)@2BFDD0C@[)Q@W6*%91S%0D)P#8EYSO(I2]UCF'_<SF1W6D4=BMS42!
M(.08^'P\,WF1V'<+E4]":!P?$F)Y18A]EL+4@,P<".'Q5[",(E02V5-EGX*<
M``+/LV-"R.L/!Q\O0K^*J0`_RZ<&--'JV6U(;B"75,C`*2:-A(GQ]#`H?$6E
M;<1%V(`N;RL1.^MDU.YL-%@":HZM=\H;./R/"NA5O`)LLTD5@C!W,DX"YPMD
M3S$CB"B)G,.:B8&Z\-][$5!,A.<-<[^*1V'EIJ>0&M!%:X?=W$2`>FY><J@Q
MITNM1-(":*7\\#ZD4%\A/8X@V"<8Z@C"`@AXW?6L&!GZ!"&3T;<2\QS3_PD<
M!8<8:11,C6<6X(HJ\P_=J4*0:2,_'DD"`<!9C[=93@!2R-AV*@V":?+,(%!V
M22D"MA^F"D&F%&'B>Z-I=A'PQ9B'F5,7)$P:!9/EF5&@\I(31L`XI@I!T#1#
MU]E4FHZZ"<DGO=!0F$;?V%2O:'/`M1DN1O7.A1<K0CI'8\.?V-7H>$'7!\Y[
M#S+'6U.\5#R6S4N9E8=#N]C4K_I&5,#'Z^&O>%N;PFUM?[6Y'@QP67HN7LK?
MB^:E.K6+0[F#I=XJ@D%H\+H5?^GJ<W^%]UQW<$W:_W</U^(E7!9Z*P#OZKJ[
M_*(O=(>+]J?_````__\#`%!+`P04``8`"````"$`IV="T^T"``#I"```&```
M`'AL+W=O<FMS:&5E=',O<VAE970W+GAM;)16RV[;,!"\%^@_$+S'M/Q,#,N!
MTR!M@18HBC[.M$1)1$11(.DX^?ONDK8@66ZB7&QK/9SA["ZY6M\^JY(\"6.E
MKF(:C<:4B"K1J:SRF/[^]7!U38EUO$IYJ2L1TQ=AZ>WFXX?U09M'6PCA"#!4
M-J:%<_6*,9L40G$[TK6HX)],&\4=/)J<V=H(GOI%JF23\7C!%)<5#0PK,X1#
M9YE,Q+U.]DI4+I`847('^[>%K.V)325#Z!0WC_OZ*M&J!HJ=+*5[\:24J&3U
M-:^TX;L2?#]',YZ<N/U#CU[)Q&BK,S<".A8VVO=\PVX8,&W6J00'F'9B1!;3
M;;2ZBZ:4;=8^07^D.-C6;V(+??AL9/I-5@*R#77""NRT?D3HUQ1#L)CU5C_X
M"OPP)!49WY?NISY\$3(O')1[#H[0V"I]N1<V@8P"S6@R1Z9$E[`!^"1*8FM`
M1OBS_S[(U!4QG<Y'\^5X&@&<[(1U#Q(I*4GVUFGU-X"B(U4@F1Q)X/M$LAA*
MPL*&O+][[OAF;?2!0-.`I*TYMF"T`N++AL`)8K<(CND-);!7"U5XVD3SV9H]
M0>:2(^8N8."SP4P:!`/11AG4ABLC&)4QM;B5NQ!HRTPORTS?(X-@J$UK\WV#
M`3-K89:7E0$RW"""H09@J\E;7SJ`!DA#4PV71K"7;I(;(C-_)-HE6W1I\11,
M%MCQ;_0-KNLJ'"-P$%MVYY?SN.RJOMZB".Y*A4C?#-[-K<Y',]/E>/2F&5S7
M53A&VLT8S1>7S<#A::N^;@;!7:D0Z9N)()-M7G]!+>!Z>*LT?F%7XQ3J^OE/
MDT>`:@N_;LBCS]20(*87+)U=$(,+A(?H+&VG4-?2]>42P2!YCZ5P'X!"<WP\
M0<=2&"SAXE7"Y.*3*$M+$KW'H3&!J[2)-@-MZQG/X[/5-@PZUOP#@Z;FN?C.
M32XK2TJ1`>=XM(3:FS"JPH/3-:0>QHUV,&+\SP)>*01<I[[M,ZW=Z0&\L.8E
M9?,/``#__P,`4$L#!!0`!@`(````(0"B9Q-@^QL``->V```8````>&PO=V]R
M:W-H965T<R]S:&5E=#@N>&ULK)U;;]O(ED;?!YC_8/C]Q*9DR7:0Y""Q>.<`
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M19G?5+^1A=^(?B8V\L3$I9]X-DX\GQ[\B7GZU?:_M7[.>\"UGW@^3CSL`?5Z
MV3^@?LY[P$L_,7-[MG=WV"-FXY[1_\Q[S&S8'^Y_#GG0D[XI]CVVN7Z\?O?F
M?O?C2*]</?3#]VMW',A>NXT-W=7OFK'??M9NZC.WE?=N,V^/I4*=]*`7R9_O
MLM7EFY,_U=<WON8#:Q:VXFJH<$WL-KN)01Z#(@9E#*H8U#%H8M#&H`O`B<2-
M]B3L5]ASFW'VAN?]80"3SF6D:J@8IFQBD,>@B$$9@RH&=0R:&+0QZ`)@5.E`
M`%5+O632A[&AK]PL';">["M?HR/%V'SGD:VQ9-0%DH,4("5(!5*#-"`M2!<2
MXTT'3GASA_^9+U"W&;W&M7=&27R%]D7+ITR.):-)D!RD`"E!*I`:I`%I0;J0
M&)-Z6L;DTYWGJO?"AB?ZH2>R,Y`KD`U(#E*`E"`52`W2@+0@74B,#+U-SI#A
MJJV,GBCW!/VT/HU>=F/18&P#DH,4("5(!5*#-"`M2!<2XT?Q888?5VW]]"1L
M%I`-2`Y2@)0@%4@-TH"T(%U(C`QW+A&&A*=?.:[:RNC)4MN?#C[K+&J6L6AL
M%I`<I``I02J0&J0!:4&ZD!@_RCTS_+AJZZ<G8;.`;$!RD`*D!*E`:I`&I`7I
M0F)DN!QL;+A(N5B]TJ%HYGO6?DO6E$=+[8J@E9`CW:^@V'`Q'JHWT\2AO7*B
M@J@DJHAJHH:H)>H,LAY=Z#S\5>?.)J*V\BCL*Z(-44Y4$)5$%5%-U!"U1)U!
MUHS+F#/,])%4V6?8]1]<#G(-8H](<<:>JH:)&Z*<J"`JB2JBFJ@A:HDZ@ZPL
MERQGR.J#J+8W/.</69A-]^=E5T0;HIRH("J)*J*:J"%JB71MIM_5^]AFS;BD
M&)IY^8&JSYQ&FH^A]D!U%KWG96/58'M#E!,51"511503-40M46>0]>A"9NCQ
MZ7C@3E[B`U484WV'`6W\Q.!PEA,51"511503-40M46>0->/BY0PS?1HU;>0#
M:GB@6J[C+AJ+IBX"RC.@@J@DJHAJHH:H)>H,LJY<^ISARI5'V:!'07]<94`;
MHIRH("J)*J*:J"%JB3J#K!F7.V>8Z6.JZ:(>1:EI%;?16#6U$5">`15$)5%%
M5!,U1"U19Y"5Y7+I#%E]C#6RPF3K#T9`FPPH)RJ(2J**J"9JB%JBSB!C9A'G
M\J</T_MR^P+SR*2F97RI;2H:NX@H)RJ(2J**J"9JB%JBSB#K:E[V7C![>Q0>
MC(@V1#E10502540U44/4$G4&63-Q]G:A::7G/_/<;L%0[E%TE(K?[*:JJ;]\
MFI].]W)6%40E4454$S5$+5%GD+4X+Y0O&,H],OT5)MW^_@FK<J*"J"2JB&JB
MAJ@EZ@RR9N)0_LQ1BLE[X3.UWOJ#2P0X3(U54QL!Y=.VAJJ"J"2JB&JBAJ@E
MZ@RRLN8E;W>_-\I,'IDV8O)F54Y4$)5$%5%-U!"U1)U!UHP+NV$,<(>IY86[
M0S[[2-7GYC`B+'R45A0*6NPBRE-3U=`\&Z*<J"`JB2JBFJ@A:HDZ@ZQ(EZ!#
MD<^\'OO`;60A@U\M@#9$.5%!5!)51#510]02=099,RX(SS#3YV9C9HS281M%
MM\VO%F/5U$9`.:L*HI*H(JJ)&J*6J#/(RG)Q>8:L/ET;60C<5PN@#5%.5!"5
M1!513=00M42=0<:,NP=NS+SX*M1^2S:Q>V0CU7E\FVZJ&CN,*"<JB$JBBJ@F
M:HA:HLX@ZW%>9%\RLGL4OA<2;8ARHH*H)*J(:J*&J"7J#+)FXLC^]"%\R63N
MD3GQR\[C&WA3U=1&/IF?CU>3<U851"511503-40M46>0E34OF2^9S#TR;<1D
MSJJ<J"`JB2JBFJ@A:HDZ@ZP9%X_#0_C+(]6R3]KAX=VCZ$@5W]B;JJ86\ZD]
M./EC54%4$E5$-5%#U!)U!EF1\U*[&BE.[1XMIT^,71%MB'*B@J@DJHAJHH:H
M)>H,LF92J?U%MX[=!U.B4QV/SO1^.X7V\_B>WU0U=5B_+4T<4,ZJ@J@DJHAJ
MHH:H)>H,LA[GA79W7(]E^80>=AC0QD\,^C`G*HA*HHJH)FJ(6J+.(&O&)>?P
M(/;,>V$?M,V!JD=1&\4W]MQQ3$J#GMD0Y40%44E4$=5$#5%+U!ED9<T+[6H#
MM)%/Z&$;`6W\1--&J"I851)51#510]02=089,V[OSVBC?;E-YAZY'\'1*+XE
M,U4-AYX-44Y4$)5$%5%-U!"U1)U!5M:\9'[&9.Z1WC@&#5=$&Z*<J"`JB2JB
MFJ@A:HDZ@ZR9><G\C,G<(W?`"]HHOF8^50W^-D0Y44%4$E5$-5%#U!)U!EE9
M\Y+Y&9.Y1Z:-F,Q9E1,51"511503-40M46>0-9-*YNOEJ_/Y%SO/F,P]<F\3
M08O%U].GJJG%F,Q951"51!513=00M42=05;DO&1^QF3ND6FQOBI`&U;E1`51
M2501U40-44O4&63-I)+YRZZGGS&:>Q2U6'P]?:J:6JS?EB8.*&=50502540U
M44/4$G4&69$N11\>0,_ZT!T&4(^"?KHBVA#E1`512501U40-44O4&63-N,@\
MPTR?L(V9'D5OAO'U]+.Q:NB9#5%.5!"51!513=00M42=05:6R\<S9/5QVLCR
M"3O,5$";,Z"<J"`JB2JBFJ@A:HDZ@XR951S-W66JE[T9[C=E8[M']DAU$5]0
MGZK&%B/*B0JBDJ@BJHD:HI:H,\B*G!?;W6=`HHL('H5'*J(-44Y4$)5$%5%-
MU!"U1)U!UDP<VU]\RV;%1.]1U&'QM?:I:NJP?EOA>R&K"J*2J"*JB1JBEJ@S
MR'J<E^A73/0>F0YCHF=53E00E40544W4$+5$G4'63)SHG[Y,M6)J]\B^%U[$
MU].GJJF-?&H/;MFPJB`JB2JBFJ@A:HDZ@ZRL>:E]Q=3ND6DCIG96Y40%44E4
M$=5$#5%+U!EDS?RZU+YB:O<H.E+%%]2GJJG%F-I951"51!513=00M42=05;D
MO-2^8FKWR+187Q6@#:MRHH*H)*J(:J*&J"7J#+)FXM3NW@O/]04CLS]GM6*@
M]RCJL/A:^U0U=9C/^,%Y(:L*HI*H(JJ)&J*6J#/(>G1!^_!`O^IS>1CH/0K:
MZ8IH0Y03%40E4454$S5$+5%GD#&S3@7Z%]T4W&_)YGF/H@Z++\-/56.'$>5$
M!5%)5!'51`U12]099#W.R_-KYGF/P@XCVA#E1`512501U40-44O4&63-Q'G^
MZ;2U9FCW*&JC^#+\5#6U$4,[JPJBDJ@BJHD:HI:H,\C*FA?:UPSM'IDV8FAG
M54Y4$)5$%5%-U!"U1)U!ULR\T+YF:/?(A/:S^.UN*IJZB)F=50512501U40-
M44O4&61=S<OL:V9VCTP7,;.S*B<JB$JBBJ@F:HA:HLX@:^;79?8U,[M'T8$J
MOIDS54TMQLS.JH*H)*J(:J*&J"7J#+(BYV7V-3.[1Z;%F-E9E1,51"511503
M-40M46>0-1-G]F?>[QC,USY?R\9T3_`BOF$S54UM-$X<4,ZJ@J@DJHAJHH:H
M)>H,LK+F!?,U@[E'IHWZJ@!M6)43%40E4454$S5$+5%GD#%SG@KF+[LGN-^4
M3>8>14>J^&;.5#7TTX8H)RJ(2J**J"9JB%JBSB`K<EXR/V<R]RCHIRNB#5%.
M5!"51!513=00M42=0=;,O&1^SF3ND8E4V65\PV:JFMK()_/@.BBK"J*2J"*J
MB1JBEJ@SR,J:E\S/F<P],FW$9,ZJG*@@*HDJHIJH(6J).H.LF3B9O_B&S3E#
MNT?V0'49W["9JJ8.\ZD]N$C%JH*H)*J(:J*&J"7J#+(>YZ5V]_FCZ):@1Z;#
MF-I9E1,51"511503-40M46>0-9-*[2^[ZWS.U.Y1U&+QS9RI:FHQIG96%40E
M4454$S5$+5%GD!4Y+[6?,[5[9%J,J9U5.5%!5!)51#510]02=099,W%J=P>Q
M%\8M)OIS'\SU8TKTE_'-G*EJ:K%QXH!R5A5$)5%%5!,U1"U19Y`5.2_1GS/1
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MD#63"O0O>RMDGK\88WD8MN*K\%/5U&'CQ`'EK"J(2J**J"9JB%JBSB#K<5Z>
MOV">]\AT&/,\JW*B@J@DJHAJHH:H)>H,LF9<<`X_\?'R/'_19_#PTR`>1>^%
M\17ZJ6KHIPU13E00E40544W4$+5$G4%6Y+P\?\$\[Y%I,>9Y5N5$!5%)5!'5
M1`U12]099,Q<QGG^Z??"?;D-[1Y%[X7Q5?BI:FPCHIRH("J)*J*:J"%JB3J#
MK*QYH?V2H=VCL(V(-D0Y44%4$E5$-5%#U!)U!EDSORRT7S*T>V0.5%IB+OHN
MM:EJZC"&=E851"511503-40M46>0]3@OM%\RM'MD.HRAG54Y44%4$E5$-5%#
MU!)U!EDS\T+[)4.[1^9`M3B-K\)/55,;,;2SJB`JB2JBFJ@A:HDZ@ZRL>:']
MDJ'=(]-&#.VLRHD*HI*H(JJ)&J*6J#/(FOEEH?V2H=VCZ$`57X2?JJ8.8VAG
M54%4$E5$-5%#U!)U!EF/\T+[)4.[1Z;#&-I9E1,51"511503-40M46>0-9,*
M[2\Z+;QD9O<HZK#X&OQ4-758ORU-'%#.JH*H)*J(:J*&J"7J#+(>YV7V2V9V
MCTR',;.S*B<JB$JBBJ@F:HA:HLX@8R8[G1?:^WJ;V@<6O1O&U]J#LJ%OM$Z2
M>_C]TC@#TT))8%HI"4Q+)8%IK20P+98$IM62P+1<$IC62PI99&Y>@L].&>$'
M%K95@DE3/S>HDR8P:0*3)C!I`I,F,&D"DR8P:0I9I.F7Q?GLE'E^8-%1++X*
M'Y0-?2:IC/0))JFHDU0P20635#!)!9-4,$D-621U7K;/3AGN!Q;TU%6"21,B
MOWH/3)K`I`E,FL"D"4R:P*0)3)I"%FF:%_2S4R;]@44'M_CZ?%`6-!C#?J).
MYE`G<V`R!R9S8#(')G-@,A>RR-R\U)^=,O8/S#88@W^B3@V&.FD"DR8P:0*3
M)C!I`I,F,&D*6:0I=0KPLD])9*<\"1A8='2++]T'94'S\3P@42>KJ)-5,%D%
MDU4P606353!9#5ED==X)07;*,X*!V>;C.4&B3LV'.FD"DR8P:0*3)C!I`I,F
M,&D*6:3IEYT=9*<\/1A8U'OQ-?V@+.@]GB$DZB05=9(*)JE@D@HFJ6"2"B:I
M(8NDSCM5R$YYKC`PVWL\6TC4J?=0)TU@T@0F36#2!"9-8-($)DTALYKV"XF&
MMY.>OM:?^85'PWM&`S/OK)?QQ?Z@:NJO81G3X-9WHDZKB(;I?;]&C981!=,Z
MHF!:2!1,*XF":2E1,*TE&K)(G$O*<\3UR=J*"].V7S/,K%_:+\>3D6FM5<R5
M)C!I`I,F,&D"DR8P:0*3II!%FESV#36]^),[F=3%GPL>6'1L8^^%"7R0"B:I
M8)(*)JE@D@HFJ6"2"B:I8)(:LDBJ2\JAU.=>M'VRUA:'E]Z'S"QP.O1>F,`'
M36#2!"9-8-($)DU@T@0F36#2!"9-(8LTN5@<:OI_]%Z?L*U!G[KU'C1^]G61
MQ;>@,K,"ZB!UG#KL$$D%DU0P20635#!)!9-4,$D%D]2015)=B`ZE/M=[?>BV
MYL(@/O0>F):8!I,F,&D"DR8P:0*3)C!I`I,F,&D*6:3)I>(YFOH4;37Y9*WD
M&#18?',J,XNC#@TV3@T:#$SFP&0.3.;`9`Y,YL!D#DSF0A:9<T%YCKD^6%MS
M8=@>&@Q,#0:F!@.3)C!I`I,F,&D"DR8P:0*3II!%FEST#36]_'-`F5\7U2H<
MHW78?/%]JV&JWH"'1I/5<>K`9!5,5L%D%4Q6P6053%;!9!5,5D,6675).;3Z
MW-&M3];67,_T_=W#T[_*_/JJ`9,FU$D3F#2!21.8-(%)$Y@T@4D3F#2%S&K:
M+X$Z0Y-?,M5H&MA9H&E@T[>+;K*!K<>Z?&1379%@Y<BFN=7(IKEU@C4CF^:V
M(YOF=I9%FEPN#C6YUVBVVG_#]N.7VYO?/^P<.#Y*=-GR^-V;_9'K?>:75;7V
M^LBM`\349$-=^%H<EF15F`S>0Z*;@Q+J$_R4$"443$+!)!1,0L$D%$Q"P22T
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MR7$X*W+LDGKH^(5'XC[P6_4]TR*6@].KS*\P&S`UM3]9F-[OY!E,9K$]F46=
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M^V5\9^QWO^ROV>^>/;??#RK;9`>5Y4.9JW[J?>B@K97#UIY^"M50]O2#UD/9
MTUMK#BMKA[*G'[0;RG[ZH-%^=V>$X7Y_V='2KW5LVZ$_V=3!9C@*7F6^+F#:
MT7V=.5J2%4-=,%?["W.U<\"T)_"[2#OJY!A,0L.YD3UWGA?:>^9HZ5<YMIK\
M^>-TX4.:P*0)3,T/)DU@T@0F36#2!"9-8-($)DTABS2Y,[0YFOHS.JNI9^9.
M^"+#QWR&U9*GBS<R-TX=&E'FP&0.3.;`9`Y,YL!D#DSFP&0N9)$Y=]XUQUQ_
MGF;-]<Q\U&)8"WEJ.FE"G32!21.8-(%)$Y@T@4D3F#2!25/((DWN!"O4Y(YB
M+_HC@$R:<"O<,WLK/,/'?*:RH<\DM=]<<!%?4L$D%4Q2P2053%+!)!5,4L$D
M-6215'="$TI][N#6GP#9WO/G3E.?Z>`&)DU@T@0F36#2!"9-8-($)DU@T@0F
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MKG4_(S&2:<Y/\I;F_"1MR?5/LJM<_R2YRG4ZMR[DNO\H0>Q`4Y)[9Q^PDGNG
MCZO)YRG3/\FJ,OV3I"K3R9SZ/GO]/OFJTHY.[V<]Q=1OY5Y0"?[^[/7[GYPY
MN!=G8L8'[<;DGM=.3.YW[<+DJT4[,'4L<_=`7N]O>K"'W#V.U_N;&AQS]S!>
M[V]:<$QGB9FVF7PUZ2PPTS:38SK+R[3-Y)A^3S>6?+5I;.&>0VI/Z#DLW'-(
MC>DY+-PV4V/:YLIM,^5>VURY;:;&M,V5V^9^[&1L_(=W;[Y??][^Q_7]Y]MO
M#T=?MY]TZGFZ_Q#4_>UG=Q&D_\?C[OO^PU"_[1X?=W?[__VRO?ZXO7<%N@+P
M:;=['/XA\2<_=O>_[T]OW_U+`````/__`P!02P,$%``&``@````A`/L%\,UX
M"0``:2\``!@```!X;"]W;W)K<VAE971S+W-H965T.2YX;6RLFMN.XD@2AN]7
MVG=`W`]@FU-9535J\-E>:;6:V;VFP56@!HRPJZO[[3?"F>D\A`>24=^4BR\C
M(M-_GB)M/__^XW0<?"^O]:$ZOPR=T60X*,_;:G<XO[\,__PC^FTY'-3-YKS;
M'*MS^3+\6=;#WU__^8_GS^KZK=Z793.`".?Z9;AOFHL_'M?;?7G:U*/J4IZA
MY*VZGC8-_+R^C^O+M=SL6J?3<>Q.)O/Q:7,X#UD$_VH3HWI[.VS+H-I^G,IS
MPX)<R^.F@?;7^\.E%M%.6YMPI\WUV\?EMVUUND"(KX?CH?G9!AT.3EL_?3]7
MU\W7(]SW#V>ZV8K8[0\2_G387JNZ>FM&$&[,&DKO^6G\-(9(K\^[`]P!RCZX
MEF\OPR^.7[C+X?CUN17HOX?RLU;^']3[ZC.^'G;%X5R"VM!/V`-?J^H;FJ8[
M1.`\)MY1VP/_O@YVY=OFX]C\I_I,RL/[OH'NGL$=X8WYNY]!66]!40@S<F<8
M:5L=H0'P=W`ZX-``138_VNOG8=?L7X:N,YJZL\72`?O!U[)NH@/&'`ZV'W53
MG?['K!P>BT5Q>12X\BC>?#1;3+Q'@G@\"%Q%$!GC1N53[@=7[C<?+9S)D[>`
M&[CA!Z7MK<.5^SGN:#F;3>?+.YYS[@E7[CFS:NF"^\'UH9;"9&U;"E?1TH55
MA4_<$:X/-=2!<<B&!0Y(UN-VHCK=@()_'FNL(T81_F/3W#$;R^W4"#;-YO7Y
M6GT.8+V!JNO+!E<OQ\=@8E*PP=!-D[^:)3`],,H7#/,R!.U@_-<PM;^_NL[3
M\_@[3,<MMUGUV.@6:V&!<P_#!B8(31"9(#9!8H+4!)D)<A,4"AB#<)UZ(-BO
M4`_#H'KBOE<"2#D]0RIA(5P"$X0FB$P0FR`Q06J"S`2Y"0H%:%+!4O4KI,(P
M+T/X>V.@<1M8K#JCA2%?9]+I1TA(2$1(3$A"2$I(1DA.2*$234A8NW^%D!@&
M)CUT5R<2G;+,R+NE9&?2*4E(2$A$2$Q(0DA*2$9(3DBA$DU)N"U-R?Y$0"QQ
M:-T*)FYTQ0BH(\B:D("0D)"(D)B0A)"4D(R0G)!")9H8L$$_(`9:ZV(PXL%%
MCB=W8DR[SD@H%A`2$A(1$A.2$)(2DA&2$U*H1-,'$I$']$%K71]&U,%"2$!(
M2$A$2$Q(0DA*2$9(3DBA$DT,/!*968,+B9U((JWS!@RDZ\2(!Q=E'#G&..J,
MNG%$2$A(1$A,2$)(2DA&2$Y(H1)-.LB1-.EN+SIHK>O#R)0=*C!)6A,2$!(2
M$A$2$Y(0DA*2$9(34JA$$P.3YP?4:,UU.02:RD58(+DN!P+-.ZM0(&D5410+
M)!T3@:1C2E$FD'3,!9*.A89T93#E5*?8[7&"9PECH'`T595A5E/9@D!8P=15
MYINKS[=06HD)%U$42Z3&FNNQ$FDE8J4491+)6,[$:%<NK42L0D.ZI)B:/B`I
MRV0A0Q*Q5Y@M@<J:I!RIDG9(-MUUC00^%+&D8T11+)$:R\AF$VDEFII2E%&4
M4U1H2-</4](']&,9+,03C5HY#&GZ<21E"(25/B2G^C`*I94('U$44Y10E%*4
M49135&A(%PNS3E4L=K`>X>.29G_8?EM5,-]@/O;,:P\.T/Q8S7)734.&-`TY
M4C5DR(.AJ$SKF:EA9R4U)+%BAU@E%*4<*6M+1JURB@K-4=<0M-(T[-$*GKQU
M8J&YL3LPY+8/!EM)U_C$#ZW:!XW\*0-#T'15K*4I5F<EQ2(HYN$5&1**4HHR
MBG**"HY8ZW6Q,'-5!]P=L5BBJXTLAEP8E,J8,9[BK!UN):=UP-%4&VR>D?N'
MT@H?#SDS8U^(:.!8NB@M,@,GPA&G#3QWFBV-)J?"0#8YLXJ<"T<>>3$U)E`A
M#-K(>G=@[JQV!\Y_=XY/EONFO#J,6=:M]0Q#+DQ$V3.>F10[W$JF'`%%(4=3
M6'>56,;&&DE'U<K8PV)I):9$TA_>6+Q3Z7@C?":M1/B\/SSIEDZ)_O!Z3V&J
M_O=ZBB7Y6D\QI,\ASQCJ:YB^N`:Y<D`&%(4<&=/*V/LCZAA3E%C%2JEC1E%N
M%:O0''7!\3A@"N[,'MT:V:%"$Y\A]@Z)K_8$!0Y#GLR+0XHBCI18,;5**$JI
M8T:M<HH*S5$3#+8O7;#;2WMKKN^#'.'B(R>]8PY+*ZO`RBKD5AXT_:]KC*QB
MQ596B56-J56LS,HJMZJQN!=+[VH\H9ESPVK;P"7'R'XX,K8-(Z]9"RMEVZ`H
MY.C.MB$=E5[WS&U#6HEU/>D/;VX;TO%&^$Q:B?!Y?WASVY"._>'UGL)3GME3
M#Z]BL`607F-(67G6W$I!`4?J*D911!UC:I50E%+'C%KE%!6:HRX8GO14P>ZL
M8NQ@J*[O+D/W5C$;J\`J5LBM[JUB-C7&5C4F5C6F5K$R*ZO<JL;B7BR]J_'$
M^$!7LP.FUM4,X8R4VX=G)/9K7-F,/(HC(VDRSR+2"H\,2S/[I7%CZ:$VR(B;
M",?N*&)LL:DPD)E?9A4Y%XX\\GQN+..%,*!'$9PO6F_\K4<1;10CJV#'7V59
M6G,K!04<:2L5<U101!UCZIA0E%+'C%KE%!6:HSY\'SM*N_0HS1%6(8<OS;?X
M4?JF56`5*^16]U8JFQICJQH3JQI3JUB9E55N56-Q+Y;>U7A2?&"E8@=+;:7B
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MUE</;+40K:\$]E*(UEOB.#X^SJ>MAE=PH&-?2>!`-'B$37W@J8R/CV%H"3QV
M\?$Y"RV!YRH0K:\$7D[Z46\+X!TE1.OK9'C5!B5]NL%+)"CIZVAX-0(E?7<*
MKS1]?"5"6[V"DE5OR1I*UKTE\)86U.EK=0"MQE>)M!YXC08E?:T.H-4AJV?<
MC73XT/FR>2__M;F^'\[UX%B^P52?M,_DKNQ3:?:CJ2Z0!,+7SE4#7SBW_^[A
MD_82/D28X/<?;U75B!_0J''WD?SK_P$``/__`P!02P,$%``&``@````A`$1`
MC'9Z%@``CH4``!D```!X;"]W;W)K<VAE971S+W-H965T,S4N>&ULK)U;;]RX
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MPW^`^^?'A]?]8?_E^([<W=@3Q6O>W&QNR-/']Y\?Z0I,V*]>=U\^7'^:;/O-
M[/KFX_LA0/_[N/MQ"/[_U>';_D?S^OBY?WS94;2IGTP/_+;?_VZD^K-!9'P#
MUO70`__Y>O5Y]^7^CZ?C?^U_J-WCUV]'ZNX%79&YL.WGO\O=X8$B2F[>31?&
MT\/^B4Z`_O?J^=$,#8K(_5\?KJ?4\./GX[</U[/EN\7J=C8A^=5ON\.Q?C0N
MKZ\>_C@<]\__9T43=F6=S-@)_<M.2)]I.V=;^I=MI^^FZ\5DL30G<*91.CJ<
M.?W+AIL\PR4;TK_N;"^^XA7[H'\O.VN:=\-9T[^7G?6&#>G?-Y_UA(;7T+KY
M/R<OZ\5BOERO\KM[X@:-^3_L9AG$/K/G)S3F[-GXP3?)[8D;.XZ':5'>'^\_
MOG_=_[BBM89.Z?#]WJQ<DZUIP4T(.Y).4^1G,X2FAO'RR;CY<$W!IL%_H&G]
MY\?%<O[^YD^:B@^LN4/-5"H*IS#SSK@M8U#%H(Y!$P,5`QV#-@9=#/H`W%#@
M3M&C@/V*Z!DW)GKNNN\<\.&<1:%R"F=2QJ"*01V#)@8J!CH&;0RZ&/0!$*&B
MQ>Y7A,JXH44W&&CSV4K&YHXU-$-/HS&2%"?)*7Y`*B`UD`:(`J*!M$`Z('U(
M1"!IY?\5@31N:-)3=YV"M%@NHDA:T>Q<)$^24R2!5$!J(`T0!40#:8%T0/J0
MB$C298E(II,`M\09]1`P=Z%WEE!T'"F`E$`J(#60!H@"HH&T0#H@?4A$,.CV
M?D$PC%H&PY+9V@<#2`FD`E(#:8`H(!I("Z0#TH=$!(/RE`N"8=0R&):$(P-(
M":0"4@-I@"@@&D@+I`/2AT0$P]0^88IP?IH8M0R&)>'(`%("J8#40!H@"H@&
MT@+I@/0A$<&@%.>"8!BU#(8E<UL0F!RG`%("J8#40!H@"H@&T@+I@/0A$<$P
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M[PK#Z70M3[UB7Z1R[FM$#2*%2"-J$76(>D:I<6@2R`N"9?--$2R+IC1W3V&8
MSV]E&(H)JWR42T05H[E7U:AJ$"DTU*AJ$75HV`N5'%DFP;P@6#8?%<&R:$[Y
M2!"L:+@7YJ$=3=BI7Z!+1G,:<R?#Z2R*<N4,5\.TGMUNEM&$K)W"NVZR7"MG
M:%U/-K--]`A$.X5WW6:Y[IPANUY.;R/7O5,,KF67F#3W@BZQ6;'H$HL6M+J=
M(CN?1W$K)E8U]2.S1%0Y9)?5^68:=5#M!-Y-@T@YQ&ZF\4,`[03>38NH<\BZ
MF4UFT3CKG6!P(\-J$N8+PFKS:Q%6B\1(GTZ7\;)@56*D`ZHH(3#S(1K\T6./
MFE6!KP:1RO*ET;!%U'E?YKZUAE$;7HD,KTG!P_":#&I*STUIXH_<K6SR+B)M
M432`HWRHH+5_6%/\D"D158QH`0XG0W1AM3?TJNDL:K'Q*G?G4VGWT8,9[0W/
MN&^]RKGOTNZC,==[P[1[V5.F/HA[:K*X-->U58;H-8NF/J$H)H!*1C-?0E2(
M:C1L4*40:31L4=4AZH6A"!@E33)@Y\?S()=E$R,S%TX+\G02]6*1I2JS5!6K
M9G3J/V^QSO+59*E45HLZRU>;I>JR6NS'?,FNCNO`D:[&@L\DC;2P+X:7HK98
M812LXB6BRB%.=!:K130^:J?PV4B#2#ED_4RGT]MX,7(*[Z=%U#GDLJ/;VZ@.
MZ)T"4QC**2Z:,5R&^87\;O!`-Q"9@D?WQ\*IO&&)J&(4W0&BJZF]83!CX`[@
M56Z)5FGW&YD6:&]XQGWK5<Y]EW2_B+*PWANFW<M1;LJ\?_D.,.7ZT0?_CE%X
M!T!4,@KO`(AJ-&Q0I1!I-&Q1U2'JA:$,V&4EY11+2D9C=P`N*<_>)\HL7Q6K
MQNX`.2TV62VJK!9UEJ\V2]5EM=B/^9)=;0K5<&Z,W`&,/+K96R3N`!:).X!%
M40$03>O*C)?Q,H%5@?LF;1BY5VE5M,IJ=-^F#2/W75H5N>^%>]D7<27\IJ>R
M%!;H(BY]@TR55<'253(2ZY0U#%"-A@T:*D0:#5M4=8AZ82@#9LJS"P:OK>;"
M''[*!1Z-NY_GC466JLQ25:P:6Z=RSJO):E%EM:BS?+59JBZKQ7[,E^SJN-X>
M6:>PR*:A;N:%F7[GNCI'56;YJE@UUM4Y+399+:JL%G66KS9+U66UV(_YDEW]
M2PKV*1;LC.AD7+99("H9!6M>A:A&PP95"I%&PQ95':)>&(J`F0$FEL$W[I(;
M_`PW=S]#%LNH++MCU=E=-U[C(ETBJA#5B!I$"I%&U"+J$/4"R;!>5AS/L#AF
M%&ZT0%0BJA#5B!I$"I%&U"+J$/4"R<A<5N^:][Q1TL@HW'6!J$14(:H1-8@4
M(HVH1=0AZ@62D8E+S?.W*7KM"I&Q2(P90"4;!JH*48VH0:00:40MH@Y1+Y",
MS&4U)2V_$!F+Q)@!5+)AH*H0U8@:1`J11M0BZA#U`LG(F*(G/XLU"V\\FRP*
MM^VP*D`EH@I1C:A!I!!I1"VB#E$OD(Q,7!"-S":L?&:,_-/WPB'_.K]TR#\A
MK!SRJAI1XY`W5`YY0XVH=<@;=@YYPUX@&9FX\GE3J3C#@LBA8`./0SYM*AG1
M.OB3S2=>X!*`&MTT7L5NHG>VR@N<&XUN6J_ZR>83+W!N>N%&AM;DXQ=,1YN^
MAT4EK3UFAM*3>-=<P8A>7#E4,AK9?.)5SK!&U"!2B#2B%E&'J&=DSUX&*\[5
M1V8H)N4SB^23[T4T$`JG\@]?2T;B,3?NITBIYHOH16?MW?O,%U^'IGQ!BRJE
MFB^B%[`ZJ\4VY0M:[%*J^2)Z#=*/M2CZ=9XN*2Y\:3IXD4\+&84U&**2$=TS
MW:BO$-5HV*!*(=)HV**J0]0+0QFPRXH%NB_'-W%&(\\GLE1EEJIBE:F`?OY$
MI,[RU62I5%:+.LM7FZ7JLEKLQWS)KKZL^C$+5)2O,1KK:FMX7E5F^:I8-=;5
M.2TV62VJK!9UEJ\V2]5EM=B/^9)='9=S;TJSS$N/>`18))9!0"4;BF70J@)4
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MR"Y^23D\>)'E,*,@=RL0E8R"I*]"5*-A@RJ%2*-ABZH.42\,9<`N*X<76`XS
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M%OLQ7[*KXVK[;<L@%N$+KJ7]F[T"4<DH6/,J1#4:-JA2B#0:MJCJ$/7"4`8L
MKG]MP-Q'_+(_O;8X%<9^)"[BDN*.568KP&F\1O>XPFM<W5\BJA#5B!I$"I%&
MU"+J$/4"R;#&-?#YQPH++'P94:A<&`I$):(*48VH0:00:40MH@Y1+Y",S&75
MZP*K5T;TMMI'QJH"5**J0E0C:A`I1!I1BZA#U`LD(K.,J\_S8V:0RS*343AF
M$)6(*D0UH@:10J01M8@Z1+U`,C*7E9E++#,9!0.D0%0BJA#5B!I$"I%&U"+J
M$/4"R<A<5I4ML2IC1*]&3[,)48FH0E0C:A`I1!I1BZA#U`LD(V/*C[`@&IE-
MMEH)]_<L&?G="85#?E$N'?+U:N605]6(&H>\H7+(&VJ!Y`7&!<QPY]Z\HWOK
MA9]-76)MPXC>.OE1857T\L.ATJG"V_EL&CW)K+S*&=:(&H]\:@"^E%<Y7UH@
M&2$ZK],0H#O$FW+!I7$2+;,6B>`P"H-CT<\WS[%G$KAKJ1D%,6Z\ZB>;Y[S`
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M!H11-(ZB39(%J\)QA*ARB'MV,EM%SU!KIP@&#2+ED/4SG\&WCK13X`A9A8GH
M>$`P#QT<T'<TY`B)7Q:S*APAB"J';,_.-O&+R-H)@@&"2#G$;J;Q;@#M!(GQ
M$6:?X^'`Y'-E430^HM?>!:O$^+"&`:J<RO;K9#F+UQ0G"(<'N%%.9=U,Z2<-
MHD]>.$%B=(0IYW@X,.-<612-CO@!":O$Z+"&`:I8Q5L)EM-H%:K12X-(22_3
M>737T\)$KAUA>DK!>%/RM<+,E%'P#J%`5#(*'\0AJM&P095"I(6AO&R3];FR
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MN?&;[F^#$QE51N']#5')*+R_(:K1L$&50J2%H;SLBS+@-6;`C$;N;UFJ,DM5
ML6KD_I;EJ\E2J:P6]9@O&7>3J6;G%6N;UX9Y!:/P_L8H6,9*1!4CL?MF'G]"
MM?:&Z;ECMPQ[U6EJIMU'%9'VAFGW,E8F&PYB];:I:5-J$4+.LH,73VM`)2,Q
M-:TJ0#4:-FBH$&EA*"\[RKC/5^MK3*T9C4U-:WA>56;YJE@U-C5S6FRR6E19
M+>HQ7S+N%Z7\:TSY&44WTJCN+%@5WD@150[9:IZJX$W\/+YV$I_#-8B40^QH
MNI[$O\NDG00?#*RC;-S,P*P=X(-A=$.TF;+,TM919ERPH5C+(,6N6!6M95&2
M6WM?Z<6&US)PK]+NHX12C[F7@RO*Z]^VEF&ZO[9(I!F`2E8%"U>%J$9?#:H4
M(BT,Y66;3#98PD?6,IOWBK6:4V&:;:=\''9&%>L<59FEJE@UMI;EM-ADM:BR
M6M1COF3<3>Z<'W>;:8NX<_)-B=\I[O--5`<5:TC12T:B`L`W!RD5U@G>O3\)
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MM7M)XO.=S>A(,LJS.1T9]OB`S8*.#+M9HB/E9K:MDGU&(V=KA@J>&_V>^J=D
M).EBDM="EY+4FPM)^9^3_U2([^CZDI='5Y>ZN+LE]7FB`2KJMQ55WGAI5+5O
M39F.1RAY)IO40*'LF&Q21^CF3,%-=3S=?2FXJ2.T`6IK=OPDSF"YW)J],HDC
MJ_FVHI=8>(1>@&W-&R\\0L\<Z7I29T`/%>EZ4D=H0_S6[(!';[3C?6NVN.,1
MVM*^-7O8\<@=7>E=\DH+.E(DC]`>M:W9@8;>RN6"CJ3B1MO3MF8K%MK0+C6*
M:,H;[=.B(RD;^K-.BD$J.O1WFQ2#U!'ZPTR*0>H(_:45>4N--_I3*O*6.D)_
M*T7>4D?HZV1;\R4PO%+Z-M/6?(P)C]#'E[;F:TMXA+ZNM#6?4\(C](D3\I8Z
M`_J&"7E+':&/E)"WU!'Z=N_6?*P7VZ&/\V[-UWCQ"'U]=VL^MXM'Z"MWVXJ^
M$X='Z,-U6_-M.CQ"WZ*CN*6.T,]`T+FESII^YX'.+76$?LB!SBUUA#[63MY2
M<X&^QD[>4D?H<^OD+76$?I!S:W[\$J^GG$RWE2WCHN6>?CER:WX<$FWHQR#)
M6^I(.:'KH5\R1!OZF21J)]4+]#M(U$[J"/W0$7D;CMR<3N[P\?WW^Z^[_[A_
M_?KX<KAZVGVA%.-V^&[9Z^-7DVG9_SCNOU.-='WUV_YXW#\/__?;[O[SCG[R
M]M;LE/VRWQ_=?]#IWOS8O_Y^^+;;'3_^OP````#__P,`4$L#!!0`!@`(````
M(0#X[NW!PQ8``"^&```9````>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;*R=
M6V_<.).&[Q?8_V#X_K/=YP.2?(@E'G188+'8P[7'Z23&V.[`W3/YYM]O422;
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M_.$QQN[^`^%?GA[?]H?]U^,-A;OU&XK[O+G=W%*D3Q^^/-$>.-FOWG9?/UY_
MGFS;S>KZ]M.'3J#_?=K]/&3_OCI\W_\T;T]?VJ?7':E-Q\D=@=_V^]^=:?7%
M(7*^!6_='8'_?+OZLOOZ\,?S\;_V/^WNZ=OW(QWN!>V1V['ME[_*W>&1%*4P
M-].%B_2X?Z8-H+^O7I[<T"!%'O[5??Y\^G+\_O%ZNKY9+Q;SY7I%87[;'8[Z
MR<6\OGK\XW#<O_R?MYJ$6#[*-$2ASQ!EMKQ9K.YF$^IT:)!9"$*?<5.R+3G3
M^SPXTF=/[V<<:=NZG:?/V./T9CY=K-;==I_Q7`9/^AS7Y2HXTF=P7-Q,UXO)
M8NF4.M,CG;#=MM+GN!XWP9$^XTX.DW5"@]&/#3<J_6$?N+&3T["B?P37R6Q@
MMW$P3=)HFIYUO?5CNCM%RH?CPZ</;_N?5S3O4.>''P]N%IML7;1X<GB93Z?+
MK\X6.DU<E,\NS,=KTH_.@P.=XG]^FBWF'V[_I-/R,=C<H\V46Q31PIV#+FPI
M@9)`2V`DL!)4$M02-!*T&;@EX4[JD6!_AWHNC%,O[O=]!)F<0JIH$5U*"90$
M6@(C@96@DJ"6H)&@S0"3BJ:LOT,J%^;C-?U]9J`%&YHL3D8K(=_)Y*0?$`5$
M`S%`+)`*2`VD`=+FA`E)4_C?(:0+0R<]':Z32'C*>J/9.25/)B<E@2@@&H@!
M8H%40&H@#9`V)TQ)VBVF9']"$*<X9]T)%G?TWA-2)Y("2`E$`=%`#!`+I`)2
M`VF`M#EA8M!E>H08SIJ+X<F,/K+QM!"GW<DH*E8"44`T$`/$`JF`U$`:(&U.
MF#Z4C8S0QUES?3S)!PN0$H@"HH$8(!9(!:0&T@!I<\+$<*61S!JFBQL:7"/S
M!A>(Z^3)C#ZR<;04X^AD=!I'0!00#<0`L4`J(#60!DB;$R8=Y4A,NO.3CK/F
M^GB2CR,@)1`%1`,Q0"R0"D@-I`'2YH2)X?+G$6ITYER.@&8T5+/Q(B_WR>HT
M8!`I1!J1060158AJ1`VBEB$NELM"\[/N_-!Q!888.P'E@P=1B4@ATH@,(HNH
M0E0C:A"U#'%E7-*9*^.JF-G:E?-C)R27$$G5/!)3TEI,2<&1K-(0.SE&I-!*
M(S*(+*(*48VH0=0RQ(5T66<NY(4AYI-4BA=W\'Z2YZU=$5<@*A$I1!J10601
M58AJ1`VBEB&NC,LB1RCCDTZF3,A#^4RUD</H9!4E+2>`%"*-R""RB"I$-:(&
M4<L0%\MEF2/$\DDI$\LC-E,!*MTJ'IVLF95"I!$91!91A:A&U"!J&>+*N/PR
M5\;-5._*G"8^4V6BA>25<H]T+5S>R1%VLDHC#)`*X;/I3",RB"RB"E&-J$'4
M,L1U=*EIKN.%B<IGLDPLC[*Q4TP`E8@4(HW((+*(*D0UH@91RQ!7QF6>N3)N
MA"TH%QB9F4]\!LLD.R6U^?B:R/%ULDKC"Y`*X=GX`BN#5A91A:A&U"!J&>(J
MNI0U5_'"^/(9+A,K3WK#A1!0.0&D$&E$!I%%5"&J$36(6H:8,M-Q*7MGSE/V
M@'@^M91KP<GJ-(P0*40:D4%D$56(:D0-HI8A+M:XE'V**7M`<W\SR2V*%XA*
M1`J11F006405HAI1@ZAEB"LC4_;S)]@4T_*(YJ?DLX@HK<B5$2U/5BJB9*41
MF8B2HXTH.5:(ZHB28Q-1<FP9XLJ,R\&GF(,'-,^5\5;SM`5EM*(<*LL69GPV
M5\DJGH8:D4DHCR5N`-ED%6-5B.J$SL1JDE6,U3+$)749]/#9?.H3[GPV#XA)
MZJV8I(!4=$S":T0FH7R?Q>JI359QGRM$=4)G8C7)*L9J&>+ZN3Q[A'X^+6?Z
M><3T"R@I4[IZG?+Y3%*%2",R">7[+%8-;;**^UPAJA/*8XDZK4E6,5;+$-?/
MY=<C]//I.-//(Z9?0+E^@-04D$9D$LKW6:RBV605][E"5">4Q5J)*J1)5C%6
MRQ#73V;[_B[UC7O\XOC]Z?'W^SU-873Q[+F(S.ANM+]'/<4B("`FJ[?*QF`9
MK&9IF4,ATC%6.AXF6652+,7*D4U648H*8]7)*HNU$LEWDZQBK);%XK*ZA'O$
ML/3Y.1N6'KG+?+J&K""5"U9)OW(*2$7D#MB?GQ:S^68]$:-&1YL4R00TIP3A
MM`G3F7"TR:H+?K,1!Z'"R#6BAH<1YT?+'+C2+LT?H;2O"IC2'KDY^K2;LY6X
M6A?38)5RCQ*1BFC5*4W/\=`#:4(P'6U2)!/0G%*)TR;T*.TW@:R<TI/ES7Q.
MT4]_Q("ML)\:49.Z3L,ZWU4F]FQ<A=*9\PHE(#&L13I31*LT&$M$*B`V/F<K
M<6G7R3'75AQ>TQ<+CT"R<D>`'C(38:K4652S1M2D,-&J959<\W&%S@P+G8#$
M`!>7\"):I6%9(E(!L9$Z6XG352?'LYK[366Q>C0_67G--Z*S*G46U:P1-6G#
MHU7+K+CFLH1ZUU61KFKRAD=`-)W%K2@0E0'-4I6A$&ET-(AL1.D1J"JBM!$U
MHB:BY-A&U#ERP<955C.LK`)RF5Z:`B<P2+WC>:MR4"P5K-R9]^L>]:!89I"5
M'=1C-2A6/<BJ&=1C>RD6/]2N$AM^P:5!#">!1^(:(-*&(CA2-1]/E1*1BBBD
M-JO5W6(NKB8ZVJ1()B!VZ>B9>OR&DI6;>M8W$YAZPIZDR#5VUJ3.7!@1HV4.
M7&E7L^5*OV\6\I5?GO'0RKP[)FP6`E0&*]J^>``4(HVQ#"(;49I,JHCR60@V
MHHE6R;&-J&<6<A59+EA/T4)31ZQ:W!-5XH9T0.?GEV*053G(2@6K2[.0W]3S
MVV4&]6@']5@-BE4/LFH&]=A>BL7/#5FW7CC46*"ZYUK<24!C[M?3?S'(JAQD
MI8+5I4,]9+O,H![MH!ZK0;'J05;-H![;2['XH78%;7Y6OV\:]&4QFP9#I9QF
MH,+=.>$S8QD0FP:]588T.AI$-J(TFU41I8VH$341)<<VHIYIT-5O4K#ILGMF
MY\)IXBL_)E(H!NE*=SI-9BNQ9E?,\I+1?\$`D8K(5\>+%=7'&Y'AZ6B3RA`3
MT*4ZP6]"J([I8CW9Y'_$RDF%_=2(FM1U[Z4[WVLV9N?C"N7.G!?*`?$D:2W6
M$HIHE1*0$I&*R"=)L^EF-=F(2#K:I$@FH`M)4K+R]9DLB3%PC:CA418W8EBT
MS(5++>MC-ST,&NUTYT]>_P/BI?):K*P4T2J-T1*1BLB/]NGD;KJ9BU&HHTV*
M9!#9@&AHQTRL0JL:48..+;/B0LJB]_Q<X8:%R)X"H@0M;F>!J$2D$&E$!I%%
M5"&J$36(6H:X,K*Z[8;8>Q[*=G.8%,TC-YVG"78M!DH1',DJ2ELB4H@T(H/(
M(JH0U8@:1"U#7$=7+N47I@LCS%=7^=6(;B<X_=@(`U2BE4*D$1E$%E&%J$;4
M(&H9XLJXRB=7YOTCS-=03#2/Q`@3\W1!MV4Z:?,1!DBAE49D$%E$%:(:48.H
M98CK.*X"G&,%&!`;8=XJ0R5:*40:D4%D$56(:D0-HI8AKLRX@FF.!5-`+G?/
M)BJQV%(DJS11^5CD&)%"*XW((+*(*D0UH@91RQ`7RR7X^>EX8:+R]0`[YT*)
MD%\*`95S0`J11F006405HAI1@ZAEB"OC4MX1RO@,F2GCD9B-Q%V;8GZRBF.F
M1*00:40&D454(:H1-8A:AIA8BW%50&?.JX"`*&F+,A2(2D0*D49D$%E$%:(:
M48.H98@K(Y/V\R>8>\A6I$T1I=7)(J)TSI41I?Q:192L-"(347*T$27'BB&^
M@^.2Z04FTP%1SI`.O;>BRU]$9;2B*W6:E)?BVJZ25734B$Q">2PQP=MD%6-5
M#'$99.9\X3AC>KSPB,D04"X#(!4=DY5&9!+*]UG,1C99I7W.>^3[/"[+76"6
M&Q#;9V_%#CT@%1WS?08KDZRR?5Z+BMLFJ[3/>2R^SRY3''Y96/C$,K\L!,3V
MV5NQ?0:DHF.^SV!EDE6^S^)>C$U6:9_S6'R?9:[YKG7)!::@`3$IO!63(F2E
M:<%&!4>Z31LW7\=821V3K'(IQ.TWFZQBK(K%XE+(Y'+P&LP"\\R`Q,J77'&,
M5FE?2T0J(K_RM:1G9?A#N#H:I#`F(+<<<)I2\=Y@LG++7O,;,654+#`7RR5]
M(\X5GR.R<\4CODH%3RPM@E6ZA)6(5$3QB:4>B2"."4ZNTC\GD7<D*R?1A'Z]
MAXM?Q;Z[+>0:C4LS%YAF!L1'D5SU+*)5.OPE(A40&Q&SC5@5U,DQ%T5<BDU?
MK)[1Y7>(>G32;>@'B*1TWL#?'6?2+<<EG9TY3SH#$L-+7!^*:)4-+T0J(#%2
MQ+RKT=$@LH-B5<R1*R.3SG=-V$O,10/*[Z<C*@/*[AHI1!H=#2(;4;H?5$6$
M]X.6XW+1SER,")]X7KA7&AS/6Y6#K%2PNG"O=%`L,\C*#NJQNA2+#SB7(^8S
M_>#+XM)GE_FD'Y"8T,246D2K;$)#I"+ZY64Q&J0P)B`V">+$E:Q^,>>SR%PM
MEUU*M>BJ,>Y1]*7/49ER'K'3$U`9'-GIZ:TRI(-5%LL@LA'EIV?>(]]OEV'F
M^WV^1EKZA)3MH$?G3[PB.)ZW*@=9J6!UZ?0<LEUF4(]V4(_5I5A<>)G`7Q`>
M,_6E1^<E+099E8.L5+"Z)/R0[3*#>K2#>JPNQ>+"]Y4+X\]T+!V6'F5G9X&H
M#"@[K14BC8X&D8TH/]/SC>#[[1+B$6>ZSY_9F>Y1=BNB6`(J$2E$&I%!9!%5
MB&I$#:*6(:[,N'Q_B?E^0/SNQ$9DWT6RBE5MB4@ATH@,(HNH0E0C:A"U##&Q
M5N,R_,Z<YW,!Y<,(48E((=*(#"*+J$)4(VH0M0QQ962&?WY&7V$J'Q"_.[$1
M:Z!%LCH-(T0*D49D$%E$%:(:48.H98B+-:XL6/D:()^-`LKO3B`J$2E$&I%!
M9!%5B&I$#:*6(:Z,S-LO#"-,UE<!98OW$:65N#*B5$*KB)*51F0B2HXVHN18
M(:HC2HY-1,FQ98@KX[+8_`KVKA)ZY7-A-I0"2O>(BVB5/9`0$"UPNNIB>C<1
M\[M*!O'$U!C&)*L01E11-AG$,!6&J9-5""-6A)ID$,.T+`R7=EP9X*HB<4LL
M(/K-C-A=$:UR#;TC+25GRU13L?RK@F.VX*P1&406486H1M0@:@.BWY*A'>)B
MC4O=5YBZ!R3*:;',5D2K5`>7`9VO@U5T]!7V=#F7"\_1($4V@R+;Z!A65><3
ML<U5-$B1ZT&1F^AXBBQ.BS8:=)'Y\9`9_849$U/W5<B::1XX+2G/Y-/!1;1*
M\U>)2$44UK0W=V)TZVB0PAA$-J"P?KU>B\FF0I<:4<.C;.3WIUOFPD65Y<+[
M)ENL(E8>Y642HC*@O$Q"I-'1H)5%5*%CC58-HI8Y<L'&51$KK"("NE#0#[(J
M!UFI8'6AH!\4RPRRLH-ZK`;%J@=9-8-Z;"_%8H=Z/:X&ZLQY#120N`"(.Q-%
MM$J3:1G0A0M`=/23Z7PQEW-0-$B1S:#(-CJ&2\L4?G`A&J3(]:#(370,D6?R
M<?4V&N`%8"TKKW?-55T4<9A\C9;/5<$J0V5`^5R%2*.C02N+J$+'&JT:1"US
MY`-X7/6UQNHKH`MSU2"K<I"5"E87YJI!L<P@*SNHQVI0K'J053.HQ_92+'ZH
MQY63:RPG`[ITJ+WC>:MR4"P5K"X=ZB$]FD$]VD$]5H-BU8.LFD$]MI=B\4/]
MM]3':ZR/`\KFO`)1&1";!GVL#&ET-.AH$57H6*-5@ZAECERP<57O&JO>@/*U
M3$0E(H5((S*(+*(*48VH0=0RQ)495^*NL<0-2*QEBCRD2%9QU:!$I!!I1`:1
M150AJA$UB%J&N%CCZL\UUI\!Y6N9B$I$"I%&9!!91!6B&E&#J&6(*R.+R/.5
M^1JKQ8BRM<R(TIIA&1`](QB'D4(KC58&K2RSXGLSKL);8X474/YP943YW@1'
M4B-;C1#/("ITU+''LXX&'>TE1R;#1E8_[\JVNR@\VPXH5R>B3)WH2"*=U)G*
MGUU1Z*A['1=B:<R@H^USI!\_.ST4Q]61M<CY(;_!NT`!L=IP?B>6=XMHE>JL
M,B#W\.=)F?F=6$=3Z*C['<6*DT%'V^^8;EAQ9<85'1LL.@)BSP;.[\029!&M
MTF10!N0>^<R4$0\5*G34@QP-.MI+CER9<3GZ!G/T@,28D>L)T2H?,SZ6&#/B
M,JW040<D',4D9=#1]CIFOPC)E9$I[86S"7/7C4=\S$S@;`I6^9CQB(^9"9Q-
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M]-Q03\N*HM%S,WTM](YP>DBDIV4^HVWK?G-$:C"?4TM7#T`+J>-O&D,+J4-?
M3^_KA]2A[V+WM=">TG>1>UHFY$-O:NEK(1]_QUANP834H;=O]/A,21U_VUSZ
M3$D=NJ3W^,RGM&W=95SZ3,B'WJC6XS,A'__4`_B0UO2*K#X?TIK>!]770EK3
M^Y#Z6DAK>L-/3PNY]'J00Z\]R=RK,HG<>UQ(XEZ%)Z0PO7^O9XO6F^T]I??8
M4E!+T=M"A=?6E1?H0Y75UM4/V/)YLOW<?[1HPWKL[^E0]=K3@>H[3I_GV\^_
M.,5IG/1T0/<LMHKN#^"FTDV)K;L+@2UTUV'K;C-@"RW]4;2^?FAMCZ+UM=#B
M'47K:Z%'9+?NF=B>?E;4#SW$@BWT5,W6/3B#+?2@S-8]"X,MY6I!+7T#DNX^
M4S]]0XQN+U,_?2UT_YBB];7<K^AHTO->N`7T9=BM^ZIK7\N"6OJVC;Y!22U]
MIPM]$WKKOB:)T>C;/Z1H[Y%;DJ+TA0'TH==NT!CL/0JSZ=;])##ZT*]V4DO?
M5M,/V5%+KSJTU?>]6UU02]';0E\\W[KOF^(6T#?+M^YKI]A"7S`GW?JVFKZ&
M32U]IQ6]QF3K?K,?H]';3+;N725]+33>J-KH:Z'Q1O='^EJ6U-*WU?1Z`&KI
MVX)[VH+[WI:"6HK>%GHWS-:]X@"W@%[^LG5O.L`6>@?,UKWAI:^%1F_OGM)[
M.ZBE;T_IC134TK>G]%(%:NFVX/9T?3I\^O#CX=ON/Q[>OCV]'JZ>=U\IS;KK
MOI3S]O3-Y?7^/\?]#UI*NK[Z;7\\[E^Z?W[?/7S9T6N5[MS;B[_N]\?X']J1
MVY_[M]\/WW>[XZ?_%P```/__`P!02P,$%``&``@````A`-092=JI!```"A4`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,C`N>&ULG%A=CZ,V%'VOU/^`>-\0
M8Y)LHI#53$?3KM25JJK=?6:(DZ`!'&$RF?GWO=<&%AL[@;[DX^;X'A]?WX/C
M[9?W(O?>6"4R7L8^F<U]CY4IWV?E,?;__>?YTV??$W52[I.<ERSV/YCPO^Q^
M_65[Y=6K.#%6>Y"A%+%_JNOS)@A$>F)%(F;\S$KXY<"K(JGA:W4,Q+EBR5X.
M*O(@G,^709%DI:\R;*HQ.?CAD*7LB:>7@I6U2E*Q/*EA_N*4G46;K4C'I"N2
MZO5R_I3RX@PI7K(\JS]D4M\KTLW78\FKY"4'W>\D2M(VM_PR2%]D:<4%/]0S
M2!>HB0XUKX-U`)EVVWT&"G#9O8H=8O^!;!XCZ@>[K5R@[QF[BMYG3YSX]?<J
MV_^9E0Q6&^J$%7CA_!6A7_<8@L'!8/2SK,!?E;=GA^22UW_SZQ\L.YYJ*/<"
M%*&PS?[CB8D45A32S,(%9DIY#A.`5Z_(<&O`BB3O\OV:[>M3[(?K&8GF2T![
M+TS4SQEF]+WT(FI>_%`8TF12.<(F![PW.>ARMEC-*;F?)%#SD?*>DCK9;2M^
M]6#/`*4X)[@#R082V_6`$,0^(#CVU[X'<Q50A+==1%;;X`T6+FTPCPH#KQTF
M[!`!D';,P#:>&<'(C"N+4WE4@3X-M=/0*30(CGUX[28_%*@P40_S<PDT@0`9
M+Q#!4`.0=8-:@490PZ8:3XU@2=TMKHI$LB/Z)5M.28M@/6T3@>;K:?QL+]MJ
M"A6"=2H5&2I`/^YM=VSCD*QF(/CVSL=Q.D,3Z>_`B*SM8J!C^JRWJ1"L4ZG(
M4`R!E>SGE6J6:$!WU,B!.D<;TO9^.+?K(=CDO66\+4BB#39,$/L6288KC"X0
M=HZQ;&U(*U%(')*PK<=+4B8`#%W/D-87(*+9`#%\`"71Z'Z-.D?X2=&$=$$.
M>\6GTP1!B#9JI$*6&DVR`3+T@3:D[S6'?Y-)3B#1A@Z7%Q";&5#Y`+_7/T,[
MD,F`6*]-Y-ALDPR!#!VA"0UK$_Y?2Y`#]85K0WJ9%G9)(7;TZ/Z1:(,-$]@L
M(;18`EG"R>>>R\F!!DGC$GJ5E@Y)V-'C):G^[UM"J$*6*EDL(1QCW.'0%-J0
M7B7'D00?#1,D#4U!)K!6R3`%=+EQ51KZ0]B$]"HY#@KA)'^0:&-/N/PA-/SA
M]E-.HHW,C4WHI7&<$<))GB#1!IOKF$`MGK"&V&T]<I3.T(:TNE#'&8%B/X_N
M'HDVV#"!;:M1BR&,ZAXYT"!I#$$K$76<$2CV\WA)B#;85&AH"-1B"&1!9ZN[
M)B='&BRV8P)U'!/H)$>0:(--F81%D^$(=[;;T`9H$])KXS@FT$DV(-&&#I<-
M4,,&I+.M8=_<$30\(\A,P*KWC^.,0"?Y@40;@EQ^$!E^<%N'1.N9VY!>&,?!
M()KD`Q)ML+E\(++YP&(QHFGD2(.E,0*]-HZ3`=PT33`"B3;8!D:@;I[4U4S!
MJB/[C>6Y\%)^P5NE$"Y;NFAWX_4@_WZ8\6CSH&["@NX7N(DZ)T?V+:F.62F\
MG!T@YUPN5*7NLM27FI]AGG`AQ6NXA)(?3W#GR.#"98[GK0/G=?L%_^9TMYB[
M_P```/__`P!02P,$%``&``@````A`#[,V>.D%@``M(0``!D```!X;"]W;W)K
M<VAE971S+W-H965T,CDN>&ULK)W9<ARWDH;O)V+>@<'[0[)WLD+2";-K7R<F
M9KFFJ9;$,,E6L&G+?ON3*``-('^<KFR%;TSYPY^)JBRLV;5\^.>?+\\7?^S>
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M39X^??C\1&>@PG[QMOOR\?*763*L[RZO/WT8`_1_3[L?!^_?%X=O^Q_%V]/G
M]NEU1]&FZZ2NP*_[_6]*6GU6B(ROP3H?K\!_O5U\WGUY^/WY_;_W/\K=T]=O
M[W2Y5W1&ZL22SW^EN\,C193<7,U7RM/C_ID.@/Y[\?*DF@9%Y.'/\>^/I\_O
MWSY>+F97MZO5<GV[(3>_[@[O^9/R>7GQ^/OA??_R_UHU,[ZTE[GQ0G^ME_75
M:G.SF%&E4B<+XX3^&B=4J?``EL:6_EI;[RQ.'#D=WGC^]-<8;DZ>Z=KHZ:^M
M2'R0Y'FLB_X:V\75;'FS5C$Z<8C454<S^FO,UE?SV]5L-65X9PSI[]G'.J.6
MJ!N&:I*F95PMYZO-[7A-3QSO[-BFZ!_VB$^>X<RV'_4/>ZAGMY^9;4#J'T<O
M9[?EF6U+ZA_V\,\_&-NP5&>T!S/54JYUYQS[>OKP_O#IP]O^QP4-H!3(P_<'
M-1S/$N70]G)]%8[]_M]U>^KORLLORLW'2VH.U*$/-%;]\6FUO/MP_0>-+X]&
M<X^:>:C86H4:3)3;E(.,@YR#@H.2@XJ#FH.&@Y:#CH.>@\$#UQ3K8\"I'?X=
M`5=N5,!MJ.XM<%=@P:)K%=8DY2#C(.>@X*#DH.*@YJ#AH.6@XZ#G8/!`$%WJ
MGW]'=)4;FJ^\YCQ?L<9Z;S349XYM?L,B?I0<0PXD`Y(#*8"40"H@-9`&2`ND
M`](#&7P2A)_&M;\C_,H-#4ATD8^A7:UNPN#>:]'B5/R/DF/\@61`<B`%D!)(
M!:0&T@!I@71`>B"#3X+X4S""^,?7:G;05NHQS#8\]YI03"W9`DF!9$!R(`60
M$D@%I`;2`&F!=$!Z((-/@A#2\NN,$"IU&$)-%K<NA$!2(!F0'$@!I`12`:F!
M-$!:(!V0'LC@DR"$M`H](X1*'890$[\5`DF!9$!R(`60$D@%I`;2`&F!=$!Z
M((-/@A"J3;2_+#O=D94Z#*$F?BL$D@+)@.1`"B`ED`I(#:0!T@+I@/1`!I\$
M(:3%Z!DA5.HPA)HL]794K4:W0%(@&9`<2`&D!%(!J8$T0%H@'9`>R."3((1J
MJW9&#$=Y&$2+EFXXM,A-,JE%ZZ,JL\BI<D2%1<ZPM,@95HAJBYQA8Y$S;!%U
M%CG#WB)G.`0H#*G:%\A[MMKQLG9IT-(/J58MW1&D5D7SW'$--5^MPC54YE1V
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MRE%5("K1L$)5C:A!PQ95':(>#8=`%499[6?.B++>_@1M6:,EK>J]*+->OIUI
MU=RM(%)$F4'+Q7&,RE%5("K1L$)5C:A!PQ95':(>#8=`%499;7G\**L1?$X_
M.U#;FQ@\]&8I"+A&2]H#N("O>=YSIE5!LP:4&570K$%5H*\2#2M4U8@:-&Q1
MU2'JT7`(5&'`U0;)#_A$E/5^*HBR1DO:)GA1AL%#JX)F;0QI(G6&"S93933@
MC:/.1O]LL%HMV`HNMPK78PJ#J'N<<%TZE?I%8LY6K!7ZK9W%";]-5+5FB^O6
MN?=]L=;917WQ(/76US%(*Q;_P2K&((4M0.WO_!8@[W)Z9Q@T!HU6M#-TUW3-
M%J[;F58%70Y09E5J9?;'I]GM?,%.*K<*-]<4B$J#J.N./SRQ@ZG0HD;4."?^
MB<$U/9Z%IUK`-3VJ[$*DMS4>S_66'>9@%>.Y!A>0%D=X`6>K,U>]HY=P66#0
MW*VTMHA2@Q9NPYDARM&P0%6)J$+#&E4-HA8-.U3UB(;`,(ST>;OS.>[.#5+3
MF>L?,W:MMR)5*E)E1K4(>B2O,1?Y*D2J4E1C)?)5BU2-J,96Y*L3J7I1C<.4
MK[!QJ3W_3XW#-([R%;U!*VJ!KIVMV0RW-2I_4C;H],R964,]WVP6&SZ[Y5;A
M3<HBUZ53J='ZEHV=%?JMG85WKGR*;**J-=LCMLZ][XL=1!?UQ6OLK2\;I-LE
M6]L,5H&3\EQE%WAC.'],USD*?X(>'=.2VA_3M<I#J5$%8[I6>2A'7P4:EH@J
M-*Q1U2!JT;!#58]H"`S#;G=>CF*..0J#IL9TD\DX.?*G(E^944V-Z9(:"U&-
MI:C&2N2K%JD:48VMR%<G4O6B&H<I7V'C4BD3OQN?WEVI)L12,P:Q/2Q/&A@5
MC2=V19DBRJPOI\I152`JT;!"58VH0<,651VB'@V'0!5&^;S4#$UW$&63FJ&%
MN3==LNW&UA@&TZ4QI,'1&?*9(+.&>B98W-YMV(R26X4_74I<E\:0YFLU7;)V
M4:';VAF<..(FJMJP^:MU[GU?[-RZJ"\>H][Z^K<Q&JPB,ENJ3(S?S<1;V+G.
MX00SI$836UAC&/0XR`=E5J6OSOQFPW]^RJW"]<D"46F0V<+.V(\D%5K4B!KG
MQ+M:&Y9-:9VAIX(MK%/9`:>WR)TK6UP-5A'9PJHD#[^`YR]W=*HHN)@F>^0O
M=P"EM/11(X*WMLD0Y09YZZ0"526B"@UK5#6(6C3L4-4C&@+#<*Q4N0<_TA,S
MDDY5!"$UV8N3"YGM7*)*1:K,J*:6.Y(:"U&-I:C&2N2K%JD:48VMR%<G4O6B
M&H<I7T'C4E?HC,8URL.4DT'AOG7#QKNM4=&$8$>?U*")?:LUU)/,BN9A-L?G
M5N%<%R+7I5.IB7C.AM4*_=;.PA]IV1S;1%5\_=`Z][XO/A-'?<%,;'T=@[1D
M)S-8!<[$"YXA^ZE?X$<OK&'H7!H-;/:2;XW*0ZE!_D".*$?#`E4EH@H-:U0U
MB%HT[%#5(QH"P["O\731Z8&<;DK@BUZ#U+K:K5UY9G`K4J4B5694JOG\^QIS
MD:]"I"I%-58B7[5(U8AJ;$6^.I&J%]4X3/D*&Y=*]LA7"0N=&_)7"0:MJ-FY
M2[UAH^W6J/Q5M$&TU/4,^1B564/S>\EBL;QC>Y_<2KR5M<AWZ51J))_=L(.N
MT''M3$X<=!-5;?AO2,Z][PN&<AWRTV'JK:]CF%:W,)9K1_H2A(V`9\9^;BS'
MA!D-SVHL\@;N+:+4H&`LUX8>RM&P0,,2486&-:H:1"T:=JCJ$0V!81CI\])$
MZJ$6EB8R:&HLUX:G5:G(5V944V.YI,9"5&,IJK$2^:I%JD948RORU8E4O:C&
M8<I7V+A4'NF,L5RGG8*Q7*/3S6:[D*A2D2HSJJG&):FQ$-58BFJL1+YJD:H1
MU=B*?'4B52^J<9CR%3:N6.;M[,3-`K-P!@5SA,FON2U`:E0TLMI=088H1U\%
MJDI$%1K6J&H0M6C8H:I'-`2&8:15CNJ,;JQ36D$W-EDN=^/QEIX`&A-?#J6(
M,D0YH@)1B:A"5"-J$+6(.D0]HB%`84A5QNB,D.H$4Q!2C6@\MNUONP"4(LH0
MY8@*1"6B"E&-J$'4(NH0]8B&``4A79Z7`1KEX4;?(+IJQY`B2A%EB')$!:(2
M486H1M0@:A%UB'I$0X#"D/*4RNF-/CV1QA>'!OG/JB%*$66(<D0%HA)1A:A&
MU"!J$76(>D1#@,*0GI<[49LLMMZVR$T\6XO<6)!:Y)*)F45.E2,J+'*&I47.
ML$)46^0,&XN<88NHL\@9]A8YPR%`84C/RQBH/"T/J=G1^B$UR!U!:@S#1SW@
MP36GLH-(CJAPR-MIK]A-4J5365\5HMJA$[X:I[*^6D2=0YXO_LMA[U36UQ"@
M\/+PO?S$((*;=GIB35TQ_\$UB_S+8U2T[7-I'WAP#0US1(5#OB_VHV+I5#8,
M%:+:H1.^&J>ROEI$G4.>+WAPS:FLKR%`X>51VV1_)?)3J1;5*7BGTHAJMD>Q
M-2KZ8U%J$*4(+<H0Y6A8.)47"GAPS:FL^PI]U4[E^8('UYS*^FK15X>J'M$0
M&(;70^TL_>LQT5WT1M1?&:IGJ>A:T+W$]CBW!M&=^!:E!JD#<=T%'EQS*FN8
M(RH0E8@J1#6B!E&+J$/4(QH,TJ<=1IEO'B>BC+M$]2R5&I0HV"Y^_%4P6Z/R
ML\R(,NO+=8(<506B$@TK5-6(&C1L4=4AZM%P"%1AE,_;.*H[S?@@HI&JPD69
MO[]K:PS]'V4190;13.7:LG;O&19H6*)AA:H:48.&+:HZ1#T:#H$JC#+?2XIO
M05(/3O&`:Z1J<P&'!]>,8="LM:&',J.BE9L+.*@*]%6B886J&E&#ABVJ.D0]
M&@Z!*@BXNC_KC"%ZE(<[38-4%5Z4V:\]6Z/R6F=J#6EUZ@SA)RIKJ']&GZU6
M_#&HW"K<FKL0N2Z=:KS7@"V)*O1;.XL3A]S$56Q!W*+[+F[(;F7HK>$Q(G<L
MV(-5C!$)+S??!8O[E[J7A/4O@U1M[@)N^%,X1N5UIA119I'YB>UN<\?BE5N%
MZX$%HM(@ZJ?CC9SLU\P*+6I$C7/BGQ@[H-89>BJXQ<^I[,#16V3/]?:._7@Y
M6,5XKN$%Y'ONGUKBJM^3^<74R,\4&Y6'4H/\3#&B'`T+5)6(*C2L4=4@:M&P
M0U6/:`@,PTBK7;-\\;K2FVQ_\6K0Q`\^(E4J4F5&-?&#C\A7(5*5HAHKD:]:
MI&I$-;8B7YU(U8MJ'*9\A8V+)Q+DXS#F%%8:J4'#&X?9=+8UJF`&-FF&B1E8
MJ^BV8S6D+E8+OH3*T75AD$JEN&/BDWOI5.,](O#L.#JNG<D)QTU4M8$1W)Q9
ML._!$5P2I=X>JHW2\I;-/8-51&;EOR5OL<*\A4'>"+Y%E!H4#.K:EX=R-"S0
ML$14H6&-J@91BX8=JGI$0V`8]CN53SAC4-?IAV!0UVAJ4)>HTI5$E1G5U*`N
M\56(:BQ%-58B7[5(U8AJ;$6^.I&J%]4X3/D*&]=YB9@5)F(,8CM6-I!LC2I8
M46M?'LJL+[=>SM&P0%2B886J&E&#ABVJ.D0]&@Z!*HRRRG.<T85U6B3HPAI-
M[5BU*I@OC>')22U;&4.S/]O0C!F^`BJW"G_'*G%=&D.:5<<=*_-;H=_:69R<
M+F.U\X?16^?>]\4.HA/5V%M?QR#QIQ,&JXA,ERKQXK<`^>))IVR"QJ#1U"96
MJ[S^E:X`91;IR[.>W;'8Y%;@^F2!J#3([&%G;'=?H46-J'%._(O%?+7.T%>Q
MP^Z<RNUAS=F;4YWSVWN'P";HP&N><OJI+>SH)<Q$&>2O=A"E!GE+FPQ1CH8%
MJDI$%1K6J&H0M6C8H:I'-`2&8:1YMN?T+P-K3/$8-+':$:E2D2HSJHG5CLA7
M(5*5HAHKD:]:I&I$-;8B7YU(U8MJ'*9\A8V+9Z(F&A>FG-8:L7TK?TK-J/QY
MV*#3F\O,&NHI9KZ@;R*Q>=@JO'E8Y+ITJG%+S/:5%?JMG84_T++4;A-5;=CZ
MKW7N?5]\T([ZXCOPWOHZ!HGG;P>KP'EXK5)>?!X^^Z[5T0L;R)7C\,D&H_+&
M]M2@8"#7AA[*T;!`PQ)1A88UJAI$+1IVJ.H1#8%AV-=4"L*/]$1?TQD+?YFS
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M(W3>*&AS)I7DSQ&`4OH(K]H3!',$H-RHO&U"@88EH@H-:U0UB%HT[%#5(U)?
M%7:;'!UI_95@_>70E]W;U]UV]_Q\N'C<_ZZ^`#R[F5':]\CU]XGO[Q+ZLA"E
MY3A?W";JF:U8"9G0HT>1DN5-HIZ@B9709Y#I01`LH>\C_S*N)WC]9!#3W\\3
M^JPD^KE?T$%%^"_+Y!>*5,1@24<4XZN$/CL7T:_I0\XQODGH`V$1/<4O%CY:
MK"1J=8(6M!I)U/(#2VBYD:CU!9;0>B)1"P@LH09/]<3.G%HTU1,KH29+]<1*
MJ$U2/;$2RH=2/;&+3@E/JB=60AE-JB=60BE+JB=60MMUJB=VB6D_3O7$2FC#
M3?7$2FA'3?7$2N@6I22CG0A&E.Y!2M1-1UA"-QDEZJXB+*&[B!)UVQ"6T*_F
M5$^LI='/XE1/K(1^]Z9Z8B7TPS;5$RNA)UL2=6\^'@$]X)*HQU=B)4LJB?4.
MNJ6?2F+>Z*D7ZE"Q$KJ]GFQB;90>_4G4@SUX!/34"97$CH`>=J"26#WT/%"B
MGFA`;_184*(>^HF5+*DD5@\]"$$E,6_WY.T^6K*E$O5@!]9##TPE6?0(4CK3
M+'H$]#P(E<2\T5-4B7H.)%+/@KSI.8X-J/0^CD2]@`-MZ(4;B7K#!I;0&S42
M]0H-+*%'OJF>V+A'SW13/;$2>FB;ZHF5T%/95$^LA-X)F*B7`.(1T$O_$O66
M/RRAM_HEZC5^6$*O[4O4>_JPA%Y91><3FW#HG51T/K$2>ND4G4^LA-XJ1><3
M*Z'7]-/YQ,8W>@\_G4^LA%ZT3^<3*Z$WZ=/YQ$KHU=%43ZS%T[NAJ9Y8";W\
MF>J)E=#;G:F>6`E]\"U1GZS"B-)WWQ+U5;=8"8V)>@''VBA]Z8I*8M[H8W"T
M'HB5T%>GR";61NF+>(GZWAT>`7V,C4IBHS)]`XQ*8O709_(2]:$O]$9?RTO4
MM_!B)30O1.NA[X-12<S;/7E3'SI#;ULJV49+Z#N"B?I*(-JD=*;J`W6Q$FHA
M46_T<<%$?1Z-;*Z/%^CPZ</WAZ^[[N'MZ]/KX>)Y]X56E#?CQRW>GKZJI;S^
MG_?]=UIITH?N]^_O^Y?QG]]V#Y]W]&7.FRM*)GS9[]_M_Z@*?NS??AN_=__I
M7P(```#__P,`4$L#!!0`!@`(````(0`2%.T>`@@``,0D```9````>&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;*R:6V^K.!"`WU?:_Q#E?4.`D`MJ<M1PEW:E
MU6HOSY20!#4)$=#VG'^_8VS'EZ&-6YV7P^G'S-@S'H\'PL.W[^?3Z+5LVJJ^
MK,?V9#H>E9>BWE67PWK\S]_Q;\OQJ.WRRRX_U9=R/?Y1MN-OFU]_>7BKF^?V
M6);=""Q<VO7XV'57W[+:XEB>\W927\L+W-G7S3GOX,_F8+77ILQWO=+Y9#G3
MZ=PZY]5E3"WXC8F->K^OBC*LBY=S>>FHD:8\Y1W,OSU6UY9;.Q<FYLYY\_QR
M_:VHSU<P\52=JNY';W0\.A=^=KC43?YT`K^_V[.\X+;[/Y#Y<U4T=5OONPF8
ML^A$L<\K:V6!I<W#K@(/2-A'3;E?CQ]M/W.68VOST`?HWZI\:Z7_C]IC_98T
MU>[WZE)"M&&=R`H\U?4S$<UV!(&RA;3C?@7^;$:[<I^_G+J_ZK>TK`['#I;;
M`X^(8_[N1UBV!404S$P<CU@JZA-,`/X=G2N2&A"1_/MZ[,#`U:X[KL?N?.(M
MIJX-XJ.GLNWBBI@<CXJ7MJO/_U$AFYFB1EQF!*[,",@;ZLZ8+ESY!,3X'XP)
ML^LG#E<^IC-QEI[MS<G,/]"<,TVX<DTQHN&L%\P&7#\U:]AV_:SARL<VG/6*
M:<*5:YK.VJ)KWJ=0F'?YYJ&IWT:P+V&5VFM.=KGM@UV>.S1VMVQZ+YD@BXB1
M1V)E/09]R),6=L#KQO/L!^L5LK9@,ELLXZ@2`9<@*4K,ACJ(=!#K(-%!JH-,
M`A8$X18)2/^?$`EBA42"^[#E0(3&U=SF$EPEU$&D@U@'B0Y2'6024-R&#?L3
MW"96H&Y(">`L]01@,K`S;UFRT$)Q$[G%`I$(D1B1!)$4D4PF2D2@#/V$B!`K
ML*D@[#=O/4_+^"T5<C\*R4WD%A)$(D1B1!)$4D0RF2@A@0G*(1D^67@Q(,*]
MYWS&6TK`34X"1$)$(D1B1!)$4D0RF2A>0?4W]XH(JUY1XO8G>U^O`D1"1")$
M8D021%)$,IDH7L%Y9.X5$5:]HD1>*T1"1")$8D021%)$,IDH7I%F53JG/LY`
M(JQZ18F\5HB$B$2(Q(@DB*2(9#)1O((3T]PK(JQZ1<F,=F+DQ`P0"1&)$(D1
M21!)$<EDHGAE0PMK[E8OK?K%T4P4#(Y$#0DYFM^D(HZ$5(Q1PI%03#D2BIF"
M5/]("R$E(VV:)@LH--VQ*IZW-6V7!Y+4A>:(M4RT#X$#@A?%K<W0XH8"CD21
M"1ERY9/%F<W4DS024MQ\C&TE0DJ<4HXW56VE0HK;RA1;:G!(HR$%9R`(T)S?
MHD#;$B4*%#G]0P^MJ^04):DO1X&B&8DY[SD=9ZG./&**(,5G'F.48)1BE#%$
M)Z&Z3%H)<Y=IXP'F^)RV-D4.K+]P9JDM:<"EA&+(T`R"(11=;?TBKDB2[W7C
MSE<K-4PQ%Q"6$R/+*5=DENVY-N>,"_26U:"19L,\:+0U48)&D0,7X?O24UT+
M;"8E]GJ(4<31HH^08^LAC+F`,)-@E'+$S$P];389%^C-J.$@78IY.&A/HX2#
M(BV'YGHXF)18Z9"\*H#-Y0@4<427U7:7FIF8"PB=!*.4(V;&P=DA#ZV&@[0W
MYN&@S9`2#HJT[-"?-VPF)98UQ"CBB"ZK/9NMM$>XF$L(.PE&*4?,CK-RM>>!
MC$L,Y`?IC,P#0OLH)2`4:?FA%<S`9E)B84.,(H:@[)""XGA:6&.LDF"4JE9L
M&VT6>2YJ=I"&2@K&UPY@VI4I,:*(OJQC1P]"(9P`9,.XHCN),(H9DFPE6"K%
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MS@\9DO9TA%&,%1,LE6)$/C80(U*WZ<<#])??<]D<RJ`\G=I14;^0#P/@H-X\
MW##]:F'K^?#+"?0^.I_[\-O#`%_X\/9^@"]]>/\]P%<^O$'&'&J@'T&!P'>@
MR/FDJN$[$%#0&1H%(@8Z0W?@JXS'_BE7]P^^UNA?J.O<@:\X!L;>NC[\E(CG
M]#@#^T,#;V<^_-"&%>#%KD]>V^([\)K6)R]A\9W0=N#.T+3@*16L#8T/CZ&@
M,W0'^D$(XY`U:/@@C/T=ZQ87^(;DFA_*/_+F4%W:T:G<0RI-^]?@#?T*A?[1
MU5=H^>%KD+J#KT?Z_Q[A:Z$2?J^83J!N[>NZXW^`B];M^Z/-_P```/__`P!0
M2P,$%``&``@````A`#7V!+A6#@``%U```!D```!X;"]W;W)K<VAE971S+W-H
M965T,S$N>&ULK)S;<N*X%H;O=]5^!XK[28*!'%Q)IB:`P6#C`SY<TX0D5(>0
M`KI[YNWW$I*0I=])1.^Y">33OY8DKV5;!YO;/_]>OS9^+K>[U>;MKMDZNV@V
MEF^+S>/J[?FNF6?>']?-QFX_?WN<OV[>EG?-?Y:[YI_W__W/[:_-]OON9;G<
M-\C#V^ZN^;+?O[OGY[O%RW(]WYUMWI=O5/*TV:[G>_IW^WR^>]\NYX\'H_7K
MN7-Q<7F^GJ_>FMR#N[7QL7EZ6BV6_<WBQWKYMN=.MLO7^9[:OWM9O>^DM_7"
MQMUZOOW^X_V/Q6;]3BZ^K5Y7^W\.3IN-]<+UG]\VV_FW5^KWWZW.?"%]'_X!
M]^O58KO9;9[V9^3NG#<4^WQS?G-.GNYO'U?4`W;8&]OETUWSKY9;.M?-\_O;
MPP$J5LM?N\KWQNYE\VNX73T&J[<E'6V*$XO`M\WF.Y/ZCPR1\3E8>X<(Q-O&
MX_)I_N-UGVY^C9:KYY<]A;M+/6(=<Q__Z2]W"SJBY.;,Z3)/B\TK-8#^-M8K
MEAIT1.9_'SY_K1[W+W?-]N59]^JBW2)YX]MRM_=6S&6SL?BQVV_6)1>UA"ON
MQ!%.Z%,X<2Y.=M(63NA3.*%*+1O0$;;T*6QOK&VIFX<C0)\GUWLI;.E3VIY=
M=[N=R^LK^Z-W)9S0IW#2/;MJ7=RT3_!!I_.A$_0I&V)]`.A0'6SI4]@ZE4Y\
M$O8692M/'I:V/#&N5=P_LSRF'7V1#5:6EE%OR;QC7XY>3C[^+9EY[(MP<WH$
M6C('V1?9&.L8L%.6'\I*&E:B8'M$9$*V5$;^1E=D1K942MJ?BRV9B^R+.!"V
M"253L:5RT2ZA')F*[(L\^B<GE"/3DGTY>CDYH1R9E^R+<'-Z%!R9ENR+;,Q7
M"77.+^^'NT5_OI_?WVXWOQIT"Z8.[=[G[(;><IE#>9_@)^GQSO'1C8/N&,S+
M7\S-79.B0_>$'=WM?MYWN^W;\Y]TAUH(S0-J'%W1DPIV.V)N^R88F,`SP=`$
M(Q/X)AB;8&*"P`2A":8FB$P0FR`Q06J"F0DR$^0F*$Q05L`YQ?P8>$K!?R/P
MS`T+O`S9@P0J$XP\Z$F%-.F;8&`"SP1#$XQ,X)M@;(*)"0(3A":8FB`R06R"
MQ`2I"68FR$R0FZ`P05D!6I3IC/XWHLS<T`BP<GH[-QW]Y'T0&KI/':\!5[JD
M=Y0<0P]D`,0#,@0R`N(#&0.9``F`A$"F0"(@,9`$2`ID!B0#D@,I@)15HJ4#
M#4'^C71@;NB&04EW##4-;O5@/W!1^[-\.$J.^0!D`,0#,@0R`N(#&0.9``F`
MA$"F0"(@,9`$2`ID!B0#D@,I@)15HN4#!4?+A_K9H;S),_4A[#)<#YQ0C"7I
M`>D#&0#Q@`R!C(#X0,9`)D`"("&0*9`(2`PD`9("F0')@.1`"B!EE6@AI0'^
M"2%E:CVDG+0/2Q.'05@/2!_(`(@'9`AD!,0',@8R`1(`"8%,@41`8B`)D!3(
M#$@&)`=2`"FK1`LIS;9.""E3ZR'EI'J6`ND#&0#Q@`R!C(#X0,9`)D`"("&0
M*9`(2`PD`9("F0')@.1`"B!EE6@AI2GP"2%E:CVDG%3/4B!](`,@'I`AD!$0
M'\@8R`1(`"0$,@42`8F!)$!2(#,@&9`<2`&DK!(MI#3Y/2&D3*V'E),.7T%E
ML]\>D#Z0`1`/R!#("(@/9`QD`B0`$@*9`HF`Q$`2("F0&9`,2`ZD`%)6B192
MMI!Y0DP/<CVH$G74"$DB-6CJ2W1Y5`TD4BI/(J4:2J14(T2^1,IP+)$RG"`*
M)%*&H43*<(HHDD@9QA(IPP11*I$RG$FD##-$N43*L)!(&98:TD/-UDEP(>R,
MK;7O7U:+[P\;OMU1,T1NTX*76`;CJRTT,Y(#XH>60%='U)-(C;'Z`K6K4RJG
M8TRI!DHEW7N(AHA&B'Q$8T031`&B$-%4(%KKE4V-E$I-&YWNA3YMC)5*&B:(
M4D0S1!FB'%&!J!2(MU[/$[;24LV3FGR@';)C0O"%&2TA..I6+PD<=52F]MGD
MFMT@Z'9SG&,[-\:"RD"HNLK04ZABV+W4C_)0J>11'B'R%:KXNKG1?8V52OJ:
M(`H44K[:%RW=5ZA4TM=4H,K!B91*^7+,/L9*)7TEB%*%*K[,/LZ42OK*$.4*
M*5_0QT*II*]2(-Y'/=_86DXUW_@"_:G7);XB1-7(*A_8IA8EF):&'%6.=%^H
MV+Y+)0VO]:@-A*IBZ`E$%S19XQ#1"`U]I5(UMB^,J\18J:3["?H*4!4BFJ)A
MA*H848*&J5)]TOJ94LG69^@K1U6!J-0,]=1ARS[5U/GB4L57B;0<X8CVSF0[
M>VP7DU^7).H+5%$-4.4)1#FBCHSC&)DT5"KI?H3(1S1&-$$4(`H131%%B&)$
M":(4T0Q1ABA'5"`J!:J[4;$5HA.BSQ>4M.ASQ/8\C^=^^P+V[(1*G>A]MFE-
M.=)1:"`0;7S*N'J(AF@X0I6/:(R&$U0%B$(TG*(J0A2C88*J%-$,#3-4Y8@*
M-"PUE7[NL\6D$Z+/UYZTZ'/4H26,2O3-O3SV/`&%VE'#[KY`';J95`QA*`N&
M7IVATS:N_$-9X]5AE[G5NC;O#2.I4&WRK5R/ZU7&F&N"[H-Z0Z/EH33\L.53
MJ5`MCZQ<Q]+P0]>)5"C7J97K6;W*."@9NL_K#8V#4DC##UM>2L6AY7J2L^6U
M$Y*<K\9I2<Y1EP;;E5SMZL.;'GO<A26YNGCU!:)+7-70&&4/T-!#-)2(32-_
MWK<Z7<QH:(`OC52;Q@(9;3(B-5&&JN5.VSBO`Z62U^M0(M',B\MKX^8]E0K5
MI@A1+-&'W4VD0OE)$<T$,KIKM"E3AI]T-U<JV=U"(M',5O?:2(M2*@[-U!.3
M+1*>D)A\35%+3(Z,JZ\Q\^JQV:%Y]16&VM6W99QU`S3T$`TE$N>F<V/D]T@*
MU$7%1S062+\AM(R9WT09?A*H0*EDH$+EGIT^[;8Q0)FB280HENBCOB92H/J:
M(IH)9/35:%*F##_I:ZY4LJ^%<L_ZVND8V5YJ)GI*LD7.:DK^WCR2+Y5JF<H1
M?Y:9;QBRV2)+2[7VTY=(/2@TD$BI/('::FEDB&B$ACZJQH@F:!B@*D0T1<,(
M53&B!`U35,T096B8HZI`5&J&6@:P)R"U#/A\.GB0ZXO9`K$'P(]W2Z=E7!1Z
M5JJ^4+6I41_[&ECY\JQ40ZL:1U:^?"O5V*K&B96OP$H56M4XM?(56:EBJQH3
M*U^IE6IF56-FY2NW4A56-99?^=)/1G.[X8N3$?<5V+2<762UV7G+&,?UI$H-
MI?H"56?GJ/*4JG)^PF1,&O)!DG/5A2&"5*@&^%:NQW6J=LN81DZ4^VHSC:,0
MU/F"F64H?8G..->.,6R:2H7J3&3E.I:&'QZG1"J4Z]3*]:Q.U6X98]5,N?_D
M..5UON`X%=*7Z$S[VIP]E%)QZ(R>]VQ;X_\>AM!,C.5^=1@B4&7,T4/4EZ@R
M#)&H,@P1J#H,031"0Q]58T03-`Q0%2*:HF&$JAA1@H8IJF:(,C3,454@*C5#
M/0/8)D,U`[ZX\O$]"2W4''TU#+%1]=DK#Y1)7PU#;'QYPM?G[1I:U3BR\N5;
MJ<96-4ZL?`56JM"JQJF5K\A*%5O5F%CY2JU4,ZL:,RM?N96JL*JQ_,J7?C*>
MMD7DX!:10.SC.(XWGUOH29&:._<%TB?*%\;M?8"&7ITAW*.&TI!/YZ]O+HT;
MXD@*5)-\*\_C>I6YRH;N@WI#8X@12L./&CZ5`M7PR,IS+`T_\IQ(@?*<6GF>
MU:N,0Y*A^[S>T#@DA33\J.&E%!P:KN<WVXFJWFQ^:]6#7='-X09'VG`#4%\8
M.M7A!J@\H=*&&UQ502/I2XU3?#0<(YJ@88"J$-$4#2-4Q8@2-$Q1-4.4H6&.
MJ@)1J1GJ&<#VF:H9\,5P@V]+:<,-L5-%(3E>X6I6/6Q4?=HGLQENV/CRA"_6
M]8_;-;2J<63ER[=2C:UJG%CY"JQ4H56-4RM?D94JMJHQL?*56JEF5C5F5KYR
M*U5A56/YE2_]9&3[6"><C'S;2SL9Q4[8ITG?<VQ4?:'Z:NQOX\NSJG%H5>/(
MRI=OI1I;U3BQ\A58J4*K&J=6OB(K56Q58V+E*[52S:QJS*Q\Y5:JPJK&\BM?
M^LG(=@JK)^/OC8WX?J-VCHI=2352Z=$XB=WW*L.EOD35L1&H/*&J#(2&B$;2
MEZK11]48T00-`U2%B*9H&*$J1I2@88JJ&:(,#7-4%8C8KPRI8\\S@/]J$/\=
MB/5R^[SL+5]?=XW%Y@?[12!ZFOC^]HCYSQ4]W+CTF@3M0QJ<?L;HK\,JG\$?
MZ.>-#F^RF-RAGSVJ\?/0=NFMY1K_'?)_"*OIJ./2:ZUH\-!UZ=W(&G[IT@MV
M-?S*I;>T:OBU2Z_Z(*>,=%D*8@FEG,MR#$LHIUR61%A"2>.R+,$2R@J7I0&6
M4-A=%F<LH9D$M:VN]S15H+;5E=!<@-I65T*#?6I;70F-YJEM=24T7*>VU95X
MCD-MJPL]K9I2V^I*:%F4VE970NN>U+:Z$EK8I+;5E=#*);6MKH0>Y7;9`[AX
M1.F);I<]=(LE],@V97A="3WI2C9UN4G[VR[;T$9OM('MLAUK+*$=:I=M26,)
M;4&[;,\92VB/V66;REA"F\C4MKH2>CZ?ZJGK#SV`[[)GI-$;/8=/+:@KH0?M
M7?9X--K0\_;4MKHHT+/35%)G0V_'4-OJ+B?T3@GUIZ[D@>IAS[AC"WI4TJLM
MH=<I7/8L.]K06Q44N;H2>FW"98^QHPV]/4$QK>LI/>-.)74V].*$RQYD)V_G
MQPL>_2S;^_QY&<ZWSZNW7>-U^407Z8O#&P!;_L-N_)_]YIWV1.B7@#9[^D&V
MP]<7^@&^);U*2+^ZUFP\;39[^0^KX/B3?O?_`P``__\#`%!+`P04``8`"```
M`"$`2\XE,9X'``"T(0``&0```'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6RL
MFEEOHT@0@-]7VO]@\3[&@/&!8H_&W-*LM%KM\4PPCE%L8P%)9O[]5M/=]%&,
MC4?S$I*/JJ*JNKJ[:/+T^=OY-'DOZJ:L+AO#FLZ,27')JWUY>=D8__P=?5H9
MDZ;-+OOL5%V*C?&]:(S/V]]_>_JHZM?F6!3M!"Q<FHUQ;-NK9YI-?BS.63.M
MKL4%[ARJ^IRU\&?]8C;7NLCVG=+Y9-JSV<(\9^7%H!:\>HR-ZG`H\R*H\K=S
M<6FID;HX92WXWQS+:\.MG?,QYLY9_?IV_917YRN8>"Y/9?N],VI,SKF7OERJ
M.GL^0=S?K'F6<]O='\C\N<SKJJD.[13,F=11'//:7)M@:?NT+R$"DO9)71PV
MQA?+2VW7,+=/78+^+8N/1OI]TARKC[@N]U_+2P'9AG$B(_!<5:]$--T3!,HF
MTHZZ$?BSGNR+0_9V:O^J/I*B?#FV,-PN1$0"\_;?@Z+)(:-@9DK=R*L3.``_
M)^>2E`9D)/O673_*?7O<&/9J:LUG"Y">/!=-&Y7$HC')WYJV.O]'92SB4V_#
M9C;@RFPXBZF[G#G6`T8<9@2NS`@\=*0#<Z8+5Q[$=.6Z\\5J"5'<\!SN=M'#
ME2FNIDMKMG;NZ"V8'EP?=G;)=.'ZF+,P93MGX?J0LVNF!]>QSIJT2KJB"[(V
MVS[5U<<$9C*,27/-R+I@>6"/5QM-<5]_/RH_J!EBY`NQLC%`'TJK@3GSOG5=
M]\E\ASK/F<P.R]BJA,\E2"D2LX$.0AU$.HAUD.@@E8`)2>@S`<7^"S)!K)!,
M\!AV'(C4.%K87(*K!#H(=1#I(-9!HH-4`DK8,#U_0=C$RL:`GWT!.-9*C7/'
M9&!J]D)+5<3O1?I<(!(B$B$2(Y(@DLI$R0@L.K\@(\0*3"I(>Q^MZR[4>'=4
MR+F5DEZD3PDB(2(1(C$B"2*I3)24@(-R2H;W(KX8$.$N<N[QCA((DQ,?D0"1
M$)$(D1B1!)%4)DI4L-B/CXH(JU%1XJQ$5(@$B(2(1(C$B"2(I#)1HH)M:'Q4
M1%B-BA)YK!`)$`D1B1")$4D0266B1$7:6VF?NEV!1%B-BA)YK!`)$`D1B1")
M$4D0266B1`4[YOBHB+`:%25SVKR1'=-')$`D1"1")$8D0225B1*5!4WO^+`Z
M:34NCN9B:G$DUI"`HT4O%7(DI"*,8HZ$8L*14$P5I,9'6@BI&+NF:3V%=>;1
MMHGV(K!)\(5Q9U$TET-G2/@6<"EX9+^[.+:E[BZAD.+F(XQB@6[82H04MY4J
M2$T0:3;T!+E3TH.WQS)_W57@-40U,(L=Z!Y93TD[%B4Y%"G)84A.#D6.W36B
M]LS2&JZ0;,HPDT"`QQ(Q-!=F8B%%^EDPH[6KB1#@9E+%C)H2TFY(*1D('=ZM
M^MAI<P+FN.F=19'=O3UV&?(9LL0.%#`$<8C!M&VM$PN%%#<?811CE&"4,D2=
M4$,F[<3XD&GSH81,D0V5(E6Y-@R^Q:1$K@*&YC#.O:+MS/3I015!JAM@5[L?
M8</Q*,,)5R2U_+ZUEDNM[4NY0.>RFC,8N`=R1J2UI9,B&V+K0W=L;0;XY$`!
M%&VQ`@88A1PMNS@<U])>Z2(N(,S$&"4,S6DZUK9F)554U&R0)D>J(++0V@MR
M[C&T=,CSAW9'2C%1I!737*T)WV)2<C$A%'(I-L#6:HYJ!RG%7$F83CBB=I;N
M8JVZDW*!@4(AG9*4FCOK">VKE'Q0I!6*-C:^Q:3$"`<8A0RQ$4:O.1%6B3%*
M5"N.I;T<IHJ*6B>DP1J?#-J.*<F@2"L.;=KZL,9ULT:,8(!1R!$KCIG^'AQQ
M`6$FQBAAB*U.SE*;PJFBHF:#-&92-NB9SJ.[+^WNE"119(OMQK<0"AAR1`,3
M8A1AQ1A+)1BEBJ(2-NR,2MBW9T0GK2Z=#)'5I5\Z;4LO@E%2P2BID$DYX/F/
MGQB-LA6/DDI&/3&]9TO-.VE/I7*[DW?:S,IU168=;$:NTS<[/D/R_L00K#%2
MKM">SA7IEF4MK:6VI$9<0JQH\2C3"5=DIF?KA;;HIURB,ZWFB'2<4HY^:DK:
MM&U54D>1/"69E(0"AN0IB5&$%6,LE6"4*HIJV`\UO39N>AFZ-R59:WQSX@:C
M;(5,ZMZ4'//$>-03DU%/3._94O-..ENIW.Y,2=H'*W5%T;V\CY$*2(=!>LV;
MHQ,RJ7MY'V,K'O7$9-03TWNVU+Q#C'+>?VZ:$R/:SD21-*=]DDZ25;$9!PPI
MTYQ*22C"BC%63#`B'SW%$VG8]",F_9YT+NJ7PB].IV:25V_D`R6LWMNG'M.O
MI[NE!V=\\-:I\Y4'IV0#?.W!.1/F$*P7@D?X#D3C$??Q'?AR^Z7KN?1GPQ?=
M[@A-YS9\Z1VPLW,\^'@P8'\.]H<>O)M[<+2.%7:N!X?3`WSAP?$NYG#B`IX.
MN03O_1YY.<<ZT(]YI`'#=Z#A`IVA.[!A0'*'G@,[`B1WZ`X<7'F[0=]\N.,/
MWH%C+/!M*/6!!1X,ZL`)ED=.:X;BL2">(6MPE`-W.AVS'V/X9G[-7HH_LOJE
MO#234W&`DIUU77)-O[K3/]KJVIU5/5<M?"[O?CW"?T<4<-HZ(T=^AZIJ^1_@
ME-G_O\7V?P```/__`P!02P,$%``&``@````A``CG0BXG"```(28``!D```!X
M;"]W;W)K<VAE971S+W-H965T,S,N>&ULK)I9;^,X#(#?%]C_$.1]D_A(TAIM
M!HU/`;O`8K''L^LXC=$D#FRWG?GW2UF2=="3:`9]&4\_DY1(410=^^'+U]-Q
M\EXV;56?'Z?.;#&=E.>BWE7GE\?I/W\GO]U-)VV7GW?YL3Z7C]-O93O]LOGU
MEX>/NGEM#V793<#"N7V<'KKN$LSG;7$H3WD[JR_E&>[LZ^:4=_!G\S)O+TV9
M[WJETW'N+A:K^2FOSE-F(6AL;-3[?56445V\G<ISQXPTY3'O8/[MH;JTPMJI
ML#%WRIO7M\MO17VZ@(GGZEAUWWJCT\FI",C+N6[RYR/X_=7Q\T+8[O]`YD]5
MT=1MO>]F8&[.)HI]OI_?S\'2YF%7@0<T[).FW#].GYR`N/?3^>:A#]"_5?G1
M*O^?M(?Z(VVJW>_5N81HPSK1%7BNZU<J2G84@?(<:2?]"OS93';E/G\[=G_5
M'UE9O1PZ6.XE>$0="W;?HK(M(*)@9N8NJ:6B/L($X-_)J:*I`1')O_;7CVK7
M'1ZGWFKFN\OUG0/RD^>R[9**VIQ.BK>VJT__,2F'VV)67&X%KH,5:V6/*\.5
M*\-@E@/[7!>N7->?N7=+9[FBL[\R8[C;^PU7,:@S6ZX77N_V%<455X2K4)1Z
MEK-><QMP_;%9PZ[M9PU7,;C=K.^Y(ER%HNVLYRQC^@2,\B[?/#3UQP1V-:Q2
M>\EIC7`"L"LRC\5NR,7OI2+D(#7R1*T\3D$?DJR%_?.^62[7#_-WR/F"RVRQ
MC*M+A$*")C@U&YD@-D%B@M0$F0F(`N80A"$2D/:?$`EJA49"^+`50(;&,]P6
M$D(E,D%L@L0$J0DR$Q`%:&[#AOT$MZD5J#I*`GBNF0!<!C;KD"6&2#B(#+%`
M)$8D021%)$.$J$2+")2A3X@(M0*;"L(^>+M<WNE+OV5"WK60#")#2!")$4D0
M21')$"$JT4("$U1#,GXNB6)`A7O/Q8RWC(";@H2(1(C$B"2(I(ADB!"5:%Y!
M];?WB@KK7C'BW4FO$(D0B1%)$$D1R1`A*M&\@O/(WBLJK'O%B+I6B$2(Q(@D
MB*2(9(@0E6A>T597.:>N9R`5UKUB1%TK1")$8D021%)$,D2(2C2OX,2T]XH*
MZUXQXK,VCIZ8(2(1(C$B"2(I(ADB1"6:5PXTP/9N]=*Z7P+Y<FL))&M()-!J
MD(H%DE()1JE`4C$32"H2#>G^T19"24;6-,W64&BZ0U6\;FO6:X\DJ0?-$6^9
M6!\"!X0HBEN'H_6`0H%DD8DX\M23Q?5]_62)I90PGV!;J922IY2[7.BV,BDE
M;!'-EAX<VF@HP1D)`G3U0Q186Z)%@2&W?V3J8Q724Y2FOAH%AGP:<]%SNJYQ
MOL9<$:3$S!.,4HPRC`A';!*ZR[25L'>9-1Y@3LQIZS#DPOH/SGB>L0RAD)**
M$4<^!&-0=$W%6$K1SMQW[O7U3;#A5*I<,9Q)J=ZP9R0AT0SK(:.MAGW(6&.B
MA8PA%RZ#YY[GZ)Z%#I>2.SW"*!9HW3^Y^*N58281`M),BE$FT/?,$"'0F]'#
M07L4^W"PCD8+!T-&!J$'+"ZE9A!",?WE`7:;2VO5^\99F?F4"`%I)L4H$XB;
M<1QC<Q(AT)O1PT&;&_MPL%9("P=#1G:8#UX.EY++&F$4"\26U7%6AA^)$)!F
M4HPRCGS8ZD/"NI[Q`$0T13TFM#6RCPEKI+28,&2DB+%E0X=+R;6-,(HY,NJ.
MX4R"%5.,,FFK+R)K(VF)IJ*'A/95]B%A79@6$H:,-%F:181+R?6-X!#HMXA$
M,4?7US?!BBE&F;1%0^(9]9IH&GI$:$^F1.3G.A/6V&F!8LB5!W#H(!1QY,FV
M+<8HP8HIELHP(IJBYC;T"IK;UWN.7EIO.#FB/S?*S>FLC$2PDHJLI&(NY<',
MOS]B8F4KM9+*K$8DMVSI<3<:X1MQQQTO+49PU"S5_L59&!4@Y%*N4I,PB@5B
MY\WZ;FW6:2$@S:0890(Q,ZNU:U1((@3PL043_)$T9!VLNLUZ`W#RZDT-2D.F
MZ,KB$PE%B6*.M'KDF>=-(A65-/2,@S*54J)ES<;-&R$G4G'<O)Y-1AO]4\4+
MNI;^44$N\I8CM7AA%'&D%B^,$JR88JD,(Z(IZF[3'E6IV3<V$>MHM:SA3>Z-
MXF4C%='4H[W?55LQE[I5O&QLI58C9E8CDENV]+C3-M<^[E3:.#08HO5@*.&>
M>5B'-)0THC(A(XZ,[LEXW(N%(B]$]^9C>2($I.74RG(F%+EESS,J#!$"(R7.
MZ,Q_;H_BAAV*61\EI<'`*.)(VZ-,44$)5DRQ8H81T13U7/FAYMO%S3='-+!#
MKKBXP>#-]U6IR,I6S*5N[5&;$5.K$3.K$<DM6WK<:9]MOT=95Z[51MZH7XUH
M"$?#[:H764G%7.I6W&U&3*U&S*Q&)+=LZ7'_C.<(^&("E4STT!!R*9B>Z"TB
MCI0]'6.48,442V48T2\Y9*UA;K,O,]B+\5/9O)1A>3RVDZ)^HU]=0.W>/`R8
M?1*R70;P8@FF;/)5`*]F1O@Z@)<;(_PN@-<#(_P^@!_8,8<:&,10J/`=*'(!
MK6KX#@04=,:L0<1`9^P.?/+RU)=_TS_X%*9_WV!R%SZ1&1E[ZP7PIA7/Z<D'
M^V,#;_T`WD-B!?C=.Z"_:N,[\"MV0'^CQG<BQX4[8]."9U6P-C8^/(R"SM@=
M:!$AC&/.0`\(8>SOS(>XP`<ZE_RE_"-O7JIS.SF6>TBE1?^6H&&?^+`_NOH"
M?05\+%-W\&5._]\#?(I5PNN<Q0SJUKZN._$'N#@?/N[:_`\``/__`P!02P,$
M%``&``@````A`"=Z@XVB`@``-P<``!D```!X;"]W;W)K<VAE971S+W-H965T
M,3DN>&ULE%7+;MLP$+P7Z#\0O$>T9-F.!<N!TR!M@!8HBC[.-$5)1$11(.DX
M^?ONBHX@UT;J7/18#6=VEMS5ZN99-^1)6J=,F],XFE`B6V$*U58Y_?7S_NJ:
M$N=Y6_#&M#*G+]+1F_7'#ZN]L8^NEM(38&A=3FOONXPQ)VJIN8M,)UOX4AJK
MN8=76S'76<F+?I%N6#*9S)GFJJ6!(;.7<)BR5$+>&;'3LO6!Q,J&>\C?U:IS
MKVQ:7$*GN7W<=5?"Z`XHMJI1_J4GI42+[*%JC>7;!GP_QRD7K]S]RPF]5L(:
M9TH?`1T+B9YZ7K(E`Z;UJE#@`,M.K"QSNHFSVR5EZU5?G]]*[MWHF;C:[#];
M57Q5K81BPS;A!FR->43H0X$A6,Q.5M_W&_#=DD*6?-?X'V;_1:JJ]K#;,S"$
MOK+BY4XZ`04%FBB9(9,P#20`5Z(5G@PH"'_N[WM5^#JGRRBYGL6S.<#)5CI_
MKY"2$K%SWN@_`10?J`))<B"!^X%D.H]FB\DT_C\)"PGU_NZXY^N5-7L"9P8D
M7<?Q!,89$)\W!$X0NT$PI$X)Y.I@$Y[6:9RNV!-43APPMP$#UP&3#`@&HH,R
MJ%VNC&!4QM)B*K<A,):9GI>9OD<&P3F%ZY#\J<&`24>8Q7EE@%QN$,&P!V#K
M#>D`ND`:#M7ET@CNI8?BADC:M\1XR^;OH47P,>TA`MTW\C@[7[S%>Z00?"P5
M(J<.<!Z/CCOV\72VB!;@^.VCCPN/)0Z1\1%,X_EY-]`R8]FWI1!\+!4B(S=A
M4(5&UM)6\I-L&D>$V>$02J`UA^@P'S<)[N>_\33;]%W%A@\PMSI>R6_<5JIU
MI)$E4$[Z$MDP^<*+-QUD"=/+>)A8_6,-/R@)W3F)H)ZE,?[U!839\,M;_P4`
M`/__`P!02P,$%``&``@````A`%7_U%==#0``5TL``!D```!X;"]W;W)K<VAE
M971S+W-H965T,C@N>&ULK)Q9;QLY$L??%]CO(.A]+.ORT8@]B-3WN5CL\:S(
M;5N(Y38D)9GY]E-LDN+QIRW*F)?(^;&JR"Z>57U\^?V/[<O@9[O;;[K7N^'X
MXG(X:%_7W</F]>EN^-__Q+_=#`?[P^KU8?72O;9WPS_;_?#W^W_^X\NO;O=]
M_]RVAP%9>-W?#9\/A[=@--JOG]OM:G_1O;6O5/+8[;:K`_UW]S3:O^W:U4.O
MM'T932XOKT;;U>9UR"T$.Q\;W>/C9MV&W?K'MGT]<".[]F5UH/;OGS=O>VEM
MN_8QMUWMOO]X^VW=;=_(Q+?-R^;P9V]T.-BN@^SIM=NMOKW0=?\QGJW6TG;_
M'S"_W:QWW;Y[/%R0N1%O*%[S[>AV1);NOSQLZ`J8VP>[]O%N^'4<--/;X>C^
M2^^@_VW:7WOM[\'^N?N5[#8/Y>:U)6]3/[$>^-9UWYEH]L`0*8]`.^Y[X%^[
MP4/[N/KQ<OAW]RMM-T_/!^KN.5T1N[#@X<^PW:_)HV3F8C)GEM;="S6`_AUL
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M`F4FIL122K#EAID-;1#9(+9!8H/4!ID-<AL4-BAM4-F@MD&C@1'Y^NAP&F=_
MA\.9&>9PZ:J%!*H'II9WI814"6T0V2"V06*#U`:9#7(;%#8H;5#9H+9!HP'#
MNS0/_P[O,C.THVG#>3*[--VY$#(T9XYCWAKQRZ/(T>5`(B`QD`1("B0#D@,I
M@)1`*B`UD$8GAOMI,?L[W,_,T()$G7QT[7QV8_F?"TT_\O]1Y.A_(!&0&$@"
M)`62`<F!%$!*(!60&DBC$\/_Y`S#_^[3G%RTF73O9NF>!2?D4TF60$(@$9`8
M2`(D!9(!R8$40$H@%9`:2*,3PX5T+CO#A4S:="$GTQOE0B`AD`A(#"0!D@+)
M@.1`"B`ED`I(#:31B>%".IZ>X4(F;;J0$WT4`@F!1$!B(`F0%$@&)`=2`"F!
M5$!J((U.#!>R,%L_EGT\D9FTZ4).]%$()`02`8F!)$!2(!F0'$@!I`12`:F!
M-#HQ7$B'T3-<R*1-%W(RXQ$K.XTN@81`(B`QD`1("B0#D@,I@)1`*B`UD$8G
MA@M9J':&#WMQTXD2S=1R*)':9$*)KHY2D41**D:42*044XF48H8HET@I%A(I
MQ1)1)9%2K"52BHV!3)>RN,!_9K,HUQJ7`LUTEW*IF6I!**5HGSN>H28S*R2(
ME)3<\&-$B4*ZK;EY'DN5E+25(<H5TFU=F;8*)25ME8@JA71;UB&\5E+25F,@
MLWM88*%W#X^'+UANY/"\67]?=.1.<K=C09Y2W"NB81Z>T`%65KE@AUGJ2*/7
M!-)[C:,I_6B]-C.]$PE;)"7-Q]*\LI6@5(HH0\4<I0I$)2I6*%4C:@Q%T_DL
MKM"=[W`R91>/7N9A"-F3;EBP/`QY>=+G/ON^6`HT5@>R4"":+IJ7)U9\$2DI
M:3Y&E"!*$66(<D0%HA)1A:A&U`C$+]OT,HL>SO`R#S8,+W,TH6F@C5++?TN6
MV6)]H;HG%&AF#.^I%5A'4I'-IY_WX]G-?'9KSH!8BBC;":+479VU/F2HF+L5
MK7864O']=I921+6S0E2[J[/:V1B*9H^R8.:,'F7BUC;-T82Z3.M1R^M+EA]D
M/:KVOE"@&<T[I8@]*A2O>8].I_.;L=VC8#O!ZE)W=9:G,E3,W8K0HR?;6:+M
M"E'MKLYJ9V,HFCW*8BN]1S^W#?$(S9BZ'$W4:K@<`PH%FJHC1H0H1L4$I5)$
M&2KF*%4@*E&Q0JD:46,HFIYF(9CNZ1-[#H_8#)=RQ&Y[J2DPMDXTR[&/5.@E
M%0FI*9W.WZ\Q]K*5>$FE7C5F7K9R+ZG"J\;2RU;E)55[U=B<LF4.+A:<GC&X
M>"QK#"X1WFI1*&WIL*]R=&I?%8I\OYK<3,;V0AVC[011*I!5G;6Z9:B8NQ5A
M%3[9SA)M5XAJ=W56.QM#T>P^%ACKW?>Y59B'UT:O<F2LPH#",4?&*@PH%E*:
MK0054T09*N8H52`J4;%"J1I18R@:GJ8#N^GICU?A7MP\P0AT8A7VD@J]I"(A
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MTZ4LA7"&2WG&P7`I1_J].[;Q,/^IJ#U$%"&*$26(4D09HAQ1@:A$5"&J$34&
M,EUJ)T-.C%+,>E#&BOE/OY>'*$04(8H1)8A21!FB'%&!J$14(:H1-08R77I>
MUF."60^)5(IH*9&Z!Q%*I#*&D41**D:42*044XF48H8HET@I%A(IQ1)1)9%2
MK"52BHV!3)>RJ/6,B<^#7&/B<Z3?(J+=OQ^XJ@6A0EKR!V[L*:GCS0M$B4*Z
M+?O&GI*2MC)$N4*Z+2L-5B@I::M$5"FDV[("]UI)25N-@<SN89&SWCV?.Z?Q
M^-OH-8Z,7A-([S6.S!M[<ROS$4V.4O**8H&T6[L)2J6(,E3,4:I`5*)BA5(U
MHL90-)S/PAC#^1^OX+VX&=X+1'&?],Q22FF;HD`G;NPI*6DK1I0@2A%EB')$
M!:(2486H1M0(1%DK:KWIY?/BW"G&N0*Q`$@EENT'+Y=22MW4"@6R,H+V\):*
MXH;9S=6-=<\PEA+*=.)E.I6*[YK.I(0RG2,JW+59*T^)BA6BVLM68RB:_6F'
MEB=F#<:0;+EA>0LZ?FO]:=_6DU)JYPL%.G%;3RKRVWKSV\LK:^N(I80RG2!*
MW;593L]0,7<K6L.ND(KO-K.4$JJ9%:+:79O5S,90-/O3#F`_M05-,:X5B#8_
MN:`M$84"Z:D"1#$J)BB5(LI0,4>I`E&)BA5*U8@:0]'T-(LW]<W^Q,SAX:F^
MJY.7^IE#@9>:.7!3STLJ])**A!1;WM^O,?:RE7A)I5XU9EZV<B^IPJO&TLM6
MY255>]78G+)E#BX6C)\QN'CL;@PN$<YK-_4H-=*/-[4[A0*=VE.%(M_XKJ^O
MY]8S?C&:3KQ,IU+Q@ST56IU[F2Y,TXZ=HY02RB$5HMI=&RS)>C/-OK13"Y];
MDC'C,.7(6)(!A4**AI]<N"-$,=I*4"I%E*%BCE(%HA(5*Y2J$36&HNGI\S(.
M4\PX",3R1.\OD$LOJ=!+*A)2IY9DWM2/VY5XU9AZU9AYV<J]I`JO&DLO6Y67
M5.U58W/*ECFXSLN]4!Z5+;;&DLS1QYVX%(H?2X5>4I&0.C6X?-J5>-68>M68
M>=G*O:0*KQI++UN5EU3M56-SRI8YN%A21M_O/[='\-2.,>8X,O8(0"%]!((-
M5F./`!0+*<U6@HHIH@P5<Y0J$)6H6*%4C8A]U:(_ZF@)#/Z5"OY>^K;=/;7+
M]N5E/UAW/]@7**[8`>2(^><Q%I-9P.["T+X))7,JZ5-O4')%)7V,9Y>0BE.#
M%)SRUP&]NN6H^R:@]Y$<_#:@EVP<?#*E%DT=)=3M042>0AWJUX!U))90QP6L
MI["$>B9@78$E])F1K_T1R_8(?7ZD/Y[:?$(-=MA9T(6XKN/K+/CJK'A!_>?J
M/@I3Z<)=IB@.I0MWE5"@21?N*J%(DB[<54)G+ZK'U;ETN*)Z7"5T>J)Z7"5T
M/*)Z7"64*@]8+A9=3QGS@.5?L812X@%+PV()9<8#EGK%$DI]4\^X2L+I);6M
M3YQ:G4E/#P01W7!':_1X0,">!\`2NO]/K7:5T`U^:INK9$%M6SC;MJ22I;.$
M[G-0VUR3*9S0U'#JQ*3#$N;8:KK30=?C*J%GG0/V<+-#ATK8T\M80D\K!^SQ
M9"RAQY$#]OPQEM#3?%2/JP7TN![5XRJAY_&H'E<)/7!'];A*Z)VK@+W4@RV@
M5Z_(FJN$WJT*V/L\J$.O6%$]KA)ZAXI6"%<)O5Y#.JXYMR`=]B(4UK.DDJ6S
MA%YD([^YEJ)P3*/7J4/OL`7LC2BLAUYE(U_W):/C9*#/&KVMGMIJM7O:O.X'
M+^TC;3J7_2M?._YA)/Z?0_=&AT;Z.$QWH`\:]7\^TP>L6GHU]/*"HI+'KCO(
M_U#5H^,GL>[_`@``__\#`%!+`P04``8`"````"$`$+Y"K%$'``"H(@``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6RLFEUOHS@4AN]7VO\0Y7Y"""$?
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M_X^J8_'NE?D^SB\9N`WC1$;@J2A>2&BP)P@::ZBUVXS`'^5HGQV2UU/]9_'N
M9_GSL8;A-N&*R(59^^]V5J7@*,A,9B912HL3=`#^CLXY20UP)/G6?+[G^_KX
M.#86$W,Y-70('SUE5>WF1'(\2E^KNCC_2X.:*^I$9JT(?+8B^GRRU*=K8ZDN
M8K0B<RZBW`$X2W,5\-EV8#E9F>9\L;JC`XM69-F)P%4K.@#3J>D`?'Z^`^M6
M1"=9P'Q6[8'>C23\\_D^Z&PLR3^JG=!H4C4Y:B=ULGDHB_<13'SH2G5-R#*B
M6T2092?-I2Y?/TI7R%.B\I7(/([!'LC$"N;8V\:<&P_:&\R+M(W9XIB9'+%C
M$602$%F[#YP^</O`ZP._#X(^"/L@ZH-8`!H8U[D'AOT,]X@,<8]=]Y8!;F?/
MS!V+8$WL/G#ZP.T#KP_\/@CZ(.R#J`]B`4A6P>*!K#)@&@TO@RRO2"M8\(2\
MTLVUG#7;-@96EB[YEG+(K@OI[$+$0<1%Q$/$1R1`)$0D0B06B>0;++;(-W+[
MN'."$AF8XS`ZG4GF?"[;M*5!QH^<[$(Z)Q%Q$'$1\1#Q$0D0"1&)$(E%(CD)
MER4Y^>/,(]&-8>Q"MY2`.XSL$+$1<1!Q$?$0\1$)$`D1B1")12*9`;?2.\P@
MT;(9E!@K;@8B-B(.(BXB'B(^(@$B(2(1(K%()#.@GKC##!(MFT&)F!F(V(@X
MB+B(>(CXB`2(A(A$B,0BD<P@^PZQ(OCQ-"'1LAF4B)F!B(V(@XB+B(>(CTB`
M2(A(A$@L$LD,J&CN,(-$RV90,J?%."EI=HC8B#B(N(AXB/B(!(B$B$2(Q"*1
MS"!5[QUN-.&R'0S-^;+!$%]6;886793#$(]R,?(8X@U]AGC#`*.0(=XP8H@W
MC"4D.T,*1''2T#)Z0O8V]3%/7[8%W:(-3"8#RN6VB*9E)MRDV1UF2_8,)*66
M'=HQQ)=>NT6&>'>?Z;V2T>%13-[%R,/(QRC`*,0HPBAND=[T7O:05([_WT-:
M?TH>4C1KMNF-TSM2!Q%;10\I,LAPO&UF4VQ?%\#M0S)>J\QE>GL<GP<PF0#W
M)N11;6]TN52+>`"3B249V5I278K6#J0A/$SH\I`6HZ#'M+<Z13-(QZY^G.F]
M^G''HGA#&R.'(>JTN5Q.427JLABNY&'D,]0J&?/U2I_*1@4LABN%&$4,4:7Y
MW%Q/C=[5Q2RF49+])37G'?[2$E7REZ(9?`C^FO*U[/0VBB]3-D8.0\LFDQ?3
M:<\2EP5P&0\CGZ&/9`(6P&5"C"*&/I*)64`C(]M*JE?1UL^MJK0&EMRF:,:G
M_XYLJ6!%$)#=(H/?K!R,7-S0PU$^1@%N&.*H"*-8:B@;1BI<T;`;\YP6Q)(S
M%)$GBT(>+OIYJ!)EZRI13AM%'@5\?$972<M3BO*5SA@H:85*49'2&>-;6O)0
MD_K]CJ&FY;XTU.T.0*A-H<QH)@%?*VV,'(:Z]7LQL'XC)8\UX^(^0VS]-LV!
M]1LIA:P95XH88NOWPAQ8OT4EV4Q2_XMF?FZAH;L(R6.*A%5E!S4'6F@HDA8:
MA%S<T&N1T-#'*,`-0QP5811+#67#R!Y!-.S&0D.W%)(S%-U::%2B;%TERFFC
M;BTT*EJ>TAE]I3,&2EJA4E2D=,;XEI8TU%`VWS/43;B\Z6O1C:%6BK*5HIPV
MZL90*VEY2E&^TAD#):U0*2I2.F-\2TL>ZI^RBR5[A-Y3D!:)RR!&=HN$U<S!
MR,4-/1SE8Q3@AB&.BC`B+X?YBDT-HR][Z8NT<U8^9[OL=*I&:?%*7N1"%;]Y
MZ#!]R[Q=6_!@!?93/0YOG[\V][$>W\);Z>;.W.<S>%L]H+,U+'B',*`_!_U!
MH;D%C\IQ@ZUIP5/C`;ZPX`'J`%]:\"QQ@*\L>*R&N:VO+`?N+/@(W,XL<O_"
M1^!^99$;%#X"26.1+,%'("LLD@;X"`R[1<89'X$'*7">X2,SZ/60\;#CAUX/
M'8%-/*@-'8&M!:@-N0Q[!U`;.@*;`U!KCFA=3L#O!*[)<_9[4C[GEVITR@Z0
M?M/FL5-)?VE`O]3%%=9D>%=>U/`+@>;?(_PB)(,'DM,)U/J'HJC9%[!%ZWYC
MLOD/``#__P,`4$L#!!0`!@`(````(0!FD"2=#!T``"ZN```9````>&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;*R=66_<R)*%WP>8_R#H_5K%6E4%VQ<6]V6`
MP6"69[5<MH6V5(:D;M_^]W.2F5F9D2<M)MU^:;F_C`B2)Q=&D"SR[3__]?#U
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M<[S__.4%_;W!(:DC.WS\JS@^WT%2A'FSW*A(=Z>OV`'\]^+A7HT-2'+[K_'O
M]_N/+U_PK_6;]7*SN\Y@?_';\?FENE<Q+R_N_GA^.3W\G[$RL724I8F"OR;*
M:OMFLUNLY@19F2#X:X*LWUQO-NOM]0Y[\LK6U\81?XWC_LWR>I-MMNH07G%$
MZWCP^!O9[5<<M\81?XWC+FU7=\81?^?M*B;LN*OX.V]7]\81?^?M:H:QJ(>&
M&I2ZUQ-US<ZC"O^PNYO8F9D=2^H?27M\I8?T.$.*VY?;]V^?3M\OL.Y@X\_?
M;M4JEAU4-#LW=,>>9\N/)@MFB8KR085Y=PG],`V>,<7_?+]>[=Y>_8E9>6=L
M;MAF*2UR:Z&FH`I;A*`,016".@1-"-H0="'H0S!XX`K"G=6#8+]"/15&J6>/
M^\8")^<JD,I:6)<B!&4(JA#4(6A"T(:@"T$?@L$#0BJL6+]"*A7FW27^^\I`
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M##X1^B`1FJ&/LI;Z:++.W,I"I"!2$JF(U$0:(BV1CDA/9/")$$,ER3/4&,VE
M'!:-->*8&>86N<6WL&A[5JVTR%E5C&J+G&-CD7-L&746.<?>(N<X""2547FE
M/X]T]OU&U7(O7^[O?K\Y87[`*#*_5LBR3>ZMLU.<RNU$N5'%A1I2NS/*+;H^
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MZZA#9_O5?BV[N+46+G27%+JWCB;T=KD(0@_68@PMNT1EOC.Z1"?*HDLTVF`]
M.2N[7@>ZY9FV6KJ163`J+=++ZGJ_##JHL@8N3,VHL<B$68;7I%IKX,)TC'J+
M=)A5M@K&V6`-QC!25I5#SY!5I]Q"5HW$2%\NMW+,Y#C5TT@G5!JK8/`'%T<J
MCE4S:I)BM>S8,>I=+'7>NJ91ZQ^)E%>EX+Z\*H-:;M5U_%C2Y)^M=/(NE-8H
M&,!!/I1C[1^5=D.F8%0:A`78GPS!@57.T5DM5\$6:V=ESWQ-//Q&#HK6.;X2
MOG-6-GP?#Q^,N<$YQL/+GE+U0=A3V69NKJNK#-%K&BU=0I%GA`J#5JZ$*!E5
M[%BS5<.H9<>.K7I&@W`4@B%IDH*]GGV-YK)L,DC-A?."O,R"7LR3K(HDJ])8
MK;#K/]YBE12K3K)JDK;8)L7JDJSZI"T.4[%D5ZMRS9\;$UW-!9]*&I'H;%;G
MY#@WR,]]&)46F41GL]L$XZ.R%BX;J1DU%NDXR^5R$2Y&UL+%Z1CU%MGL:+$(
MZH#!6G`*@YQBEHRF\'$+^<T8`2<0F8('Y\?<6CG'@E%I4'`&"(ZF<H[>C*$S
M@+.R2W03#Q]<0VN=XROA.V=EP_?1\)L@"QN<8SR\'.6JS/-'^4]=[5B:^M&)
M?V.0?P9@5!CDGP$85>Q8LU7#J&7'CJUZ1H-PE(+-*RGQ"(5:`_QSHT%39P!3
M4KYZGBB28I7&:NH,D++%.FF+3=(6VZ1879)5G[3%82J6[&I5J/IS8^(,H,R#
MKM9(G`$T$F<`C8("()C6I1HO"!]8!<M@9:R\\'7<,0C?Q*V"\"V'[^*.0?@^
M;A6$'T1XV1=A)?QSZQ07R%!*R2K6*4*%L1+KE+;R4,6Q:G9L&+7LV+%5SV@0
MCE(P59[-&+RZFA/KE"GP,.Y^G#?FRQ2K(LFJ-%93ZU3*%NND+39)6VR38G5)
M5GW2%H>I6+*KPWI[8IWB(ANC?YP$$UV=8E4DQ2J-U517IVRQ3MIBD[3%-BE6
MEV35)VUQF(HEN_J7%.Q++M@-PL[8;#-G5!CDK7DEHXH=:[9J&+7LV+%5SV@0
MCD(P-<!F+(.CN3R'&^0_),"H8%0RJAC5C!I&+:..4<]H$$@J,Z^^77%]:Y!\
M8F`37(;-G94=606CDE'%J&;4,&H9=8QZ1H-`4JQY5:RZ>QND@@;YCP\P*AB5
MC"I&-:.&4<NH8]0S&@22RH0%Y.LG']Q,)64,<E<!<VOE;BL6%KDK%:5%SJIB
M5%OD'!N+G&/+J+/(.?86.<=!(*E,6"G^5,J*M98$,\A[D,!:N>6[,`@]]X.;
MX,[`3LR*P]3.RH0)[ATUSL"&:3E,YZQ^<!/<&=@P@P@CI56U4'IRB[6;--0(
M5P3MYG)KY6NHK29N@AM'_R8XHYI1PZAEU#'J&0T&X?(_#DB*I0J5&6+INL:O
M!-0#A*I&$E?@-L%`R*V5NPA4&"0NM_%]W9C5>A/<<*E<>*\<H8MRL5BTQ29F
MM=X$-X+:I"UVL5BTQ3YFM=X$EV.'J2W*?E5UD-^O/[>^Z&I*=+<IL-Q$R%>$
M"H,P2>T,*AE5[%BS5<.H9<>.K7I&@W"4@JEJPA=LXE2EBP^A3$H]DJN$2$T7
M+!X_+IR+)*O26*DT[L>QJJ18=9)5D[3%-BE6EV35)VUQF(HENSJLDR:ZF@NB
ME4:O=V*>9%4D697&:JJK4_:K3MIBD[3%-BE6EV35)VUQF(HENGH=5G@_M0R.
M463A9Y!?$C,J#/*70485.]9LU3!JV;%CJY[1(!RE8/,*/U0L8?)DD+J8?EZ4
MUN$]RMQ:N?RY8%0:)"YKKS?!A>'*.;HM\C,9SLJ>DIIX^."&7^L<7PG?.2L;
MOH^'#V[X#<XQ'EYVS[Q24^560:EID$S7ML$5^=Q:>>D:H](@]<=U]3:H\2OG
MZ*PBW:-W%?<GK7Y-+#P_$.;"6\>.41^+M0X?$1R<8WQ795_,*V[5(`[[0B,Y
M5;9!;IL;1US-MP=8,"H-4G^\O@BRULHY.JM(7YC]<EMLXN&#%+5-"M\Y*WM`
M?3Q\\&##X!SC>R^[)ZRP7S_+K[F4-DA,E=4J..;<6KF!6S`J#<(`&TO<X,@J
M]J@9-3+(+GS0HF67CE$OHVS#^3H(%RFIJGC]'%F=39.>W5-%<CCX-9*#?TV#
MWUBYH5B86-Y\*`W"^%#J9N&SEA6[U(P:B\R3+.LP3&L-W,YTC'J#S,ZLLV`]
M'(2+U'=>,;[F8MP@,637V^"$F5LK?\B:*MZATEJ99V@C#QI9"^=4,VHLTG%B
M#QI9"Q>G8]1;9#IYSP\:68LQCE3VEY3#ZHG><!13[9L;*R\U+`P2>:!V]%#%
MCC4[-HQ:=NS8JF<T"$<IV+QR>,WEL$$3-5*259%D51JKB1HI*5:=9-4D;;%-
MBM4E6?5)6QRF8LFNGE<.K[D<-D@NY=L@C\ZME5L]"X/4>?V<M-#EL3)N%2QJ
M%8>OXXY!KMO$K8+P+8?OXHY!^#YN%80?1'C1/9M?4L*.460):Y"W3N6,"H.\
M=:ID5+%CS58-HY8=.[;J&0W"40HVKX3=<`EKT,32E615)%F5QFIBZ4J*52=9
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MZAD-`DFQYI6:&RXU#<*5="M#SJA@5#*J&-6,&D8MHXY1SV@02"HSKS+;<&5F
MD;L/GUOD5O7"(E>9E18YJXI1;9%S;"QRCJU`X@"W86WS^CP9S6418Q"N69Z[
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MZ`BN:^=;;>7U8<&H-,C<'=\N@U6H8I>:42.C+-?!::\5+F+MV/EY*/;XI_*O
M,8C4R"#O0E+.J##(NY!4,JK8L6:KAE$K'.5A^WDG#OOU<\B.\TN#)JZ>)ED5
M25:EL9JX>IH4JTZR:I*VV$[%DKK[N>VT[IS:[C3"Q3^;FN4&>0M&P:BTR*P[
MN^5V'\S8RIJX9:9FU%AD`JUVJT40J+4FO/;L_#QW^O@YS1T#4)H;K*&YM7*G
ME()1:9"?YK)5S:AAQU98R2[WT]SI0^8L=Z=1</8)KRL:*S$*M*.'2AO+3WS7
MU\'%I<K%<@DB/ROFK.Q0;.+AP]78.<;#2_EF9;OJ;:S!V<H@>;8*L]3<6/EG
M*T:E01@Q;L_7U^$YRSDZJXA\G`0GA6^GPDOY5&9IKWAC]/W<^4VGI_[%[IW)
M6%T]G3,J#!+G-^WHH8H=:W9L&+7"41[VK`QXQQFP05/G-Y.GHBO/E12]M:M(
MBE4:JZGS6\H6ZZ0M-DE;;*=B2=UGI=H[3K4-$N<W2H@+8R56-FTE'BA9AV\G
MK)RCUV'T:S%GY5:V:/B@(FJ=8SR\U`K3\>]/314D2#TU$JDGH6*GD3</2T:5
M05ZLFJT:1JUP%(=]'63<KZ>>H[4\/H,FIF:259%D51JKB:F9%*M.LFJ2MMA.
MQ9*Z^RD_EO*)G/^:<WZ#@C-I4'CFQLH_DS(J+=+E/,K@?7A1OK(F+HFK&346
MF4#+ZVP;SDIKPE<&KE4V;<^.2I/DQYI'SV!<JF!X$Q-6Z//)8'T=Y,:Y<?26
MKH)1:5"PF@5I;N4<W18YT7!6Y]4L'CY(*5OG&`\OAY>?V5LI9S^E<<T9OT'>
M$I0S*@SRES-&%3O6;-4P:H6C/&X_O4^85IS?7YLT_=4D(D^R*I*L2F,UM9ZE
M[%>=M,4F:8OM5"PIO,J?_;D[<2+1Z39ZR,Z"FVN-Y"/S^Z`8RJV5<RP,$F4`
MWSZ(67&QX,+')]GXL8`Z%HNVV,2L:(OMU!:ERG[]\//3F@N(:RX@&!4&B6G-
M!00[UNS8,&J%HSQNE6?/&%TZ+1>C*R53SZ]3K(HDJ])834WKE"W625MLDK;8
M3L62PJM$>X;P.B\7PFLTE1^F6!77*5:EL9H2/B56G;3%)FF+[50L*;PJ"'SA
M?^I2P;4N*T1_4/&1&ROOG%X8)&8ZE2@5.];LV#!JA:,X[KU?CZ@5[O7SR&@N
M$S^#O`?7<D8%HY)1Q:AFU#!J&76,>D:#0%*9>17#GBL&@^2S;/O@>F#NK.RI
MN6!4,JH8U8P:1BVCCE'/:!!(BA66$A/#2!<+_CS9:R2&$:&"K4I&%:.:4<.H
M9=0QZAD-`DEEPLI@0ADN`?8:!<,H>$`@=U9N&)T=+2K9JF)4,VH8M8PZ1CVC
M02`IUKQR8L_EA$%X688]YIQ1P:AD5#&J&36,6D8=HY[1()!49EZ^O^=\WR`\
ME.B4T58>*MBJ9%0QJADUC%I&':.>T2"05";,T2<F&"?C>Y-3^\H0*MBJ9%0Q
MJADUC%I&':.>T2"05$;ENGY.,Z&,3HW%HJQ1L/0$=WSR_=G*CJR"4<FH8E0S
M:ABUC#I&/:-!("F6RD]GB*7362&61NIQ5W<%+/QD5KX_6SFQ")5L53&J&36,
M6D8=HY[1()`4*\R6)T86I\5[D]WZ<XY0P58EHXI1S:AAU#+J&/6,!H&$,MEB
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MRA&#<L2@'#$HY[-`N7DI?;;@G-XR.36UG<<PP(A!)F*0B1AD(@:9B$$F8I")
M&&0B!IE\%L@T+[_/%IS@6S8Y-4W6[TZ44(X8E",&Y8A!.6)0CAB4(P;EB$$Y
M8E#.9X%R\_+_;,$%@&7!U`QOZWIFWM34X>34)`;EB$$Y8E".&)0C!N6(03EB
M4,YG@7(J(T\O!K*%SN#]:L`R_X)6A&&`:5_/#@.,&&0B!IF(029BD(D89"(&
MF8A!)I\%,H5EP-_(V+A$R!:F(,`.>`55\!@`,K:SF3?VB$%48A"5&$0E!E&)
M051B$)481"4&47TF1<U4ACQC[(WV00%AF#>F\HQ9$6%EA%415D=8$V%MA'41
MUD?8(%D@D\IY?9G&&S8JQ9OY+H,LT]FSF+R&!2>,X!$1:*I=O<H*FA*#IL2@
M*3%H2@R:$H.FQ*`I,6A*#)KZ+-!4)<B^IJ^7]1DD"Q^_LTP./9-XNQ_-0B9B
MD(D89"(&F8A!)F*0B1AD(@:9B$$FGP4RJ6S8ETD-/?7^GMDC3Z?5V)1=N6ZR
M[)QJNT5OLP@?R_#,K"LD/;M:!DF)05)BD)08)"4&28E!4F*0E!@D]5D@J4J3
M?4FG1IY.JZ5RFLF11PPR$8-,Q"`3,<A$##(1@TS$(!,QR$0,,ODLD$FER7-D
MTFFUE,FDVOY9=;,([TIFV=G,#B8H1PS*$8-RQ*`<,2A'#,H1@W+$H!PQ*.>S
M0#F5)L]13J?54CF3:KME#&<`8I")&&0B!IF(029BD(D89"(&F8A!)F*0R6>!
M3"HG]F522]MV-7[[?/;JIO-K*:%FXKRZ683W,K/L;.8-/F)0E1A4)095B4%5
M8E"5&%0E!E6)056?!:JJ%-I7=6IUTRFW5$XSN;H1P^`C!IF(029BD(D89"(&
MF8A!)F*0B1AD\ED@DTJ*Y\BDDV@ITSFQ]D^?X1VKS'[?WJ_TF4&Y<S@[$*$<
M,2A'#,H1@W+$H!PQ*$<,ROE,*C=^PWV&<N:;[T(YP\0`8U9DS,H(JR*LCK`F
MPMH(ZR*LC[!!LD`FE?KZ,OU\O:H>FPU^>9(9%BQNP2_U<\_,CBF(ZB?EXT.O
M$)481"4&48E!5&(0E1A$)091B4%4GP6BJD39%W5B<<-/(U@Y/]D>#Q\R$8-,
MQ"`3,<A$##(1@TS$(!,QR$0,,A&#3#X+9%+)KR_3WQA[.H^6L_><6_OK'MW=
MLE]U]]<]9A#U',Z.48A*#*(2@ZC$("HQB$H,HA*#J#X+1%6ILB_JU-C3J;54
MSD^W[=@CAK%'##(1@TS$(!,QR$0,,A&#3,0@$S'(Y#,MT]7SE^/QI;A]N7W_
M]N'X]/F8'[]^?;ZX._WQB+1.70GP^,73\=.[RQM,]<,XW]'Q9Y]SVU*UC>4J
MMZU4V_C+?&Y;J[;Q7674EFW0ALP]MKULJ]K&']*SWTZUC9][Y+9KU38.<F[;
MJ[;Q'B6U+1=HPPDNMB\+Y8?K=K&V3/GA`ENT3>D)J:-M2D\]&FE?,J4G2N:H
MG](3=6*L;:'\<,,NVJ;\<$LJVJ;Z`?=AHFVJ'W"G(=JF^@'7TJ-MJA]P`3G2
MMH<;GL:)M<`)CY[$6M`%>/0BTH+G"M26XCVP4#V`>^11/]4#N&H8:=O##4^\
MQEK@A"<^8RT0'X\WQEH@/1[OB[5`>#S>%FN!['B\*]*R032\Z#76@FAX=6FL
M!='PZLY8"_H"[ZF,M:`O\)[&2,L>@N/AZ4@+@D5C(50\$@+%XJRP!?RH(+*%
M%7H&GR6.M:!G\#X_;L$3]H<2C\%S"QZA/ZAGYKGE0W;X$(MUH\93Q/X&&X_:
M8U#$QL2']>'##U9%=&^\=]$=L2VC:V,]B]\Y']0/F_G8\$/F@_KE,K?@QX10
M*K:_^+4@E(JUX)=*\(GM`7Z*!)]8"]X+>5#O08SLP79Y4"\0C+3L%CB>V)C`
M.X%P/+$6O(8!/K$]P'L6X!-KP6NO#Z7^%7ZP+N.]U@?U(FO>-[RX^J#>5,TM
M-SC2F^B1YFC)HRUX=>=!O9B3H^&UE6B)Z8:W=A[4"RK9!R_OA**Q:'A[)5IB
M/OAXRZ'$SWDCT="B/L?"+?C\RD%];X5;\#T%*!K=`[2H+R2P#[Z(`$5C+<5J
M<U#?^V4??('UH#ZYRBWXQ.I!?5.56_`-542+M>!#AM`@M@?X4B$TB+7@4X30
M(-92+#$;E[$Y5Z.EB;9T:.FC+?B6-8XTMDK@\]0XTE@+OCB-(XVU%$N,^&CV
M5J.EB;9T:.FC+<42<T[_R#N</VAIHBT=6OIH"RYJ'7!))-)SR,H/R,(C+<BY
M#\BQ(RW(J!$MUE(@Y>JC&5>1H>>B.6.-EB;:TJ&EURU79Q&>W[_]=OOY^!^W
M3Y_O'Y\OOAX_(1%?C)=7G^X_JY)0_\_+Z1L2],N+WTXO+Z>'\9]?CK<?CT_*
M`%>Y/YU.+_9_,*"OOI^>?A^3_??_+P````#__P,`4$L#!!0`!@`(````(0!4
M,!9W-P8``!$:```9````>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;*Q9VXZC
M2`Q]7VG_`?$^(4!"+DHRZ@1J=Z19:;7:RS--2((ZA`CHV]^O71=2KLHD]*A?
MALG!-CZVJ^RJ7GQ]*X_.2UXW175:NOY@Z#KY*:NVQ6F_=/_YFWV9ND[3IJ=M
M>JQ.^=)]SQOWZ^K77Q:O5?W4'/*\=<#"J5FZA[8]SSVOR0YYF3:#ZIR?X,VN
MJLNTA9_UWFO.=9YNN5)Y](+A,/+*M#BYPL*\[F.CVNV*+(^K[+G,3ZTP4N?'
MM`7_FT-Q;I2U,NMCKDSKI^?SEZPJSV#BL3@6[3LWZCIE-O^V/U5U^G@$WF_^
M*,V4;?[#,E\665TUU:X=@#E/.&ISGGDS#RRM%ML"&&#8G3K?+=T'?\Z"R/56
M"QZ@?XO\M='^[S2'ZO6WNMA^+TXY1!ORA!EXK*HG%/VV10B4/4N;\0S\63O;
M?)<^']N_JM??\V)_:"'=8V"$Q.;;]SAO,H@HF!D$8[2454=P`/YUR@)+`R*2
MOO'G:[%M#TLW'`]&P7@R]4'>><R;EA5HTW6RYZ:MRO^$E"]M"2N!M`)/924:
MC"?#D!NYH1A*17A*1?WK-Q1'4A&>4M$?#OS1,$*O;^C!6\X7GLI3,'%#(9(*
M\.SEH2<"S/,5IVVZ6M35JP.+`"+8G%-<4OX<C*E$B4]WJ?M1YB!E:.0!K2S=
MF>M`3AHHMY?5>!@MO!<HD4S*K&V9@$ILE`36`YJ-32`Q`:8!'C#J:$'*/X$6
M6D%:RJ&U`BX\0X.#DE`JL0DD)L`T@'"`ZOL$#F@%EL_-U$@9J+XN?Q.#5R?2
M$;.0Q$*8CA!N4-V?P`VM0.%"`#N_[;H30N$M<IU(1\Y"$@MA.D+(P:=T<M<W
M/;5T4)AS4-]>"P0<5LC&0F(+22R$Z0CQ#]9Y?_]0F/HGD!`>6M3->NF$%(G8
M0A(+83I"7)Y\Q&44IBX+1`^IA<06DE@(TQ'B'PXNQC8:A8,)I."#.RD:HKX+
M)(2'%NZIL3P[H2[<%I)8"-,10@=V<IW.[0I&8>JR0$:B&^-.OK&0V$(2"V$Z
M0OSS82+I[R"7IAXJ:'199`JZK+M807Q2XBTI4=!%BA&(NHGM22N+VW'T13.#
M[4PE<2VAP.<]-1CZ(R/O2N"B$TMHI.^*03BDBHE2#(7E*#+:-5,"W#)EA0VK
M/RO1W@@K`04CQ6I,G=O@C@XE)294.0I84**D)L+,-#)Z,5,"/'V4`C:F_A1$
M&R,4!'1)C!&^C2\%],184**D9!9F9GZ9$KB2!6P__2F(9D4H".B2!7,+]Z7`
MI?IC&TH4)++@3R(CF4P)7,D"=JC^%$0_(Q0$=,F"N2WBF0,+2<^"!252"E:,
MF%Q]6HZ,6*%UA`VK/P/1W@@#`4$2]-U]1AW8^%)*SX0%)5)J)(K)CXQ\,F*%
MTL"^IM$0IP#>OMI#D3VM*V@]L#M=V;_P8_(,()HC82>@8-KM:!O?@F()A9>]
M.+$A1A2I]]C&-.^O>`G'K\Y-T?2(FP+",UK78@/?6M%]I&*_CU0BI4)H8S_^
M(KMGBT8!FV7_*(C62J(@(%A,%Y_&OM$W-KZ4TE>4@.XU'*DHJW,XG1@!9L0T
MX188[?ZGZI,;H5.`A/3ZM*%80GI]VA`CBM3[#TT!&']CG)+0G?KL)17WDDJD
MU)WZO&>+1@$;>._ZA!W;BH*<`&ZO4JEX.U9Q+ZE$2MV+PAV_:!1P!M"B\'.5
M+`8)??$&<K;0=EH;BB5$*EDH:A`CBM1[G`@T[V_OM-C4S$H6D'X0DU(:%-M0
M8D.,0-1-;/&:FQCD8#P`](.',:PBDX&`Z'',-R:&C50$*37*QS:4V!`C$"6%
M#5\C=2?V8CP@)2(@+=`;&+"1GP;%-I38$-X=7Q2%F^(N6-PMEGF]SS?Y\=@X
M6?6,][S0O5>+#A:7T.L@4K?0YAMXP6<=$Y_,X0@.(37QZ1S.LE?PV1S.D%?P
M8`1?YO.&:2D8PQM^N#/>P)@RQ[G$M@8-8I[`]G_M30AOPBMOX`+^@;=0XRMK
MN)CGQV83#\"M*W;6X1PNV>PO/XS`_M40`O.KQ($WI^UU7X8+^7.ZS_](ZWUQ
M:IQCOH-$#OE46(LK??&CK<Y\.GRL6KB)Y_\]P)]><CCW#W'1[:JJ53_`4Z_[
M8\[J?P```/__`P!02P,$%``&``@````A`+OH[!UK"0``&R\``!D```!X;"]W
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M4[6[U$W]VDY`;LHJ2N_Y<?HX!:67IWT%=X"VCR[EZ_/XB^,7[FH\?7GJ#/IO
M57XVRO]'S:'^C"_5OJC.);@-[80M\+6NOV%HND<$R5.2'74M\,_+:%^^;C^.
M[;_JSZ2LW@XM-/<"[@AOS-__#,IF!XZ"S,1=H-*N/D(%X-_1J<*N`8YL?SR/
M72BXVK>'Y[&WG"P>9IX#X:.O9=-&%4J.1[N/IJU/_V-!#I=B(AX7@5\N`O&6
MN7.>"[\\=WFU+*A55V'X%64YDP=G]N@]`+I229#M$N%7)-Y]HP]<`WZYAC=Q
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MA]&=8>)&UXR`.X)L"`D("0F)"(D)20A)"<D(R0DI5**9`<O['69@M&X&(UZW
M9>LF[PTA`2$A(1$A,2$)(2DA&2$Y(85*-#-@GW*'&1BMF\&(VC,("0@)"8D(
MB0E)"$D)R0C)"2E4HIF!1QYUBW!]F&"T;@8C:L\@)"`D)"0B)"8D(20E)",D
M)Z10B68&;''N,`.C=3,8F;-S`.YQ-H0$A(2$1(3$A"2$I(1DA.2$%"K1S,!]
M\1UN=.&Z'0+-Y1PJD)Q6`X&6?50HD(R**(H%DHF)0#(QI2@32";F`LG$0D.Z
M,[ACM!\T>#(P.@I'<]49%C67-0A$%$SK_3+NNL:^.I118J6**(HE4K6,+4$B
MHX162E$FD=1R9D:]<ADEM`H-Z9;BSO(.2]E&%#8X0GN-FQUP6;.4(]72'LFJ
MNZZQ_PZ%EDR,*(HE4K6,S6@BHT154XHRBG**"@WI_N&.\@[_V`84]$2EU@Y#
MFG\<21L"$:5WR;F^LPQEE)"/*(HI2BA**<HHRBDJ-*2;A9M&U2QV+I[@L;\]
M5+MOZQK&&XS'@<70@_,O/Q6SK:?F(4.:AQRI'C+D05=4AK5QH`Z=/DIZ2+1B
M&I50E'*DS"T9C<HI*K1$W4/<:ZH>#G@%CW]ZLS#<6!T8<KM'>6Q3B<_H,$KN
M,P..H.JJ62NSP[%$Y08CF2C\BRE**$HIRBC**2HX8K77S<*]Z!UFL:VKUK,8
M<J%3*GW&.!MO'!XEAW7`T5SK;-[,](\E0A0^W8$G=_KUB`K'5L*)2,1A\_W%
M7:R,*J<B0%8YLU+.12)7?C"?2!4BH%/6FP-WPVISX/AWE_@L>&C(J]V8[:.U
MEF'(A;$I6\9S=`,W#H^26XZ`HI"C.<R[BI:QL$8R48TRUK!81HG^GPS+&Y-W
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MR&<R2LCGP_+FLB$3A^7UEL)3GME2=\]BL`205F-(F7DV/$I!`4?J+$911!-C
M&I50E-+$C$;E%!5:HFX8GO14PV[,8NQ@J,[O+D.W9C&;J,!**^11MV8QFQ)C
MJQ(3JQ)3*ZW,*BJW*K&XI:4W-1XB[VAJ=N;4FIHA')%R^?",C?T&9S9C'\61
ML6DRSR(R"H\,*W/W2W5CF:%6R-!-1&)_%#&6V%0$R)U?9J6<BT2NO%P:TW@A
M`NA1!,>+UAJ_]"BB4S%V%>Q$K$Q+&QZEH(`C;:9BB0J*:&),$Q.*4IJ8T:B<
MHD)+U+LOGE3OZ+[L8*MU7WY(OK'?LHD*7)NHD$?=FJELM&*K$A.K$E,KK<PJ
M*K<JL;BEI3>U>4R_L2C1L[G+3]TWFMHF*K#2"GG4K::V*3&V*C&Q*C&UTLJL
MHG*K$HM;6GI3#YWS[]^PT3,_3';=*B2?*&XH"CA2YKR0HH@FQC0JH2BEB1F-
MRBG";R1E[9EA[)M']I77J;R\E9OR>&Q&N_H#OV>$][`O3SUF'UNNESZ\"X?M
MMLD??'@M/,!7/KPA'>"//KPLI!S<\]$N>@7L\=$/>@7NW\<;IE?@T]`OW3)I
MUA8^&>W>JYK<A4])!W36G@]?V0SHST%_J.#UW(>/26C">N'#=Q64PRX?;GNH
M:-C&PVT/78%].MSVT!58B4%MJ!Q8:D%MZ`JLI:`V>,5Q?'R<3VL-K^#`QZ$K
M\*0=<H;4X*F,CX]AJ!H\=O'Q.0N]`L]50&WH"KR<]*/!&L`[2E`;:F1XU097
MAGR#ETAP9:BAX=4(7!FZ4WBEZ>,K$5KK-5Q9#U[9P)7-X!5X2PON#-4Z@%KC
MJT1:#KQ&@RM#M0Z@UOCJ!W*F?4^'3Y/?MV_E/[:7M^K<C([E*PSU6?=,[L(^
M;F9_M/4[;`+AT]6ZA8^2N_\>X"/T$CY$F$U@#7RMZU;\@07TG[6__!\``/__
M`P!02P,$%``&``@````A`+I$>/`B"0``)2P``!D```!X;"]W;W)K<VAE971S
M+W-H965T,C0N>&ULK)K;<N)($H;O)V+>@>!^#!('&\+V1(/.QXV-W9UK&LLV
MT8`<2&YWO_UF256JPZ^EP3LW!G_*_*7*JBQE"MW_^>.P'WPO3M6N/#X,K9OQ
M<%`<M^73[OCR,/SWO[P_[H:#JMX<GS;[\E@\#'\6U?#/Q]]_N_\H3]^JUZ*H
M!Z1PK!Z&KW7]MAR-JNUK<=A4-^5;<:0CS^7IL*GIW]/+J'H[%9NGQNFP']GC
M\7QTV.R.PU9A>;I$HWQ^WFT+I]R^'XICW8J<BOVFINNO7G=OE5`[;"^1.VQ.
MW][?_MB6AS>2^+K;[^J?C>AP<-@NPY=C>=I\W=.X?UC3S59H-_^`_&&W/955
M^5S?D-RHO5`<\V*T&)'2X_W3CD;`PCXX%<\/PR_6,K<GP]'C?1.@_^R*CTKY
M/JA>RP__M'M*=L>"HDWSQ&;@:UE^8Z;A$T/D/`)OKYF!?YP&3\7SYGU?_[/\
M"(K=RVM-TSVC$;&!+9]^.D6UI8B2S(T]8TK;<D\70'\'AQU;&A21S8^'H4TG
MWCW5KP_#R?QF=CN>6&0^^%I4M;=CDL/!]KVJR\-?K9'%I5J1*1>A3RYBW=S-
M9M/YW>WE(F397`E]<I'YC7TWLV;S*ZYDSD7HL[N2:T=SRS7HL].X>C247\UH
MZ//SHUEP$?KLKN3:T5BTI)HK85\ZE:O'8XF%PKY\?D06K;/V:N2"LZY>;]9$
MJ-"7_V-,8MU:<N%^8LVQ=&O'))?NQ6,:M?G8I+>SJ3>/]Z?R8T![)H6Y>MNP
M'=A:LC.(Q&[3L$OU_Y7IE.),Y0N3>1C2`J(DKFA[^OY(&74_^DY;RI;;K-#&
MUBW6PH+M'TS6,8%K`L\$O@D"$X0FB$P0FR`Q06J"S`2Y`D84ZR[@M"#_CH`S
M&19P$:J5`'(&)D9TA85P<4S@FL`S@6^"P`2A"2(3Q"9(3)":(#-!K@`MNI2H
M$-T)[4C]]RFQ>ID7W9'.KEYN0RG2+?%;(\"=21=A("X0#X@/)``2`HF`Q$`2
M("F0#$BN$BW:M)]!M-DF<N7FP61H_Z$Y[4*+NT=K-#D7_\ZDBS\0%X@'Q`<2
M``F!1$!B(`F0%$@&)%>)%G\*AA;_\ZN<63=A%N%9M81B*L@:B`/$!>(!\8$$
M0$(@$9`82`(D!9(!R56BA9`JN"M"R*SU$+9D0A_*VIT;&T-G).+L`'&!>$!\
M(`&0$$@$)`:2`$F!9$!RE6A1I9KVBJ@R:SVJ+9FVY3^K!-9`'"`N$`^(#R0`
M$@*)@,1`$B`ID`Q(KA(MA*QS5@NS\[G-K/40<C*5N<V)S':'DWEGXX*-!\0'
MKP!L0B`1>,5@DP!)P2L#FUPE6@BI'-5"V-:V-ZQ9K%]WVV^KDG*6ZK2>T$ZH
MAFTK6R:B1[8E<ZLI<^VQ9=99W..NBZK3DHE^@S.J![<S$IN$!T)^9Z/N-G?Z
M;A-T1D(H!*&HLU&%%KI0W!D)H02$TLY&$;+'NE#6&0FA7!72YHRUC]JD]4P.
M->IB=AIS?7HXLIL'&LT<KH65,B4<3=E:Z%H6V](OW)56XLH]1#ZB`%&(*$(4
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M'(ET/".?2BLAG_7+&_MJ+AW[Y?6%P/I'=2'\8O;;=E.;?;4#Y;=40`Y[O$EK
M1&DG740>(A]1@"A$%"&*$26(4D09HEQ#>DA9/WE%2)FYL;.V2`G6FCTYT>/G
M('(1>8A\1`&B$%&$*$:4($H198AR#>DA9<WD%2%M>T]ME?)V5%9Y:PN0@\A%
MY"'R$06(0D01HAA1@BA%E"'*-:2'E#675X2T[46UD*KM*4]\0(X%R$7D(?(1
M!8A"1!&B&%&"*$64(<HUI(>4-9M7A)3WIO*&N*)JO-D+E,9<(*4S%TB65*Y`
MTLI#Y`LD'0.!I&.(*!)(.L8"2<<$42J0=,P$DHZYAO20LEY0#>FGVG2+=Y1J
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MA6!$=RVLI*.#R.5(VP5F$V/[\*2C/&//0N!/%.09@UYY\\%`>)%\)*W$3,6]
M\E.S<Y>.9ZX^E59"/NN5-X/#7M)K,HX2KYL.-3CM0FC?PVM?U#D4IY=B7>SW
MU6!;OK-W[$CC\;[#[0N`*VNV9-T570X<F=.1)L/AR"T=N>WQ<>SQDMV;4(U>
M-/S23!EHD52/_<JF%Q/[^&1)[Q7TZ$])O^_`:KJD'\+1847C[ATVC;IWT#3F
MWB$OEO03#.K[BR7]HH(\6BSI!Q+DZ6))OW<@=RP**3V1[SM"IZ;:"H]0";ED
M!2(>H8)PR<H]/$+E'9VG[\C*HA#2,PWR&76S1R]IOFU>BG1S>MD=J\&^>*8%
M-FY^(SNUKWFV_]3E&Q5L]*IF6=/KF<W75WH=MZ#?9L<W].#BN2QK\0\[0?>"
M[^-_`0``__\#`%!+`P04``8`"````"$`6DVF1K@D``!MZ0``&0```'AL+W=O
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MM]?W=P]WGQ[?:'$G_8IRFR].+DZTI`_O/MYJ"YSV5_<WG]Z_OLS>=MDF>WWR
MX=W!T/_>WOSQ$/S_5P]?[OXH[V\_=K??;Z1;.\KM@E_N[GYUI?5'AS3S">8N
M#KO@/^]??;SY=/7;U\?_NONCNKG]_.51^WNM37);]O;C7_N;AVLIU6+>+-=N
M2==W7[4"^M]7WVY=;TC)U9^'?_^X_?CXY?WKU=F;]6:QRE3^ZI>;A\?BUBWR
M]:OKWQX>[[[]7U]TV*)Q(4N_$/V;6,@3,Z[\C*?CC)OIPY^83ZMV6&O].^\#
MS_R,FW'&EWV@OB^'#]2_\S[PPL^8N3W;NWO9)V;CGM'_F?>9V;`_W/]YR8>>
M]$UQZ+']U>/5AW?W=W^\TC=7'_WPX\H=![*W;F%#=_6[9NRWG[6;^LPMY=(M
MYOUKJ5`G/>A+\ON']>GRW<GOZNMK7[-E352Q&RI<$[O%[F.0QZ"(01F#*@9U
M#)H8M#'H`G`B<:,]"?L[[+G%.'O#=F\',.E<69F[H6*891^#/`9%#,H85#&H
M8]#$H(U!%P"C2@<"J%KI*Y,^C`U]Y>;2`2OHJVQ]855L?8V.%&/S;6S);BP9
M=8'D(`5("5*!U"`-2`O2A<1XTX$3WMSA?^87U"U&WW'MG5%2=I993=N^:/64
MR;%D-`F2@Q0@)4@%4H,T("U(%Q)C4IME3#[=>:[Z(&S8T&U/9&<@.Y`]2`Y2
M@)0@%4@-TH"T(%U(C`R=)F?(<-561D]6.LO^O)]V8]%@;`^2@Q0@)4@%4H,T
M("U(%Q+C1QLVPX^KMGYZ$C8+R!XD!RE`2I`*I`9I0%J0+B1&AAM+Q"%AN7ZC
MYIIY%'(+LIYZLM(_01_%N6`L&OL()`<I0$J0"J0&:4!:D"XD1ITBD5'W]$''
M55L_/0G["&0/DH,4("5(!5*#-"`M2!<2(\-%9&/CV+3IEG/P%'9-%)&VAT]3
M>%";CKT5!X.I9FPMHIRH("J)*J*:J"%JB3J#K%873\/OY]--YL8=49=Y%+89
MT9XH)RJ(2J**J"9JB%JBSB!KQJ71&6;Z\*J4-'3#UB4FR8I.=%&K[::J8<8]
M44Y4$)5$%5%-U!"U1)U!5I;+H#-D]9%5RQNV>9N%*?8P@ML1[8ERHH*H)*J(
M:J*&J"7J#+)F7*8,S;CCUE$GP*Q/IT::#ZPZA8R'J>SLU$;SG9]1)\K!]IXH
M)RJ(2J**J"9JB%JBSB#KT<71T.,S!ZH^O1I9/3('*J"]&Q^Y+^T4U7.B@J@D
MJHAJHH:H)>H,LF9<$`W-''MF[`.M^Y*/S;0ZL[VTS7SJE:6Q""?&L6;J-Z!\
M6M)051"51!513=00M42=0=:J2[2AU6?ZK0_`IM_"3.R/:$#[#"@G*HA*HHJH
M)FJ(6B)=EPZ^!]:,"ZPSS/3YUICQD5<?,391W&F[;"P:^F-/E!,51"511503
M-40M46>0=>7R[`Q7??PUKL)$[+L(:)\!Y40%44E4$=5$#5%+U!EDS"SC//_T
M]^M0;H<W'D7CO[4]8.VFJK&-B'*B@J@DJHAJHH:H)>H,LK+FI?0E4[I'P6EM
M1[0GRHD*HI*H(JJ)&J*6J#/(FHE3^I$GO^48WX-#4G1BV_HB29R*HIK=5#/U
MFQ\'!)&"50512501U40-44O4&62MSHOS2\9YCTR_(>'O6943%40E4454$S5$
M+5%GD#43Q_EG#EO,[$N?V<W)#UTT%DU=!)1/BQJJ"J*2J"*JB1JBEJ@SR+IR
M4?KE)S]W2SFZMN"1Z:*^*D![5N5$!5%)5!'51`U12]099,VX.!R:<4>MM8[:
M,Z^)+OM8'>8%CZ*S8A3C=U/5T#E[HIRH("J)*J*:J"%JB3J#K$4744.+SWP7
M^T1K9/4H:*;=$FA/E!,51"511503-40M46>0-1-']&//BF-VGTYXV5ETL-HN
M?5)_\K0XUDP-!Y1/2QJJ"J*2J"*JB1JBEJ@SR&IU*7M&P_6AW#0<<OIN";0G
MRHD*HI*H(JJ)&J*6J#/(F'%WXV>8.93;-.]1=+$T:K7=5#4TR)XH)RJ(2J**
MJ"9JB%JBSB`K:UZ:7S'->Q0>MXCV1#E10502540U44/4$G4&63.I-+\Z=P^G
MS3TUKL9`/W3*UJ/HU'@>#1BGJF'&/5%.5!"51!513=00M42=05;DO`"_8H#W
MR+08`SRK<J*"J"2JB&JBAJ@EZ@RR9ER,?ODQ?-6G[O`8[E'41M&31;NI:FHC
MG^"GZ_`YJPJBDJ@BJHD:HI:H,\C*<F%[AJP^FQM9/3)M!+37Y/BB.U%!5!)5
M1#510]02=099,ZD$?]1MG14SO$>VPS:+^$#5SZBJJ<.`\FE90U5!5!)51#51
M0]02=099C_,RO(L'T1C1(^VJ80-W1'NBG*@@*HDJHIJH(6J).H.L&1>/P^_>
MD1G>=5&O+,CPF_CQ/5_E&GZ\)(_PA<"^GV8;Y.=$!5%)5!'51`U12]099+7.
MR_`K9GB/3,,QP[,J)RJ(2J**J"9JB%JBSB!CYG1>AC^4VPSOD>OIL8GT]PW1
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M#BAG54%4$E5$-5%#U!)U!EE9\S+\*3.\1Z:-^JH`[5F5$Q5$)5%%5!,U1"U1
M9Y`U$V?X9]IHC.K#KM^>]BAJH_@AAZEJF'%/E!,51"511503-40M46>0E34O
MF9\RF7MD(A63.:MRHH*H)*J(:J*&J"7J##)FUG$R/W(H>%A._.S[)KHWN/55
M3PX%IYJQX8ARHH*H)*J(:J*&J"7J#+):YV5X=W\VNO;@4=AP1'NBG*@@*HDJ
MHIJH(6J).H.LF3C#/WW<6C.G>Q0-!:-6VTU54QOYG+X9,VO.JH*H)*J(:J*&
MJ"7J#+*RYN7T-7.Z1Z:-^JH`[5F5$Q5$)5%%5!,U1"U19Y`UD\KI9ZLW&T7$
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MWJ,H?46MMINJA@;9$^5$!5%)5!'51`U12]099&7-"_%G#/$>A6U$M"?*B0JB
MDJ@BJHD:HI:H,\B:B4.\.VX=E[[.&/`]LJ?&\_@>]50UM9@/^,&%>%851"51
M1503-40M46>0%3DOX)\QX'MD6HP!GU4Y44%4$E5$-5%#U!)U!EDSJ8!_U(7X
M,^9[CZ(.B^\F3E53AS'?LZH@*HDJHIJH(6J).H.LQWGY_HSYWB/387U5@/:L
MRHD*HI*H(JJ)&J*6J#/(FDGE>_>WL#/'CV=CN)]B578>W3?<^BHIFZKB\#75
M3`WGH_T4<W-6%40E4454$S5$+5%GD-4Z+^V?,>U[%'37CFA/E!,51"511503
M-40M46>0->."],OOB9WUN3N\)^:1#5]QJ^VFJJF-?(8/+GVQJB`JB2JBFJ@A
M:HDZ@ZRL>1G^C!G>(]-&S/"LRHD*HI*H(JJ)&J*6J#/(F-G$&?[XZQ*'1=E\
M[U%T:HSO44]58XL1Y40%44E4$=5$#5%+U!ED1<[+]_HUU?@BO4=ABQ'MB7*B
M@J@DJHAJHH:H)>H,LF92^7ZCWV>=?7+<,-Y[%'58?/MZJIHZC/&>50512501
MU40-44O4&60]SHOW&\9[CTR',=ZS*B<JB$JBBJ@F:HA:HLX@:^9OB_<;QGN/
MH@Z+[VQ/55.',=ZSJB`JB2JBFJ@A:HDZ@ZQ'E\1?GBG<[9'H1J-'IL/ZJ@#M
M6943%40E4454$S5$+5%GD#43Q_NG+W5MQA0_=,/6HZB-XAN-4]4PXYXH)RJ(
M2J**J"9JB%JBSB`K:UYHWS"T>Q3TS(YH3Y03%40E4454$S5$+5%GD#43A_8C
M+]%OQC0_C?].HY/>UA=)XE04#Q*GFJG??+H/!HFL*HA*HHJH)FJ(6J+.(&MU
M7KK?,-U[9/J-Z9Y5.5%!5!)51#510]02=089,^=QNG_ZL'4HMPG>(S-(C#MM
M-Q6-7424$Q5$)5%%5!,U1"U19Y!U-2_`GS/`>Q1V$=&>*"<JB$JBBJ@F:HA:
MHLX@:R85X(^[=WW.!.]1=&*,#U13U=1B3/"L*HA*HHJH)FJ(6J+.("MR7H(_
M9X+WR+08$SRK<J*"J"2JB&JBAJ@EZ@RR9E()_HC+I^=C?I_.>=EY]"#$UE<]
M>6:<:J:&\X$^.#.RJB`JB2JBFJ@A:HDZ@ZS6>8'^G('>(]-P#/2LRHD*HI*H
M(JJ)&J*6J#/(FID7Z,\9Z#TR9T:TVFZJFMJH7Y9F'%#.JH*H)*J(:J*&J"7J
M#+*RY@7Z<P9ZCTP;]54!VK,J)RJ(2J**J"9JB%JBSB!K)A7HCSPUCIE^:(OM
MN8_B^F?Z$Y_S^/&(J6J8<4^4$Q5$)5%%5!,U1"U19Y`5.2_#GS/#>Q3TTXYH
M3Y03%40E4454$S5$+5%GD#%S$6?X(\>,A^7$#]5?1`]";'V5+$XM%V>QJ69L
M.**<J"`JB2JBFJ@A:HDZ@ZS6>7'_@G'?H[#AB/9$.5%!5!)51#510]02=099
M,W'<?WK0>,%([Y$]-<:MMINJIC;RD3XX-;*J("J)*J*:J"%JB3J#K*QYD?Z"
MD=XCTT:,]*S*B0JBDJ@BJHD:HI:H,\B:247ZHYZYN1A#_=`H6X_LH/$B?N9F
MJAIFW!/E1`512501U40-44O4&60]SLOP%\SP'ID.8X9G54Y4$)5$%5%-U!"U
M1)U!UDR<X8]_</""^=ZCJ,6B)W%V4]748C[?!P\.LJH@*HDJHIJH(6J).H.L
MR'GY_H+YWB/38LSWK,J)"J*2J"*JB1JBEJ@SR)KY^_+]!?.]1U&+Q8]'3%53
MBXT#@P'EK"J(2J**J"9JB%JBSB`K<EZ^OV"^]\BT6%\5H#VK<J*"J"2JB&JB
MAJ@EZ@PR9K)%*N`?=:+L%V4OX`\L:K+H9M$N*!M::I]@>DV46UOWITOCU0N]
M)PI,+XH"TYNBP/2J*#"]*PI,+XL"T]NB0A9)G1?OLP7S_<""]I*FOBY@T@0F
M36#2!"9-8-($)DU@T@0F36#2%+)(4YSUW2GTR-[C."!;^#QO+F!<Q,].!&5!
M[XVS#DQ2P2053%+!)!5,4L$D%4Q2P20U9)'4>6.";,%!P<""/E/O<5B08-*$
M.FD"DR8P:0*3)C!I`I,F,&D*6:0I-4`XXII_MAC'!],UB^PB>K1B.Y1)Z506
M7]H(BH:VT_>[7WZP+^083([!Y!A,CL'D&$R.P>083(Y#%CF>-WC(%AP]#"S8
M?+4BQP\))DVHDR8P:0*3)C!I`I,F,&D"DZ:019KBD<33ESRR!8<+`XLN>D1=
M*'-^=#!=XE"#@<D<F,R!R1R8S(')')C,@<D<F,R%+#(W;^B0+3AV&)AM,(X>
M$G72A#II`I,F,&D"DR8P:0*3)C!I"EFD*36../(\RW%$MAC'`].A+;O@P6TL
M"PYN8)(*)JE@D@HFJ6"2"B:I8)(*)JDABZ3.&U-D"PXJ!F9[C\.*1)TTH4Z:
MP*0)3)K`I`E,FL"D"4R:0F8U'5ZJ&C[5Z3+><?>H,O^"UO#/2`86#3"B>^Z[
MH&QJON%]K]-@0F];#4/]X45B>MTJF-ZW"J87KH+IC:M@>N4JF-ZY"J:7KH8L
MLNI"=6CUF5.&?X&K-1<&<__.-/.BUP/3.VE1)TU@T@0F36#2!"9-8-($)DU@
MTA2R2).+R:&F(^]>91+G'S8.#W'1O=#M4*;O\U2&XZ!?5O"EEV.?YX.'.Q),
MCE$GQV!R#";'8'(,)L=@<ARRR+'+V*'CYUJQS^1:XO!-E+<PIP^M""9-8&I%
M,&D"DR8P:0*3)C!I`I,F,&D*6:3)Q>0YFOI8;37YJ*TS_71'_B+J0AWKQK+!
ML,R!R1R8S(')')C,@<D<F,R!R1R8S(4L,N>2\QQS?=*VYL+T/308F#2!21.8
M-(%)$Y@T@4D3F#2!21.8-(4LTN1B<JCI^(LI_GVOUJ!/X0I$8^\M%]$-?/7>
M6!;T'IBD@DDJF*2"22J8I())*IBD@DEJR"*I+E2'4I\[N/4AW)H+@_G0>V#J
M/3!I`I,F,&D"DR8P:0*3)C!I`I.FD$6:7$P.-1U]GNWSMOR%71;=6=7YPL=R
M?1O&9N1Y=BP*6A%,CL'D&$R.P>083([!Y!A,CL'D.&218Y>Q0\?/M6*?R6TK
MACE]:$4PM2*8-(%)$Y@T@4D3F#2!21.8-(%)4\BLIL/K86=H\J^3-9J&5\RJ
MX<?V6BZB+MQE4]G48&1YHJY(L#+!J@2K$ZQ)L#;!.LLB<RY'SS'7YVYK+LSB
MOL',:VD/;)^121/FE28P:0*3)C!I`I,F,&D"DZ:019I<%`XU'7^>]:^6M09]
MTM:!(.B]^,9_-KR5=AJ[2NHXZ]"/D@HFJ6"2"B:I8)(*)JE@D@HFJ2&+I+K@
M'$I]YN#F7SUKS87A>^@],&D"DR8P:0*3)C!I`I,F,&D"DR8P:0I9I,FEY%#3
MO]![?>"V!GT(M[T7/Q&0#>^R-;TWSAKT'IBD@DDJF*2"22J8I())*IBDABR2
MZC)U*/6YWNLSN#47YO*A]\#4>V#J/3!I`I,F,&D"DR8P:0*3)C!I"EFDR:7D
M4-.Q&<^_JE;^PB-<]$C`-AO>:*LU&@^$R'A3T=!V<NSC?'@MA4R.42?'8'(,
M)L=@<@PFQV!R'++(L8O8H>/G6K&/Y+85PY@^M"*8-(&I%<&D"4R:P*0)3)K`
MI`E,FL"D*621)I>2YVCJ4[75U#-SPVRYB+I0&6\L"QH,3.;`9`Y,YL!D#DSF
MP&0.3.;`9"YDD3D7G.>8ZX.V-1>&[Z'!P-1@8-($)DU@T@0F36#2!"9-8-($
M)DTALYH.;Z4--1U_GO4ON#4&AY?>:C^-A[;E`@^F3&53[Y'E&5F18&6"50E6
M)UB38&V"=99%4EVF#J4^<W#S+\"UYL)<[GO/O"CWP/89F31A7FD"DR8P:0*3
M)C!I`I,F,&D*6:3)I>10T['G6?_>6_D+NRQZ)&";#:_'??(\.Q4%K>CC?'B>
M99T<HTZ.P>083([!Y!A,CL'D.&218Q>Q0\?/M6(?R6TKAC%]:$4PM2*86A%,
MFL"D"4R:P*0)3)K`I`E,FD(6:7*A>8ZF/F1;33YXZVP>'.NB+MQEP]MUPP=3
MR&1N7-S0B#(')G-@,@<F<V`R!R9S8#(7LLB<R]%SS/6YVYKK67"?4)K`U&!@
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M`K:9KW)'XO$DC*/@5#0<\?;!C`/+$ZQ(L#+!J@2K$ZQ)L#;!.LLBQ2YBAXJ?
MZ43_KE[3B>;]O;X3R:0IC/.'.FD"DR8P:0*3)C!I`I,F,&D"DZ:019I<2IZC
MJ4_55I-/VCK6CNT5-^$N&][A&T8\,HD;ES;TG,2!21R8Q(%)')C$@4D<F,2%
M+!+G<O,<<7W.MN+"[#WT%YCZ"TR:P*0)3)K`I`E,FL"D"4R:P*0I9)$F%Y)#
M3<>?9?TK>JU!G\%U1AI;;[G`(U%^5IVXAIZ2U''6@4DJF*2"22J8I())*IBD
M@DDJF*2&+)+J(G4H]<_L].KZ[<>_]C</US??96+Q1I?R/[P[]-1EYE_A:\V%
ML7SH/3!I`I,F,&D"DR8P:0*3)C!I`I,F,&D*6:3)9>10T[_0>WW<M@;'"![T
M7H9'HOPK@6WOC;,&O0<FJ6"2"B:I8)(*)JE@D@HFJ2&+I+I$'4I]KO?Z!&[-
MA:E\Z#TP]1Z8>@],FL"D"4R:P*0)3)K`I`E,FD(6:7(9.=1T=,+KP[;\A5T6
M/8RBB.<SN;X-XX&0$6\L&MI.CL'D&$R.P>083([!Y!A,CL'D&$R.0Q8Y=@$[
M=/Q<*_:!W+9B&-*'5@23)C!I`I,F,&D"DR8P:0*3)C!I`I.FD%E-AW?[SM#D
MWP5L-`WO!U;#C^VUS*(NW&53V=1@9'FBKDBP,L&J!*L3K$FP-L$ZRR)S+C?/
M,=?G;&LNS-Z^P<P[A0]LGY%)$^:5)C!I`I,F,&D"DR8P:0*3II!%FEQ*#C6Y
M8]V1E_'\&X2M0I_"=20(F@_/1`TO'PY#'IFLCHL;FE16P6053%;!9!5,5L%D
M%4Q60Q99=:$ZM/K,T<V_8=B:ZX.YQG_#INH["J;F`Y,F,&D"DR8P:0*3)C!I
M`I,F,&D*6:3)Q>0YFOI8;35Y=AIJ\FRZO25-GIV-==*$.FD"DR;,*TVHDR8P
M:<*\TH0Z:0I9I,G%Y%!3GT<.;YE^_')[_>OV3M\M?<<37;::1A+^'</67I_`
M]7QXT&2>F>]BS]Q]N>!K'#U>)J%CV;`X"0634#`)!9-0,`D%DU`P">V9'LO6
MND1"743^&X3V2=L*[9F>)1X,Z%OKZXS0GND.WH=WOW_0$\IT.58,2Y)++$DN
MQSJ_I.C@*K-CQ;`DF<629':L\TN*,H(\CQ7#DN0Y7%+DV67LT'.B0<.QKG]%
ML17:YW3W5&_0>7C8Q\^JYU2'-=-7WL\Z,76H9[WW]6:S6,>_2B_-F%&:P236
M+FQU>G$>CR%E&C/*-)C<FH6=GJXO%JMH,R4[G#&2[<+V'-E].+>R>^:>N`QD
MX^D6_\YC/0T7R/:S3DRR/=L<FOQL$?_-D4QC+ID&D^EGEB3-F$N:P:3YF27)
M<3A7Y-@E]=#QD4?B/O!;]3W3`V"#4QTXP-34/=,-[*%.GL%D%O/*+.ID%DPN
M,:]<HDXNP60OG-?:.[SC.+3WS.'`OQ/9:/+,/>P:="B>27A1V3Y[45D^E+F'
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M.&]DSXWS:&_VNU@S_])N'4;#-!7=\-`WS(\UM49CZ(J*Y'@L&F*!'(/IFP,F
MQV!R#";'8'(,)L=@<@PFQR&+'+OA7>CXN3-2/QRT9Z2>Z8&A08DT@4D3F#2!
M21.8-(%)$Y@T@4D3F#2!25/((DUNA#9'4S^BLYIZYAXR'-MKF;'!QK+!ILR!
MR1R8S(')')C,@<D<F,R!R1R8S(4L,N=&9W/,]:,Y:\Z/^DR#@4D3F#2!21.8
M-(%)$Y@T@4D3F#2!25/(K*;#V[I#3>Y,<=RO[OD7?QN#T\O`P][#\Z53V=1[
M9'E&5B18F6!5@M4)UB18FV"=99%4-]@)I3YS</,O!K?F^@&3.;B9%XC[.W)D
MTH1YI0E,FL"D"4R:P*0)3)K`I"EDO::3AR\W-X_[J\>K#^^^W=Q_OMG=?/WZ
M\.KZ[C?W4%"F]V4$_-7]S:?WKR]U+GE[Z1:F!AGGZ:>Y$^C;P\DF.6WCIAVN
M^G.^<S?M<!V*TR[<M(ODYVT6FJ9>3'W>)G/34NNI)YS.M0T*'JGY-.WP&$%R
MFEL7W3M/35N[=='=Z^0TMRZZ)9J<MG33#LD.V[Y>N6FKQ'S:AH6V08^4I):I
M:5K/]+J<NG7I;_'A\T[=NN@IQN0RW;KHT;WDM%,W[3`>YS+7;MI/7+M^T=-#
MR66Z?DENWZ7^6$O;K@>F4_-IFAZF3F_#RFV#;H`DYW/;T*=D;,/*;4-_!.`T
MMPWZ^XKD,MTVZ'R?G.;ZK'_,B\MT?9;<ODO]0;C;]G0O:=KA+\93G[=TZZ(_
MDTY.<^O2CR2P+DNW+OKKU]1\*]=G&ALFI[D^^\EZ9FY=^CN`T>==ZD>-M'T:
MO::6J6F'7SU*3G/KJ9_Z24U;NO7L;Y!%GZ=?#G#KJ7L]R?E<+_47^SB?ZR5=
MX$O.YWI)MS22TUPO_63[%F[[]"NRJ?D6;OOTTZFI:9G;/OT`:'*:VS[]ZB6G
MR;7['B7W@_MU2C=?^GN4N6W7SQ=RF9K/;;M^H"\YS6V[?I4N.<WUKGY<+3'M
M0INNEU(DINBU"II+[U9(3G-;KA<*)*>YK=/OXB>GN:W3C\%SVJ5^O]P9^\DR
MW9;K!\XYWU8_Z.VFI;=\X;9<OUN=G,]]4_1CS9QV>>%.`,G5U)OQ)"PIY4).
M]#HU+FY[(2-Z=UAJBGPH"Z2F:(OU-JC4%&VOWH:4FJ*MU>M]4E.TK7J]36J*
MOA=Z7TMBRKG66B\Q3DW16NLEOIQR>:Y]J'<8<HI>MJMYDMMSKNW1&UI3\VA[
M]#K2U!1MCU['F9JB[='[)5-3U.KI==MH>S:I[=ENM-:;Y%IOM-:;Y%IOM-:;
MY%IOM-:;U%I?;G1D3AK=:HI[YWUB>S;:'KWS/3'E7#VJ-YRGIJA']8;OQ)0S
M;:DNP*6F:$N3@>[2Y=7D]FQ=6M65D=32Y"`=5<^TI>F@>J8M3<=4EU+3(=5E
MU&1$W6[4UYMD7Z^UI7K0)+'6:VV/'HU(3='VZ#X^IURNM4^3WK::TNF^-.?9
MKK6ENN>:F'*F+=4-SM04;:GN*J6F:$MUQR0U11VOR^R)*:?:TG1L/-66)D/C
MUN5Z/1V<6IJV)QGJ+Y7I+Y/>MB[MI\/^6EN:COIK;6DZZ+N<GXSYV[4Z7L]I
M)=9ZI2U-1LO+E?9I<GNVFM*E(^=*#I*!<^O&$NFAA!M)I`<2;AR1'D:<:DO3
M@XA3;6EZ"'&JCD\.("Z7VM*D@ZVF=.E`Z_)L.LZZ-)L.LRMM:3K*NM%&>K#A
MQAKIH<9*6YH>:+AQ1GJ8L5+')P<9ETMEN'2LUY0N'5Z76K=T=%UJW=+!=:EU
M2\=6-^KH'\R)0[(;<R373:-OK77R>*`I&N^G.OXP:D@=Q;:'<4'RNYUI;Z<'
M!6Y,D!X2N!%!>MVTL-1Q3S%,42QY3#XD\^01,=.G_"1(:K_])'AKO_TD=FN_
M_21T:[\EU^TRTRY(>M8,*>[:*<5=HR?XI6)6RM;6?=$3]5NM:-*A&B+9#VJN
M9#?HJY_J!5T>7K[5]>#4-NCR[_*MKO>FINGR[O*MKN>FIFF9:[?,U'IKF6NW
MS-0T+7/MEIF:I@>NW+3D.5[3SO1YR;.\>RY3GY><YIZT=,M,>70/>+EEIO:5
M>X#++3,US3V@Y99YF'8R?O4?/KS[<?7YYC^N[C_??G]X]?7FDZXE+@Y/#M_?
M?G97M?O_>+S[<7B"^)>[Q\>[;X?_^^7FZN/-O2O0';A/=W>/PW_H]'?RQ]W]
MKX?KE1_^7P````#__P,`4$L#!!0`!@`(````(0!*ZT<0H0(``#@'```9````
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;)156V^;,!1^G[3_8/F].)"0-"BD
M2E=UJ[1)T[3+LV,,6,48V4[3_ON=@U-&EJY+7[@</G_?N;.Z>M0->9#6*=/F
M-(XFE,A6F$*U54Y_?+^]N*3$>=X6O#&MS.F3=/1J_?[=:F_LO:NE]`086I?3
MVOLN8\R)6FKN(M/)%KZ4QFKNX=56S'56\J(_I!N63"9SIKEJ:6#([#D<IBR5
MD#=&[+1L?2"QLN$>_'>UZMPSFQ;GT&EN[W?=A3"Z`XJM:I1_ZDDIT2*[JUIC
M^;:!N!_C&1?/W/W+";U6PAIG2A\!'0N.GL:\9$L&3.M5H2`"3#NQLLSI)LZN
MEY2M5WU^?BJY=Z-GXFJS_VA5\5FU$I(-9<(";(VY1^A=@28XS$Y.W_8%^&I)
M(4N^:_PWL_\D555[J'8*`6%<6?%T(YV`A`)-E*3()$P##L"5:(6=`0GAC_U]
MKPI?YS291\EE&J=SP).M=/Y6(2<E8N>\T;\"*CYP!9;DP`+W`\MT'J6+R33^
M/PD+'O4!WG#/URMK]@2:!B1=Q[$%XPR(7XX(0D'L!L$Y75("OCJHPL,ZC9,5
M>X#4B0/F.F#@.F#^(!B(#LJ@=KXR@E$9<XNN7`?#6&8Z.'(D,WV+#()S"M?!
M^=,``V8VPBQ>5@;(^0$B&&H`8;TB'4!G2$-3G2^-X%YZ2&ZPS/J9&)=L_A9:
M!!_3'BPP?J,8_U&VQ5ND$'PL%2RG$>!"'K5[&.1IM("(7V]]/'@L<;",6S"-
M9R^W`HS,6/9U*00?2P7+*)JPJ<(@:VDK^4$VC2/"['`+)3":@W58D)L$Z_FW
M?99M^JEBPP=87!VOY!=N*]4ZTL@2*"=]BFQ8?>'%FPZ\A.UE/&RL_K&&/Y2$
MZ9Q$D,_2&/_\`L)L^.>M?P,``/__`P!02P,$%``&``@````A`$`PN,\S`0``
M0`(``!$`"`%D;V-0<F]P<R]C;W)E+GAM;""B!`$HH``!````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````)R144O#,!2%WP7_0\E[FW8=0T.;@<J>'`A.
M%-]B<K<%FS3D1KO]>[.NJQ-]$O(2SKE?SCVIYCO3))_@4;>V)D66DP2L;)6V
MFYH\K1;I%4DP"*M$TUJHR1Z0S/GE124=DZV'!]\Z\$$#)I%DD4E7DVT(CE&*
M<@M&8!8=-HKKUAL1XM5OJ!/R76R`3O)\1@T$H400]`!,W4@D`U+)$>D^?-,#
ME*30@`$;D!990;^]`;S!/P=ZY<QI=-B[N-,0]YRMY%$<W3O4H['KNJPK^Q@Q
M?T%?EO>/_:JIMH>N)!!^Z*<1&):QRK4&=;/GNS??)(C;BO[6*B7[=$QZ$`%4
M$M]CQW0GY;F\O5LM")_DQ33-RWA6Q8R5UVPZ?:WHR37,\Q%HA@#_)IX`O,_]
M\\_Y%P```/__`P!02P,$%``&``@````A`"$FT`7"`P``,@X``!``"`%D;V-0
M<F]P<R]A<'`N>&UL(*($`2B@``$`````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````G%==<YLZ$'V_,_T/'MX;G#3-W,E@.C*6;4U!4"3<YDFC8CEF2L`#
MJB>YO_XN)A]V(]1)WH2T9_?L:H^$O"_W=^5HKYJVJ*N)<WXV=D:JRNMU4=U.
MG(S//_[KC%HMJ[4LZTI-G`?5.E_\#_]X25/O5*,+U8[`1=5.G*W6NVO7;?.M
MNI/M&2Q7L+*IFSNIX;.Y=>O-ILC5K,Y_WZE*NQ?C\96K[K6JUFK]<??LT.D]
M7N_U>YVNZ[SCUZ[XPPX(^Q[:[<HBEQJR]*,B;^JVWN@1OL]5Z;G'BQZP8RK_
MW13ZP1][[O&GQW)9J@`<^QM9MLIS7R:\I9)=T1)9-*WO[?7U7N6Z;D9M\1^4
M[<(9_92MZNA,G+UL"EEIH-69]1^'<;EK=>-_KYM?[58IW7HN&/23A^&Q[?&X
MN/2OS@\6,#JU[#ST3&#AE",O=*G:>)/(1ALH7YT?<SZPZ!GWA)YV44!O"%QI
MJ)<@5;_;17W,_#F'(*8L#LD,<3P34Q0B&F#!EAAS]E9[D<B_0QB'2!&FG(EX
M+N($OQ7">/Q62(#,N5#$LQ1W/*89(Q0S)A"=B7B%TQ4Q$V-9%*'TIL,PLJ!D
M3@)$N4!!$&>4#Q"+DA0O,65DA448,S.9.2*I6*$PPR+"B`&Q0Y6,+H'"5\S1
M-(2MPD&6$DZPV6N20HE3?G-(#'_+2-)Y%12;N1+*$5V0SC%B#'K@@%O$\>P[
M"4,C%T@]S:!W\(\$4AR@$?,E3B%WNN`XC41(T)2$PZQ[HQA18T3H@.#K,@YG
M.&6BRXG?#-M-$0-R01QU[!`GL=EGBE>89N8]#^(P1-,X/:`%6J38LC6$0BPL
M./HQ4`I8C@CO%=!U&PB0$[K`-!C:PQ1STG>#8&@%MDPDH%-SSCC$02?E;QE*
MH8SAC9@3"J(F*!0S,\3:TOT1]GC>/9\:=AE<&.-T>W"J`\'E3SCMC-8#<K!!
MC*JP`8;%T:&,M.P",1?K3X78*`T+99#200ZOV]P6Y;A);7;67A7&`C%K`YH+
M9#^'S1A[!WXR<[-V^N4[,)_?@;DR8@SJF"DMB_)M\N@QQ@AF>=B"6/0!,&,0
MNS[,!\,K?=@X600RQ,D.,;?7\PTD;&0,-]'?[0U2[6,8"SJD[AYB)O]XF5FI
M#%UJ/<A(Y>34L)7%9"C,>V\_88;2,]Z'C^D:J=M/I1-J)S_G?_R.AT7UJ\UV
MO)Y)K9[>&Z>3'MO*1JWA3_QI_67"6\)3HRD[)\%65K=J_63S>J%[':WZ)Z!_
M?GDV_C2&A\_1G.>^//;\_P$``/__`P!02P$"+0`4``8`"````"$`#G&_S#("
M``"D)```$P``````````````````````6T-O;G1E;G1?5'EP97-=+GAM;%!+
M`0(M`!0`!@`(````(0"U53`C]0```$P"```+`````````````````&L$``!?
M<F5L<R\N<F5L<U!+`0(M`!0`!@`(````(0"-&-.G>0(``#$D```:````````
M`````````)$'``!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+`0(M`!0`
M!@`(````(0"\._-_]P0``"<2```/`````````````````$H+``!X;"]W;W)K
M8F]O:RYX;6Q02P$"+0`4``8`"````"$`9A%PB7L%``#4%0``&```````````
M``````!N$```>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!`BT`%``&``@`
M```A`-1E2CRB!@``]1X``!D`````````````````'Q8``'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6Q02P$"+0`4``8`"````"$`D->D%IT$``#5$P``&0``
M``````````````#X'```>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+`0(M
M`!0`!@`(````(0!5OS:2P@4``-X:```9`````````````````,PA``!X;"]W
M;W)K<VAE971S+W-H965T-#<N>&UL4$L!`BT`%``&``@````A``6.H#L4`P``
MO@@``!D`````````````````Q2<``'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6Q02P$"+0`4``8`"````"$`0(%NS;D$```L%```&0`````````````````0
M*P``>&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+`0(M`!0`!@`(````(0"B
M!%B`@@,``-4+```9```````````````````P``!X;"]W;W)K<VAE971S+W-H
M965T-3`N>&UL4$L!`BT`%``&``@````A`*-9'SOD`P``+@\``!D`````````
M````````N3,``'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"+0`4``8`
M"````"$`8C+R"IP$``!*$P``&0````````````````#4-P``>&PO=V]R:W-H
M965T<R]S:&5E=#0S+GAM;%!+`0(M`!0`!@`(````(0`+G%!81@,``.(*```9
M`````````````````*<\``!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L!
M`BT`%``&``@````A`%F/[<&,"0``\"X``!D`````````````````)$```'AL
M+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"+0`4``8`"````"$`0;ZO!1$$
M``"@#P``&0````````````````#G20``>&PO=V]R:W-H965T<R]S:&5E=#,X
M+GAM;%!+`0(M`!0`!@`(````(0#U_%V>]`(``)X(```9````````````````
M`"].``!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L!`BT`%``&``@````A
M`!8:/O%``P``I@L``!D`````````````````6E$``'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"+0`4``8`"````"$`>=SA85T#``!>"P``&0``````
M``````````#15```>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+`0(M`!0`
M!@`(````(0`CN,+2&P0``.\/```9`````````````````&58``!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L!`BT`%``&``@````A`-F6A1(>!P``HR<`
M`!D`````````````````MUP``'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"+0`4``8`"````"$`+NQ>\MD)``#O.```&0`````````````````,9```
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+`0(M`!0`!@`(````(0#[8J5M
ME`8``*<;```3`````````````````!QN``!X;"]T:&5M92]T:&5M93$N>&UL
M4$L!`BT`%``&``@````A`,0S?@"]"P``(&L```T`````````````````X70`
M`'AL+W-T>6QE<RYX;6Q02P$"+0`4``8`"````"$`C+F.I-5K``!+8`$`%```
M``````````````#)@```>&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"+0`4``8`
M"````"$`_O,8>^L"``!0"0``&`````````````````#0[```>&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L!`BT`%``&``@````A`&KDMLQT!0``3!8``!@`
M````````````````\>\``'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+`0(M
M`!0`!@`(````(0!H-#-O-`0``&4/```9`````````````````)OU``!X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L!`BT`%``&``@````A`+4:?#[N`@``
MBP@``!D`````````````````!OH``'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6Q02P$"+0`4``8`"````"$`(1.`OVH#``"$"P``&0`````````````````K
M_0``>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+`0(M`!0`!@`(````(0"V
MI^!6I`0``+82```9`````````````````,P``0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L!`BT`%``&``@````A`,8Q'=$2!```]0\``!D`````````
M````````IP4!`'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"+0`4``8`
M"````"$`,8]59-D$``"%%@``&0````````````````#P"0$`>&PO=V]R:W-H
M965T<R]S:&5E=#4V+GAM;%!+`0(M`!0`!@`(````(0!Q[]H,9`H``*)$```9
M```````````````````/`0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L!
M`BT`%``&``@````A`$H+7N9C!@``N2```!D`````````````````FQD!`'AL
M+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"+0`4``8`"````"$``:YDP@0$
M``!G$```&``````````````````U(`$`>&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L!`BT`%``&``@````A`)5%"_N%!0``!18``!D`````````````````
M;R0!`'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"+0`4``8`"````"$`
M33X,56$4``!H=```&0`````````````````K*@$`>&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+`0(M`!0`!@`(````(0"8+:U:D0\``,99```9````````
M`````````,,^`0!X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L!`BT`%``&
M``@````A`"LG%QB=!P``W"$``!D`````````````````BTX!`'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"+0`4``8`"````"$`\0P6+/T(``!E*P``
M&0````````````````!?5@$`>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M`0(M`!0`!@`(````(0`$"F;!GP(``#<'```9`````````````````)-?`0!X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L!`BT`%``&``@````A`$]:D@**
M`P``VPP``!D`````````````````:6(!`'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"+0`4``8`"````"$`Y#.A,H((```9*```&0``````````````
M```J9@$`>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+`0(M`!0`!@`(````
M(0!KDQ`&3!<``#6)```9`````````````````.-N`0!X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L!`BT`%``&``@````A`!`.\\CX#0``;4\``!D`````
M````````````9H8!`'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"+0`4
M``8`"````"$`G`N_5D()``#3,```&`````````````````"5E`$`>&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L!`BT`%``&``@````A`"P:2#)3!P``K1\`
M`!@`````````````````#9X!`'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+
M`0(M`!0`!@`(````(0"G9T+3[0(``.D(```8`````````````````):E`0!X
M;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"+0`4``8`"````"$`HF<38/L;
M``#7M@``&`````````````````"YJ`$`>&PO=V]R:W-H965T<R]S:&5E=#@N
M>&UL4$L!`BT`%``&``@````A`/L%\,UX"0``:2\``!@`````````````````
MZL0!`'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+`0(M`!0`!@`(````(0!$
M0(QV>A8``(Z%```9`````````````````)C.`0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L!`BT`%``&``@````A`/CN[<'#%@``+X8``!D`````````
M````````2>4!`'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"+0`4``8`
M"````"$`U!E)VJD$```*%0``&0````````````````!#_`$`>&PO=V]R:W-H
M965T<R]S:&5E=#(P+GAM;%!+`0(M`!0`!@`(````(0`^S-GCI!8``+2$```9
M`````````````````",!`@!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L!
M`BT`%``&``@````A`!(4[1X""```Q"0``!D`````````````````_A<"`'AL
M+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"+0`4``8`"````"$`-?8$N%8.
M```74```&0`````````````````W(`(`>&PO=V]R:W-H965T<R]S:&5E=#,Q
M+GAM;%!+`0(M`!0`!@`(````(0!+SB4QG@<``+0A```9````````````````
M`,0N`@!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L!`BT`%``&``@````A
M``CG0BXG"```(28``!D`````````````````F38"`'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6Q02P$"+0`4``8`"````"$`)WJ#C:("```W!P``&0``````
M``````````#W/@(`>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+`0(M`!0`
M!@`(````(0!5_]1770T``%=+```9`````````````````-!!`@!X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L!`BT`%``&``@````A`!"^0JQ1!P``J"(`
M`!D`````````````````9$\"`'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"+0`4``8`"````"$`9I`DG0P=```NK@``&0````````````````#L5@(`
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+`0(M`!0`!@`(````(0!4,!9W
M-P8``!$:```9`````````````````"]T`@!X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L!`BT`%``&``@````A`+OH[!UK"0``&R\``!D`````````````
M````G7H"`'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"+0`4``8`"```
M`"$`ND1X\"()```E+```&0`````````````````_A`(`>&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+`0(M`!0`!@`(````(0!:3:9&N"0``&WI```9````
M`````````````)B-`@!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L!`BT`
M%``&``@````A`$KK1Q"A`@``.`<``!D`````````````````A[("`'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6Q02P$"+0`4``8`"````"$`0#"XSS,!``!`
M`@``$0````````````````!?M0(`9&]C4')O<',O8V]R92YX;6Q02P$"+0`4
M``8`"````"$`(2;0!<(#```R#@``$`````````````````#)MP(`9&]C4')O
@<',O87!P+GAM;%!+!08`````1@!&`!P3``#!O`(`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUQAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>REVENUE (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="7">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Collaboration arrangement for development and commercialization of oral rotavirus strain

</div>
          <div>Glaxo

</div>
          <div>Rotarix</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Collaboration arrangement for development and commercialization of oral rotavirus strain

</div>
          <div>Glaxo

</div>
          <div>Rotarix</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Collaboration arrangement for development and commercialization of oral rotavirus strain

</div>
          <div>Glaxo

</div>
          <div>Rotarix</div>
        </th>
        <th class="th">
          <div>Dec. 31, 1995

</div>
          <div>License agreements

</div>
          <div>Cincinnati Children's Hospital Medical Center

</div>
          <div>Rotarix</div>
        </th>
        <th class="th">
          <div>May 31, 2005

</div>
          <div>Royalty Agreement

</div>
          <div>PRF

</div>
          <div>Rotarix</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>REVENUE</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived', window );">Percentage of license fee payable on net royalties received</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">30.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_PercentageOfInterestInNetRoyaltiesSold', window );">Percentage of interest in net royalties sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">70.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Product royalty expense</a></td>
        <td class="nump">$ 2,334<span></span></td>
        <td class="nump">$ 10,775<span></span></td>
        <td class="nump">$ 9,119<span></span></td>
        <td class="nump">$ 2,300<span></span></td>
        <td class="nump">$ 10,800<span></span></td>
        <td class="nump">$ 9,100<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_PercentageOfInterestInNetRoyaltiesSold">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the percentage of interest in net royalties sold.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_PercentageOfInterestInNetRoyaltiesSold</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of license fee payable to third party on net royalties received.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_PercentageOfLicenseFeeDueOnNetRoyaltiesReceived</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHOAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property and Equipment</a></td>
        <td class="nump">$ 21,965<span></span></td>
        <td class="nump">$ 19,530<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less Accumulated Depreciation and Amortization</a></td>
        <td class="num">(11,992)<span></span></td>
        <td class="num">(12,325)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net</a></td>
        <td class="nump">9,973<span></span></td>
        <td class="nump">7,205<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
        <td class="nump">1,932<span></span></td>
        <td class="nump">2,047<span></span></td>
        <td class="nump">2,248<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Laboratory Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property and Equipment</a></td>
        <td class="nump">3,699<span></span></td>
        <td class="nump">3,164<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Manufacturing Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property and Equipment</a></td>
        <td class="nump">2,130<span></span></td>
        <td class="nump">2,055<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Office Furniture and Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property and Equipment</a></td>
        <td class="nump">1,386<span></span></td>
        <td class="nump">1,264<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property and Equipment</a></td>
        <td class="nump">14,493<span></span></td>
        <td class="nump">12,932<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Construction in Progress</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property and Equipment</a></td>
        <td class="nump">$ 257<span></span></td>
        <td class="nump">$ 115<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>OTHER LONG-TERM LIABILITIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>OTHER LONG-TERM LIABILITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock', window );">Schedule of Other long-term liabilities</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 593px;" border="0" cellspacing="0" cellpadding="0" width="593">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred Rent</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">419</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">434</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net Deferred Tax Liability related to IPR&amp;D</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred Income from Sale of Tax Benefits</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,630</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,118</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred Revenue</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,168</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Loan Payable</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">472</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">39</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7,878</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,724</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Less Current Portion</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(928</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(388</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Long-Term Portion</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,950</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,336</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of other long-term liabilities, not separately disclosed on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGYDI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Income tax benefit (provision):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 30,962<span></span></td>
        <td class="nump">$ 19,394<span></span></td>
        <td class="nump">$ 16,204<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,920<span></span></td>
        <td class="nump">4,237<span></span></td>
        <td class="nump">3,131<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Foreign</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">84<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits', window );">Expiration of Net Operating Losses and Research &amp; Development Tax Credits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(126)<span></span></td>
        <td class="num">(1,426)<span></span></td>
        <td class="num">(411)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance', window );">Income tax benefit (provision) before valuation allowance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">35,756<span></span></td>
        <td class="nump">22,205<span></span></td>
        <td class="nump">19,008<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax valuation allowance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(35,756)<span></span></td>
        <td class="num">(22,205)<span></span></td>
        <td class="num">(19,008)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Reconciliation between the amount of reported income tax and the amount computed using U.S. Statutory rate</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Statutory rate (as a percent)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">34.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Pre-tax loss</a></td>
        <td class="num">(22,062)<span></span></td>
        <td class="num">(23,140)<span></span></td>
        <td class="num">(19,016)<span></span></td>
        <td class="num">(17,332)<span></span></td>
        <td class="num">(16,807)<span></span></td>
        <td class="num">(15,027)<span></span></td>
        <td class="num">(13,773)<span></span></td>
        <td class="num">(13,516)<span></span></td>
        <td class="num">(81,550)<span></span></td>
        <td class="num">(59,123)<span></span></td>
        <td class="num">(44,799)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Loss at Statutory Rates</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(27,727)<span></span></td>
        <td class="num">(20,102)<span></span></td>
        <td class="num">(15,213)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and Development Credits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,261)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,736)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State Taxes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,920)<span></span></td>
        <td class="num">(4,237)<span></span></td>
        <td class="num">(3,131)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">26<span></span></td>
        <td class="nump">708<span></span></td>
        <td class="nump">661<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits', window );">Expiration of Net Operating Losses and Research &amp; Development Tax Credits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">126<span></span></td>
        <td class="nump">1,426<span></span></td>
        <td class="nump">411<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in Valuation Allowance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">35,756<span></span></td>
        <td class="nump">22,205<span></span></td>
        <td class="nump">19,008<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Gross Deferred Tax Assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net Operating Loss Carryforwards</a></td>
        <td class="nump">79,558<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">67,728<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">79,558<span></span></td>
        <td class="nump">67,728<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax Credit Carryforwards</a></td>
        <td class="nump">25,582<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,692<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,582<span></span></td>
        <td class="nump">20,692<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Deferred Expenses</a></td>
        <td class="nump">61,370<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">43,226<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">61,370<span></span></td>
        <td class="nump">43,226<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based Compensation</a></td>
        <td class="nump">3,926<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,264<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,926<span></span></td>
        <td class="nump">3,264<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Fixed Assets</a></td>
        <td class="nump">1,638<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,156<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,638<span></span></td>
        <td class="nump">2,156<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Accrued Expenses and Other</a></td>
        <td class="nump">623<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">241<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">623<span></span></td>
        <td class="nump">241<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross Deferred Tax Assets</a></td>
        <td class="nump">172,697<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">137,307<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">172,697<span></span></td>
        <td class="nump">137,307<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Gross Deferred Tax Liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets', window );">Other Acquired Intangibles</a></td>
        <td class="num">(4,115)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,481)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,115)<span></span></td>
        <td class="num">(4,481)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets', window );">IPR&amp;D Intangibles</a></td>
        <td class="num">(4,661)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,661)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,661)<span></span></td>
        <td class="num">(4,661)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross Deferred Tax Liabilities</a></td>
        <td class="num">(8,776)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(9,142)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(8,776)<span></span></td>
        <td class="num">(9,142)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DeferredTaxAssetsLiabilitiesGross', window );">Total Deferred Tax Assets and Liabilities</a></td>
        <td class="nump">163,921<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">128,165<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">163,921<span></span></td>
        <td class="nump">128,165<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets Valuation Allowance</a></td>
        <td class="num">(168,582)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(132,826)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(168,582)<span></span></td>
        <td class="num">(132,826)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net Deferred Tax Asset (Liability)</a></td>
        <td class="num">$ (4,661)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (4,661)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (4,661)<span></span></td>
        <td class="num">$ (4,661)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences from in-process research and development intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DeferredTaxAssetsInProcessResearchAndDevelopmentIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DeferredTaxAssetsLiabilitiesGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DeferredTaxAssetsLiabilitiesGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences from other acquired intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DeferredTaxLiabilitiesOtherAcquiredIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reflects the amounts of net operating losses and research and development tax credits expired during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations before the effect of the change during the period in the valuation allowance for a specified deferred tax asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of the difference between total income tax expense or benefit as reported in the Income Statement and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to expiration of net operating losses and research and development tax credits under enacted tax laws during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_IncomeTaxReconciliationExpirationOfNetOperatingLossesAndResearchAndDevelopmentTaxCredits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Liability<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510232<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 15<br><br> -Subparagraph b(2)<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredIncomeTaxLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGrossAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The tax effect as of the balance sheet date of the amount of future tax deductions arising from all unused tax credit carryforwards which have been reduced by a valuation allowance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Carryforwards<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from other provisions, reserves, allowances, and accruals not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences net of deferred tax asset attributable to deductible temporary differences and carryforwards after valuation allowances.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31931-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current and deferred income tax expense (benefit) attributable to income (loss) from continuing domestic operations within the country of domicile of the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32672-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current and deferred income tax expense (benefit) attributable to income (loss) from continuing foreign operations not within the country of domicile of the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32123-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationOtherAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationTaxCreditsResearch</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a)-(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the change in the period in the valuation allowance for a specified deferred tax asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32123-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELIAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Basis of Presentation</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The accompanying consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation. The Company operates in one segment, which is the business of development, manufacturing and commercialization of novel therapeutics for human health care.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Use of Estimates</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S.&#160;GAAP) requires management to make estimates and use assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Cash and Cash Equivalents</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company considers all highly liquid investments purchased with a maturity date of 90&#160;days or less at the date of purchase to be cash equivalents. Cash equivalents consist principally of money market funds and debt securities.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Marketable Securities</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company invests its excess cash balances in marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds. The Company classifies all of its marketable securities as current assets on the consolidated balance sheets because they are available-for-sale and available to fund current operations. Marketable securities are stated at fair value with their unrealized gains and losses included as a component of accumulated other comprehensive income (loss), which is a separate component of stockholders' equity, until such gains and losses are realized. If a decline in the fair value is considered other-than-temporary, based on available evidence, the unrealized loss is transferred from other comprehensive income (loss) to the consolidated statements of operations. Realized gains and losses are determined on the specific identification method and are included in investment and other income, net.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and of Significant Customers and Suppliers</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Concentration of Credit Risk and of Significant Customers and Suppliers</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, marketable securities and accounts receivable. The Company invests its cash, cash equivalents and marketable securities in debt instruments and interest bearing accounts at major financial institutions in excess of insured limits. The Company mitigates credit risk by limiting the investment type and maturity to securities that preserve capital, maintain liquidity and have a high credit quality. The Company has not historically experienced credit losses from its accounts receivable and therefore has not established an allowance for doubtful accounts.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Revenue from Glaxo represented 57%, 96% and 98% for the years ended December&#160;31, 2013, 2012 and 2011 and of total Company revenue, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company relies on contract manufacturing organizations (CMO) to manufacture drug substance and drug product for its late-stage clinical studies of rindopepimut and glembatumumab vedotin as well as for future commercial supplies. The Company also relies on CMOs for supply of raw materials as well as filling, packaging, storage and shipping of drug product. These clinical studies would be adversely affected by a significant interruption in the supply of rindopepimut and glembatumumab vedotin.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Fair Value Measurements</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has certain assets and liabilities that are measured at fair value in the financial statements. The Company seeks to maximize the use of observable inputs (market data obtained from sources independent from the Company) and to minimize the use of unobservable inputs (the Company's assumptions about how market participants would price assets and liabilities) when measuring the fair value of its assets and liabilities. These assets and liabilities are classified into one of three levels of the following fair value hierarchy as defined by U.S.&#160;GAAP:</font></p>
<ul>
<li style="list-style: none;">
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Level&#160;2: Observable inputs other than Level&#160;1 prices, such as quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Level&#160;3: Unobservable inputs based on the Company's assessment of the assumptions that market participants would use in pricing the asset or liability.</font></p></li></ul>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Property and Equipment</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property and equipment is stated at cost and depreciated over the estimated useful lives of the related assets using the straight-line method. Laboratory equipment and office furniture and equipment are depreciated over five years and computer equipment is depreciated over three years. Manufacturing equipment is amortized over seven to ten years. Leasehold improvements are amortized over the shorter of the estimated useful life or the non-cancelable term of the related lease, including any renewals that are reasonably assured of occurring. Property and equipment under construction is classified as construction in progress and is depreciated or amortized only after the asset is placed in service. Expenditures for maintenance and repairs are charged to expense whereas the costs of significant improvements which extend the life of the underlying asset are capitalized. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are eliminated and any resulting gain or loss is reflected in the Company's consolidated statements of operations and comprehensive loss.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The treatment of costs to construct property and equipment depends on the nature of the costs and the stage of construction. Costs incurred in the project planning, design, construction and installation phases are capitalized as part of the cost of the asset. The Company stops capitalizing these costs when the asset is substantially complete and ready for its intended use. For manufacturing property and equipment, the Company also capitalizes the cost of validating these assets for the underlying manufacturing process. The Company completes the capitalization of validation costs when the asset is substantially complete and ready for its intended use. Costs capitalized include incremental labor and fringe benefits, and direct consultancy services.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Business Combinations</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records the fair value of the consideration transferred to acquire a business to the tangible assets and identifiable intangible assets acquired and liabilities assumed on the basis of their fair values at the date of acquisition. The Company assesses the fair value of assets, including intangible assets such as in-process research and development (IPR&amp;D), using a variety of methods including present value models. Each asset is measured at fair value from the perspective of a market participant. The method used to estimate the fair values of IPR&amp;D assets incorporates significant assumptions regarding the estimates a market participant would make in order to evaluate an asset, including a market participant's assumptions regarding the probability of completing IPR&amp;D projects, which would require obtaining regulatory approval for marketing of the associated drug candidate; a market participant's estimates regarding the timing of and the expected costs to complete IPR&amp;D projects; a market participant's estimates of future cash flows from potential product sales; and the appropriate discount rates for a market participant. Transaction costs and restructuring costs associated with the transaction are expensed as incurred.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In connection with the acquisition of CuraGen Corporation ("CuraGen") in October 2009, the Company assumed CuraGen's $12.5&#160;million in 4% convertible subordinated debt due February&#160;15, 2011 (the "Convertible Subordinated Debt"). In February 2011, the Company paid $12.8&#160;million and satisfied all the outstanding principal and accrued interest related to the Convertible Subordinated Debt.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Intangible Assets</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IPR&amp;D assets acquired in a business combination initially are recorded at fair value and accounted for as indefinite-lived intangible assets. These assets are maintained on the Company's consolidated balance sheets until either the project underlying them is completed or the assets become impaired. If a project is completed, the carrying value of the related intangible asset is amortized over the remaining estimated life of the asset beginning in the period in which the project is completed. If a project becomes impaired or is abandoned, the carrying value of the related intangible asset is written down to its fair value and an impairment charge is taken in the period in which the impairment occurs.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In January 2013, the Company adopted a new U.S.&#160;GAAP accounting standard which amended guidance applicable to annual impairment tests of indefinite-lived intangible assets. The amended guidance added an optional qualitative assessment for determining whether an indefinite-lived intangible asset is impaired. Prior to this guidance, companies were required to perform an annual impairment test that included a calculation of the fair value of the asset and a comparison of that fair value with its carrying value. If the carrying value exceeded the fair value, an impairment was recorded. The amended guidance allows a company the option to perform a qualitative assessment, considering both negative and positive evidence, regarding the potential impairment of the indefinite-lived intangible asset. If, based on the qualitative analysis, the company determines that it is more likely than not that the fair value of such an asset exceeds its carrying value, the company would be permitted to conclude that the indefinite-lived intangible asset was not impaired without a quantitative calculation of the fair value of the asset. Otherwise, the company would perform the quantitative calculation of the fair value and the comparison with the carrying value. The Company's adoption of this new standard did not have a material effect on its operating results or financial position.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IPR&amp;D assets are tested for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. As part of the annual impairment test of the IPR&amp;D assets as of July&#160;1, 2013, the Company bypassed the optional qualitative assessment and performed a calculation of the fair value of the asset. The Company concluded that the IPR&amp;D assets were not impaired.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Intangible assets acquired in a business combination with a finite life are recorded at fair value and amortized over the greater of economic consumption or on a straight-line basis over their estimated useful life.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Goodwill</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The difference between the purchase price and the fair value of assets acquired and liabilities assumed in a business combination is allocated to goodwill. Goodwill is evaluated for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. The Company has the option to assess qualitative factors to determine if it is more likely than not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment test required under U.S.&#160;GAAP. As part of its annual impairment test of the goodwill asset as of July&#160;1, 2013, the Company bypassed the optional qualitative assessment and performed the two-step impairment test. The Company concluded that the goodwill asset was not impaired.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Impairment of Long-Lived Assets</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company evaluates the recoverability of its long-lived assets, including property and equipment, and intangible assets when circumstances indicate that an event of impairment may have occurred. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the assets, the assets are written-down to their estimated fair values.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Revenue Recognition</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company recognizes revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the seller's price to the buyer is fixed or determinable; and collectability is reasonably assured.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has entered into and in the future may enter into biopharmaceutical product development agreements with collaborative partners for the research and development of therapeutic drug products. The terms of the agreements may include nonrefundable signing and licensing fees, funding for research, development and manufacturing, milestone payments and royalties on any product sales derived from collaborations. These multiple element arrangements are analyzed to determine whether the deliverables can be separated or whether they must be accounted for as a single unit of accounting. In accounting for these transactions, the Company allocates revenue to the various elements based on their relative fair value. The fair value of a revenue generating element can be based on current selling prices offered by the Company or another party for current products or the Company's best estimate of a selling price for future products. Revenue allocated to an individual element is recognized when all other revenue recognition criteria are met for that element.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;These collaborative and other agreements may contain milestone payments. Revenues from milestones, if they are considered substantive, are recognized upon successful accomplishment of the milestones. Determining whether a milestone is substantive involves judgment, including an assessment of the Company's involvement in achieving the milestones and whether the amount of the payment is commensurate to the Company's performance. If not considered substantive, milestones are initially deferred and recognized over the remaining performance obligation.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payments received to fund certain research activities are recognized as revenue in the period in which the research activities are performed. Revenue from contracts and grants is recognized as the services are performed and recorded as effort is expended on the contracted work and billed to the government or the Company's contractual partner. Payments received in advance that are related to future performance are deferred and recognized as revenue when the research projects are performed.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Product royalty revenue consists of payments received from licensees for a portion of sales proceeds from products that utilize the Company's licensed technologies and are recognized when the amount of and basis for such royalty payments are reported to the Company in accurate and appropriate form and in accordance with the related license agreement.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Research and Development Expenses</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research and development costs, including internal and contract research costs, are expensed as incurred. Research and development expenses consist mainly of clinical trial costs, manufacturing of clinical material, toxicology and other studies, personnel costs, depreciation, license fees and funding of outside research.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clinical trial expenses include expenses associated with clinical research organizations (CRO). The invoicing from CROs for services rendered can lag several months. We accrue the cost of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, and project management costs. We maintain regular communication with our CROs to gauge the reasonableness of our estimates. Differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period in which they become known.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Patent Costs</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Patent costs are expensed as incurred. Certain patent costs are reimbursed by the Company's product development and licensing partners. Any reimbursed patent costs are recorded as product development and licensing agreement revenues in the Company's financial statements.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Stock-Based Compensation</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records stock-based compensation expense for all stock-based awards made to employees and directors based on the estimated fair values of the stock-based awards expected to vest at the grant date and is adjusted, if necessary, to reflect actual forfeitures. Compensation expense for all stock-based awards to employees and directors is recognized using the straight-line method over the term of vesting or performance.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records stock-based compensation expense for stock options granted to non-employees based on the fair value of the stock options which is re-measured over the vesting term resulting in periodic adjustments to stock-based compensation expense.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Foreign Currency Translation</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net unrealized gains and losses resulting from foreign currency translation are included in other comprehensive income (loss). At December&#160;31, 2013 and December&#160;31, 2012, accumulated other comprehensive income includes a net unrealized gain related to foreign currency translation of $2.6&#160;million. In 2011, the Company's foreign subsidiary voluntarily liquidated in order to consolidate the Company's foreign operations into Celldex Therapeutics,&#160;Inc.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Income Taxes</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company uses the asset and liability method to account for income taxes, including the recognition of deferred tax assets and deferred tax liabilities for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax basis. Quarterly, the Company reviews its deferred tax assets for recovery. A valuation allowance is established when the Company believes that it is more likely than not that its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records uncertain tax positions in the financial statements only if it is more likely than not that the uncertain tax position will be sustained upon examination by the taxing authorities. The Company records interest and penalties related to uncertain tax positions in income tax expense.</font></p>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Comprehensive Loss</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Comprehensive loss is comprised of net loss and certain changes in stockholders' equity that are excluded from net loss. The Company includes foreign currency translation adjustments and unrealized gains and losses on marketable securities in other comprehensive loss. The consolidated statements of operations and comprehensive loss reflect total comprehensive loss for the years ended December&#160;31, 2013, 2012 and 2011.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In January 2013, the Company adopted a new U.S.&#160;GAAP accounting standard which requires the Company to separately disclose, on a prospective basis, the change in each component of other comprehensive income (loss) relating to reclassification adjustments and current period other comprehensive income (loss). As the new guidance relates to presentation only, the adoption did not have a material impact on the Company's results of operations or financial position.</font></p>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Net Loss Per Share</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>Year Ended December&#160;31,</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Stock options</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,770,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,349,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,459,034</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Restricted stock</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,776,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,355,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,465,034</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><i>Recent Accounting Pronouncements</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company's financial position or results of operations upon adoption.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_PatentCostsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for patent costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_PatentCostsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2303973<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 05<br><br> -Paragraph 4<br><br> -Subparagraph (a)-(d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122427<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for credit risk.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61082-112788<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61044-112788<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskCreditRisk</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175856<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175826<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175892<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144471<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2196929<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section M<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 2, 12<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62652-112803<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2127266<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Research and Development<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpensePolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2228939<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>OTHER LONG-TERM LIABILITIES (Details 2) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013

</div>
          <div>Rockefeller Development Services Agreement</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Rockefeller Development Services Agreement</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Other Long-Term Liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices', window );">Approved project plan for the development services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 4,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementAgreementTerm', window );">Term of the agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementUpfrontPaymentAmount', window );">Upfront payment recognized as revenue over the term of the agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromContractsAndGrants', window );">Contracts and Grants</a></td>
        <td class="nump">$ 1,617,000<span></span></td>
        <td class="nump">$ 281,000<span></span></td>
        <td class="nump">$ 36,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,400,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementAgreementTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the term of the collaborative arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementAgreementTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the estimated cost for the development services under the agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementEstimatedCostForDevelopmentServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementUpfrontPaymentAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of upfront payment for development services, which is recorded by the entity as revenue over the term of the agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementUpfrontPaymentAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromContractsAndGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents revenue earned during the period arising from products sold or services provided under the terms of a contract. Also include revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_RevenueFromContractsAndGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKIAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net loss per share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
        <td class="nump">5,776,544<span></span></td>
        <td class="nump">5,355,810<span></span></td>
        <td class="nump">4,465,034<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock options</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net loss per share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
        <td class="nump">5,770,544<span></span></td>
        <td class="nump">5,349,810<span></span></td>
        <td class="nump">4,459,034<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restricted stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net loss per share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
        <td class="nump">6,000<span></span></td>
        <td class="nump">6,000<span></span></td>
        <td class="nump">6,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of selected quarterly financial data (unaudited)</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 629px;" border="0" cellspacing="0" cellpadding="0" width="629">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" nowrap="nowrap" align="left">
<div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"><font size="1"><b>2013 <!-- COMMAND=ADD_SCROPPEDRULE,17pt --></b></font></div></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q1 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q2 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q3 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q4 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands, except per share amounts)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total revenue</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,414</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">97</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">980</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">620</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net loss</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(17,332</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(19,016</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(23,140</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(22,062</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Basic and diluted net loss per common share</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.23</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.24</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.29</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><br /></font>&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 631px;" border="0" cellspacing="0" cellpadding="0" width="631">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" nowrap="nowrap" align="left">
<div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"><font size="1"><b>2012 <!-- COMMAND=ADD_SCROPPEDRULE,17pt --></b></font></div></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q1 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q2 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q3 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q4 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands, except per share amounts)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total revenue</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,433</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,009</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,113</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,647</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net loss</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(13,516</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(13,773</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(15,027</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(16,807</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Basic and diluted net loss per common share</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.23</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.25</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25249566&amp;loc=d3e1280-108306<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3ABI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShelfRegistrationStatementAmount', window );">Maximum value of securities for which the entity filed a shelf registration statement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 200,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 150,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued (in shares)</a></td>
        <td class="nump">7,813,483<span></span></td>
        <td class="nump">21,613,483<span></span></td>
        <td class="nump">12,075,000<span></span></td>
        <td class="nump">11,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">295,697,000<span></span></td>
        <td class="nump">83,784,000<span></span></td>
        <td class="nump">36,023,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from sale of stock in an underwritten public offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">278,563,000<span></span></td>
        <td class="nump">43,483,000<span></span></td>
        <td class="nump">33,695,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Class C Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series C-1 Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">350,000<span></span></td>
        <td class="nump">350,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cantor Amendment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,433,608<span></span></td>
        <td class="nump">8,003,290<span></span></td>
        <td class="nump">575,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 17,100,000<span></span></td>
        <td class="nump">$ 40,100,000<span></span></td>
        <td class="nump">$ 2,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Shareholder Rights Plan</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Shareholder Rights Plan</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany', window );">Number of multiples of the exercise price that the Right holder has a right to receive in value of the acquiring company's common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Shareholder Rights Plan | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Shareholder Rights Plan</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany', window );">Percentage of assets or earning power sold allowing the Right holder a right to receive common stock of the acquiring company</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Shareholder Rights Plan | Series C-1 Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Shareholder Rights Plan</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare', window );">Number of preferred stock purchase rights for each outstanding share of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares callable by rights</a></td>
        <td class="nump">0.0001<span></span></td>
        <td class="nump">0.0001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Exercise price (in dollars per unit)</a></td>
        <td class="nump">35.00<span></span></td>
        <td class="nump">35.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired', window );">Number of multiples of the exercise price that the Right holder has right to receive in value if 15% or more of the outstanding common stock is acquired</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Shareholder Rights Plan | Series C-1 Preferred Stock | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Shareholder Rights Plan</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired', window );">Percentage of common stock to be acquired for rights to be exercisable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender', window );">Percentage of common stock to be acquired in a tender offer for rights to be exercisable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the percentage of assets or earning power sold which would allow the right holder the right to receive the common stock of the acquiring entity with a value that is twice the right's exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfAssetsOrEarningPowerSoldForHolderRightToReceiveCommonStockOfAcquiringCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the percentage of the entity's outstanding common stock that must be acquired for rights to become exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquired</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the percentage of the entity's outstanding common stock that must be acquired in a tender offer for rights to become exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ClassOfWarrantOrRightConditionOnExerciseOfRightsPercentageOfCommonStockAcquiredThroughTender</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the number of rights that were distributed for each outstanding share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ClassOfWarrantOrRightNumberOfRightsPerCommonStockShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:decimalItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the number of multiples of the exercise price that the right holder has the right to receive in value of the acquiring entity's common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInCommonStockValueOfAcquiringCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the number of multiples of the exercise price that the right holder has the right to receive in value, if 15 percent or more of the outstanding common stock is acquired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_NumberOfMultiplesClassOfWarrantOrRightConditionOnExerciseOfRightsOfExercisePriceHolderCanReceiveInValueIfFifteenPercentOrMoreOfCommonStockIsAcquired</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShelfRegistrationStatementAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the maximum value of securities for which the entity filed a shelf registration statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ShelfRegistrationStatementAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_StockholdersEquityLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_StockholdersEquityLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WarrantsAndRightsNoteDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1YAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Details) (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
        <td class="nump">$ 620<span></span></td>
        <td class="nump">$ 980<span></span></td>
        <td class="nump">$ 97<span></span></td>
        <td class="nump">$ 2,414<span></span></td>
        <td class="nump">$ 3,647<span></span></td>
        <td class="nump">$ 3,113<span></span></td>
        <td class="nump">$ 2,009<span></span></td>
        <td class="nump">$ 2,433<span></span></td>
        <td class="nump">$ 4,111<span></span></td>
        <td class="nump">$ 11,202<span></span></td>
        <td class="nump">$ 9,265<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income</a></td>
        <td class="num">$ (22,062)<span></span></td>
        <td class="num">$ (23,140)<span></span></td>
        <td class="num">$ (19,016)<span></span></td>
        <td class="num">$ (17,332)<span></span></td>
        <td class="num">$ (16,807)<span></span></td>
        <td class="num">$ (15,027)<span></span></td>
        <td class="num">$ (13,773)<span></span></td>
        <td class="num">$ (13,516)<span></span></td>
        <td class="num">$ (81,550)<span></span></td>
        <td class="num">$ (59,123)<span></span></td>
        <td class="num">$ (44,799)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share (in dollars per share)</a></td>
        <td class="num">$ (0.27)<span></span></td>
        <td class="num">$ (0.29)<span></span></td>
        <td class="num">$ (0.24)<span></span></td>
        <td class="num">$ (0.23)<span></span></td>
        <td class="num">$ (0.27)<span></span></td>
        <td class="num">$ (0.25)<span></span></td>
        <td class="num">$ (0.23)<span></span></td>
        <td class="num">$ (0.27)<span></span></td>
        <td class="num">$ (1.02)<span></span></td>
        <td class="num">$ (1.02)<span></span></td>
        <td class="num">$ (1.13)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E16AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Intangible Assets and Goodwill</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
        <td class="nump">$ 8,965,000<span></span></td>
        <td class="nump">$ 8,965,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-lived intangible asset</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(4,776,000)<span></span></td>
        <td class="num">(3,763,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Total Intangible Assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost of total intangible assets</a></td>
        <td class="nump">27,596,000<span></span></td>
        <td class="nump">27,596,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
        <td class="nump">22,820,000<span></span></td>
        <td class="nump">23,833,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense for intangible assets</a></td>
        <td class="nump">1,013,000<span></span></td>
        <td class="nump">1,090,000<span></span></td>
        <td class="nump">1,913,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Estimated future amortization expense of intangible assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2014</a></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2015</a></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2016</a></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2017</a></td>
        <td class="nump">900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2018</a></td>
        <td class="nump">900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Amgen Amendment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-lived intangible asset</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
        <td class="text">16 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
        <td class="nump">14,500,000<span></span></td>
        <td class="nump">14,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(3,812,000)<span></span></td>
        <td class="num">(2,915,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
        <td class="nump">10,688,000<span></span></td>
        <td class="nump">11,585,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Core Technology</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-lived intangible asset</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
        <td class="text">11 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
        <td class="nump">1,296,000<span></span></td>
        <td class="nump">1,296,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(964,000)<span></span></td>
        <td class="num">(848,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
        <td class="nump">332,000<span></span></td>
        <td class="nump">448,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">IPR&amp;D</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived intangible assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
        <td class="nump">$ 11,800,000<span></span></td>
        <td class="nump">$ 11,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the next fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the fifth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the fourth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the third fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the second fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNetAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsGrossExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph ((a)(1),(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMPREHENSIVE LOSS<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>COMPREHENSIVE LOSS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE LOSS</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(3) COMPREHENSIVE LOSS</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The changes in accumulated other comprehensive income (loss) by component for the year ended December&#160;31, 2013 are summarized below. No amounts were reclassified out of accumulated other comprehensive income during the years ended December&#160;31, 2013, 2012 and 2011.</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="96"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="73"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Unrealized Gain<br />
(Loss) on<br />
Marketable<br />
Securities, net of tax</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Foreign<br />
Currency Items</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Total</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Balance at December&#160;31, 2012</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">156</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,589</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,745</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other comprehensive income (loss) before reclassifications</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(74</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(77</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Amounts reclassified from other comprehensive income</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net current-period other comprehensive income</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(74</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(77</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Balance at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">82</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,586</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,668</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTaxAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e689-108580<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669619-108580<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e640-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 17<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e716-108580<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e709-108580<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Reclassification Adjustments<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNoteTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>31
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7T)!3$%.0T5?4TA%1513/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0T].4T],241!5$5$7T)!3$%.0T5?4TA%15137U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7U-4051%345.5%-?3T9?3U!%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].4T],241!5$5$7U-4051%345.5%-?3T9?4U1//"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!
M5$5$7U-4051%345.5%-?3T9?0T%3/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3D%455)%7T]&7T)54TE.15-37T%.1%]/5D525DE%
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#`W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U5-34%2
M65]/1E]324=.249)0T%.5%]!0T-/54Y4/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^0T]-4%)%2$5.4TE615],3U-3/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#`Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1D%)4E]604Q515]-14%3
M55)%345.5%,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y-05)+151!0DQ%7U-%0U52251)15,\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3$N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y04D]015)465]!3D1?15%525!-14Y47TY%5#PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970Q,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.5$%.1TE"
M3$5?05-315137T%.1%]'3T]$5TE,3#PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,RYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D%#0U)5141?15A014Y315,\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y/5$A%4E],3TY'5$5235],24%"
M24Q)5$E%4SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970Q-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/E1%4DU?3$]!3CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-BYH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/E-43T-+2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3<N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y35$]#2T)!4T5$7T-/35!%3E-!5$E/3CPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970Q."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E)%5D5.544\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,3DN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TQ,04)/4D%4
M24].7T%'4D5%345.5%,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C`N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y)3D-/345?5$%815,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C$N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y#3TU-251-14Y44U]!3D1?0T].5$E.1T5.0TE%4SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E)%5$E214U%
M3E1?4T%624Y'4U]03$%./"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(S+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^4T5,14-4141?455!4E1%4DQ97T9)3D%.0TE!3%]$/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#(T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U5-34%265]/1E]3
M24=.249)0T%.5%]!0T-/54Y4,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-2YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.5#(\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,C8N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TU04D5(
M14Y3259%7TQ/4U-?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(W+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^1D%)4E]604Q515]-14%355)%345.5%-?5&%B;&5S/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#(X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^34%22T5404),
M15]314-54DE424537U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R.2YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E!23U!%4E197T%.1%]%455)4$U%3E1?3D547U1A8CPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970S,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.5$%.1TE"
M3$5?05-315137T%.1%]'3T]$5TE,3#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S$N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y!0T-2545$7T584$5.4T537U1A8FQE<SPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970S,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D]42$527TQ/3D=4
M15)-7TQ)04))3$E424537U1A8CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-43T-+0D%3141?0T]-4$5.4T%424].7U1A8FQE<SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970S-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.0T]-15]4
M05A%4U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,S4N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y#3TU-251-14Y44U]!3D1?0T].5$E.1T5.0TE%4U\\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,S8N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y314Q%0U1%1%]154%25$52
M3%E?1DE.04Y#24%,7T0Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,W+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^3D%455)%7T]&7T)54TE.15-37T%.1%]/5D525DE%,3PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970S."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-534U!4EE?3T9?
M4TE'3DE&24-!3E1?04-#3U5.5#,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,SDN:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y354U-05)97T]&7U-)1TY)1DE#04Y47T%#0T]53E0T
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#0P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U5-34%2
M65]/1E]324=.249)0T%.5%]!0T-/54Y4-3PO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,2YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#
M3U5.5#8\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T-#(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#
M3TU04D5(14Y3259%7TQ/4U-?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,RYH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/D9!25)?5D%,545?345!4U5214U%3E137T1E
M=&%I;#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970T-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DU!
M4DM%5$%"3$5?4T5#55))5$E%4U]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0U+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4%)/4$525%E?04Y$7T5154E0345.5%].
M151?1&5T/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#0V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M24Y404Y'24),15]!4U-%5%-?04Y$7T=/3T1724Q,,CPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T
M-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D%#0U)5141?15A014Y315-?1&5T
M86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970T."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D]4
M2$527TQ/3D=415)-7TQ)04))3$E424537T1E=#PO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T.2YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/D]42$527TQ/3D=415)-7TQ)04))3$E4
M24537T1E=#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T-3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y415)-7TQ/04Y?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970U,2YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-43T-+2$],1$524U]%455)5%E?1&5T86EL<SPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970U,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-43T-+0D%3141?
M0T]-4$5.4T%424].7T1E=&%I;#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970U,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-43T-+0D%3141?0T]-4$5.4T%424].7T1E=&%I;#$\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T-30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y2159%3E5%
M7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T-34N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y#3TQ,04)/4D%424].7T%'4D5%345.5%-?1&5T86D\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M-38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y)3D-/345?5$%815-?1&5T86EL
M<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970U-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DE.0T]-
M15]405A%4U]$971A:6QS7S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-3@N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y#3TU-251-14Y44U]!3D1?0T].5$E.1T5.0TE%4U\Q/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#4Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4D5425)%345.
M5%]3059)3D=37U!,04Y?1&5T86EL/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#8P+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^4T5,14-4141?455!4E1%4DQ97T9)3D%.0TE!3%]$
M,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970V,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@(#PO>#I%>&-E;%=O<FMS:&5E=',^#0H@(#QX.E-T>6QE<VAE970@
M2%)E9CTS1")7;W)K<VAE971S+W)E<&]R="YC<W,B+SX-"B`@/'@Z06-T:79E
M4VAE970^,#PO>#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T<G5C='5R
M93Y&86QS93PO>#I0<F]T96-T4W1R=6-T=7)E/@T*("`\>#I0<F]T96-T5VEN
M9&]W<SY&86QS93PO>#I0<F]T96-T5VEN9&]W<SX-"B`\+W@Z17AC96Q7;W)K
M8F]O:SX-"CPO>&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-
M"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC<F]S
M;V9T($5X8V5L(%A0(&]R(&YE=V5R+CPO<#X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA
M7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D
M,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%5E)!13X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y($EN9F]R;6%T:6]N("A54T0@
M)"D\8G(^26X@0FEL;&EO;G,L(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@
M;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D9E8BX@,3DL(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y($EN9F]R;6%T
M:6]N/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5N=&ET>2!296=I<W1R86YT($YA;64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B=#96QL9&5X(%1H97)A<&5U=&EC<RP@26YC+CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M;G1I='D@0V5N=')A;"!);F1E>"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<P,#`P-S0T,C$X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT(%1Y<&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q,"U+/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT(%!E
M<FEO9"!%;F0@1&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M1&5C(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%M96YD;65N="!&;&%G/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG9F%L<V4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R<F5N="!&:7-C86P@
M665A<B!%;F0@1&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)RTM,3(M,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16YT:71Y(%=E;&PM:VYO=VX@4V5A<V]N960@27-S=65R
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG665S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET
M>2!6;VQU;G1A<GD@1FEL97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG3F\\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16YT:71Y($-U<G)E;G0@4F5P;W)T:6YG(%-T871U<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)UEE<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@
M1FEL97(@0V%T96=O<GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B=,87)G92!!8V-E;&5R871E9"!&:6QE<CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@4'5B;&EC($9L
M;V%T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XS/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M;G1I='D@0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I;F<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX.2PR-3$L-S0W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE
M;G0@1FES8V%L(%EE87(@1F]C=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<R,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@1F]C=7,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=&63QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15%'04<^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0Q/CQS=')O;F<^0T].4T],241!5$5$($)!3$%.0T4@4TA%1513
M("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P
M96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT($%S<V5T<SH\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!#87-H
M($5Q=6EV86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$V.2PT,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(T+#@Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36%R:V5T86)L92!396-U<FET:65S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,S,L-3@Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3DL,#8U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O
M=6YT<R!A;F0@3W1H97(@4F5C96EV86)L97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&%N9"!/=&AE<B!#=7)R96YT
M($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW,3<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#$P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L($-U<G)E;G0@07-S971S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS,#4L,3@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^.#4L,3$T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@17%U
M:7!M96YT+"!.970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL
M.3<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-RPR,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DEN=&%N9VEB;&4@07-S971S+"!.970\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(R+#@R,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#@S,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@07-S971S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,C0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=O;V1W
M:6QL/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#DV-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@L.38U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS-#<L,#DU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3(U+#4T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT($QI86)I;&ET:65S
M.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D%C8V]U;G1S(%!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L,C0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-S0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-R=65D($5X<&5N<V5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-RPQ-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PY-C`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@4&]R=&EO
M;B!O9B!,;VYG+51E<FT@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/CDR.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0W5R<F5N="!0;W)T:6]N(&]F(%1E<FT@
M3&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-3DR/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5&]T86P@0W5R<F5N="!,:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C`L,S4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3<L-C@U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y497)M($QO86XL(&QE<W,@0W5R
M<F5N="!0;W)T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-2PW-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]T:&5R($QO;F<M5&5R;2!,:6%B:6QI=&EE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-BPY-3`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#,S-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L($QI86)I
M;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-RPS,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M.2PW-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O;6UI=&UE;G1S(&%N9"!#;VYT:6YG96YT($QI86)I;&ET:65S
M("A.;W1E<R`Q-"!A;F0@,38I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C
M:VAO;&1E<G,G($5Q=6ET>3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VLL
M("0N,#$@4&%R(%9A;'5E.R`S+#`P,"PP,#`@4VAA<F5S($%U=&AO<FEZ960[
M($YO(%-H87)E<R!)<W-U960@86YD($]U='-T86YD:6YG(&%T($1E8V5M8F5R
M(#,Q+"`R,#$S(&%N9"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N(%-T;V-K
M+"`D+C`P,2!087(@5F%L=64[(#(Y-RPP,#`L,#`P(%-H87)E<R!!=71H;W)I
M>F5D.R`X.2PR-#8L.#,R(&%N9"`V-"PS-3DL-3$S(%-H87)E<R!)<W-U960@
M86YD($]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$S(&%N9"`R,#$R
M+"!R97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%D9&ET:6]N86P@4&%I9"U);B!#87!I=&%L/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV-C(L-S$W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4W+#`Y-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T
M960@3W1H97(@0V]M<')E:&5N<VEV92!);F-O;64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L-C8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW-#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W5M=6QA=&5D($1E9FEC
M:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,T-2PV-SDI/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C8T
M+#$R.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;"!3=&]C:VAO;&1E<G,G($5Q=6ET>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S$Y+#<Y-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDU+#<W-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L($QI
M86)I;&ET:65S(&%N9"!3=&]C:VAO;&1E<G,G($5Q=6ET>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-#<L,#DU/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,C4L-30Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
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M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P139.04,^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0Q/CQS=')O;F<^0T].4T],241!5$5$($)!3$%.0T4@4TA%
M1513("A087)E;G1H971I8V%L*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#3TY3
M3TQ)1$%4140@0D%,04Y#12!32$5%5%,\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!0<F5F97)R960@
M4W1O8VLL(%!A<B!686QU92`H:6X@9&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E
M<G1I8FQE(%!R969E<G)E9"!3=&]C:RP@4VAA<F5S($%U=&AO<FEZ960\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,#`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]N=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K+"!3:&%R97,@27-S=65D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB
M;&4@4')E9F5R<F5D(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I;F<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@4W1O8VLL(%!A
M<B!686QU92`H:6X@9&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N(%-T;V-K
M+"!3:&%R97,@075T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,CDW+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR.3<L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N(%-T;V-K+"!3
M:&%R97,@27-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX
M.2PR-#8L.#,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-C0L,S4Y+#4Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T
M<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@Y+#(T
M-BPX,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV-"PS-3DL-3$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P15=004<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T].
M4T],241!5$5$(%-4051%345.5%,@3T8@3U!%4D%424].4R!!3D0@0T]-4%)%
M2$5.4TE612!,3U-3("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@
M4&5R(%-H87)E(&1A=&$L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E)%5D5.544Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R;V1U8W0@1&5V96QO<&UE;G0@86YD($QI8V5N<VEN9R!!
M9W)E96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,30V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;G1R86-T<R!A;F0@1W)A;G1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(X,3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]D=6-T(%)O>6%L
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS,S0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PW
M-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XY+#$Q.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E1O=&%L(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0L,3$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3$L,C`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^.2PR-C4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3U!%4D%424Y'
M($584$5.4T4Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!$979E;&]P;65N=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-C<L-#`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#<L,SDX/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S(L-#,Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2;WEA
M;'1Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,S-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#<W
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/CDL,3$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y'96YE<F%L(&%N9"!!9&UI;FES=')A=&EV93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,30L.#`U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L,#$V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PQ.3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T
M:7IA=&EO;B!O9B!!8W%U:7)E9"!);G1A;F=I8FQE($%S<V5T<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP,3,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`Y,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.3$S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P@3W!E<F%T:6YG($5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@U+#4U,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8Y+#(W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4R+#8V-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P97)A=&EN9R!,;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X,2PT-#(I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3@L,#<W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0S
M+#,Y.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DEN=F5S=&UE;G0@86YD($]T:&5R($EN8V]M92P@3F5T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,S`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.38\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T
M($5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DR-RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M+#4W-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#<Y-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@3&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH.#$L-34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#4Y+#$R,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-"PW.3DI/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I8R!A;F0@1&EL
M=71E9"!.970@3&]S<R!097(@0V]M;6]N(%-H87)E("A.;W1E(#(I("AI;B!D
M;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H,2XP,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B0@*#$N,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XD("@Q+C$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S(%5S960@:6X@0V%L
M8W5L871I;F<@0F%S:6,@86YD($1I;'5T960@3F5T($QO<W,@<&5R(%-H87)E
M("A.;W1E(#(I("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW.2PW-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU-RPW,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS.2PU,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0T]-4%)%2$5.
M4TE612!,3U-3.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.970@3&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH.#$L-34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#4Y+#$R,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T-"PW.3DI/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]T:&5R($-O
M;7!R96AE;G-I=F4@26YC;VUE("A,;W-S*3H\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!#=7)R96YC>2!4
M<F%N<VQA=&EO;B!!9&IU<W1M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E5N<F5A;&EZ960@*$QO<W,I($=A:6X@;VX@36%R
M:V5T86)L92!396-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@W-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#DP*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;7!R96AE;G-I=F4@3&]S<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@X,2PV,C<I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U.2PP,S`I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@T-"PX
M.3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14A+1$D^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0T].4T],241!5$5$(%-4
M051%345.5%,@3T8@4U1/0TM(3TQ$15)3)R!%455)5%D@*%531"`D*3QB<CY)
M;B!4:&]U<V%N9',L(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W
M:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E1O=&%L/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D-O;6UO;B!3=&]C:SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y!9&1I=&EO;F%L(%!A:60M26X@0V%P:71A;#QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y!8V-U;75L871E9"!/=&AE<B!#;VUP<F5H96YS
M:79E($EN8V]M93QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!
M8V-U;75L871E9"!$969I8VET/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L(#(P,3`\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-S4L,C4U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C,R+#8W.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,BPW-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#$V,"PR,#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E("AI;B!S:&%R97,I(&%T($1E8RX@
M,S$L(#(P,3`\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,BPP
M-34L,S@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DEN8W)E87-E("A$96-R96%S92D@:6X@4W1O
M8VMH;VQD97)S)R!%<75I='D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@27-S=65D('5N9&5R(%-T;V-K
M($]P=&EO;B!A;F0@16UP;&]Y964@4W1O8VL@4'5R8VAA<V4@4&QA;G,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S
M($ES<W5E9"!U;F1E<B!3=&]C:R!/<'1I;VX@86YD($5M<&QO>65E(%-T;V-K
M(%!U<F-H87-E(%!L86YS("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.#`L,C4T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@27-S=65D(&EN($-O
M;FYE8W1I;VX@=VET:"!#86YT;W(@06=R965M96YT/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#$U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#$U-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@27-S=65D
M(&EN($-O;FYE8W1I;VX@=VET:"!#86YT;W(@06=R965M96YT("AI;B!S:&%R
M97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3<U+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4VAA<F5S($ES<W5E9"!I;B!5;F1E<G=R:71T96X@3V9F97)I;F<\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S+#8Y-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,L-C@T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-H87)E<R!)<W-U960@:6X@56YD97)W<FET=&5N($]F9F5R:6YG("AI;B!S
M:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PU,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3$L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4VAA<F4M0F%S960@0V]M<&5N<V%T:6]N/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,T,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,T,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&
M;W)E:6=N($-U<G)E;F-Y(%1R86YS;&%T:6]N($%D:G5S=&UE;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D
M($=A:6YS("A,;W-S97,I(&]N($UA<FME=&%B;&4@4V5C=7)I=&EE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.3`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@3&]S
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#0L-SDY*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0T
M+#<Y.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D)A;&%N8V4@870@1&5C+B`S,2P@,C`Q,3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-C@L-S(R/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S$L,#,R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV-3(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,#4L,#`V
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0F%L86YC92`H:6X@<VAA<F5S*2!A="!$96,N(#,Q+"`R,#$Q/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#0L,C$P+#8S-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY);F-R96%S92`H1&5C<F5A<V4I(&EN(%-T;V-K:&]L9&5R<R<@17%U
M:71Y/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4VAA<F5S($ES<W5E9"!U;F1E<B!3=&]C:R!/<'1I;VX@86YD($5M
M<&QO>65E(%-T;V-K(%!U<F-H87-E(%!L86YS/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,38S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!)<W-U960@=6YD97(@
M4W1O8VL@3W!T:6]N(&%N9"!%;7!L;WEE92!3=&]C:R!0=7)C:&%S92!0;&%N
M<R`H:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<P+#4X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4VAA<F5S($ES<W5E9"!I;B!#;VYN96-T:6]N('=I=&@@
M0V%N=&]R($%G<F5E;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#`L,3,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0P+#$S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@27-S=65D(&EN($-O;FYE8W1I
M;VX@=VET:"!#86YT;W(@06=R965M96YT("AI;B!S:&%R97,I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PP,#,L,CDP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@
M27-S=65D(&EN(%5N9&5R=W)I='1E;B!/9F9E<FEN9SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#,L-#@S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,RPT-S$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S($ES
M<W5E9"!I;B!5;F1E<G=R:71T96X@3V9F97)I;F<@*&EN('-H87)E<RD\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#`W-2PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPP-S4L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3:&%R92U"87-E9"!#;VUP96YS871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L,CDX/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,CDX/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F5I9VX@0W5R
M<F5N8WD@5')A;G-L871I;VX@061J=7-T;65N=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D($=A:6YS("A,;W-S
M97,I(&]N($UA<FME=&%B;&4@4V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/CDQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T($QO<W,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#4Y+#$R,RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U.2PQ,C,I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E
M(&%T($1E8RX@,S$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDU+#<W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S4W+#`Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L-S0U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C8T+#$R.2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN
M('-H87)E<RD@870@1&5C+B`S,2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C0L,S4Y+#4Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8T+#,U.2PU,3,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M26YC<F5A<V4@*$1E8W)E87-E*2!I;B!3=&]C:VAO;&1E<G,G($5Q=6ET>3PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-H87)E<R!)<W-U960@=6YD97(@4W1O8VL@3W!T:6]N(&%N9"!%;7!L;WEE
M92!3=&]C:R!0=7)C:&%S92!0;&%N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-2PT,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-2PT,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S($ES<W5E9"!U;F1E<B!3
M=&]C:R!/<'1I;VX@86YD($5M<&QO>65E(%-T;V-K(%!U<F-H87-E(%!L86YS
M("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#0P+#(R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4VAA<F5S($ES<W5E9"!I;B!#;VYN96-T:6]N('=I=&@@
M0V%N=&]R($%G<F5E;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3<L,3,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$W+#$S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@27-S=65D(&EN($-O;FYE8W1I
M;VX@=VET:"!#86YT;W(@06=R965M96YT("AI;B!S:&%R97,I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT,S,L-C`X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@
M27-S=65D(&EN(%5N9&5R=W)I='1E;B!/9F9E<FEN9SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C<X+#4V,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C<X+#4T,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@
M27-S=65D(&EN(%5N9&5R=W)I='1E;B!/9F9E<FEN9R`H:6X@<VAA<F5S*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L-C$S+#0X,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q+#8Q
M,RPT.#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-H87)E+4)A<V5D($-O;7!E;G-A=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-"PU-#@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PU-#@\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!#
M=7)R96YC>2!4<F%N<VQA=&EO;B!!9&IU<W1M96YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YR96%L:7IE9"!'86EN<R`H
M3&]S<V5S*2!O;B!-87)K971A8FQE(%-E8W5R:71I97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#<T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S0I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T($QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@Q+#4U,"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X,2PU-3`I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"
M86QA;F-E(&%T($1E8RX@,S$L(#(P,3,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,S$Y+#<Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@.#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8V,BPW,3<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L-C8X/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@S-#4L
M-C<Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0F%L86YC92`H:6X@<VAA<F5S*2!A="!$96,N(#,Q+"`R,#$S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX.2PR-#8L.#,R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#DL,C0V
M+#@S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B
M-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T,#8N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$532$)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3E-/3$E$051%
M1"!35$%414U%3E13($]&($-!4T@@1DQ/5U,@*%531"`D*3QB<CY);B!4:&]U
M<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@1FQO
M=W,@1G)O;2!/<&5R871I;F<@06-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T($QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H.#$L-34P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-3DL,3(S*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M-#0L-SDY*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY!9&IU<W1M96YT<R!T;R!296-O;F-I;&4@3F5T
M($QO<W,@=&\@0V%S:"!5<V5D(&EN($]P97)A=&EN9R!!8W1I=FET:65S.CPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$
M97!R96-I871I;VX@86YD($%M;W)T:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PY,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#`T-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C0X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ871I;VX@
M;V8@26YT86YG:6)L92!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PP.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+#DQ,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N(&%N9"!0<F5M
M:75M(&]F($UA<FME=&%B;&4@4V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PS-C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-C8P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296%L:7IE9"`H1V%I;BD@
M3&]S<R!O;B!386QE<R!A;F0@36%T=7)I=&EE<R!O9B!-87)K971A8FQE(%-E
M8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D=A:6X@;VX@4V%L92!O<B!$:7-P;W-A;"!O9B!!<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#(Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<T*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4X*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM0F%S960@
M0V]M<&5N<V%T:6]N($5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0L-30X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPR.3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#,T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]N+4-A<V@@26YT97)E<W0@17AP
M96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,C8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^0VAA;F=E<R!I;B!/<&5R871I;F<@07-S971S(&%N9"!,:6%B
M:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06-C;W5N=',@86YD($]T:&5R(%)E8V5I=F%B;&5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-#4I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED
M(&%N9"!/=&AE<B!#=7)R96YT($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-S`V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C0Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!!<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(W-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DU*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!087EA
M8FQE(&%N9"!!8V-R=65D($5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW+#(S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L-S8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPP-S8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R($QI86)I;&ET:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,Q-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$S."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@0V%S:"!5<V5D(&EN($]P97)A=&EN9R!!8W1I=FET:65S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-RPV-CDI/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#DL-S@R*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,U+#8U
M."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^0V%S:"!&;&]W<R!&<F]M($EN=F5S=&EN9R!!8W1I=FET
M:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y386QE<R!A;F0@36%T=7)I=&EE<R!O9B!-87)K971A8FQE(%-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X+#@Y-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R
M+#,V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4Q+#`P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4'5R8VAA<V5S(&]F($UA<FME=&%B;&4@4V5C=7)I=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3$R+#$Q."D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V.2PR
M-34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-3(L-S$W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06-Q=6ES:71I;VX@;V8@4')O<&5R='D@86YD($5Q=6EP
M;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PR,3DI/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S`S
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#4P.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!R;V-E961S(&9R;VT@4V%L92!O<B!$:7-P;W-A;"!O9B!!<W-E
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$X/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.
M970@0V%S:"!5<V5D(&EN($EN=F5S=&EN9R!!8W1I=FET:65S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-RPT,C(I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,38L.3@P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,34U*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#87-H($9L;W=S($9R;VT@1FEN86YC:6YG($%C=&EV:71I97,Z
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYE="!0<F]C965D<R!F<F]M(%-T;V-K($ES<W5A;F-E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,CDU+#8Y-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@S+#<X-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V+#`R,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!)<W-U86YC92!O9B!3=&]C:R!F<F]M($5M<&QO>65E($)E
M;F5F:70@4&QA;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L
M-#`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/BA087EM96YT<RD@27-S=6%N8V4@;V8@5&5R;2!,;V%N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,2PP,CDI/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPY-S$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!A>6UE;G0@;V8@0V]N=F5R=&EB;&4@4W5B;W)D:6YA=&5D($1E8G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3(L-3`S*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&%Y;65N
M="!O9B!/=&AE<B!,:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-#<R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#4U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#@V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!#87-H(%!R;W9I9&5D(&)Y($9I
M;F%N8VEN9R!!8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR.#DL-3DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-SDL-S4X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C@L-#,T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%9F9E8W0@;V8@17AC:&%N9V4@
M4F%T92!#:&%N9V5S(&]N($-A<V@@86YD($-A<V@@17%U:79A;&5N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DI/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T($EN8W)E
M87-E("A$96-R96%S92D@:6X@0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30T+#4P-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#DY.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DL
M,S@X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<R!A="!"96=I;FYI;F<@
M;V8@4&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-"PX
M.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ,2PX.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,2PR.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD($-A<V@@17%U:79A;&5N=',@870@
M16YD(&]F(%!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,38Y+#0P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(T+#@Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Q+#@Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=7!P;&5M96YT86P@1&ES
M8VQO<W5R92!O9B!#87-H($9L;W<@26YF;W)M871I;VX\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!086ED(&9O
M<B!);G1E<F5S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M+#(P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,2PS.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$L-38P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F
M96(X,30-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#$R-#!B,3)?
M-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T+U=O<FMS:&5E=',O4VAE970P
M-RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DY!
M5%5212!/1B!"55-)3D534R!!3D0@3U9%4E9)15<\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3D%455)%($]&($)5
M4TE.15-3($%.1"!/5D525DE%5SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3D%455)%($]&($)54TE.15-3($%.1"!/5D52
M5DE%5SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y
M;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0R/CQB/B@Q*2!.05154D4@3T8@0E5324Y%4U,@04Y$($]6
M15)62457/"]B/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
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M9&4@<FEN9&]P97!I;75T("AA;'-O(')E9F5R<F5D('1O(&%S($-$6"TQ,3`I
M(&%N9"!G;&5M8F%T=6UU;6%B('9E9&]T:6X@*&%L<V\@<F5F97)R960@=&\@
M87,@0T18+3`Q,2DN(%)I;F1O<&5P:6UU="!I<R!A('1A<F=E=&5D(&EM;75N
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M(&=R;W=T:"!F86-T;W(@86YD($-$6"TQ-#`Q+"!A('1A<F=E=&5D(&EM;75N
M;W1H97)A<&5U=&EC(&%I;65D(&%T(&%N=&EG96X@<')E<V5N=&EN9R!C96QL
M<R!F;W(@8V%N8V5R(&EN9&EC871I;VYS+CPO9F]N=#X\+W`^#0H\<"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M!
M="!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!T:&4@0V]M<&%N>2!H860@8V%S
M:"P@8V%S:"!E<75I=F%L96YT<R!A;F0@;6%R:V5T86)L92!S96-U<FET:65S
M(&]F("0S,#,N,"8C,38P.VUI;&QI;VXN(%1H92!#;VUP86YY(&EN8W5R<F5D
M(&$@;&]S<R!O9B`D.#$N-B8C,38P.VUI;&QI;VX@9F]R('1H92!Y96%R(&5N
M9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,N($YE="!C87-H('5S960@:6X@
M;W!E<F%T:6]N<R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(F(S$V,#LS
M,2P@,C`Q,R!W87,@)#8W+C<F(S$V,#MM:6QL:6]N+B!4:&4@0V]M<&%N>2!B
M96QI979E<R!T:&%T('1H92!C87-H+"!C87-H(&5Q=6EV86QE;G1S(&%N9"!M
M87)K971A8FQE('-E8W5R:71I97,@870@1&5C96UB97(F(S$V,#LS,2P@,C`Q
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M/"]F;VYT/CPO<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U
M9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R
M7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T
M,#@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M54U-05)9($]&(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4U5-34%262!/1B!324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#2453/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y354U-
M05)9($]&(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M
M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^#0H\
M<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CX\8CXH,BD@4U5-34%262!/1B!324=.249)0T%.5"!!0T-/54Y424Y'(%!/
M3$E#2453/"]B/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
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M96YT<R!P=7)C:&%S960@=VET:"!A(&UA='5R:71Y(&1A=&4@;V8@.3`F(S$V
M,#MD87ES(&]R(&QE<W,@870@=&AE(&1A=&4@;V8@<'5R8VAA<V4@=&\@8F4@
M8V%S:"!E<75I=F%L96YT<RX@0V%S:"!E<75I=F%L96YT<R!C;VYS:7-T('!R
M:6YC:7!A;&QY(&]F(&UO;F5Y(&UA<FME="!F=6YD<R!A;F0@9&5B="!S96-U
M<FET:65S+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
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M;G-F97)R960@9G)O;2!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S
M<RD@=&\@=&AE(&-O;G-O;&ED871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO
M;G,N(%)E86QI>F5D(&=A:6YS(&%N9"!L;W-S97,@87)E(&1E=&5R;6EN960@
M;VX@=&AE('-P96-I9FEC(&ED96YT:69I8V%T:6]N(&UE=&AO9"!A;F0@87)E
M(&EN8VQU9&5D(&EN(&EN=F5S=&UE;G0@86YD(&]T:&5R(&EN8V]M92P@;F5T
M+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CX\:3Y#;VYC96YT<F%T:6]N(&]F($-R961I="!2
M:7-K(&%N9"!O9B!3:6=N:69I8V%N="!#=7-T;VUE<G,@86YD(%-U<'!L:65R
M<SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1FEN86YC:6%L(&EN<W1R=6UE;G1S
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M;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[4F5V96YU92!F<F]M($=L87AO(')E<')E<V5N=&5D
M(#4W)2P@.38E(&%N9"`Y."4@9F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E
M<B8C,38P.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q(&%N9"!O9B!T;W1A;"!#
M;VUP86YY(')E=F5N=64L(')E<W!E8W1I=F5L>2X\+V9O;G0^/"]P/@T*/'`@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[5&AE($-O;7!A;GD@<F5L:65S(&]N(&-O;G1R86-T(&UA;G5F86-T=7)I
M;F<@;W)G86YI>F%T:6]N<R`H0TU/*2!T;R!M86YU9F%C='5R92!D<G5G('-U
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M961O=&EN+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y&86ER(%9A;'5E($UE87-U<F5M
M96YT<SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@:&%S(&-E
M<G1A:6X@87-S971S(&%N9"!L:6%B:6QI=&EE<R!T:&%T(&%R92!M96%S=7)E
M9"!A="!F86ER('9A;'5E(&EN('1H92!F:6YA;F-I86P@<W1A=&5M96YT<RX@
M5&AE($-O;7!A;GD@<V5E:W,@=&\@;6%X:6UI>F4@=&AE('5S92!O9B!O8G-E
M<G9A8FQE(&EN<'5T<R`H;6%R:V5T(&1A=&$@;V)T86EN960@9G)O;2!S;W5R
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M)B,Q-C`[1T%!4#H\+V9O;G0^/"]P/@T*/'5L/@T*/&QI('-T>6QE/3-$)VQI
M<W0M<W1Y;&4Z(&YO;F4[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TQE=F5L)B,Q-C`[,3H@3V)S97)V
M86)L92!I;G!U=',@<W5C:"!A<R!Q=6]T960@<')I8V5S(&EN(&%C=&EV92!M
M87)K971S(&9O<B!I9&5N=&EC86P@87-S971S(&]R(&QI86)I;&ET:65S+B!!
M;B!A8W1I=F4@;6%R:V5T(&9O<B!A;B!A<W-E="!O<B!L:6%B:6QI='D@:7,@
M82!M87)K970@:6X@=VAI8V@@=')A;G-A8W1I;VYS(&9O<B!T:&4@87-S970@
M;W(@;&EA8FEL:71Y(&]C8W5R('=I=&@@<W5F9FEC:65N="!F<F5Q=65N8WD@
M86YD('9O;'5M92!T;R!P<F]V:61E('!R:6-I;F<@:6YF;W)M871I;VX@;VX@
M86X@;VYG;VEN9R!B87-I<RX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[3&5V96PF(S$V
M,#LR.B!/8G-E<G9A8FQE(&EN<'5T<R!O=&AE<B!T:&%N($QE=F5L)B,Q-C`[
M,2!P<FEC97,L('-U8V@@87,@<75O=&5D('!R:6-E<R!I;B!A8W1I=F4@;6%R
M:V5T<R!F;W(@<VEM:6QA<B!A<W-E=',@;W(@;&EA8FEL:71I97,@86YD('%U
M;W1E9"!P<FEC97,@9F]R(&ED96YT:6-A;"!A<W-E=',@;W(@;&EA8FEL:71I
M97,@:6X@;6%R:V5T<R!T:&%T(&%R92!N;W0@86-T:79E+CPO9F]N=#X\+W`^
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M('-E<G9I8V5S+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
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M8V5S<R!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0@*$E04B9A;7`[1"DL('5S
M:6YG(&$@=F%R:65T>2!O9B!M971H;V1S(&EN8VQU9&EN9R!P<F5S96YT('9A
M;'5E(&UO9&5L<RX@16%C:"!A<W-E="!I<R!M96%S=7)E9"!A="!F86ER('9A
M;'5E(&9R;VT@=&AE('!E<G-P96-T:79E(&]F(&$@;6%R:V5T('!A<G1I8VEP
M86YT+B!4:&4@;65T:&]D('5S960@=&\@97-T:6UA=&4@=&AE(&9A:7(@=F%L
M=65S(&]F($E04B9A;7`[1"!A<W-E=',@:6YC;W)P;W)A=&5S('-I9VYI9FEC
M86YT(&%S<W5M<'1I;VYS(')E9V%R9&EN9R!T:&4@97-T:6UA=&5S(&$@;6%R
M:V5T('!A<G1I8VEP86YT('=O=6QD(&UA:V4@:6X@;W)D97(@=&\@979A;'5A
M=&4@86X@87-S970L(&EN8VQU9&EN9R!A(&UA<FME="!P87)T:6-I<&%N="=S
M(&%S<W5M<'1I;VYS(')E9V%R9&EN9R!T:&4@<')O8F%B:6QI='D@;V8@8V]M
M<&QE=&EN9R!)4%(F86UP.T0@<')O:F5C=',L('=H:6-H('=O=6QD(')E<75I
M<F4@;V)T86EN:6YG(')E9W5L871O<GD@87!P<F]V86P@9F]R(&UA<FME=&EN
M9R!O9B!T:&4@87-S;V-I871E9"!D<G5G(&-A;F1I9&%T93L@82!M87)K970@
M<&%R=&EC:7!A;G0G<R!E<W1I;6%T97,@<F5G87)D:6YG('1H92!T:6UI;F<@
M;V8@86YD('1H92!E>'!E8W1E9"!C;W-T<R!T;R!C;VUP;&5T92!)4%(F86UP
M.T0@<')O:F5C=',[(&$@;6%R:V5T('!A<G1I8VEP86YT)W,@97-T:6UA=&5S
M(&]F(&9U='5R92!C87-H(&9L;W=S(&9R;VT@<&]T96YT:6%L('!R;V1U8W0@
M<V%L97,[(&%N9"!T:&4@87!P<F]P<FEA=&4@9&ES8V]U;G0@<F%T97,@9F]R
M(&$@;6%R:V5T('!A<G1I8VEP86YT+B!4<F%N<V%C=&EO;B!C;W-T<R!A;F0@
M<F5S=')U8W1U<FEN9R!C;W-T<R!A<W-O8VEA=&5D('=I=&@@=&AE('1R86YS
M86-T:6]N(&%R92!E>'!E;G-E9"!A<R!I;F-U<G)E9"X\+V9O;G0^/"]P/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[26X@8V]N;F5C=&EO;B!W:71H('1H92!A8W%U:7-I=&EO;B!O9B!#
M=7)A1V5N($-O<G!O<F%T:6]N("@B0W5R84=E;B(I(&EN($]C=&]B97(@,C`P
M.2P@=&AE($-O;7!A;GD@87-S=6UE9"!#=7)A1V5N)W,@)#$R+C4F(S$V,#MM
M:6QL:6]N(&EN(#0E(&-O;G9E<G1I8FQE('-U8F]R9&EN871E9"!D96)T(&1U
M92!&96)R=6%R>28C,38P.S$U+"`R,#$Q("AT:&4@(D-O;G9E<G1I8FQE(%-U
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M9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#M)4%(F86UP.T0@87-S971S(&%C<75I<F5D(&EN
M(&$@8G5S:6YE<W,@8V]M8FEN871I;VX@:6YI=&EA;&QY(&%R92!R96-O<F1E
M9"!A="!F86ER('9A;'5E(&%N9"!A8V-O=6YT960@9F]R(&%S(&EN9&5F:6YI
M=&4M;&EV960@:6YT86YG:6)L92!A<W-E=',N(%1H97-E(&%S<V5T<R!A<F4@
M;6%I;G1A:6YE9"!O;B!T:&4@0V]M<&%N>2=S(&-O;G-O;&ED871E9"!B86QA
M;F-E('-H965T<R!U;G1I;"!E:71H97(@=&AE('!R;VIE8W0@=6YD97)L>6EN
M9R!T:&5M(&ES(&-O;7!L971E9"!O<B!T:&4@87-S971S(&)E8V]M92!I;7!A
M:7)E9"X@268@82!P<F]J96-T(&ES(&-O;7!L971E9"P@=&AE(&-A<G)Y:6YG
M('9A;'5E(&]F('1H92!R96QA=&5D(&EN=&%N9VEB;&4@87-S970@:7,@86UO
M<G1I>F5D(&]V97(@=&AE(')E;6%I;FEN9R!E<W1I;6%T960@;&EF92!O9B!T
M:&4@87-S970@8F5G:6YN:6YG(&EN('1H92!P97)I;V0@:6X@=VAI8V@@=&AE
M('!R;VIE8W0@:7,@8V]M<&QE=&5D+B!)9B!A('!R;VIE8W0@8F5C;VUE<R!I
M;7!A:7)E9"!O<B!I<R!A8F%N9&]N960L('1H92!C87)R>6EN9R!V86QU92!O
M9B!T:&4@<F5L871E9"!I;G1A;F=I8FQE(&%S<V5T(&ES('=R:71T96X@9&]W
M;B!T;R!I=',@9F%I<B!V86QU92!A;F0@86X@:6UP86ER;65N="!C:&%R9V4@
M:7,@=&%K96X@:6X@=&AE('!E<FEO9"!I;B!W:&EC:"!T:&4@:6UP86ER;65N
M="!O8V-U<G,N/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TEN($IA;G5A<GD@,C`Q,RP@
M=&AE($-O;7!A;GD@861O<'1E9"!A(&YE=R!5+E,N)B,Q-C`[1T%!4"!A8V-O
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M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TE04B9A;7`[
M1"!A<W-E=',@87)E('1E<W1E9"!F;W(@:6UP86ER;65N="!O;B!A;B!A;FYU
M86P@8F%S:7,@9'5R:6YG('1H92!T:&ER9"!Q=6%R=&5R+"!O<B!E87)L:65R
M(&EF(&EM<&%I<FUE;G0@:6YD:6-A=&]R<R!A<F4@<')E<V5N="X@07,@<&%R
M="!O9B!T:&4@86YN=6%L(&EM<&%I<FUE;G0@=&5S="!O9B!T:&4@25!2)F%M
M<#M$(&%S<V5T<R!A<R!O9B!*=6QY)B,Q-C`[,2P@,C`Q,RP@=&AE($-O;7!A
M;GD@8GEP87-S960@=&AE(&]P=&EO;F%L('%U86QI=&%T:79E(&%S<V5S<VUE
M;G0@86YD('!E<F9O<FUE9"!A(&-A;&-U;&%T:6]N(&]F('1H92!F86ER('9A
M;'5E(&]F('1H92!A<W-E="X@5&AE($-O;7!A;GD@8V]N8VQU9&5D('1H870@
M=&AE($E04B9A;7`[1"!A<W-E=',@=V5R92!N;W0@:6UP86ER960N/"]F;VYT
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M<SLG/CQF;VYT('-I>F4],T0R/CQI/D=O;V1W:6QL/"]I/CPO9F]N=#X\+W`^
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M96YT('1E<W0@<F5Q=6ER960@=6YD97(@52Y3+B8C,38P.T=!05`N($%S('!A
M<G0@;V8@:71S(&%N;G5A;"!I;7!A:7)M96YT('1E<W0@;V8@=&AE(&=O;V1W
M:6QL(&%S<V5T(&%S(&]F($IU;'DF(S$V,#LQ+"`R,#$S+"!T:&4@0V]M<&%N
M>2!B>7!A<W-E9"!T:&4@;W!T:6]N86P@<75A;&ET871I=F4@87-S97-S;65N
M="!A;F0@<&5R9F]R;65D('1H92!T=V\M<W1E<"!I;7!A:7)M96YT('1E<W0N
M(%1H92!#;VUP86YY(&-O;F-L=61E9"!T:&%T('1H92!G;V]D=VEL;"!A<W-E
M="!W87,@;F]T(&EM<&%I<F5D+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y);7!A:7)M
M96YT(&]F($QO;F<M3&EV960@07-S971S/"]I/CPO9F]N=#X\+W`^#0H\<"!S
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M=VX@=&\@=&AE:7(@97-T:6UA=&5D(&9A:7(@=F%L=65S+CPO9F]N=#X\+W`^
M#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE
M/3-$,CX\:3Y2979E;G5E(%)E8V]G;FET:6]N/"]I/CPO9F]N=#X\+W`^#0H\
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M('1H870@96QE;65N="X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE<V4@8V]L;&%B
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M+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
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M:&4@<F5L871E9"!L:6-E;G-E(&%G<F5E;65N="X\+V9O;G0^/"]P/@T*/'`@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M/&D^4F5S96%R8V@@86YD($1E=F5L;W!M96YT($5X<&5N<V5S/"]I/CPO9F]N
M=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
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M:&5Y(&)E8V]M92!K;F]W;BX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^4&%T96YT($-O
M<W1S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
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M/E-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;CPO:3X\+V9O;G0^/"]P/@T*/'`@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[5&AE($-O;7!A;GD@<F5C;W)D<R!S=&]C:RUB87-E9"!C;VUP96YS871I
M;VX@97AP96YS92!F;W(@86QL('-T;V-K+6)A<V5D(&%W87)D<R!M861E('1O
M(&5M<&QO>65E<R!A;F0@9&ER96-T;W)S(&)A<V5D(&]N('1H92!E<W1I;6%T
M960@9F%I<B!V86QU97,@;V8@=&AE('-T;V-K+6)A<V5D(&%W87)D<R!E>'!E
M8W1E9"!T;R!V97-T(&%T('1H92!G<F%N="!D871E(&%N9"!I<R!A9&IU<W1E
M9"P@:68@;F5C97-S87)Y+"!T;R!R969L96-T(&%C='5A;"!F;W)F96ET=7)E
M<RX@0V]M<&5N<V%T:6]N(&5X<&5N<V4@9F]R(&%L;"!S=&]C:RUB87-E9"!A
M=V%R9',@=&\@96UP;&]Y965S(&%N9"!D:7)E8W1O<G,@:7,@<F5C;V=N:7IE
M9"!U<VEN9R!T:&4@<W1R86EG:'0M;&EN92!M971H;V0@;W9E<B!T:&4@=&5R
M;2!O9B!V97-T:6YG(&]R('!E<F9O<FUA;F-E+CPO9F]N=#X\+W`^#0H\<"!S
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M;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E+CPO9F]N=#X\+W`^#0H\
M<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CX\:3Y&;W)E:6=N($-U<G)E;F-Y(%1R86YS;&%T:6]N/"]I/CPO9F]N=#X\
M+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#M.970@=6YR96%L:7IE9"!G86EN<R!A;F0@;&]S<V5S(')E
M<W5L=&EN9R!F<F]M(&9O<F5I9VX@8W5R<F5N8WD@=')A;G-L871I;VX@87)E
M(&EN8VQU9&5D(&EN(&]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE("AL;W-S
M*2X@070@1&5C96UB97(F(S$V,#LS,2P@,C`Q,R!A;F0@1&5C96UB97(F(S$V
M,#LS,2P@,C`Q,BP@86-C=6UU;&%T960@;W1H97(@8V]M<')E:&5N<VEV92!I
M;F-O;64@:6YC;'5D97,@82!N970@=6YR96%L:7IE9"!G86EN(')E;&%T960@
M=&\@9F]R96EG;B!C=7)R96YC>2!T<F%N<VQA=&EO;B!O9B`D,BXV)B,Q-C`[
M;6EL;&EO;BX@26X@,C`Q,2P@=&AE($-O;7!A;GDG<R!F;W)E:6=N('-U8G-I
M9&EA<GD@=F]L=6YT87)I;'D@;&EQ=6ED871E9"!I;B!O<F1E<B!T;R!C;VYS
M;VQI9&%T92!T:&4@0V]M<&%N>2=S(&9O<F5I9VX@;W!E<F%T:6]N<R!I;G1O
M($-E;&QD97@@5&AE<F%P975T:6-S+"8C,38P.TEN8RX\+V9O;G0^/"]P/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^/&D^26YC;VUE(%1A>&5S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS
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M9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
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M+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[0V]M<')E:&5N<VEV92!L;W-S(&ES(&-O;7!R
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M1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@,C`Q,B!A;F0@,C`Q,2X\+V9O;G0^
M/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[26X@2F%N=6%R>2`R,#$S+"!T:&4@0V]M<&%N>2!A9&]P
M=&5D(&$@;F5W(%4N4RXF(S$V,#M'04%0(&%C8V]U;G1I;F<@<W1A;F1A<F0@
M=VAI8V@@<F5Q=6ER97,@=&AE($-O;7!A;GD@=&\@<V5P87)A=&5L>2!D:7-C
M;&]S92P@;VX@82!P<F]S<&5C=&EV92!B87-I<RP@=&AE(&-H86YG92!I;B!E
M86-H(&-O;7!O;F5N="!O9B!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H
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M97)A=&EO;G,@;W(@9FEN86YC:6%L('!O<VET:6]N+CPO9F]N=#X\+W`^#0H\
M<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CX\:3Y.970@3&]S<R!097(@4VAA<F4\+VD^/"]F;VYT/CPO<#X-"CQP('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P
M.T)A<VEC(&YE="!L;W-S('!E<B!C;VUM;VX@<VAA<F4@:7,@8F%S960@=7!O
M;B!T:&4@=V5I9VAT960M879E<F%G92!N=6UB97(@;V8@8V]M;6]N('-H87)E
M<R!O=71S=&%N9&EN9R!D=7)I;F<@=&AE('!E<FEO9"P@97AC;'5D:6YG(')E
M<W1R:6-T960@<W1O8VL@=&AA="!H87,@8F5E;B!I<W-U960@8G5T(&ES(&YO
M="!Y970@=F5S=&5D+B!$:6QU=&5D(&YE="!L;W-S('!E<B!C;VUM;VX@<VAA
M<F4@:7,@8F%S960@=7!O;B!T:&4@=V5I9VAT960M879E<F%G92!N=6UB97(@
M;V8@8V]M;6]N('-H87)E<R!O=71S=&%N9&EN9R!D=7)I;F<@=&AE('!E<FEO
M9"!P;'5S(&%D9&ET:6]N86P@=V5I9VAT960M879E<F%G92!P;W1E;G1I86QL
M>2!D:6QU=&EV92!C;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG(&1U<FEN9R!T
M:&4@<&5R:6]D('=H96X@=&AE(&5F9F5C="!I<R!D:6QU=&EV92X@5&AE('!O
M=&5N=&EA;&QY(&1I;'5T:79E(&-O;6UO;B!S:&%R97,@=&AA="!H879E(&YO
M="!B965N(&EN8VQU9&5D(&EN('1H92!N970@;&]S<R!P97(@8V]M;6]N('-H
M87)E(&-A;&-U;&%T:6]N<R!B96-A=7-E('1H92!E9F9E8W0@=V]U;&0@:&%V
M92!B965N(&%N=&DM9&EL=71I=F4@87)E(&%S(&9O;&QO=W,Z/"]F;VYT/CPO
M<#X-"CQD:78@<W1Y;&4],T0G4$]3251)3TXZ(')E;&%T:79E.R!0041$24Y'
M+4)/5%1/33H@,'!T.R!0041$24Y'+4Q%1E0Z(#!P=#L@5TE$5$@Z(#<P)3L@
M4$%$1$E.1RU224=(5#H@,'!T.R!-05)'24XM3$5&5#H@,34E.R!0041$24Y'
M+51/4#H@,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U1!0DQ%5TE$5$@L
M(C$P,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!
M1T=%1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@
M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$,3`P)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L^#0H-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%
M5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
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M3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN
M9SHP.R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$."!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY996%R($5N9&5D($1E8V5M8F5R)B,Q
M-C`[,S$L/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H
M/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O
M;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS
M1&QE9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q
M/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N
M/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4]
M,T0Q/CQB/C(P,3$\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$
M=&]P(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-"PT
M-3DL,#,T/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A
M;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^4F5S=')I8W1E9"!S
M=&]C:SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R
M/C8L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M+#`P,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-BPP
M,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M
M4TE:13H@,2XU<'0[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]7
M4TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'5514
M15)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D
M:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O
M;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L
M;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P
M=#LG/B8C,38P.SPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M,CXU+#,U-2PX,3`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4]
M,T0R/C0L-#8U+#`S-#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I
M;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-
M04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!
M3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F
M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
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M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H
M=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R
M,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!
M1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'
M4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.R!&3TY4+5-)6D4Z(#$N-7!T.R<@
M=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&
M1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH
M96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R
M+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^#0H\<"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y296-E
M;G0@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<SPO:3X\+V9O;G0^/"]P/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[1G)O;2!T:6UE('1O('1I;64L(&YE=R!A8V-O=6YT:6YG('!R;VYO
M=6YC96UE;G1S(&%R92!I<W-U960@8GD@=&AE($9I;F%N8VEA;"!!8V-O=6YT
M:6YG(%-T86YD87)D<R!";V%R9"`H1D%30BD@;W(@;W1H97(@<W1A;F1A<F0@
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M;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/35!2
M14A%3E-)5D4@3$]34SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY#3TU04D5(14Y3259%($Q/4U,\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-/35!214A%3E-)
M5D4@3$]34SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@
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M;G0@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@
M87)E('-U;6UA<FEZ960@8F5L;W<N($YO(&%M;W5N=',@=V5R92!R96-L87-S
M:69I960@;W5T(&]F(&%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R96AE;G-I=F4@
M:6YC;VUE(&1U<FEN9R!T:&4@>65A<G,@96YD960@1&5C96UB97(F(S$V,#LS
M,2P@,C`Q,RP@,C`Q,B!A;F0@,C`Q,2X\+V9O;G0^/"]P/@T*/&1I=B!S='EL
M93TS1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[
M(%!!1$1)3D<M3$5&5#H@,'!T.R!724142#H@.#`E.R!0041$24Y'+5))1TA4
M.B`P<'0[($U!4D=)3BU,1494.B`Q,"4[(%!!1$1)3D<M5$]0.B`P<'0[)SX-
M"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0R/CPA+2T@0T]-34%.1#U!1$1?5$%"3$5724142"PB,3`P)2(@+2T^/"]F
M;VYT/CPO<#X-"CPA+2T@57-E<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%("TM
M/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L92!B;W)D97(],T0P(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E('-T
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M14Y$("TM/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
M1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A
M;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB<B`O
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I
M>F4],T0Q/CQB/E5N<F5A;&EZ960@1V%I;CQB<B`O/@T**$QO<W,I(&]N/&)R
M("\^#0I-87)K971A8FQE/&)R("\^#0I396-U<FET:65S+"!N970@;V8@=&%X
M/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E
M<CX\9F]N="!S:7IE/3-$,3X\8CY&;W)E:6=N/&)R("\^#0I#=7)R96YC>2!)
M=&5M<SPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C
M96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^5&]T86P\+V(^/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1'!A
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M)SX\9F]N="!S:7IE/3-$,CY"86QA;F-E(&%T($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@
M+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[
M)SX\9F]N="!S:7IE/3-$,CY/=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H
M;&]S<RD@8F5F;W)E(')E8VQA<W-I9FEC871I;VYS/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^*#<T/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M*3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^*#,\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH
M-S<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^06UO
M=6YT<R!R96-L87-S:69I960@9G)O;2!O=&AE<B!C;VUP<F5H96YS:79E(&EN
M8V]M93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
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M('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A
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M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O
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M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH-S0\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M.B`Q+C5P=#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&
M1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG
M:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F
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M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P
M=#LG/CQF;VYT('-I>F4],T0R/D)A;&%N8V4@870@1&5C96UB97(F(S$V,#LS
M,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F
M9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L
M(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN
M92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-34%.
M1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$
M/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C%P=#LB("TM/CPO9F]N
M=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],
M3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB
M;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
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M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.R!&3TY4
M+5-)6D4Z(#$N-7!T.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F
M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB
M(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE
M+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX\+W1A8FQE
M/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!
M0DQ%("TM/CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
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M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/D9!25(@5D%,544@345!4U5214U%3E13/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9!25(@5D%,544@345!4U52
M14U%3E13/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&04E2(%9!3%5%($U%05-54D5-14Y44SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX-"CQP('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQB/B@T*2!&
M04E2(%9!3%5%($U%05-54D5-14Y44SPO8CX\+V9O;G0^/"]P/@T*/'`@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M5&AE(&9O;&QO=VEN9R!T86)L97,@<V5T(&9O<G1H('1H92!#;VUP86YY)W,@
M9FEN86YC:6%L(&%S<V5T<R!S=6)J96-T('1O(&9A:7(@=F%L=64@;65A<W5R
M96UE;G1S.CPO9F]N=#X\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424]..B!R
M96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P
M<'0[(%=)1%1(.B`X,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%
M1E0Z(#$P)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$
M/4%$1%]404),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*/"$M+2!5
M<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[/@T*#0H\='(@<W1Y;&4],T1P861D:6YG.C`[/CPA+2T@5$%"3$4@
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M861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N
M/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/D%S(&]F/&)R("\^#0I$96-E
M;6)E<B8C,38P.S,Q+"`R,#$S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P
M.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY,979E;"8C
M,38P.S$\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$
M8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/DQE=F5L)B,Q-C`[,CPO8CX\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@
M<VEZ93TS1#$^/&(^3&5V96PF(S$V,#LS/"]B/CPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q
M/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG
M.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[
M/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#$Q
M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/BA);B!T:&]U<V%N
M9',I/"]B/CPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\
M+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O
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M+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^36%R:V5T86)L92!S96-U<FET:65S
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<VEZ93TS1#(^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\
M(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB
M("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
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M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%2
M1TE.+4Q%1E0Z(#$P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-I>F4],T0R/C(X,BPQ,S`\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C(X,BPQ,S`\+V9O;G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/B8C.#(Q,CL\+V9O;G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU
M<'0[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/
M4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L
M:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA+2T@
M0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#
M3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[(B`M
M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
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M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS
M1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW
M-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/
M3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F
M9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?
M4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'
M551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I=CX-"CPA
M+2T@96YD(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I
M=CX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0R/CQB<B`O/CPO9F]N=#XF(S$V,#L\+W`^#0H\9&EV('-T>6QE/3-$
M)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$
M1$E.1RU,1494.B`P<'0[(%=)1%1(.B`X,"4[(%!!1$1)3D<M4DE'2%0Z(#!P
M=#L@34%21TE.+4Q%1E0Z(#$P)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M/"$M+2!#3TU-04Y$/4%$1%]404),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^
M/"]P/@T*/"$M+2!5<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[/@T*#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
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M='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q
M-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P
M86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/D%S(&]F
M/&)R("\^#0I$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$
M,3X\8CY,979E;"8C,38P.S$\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[
M/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X]
M,T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/DQE=F5L)B,Q
M-C`[,CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C
M96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^3&5V96PF(S$V,#LS/"]B/CPO9F]N
M=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y
M;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F
M;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#$Q(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB
M/BA);B!T:&]U<V%N9',I/"]B/CPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C
M,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-
M05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/DUA<FME=&%B;&4@
M<V5C=7)I=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-I>F4],T0R/C4Y+#`V-3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&
M1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG
M:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@
M8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2
M+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI
M;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z
M,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R
M/C4Y+#`V-3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F
M9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
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M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX\+W1A
M8FQE/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$
M(%1!0DQ%("TM/CPO9&EV/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE<F4@:&%V92!B965N(&YO('1R
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M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V
M7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K
M<VAE971S+U-H965T,3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY-05)+151!0DQ%(%-%0U52251)15,\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^34%22T5404),
M12!314-54DE42453/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y-05)+151!0DQ%(%-%0U52251)15,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ
M,"XP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^#0H\<"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\8CXH
M-2D@34%22T5404),12!314-54DE42453/"]B/CPO9F]N=#X\+W`^#0H\<"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#M!('-U;6UA<GD@;V8@;6%R:V5T86)L92!S96-U<FET:65S(&ES('-H;W=N
M(&)E;&]W.CPO9F]N=#X\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424]..B!R
M96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P
M<'0[(%=)1%1(.B`X,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%
M1E0Z(#$P)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$
M/4%$1%]404),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*/"$M+2!5
M<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[/@T*#0H\='(@<W1Y;&4],T1P861D:6YG.C`[/CPA+2T@5$%"3$4@
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M861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N
M/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/D%M;W)T:7IE9#QB<B`O/@T*
M0V]S=#PO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C
M96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^1W)O<W,\8G(@+SX-"E5N<F5A;&EZ
M960\8G(@+SX-"D=A:6YS/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO
M9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY'<F]S<SQB<B`O
M/@T*56YR96%L:7IE9#QB<B`O/@T*3&]S<V5S/"]B/CPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[
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M:7IE/3-$,CX\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]B/CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
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M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
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M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M;G0@86YD(&UU;FEC:7!A;"!O8FQI9V%T:6]N<SPO9F]N=#X\+W`^/"]T9#X-
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M:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
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M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M('EE87)S)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T
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M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ."PR.#8\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O
M;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN
M9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%
M0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))
M1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#,P<'0[)SX\9F]N="!S:7IE/3-$
M,CY4;W1A;"!5+E,N(&=O=F5R;FUE;G0@86YD(&UU;FEC:7!A;"!O8FQI9V%T
M:6]N<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
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M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:
M13H@,2XU<'0[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#
M3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/
M34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^
M/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T1W:&ET93X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-
M05)'24XM3$5&5#H@-#!P=#LG/CQF;VYT('-I>F4],T0R/DUA='5R:6YG(&EN
M(&]N92!Y96%R(&]R(&QE<W,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z
M,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`T,'!T.R<^/&9O;G0@<VEZ93TS1#(^36%T=7)I;F<@869T97(@;VYE
M('EE87(@=&AR;W5G:"!T:')E92!Y96%R<R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
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M<VEZ93TS1#(^,C`L-S8X/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:
M13H@,2XU<'0[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#
M3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/
M34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^
M/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`S
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@8V]R<&]R871E(&1E8G0@<V5C
M=7)I=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB
M(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE
M+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO
M='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I
M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z
M,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@;6%R:V5T86)L92!S
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M:'0^/&9O;G0@<VEZ93TS1#(^,3`T/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/
M3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L
M(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N
M,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H
M=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D
M9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=3
M2$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%
M4D=2240L(FQI;F4M:&5I9VAT.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
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M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.R!&
M3TY4+5-)6D4Z(#$N-7!T.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/
M4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L
M:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D
M/CPO='(^/"]T86)L93X\+V1I=CX-"CPA+2T@96YD(&]F('5S97(M<W!E8VEF
M:65D(%1!1T=%1"!404),12`M+3X\+V1I=CX-"CQP('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQB<B`O/CPO9F]N=#XF
M(S$V,#L\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@
M4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(
M.B`X,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$P)3L@
M4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]404),
M15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*/"$M+2!5<V5R+7-P96-I
M9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L:6=N/3-$8V5N=&5R/@T*
M/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[/@T*
M#0H\='(@<W1Y;&4],T1P861D:6YG.C`[/CPA+2T@5$%"3$4@0T],54U.(%=)
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M3B!724142%,@14Y$("TM/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
M('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R
M/CQF;VYT('-I>F4],T0Q/CQB/D%M;W)T:7IE9#QB<B`O/@T*0V]S=#PO8CX\
M+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O
M;G0@<VEZ93TS1#$^/&(^1W)O<W,\8G(@+SX-"E5N<F5A;&EZ960\8G(@+SX-
M"D=A:6YS/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY'<F]S<SQB<B`O/@T*56YR96%L
M:7IE9#QB<B`O/@T*3&]S<V5S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P
M.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
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M8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]B/CPO9F]N=#X\+W`^/"]T9#X-
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M:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M;FEC:7!A;"!O8FQI9V%T:6]N<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`T,'!T.R<^/&9O;G0@
M<VEZ93TS1#(^36%T=7)I;F<@869T97(@;VYE('EE87(@=&AR;W5G:"!T:')E
M92!Y96%R<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$
M14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2
M240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`S,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@52Y3+B!G
M;W9E<FYM96YT(&%N9"!M=6YI8VEP86P@;V)L:6=A=&EO;G,F(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M25I%.B`Q+C5P=#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F
M9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&
M1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH
M96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM
M($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@
M0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M
M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H
M=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&
M5#H@,S!P=#LG/CQF;VYT('-I>F4],T0R/D-O<G!O<F%T92!D96)T('-E8W5R
M:71I97,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M($U!4D=)3BU,1494.B`T,'!T.R<^/&9O;G0@<VEZ93TS1#(^36%T=7)I;F<@
M:6X@;VYE('EE87(@;W(@;&5S<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I
M;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G
M5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)
M3BU,1494.B`T,'!T.R<^/&9O;G0@<VEZ93TS1#(^36%T=7)I;F<@869T97(@
M;VYE('EE87(@=&AR;W5G:"!T:')E92!Y96%R<SPO9F]N=#X\+W`^/"]T9#X-
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H
M=#X\9F]N="!S:7IE/3-$,CXQ-#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^*#,\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@
M0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#
M3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,S!P=#LG/CQF;VYT('-I
M>F4],T0R/E1O=&%L(&-O<G!O<F%T92!D96)T('-E8W5R:71I97,\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA
M+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M
M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M
M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F
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M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^/&9O
M;G0@<VEZ93TS1#(^5&]T86P@;6%R:V5T86)L92!S96-U<FET:65S/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-3@L
M.3`Y/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[
M)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\
M(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB
M("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O
M;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F
M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
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M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I
M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.R!&3TY4+5-)6D4Z(#$N-7!T.R<@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA
M+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M
M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M
M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I
M=CX-"CPA+2T@96YD(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M
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M87)I;'D@:6UP86ER960@87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RX\
M+V9O;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!2
M3U!%4E19($%.1"!%455)4$U%3E0L($Y%5#QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY04D]015)462!!3D0@15%5
M25!-14Y4+"!.150\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!23U!%4E19($%.1"!%455)4$U%3E0L($Y%5#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US
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M:&4@9F]L;&]W:6YG.CPO9F]N=#X\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE4
M24]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,
M1494.B`P<'0[(%=)1%1(.B`W,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%2
M1TE.+4Q%1E0Z(#$U)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#
M3TU-04Y$/4%$1%]404),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*
M/"$M+2!5<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[/@T*#0H\='(@<W1Y;&4],T1P861D:6YG.C`[/CPA+2T@
M5$%"3$4@0T],54U.(%=)1%1(4R!3150@+2T^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=VED=&@],T0Q,CX\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$-R!A
M;&EG;CTS1')I9VAT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=VED=&@],T0X.#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$,3(^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!W:61T:#TS1#<@86QI9VX],T1R:6=H
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I
M9'1H/3-$.#@^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!W:61T:#TS1#$R/CPO=&0^/"$M+2!404),12!#3TQ534X@5TE$5$A3
M($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX]
M,T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@
M+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S
M:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]B/CPO9F]N=#X\
M+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@
M=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE
M/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^
M)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#4@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^*$EN('1H
M;W5S86YD<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F
M;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
M.R<^/&9O;G0@<VEZ93TS1#(^3&%B;W)A=&]R>2!%<75I<&UE;G0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^36%N=69A8W1U<FEN9R!%<75I<&UE;G0\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3&5A
M<V5H;VQD($EM<')O=F5M96YT<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL
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M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI
M9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ,34\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I
M;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$
M/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]
M041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D
M:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@
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M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXQ.2PU,S`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
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M='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-
M04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!
M3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D
M/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O
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M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS
M1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@
M+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y
M;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F
M9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F;VYT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T
M<CX\+W1A8FQE/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@
M5$%'1T5$(%1!0DQ%("TM/CPO9&EV/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1&5P<F5C:6%T:6]N(&%N
M9"!A;6]R=&EZ871I;VX@97AP96YS92!R96QA=&5D('1O('!R;W!E<G1Y(&%N
M9"!E<75I<&UE;G0@=V%S("0Q+CDF(S$V,#MM:6QL:6]N+"`D,BXP)B,Q-C`[
M;6EL;&EO;B!A;F0@)#(N,B8C,38P.VUI;&QI;VX@9F]R('1H92!Y96%R<R!E
M;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q+"!R
M97-P96-T:79E;'DN/"]F;VYT/CPO<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V
M7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K
M<VAE971S+U-H965T,3,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY)3E1!3D=)0DQ%($%34T544R!!3D0@1T]/1%=)3$P\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M24Y404Y'24),12!!4U-%5%,@04Y$($=/3T1724Q,/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)3E1!3D=)0DQ%($%34T54
M4R!!3D0@1T]/1%=)3$P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\8CXH-RD@24Y404Y'24),12!!4U-%
M5%,@04Y$($=/3T1724Q,/"]B/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M);G1A;F=I
M8FQE(&%S<V5T<RP@;F5T(&]F(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;BP@
M86YD(&=O;V1W:6QL(&%R92!A<R!F;VQL;W=S.CPO9F]N=#X\+W`^#0H\9&EV
M('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ
M(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(.B`U-"4[(%!!1$1)3D<M
M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$P)3L@4$%$1$E.1RU43U`Z(#!P
M=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]404),15=)1%1(+"(Q-3`E(B`M
M+3X\+V9O;G0^/"]P/@T*/"$M+2!5<V5R+7-P96-I9FEE9"!404='140@5$%"
M3$4@+2T^#0H\9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE(&)O<F1E<CTS
M1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$U
M,"4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[/@T*#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[/CPA+2T@5$%"3$4@0T],54U.(%=)1%1(4R!3150@+2T^#0H\
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M14Y$("TM/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
M1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A
M;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB<B`O
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0Q,"!A;&EG;CTS1&-E;G1E<CX\9F]N="!S
M:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]B/CPO9F]N=#X\
M+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@
M=&EM97,[)R!C;VQS<&%N/3-$."!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE
M/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^
M)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$8V5N=&5R/CQF
M;VYT('-I>F4],T0Q/CQB/D5S=&EM871E9#QB<B`O/@T*3&EF93PO8CX\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@
M<VEZ93TS1#$^/&(^0V]S=#PO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\
M+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^06-C=6UU;&%T
M960\8G(@+SX-"D%M;W)T:7IA=&EO;CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF
M(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^3F5T
M/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E
M<CX\9F]N="!S:7IE/3-$,3X\8CY#;W-T/"]B/CPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q
M/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY!
M8V-U;75L871E9#QB<B`O/@T*06UO<G1I>F%T:6]N/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$
M,3X\8CY.970\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
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M)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#$W(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/BA);B!T
M:&]U<V%N9',I/"]B/CPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO
M9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-
M05)'24XM3$5&5#H@,C!P=#LG/CQF;VYT('-I>F4],T0R/DE04B9A;7`[1#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M;G0@<VEZ93TS1#(^,3$L.#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ,2PX,#`\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M<VEZ93TS1#(^,3$L.#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D
M:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#(P<'0[)SX\9F]N="!S:7IE/3-$,CY!
M;6=E;B!!;65N9&UE;G0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-I>F4],T0R/C$V)B,Q-C`[>65A<G,\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<VEZ93TS1#(^,3`L-C@X/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE
M/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXQ-"PU,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R!-05)'24XM3$5&5#H@,C!P=#LG/CQF;VYT('-I>F4],T0R/D-O<F4@
M5&5C:&YO;&]G>3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<VEZ93TS1#(^,2PR.38\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%
M0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))
M1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],
M3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB
M;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX]
M,T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V
M86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@26YT
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M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXR,BPX,C`\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D
M:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O
M;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
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M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].
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M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F
M9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N
M,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
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M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
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M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G
M8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L
M(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN
M92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@
M+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP
M<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX\+W1A8FQE
M/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!
M0DQ%("TM/CPO9&EV/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($E04B9A;7`[1"!I;G1A;F=I8FQE
M(&%S<V5T('=A<R!R96-O<F1E9"!I;B!C;VYN96-T:6]N('=I=&@@=&AE(&%C
M<75I<VET:6]N(&]F($-U<F%'96X@86YD(')E;&%T97,@=&\@=&AE(&1E=F5L
M;W!M96YT(&]F(&=L96UB871U;75M86(@=F5D;W1I;BX@070@=&AE(&1A=&4@
M;V8@86-Q=6ES:71I;VX@86YD(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L
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M8V5R('1H870@;W9E<BUE>'!R97-S(&=P3DU"+CPO9F]N=#X\+W`^#0H\<"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#M!;6]R=&EZ871I;VX@97AP96YS92!F;W(@:6YT86YG:6)L92!A<W-E=',@
M=V%S("0Q+C`F(S$V,#MM:6QL:6]N+"`D,2XQ)B,Q-C`[;6EL;&EO;B!A;F0@
M)#$N.28C,38P.VUI;&QI;VX@9F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E
M<B8C,38P.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q+"!R97-P96-T:79E;'DN
M(%1H92!E<W1I;6%T960@9G5T=7)E(&%M;W)T:7IA=&EO;B!E>'!E;G-E(&]F
M(&EN=&%N9VEB;&4@87-S971S(&9O<B!T:&4@>65A<G,@96YD960@1&5C96UB
M97(F(S$V,#LS,2P@,C`Q-"P@,C`Q-2P@,C`Q-BP@,C`Q-R!A;F0@,C`Q."!I
M<R`D,2XP)B,Q-C`[;6EL;&EO;BP@)#$N,"8C,38P.VUI;&QI;VXL("0Q+C`F
M(S$V,#MM:6QL:6]N+"`D,"XY)B,Q-C`[;6EL;&EO;B!A;F0@)#`N.28C,38P
M.VUI;&QI;VXL(')E<W!E8W1I=F5L>2X\+V9O;G0^/"]P/@T*/"]D:78^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D%#0U)5140@15A014Y315,\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^04-#
M4E5%1"!%6%!%3E-%4SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^04-#4E5%1"!%6%!%3E-%4SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R<^#0H\<"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\8CXH."D@
M04-#4E5%1"!%6%!%3E-%4SPO8CX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[06-C<G5E
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M,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!1T=%
M1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@<W1Y
M;&4],T0G=&5X="UA;&EG;CIL969T.U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(
M.B`U-#-P>#LG(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#4T,SX-"@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z
M,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$
M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^/"$M+2!404),
M12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF
M;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C
M,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY$96-E
M;6)E<B8C,38P.S,Q+#QB<B`O/@T*,C`Q,SPO8CX\+V9O;G0^/"]T:#X-"CQT
M:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^
M1&5C96UB97(F(S$V,#LS,2P\8G(@+SX-"C(P,3(\+V(^/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
M;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#4@86QI9VX]
M,T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^*$EN('1H;W5S86YD<RD\+V(^
M/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&
M1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S
M:7IE/3-$,CY!8V-R=65D(%)O>6%L='D@86YD($QI8V5N<V4@1F5E<SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^06-C<G5E9"!087ER;VQL(&%N
M9"!%;7!L;WEE92!"96YE9FET<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
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M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C$Q+#@T,#PO9F]N
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-RPU-CD\+V9O;G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@
M<VEZ93TS1#(^06-C<G5E9"!0<F]F97-S:6]N86P@1F5E<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,S$W/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\
M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^3W1H97(@06-C<G5E9"!%>'!E;G-E<SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,
M1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P
M=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
M(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$
M/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]
M041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.
M1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z
M(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O
M;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-
M.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[
M(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H
M:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@
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M:7IE/3-$,CXQ,"PY-C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D
M:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[
M(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.
M1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=3
M2$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%
M4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
M;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/
M5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U54
M5$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\
M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA+2T@
M0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#
M3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[(B`M
M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
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M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS
M1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0
M041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.
M1RU224=(5#H@,'!X.R!&3TY4+5-)6D4Z(#$N-7!T.R!0041$24Y'+51/4#H@
M,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],
M3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB
M;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N
M9"!O9B!U<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D]42$52($Q/3D<M5$5232!,
M24%"24Q)5$E%4SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY/5$A%4B!,3TY'+51%4DT@3$E!0DE,251)15,\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]42$52
M($Q/3D<M5$5232!,24%"24Q)5$E%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
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M7U1!0DQ%5TE$5$@L(C$P,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M
M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT
M97(^#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L^#0H-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L^/"$M+2!404),12!#3TQ5
M34X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@
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M='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-
M"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE
M9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB
M/D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V(^/"]F;VYT/CPO=&@^#0H\=&@@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^
M)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O
M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/D1E
M8V5M8F5R)B,Q-C`[,S$L(#(P,3(\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q
M-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@
M=F%L:6=N/3-$8F]T=&]M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&%L:6=N/3-$;&5F=#X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O
M;G0^/&)R("\^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$-2!A;&EG
M;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXH26X@=&AO=7-A;F1S*3PO
M8CX\+V9O;G0^/&)R("\^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X\
M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^1&5F97)R960@4F5N=#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G
M5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)
M3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3F5T($1E9F5R<F5D(%1A
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-"PV-C$\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG
M/CQF;VYT('-I>F4],T0R/D1E9F5R<F5D($EN8V]M92!F<F]M(%-A;&4@;V8@
M5&%X($)E;F5F:71S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE
M/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^,2PV,S`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@
M<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^1&5F97)R
M960@4F5V96YU93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL
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M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@
M=F%L:6=N/3-$=&]P(&)G8V]L;W(],T1W:&ET93X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL
M93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@
M34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY/=&AE<CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],
M3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB
M;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP
M.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<VEZ93TS1#(^-BPW,C0\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T1W:&ET93X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE
M/3-$,CY,97-S($-U<G)E;G0@4&]R=&EO;CPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-
M04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!
M3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@
M+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP
M+C%P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@
M=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/DQO;F<M5&5R
M;2!0;W)T:6]N/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N
M="!S:7IE/3-$,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<VEZ93TS1#(^-BPY-3`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B
M("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z
M,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T
M;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/
M3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L
M(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA
M+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M
M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[
M(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW
M-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z
M,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
M(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$
M/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]
M041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX\+W1A8FQE
M/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!
M0DQ%("TM/CPO9&EV/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[26X@2F%N=6%R>2`R,#$S+"`R,#$R(&%N
M9"`R,#$Q+"!T:&4@0V]M<&%N>2!R96-E:79E9"!A<'!R;W9A;"!F<F]M('1H
M92!.97<@2F5R<V5Y($5C;VYO;6EC($1E=F5L;W!M96YT($%U=&AO<FET>2!A
M;F0@86=R965D('1O('-E;&P@3F5W($IE<G-E>2!T87@@8F5N969I=',@=V]R
M=&@@)#`N."8C,38P.VUI;&QI;VXL("0P+C@F(S$V,#MM:6QL:6]N(&%N9"`D
M,"XV)B,Q-C`[;6EL;&EO;B!T;R!A;B!I;F1E<&5N9&5N="!T:&ER9"!P87)T
M>2!F;W(@)#`N."8C,38P.VUI;&QI;VXL("0P+C<F(S$V,#MM:6QL:6]N(&%N
M9"`D,"XU)B,Q-C`[;6EL;&EO;BP@<F5S<&5C=&EV96QY+B!5;F1E<B!T:&4@
M86=R965M96YT+"!T:&4@0V]M<&%N>2!M=7-T(&UA:6YT86EN(&$@8F%S92!O
M9B!O<&5R871I;VYS(&EN($YE=R!*97)S97D@9F]R(&9I=F4@>65A<G,@;W(@
M=&AE('1A>"!B96YE9FET<R!M=7-T(&)E('!A:60@8F%C:R!O;B!A('!R;RUR
M871A(&)A<VES(&)A<V5D(&]N('1H92!N=6UB97(@;V8@>65A<G,@8V]M<&QE
M=&5D+B!$=7)I;F<@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3,@86YD(#(P,3(L('1H92!#;VUP86YY(')E8V]R9&5D("0P+C(F(S$V
M,#MM:6QL:6]N(&%N9"`D,"XQ)B,Q-C`[;6EL;&EO;B!T;R!O=&AE<B!I;F-O
M;64@<F5L871E9"!T;R!T:&4@<V%L92!O9B!T:&5S92!T87@@8F5N969I=',L
M(')E<W!E8W1I=F5L>2X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[26X@4V5P=&5M8F5R
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M(&1U<FEN9R!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S
M+CPO9F]N=#X\+W`^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B
M-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q
M,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E
M=#$V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M5$5232!,3T%./&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E1%4DT@3$]!3CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5$5232!,3T%./"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&(^*#$P
M*2!415)-($Q/04X\+V(^/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TEN($1E8V5M8F5R
M(#(P,3`L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(&QO86X@86YD('-E
M8W5R:71Y(&%G<F5E;65N="!W:71H($UI9$-A<"!&:6YA;F-I86PL)B,Q-C`[
M3$Q#('!U<G-U86YT('1O('=H:6-H('1H92!#;VUP86YY(&)O<G)O=V5D("0Q
M,"XP)B,Q-C`[;6EL;&EO;B!U;F1E<B!A('1E<FT@;&]A;B!F<F]M($UI9$-A
M<"X@26X@36%R8V@@,C`Q,2P@=&AE($-O;7!A;GD@86UE;F1E9"!T:&4@;&]A
M;B!A9W)E96UE;G0@86YD(&)O<G)O=V5D(&%N(&%D9&ET:6]N86P@)#4N,"8C
M,38P.VUI;&QI;VX@9G)O;2!'96YE<F%L($5L96-T<FEC($-A<&ET86P@0V]R
M<&]R871I;VX@=&\@:6YC<F5A<V4@=&AE(&%M;W5N="!O=V5D('5N9&5R('1H
M92!T97)M(&QO86X@=&\@)#$U+C`F(S$V,#MM:6QL:6]N+B!);B!-87)C:"`R
M,#$R+"!T:&4@0V]M<&%N>2!A;65N9&5D('1H92!L;V%N(&%G<F5E;65N="!T
M;R!E>'1E;F0@=&AE(&UA='5R:71Y(&1A=&4@9G)O;2!$96-E;6)E<B`R,#$S
M('1O($1E8V5M8F5R(#(P,30N($EN($UA>2`R,#$S+"!T:&4@0V]M<&%N>2!E
M;&5C=&5D('1O('!R97!A>2!T:&4@;W5T<W1A;F1I;F<@<')I;F-I<&%L('5N
M9&5R('1H92!T97)M(&QO86X@:6X@9G5L;"P@<'5R<W5A;G0@=&\@=&AE('1E
M<FUS(&]F(&ET<R!L;V%N(&%G<F5E;65N="P@87,@86UE;F1E9"P@86YD('!A
M:60@)#@N."8C,38P.VUI;&QI;VX@:6X@<')I;F-I<&%L(&%N9"`D,"XW)B,Q
M-C`[;6EL;&EO;B!I;B!I;G1E<F5S="P@<')E<&%Y;65N="!A;F0@9FEN86P@
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M<FT@;&]A;B!W87,@)#`N."8C,38P.VUI;&QI;VXL("0Q+C4F(S$V,#MM:6QL
M:6]N(&%N9"`D,2XV)B,Q-C`[;6EL;&EO;B!F;W(@=&AE('EE87)S(&5N9&5D
M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$L(')E<W!E
M8W1I=F5L>2X\+V9O;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
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M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/E-43T-+2$],1$524R<@15%52519/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-43T-+2$],1$524R<@
M15%52519/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y35$]#2TA/3$1%4E,G($5154E463PO=&0^#0H@("`@("`@(#QT9"!C
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M;B!3=&]C:SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[26X@07!R:6P@,C`Q,"P@
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M=V5N="!E9F9E8W1I=F4@;VX@07!R:6PF(S$V,#LR,BP@,C`Q,"X@26X@1&5C
M96UB97(@,C`Q,BP@=&AE($-O;7!A;GD@9FEL960@82!N97<@<VAE;&8@<F5G
M:7-T<F%T:6]N('-T871E;65N="!W:71H('1H92!396-U<FET:65S(&%N9"!%
M>&-H86YG92!#;VUM:7-S:6]N('1O(')E9VES=&5R(&9O<B!S86QE(&%N>2!C
M;VUB:6YA=&EO;B!O9B!T:&4@='EP97,@;V8@<V5C=7)I=&EE<R!D97-C<FEB
M960@:6X@=&AE(&YE=R!S:&5L9B!R96=I<W1R871I;VX@<W1A=&5M96YT('5P
M('1O(&$@9&]L;&%R(&%M;W5N="!O9B`D,C`P)B,Q-C`[;6EL;&EO;BX@5&AE
M(&YE=R!S:&5L9B!R96=I<W1R871I;VX@=V5N="!E9F9E8W1I=F4@;VX@2F%N
M=6%R>28C,38P.S$V+"`R,#$S+B!);B!$96-E;6)E<B`R,#$S+"!T:&4@0V]M
M<&%N>2!F:6QE9"!A(&YE=R!A=71O;6%T:6,@<VAE;&8@<F5G:7-T<F%T:6]N
M('-T871E;65N="X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1'5R:6YG('1H92!Y96%R
M<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q
M+"!#;VUP86YY(&ES<W5E9"`R,2PV,3,L-#@S+"`Q,BPP-S4L,#`P(&%N9"`Q
M,2PU,#`L,#`P('-H87)E<R!O9B!I=',@8V]M;6]N('-T;V-K(&EN('5N9&5R
M=W)I='1E;B!P=6)L:6,@;V9F97)I;F=S(')E<W5L=&EN9R!I;B!N970@<')O
M8V5E9',@=&\@=&AE($-O;7!A;GD@;V8@)#(W."XV)B,Q-C`[;6EL;&EO;BP@
M)#0S+C4F(S$V,#MM:6QL:6]N(&%N9"`D,S,N-R8C,38P.VUI;&QI;VXL(&%F
M=&5R(&1E9'5C=&EN9R!U;F1E<G=R:71I;F<@9F5E<R!A;F0@;V9F97)I;F<@
M97AP96YS97,L(')E<W!E8W1I=F5L>2X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1'5R
M:6YG('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"`R
M,#$R(&%N9"`R,#$Q+"!#;VUP86YY(&ES<W5E9"`R+#0S,RPV,#@L(#@L,#`S
M+#(Y,"!A;F0@-3<U+#`P,"!S:&%R97,@;V8@:71S(&-O;6UO;B!S=&]C:R!U
M;F1E<B!O=7(@8V]N=')O;&QE9"!E<75I='D@;V9F97)I;F<@<V%L97,@86=R
M965M96YT('=I=&@@0V%N=&]R($9I='IG97)A;&0F(S$V,#LF86UP.R8C,38P
M.T-O+BP@87,@86UE;F1E9"P@<F5S=6QT:6YG(&EN(&YE="!P<F]C965D<R!T
M;R!T:&4@0V]M<&%N>2!O9B`D,3<N,28C,38P.VUI;&QI;VXL("0T,"XQ)B,Q
M-C`[;6EL;&EO;B!A;F0@)#(N,B8C,38P.VUI;&QI;VXL(&%F=&5R(&1E9'5C
M=&EN9R!C;VUM:7-S:6]N(&%N9"!O9F9E<FEN9R!E>'!E;G-E<RP@<F5S<&5C
M=&EV96QY+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y#;VYV97)T:6)L92!0<F5F97)R
M960@4W1O8VL\+VD^/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.T%T($1E8V5M8F5R)B,Q
M-C`[,S$L(#(P,3,L('1H92!#;VUP86YY(&AA9"!A=71H;W)I>F5D(#,L,#`P
M+#`P,"!S:&%R97,@;V8@<')E9F5R<F5D('-T;V-K(&%L;"!O9B!W:&EC:"!H
M879E(&)E96X@9&5S:6=N871E9"!#;&%S<R8C,38P.T,@4')E9F5R<F5D(%-T
M;V-K(&EN8VQU9&EN9R`S-3`L,#`P('-H87)E<R!W:&EC:"!H879E(&)E96X@
M9&5S:6=N871E9"!397)I97,F(S$V,#M#+3$F(S$V,#M*=6YI;W(@4&%R=&EC
M:7!A=&EN9R!#=6UU;&%T:79E(%!R969E<G)E9"!3=&]C:R`H=&AE(")397)I
M97,F(S$V,#M#+3$@4')E9F5R<F5D(%-T;V-K(BDN/"]F;VYT/CPO<#X-"CQP
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R
M/CQI/E-H87)E:&]L9&5R(%)I9VAT<R!0;&%N/"]I/CPO9F]N=#X\+W`^#0H\
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M+D$N+"!A<R!2:6=H=',@06=E;G0@*'1H92`B4FEG:'1S($%G<F5E;65N="(I
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M9B!A('-H87)E("AA(")5;FET(BD@;V8@4V5R:65S)B,Q-C`[0RTQ(%!R969E
M<G)E9"!3=&]C:R!A="!A(&-A<V@@97AE<F-I<V4@<')I8V4@;V8@)#,U+C`P
M('!E<B!5;FET+"!S=6)J96-T('1O(&%D:G5S=&UE;G0N(%1H92!2:6=H=',@
M=VEL;"!T<F%D92!S97!A<F%T96QY(&9R;VT@=&AE(&-O;6UO;B!S=&]C:R!A
M;F0@=VEL;"!B96-O;64@97AE<F-I<V%B;&4@;VYL>2!W:&5N(&$@<&5R<V]N
M(&]R(&=R;W5P(&AA<R!A8W%U:7)E9"`Q-24@;W(@;6]R92!O9B!T:&4@;W5T
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M;W(@9W)O=7`@86-Q=6ER97,@,34E(&]R(&UO<F4@;V8@=&AE(&]U='-T86YD
M:6YG(&-O;6UO;B!S=&]C:R!E86-H(&AO;&1E<B!O9B!A(%)I9VAT("AE>&-E
M<'0@9F]R(&%N>2!S=6-H('!E<G-O;B!O<B!G<F]U<"D@=V]U;&0@8F4@96YT
M:71L960@=&\@<F5C96EV92!U<&]N(&5X97)C:7-E('-U9F9I8VEE;G0@56YI
M=',@;V8@4V5R:65S)B,Q-C`[0RTQ(%!R969E<G)E9"!3=&]C:R!T;R!E<75A
M;"!A('9A;'5E(&]F('1W;R!T:6UE<R!T:&4@97AE<F-I<V4@<')I8V4@;V8@
M=&AE(%)I9VAT+B!);B!T:&4@979E;G0@=&AE($-O;7!A;GD@:7,@86-Q=6ER
M960@:6X@82!M97)G97(@;W(@;W1H97(@8G5S:6YE<W,@8V]M8FEN871I;VX@
M=')A;G-A8W1I;VX@;W(@:68@-3`E(&]R(&UO<F4@;V8@=&AE($-O;7!A;GDG
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M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/E-43T-++4)!4T5$($-/35!%3E-!5$E/3CQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3
M5$]#2RU"05-%1"!#3TU014Y3051)3TX\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-43T-++4)!4T5$($-/35!%3E-!5$E/
M3CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4]
M,T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/CQB/B@Q,BD@4U1/0TLM0D%3140@0T]-4$5.4T%424]./"]B
M/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#M4:&4@0V]M<&%N>2!H87,@=&AE(&9O;&QO
M=VEN9R!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@<&QA;G,Z('1H92`R,#`T
M($5M<&QO>65E(%-T;V-K(%!U<F-H87-E(%!L86X@*'1H92`B,C`P-"!%4U!0
M(%!L86XB*2P@=&AE(#(P,#@@4W1O8VL@3W!T:6]N(&%N9"!);F-E;G1I=F4@
M4&QA;B`H=&AE("(R,#`X(%!L86XB*2P@0V5L;&1E>"!297-E87)C:"=S(#(P
M,#4@17%U:71Y($EN8V5N=&EV92!0;&%N("AT:&4@(D-E;&QD97@@4F5S96%R
M8V@@,C`P-2!0;&%N(BD@86YD($-U<F%'96X@,C`P-R!3=&]C:R!0;&%N("AT
M:&4@(D-U<F%'96X@,C`P-R!0;&%N(BDN(%1H97)E(&%R92!N;R!S:&%R97,@
M879A:6QA8FQE(&9O<B!F=71U<F4@9W)A;G0@=6YD97(@=&AE($-E;&QD97@@
M4F5S96%R8V@@,C`P-2!0;&%N(&%N9"!#=7)A1V5N(#(P,#<@4&QA;BX\+V9O
M;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^/&D^16UP;&]Y964@4W1O8VL@4'5R8VAA<V4@4&QA;CPO
M:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[070@1&5C96UB97(F(S$V,#LS,2P@,C`Q
M,RP@82!T;W1A;"!O9B`R,#`L,#`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@
M87)E(')E<V5R=F5D(&9O<B!I<W-U86YC92!U;F1E<B!T:&4@,C`P-"!%4U!0
M(%!L86XN(%5N9&5R('1H92`R,#`T($534%`@4&QA;BP@96%C:"!P87)T:6-I
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M960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q,BP@=&AE($-O;7!A
M;GD@:7-S=65D(#$Q+#@R,R!A;F0@-2PY,S4@<VAA<F5S('5N9&5R('1H92`R
M,#`T($534%`@4&QA;BP@<F5S<&5C=&EV96QY+B!!="!$96-E;6)E<B8C,38P
M.S,Q+"`R,#$S+"`Q-C0L,3(T('-H87)E<R!W97)E(&%V86EL86)L92!F;W(@
M:7-S=6%N8V4@=6YD97(@=&AE(#(P,#0@15-04"!0;&%N+CPO9F]N=#X\+W`^
M#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE
M/3-$,CX\:3Y%;7!L;WEE92!3=&]C:R!/<'1I;VX@86YD($EN8V5N=&EV92!0
M;&%N/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M4:&4@,C`P."!0;&%N('!E<FUI
M=',@=&AE(&=R86YT:6YG(&]F(&EN8V5N=&EV92!S=&]C:R!O<'1I;VYS("AI
M;G1E;F1E9"!T;R!Q=6%L:69Y(&%S('-U8V@@=6YD97(@4V5C=&EO;B8C,38P
M.S0R,D$@;V8@=&AE($EN=&5R;F%L(%)E=F5N=64@0V]D92!O9B`Q.3@V+"!A
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M+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[070@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@
M=&AE(#(P,#@@4&QA;B!A;&QO=V5D(&9O<B!A(&UA>&EM=6T@;V8@-RPT,#`L
M,#`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=&\@8F4@:7-S=65D(&9O<B!G
M<F%N=',@;V8@4W1O8VL@3W!T:6]N<R!A;F0@;W1H97(@07=A<F1S(&UA9&4@
M<')I;W(@=&\@36%R8V@F(S$V,#LW+"`R,#$X(&%N9"!G<F%N=',@;V8@26YC
M96YT:79E(%-T;V-K($]P=&EO;G,@;6%D92!P<FEO<B!T;R!/8W1O8F5R)B,Q
M-C`[,C`L(#(P,3<N(%1H92!#;VUP86YY)W,@8F]A<F0@;V8@9&ER96-T;W)S
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M(&]P=&EO;B!C86YN;W0@97AC965D('1E;B!Y96%R<R`H9FEV92!Y96%R<R!F
M;W(@;W!T:6]N<R!G<F%N=&5D('1O(&AO;&1E<G,@;V8@;6]R92!T:&%N(#$P
M)2!O9B!T:&4@=F]T:6YG('-T;V-K(&]F('1H92!#;VUP86YY*2!A;F0@=&AE
M(&5X97)C:7-E('!R:6-E(&]F('-T;V-K(&]P=&EO;G,@8V%N;F]T(&)E(&QE
M<W,@=&AA;B!T:&4@9F%I<B!M87)K970@=F%L=64@;V8@=&AE(&-O;6UO;B!S
M=&]C:R!A="!T:&4@9&%T92!O9B!G<F%N="`H,3$P)2!O9B!F86ER(&UA<FME
M="!V86QU92!F;W(@:6YC96YT:79E('-T;V-K(&]P=&EO;G,@9W)A;G1E9"!T
M;R!H;VQD97)S(&]F(&UO<F4@=&AA;B`Q,"4@;V8@=&AE('9O=&EN9R!S=&]C
M:R!O9B!T:&4@0V]M<&%N>2DN(%9E<W1I;F<@;V8@86QL(&5M<&QO>65E(&%N
M9"!N;VXM96UP;&]Y964@9&ER96-T;W(@<W1O8VL@;W!T:6]N(&%W87)D<R!I
M<R!A8V-E;&5R871E9"!U<&]N(&$@8VAA;F=E(&EN(&-O;G1R;VP@87,@9&5F
M:6YE9"!I;B!T:&4@,C`P."!0;&%N+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M!('-U
M;6UA<GD@;V8@<W1O8VL@;W!T:6]N(&%C=&EV:71Y(&9O<B!T:&4@>65A<B!E
M;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S(&ES(&%S(&9O;&QO=W,Z/"]F
M;VYT/CPO<#X-"CQD:78@<W1Y;&4],T0G4$]3251)3TXZ(')E;&%T:79E.R!0
M041$24Y'+4)/5%1/33H@,'!T.R!0041$24Y'+4Q%1E0Z(#!P=#L@5TE$5$@Z
M(#@P)3L@4$%$1$E.1RU224=(5#H@,'!T.R!-05)'24XM3$5&5#H@,3`E.R!0
M041$24Y'+51/4#H@,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U1!0DQ%
M5TE$5$@L(C$P,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF
M:65D(%1!1T=%1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\
M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L^#0H-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L^/"$M+2!404),12!#3TQ534X@5TE$
M5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
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M04),12!#3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$
M<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\
M+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY3:&%R97,\+V(^/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I
M>F4],T0Q/CQB/E=E:6=H=&5D/&)R("\^#0I!=F5R86=E/&)R("\^#0I%>&5R
M8VES93QB<B`O/@T*4')I8V4\8G(@+SX-"E!E<B!3:&%R93PO8CX\+V9O;G0^
M/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ
M93TS1#$^/&(^5V5I9VAT960\8G(@+SX-"D%V97)A9V4\8G(@+SX-"E)E;6%I
M;FEN9SQB<B`O/@T*0V]N=')A8W1U86P\8G(@+SX-"E1E<FT@*$EN(%EE87)S
M*3PO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X\+W1R
M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
M.R<^/&9O;G0@<VEZ93TS1#(^3W!T:6]N<R!/=71S=&%N9&EN9R!A="!$96-E
M;6)E<B8C,38P.S,Q+"`R,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M,T1R:6=H=#X\9F]N="!S:7IE/3-$,CXW+C`\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^,2PR-3(L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
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M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG
M.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
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M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG
M/CQF;VYT('-I>F4],T0R/D]P=&EO;G,@3W5T<W1A;F1I;F<@870@1&5C96UB
M97(F(S$V,#LS,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T
M.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A
M9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-
M34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-
M04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C%P=#LB("TM/CPO
M9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\
M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB
M(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE
M+6AE:6=H=#HP+C<U<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y
M;&4],T0G<&%D9&EN9SHP.R!&3TY4+5-)6D4Z(#$N-7!T.R<@=F%L:6=N/3-$
M=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T
M.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
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M<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M:6=H=#X\9F]N="!S:7IE/3-$,CXW+C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C0T-%149&
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I
M>F4],T0R/D]P=&EO;G,@17AE<F-I<V%B;&4@870@1&5C96UB97(F(S$V,#LS
M,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^-2XV/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D
M:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^4VAA
M<F5S($%V86EL86)L92!F;W(@1W)A;G0@=6YD97(@=&AE(#(P,#@@4&QA;CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C(L,3`R
M+#DT,CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E
M<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%("TM/CPO9&EV/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE
M('1O=&%L(&EN=')I;G-I8R!V86QU92!O9B!S=&]C:R!O<'1I;VYS(&5X97)C
M:7-E9"!D=7)I;F<@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3,L(#(P,3(@86YD(#(P,3$@=V%S("0Q,"XP)B,Q-C`[;6EL;&EO;BP@
M)#`N,B8C,38P.VUI;&QI;VX@86YD("0P+C`S)B,Q-C`[;6EL;&EO;BP@<F5S
M<&5C=&EV96QY+B!4:&4@=V5I9VAT960@879E<F%G92!G<F%N="UD871E(&9A
M:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!G<F%N=&5D(&1U<FEN9R!T:&4@
M>65A<G,@96YD960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@,C`Q,B!A;F0@
M,C`Q,2!W87,@)#$P+C4Q+"`D,RXV-R!A;F0@)#$N.#,L(')E<W!E8W1I=F5L
M>2X@5&AE('1O=&%L(&9A:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!V97-T
M960@9'5R:6YG('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R
M,#$S+"`R,#$R(&%N9"`R,#$Q('=A<R`D,BXT)B,Q-C`[;6EL;&EO;BP@)#(N
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M96UB97(F(S$V,#LS,2P@,C`Q,R!W87,@)#DR+C8F(S$V,#MM:6QL:6]N+B!4
M:&4@86=G<F5G871E(&EN=')I;G-I8R!V86QU92!O9B!S=&]C:R!O<'1I;VYS
M('9E<W1E9"!A;F0@97AP96-T960@=&\@=F5S="!A="!$96-E;6)E<B8C,38P
M.S,Q+"`R,#$S('=A<R`D.3$N.28C,38P.VUI;&QI;VXN($%S(&]F($1E8V5M
M8F5R)B,Q-C`[,S$L(#(P,3,L('1O=&%L(&-O;7!E;G-A=&EO;B!C;W-T(')E
M;&%T960@=&\@;F]N+79E<W1E9"!E;7!L;WEE92!A;F0@;F]N+65M<&QO>65E
M(&1I<F5C=&]R('-T;V-K(&]P=&EO;G,@;F]T('EE="!R96-O9VYI>F5D('=A
M<R!A<'!R;WAI;6%T96QY("0Q-"XT)B,Q-C`[;6EL;&EO;BP@;F5T(&]F(&5S
M=&EM871E9"!F;W)F96ET=7)E<RP@=VAI8V@@:7,@97AP96-T960@=&\@8F4@
M<F5C;V=N:7IE9"!A<R!E>'!E;G-E(&]V97(@82!W96EG:'1E9"!A=F5R86=E
M('!E<FEO9"!O9B`R+C@F(S$V,#MY96%R<RX\+V9O;G0^/"]P/@T*/'`@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^
M4F5S=')I8W1E9"!3=&]C:SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[02!S=6UM
M87)Y(&]F(')E<W1R:6-T960@<W1O8VL@86-T:79I='D@=6YD97(@=&AE(#(P
M,#@@4&QA;B!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(F(S$V,#LS,2P@
M,C`Q,R!I<R!A<R!F;VQL;W=S.CPO9F]N=#X\+W`^#0H\9&EV('-T>6QE/3-$
M)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$
M1$E.1RU,1494.B`P<'0[(%=)1%1(.B`W,"4[(%!!1$1)3D<M4DE'2%0Z(#!P
M=#L@34%21TE.+4Q%1E0Z(#$U)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M/"$M+2!#3TU-04Y$/4%$1%]404),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^
M/"]P/@T*/"$M+2!5<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[/@T*#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
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M5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V
M86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N
M=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\
M9F]N="!S:7IE/3-$,3X\8CY3:&%R97,\+V(^/"]F;VYT/CPO=&@^#0H\=&@@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^
M)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O
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M<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^3W5T<W1A;F1I;F<@86YD('5N=F5S=&5D(&%T($1E8V5M8F5R)B,Q-C`[
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M/3-$,CXV+#`P,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
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M9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
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M,CXQ,BPP,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-I>F4],T0R/C$U+C(P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D
M:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY6
M97-T960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C
M,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXH,3(L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/D-A;F-E;&5D
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F
M9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]2
M3U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=5
M5%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
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M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP
M.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
M.R<^/&9O;G0@<VEZ93TS1#(^3W5T<W1A;F1I;F<@86YD('5N=F5S=&5D(&%T
M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
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M:6=H=#X\9F]N="!S:7IE/3-$,CXV+#`P,#PO9F]N=#X\+W1D/@T*/'1D('-T
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M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,34N,C`\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V
M86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&
M1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE
M:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G
M8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
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M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A
M9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^
M/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW
M-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
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M)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/
M3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F
M9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?
M4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'
M551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/@T*/"$M+2!E
M;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%("TM/CPO9&EV/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^/&D^5F%L=6%T:6]N(&%N9"!%>'!E;G-E<R!);F9O<FUA=&EO;CPO:3X\
M+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X
M<&5N<V4@9F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R
M,#$S+"`R,#$R(&%N9"`R,#$Q('=A<R!R96-O<F1E9"!A<R!F;VQL;W=S.CPO
M9F]N=#X\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@
M4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(
M.B`W,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$U)3L@
M4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]404),
M15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*/"$M+2!5<V5R+7-P96-I
M9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L:6=N/3-$8V5N=&5R/@T*
M/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[/@T*
M#0H\='(@<W1Y;&4],T1P861D:6YG.C`[/CPA+2T@5$%"3$4@0T],54U.(%=)
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M/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^,C`Q,SPO8CX\+V9O;G0^
M/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ
M93TS1#$^/&(^,C`Q,CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^,C`Q,3PO8CX\+V9O
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M,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
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M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^1V5N97)A;"!A;F0@861M:6YI<W1R
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXY,S`\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:
M13H@,2XU<'0[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!
M1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'
M4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG
M.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
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M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG
M('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C
M1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M
M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A
M;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
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M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
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M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA
M+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M
M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[
M(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW
M-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP
M.R!&3TY4+5-)6D4Z(#$N-7!T.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D
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M1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@,C`Q,B!A;F0@,C`Q,2!W97)E('9A
M;'5E9"!U<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O<'1I;VXM<')I8VEN9R!M
M;V1E;"!W:71H('1H92!F;VQL;W=I;F<@87-S=6UP=&EO;G,Z/"]F;VYT/CPO
M<#X-"CQD:78@<W1Y;&4],T0G4$]3251)3TXZ(')E;&%T:79E.R!0041$24Y'
M+4)/5%1/33H@,'!T.R!0041$24Y'+4Q%1E0Z(#!P=#L@5TE$5$@Z(#@P)3L@
M4$%$1$E.1RU224=(5#H@,'!T.R!-05)'24XM3$5&5#H@,3`E.R!0041$24Y'
M+51/4#H@,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U1!0DQ%5TE$5$@L
M(C$P,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!
M1T=%1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@
M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$,3`P)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L^#0H-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%
M5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!W:61T:#TS1#$R/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=VED=&@],T0X."!A;&EG;CTS1&-E;G1E<CX\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$,3(^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!W:61T
M:#TS1#@X(&%L:6=N/3-$8V5N=&5R/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=VED=&@],T0Q,CX\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$.#@@86QI9VX],T1C
M96YT97(^/"]T9#X\(2TM(%1!0DQ%($-/3%5-3B!724142%,@14Y$("TM/CPO
M='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-
M"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE
M9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/EEE87(@16YD960\
M8G(@+SX-"D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V(^/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/EEE87(@16YD
M960\8G(@+SX-"D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3(\+V(^/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/EEE87(@
M16YD960\8G(@+SX-"D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3$\+V(^/"]F;VYT
M/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$
M=&]P(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0R/C<P)B,Q-C`[+28C
M,38P.S<R)3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ
M93TS1#(^-C@F(S$V,#LM)B,Q-C`[-S`E/"]F;VYT/CPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T1W
M:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N
M="!S:7IE/3-$,CY%>'!E8W1E9"!O<'1I;VX@=&5R;3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M/3-$,CXV+C`@665A<G,\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^4FES:RUF<F5E(&EN=&5R97-T(')A=&4\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,CXQ+C(F(S$V,#LM)B,Q-C`[
M,BXQ)3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS
M1#(^,"XY)B,Q-C`[+28C,38P.S$N-"4\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M9"!Y:65L9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT
M('-I>F4],T0R/DYO;F4\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF
M;VYT('-I>F4],T0R/DYO;F4\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M;VYT/CPO<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B
M.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q
M,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T,3DN
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY2159%
M3E5%/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E)%5D5.544\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)%5D5.544\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^#0H\<"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\8CXH,3,I(%)%5D5.544\
M+V(^/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.TEN(#$Y.3<L('1H92!#;VUP86YY(&QI
M8V5N<V5D(&ET<R!O<F%L(')O=&%V:7)U<R!S=')A:6X@=&\@1VQA>&]3;6ET
M:$ML:6YE)B,Q-C`[<&QC("A';&%X;RD@86YD($=L87AO(&%S<W5M960@<F5S
M<&]N<VEB:6QI='D@9F]R(&%L;"!S=6)S97%U96YT(&-L:6YI8V%L('1R:6%L
M<R!A;F0@86QL(&]T:&5R(&1E=F5L;W!M96YT(&%C=&EV:71I97,N(%1H92!#
M;VUP86YY)W,@;&EC96YS960M:6X@=&AE(')O=&%V:7)U<R!S=')A:6X@=&AA
M="!W87,@=7-E9"!T;R!D979E;&]P($=L87AO)W,@4F]T87)I>"!R;W1A=FER
M=7,@=F%C8VEN92!I;B`Q.3DU(&%N9"!O=V5D(&$@;&EC96YS92!F964@;V8@
M,S`E('1O($-I;F-I;FYA=&D@0VAI;&1R96XG<R!(;W-P:71A;"!-961I8V%L
M($-E;G1E<B`H0T-(*2!O;B!N970@<F]Y86QT:65S(')E8V5I=F5D(&9R;VT@
M1VQA>&\N($EN($UA>2`R,#`U+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@
M86X@86=R965M96YT('=H97)E8GD@86X@869F:6QI871E(&]F(%!A=6P@4F]Y
M86QT>2!&=6YD($E)+"8C,38P.TPN4"X@*%!21BD@<'5R8VAA<V5D(&$@-S`E
M(&EN=&5R97-T(&EN('1H92!N970@<F]Y86QT:65S('1H92!#;VUP86YY(')E
M8V5I=F5D(&]N('=O<FQD=VED92!S86QE<R!O9B!2;W1A<FEX+B!);B!$96-E
M;6)E<B`R,#$R+"!T:&4@1VQA>&\@86=R965M96YT(&5X<&ER960@875T;VUA
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M+C,F(S$V,#MM:6QL:6]N+"`D,3`N."8C,38P.VUI;&QI;VX@86YD("0Y+C$F
M(S$V,#MM:6QL:6]N(&9O<B!T:&4@>65A<G,@96YD960@1&5C96UB97(F(S$V
M,#LS,2P@,C`Q,RP@,C`Q,B!A;F0@,C`Q,2P@<F5S<&5C=&EV96QY+CPO9F]N
M=#X\+W`^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q
M-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W
M7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#(P+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T],3$%"
M3U)!5$E/3B!!1U)%14U%3E13/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-/3$Q!0D]2051)3TX@04=2145-14Y4
M4SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0T],3$%"3U)!5$E/3B!!1U)%14U%3E13/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].
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M86)L92!L:6-E;G-E(&9E92!E>'!E;G-E('=A<R`D,"XW)B,Q-C`[;6EL;&EO
M;BP@)#`N-R8C,38P.VUI;&QI;VX@86YD("0Q+C0F(S$V,#MM:6QL:6]N(&9O
M<B!T:&4@>65A<G,@96YD960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@,C`Q
M,B!A;F0@,C`Q,2P@<F5S<&5C=&EV96QY+CPO9F]N=#X\+W`^#0H\<"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y-
M961A<F5X+"8C,38P.TEN8RXL(&$@<W5B<VED:6%R>2!O9B!"<FES=&]L+4UY
M97)S(%-Q=6EB8B`H365D87)E>"D\+VD^/"]F;VYT/CPO<#X-"CQP('-T>6QE
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M;&EC96YS960@<')O9'5C="X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A
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M960@=&\@<&%Y(&UI;&5S=&]N97,@;V8@=7`@=&\@)#<N,"8C,38P.VUI;&QI
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M:"!L:6-E;G-E9"!A;G1I8F]D:65S('5N=&EL('1H92!L871E<B!O9B`H:2DF
M(S$V,#MT:&4@97AP:7)A=&EO;B!O9B!T:&4@;&%S="!T;R!E>'!I<F4@87!P
M;&EC86)L92!P871E;G0@86YD("AI:2DF(S$V,#MT:&4@=&5N=&@@86YN:79E
M<G-A<GD@;V8@=&AE(&9I<G-T(&-O;6UE<F-I86P@<V%L92!O9B!S=6-H(&QI
M8V5N<V5D('!R;V1U8W0N($EN(%-E<'1E;6)E<B`R,#$P+"!T:&4@0V]M<&%N
M>2!E>&5R8VES960@86X@;W!T:6]N('5N9&5R('1H92!A9W)E96UE;G0L('=H
M97)E8GD@:70@;&EC96YS960@9G)O;2!-961A<F5X(&%C8V5S<R!T;R!T:&4@
M56QT:4UA8B!T96-H;F]L;V=Y('1O(&1E=F5L;W`@86YD(&-O;6UE<F-I86QI
M>F4@:'5M86X@86YT:6)O9&EE<R!T;R!#1#(W+"!I;F-L=61I;F<@=F%R;&EL
M=6UA8BX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^4F]C:V5F96QL97(@56YI=F5R<VET
M>2`H4F]C:V5F96QL97(I/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M);B!.;W9E
M;6)E<B`R,#`U+"!T:&4@0V]M<&%N>2!A;F0@4F]C:V5F96QL97(@96YT97)E
M9"!I;G1O(&$@;&EC96YS92!A9W)E96UE;G0@9F]R('1H92!E>&-L=7-I=F4@
M=V]R;&1W:61E(')I9VAT<R!T;R!H=6UA;B!$14,M,C`U(')E8V5P=&]R+"!W
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M;6EL97-T;VYE<R!O9B!U<"!T;R`D,RXY)B,Q-C`[;6EL;&EO;B!U<&]N(&]B
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M,C`U(')E8V5P=&]R+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y$=6ME(%5N:79E<G-I
M='D@0G)A:6X@5'5M;W(@0V%N8V5R($-E;G1E<B`H1'5K92D\+VD^/"]F;VYT
M/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R8C,38P.TEN(%-E<'1E;6)E<B`R,#`V+"!T:&4@0V]M<&%N>2!A
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M(&UI;&5S=&]N92!O9B!U<"!T;R`D,"XW)B,Q-C`[;6EL;&EO;B!U<&]N(&]B
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M/CQI/DQU9'=I9R!);G-T:71U=&4@9F]R($-A;F-E<B!297-E87)C:"`H3'5D
M=VEG*3PO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[26X@3V-T;V)E<B`R,#`V+"!T
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M=7`@=&\@)#$N,"8C,38P.VUI;&QI;VX@=7!O;B!O8G1A:6YI;F<@9FER<W0@
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M;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^/&D^06QT97)I<R!4:&5R87!E=71I8W,L)B,Q-C`[26YC
M+B`H06QT97)I<RD\+VD^/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TEN($]C=&]B97(@
M,C`P-2P@=&AE($-O;7!A;GD@8V]M<&QE=&5D('1H92!A8W%U:7-I=&EO;B!O
M9B!T:&4@87-S971S(&]F($%L=&5R:7,L(&EN8VQU9&EN9R!T:&4@14=&4G9)
M24D@;6]L96-U;&4N(%1H92!#;VUP86YY(&UA>2!B92!R97%U:7)E9"!T;R!P
M87D@06QT97)I<R!U<"!T;R`D-2XP)B,Q-C`[;6EL;&EO;B!U<&]N(&]B=&%I
M;FEN9R!T:&4@9FER<W0@87!P<F]V86P@9F]R(&-O;6UE<F-I86P@<V%L92!O
M9B!A('!R;V1U8W0@8V]N=&%I;FEN9R!%1T92=DE)22P@:6YC;'5D:6YG(')I
M;F1O<&5P:6UU="X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^56YI=F5R<VET>2!O9B!3
M;W5T:&%M<'1O;BP@54L@*%-O=71H86UP=&]N*3PO:3X\+V9O;G0^/"]P/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[26X@3F]V96UB97(@,C`P."P@=&AE($-O;7!A;GD@96YT97)E9"!I
M;G1O(&$@;&EC96YS92!A9W)E96UE;G0@=VET:"!3;W5T:&%M<'1O;B!T;R!D
M979E;&]P(&AU;6%N(&%N=&EB;V1I97,@=&]W87)D<R!#1#(W+"!A('!O=&5N
M=&EA;&QY(&EM<&]R=&%N="!T87)G970@9F]R(&EM;75N;W1H97)A<'D@;V8@
M=F%R:6]U<R!C86YC97)S+B!4:&4@0V]M<&%N>2!M87D@8F4@<F5Q=6ER960@
M=&\@<&%Y(&UI;&5S=&]N97,@;V8@=7`@=&\@87!P<F]X:6UA=&5L>2`D,2XT
M)B,Q-C`[;6EL;&EO;B!U<&]N(&]B=&%I;FEN9R!F:7)S="!A<'!R;W9A;"!F
M;W(@8V]M;65R8VEA;"!S86QE(&EN(&$@9FER<W0@:6YD:6-A=&EO;B!A;F0@
M<F]Y86QT>2!P87EM96YT<R!I;B!T:&4@;&]W+7-I;F=L92!D:6=I=',@;VX@
M86YY(&YE="!P<F]D=6-T('-A;&5S('1O(%-O=71H86UP=&]N('=I=&@@<F5S
M<&5C="!T;R!D979E;&]P;65N="!A;F0@8V]M;65R8VEA;&EZ871I;VX@;V8@
M=F%R;&EL=6UA8BX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
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M;R!#1%@M,S`Q(&%N9"!#1#0P(&QI9V%N9"`H0T0T,$PI+B!#1%@M,S`Q(&%N
M9"!#1#0P3"!A<F4@:6UM=6YE(&UO9'5L871I;F<@;6]L96-U;&5S('1H870@
M:6YC<F5A<V4@=&AE(&YU;6)E<G,@86YD(&%C=&EV:71Y(&]F(&EM;75N92!C
M96QL<R!T:&%T(&-O;G1R;VP@:6UM=6YE(')E<W!O;G-E<RX@5&AE($-O;7!A
M;GD@;6%Y(&)E(')E<75I<F5D('1O('!A>2!M:6QE<W1O;F5S(&]F('5P('1O
M("0Q+C`F(S$V,#MM:6QL:6]N('5P;VX@;V)T86EN:6YG(&9I<G-T(&%P<')O
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M0T18+3,P,2X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^4V5A='1L92!'96YE=&EC<RPF
M(S$V,#M);F,N("A396%T=&QE($=E;F5T:6-S*3PO:3X\+V9O;G0^/"]P/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[26X@8V]N;F5C=&EO;B!W:71H('1H92!#=7)A1V5N(&%C<75I<VET
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M(&)E(')E<75I<F5D('1O('!A>2!M:6QE<W1O;F5S(&]F('5P('1O("0U+C`F
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M86(@=F5D;W1I;B!A;F0@0T18+3`Q-"X\+V9O;G0^/"]P/@T*/"]D:78^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DE.0T]-12!405A%4SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY)3D-/344@
M5$%815,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DE.0T]-12!405A%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQB/B@Q-2D@24Y#3TU%(%1!6$53
M/"]B/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
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M1$E.1RU224=(5#H@,'!T.R!-05)'24XM3$5&5#H@,3`E.R!0041$24Y'+51/
M4#H@,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U1!0DQ%5TE$5$@L(C$P
M,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!1T=%
M1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@8F]R
M9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$,3`P)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L^#0H-"CQT<B!S='EL
M93TS1'!A9&1I;F<Z,#L^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%5"`M
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M:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!W:61T:#TS1#$R/CPO=&0^/"$M+2!404),12!#3TQ5
M34X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP
M.R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$."!A;&EG;CTS1&-E;G1E
M<CX\9F]N="!S:7IE/3-$,3X\8CY996%R($5N9&5D($1E8V5M8F5R)B,Q-C`[
M,S$L/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO
M='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-
M"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE
M9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB
M/C(P,3,\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$
M8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q
M/CQB/C(P,3$\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
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M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
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M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,S`L.38R/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
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M,C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXS+#$S,3PO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$=VAI=&4^
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M($YE="!/<&5R871I;F<@3&]S<V5S(&%N9"!297-E87)C:"8C,38P.R9A;7`[
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M='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-
M04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!
M3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&
M1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH
M96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M/&9O;G0@<VEZ93TS1#(^,3DL,#`X/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^1&5F97)R960@=&%X('9A;'5A=&EO;B!A
M;&QO=V%N8V4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]2
M3U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=5
M5%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ
M<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M($U!4D=)3BU,1494.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXD/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXD/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S@R,3([/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-
M04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!
M3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&
M1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH
M96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#
M3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/
M34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N-S5P=#LB("TM
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M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O
M;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I=CX-"CPA+2T@96YD(&]F('5S
M97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I=CX-"CQP('-T>6QE
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M4$%$1$E.1RU224=(5#H@,'!T.R!-05)'24XM3$5&5#H@,3`E.R!0041$24Y'
M+51/4#H@,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U1!0DQ%5TE$5$@L
M(C$P,"4B("TM/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!
M1T=%1"!404),12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@
M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$,3`P)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L^#0H-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%
M5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
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M.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!W:61T:#TS1#$R/CPO=&0^/"$M+2!404),12!#
M3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN
M9SHP.R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$S/"]B/CPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\
M8CXR,#$R/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$Q/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^
M)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#@@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^*$EN('1H
M;W5S86YD<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F
M;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
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M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-34%.
M1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$
M/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[(B`M+3X\+V9O
M;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O
M;G0@<VEZ93TS1#(^3&]S<R!A="!3=&%T=71O<GD@4F%T97,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^
M/&9O;G0@<VEZ93TS1#(^4F5S96%R8V@@86YD($1E=F5L;W!M96YT($-R961I
M=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH,RPR
M-C$\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S@R,3([/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M
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M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R
M/D5X<&ER871I;VX@;V8@3F5T($]P97)A=&EN9R!,;W-S97,@86YD(%)E<V5A
M<F-H)B,Q-C`[)F%M<#L@1&5V96QO<&UE;G0@5&%X($-R961I=',\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M;&]W86YC93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M,C`U/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ.2PP,#@\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A
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M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S@R,3([/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S
M:7IE/3-$,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S@R
M,3([/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXF(S@R,3([/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU
M<'0[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P
M=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D
M9&EN9SHP.R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
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M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\
M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P
M=#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T
M.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I=CX-"CPA
M+2T@96YD(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I
M=CX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.T1E9F5R<F5D('1A>"!A<W-E=',@86YD(&QI86)I;&ET:65S
M(&%R92!R96-O9VYI>F5D(&)A<V5D(&]N('1E;7!O<F%R>2!D:69F97)E;F-E
M<R!B971W965N('1H92!F:6YA;F-I86P@<F5P;W)T:6YG(&%N9"!T87@@8F%S
M:7,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE<R!U<VEN9R!F=71U<F4@97AP
M96-T960@96YA8W1E9"!R871E<RX@02!V86QU871I;VX@86QL;W=A;F-E(&ES
M(')E8V]R9&5D(&%G86EN<W0@9&5F97)R960@=&%X(&%S<V5T<R!I9B!I="!I
M<R!M;W)E(&QI:V5L>2!T:&%N(&YO="!T:&%T('-O;64@;W(@86QL(&]F('1H
M92!D969E<G)E9"!T87@@87-S971S('=I;&P@;F]T(&)E(')E86QI>F5D+CPO
M9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#M4:&4@<')I;F-I<&%L(&-O;7!O;F5N=',@;V8@
M=&AE(&1E9F5R<F5D('1A>"!A<W-E=',@86YD(&QI86)I;&ET:65S(&%T($1E
M8V5M8F5R)B,Q-C`[,S$L(#(P,3,@86YD(#(P,3(L(')E<W!E8W1I=F5L>2P@
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M($-/34U!3D0]041$7U1!0DQ%5TE$5$@L(C$P,"4B("TM/CPO9F]N=#X\+W`^
M#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X-"CQD:78@
M86QI9VX],T1C96YT97(^#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1'1E
M>'0M86QI9VXZ;&5F=#L^#0H-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L^/"$M
M+2!404),12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&
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M2%,@14Y$("TM/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB
M<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT
M('-I>F4],T0Q/CQB/D1E8V5M8F5R)B,Q-C`[,S$L/&)R("\^#0HR,#$S/"]B
M/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\
M9F]N="!S:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+#QB<B`O/@T*,C`Q
M,CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X\+W1R
M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1B;W1T;VT^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T
M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q
M/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0U(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I
M>F4],T0Q/CQB/BA);B!T:&]U<V%N9',I/"]B/CPO9F]N=#X\8G(@+SX\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT
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M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H
M:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,C!P=#LG/CQF;VYT
M('-I>F4],T0R/D1E9F5R<F5D($5X<&5N<V5S/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C
M0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,C!P=#LG/CQF
M;VYT('-I>F4],T0R/E-T;V-K+6)A<V5D($-O;7!E;G-A=&EO;CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,C!P
M=#LG/CQF;VYT('-I>F4],T0R/D9I>&5D($%S<V5T<SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS
M1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P
M=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2
M+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI
M;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$
M,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
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M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
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M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SXF
M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C$W,BPV
M.3<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N
M/3-$=&]P(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'
M24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/D=R;W-S($1E9F5R<F5D
M(%1A>"!,:6%B:6QI=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P
M861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^
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M861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT
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M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS
M1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP
M.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R!-05)'24XM3$5&5#H@,3!P=#LG/B8C,38P.SPO<#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<VEZ93TS1#(^*#@L-S<V/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-I>F4],T0R/BD\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^*#DL,30R/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I
M>F4],T0R/BD\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I
M;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-
M04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!
M3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
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M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@
M=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
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M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,3(X+#$V-3PO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,C!P
M=#LG/CQF;VYT('-I>F4],T0R/D1E9F5R<F5D(%1A>"!!<W-E=',@5F%L=6%T
M:6]N($%L;&]W86YC93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F
M9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\
M(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T
M.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI
M9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3F5T($1E9F5R<F5D
M(%1A>"!!<W-E="`H3&EA8FEL:71Y*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M"CQT<B!S='EL93TS1"=P861D:6YG.C`[($9/3E0M4TE:13H@,2XU<'0[)R!V
M86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&
M1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE
M:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F
M9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N
M-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D
M9&EN9SHP.R!&3TY4+5-)6D4Z(#$N-7!T.R<@=F%L:6=N/3-$=&]P(&)G8V]L
M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/CPO
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M(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q,B!R96QA=&5S('1O('1H92!T96UP;W)A
M<GD@9&EF9F5R96YC97,@87-S;V-I871E9"!W:71H('1H92!)4%(F86UP.T0@
M:6YT86YG:6)L92!A<W-E=',@86-Q=6ER960@:6X@=&AE($-U<F%'96X@86-Q
M=6ES:71I;VXL('=H:6-H(&%R92!N;W0@9&5D=6-T:6)L92!F;W(@=&%X('!U
M<G!O<V5S+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M!<R!O9B!$96-E;6)E<B8C,38P
M.S,Q+"`R,#$S+"!T:&4@0V]M<&%N>2!H860@=&AE(&9O;&QO=VEN9R!F961E
M<F%L(&YE="!O<&5R871I;F<@;&]S<R`H(DY/3"(I(&-A<G)Y9F]R=V%R9',Z
M/"]F;VYT/CPO<#X-"CQU;#X-"CQL:2!S='EL93TS1"=L:7-T+7-T>6QE.B!N
M;VYE.R<^#0H\9&P@8V]M<&%C=#TS1&-O;7!A8W0^#0H\9'0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM0D]45$]-.B`M,3%P=#LG/CQF
M;VYT('-I>F4],T0R/B8C.#(R-CL\+V9O;G0^/"]D=#X-"CQD9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CY0<FEO<B!T
M;R!T:&4@;65R9V5R(&]F('1H92!#;VUP86YY(&%N9"!!5D%.5"P@)#,S+C`F
M(S$V,#MM:6QL:6]N('=A<R!G96YE<F%T960@8GD@=&AE($-O;7!A;GD@=VAI
M8V@@97AP:7)E(&%T('9A<FEO=7,@9&%T97,@<W1A<G1I;F<@:6X@,C`R,R!A
M;F0@9V]I;F<@=&AR;W5G:"`R,#(X.SPO9F]N=#X@/&9O;G0@<VEZ93TS1#(^
M/&)R("\^#0H\8G(@+SX\+V9O;G0^/"]D9#X-"CQD="!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[($U!4D=)3BU"3U143TTZ("TQ,7!T.R<^/&9O;G0@
M<VEZ93TS1#(^)B,X,C(V.SPO9F]N=#X\+V1T/@T*/&1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/E!R:6]R('1O('1H
M92!M97)G97(@;V8@=&AE($-O;7!A;GD@86YD($%604Y4+"`D,3`Q+C(F(S$V
M,#MM:6QL:6]N+"!N970@;V8@97AP:7)A=&EO;G,@86YD('5T:6QI>F%T:6]N
M+"!W87,@9V5N97)A=&5D(&)Y($%604Y4('=H:6-H(&5X<&ER92!A="!V87)I
M;W5S(&1A=&5S('-T87)T:6YG(&EN(#(P,3@@86YD(&=O:6YG('1H<F]U9V@@
M,C`R."X@1'5R:6YG('1H92!Y96%R<R!E;F1E9"P@1&5C96UB97(F(S$V,#LS
M,2P@,C`Q,R!A;F0@,C`Q,BP@3D],<R!O9B`D,"!A;F0@)#$V+C0F(S$V,#MM
M:6QL:6]N(&5X<&ER960L(')E<W!E8W1I=F5L>3L\+V9O;G0^(#QF;VYT('-I
M>F4],T0R/CQB<B`O/@T*/&)R("\^/"]F;VYT/CPO9&0^#0H\9'0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM0D]45$]-.B`M,3%P=#LG
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M=&EN9R!I;B`R,#(X(&%N9"!G;VEN9R!T:')O=6=H(#(P,S,[(&%N9#PO9F]N
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M>2P@)#4Q."XS)B,Q-C`[;6EL;&EO;B!W87,@9V5N97)A=&5D(&)Y($-U<F%'
M96XN/"]F;VYT/CPO9&0^/"]D;#X\+VQI/CPO=6P^#0H\<"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M!<R!O9B!$
M96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!T:&4@0V]M<&%N>2!H87,@86X@861D
M:71I;VYA;"`D-BXP)B,Q-C`[;6EL;&EO;B!O9B!F961E<F%L(&%N9"!S=&%T
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M;W)D86YC92!W:71H($%30R`W,3@N/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$
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M(&EN('1H92!S=&]C:R!O9B!A(&-O<G!O<F%T:6]N(&)Y(&UO<F4@=&AA;B`U
M,"8C,38P.W!E<F-E;G1A9V4@<&]I;G1S(&]V97(@82!T:')E92UY96%R('!E
M<FEO9"X@4W5C:"!O=VYE<G-H:7`@8VAA;F=E<R!C86X@<VEG;FEF:6-A;G1L
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M9R!.3TQS(&]F("0T,"XT)B,Q-C`[;6EL;&EO;BX@1F]L;&]W:6YG('1H92!M
M97)G97(@;V8@=&AE($-O;7!A;GD@86YD($%604Y4+"!T:&4@0V]M<&%N>2!E
M>'!E<FEE;F-E9"!C:&%N9V5S(&EN(&]W;F5R<VAI<"!A<R!D969I;F5D(&)Y
M(%-E8W1I;VXF(S$V,#LS.#(@:6X@2G5N92`R,#`Y(&%N9"!$96-E;6)E<B`R
M,#`Y+B!&=7)T:&5R+"!P<FEO<B!T;R!T:&4@059!3E0@;65R9V5R+"!T:&4@
M0V]M<&%N>2!A<R!A('-T86YD(&%L;VYE(&-O;7!A;GD@97AP97)I96YC960@
M82!C:&%N9V4@:6X@;W=N97)S:&EP(&EN($]C=&]B97(@,C`P-RX@07,@82!R
M97-U;'0@;V8@=&AE(&]W;F5R<VAI<"!C:&%N9V4@:6X@3V-T;V)E<B`R,#`W
M+"!U=&EL:7IA=&EO;B!O9B!T:&4@0V]M<&%N>2=S($Y/3',@<')I;W(@=&\@
M3V-T;V)E<B`R,#`W(&ES('-U8FIE8W0@=&\@86X@86YN=6%L(&QI;6ET871I
M;VX@;V8@)#0N-28C,38P.VUI;&QI;VX@;VX@)#(X+C,F(S$V,#MM:6QL:6]N
M(&]F($Y/3',@9V5N97)A=&5D(&)E9F]R92!T:&%T(&1A=&4N($%S(&$@<F5S
M=6QT(&]F('1H92!O=VYE<G-H:7`@8VAA;F=E<R!I;B!*=6YE(#(P,#D@86YD
M($1E8V5M8F5R(#(P,#DL('1H97)E(&ES(&%N(&%N;G5A;"!L:6UI=&%T:6]N
M(&%M;W5N="!O9B`D-BXP)B,Q-C`[;6EL;&EO;B!O;B`D-C<N-R8C,38P.VUI
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M<V5A<F-H(&%N9"!D979E;&]P;65N="`H(E(F86UP.T0B*2!C<F5D:71S(&]F
M("0R,"XX)B,Q-C`[;6EL;&EO;B!A;F0@)#$T+C0F(S$V,#MM:6QL:6]N+"!R
M97-P96-T:79E;'DL('=I;&P@8F4@=71I;&EZ960@:6X@=&AE(&9U='5R92!P
M97)I;V1S+B!&=7)T:&5R+"!T:&4@0V]M<&%N>2=S(&%B:6QI='D@=&\@=7-E
M('1H92!S=&%T92!.3TQS(&]F(&%P<')O>&EM871E;'D@)#$P."XS)B,Q-C`[
M;6EL;&EO;B!A;F0@=&AE(')E;6%I;FEN9R!F961E<F%L(&%N9"!S=&%T92!2
M)F%M<#M$(&-R961I="!C87)R>69O<G=A<F1S(&]F(&%P<')O>&EM871E;'D@
M)#$Y+C0F(S$V,#MM:6QL:6]N(&%N9"`D.2XS)B,Q-C`[;6EL;&EO;BP@<F5S
M<&5C=&EV96QY+"!M87D@8F4@<W5B<W1A;G1I86QL>2!L:6UI=&5D+B!4:&5S
M92!S=&%T92!.3TQS(&%N9"!F961E<F%L(&%N9"!S=&%T92!C<F5D:71S(&5X
M<&ER92!A="!V87)I;W5S(&1A=&5S('-T87)T:6YG(&EN(#(P,38@9V]I;F<@
M=&AR;W5G:"`R,#,S+B!4:&4@0V]M<&%N>2!H87,@;F]T('EE="!C;VUP;&5T
M960@82!S='5D>2!O9B!T:&5S92!C<F5D:71S('1O('-U8G-T86YT:6%T92!T
M:&4@86UO=6YT<RX@56YT:6P@82!S='5D>2!I<R!C;VUP;&5T960L(&YO(&%M
M;W5N=',@87)E(&)E:6YG('!R97-E;G1E9"!A<R!A;B!U;F-E<G1A:6X@=&%X
M('!O<VET:6]N+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
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M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[5&AE($-O;7!A;GD@87!P;&EE<R!T:&4@875T:&]R:71A=&EV92!G
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M96-E;6)E<B8C,38P.S,Q+"`R,#$S(&%N9"`R,#$R+"!W92!H860@;F\@=6YR
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M+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
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M:6]N<R!F;W(@86YY('1A>"!Y96%R+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS
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M;W)W87)D<RP@8V%P:71A;&EZ960@4B9A;7`[1"!E>'!E;F1I='5R97,@86YD
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M86EN=&%I;F5D(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@86=A:6YS="!T
M:&4@0V]M<&%N>2=S(&YE="!D969E<G)E9"!T87@@87-S971S+CPO9F]N=#X\
M+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#M4:&4@06UE<FEC86X@5&%X<&%Y97(@4F5L:65F($%C="!O
M9B`R,#$R('=A<R!E;F%C=&5D(&]N($IA;G5A<GDF(S$V,#LR+"`R,#$S('5N
M9&5R('=H:6-H('1H92!F961E<F%L(')E<V5A<F-H(&%N9"!D979E;&]P;65N
M="!C<F5D:70@=V%S(')E=')O86-T:79E;'D@97AT96YD960@9F]R(&%M;W5N
M=',@<&%I9"!O<B!I;F-U<G)E9"!A9G1E<B!$96-E;6)E<B8C,38P.S,Q+"`R
M,#$Q('1H<F]U9V@@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RX@5&AE(&5F9F5C
M=',@;V8@=&AE(&-H86YG92!I;B!T:&4@=&%X(&QA=R!W97)E(')E8V]G;FEZ
M960@:6X@=&AE(&9I<G-T('%U87)T97(@;V8@,C`Q,RP@=VAI8V@@:7,@=&AE
M('%U87)T97(@:6X@=VAI8V@@=&AE(&QA=R!W87,@96YA8W1E9"X\+V9O;G0^
M/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/34U)5$U%
M3E13($%.1"!#3TY424Y'14Y#2453/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-/34U)5$U%3E13($%.1"!#3TY4
M24Y'14Y#2453/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#3TU-251-14Y44R!!3D0@0T].5$E.1T5.0TE%4SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US
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M('1H<F]U9V@@,C`Q.2X@0V5R=&%I;B!O9B!T:&5S92!F86-I;&ET>2!L96%S
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M(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@9&\@;F]T(&EN8VQU9&4@=&AE
M(&5X97)C:7-E(&]F(')E;F5W86P@=&5R;7,@;W(@96%R;'D@=&5R;6EN871I
M;VX@<')O=FES:6]N<R`H:6X@=&AO=7-A;F1S*3H\+V9O;G0^/"]P/@T*/&1I
M=B!S='EL93TS1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-
M.B`P<'0[(%!!1$1)3D<M3$5&5#H@,'!T.R!724142#H@-S`E.R!0041$24Y'
M+5))1TA4.B`P<'0[($U!4D=)3BU,1494.B`Q-24[(%!!1$1)3D<M5$]0.B`P
M<'0[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?5$%"3$5724142"PB,3`P)2(@
M+2T^/"]F;VYT/CPO<#X-"CPA+2T@57-E<BUS<&5C:69I960@5$%'1T5$(%1!
M0DQ%("TM/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L92!B;W)D97(]
M,T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q
M,#`E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.SX-"@T*/'1R('-T>6QE/3-$
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M=&0^/"$M+2!404),12!#3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R
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M.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@
M<VEZ93TS1#(^,C`Q-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
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M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O
M;G0@<VEZ93TS1#(^,C`Q-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
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M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF
M;VYT('-I>F4],T0R/C(P,3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N
M="!S:7IE/3-$,CXQ+#<V-3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N
M=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG
M/CQF;VYT('-I>F4],T0R/C(P,3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXU,#$\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O
M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^
M/&9O;G0@<VEZ93TS1#(^5&AE<F5A9G1E<CPO9F]N=#X\+W`^/"]T9#X-"CQT
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M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/
M4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L
M:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[
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M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@;6EN:6UU;2!L96%S92!P87EM
M96YT<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
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M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&
M1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H
M=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V
M,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS
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M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@
M+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP
M+C<U<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%
M.B`Q+C5P=#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&
M1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG
M:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R
M+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^#0H\<"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M4:&4@
M0V]M<&%N>2=S('1O=&%L(')E;G0@86YD($-!32!E>'!E;G-E(&9O<B!A;&P@
M9F%C:6QI='D@;&5A<V5S('=A<R`D,BXW)B,Q-C`[;6EL;&EO;BP@)#(N-28C
M,38P.VUI;&QI;VX@86YD("0R+C4F(S$V,#MM:6QL:6]N(&9O<B!T:&4@>65A
M<G,@96YD960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@,C`Q,B!A;F0@,C`Q
M,2P@<F5S<&5C=&EV96QY+CPO9F]N=#X\+W`^#0H\+V1I=CX\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?
M-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O
M5V]R:W-H965T<R]3:&5E=#(S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^4D5425)%345.5"!3059)3D=3(%!,04X\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4D54
M25)%345.5"!3059)3D=3(%!,04X\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)%5$E214U%3E0@4T%624Y'4R!03$%./"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F
M;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG
M/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^/&(^*#$W*2!2151)4D5-14Y4(%-!5DE.1U,@4$Q!3CPO8CX\+V9O
M;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@;6%I;G1A:6YS(&$@-#`Q*&LI
M(%!L86X@=VAI8V@@:7,@879A:6QA8FQE('1O('-U8G-T86YT:6%L;'D@86QL
M(&5M<&QO>65E<RX@56YD97(@=&AE('1E<FUS(&]F('1H92`T,#$H:RD@4&QA
M;BP@<&%R=&EC:7!A;G1S(&UA>2!E;&5C="!T;R!C;VYT<FEB=71E('5P('1O
M(#$U)2!O9B!T:&5I<B!C;VUP96YS871I;VXL(&]R('1H92!S=&%T=71O<GD@
M<')E<V-R:6)E9"!L:6UI=',N(%1H92!#;VUP86YY(&UA>2!M86ME(#4P)2!M
M871C:&EN9R!C;VYT<FEB=71I;VYS(&]N('5P('1O(#0E(&]F(&$@<&%R=&EC
M:7!A;G0G<R!A;FYU86P@<V%L87)Y+B!"96YE9FET(&5X<&5N<V4@9F]R('1H
M92`T,#$H:RD@4&QA;B!W87,@)#`N,R8C,38P.VUI;&QI;VXL("0P+C(F(S$V
M,#MM:6QL:6]N(&%N9"`D,"XR)B,Q-C`[;6EL;&EO;B!F;W(@=&AE('EE87)S
M(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$L
M(')E<W!E8W1I=F5L>2X\+V9O;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E-%3$5#5$5$(%%505)415),62!&24Y!3D-)04P@1$%4
M02`H56YA=61I=&5D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY314Q%0U1%1"!154%25$523%D@1DE.04Y#24%,
M($1!5$$@*%5N875D:71E9"D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-%3$5#5$5$(%%505)415),62!&24Y!3D-)04P@
M1$%402`H56YA=61I=&5D*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\8CXH,3@I(%-%3$5#5$5$(%%5
M05)415),62!&24Y!3D-)04P@1$%402`H56YA=61I=&5D*3PO8CX\+V9O;G0^
M/"]P/@T*/&1I=B!S='EL93TS1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)
M3D<M0D]45$]-.B`P<'0[(%!!1$1)3D<M3$5&5#H@,'!T.R!724142#H@-S`E
M.R!0041$24Y'+5))1TA4.B`P<'0[($U!4D=)3BU,1494.B`Q-24[(%!!1$1)
M3D<M5$]0.B`P<'0[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?5$%"3$572414
M2"PB,3`P)2(@+2T^/"]F;VYT/CPO<#X-"CPA+2T@57-E<BUS<&5C:69I960@
M5$%'1T5$(%1!0DQ%("TM/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L
M92!S='EL93TS1"=T97AT+6%L:6=N.FQE9G0[5$585"U!3$E'3CH@;&5F=#L@
M5TE$5$@Z(#8Q,7!X.R<@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('=I9'1H/3-$-C$Q/@T*#0H\='(@<W1Y;&4],T0G<&%D
M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)SX\(2TM
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M.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
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M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!W:61T:#TS1#$R/CPO=&0^
M/"$M+2!404),12!#3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'
M+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@
M,'!X.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^#0H\
M9&EV('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!724142#H@,3=P=#L@34%21TE.+4)/5%1/33H@,'!T.R<^/&9O;G0@<VEZ
M93TS1#$^/&(^,C`Q,R`\(2TM($-/34U!3D0]041$7U-#4D]04$5$4E5,12PQ
M-W!T("TM/CPO8CX\+V9O;G0^/"]D:78^/"]T:#X-"CQT:"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^43$@,C`Q,SPO8CX\
M+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O
M;G0@<VEZ93TS1#$^/&(^43(@,C`Q,SPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF
M(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^43,@
M,C`Q,SPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C
M96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^430@,C`Q,SPO8CX\+V9O;G0^/"]T
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M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@<F5V96YU93PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
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M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXV,C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@
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M>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
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M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M/&9O;G0@<VEZ93TS1#(^*#(R+#`V,CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE
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M:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ
M93TS1#(^0F%S:6,@86YD(&1I;'5T960@;F5T(&QO<W,@<&5R(&-O;6UO;B!S
M:&%R93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
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M<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^*#`N,C0\+V9O;G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I=CX-"CQP('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQB<B`O/CPO9F]N
M=#XF(S$V,#L\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV
M93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)
M1%1(.B`W,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$U
M)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]4
M04),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*/"$M+2!5<V5R+7-P
M96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M415A4+4%,24=.
M.B!L969T.R!724142#H@-C`Y<'@[)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0V,#D^#0H-"CQT<B!S='EL
M93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,
M1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P
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M:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[
M(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)
M3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M;&5F=#X-"CQD:78@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[(%=)1%1(.B`Q-W!T.R!-05)'24XM0D]45$]-.B`P<'0[)SX\
M9F]N="!S:7IE/3-$,3X\8CXR,#$R(#PA+2T@0T]-34%.1#U!1$1?4T-23U!0
M141254Q%+#$W<'0@+2T^/"]B/CPO9F]N=#X\+V1I=CX\+W1H/@T*/'1H('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C
M,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY1,2`R
M,#$R/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY1,B`R,#$R/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$
M,3X\8CY1,R`R,#$R/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N
M=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A
M;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY1-"`R,#$R/"]B/CPO
M9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&
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M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
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M>F4],T0R/C(L,#`Y/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^0F%S:6,@86YD(&1I;'5T960@;F5T(&QO
M<W,@<&5R(&-O;6UO;B!S:&%R93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/CQF
M;VYT('-I>F4],T0R/B@P+C(W/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^*3PO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS
M1#(^*#`N,C,\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M96YD(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I=CX\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X
M85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#(U+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%3$E!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY354U-05)9($]&(%-)
M1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,@*%!O;&EC:65S*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3
M54U-05)9($]&(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A<VES
M(&]F(%!R97-E;G1A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQI/D)A<VES(&]F(%!R97-E;G1A
M=&EO;CPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE(&%C8V]M<&%N>6EN9R!C
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M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y5<V4@;V8@17-T:6UA=&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^57-E(&]F($5S=&EM871E
M<SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE('!R97!A<F%T:6]N(&]F('1H
M92!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N9F]R
M;6ET>2!W:71H(&%C8V]U;G1I;F<@<')I;F-I<&QE<R!G96YE<F%L;'D@86-C
M97!T960@:6X@=&AE(%5N:71E9"!3=&%T97,@;V8@06UE<FEC82`H52Y3+B8C
M,38P.T=!05`I(')E<75I<F5S(&UA;F%G96UE;G0@=&\@;6%K92!E<W1I;6%T
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M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!#87-H($5Q=6EV
M86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S
M='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^/&D^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<SPO
M:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@8V]N<VED97)S(&%L
M;"!H:6=H;'D@;&EQ=6ED(&EN=F5S=&UE;G1S('!U<F-H87-E9"!W:71H(&$@
M;6%T=7)I='D@9&%T92!O9B`Y,"8C,38P.V1A>7,@;W(@;&5S<R!A="!T:&4@
M9&%T92!O9B!P=7)C:&%S92!T;R!B92!C87-H(&5Q=6EV86QE;G1S+B!#87-H
M(&5Q=6EV86QE;G1S(&-O;G-I<W0@<')I;F-I<&%L;'D@;V8@;6]N97D@;6%R
M:V5T(&9U;F1S(&%N9"!D96)T('-E8W5R:71I97,N/"]F;VYT/CPO<#X-"CPO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^36%R:V5T86)L92!396-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^36%R:V5T
M86)L92!396-U<FET:65S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&
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M:79E(&EN8V]M92`H;&]S<RDL('=H:6-H(&ES(&$@<V5P87)A=&4@8V]M<&]N
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M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYC96YT<F%T
M:6]N(&]F($-R961I="!2:7-K(&%N9"!O9B!3:6=N:69I8V%N="!#=7-T;VUE
M<G,@86YD(%-U<'!L:65R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQI/D-O;F-E;G1R871I;VX@;V8@
M0W)E9&ET(%)I<VL@86YD(&]F(%-I9VYI9FEC86YT($-U<W1O;65R<R!A;F0@
M4W5P<&QI97)S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!
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M;G1S+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M2979E;G5E(&9R;VT@1VQA>&\@<F5P
M<F5S96YT960@-3<E+"`Y-B4@86YD(#DX)2!F;W(@=&AE('EE87)S(&5N9&5D
M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$@86YD(&]F
M('1O=&%L($-O;7!A;GD@<F5V96YU92P@<F5S<&5C=&EV96QY+CPO9F]N=#X\
M+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
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M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!686QU
M92!-96%S=7)E;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\:3Y&86ER(%9A;'5E($UE87-U<F5M
M96YT<SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@:&%S(&-E
M<G1A:6X@87-S971S(&%N9"!L:6%B:6QI=&EE<R!T:&%T(&%R92!M96%S=7)E
M9"!A="!F86ER('9A;'5E(&EN('1H92!F:6YA;F-I86P@<W1A=&5M96YT<RX@
M5&AE($-O;7!A;GD@<V5E:W,@=&\@;6%X:6UI>F4@=&AE('5S92!O9B!O8G-E
M<G9A8FQE(&EN<'5T<R`H;6%R:V5T(&1A=&$@;V)T86EN960@9G)O;2!S;W5R
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M)B,Q-C`[1T%!4#H\+V9O;G0^/"]P/@T*/'5L/@T*/&QI('-T>6QE/3-$)VQI
M<W0M<W1Y;&4Z(&YO;F4[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TQE=F5L)B,Q-C`[,3H@3V)S97)V
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M86X@;VYG;VEN9R!B87-I<RX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[3&5V96PF(S$V
M,#LR.B!/8G-E<G9A8FQE(&EN<'5T<R!O=&AE<B!T:&%N($QE=F5L)B,Q-C`[
M,2!P<FEC97,L('-U8V@@87,@<75O=&5D('!R:6-E<R!I;B!A8W1I=F4@;6%R
M:V5T<R!F;W(@<VEM:6QA<B!A<W-E=',@;W(@;&EA8FEL:71I97,@86YD('%U
M;W1E9"!P<FEC97,@9F]R(&ED96YT:6-A;"!A<W-E=',@;W(@;&EA8FEL:71I
M97,@:6X@;6%R:V5T<R!T:&%T(&%R92!N;W0@86-T:79E+CPO9F]N=#X\+W`^
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M/"]U;#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD($5Q=6EP;65N=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US
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M+CPO9F]N=#X\+W`^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)U<VEN97-S($-O;6)I;F%T:6]N<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G
M9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0R/CQI/D)U<VEN97-S($-O;6)I;F%T:6]N<SPO:3X\+V9O;G0^/"]P
M/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[5&AE($-O;7!A;GD@<F5C;W)D<R!T:&4@9F%I<B!V86QU92!O
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M979E;&]P;65N="`H25!2)F%M<#M$*2P@=7-I;F<@82!V87)I971Y(&]F(&UE
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M:6YG('1H92!P<F]B86)I;&ET>2!O9B!C;VUP;&5T:6YG($E04B9A;7`[1"!P
M<F]J96-T<RP@=VAI8V@@=V]U;&0@<F5Q=6ER92!O8G1A:6YI;F<@<F5G=6QA
M=&]R>2!A<'!R;W9A;"!F;W(@;6%R:V5T:6YG(&]F('1H92!A<W-O8VEA=&5D
M(&1R=6<@8V%N9&ED871E.R!A(&UA<FME="!P87)T:6-I<&%N="=S(&5S=&EM
M871E<R!R96=A<F1I;F<@=&AE('1I;6EN9R!O9B!A;F0@=&AE(&5X<&5C=&5D
M(&-O<W1S('1O(&-O;7!L971E($E04B9A;7`[1"!P<F]J96-T<SL@82!M87)K
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M(&%S(&EN8W5R<F5D+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M);B!C;VYN96-T:6]N
M('=I=&@@=&AE(&%C<75I<VET:6]N(&]F($-U<F%'96X@0V]R<&]R871I;VX@
M*")#=7)A1V5N(BD@:6X@3V-T;V)E<B`R,#`Y+"!T:&4@0V]M<&%N>2!A<W-U
M;65D($-U<F%'96XG<R`D,3(N-28C,38P.VUI;&QI;VX@:6X@-"4@8V]N=F5R
M=&EB;&4@<W5B;W)D:6YA=&5D(&1E8G0@9'5E($9E8G)U87)Y)B,Q-C`[,34L
M(#(P,3$@*'1H92`B0V]N=F5R=&EB;&4@4W5B;W)D:6YA=&5D($1E8G0B*2X@
M26X@1F5B<G5A<GD@,C`Q,2P@=&AE($-O;7!A;GD@<&%I9"`D,3(N."8C,38P
M.VUI;&QI;VX@86YD('-A=&ES9FEE9"!A;&P@=&AE(&]U='-T86YD:6YG('!R
M:6YC:7!A;"!A;F0@86-C<G5E9"!I;G1E<F5S="!R96QA=&5D('1O('1H92!#
M;VYV97)T:6)L92!3=6)O<F1I;F%T960@1&5B="X\+V9O;G0^/"]P/@T*/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y);G1A;F=I8FQE($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX-"CQP('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQI/DEN=&%N9VEB;&4@
M07-S971S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
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M;G5A<GD@,C`Q,RP@=&AE($-O;7!A;GD@861O<'1E9"!A(&YE=R!5+E,N)B,Q
M-C`[1T%!4"!A8V-O=6YT:6YG('-T86YD87)D('=H:6-H(&%M96YD960@9W5I
M9&%N8V4@87!P;&EC86)L92!T;R!A;FYU86P@:6UP86ER;65N="!T97-T<R!O
M9B!I;F1E9FEN:71E+6QI=F5D(&EN=&%N9VEB;&4@87-S971S+B!4:&4@86UE
M;F1E9"!G=6ED86YC92!A9&1E9"!A;B!O<'1I;VYA;"!Q=6%L:71A=&EV92!A
M<W-E<W-M96YT(&9O<B!D971E<FUI;FEN9R!W:&5T:&5R(&%N(&EN9&5F:6YI
M=&4M;&EV960@:6YT86YG:6)L92!A<W-E="!I<R!I;7!A:7)E9"X@4')I;W(@
M=&\@=&AI<R!G=6ED86YC92P@8V]M<&%N:65S('=E<F4@<F5Q=6ER960@=&\@
M<&5R9F]R;2!A;B!A;FYU86P@:6UP86ER;65N="!T97-T('1H870@:6YC;'5D
M960@82!C86QC=6QA=&EO;B!O9B!T:&4@9F%I<B!V86QU92!O9B!T:&4@87-S
M970@86YD(&$@8V]M<&%R:7-O;B!O9B!T:&%T(&9A:7(@=F%L=64@=VET:"!I
M=',@8V%R<GEI;F<@=F%L=64N($EF('1H92!C87)R>6EN9R!V86QU92!E>&-E
M961E9"!T:&4@9F%I<B!V86QU92P@86X@:6UP86ER;65N="!W87,@<F5C;W)D
M960N(%1H92!A;65N9&5D(&=U:61A;F-E(&%L;&]W<R!A(&-O;7!A;GD@=&AE
M(&]P=&EO;B!T;R!P97)F;W)M(&$@<75A;&ET871I=F4@87-S97-S;65N="P@
M8V]N<VED97)I;F<@8F]T:"!N96=A=&EV92!A;F0@<&]S:71I=F4@979I9&5N
M8V4L(')E9V%R9&EN9R!T:&4@<&]T96YT:6%L(&EM<&%I<FUE;G0@;V8@=&AE
M(&EN9&5F:6YI=&4M;&EV960@:6YT86YG:6)L92!A<W-E="X@268L(&)A<V5D
M(&]N('1H92!Q=6%L:71A=&EV92!A;F%L>7-I<RP@=&AE(&-O;7!A;GD@9&5T
M97)M:6YE<R!T:&%T(&ET(&ES(&UO<F4@;&EK96QY('1H86X@;F]T('1H870@
M=&AE(&9A:7(@=F%L=64@;V8@<W5C:"!A;B!A<W-E="!E>&-E961S(&ET<R!C
M87)R>6EN9R!V86QU92P@=&AE(&-O;7!A;GD@=V]U;&0@8F4@<&5R;6ET=&5D
M('1O(&-O;F-L=61E('1H870@=&AE(&EN9&5F:6YI=&4M;&EV960@:6YT86YG
M:6)L92!A<W-E="!W87,@;F]T(&EM<&%I<F5D('=I=&AO=70@82!Q=6%N=&ET
M871I=F4@8V%L8W5L871I;VX@;V8@=&AE(&9A:7(@=F%L=64@;V8@=&AE(&%S
M<V5T+B!/=&AE<G=I<V4L('1H92!C;VUP86YY('=O=6QD('!E<F9O<FT@=&AE
M('%U86YT:71A=&EV92!C86QC=6QA=&EO;B!O9B!T:&4@9F%I<B!V86QU92!A
M;F0@=&AE(&-O;7!A<FES;VX@=VET:"!T:&4@8V%R<GEI;F<@=F%L=64N(%1H
M92!#;VUP86YY)W,@861O<'1I;VX@;V8@=&AI<R!N97<@<W1A;F1A<F0@9&ED
M(&YO="!H879E(&$@;6%T97)I86P@969F96-T(&]N(&ET<R!O<&5R871I;F<@
M<F5S=6QT<R!O<B!F:6YA;F-I86P@<&]S:71I;VXN/"]F;VYT/CPO<#X-"CQP
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R
M/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.TE04B9A;7`[1"!A<W-E=',@87)E('1E<W1E9"!F;W(@:6UP86ER;65N
M="!O;B!A;B!A;FYU86P@8F%S:7,@9'5R:6YG('1H92!T:&ER9"!Q=6%R=&5R
M+"!O<B!E87)L:65R(&EF(&EM<&%I<FUE;G0@:6YD:6-A=&]R<R!A<F4@<')E
M<V5N="X@07,@<&%R="!O9B!T:&4@86YN=6%L(&EM<&%I<FUE;G0@=&5S="!O
M9B!T:&4@25!2)F%M<#M$(&%S<V5T<R!A<R!O9B!*=6QY)B,Q-C`[,2P@,C`Q
M,RP@=&AE($-O;7!A;GD@8GEP87-S960@=&AE(&]P=&EO;F%L('%U86QI=&%T
M:79E(&%S<V5S<VUE;G0@86YD('!E<F9O<FUE9"!A(&-A;&-U;&%T:6]N(&]F
M('1H92!F86ER('9A;'5E(&]F('1H92!A<W-E="X@5&AE($-O;7!A;GD@8V]N
M8VQU9&5D('1H870@=&AE($E04B9A;7`[1"!A<W-E=',@=V5R92!N;W0@:6UP
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M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&P\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,CX\:3Y';V]D=VEL;#PO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE
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M9F]R;2!T:&4@='=O+7-T97`@9V]O9'=I;&P@:6UP86ER;65N="!T97-T(')E
M<75I<F5D('5N9&5R(%4N4RXF(S$V,#M'04%0+B!!<R!P87)T(&]F(&ET<R!A
M;FYU86P@:6UP86ER;65N="!T97-T(&]F('1H92!G;V]D=VEL;"!A<W-E="!A
M<R!O9B!*=6QY)B,Q-C`[,2P@,C`Q,RP@=&AE($-O;7!A;GD@8GEP87-S960@
M=&AE(&]P=&EO;F%L('%U86QI=&%T:79E(&%S<V5S<VUE;G0@86YD('!E<F9O
M<FUE9"!T:&4@='=O+7-T97`@:6UP86ER;65N="!T97-T+B!4:&4@0V]M<&%N
M>2!C;VYC;'5D960@=&AA="!T:&4@9V]O9'=I;&P@87-S970@=V%S(&YO="!I
M;7!A:7)E9"X\+V9O;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);7!A:7)M96YT(&]F($QO
M;F<M3&EV960@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^26UP86ER;65N="!O9B!,;VYG
M+4QI=F5D($%S<V5T<SPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A
M;GD@979A;'5A=&5S('1H92!R96-O=F5R86)I;&ET>2!O9B!I=',@;&]N9RUL
M:79E9"!A<W-E=',L(&EN8VQU9&EN9R!P<F]P97)T>2!A;F0@97%U:7!M96YT
M+"!A;F0@:6YT86YG:6)L92!A<W-E=',@=VAE;B!C:7)C=6US=&%N8V5S(&EN
M9&EC871E('1H870@86X@979E;G0@;V8@:6UP86ER;65N="!M87D@:&%V92!O
M8V-U<G)E9"X@1&5T97)M:6YA=&EO;B!O9B!R96-O=F5R86)I;&ET>2!I<R!B
M87-E9"!O;B!A;B!E<W1I;6%T92!O9B!U;F1I<V-O=6YT960@9G5T=7)E(&-A
M<V@@9FQO=W,@<F5S=6QT:6YG(&9R;VT@=&AE('5S92!O9B!T:&4@87-S970@
M86YD(&ET<R!E=F5N='5A;"!D:7-P;W-I=&EO;BX@26X@=&AE(&5V96YT('1H
M870@<W5C:"!C87-H(&9L;W=S(&%R92!N;W0@97AP96-T960@=&\@8F4@<W5F
M9FEC:65N="!T;R!R96-O=F5R('1H92!C87)R>6EN9R!A;6]U;G0@;V8@=&AE
M(&%S<V5T<RP@=&AE(&%S<V5T<R!A<F4@=W)I='1E;BUD;W=N('1O('1H96ER
M(&5S=&EM871E9"!F86ER('9A;'5E<RX\+V9O;G0^/"]P/@T*/"]D:78^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2
M979E;G5E(%)E8V]G;FET:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^4F5V96YU92!296-O9VYI
M=&EO;CPO:3X\+V9O;G0^/"]P/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@<F5C;V=N
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M=&%B:6QI='D@:7,@<F5A<V]N86)L>2!A<W-U<F5D+CPO9F]N=#X\+W`^#0H\
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M<&5R9F]R;6%N8V4@;V)L:6=A=&EO;BX\+V9O;G0^/"]P/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[4&%Y
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M=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#M0<F]D=6-T(')O>6%L='D@<F5V96YU92!C;VYS:7-T
M<R!O9B!P87EM96YT<R!R96-E:79E9"!F<F]M(&QI8V5N<V5E<R!F;W(@82!P
M;W)T:6]N(&]F('-A;&5S('!R;V-E961S(&9R;VT@<')O9'5C=',@=&AA="!U
M=&EL:7IE('1H92!#;VUP86YY)W,@;&EC96YS960@=&5C:&YO;&]G:65S(&%N
M9"!A<F4@<F5C;V=N:7IE9"!W:&5N('1H92!A;6]U;G0@;V8@86YD(&)A<VES
M(&9O<B!S=6-H(')O>6%L='D@<&%Y;65N=',@87)E(')E<&]R=&5D('1O('1H
M92!#;VUP86YY(&EN(&%C8W5R871E(&%N9"!A<'!R;W!R:6%T92!F;W)M(&%N
M9"!I;B!A8V-O<F1A;F-E('=I=&@@=&AE(')E;&%T960@;&EC96YS92!A9W)E
M96UE;G0N/"]F;VYT/CPO<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD($1E=F5L
M;W!M96YT($5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^4F5S96%R8V@@86YD($1E=F5L
M;W!M96YT($5X<&5N<V5S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&
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M;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0871E;G0@0V]S=',\+W1D/@T*("`@("`@("`\
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M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3=&]C:RU"87-E9"!#;VUP96YS871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ
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M;V8@=F5S=&EN9R!O<B!P97)F;W)M86YC92X\+V9O;G0^/"]P/@T*/'`@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
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M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&;W)E:6=N($-U<G)E;F-Y(%1R86YS;&%T:6]N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z
M,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^
M1F]R96EG;B!#=7)R96YC>2!4<F%N<VQA=&EO;CPO:3X\+V9O;G0^/"]P/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[3F5T('5N<F5A;&EZ960@9V%I;G,@86YD(&QO<W-E<R!R97-U;'1I
M;F<@9G)O;2!F;W)E:6=N(&-U<G)E;F-Y('1R86YS;&%T:6]N(&%R92!I;F-L
M=61E9"!I;B!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RDN($%T
M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@86YD($1E8V5M8F5R)B,Q-C`[,S$L
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M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^26YC;VUE(%1A>&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^26YC;VUE(%1A>&5S/"]I/CPO
M9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
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M92!P97)I;V0@;V8@8VAA;F=E+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&
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M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V]M<')E:&5N<VEV92!,;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^0V]M<')E:&5N<VEV92!,
M;W-S/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@
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M<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q
M+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#M);B!*86YU87)Y(#(P,3,L('1H92!#;VUP
M86YY(&%D;W!T960@82!N97<@52Y3+B8C,38P.T=!05`@86-C;W5N=&EN9R!S
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M:79E(&EN8V]M92`H;&]S<RDN($%S('1H92!N97<@9W5I9&%N8V4@<F5L871E
M<R!T;R!P<F5S96YT871I;VX@;VYL>2P@=&AE(&%D;W!T:6]N(&1I9"!N;W0@
M:&%V92!A(&UA=&5R:6%L(&EM<&%C="!O;B!T:&4@0V]M<&%N>2=S(')E<W5L
M=',@;V8@;W!E<F%T:6]N<R!O<B!F:6YA;F-I86P@<&]S:71I;VXN/"]F;VYT
M/CPO<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3F5T($QO<W,@4&5R(%-H87)E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z
M,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/&D^
M3F5T($QO<W,@4&5R(%-H87)E/"]I/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS
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M;B!A;G1I+61I;'5T:79E(&%R92!A<R!F;VQL;W=S.CPO9F]N=#X\+W`^#0H\
M9&EV('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U14
M3TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(.B`W,"4[(%!!1$1)
M3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$U)3L@4$%$1$E.1RU43U`Z
M(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]404),15=)1%1(+"(Q,#`E
M(B`M+3X\+V9O;G0^/"]P/@T*/"$M+2!5<V5R+7-P96-I9FEE9"!404='140@
M5$%"3$4@+2T^#0H\9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[/@T*#0H\='(@<W1Y;&4]
M,T1P861D:6YG.C`[/CPA+2T@5$%"3$4@0T],54U.(%=)1%1(4R!3150@+2T^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L
M969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=VED=&@],T0Q,CX\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('=I9'1H/3-$-R!A;&EG;CTS1')I9VAT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=VED=&@],T0U-3X\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$,3(^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!W:61T
M:#TS1#<@86QI9VX],T1R:6=H=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$-34^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!W:61T:#TS1#$R/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=VED=&@],T0W(&%L:6=N
M/3-$<FEG:'0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!W:61T:#TS1#4U/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=VED=&@],T0Q,CX\+W1D/CPA+2T@5$%"3$4@0T],54U.
M(%=)1%1(4R!%3D0@+2T^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@
M=F%L:6=N/3-$8F]T=&]M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&%L:6=N/3-$;&5F=#X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O
M;G0^/&)R("\^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].
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M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR
M,#$S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$R/"]B/CPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\
M8CXR,#$Q/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H
M/CPO='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O<"!B
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M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-2PW-S`L-30T/"]F
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M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXU+#,T.2PX,3`\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C0L-#4Y+#`S
M-#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O
M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXV+#`P
M,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-BPP,#`\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C8L,#`P/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.R!&3TY4+5-)6D4Z
M(#$N-7!T.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%
M0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))
M1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP
M.R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
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M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\
M='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
M(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SXF
M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-2PS
M-34L.#$P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXT
M+#0V-2PP,S0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M($9/3E0M4TE:13H@,2XU<'0[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F
M9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T1P861D:6YG.C`[('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM
M($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@
M0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M
M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
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M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$=&]P
M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],
M3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB
M;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
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M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-E;G0@
M06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX-"CQP('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CQI/E)E8V5N="!!
M8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]I/CPO9F]N=#X\+W`^#0H\<"!S
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M+W`^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X
M8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#(V+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4U5-34%262!/
M1B!324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#2453("A486)L97,I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-534U!4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4SPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H
M961U;&4@;V8@<&]T96YT:6%L;'D@9&EL=71I=F4@8V]M;6]N('-H87)E<R!T
M:&%T(&AA=F4@;F]T(&)E96X@:6YC;'5D960@:6X@=&AE(&YE="!L;W-S('!E
M<B!C;VUM;VX@<VAA<F4@8V%L8W5L871I;VYS(&)E8V%U<V4@=&AE(&5F9F5C
M="!W;W5L9"!H879E(&)E96X@86YT:2UD:6QU=&EV93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P
M+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R<^#0H\<"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\9&EV('-T
M>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P
M=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(.B`W,"4[(%!!1$1)3D<M4DE'
M2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$U)3L@4$%$1$E.1RU43U`Z(#!P=#LG
M/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]P
M/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L92!S='EL93TS1"=T97AT
M+6%L:6=N.FQE9G0[5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#4Y,7!X.R<@
M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$-3DQ/@T*#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M
M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)SX\(2TM(%1!0DQ%($-/3%5-3B!7
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M,T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&
M5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[
M)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$."!A;&EG;CTS1&-E;G1E
M<CX\9F]N="!S:7IE/3-$,3X\8CY996%R($5N9&5D($1E8V5M8F5R)B,Q-C`[
M,S$L/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO
M='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P
M<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!
M1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO
M9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$S/"]B/CPO
M9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N
M="!S:7IE/3-$,3X\8CXR,#$R/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P
M.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$Q/"]B
M/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\
M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^4W1O8VL@;W!T:6]N<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<VEZ93TS1#(^-2PS-#DL.#$P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H
M=#X\9F]N="!S:7IE/3-$,CXT+#0U.2PP,S0\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.
M1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z
M(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^4F5S
M=')I8W1E9"!S=&]C:SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-I>F4],T0R/C8L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M:7IE/3-$,CXV+#`P,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^-BPP,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.1RU4
M3U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$
M14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2
M240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N
M/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$
M,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%
M0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))
M1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
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M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494
M.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG
M('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S
M='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U3
M25I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.
M1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM
M($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@
M0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M
M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
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M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
M(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F
M9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]2
M3U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=5
M5%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/@T*
M/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%("TM/CPO
M9&EV/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB
M-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T,C<N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TU04D5(14Y3
M259%($Q/4U,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^0T]-4%)%2$5.4TE612!,3U-3/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y
M(&]F(&-H86YG97,@:6X@86-C=6UU;&%T960@;W1H97(@8V]M<')E:&5N<VEV
M92!I;F-O;64@*&QO<W,I(&)Y(&-O;7!O;F5N=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R<^#0H\<"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\9&EV('-T>6QE
M/3-$)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@
M4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(.B`X,"4[(%!!1$1)3D<M4DE'2%0Z
M(#!P=#L@34%21TE.+4Q%1E0Z(#$P)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*
M/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]P/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L92!S='EL93TS1"=T97AT+6%L
M:6=N.FQE9G0[5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#8W-7!X.R<@8F]R
M9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$-C<U/@T*#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)SX\(2TM(%1!0DQ%($-/3%5-3B!72414
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M<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@
M,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N
M=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\
M9F]N="!S:7IE/3-$,3X\8CY5;G)E86QI>F5D($=A:6X\8G(@+SX-"BA,;W-S
M*2!O;CQB<B`O/@T*36%R:V5T86)L93QB<B`O/@T*4V5C=7)I=&EE<RP@;F5T
M(&]F('1A>#PO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T
M:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^1F]R96EG;CQB<B`O/@T*0W5R
M<F5N8WD@271E;7,\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/E1O=&%L/"]B/CPO9F]N
M=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y
M;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M
M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P
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M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$
M,CY"86QA;F-E(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3(\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[
M(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)
M3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3W1H97(@8V]M
M<')E:&5N<VEV92!I;F-O;64@*&QO<W,I(&)E9F]R92!R96-L87-S:69I8V%T
M:6]N<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
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M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C
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M='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P
M<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/
M3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$
M/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]
M041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'
M+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(
M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@
M+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXH-S0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB
M(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE
M+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.
M1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z
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M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$
M,CY"86QA;F-E(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U3
M25I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$
M7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?
M1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M+3X\
M+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I
M;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@
M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&
M1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE
M:6=H=#HP+C<U<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I=CX-"CPA+2T@96YD(&]F
M('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I=CX\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P
M8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P
M8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#(X+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^1D%)4B!604Q512!-14%355)%345.
M5%,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^1D%)4B!604Q512!-14%355)%345.5%,\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE
M(&]F(&9I;F%N8VEA;"!A<W-E=',@<W5B:F5C="!T;R!F86ER('9A;'5E(&UE
M87-U<F5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD
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M,3`E.R!0041$24Y'+51/4#H@,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M415A4+4%,24=.
M.B!L969T.R<@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)3X-"@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z
M,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$
M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^/"$M+2!404),
M12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494
M.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG
M('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R
M/CQF;VYT('-I>F4],T0Q/CQB/D%S(&]F/&)R("\^#0I$96-E;6)E<B8C,38P
M.S,Q+"`R,#$S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\
M+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY,979E;"8C,38P.S$\+V(^
M/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF
M;VYT('-I>F4],T0Q/CQB/DQE=F5L)B,Q-C`[,CPO8CX\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE
M/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^
M/&(^3&5V96PF(S$V,#LS/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO
M9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)
M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^
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M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/DUO;F5Y
M(&UA<FME="!F=6YD<R!A;F0@8V%S:"!E<75I=F%L96YT<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C$T."PU
M-#D\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^36%R:V5T86)L92!S96-U<FET
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M,T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%
M1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X
M.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^
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M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P
M<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/
M4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L
M:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)
M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C
M1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M
M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/
M3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L
M(FQI;F4M:&5I9VAT.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$
M24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!&3TY4+5-)6D4Z
M(#$N-7!T.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L
M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^
M/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R+7-P96-I9FEE9"!404='140@5$%"
M3$4@+2T^/"]D:78^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CX\8G(@+SX\+V9O;G0^)B,Q-C`[/"]P/@T*/&1I
M=B!S='EL93TS1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-
M.B`P<'0[(%!!1$1)3D<M3$5&5#H@,'!T.R!724142#H@.#`E.R!0041$24Y'
M+5))1TA4.B`P<'0[($U!4D=)3BU,1494.B`Q,"4[(%!!1$1)3D<M5$]0.B`P
M<'0[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT
M('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?5$%"3$5724142"PB,3`P)2(@
M+2T^/"]F;VYT/CPO<#X-"CPA+2T@57-E<BUS<&5C:69I960@5$%'1T5$(%1!
M0DQ%("TM/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L92!S='EL93TS
M1"=T97AT+6%L:6=N.FQE9G0[5$585"U!3$E'3CH@;&5F=#LG(&)O<F1E<CTS
M1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4^#0H-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG/CPA+2T@5$%"3$4@0T],54U.(%=)1%1(4R!3
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M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L
M969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*
M/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\
M8CY!<R!O9CQB<B`O/@T*1&5C96UB97(F(S$V,#LS,2P@,C`Q,CPO8CX\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@
M<VEZ93TS1#$^/&(^3&5V96PF(S$V,#LQ/"]B/CPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q
M/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY,
M979E;"8C,38P.S(\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/DQE=F5L)B,Q-C`[,SPO
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M('1H;W5S86YD<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[
M/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$
M1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M
M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C4Y
M+#`V-3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L
M(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN
M92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'
M+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(
M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L
M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
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M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
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M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!
M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P
M<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/
M3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T
M;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^
M/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[
M(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[
M(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)
M3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@
M+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
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M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F
M9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N
M-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I
M;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@
M4$%$1$E.1RU224=(5#H@,'!X.R!&3TY4+5-)6D4Z(#$N-7!T.R!0041$24Y'
M+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N
M9"!O9B!U<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^#0H\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X
M85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#(Y+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^34%22T5404),12!314-5
M4DE42453("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DU!4DM%5$%"3$4@4T5#55))5$E%4SPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5M;6%R
M>2!O9B!M87)K971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#LG/@T*/'`@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS
M1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!
M1$1)3D<M3$5&5#H@,'!T.R!724142#H@.#`E.R!0041$24Y'+5))1TA4.B`P
M<'0[($U!4D=)3BU,1494.B`Q,"4[(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD
M:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@<W1Y;&4],T0G=&5X="UA;&EG
M;CIL969T.U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`V-35P>#LG(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#8U-3X-"@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/
M33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X
M.R!0041$24Y'+51/4#H@,'!X.R<^/"$M+2!404),12!#3TQ534X@5TE$5$A3
M(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A
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M1%1(4R!%3D0@+2T^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$
M1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M
M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O
M;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS
M1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q
M/CQB/D%M;W)T:7IE9#QB<B`O/@T*0V]S=#PO8CX\+V9O;G0^/"]T:#X-"CQT
M:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^
M1W)O<W,\8G(@+SX-"E5N<F5A;&EZ960\8G(@+SX-"D=A:6YS/"]B/CPO9F]N
M=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S
M:7IE/3-$,3X\8CY'<F]S<SQB<B`O/@T*56YR96%L:7IE9#QB<B`O/@T*3&]S
M<V5S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
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M;W5S86YD<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F
M;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.
M1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'
M2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I
M>F4],T0R/CQB/D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V(^/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$
M24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU2
M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`S,'!T.R<^/&9O;G0@
M<VEZ93TS1#(^52Y3+B!G;W9E<FYM96YT(&%N9"!M=6YI8VEP86P@;V)L:6=A
M=&EO;G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&
M5#H@-#!P=#LG/CQF;VYT('-I>F4],T0R/DUA='5R:6YG(&EN(&]N92!Y96%R
M(&]R(&QE<W,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#0P<'0[)SX\9F]N="!S
M:7IE/3-$,CY-871U<FEN9R!A9G1E<B!O;F4@>65A<B!T:')O=6=H('1H<F5E
M('EE87)S)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T
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M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!
M1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'
M4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V
M,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M
M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM
M($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@
M0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[(B`M
M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H
M=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP
M.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$
M24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`S,'!T.R<^/&9O
M;G0@<VEZ93TS1#(^5&]T86P@52Y3+B!G;W9E<FYM96YT(&%N9"!M=6YI8VEP
M86P@;V)L:6=A=&EO;G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXD/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH.#PO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/BD\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/B0\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I
M9VAT/CQF;VYT('-I>F4],T0R/C<S+#@T,#PO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C
M,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP
M.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$
M24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$
M1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU4
M3U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R!-05)'24XM3$5&5#H@,S!P=#LG/CQF;VYT('-I>F4],T0R/D-O
M<G!O<F%T92!D96)T('-E8W5R:71I97,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R!-05)'24XM3$5&5#H@-#!P=#LG/CQF;VYT('-I>F4],T0R/DUA
M='5R:6YG(&EN(&]N92!Y96%R(&]R(&QE<W,\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494
M.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&
M5#H@-#!P=#LG/CQF;VYT('-I>F4],T0R/DUA='5R:6YG(&%F=&5R(&]N92!Y
M96%R('1H<F]U9V@@=&AR964@>65A<G,F(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#
M3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/
M34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
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M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.
M1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z
M(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^#0H\<"!S='EL93TS1"=4
M15A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.
M+4Q%1E0Z(#,P<'0[)SX\9F]N="!S:7IE/3-$,CY4;W1A;"!C;W)P;W)A=&4@
M9&5B="!S96-U<FET:65S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<VEZ93TS1#(^-3DL-S,T/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.1RU4
M3U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&
M1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG
M:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0
M041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'
M+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]2
M3U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=5
M5%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/
M33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X
M.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^
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M:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,3`T/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.
M1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q
M+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'
M+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(
M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@
M+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z
M,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$
M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&
M1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H
M=#HP+C<U<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
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M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
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M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I=CX-"CPA+2T@96YD
M(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I=CX-"CQP
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R
M/CQB<B`O/CPO9F]N=#XF(S$V,#L\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE4
M24]..B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,
M1494.B`P<'0[(%=)1%1(.B`X,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%2
M1TE.+4Q%1E0Z(#$P)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#
M3TU-04Y$/4%$1%]404),15=)1%1(+"(Q,#`E(B`M+3X\+V9O;G0^/"]P/@T*
M/"$M+2!5<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F
M=#M415A4+4%,24=..B!L969T.R!724142#H@-C8Q<'@[)R!B;W)D97(],T0P
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0V-C$^
M#0H-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG/CPA+2T@5$%"3$4@0T],54U.(%=)1%1(4R!3150@
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M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T
M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q
M/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY!
M;6]R=&EZ960\8G(@+SX-"D-O<W0\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q
M-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P
M86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/D=R;W-S
M/&)R("\^#0I5;G)E86QI>F5D/&)R("\^#0I'86EN<SPO8CX\+V9O;G0^/"]T
M:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS
M1#$^/&(^1W)O<W,\8G(@+SX-"E5N<F5A;&EZ960\8G(@+SX-"DQO<W-E<SPO
M8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^
M/&9O;G0@<VEZ93TS1#$^/&(^1F%I<CQB<B`O/@T*5F%L=64\+V(^/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL
M93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,
M1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P
M>#LG('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[
M/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\
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M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$
M,CX\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]B/CPO9F]N=#X\+W`^/"]T
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M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^/&9O;G0@<VEZ
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M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&
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M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
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M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#X\9F]N="!S:7IE/3-$,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N
M="!S:7IE/3-$,CXR.#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<VEZ93TS1#(^,34L-3DT/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@-#!P=#LG/CQF
M;VYT('-I>F4],T0R/DUA='5R:6YG(&%F=&5R(&]N92!Y96%R('1H<F]U9V@@
M=&AR964@>65A<G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE
M/3-$,CXQ.2PW.3<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R
M/CDY/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)
M3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F
M9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C
M1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M
M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F
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M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O
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M.R8C,38P.R8C,38P.R8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)
M3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F
M9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C
M1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M
M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F
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M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,S!P=#LG/CQF;VYT('-I>F4]
M,T0R/D-O<G!O<F%T92!D96)T('-E8W5R:71I97,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I
M9VAT/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C
M,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@-#!P=#LG/CQF;VYT('-I>F4]
M,T0R/DUA='5R:6YG(&EN(&]N92!Y96%R(&]R(&QE<W,\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
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M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M,C`T/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U3
M25I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$
M7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?
M1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0
M041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.
M1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N
M,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H
M=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
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M.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,S!P
M=#LG/CQF;VYT('-I>F4],T0R/E1O=&%L(&-O<G!O<F%T92!D96)T('-E8W5R
M:71I97,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494
M.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG
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M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$
M1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU4
M3U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-
M05)'24XM3$5&5#H@,C!P=#LG/CQF;VYT('-I>F4],T0R/E1O=&%L(&UA<FME
M=&%B;&4@<V5C=7)I=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M1')I9VAT/CQF;VYT('-I>F4],T0R/C4Y+#`V-3PO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.
M1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F
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M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
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M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494
M.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],
M3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB
M;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T
M9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R+7-P96-I
M9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E!23U!%4E19($%.1"!%455)4$U%3E0L($Y%5"`H5&%B
M;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY04D]015)462!!3D0@15%525!-14Y4+"!.150\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F
M('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#LG/@T*/'`@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS1"=0
M3U-)5$E/3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!1$1)
M3D<M3$5&5#H@,'!T.R!724142#H@-S`E.R!0041$24Y'+5))1TA4.B`P<'0[
M($U!4D=)3BU,1494.B`Q-24[(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD:78@
M86QI9VX],T1C96YT97(^#0H\=&%B;&4@<W1Y;&4],T0G=&5X="UA;&EG;CIL
M969T.U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`V,C%P>#LG(&)O<F1E<CTS
M1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#8R
M,3X-"@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@
M,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0
M041$24Y'+51/4#H@,'!X.R<^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%
M5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
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M;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M
M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P
M<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$S
M/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&
M3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E
M<CX\9F]N="!S:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]B
M/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\
M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].
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M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S
M:7IE/3-$,CY,86)O<F%T;W)Y($5Q=6EP;65N=#PO9F]N=#X\+W`^/"]T9#X-
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M
M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P
M<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^36%N=69A8W1U<FEN9R!%<75I
M<&UE;G0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3V9F:6-E($9U<FYI
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M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
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M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^
M/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[
M(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$
M24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU2
M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\
M(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T
M.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G
M5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)
M3BU,1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&]T86P@4')O<&5R='D@
M86YD($5Q=6EP;65N=#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
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M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/DQE
M<W,@06-C=6UU;&%T960@1&5P<F5C:6%T:6]N(&%N9"!!;6]R=&EZ871I;VX\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB
M(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE
M+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A
M9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P
M>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C
M1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M
M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI
M9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-
M.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[
M(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M,T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#
M3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$
M+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%
M1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X
M.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/
M3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L
M(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M
M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N-S5P=#LB
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M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U3
M25I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!3D0]041$
M7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?
M1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX\
M+W1A8FQE/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'
M1T5$(%1!0DQ%("TM/CPO9&EV/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?
M-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q
M,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S
M+U-H965T,S$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY)3E1!3D=)0DQ%($%34T544R!!3D0@1T]/1%=)3$P@*%1A8FQE<RD\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^24Y404Y'24),12!!4U-%5%,@04Y$($=/3T1724Q,/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!I
M;G1A;F=I8FQE(&%S<V5T<RP@;F5T(&]F(&%C8W5M=6QA=&5D(&%M;W)T:7IA
M=&EO;BP@86YD(&=O;V1W:6QL/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M
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M24XM3$5&5#H@,3`E.R!0041$24Y'+51/4#H@,'!T.R<^#0H\<"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M4
M15A4+4%,24=..B!L969T.R!724142#H@-C@R<'@[)R!B;W)D97(],T0P(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0V.#(^#0H-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.
M1RU43U`Z(#!P>#LG/CPA+2T@5$%"3$4@0T],54U.(%=)1%1(4R!3150@+2T^
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M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L
M969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*
M/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,3`@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^
M/&(^1&5C96UB97(F(S$V,#LS,2P@,C`Q,SPO8CX\+V9O;G0^/"]T:#X-"CQT
M:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#@@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^
M1&5C96UB97(F(S$V,#LS,2P@,C`Q,CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S
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M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^17-T
M:6UA=&5D/&)R("\^#0I,:69E/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P
M.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY#;W-T/"]B
M/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\
M9F]N="!S:7IE/3-$,3X\8CY!8V-U;75L871E9#QB<B`O/@T*06UO<G1I>F%T
M:6]N/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY.970\+V(^/"]F;VYT/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB
M/D-O<W0\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$
M8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/D%C8W5M=6QA=&5D/&)R("\^#0I!
M;6]R=&EZ871I;VX\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
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M/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^
M)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#$W(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I
M>F4],T0Q/CQB/BA);B!T:&]U<V%N9',I/"]B/CPO9F]N=#X\8G(@+SX\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T0G
M<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@
M,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^26YT86YG:6)L
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C
M,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^25!2)F%M<#M$/"]F;VYT/CPO
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M/3-$,CXQ,2PX,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,3$L.#`P/"]F;VYT/CPO
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M,CXQ,2PX,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O
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M)B,Q-C`[>65A<G,\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
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M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,3`L
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M,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C$Q)B,Q-C`[>65A<G,\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(
M041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$52
M1U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V
M,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M
M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO
M<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
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M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@
M+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[
M)SX\9F]N="!S:7IE/3-$,CY4;W1A;"!);G1A;F=I8FQE($%S<V5T<SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$
M24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/
M4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
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M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$
M7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?
M1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!
M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@
M8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2
M+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI
M;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
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M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
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M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$
M1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M
M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2
M+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI
M;F4M:&5I9VAT.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@
M,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO
M<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-
M34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-
M04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C
M;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS
M<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[
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M/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B
M-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T,S(N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY!0T-2545$($584$5.
M4T53("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D%#0U)5140@15A014Y315,\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(&%C
M8W)U960@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.T9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS1"=03U-)5$E/3CH@
M<F5L871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!1$1)3D<M3$5&5#H@
M,'!T.R!724142#H@-S`E.R!0041$24Y'+5))1TA4.B`P<'0[($U!4D=)3BU,
M1494.B`Q-24[(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD:78@86QI9VX],T1C
M96YT97(^#0H\=&%B;&4@<W1Y;&4],T0G=&5X="UA;&EG;CIL969T.U1%6%0M
M04Q)1TXZ(&QE9G0[(%=)1%1(.B`U-C5P>#LG(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#4V-3X-"@T*/'1R
M('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$
M24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/
M4#H@,'!X.R<^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT
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M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI
M9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N
M="!S:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+#QB<B`O/@T*,C`Q,SPO
M8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^
M/&9O;G0@<VEZ93TS1#$^/&(^1&5C96UB97(F(S$V,#LS,2P\8G(@+SX-"C(P
M,3(\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F
M;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M8V]L<W!A;CTS1#4@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^
M*$EN('1H;W5S86YD<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q
M-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4
M+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%
M1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY!8V-R=65D(%)O>6%L='D@86YD
M($QI8V5N<V4@1F5E<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$
M1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU4
M3U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^
M06-C<G5E9"!087ER;VQL(&%N9"!%;7!L;WEE92!"96YE9FET<SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&
M1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S
M:7IE/3-$,CY!8V-R=65D(%)E<V5A<F-H(&%N9"!$979E;&]P;65N="!#;VYT
M<F%C="!#;W-T<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^-RPU-CD\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,
M1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^06-C<G5E9"!0<F]F97-S:6]N
M86P@1F5E<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^
M,S$W/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO
M9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)
M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^3W1H97(@06-C<G5E9"!%>'!E;G-E<SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P
M,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&
M1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG
M:'0Z,"XQ<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
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M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ,"PY-C`\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U3
M25I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F
M9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\
M(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA
M+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XQ<'0[
M(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
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M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)
M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-I>F4],T0R/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB
M(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE
M+6AE:6=H=#HP+C<U<'0[(B`M+3X\+V9O;G0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'
M+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!&3TY4+5-)6D4Z(#$N
M-7!T.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B
M;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R+7-P96-I9FEE9"!404='140@
M5$%"3$4@+2T^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
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M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/D]42$52($Q/3D<M5$5232!,24%"24Q)5$E%4R`H5&%B;&5S*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/5$A%
M4B!,3TY'+51%4DT@3$E!0DE,251)15,\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($]T:&5R(&QO;F<M
M=&5R;2!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78@<W1Y;&4],T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424].
M.B!R96QA=&EV93L@4$%$1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494
M.B`P<'0[(%=)1%1(.B`W,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.
M+4Q%1E0Z(#$U)3L@4$%$1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<CX-"CQT86)L92!S='EL93TS1"=T97AT+6%L:6=N.FQE9G0[5$58
M5"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#4Y,W!X.R<@8F]R9&5R/3-$,"!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$-3DS/@T*#0H\
M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)SX\(2TM(%1!0DQ%($-/3%5-3B!724142%,@4T54("TM/@T*
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M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
M;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF
M;VYT('-I>F4],T0Q/CQB/D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V(^/"]F
M;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT
M('-I>F4],T0Q/CQB/D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3(\+V(^/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL
M93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,
M1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P
M>#LG('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[
M/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#4@
M86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^*$EN('1H;W5S86YD
M<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO
M=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
M=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^-"PV-C$\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D
M:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[
M(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%2
M1TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY$969E<G)E9"!);F-O
M;64@9G)O;2!386QE(&]F(%1A>"!"96YE9FET<SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^,2PQ-C@\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.
M1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'
M2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O
M;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
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M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'
M+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@
M,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
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M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#
M145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#(P<'0[)SX\9F]N
M="!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M4&]R=&EO;CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B
M("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z
M,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/
M5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@
M,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=4
M15A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.
M+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY,;VYG+51E<FT@4&]R=&EO
M;CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS
M1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I
M>F4],T0R/C8L.34P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-I>F4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXV+#,S-CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z
M(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!&3TY4+5-)6D4Z(#$N-7!T.R!0
M041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F
M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$
M7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?
M1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%
M1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X
M.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F
M9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\
M(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N-S5P
M=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!
M1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'
M4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\+V1I=CX-"CPA
M+2T@96YD(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),12`M+3X\+V1I
M=CX\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?
M8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#,T+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%,4%!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY35$]#2RU"05-%
M1"!#3TU014Y3051)3TX@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U1/0TLM0D%3140@0T]-4$5.
M4T%424]./"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=6UM87)Y(&]F('-T;V-K(&]P=&EO;B!A8W1I=FET>3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N="US
M:7IE.C$P+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R<^#0H\
M<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\
M9&EV('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@4$%$1$E.1RU"3U14
M3TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(.B`X,"4[(%!!1$1)
M3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$P)3L@4$%$1$E.1RU43U`Z
M(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]P/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L92!S='EL93TS
M1"=T97AT+6%L:6=N.FQE9G0[5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#8T
M,W!X.R<@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$-C0S/@T*#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!
M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)SX\(2TM(%1!0DQ%($-/
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M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C
M,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY3:&%R97,\+V(^/"]F;VYT/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4]
M,T0Q/CQB/E=E:6=H=&5D/&)R("\^#0I!=F5R86=E/&)R("\^#0I%>&5R8VES
M93QB<B`O/@T*4')I8V4\8G(@+SX-"E!E<B!3:&%R93PO8CX\+V9O;G0^/"]T
M:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS
M1#$^/&(^5V5I9VAT960\8G(@+SX-"D%V97)A9V4\8G(@+SX-"E)E;6%I;FEN
M9SQB<B`O/@T*0V]N=')A8W1U86P\8G(@+SX-"E1E<FT@*$EN(%EE87)S*3PO
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M='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4]
M,T0R/D]P=&EO;G,@3W5T<W1A;F1I;F<@870@1&5C96UB97(F(S$V,#LS,2P@
M,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^-RXP/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ+#(U,BPP,#`\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.
M1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'
M2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O
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M,T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
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M/3-$,CY#86YC96QE9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-I>F4],T0R/B@Q-"PX-C$\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^*3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-I>F4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXV+CDW/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N
M="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F
M9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]2
M3U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=5
M5%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
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M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS
M1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
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M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!
M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3W!T:6]N<R!/=71S=&%N9&EN9R!A
M="!$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<VEZ93TS1#(^-2PW-S`L-30T/"]F;VYT/CPO=&0^#0H\
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M86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXW+C`\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U3
M25I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M
M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM
M($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@
M<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
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M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$
M14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2
M240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
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M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&
M5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[
M)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[(B`M+3X\+V9O;G0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI
M9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&
M1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H
M=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
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M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE
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M.S,Q+"`R,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^-2PW,3(L-3DV/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-I>F4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H
M=#X\9F]N="!S:7IE/3-$,CXX+C$R/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE
M/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\
M9F]N="!S:7IE/3-$,CXW+C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
M;&EG;CTS1'1O<"!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL
M93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@
M34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY/<'1I;VYS($5X
M97)C:7-A8FQE(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXS+#(Y-RPQ.3`\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C8N
M,S`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C4N-CPO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/
M5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@
M,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\
M9F]N="!S:7IE/3-$,CY3:&%R97,@079A:6QA8FQE(&9O<B!'<F%N="!U;F1E
M<B!T:&4@,C`P."!0;&%N/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F(')E<W1R:6-T960@<W1O8VL@86-T
M:79I='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV('-T
M>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.T9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS1"=03U-)5$E/3CH@<F5L871I=F4[
M(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!1$1)3D<M3$5&5#H@,'!T.R!72414
M2#H@-S`E.R!0041$24Y'+5))1TA4.B`P<'0[($U!4D=)3BU,1494.B`Q-24[
M(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD:78@86QI9VX],T1C96YT97(^#0H\
M=&%B;&4@<W1Y;&4],T0G=&5X="UA;&EG;CIL969T.U1%6%0M04Q)1TXZ(&QE
M9G0[(%=)1%1(.B`U-SEP>#LG(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#4W.3X-"@T*/'1R('-T>6QE/3-$
M)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z
M(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^
M/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS
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M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T
M;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$
M,3X\8CY3:&%R97,\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
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M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&
M5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/D]U='-T86YD:6YG(&%N9"!U;G9E
M<W1E9"!A="!$96-E;6)E<B8C,38P.S,Q+"`R,#$R/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-BPP,#`\+V9O;G0^/"]T9#X-
M"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C0N-3`\+V9O;G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@
M<VEZ93TS1#(^1W)A;G1E9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4]
M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-I>F4],T0R/C$R+#`P,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
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M<FEG:'0^/&9O;G0@<VEZ93TS1#(^,34N,C`\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.
M1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z
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M,CXH,3(L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY#86YC96QE9#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
M1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M
M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C!P
M=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
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M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0
M041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'
M+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
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M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@
M+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[
M)SX\9F]N="!S:7IE/3-$,CY/=71S=&%N9&EN9R!A;F0@=6YV97-T960@870@
M1&5C96UB97(F(S$V,#LS,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-I>F4],T0R/C8L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM
M($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@
M0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S
M;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y
M;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M
M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P
M<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$
M/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]
M041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
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M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$
M,CX\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XW
M-7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@
M86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D
M:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[
M(%!!1$1)3D<M4DE'2%0Z(#!P>#L@1D].5"U325I%.B`Q+C5P=#L@4$%$1$E.
M1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$(V9F9F9F9CX-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/"$M+2!#3TU-04Y$/4%$1%]23U=3
M2$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%
M4D=2240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!C
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M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N9"!O
M9B!U<V5R+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y38VAE9'5L92!O9B!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@97AP96YS
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4]
M,T0G9F]N="US:7IE.C$P+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V
M,#L\+W`^#0H\9&EV('-T>6QE/3-$)U!/4TE424]..B!R96QA=&EV93L@4$%$
M1$E.1RU"3U143TTZ(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[(%=)1%1(.B`W
M,"4[(%!!1$1)3D<M4DE'2%0Z(#!P=#L@34%21TE.+4Q%1E0Z(#$U)3L@4$%$
M1$E.1RU43U`Z(#!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!A;&EG;CTS1&-E;G1E<CX-"CQT86)L
M92!S='EL93TS1"=T97AT+6%L:6=N.FQE9G0[5$585"U!3$E'3CH@;&5F=#L@
M5TE$5$@Z(#4X-7!X.R<@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('=I9'1H/3-$-3@U/@T*#0H\='(@<W1Y;&4],T0G<&%D
M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)SX\(2TM
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M='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P
M<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!
M1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1L969T/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@+SX\+W1H/@T*/'1H('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO
M9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P
M,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$S/"]B/CPO
M9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N
M="!S:7IE/3-$,3X\8CXR,#$R/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P
M.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXR,#$Q/"]B
M/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/CPO='(^#0H\
M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].
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M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$
M,CXD/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ
M93TS1#(^,BPV-#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M<F%L(&%N9"!A9&UI;FES=')A=&EV93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-I>F4],T0R/C$L.3`X/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/
M5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U54
M5$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A
M9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P
M>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L
M:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
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M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/
M5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U54
M5$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A
M9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P
M>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L
M:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
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M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F
M;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[
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M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
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M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG
M;CTS1&)O='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&
M1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH
M96EG:'0Z,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R
M+7-P96-I9FEE9"!404='140@5$%"3$4@+2T^/"]D:78^/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE
M9'5L92!O9B!A<W-U;7!T:6]N<R!U<V5D(&9O<B!T:&4@9F%I<B!V86QU97,@
M;V8@96UP;&]Y964@<W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z
M,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CM&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)SX-"CQP('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD:78@
M<W1Y;&4],T0G4$]3251)3TXZ(')E;&%T:79E.R!0041$24Y'+4)/5%1/33H@
M,'!T.R!0041$24Y'+4Q%1E0Z(#!P=#L@5TE$5$@Z(#@P)3L@4$%$1$E.1RU2
M24=(5#H@,'!T.R!-05)'24XM3$5&5#H@,3`E.R!0041$24Y'+51/4#H@,'!T
M.R<^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\
M+W`^#0H\9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE('-T>6QE/3-$)W1E
M>'0M86QI9VXZ;&5F=#M415A4+4%,24=..B!L969T.R!724142#H@-C`Q<'@[
M)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M=VED=&@],T0V,#$^#0H-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.
M1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'
M2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG/CPA+2T@5$%"3$4@0T],54U.
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M($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'
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M5$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^665A<B!%;F1E9#QB
M<B`O/@T*1&5C96UB97(F(S$V,#LS,2P@,C`Q,SPO8CX\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE
M/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^665A<B!%;F1E
M9#QB<B`O/@T*1&5C96UB97(F(S$V,#LS,2P@,C`Q,CPO8CX\+V9O;G0^/"]T
M:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^665A<B!%
M;F1E9#QB<B`O/@T*1&5C96UB97(F(S$V,#LS,2P@,C`Q,3PO8CX\+V9O;G0^
M/"]T:#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/
M5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@
M,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M8V5N=&5R/CQF;VYT('-I>F4],T0R/C<P)B,Q-C`[+28C,38P.S<R)3PO9F]N
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#(^-C@F(S$V
M,#LM)B,Q-C`[-S`E/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
M;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^17AP96-T960@;W!T
M:6]N('1E<FT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&-E;G1E<CX\9F]N
M="!S:7IE/3-$,CXV+C`@665A<G,\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R/3-$
M(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\
M9F]N="!S:7IE/3-$,CY2:7-K+69R964@:6YT97)E<W0@<F%T93PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M9F]N="!S:7IE/3-$,CXP+CDF(S$V,#LM)B,Q-C`[,2XT)3PO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#(^,2XT)B,Q-C`[+28C
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M9"!Y:65L9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT
M('-I>F4],T0R/DYO;F4\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF
M;VYT('-I>F4],T0R/DYO;F4\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ
M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R
M/CQF;VYT('-I>F4],T0R/DYO;F4\+V9O;G0^/"]T9#X\+W1R/CPO=&%B;&4^
M/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R+7-P96-I9FEE9"!404='140@5$%"
M3$4@+2T^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14M(/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DE.
M0T]-12!405A%4R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY)3D-/344@5$%815,\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F
M(&-O;7!O;F5N=',@;V8@:6YC;VUE('1A>"!E>'!E;G-E(&%T=')I8G5T86)L
M92!T;R!C;VYT:6YU:6YG(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.T9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#LG/@T*/'`@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS
M1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!
M1$1)3D<M3$5&5#H@,'!T.R!724142#H@.#`E.R!0041$24Y'+5))1TA4.B`P
M<'0[($U!4D=)3BU,1494.B`Q,"4[(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD
M:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@<W1Y;&4],T0G=&5X="UA;&EG
M;CIL969T.U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`W,#-P>#LG(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#<P,SX-"@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/
M33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X
M.R!0041$24Y'+51/4#H@,'!X.R<^/"$M+2!404),12!#3TQ534X@5TE$5$A3
M(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A
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M24Q9.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!W:61T:#TS1#$R/CPO=&0^/"$M+2!404),
M12!#3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$)W!A
M9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P
M>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L
M:6=N/3-$8F]T=&]M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&%L:6=N/3-$;&5F=#X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^
M/&)R("\^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&
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M/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI
M9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^,C`Q,SPO8CX\+V9O;G0^
M/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ
M93TS1#$^/&(^,C`Q,CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^,C`Q,3PO8CX\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'
M+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@
M,'!X.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$;&5F=#X\9F]N="!S:7IE/3-$,3XF(S$V
M,#L\+V9O;G0^/&)R("\^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-
M"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$
M."!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CXH26X@=&AO=7-A
M;F1S*3PO8CX\+V9O;G0^/&)R("\^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^
M/"]T:#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/
M5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@
M,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^26YC;VUE('1A>"!B96YE9FET("AP<F]V:7-I;VXI.CPO9F]N=#X\+W`^
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M/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R
M:6=H=#X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z
M,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$
M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,C!P=#LG/CQF
M;VYT('-I>F4],T0R/D9E9&5R86P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXD/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX]
M,T1R:6=H=#X\9F]N="!S:7IE/3-$,CXS,"PY-C(\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,
M63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/B0\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A
M;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C$Y+#,Y-#PO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^
M)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,38L,C`T/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,
M1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P
M>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^-"PY,C`\+V9O;G0^/"]T9#X-
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H
M=#X\9F]N="!S:7IE/3-$,CXS+#$S,3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!
M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^/&9O;G0@
M<VEZ93TS1#(^1F]R96EG;CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
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M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#
M145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R!-05)'24XM3$5&5#H@,C!P=#LG/CQF;VYT('-I>F4],T0R/D5X<&ER
M871I;VX@;V8@3F5T($]P97)A=&EN9R!,;W-S97,@86YD(%)E<V5A<F-H)B,Q
M-C`[)F%M<#L@1&5V96QO<&UE;G0@5&%X($-R961I=',\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O
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M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D
M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
M.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,3DL,#`X/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,
M1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P
M>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S
M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH,3DL,#`X
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y
M;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M
M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU
M<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$
M14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2
M240L(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X
M.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$
M24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F
M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$
M1%]23U=32$%$14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$
M7T=55%1%4D=2240L(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@
M=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$
M1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M
M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SXF(S$V,#L\
M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
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M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@
M0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#
M3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N
M/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O
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M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,
M63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG
M:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y
M;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M
M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P
M<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$
M14-/3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2
M240L(FQI;F4M:&5I9VAT.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T
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M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ
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M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@
M+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP
M<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)
M3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X]
M,T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T
M('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/@T*
M/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%("TM/CPO
M9&EV/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4V-H961U;&4@;V8@<F5C;VYC:6QI871I;VX@8F5T=V5E
M;B!T:&4@86UO=6YT(&]F(')E<&]R=&5D(&EN8V]M92!T87@@86YD('1H92!A
M;6]U;G0@8V]M<'5T960@=7-I;F<@=&AE(%4N4RX@4W1A='5T;W)Y(')A=&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.T9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[
M/"]P/@T*/&1I=B!S='EL93TS1"=03U-)5$E/3CH@<F5L871I=F4[(%!!1$1)
M3D<M0D]45$]-.B`P<'0[(%!!1$1)3D<M3$5&5#H@,'!T.R!724142#H@.#`E
M.R!0041$24Y'+5))1TA4.B`P<'0[($U!4D=)3BU,1494.B`Q,"4[(%!!1$1)
M3D<M5$]0.B`P<'0[)SX-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C,38P.SPO<#X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@
M<W1Y;&4],T0G=&5X="UA;&EG;CIL969T.U1%6%0M04Q)1TXZ(&QE9G0[(%=)
M1%1(.B`V.#5P>#LG(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!W:61T:#TS1#8X-3X-"@T*/'1R('-T>6QE/3-$)W!A9&1I
M;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@
M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^/"$M+2!4
M04),12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4
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M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!W:61T:#TS
M1#$R/CPO=&0^/"$M+2!404),12!#3TQ534X@5TE$5$A3($5.1"`M+3X\+W1R
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M;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@
M86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^,C`Q,SPO8CX\+V9O
M;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\
M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&04U)
M3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O;G0@
M<VEZ93TS1#$^/&(^,C`Q,CPO8CX\+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS
M1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\
M+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS
M1#(@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^,C`Q,3PO8CX\
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M:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ
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M.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$
M24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^#0H\
M=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&1D9&
M(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I9VAT
M.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A
M;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z
M(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2
M+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI
M;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT
M9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF
M(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS
M1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P
M>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$
M1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(V9F
M9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!3D0]
M041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.1#U!
M1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F;VYT
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G
M<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@
M,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!
M1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F
M9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2
M+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI
M;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$
M24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/
M4#H@,'!X.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T1W:&ET93X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'
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M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH,34L,C$S/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O
M;G0@<VEZ93TS1#(^*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G
M<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@
M,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^#0H\<"!S='EL93TS1"=415A4+4E.
M1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z
M(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY297-E87)C:"!A;F0@1&5V96QO<&UE
M;G0@0W)E9&ET<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
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M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&
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M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SL@34%21TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$
M,CY/=&AE<CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R
M/C(V/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@
M,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^17AP:7)A=&EO;B!O9B!.970@3W!E<F%T
M:6YG($QO<W-E<R!A;F0@4F5S96%R8V@F(S$V,#LF86UP.R!$979E;&]P;65N
M="!487@@0W)E9&ET<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&
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M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^#0H\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SL@34%2
M1TE.+4Q%1E0Z(#$P<'0[)SX\9F]N="!S:7IE/3-$,CY#:&%N9V4@:6X@5F%L
M=6%T:6]N($%L;&]W86YC93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS
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M93TS1#(^,C(L,C`U/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.
M1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$
M/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A
M;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.
M1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'
M2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I
M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM
M97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X
M,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G
M<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@
M,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q
M,'!T.R<^/&9O;G0@<VEZ93TS1#(^26YC;VUE('1A>"`H8F5N969I="D@<')O
M=FES:6]N/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-
M24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<VEZ93TS1#(^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/B8C,38P
M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^)#PO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<VEZ93TS1#(^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-F9F9F9F8^
M#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P
M,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%
M1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X
M.R<@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F9F9F/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/
M3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L
M(FQI;F4M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X-
M"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)SXF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XQ
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@86QI9VX],T1R:6=H=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XQ<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ
M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@
M4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,"XW-7!T.R(@+2T^/"]F
M;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
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M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&
M5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[
M(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/
M3$]2+"(C1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L
M(FQI;F4M:&5I9VAT.C!P=#LB("TM/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/CPO
M=&%B;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R+7-P96-I9FEE9"!404='
M140@5$%"3$4@+2T^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!P<FEN8VEP
M86P@8V]M<&]N96YT<R!O9B!T:&4@9&5F97)R960@=&%X(&%S<V5T<R!A;F0@
M;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M9&EV('-T>6QE/3-$)V9O;G0M<VEZ93HQ,"XP<'0[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.T9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P=#LG/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS1"=03U-)5$E/3CH@<F5L
M871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!1$1)3D<M3$5&5#H@,'!T
M.R!724142#H@-S`E.R!0041$24Y'+5))1TA4.B`P<'0[($U!4D=)3BU,1494
M.B`Q-24[(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO<#X-"CQD:78@86QI9VX],T1C96YT
M97(^#0H\=&%B;&4@<W1Y;&4],T0G=&5X="UA;&EG;CIL969T.U1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`V-#EP>#LG(&)O<F1E<CTS1#`@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#8T.3X-"@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0041$24Y'
M+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@
M,'!X.R<^/"$M+2!404),12!#3TQ534X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S
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M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX]
M,T1B;W1T;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M86QI9VX],T1L969T/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\8G(@
M+SX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF
M;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,
M63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S
M:7IE/3-$,3X\8CY$96-E;6)E<B8C,38P.S,Q+#QB<B`O/@T*,C`Q,SPO8CX\
M+V9O;G0^/"]T:#X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T:#X-"CQT:"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&9O
M;G0@<VEZ93TS1#$^/&(^1&5C96UB97(F(S$V,#LS,2P\8G(@+SX-"C(P,3(\
M+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^/"]T<CX-
M"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@
M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.
M1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<VEZ93TS
M1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@8V]L
M<W!A;CTS1#4@86QI9VX],T1C96YT97(^/&9O;G0@<VEZ93TS1#$^/&(^*$EN
M('1H;W5S86YD<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[
M/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$
M1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M
M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
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M97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
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M=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[
M/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$
M1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M
M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B
M9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R
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M<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].
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M;3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,C!P=#LG/CQF;VYT('-I>F4],T0R
M/E1A>"!#<F5D:70@0V%R<GEF;W)W87)D<SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-I>F4],T0R/C(U+#4X,CPO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<VEZ93TS1#(^,C`L-CDR/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
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M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<VEZ93TS1#(^,RPR-C0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D
M:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[
M(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG
M;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G
M5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)
M3BU,1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^1FEX960@07-S971S/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^,2PV,S@\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4],T0R/C(L,34V/"]F
M;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS
M1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`R,'!T.R<^
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO
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M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T
M.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/
M33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X
M.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
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M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M/3-$,CXQ,S<L,S`W/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0R
M/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN
M9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0
M041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX]
M,T1T;W`@8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G
M5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)
M3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^1W)O<W,@1&5F97)R960@
M5&%X($QI86)I;&ET:65S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
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M93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P
M861D:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P
M<'@[(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A
M;&EG;CTS1'1O<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^3W1H97(@06-Q=6ER
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M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`R,'!T.R<^/&9O;G0@<VEZ93TS1#(^25!2)F%M<#M$($EN=&%N9VEB;&5S
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,CXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT
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M9VX],T1B;W1T;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM
M/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T
M.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P
M="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&
M3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/
M33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X
M.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C
M9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
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M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M
M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O
M<"!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/@T*/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494
M.B`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&
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M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[(%!!1$1)3D<M5$]0.B`P<'@[)R!V
M86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&
M1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE
M:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O
M;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P
M,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF
M(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)
M3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))
M1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C
M;VQO<CTS1"-F9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C
M1D9&1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M
M:&5I9VAT.C`N,7!T.R(@+2T^/"]F;VYT/B8C.#(P,SL\+W1D/@T*/'1D('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V
M86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX]
M,T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
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M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S.R!-
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M;VT^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
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M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O
M='1O;3X\(2TM($-/34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B
M("TM/CPA+2T@0T]-34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z
M,'!T.R(@+2T^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$
M<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P
M(#%P="!S;VQI9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/
M5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@
M,'!X.R!0041$24Y'+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(]
M,T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
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M3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T
M=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG
M.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!
M1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS
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M;W(],T0C9F9F9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3X\(2TM($-/
M34U!3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-
M34%.1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4
M+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI
M9#L@3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@
M3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!34E,
M63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$24Y'+4)/5%1/33H@,'!X.R!0
M041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'
M+51/4#H@,'!X.R<@=F%L:6=N/3-$=&]P(&)G8V]L;W(],T0C9F9F9F9F/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ
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M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C
M.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@
M1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N,7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S
M.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"
M3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z
M(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1'1O<"!B9V-O;&]R
M/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<VEZ93TS1#(^/"$M+2!#3TU-04Y$/4%$1%]23U=32$%$14-/3$]2+"(C1D9&
M1D9&(B`M+3X\(2TM($-/34U!3D0]041$7T=55%1%4D=2240L(FQI;F4M:&5I
M9VAT.C`N-S5P=#LB("TM/CPO9F]N=#XF(S@R,#,[/"]T9#X-"CQT9"!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[
M)R!V86QI9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L
M:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG
M('9A;&EG;CTS1&)O='1O;3XF(S@R,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,"XW-7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI
M9VX],T1B;W1T;VT^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@
M=F%L:6=N/3-$8F]T=&]M/B8C.#(P,SL\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&
M5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[($9/3E0M4TE:13H@,2XU<'0[
M(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1T;W`@8F=C;VQO<CTS1"-F
M9F9F9F8^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P=#L@1D].5"U&
M04U)3%DZ('1I;65S.R<@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/CPO='(^/"]T86)L93X\
M+V1I=CX-"CPA+2T@96YD(&]F('5S97(M<W!E8VEF:65D(%1!1T=%1"!404),
M12`M+3X\+V1I=CX\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E
M8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V
M,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#,V
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T]-
M34E4345.5%,@04Y$($-/3E1)3D=%3D-)15,@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0T]-34E4
M345.5%,@04Y$($-/3E1)3D=%3D-)15,\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(&]B;&EG871I;VYS
M(&9O<B!B87-E(')E;G0@86YD($-!32!C;W-T<R!U;F1E<B!F86-I;&ET>2!A
M;F0@;W1H97(@;F]N+6-A;F-E;&%B;&4@;W!E<F%T:6YG(&QE87-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78@<W1Y;&4],T0G9F]N
M="US:7IE.C$P+C!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX-
M"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4]
M,T0R/E1H92!F;VQL;W=I;F<@;V)L:6=A=&EO;G,@9F]R(&)A<V4@<F5N="!A
M;F0@0T%-(&-O<W1S('5N9&5R(&9A8VEL:71Y(&%N9"!O=&AE<B!N;VXM8V%N
M8V5L86)L92!O<&5R871I;F<@;&5A<V5S(&%S(&]F($1E8V5M8F5R)B,Q-C`[
M,S$L(#(P,3,@9&\@;F]T(&EN8VQU9&4@=&AE(&5X97)C:7-E(&]F(')E;F5W
M86P@=&5R;7,@;W(@96%R;'D@=&5R;6EN871I;VX@<')O=FES:6]N<R`H:6X@
M=&AO=7-A;F1S*3H\+V9O;G0^/"]P/@T*/&1I=B!S='EL93TS1"=03U-)5$E/
M3CH@<F5L871I=F4[(%!!1$1)3D<M0D]45$]-.B`P<'0[(%!!1$1)3D<M3$5&
M5#H@,'!T.R!724142#H@-S`E.R!0041$24Y'+5))1TA4.B`P<'0[($U!4D=)
M3BU,1494.B`Q-24[(%!!1$1)3D<M5$]0.B`P<'0[)SX-"CQP('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-
M34%.1#U!1$1?5$%"3$5724142"PB,3`P)2(@+2T^/"]F;VYT/CPO<#X-"CPA
M+2T@57-E<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%("TM/@T*/&1I=B!A;&EG
M;CTS1&-E;G1E<CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E('-T>6QE/3-$=&5X="UA
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M34X@5TE$5$A3($5.1"`M+3X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP
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M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[
M($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^,C`Q-3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
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M;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T-%
M149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@
M<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM
M97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^,C`Q-CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T1W
M:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-"CQP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/C(P,3<\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXQ+#<V-3PO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX-
M"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF;VYT('-I>F4],T0R/C(P
M,3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@
M=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^5&AE
M<F5A9G1E<CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
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M/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA
M+2T@0T]-34%.1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M
M+2!#3TU-04Y$/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M
M+3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)
M1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO
M='(^#0H\='(@<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B
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M/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)
M3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#`N,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I
M9VAT/B8C.#(P,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P
M+C%P=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T-%149&/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS
M1#(^5&]T86P@;6EN:6UU;2!L96%S92!P87EM96YT<SPO9F]N=#X\+W`^/"]T
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M2$5)1TA4.B`P<'0[($9/3E0M1D%-24Q9.B!T:6UE<SLG/CPA+2T@0T]-34%.
M1#U!1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$
M/4%$1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP<'0[(B`M+3XF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($Q)3D4M2$5)1TA4.B`P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T1P861D:6YG.C`[('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
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M>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M,7!T.R!&3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/B8C.#(P
M,SL\+W1D/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C%P=#L@1D].
M5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1'!A9&1I;F<Z,#L@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C9F9F
M9F9F/@T*/'1D('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`P+C<U<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/CPA+2T@0T]-34%.1#U!
M1$1?4D]74TA!1$5#3TQ/4BPB(T9&1D9&1B(@+2T^/"$M+2!#3TU-04Y$/4%$
M1%]'551415)'4DE$+")L:6YE+6AE:6=H=#HP+C<U<'0[(B`M+3X\+V9O;G0^
M)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#`N-S5P=#L@1D].5"U&04U)3%DZ('1I;65S
M.R<^)B,X,C`S.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#`N
M-S5P=#L@1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#XF(S@R
M,#,[/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,"XW-7!T.R!&
M3TY4+49!34E,63H@=&EM97,[)SXF(S@R,#,[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W!A9&1I;F<Z,#L@1D].5"U325I%.B`Q+C5P=#LG('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(V9F9F9F9CX-"CQT9"!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,'!T.R!&3TY4+49!34E,63H@=&EM97,[)SX\(2TM($-/34U!
M3D0]041$7U)/5U-(041%0T],3U(L(B-&1D9&1D8B("TM/CPA+2T@0T]-34%.
M1#U!1$1?1U545$521U))1"PB;&EN92UH96EG:'0Z,'!T.R(@+2T^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=,24Y%+4A%24=(5#H@,'!T.R!&3TY4+49!
M34E,63H@=&EM97,[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!,24Y%+4A%24=(5#H@,'!T
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R<^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B
M;&4^/"]D:78^#0H\(2TM(&5N9"!O9B!U<V5R+7-P96-I9FEE9"!404='140@
M5$%"3$4@+2T^/"]D:78^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C
M,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T
M,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3
M:&5E=#,W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^4T5,14-4140@455!4E1%4DQ9($9)3D%.0TE!3"!$051!("A5;F%U9&ET
M960I("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-%3$5#5$5$(%%505)415),62!&24Y!3D-)04P@
M1$%402`H56YA=61I=&5D*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@<V5L96-T960@<75A<G1E<FQY
M(&9I;F%N8VEA;"!D871A("AU;F%U9&ET960I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T
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M<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SXF(S$V,#L\+W`^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI
M9VXZ;&5F=#M415A4+4%,24=..B!L969T.R!724142#H@-C(Y<'@[)R!B;W)D
M97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@]
M,T0V,CD^#0H-"CQT<B!S='EL93TS1"=P861D:6YG.C`[4$%$1$E.1RU"3U14
M3TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D<M4DE'2%0Z(#!P
M>#L@4$%$1$E.1RU43U`Z(#!P>#LG/CPA+2T@5$%"3$4@0T],54U.(%=)1%1(
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M/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT
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M1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'
M+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T
M;VT^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#X-"CQD:78@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[(%=)1%1(.B`Q-W!T.R!-05)'
M24XM0D]45$]-.B`P<'0[)SX\9F]N="!S:7IE/3-$,3X\8CXR,#$S(#PA+2T@
M0T]-34%.1#U!1$1?4T-23U!0141254Q%+#$W<'0@+2T^/"]B/CPO9F]N=#X\
M+V1I=CX\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG
M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!
M34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N
M="!S:7IE/3-$,3X\8CY1,2`R,#$S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C
M,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS
M<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY1,B`R
M,#$S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9
M.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*
M/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M.R!&3TY4+49!34E,63H@=&EM97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E
M;G1E<CX\9F]N="!S:7IE/3-$,3X\8CY1,R`R,#$S/"]B/CPO9F]N=#X\+W1H
M/@T*/'1H('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I
M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM
M97,[)R!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\9F]N="!S:7IE/3-$
M,3X\8CY1-"`R,#$S/"]B/CPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N
M=#X\+W1H/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M
M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT^#0H\
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M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4
M.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXD/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI
M9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXY.#`\+V9O;G0^/"]T9#X-"CQT
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M9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X
M.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*/'1D('-T>6QE/3-$)T9/
M3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!4D=)3BU,1494.B`Q,'!T
M.R<^/&9O;G0@<VEZ93TS1#(^3F5T(&QO<W,\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^
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M;G0@<VEZ93TS1#(^*#$Y+#`Q-CPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)T9/3E0M1D%-24Q9.B!T:6UE<SLG/CQF;VYT('-I>F4],T0R/BD\+V9O;G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N
M="!S:7IE/3-$,CXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,[)R!A;&EG;CTS1')I9VAT/CQF;VYT('-I>F4]
M,T0R/B@R,RPQ-#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N="!S:7IE/3-$,CXH,C(L
M,#8R/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!1$1)
M3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M5$]0
M.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#0T5%1D8^#0H\
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M/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^*#`N,C,\+V9O;G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$
M,CXI/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
M;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^*#`N,C<\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^/"]T<CX\+W1A8FQE/CPO
M9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I960@5$%'1T5$(%1!0DQ%
M("TM/CPO9&EV/@T*/'`@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
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M/CPO9F]N=#X\+W`^#0H\(2TM(%5S97(M<W!E8VEF:65D(%1!1T=%1"!404),
M12`M+3X-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@<W1Y;&4],T0G
M=&5X="UA;&EG;CIL969T.U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`V,S%P
M>#LG(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,"!W:61T:#TS1#8S,3X-"@T*/'1R('-T>6QE/3-$)W!A9&1I;F<Z,#M0041$
M24Y'+4)/5%1/33H@,'!X.R!0041$24Y'+4Q%1E0Z(#!P>#L@4$%$1$E.1RU2
M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^/"$M+2!404),12!#3TQ5
M34X@5TE$5$A3(%-%5"`M+3X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@
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M)T9/3E0M1D%-24Q9.B!T:6UE<SLG('=I9'1H/3-$-3`^/"]T9#X-"CQT9"!S
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M:6YG.C`[4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[
M(%!!1$1)3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG
M;CTS1&)O='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/@T*/&1I=B!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9#L@5TE$5$@Z(#$W
M<'0[($U!4D=)3BU"3U143TTZ(#!P=#LG/CQF;VYT('-I>F4],T0Q/CQB/C(P
M,3(@/"$M+2!#3TU-04Y$/4%$1%]30U)/4%!%1%)53$4L,3=P="`M+3X\+V(^
M/"]F;VYT/CPO9&EV/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\
M=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[
M($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N
M=&5R/CQF;VYT('-I>F4],T0Q/CQB/E$Q(#(P,3(\+V(^/"]F;VYT/CPO=&@^
M#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ
M93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE
M<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q
M/CQB/E$R(#(P,3(\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT
M/CPO=&@^#0H\=&@@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60[($9/3E0M1D%-24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L
M:6=N/3-$8V5N=&5R/CQF;VYT('-I>F4],T0Q/CQB/E$S(#(P,3(\+V(^/"]F
M;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^
M/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60[($9/3E0M1D%-
M24Q9.B!T:6UE<SLG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT
M('-I>F4],T0Q/CQB/E$T(#(P,3(\+V(^/"]F;VYT/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q
M-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O
M='1O;3X-"CQT:"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[)R!A;&EG
M;CTS1&QE9G0^/&9O;G0@<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CQB<B`O/CPO
M=&@^#0H\=&@@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@
M<VEZ93TS1#$^)B,Q-C`[/"]F;VYT/CPO=&@^#0H\=&@@<W1Y;&4],T0G1D].
M5"U&04U)3%DZ('1I;65S.R<@8V]L<W!A;CTS1#$Q(&%L:6=N/3-$8V5N=&5R
M/CQF;VYT('-I>F4],T0Q/CQB/BA);B!T:&]U<V%N9',L(&5X8V5P="!P97(@
M<VAA<F4@86UO=6YT<RD\+V(^/"]F;VYT/CQB<B`O/CPO=&@^#0H\=&@@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#$^)B,Q
M-C`[/"]F;VYT/CPO=&@^/"]T<CX-"CQT<B!S='EL93TS1"=P861D:6YG.C`[
M4$%$1$E.1RU"3U143TTZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)
M3D<M4DE'2%0Z(#!P>#L@4$%$1$E.1RU43U`Z(#!P>#LG('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-#145&1CX-"CQT9"!S='EL93TS1"=&3TY4+49!
M34E,63H@=&EM97,[)SX-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S.R!-05)'24XM3$5&5#H@,3!P=#LG/CQF
M;VYT('-I>F4],T0R/E1O=&%L(')E=F5N=64\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS
M1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)
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M/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
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M='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]45$]-.B`P<'@[(%!!
M1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P<'@[(%!!1$1)3D<M
M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1'=H:71E/@T*
M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<SLG/@T*/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z("TQ,'!T.R!&3TY4+49!34E,63H@=&EM97,[($U!
M4D=)3BU,1494.B`Q,'!T.R<^/&9O;G0@<VEZ93TS1#(^3F5T(&QO<W,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S
M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I
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M.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G1D].5"U&04U)3%DZ('1I;65S.R<@86QI9VX],T1R:6=H=#X\9F]N
M="!S:7IE/3-$,CXH,38L.#`W/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^*3PO9F]N=#X\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G<&%D9&EN9SHP.U!!1$1)3D<M0D]4
M5$]-.B`P<'@[(%!!1$1)3D<M3$5&5#H@,'!X.R!0041$24Y'+5))1TA4.B`P
M<'@[(%!!1$1)3D<M5$]0.B`P<'@[)R!V86QI9VX],T1B;W1T;VT@8F=C;VQO
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M.B!T:6UE<SLG(&%L:6=N/3-$<FEG:'0^/&9O;G0@<VEZ93TS1#(^*#`N,C<\
M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,[
M)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ('1I;65S.R<^/&9O;G0@<VEZ93TS1#(^)B,Q-C`[/"]F
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M<VEZ93TS1#(^*#`N,C<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=&3TY4
M+49!34E,63H@=&EM97,[)SX\9F]N="!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^
M/"]T<CX\+W1A8FQE/CPO9&EV/@T*/"$M+2!E;F0@;V8@=7-E<BUS<&5C:69I
M960@5$%'1T5$(%1!0DQ%("TM/CPO9&EV/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V
M7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K
M<VAE971S+U-H965T,S@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,5$%%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/DY!5%5212!/1B!"55-)3D534R!!3D0@3U9%4E9)15<@
M*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#@^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DY!5%5212!/1B!"55-)3D534R!!3D0@3U9%4E9)15<\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#87-H+"!C87-H(&5Q=6EV86QE;G1S(&%N9"!M87)K971A8FQE('-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,S`S+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`S,#,L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@3&]S<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C(L,#8R+#`P,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,RPQ-#`L,#`P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$Y+#`Q-BPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3<L,S,R+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-BPX,#<L,#`P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$U+#`R-RPP,#`I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3,L-S<S+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,RPU,38L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#@Q+#4U,"PP,#`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3DL,3(S+#`P,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T
M-"PW.3DL,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;VYS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-C<L-C8Y+#`P
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B0@*#0Y+#<X,BPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@S-2PV-3@L,#`P*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W
M.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE
M971S+U-H965T,SDN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)4$%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/E-534U!4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.5$E.1R!0
M3TQ)0TE%4R`H1&5T86EL<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D)A<VES(&]F(%!R97-E;G1A=&EO
M;CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.=6UB97(@;V8@;W!E<F%T:6YG('-E9VUE;G1S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E=F5N=64@?"!#=7-T;VUE<B!C;VYC
M96YT<F%T:6]N('P@1VQA>&\\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY#;VYC96YT<F%T:6]N(')I<VL\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N8V5N=')A
M=&EO;B!R:7-K("AA<R!A('!E<F-E;G0I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU-RXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY-BXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XY."XP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B
M-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H
M965T<R]3:&5E=#0P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%6$A!13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY354U-05)9($]&(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@
M4$],24-)15,@*$1E=&%I;',@,BD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQA8F]R871O<GD@97%U:7!M96YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y(&%N
M9"!E<75I<&UE;G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5S=&EM871E9"!U<V5F=6P@;&EV97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9I8V4@9G5R;FET=7)E
M(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4')O<&5R='D@86YD(&5Q=6EP;65N=#PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D('5S
M969U;"!L:79E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@
M>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O;7!U=&5R(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T>2!A;F0@97%U:7!M96YT
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M<W1I;6%T960@=7-E9G5L(&QI=F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG,R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36%N=69A8W1U<FEN9R!E<75I<&UE;G0@?"!-
M:6YI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!U<V5F=6P@;&EV
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<W('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-
M86YU9F%C='5R:6YG(&5Q=6EP;65N="!\($UA>&EM=6T\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='D@86YD(&5Q
M=6EP;65N=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17-T:6UA=&5D('5S969U;"!L:79E<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
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M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P15)#044^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS
M=')O;F<^4U5-34%262!/1B!324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#
M2453("A$971A:6QS(#,I("A54T0@)"D\8G(^26X@36EL;&EO;G,L('5N;&5S
M<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,3$\8G(^0W5R84=E;CQB
M<CXT)2!C;VYV97)T:6)L92!S=6)O<F1I;F%T960@9&5B=#QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y/8W0N(#,Q+"`R,#`Y/&)R/D-U<F%'
M96X\8G(^-"4@8V]N=F5R=&EB;&4@<W5B;W)D:6YA=&5D(&1E8G0\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06-Q=6ES
M:71I;VX@;V8@0W5R84=E;B!#;W)P;W)A=&EO;CPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB;&4@<W5B
M;W)D:6YA=&4@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`Q,BXU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);G1E<F5S="!R871E("AA<R!A('!E<F-E;G0I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+C`P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&%Y;65N="!O
M9B!O=71S=&%N9&EN9R!P<FEN8VEP86P@86YD(&%C8W)U960@:6YT97)E<W0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(N.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1F]R96EG;B!#=7)R96YC>2!4<F%N<VQA=&EO;CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T('5N<F5A;&EZ
M960@9V%I;B!R96QA=&5D('1O(&9O<F5I9VX@8W5R<F5N8WD@=')A;G-L871I
M;VX@:6YC;'5D960@:6X@86-C=6UU;&%T960@;W1H97(@8V]M<')E:&5N<VEV
M92!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BXV
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R+C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B
M-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T-#(N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5+24%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-534U!4ED@3T8@
M4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4R`H1&5T86EL<R`T*3QB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^3F5T(&QO<W,@<&5R('-H87)E/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!O=&5N=&EA;&QY(&1I;'5T:79E
M(&-O;6UO;B!S:&%R97,@=&AA="!H879E(&YO="!B965N(&EN8VQU9&5D(&EN
M('1H92!N970@;&]S<R!P97(@8V]M;6]N('-H87)E(&-A;&-U;&%T:6]N<R!B
M96-A=7-E('1H92!E9F9E8W0@=V]U;&0@:&%V92!B965N(&%N=&DM9&EL=71I
M=F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-S<V+#4T-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L
M,S4U+#@Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0L-#8U+#`S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4W1O8VL@;W!T:6]N<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYE="!L;W-S('!E<B!S
M:&%R93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0;W1E;G1I86QL>2!D:6QU=&EV92!C;VUM;VX@<VAA<F5S('1H870@
M:&%V92!N;W0@8F5E;B!I;F-L=61E9"!I;B!T:&4@;F5T(&QO<W,@<&5R(&-O
M;6UO;B!S:&%R92!C86QC=6QA=&EO;G,@8F5C875S92!T:&4@969F96-T('=O
M=6QD(&AA=F4@8F5E;B!A;G1I+61I;'5T:79E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU+#<W,"PU-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#,T.2PX,3`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#0U.2PP,S0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E
M<W1R:6-T960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY.970@;&]S<R!P97(@<VAA<F4\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&]T96YT:6%L;'D@
M9&EL=71I=F4@8V]M;6]N('-H87)E<R!T:&%T(&AA=F4@;F]T(&)E96X@:6YC
M;'5D960@:6X@=&AE(&YE="!L;W-S('!E<B!C;VUM;VX@<VAA<F4@8V%L8W5L
M871I;VYS(&)E8V%U<V4@=&AE(&5F9F5C="!W;W5L9"!H879E(&)E96X@86YT
M:2UD:6QU=&EV93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P141%04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T]-4%)%
M2$5.4TE612!,3U-3("A$971A:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S86YD
M<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0T]-4%)%2$5.4TE6
M12!,3U-3/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%M;W5N=',@<F5C;&%S<VEF:65D(&9R;VT@;W1H97(@8V]M<')E
M:&5N<VEV92!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY#:&%N9V5S(&EN(&%C8W5M=6QA=&5D(&]T
M:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE("AL;W-S*2!B>2!C;VUP;VYE;G0\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F%L86YC92!A="!T:&4@8F5G:6YN:6YG(&]F('1H92!P97)I;V0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S0U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&-O;7!R
M96AE;G-I=F4@:6YC;VUE("AL;W-S*2!B969O<F4@<F5C;&%S<VEF:6-A=&EO
M;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&-U<G)E;G0M<&5R:6]D(&]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A
M="!T:&4@96YD(&]F('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(L-C8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPW-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D($=A:6X@*$QO<W,I
M(&]N($UA<FME=&%B;&4@4V5C=7)I=&EE<RP@;F5T(&]F('1A>#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-H86YG97,@
M:6X@86-C=6UU;&%T960@;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64@*&QO
M<W,I(&)Y(&-O;7!O;F5N=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T('1H92!B96=I;FYI;F<@;V8@
M=&AE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE("AL;W-S*2!B969O<F4@
M<F5C;&%S<VEF:6-A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#<T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&-U<G)E;G0M<&5R:6]D(&]T:&5R(&-O;7!R96AE
M;G-I=F4@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W
M-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0F%L86YC92!A="!T:&4@96YD(&]F('1H92!P97)I;V0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F5I9VX@0W5R<F5N
M8WD@271E;7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#:&%N9V5S(&EN(&%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R96AE
M;G-I=F4@:6YC;VUE("AL;W-S*2!B>2!C;VUP;VYE;G0\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!T
M:&4@8F5G:6YN:6YG(&]F('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-3@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&-O;7!R96AE;G-I=F4@:6YC
M;VUE("AL;W-S*2!B969O<F4@<F5C;&%S<VEF:6-A=&EO;G,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8W5R<F5N="UP97)I
M;V0@;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@=&AE(&5N9"!O9B!T
M:&4@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L
M-3@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X
M85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#0T+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%5UA!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY&04E2(%9!3%5%($U%
M05-54D5-14Y44R`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L
M('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@=F%L
M=64@;65A<W5R96UE;G1S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^07-S971S('1R86YS9F5R<F5D(&)E='=E96X@=&AE
M(&9A:7(@=F%L=64@;65A<W5R96UE;G0@8VQA<W-I9FEC871I;VYS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,:6%B:6QI=&EE<R!T
M<F%N<V9E<G)E9"!B971W965N('1H92!F86ER('9A;'5E(&UE87-U<F5M96YT
M(&-L87-S:69I8V%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D9A:7(@5F%L=64@365A<W5R96UE;G1S('P@1F%I<B!V86QU93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I
M<B!V86QU92!M96%S=7)E;65N=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y-;VYE>2!M87)K970@9G5N9',@86YD(&-A
M<V@@97%U:79A;&5N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$T."PU-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ."PV.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DUA<FME=&%B;&4@<V5C=7)I=&EE<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,S+#4X,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y+#`V-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L
M(&9I;F%N8VEA;"!A<W-E=',@870@9F%I<B!V86QU93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C@R+#$S,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<W+#<U,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!686QU92!-
M96%S=7)E;65N=',@?"!,979E;"`Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&86ER('9A;'5E(&UE87-U<F5M96YT<SPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUO
M;F5Y(&UA<FME="!F=6YD<R!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#8X.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&9I;F%N
M8VEA;"!A<W-E=',@870@9F%I<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$X+#8X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!686QU92!-96%S=7)E;65N=',@
M?"!,979E;"`R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY&86ER('9A;'5E(&UE87-U<F5M96YT<SPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUO;F5Y(&UA<FME="!F
M=6YD<R!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,30X+#4T.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA<FME=&%B;&4@<V5C=7)I=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,S+#4X,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y+#`V-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L(&9I;F%N8VEA;"!A<W-E=',@870@9F%I<B!V86QU93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R.#(L,3,P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U.2PP-C4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R
M7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F
M96(X,30O5V]R:W-H965T<R]3:&5E=#0U+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%0TA"1SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY-05)+151!0DQ%(%-%0U52251)15,@
M*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H
M97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!;6]R=&EZ960@0V]S=#PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R
M=&EZ960@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M,S,L-#DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`U."PY,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1W)O<W,@56YR96%L:7IE9"!'86EN
M<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y'<F]S<R!5;G)E86QI>F5D($=A:6YS/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1W)O<W,@56YR96%L:7IE9"!,
M;W-S97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1W)O<W,@56YR96%L:7IE9"!,;W-S97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#(R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I
M<B!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,S+#4X
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4Y+#`V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^36%R:V5T86)L92!S96-U<FET:65S(&-O;G-I9&5R960@=&\@
M8F4@;W1H97(M=&AA;BUT96UP;W)A<FEL>2!I;7!A:7)E9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E4N4RX@9V]V97)N;65N="!A;F0@
M;75N:6-I<&%L(&]B;&EG871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY!;6]R=&EZ960@0V]S=#PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA='5R:6YG(&EN
M(&]N92!Y96%R(&]R(&QE<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4U+#4S,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$U+#4V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36%T=7)I;F<@869T97(@;VYE('EE87(@=&AR
M;W5G:"!T:')E92!Y96%R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3@L,C,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3DL-SDW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F5D(&-O<W0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<S+#<V-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,U+#,V,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY'<F]S
M<R!5;G)E86QI>F5D($=A:6YS/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36%T=7)I;F<@:6X@;VYE('EE87(@;W(@;&5S
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%T=7)I
M;F<@869T97(@;VYE('EE87(@=&AR;W5G:"!T:')E92!Y96%R<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R;W-S(%5N<F5A;&EZ
M960@1V%I;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D=R;W-S(%5N<F5A;&EZ960@3&]S<V5S/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%T=7)I;F<@:6X@
M;VYE('EE87(@;W(@;&5S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y-871U<FEN9R!A9G1E<B!O;F4@>65A<B!T:')O=6=H('1H<F5E
M('EE87)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1W)O<W,@56YR96%L:7IE9"!,;W-S97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I<B!686QU93PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA='5R:6YG(&EN
M(&]N92!Y96%R(&]R(&QE<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4U+#4U-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$U+#4Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36%T=7)I;F<@869T97(@;VYE('EE87(@=&AR
M;W5G:"!T:')E92!Y96%R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3@L,C@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3DL.#DU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1F%I<B!686QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S,L.#0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S4L-#@Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;W)P;W)A=&4@9&5B="!S
M96-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY!;6]R=&EZ960@0V]S=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA='5R:6YG(&EN(&]N92!Y96%R(&]R
M(&QE<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X+#DW,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W
M+#,U,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^36%T=7)I;F<@869T97(@;VYE('EE87(@=&AR;W5G:"!T:')E92!Y
M96%R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L-S8Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPQ
M.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!;6]R=&EZ960@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-3DL-S,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C,L-30V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D=R;W-S(%5N<F5A;&EZ960@
M1V%I;G,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y-871U<FEN9R!I;B!O;F4@>65A<B!O<B!L97-S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA='5R:6YG(&%F=&5R(&]N92!Y
M96%R('1H<F]U9V@@=&AR964@>65A<G,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!5;G)E86QI>F5D($=A:6YS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D=R;W-S
M(%5N<F5A;&EZ960@3&]S<V5S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36%T=7)I;F<@:6X@;VYE('EE87(@;W(@;&5S
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%T=7)I
M;F<@869T97(@;VYE('EE87(@=&AR;W5G:"!T:')E92!Y96%R<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R;W-S(%5N<F5A;&EZ
M960@3&]S<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY&86ER(%9A;'5E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^36%T=7)I;F<@:6X@;VYE('EE87(@;W(@
M;&5S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S@L.3<S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L
M,S<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y-871U<FEN9R!A9G1E<B!O;F4@>65A<B!T:')O=6=H('1H<F5E('EE
M87)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PW-C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#(P
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D9A:7(@5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-3DL-S0Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`R,RPU-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E
M8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D,3(T,&(Q,E\V
M,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T<R]3:&5E=#0V
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%2$]!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY0
M4D]015)462!!3D0@15%525!-14Y4+"!.150@*$1E=&%I;',I("A54T0@)"D\
M8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY0<F]P97)T>2!A;F0@97%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(%!R;W!E<G1Y(&%N9"!%
M<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C$L
M.38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`Q.2PU,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,97-S($%C8W5M=6QA=&5D($1E<')E8VEA=&EO;B!A
M;F0@06UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q,2PY.3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3(L,S(U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@17%U:7!M96YT+"!.
M970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL.3<S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPR,#4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;B!E>'!E;G-E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DS,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,#0W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPR-#@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQA
M8F]R871O<GD@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='D@86YD(&5Q=6EP;65N=#PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A
M;"!0<F]P97)T>2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#8Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,38T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%N=69A8W1U<FEN9R!%<75I<&UE
M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY0<F]P97)T>2!A;F0@97%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(%!R;W!E<G1Y(&%N9"!%
M<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,3,P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BPP-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/9F9I8V4@1G5R;FET=7)E(&%N9"!%<75I<&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T
M>2!A;F0@97%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L(%!R;W!E<G1Y(&%N9"!%<75I<&UE;G0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S@V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR-C0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M96%S96AO;&0@26UP<F]V96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='D@86YD(&5Q=6EP;65N=#PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M;W1A;"!0<F]P97)T>2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-"PT.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPY,S(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYS=')U8W1I;VX@:6X@
M4')O9W)E<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY0<F]P97)T>2!A;F0@97%U:7!M96YT/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(%!R;W!E<G1Y
M(&%N9"!%<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,C4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P13$V04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^24Y404Y'
M24),12!!4U-%5%,@04Y$($=/3T1724Q,("A$971A:6QS*2`H55-$("0I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY);G1A;F=I8FQE($%S<V5T<R!A;F0@1V]O9'=I;&P\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&P\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@."PY-C4L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X
M+#DV-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D9I;FET92UL:79E9"!I;G1A;F=I8FQE(&%S
M<V5T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%C8W5M=6QA=&5D($%M;W)T:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-"PW-S8L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L-S8S+#`P,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E1O=&%L($EN=&%N9VEB;&4@07-S971S/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;W-T(&]F('1O=&%L(&EN=&%N
M9VEB;&4@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-RPU.38L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C<L-3DV+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G1A;F=I8FQE($%S<V5T<RP@3F5T
M("A%>&-L=61I;F<@1V]O9'=I;&PI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,BPX,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C,L.#,S+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO;B!E
M>'!E;G-E(&9O<B!I;G1A;F=I8FQE(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PP,3,L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP.3`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY,3,L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D5S=&EM871E9"!F=71U<F4@86UO<G1I>F%T:6]N(&5X<&5N<V4@
M;V8@:6YT86YG:6)L92!A<W-E=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^,C`Q-#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,34\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XR,#$V/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^,C`Q-SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XR,#$X/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M9V5N($%M
M96YD;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D9I;FET92UL:79E9"!I;G1A;F=I8FQE(&%S<V5T/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E
M9"!,:69E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,38@>65A
M<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L
M-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$T+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!!;6]R=&EZ871I;VX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L.#$R+#`P,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#DQ
M-2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`L-C@X+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Q+#4X-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;W)E(%1E8VAN;VQO9WD\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&:6YI=&4M
M;&EV960@:6YT86YG:6)L92!A<W-E=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@3&EF93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$Q('EE87)S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O<W0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,CDV+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,CDV+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%C8W5M=6QA=&5D($%M;W)T:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH.38T+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@X-#@L,#`P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S,BPP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#@L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^25!2
M)F%M<#M$/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^26YD969I;FET92UL:79E9"!I;G1A;F=I8FQE(&%S<V5T<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YD
M969I;FET92UL:79E9"!I;G1A;F=I8FQE(&%S<V5T<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q,2PX,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,2PX,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B
M,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B
M-69E8C@Q-"]7;W)K<VAE971S+U-H965T-#@N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V24%#
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D%#0U)5140@15A014Y315,@*$1E
M=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W
M:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!0T-2545$($584$5.4T53/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E
M9"!2;WEA;'1Y(&%N9"!,:6-E;G-E($9E97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#<W-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!087ER;VQL(&%N
M9"!%;7!L;WEE92!"96YE9FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPU,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XY,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@4F5S96%R8V@@86YD($1E=F5L;W!M
M96YT($-O;G1R86-T($-O<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,2PX-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW+#4V.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!0<F]F97-S:6]N86P@1F5E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-34V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!!
M8V-R=65D($5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#`Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%C8W)U960@17AP96YS97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,3<L,3<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,"PY-C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB
M-E]B-SAA7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B]D,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R
M:W-H965T<R]3:&5E=#0Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-$)!1SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY/5$A%4B!,3TY'+51%4DT@3$E!0DE,251)15,@*$1E
M=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,2!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2F%N+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*86XN(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]42$52($Q/
M3D<M5$5232!,24%"24Q)5$E%4SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(%)E;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#$Y+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#,T+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F5T($1E9F5R<F5D(%1A>"!,:6%B:6QI='D@<F5L871E9"!T;R!)4%(F86UP
M.T0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-C8Q+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0L-C8Q+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&5F97)R960@26YC;VUE(&9R;VT@4V%L92!O9B!487@@
M0F5N969I=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M-C,P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,3$X+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@4F5V96YU93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ-C@L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]A;B!087EA
M8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#<R+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W1H97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-RPX-S@L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-BPW,C0L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S($-U<G)E;G0@4&]R=&EO;CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.3(X+#`P,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S.#@L
M,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DQO;F<M5&5R;2!0;W)T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XV+#DU,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#,S-BPP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W5N="!A="!W
M:&EC:"!.97<@2F5R<V5Y('1A>"!B96YE9FET(&%G<F5E9"!T;R!B92!S;VQD
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06UO=6YT(&]F('-A;&4@;V8@3F5W($IE<G-E>2!T87@@
M8F5N969I=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E!E<FEO9"!F;W(@=VAI8V@@8F%S92!O9B!O
M<&5R871I;VYS(&UU<W0@8F4@;6%I;G1A:6YE9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!I;F-O;64@<F5L
M871E9"!T;R!S86QE(&]F('1A>"!B96YE9FET<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`R,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P155#044^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^3U1(15(@3$].1RU415)-($Q)04))3$E42453
M("A$971A:6QS(#(I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S
M,"P@,C`Q,SQB<CY2;V-K969E;&QE<B!$979E;&]P;65N="!397)V:6-E<R!!
M9W)E96UE;G0\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,SQB<CY2;V-K969E;&QE<B!$979E;&]P;65N="!397)V:6-E
M<R!!9W)E96UE;G0\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3W1H97(@3&]N9RU497)M($QI86)I;&ET:65S/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07!P
M<F]V960@<')O:F5C="!P;&%N(&9O<B!T:&4@9&5V96QO<&UE;G0@<V5R=FEC
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"PX,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&5R;2!O9B!T:&4@86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG,R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5P9G)O;G0@<&%Y;65N="!R
M96-O9VYI>F5D(&%S(')E=F5N=64@;W9E<B!T:&4@=&5R;2!O9B!T:&4@86=R
M965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VYT<F%C=',@86YD($=R86YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q+#8Q-RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(X,2PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,V+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$L-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB
M-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T-3$N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5'4T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E1%4DT@3$]!
M3B`H1&5T86EL<RD@*%1E<FT@3&]A;BP@55-$("0I/&)R/DEN($UI;&QI;VYS
M+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#(^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%Y(#,Q+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@
M,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,#QB<CY-:61#87`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q,3QB<CY'14-#/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E1E<FT@3&]A;CPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06UO=6YT(&)O<G)O=V5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D%M;W5N="!O=V5D('5N9&5R('1H92!T97)M(&QO
M86X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2
M97!A>6UE;G0@;V8@<')I;F-I<&%L(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^."XX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]U;G0@;V8@:6YT97)E<W0L
M('!R97!A>6UE;G0@86YD(&9I;F%L('!A>6UE;G0@9F5E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,"XW/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G1E<F5S="!E>'!E
M;G-E(&]N('1H92!T97)M(&QO86X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,2XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q+C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA
M7S5C,S!B-69E8C@Q-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D
M,3(T,&(Q,E\V,3(W7S0X8C9?8C<X85\U8S,P8C5F96(X,30O5V]R:W-H965T
M<R]3:&5E=#4R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%,T%"23X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY35$]#2TA/3$1%4E,G($5154E462`H1&5T86EL<RD@*%531"`D
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D%P<BX@,S`L(#(P,3`\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VMH;VQD97)S)R!%<75I='D\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-
M87AI;75M('9A;'5E(&]F('-E8W5R:71I97,@9F]R('=H:6-H('1H92!E;G1I
M='D@9FEL960@82!S:&5L9B!R96=I<W1R871I;VX@<W1A=&5M96YT/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C`P+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M-3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]M;6]N('-T;V-K(&ES<W5E9"`H:6X@<VAA<F5S*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPX,3,L-#@S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L-C$S
M+#0X,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$R+#`W-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,2PU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T('!R;V-E961S(&9R;VT@
M<V%L92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR.34L-CDW+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C@S+#<X-"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-BPP,C,L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M('!R;V-E961S(&9R;VT@<V%L92!O9B!S=&]C:R!I;B!A;B!U;F1E<G=R:71T
M96X@<'5B;&EC(&]F9F5R:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C<X+#4V,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT,RPT.#,L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,L-CDU+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E
M<G)E9"!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,#`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,#`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;&%S<R!#(%!R969E<G)E9"!3=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VMH;VQD97)S)R!%<75I
M='D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!A=71H;W)I>F5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#`P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-E<FEE<R!#+3$@4')E9F5R<F5D(%-T;V-K/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,G
M($5Q=6ET>3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,U,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-3`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#86YT;W(@06UE;F1M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,G($5Q=6ET>3PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;6UO;B!S=&]C:R!I<W-U960@*&EN('-H87)E<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#0S,RPV,#@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#`P,RPR.3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-S4L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T('!R;V-E961S(&9R;VT@<V%L92!O9B!C;VUM;VX@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W+#$P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0P
M+#$P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(L,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E:&]L9&5R(%)I9VAT<R!0;&%N
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY3:&%R96AO;&1E<B!2:6=H=',@4&QA;CPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!M=6QT:7!L
M97,@;V8@=&AE(&5X97)C:7-E('!R:6-E('1H870@=&AE(%)I9VAT(&AO;&1E
M<B!H87,@82!R:6=H="!T;R!R96-E:79E(&EN('9A;'5E(&]F('1H92!A8W%U
M:7)I;F<@8V]M<&%N>2=S(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E:&]L9&5R(%)I9VAT<R!0;&%N
M('P@36EN:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4VAA<F5H;VQD97(@4FEG:'1S(%!L86X\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C96YT
M86=E(&]F(&%S<V5T<R!O<B!E87)N:6YG('!O=V5R('-O;&0@86QL;W=I;F<@
M=&AE(%)I9VAT(&AO;&1E<B!A(')I9VAT('1O(')E8V5I=F4@8V]M;6]N('-T
M;V-K(&]F('1H92!A8W%U:7)I;F<@8V]M<&%N>3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5H;VQD97(@4FEG:'1S
M(%!L86X@?"!397)I97,@0RTQ(%!R969E<G)E9"!3=&]C:SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F5H;VQD
M97(@4FEG:'1S(%!L86X\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@<')E9F5R<F5D('-T;V-K('!U
M<F-H87-E(')I9VAT<R!F;W(@96%C:"!O=71S=&%N9&EN9R!S:&%R92!O9B!C
M;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.=6UB97(@;V8@<VAA<F5S(&-A;&QA8FQE(&)Y(')I9VAT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,#`Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,#`Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M>&5R8VES92!P<FEC92`H:6X@9&]L;&%R<R!P97(@=6YI="D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!M=6QT
M:7!L97,@;V8@=&AE(&5X97)C:7-E('!R:6-E('1H870@=&AE(%)I9VAT(&AO
M;&1E<B!H87,@<FEG:'0@=&\@<F5C96EV92!I;B!V86QU92!I9B`Q-24@;W(@
M;6]R92!O9B!T:&4@;W5T<W1A;F1I;F<@8V]M;6]N('-T;V-K(&ES(&%C<75I
M<F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA
M<F5H;VQD97(@4FEG:'1S(%!L86X@?"!397)I97,@0RTQ(%!R969E<G)E9"!3
M=&]C:R!\($UI;FEM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-H87)E:&]L9&5R(%)I9VAT<R!0;&%N/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R
M8V5N=&%G92!O9B!C;VUM;VX@<W1O8VL@=&\@8F4@86-Q=6ER960@9F]R(')I
M9VAT<R!T;R!B92!E>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!C;VUM;VX@<W1O
M8VL@=&\@8F4@86-Q=6ER960@:6X@82!T96YD97(@;V9F97(@9F]R(')I9VAT
M<R!T;R!B92!E>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B
M.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q
M,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T-3,N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$584D-)/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-4
M3T-++4)!4T5$($-/35!%3E-!5$E/3B`H1&5T86EL<RD@*%531"`D*3QB<CY)
M;B!-:6QL:6]N<RP@97AC97!T(%-H87)E(&1A=&$L('5N;&5S<R!O=&AE<G=I
M<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-H87)E<R!A=F%I;&%B;&4@9F]R(&ES<W5A;F-E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#$P,BPY-#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R97,\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3W!T:6]N<R!/=71S=&%N9&EN9R!A="!B96=I;FYI;F<@;V8@=&AE('!E<FEO
M9"`H:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-2PS-#DL.#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D=R86YT960@*&EN('-H87)E<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L,C4R+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES960@*&EN
M('-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@Q-BPT
M,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-A;F-E;&5D("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q-"PX-C$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@3W5T<W1A;F1I;F<@
M870@=&AE(&5N9"!O9B!T:&4@<&5R:6]D("AI;B!S:&%R97,I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#<W,"PU-#0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#,T.2PX,3`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(%9E<W1E9"!A;F0@17AP96-T960@=&\@5F5S="!A="!T:&4@96YD
M(&]F('1H92!P97)I;V0@*&EN('-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4L-S$R+#4Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS($5X97)C:7-A8FQE
M(&%T('1H92!E;F0@;V8@=&AE('!E<FEO9"`H:6X@<VAA<F5S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPR.3<L,3DP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!!
M=F%I;&%B;&4@9F]R($=R86YT('5N9&5R('1H92`R,#`X(%!L86X@*&EN('-H
M87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,3`R+#DT
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I8V4@
M4&5R(%-H87)E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D]P=&EO;G,@3W5T<W1A;F1I;F<@870@8F5G:6YN:6YG(&]F
M('1H92!P97)I;V0@*&EN(&1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+CDX/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT960@*&EN(&1O
M;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`Q-BXT-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%>&5R8VES960@*&EN(&1O;&QA<G,@<&5R('-H87)E
M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V+C4S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A
M;F-E;&5D("AI;B!D;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-BXY-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS($]U='-T86YD:6YG
M(&%T('1H92!E;F0@;V8@=&AE('!E<FEO9"`H:6X@9&]L;&%R<R!P97(@<VAA
M<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#@N,3<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4N
M.3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y/<'1I;VYS(%9E<W1E9"!A;F0@17AP96-T960@=&\@5F5S="!A="!T
M:&4@96YD(&]F('1H92!P97)I;V0@*&EN(&1O;&QA<G,@<&5R('-H87)E*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X+C$R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO
M;G,@17AE<F-I<V%B;&4@870@=&AE(&5N9"!O9B!T:&4@<&5R:6]D("AI;B!D
M;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-BXS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^5V5I9VAT960@079E<F%G92!296UA:6YI
M;F<@0V]N=')A8W1U86P@5&5R;3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS($]U='-T86YD:6YG(&%T(&)E
M9VEN;FEN9R!O9B!T:&4@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG-R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<W('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!/=71S=&%N9&EN
M9R!A="!T:&4@96YD(&]F('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<W('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)S<@>65A<G,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(%9E<W1E
M9"!A;F0@17AP96-T960@=&\@5F5S="!A="!T:&4@96YD(&]F('1H92!P97)I
M;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<W('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D]P=&EO;G,@17AE<F-I<V%B;&4@870@=&AE(&5N9"!O9B!T:&4@<&5R:6]D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-2!Y96%R<R`W(&UO
M;G1H<R`V(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!9&1I=&EO;F%L(&EN9F]R;6%T:6]N
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L(&EN=')I;G-I8R!V86QU92!O9B!S=&]C:R!O<'1I;VYS(&5X97)C
M:7-E9"`H:6X@9&]L;&%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XP,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@879E<F%G92!G<F%N="UD
M871E(&9A:7(@=F%L=64@*&EN(&1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,"XU,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RXV-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XX,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1F%I<B!V86QU92!O9B!S=&]C:R!O<'1I;VYS('9E<W1E9"`H:6X@9&]L;&%R
M<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(N-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(N,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(N-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06=G<F5G871E(&EN=')I;G-I8R!V86QU92!O9B!S=&]C:R!O<'1I;VYS(&]U
M='-T86YD:6YG("AI;B!D;VQL87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.3(N-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@:6YT<FEN<VEC('9A;'5E(&]F
M('-T;V-K(&]P=&EO;G,@=F5S=&5D(&%N9"!E>'!E8W1E9"!T;R!V97-T("AI
M;B!D;VQL87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3$N
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;"!C;VUP96YS871I;VX@8V]S="!N;W0@>65T(')E8V]G;FEZ
M960@*&EN(&1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#$T+C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^5V5I9VAT960@879E<F%G92!P97)I;V0@;W9E<B!W:&EC
M:"!C;VUP96YS871I;VX@8V]S="!I<R!E>'!E8W1E9"!T;R!B92!R96-O9VYI
M>F5D(&%S(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<R('EE87)S(#D@;6]N=&AS(#$X(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!S=&]C
M:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-H87)E<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/=71S=&%N9&EN9R!A;F0@=6YV97-T960@870@=&AE(&)E9VEN
M;FEN9R!O9B!T:&4@<&5R:6]D("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=&5D("AI;B!S:&%R97,I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F5S
M=&5D("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q,BPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%N9"!U;G9E<W1E9"!A="!T:&4@
M96YD(&]F('1H92!P97)I;V0@*&EN('-H87)E<RD\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^5V5I9VAT960@079E
M<F%G92!'<F%N="!$871E($9A:7(@5F%L=64@*'!E<B!S:&%R92D\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A
M;F1I;F<@86YD('5N=F5S=&5D(&%T('1H92!B96=I;FYI;F<@;V8@=&AE('!E
M<FEO9"`H:6X@9&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#0N-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=&5D("AI;B!D;VQL87)S('!E
M<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,34N
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y697-T960@*&EN(&1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y+C@U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%N
M9"!U;G9E<W1E9"!A="!T:&4@96YD(&]F('1H92!P97)I;V0@*&EN(&1O;&QA
M<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q-2XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-E;&QD97@@4F5S96%R8V@@,C`P-2!0;&%N(&%N9"!#=7)A
M1V5N(#(P,#<@4&QA;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;CPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@
M879A:6QA8FQE(&9O<B!I<W-U86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E<SPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@079A:6QA8FQE
M(&9O<B!'<F%N="!U;F1E<B!T:&4@,C`P."!0;&%N("AI;B!S:&%R97,I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,#0@15-04"!0
M;&%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!R97-E
M<G9E9"!F;W(@:7-S=6%N8V4@*&EN('-H87)E<RD\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'5R8VAA<V4@<')I8V4@87,@
M82!P97)C96YT86=E(&]F('1H92!L;W=E<B!O9B!T:&4@9F%I<B!M87)K970@
M=F%L=64@;V8@=&AE(&-O;6UO;B!S=&]C:R!A="!E:71H97(@=&AE(&)E9VEN
M;FEN9R!O9B!T:&4@;V9F97)I;F<@<&5R:6]D(&]R('1H92!A<'!L:6-A8FQE
M(&5X97)C:7-E(&1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C@U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y3:&%R97,@:7-S=65D('5N9&5R('1H92!P;&%N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PX,C,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#DS-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E
M<R!A=F%I;&%B;&4@9F]R(&ES<W5A;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-C0L,3(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F5S/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!!
M=F%I;&%B;&4@9F]R($=R86YT('5N9&5R('1H92`R,#`X(%!L86X@*&EN('-H
M87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V-"PQ,C0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^,C`P."!0;&%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA>&EM=6T@
M<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!T;R!B92!I<W-U960@9F]R(&=R86YT
M<R`H:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-RPT,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E1E<FUS(&]F(&]P=&EO;G,@9W)A;G1E9"!T;R!T:&4@
M:&]L9&5R<R!O9B!M;W)E('1H86X@,3`E(&]F('1H92!V;W1I;F<@<W1O8VL\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<U('EE87)S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1H
M<F5S:&]L9"!P97)C96YT86=E(&]F('9O=&EN9R!S=&]C:SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3`N,#`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E('!R:6-E
M(&%S(&$@<&5R8V5N=&%G92!O9B!F86ER(&UA<FME="!V86QU92!F;W(@;W!T
M:6]N<R!G<F%N=&5D('1O('1H92!H;VQD97)S(&]F(&UO<F4@=&AA;B`Q,"4@
M;V8@=&AE('9O=&EN9R!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3$P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#XR,#`X(%!L86X@?"!-87AI;75M/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VLM0F%S
M960@0V]M<&5N<V%T:6]N/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E9E<W1I;F<@<&5R:6]D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG-"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y497)M<R!O9B!O<'1I;VYS
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,3`@>65A<G,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B
M,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B
M-69E8C@Q-"]7;W)K<VAE971S+U-H965T-30N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5$14%'
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-43T-++4)!4T5$($-/35!%3E-!
M5$E/3B`H1&5T86EL<R`R*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL
M97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^5F%L=6%T:6]N(&%N9"!%>'!E
M;G-E<R!);F9O<FUA=&EO;CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!S=&]C:RUB87-E9"!C;VUP96YS871I
M;VX@97AP96YS92`H:6X@9&]L;&%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@-"PU-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#(L,CDX/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#,T,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!<W-U
M;7!T:6]N<R!U<V5D(&9O<B!F86ER('9A;'5E<R!O9B!E;7!L;WEE92!A;F0@
M9&ER96-T;W(@<W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&1I=FED
M96YD('!A>6%B;&4@:6X@9F]R97-E96%B;&4@9G5T=7)E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&]P=&EO;G,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!<W-U;7!T
M:6]N<R!U<V5D(&9O<B!F86ER('9A;'5E<R!O9B!E;7!L;WEE92!A;F0@9&ER
M96-T;W(@<W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D('-T;V-K('!R
M:6-E('9O;&%T:6QI='DL(&UI;FEM=6T@*&%S(&$@<&5R8V5N="D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Q+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<P+C`P)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X+C`P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M17AP96-T960@<W1O8VL@<')I8V4@=F]L871I;&ET>2P@;6%X:6UU;2`H87,@
M82!P97)C96YT*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S(N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-S(N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-S`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%>'!E8W1E9"!O<'1I;VX@=&5R;3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S8@>65A<G,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-B!Y96%R<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<V('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y2:7-K+69R964@:6YT97)E<W0@<F%T92P@;6EN:6UU;2`H87,@82!P
M97)C96YT*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XR,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M+CDP)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$N-#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y2:7-K+69R964@:6YT97)E<W0@<F%T92P@;6%X:6UU;2`H
M87,@82!P97)C96YT*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BXQ,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+C0P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(N.3`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%>'!E8W1E9"!D:79I9&5N9"!Y:65L9"`H87,@
M82!P97)C96YT*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP
M,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XP+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y297-E87)C:"!A;F0@9&5V96QO<&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY686QU871I
M;VX@86YD($5X<&5N<V5S($EN9F]R;6%T:6]N/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L('-T;V-K+6)A<V5D
M(&-O;7!E;G-A=&EO;B!E>'!E;G-E("AI;B!D;VQL87)S*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV-#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0Q-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#$R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'96YE<F%L
M(&%N9"!A9&UI;FES=')A=&EV93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E9A;'5A=&EO;B!A;F0@17AP96YS97,@26YF
M;W)M871I;VX\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N
M<V4@*&EN(&1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#$L.3`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`X.#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#DS,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U
M9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R
M7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T
M-34N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5544%%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/E)%5D5.544@*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U
M;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0W/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M0V]L;&%B;W)A=&EO;B!A<G)A;F=E;65N="!F;W(@9&5V96QO<&UE;G0@86YD
M(&-O;6UE<F-I86QI>F%T:6]N(&]F(&]R86P@<F]T879I<G5S('-T<F%I;CQB
M<CY';&%X;SQB<CY2;W1A<FEX/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^0V]L;&%B;W)A=&EO;B!A<G)A;F=E
M;65N="!F;W(@9&5V96QO<&UE;G0@86YD(&-O;6UE<F-I86QI>F%T:6]N(&]F
M(&]R86P@<F]T879I<G5S('-T<F%I;CQB<CY';&%X;SQB<CY2;W1A<FEX/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^0V]L;&%B;W)A=&EO;B!A<G)A;F=E;65N="!F;W(@9&5V96QO<&UE;G0@
M86YD(&-O;6UE<F-I86QI>F%T:6]N(&]F(&]R86P@<F]T879I<G5S('-T<F%I
M;CQB<CY';&%X;SQB<CY2;W1A<FEX/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#$Y.34\8G(^3&EC96YS92!A9W)E96UE;G1S
M/&)R/D-I;F-I;FYA=&D@0VAI;&1R96XG<R!(;W-P:71A;"!-961I8V%L($-E
M;G1E<CQB<CY2;W1A<FEX/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA>2`S,2P@,C`P-3QB<CY2;WEA;'1Y($%G<F5E;65N=#QB<CY04D8\
M8G(^4F]T87)I>#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY2159%3E5%/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!L:6-E;G-E
M(&9E92!P87EA8FQE(&]N(&YE="!R;WEA;'1I97,@<F5C96EV960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P+C`P)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E
M;G1A9V4@;V8@:6YT97)E<W0@:6X@;F5T(')O>6%L=&EE<R!S;VQD/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]D
M=6-T(')O>6%L='D@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R+#,S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,3`L-S<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y+#$Q.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPS,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$P+#@P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M.2PQ,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B
M-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T-38N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$4S34%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3$Q!0D]2051)
M3TX@04=2145-14Y44R`H1&5T86EL<RD@*$QI8V5N<V4@86=R965M96YT<RP@
M55-$("0I/&)R/DEN($UI;&QI;VYS+"!U;FQE<W,@;W1H97)W:7-E('-P96-I
M9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0T/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0V/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3,\8G(^365D87)E>#QB<CY-87AI;75M/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^4F]C
M:V5F96QL97(\8G(^36%X:6UU;3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D1U:V4\8G(^36%X:6UU;3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R
M/DQU9'=I9SQB<CY-87AI;75M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^06QT97)I<SQB<CY-87AI;75M/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\
M8G(^4V]U=&AA;7!T;VX\8G(^36%X:6UU;3QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D%M9V5N/&)R/DUA>&EM
M=6T\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@
M,C`Q-#QB<CY396%T=&QE($=E;F5T:6-S/&)R/D-U<F%'96X\8G(^4W5B<V5Q
M=65N="!E=F5N=#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/E-E871T;&4@1V5N971I8W,\8G(^0W5R84=E;CQB
M<CY-87AI;75M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D-O;&QA8F]R871I=F4@06=R965M96YT<SPO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.
M;VYR969U;F1A8FQE(&QI8V5N<V4@9F5E(&5X<&5N<V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XW/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4&5R:6]D(&9R;VT@=&AE(&9I<G-T(&-O;6UE<F-I86P@<V%L92!O9B!L:6-E
M;G-E9"!P<F]D=6-T(&9O<B!R;WEA;'1Y('!A>6UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<Q,"!Y96%R<SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6QE
M<W1O;F4@<&%Y;65N="!D=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS+CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XP+C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$N-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&%Y;65N="!M861E(&EN(&-O;FYE
M8W1I;VX@=VET:"!I;FET:6%T:6]N(&]F($U%5%))0SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BXU/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T
M.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7
M;W)K<VAE971S+U-H965T-3<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5'641)/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/DE.0T]-12!405A%4R`H1&5T86EL<RD@*%531"`D
M*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#@^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y3
M97`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M92!T87@@8F5N
M969I="`H<')O=FES:6]N*3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&961E<F%L/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,S`L.38R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q.2PS.30\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$V+#(P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-"PY,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT+#(S-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L,3,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&ER871I;VX@
M;V8@3F5T($]P97)A=&EN9R!,;W-S97,@86YD(%)E<V5A<F-H("9A;7`[($1E
M=F5L;W!M96YT(%1A>"!#<F5D:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$R-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Q+#0R-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T,3$I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE('1A>"!B
M96YE9FET("AP<F]V:7-I;VXI(&)E9F]R92!V86QU871I;VX@86QL;W=A;F-E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,U+#<U
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(R+#(P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$Y+#`P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5F97)R960@=&%X('9A;'5A=&EO;B!A;&QO=V%N
M8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S4L
M-S4V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#(R+#(P-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q.2PP,#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE('1A>"!B96YE9FET("AP<F]V
M:7-I;VXI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY296-O;F-I;&EA=&EO;B!B971W965N('1H92!A;6]U
M;G0@;V8@<F5P;W)T960@:6YC;VUE('1A>"!A;F0@=&AE(&%M;W5N="!C;VUP
M=71E9"!U<VEN9R!5+E,N(%-T871U=&]R>2!R871E/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^52Y3+B!3
M=&%T=71O<GD@<F%T92`H87,@82!P97)C96YT*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-"XP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E+71A>"!L;W-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,BPP-C(I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C,L,30P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$Y+#`Q-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q-RPS,S(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,38L.#`W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#$U+#`R-RD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,RPW-S,I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,L-3$V*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@Q
M+#4U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@U.2PQ,C,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-#0L-SDY*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!A="!3=&%T=71O<GD@4F%T97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C<L-S(W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(P+#$P,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q-2PR,3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y297-E87)C:"!A;F0@1&5V96QO<&UE;G0@0W)E
M9&ET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S
M+#(V,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,2PW,S8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=&%T92!487AE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T+#DR,"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#(S-RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#$S,2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-C8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%>'!I<F%T:6]N(&]F($YE="!/<&5R871I;F<@3&]S<V5S(&%N9"!2
M97-E87)C:"`F86UP.R!$979E;&]P;65N="!487@@0W)E9&ET<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0R-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0Q,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0VAA;F=E(&EN(%9A;'5A=&EO;B!!;&QO=V%N8V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4L-S4V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(L,C`U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL,#`X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M26YC;VUE('1A>"!B96YE9FET("AP<F]V:7-I;VXI/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY'<F]S<R!$
M969E<G)E9"!487@@07-S971S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T($]P97)A=&EN9R!,;W-S
M($-A<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<Y+#4U.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8W+#<R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<Y+#4U.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8W+#<R.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1A>"!#<F5D:70@
M0V%R<GEF;W)W87)D<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C4L-3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C`L-CDR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C4L-3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L-CDR/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@17AP
M96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8Q+#,W,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0S+#(R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8Q+#,W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0S+#(R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D($-O;7!E;G-A
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPY,C8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#(V-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,L.3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RPR-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y&:7AE9"!!<W-E=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L-C,X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ-38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8S.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,34V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06-C<G5E9"!%>'!E;G-E<R!A;F0@3W1H97(\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(T,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8R,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!$
M969E<G)E9"!487@@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-S(L-CDW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3,W+#,P-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W,BPV.3<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,S<L,S`W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY'<F]S<R!$969E<G)E9"!487@@3&EA8FEL:71I97,\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=&AE<B!!8W%U:7)E9"!);G1A;F=I8FQE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-"PQ,34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-"PT.#$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PQ,34I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PT.#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M25!2)F%M<#M$($EN=&%N9VEB;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@T+#8V,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@T+#8V,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#8V,2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#8V,2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O
M<W,@1&5F97)R960@5&%X($QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@X+#<W-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y+#$T,BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X+#<W-BD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y+#$T,BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@1&5F97)R960@5&%X($%S<V5T<R!A;F0@3&EA8FEL:71I97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V,RPY,C$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C@L
M,38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,38S+#DR,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R."PQ-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!487@@07-S971S(%9A
M;'5A=&EO;B!!;&QO=V%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$V."PU.#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3,R+#@R-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-C@L-3@R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$S,BPX,C8I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYE="!$969E<G)E9"!487@@07-S970@*$QI86)I;&ET>2D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-"PV-C$I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@T+#8V,2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#0L-C8Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H-"PV-C$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B
M.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q
M,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T-3@N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5514%)/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DE.
M0T]-12!405A%4R`H1&5T86EL<R`R*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F5T(&]P97)A
M=&EN9R!L;W-S(&%N9"!T87@@8W)E9&ET(&-A<G)Y9F]R=V%R9',\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;W!E
M<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`V+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@<W1A=&5S(&EN
M('=H:6-H('1H92!E;G1I='D@<')I;6%R:6QY(&]P97)A=&5S(&]R(&AA<R!O
M<&5R871E9"!A;F0@:&%S(&EN8V]M92!T87@@;F5X=7,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E8V]G;FEZ960@=&%X(&)E;F5F
M:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R84=E
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M3F5T(&]P97)A=&EN9R!L;W-S(&%N9"!T87@@8W)E9&ET(&-A<G)Y9F]R=V%R
M9',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y!<W-E=',@<F5C;W)D960@9F]R(&YE="!O<&5R871I;F<@;&]S<V5S(&YO
M="!Y970@=71I;&EZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&961E<F%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY.970@;W!E<F%T:6YG(&QO<W,@86YD('1A>"!C<F5D:70@
M8V%R<GEF;W)W87)D<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!E<FEO9"!O9B!R96-O9VYI=&EO;B!O9B!U;G)E86QI
M>F5D(&QO<W,@;W(@9V%I;B!A9G1E<B!T:&4@;W=N97)S:&EP(&-H86YG93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&961E
M<F%L('P@4B9A;7`[1"!C<F5D:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DYE="!O<&5R871I;F<@;&]S<R!A;F0@=&%X
M(&-R961I="!C87)R>69O<G=A<F1S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&%X(&-R961I="!C87)R>69O<G=A<F1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PX,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5&%X(&-R961I="!C87)R>69O<G=A<F1S('=I=&@@<W5B<W1A;G1I86P@;&EM
M:71A=&EO;G,@;VX@=7-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ.2PT,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1F5D97)A;"!\($]W;F5R<VAI<"!C:&%N9V4@:6X@
M3V-T;V)E<B`R,#`W/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY.970@;W!E<F%T:6YG(&QO<W,@86YD('1A>"!C<F5D:70@
M8V%R<GEF;W)W87)D<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR."PS,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06YN=6%L(&QI;6ET871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D9E9&5R86P@?"!/=VYE<G-H:7`@8VAA;F=E<R!I
M;B!*=6YE(#(P,#D@86YD($1E8V5M8F5R(#(P,#D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYE="!O<&5R871I;F<@;&]S
M<R!A;F0@=&%X(&-R961I="!C87)R>69O<G=A<F1S/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P97)A=&EN9R!L
M;W-S(&-A<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8W+#<P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!;FYU86P@;&EM:71A=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F5D97)A;"!\(%!R
M:6]R('1O(&UE<F=E<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3F5T(&]P97)A=&EN9R!L;W-S(&%N9"!T87@@8W)E9&ET
M(&-A<G)Y9F]R=V%R9',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,L,#`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9E9&5R86P@?"!#=7)A1V5N('P@4')I;W(@=&\@86-Q=6ES:71I;VX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYE="!O
M<&5R871I;F<@;&]S<R!A;F0@=&%X(&-R961I="!C87)R>69O<G=A<F1S/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&]P97)A=&EN9R!L;W-S(&-A<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4Q."PS,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F5D97)A;"!\($%604Y4
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.
M970@;W!E<F%T:6YG(&QO<W,@86YD('1A>"!C<F5D:70@8V%R<GEF;W)W87)D
M<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYE="!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,S$L-S`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@8V%R<GEF
M;W)W87)D<R!W:71H(&QI;6ET871I;VYS(&]N('5S93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#`L-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@8V%R<GEF;W)W
M87)D<R!R96UO=&5L>2!L:6ME;'D@=&\@8F4@=71I;&EZ960@:6X@9G5T=7)E
M('!E<FEO9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8P+#@P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y&961E<F%L('P@059!3E0@?"!0<FEO<B!T;R!M97)G97(\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYE="!O
M<&5R871I;F<@;&]S<R!A;F0@=&%X(&-R961I="!C87)R>69O<G=A<F1S/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3D],
M+"!N970@;V8@97AP:7)A=&EO;G,@86YD('5T:6QI>F%T:6]N/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#$L,C`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DY/3',@97AP
M:7)E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#0P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-T871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY.970@;W!E<F%T:6YG(&QO<W,@86YD('1A>"!C<F5D:70@8V%R
M<GEF;W)W87)D<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E1A>"!C<F5D:70@8V%R<GEF;W)W87)D<R!W:71H('-U8G-T
M86YT:6%L(&QI;6ET871I;VYS(&]N('5S93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3`X+#,P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&%T92!\(%(F86UP.T0@8W)E
M9&ET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.970@;W!E<F%T:6YG(&QO<W,@86YD('1A>"!C<F5D:70@8V%R<GEF;W)W
M87)D<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1A>"!C<F5D:70@8V%R<GEF;W)W87)D<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,30L-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1A>"!C<F5D:70@8V%R<GEF
M;W)W87)D<R!W:71H('-U8G-T86YT:6%L(&QI;6ET871I;VYS(&]N('5S93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y+#,P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15%$044^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T]-34E4345.5%,@04Y$($-/3E1)
M3D=%3D-)15,@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]B;&EG871I;VYS
M(&9O<B!B87-E(')E;G0@86YD($-!32!C;W-T<R!U;F1E<B!F86-I;&ET>2!A
M;F0@;W1H97(@;F]N+6-A;F-E;&%B;&4@;W!E<F%T:6YG(&QE87-E<SPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XR,#$T
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L-C8V+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#XR,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#@V,RPP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^,C`Q-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY
M,30L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/C(P,3<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L-S8U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#XR,#$X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU,#$L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1H97)E869T97(\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$V-RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&UI;FEM=6T@;&5A<V4@
M<&%Y;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#@W
M-BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P@<F5N="!A;F0@0T%-(&5X<&5N<V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPW,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#4P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#(L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R7S8Q,C=?-#AB
M-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+U-H965T-C`N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$552D%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E)%5$E214U%
M3E0@4T%624Y'4R!03$%.("A$971A:6QS*2`H55-$("0I/&)R/DEN($UI;&QI
M;VYS+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY2151)4D5-14Y4
M(%-!5DE.1U,@4$Q!3CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y-87AI;75M(&-O;G1R:6)U=&EO;B!B>2!P87)T:6-I
M<&%N=',@*&%S(&$@<&5R8V5N="D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%;7!L;WEE<B!M871C:"`H87,@82!P97)C96YT
M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA
M>&EM=6T@<&5R8V5N=&%G92!O9B!E;7!L;WEE97,G(&=R;W-S('!A>2!S=6)J
M96-T('1O(&5M<&QO>65R(&UA=&-H/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y"96YE9FET(&5X<&5N<V4@9F]R('1H92`T,#$H
M:RD@4&QA;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#`N,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P13%9044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4T5,14-4140@
M455!4E1%4DQ9($9)3D%.0TE!3"!$051!("A5;F%U9&ET960I("A$971A:6QS
M*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@97AC97!T(%!E<B!3:&%R92!D
M871A+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0X/C,@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY314Q%0U1%1"!154%25$523%D@1DE.04Y#24%,
M($1!5$$@*%5N875D:71E9"D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!R979E;G5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8R,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.3@P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPT
M,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#,L-C0W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`S+#$Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,BPP,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L-#,S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+#$Q,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3$L,C`R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Y+#(V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3F5T("AL;W-S*2!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,C(L,#8R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C,L,30P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3DL,#$V*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3<L
M,S,R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H,38L.#`W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,34L,#(W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3,L-S<S*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3,L-3$V*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H.#$L
M-34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H-3DL,3(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H-#0L-SDY*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@86YD(&1I;'5T960@;F5T
M(&QO<W,@<&5R(&-O;6UO;B!S:&%R92`H:6X@9&]L;&%R<R!P97(@<VAA<F4I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,C<I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C(Y
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H,"XR-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#`N,C,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@P+C(W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XR-2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,C,I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C(W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,2XP,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#$N,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XD("@Q+C$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U
M9F5B.#$T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V0Q,C0P8C$R
M7S8Q,C=?-#AB-E]B-SAA7S5C,S!B-69E8C@Q-"]7;W)K<VAE971S+V9I;&5L
M:7-T+GAM;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC<F]S
M;V9T+6-O;3IO9F9I8V4Z;V9F:6-E(CX-"B`\;SI-86EN1FEL92!(4F5F/3-$
M(BXN+U=O<FMB;V]K+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#(N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`S+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`V+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970P-RYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,#@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#`Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,"YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3$N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,30N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$U+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970Q-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,3<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$X+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q.2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,BYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C,N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#(T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970R-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C8N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(W+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970R."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,CDN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,P+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S,2YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,S(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#,S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S-"YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S4N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#,V+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970S-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S@N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,Y+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970T,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T-#$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0R
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T,RYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T-#0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#0U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T
M-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#<N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0X+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970T.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M-3`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#4Q+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970U,BYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T-3,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#4T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970U-2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-38N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#4W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970U."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-3DN:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#8P+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970V,2YH=&UL(B\^#0H\+WAM;#X-"BTM+2TM+3U?3F5X
M=%!A<G1?9#$R-#!B,3)?-C$R-U\T.&(V7V(W.&%?-6,S,&(U9F5B.#$T+2T-
!"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDEAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMPREHENSIVE LOSS (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>COMPREHENSIVE LOSS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from other comprehensive income</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income (loss) by component</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance at the beginning of the period</a></td>
        <td class="nump">2,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
        <td class="num">(77)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
        <td class="num">(77)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance at the end of the period</a></td>
        <td class="nump">2,668<span></span></td>
        <td class="nump">2,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Unrealized Gain (Loss) on Marketable Securities, net of tax</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income (loss) by component</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance at the beginning of the period</a></td>
        <td class="nump">156<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
        <td class="num">(74)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
        <td class="num">(74)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance at the end of the period</a></td>
        <td class="nump">82<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign Currency Items</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income (loss) by component</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance at the beginning of the period</a></td>
        <td class="nump">2,589<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
        <td class="num">(3)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
        <td class="num">(3)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance at the end of the period</a></td>
        <td class="nump">$ 2,586<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AccumulatedOtherComprehensiveIncomeLossRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTaxAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Summary of marketable securities</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 655px;" border="0" cellspacing="0" cellpadding="0" width="655">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Amortized<br />
Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Gains</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Losses</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Fair<br />
Value</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2"><b>December&#160;31, 2013</b></font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">U.S. government and municipal obligations</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">55,531</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">55,554</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">18,234</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">56</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">18,286</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total U.S. government and municipal obligations</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">73,765</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">83</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(8</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">73,840</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">38,973</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">9</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(9</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">38,973</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">20,761</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">12</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(5</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">20,768</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">59,734</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">21</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(14</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">59,741</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">133,499</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">104</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(22</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">133,581</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><br /></font>&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 661px;" border="0" cellspacing="0" cellpadding="0" width="661">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="49"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Amortized<br />
Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Gains</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Losses</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Fair<br />
Value</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2"><b>December&#160;31, 2012</b></font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">U.S. government and municipal obligations</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">15,566</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">28</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">15,594</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,797</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">99</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,895</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total U.S. government and municipal obligations&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,363</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">127</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,489</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">17,353</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">23</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">17,372</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">6,193</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">14</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">6,204</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">23,546</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">37</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(7</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">23,576</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">58,909</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">164</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(8</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of financial assets subject to fair value measurements</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left;" border="0" cellspacing="0" cellpadding="0" width="100%">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="36"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>As of<br />
December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;1</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;2</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;3</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Money market funds and cash equivalents</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">148,549</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">148,549</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">133,581</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">133,581</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">282,130</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">282,130</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><br /></font>&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left;" border="0" cellspacing="0" cellpadding="0" width="100%">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="36"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>As of<br />
December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;1</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;2</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;3</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Money market funds and cash equivalents</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">18,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">18,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">77,753</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">18,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19190-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3MAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COLLABORATION AGREEMENTS (Details) (License agreements, USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="4">12 Months Ended</th>
        <th class="th" colspan="6"></th>
        <th class="th" colspan="1">2 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Medarex

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Rockefeller

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Duke

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Ludwig

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Alteris

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Southampton

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Amgen

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014

</div>
          <div>Seattle Genetics

</div>
          <div>CuraGen

</div>
          <div>Subsequent event</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Seattle Genetics

</div>
          <div>CuraGen

</div>
          <div>Maximum</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Agreements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_NonRefundableLicenseFee', window );">Nonrefundable license fee expense</a></td>
        <td class="nump">$ 0.7<span></span></td>
        <td class="nump">$ 0.7<span></span></td>
        <td class="nump">$ 1.4<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct', window );">Period from the first commercial sale of licensed product for royalty payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementTotalPotentialMilestonePayments', window );">Milestone payment due</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7.0<span></span></td>
        <td class="nump">3.9<span></span></td>
        <td class="nump">0.7<span></span></td>
        <td class="nump">1.0<span></span></td>
        <td class="nump">5.0<span></span></td>
        <td class="nump">1.4<span></span></td>
        <td class="nump">1.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5.0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric', window );">Payment made in connection with initiation of METRIC</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of payment made in connection with the initiation of METRIC, based on the terms of the collaborative arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementMilestonePaymentsMadeInConnectionWithInitiationOfMetric</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the period from the first commercial sale of licensed product for royalty payment under the collaborative arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementRoyaltyPaymentPeriodFromFirstCommercialSaleOfLicensedProduct</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementTotalPotentialMilestonePayments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the total amount of potential milestone payments to be made by the entity based on terms of the collaborative arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementTotalPotentialMilestonePayments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_NonRefundableLicenseFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of nonrefundable license fee expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_NonRefundableLicenseFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWXAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels', window );">Assets transferred between the fair value measurement classifications</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels', window );">Liabilities transferred between the fair value measurement classifications</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value Measurements | Fair value</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds and cash equivalents</a></td>
        <td class="nump">148,549<span></span></td>
        <td class="nump">18,688<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">133,581<span></span></td>
        <td class="nump">59,065<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets at fair value</a></td>
        <td class="nump">282,130<span></span></td>
        <td class="nump">77,753<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value Measurements | Level 1</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds and cash equivalents</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">18,688<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets at fair value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">18,688<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value Measurements | Level 2</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds and cash equivalents</a></td>
        <td class="nump">148,549<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">133,581<span></span></td>
        <td class="nump">59,065<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets at fair value</a></td>
        <td class="nump">$ 282,130<span></span></td>
        <td class="nump">$ 59,065<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of transfer of assets measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of transfer of liabilities measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>PROPERTY AND EQUIPMENT, NET</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 621px;" border="0" cellspacing="0" cellpadding="0" width="621">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Laboratory Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,699</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,164</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Manufacturing Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,130</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,055</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Office Furniture and Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,386</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,264</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Leasehold Improvements</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">14,493</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">12,932</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Construction in Progress</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">257</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">115</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total Property and Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">21,965</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,530</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Less Accumulated Depreciation and Amortization</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(11,992</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(12,325</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">9,973</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">7,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>INTANGIBLE ASSETS AND GOODWILL</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of intangible assets, net of accumulated amortization, and goodwill</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 54%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 682px;" border="0" cellspacing="0" cellpadding="0" width="682">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="58" align="right"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="61"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="61"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="10" align="center"><font size="1"><b>December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Estimated<br />
Life</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Accumulated<br />
Amortization</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Net</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Accumulated<br />
Amortization</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Net</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="17" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Intangible Assets:</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">IPR&amp;D</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">Indefinite</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Amgen Amendment</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">16&#160;years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">14,500</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(3,812</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">10,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">14,500</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(2,915</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,585</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Core Technology</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11&#160;years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,296</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(964</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">332</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,296</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(848</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">448</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total Intangible Assets</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">27,596</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,776</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">22,820</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">27,596</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(3,763</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">23,833</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Goodwill</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">Indefinite</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Basis of Presentation</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The accompanying consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation. The Company operates in one segment, which is the business of development, manufacturing and commercialization of novel therapeutics for human health care.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Use of Estimates</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S.&#160;GAAP) requires management to make estimates and use assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Cash and Cash Equivalents</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company considers all highly liquid investments purchased with a maturity date of 90&#160;days or less at the date of purchase to be cash equivalents. Cash equivalents consist principally of money market funds and debt securities.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Marketable Securities</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company invests its excess cash balances in marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds. The Company classifies all of its marketable securities as current assets on the consolidated balance sheets because they are available-for-sale and available to fund current operations. Marketable securities are stated at fair value with their unrealized gains and losses included as a component of accumulated other comprehensive income (loss), which is a separate component of stockholders' equity, until such gains and losses are realized. If a decline in the fair value is considered other-than-temporary, based on available evidence, the unrealized loss is transferred from other comprehensive income (loss) to the consolidated statements of operations. Realized gains and losses are determined on the specific identification method and are included in investment and other income, net.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Concentration of Credit Risk and of Significant Customers and Suppliers</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, marketable securities and accounts receivable. The Company invests its cash, cash equivalents and marketable securities in debt instruments and interest bearing accounts at major financial institutions in excess of insured limits. The Company mitigates credit risk by limiting the investment type and maturity to securities that preserve capital, maintain liquidity and have a high credit quality. The Company has not historically experienced credit losses from its accounts receivable and therefore has not established an allowance for doubtful accounts.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Revenue from Glaxo represented 57%, 96% and 98% for the years ended December&#160;31, 2013, 2012 and 2011 and of total Company revenue, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company relies on contract manufacturing organizations (CMO) to manufacture drug substance and drug product for its late-stage clinical studies of rindopepimut and glembatumumab vedotin as well as for future commercial supplies. The Company also relies on CMOs for supply of raw materials as well as filling, packaging, storage and shipping of drug product. These clinical studies would be adversely affected by a significant interruption in the supply of rindopepimut and glembatumumab vedotin.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Fair Value Measurements</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has certain assets and liabilities that are measured at fair value in the financial statements. The Company seeks to maximize the use of observable inputs (market data obtained from sources independent from the Company) and to minimize the use of unobservable inputs (the Company's assumptions about how market participants would price assets and liabilities) when measuring the fair value of its assets and liabilities. These assets and liabilities are classified into one of three levels of the following fair value hierarchy as defined by U.S.&#160;GAAP:</font></p>
<ul>
<li style="list-style: none;">
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Level&#160;1: Observable inputs such as quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Level&#160;2: Observable inputs other than Level&#160;1 prices, such as quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Level&#160;3: Unobservable inputs based on the Company's assessment of the assumptions that market participants would use in pricing the asset or liability.</font></p></li></ul>
<p style="FONT-FAMILY: times;"><font size="2"><i>Property and Equipment</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property and equipment is stated at cost and depreciated over the estimated useful lives of the related assets using the straight-line method. Laboratory equipment and office furniture and equipment are depreciated over five years and computer equipment is depreciated over three years. Manufacturing equipment is amortized over seven to ten years. Leasehold improvements are amortized over the shorter of the estimated useful life or the non-cancelable term of the related lease, including any renewals that are reasonably assured of occurring. Property and equipment under construction is classified as construction in progress and is depreciated or amortized only after the asset is placed in service. Expenditures for maintenance and repairs are charged to expense whereas the costs of significant improvements which extend the life of the underlying asset are capitalized. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are eliminated and any resulting gain or loss is reflected in the Company's consolidated statements of operations and comprehensive loss.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The treatment of costs to construct property and equipment depends on the nature of the costs and the stage of construction. Costs incurred in the project planning, design, construction and installation phases are capitalized as part of the cost of the asset. The Company stops capitalizing these costs when the asset is substantially complete and ready for its intended use. For manufacturing property and equipment, the Company also capitalizes the cost of validating these assets for the underlying manufacturing process. The Company completes the capitalization of validation costs when the asset is substantially complete and ready for its intended use. Costs capitalized include incremental labor and fringe benefits, and direct consultancy services.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Business Combinations</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records the fair value of the consideration transferred to acquire a business to the tangible assets and identifiable intangible assets acquired and liabilities assumed on the basis of their fair values at the date of acquisition. The Company assesses the fair value of assets, including intangible assets such as in-process research and development (IPR&amp;D), using a variety of methods including present value models. Each asset is measured at fair value from the perspective of a market participant. The method used to estimate the fair values of IPR&amp;D assets incorporates significant assumptions regarding the estimates a market participant would make in order to evaluate an asset, including a market participant's assumptions regarding the probability of completing IPR&amp;D projects, which would require obtaining regulatory approval for marketing of the associated drug candidate; a market participant's estimates regarding the timing of and the expected costs to complete IPR&amp;D projects; a market participant's estimates of future cash flows from potential product sales; and the appropriate discount rates for a market participant. Transaction costs and restructuring costs associated with the transaction are expensed as incurred.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In connection with the acquisition of CuraGen Corporation ("CuraGen") in October 2009, the Company assumed CuraGen's $12.5&#160;million in 4% convertible subordinated debt due February&#160;15, 2011 (the "Convertible Subordinated Debt"). In February 2011, the Company paid $12.8&#160;million and satisfied all the outstanding principal and accrued interest related to the Convertible Subordinated Debt.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Intangible Assets</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IPR&amp;D assets acquired in a business combination initially are recorded at fair value and accounted for as indefinite-lived intangible assets. These assets are maintained on the Company's consolidated balance sheets until either the project underlying them is completed or the assets become impaired. If a project is completed, the carrying value of the related intangible asset is amortized over the remaining estimated life of the asset beginning in the period in which the project is completed. If a project becomes impaired or is abandoned, the carrying value of the related intangible asset is written down to its fair value and an impairment charge is taken in the period in which the impairment occurs.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In January 2013, the Company adopted a new U.S.&#160;GAAP accounting standard which amended guidance applicable to annual impairment tests of indefinite-lived intangible assets. The amended guidance added an optional qualitative assessment for determining whether an indefinite-lived intangible asset is impaired. Prior to this guidance, companies were required to perform an annual impairment test that included a calculation of the fair value of the asset and a comparison of that fair value with its carrying value. If the carrying value exceeded the fair value, an impairment was recorded. The amended guidance allows a company the option to perform a qualitative assessment, considering both negative and positive evidence, regarding the potential impairment of the indefinite-lived intangible asset. If, based on the qualitative analysis, the company determines that it is more likely than not that the fair value of such an asset exceeds its carrying value, the company would be permitted to conclude that the indefinite-lived intangible asset was not impaired without a quantitative calculation of the fair value of the asset. Otherwise, the company would perform the quantitative calculation of the fair value and the comparison with the carrying value. The Company's adoption of this new standard did not have a material effect on its operating results or financial position.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IPR&amp;D assets are tested for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. As part of the annual impairment test of the IPR&amp;D assets as of July&#160;1, 2013, the Company bypassed the optional qualitative assessment and performed a calculation of the fair value of the asset. The Company concluded that the IPR&amp;D assets were not impaired.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Intangible assets acquired in a business combination with a finite life are recorded at fair value and amortized over the greater of economic consumption or on a straight-line basis over their estimated useful life.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Goodwill</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The difference between the purchase price and the fair value of assets acquired and liabilities assumed in a business combination is allocated to goodwill. Goodwill is evaluated for impairment on an annual basis during the third quarter, or earlier if impairment indicators are present. The Company has the option to assess qualitative factors to determine if it is more likely than not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment test required under U.S.&#160;GAAP. As part of its annual impairment test of the goodwill asset as of July&#160;1, 2013, the Company bypassed the optional qualitative assessment and performed the two-step impairment test. The Company concluded that the goodwill asset was not impaired.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Impairment of Long-Lived Assets</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company evaluates the recoverability of its long-lived assets, including property and equipment, and intangible assets when circumstances indicate that an event of impairment may have occurred. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the assets, the assets are written-down to their estimated fair values.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Revenue Recognition</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company recognizes revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the seller's price to the buyer is fixed or determinable; and collectability is reasonably assured.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has entered into and in the future may enter into biopharmaceutical product development agreements with collaborative partners for the research and development of therapeutic drug products. The terms of the agreements may include nonrefundable signing and licensing fees, funding for research, development and manufacturing, milestone payments and royalties on any product sales derived from collaborations. These multiple element arrangements are analyzed to determine whether the deliverables can be separated or whether they must be accounted for as a single unit of accounting. In accounting for these transactions, the Company allocates revenue to the various elements based on their relative fair value. The fair value of a revenue generating element can be based on current selling prices offered by the Company or another party for current products or the Company's best estimate of a selling price for future products. Revenue allocated to an individual element is recognized when all other revenue recognition criteria are met for that element.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;These collaborative and other agreements may contain milestone payments. Revenues from milestones, if they are considered substantive, are recognized upon successful accomplishment of the milestones. Determining whether a milestone is substantive involves judgment, including an assessment of the Company's involvement in achieving the milestones and whether the amount of the payment is commensurate to the Company's performance. If not considered substantive, milestones are initially deferred and recognized over the remaining performance obligation.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payments received to fund certain research activities are recognized as revenue in the period in which the research activities are performed. Revenue from contracts and grants is recognized as the services are performed and recorded as effort is expended on the contracted work and billed to the government or the Company's contractual partner. Payments received in advance that are related to future performance are deferred and recognized as revenue when the research projects are performed.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Product royalty revenue consists of payments received from licensees for a portion of sales proceeds from products that utilize the Company's licensed technologies and are recognized when the amount of and basis for such royalty payments are reported to the Company in accurate and appropriate form and in accordance with the related license agreement.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Research and Development Expenses</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research and development costs, including internal and contract research costs, are expensed as incurred. Research and development expenses consist mainly of clinical trial costs, manufacturing of clinical material, toxicology and other studies, personnel costs, depreciation, license fees and funding of outside research.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clinical trial expenses include expenses associated with clinical research organizations (CRO). The invoicing from CROs for services rendered can lag several months. We accrue the cost of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, and project management costs. We maintain regular communication with our CROs to gauge the reasonableness of our estimates. Differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period in which they become known.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Patent Costs</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Patent costs are expensed as incurred. Certain patent costs are reimbursed by the Company's product development and licensing partners. Any reimbursed patent costs are recorded as product development and licensing agreement revenues in the Company's financial statements.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Stock-Based Compensation</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records stock-based compensation expense for all stock-based awards made to employees and directors based on the estimated fair values of the stock-based awards expected to vest at the grant date and is adjusted, if necessary, to reflect actual forfeitures. Compensation expense for all stock-based awards to employees and directors is recognized using the straight-line method over the term of vesting or performance.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records stock-based compensation expense for stock options granted to non-employees based on the fair value of the stock options which is re-measured over the vesting term resulting in periodic adjustments to stock-based compensation expense.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Foreign Currency Translation</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net unrealized gains and losses resulting from foreign currency translation are included in other comprehensive income (loss). At December&#160;31, 2013 and December&#160;31, 2012, accumulated other comprehensive income includes a net unrealized gain related to foreign currency translation of $2.6&#160;million. In 2011, the Company's foreign subsidiary voluntarily liquidated in order to consolidate the Company's foreign operations into Celldex Therapeutics,&#160;Inc.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Income Taxes</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company uses the asset and liability method to account for income taxes, including the recognition of deferred tax assets and deferred tax liabilities for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax basis. Quarterly, the Company reviews its deferred tax assets for recovery. A valuation allowance is established when the Company believes that it is more likely than not that its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company records uncertain tax positions in the financial statements only if it is more likely than not that the uncertain tax position will be sustained upon examination by the taxing authorities. The Company records interest and penalties related to uncertain tax positions in income tax expense.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Comprehensive Loss</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Comprehensive loss is comprised of net loss and certain changes in stockholders' equity that are excluded from net loss. The Company includes foreign currency translation adjustments and unrealized gains and losses on marketable securities in other comprehensive loss. The consolidated statements of operations and comprehensive loss reflect total comprehensive loss for the years ended December&#160;31, 2013, 2012 and 2011.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In January 2013, the Company adopted a new U.S.&#160;GAAP accounting standard which requires the Company to separately disclose, on a prospective basis, the change in each component of other comprehensive income (loss) relating to reclassification adjustments and current period other comprehensive income (loss). As the new guidance relates to presentation only, the adoption did not have a material impact on the Company's results of operations or financial position.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Net Loss Per Share</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>Year Ended December&#160;31,</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Stock options</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,770,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,349,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,459,034</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Restricted stock</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,776,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,355,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,465,034</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><i>Recent Accounting Pronouncements</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company's financial position or results of operations upon adoption.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 565px;" border="0" cellspacing="0" cellpadding="0" width="565">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Royalty and License Fees</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">250</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,776</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Payroll and Employee Benefits</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,515</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">925</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Research and Development Contract Costs</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,840</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7,569</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Professional Fees</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">556</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">317</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other Accrued Expenses</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,018</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">373</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">17,179</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">10,960</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PayablesAndAccrualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of accrued liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EXHAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Laboratory equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Office furniture and equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Computer equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
        <td class="text">3 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Manufacturing equipment | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
        <td class="text">7 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Manufacturing equipment | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
        <td class="text">10 years<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EXRCI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details) (USD $)<br>In Millions, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock options</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
        <td class="nump">2,102,942<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding at beginning of the period (in shares)</a></td>
        <td class="nump">5,349,810<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
        <td class="nump">1,252,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
        <td class="num">(816,405)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares)</a></td>
        <td class="num">(14,861)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding at the end of the period (in shares)</a></td>
        <td class="nump">5,770,544<span></span></td>
        <td class="nump">5,349,810<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Vested and Expected to Vest at the end of the period (in shares)</a></td>
        <td class="nump">5,712,596<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable at the end of the period (in shares)</a></td>
        <td class="nump">3,297,190<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant under the 2008 Plan (in shares)</a></td>
        <td class="nump">2,102,942<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price Per Share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding at beginning of the period (in dollars per share)</a></td>
        <td class="nump">$ 5.98<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
        <td class="nump">$ 16.44<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
        <td class="nump">$ 6.53<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (in dollars per share)</a></td>
        <td class="nump">$ 6.97<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding at the end of the period (in dollars per share)</a></td>
        <td class="nump">$ 8.17<span></span></td>
        <td class="nump">$ 5.98<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options Vested and Expected to Vest at the end of the period (in dollars per share)</a></td>
        <td class="nump">$ 8.12<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable at the end of the period (in dollars per share)</a></td>
        <td class="nump">$ 6.30<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding at beginning of the period</a></td>
        <td class="text">7 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding at the end of the period</a></td>
        <td class="text">7 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Vested and Expected to Vest at the end of the period</a></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Exercisable at the end of the period</a></td>
        <td class="text">5 years 7 months 6 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Additional information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised (in dollars)</a></td>
        <td class="nump">$ 10.00<span></span></td>
        <td class="nump">$ 0.20<span></span></td>
        <td class="nump">$ 0.03<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value (in dollars per share)</a></td>
        <td class="nump">$ 10.51<span></span></td>
        <td class="nump">$ 3.67<span></span></td>
        <td class="nump">$ 1.83<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of stock options vested (in dollars)</a></td>
        <td class="nump">2.4<span></span></td>
        <td class="nump">2.1<span></span></td>
        <td class="nump">2.6<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of stock options outstanding (in dollars)</a></td>
        <td class="nump">92.6<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value of stock options vested and expected to vest (in dollars)</a></td>
        <td class="nump">91.9<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total compensation cost not yet recognized (in dollars)</a></td>
        <td class="nump">$ 14.4<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period over which compensation cost is expected to be recognized as expense</a></td>
        <td class="text">2 years 9 months 18 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restricted stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding and unvested at the beginning of the period (in shares)</a></td>
        <td class="nump">6,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
        <td class="nump">12,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
        <td class="num">(12,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding and unvested at the end of the period (in shares)</a></td>
        <td class="nump">6,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value (per share)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding and unvested at the beginning of the period (in dollars per share)</a></td>
        <td class="nump">$ 4.50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
        <td class="nump">$ 15.20<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
        <td class="nump">$ 9.85<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding and unvested at the end of the period (in dollars per share)</a></td>
        <td class="nump">$ 15.20<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Celldex Research 2005 Plan and CuraGen 2007 Plan</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant under the 2008 Plan (in shares)</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2004 ESPP Plan</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance (in shares)</a></td>
        <td class="nump">200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price as a percentage of the lower of the fair market value of the common stock at either the beginning of the offering period or the applicable exercise date</a></td>
        <td class="nump">85.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under the plan</a></td>
        <td class="nump">11,823<span></span></td>
        <td class="nump">5,935<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
        <td class="nump">164,124<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant under the 2008 Plan (in shares)</a></td>
        <td class="nump">164,124<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2008 Plan</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum shares of common stock to be issued for grants (in shares)</a></td>
        <td class="nump">7,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock', window );">Terms of options granted to the holders of more than 10% of the voting stock</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock', window );">Threshold percentage of voting stock</a></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock', window );">Exercise price as a percentage of fair market value for options granted to the holders of more than 10% of the voting stock</a></td>
        <td class="nump">110.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2008 Plan | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm', window );">Terms of options</a></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the exercise price as a percentage of the fair market for options granted to the holders of than 10 percent of voting stock of the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisePriceAsPercentageOfFairMarketValueForHoldersOfMoreThanTenPercentOfVotingStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The period of time, from the grant date until the time at which the share-based option award expires.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the term of options granted to the holders of more than 10 percent of voting stock of the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTermForHoldersOfMoreThanTenPercentOfVotingStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the threshold percentage of voting stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsThresholdPercentageOfVotingStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate number of common shares reserved for future issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested options awarded to employees as compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Purchase price of common stock expressed as a percentage of its fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of an employee stock purchase plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQGAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
        <td class="nump">$ 169,402<span></span></td>
        <td class="nump">$ 24,897<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable Securities</a></td>
        <td class="nump">133,581<span></span></td>
        <td class="nump">59,065<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts and Other Receivables</a></td>
        <td class="nump">489<span></span></td>
        <td class="nump">44<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and Other Current Assets</a></td>
        <td class="nump">1,717<span></span></td>
        <td class="nump">1,108<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
        <td class="nump">305,189<span></span></td>
        <td class="nump">85,114<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net</a></td>
        <td class="nump">9,973<span></span></td>
        <td class="nump">7,205<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
        <td class="nump">22,820<span></span></td>
        <td class="nump">23,833<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
        <td class="nump">148<span></span></td>
        <td class="nump">424<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
        <td class="nump">8,965<span></span></td>
        <td class="nump">8,965<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
        <td class="nump">347,095<span></span></td>
        <td class="nump">125,541<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
        <td class="nump">2,243<span></span></td>
        <td class="nump">745<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Expenses</a></td>
        <td class="nump">17,179<span></span></td>
        <td class="nump">10,960<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Current Portion of Long-Term Liabilities</a></td>
        <td class="nump">928<span></span></td>
        <td class="nump">388<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current Portion of Term Loan</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,592<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
        <td class="nump">20,350<span></span></td>
        <td class="nump">17,685<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Term Loan, less Current Portion</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,746<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Long-Term Liabilities</a></td>
        <td class="nump">6,950<span></span></td>
        <td class="nump">6,336<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
        <td class="nump">27,300<span></span></td>
        <td class="nump">29,767<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingent Liabilities (Notes 14 and 16)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at December 31, 2013 and 2012</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,246,832 and 64,359,513 Shares Issued and Outstanding at December 31, 2013 and 2012, respectively</a></td>
        <td class="nump">89<span></span></td>
        <td class="nump">64<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid-In Capital</a></td>
        <td class="nump">662,717<span></span></td>
        <td class="nump">357,094<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income</a></td>
        <td class="nump">2,668<span></span></td>
        <td class="nump">2,745<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
        <td class="num">(345,679)<span></span></td>
        <td class="num">(264,129)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
        <td class="nump">319,795<span></span></td>
        <td class="nump">95,774<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
        <td class="nump">$ 347,095<span></span></td>
        <td class="nump">$ 125,541<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers, clients, or other third-parties, or arising from transactions not separately disclosed, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsAndOtherReceivablesNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapitalCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investments in debt securities classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph ((a)(1),(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 24<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SecuredDebtCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 22<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SecuredLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECHBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">$ 133,499<span></span></td>
        <td class="nump">$ 58,909<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract', window );"><strong>Gross Unrealized Gains</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments', window );">Gross Unrealized Gains</a></td>
        <td class="nump">104<span></span></td>
        <td class="nump">164<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments', window );">Gross Unrealized Losses</a></td>
        <td class="num">(22)<span></span></td>
        <td class="num">(8)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
        <td class="nump">133,581<span></span></td>
        <td class="nump">59,065<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired', window );">Marketable securities considered to be other-than-temporarily impaired</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">U.S. government and municipal obligations</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Maturing in one year or less</a></td>
        <td class="nump">55,531<span></span></td>
        <td class="nump">15,566<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost', window );">Maturing after one year through three years</a></td>
        <td class="nump">18,234<span></span></td>
        <td class="nump">19,797<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">73,765<span></span></td>
        <td class="nump">35,363<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract', window );"><strong>Gross Unrealized Gains</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain', window );">Maturing in one year or less</a></td>
        <td class="nump">27<span></span></td>
        <td class="nump">28<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain', window );">Maturing after one year through three years</a></td>
        <td class="nump">56<span></span></td>
        <td class="nump">99<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments', window );">Gross Unrealized Gains</a></td>
        <td class="nump">83<span></span></td>
        <td class="nump">127<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses', window );">Maturing in one year or less</a></td>
        <td class="num">(4)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses', window );">Maturing after one year through three years</a></td>
        <td class="num">(4)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments', window );">Gross Unrealized Losses</a></td>
        <td class="num">(8)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Maturing in one year or less</a></td>
        <td class="nump">55,554<span></span></td>
        <td class="nump">15,594<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Maturing after one year through three years</a></td>
        <td class="nump">18,286<span></span></td>
        <td class="nump">19,895<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
        <td class="nump">73,840<span></span></td>
        <td class="nump">35,489<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Corporate debt securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Maturing in one year or less</a></td>
        <td class="nump">38,973<span></span></td>
        <td class="nump">17,353<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost', window );">Maturing after one year through three years</a></td>
        <td class="nump">20,761<span></span></td>
        <td class="nump">6,193<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">59,734<span></span></td>
        <td class="nump">23,546<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract', window );"><strong>Gross Unrealized Gains</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain', window );">Maturing in one year or less</a></td>
        <td class="nump">9<span></span></td>
        <td class="nump">23<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain', window );">Maturing after one year through three years</a></td>
        <td class="nump">12<span></span></td>
        <td class="nump">14<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments', window );">Gross Unrealized Gains</a></td>
        <td class="nump">21<span></span></td>
        <td class="nump">37<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses', window );">Maturing in one year or less</a></td>
        <td class="num">(9)<span></span></td>
        <td class="num">(4)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses', window );">Maturing after one year through three years</a></td>
        <td class="num">(5)<span></span></td>
        <td class="num">(3)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments', window );">Gross Unrealized Losses</a></td>
        <td class="num">(14)<span></span></td>
        <td class="num">(7)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Maturing in one year or less</a></td>
        <td class="nump">38,973<span></span></td>
        <td class="nump">17,372<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Maturing after one year through three years</a></td>
        <td class="nump">20,768<span></span></td>
        <td class="nump">6,204<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
        <td class="nump">$ 59,741<span></span></td>
        <td class="nump">$ 23,576<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of investment in debt and equity securities considered to be other-than-temporarily impaired, categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature after one year and through three years from the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the gross unrealized losses on securities, at a point in time, which are expected to mature after one year and through three years from the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedLosses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the gross unrealized losses on securities, at a point in time, which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated unrealized gain before deducting unrealized loss on investments in available-for-sale securities impacting investments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated unrealized loss before deducting unrealized gain on investments in available-for-sale securities impacting investments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at cost, net of adjustments, which include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investments in debt securities classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESHBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">$ (81,550)<span></span></td>
        <td class="num">$ (59,123)<span></span></td>
        <td class="num">$ (44,799)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Loss to Cash Used in Operating Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
        <td class="nump">1,932<span></span></td>
        <td class="nump">2,047<span></span></td>
        <td class="nump">2,248<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
        <td class="nump">1,013<span></span></td>
        <td class="nump">1,090<span></span></td>
        <td class="nump">1,913<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization and Premium of Marketable Securities</a></td>
        <td class="num">(1,366)<span></span></td>
        <td class="num">(660)<span></span></td>
        <td class="nump">17<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Realized (Gain) Loss on Sales and Maturities of Marketable Securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(6)<span></span></td>
        <td class="nump">5<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on Sale or Disposal of Assets</a></td>
        <td class="num">(21)<span></span></td>
        <td class="num">(74)<span></span></td>
        <td class="num">(58)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-Based Compensation Expense</a></td>
        <td class="nump">4,548<span></span></td>
        <td class="nump">2,298<span></span></td>
        <td class="nump">2,342<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Non-Cash Interest Expense</a></td>
        <td class="nump">97<span></span></td>
        <td class="nump">226<span></span></td>
        <td class="nump">307<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in Operating Assets and Liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts and Other Receivables</a></td>
        <td class="num">(445)<span></span></td>
        <td class="nump">126<span></span></td>
        <td class="nump">154<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and Other Current Assets</a></td>
        <td class="num">(706)<span></span></td>
        <td class="nump">33<span></span></td>
        <td class="nump">241<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other Assets</a></td>
        <td class="nump">276<span></span></td>
        <td class="num">(95)<span></span></td>
        <td class="nump">34<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts Payable and Accrued Expenses</a></td>
        <td class="nump">7,236<span></span></td>
        <td class="nump">3,762<span></span></td>
        <td class="nump">2,076<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other Liabilities</a></td>
        <td class="nump">1,317<span></span></td>
        <td class="nump">594<span></span></td>
        <td class="num">(138)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Used in Operating Activities</a></td>
        <td class="num">(67,669)<span></span></td>
        <td class="num">(49,782)<span></span></td>
        <td class="num">(35,658)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sales and Maturities of Marketable Securities</a></td>
        <td class="nump">38,894<span></span></td>
        <td class="nump">52,360<span></span></td>
        <td class="nump">51,003<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of Marketable Securities</a></td>
        <td class="num">(112,118)<span></span></td>
        <td class="num">(69,255)<span></span></td>
        <td class="num">(52,717)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of Property and Equipment</a></td>
        <td class="num">(4,219)<span></span></td>
        <td class="num">(303)<span></span></td>
        <td class="num">(509)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from Sale or Disposal of Assets</a></td>
        <td class="nump">21<span></span></td>
        <td class="nump">218<span></span></td>
        <td class="nump">68<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net Cash Used in Investing Activities</a></td>
        <td class="num">(77,422)<span></span></td>
        <td class="num">(16,980)<span></span></td>
        <td class="num">(2,155)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net Proceeds from Stock Issuances</a></td>
        <td class="nump">295,697<span></span></td>
        <td class="nump">83,784<span></span></td>
        <td class="nump">36,023<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from Issuance of Stock from Employee Benefit Plans</a></td>
        <td class="nump">5,403<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">(Payments) Issuance of Term Loan</a></td>
        <td class="num">(11,029)<span></span></td>
        <td class="num">(3,971)<span></span></td>
        <td class="nump">5,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payment of Convertible Subordinated Debt</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(12,503)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Payment of Other Liabilities</a></td>
        <td class="num">(472)<span></span></td>
        <td class="num">(55)<span></span></td>
        <td class="num">(86)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net Cash Provided by Financing Activities</a></td>
        <td class="nump">289,599<span></span></td>
        <td class="nump">79,758<span></span></td>
        <td class="nump">28,434<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations', window );">Effect of Exchange Rate Changes on Cash and Cash Equivalents</a></td>
        <td class="num">(3)<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="num">(9)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInContinuingOperations', window );">Net Increase (Decrease) in Cash and Cash Equivalents</a></td>
        <td class="nump">144,505<span></span></td>
        <td class="nump">12,998<span></span></td>
        <td class="num">(9,388)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at Beginning of Period</a></td>
        <td class="nump">24,897<span></span></td>
        <td class="nump">11,899<span></span></td>
        <td class="nump">21,287<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at End of Period</a></td>
        <td class="nump">169,402<span></span></td>
        <td class="nump">24,897<span></span></td>
        <td class="nump">11,899<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash Paid for Interest</a></td>
        <td class="nump">$ 1,209<span></span></td>
        <td class="nump">$ 1,384<span></span></td>
        <td class="nump">$ 1,560<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDebtDiscountPremium</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(c))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(c)-(e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireMarketableSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfProductiveAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from the stock plan during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockPlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfConvertibleDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow attributable to repayments of borrowings not otherwise defined in the taxonomy (with maturities initially due after one year or beyond the operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfOtherLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQDAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Obligations for base rent and CAM costs under facility and other non-cancelable operating leases</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2014</a></td>
        <td class="nump">$ 2,666,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2015</a></td>
        <td class="nump">2,863,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2016</a></td>
        <td class="nump">2,914,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2017</a></td>
        <td class="nump">1,765,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2018</a></td>
        <td class="nump">501,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
        <td class="nump">167,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total minimum lease payments</a></td>
        <td class="nump">10,876,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Total rent and CAM expense</a></td>
        <td class="nump">$ 2,700,000<span></span></td>
        <td class="nump">$ 2,500,000<span></span></td>
        <td class="nump">$ 2,500,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the next fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the forth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the third fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing after the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesRentExpenseNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAXES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of income tax expense attributable to continuing operations</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 703px;" border="0" cellspacing="0" cellpadding="0" width="703">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>Year Ended December&#160;31,</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Income tax benefit (provision):</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Federal</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">30,962</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,394</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">16,204</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">State</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">4,920</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">4,237</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,131</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Foreign</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">84</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Expiration of Net Operating Losses and Research&#160;&amp; Development Tax Credits</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(126</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1,426</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(411</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,756</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">22,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,008</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred tax valuation allowance</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(35,756</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(22,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(19,008</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 685px;" border="0" cellspacing="0" cellpadding="0" width="685">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Pre-tax loss</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(81,550</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(59,123</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(44,799</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Loss at Statutory Rates</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(27,727</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(20,102</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(15,213</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Research and Development Credits</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3,261</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1,736</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">State Taxes</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4,920</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4,237</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3,131</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">26</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">708</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">661</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expiration of Net Operating Losses and Research&#160;&amp; Development Tax Credits</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">126</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,426</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">411</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Change in Valuation Allowance</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,756</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">22,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,008</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Income tax (benefit) provision</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of principal components of the deferred tax assets and liabilities</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 649px;" border="0" cellspacing="0" cellpadding="0" width="649">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Gross Deferred Tax Assets</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Net Operating Loss Carryforwards</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">79,558</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">67,728</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Tax Credit Carryforwards</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">25,582</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">20,692</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Deferred Expenses</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">61,370</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">43,226</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Stock-based Compensation</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,926</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,264</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Fixed Assets</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,638</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,156</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Accrued Expenses and Other</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">623</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">241</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">172,697</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">137,307</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Gross Deferred Tax Liabilities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Other Acquired Intangibles</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,115</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,481</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">IPR&amp;D Intangibles</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(8,776</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(9,142</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total Deferred Tax Assets and Liabilities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">163,921</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">128,165</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Deferred Tax Assets Valuation Allowance</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(168,582</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(132,826</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net Deferred Tax Asset (Liability)</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(16) COMMITMENTS AND CONTINGENCIES</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has facility and equipment leases that expire at various dates through 2019. Certain of these facility leases contain renewal options, early termination provisions, and provisions that escalate the base rent payments and require the Company to pay common area maintenance costs ("CAM") during the lease term. The following obligations for base rent and CAM costs under facility and other non-cancelable operating leases as of December&#160;31, 2013 do not include the exercise of renewal terms or early termination provisions (in thousands):</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2014</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,666</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2015</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,863</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2016</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,914</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2017</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,765</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2018</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">501</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Thereafter</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">167</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total minimum lease payments</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">10,876</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company's total rent and CAM expense for all facility leases was $2.7&#160;million, $2.5&#160;million and $2.5&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of obligations for base rent and CAM costs under facility and other non-cancelable operating leases</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2">The following obligations for base rent and CAM costs under facility and other non-cancelable operating leases as of December&#160;31, 2013 do not include the exercise of renewal terms or early termination provisions (in thousands):</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2014</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,666</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2015</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,863</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2016</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,914</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2017</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,765</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">2018</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">501</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Thereafter</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">167</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total minimum lease payments</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">10,876</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SELECTED QUARTERLY FINANCIAL DATA (Unaudited)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(18) SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</b></font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 611px;" border="0" cellspacing="0" cellpadding="0" width="611">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" nowrap="nowrap" align="left">
<div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"><font size="1"><b>2013 <!-- COMMAND=ADD_SCROPPEDRULE,17pt --></b></font></div></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q1 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q2 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q3 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q4 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands, except per share amounts)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total revenue</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,414</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">97</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">980</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">620</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net loss</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(17,332</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(19,016</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(23,140</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(22,062</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Basic and diluted net loss per common share</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.23</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.24</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.29</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><br /></font>&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 609px;" border="0" cellspacing="0" cellpadding="0" width="609">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" nowrap="nowrap" align="left">
<div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 17pt; MARGIN-BOTTOM: 0pt;"><font size="1"><b>2012 <!-- COMMAND=ADD_SCROPPEDRULE,17pt --></b></font></div></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q1 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q2 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q3 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Q4 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands, except per share amounts)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total revenue</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,433</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,009</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,113</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,647</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net loss</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(13,516</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(13,773</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(15,027</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(16,807</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Basic and diluted net loss per common share</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.23</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.25</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(0.27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the quarterly financial data in the annual financial statements.  The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e765-108305<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e725-108305<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25249566&amp;loc=d3e1280-108306<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section G<br><br> -Subsection 1<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-K (SK)<br><br> -Number 229<br><br> -Section 302<br><br> -Paragraph a<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NATURE OF BUSINESS AND OVERVIEW<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>NATURE OF BUSINESS AND OVERVIEW</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">NATURE OF BUSINESS AND OVERVIEW</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(1) NATURE OF BUSINESS AND OVERVIEW</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Celldex Therapeutics,&#160;Inc. (the "Company" or "Celldex") is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's lead drug candidates include rindopepimut (also referred to as CDX-110) and glembatumumab vedotin (also referred to as CDX-011). Rindopepimut is a targeted immunotherapeutic in a pivotal Phase&#160;3 study for the treatment of front-line glioblastoma and a Phase&#160;2 study for the treatment of recurrent glioblastoma. Glembatumumab vedotin is an antibody-drug conjugate in a randomized study in patients with triple negative breast cancer that over-express gpNMB designed to obtain accelerated approval. The Company has a number of earlier stage candidates in clinical development, including varlilumab (also referred to as CDX-1127), a fully human therapeutic monoclonal antibody in a Phase&#160;1 study for cancer indications, CDX-301, an immune cell mobilizing agent and dendritic cell growth factor and CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells for cancer indications.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At December&#160;31, 2013, the Company had cash, cash equivalents and marketable securities of $303.0&#160;million. The Company incurred a loss of $81.6&#160;million for the year ended December&#160;31, 2013. Net cash used in operations for the year ended December&#160;31, 2013 was $67.7&#160;million. The Company believes that the cash, cash equivalents and marketable securities at December&#160;31, 2013 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the next twelve months, the Company may take further steps to raise additional capital to meet its long-term liquidity needs. These capital raising activities may include, but may not be limited to, one or more of the following: the licensing of technology programs with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While the Company continues to seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and the Company's negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the Company will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to the Company's stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict the Company's ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce the Company's economic potential from products under development.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccounting</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6NAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONSOLIDATED BALANCE SHEETS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible Preferred Stock, Par Value (in dollars per share)</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible Preferred Stock, Shares Authorized</a></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="nump">3,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible Preferred Stock, Shares Issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible Preferred Stock, Shares Outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value (in dollars per share)</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
        <td class="nump">297,000,000<span></span></td>
        <td class="nump">297,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
        <td class="nump">89,246,832<span></span></td>
        <td class="nump">64,359,513<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
        <td class="nump">89,246,832<span></span></td>
        <td class="nump">64,359,513<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfFinancialPositionAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(11) STOCKHOLDERS' EQUITY</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Common Stock</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In April 2010, the Company filed a shelf registration statement with the Securities and Exchange Commission to register for sale any combination of the types of securities described in the shelf registration statement up to a dollar amount of $150&#160;million. The shelf registration went effective on April&#160;22, 2010. In December 2012, the Company filed a new shelf registration statement with the Securities and Exchange Commission to register for sale any combination of the types of securities described in the new shelf registration statement up to a dollar amount of $200&#160;million. The new shelf registration went effective on January&#160;16, 2013. In December 2013, the Company filed a new automatic shelf registration statement.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2013, 2012 and 2011, Company issued 21,613,483, 12,075,000 and 11,500,000 shares of its common stock in underwritten public offerings resulting in net proceeds to the Company of $278.6&#160;million, $43.5&#160;million and $33.7&#160;million, after deducting underwriting fees and offering expenses, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2013, 2012 and 2011, Company issued 2,433,608, 8,003,290 and 575,000 shares of its common stock under our controlled equity offering sales agreement with Cantor Fitzgerald&#160;&amp;&#160;Co., as amended, resulting in net proceeds to the Company of $17.1&#160;million, $40.1&#160;million and $2.2&#160;million, after deducting commission and offering expenses, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Convertible Preferred Stock</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At December&#160;31, 2013, the Company had authorized 3,000,000 shares of preferred stock all of which have been designated Class&#160;C Preferred Stock including 350,000 shares which have been designated Series&#160;C-1&#160;Junior Participating Cumulative Preferred Stock (the "Series&#160;C-1 Preferred Stock").</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Shareholder Rights Plan</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company's Board has adopted a Shareholder Rights Plan, as set forth in the Shareholder Rights Agreement, as amended, between the Company and Computershare Trust Company, N.A., as Rights Agent (the "Rights Agreement"). Pursuant to the terms of the Rights Agreement, the Board declared a dividend distribution of one Preferred Stock Purchase Right (a "Right") for each outstanding share of the Company's common stock. Each Right, which expires in November 2014, entitles their holder to purchase from the Company one ten-thousandth of a share (a "Unit") of Series&#160;C-1 Preferred Stock at a cash exercise price of $35.00 per Unit, subject to adjustment. The Rights will trade separately from the common stock and will become exercisable only when a person or group has acquired 15% or more of the outstanding common stock or upon the commencement by a person or group of a tender offer that would result in such person or group acquiring 15% or more of the outstanding common stock other than as a result of repurchases of stock by the Company or certain inadvertent actions by a shareholder. In the event a person or group acquires 15% or more of the outstanding common stock each holder of a Right (except for any such person or group) would be entitled to receive upon exercise sufficient Units of Series&#160;C-1 Preferred Stock to equal a value of two times the exercise price of the Right. In the event the Company is acquired in a merger or other business combination transaction or if 50% or more of the Company's assets or earning power is sold, each holder of a Right (except for any such person or group described above) would receive upon exercise common stock of the acquiring company with a value equal to two times the exercise price of the Right.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVRAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information (USD $)<br>In Billions, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Feb. 19, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Celldex Therapeutics, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000744218<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-K<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Dec. 31,
				 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Large Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.3<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">89,251,747<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">FY<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK-BASED COMPENSATION</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(12) STOCK-BASED COMPENSATION</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has the following stock-based compensation plans: the 2004 Employee Stock Purchase Plan (the "2004 ESPP Plan"), the 2008 Stock Option and Incentive Plan (the "2008 Plan"), Celldex Research's 2005 Equity Incentive Plan (the "Celldex Research 2005 Plan") and CuraGen 2007 Stock Plan (the "CuraGen 2007 Plan"). There are no shares available for future grant under the Celldex Research 2005 Plan and CuraGen 2007 Plan.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Employee Stock Purchase Plan</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At December&#160;31, 2013, a total of 200,000 shares of common stock are reserved for issuance under the 2004 ESPP Plan. Under the 2004 ESPP Plan, each participating employee may purchase shares of common stock through payroll deductions at a purchase price equal to 85% of the lower of the fair market value of the common stock at either the beginning of the offering period or the applicable exercise date. During the years ended December&#160;31, 2013 and 2012, the Company issued 11,823 and 5,935 shares under the 2004 ESPP Plan, respectively. At December&#160;31, 2013, 164,124 shares were available for issuance under the 2004 ESPP Plan.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Employee Stock Option and Incentive Plan</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The 2008 Plan permits the granting of incentive stock options (intended to qualify as such under Section&#160;422A of the Internal Revenue Code of 1986, as amended), non-qualified stock options, stock appreciation rights, performance share units, restricted stock and other awards of restricted stock in lieu of cash bonuses to employees, consultants and non-employee directors.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At December&#160;31, 2013, the 2008 Plan allowed for a maximum of 7,400,000 shares of common stock to be issued for grants of Stock Options and other Awards made prior to March&#160;7, 2018 and grants of Incentive Stock Options made prior to October&#160;20, 2017. The Company's board of directors determines the term of each option, option price, and number of shares for which each option is granted and the rate at which each option vests. Options generally vest over a period not to exceed four years. The term of each option cannot exceed ten years (five years for options granted to holders of more than 10% of the voting stock of the Company) and the exercise price of stock options cannot be less than the fair market value of the common stock at the date of grant (110% of fair market value for incentive stock options granted to holders of more than 10% of the voting stock of the Company). Vesting of all employee and non-employee director stock option awards is accelerated upon a change in control as defined in the 2008 Plan.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A summary of stock option activity for the year ended December&#160;31, 2013 is as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="47"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="74"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Shares</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Weighted<br />
Average<br />
Exercise<br />
Price<br />
Per Share</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Weighted<br />
Average<br />
Remaining<br />
Contractual<br />
Term (In Years)</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Outstanding at December&#160;31, 2012</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,349,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5.98</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7.0</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Granted</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,252,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">16.44</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Exercised</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(816,405</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6.53</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Canceled</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(14,861</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6.97</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Outstanding at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,770,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8.17</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7.0</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Vested and Expected to Vest at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,712,596</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8.12</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7.0</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Exercisable at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,297,190</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6.30</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5.6</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Shares Available for Grant under the 2008 Plan</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,102,942</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The total intrinsic value of stock options exercised during the years ended December&#160;31, 2013, 2012 and 2011 was $10.0&#160;million, $0.2&#160;million and $0.03&#160;million, respectively. The weighted average grant-date fair value of stock options granted during the years ended December&#160;31, 2013, 2012 and 2011 was $10.51, $3.67 and $1.83, respectively. The total fair value of stock options vested during the years ended December&#160;31, 2013, 2012 and 2011 was $2.4&#160;million, $2.1&#160;million and $2.6&#160;million, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The aggregate intrinsic value of stock options outstanding at December&#160;31, 2013 was $92.6&#160;million. The aggregate intrinsic value of stock options vested and expected to vest at December&#160;31, 2013 was $91.9&#160;million. As of December&#160;31, 2013, total compensation cost related to non-vested employee and non-employee director stock options not yet recognized was approximately $14.4&#160;million, net of estimated forfeitures, which is expected to be recognized as expense over a weighted average period of 2.8&#160;years.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Restricted Stock</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A summary of restricted stock activity under the 2008 Plan for the year ended December&#160;31, 2013 is as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="44"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="54"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Shares</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Weighted<br />
Average<br />
Grant Date<br />
Fair Value<br />
(per share)</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Outstanding and unvested at December&#160;31, 2012</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4.50</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Granted</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">12,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">15.20</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Vested</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(12,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">9.85</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Canceled</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Outstanding and unvested at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">15.20</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><i>Valuation and Expenses Information</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stock-based compensation expense for the years ended December&#160;31, 2013, 2012 and 2011 was recorded as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Research and development</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,640</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,415</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,412</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">General and administrative</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,908</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">883</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">930</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total stock-based compensation expense</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,548</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,298</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,342</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The fair values of employee stock options granted during the years ended December&#160;31, 2013, 2012 and 2011 were valued using the Black-Scholes option-pricing model with the following assumptions:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="88" align="center"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="88" align="center"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="88" align="center"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Year Ended<br />
December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Year Ended<br />
December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Year Ended<br />
December&#160;31, 2011</b></font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expected stock price volatility</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">71&#160;-&#160;72%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">70&#160;-&#160;72%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">68&#160;-&#160;70%</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expected option term</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">6.0 Years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">6.0 Years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">6.0 Years</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Risk-free interest rate</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">1.2&#160;-&#160;2.1%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">0.9&#160;-&#160;1.4%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">1.4&#160;-&#160;2.9%</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expected dividend yield</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">None</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">None</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">None</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company estimates expected term based on historical exercise patterns. The Company uses its historical stock price volatility consistent with the expected term of grant as the basis for its expected volatility assumption. The risk-free interest rate is based upon the yield of U.S. Treasury securities consistent with the expected term of the option. The dividend yield assumption is based on the Company's history of zero dividend payouts and expectation that no dividends will be paid in the foreseeable future.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWPAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements', window );">Product Development and Licensing Agreements</a></td>
        <td class="nump">$ 160<span></span></td>
        <td class="nump">$ 146<span></span></td>
        <td class="nump">$ 110<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromContractsAndGrants', window );">Contracts and Grants</a></td>
        <td class="nump">1,617<span></span></td>
        <td class="nump">281<span></span></td>
        <td class="nump">36<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyRevenue', window );">Product Royalties</a></td>
        <td class="nump">2,334<span></span></td>
        <td class="nump">10,775<span></span></td>
        <td class="nump">9,119<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
        <td class="nump">4,111<span></span></td>
        <td class="nump">11,202<span></span></td>
        <td class="nump">9,265<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>OPERATING EXPENSE:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
        <td class="nump">67,401<span></span></td>
        <td class="nump">47,398<span></span></td>
        <td class="nump">32,439<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty</a></td>
        <td class="nump">2,334<span></span></td>
        <td class="nump">10,775<span></span></td>
        <td class="nump">9,119<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and Administrative</a></td>
        <td class="nump">14,805<span></span></td>
        <td class="nump">10,016<span></span></td>
        <td class="nump">9,193<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquired Intangible Assets</a></td>
        <td class="nump">1,013<span></span></td>
        <td class="nump">1,090<span></span></td>
        <td class="nump">1,913<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Operating Expense</a></td>
        <td class="nump">85,553<span></span></td>
        <td class="nump">69,279<span></span></td>
        <td class="nump">52,664<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
        <td class="num">(81,442)<span></span></td>
        <td class="num">(58,077)<span></span></td>
        <td class="num">(43,399)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Investment and Other Income, Net</a></td>
        <td class="nump">819<span></span></td>
        <td class="nump">530<span></span></td>
        <td class="nump">396<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
        <td class="num">(927)<span></span></td>
        <td class="num">(1,576)<span></span></td>
        <td class="num">(1,796)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">(81,550)<span></span></td>
        <td class="num">(59,123)<span></span></td>
        <td class="num">(44,799)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted Net Loss Per Common Share (Note 2) (in dollars per share)</a></td>
        <td class="num">$ (1.02)<span></span></td>
        <td class="num">$ (1.02)<span></span></td>
        <td class="num">$ (1.13)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 2) (in shares)</a></td>
        <td class="nump">79,777<span></span></td>
        <td class="nump">57,713<span></span></td>
        <td class="nump">39,501<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>COMPREHENSIVE LOSS:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">(81,550)<span></span></td>
        <td class="num">(59,123)<span></span></td>
        <td class="num">(44,799)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other Comprehensive Income (Loss):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
        <td class="num">(3)<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="num">(9)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized (Loss) Gain on Marketable Securities</a></td>
        <td class="num">(74)<span></span></td>
        <td class="nump">91<span></span></td>
        <td class="num">(90)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Loss</a></td>
        <td class="num">$ (81,627)<span></span></td>
        <td class="num">$ (59,030)<span></span></td>
        <td class="num">$ (44,898)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromContractsAndGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents revenue earned during the period arising from products sold or services provided under the terms of a contract. Also include revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_RevenueFromContractsAndGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents revenue from product development and licensing agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_RevenueFromProductDevelopmentAndLicensingAgreements</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e557-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTaxAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total costs of sales and operating expenses for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestAndOtherIncome</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the cost of borrowed funds accounted for as interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7656940&amp;loc=SL4569643-111683<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 19<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7656940&amp;loc=SL4569616-111683<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1A<br><br><br><br> -Subparagraph (c)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-108580<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenuesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>PROPERTY AND EQUIPMENT, NET</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(6) PROPERTY AND EQUIPMENT, NET</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property and equipment include the following:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Laboratory Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,699</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,164</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Manufacturing Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,130</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,055</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Office Furniture and Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,386</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,264</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Leasehold Improvements</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">14,493</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">12,932</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Construction in Progress</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">257</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">115</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total Property and Equipment</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">21,965</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,530</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Less Accumulated Depreciation and Amortization</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(11,992</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(12,325</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">9,973</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">7,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Depreciation and amortization expense related to property and equipment was $1.9&#160;million, $2.0&#160;million and $2.2&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13-14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(5) MARKETABLE SECURITIES</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A summary of marketable securities is shown below:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Amortized<br />
Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Gains</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Losses</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Fair<br />
Value</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2"><b>December&#160;31, 2013</b></font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">U.S. government and municipal obligations</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">55,531</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">27</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">55,554</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">18,234</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">56</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">18,286</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total U.S. government and municipal obligations</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">73,765</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">83</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(8</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">73,840</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">38,973</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">9</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(9</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">38,973</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">20,761</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">12</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(5</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">20,768</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">59,734</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">21</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(14</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">59,741</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">133,499</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">104</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(22</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">133,581</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><br /></font>&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="49"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Amortized<br />
Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Gains</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Gross<br />
Unrealized<br />
Losses</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Fair<br />
Value</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2"><b>December&#160;31, 2012</b></font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">U.S. government and municipal obligations</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">15,566</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">28</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">15,594</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,797</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">99</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,895</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total U.S. government and municipal obligations&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,363</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">127</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,489</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing in one year or less</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">17,353</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">23</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">17,372</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 40pt;"><font size="2">Maturing after one year through three years</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">6,193</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">14</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">6,204</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 30pt;"><font size="2">Total corporate debt securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">23,546</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">37</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(7</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">23,576</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total marketable securities</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">58,909</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">164</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(8</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The marketable securities held by the Company were high investment grade and there were no marketable securities that the Company considered to be other-than-temporarily impaired as of December&#160;31, 2013.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for  investments in certain debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -Glossary Debt Security<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6379141&amp;loc=d3e15032-111544<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -Glossary Equity Security<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6511694<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RETIREMENT SAVINGS PLAN<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>RETIREMENT SAVINGS PLAN</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT SAVINGS PLAN</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(17) RETIREMENT SAVINGS PLAN</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company maintains a 401(k) Plan which is available to substantially all employees. Under the terms of the 401(k) Plan, participants may elect to contribute up to 15% of their compensation, or the statutory prescribed limits. The Company may make 50% matching contributions on up to 4% of a participant's annual salary. Benefit expense for the 401(k) Plan was $0.3&#160;million, $0.2&#160;million and $0.2&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CompensationAndRetirementDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for pension and other postretirement benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>REVENUE<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_SignificantRevenueArrangementsDisclosureAbstract', window );"><strong>REVENUE</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_SignificantRevenueArrangementsDisclosureTextBlock', window );">REVENUE</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(13) REVENUE</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In 1997, the Company licensed its oral rotavirus strain to GlaxoSmithKline&#160;plc (Glaxo) and Glaxo assumed responsibility for all subsequent clinical trials and all other development activities. The Company's licensed-in the rotavirus strain that was used to develop Glaxo's Rotarix rotavirus vaccine in 1995 and owed a license fee of 30% to Cincinnati Children's Hospital Medical Center (CCH) on net royalties received from Glaxo. In May 2005, the Company entered into an agreement whereby an affiliate of Paul Royalty Fund II,&#160;L.P. (PRF) purchased a 70% interest in the net royalties the Company received on worldwide sales of Rotarix. In December 2012, the Glaxo agreement expired automatically upon the expiration of the last relevant patent right covered by the Glaxo agreement. The Company's retained interests in Rotarix net royalties which were not sold to PRF are recorded as product royalty revenue and a corresponding amount that is payable to CCH is recorded as royalty expense. Product royalty revenue and royalty expense related to the Company's retained interest in Rotarix was $2.3&#160;million, $10.8&#160;million and $9.1&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_SignificantRevenueArrangementsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_SignificantRevenueArrangementsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_SignificantRevenueArrangementsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element may be used to capture the complete disclosure pertaining to an entity's significant revenue contracts and arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_SignificantRevenueArrangementsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>OTHER LONG-TERM LIABILITIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>OTHER LONG-TERM LIABILITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER LONG-TERM LIABILITIES</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(9) OTHER LONG-TERM LIABILITIES</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other long-term liabilities include the following:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred Rent</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">419</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">434</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net Deferred Tax Liability related to IPR&amp;D</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred Income from Sale of Tax Benefits</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,630</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,118</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred Revenue</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,168</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Loan Payable</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">472</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">39</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7,878</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,724</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Less Current Portion</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(928</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(388</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Long-Term Portion</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,950</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,336</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In January 2013, 2012 and 2011, the Company received approval from the New Jersey Economic Development Authority and agreed to sell New Jersey tax benefits worth $0.8&#160;million, $0.8&#160;million and $0.6&#160;million to an independent third party for $0.8&#160;million, $0.7&#160;million and $0.5&#160;million, respectively. Under the agreement, the Company must maintain a base of operations in New Jersey for five years or the tax benefits must be paid back on a pro-rata basis based on the number of years completed. During the years ended December&#160;31, 2013 and 2012, the Company recorded $0.2&#160;million and $0.1&#160;million to other income related to the sale of these tax benefits, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In September 2013, the Company entered into an agreement with Rockefeller University pursuant to which the Company will perform research and development services for Rockefeller. The agreement includes an approved project plan for the development services of $4.8&#160;million and a term of three years. The agreement included an upfront payment of $1.3&#160;million which is being recognized as revenue over the term of the agreement. The Company will bill Rockefeller quarterly for actual time and direct costs incurred and record those amounts to revenue in the quarter the services are performed. The Company recorded $1.4&#160;million in revenue related to the Rockefeller agreement during the year ended December&#160;31, 2013.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for other liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20, 24<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20,24)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RETIREMENT SAVINGS PLAN (Details) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>RETIREMENT SAVINGS PLAN</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum contribution by participants (as a percent)</a></td>
        <td class="nump">15.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer match (as a percent)</a></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Maximum percentage of employees' gross pay subject to employer match</a></td>
        <td class="nump">4.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Benefit expense for the 401(k) Plan</a></td>
        <td class="nump">$ 0.3<span></span></td>
        <td class="nump">$ 0.2<span></span></td>
        <td class="nump">$ 0.2<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CompensationAndRetirementDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the cost recognized during the period for defined contribution plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -SubTopic 70<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6414718&amp;loc=d3e28014-114942<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanCostRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage employer matches of the employee's percentage contribution matched.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>INTANGIBLE ASSETS AND GOODWILL</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS AND GOODWILL</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(7) INTANGIBLE ASSETS AND GOODWILL</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Intangible assets, net of accumulated amortization, and goodwill are as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 54%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"150%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="150%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="58" align="right"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="61"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="61"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="10" align="center"><font size="1"><b>December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Estimated<br />
Life</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Accumulated<br />
Amortization</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Net</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Cost</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Accumulated<br />
Amortization</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Net</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="17" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Intangible Assets:</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">IPR&amp;D</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">Indefinite</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,800</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Amgen Amendment</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">16&#160;years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">14,500</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(3,812</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">10,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">14,500</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(2,915</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,585</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Core Technology</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11&#160;years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,296</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(964</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">332</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,296</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(848</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">448</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total Intangible Assets</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">27,596</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,776</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">22,820</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">27,596</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(3,763</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">23,833</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Goodwill</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">Indefinite</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8,965</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The IPR&amp;D intangible asset was recorded in connection with the acquisition of CuraGen and relates to the development of glembatumumab vedotin. At the date of acquisition and at December&#160;31, 2013, glembatumumab vedotin had not yet reached technological feasibility nor did it have any alternative future use. Glembatumumab vedotin is in a randomized, accelerated approval study in patients with triple negative breast cancer that over-express gpNMB.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amortization expense for intangible assets was $1.0&#160;million, $1.1&#160;million and $1.9&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively. The estimated future amortization expense of intangible assets for the years ended December&#160;31, 2014, 2015, 2016, 2017 and 2018 is $1.0&#160;million, $1.0&#160;million, $1.0&#160;million, $0.9&#160;million and $0.9&#160;million, respectively.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-109275<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13854-109267<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCRUED EXPENSES</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(8) ACCRUED EXPENSES</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accrued expenses include the following:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 543px;" border="0" cellspacing="0" cellpadding="0" width="543">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Royalty and License Fees</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">250</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,776</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Payroll and Employee Benefits</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,515</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">925</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Research and Development Contract Costs</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11,840</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7,569</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Accrued Professional Fees</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">556</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">317</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other Accrued Expenses</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,018</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">373</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">17,179</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">10,960</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PayablesAndAccrualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>TERM LOAN<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>TERM LOAN</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">TERM LOAN</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(10) TERM LOAN</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In December 2010, the Company entered into a loan and security agreement with MidCap Financial,&#160;LLC pursuant to which the Company borrowed $10.0&#160;million under a term loan from MidCap. In March 2011, the Company amended the loan agreement and borrowed an additional $5.0&#160;million from General Electric Capital Corporation to increase the amount owed under the term loan to $15.0&#160;million. In March 2012, the Company amended the loan agreement to extend the maturity date from December 2013 to December 2014. In May 2013, the Company elected to prepay the outstanding principal under the term loan in full, pursuant to the terms of its loan agreement, as amended, and paid $8.8&#160;million in principal and $0.7&#160;million in interest, prepayment and final payment fees. The Company's obligations under the loan agreement had been collateralized by a first priority security interest in substantially all of its assets, other than its intellectual property. In connection with the repayment of the term loan and the termination of the loan agreement, those security interests were released. Interest expense on the term loan was $0.8&#160;million, $1.5&#160;million and $1.6&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-term debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK-BASED COMPENSATION</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 643px;" border="0" cellspacing="0" cellpadding="0" width="643">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="47"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="74"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Shares</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Weighted<br />
Average<br />
Exercise<br />
Price<br />
Per Share</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Weighted<br />
Average<br />
Remaining<br />
Contractual<br />
Term (In Years)</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Outstanding at December&#160;31, 2012</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,349,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5.98</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7.0</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Granted</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,252,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">16.44</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Exercised</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(816,405</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6.53</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Canceled</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(14,861</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6.97</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Outstanding at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,770,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8.17</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7.0</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Vested and Expected to Vest at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,712,596</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">8.12</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">7.0</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Options Exercisable at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,297,190</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6.30</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5.6</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Shares Available for Grant under the 2008 Plan</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,102,942</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of restricted stock activity</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 579px;" border="0" cellspacing="0" cellpadding="0" width="579">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="44"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="54"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Shares</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Weighted<br />
Average<br />
Grant Date<br />
Fair Value<br />
(per share)</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Outstanding and unvested at December&#160;31, 2012</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4.50</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Granted</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">12,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">15.20</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Vested</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(12,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">9.85</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Canceled</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Outstanding and unvested at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">15.20</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of stock-based compensation expense</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 585px;" border="0" cellspacing="0" cellpadding="0" width="585">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Research and development</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,640</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,415</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,412</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">General and administrative</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,908</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">883</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">930</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Total stock-based compensation expense</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,548</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,298</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,342</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used for the fair values of employee stock options granted</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 601px;" border="0" cellspacing="0" cellpadding="0" width="601">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="88" align="center"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="88" align="center"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="88" align="center"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Year Ended<br />
December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Year Ended<br />
December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" align="center"><font size="1"><b>Year Ended<br />
December&#160;31, 2011</b></font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expected stock price volatility</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">71&#160;-&#160;72%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">70&#160;-&#160;72%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">68&#160;-&#160;70%</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expected option term</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">6.0 Years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">6.0 Years</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">6.0 Years</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Risk-free interest rate</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">1.2&#160;-&#160;2.1%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">0.9&#160;-&#160;1.4%</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">1.4&#160;-&#160;2.9%</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expected dividend yield</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">None</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">None</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="center"><font size="2">None</font></td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the changes in outstanding nonvested shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGSAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>TERM LOAN (Details) (Term Loan, USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>May 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>MidCap</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2011

</div>
          <div>GECC</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Term Loan</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Amount borrowed</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10.0<span></span></td>
        <td class="nump">$ 5.0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Amount owed under the term loan</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RepaymentOfLongTermDebtPrincipalAmount', window );">Repayment of principal amount</a></td>
        <td class="nump">8.8<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DebtInstrumentInterestAndPrepaymentFees', window );">Amount of interest, prepayment and final payment fees</a></td>
        <td class="nump">0.7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseLongTermDebt', window );">Interest expense on the term loan</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.8<span></span></td>
        <td class="nump">$ 1.5<span></span></td>
        <td class="nump">$ 1.6<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DebtInstrumentInterestAndPrepaymentFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of interest, prepayment and final payment fees paid by the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DebtInstrumentInterestAndPrepaymentFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RepaymentOfLongTermDebtPrincipalAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the amount of principal repaid by the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_RepaymentOfLongTermDebtPrincipalAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate amount of interest paid or due on all long-term debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 8<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpenseLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.16)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 16<br><br> -Article 9<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.16)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SecuredDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>INCOME TAXES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(15) INCOME TAXES</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The components of income tax expense attributable to continuing operations consist of the following:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>Year Ended December&#160;31,</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Income tax benefit (provision):</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Federal</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">30,962</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,394</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">16,204</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">State</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">4,920</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">4,237</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">3,131</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Foreign</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">84</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Expiration of Net Operating Losses and Research&#160;&amp; Development Tax Credits</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(126</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1,426</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(411</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,756</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">22,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,008</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Deferred tax valuation allowance</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(35,756</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(22,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(19,008</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate of 34% follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="50"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Pre-tax loss</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(81,550</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(59,123</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(44,799</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Loss at Statutory Rates</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(27,727</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(20,102</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(15,213</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Research and Development Credits</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3,261</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(1,736</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">State Taxes</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4,920</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(4,237</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3,131</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">26</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">708</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">661</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Expiration of Net Operating Losses and Research&#160;&amp; Development Tax Credits</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">126</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">1,426</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">411</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Change in Valuation Allowance</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">35,756</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">22,205</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">19,008</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Income tax (benefit) provision</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Deferred tax assets and liabilities are recognized based on temporary differences between the financial reporting and tax basis of assets and liabilities using future expected enacted rates. A valuation allowance is recorded against deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The principal components of the deferred tax assets and liabilities at December&#160;31, 2013 and 2012, respectively, are as follows:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="64"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>December&#160;31,<br />
2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Gross Deferred Tax Assets</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Net Operating Loss Carryforwards</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">79,558</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">67,728</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Tax Credit Carryforwards</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">25,582</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">20,692</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Deferred Expenses</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">61,370</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">43,226</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Stock-based Compensation</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,926</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">3,264</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Fixed Assets</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">1,638</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">2,156</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Accrued Expenses and Other</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">623</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">241</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">172,697</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">137,307</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Gross Deferred Tax Liabilities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Other Acquired Intangibles</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,115</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,481</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">IPR&amp;D Intangibles</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(8,776</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(9,142</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Total Deferred Tax Assets and Liabilities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">163,921</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">128,165</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 20pt;"><font size="2">Deferred Tax Assets Valuation Allowance</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(168,582</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(132,826</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net Deferred Tax Asset (Liability)</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">(4,661</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">)</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The net deferred tax liability of $4.7&#160;million at December&#160;31, 2013 and 2012 relates to the temporary differences associated with the IPR&amp;D intangible assets acquired in the CuraGen acquisition, which are not deductible for tax purposes.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of December&#160;31, 2013, the Company had the following federal net operating loss ("NOL") carryforwards:</font></p>
<ul>
<li style="list-style: none;">
<dl compact="compact">
<dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"><font size="2">&#8226;</font></dt>
<dd style="FONT-FAMILY: times;"><font size="2">Prior to the merger of the Company and AVANT, $33.0&#160;million was generated by the Company which expire at various dates starting in 2023 and going through 2028;</font> <font size="2"><br />
<br /></font></dd>
<dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"><font size="2">&#8226;</font></dt>
<dd style="FONT-FAMILY: times;"><font size="2">Prior to the merger of the Company and AVANT, $101.2&#160;million, net of expirations and utilization, was generated by AVANT which expire at various dates starting in 2018 and going through 2028. During the years ended, December&#160;31, 2013 and 2012, NOLs of $0 and $16.4&#160;million expired, respectively;</font> <font size="2"><br />
<br /></font></dd>
<dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"><font size="2">&#8226;</font></dt>
<dd style="FONT-FAMILY: times;"><font size="2">Following the merger of the Company and AVANT, $131.7&#160;million was generated by the combined company which expire at various dates starting in 2028 and going through 2033; and</font> <font size="2"><br />
<br /></font></dd>
<dt style="FONT-FAMILY: times; MARGIN-BOTTOM: -11pt;"><font size="2">&#8226;</font></dt>
<dd style="FONT-FAMILY: times;"><font size="2">Prior to its acquisition by the Company, $518.3&#160;million was generated by CuraGen.</font></dd></dl></li></ul>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of December&#160;31, 2013, the Company has an additional $6.0&#160;million of federal and state net operating losses not reflected above, that are attributable to stock option exercises which will be recorded as an increase in additional paid in capital on the consolidated balance sheet once they are "realized" in accordance with ASC 718.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In general, an ownership change, as defined by Section&#160;382 of the Internal Revenue Code, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50&#160;percentage points over a three-year period. Such ownership changes can significantly limit the amount of NOLs that may be utilized in future periods. The Company currently expects that it is remote that the CuraGen NOLs may be utilized and, as such, no related asset has been recorded for such losses. The Company has not completed an analysis of losses generated by AVANT, however, the Company believes it is remote that $60.8&#160;million of the AVANT NOLs may be utilized in future periods and there may be substantial limitations on the Company's ability to use the remaining NOLs of $40.4&#160;million. Following the merger of the Company and AVANT, the Company experienced changes in ownership as defined by Section&#160;382 in June 2009 and December 2009. Further, prior to the AVANT merger, the Company as a stand alone company experienced a change in ownership in October 2007. As a result of the ownership change in October 2007, utilization of the Company's NOLs prior to October 2007 is subject to an annual limitation of $4.5&#160;million on $28.3&#160;million of NOLs generated before that date. As a result of the ownership changes in June 2009 and December 2009, there is an annual limitation amount of $6.0&#160;million on $67.7&#160;million NOLs. Any unused annual limitation may be carried over to later years, and the amount of the limitation may, under certain circumstances, be subject to adjustment if the fair value of the Company's net assets are determined to be below or in excess of the tax basis of such assets at the time of the ownership change, and such unrealized loss or gain is recognized during the five-year period after the ownership change.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Similar to the AVANT and CuraGen NOL carryforwards above, the Company believes that it is not more likely than not that federal and state research and development ("R&amp;D") credits of $20.8&#160;million and $14.4&#160;million, respectively, will be utilized in the future periods. Further, the Company's ability to use the state NOLs of approximately $108.3&#160;million and the remaining federal and state R&amp;D credit carryforwards of approximately $19.4&#160;million and $9.3&#160;million, respectively, may be substantially limited. These state NOLs and federal and state credits expire at various dates starting in 2016 going through 2033. The Company has not yet completed a study of these credits to substantiate the amounts. Until a study is completed, no amounts are being presented as an uncertain tax position.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent ownership changes, as defined in Section&#160;382, could further limit the amount of net operating loss carryforwards and research and development credits that can be utilized annually to offset future taxable income.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company applies the authoritative guidance on account for and disclosure of uncertainty in income tax positions which requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements is reduced to the largest benefit that has a greater than fifty perfect likelihood of being realized upon the ultimate settlement with the relevant taxing authority. At December&#160;31, 2013 and 2012, we had no unrecognized tax benefits. A full valuation allowance has been provided against our deferred tax assets and liabilities and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the consolidated balance sheet or statement of operations if an adjustment were required.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Massachusetts, New Jersey and Connecticut are the three states in which the Company primarily operates or has operated and has income tax nexus. The Company is not currently under examination by any other jurisdictions for any tax year.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has evaluated the positive and negative evidence bearing upon the realizability of its net deferred tax assets, which are comprised principally of net operating loss carryforwards, capitalized R&amp;D expenditures and R&amp;D tax credit carryforwards. The Company has determined that it is more likely than not that it will not recognize the benefits of federal and state deferred tax assets and, as a result, a full valuation allowance was maintained at December&#160;31, 2013 against the Company's net deferred tax assets.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The American Taxpayer Relief Act of 2012 was enacted on January&#160;2, 2013 under which the federal research and development credit was retroactively extended for amounts paid or incurred after December&#160;31, 2011 through December&#160;31, 2013. The effects of the change in the tax law were recognized in the first quarter of 2013, which is the quarter in which the law was enacted.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 591px;" border="0" cellspacing="0" cellpadding="0" width="591">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="55"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>Year Ended December&#160;31,</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>2011</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Stock options</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,770,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,349,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,459,034</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Restricted stock</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">6,000</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,776,544</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">5,355,810</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">4,465,034</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E4BAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>OTHER LONG-TERM LIABILITIES (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jan. 31, 2013</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>OTHER LONG-TERM LIABILITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCredit', window );">Deferred Rent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 419,000<span></span></td>
        <td class="nump">$ 434,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net Deferred Tax Liability related to IPR&amp;D</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,661,000<span></span></td>
        <td class="nump">4,661,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DeferredIncomeFromSaleOfTaxBenefits', window );">Deferred Income from Sale of Tax Benefits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,630,000<span></span></td>
        <td class="nump">1,118,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,168,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan Payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">472,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilities', window );">Other</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">39,000<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Total</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,878,000<span></span></td>
        <td class="nump">6,724,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Less Current Portion</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(928,000)<span></span></td>
        <td class="num">(388,000)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Long-Term Portion</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,950,000<span></span></td>
        <td class="nump">6,336,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ValueOfTaxBenefitsAgreedToBeSold', window );">Amount at which New Jersey tax benefit agreed to be sold</a></td>
        <td class="nump">800,000<span></span></td>
        <td class="nump">800,000<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ValueAtWhichTaxBenefitsSold', window );">Amount of sale of New Jersey tax benefit</a></td>
        <td class="nump">800,000<span></span></td>
        <td class="nump">700,000<span></span></td>
        <td class="nump">500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained', window );">Period for which base of operations must be maintained</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Other income related to sale of tax benefits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 200,000<span></span></td>
        <td class="nump">$ 100,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DeferredIncomeFromSaleOfTaxBenefits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the deferred income from the sale of tax benefit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DeferredIncomeFromSaleOfTaxBenefits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents period for which base of operations must be maintained in New Jersey.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_PeriodForWhichBaseOfOperationsMustBeMaintained</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ValueAtWhichTaxBenefitsSold">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the value at which tax benefit sold by the entity during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ValueAtWhichTaxBenefitsSold</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ValueOfTaxBenefitsAgreedToBeSold">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the value of tax benefits agreed to be sold by the entity during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_ValueOfTaxBenefitsAgreedToBeSold</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative difference between the rental payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense over the term of the leased property by the lessor or lessee, respectively.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39896-112707<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences net of deferred tax asset attributable to deductible temporary differences and carryforwards after valuation allowances.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31931-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of other assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.16)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.16(a)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LoansPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate carrying amount, as of the balance sheet date, of liabilities not separately disclosed in the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 15<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.15)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.24)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 24<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 24<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherSundryLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ERCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011

</div>
          <div>CuraGen

</div>
          <div>4% convertible subordinated debt</div>
        </th>
        <th class="th">
          <div>Oct. 31, 2009

</div>
          <div>CuraGen

</div>
          <div>4% convertible subordinated debt</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Acquisition of CuraGen Corporation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleSubordinatedDebt', window );">Convertible subordinate debt</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 12.5<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment of outstanding principal and accrued interest</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12.8<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTranslationAbstract', window );"><strong>Foreign Currency Translation</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Net unrealized gain related to foreign currency translation included in accumulated other comprehensive income</a></td>
        <td class="nump">$ 2.6<span></span></td>
        <td class="nump">$ 2.6<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-108580<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleSubordinatedDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Including the current and noncurrent portions, the carrying value of convertible subordinated debt, as of the balance sheet date, initially scheduled to be repaid after one year or beyond the normal operating cycle if longer. This form of debt can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder, and places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.16)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 16<br><br> -Article 9<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.16)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX210.5-02.22))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Article 5<br><br> -Subsection 20, 22<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertibleSubordinatedDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Contractual interest rate for funds borrowed, under the debt agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateStatedPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTranslationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTranslationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHKDI">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
        <th class="th">
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Additional Paid-In Capital</div>
        </th>
        <th class="th">
          <div>Accumulated Other Comprehensive Income</div>
        </th>
        <th class="th">
          <div>Accumulated Deficit</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2010</a></td>
        <td class="nump">$ 75,255<span></span></td>
        <td class="nump">$ 32<span></span></td>
        <td class="nump">$ 232,679<span></span></td>
        <td class="nump">$ 2,751<span></span></td>
        <td class="num">$ (160,207)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2010</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">32,055,382<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares Issued under Stock Option and Employee Stock Purchase Plans</a></td>
        <td class="nump">173<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">173<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares Issued under Stock Option and Employee Stock Purchase Plans (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">80,254<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Shares Issued in Connection with Cantor Agreement</a></td>
        <td class="nump">2,155<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">2,154<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares Issued in Connection with Cantor Agreement (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">575,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares Issued in Underwritten Offering</a></td>
        <td class="nump">33,695<span></span></td>
        <td class="nump">11<span></span></td>
        <td class="nump">33,684<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares Issued in Underwritten Offering (in shares)</a></td>
        <td class="nump">11,500,000<span></span></td>
        <td class="nump">11,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-Based Compensation</a></td>
        <td class="nump">2,342<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,342<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
        <td class="num">(9)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(9)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized Gains (Losses) on Marketable Securities</a></td>
        <td class="num">(90)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(90)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">(44,799)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(44,799)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2011</a></td>
        <td class="nump">68,722<span></span></td>
        <td class="nump">44<span></span></td>
        <td class="nump">271,032<span></span></td>
        <td class="nump">2,652<span></span></td>
        <td class="num">(205,006)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">44,210,636<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares Issued under Stock Option and Employee Stock Purchase Plans</a></td>
        <td class="nump">163<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">163<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares Issued under Stock Option and Employee Stock Purchase Plans (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">70,587<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Shares Issued in Connection with Cantor Agreement</a></td>
        <td class="nump">40,138<span></span></td>
        <td class="nump">8<span></span></td>
        <td class="nump">40,130<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares Issued in Connection with Cantor Agreement (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,003,290<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares Issued in Underwritten Offering</a></td>
        <td class="nump">43,483<span></span></td>
        <td class="nump">12<span></span></td>
        <td class="nump">43,471<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares Issued in Underwritten Offering (in shares)</a></td>
        <td class="nump">12,075,000<span></span></td>
        <td class="nump">12,075,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-Based Compensation</a></td>
        <td class="nump">2,298<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,298<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized Gains (Losses) on Marketable Securities</a></td>
        <td class="nump">91<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">91<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">(59,123)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(59,123)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2012</a></td>
        <td class="nump">95,774<span></span></td>
        <td class="nump">64<span></span></td>
        <td class="nump">357,094<span></span></td>
        <td class="nump">2,745<span></span></td>
        <td class="num">(264,129)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2012</a></td>
        <td class="nump">64,359,513<span></span></td>
        <td class="nump">64,359,513<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares Issued under Stock Option and Employee Stock Purchase Plans</a></td>
        <td class="nump">5,403<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">5,402<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares Issued under Stock Option and Employee Stock Purchase Plans (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">840,228<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Shares Issued in Connection with Cantor Agreement</a></td>
        <td class="nump">17,134<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="nump">17,132<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares Issued in Connection with Cantor Agreement (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,433,608<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares Issued in Underwritten Offering</a></td>
        <td class="nump">278,563<span></span></td>
        <td class="nump">22<span></span></td>
        <td class="nump">278,541<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares Issued in Underwritten Offering (in shares)</a></td>
        <td class="nump">21,613,483<span></span></td>
        <td class="nump">21,613,483<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-Based Compensation</a></td>
        <td class="nump">4,548<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,548<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
        <td class="num">(3)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized Gains (Losses) on Marketable Securities</a></td>
        <td class="num">(74)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(74)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">(81,550)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(81,550)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2013</a></td>
        <td class="nump">$ 319,795<span></span></td>
        <td class="nump">$ 89<span></span></td>
        <td class="nump">$ 662,717<span></span></td>
        <td class="nump">$ 2,668<span></span></td>
        <td class="num">$ (345,679)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2013</a></td>
        <td class="nump">89,246,832<span></span></td>
        <td class="nump">89,246,832<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11149-113907<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11178-113907<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7656940&amp;loc=SL4569643-111683<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7656940&amp;loc=SL4569616-111683<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -Subparagraph (c)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of an employee stock purchase plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENTS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(4) FAIR VALUE MEASUREMENTS</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following tables set forth the Company's financial assets subject to fair value measurements:</font></p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="51"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="36"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>As of<br />
December&#160;31, 2013</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;1</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;2</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;3</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Money market funds and cash equivalents</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">148,549</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">148,549</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">133,581</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">133,581</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">282,130</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">282,130</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2"><br /></font>&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p>
<!-- User-specified TAGGED TABLE -->
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;">

<tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="88"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="45"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="36"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>As of<br />
December&#160;31, 2012</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;1</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;2</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Level&#160;3</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="11" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Money market funds and cash equivalents</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">18,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">18,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;" valign="top" bgcolor="white">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Marketable securities</font></p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;" valign="bottom">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;">&#160;</p></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">77,753</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">18,688</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">59,065</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;" valign="bottom"><font size="2">&#160;</font></td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" valign="bottom">&#8203;</td></tr>
<tr style="padding:0; FONT-SIZE: 1.5pt;" valign="top" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;" valign="bottom">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;There have been no transfers of assets or liabilities between the fair value measurement classifications. The Company's financial instruments consist mainly of cash and cash equivalents, marketable securities, short-term accounts receivable and accounts payable. The Company values its marketable securities utilizing independent pricing services which normally derive security prices from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. At each balance sheet date, observable market inputs may include trade information, broker or dealer quotes, bids, offers or a combination of these data sources. Short-term accounts receivable and accounts payable are reflected in the accompanying consolidated financial statements at cost, which approximates fair value due to the short-term nature of these instruments.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13504-108611<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUEAI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INCOME TAXES (Details 2) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">$ 6,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which the entity primarily operates or has operated and has income tax nexus</a></td>
        <td class="nump">3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">CuraGen</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized', window );">Assets recorded for net operating losses not yet utilized</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange', window );">Period of recognition of unrealized loss or gain after the ownership change</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | R&amp;D credit</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
        <td class="nump">20,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse', window );">Tax credit carryforwards with substantial limitations on use</a></td>
        <td class="nump">19,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Ownership change in October 2007</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">28,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossCarryforwardsAnnualLimitationAmount', window );">Annual limitation</a></td>
        <td class="nump">4,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Ownership changes in June 2009 and December 2009</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">67,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossCarryforwardsAnnualLimitationAmount', window );">Annual limitation</a></td>
        <td class="nump">6,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Prior to merger</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">33,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | CuraGen | Prior to acquisition</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">518,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | AVANT</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">131,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossCarryforwardsWithLimitationsOnUse', window );">Loss carryforwards with limitations on use</a></td>
        <td class="nump">40,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized', window );">Loss carryforwards remotely likely to be utilized in future periods</a></td>
        <td class="nump">60,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | AVANT | Prior to merger</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization', window );">NOL, net of expirations and utilization</a></td>
        <td class="nump">101,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossCarryforwardsExpired', window );">NOLs expired</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">16,400,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">State</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse', window );">Tax credit carryforwards with substantial limitations on use</a></td>
        <td class="nump">108,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">State | R&amp;D credit</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems', window );"><strong>Net operating loss and tax credit carryforwards</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
        <td class="nump">14,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse', window );">Tax credit carryforwards with substantial limitations on use</a></td>
        <td class="nump">$ 9,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents amount of deferred tax assets attributable to deductible operating loss carryforwards not yet utilized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_DeferredTaxAssetsOperatingLossCarryforwardsNotYetUtilized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_OperatingLossAndTaxCreditCarryforwardsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_OperatingLossAndTaxCreditCarryforwardsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_OperatingLossCarryforwardsAnnualLimitationAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the annual limitation on operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_OperatingLossCarryforwardsAnnualLimitationAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_OperatingLossCarryforwardsExpired">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the operating loss carryforwards that were expired during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_OperatingLossCarryforwardsExpired</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of domestic, foreign and state and local operating loss carryforwards, net of expirations and utilization but before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_OperatingLossCarryforwardsNetOfExpirationsAndUtilization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the operating loss carryforwards that are remotely likely to be utilized in future periods.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_OperatingLossCarryforwardsRemotelyLikelyToBeUtilized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_OperatingLossCarryforwardsWithLimitationsOnUse">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the operating loss carryforwards with limitations on use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_OperatingLossCarryforwardsWithLimitationsOnUse</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the period of recognition of unrealized gain (loss) after ownership change.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_PeriodOfRecognitionOfUnrealizedGainLossAfterOwnershipChange</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the tax credit carryforward, with substantial limitations on use before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_TaxCreditCarryforwardAmountWithSubstantialLimitationsOnUse</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of states the entity operates in as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NumberOfStatesInWhichEntityOperates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Carryforwards<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TaxCreditCarryforwardAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Unrecognized Tax Benefit<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6527854<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15A<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=SL6600010-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrecognizedTaxBenefits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMPREHENSIVE LOSS (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>COMPREHENSIVE LOSS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of changes in accumulated other comprehensive income (loss) by component</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 80%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt;">
<p style="FONT-FAMILY: times;">&#160;</p>
<div align="center">
<table style="text-align:left;TEXT-ALIGN: left; WIDTH: 675px;" border="0" cellspacing="0" cellpadding="0" width="675">

<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"><!-- TABLE COLUMN WIDTHS SET -->
<td style="FONT-FAMILY: times;" align="left"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="96"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="73"></td>
<td style="FONT-FAMILY: times;" width="12"></td>
<td style="FONT-FAMILY: times;" width="7" align="right"></td>
<td style="FONT-FAMILY: times;" width="39"></td>
<td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="2">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Unrealized Gain<br />
(Loss) on<br />
Marketable<br />
Securities, net of tax</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Foreign<br />
Currency Items</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Total</b></font></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom">
<th style="FONT-FAMILY: times;" align="left"><font size="1">&#160;</font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th>
<th style="FONT-FAMILY: times;" colspan="8" align="center"><font size="1"><b>(In thousands)</b></font><br /></th>
<th style="FONT-FAMILY: times;"><font size="1">&#160;</font></th></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Balance at December&#160;31, 2012</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">156</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,589</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,745</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Other comprehensive income (loss) before reclassifications</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(74</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(77</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Amounts reclassified from other comprehensive income</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">&#8212;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="white">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Net current-period other comprehensive income</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(74</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(3</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">(77</font></td>
<td style="FONT-FAMILY: times;"><font size="2">)</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#CCEEFF">
<td style="FONT-FAMILY: times;">
<p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Balance at December&#160;31, 2013</font></p></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">82</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,586</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">$</font></td>
<td style="FONT-FAMILY: times;" align="right"><font size="2">2,668</font></td>
<td style="FONT-FAMILY: times;"><font size="2">&#160;</font></td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.1pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.1pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;" --></font>&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;" align="right">&#8203;</td>
<td style="LINE-HEIGHT: 0.75pt; FONT-FAMILY: times;">&#8203;</td></tr>
<tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 1.5pt; PADDING-TOP: 0px;" valign="bottom" bgcolor="#ffffff">
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;"><!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" --><!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;" -->&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td>
<td style="BORDER-BOTTOM: #000000 1pt solid; LINE-HEIGHT: 0pt; FONT-FAMILY: times;" colspan="2" align="right">&#160;</td>
<td style="LINE-HEIGHT: 0pt; FONT-FAMILY: times;">&#160;</td></tr></table></div>
<!-- end of user-specified TAGGED TABLE --></div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTaxAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>170</ContextCount>
  <ElementCount>330</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>69</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/BalanceSheet</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/BalanceSheetParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/StatementOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0030 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/StatementOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0040 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/CashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1010 - Disclosure - NATURE OF BUSINESS AND OVERVIEW</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverview</Role>
      <ShortName>NATURE OF BUSINESS AND OVERVIEW</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1030 - Disclosure - COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureComprehensiveLoss</Role>
      <ShortName>COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1040 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1050 - Disclosure - MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities</Role>
      <ShortName>MARKETABLE SECURITIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1060 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1080 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureAccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1090 - Disclosure - OTHER LONG-TERM LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities</Role>
      <ShortName>OTHER LONG-TERM LIABILITIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1100 - Disclosure - TERM LOAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureTermLoan</Role>
      <ShortName>TERM LOAN</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1110 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1120 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1130 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureRevenue</Role>
      <ShortName>REVENUE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1140 - Disclosure - COLLABORATION AGREEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreements</Role>
      <ShortName>COLLABORATION AGREEMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1150 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1160 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1170 - Disclosure - RETIREMENT SAVINGS PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlan</Role>
      <ShortName>RETIREMENT SAVINGS PLAN</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1180 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialData</Role>
      <ShortName>SELECTED QUARTERLY FINANCIAL DATA (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>3020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>3030 - Disclosure - COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossTables</Role>
      <ShortName>COMPREHENSIVE LOSS (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>3040 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>3050 - Disclosure - MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables</Role>
      <ShortName>MARKETABLE SECURITIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>3060 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>3070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>3080 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>3090 - Disclosure - OTHER LONG-TERM LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables</Role>
      <ShortName>OTHER LONG-TERM LIABILITIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>3120 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>3150 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>3160 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>3180 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataTables</Role>
      <ShortName>SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>4010 - Disclosure - NATURE OF BUSINESS AND OVERVIEW (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureNatureOfBusinessAndOverviewDetails</Role>
      <ShortName>NATURE OF BUSINESS AND OVERVIEW (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>4020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>4021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>4022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>4023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>4030 - Disclosure - COMPREHENSIVE LOSS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureComprehensiveLossDetails</Role>
      <ShortName>COMPREHENSIVE LOSS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>4040 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>4050 - Disclosure - MARKETABLE SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>4060 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>4070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>4080 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureAccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>4090 - Disclosure - OTHER LONG-TERM LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails</Role>
      <ShortName>OTHER LONG-TERM LIABILITIES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>4091 - Disclosure - OTHER LONG-TERM LIABILITIES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails2</Role>
      <ShortName>OTHER LONG-TERM LIABILITIES (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>4100 - Disclosure - TERM LOAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureTermLoanDetails</Role>
      <ShortName>TERM LOAN (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>4110 - Disclosure - STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>4120 - Disclosure - STOCK-BASED COMPENSATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>4121 - Disclosure - STOCK-BASED COMPENSATION (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationDetails2</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>4130 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureRevenueDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>4140 - Disclosure - COLLABORATION AGREEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureCollaborationAgreementsDetails</Role>
      <ShortName>COLLABORATION AGREEMENTS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>4150 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>4151 - Disclosure - INCOME TAXES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails2</Role>
      <ShortName>INCOME TAXES (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>4160 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>4170 - Disclosure - RETIREMENT SAVINGS PLAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureRetirementSavingsPlanDetails</Role>
      <ShortName>RETIREMENT SAVINGS PLAN (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>4180 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSelectedQuarterlyFinancialDataDetails</Role>
      <ShortName>SELECTED QUARTERLY FINANCIAL DATA (Unaudited) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element cldx_RevenueFromContractsAndGrants had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_RoyaltyExpense had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">'Monetary' elements on report '4010 - Disclosure - NATURE OF BUSINESS AND OVERVIEW (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '4070 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '4090 - Disclosure - OTHER LONG-TERM LIABILITIES (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '4091 - Disclosure - OTHER LONG-TERM LIABILITIES (Details 2)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '4110 - Disclosure - STOCKHOLDERS' EQUITY (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '4151 - Disclosure - INCOME TAXES (Details 2)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '4160 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 0010 - Statement - CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">Process Flow-Through: 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2012'</Log>
    <Log type="Info">Process Flow-Through: 0040 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</Log>
  </Logs>
  <InputFiles>
    <File>cldx-20131231.xml</File>
    <File>cldx-20131231.xsd</File>
    <File>cldx-20131231_cal.xml</File>
    <File>cldx-20131231_def.xml</File>
    <File>cldx-20131231_lab.xml</File>
    <File>cldx-20131231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>78
<FILENAME>0001047469-14-001653-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001047469-14-001653-xbrl.zip
M4$L#!!0````(`)5<8T2F=$*C81X!`%<:$@`1`!P`8VQD>"TR,#$S,3(S,2YX
M;6Q55`D``YJO%%.:KQ13=7@+``$$)0X```0Y`0``[%U;<]LXLGX_5><_^/A=
M,2^Z,97,EBS'6>W8D6([,WN>7#`)29A0H`8D'6M__0*\B:0H4J!%B90P-17;
M$LEN='_]=>-"X-,_WA;FQ2LD-K+PYTOY@W1Y`;%N&0C//E^Z=@O8.D*7__CM
M?__GT_^U6A=#`H$#C8N7U<4])`29YL70(DN+`(<^X*+5"B_\"C$DX:6W[E_(
ML=V+$7:H)`?,X,6__P38N+B6Y+ZVOBMQT^AA]'@Q(99#G_N'K^!%^X/T0?G0
M]V]X>R$F^LC^O:"-P+;W*_I\.7><Y<>KJU^_?GU@GWRPR.Q*D23U"F$J&^OP
M,KA>-XVWQ.4Z-$T#OCESJL42N@[2[0^ZM:!WRZJLJ')XHXGPSQPY[.L78$=R
MJ!EG`"RC.Z;`?O&N#K[PGM^2Y-9:`GN@L6Y+_/G=*__+Z%([V>9?:GBE?/7O
M^[M'?0X7H)5N.[*MMB+W\JSE7Q$UPB%;+]:NZ+>1/AO6"322-4V[\KX-+S5@
MJHDVU#_,K-<K^D7<*-3;%Q>?V)T?;:\Y#W!ZX3WIH[-:PL^7-EHL3=8V[[,Y
M@=//E\R[K=!S']YLX_+BRG^0#QS=HFA\<RZ0\?ER1*]3?#'1]Q`[R%D%GT6?
M(H-]/D607'BJP$1+0_V'H]\O?Y/H?[TVM6'_TU7ZYE#458:L0-(2$F09&_(]
M/SJ_,85;]']5CAX>?)-\<NPIX4=!PW-M\?SC\:M%:0$OJ&H#;-R[&.EH"<SQ
MBXEF7K#;]W#Q`LD1K!8]UH8SIE_T<?"%0=5X6YI48<?7\<)`]#J?XH*8^W@/
M_K+($T6//9[>P!?6R"]_NU3W1ZB[!#D(VH,W9%_^QG#T<6=S?+K*U&"M^566
MZG7%@=JTF%"KL<5-8_B!MI<X-S2'^LB@_"E%UEA_E[H)8F-]2\*`X3?[,*#<
M/`/*_`:4JS-@,Z(Q84"5WX!J-09D="8]#ZW%PL*/CJ7_;';Z>G2H4=C=?M*B
M[5I:F/X9)*WPLHWV'B$_2=7E)UDX]`@.E:LL/(5#3ZN"%`X]@D,K*H/]'#HP
M#,1Z/,"<`&2,\!`LD0/,LW!N;MM/+;<*1]?'T97F7.'H^CBZTEPL'%T?1U>;
MHW7=7;@FFTL9L^D,9A0"Y\QTKW"$=6L!S\/IN]KAY'*W`$#M`5!M3A<`J#T`
MJLWU`@"U!T"E-<`#=`#"T/@""$9XUO#YVAV]G=WH4\ONPK7'=&VE>5NX]IBN
MK30C"]<>T[55YMI&3,P?*#DUS185L?F-F)X^9*#7>-F.F-,^#@KJM?I-3(0?
M!P7U68%V(R95ZS`%4^M,(=!1)W34+8,(=-0)';7++&+`OYX#_O7..`(U#4!-
MO3*1F(`XPE!FK5E$X.&X>*@7/XC%!\W(*O6J8,4$V;%9I#YX\"9,OS?CE>O$
M'*/4;:E2)=/'C^.F6:/=DFB2T:J866.CZ=@AEFG"8-N&\71*GX1G$V+-"%@,
M:%08T&@F@WA;3G@#YR/;=J%QO6(;58RG8=O6^U+P6.',*<4O5!^!"0.*?1ZZ
MMD,3,$W*6*?-\_<P>D!V,%WQ_-4$;];C`CGSWTW*T!-3;R:<UA,RJ79>KZXA
MUN<+0'XF<U+,2D6H>:<"#-BI::-\K^Q3'V\/F%!>?+N7;9X7M3WM^XL0$B'4
ML!"JUW")*D)(A%#30JA>A9SZ?.O2[K+C$CC`QBUZ8[\U?+R`UNS4&,YJ8@(<
M;D>W9$_+PN?VY@MT4'3<@1>V)ZE%5I$5SP`<'FML;;H`AK\(;^DZD)P3+&(+
M\K+:+G!!<7$/L#L%.N51A&<I`SW?(XP6[N(,H.(Q2)XM]EGX/``\2T$T86D!
MS$)@@C<!S,,`,VYI`4Q9>?ZR6)K6"D+:0[)=T_%]]\W"X><WB$"=EB'>./9X
MR?I/S<;I@#[30*;KH%>XWB3ZRYMNN@8T;HFU\!.LUU4<3\/YO`DDCW-`X/4J
M^P$Q?)<VJ1B7]-:@V`Y!N@.-$WC'HE*PK:>>,RPFL"3+@MS.G=SJ-6(L"W)K
M,+G5"TNJ(+=S)[=Z=25406X-)K?Z8&G$3J+ZWGZ^ER55?AZZ!'R%.'8Z63C?
M:N%72!ST8L)']\4B!L)L>2X[`ZC9P+MV;82A;0_TOUUD>R_+Q5>*;;''/L=-
MF`U'F"+398U(#SX7F/U0Z%TO4)2TEBQ5M?7'=_GY7E($#`4,=ZL0%>X*D=ZB
M]"L@T>1+@=^@\P,3"$ST'VB,J/%LA[7[*T#XSK(;/N7._Q;'3N8X/)55>QA@
MK/U/!&#;]`)W8/SE^JT_-Q#D&.&T7*\*)F@<$U2XSYTJF*#63%#AZ9>""1K"
M!#7MG&]@2-!'/>BCIGCQ"\];@,@?P'3A/02V2SSCV@]L3(RM``EZTM%%([QT
M'?L.OD)3;C:2HB9=KV(MOR7P;Q=B?95:"KR#D?;9O8XI%_WZ3VH`0/3YRK/^
M%OTV_7-JU?).>/UB.VA!8V0\C2Z/?KE!MFY:[%8!X-H`F,=AIU/U<3"P0+1`
M]&EQ=%;.4@2`:P/@'/^<)0,+O`J\UH)?V6;W_M0>9'-JZ_4+S0:C]XXN>QO!
M'D]9NX+7%)S5M@4:N58X+9>KSS\>OUJOD&!ONA4;]RZFC5H"<_QBHIDWNG$N
M[O?FN'<VQVFE*E6$?BU#O]+J1+QH?;P7K0^5T?->NSM]-[_GI<.F>5ILJG'D
M334.Y>@[VDV"<\LT1HLEH<6*UU\Z(T_GM/_47,U>27"(J[.Z<X2]C2%AT^?H
M.;>]V&Z`TW*VV/>F)N58I;TL48[5J!RKU-.B'*M/.5:IHT4Y5J=RK.(Q,E&.
MU:D<JW1TS&N?3IOW`&W(YH:H<6[8W(]U`CE[A`TX192AX1UZ90M?J>%F[,6J
M@6U#Q[Y>^1N;FL!.#9#N9)53J\P%%)H$A6I7TB]F$'M',S3?\[<\7O<*^*S6
M'\K#-5WL'&Y-2N`3U.?8,JW9ZMQ@D=7Z,X?%2+#%4=GB@-/F(O"/$OB'Z@>(
M&*Y!#%>]ZDW$\+%CN"(/K_=SD1MQ!-_[-Y^CMU2T2VM3S5AJ@]+*S*@VU8RE
MBNL*S:A2,VK/$V(9KN[$!AX&V+A#.B-&/!O,"(3-S]O^$9(#0MCFYEX;U_S-
M98!C]<HT?N!HL<-8]]M9%Y!I`F1JTI'WN4:A7--Y]A8$G\(^;W<6GCF0+%A+
M-F=Y-IIY+`AT^%FC4]WIL\+YY[NGO'#^&>^Y+9Q_EIF?#0Y)7N9OJU(CNFNQ
MX12I);5C!?0^AU.\9<D[GUS?M%CQ"F1O8^Z1;;O0\)?!C*=AV^(#9[M;0211
MFD0%;!H!F[JEWQ']@&!@/M#N*G;A(R2OM*LZ>G@,]D\8_#'X]A3\/J$BR)-U
M#\D,DF8B:;V\1K<6\`F\#5QG;A&J='KY3:Y9BJ##HTK^MN`Q^^]#:!!)P''M
M\=1WY``;V:(SW'WF1<L[3XEY?KP>-C5@!K\`,5)O'(BS7<K7OJSC0Q"TAQ,"
M:8HB)W'"2[3/IS<-.IYZ34KW@[:V^G36-OC#FNS`%:4179M4G,B\1RY4&B=#
M?T]8]`K/+%3R&WYBT?+LG?'$WG2!Y`'-YH[-WID(\N9I06#WWDR.3?99@38&
MB_7.YP+``L"-)]/G>X37Y[D+9-8=F3S*/+#5"DGA"6^?.8T7AXZ(#0''^L!1
M`/`,02%K6N?97TT&H[5D=IC:$=81QC29#.?(-`B]Z)^6O40.,.^A@71@#B$;
MV`XN?[!H0]`;^_&*B&O_`71Z>\.WH\];FK?%;OLDM:'E,@LO*4)6W\`B/ES*
MYYU]*A4L21R38!XCIE0N!@X?;`S>G,'FW5(5`TN=8'7B@[4"IK-*+=]\GCS<
MIC\ZNZC*-LV!@FK3`><9.`RJW&LZ_5NJ6Y%@FO[68[1O$X/.K462BZ.'UF(!
MB8[8.7'!X>^!X8.0^FJ"-^MQ@9SY[R:U\<34SS76]F;3`X7G-L^=:Y#6;/V'
M(H)4!*D(TG20UFMMGRJ"5`2I"-(:#\KX.X=G#RZ<8NR4'$<Y`ZZ6!0Q$7>UM
M7"M@()+"5A@\WT,#$/@VPF']=0_>FCNU6/^Q][2]JY['C'OSS`-A)`)!!,*)
MK;+*Q_2#I?^$4VB:D/S`M'=);*JX@/<AX)UC>H'T_2/]QOT)UW:^)@#A)W=A
MD2'`.B2)Q08"^)4"?W=/B#C8?QS<N<8O-!M16<AQ'7@;VCW<O%W$P"%B8#<O
M"/SO'_\#D[H$V4]S2,`2N@[2;5'1'PCU>;876-\_UM=9=CQ]M%QG#A9+Q\(_
M?A=P/P3<"\PO$%\!N[-MR@6?'XK/$]86>-X_GA\A<!P3?H48TFRY!O;0)8!^
M.+3(TEL7$.W;(1!?*>*W^&.?TO,WV=GF>!%\[SG6+7]C*;&9U#XWDVK(ODZ'
M>?]9$;N:B5W-:HC^FJY;VHVO1<B(D#G%A,&-?H'T^B#]U&"VM0<:A&#,8`*,
MC>\:EN#@#0"<6X2,?V%([#E:#N>L0SW"8]VQZ!<*Q:T(B7T`,F7A&`:+;7]N
M:$S.+`ODO9N,J1)#`@WD#`$AJZE%V+;#26WX9O.;ACAOPS!V8)BE`_-?+D&V
M@?18(7`>B"NP@D#<X1`G(-9P+^]TSL.I>OF=J:N2D;^ZO9K!67+;(_PO%T-:
M]&DT?&Z@[EW%_A10.FC]7>2(TZ(PY7L#3W4N=SBV6MD9XPT\CD!A9ZUQF[!;
MT?G&RG>UD2;L\9NPJB.BE>_M)IJ0'?I7A]FZX)3[YIFPW`GW57&AVD0N5/FY
M4*V."]4F<J'*SX5J=5RH-I$+57XNK+3_$AXWUN`3-:(-F$R`UXLCPT\S&GA:
MM;WPX1D./O@K]83CSW2]6>Q0R`$V1EAG[7J%S(B*)/5/"0KK@P^*VGMJM+Y3
MHT_C]8JJ7,ZC0UW>,:AQQA'$<U3BJ2DR1HE:A/L\XZ:BI9&'.L=REU+EO+A`
M0\/04.D;1>+0]Z8@HJ:]'G]W8`&C1L*H/KL+^Y7*`[0=@G2GT<<(;X%';-7=
M9AM/K<@0CCR)^F"+(T^(M&OAS)KV'F]"3O96"7MKL:(#1+Z\+=G.&LT.;']I
M7'26-5LRNWX]*;U*.J?]H@2D.&';G!!@LC>]C`7"B,:3=P;-^2!E)PL(K-#N
M@N"4>G)*??H#/DX$I]274^J%%55P2DTYI5[UK"HXI<:<4A^L^,,80VB:!GP+
M0^O+WRYM57JJL<,.4_2W4_#ZCL''#7]M/V/&=0_6.)WAD0`@6[;1:*K7J]DT
MI#E>92E"^MY^OJ<=VGMD#,'R%F&`V2FI=W?#</0+ZBZ!-,N^.,WTMG^R!E6?
MG2E`7"]34.*$)'Z@TI;6%_F:!VUW%IXYD"R8*IM#<AMF/DI*DEI>[YDG)4D5
M=HF^R\_W4E3$?#&ASH8MJ:>0`\S-_97.`JH[&N/<D"NSMXQX.VB5O)@T6B-7
ME9N/R9J#()8E4_[<9Y9L4W\J]]MW=MNV&?FC^V+#OUW6-7VE_P2?;MFHNZG(
M./ZVW,?=ECSEY(S@R$+!/C5HRL&^;?X>+[U%:2G]?9"TBY$?T3\>;U*QMH#`
MIOSU&[(M&B^]C_2*\$'A5_&'LR=E/OEQ#@BTMSP\:+1W2:FG3^B5N<]>TE]+
M/7GDP,66)WL@0O3[<@;QX9/W[`!AI1Y/_32!Q+-Z2H2!7BG;I8'%;OQ&ZRI*
M1-9&J.T,@SCTLI\8$W<#L;6@'8M<@4702$O<?&CX;:S=.UKO!_VST<;S4,2N
MKM!R4:8!-AMS9C_8B-`K,!FE#OQ]QQ">_0%,%WK&?0(S^?+"@#I:`-/^?-E2
M+R\"4GJ`TV`-V.4%$^'][9&2TNYK/9JV/UUQ"4SJ.'@%R`0O)CL[[Y%>[]5F
M-"U#VRO/@!/\]2=RY@B/,?Q_",A@81$'_0<:0\MVP@8HA0UX_O'XU7J%!'M9
M!QOWM#TZ6@)S_&*BF9?NP^HFU52YT^EV$TU]O]XI.^@ZJPMLJM;8F;,3!'5(
M#4@%V-^@0^L20G4.FZIR^ZK=3FJ_B[2D@A,"EP`9P4AT>./`MJ%CI]1K<ZLG
MRU(_H>`.TE+VRU*DPZU(OR/+*5-QRNP6R533,E6I(_>U785.B$4K"&?%1F\9
MB%F@>?-)U'&A#CWN=O<4J9-RP'8Q285&F/9<9HABQ]>:7O#E33==@P;\5\LR
M?B'3#!7K\Y.,VE?5A&:[R$MJ&,/.-POK27]I_+&D)!&2^?BD!FD[R!(_,K5N
MTD/9;?7UB.3PL[JL=#IM.0.-N7(*R7<3]>V>I'6*Y01,-0$K1D^I8)/YF;#7
M[F1285+`AA+$A<8=`B_(]&@]K4<)RI,TEE&2FF1+R4!SCBK\I*?V^YN`+E(C
M-HB2UJ"0`C<TZ'0T):'"YM.3TG/:ST]^<J_;3X*BJ/$YX@LI;B,2%$GM2%SB
M`^NP4:ZG8)0KDL_/9YU>NYME_/CC\R&XR:H*/\%U5;6;"\-MY!J[)!)?HIK5
M>MW>-B^DZFIKL;#\.=1$":T4EZ`;C4ZFDO234S1D&-Z`%3`GM#8:X6@X/;HI
MTH2?%]4.Y>-4Z5,H;X,FW85K`@?ZY1J]<$G@G`T`O4)__<.=9;.$/9X^@;=(
M67[R5#)8G$=T4N\'Z`"$H?$%$$R+"#OVL!LX9>--D:K\Y-I2NFU9299WQ0)3
M\<YL/;=,`Q+;G]N/%.+G6JW3ZR7]O/GXK0%&*\$<94I0[V:U421M9]/P,[$J
M:[U43;(WVQ3R\BX5$I]M:"=J"BEA^A=.`!D3;_V1X7%+.!85=2H3E#WZ=ENH
MXGHT2_K`!DKYY+Y+5[E05^50NOK#J,$6OK1O'^FH<-DS'(UEG9UT5SA'6BG-
M5"[K5:;9R+;=F%;M4O8JT,>7P:U+IY2%]J3+V'78;"#KT$8*=:LP3DQ0.:UZ
M59AIJU:QPJ.0(/KO(K,X0^P@M;R:VKMX;%]J;B.*-E]*"/VK>,/"VPK;?)[8
M12L^\J]$JR1=M(NI/DNC;EOM:!U9S5$HBS**E"EF]RRG]36EW>VKRGN5R:")
M=CEFWT&C7:ABNUKE2'X'KVVHY<WZ!-OXWQ)K,2&6X>I.[&T`=BZ(-_E-[UE/
M?T>JYI;Y-YF5=="I+RMZ3XKG=@F\=7,9<P$5*#ZD8@G0O2F/KP3$5<SM)V3:
M5NG+F2IN"N%6)K>;D&DO-=O/VW2)^J#6"IC.*K@CFC')';?)!IK4ZR5[*<E'
M[R0V=[PFL]F:+&N[2_4_C,S<R1VIR6ZFK$A*JA?O/[1`5.Y03';3E-10_Q9)
MV:;,'4VYR1R`5-5V>5/F#HEDRFO+LKR3)7->FXK$\S-CNZ=J_93\'$EEE.)G
M/55IJ^E!HMV5\OV5UH*?V+;&,H]8?@K;%LN94@O>D8KF8<LPF20GAZ`+9)53
MK`S7:6IYO8)5!][ZAO$T/7T:J56"$B4M-8.5*ZF45OSL*6NR6EHKMC"#9<S`
MD&L]"EEU<VA?4WI:JKN1?/B.H@L)=L,$':6[,;&0)SH[D+N%U+IS)LG$Y=8&
M%[+GAMQ^I]-1.1H\7K)E7+1L7$\-1-+Y6;/5Z5/>3,Y=;0K870-^`FVU5573
M]J9!KY`[-SS0ZLOMML*G@7>^&;2=<'F/?UVD1"%/;LYDJDD^RA;`I40A*VYF
M<JU;6HE4!/8*V6^3DSN];/&9(;A-;B';;;)N;TNS,^5^@\X:%-%2NB<KUI,.
MYC6N@8WT2*]"*LR(34U6DM3`*7P_FA=R:49,MWNIF#Z*YOQL3+F@DUK1\"[-
MPVG2<!S3NX25Q<ATG?7`5R_!W$HA.-9#J2WY@Q0;9BJ05TXYK4`Y.4>Y^&`3
MEW)_0C2;TT\'KY2*9_";RQ:WCJ?>C;%!JBTZ][E*Z'!\K-/KI0JP<EKLM25<
M-7<TX:5U)'GO+;F!2T)5\<I1^KL)@WW2XV5JI#=_4:Y([60ILHN\=VC(7Z`K
M2KO_3@VWK?&XM0CU$/873>FK)P*P#?3@<=Y?IK_KAO&7:SO!<E9O1<B$B:)?
M.`Y!+Z[CL],$Q-<T]?G[`*F"Z)!:U\%@_#V7EE9WB_W`!`*331']DR8LMN88
M(,RRVABOWP$8$,0&I6_HGW@V\5[X2J]ZZO,/7&GR3L9YKX8'M@/_6%DK->QP
M&$-D"-AH2YF^HR:E>BTY@O@U*M.7;/=3XZ/[U$@KU;?L*KUR&K%%U7X^28P"
MW2`[>@-F0N`"N0M[A%^A3Q911UCC[X-V,U9U\RNPUT;P]V%;<F_OC;@'Y"?T
M"'<=?&%`1JKR=WB3O<X\(274X>\'MSHE]8EQ$S#A>)IX`2=Z^R;2C+\GG%KT
MN9N\=^G(W^?M]-^M8]@I8B_9+=C00Z)<U0JSS68-IZ38,%L"EQ:%>6*S:%93
MHVN[:)&*5OCBA!$;1&ND4&&:R#!+ZH7((EDE5:,U#_\0G-1[CVXTG]#"P88W
MT/\YPCGO2Z[UY,\5+5E)#YIQ2-Z+TF5R0Z==G=+!BY\WP;+`S!=`U]KSIXO6
MQMN$9338;RM*9!DEM6B^FF9XET;#^&FU^5-0:C7[;@+?IV2)<5>U"-YEM$R]
M9LA&-S9>]UMKS9^EU%Y7V3$J\U38;S-*I#EI8_JBBF8D/9BI.W]&[&A\P-FK
MOOEO%&\A<K6_'X79G@'`GM/RC.U*85RO?M"RA-X=A8CNH%?_=4:J%,(N_2SX
MTL*Q-I3(H&VMUT\"_WW*5-.P$EE6[713U7`=&U:8@#<[\]U>M[LQK;6WAM&'
MZ/]E[UV;&[>1A>'OJ<I_X..3G/54R8ZHNSP[J?+8GHG.\=A>6Y.<?;^D*!*2
MN*%(+2^VM;_^[09`$J0HB;)NI(Q39S.R1`+=C;ZCT2#$\+`$$H,&;//!FG',
M[H=9T5B,R_KIW6:MGHKVUYY^:]"_H4H$7(CZ5J'79C3N[SNTNYI+ED.\?@*T
MU:TU4VTJ\DRY$93KIR>;M78J?;(-*!<VY(A!73_[6$\S0.Y9-X=V_<QDL]K=
M#K0I-J>)!:PM-Y])NJ_%^E6$-37=RF;5;&^';OU2PM9FP"U0U2SIE]]N+#\I
MOR!6;M$\S&J[D1.8W2"V_G;H64U-*;4BXK5^5?E9N]VHY7+-WH28R+EX,$FS
M=>#>C%X(ZO)#^YG,UJFW.XV%@I(YW9NA6S]"!:>CMMAPKPE==!6`L-CKE_PT
M&\M<B6B*/$3*[&JR_#!_-O]!3)3JN[!ZPK<#N'Z\>%;OMM5]P5=?/SYLSI_W
M7@^\1S+E%AIY$83<];'N.@G7^B8,!#K%;$LF6@P1:R^32:OUP[5.:R%`<_/D
M4M"\O7]N!5U?W_#4.HU4JFLS6-Y$ZC<$7>FS47LG]1OVWKKM?,'\FTB]+;S>
M4._?Z3;G:U2WAMC-<$AT_WYX\ZJ/L5OTH^:3>SN[R^ARU-ZP[9?`:E-(=H77
M^AG65(75=A%;L/C+<5C?<H*U[>82I]U`W'A#KK6;;K*W7XA76MDYT58;C68U
M5URR&N3P+`"V$8MA>L.!LWHGG6*/!\XSY1M.DS53&;[%4RYN_J0V5K8XJ_XI
M>.O938CKJ0*`-W?&4ALKVYBIJ\%IK-=$;!DXJYN8K0:GM3UP5K8QJZ\&)]70
M=Q4X*WIZJ(W5_6R6<U!4TUZK-IOUSL9M/M+PK6YDLYRE0OCP"I!JJ][:,GS-
MU9ULEO/8;GNVJ,D&"-DM4G+!]\8V+DO$87FO!,9Y"SI%9HM&K5YKM=<3CV7@
M+=7IC/'6`P^"\NVIVN7M&!C?K05>1I_.3<!;:0GJZX'7:LWM?FP"WDK+`+RW
MNO7GHH5NJEL#=*7-4#<`M-7<'C^N;L&^"44;ZW7/7`;HZH:9FU`TM0^R`:#+
M&TTP'DTW?,V&Z@S&JE6W)CS+&TTPGLP)&+T=H+4UP')<U9$7L/GFNIL`MM*6
MU/,"5F\TMVCDEK>?H#PVEW)JIO?*-YE_=<`PO]'8KKU!:S'G1#R-PYR6F\G4
M<F:$L+V$P-7'FD>2VQ:MY3TRKW/[H)UJK=E(P;T^7%M&;GFKS>O<#FR[VNRT
M]XD<U<PQ'LL#F?R+U&QG</=2&-X.\_+@)C_MP>;405OM!>CV\HCG.G=$46M@
M8_[.CH"^(R_TIYC3V\M#H?P<HJK-U`96/D@V@WYY*]#\O**")[`&AV\)^OJV
MF`:\CWJC4]\)]+2I;8K;5]?0K\[99$0#RR9_,ZRK]X]RY)?V!.OJ/:'5L&:X
M`=N!-8.!5Y?KY>"#_(SP!L;-`'IUX5X.H/-3>3M`K]RVR<,9.P5ZH?L2(;&Z
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MTY:;R&X6TJWN_9/1G?>`0=L;^@#-'8G::7BPNBG0_!&<>BOKHLB".L_;Z#>T
M7R]O0PEY0TGQ`=,:M=4MCN8O,:FFNS?L4D1J;VANU,#\?UE$I+:Z$=+JQF#%
M$9$4>ZW?I0$3-!LEQO:W<-O.336:C7<7W]96-W/:H-KJK/Y>8K#:ZGY3F]`Q
MU<*QT`%%;743J]S%5%N^3P"_\NZ'O)&4&=\(6<..5?.Z\=?_MOR/AOFL>/[,
M(I].AO#$F0?TO5"KY]6I_Y%^,=0FIC6[Z)L3L)M@SI1'9Z+9'T_^>^1__/$'
M'&(:#O#E_JY_]N7R6^_VGQ>*CR^PQ_`A'$O!P?&6@/#+`7XX53\H=Y?][X\W
MROT7Y?/WI][=S=.3<GEWK=S_?O/X>^_F#WSVET'XUB\X5O3'=&-`M,GTXW^I
MK>J6/ET1"U;H5>D#%VM3$OBF[E7BGV%]SY538''E!'E<LV<GBN/"'^RUDP^*
MZ2F:,C"=*2C?B:;3$30+%I`^K0P=/0"%K#BV@J,8\25JBF8;^-B$N+J)DL*Z
M<SI#Q2/8V=]2S,DDL!V?0C93?**/;<=R1M@99@A`X'@^"!G50OB>CF>A73HN
M?4LQS.'0U`/+/_.=,_HH?.5A5RWO'#%6.$Y_\Q2+:(9BN,$(1S%,`Q0#.%ZV
M;@4&44`Z#6=*IN8D\)53$"5'<7E+/\5W%,U3KJ[_#X^Z?Z"3CRR0(,T'_3+1
M!LHS,1S@[\7O@>/_X5QY%.>@1/4U=T3H_0D"'2A]`3#X?6H^.V#UE`?T?.,E
MJP-?!<8LFT1#%Z7$`G$'*$UG8&F>#Q)"P=;2(]66C>2B$J/F2QSH7/F:B3PB
M!#"#H`\<8W;&".W8_PI&0&B&#M@6PYG0.X;9M/#M%'B"=E%^,?TQS&].+:+8
M9$3O65,&V"#-#Y?='\/R.L`Y9^05E+'G*:/IW;?/P'(>&#1&<6>`JD[1=)U8
M>$H.OM6F4]=YUJP$0RA`"`#)IE=+(+9$<RT3/GJ^-B))%E%T("?E>8&Y*YQW
M4*\]X[L6)<<2WJFU/U1@RF%@63`]/$T%)EIQ4*B.;J'+$U&1D2VU9JJP9IPP
MP%@`'CT16*&3U:MJ!9>#\A5@`[(,XV-7N?\@O(`AETZ#V`8:*IT],W*=%UB&
M(?@##A,S"GJ##K>,7350:D!IGX(.HRNX/H1I?1S96P#N>0D4Z*6O7!.=FDQ!
M!H$B:+4J5&YBI@*%IWGC"OVO0N)#O928DZ@?%6C`J`<6,-]/]6K]O!J/#B8.
M1,Y.<BSP6T"92E,L[)Z-[W74\];<:Y$XSX"I%5AA>&<Q!N=@17T&+]7CP'-.
M?+1UK:&4%V#VGUKM\_8*5`8$9.T9<*<BC>.O335MV:J`-@%N'L`+`=H'U#`H
MBA,"F&(/G`E5#"^.^Q=E4!9<@-32]E:3:.9A`/^96IJ-RB5%%)C?HLH)H;?!
MDU'\%V*!S@(Y]L>E8&SFE"Y`(,G8$PW,L_87`9*XU/!Z/IEZ2%-7`WNK:%&\
M%E$SI+<)Q`2U-CKSB3M1+!-H;&#1NXT]3BA;>"1>`HVZRXH6M2^@4W,S75$@
M[*!?@/;!Y;7,B>E3-5L!_X.@XS*!\`9%`Z$?.I;EO,!X%_1/*[S%FOX>.ALS
MT%7.R-4FW`:15Y-V2<+!;/`O=1A$&SCLYD^P5ZYO@[];4:8@@]C^!&"",=$:
M@:LS,.U0#YN\=0M.9I`!&`PN2N(/.G6D@9K@2>/OS*L1V/S9!#?`!7D`(PJ<
MJ'/NA$>GP0`0@D'`U*!3?Z[\,38!'''9='9FG-"5\@CY*UZ=L>L$HW'"!$Z(
M9K-U=ZD%1`K;:,"\P*4`4VD5EGH8=IN(Y$T+8P1T!]$(3YG@XMHC38;41EA6
MA<J7GW#0P.J#)T%;42)Q3=;*W0Y!/@MY@PQ!_GS&&"#"8&;0QD;+!H;'"5P=
M502@@2J-,IE+J(N"UGD>)Y%F$2H4;@>4GD]M%GP,F3_)$BYA`;,W-J>P"G'J
M@FHRX/2(3`QF&-O`&ZOP71@T201/B*D^4KZ)7V?T"RE<X9+Q[*#0H@=D@JH#
M^\NT*&_7`@Z198ZXWF+^^#.QZ5WH%',\8^^:NI\"@W6@G5&/BNH]HE!_*>3U
MCW0L0:!0(^!C(W0E8O+@K`@F3`-..JZF2Z\JI78O9'?*',K+V-3'\*`1Z"0%
M#0$^!L=1![;PT:E`UG.="0HN-M'S()`U,!B(O;/EZO<7B#+QKSC0G8M54TG`
MF+KQ(P^.A:;%ZX/N_&PY<;.Q&G8U+FY\6_N@/'W_]NWR\9\8X#[UOM[UOO2N
M+N_ZRN75U?WWNW[O[JOR<'_;N^K=/.TVU(4O3?Q`R8\JZ(&YC91SZ!QF2:)L
M]&Y`WS&6I4X%L#XPB$$]#2["P+<07OA<AT.08!$N>8)SP6U7J(Y0SM"$OH!2
ML&9GS@OZ(EXP\,"*:NX,]`VH*Q-U5!B0#S0+-1L3=S].[WG@GF),14!A$K2<
M-H4--6P$ZYRGQJ6?AD%H83TR8M$/$U?3H\!&)I#:.B%&`M8-,)I@GL;"?(`-
M2LD2HR'F8[$@:4Q`88Q!J[ED)UY5R(3?/6J2;[A_Z)6._Z9X%X$;$96ZU2NY
MD"T_4'N"^IYZ0%J<L0/7`]Z8XET6(W89.L2NS*XSUL%)OMO4"7OR*:/`S)>P
MPJ`LE=/OYT_G,8Q?+R\?/H1>-MH%&P+12>B;HW<9^N:,=P-T+,%03Z:,?9G[
M03LIT7D!77`$,"":T%;U.+7&6K<RZQ3W;P^]#</T(,8&V\^]+XHE#887O,=F
M,D+,\M$TG"T+0!?$@WID^!`)[^0V8E><O42)3]/%(.$@/S0\01N*;F9@&33S
M!3:/VD%_['@"\78J)=B:B&4&\(/0MJITXB(XR:!,P=]"QU09FZ,Q\#B+4]"]
MBN[YFO(M:(-+";`L:]I-V0/7MBN$\(8VHRZ.A6I18"-\+AP)^7Y`YJ+><T9;
M,0ZF,$*PR>61BB%Z[*"29SQ`IM&JQ[,ZX#;&0<1.^2'NL:W$NQZEY06VWAZU
MN.15IU$=KD5D4T'E9><CXFS@)+!-ND;*P('%B)^I**@/E1&F,&V6(!_A%ESB
M$5P_Y,$S"$D-5#;NU*'^-PZ63&HKN@5J"_Q2PE@7&,*D<5%FO@0PX>E<KNMX
MPCZASCB>BC<F^,B`Z!IJ87AN1L.I*/HX`XMQY@%WLL1R%/;1*`G-/)\K=FS.
ME6_9@,&P5'?2_.%0,UWEF6X]LXSPF,`70;35IHPTDT<RF`2+4_@&"U#0"0*A
M8!EL+=X"Y*&&+F[CX:MX"?TICO1!<&DT@(]:4I(<3PS._L:CNXJ"IA+4?P#O
MS@&'R(6@GRL]``DWZVAVGAM/`6'3BW11"/`9V#S[#.P*,H$+D]'-;QI<1R0G
MV"8.%HUE;`12T2PA>FCH`_*$-+47*VD1QJ4)WA`,'-!"7-C'A8N#^!L$`SS3
MCO>(O"G1,9Q2$'"?!E;4:9D0L&0&XRB7Q"N+VPN1(A9V?QC,%<4F*P*^36V>
M`^2U_=BUN@)2FK[R:'I_,7"&BA`B*E<!;I50BP(_/@73*6XME$LK?HD<&UA2
MWPW8PE,7+(K"P0A!)/(ODDP?(//H(L4HO^B,9"Z2#*P8*"D(<R.[1O?VLC+`
ME47J#'F$7U&$.U7\XK-TQCS6YFLGF('IJ!T5T:?!&.],",I18U%-"(:&N<E_
M@<T?)FAG^@%O$VF'-@4UM8U>J,%2F"F]#M]@S@:`$*DVF+&'0T=1$`E_-B4<
M%>Z2T'Q?A`M;-HRMW><HV8JD!61PNRS.RE+S@V&B1JU0","_P0&%G^>WT#`1
M.X85=-#A1X9`E]8U41\9X<M<%U#5@TN1L6ZARPPQ,>9OPY$!/_C5!&MDT-U%
M3.=2^X31H>$$`W\86-%X9<BY/S+WGQ'CJZ6]XF8AWRP#))OMGRM*M_4SI4>W
M\W-B_\5;N0%#_UNC+V.U::B;?+J+'"X;CT`J&%"`(L8\I#4K`^U$WG-Q!XGZ
M,!C$N9KNIW(-CCO2;)YB\)33JV_W'UB8&3Y$6#$`IE)\RE/4<\:O>%J1TI[N
M7H`HGO%]X7`G&/=@^>9=HG9@<74`L/0+[K%J++<Q#"@,<3H$(*%V(J4+^'YR
MB"W@P=ZG3],@P-5>4.Y!ZN#9Q#2X]89IXZFF_Z6-Z$>45$0$X<2$]91OAXB(
M1YLR:61?:.2)N7$#7%B/8"Z`AN/H.<[0;1*,(-63;C`-T_C4\,=`YR+:3JWZ
M%_2\6)7C-Z*A-IZ4.HY%I:D3E]4_9*<S6`8%V&["$$Z[W*%/FI'42'(E[B5Y
M3)Y>32SI8+XGRZ`Y`[0S5*V;]C0`.$YYB`J.I,9+-$)?--RL`7X@4]1O0#&>
MU(BF8T4W.!LP9'JVP,Z8+[6;(221M($#'#=V7L*P&7?T:+Q&JU`HAX-_HI,%
M-/P`80*Q.0%#4RR0D`=AV2^'DK4HVX0*(8SI#+;G1+<U,?'D$J)8F%N-$E'1
M]J8X_Q@\3<W5QS/4``894DJ#<,ZGXBZ6\G=@Q9\M,V1VL,7^&?U\`0;:)EO8
ME]BR1-PBB81JF0OE?HX]:*P&Y/EWX*#JHLM-W3.Z[4PX9S`]RT(4U()AV.PF
M5_0R]1JK#N`B*#X]8Z$E?PIF8_%F(D,?FON,EQT(9ET6%`M5#4-,I](D`C+3
MLV.!IXJ2,F7=PRENM/22IGAY`(-U6O#?D8._#'#OI0SF/[6RM:R5Y1N*$#0K
M:4;@RUQ9:_4]4#>6YF:O/25Y<I0<'!.GD`1]C,XNF[Z$*U&_4+YG*.$H53&G
MC"$$"HL,.;,G<_R+-3/J?*P:Y%R=+2J+2$@_6;%I%U7<AKY$>"4>98GH/KQ2
MN1()%$A\D:`G9.=TQPOK!B%F`0^!9M:>"5-:<645+!,&9I;Y'&^;T#()FJ:C
M0A%XX0)BX0"$FKQHE>6`SI5;5D'@N#,!&!;/#-$Z#P/7-JD+G82799Q2T`U1
MKED(Q?<@@4/A^P2:&3BAS:6O8?)2C"X2+VKLWOOP-2QNMFD&#?[A;]]B23)F
M#A5S@JHYW"A"\)-O4XJ,<=O(#2F70=<A":N)P`J?T;I**RJT25,<Z]2(6*_*
M`BB;O&#`$.D@K+5U;!AEQLIC"(T=J=E!G,^5!1S"BB\PD^.[@<[<?4_T8S0O
M]:O-2J[HS@AF5%*T=T6:V#3(\(EH%^$%6@M%,X,>._1SKM"[UPW*$TP1T_0&
M%KOPX(Y>U>YR-VN,Q:S4J>2;<.C7(0EXXM-C:<Y$1",N'3/>Y!4F,'AUV3`J
M/*,DL6@=`(.83LG2+BP5_'T*A'")S^L-:0&-9O$<+A6S>#/3,+VIX['EB+<6
MN30)*>Z(B$ADG%'8Y:?Y,CLLQ$'`,%=+U2;/$O-RA'A;-U;9N=+`D63%.64<
MN@SVK#]WSH`N/\MC,KY%CLUB?A:T1)LIMN8'<?TA&R9<,I9!8-O.D3"<`YEI
MBC(L[N7$A^EH7I56G]+(G56Y5Y*BQ!*2,++%:M"4*>XK>FE^0Q%$:RH")EA?
MXJ>B.]^9>O'[7%%[(4(T`$I((T^B\)PP,H%%_%#H-%ZL;E(T?9;#`DUVKGRA
M0BKJU6PJ)VM1:48D1LY+8`1!$*UCB4#F,A0ZUH)DSLV,J=G4!AO'A,\1SAGM
M`X2ST3345DG#N$)<PO"HBHG7QR-5P,&D97:L5!F1P.(>&T(^G^\C&J!==)]R
M#`B]QK8:J;;<[9[PY[`<Z$JHB"V5,Y1,->J.:W@9@7ZX188[=HP+Q*TV//O!
M+DP6"B?#G358C1&M'A92`>%N&'>BYQYA@QGS:0/TGV-7>Q`6T[&]TQCDN3H$
M.B(KM$TE':F/3K)P9L"(WL0\I&&$9=IG7*S0[A!,2W#O,3XC=MI[>*1TQ_]=
M?ZAPQU##0S4F\5F9`_4)Q3UVGC'G8$T<@U@@NC<:G9=+WH(<5Y1<`D43YK\I
M8AEA!Z,*WY:DIR/07^#N6(HXE.0)9$)RX#8EW\7W$@Z%&/BX9*2Y1N@3"X50
M&6#Q8(B63%$CC@X80H:`T%I=GGY(.'T9`Z5R8TD88.D&4?)A&*HN_#6))3=5
M7KB!SH#C95X\V\<*LT?HJ*!''Q[)XFX:@A66Y3/=Z7!?,'E>[^,B)&)R)5'P
MT?\9B7X3.GO4R1%,/%?)V5CEF!-/W?%L/FXO#BWGA>]VQ?7*X9X".GF\>IJB
MBH2`:!87#6O3<!]+88Q"TTC9/!EGC`07@U9R!Z$YX]_'E`RK*<1\$W,2F?MK
M,(%E7D@9G+8>W?JQ"<,D0D_0:72G/G"UKV"3K[@$XM>G)_Q;/-QJ*_>Z[^`)
MB%JUVDUY&ERQ\L=AT7]2:^?-&(;PP!6,TO@9P0GOQ$6S[R`?<L=\`)XBZ)XO
M9.`&FCL3TE+-"MNJ"X_@QD,\B4/@-:LG'\X5P#H<A+Z7!'B*U_`AC)UY&.F.
M#Q#`8S&99;'"X\!']\00BCWI`40:6;@!$?:[PY`C.K.P!-2=NA>]V.!<4@U;
M*M<BTT1$MIV>^,PZ402_F-R)9,$Z.B5SQDTHB\`-%E0A;&MEB*^3,\S(&/,6
M.[TO@3M$O#8@*X6WK&2,54,1DR=BXTA&\+SAZPFK=F*JUU#$M#<M.\-:)(BW
M-20*+YP*!Q)?Y/&RYKHS=A!7\,Q"?DUCFY&R88]/N*&*\RUB3,_>'9"120.R
M*%"C1;I".E]`680TA01#T8MP1`H@7`,\(VV_';$7U_0Q[V0X+S0'A9%%FC]L
M/BOUOU@BA):)@3MA+T-+>(MFA4H1VX/"_!\(]+B^3)W7U0R'%K)K]*3?_!:9
M6`I/U23X%IP@VH1%:Z,`Y(!FF'#W7@^+("%J#VB#@XAD/N$II9SBF#&#8;`Z
M&&?*#YBQLAQV#$W(J]/J&%YU1T_GC0D51USY59,C)\2"]P!<X#*-#]^'D%1X
M\P=:$T"H-N+J"W>>B(M;3:P;0!816,8Q+ML$+K?TP$J<6YB/LW@>C78QH+.[
MIA<^GU$WRDJ^1.FA`I@A5%B211"0Y+R5E)S@T>90Z2Y:'XMZ?EK4&H,:6%8`
M(1)FP;)5HEB2;LLY@$74"`'Q9F<BG\6"SY3#'GF;HJ0.>;'8BG5'\E22>S8)
M,('=9A!7A@E*AF!4VLG3R"8+O+"$RS+_POH0NA6'NUO1.<ODTK)0,=PM96OA
M9:Q><MZH$&6*T_O<*\&B0YHBB>9:S>TOO-(LTL/(/5@A0%<)J,GQS\^CYPIM
M&/1B>IE`AUS`"9QWAC!@$%@_<GG3?"Y$\AC@&9P%Z:"F1U5=I,P@L&(U?*SF
M+ZPCPD.V:*;0[T"MQ;*\['0M/822J'(,3^N6PAYDNE\NH:J)^TRB^-B"(F.9
M%>&L#M#3Q2U@#;=KZ`'OL(V(.11'X1TO'+[YP+,7Y^"^)M*R"_0E_S4;<FI2
M_B>PQ)@BJS7%8#;%5PQ!*2TV(%3=,$9=4T.G\Z>AEH]$,A,+:D1$,2P%)RW.
MT"WVXOG1(::4F'^YRIV?=U5'N%?!V]:$1Z-IDG?")=VE?)O:6>5Y03X(S)&Y
MK[C3R.VKXQAXOKY4`1LR-#MMAT87K([_0GB6/SK(Q2O&[+07(1Y)7)6^71+Z
MT?,]CAZ&WR-.QG,E)"@^$F;_]JS#TB6(2:>'*96$GF'=A6CN+?(?Z%PKG(<0
M:V6"/(W6/S+:2-+0R67#V`33SNCU"YX71??%.</F)?%P:74;.;-L8WL^*DCH
M;5KLMU1O1Q-Q%W8/&CN!:`JLE1HZ!6_:0]IM:B?AN-YBVYA;ZKB5,-$CDCF4
M38\'\-B%PQ62ZU&3'.:FSF^R+-H8Y2=24H:(;D/JIJL'$U;<[H7B&S9QL16L
M4F$<'-,<6W503Y!5?6"D<\U%-#+^*>!-H=`+1PTW1VAE;IC21ITTER&/2Q&B
M+1E>TIN,]^A93`0698S50O`MJQ[3P@P3BA<-)X0YPMJZ*.W/3MPFVT)QC)*^
M-#NRG8"&!S^"S\BS+6=AMB5M5X7=H9V*37BJ1.AY6UI1<1D._Z&;.0PMRL[\
MA*N?*'S680$P8.%%[?X%W=4+-$^,D]G^#SSB@IBP<AO:+8@VV$&!<YGE"IF>
M%N/P?7*A9X:+X3[\_)%5<Q#+(B[$5\ST\Z3X()@1FL@;FJ]LH-#$86+H(Z^1
ML;#01A"@^<JK,OB_:<-/&R6%9>M,+['58I*/ND7HI33?4#3<(DMT$`57-RRX
M0L\YNQE75-VQ<)>9,4[4KE`\[<*S;:P)42CN\;1"^S&LM7,)'F]F9P5Q)Y=W
M-8D[(0T)UACC0_0O`"P$JC+7&S51@5(!O\8"U8$%_[QY$]_8BSLFV;2&*[&7
MJ&"^Z#D\39%LO12F]2>H9[&Q)K$(+Y*,1($7(6)ZYS],/\9.6>A2T9H!)BF(
MN1<V!PM/25-&%QZ>P8ST@.3\7@2>$;)'%J&]A_D9;9YAI?I<2+CR1?426Y9>
MNA:(N<6QKN""B-4#3N"%&">KD4V7-^UZ%GUUQ@<IWST:E[4_H8"%5.14B$8.
MS[RC:N#[:3K='AY2N1C,$J#3PAU6KXY\S!MZ\B&BSE:<L>-TS@`]2]'*:LGY
MQ,-E,8>'!B(11K!TL`E:$BUKB)7IQ2K8$%0OA32DAAL;FCD=S!<.K#$?LB3*
MC-:WB>HE/FB>T@=XY!"K)^<%-J(T+P"(GF#-[_RPCX)PSC\J$'O&G+-+1.H'
M6"4*/@W&,N%)U\D4#\2*N=UXDMA=2Z3]!4#%BC1ZZI^VC_.4?P7&*-W6EJ=E
MD\7Z,2?R=WEP"+"-3;"X/*J,84H$9U2Y)CRKL$\=VRN#C]B8S\_HC,>C&_1F
M:2H?W;I%9!1GIXT$PJU3(VS,RRHF(D)G[`(*\PE-],K`RP^A]6#GJYFPLZX<
M_'A@;"?C/ILIUM-BE;ID2W#10%$H&JL>;I_885W&%2.7'NU(:AR>0H@<L,1P
MT;JYO.,':P9)TQ^T_#O>O0BG(JS1*WT37"XKKF`0&K',J=GP;=2,W,TX5^8)
MBWQO/`O-,=UX>Y82G>EA@978^81L+M12+F^"PF%!4HJ^9>!'[J\P1R8Z@!XV
M?Z!>UW2.M)1?F%]%HG*H*;N"@NX<4>^'UA?BEE&R(21=#'#UK/"PJ-`'G@UI
M)-O-ASU'TJ8OJ;`H#]$$&CN"C0TK.5*QR^8*C;^26HRI29TI.#JC4/[%-TT-
M_A!P..67:)<G.LW!X(]MTHXC2\&COA;\UQO>NJQ4<>;CHOB`ELNEBEI!-_!2
MJ*C%0"2,_/F%]7/*PIFBEF]AZQ.T-^Q,?'3>WJ=;<'R.5%L#X;%PLPY<8N?5
MU%DSX]AIX:?V*S0DQDJY:$CQH$@E8BB,7)2P[36?"\O#\!AIB'@9U,U5DHP1
MP<,H+OHB71T9$39:YG03B<?[#RQ*0-^''4&D>@=^X"HAM%IALH`&"98VBJZ\
MX.W!E3\(K[#CQHKEB^??-^?+'&$VT=Y&\8<3N(G(`*]$$KHL5G!N$SNUA/6A
M+'T8EB0)_1CIKQ3&J$4,J]ZE7:-H@S-A.POGI13`K0DM&!&NKWA2@X2=047X
MT%6-]E2\:%.%6UQ]P1+2Y&>475OT5.0?T-P-:Q6.1_;#O>U0UVOTAJ-POV2A
MDS,+Z]'^LIV7W;:D>-"P@H,=_BB58N6`\ZKCA5KQBON?T_3C+C$G@\#UYL)D
MFF#+R`LE<BYA'@@/X\_$L3+FB5W'U>-&)C;NVCEW-BZS5\8N>83>NG3VF0J]
M>`M:J?@EG?#%\S6TN]X9TV:Z@%AT0).Z@):5>%![T?#="?9*Q!,0_,Y(3SC_
MA'N-B;JFS/Q\&(]F#"YN'F#+K?`8#0U?V&$:?HPUU"@TV(^V("MLDX%U>^8:
M#G`9$G96]3RQC'FP78)H,I9:?L@ZCGK#4\.('6_G+H;;Q\Q0_.H%?@*&+BE;
M:3Q8'5,YP4#SM2_)4:)&DBXYBTXA1<0.B4R)'F^"H5JDQ@>OTXGO0J2=W%8@
MLMLV2>R^0"6\,%`1[@@LE<[!:VZ6-1)-[4<..=YZB+<?XSW7GG)E1TTP34LO
MK&'AU8*?:Y6\K4PY3/1JJWET$ZF)9>CAU4*UC)N%:(I^[MC)W[QHM+@Q/>U%
M`ZXC;?/(^@N&[>:C\VK".8(%XPG'R^FN48[+['9[\H12N:^]EBSP%=5C$![L
MC+?8XRY#W#+0LZOL-!ISCBG>/N(M1LEA,4.X%4#;_X?'7[57\7!KXGNQ_"EJ
M>62S$VY"L0`^BCS"6AS1\ZOQU:-TJRHCA,APR*+^Z[Q`B^[_1&<_<1;6!$GY
M!ZN"LF;)72;P_DSRPLJ2L_!CNWRTB``O9%!8L0?5$U''2M-+=+.,DDO95V*M
MJH5:!`FMV^&7(\5]AZ_&N-M'G=<,T,+<&8M\6+D4?DKKN*2$XJ2TR90G]/?C
M;V*2@DY95L\AL,-,.463%YQ$WG]FTW_:J21'&1NM<\D<7[BUS.-'K^@&$'G5
MH@(<'AW!:S1`"4!:W;BUW!PBT>$]5A]F\XUDP0XL0366^KTX&E<)@X8WSI9*
MQ2;!#[NJ4"MM\N8M:)+I#YJP%Z/'PIG57SS>5R"O7!:IN(9CS=T1R.S_<N]%
M<"_I11M+O")G<</[3$<DAFF3KC'QY3BT=6W&`QLUQBV#7MK5P;7H_A5Q/-HN
MFA5SX"XINR6%5%@9.:CYR%A20\G/M5#&I5VM-9H2%SKEK^XPSPHPT(>@!7B\
M6Y2>S:!1602W+SF\;88?4B<ZG\6TGL?:(\;W3%'-S4O[PK,RBX[%8*TD.Q:3
MM(;1L9@$;^_OD$RH0S'&0<VI/`"!GL:@-DJE0]G5YI&:G+)5IC<DCC5V@Q^+
M@JE=Q"5X(9C5(,:9ANEU8,?X.D/Q32]QT%VH?F<<5>'*E9]PHC?B4:6%43U5
MP%C@1K/(>'LC9BG9'<[((S,`]YD>'L*<MA7@F_M'09E:@2=>SC@WK-BV/[J`
M<)T9(I^5'P[#<P1\'*;Q<\S`B2GFY=,^YF+:"<>0$G>3A`"Q$W9QQ2:&%&<1
M(#3E[_'B46]Y]UOAFKZ'^Z=>OW=_=Q'5C'U4'BZOKWMW7\\^W_?[]]\N%+R]
M+_KR]N9+GW_U1^^Z_]N%TJ[^'/_\V/OZ6_C[M\O'K[T[_H;:%)[JWS^P9[9R
M\=__.SM3KNZ_?;N\N_X$$_S9O_Q\>T.!JYRHU>K/)\K9V4H5@8-\]XA[QJ_O
M@!7K7W[]>G.MT.'X$#']P*,8V9].=%KT*:#!/(D!S0)\.JF>L`NB0:\"NT5_
M3Y&3^=\OIN&//W%`.0GP;L4S.L.%1881F?@,;O@8'^:B^C%!"P;PU?WM]V]W
M;)&>E*>;?@(%WUA&[A`[G#P:^A??R/U^B%1MD[?;$1PN"OLF0S6;$HWC16,9
MX]_<78OB[[O"=%F"1+O>(98#Q_>=B2C9X[5%9IE+D59&`U?Y)09SG'?>C*G4
M55,M&/[S_>/US6.D]O^K2O]/4:<P,(8Z'Y5,Q'4']1N@WCG)T(K9L%G\NM9_
MXL7K-XO#&PKM(%MY[X5&AV6:E5"6GVEJZS,-!HP'9XQBT*$FZ4#IH!Z<#FLJ
M"M^9GBB#$9:U@9OX7U=7-S=?OHAZ8[DI7*AO(B^Z?_-__;/>W?7-'3C?9RIU
MR#.&2CGID4^>:;V>Q'W@!=[TND8]`Y-U+6=YILOVH.8F;U;:[6JEV6B4&-6B
M4K;>Z%8Z:K7$J!:3LHU*H]FM5.M%X=F-]/'+V/1)T;7Q8RJ5)Q7RSIB[50$?
MIL1H2JI*JA96"3-%^-3[_VY`Y9TW4><M<I.']/\R%?-M[^[F[+<;(?V\#F[I
M%/+C_1]/OUU>WUS=W]X_5D[^ZPO]/S&1G'[CZ_=^_^;QZV/ONG*"5:AG8[I#
M<4%U>/A>DF#92[(!(GF&7QV?O0V`K`A.X%2)N<1\#YAO%H7G5B_GZKH*)M?&
MU1:U#H4P>^.+TJU3J];SK\N:^)9\AD6L7%Z,),V*.$-Q:+:9VBQ>\C)I&F08
MO,6\9$OF)7>3EVPV95YR-WG)5K-L>4D9$LOP2&(N,9<AL0R)"S%#<4*5\LP@
M:59FFNU+;;:;A=>;[>96%>>:&)=^BBWQ=*%PDF0KZA0%(IL,=66H*P,^B?DA
M0EWV$<_B17\9YG,,`PHPL6G?@F#EJ;_YUS?N.XO%[<IE?(S]P75L![M5T&/A
M=,*R'&O^0N^W,2>LJSG\6Z$'TX4S^M,$<JSU"C]HS!I^?(G.D0LD>>(G^SWE
MLX,'_$^_7#Y]_D"O?^,=8/G)?X_X/KM4%#O"QBTEPC8"J:L)M+@;7K3H[(@M
MGJ/%A@[GRG?;HFT]?7[7)6T:$.!]5:E;K!)];?"7\`P]O4H(T,6V*0Q7+\(G
M@C`\8!U/'[6XR7LV?_X(OL)NY<@XL4\/98==`):?U`_9_>^_!-[92-.F%T\@
M@K2'@>W'B_0`"D0'HO?)J__9<O2_?OWQ!T7Y>_A.HFL(:R]UY_@D>EHQC4\G
M?6U44_%@+(`"/SR2X:>3:SSC<_(K0B(<5D9@SY"5+]3J.:H+^L50FYC6[**/
M;*_<`><].A/-WL[1X@%^.*U_0&/_\'CSV\W=4^_W&^7V_NF)4FE0$AGM1QTM
MO+!-=XY^:[R9Q6`FM+\0.Y.L;$Q"F=P+)A/-I?U70%R<EW/ESHEZ5O$+EL,.
M&0A/$-Z<D@=$X1S_#GJE;/>@?"??0?FJ/"@O#\JO]?86CV9W6T>!1KM^%&C4
MN]M%8QGCRX/R67OV13GC^CUN8O95,VV1#C_^<'I+[;23^OI;U-DL^?U3U.:L
M0MO1H#>LO2[S9]X+E7DWX"2YHM;`/9],/$DF_V,?V]8=G!"'55,E:,VP?-W?
MT*WCE%Y)ZP0>>,_>AR4,L'_<W\8,;R]BS7#'=W'&\[-FL7NUEK37KBUPU]?T
M&MYBBM=Q2O*5Z_VTASG49FN36=X/H6J59J<K296/5.U&\T"DVE3WK7?:?4^:
M[WYU6HI@&^"Y]JI;:DRR8]8MAF2<MC<JBUXX[H<C($U=4F81T[3W2YHC]>TN
M>0H\D?VFW<\7Y[NE;LO-IF%-BEHK,C*25H49OC2TRJ4/E]55S6O(C4NK0KA*
M5TJ5>[BME='LJVQ&8G9$F&WL`VWA(,]BE;5;P=_7P9TRC+CK`Q)E&%'2X)`T
MV%03%3+;A#?+\&MXSE9>PR.#,)E@D@FF73)-$1-,,J"2SKG$[&@PDP&5#*AD
M,"%I<'@:;*R)BKF]E:=T*<,%+F`H5:`RDTY&L9>D4W;EDBSRRDFJ5JMS(%+)
MP$LZ\1*S]X69#+QDX"6##DF#P]-@CYIH<3NE@ZFBO75U*\>0.^^;58XA)1D.
M3089$TG_6F+VOC`39)Y]W%GCLOF^3JMZ-"4[.GW13/=WS0K(M>GIEN,%KM#\
M*6[GI!:YG5/C@_+ELO>H_'YY^_U&^79S^?3]\>;;S5V_?#V=AHYE.2^T`Q*R
MC(>]T+!%DS]>V"9,\^`9>#`8_(OH/O9L&\*:HO4(B#(A&BXI[=-VL90&LC72
M/$UD:Z0,%^IH6B-U.D>!1E.5:!0'C?J6^VTMDU_9X2EK(ZHH374NL5NGB/V/
M/ZS8-U_@J+P7@MV29V+%D*J2)G,TJ4F:S-'D\+)S6.U;^L95&%R^W\Y5A;][
M-<O6?W-L,E,FM!^A,@Q@#6@#7EWSQ@KY=V`"5%';\XVKP<IQ+^5FI3UOFU-M
M="K-QD8=G>0=H[MK"5`.9"7CEF"ZTC+N1M9PO:.EA[*%45=>Q8L:\4K+MV,%
M4J]7FAVU($Q>@NE*JT`DXQ:,N,5<R^(Q;B[+)V_+VQ8B>RTP*/S-:1)SB?G[
MP7RC(&,;YP\*<[7SGLXCR*O*RX"1I%D19Y`T*S/--C,UQ=O=29I3F:3:YIRU
M3JVBUJL%B4=+,%UI8WW)N`4C;C'7LGB,*Y-4,DDE$Q82<XFY3%+))%7Q9RA.
M(%R>&23-),W>%\WV96J6]%LHBJW96U>4K?%;H:;8>=\,2;:RX"3)5M0I"D0V
MF4^2^2296Y"82\SWF4]B'W?68VB#_CSBZ<NDXYW<<V83R1XT_AQ-9`^:56>A
MR]PNY$AZT#2:$HWBH"%[T!2R"T+!>]#(WB(CV8-&]J"1/6C>H'UE#QK9@T;V
MH%FY-L=8*ZIV*JW.1O=-2=H>+6V+N93%*\,MP72EI>U&ME!VH"D#TQU"-S>[
ME6JK61`>+\%TI=4?DF^+1=MB+F7Q^#:7W9.E&-M"1&Y.2\PEYN\3\XU"#'FT
MIPS%_;N?H3C'!\HS@Z29I-G[HMEFIJ9X.SNR_\SNYFRW*^UFO2#AZ)'1MO1;
M,P6FK4Q1R1253%')H%UB+C&7F,L4E4Q1%62&XH3!Y9E!TDS2['W1;%^F1G:?
MV0&_%6J*`C6V*-,4DFR2;.^2;#*?)/-),K<@,9>8[S.?Q#X6K?M,#/16/O7'
MQ"7*6'LFRH`06[$=Q7<UVQL2%\_8*YKG$1\^N8IE:@/3HF<PX%'_!9_VQT09
M:J:+Y`V(,B&:%[AD0@!HW8)7@1RZYIN.[9TK,)-RY4Q@M6=_\Y2A:6NV;FJ6
M8MJ>[P;XC@?L8'NFYRL3S;2M&<Y/CSUFG7^L\".2J>,A%<4;.ZY_YA-WHFBZ
M[@0XKDMT`B_BHSA6]/U4F^&7">`8+IYBPN^94RB!#W3X#UA=@-T@4^`!1'CJ
MFMAS!AYTGTT='GL9F_H8".I.-`N0,8AK/D?CS.CS\-30=284/MN'AUPR!>B!
MA6`1#/P5"&_B\$!'"U?!,R>FI;D)C"?:7SBQ9OPK\'Q&R('FP2".#<^/;+H*
M`*$S0-@H-G2--9TOS:6O$`U@'6@6+`K`.";$5PS-)Q7Q)7XFU;2G`:7-##[J
M5F`0!BW\-41D<="*,G"=OXB+(!L$5LQ5_ATX/D([,`WXKS-D'.8J&JSZ9`#L
M@._AD@-3>01GUT"Y!"X0Z5QY6G]1%0T8VR5#B^A(4)-Q*SY%EQDIANR&ZDO#
M!V*.]'SX@M%1`T9V/+_"%U.;3EWGU00<<6UBQC?@?[Y#)Q#8#U`":8A1$CC]
M?'[K4.B-%"J*O_\2>&<C39M>?(&Y?L>IKDU/MQR4,J]/7OW/EJ/_]>N//RC*
MW\-'>_8SX6S0LZ_)P+^TC?@DU0U(D#][BK@'?KPBK@_RUH<U!*)<4H&/IXEF
M`3[\=-+71C6UAGK;QIY)CV3XZ>2Z5E7K)[\BX$*C*\3M##77A5H]1[U,OQAJ
MP+ZSBSYJ.>6.O"B/SD2SM].6:H`?3IL?L";G?V^8\GVZN?K^V.OW;IXH70?S
M^8H4Z8NAE2\5+YB`N%$5F*V$3`]9[<4&76PY+Q=+D9+]Q^9I(ON/K>J#4>96
M44U5HB'1*#@:R^17]A_+JJXJ2INDRPDX>?"#(5+@QQ^NP%5<YF>\%_)\=1W/
M2Y+FN^U"&#!/LJ_@>7J29FO1[!:>)))H\`'#HB1M:)!T<-(<5F?+KF6E[EH6
MYD;??+PE(\;:17N6B/0+6V\N;1_XEC,Q;W%0BC/\6O7L!<=%DJHHPTM2'1VI
M-C48ZW7WVI:YJ!VLFU=Q5_*8N+(`PTM225*]7U*5-8ZH+S<,W\^?SI61\TQ<
MFU8.X&;N)+!-W9SBGO<`L&$U!-)8E(=7"S"\))4DU?LE53ECB,:J&,*'P($6
M7BF.3909T6B)D46\<EB'O72GR-F-HEEIUM7R2]H^:%5K2SKEF>.TL1,Z?3@2
M\J#(-7=#HN.-'O*:!&WH8[UI:!7\L>L$HS'^2]A7WK:K]#(_E<$*%4,AJ9U*
MK7XH:2C`\'F51JO`.!2#1$4T.\6@#,I8YU`,E,OB+#NV.&^#-CZY&,)5NI.*
MN8?;VEFM?9W-DIA)S$J`V<;^\Q::32U6QKM5:?MJ+E6&$7?=D*8,(TH:2!H<
ME@:;:N/#I+=7[(3V'5^SE./:#RU0^JU=K[0WZ[_\?FC5V:B_^ONAT^E&O=)W
MDWHH$'E`Y#J-JLP_R/Q#"2,^B9G$K#B8R?R#S#_(N%/20-*@"#386!L7LQ;[
MRG&GCJOY1#'(P)<'=4I9^EF`X26I)*G>+ZDV-0ZR]OK(LX;U3J7;EAG67'-T
M)9ER):)W0Z=C240?5.+*&BS(TNLB>15;E(9:M=)N%?GL3S'(I-8*C$,Q2'2Z
MF_WT(RB]IC*VF]UAN?4IMSXE9A*S]X+9QOZSW/J4VSV2!I(&D@8%V/HL<.FU
M7NKMSP*EVYK=2KO09[L+1*M:D1,Q!:+3J5K`8]X%H@_*7.-0O"03#C+$DYA)
MS(X#,YEPD`D'&6A*&D@:%($&&VOC`Y5/K+@0@:4<,F]WE>F&-3?JZ_5*HRLK
MQ?(1JRH3,_D2#K7=U'\<2\(!I:[9D1D'F7$H8XPG,9.8%0<SF7&0&0<9:4H:
M2!H4@09[U,;M9N'4<;NY57V\`L/"#[DE-I1DD&209-@"S#+PEZ&6Q$QB=AR8
M"=J,?<2MH.@OPWR.YT1506Q#<89*X!'WS)L2W1R:Q%#ZEU^_WES#/Y]O;T2_
M+?%ZM)FUMK,Y<)5?%OB"$3;3>"*8-9SJX?ZIU^_=WUTH+K$TWWPF'Y4'4'.]
MNZ_1XE&:A5^RG3/ZU1^]Z_YO%TJG^G/\\Z-`YL1>FRH^U;]_8,]D;>5M[&I3
M*E/@*B=JM?ISMJ><H@D.\GWEHL7TX[RH$]LGKFB8Z$[AP'$-`H:K"@Q,+.1@
M'<Q>]#<W@_3O%]/PQY\XH)P$/GGUS^@,%Q891F1:$NJ(M&``@T7[_NV.+=*3
M\G333Z"0;W\!)S^).3___D2(5&V3M]L+]CG>,%2C>Q1H-%6)1G'0:#2WB\8R
M^;VYNQ:UV-JI#^'Q\=J2O\[F7\(4^>.\\V9,I:[>9\P<?K7KD=?1$)1[-FR(
M+WZXG#BN#S\8(@5^_.'*\7P*Z"#;_+P7\GQU'=:"*B;-=]LE,,P<R;YJ)K\W
M0=(L+\UNX4DBB08?OFBFFZ3-[YH5D(.3YK`Z>R64A]?9RSE!5==GA=.>K?AC
M)_`TV_`^+.&`_2/_-FXX?+FDNKQ<,B+]-=')9$#<F!)UM:+4JKQ;SP)!+&`!
MY8Z'+TNWS`(,+TDE2?5^2;6IP3C,@?X5U?7?2EM7+[FR*,-+4DE2O5]2E36.
M6-'IY;BNUY2\6I3A):DDJ=XOJ<H90\@K+^B7>SDLV*PT6ZWR2]I>.H(=JFUT
MR>@4UH>JM2-0X?L2PNZA3G^7-9[8XBT89;`9Q9`&M5MI=]L%QJ,89"ITSXMB
MD.AT-PT*CN"&"I"Q3G<W]W?(]@WR%(?$3&+V7C#;V+>5[1ODD75)`TD#28,"
MM&\H\`T5^7<O8S.UNT]ER&<4*/U6;U;J+7GM<\Z[-XN<_2D0H8J8WR@0>4#F
M&IU#9<EDDD.&E1(SB=EQ8":3'#+)(8-;20-)@R+08&-M7,SR[*M27\%9C+"S
M%+A(4A5E>$FJHR/5IL9!EF,?>=90;5?J39F*SE>.+>F4+Q,M[V=>)7+MW=PH
M)8NO9?'U%CFU55&[1=9YQ:#2CJZC/R82G>Z&BXZ@]KI5J1WL&L9<MD#N2LI]
M((F9Q*SPF&WLV<I=2;D3(VD@:2!I4(!=R0*77NNEWIDL4"*L5J\T&[(52+[R
M55D%G2_3L!LZ'4ON&46N?2B1D_D&&>%)S"1FQX&9S#?(?(.,,R4-)`V*0(.-
MM?&!ZAI6W%[`,@Z3TMYA4*#0I]FI=*M%;I-6(%JIK2+7-!2(4*>[Z=!Z+.F&
M9K=2;<G.<C+=4,8`3V(F,2L.9C+=(-,-,LR4-)`T*`(-]JB-V\W"J>-V<ZOZ
M>`6&A1]R2VPHR2#)(,FP!9AEX"]#+8F9Q.PX,!.T&?N(^T#17X;Y',^)JH+8
MAN(,E<`C[IDW);HY-(FA]"^_?KVYAG\^W]Z(?EOB]6@GZZV)V*U\ZH])]H:7
M,B:6H0QFB@]/7#D36)69\D)<HHQA0133?B:>3YLACUS-(+0E,CP*O].';&?!
ML/Y8\Q-CZH[MF0:\`^\[RH`H#@YS!L_99SZ98/&O:UHSQ83'37Q*\Y#DUT0G
MDP%Q8U3J:D6I5=7Z^7R*>AJ3/5R$O_\2>&<C39M>]")4O)Y]30;^I6W$]YC?
M_#LP_=E3A`#\>$5<7S/M/N`-UNW2\XCO79N>;CE>X)(^>?4_6X[^UZ\__J`H
M?P]G>7"=*;PW>[`T&V?`<:<X:<:;BFE\.NEKHYI:1Y&P??CAD0P_G5PC?B>_
M(AZ`1LA`B.H9,LF%6CU'EJ=?#+4)D.VBCPREW)$7Y=&9:';F7NK:X<X`/YRV
M/B@/C_</-X_]?RI@+Y6;?WSO/7R[N>M7E+N;/B7V8#YF2:U',<0@7!W*QB1<
M&N!RW0J`N9%?AXYE.2_HSBS%1UB7A_NG7K]W?W>AN,32?/.9?%0>P*GHW7V-
M5"754.&7;).:?O5'[[K_VX72KOX<__PH*+7$MK;:%)[JWS^P9[:RTFE_B.HT
M"ESE1*U6?\Z.2U,TP4&^KU21,?VXYM=A"8@KNH%4F0P<%]3%IY,JR`:QT%[H
ML"K1W]SII'^_F(8__L0!Y21`83JC,UQ89!B1:4EB0:0%`QC\Q^_?[M@B/2E/
M-_T$"ODV\W#RD]C.Y-\,#)&J;?)V>\&FXAN&ZG0D&AEH+..8&]"6@MRLG=H2
M'A^OS6OK;.X.7.67&,QQWGDSIE)7[R-G#K_:M<SK2`KJ)!NVT+`M=BV6V;1W
M3YW:P:ES6&%:">7AA6DY,S379X;3G@W.D1-XX#=Y'Y8PP/YQ?QLS'+Y&45U>
MHWBK#?`XI./.E"B$6.!\K6G*WF(?REDH5:^T"GV%:Z%(=;CJQ$TE^#"GFE?(
M[S?-#H::SANHE4N$B\'VM8I:KQ88C:)0J=HL="UH^4SO_7!HZD3Y$KBV"?++
M<IY2@M]0\%ZI=XK<B:`H5*I)T[M5UYEH'AD[EJ'T)E/7>28TYR_E=HW>FY6&
M;%&:XQ+%2K<N6PYO57:O'-OSW4#'6U:Q$_V#ZXS<LG2@+P9;UII%[FI3#!JI
M:J%]9EE&)0M7WAUF&ULT>19'GC^0-'B7+29S-7Q(%/_(?,X;/$NUTCW8P?,"
M#)_7N>Q6F@?+7!]I7'@+,:!RJ>O!)+`TGQC*-9FZ1#<U&BBB0%].'-<W_T._
MD#*=O]>&"D+=W4T6XPAN$CE5:Y5Z;3<Z;R%Y9(PH(RF)F8P198Q8O/BH."/*
M&/'-'F92M130-RQ095BWTFT7>2^P0*1J5VI5N:\@?<8R>E;'BYGT&:7/*'W&
M0]-@CU(H>SL5?4C9S>?09)#NHG2J)&:R,TSUX]Q&FB9LI"GD=4ILC[#.%JQU
MRS2[A\:+YBD_J>?=>.2):5DP1D7YJ79>G?N:O@Z_U.9_&3HN;<4Q(YKK(87I
M?M^BP]KL4#(=#C[`ER[!A<`^'-9LW28QZ[1O239^^>HXQ@L@`"_U;%^S1R;P
MS<*F,7'KET:16[^T/RB]N_[EW=<>,O+ET]--_XGV@/EZ?W_]1^_VEE)Q,._5
MI`A=#%:/UT71Z,)4%)OX*+Z:L+,L\G^%LM6(+ZVBX6$@C[>(\?;9(*;9R-4@
MIGJ8!C'-LC2(:<H&,:FWFYWMM58I3(^71O,HT&BI1X'&D:S&D:`AF4JV<5IM
M^`_5J$BMRCY.2\C3V2)U9!^G8Y6F=5GDQH,W,?81L?[QAUMS2`[.(]N6H#=T
M0KMR/%_2P?\HE%\G&66N]/J=$^J.2'Z1<B/EIHQR(WV2-PQ_K&C%84E[?6X^
MGIZ9OC/=X(388EG9Z8DQ(=G/=F$6I>L9,?*G$#+0R01@2^6MZ0WW?*6HNYG\
MN*>3I)6D+=]TDK22M.6;3I)6DC8UW49.Z7I'RG;EDJYH0])[>*1DP/]=OR=O
MM&<;9&C:L$0%X;4=XKK90;.WS:FJE4YUHXXCDK;+$>[4U%I1%.61$5@RKZ1M
M&6DK%<-[8MZ-O-.BI$Q7^*>7DQ&QE<L)L8WM=<8K!W^KK7AZ>NR@(&Q7@NGR
M-Y5O%D::2S!=W@9E]4I'W:A]6VX\-VKG5@YJJM5*J],I,9X%):N4_9W(?JW2
MW:R1O93]A+O9[.R'FC(9BM5A+E'Z1!_;`/1H]JZ<354ZFSNF<*76W>CF,4G5
M+'O3W>RB,FEMXLGKF]T<)?E32OV^I+[3V$]$]`ZDOK$G4NZA7V0JP[EQ]Y]%
MN)6N&U`F(KL;?J==<MZ,R];Z`:6QW5=_((FYQ%QB+C&7F&^6B]I&]]S\;L]N
M_85]==-=O#*[FF'7?6'WCY&D61%GD#23-),T*^8,DF9EIMEF3EI!ZM-6'.EE
MU[C.'>R=3W$=[];A>TH\'Z+FM-:N-$N]AU!@VIXV*NWV?FB[U:V$`I.T5JN`
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M>=$\Q26ZXQJ`FFG#FMDVT7W3L947TQ\K/@RAZ?\.3,^D7P(]K@)7^TIL10/R
MN,32?.(IOD.?-,@SL9PI7N&(3XXL,AEH?C`))MI`>2:&XYOVN7+ILX?A37Q*
M'!['U'SEFNCP)G%C5.IJ1:E5U7HE>U!EK!F*[?C*#'!RB::/`1T_O.+'U#5+
M&1+-,P>F9?HS>-)5#!,0]N'%9\#0G@&'^L2U-=^$OX>!'[@$5_Y<^9HYG^DA
MM33%!8B=":RA40%$=&(1%]`")*93UP&^!#X(C!D^.X6A@2X>IZMK3F$1;#)B
M,PX`:,]7=,W6B0OD`2(XS\!WY'7J$L]31M.[;Y_/D_DX_&-:-)Z[G#BN;_Y'
MH\L)T!/;`WH"O=.LYU'>^TD]K\8O3TS+@O<J^+4Z]S7E#OBE._\+3H`\1>\T
M0L&%)5C&1/#?&AT./L"70.(I<CUP[^Q<0;$A'A".KB3G!2T++^#>>;36@J5!
M_]ND_VW1_[9#N#K(9(OIL\[7U2R:46IF_9*BQU*F"]7>WW\)O+.1IDTOPN,L
ME[81]\MC[?*N34^W'`_(V2>O_F?+T?_Z]<<?%.7OX;N7NNX$(",/V@Q5,_SI
M!L2X-34JMR;Q8-![H*TK?!4/"HK)!0F+QE9,X]-)7QO5U"8:(]N''Q[)\-/)
M-3+!R:\(/X`?B@VB>(:B<:%6S]'8T"^&&E!E=M%',5+NR(ORZ$PT^V-"QM(_
M)J+-Z/#/1E(*7P[PPVGG@W)Y=?7X'4S0S?\]W-P]W3S1=1C,Y^N+J1_8FH8B
MA&I4MP*#4)$9.I;EO&#(OA038=$>[I]Z_=[]W04S1<"Q'Y4'B)5[=U\CCX8Z
M#N&7[$@6_>J/WG7_MPNE7?TY_OE1\#62A[B:PE/]^P?VS%86-AWF4]>"`E<Y
M4:O5G[-W8U(TP4&^K_148OIQETD'@2&NF.U`P0M108DYHT]>6&3H?Z3'WRYO
M>U^!WO2+D(;-1GWZ"I[8`!T)]]-)%02.6.C^Z;":T=\\(4/_?C$-?_SI!-[D
MLR_.WLPOZ.O\@KYF+.+KW)*]?DR0G='FZO[V^[<[ALN3\G333U!K154Y)R22
M(QIZG:IT3@>UMLG;[055]&\8JM60:&2@L8QC;NZN11%=E8S<+CLO/K4*;N:Z
MC+O.68B!J_P2XSS..V_&5.KJ8Q>9PZ^.7#,1SXA+!368#5MH?S,=.9$:/_Z`
MSL4RDRQ))9*J=G!2'9',KD3Y\#*[G,V:Z[/9:<\&W]$)/(AGO`]+N&G_N!^2
MLTK99CT,#AZ=F6;Y,QJBWIHZC;6_$/*N^JT?I)-K4W9TWLF<ZM[ZCV_I\.I>
MM%(IVK.$.NE!F[F.95&==#.96LZ,$.4SL<G0/)*+((HIKO5*4RW*N>\23)>3
MJMU:46A:''54-B>)>$1S]3'52-?"SML5O.%J.G[PI&K:I557*YU&F3VF8I*U
M76FVN@5!LSC:J5S.DNL,B>>9CJU9QQ.Y%5-<FLVB1!8EF"ZOTZFV"X)D<110
M2=PC6A^@A(KHAF\S2_VS.R^H4E4[)4:SF%2MMTMUH](F&FCN;,8:.DF>UI#U
MOQ+S[70AVH\7(5L:E:`UP^YG*$[SA_+,4!R:%4>?%"XMDE2_)8PRBKR-VJZH
M[:*D!H^-MM5*MU649+:,.63,<1R>]_O%O#@^@HPYRN#=OB?_N3PS%(=FI=0G
MLN.?;(54/IS>%]EDL"&#C>-PN=\OYH(,LX\[:.TB?H[['6RW9T&R'\+B]S*:
M'+2VWN0@*SWZQK8%W0_*??^WFT?E]A[5WLWC-V"]R\^]VUZ_5[(.!JS`Q'+L
MT9E/W(EBQ>LCFQD4L9G!^DT)&*"<!.DF"'S\Q:Y"@A:RP\#<4)V.1&.W'09D
M4X##GW179!^`%=0IR=%_>5I?GM9??0E(.8JCK\F00,"!A\<`_VP7;%V#)G?4
M%\S94&6IPFX(6V\4A+`;Z8S"E2YET>".8#M6KC7ZVJL2IB-FO/FK@<U?$UUF
MCT*O%%/:&I562RTQFI*J.]4H9?-">K;N3(@R=)V)\J19M*$NZAC95F,/I[9:
M]:)4^Y5@NMQ450MS%N[X?1,AFGDF=D"DNM@E8[>*PM@EF"XG5<-Z!+56%&3?
M@_MQZVBVPK=KI<IX1\Q=@NGR1BSM6D&0/'XO@^[W2STA]421ILO;1:(H&>A<
M:D+>TKDM1&1QH,1\<W=>'ILJP0&=W<]0G"-`Y9FA.#0[BHB^MMQ%[SN^9DD7
M?6=N9+O2:<OLW[:IVJJT:[*086]9/[Q&E1^W4![P,D_'EBIC9\Q]VJWM1V-\
M>`>TK'<.3$L9OLOP78;O,GR7X7OY9BA.*%J>&8I#LZ,(WU=NR-NCLSZ>I3TF
MO[S`!?2M2E?>]+<KTM;K1;F/0WKMTFN77KOTVJ777KX9BN.!EF>&XM!L7RI`
MMA?<`;\5:HH"]<DKTQ0%(IOTPJ47+KWPH^P(F,J-9<&;)WS?RJ>>K?R/9@>:
M.Z.=AUB''7HW-'Q0*[0EW94S@37"D_LZ,9\!/VTZ=1V@*#N"BX]@][__(:Y'
M9LJ-[MC.Q-03ETM?!O[8<?'X/PZMC5S".@!XQ++$EWWM51GP8[S*B^/Z8^6G
MZGDGAG=B6I;IV)7LK^GH\$MK_A>83+,5TS;(%!8-8?+'IFLH4\T%J(:.NV2B
M]L*)FADON`0Y`?OP6;-SY3M,YE(:4:R1&DFJ3@+/5R:::?OP/T53!II'3S0[
M4^)JF-;$_H`BC1#6(8RNS(CF>HK#1D]0CHXY(("<:<"`^E\*@JS`JIW!F'0.
MTZ,S&?@+OF\'V&T))V;#Z@">17QBG"O7@0OFAC[%?D,"XN7AB_I7A?Q3F^,?
M[*E'"5=;2%(U<^T<VC[19">_A182.+['SX##9R])B-1B+$@0%TP>G\C4IX3E
M$BF2D#9,`LR!6R@_1SREO)@@*X^._A<9@DS!R]]M0-KU4.:F@>L%&K*\H[R,
M37V<&/,%J*P`LP%?39!>\?7PAB#!H.&>39UXE/V$><Z5OLC;82]+CT)']02`
M"__\"U9!F5KP[9!S;.;HL(P_-19)MJ;0UIETJ6$^QHT+`#`0@&`*&@J^FVHS
M^AN.KI[7YT=G5$&9(,CJR*DC&Y891O'@+WI.6`%4N*Q%4`@3,S@21!W@?\0U
M^3<H6GC98D*LZ7X`2A19C)';=)%(NN/YM"=H0$\IXR],<K`%%C"X-J&=8W$Q
M0\A,)L-\>"84(44UEX2KB\+<SQ1(];PQ3Q08-9P@)7$B3C'EC:2>6*DFELOC
M?,_<''UMDXUP<8<(-XBNR<#/:'W;+G+K6[7Z06$-;^\O[R@]!O.A<%%56+CF
MN,S591I,L?!4+;*X1X#?J8.05&G?3.-*FRI?3%NS=5.S*O%$M[=7*U3;P'%=
MYX4R."S>/(<'U#ASM4)!H1X-F_-<`4R^464X[PMI$\;=^!W#(0(;L8DFQE\@
M6O/9G?8_-;.@H'-^!9/EPB,W%N@`%]PG@,#TX8LKQYTZS!-`)$$ON`1=!*I\
MJ"I0Z$Q!Y&C$V,#S/ZE9<R9QJ^7&#08$<4&O%W^<:#Y;,P.4`T-#7/DZ/BY^
MT>#3SK(L&^+--,S4):"PZ:].X'L^$!3URA2TBVY.@219J(*R&@:654EP1/@(
MM2OH&"71J:!VY]A6Z+I1A^FG3I8!@@EB"+BODN$8FOC_R.(>#,\PB;AB:"(3
MA-\,"?$2^OAO`.8`PA3N]<58IA9AK`&#$6)C](1J&=B&FJH!+!W,X8+O!Y`R
M=SL2JQ`H!-`+!DA5'\0)3!'\)R2/YGD$O2;F;?ECI"NU13[J>F:NP):#.?%G
M="U!?]KH7J$)16E%:&.<N8F,%TGCC(/?`"WH>_RA],HP6S<'/D0%\"_:(Q0"
M`X'@>!%V9WOHS\:3OL`B+_+MU0P/GBVNFA5$A*Y+/C=X+IC*[XS.&[],6Y8T
M=T\^?#5V+&`;[^;?`9#MSO')TN[OG4*;0/6#\M2_O_K?W^YOKV\>G_ZFW/SC
M>Z__S]U:0_C2Q`\@E!-8<DI4.K19'OM["?)O91C?H6FA35*\,;&&P(XCT_.Y
M:0&%X`MF%]]Z8L)G4F?>4&Y>=5`((SK:Q/0\;I#8**`N4#AH*(8S09PV2$FX
M/YLR!]^+QX5`07?-`?4'F-NZ#+)@2L-XQ4"]YT;6#YWZ9I:-ZV</^()CD>&0
MB2(J#$JO>(!:C8INE:HXT8#5LLEI`_<7EZ0KH5M,UEIU$5D7##I/6IY=BH=1
M6]S[3Q.WOIBX6N"#<O'!*UJ&2!GB^[5S*7-&)*0/L$L`;];42@N>:G3@2>#/
M:KM9P=0L/@]/-ZM5^J<WAC`P\H)TIMH\G]H"[@:_`/^`9P?^$_@@.CPZ)`@J
MAK]>8/D(-3QJ$W0N')T0PPL]K!`BRC'M3H;A!$O;J"\TM?5ZAB,%_M@010"H
M$^AT]@A*_`.=)_IV"&=H_TN8\]D^3U0:]7JE5>U4E`XL?[U2ZS*.:'+N6,(.
MS.MT`I<Z!BZH!!B04&\BIC7J)"\=J5V!1PGZZHOI_V>$/JF1PA7_%W]UY9PG
MW>^UV$QM9^0)D<LR\X>4RVH9.<=Y)M-C17PH[HH=$/L9'&T3+R-Y<,.F=>7S
M1R[]I:PL+BU&-AK;*L"`IH[,FF+8:40)QJ\\>F&Q_U@#HT-#([""YLBF.:LK
M"\(:@?'2Q.090USE>C,QW9)!GX`MB#CJF<!W_Q/8$'XI#QJL'L:+E+.N@DG`
MKN>9`^`4:7"2,63ZR9,/.^6X)T2;!1#*(V[#><J#I=FEXK9D//W9T5P#5A#T
MC.%,?>I0+,"2:B,(?]'I`FW&G:>,AR^STP<#XK\@DR0R*:!"\',`2H;RE-)W
M<6N&_UY1[LXOF1J,QD9URO@A/1TLOO*P*+E!L[)S\.&WC`0&T<&WH_A#9&<:
MA.:;P8<R!T'H43KV/&O"A."B>GQPY53C<)U\H,XIT4!`Q"0-PY(#%*^#:&+.
ME1M\BPY3X3(&ZM5T"=OI<I[CA%$%\X6FC]8&!C1=A2\%9HE"R*)-R,A`V$@8
M^RR\,0)6$P#2.&R(PG?;1`S@VQQ"IV@^O*QK'H))7-V$.2%>T"F:/]6;YZ`P
MIFS#!?#Q@@'=ZD"/VO@7+':\-\#7AVX-@/-J8'ICJH$72W!#(,0B88V1@=A6
M`J$[7QP`>D&58\-K+V-"=_:`OW`1767D.N#/4X[7P6HC%FKS9_QEXL0K(RY9
M8D)X+ICR%`K^0&R=F7B:7$I/0\F*Z4"Z<SAD.2-P!YS`,KA!9_DF6.+TNPP\
M!&`M^.+,%*(83N)@3!!R!(N(Z..#69(SP*L!DZK1))UFH'FEN3F=9=PHCEXL
M\31$P?=Q%\3/P)^3V%L+!2HSG(\I`;EHD5>=3'VV,P2P9A'M`R?M@(1R8;!X
MD6[,LY6+>-0+AD,P/P@YLJ:7E]TQQ_MOS/1I6#41,(1>'*;)&3GFQ"!2/RF2
MB<0W!9:D.]T3XHZ0!BY?U4'@F3:>MQ<C71`4VV,+A$^:0Z59G:-UK&A8!E.A
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MAY@(KXN_LK>HL0;=@LZ"[82Q@/:LF1:UN[3^)O!!&$`MH"\6;]0L!F8>%/QV
MI][\LN4KE4N_(H`$#P0;.:%>K,V%BTEOBNX<864$L#XN(^9+-.`J80F3'"W6
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MM,00'@R0[=AG;`HS2C!Q."JA_$RGX.^9S&+26F7XB==74;YA469@A^6'6,SA
MQ^DJ3"I2\=->("[W6.22>@B\8\LD`=48&'8.'#O`L`8]<\X@,#8X4AC[:%@+
MAL,B\)$"8K5DCNN5(0&>(T,8\X^&?@S7WQ!#:*_F)*#5>.U*8[GZ!_)!X,05
MS9!Z]91X&!<)XN8)BW3)%FF"P3JMJ<!!:-U,#&B;PMFA;\4CQO*:'#LYU#VL
M40+K6I6.UDX7A@QH%@?&C186[`4KH^!10EB4R%(R=+8*_Y=9$%;A$M?Y<BHA
M(7@2)GX3XR6*"R]`I'4=6.2#T?W<P\]8F'$>H3ABI4S6C/[`RB:UT*#8#J\B
MPMP^3!ZX8AEG!A(@`C:^Q-_`+2IF:$Z%(FA$(E08(=PP"X]T<$0:+M*\@5J-
M[.>SXT<><2J6_!#A/1]^)144AP]8R\+@E<ZQECVFQ;!(7/B=>92G*@=R?@QJ
MHQ:HRBUA?J[\#NO&U3+FUR.MLE#-)``)51L-^'5B81T[%JA-:1$ZW_$V[7"#
M"56P08;`R-&6=23MI=!>8(HF$SQ!D6(-FE=Z-OGQ@MQEL91N'@_8O(NE%!"B
MYH?[IQY&JA>L6!>XXZ/R<'E]W;O[&AW<H>=CPB]9DQ7Z%;TO_$+I5'^.?WX4
MCM2DVK((3_7O']@S6XG#TR?#Z`D:"ESE1*U6?\X^$)JB"0[R?>6!G)A^_&20
M<!DQ/V-$?<(!5DB[GTZJ)PJP,IY6TD$RHK_Y63SZ=WA'.P64DP!3'6=TA@N\
MT#DDTY+CO2(MLBYU?[KI)U!8T1>$8Y>X37J=OB(++YY?Y^WV@CXH;QBJV3P*
M-!KMHT"CW=@N&LL8_^;N6A3_@UW`OK*/SN$O8%]]7C,3\8S3F+FO:*?I7V]9
MFO2]4.(/>GJ9&"(K_/C#)7C!VH@DO[SAKF7RVP?T,U-?892+%)8$7HO`CP1/
M5H)"2'Y]A9XG.WZ5_(&VDSOMV<H_,:SX<'!JKZGI2MG'+PP;[X4-4VU)1B#C
M#K,2]OG;\W0Y^]`U*_5&M])199N_W9#WO"LO1-@V4=OG1>'6C;1U*:Y#^,HR
M3%(#[XR;U4JM6<,L]O&C>@@-K+;.&T6Y/:4$TZUU&6>!<'T/?G,8/$IMO#O&
M/NVHK4JCVMP+IEN]DZ;`.KAUWJR7F'6*R:F%P_7XG>$KK/>PI/[=I?Y5&Y5.
M2Y7J=ZOJM]LN,><4DU$+AVLN]2O[QVX+D3S#OY\NJJ487I*J9*3:+*B7-V24
MX"Z&W<]0G-L>RC.#I%F9:;:9VBQ'+G3=&H*,_).,V;=60]!N5RO-4F^S%#A\
M[YRK,GQ_YS4$,FZ7<7MQH\5W$8R68OABD$K&[3)N/Z)XJCPS2)J5F6;[4IOR
M-M`=\%NAIBC0M99EFD*2K>QDD\&T#*9+'L*]BPBQ%,,7@U0;>86E**L,]W*P
M"0UO/W3S.HUN!\.OY=[.X?9VU%JEV6T=/ZH'VMO).-U<&LH6<R%+MK=S)#OQ
M-T*G>JFM#\/Y>/%/NZ)VB\+_1Z:M6^?U,E.VF`O9/"^*;W'\GC;KV:1<)AH@
M?TWU-(]Z,4I%O3.FKU74:JW2;4CG[^C/Y91@NK*25E#8["/JM.@O?A<*@PFS
MIX3>[Z<$*UN%SK]>C,:SM&$RO?K`M'W7M#U31VH&&3V*PQ[&AF)L>-DDNTX;
M+V:)'XWO7ZQF7+(87I9>K6>\D>S>CQB]\.YNBL8:NK&NQF?LBGELA[P`Q;#Y
M\=80;,+O/]7/6^WP0G"\8G4>7K8"RR![9HFL[0!6.V]D$;ZVY-[+K/M8RW9'
M*E):&XU<,D(^6,GO3MXZ<$;4;A:1V/*N,>ESG+`D0L+R>67"D@.AGG<S@+BD
M3;R7]L>G')BXRD=W8$Z7W<Z$,&#3;@[>FLV\/=JQ?49P.-T9V?1B3H07+T)P
M7LT)N[[N)[61R9AXD2OV<_=\^B3MNS\D)MZ>XX67_YE>@EX#(DZE>>'=JV$C
M^3D%$5Y5,E1JYYT8!M96?A>\;?';.A[CBQM*>"VKV+9\_IZ*L'5Y1B!0EG;F
M[7SMS)NRG;EL9[[6V]OL`[[E!MH'0J,I^X#/2['L`YZIV]X+)=9H4\UR;M?@
M("6__X)1Q>_H;2:_/\7[ANG]/;)%]5XVM<1P`MSFP`Y]?=FG^B"YIY;LD+JK
M.1OGS:)0=B/54HH=&-E/>=?LK,IFRKNC;?.\5A32O@<WA%5$2F6Q,X8^W:.V
M>"_M)KOGG?VT3Y;^A&Q)N[=M[TY-K94964G;+:H,>8)L6XC($V2E&[X8I-K,
M_9<]1DK0F6'W,Q2G]T-Y9B@.S=Y#!N!-&Q'RB(W<B"AAXJ!TV449!L@PH+A^
MN@P#9!AP#`[G>W)IRS-#<6BV+Q4@V^;M@-\*-46!&IF5:8H"D4VZ[=)M+[E?
M_=[<=O:Q:"=W+7[B"VNQV0F[L"V9[1%/Z=E#QYW0'^B493D#1D^MG0TT/!B<
M.#\8'KD33WJ][<`J'N5S#7:03YX!DV?`Y!FPN:'J78G&\:*QC/'E4;:LC'M1
M#G!%6V>#;`7]CNA0DW2@=%`/3H?#*HJ54!Y>42Q?]L[ZRW[:L\$'=@(/_%IO
MV7G+_>.^)C.4LN3AD7@0?.AC&E88Y)E8SG0":[?`85[7;LOM]P5SUBJM1E&V
MWX^,M&JEH1;E3,01DK8H710WTLZE.&[RE=C$U2RJFC5C8MJFY[LT47,4VKF8
M8J56NM5.B=$L)E4[G8PRR=(@64R:=@O3'SN7*I8;@=M"1&X$2LS?-^:;1>:R
M$+$$)6^[GZ$X177EF4'2K,PTVTQMEB.AV:?MFKT5I1='$4`7.%'4J#0;98ZB
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M$W,3WO_-G#UTN,`Y<]`OLDQ_ML!_6%>/%Z.L8#$SL=G;:CS_6?RQ7?MYF]`4
M%?GJ.T:^U<E&OKH0^8UT0RF.F$6:@<5B"A!P\J[40>N\JJ!9\=Z#`$A<MR3;
M);'[CZ;WU]G0)40QD5K$\Q67WX+];@1</:]EJOW:N?H>C%[UO)N)OGK>>`_H
M`YH+5K\KK;ZA&.:S:6!Z>V82ZSBN-<S+&7>.G:$()9K'AZ8@S^SC.]CMN7(F
M4\V>*6#RS0F8?(\>?*$RCRZ^PD[&@,,_-CW?<4U=L^`)XNJF1Y2IYL-#MG>N
MB$,%V(K5]#WQE>Q\@J([M@</P9K%VSG)^8'`=*L)^Y;BKP"/Z=%^J#A#]*PP
M9KP)Q,!RLWT;!89AR`53C&=P`PMU&\[X_?P)WG6)Y@7N3/&('KBF;P)6N>#%
M+QT!@*3N%."+0>``<`K^+23=#(?[#W&=>(RI-G,"P!SWS]C,[+B2/]9\Q8X?
M]`!`RU(&N$BF`:CSK3+`GQ"Z0S,,_,`EYPMT.>/3D&O__DO@G8TT;7IQ;7JZ
MY0!=R/WP2C@O]8B;9\2X<CS?>QIK+OF,B#UH,^P1Y?7)J__9`A;X]<<?%.7O
MNF6\7CR!O(+(Z+"XC^29V`&Y=&&E1X2^$<\3O:N8!E@Y;52KX2820`P_/)+A
MIY-K3`J?_(H`"QM[B-,9BL^%6CU',T>_&&H3TYI=]%'4E#ORHCPZ$\W>SC8<
M31^>JO4/RN/-[S=WWV\H"1<D%0O7A+AG*VJWVZZ(G*A8(+`V<BA*FX,]9ES'
MUYY--_`4[#&#?.4H7RWMU7F:@$3\+]:JQ&-.+5TYI;]^H!Q+/S()@#&!%Z<H
M4`,FN"C4&O"L%PP\\N\`A4R'X:C^\%U3LQC7XR,.P.B*7<@43?>!\U%($\H(
M1"E$X8S+P#P"*#K8(SE`1`$=/BZ#%D9XA#=<\U5X\UG3=4`4Q0IHUJ1P.2_8
M73F<3AF"P@'IK5=_QB&O3!M>L$%4E*NQ:1DNL6'@WQQO:N(IQ&_$H&A>4>NE
MG%Y=_?8!E8)-0%DY,\VBVL<E.C&?89:AZTP8=.<*+-LW;:;4JM5F<NGH4+AR
M-LROV8HV`AU(:?4"Q".#&?UR.`3BHSH$6!^TP`)D<;J9\B4`G'J]2KR8M^</
MY\KIP^.7#\HT</4QU5P:MG:.-2NG<1)N$:H(!\#NQ7$MXP74E>)I%JLVX*2F
M:(7)>KJ3P7#C_!-A`AK01!RU`'P`("[0T)K%"IW^S/0CU\N6ANJ?6.09;0K8
M+QR%UIB`1GFF]`+"9$R5YBJ7^,`[C+P4=0]Q#SDEB3^X^OJ8%3K8#MWHH&P&
ME%1`429:<T]=QPCT\&4D%]6,C/$!1)?)#+MX<.($`#UE7[`D8!FH7D=NN_H-
MOQ$'#@?DQUK/E8<E,Z4>9I413#;\Y500B8`B]5/MO!YS$*A>"Q:CHOP$*KDS
M]SV=^Z?NN3K_RT8-T"M4TQ#4$,2:Y;5X;S-2S,"%UK)GZ\Z$]+77I>9,+;0Y
M:WY0>G=7]]]NP*?]OYNG4MDTE%D\U0U.O^U3!6/2%5%\[37B;G!B77,0^*'T
MX%J8=H`BYDP)TQ^1ZQ<JDJCH2!8:R4*CTA<:;;%O>[,JT3A>-)8QOBRMVG49
MS";ML^.2F&S':9E=+V(3[??745U>O7!(.AQ-+9V\>N'8%<76;<?Q7+T0[A:]
MN4`C(XK:Q<9K+PY3!\0F0]-73J>N\VQZ$(Q^6!1SKNGFO<5W*L[P.5LUE0(7
M2:JB#%\64FVJ]]8K/]F6UJLMUWI?B('W&)1"N^VE.UV^.>K52K>U43NZ]T,K
MM5NI=QN25KEHU:K4JH>B55D=NQ4J[LG?6EUM<8W3%GFP4>G6-KJ]XIU0J59O
M%QB-8E"I7E'K:DG563']-<<E`*Y49VO&#9V:6BLR,I)6A1D^[[59TDW;JF:[
M252.W1%?N6>E(/9(N74\K'#&ZJ+P4M14[0G^3[D6JA/[VJMRY1+#]#..F4EE
MN6"R4[76V@D6'XZ!-I6&I,Y"ZC34W3AZ"VF32P\N:TTXKQDW[DX8PE6Z;H2Y
MA]M:)[I]=9Z3F!T19AO[/EOHA;]8W^Y6\/?5^[X,(^ZZQW@91I0T."0--M5$
MA\DN"3402?4J(Z)%&<QFI=W<C==_3&2JU2JU:K/`>!2#3&JW4MWL"OL-\-C8
M>2IFX=8U&1(7CQ%BZ1:V-69))`U/"VFV+K?^U@CB=ZCMCB''L4,M=PSDV:%V
MDUD@F062F$G,9!9(9H$*$/T79T1)`YD%.N8L4(&*<\M1'2,))@GV=H+)<$JZ
MYA*S]X69#*=D."5#"4F#P]-@CYIH\>7(!U-%>[NCO1Q#[OP6['(,*<EP:#+(
MF$CZUQ*S]X69(//LXY%?3'%)6U?;.FU-CN4S`^*_$,*:>O.VUX"@2Z:.Z]/N
MTU&W)#R5)3R%S7\#/W&U.+W<`8_A!_2&!9<W/Z\W?N9-?>7=X;*EKVSI*PPE
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MP/#Y>[:WZWON9W:4GAJ]1`LO59#>V5H[ICN[2^L(%-GI[N[0.@;J[.[NK/?F
MFMW[8^)*M96_F:_L=[R*1.V#=?$MP/`Y:=3:D0^_I2XV97/!Y`59!>#I7=V/
M=50TVMD]6<=$I5W=E[5[[5A0+^]JK-DCHIBV\GO4!/Y2-H%?FS'EC1?RQHLM
M&H/"WW@A"R7DIKO$[&@PV]B[D<7CLFA8TD#2X.#%XX7,0O7BQC^G`V*3H>E_
M4*:N\VQZ$'"5(LPJT)'*<NSE2X))@LD@3`9A,E21F,D@3`9A97"^BS.BI$&9
M@S!Y@E>>V91D.#S,QT4&&1-)_UIB]KXP$V2>?3SREO+79$A<%V"F3>(]C_BL
M0-$RM8%IF;Z)!8LNH8WG1S8`8B@#S8/_.K;BD\G4<35WIACF$(8AM@Y/BSWI
MAZ:MV;JI6;PG/59!TD[T,!D,8WI(O`6SLL[TP\`/8'KR"L3%?O7$UNB_V)[>
M.U<N4=?R,B(M+"-28%R$US7@06VDF;;G*T8&HN90,7U\>N+`');Y%[%F`+=F
M*[;CXP=DWPE1'!<'1U@1J:R17DSX'5\:(*F`<X%0Y_.YMFG1EK\/^$Q=$]9H
M"HN$MP(X-K%];QFN<^SA*]=$)Y,!<>.!ZVI%P3[,]&EL1%P!NJ"$X&T`UJQ"
MF4KS#G&U0#O?U0)->;6`O%I@K;>WV,R^U9!HR)[\JU1*B7JP9UH(D1H__B#;
M]J]#JL-W]C^LF)6^HWWS/7>T]YWI!F<5%O/43JMJOKK8"2F*F/!LUB5UB1<X
M:NN:O0RLUK4MY9ENK<J(DN,J29MKNHUTR'IU>+O2(+7E&F3^/*ARI;GN;.BX
M+YIK'(<BV4M=U=OF;'<KS>9&YUPD;1?-V<(>=T6A[5&X(RN427PV_`B52#'E
MJM:L-#L;-2J49,TB:[72ZA:%K,?OA401S,WKE-C>MIJ%2=;.LHIJI=[>J+F8
M)&M67X9ZI;99^XJB:(R2.!M/OJ/_=<:V?J^<">H-NNLJ5<?.>+Q>Z1:&Q4LP
M76ZJUEJ-@J!Y_*[&%_,5%(;,DNZ8J=5*JUZ4T+L$T^4-2RKJ9BUVBJ(J2N)C
M7.JZ&PAA":T=VF);4,GD60'*9O?I2IIF*8[&1EWC]JTVEI6PIQ3)QO7KBW`K
M73U[)B)[K95.\^:^:J<EYBLQW\Q:;^%8;7X5LEO9V]<QV\4K4]X9=GT<4])L
MEQ@=06POE$,EE9QTOK<5M[=KE59WH]LU)%VSZ%IO5^K5HM#U*&+W]6LC;^,S
M0C)^WQFK'P6NDK2[5R3%\"E6I`!IMD^YU/\=F*A&>K:OV2-S8$D5LD,^/VU4
M5'6C)NFY\=SHRJ_24+/1V4_^;UM7A!73XUBA*GH/CW2=\7_74E/LB[<WO"]*
M:HIB43.7II`;!-M"1*;))>:;&VBY05""5/3N9RA.LKL\,Q2'9D<0S,L-@IV[
MB)U*N[V?&K3WX'!W*VIC/^>,I,,M'>[BN9WO%W/I<$N'^XB<Q_+,4!R:;:8"
MRI$4[SN^9F6U***U]')'?B_%)RT\N5>4"O`23)>7KK5.16WM9Y]2[L4+;0($
M+?+[KBYMEQR?%:^JK<[>&HZ\A_A?K=<JG3T=JI89`)D!*%X<_'XQEQD`F0$X
MHFBV/#,4AV9'D0%848B/+4;G/7?E-(S]9QE^20D=]@(WPBQ"69<DJ73;I=M^
M/,[K^\5<NNW2;3\B%[0\,Q2'9OM2`4LNH2V*#MC;5=%;X[="3;'SRX0EV7:,
MD_3"I1<NO?!#>N'LXY%?BXSWXMHD=6MP>.GM#''[J7'>CI^?F)9%[R#.=1<N
MN[N6>(KOT%MVLR]2UCS/T4T-;SM^,?TQ?3)YZ-6,#KU&=_.&)^=-=@'S5>!J
M7XG-OO=,W+FO*"]C4Q_3"WAM!U$T`MVG@PP=ER(Z#=RIXQ&O##<87]*[BA<3
MO<+HX$Q`GF;*6#/8Q=3TVF%ZP30QB*M9=+6=Z&HF"[N9G)[<W=^>?%!T\7:5
MY3<5!U;\V3)#`EFFYY_1SQ=`<IN(UP@;[-IE3?<_G?`/XJ_^$B*'>>%0_YRI
MZM+4<&A1:ZV,5*SA"[,N3:4M'/_!-9&!&$]/B#LB;GB/=$A_E(#+WR_O^A7E
MIWK]O#HO02^:IXR(C0N!=XW/$J\SSB6O4Q-OC_9!?<&4@:<85)H\7V-7C`/S
MUZHU)F\C![_QQZX3C,;X=2>)O++0CX^OVQ3_RJ"<\3[62ZVJY[6Y!:LPR1FR
M5:&U0:S8,/!!5_Y'XRHGO:ITT+764^TL6,]SY3IPV9=$F1'-]=#^$*.2[UIR
MD'&J0GZJTB]_4EOGC7FV9#`:R5O,)2>%;=XC=9J3E>IJEO7,E'U0B@/P?@VF
M)M=5`ME,4Z]_Q._E\J44@1FZ$,Q52*E?6+BFVCFOYU@X[G=D.!!&[$\:5O31
M,J./H@DMIXN!^D_!8!1I"*[%3ZTL0P=#AKX'LBCPK4\RO!!@:?327#*T0.T`
M=;6!\TQP2F!]C4J`[YJ#@'KDN(8>WM0"@_A,;1%7-W$0)C4O,+DR(#"<[K@&
MCD:!-6W=)9I'4&@$P*>:23U)79N:6%?NV%PB;1K>L,76+*P"5;PQ0=CQ(SPS
MHZ"=P*!@`XAQ0@?6<4[Z,/5G+Y^NE#;P4PF<S)[-V=NJ(+F<%_CLC<VIHH_!
M`8?5`#)"J$#5%'#_$QH(QQ8XI5,+U6$/[WI&XCZ29V('R#<&H68EL$#ZAJXS
M47Q7LSU-9[:4KTVH7..Y84"=N+X&I/7&0.ZQ8P$[`:^ZX,`/+%-71J#OIEX8
M"W#&&"H:K*"+`4<HXQ/'Q54#S)H"HP(;XLW4VH@H4]"?`!PPG@MO@QXEY`PM
MK0+/F(YQKCP%P%QILGC`.``;!)@0_\%'WYI!##4Q?0J.-G$"FWH.U`)3?IYH
M,^1.YCJP*&88^`%`QR;RSI6^(&IZ`+$9'1:L`="<CP(3F!Y0=.+XA'TCAD)T
MMO1$((%T$3W``SP:AT=H!HNKJ$P/"+P<R0V&2O@PE]$D7/@X"BU:+(O088#]
M8=%GGDEU"1?L>8^HHHR=%V`,-ZE3!L0RX5LO`[6?6M7S3J9VP0&8FY6)\AQM
MJ1K"_FLD?-8+!J"6;-\$=J4+Q]T[K@<X='^#-WE<#.H'8G[Z(\`(G(E<&SE8
MC6J&9W6NK.D\B%_CLKLFALM&Q'.F*)\YY!*>_Y_`)J#)JUTZ3ZCHZ3<`7N`B
M42K*5'27&6$9L$F84*.B-H>1-`N"O<AO$8'5.+A):.&/>]UW^-SM<^42QV*J
M(:1(6LC2+U5$QSM%1E@INA@1)N*+R%BPX/\"&N%/E&/M(+'R/._1S&`W6_FI
MEND:A/(M\#H9<GWC4Y\M%YK>BG6J<,XUO6S(8VVSP!H#`JUVEE.*T`.(L("!
M'7A4EM.#<W'!/`'FN:B:!!*B!G%91%()A4L`!/]*#@)K!X&+&ZEUW73U8(*\
MI!,8@DEDM$#&OP+/GX#^4TPVV%`S7<SH@5&96W=T+,(<$9#)`*WD3JA<P%`P
M,&@8YP5-AXE.`TSGA6-@0FB@<<5%55XX#M.K:(L7K1I#F[X4V*$SP)(K,-4(
M<:3J3'?`1N!/1AS)#2'$$HV,H@V1G%G3E,&%>(*5MK24_D#J"'8IF6F*/;T,
M0R`8.K0TU();YE\0E#)#CE_29^9]3!`TH"JN(WQEP&B6,Z5L='HB)!<Q[T4O
M%V:ZNY9I95C`W,A0Z\E`N1(YGJ+YH:N<,N^1MEUI8!@RH7'1IE/7>34G\!V0
MX">UFJF,0B&,C=,\><0$*Z-`:EDR9NMFI0PH<;H98*1I,V]M0T>)&-2Q\!+8
MXKCS8(>+E3.9TLJ(B;.=F!E).#(P4&#,N,![\;P8>40(^$30=;"JW^%+*WH7
M>#8:D#I;_#FJF08$P9HBD]I^%*`$=J@3:7[:8?%I*>0>B$+^':!\S=FT1-P`
MN&7Y)Q6@56#!BC/!R'2@,W+7*4T";+)0[*,51'6!'GO2,49C9U')<X9#=(:Y
MR,)"T)`3XA-G4@H5+'(W2#!H4H\1,O#'CDOM\#-11H')@E2'A:Q(8_3V*=E,
M3P?R(OJXO14R)2@FT^:$2#!H&':[A&[+>`E=#A2-S#`\1^CR:IGCI-UAD*!L
MC>\P1>(A5+!ZP93F`#28@B=B87`KP&URY`?'"L+1<=0HYIE.P513$XV'Q4?,
M/P&-AVX!=43H-;`\"O")/K8AO+/0&^;F`K^/A!0<?#>;.!-"_,COS[9@`"7&
MM97(%>%<+_@,H24!'&T=0Q6J$)&U/>9=&('._!SJ<6G@LGL^T,D&P>-&DN9L
M(%PF&G,Q8/JA.81E!:$:HK]%`3/'CD/W-9F.BOP92F4<&_Q7:A,4$!/?HB#$
M6W=`7?(,VA&QP-=#KIN!<YEKUQ",**$;6*`QT9N*"$`]-(8.>JH@H&!KGZ.3
MNEIX4C<.8V$MGTV:_D$?#*CA!&YRKU.+NP98<=<`%B>;0Y;@BOU/+^1PNE#H
M@\<_OE#U-2"A^AC,4F_SA<D`&`U2X(6N?300X&_2C;+PU64)*3=F!UPZKB9I
M8B6-Q@O.$B)2!H7V#59)TX%$P&Y`ICORHOP/6!C"XN4KQ[;1H.@!2Q12"<+4
M#:,(C:B8>A)5"\2&$W`<0`H9J0C5`\@Y_&^:+*%?"#)MD]<@E03AGFF<HV&Q
MC:"-&"O`1%3S_0M<?\\P>=:+:=P9'1R#@#(L1]I[(HREB2'H0S`P2#Z;C)BU
M(2B'R*X#0!+50J1,F'H1*@Y0M\[5)#`Y%??TT;4"2L+O\`\HQ"DUWSF\A$J8
MYZ5*172#,7-A@X\0N/Q23O%'A"++3Y[W)L6@,PY?%H<NIL_"!I;_YNJ.TB;4
M=ME)]`6*K,)2,RS/`'\LUI.XG8$!`K>B*XHZN`J=C[<SX"@+&U^B+4=?L*^]
M3K49B.<C1IY#Y5*G:I16L2"9B*W170F@W_]HX"JZLWB@&J<0$_Q8U80KML(C
MI>.[Q'<=C8=*P(@^W=IEZH%'#727@KD8`24W2Q0L7#(U"GH6KRIC7C(<TJPR
M]VCBA%OHC%C:2V@UYMT1%YCBWT`1GZ4SV4X1HX+)/,'PUX0BIF/&E%W.,6'M
MU-]_";RSD:9-+WI4*<.R74>^:A_(]MER]+]^_?$'1?E[^"0P*X02U$^ZM`VP
M%J@70!>!G<]X5S&-3R=];52KU;`^#6*S5_^1##^=7"-B)[_2[4?S.>1@!/@,
MN?1"K9YC_1G]8@BZWYI=])&CJ;EZ="::+9;#O%$$<%\6/YRJK0^TB++7_W9S
MUW]2+N^NX>^[?N_NZ\W=5>_FB5)MD+V!6TA1%#7H4-.9.4")04>%R8N%>W<\
M@%L4_\>!OMH]5ZYX-!V%\='(?"Q<87P`;#=YP:T_NI\(-@(D%A4U5>118/!L
M>NQ7A"O^FT/D07`0I@0P=,!!?1#;&?/167!*O:YT?`3/H#V;H'8&>\B4,K&I
MDM8=S\<:K:O+;R<?Q,0AQ8!"R*0XKO5R!A:/9IB#$0-#_:7+;WQ0IK`2Q&8^
MBNW89SK.;M'05["FC&K:BIUBQ7"H-6-1&$,WW*+%-T-J(_#4[UI&;>64JAI8
M8@#0^["\,$T0S8?[IUZ_=W]WP0(^T*P?E8?+ZVL0D:@B@5:,AE^R<\?TJS]Z
MU_W?+I1V]>?XYT>AR#1Y4KDI/-6_?V#/;$78T[72M*:4`E<Y4:O5G[./2*1H
M@H-\7UFB&M./U\KBIBAQQ9)QR@P#W!AT/YU403T2"^MW=>",Z&]>G4[_?C$-
M?_R)`\I)@/KTC,YP89%A1*8E!UY$6C"`K^YOOW^[8XOTI#S=]!,HK#@@R['#
MR:.AUSE@&R)5V^3M]H(3P6\8JM'<+AK+2'T#5D9@N/QGE<*"[S=W&<@0IEUT
M%0#EU5@@2VL2.(_MG)MHC?7;QR'V?'/4*JW61JVF-B#5IFRX7H.Z_3%A1O>_
M`C)A,7B\5NFTZB7EO^*JP0R)EARXD`.[66:C%!Q85`V8<:FQY+\%DZF5]F;]
M8J4&S.#`CN3`W!S8K&[4M4CJOU1[<]P(I.E=R8/YM6`KPV84AP>7'=:?UXH;
MG]</X2K=^?S<PVWM5/J^3J$O'&YC&[J%]D^+V7^W3+2O=D]E&''7K8@6CWBD
M7AR[)F1BVN8DF/`-DW`_IA26M4!I/K5:Z6QV19^TL-+"2@LK+:RTL+OEP,7]
MQP[&@GOKYU>.(7?>:&Y#/I265%K2U9:4?7P''=+B<E>?!A2)4BI:-.RQIF*:
M9<U5F&&-XT^UC!.W%?PZXXPQ/4^7^0OM6Y9L_K.T70>M7N7'*M3D:;QURRW7
M*Z),%F`^`'T`?'CO'JO+'AS/=XEONO2PPF=>XKRT%+->Z%+,]@?E\:;?>[S!
M4DSEZ?+WWMW7)^7A]O*.TG(P;_-2Y"X<IT=5X5A(WJBJIW]]4!XLS8[+>K5G
MS;2B5BR)$YTH!&0RM9P9(?1,I,&/,_-J/U9D+(Q:@9C<]4TLX<<Z23PF2BQ^
M^AN7G;9](4HPQ2_4YL]\"-.E9P"`N?B9+RX=6!P?^(X[HZ<K=7@;SV+C<<)4
MK3Y.--'^(DJS^C-\\/4QECA&,X8M(-B\C9]92Q$!5#ROR\[(>YJEN;-SA3-S
M0B>DD&7ZH)IY7!:^GF\\QO1!YB\'U`=OE>FD9O@'*PRW9E_"0VT]&Y":T`7-
MT`.-K>N!A,2E?TRX05NKZ>1:H_-!>;JYO;GJ@R'\Q_?+1_!;;O^I?.G=7=Y=
M]2YOE>O+_J5R^MW6`@,/2'_(J4MD`>P\3;9;`+N@D)7F+R]O>U^!WO2+D(8M
M59V^@NNV?N$LO,EG7^RJSR_HZ_R"OF8LXNO<DKW*6ML50S6K$@V)1L'16":_
M:Q9P;U>Y++XISA\O1=5V7EQM^NF$_3NO5N8LW^IPF^MFM2T8,]$F9EDE-6G"
MZ4&7+!OU=/5X__!P<_WX_?:F@C.()%]@P;F#Q59EG)<RBX%<MJ.2.?QJDN7-
M1PAF<SD!_Z%2OW096=X-*6J2%"$IZI(4(2D:Q2!%F6Q%ELNY#LJ)ML<'8;3E
M;`0AP=I\=-H3#E!6:-\[X-HI<5E#U?"$^;(0<_]D*0#3E:2^Q64==A>$P&OZ
ME8NC\6,K:*E5&@<[M5$R4G4/55E;-CIUJI)0>>9HU0Y%J$*9E4(>/L";U;%K
M4BGL23%$YE1M5^KUVDX0V>CN\Z*0IUO)/%$JR4/)4ZM7U,9N%.)1D*=6J;;V
M+%R%,A,%C3X^:YZI\WZQ5H#=T6QN.FALR1L:T1!3VI+\[%X]K^VFG<$QZ`(@
MSFYBMB,A3E<29S%Q=A/%YK$A[&/12B6M1;>\)1=&5I<L,%^%J"ZI=M]:75+M
M\MEE=<G;WRYP(8!$0Z(AJTO*6UU2D]4E&U>7U):1Y=V0HB9)D:@ND:08A=4E
MAR=%F6R%K"Z9YR-977*D^5U97;)9=4G]4%UI2T>J:G4W><NC(U6]HJJ2JW*2
MJM4H=$-`660BBTS6JZ*H5YJRBF(9>=IMN7.ZD#S-2G7?.V!E(D^KTJD>;H/P
M\&:BH$&(+#+9";OO?S>\7,21=F0)<79SU\"1$.<(BTS$SW$+F'S-6UC#%X.8
M%S>V;_JS1S(R/=_5;/].FY"XM4LSL[7+%;$L@[QBVQY7FY+`-W6OHO1L_?SO
MORP:,SWC%;'A-P`.!OI?,HNG;&5.B7GW=J-14SOB%*E!XCFN'3W`GC?]V53`
MIITYM%H]^U\VJ/C6_%@/Q#4=X\8VKO$ZR6C03N:@^-\SM7965Y-#)P:)Y[B$
MWPS\_8NEC>*QNYEC#S7+(VS8Q'OQ<%?LVNLO)EY^^4^BN6FHZ]7,D<]$D!<-
MDE[)/X`;_M=V7NPGHGF.38R>YP5XKVPXEYHYUS^))R[E@E'2D_WN6('M:RZP
MMT5<+YXD^U[8.T><(_7R'$LRA!_)U'&QD=H3MJP2ILCN=Y;"(WN0]%04@"L@
MY@@[8D4S9'=2NM7<$5$N=9U8_`YT^KHX:V*\]&0/P<`R]2^6@[=:AU.!9!N@
M:";`2Y].SE),W,.)_P$D#6R3??/]Z1HDI5[E_R?.+0P_1U'J!S[YH'&>T!?T
M[@,?>Y*A$QV#TA)!Z=U]R8#EZ5Z`A0UU\FNG6VNJ[48[0?XE,\Z+=,S;7^`;
M8:FS-07^-RG.J0$6S<"D/C5'MN+X\L^L&80!DKVZ@"NPPY=C7TZ0W_Y#U?S]
M$'M\T?V=2]MX<,G$#"9>SWXF'FL6&`/13;!!)H?/,4&K13E@,Q"2:'S53/L6
MHH=[^TFSR/WPP<7;;8&W+#`?-]%5PR'8C>K:8-?4!-#Y)DP""0;.Q>Z1UX3]
MV[-IE[7[\![>2W;9>P2DNC:09[5VDK;YIDPU=N2M]/O.I4[O-?ZFN7\1ZH$\
M$3UP3=\D`I2U]3E`K:EJ)P%GKCE7@)E8`F":C&6OKPTK>`S=Y9`NG#8)+BAT
M_N;]D*[!K6./^L2=7).!`&%C?0C;M02`2R=*,R1X>B!0#W@'?01"<_T%K56[
M*;:+!TY/&4DP=AS5O'$\<4*/GS4SU'AZXGJU'MJ3Q1,D`:"JG?H&QC6]=9NI
M1J;L[\@+_4E@[_92XT+)\2<V3G4=RR)T\?W9_7!(Z-"N,W*U"76RB/&-=G#,
ML$/`E_56M1/CD`_&)%Z848$5!V6*2A/?<<"JSMA_YYLN-K*M!\8$!VV^:H;9
M(=I2%/2^!RM)+0(-5\PH<%E4MUV<KJN:KK.6I+S_**WXH>[7,`RM%.QJ2IA)
M=<F0M4<=1U>STU:EP\2U\I@R,^'IES'PV^P,_%T8#SNUFH9)FY5>6I:"U\R[
M?')EH%EXYSN[J1[#*4_3V=!C[9DH`T)LA6`C59O"9MH"K/!8LKDJ`PSEPU;`
MR58\,D+H*W$+601V$'BF33P*O$&>B>5,V5/`)L$0IF?7W2-`F.G#&^0A$F>&
M']^Q'7@'1XJB0]H4=1S`^\J8:)8_5G20A77;F^:3D:1<???`NM]XP$`,[U!^
MLD.K8L@/P(QDC*`NG>A,73!B;L0/R%.K!8AQ+N8JL$_WBPE,HD4K#4.:\,;4
M`I*/B`V<19L:ZUC5Q+@>)_EN8U-6!6,N0KD75+=KZIIR^OW\Z3R&\>OEY<,'
MD%CJ`&!O8UL;42BPIS!M/DPBCD$N#V!!-%#:DRF3/'\,H90&5H++NTNC/9B9
M5U71IL3,&\37+5,;8/=Q,Y1B>,6(NO#BP\B*M'6WO_`]-I,18I:/IN%L60#R
M$B+V$.^-["D&D^WX)4I\:K]`.8'HT^(C+[!@$%@<"W<`T%PJ0]>98,69)Q!O
M70%/"FM2D-$5X!X!6NEG<-L!D47VL9F=X"B&?%.WB7:JQP\"-J43]-"N(">:
M!B9DL,_XV!R-03HM$S!#V8SCSFG@ZF.(8PPNW]C@&Z.#&65LY,IN-9[!T&8>
M]@^WT!8)`H#/A2.AQ`Y`%)"2)*;D.:.M\`V#T?-#34(5"`PT`3N('<<Q7E&&
M@6TP@3#0K?>BV&7MSOQYN#7)X%DA$WLAYNKL5%HQN#J&7XD1*"U',Z[UJ+.&
MQ;/`@93'(G<,3,XDQM@3(FM;MP*:X9I`J$`Y31DXP%+Q,Q4%[9$R`C_)M:G=
MT?#:AEGB$>1"E*0SB$$,5/8NJ&/D?APLU31?M\!LX*X!$T!@:Y/V[,^"3P-,
M6)(RM#6./6]..)Z*-R;XR(#H&EI!>`[,+M8/AU<-G('%/O.`ORG`B1L(4)JB
MN6*?^%SYE@V8RZX)0#,%HJB9+NZ+!X3I"G:W0&"[!'U->&;$;D)`.^EX7D1X
M?!LO2$#_&40;9QZBHQ!,`HN.[:!C2G]VR1@;YH,7#:\Z$Z*<XD@?!&]8`_BH
M)T.2XWD8X8$+CRKO;U3+^+.*@JX*F-\`WIT##I$+03]7>GAI`<2E>!M.Z+P(
M")M>I%%#@,_`Y[#/P*XC$[@PV8"J4;R)("(Y>88W8-$J=#R!5'1C'IU[#!_`
M6..HU%ZOI`4NXQQO"`X&T$)<V,>%BX/X&P0OFS!M!C>]%8)M=ND*`N[C)^8T
M3@AX$@;C*)?$*PNDBLT)_9EAP&"N8!7"NIIZL=I-^1^.K=/M)@3PT?3^N@(J
MFCY^BO5S]BY$,?1S`@%<.(:`0C'0V`[DDSFRZ2K`(%<!</F$VG3X\2F83BT3
M_BJ51H\V08%#/-\-&--2]WWJ^"2\'`4"\'^%OGRH4MDU)S'%**_KC&0ND@S\
M"%"PL&:19X$/@(VHS'DCE46J&/F;Q3B80-`)O`"/)'6[:(FRAZ?C+#)&S),1
MT:<Y")[A`\6NL6`^!`-(,]'^!5[7,$$[T^=WK\"(W!ZBE;$Q@EEPD0M`,*+A
MBDBUP8P]'`89@CC[N%G+4.%.(=YB$^/"E@U32NXS>GQ3T]>L2G0K#O<W\3UJ
M.C$[HE$+&@+P;PA>X.<DF.!$*K;CPX/`[A@L(D-@..2:J$N-\&6NQZC:Q*7(
M6+<PW'()V$02C0SXP:\F6%+4:&B@G1=J6S$I8CC!P!\&5C3><OU5#+%Z9*$C
M(\972WMU,%ADR3Y`LMG^N:)T6S]3>G0[/V]V)4ZHF]@M7^&R\>AUG?MRBD$[
MD?=<8B%C.S:[WTC3_52*S7%'FLTS:YYR>O7M_@-+480/@5%U@U%XUY/.6)!^
M-74=(X`!D?;(K^C\G,%#(Q`=<#N0T8$>X*BR?`),9X`EGYJ3@!G6D07+`X(X
M"2;:0'DFA@,RBZ[5"P$/4V,IO6%`88BS@``)M1,I7:!9GB-@"WBP]^G3-`QS
MM1>4>Y`Z>#8Q#5ZK9(_P.BK]+VU$/Z*D(B((IS<VIU-*JV$"<0J`EX'L"\U:
M0,RH&>!^>P3S2#25@U[O#%T^P0A2/>D&-.\3.FH"T+F(MOZM;@L]C:1+\@4\
MQM_18?Q&--3#M,!DZ;9!LZ!WME%_`M%1*#Z*@%"Y'(ZT9=&)2VW3@JP>2R2"
M!$T8PNG()PP-,G)[20'S"/G+8ZKA%<SK?P@+`5@BV1F@R:06RK2G`<!QRO,=
MX,]K\#."&(8$GA.X++XUR!15-5",Y_:BZ3XP2^>P2]Q3LP5VQGS"RWA!FY!+
MU08.",_8>0ES,(EKYYBP@JNEDP4T_`#1&K$Y`4.O0B`ACX6S7PZ5Q**D*^JV
M,+2F3I-#MTUH_M4E1+%P=R3*QPX=-.T(@S#_&)QFS=7',U1F!AE22H.>F<](
M7RSE[\"*/UMFR.S@5H"HXN<+\#5LL@5QW+)$W"*)XC_5"^5^CCUHR`SD^7?@
MH!:FRTT]38T:=LX9S&2P2!$5>IB]<),K>IEZC=T!RD50?'K&(GS^E!G>HYC8
M8PL]EXR7'1T\4Y:;\((AV`N3B0HXYC27@\ST[%C@=*.D@%7"Z)SB1JN?XJI,
M&L3C?T<._C+`7:XR>#*IE:UEK2P+SS%WH:09@2]S9:W5]T#=6)J;O?:4Y,E1
M<G!,G,D3]#'Z[6SZ$JY$_4+YGJ&$HXS1G#*&:&[",UN<V9-;78LU,^I\H%_(
MU=FBLHB$]),5FW91Q<V[1;F]G52=T:+ZGH4^TO;OL]R>CQ1B0UD]0J54+E("
M!1(7>7E"\E=W/)]OPT!8"9X/3=P^\RMKP_U%RGX8.UL@IY$5IHT/:1:8"CO6
M,HSX%;2NAB<%SFC6E:48SY5;<$#`U<8ZW!@8%G(.T>L8!JYMTB@G"2]+:*:@
M&Z*^8E$NKXX`R8/O$VAFX(2^!'T-<^-B`)AX46,%EN%K'H;`-$$+__"W;[%*
M$!/3BCE!DQ/N`[..'^+;E")CW!5V0\IET'5(P@M\P;LXTS'$Y.E]XD[2%*=W
M:U>$#1`6X]KD!6.Z2+>ZM,(;1IE134-3W$-F3A'G<V4!AP3TSF),MOENH+.(
MS!/],\U+_8J*R1FY=/L0DUXIVKLB36P:!_I$M/?PPM32=)9X1G4*#'&NW.!>
MN4%Y@AD8FH$B=A1_8_6#Z7+W<8S5V]19#N\??L$,D>;QO+K'LNB)H%-<.N:4
M@#(B?"^?+<J0Y_@-/.M!:4TAIE.RS!C;:?@^!4+$EP`CTKA94XEF%VH5#-.;
M.AY;CKAR@$N3L(,2$9%>A`PS"O5'-*5)EQUK!!`PW`J@YH!O0O!"J;AJ(S9%
MN789(LF*MRQPZ#+8:8S8?%A[/[2V;/E9JIGQ+7)L%O.S8"S:J[,UGY>.Q%P4
M+AE+\K"JDD@8SH',-(MLTPVYB/@P'4U]`Y_;-DVN&`1YL9(4)98SAI$MBRW[
M%#??O32_H0BBER`")G@5Q$]%K;XS]>+WN:+V0H1H8)>0QN2=YL@$%O%#H=.,
M693MH@)I,$UVKGRA0BKJU6PJ5Y*U>IBTBI'S$ACAB5U#\V.0N0R%`8,@F7,S
M8_8\M7_+,>%SA'-&6S7A;#13N%72,*X0EY!OMN&_3&>`XVRAD:1C#1$)+#MD
MEXE7^"%@%WD(.0:$7F,[V51;KETXD===2U7/\HI%H.<`%1'JB73M1/99MF*X
M=2'\BHA`J;RZ9%I;=US#R\C$A%O)N+/-V%G<D@8]J+&B?`C+HR)4O@,-;#4R
MZ29+G*L)=XUYE#/W"!O,F,_K8(`3QT*#L%Z9U1C$(,]5'=$1/7.^L)8%420+
M9P:,Z!;-0QJ&P*9]QO4#&E"">2/N!D=5N,II[^&1TAW_=_VAPCU<#69T3>*S
MHB;JW(JU*'QWAH,U<0QB@0ZZT>B\7(4L2$)&V3\0S'"OA2*6$1<RJO#M^\#C
MC@_W*U/$H21/(!.2`[?S>;6+E_",Q,C4)2/--4+G7BC8S`"+1ZNTM)-Z(^A)
M(F0(B$;5))L[X;UF#)1*7B9A@*4;1-FA8:B#\=<DEMSF>F&A"0..EZ/R="R^
M!:.CQX6AB39%EQ`T,?,W$2R^Y\&-@,.=6KH%HN.!-^39CXN0B,F51,%'1VXD
M.H#HM5)O3?!5N&W)QBK'G#!\N'.$6]E#RWGA.ZO1KGRT?X7>*H[)P:&$F+J(
M+*VAQ3U3A3$*S?-E\V2<TA-\)=S_1O^&V67^?4S)L.I(3`@R;Y?Y\0836.9.
ME<'[[-%M1ILP3"+T!)U&JT("5_L*SL45ET#\^O2$?WOR`<7G7O>=`0A0K5KM
MIEPFKECYX[#H/ZFU\V8,PP1W\UAHUO@9P8%0U*>:$/P7!_F01Q@#<'E!]WPA
M`S?0W)F0-VQ6V+8PW5,XN1*&>!*'P.-2)Q_.%<`Z'(2^EP1XBD>G$,;./(QT
M=Q$(X+'@TK+8V0[A"&M42AI6<K@!$6HKPMB)6["EH*Y]%F*AQY,Z6>DXQ@L@
M!*Y4+S([[-A@^N^TPY1]$K\8#E,,N\*`+Y6SE&GT(F\%,]^Q^Z/'"PR_F-R_
M9WD4=+/FS+505(1[>J@4V6[>$%\G9Y@L,^9]D/16&&Y*\LJ:K*SQLF)15@=)
M3)[[CX-,(2B"KR>LSI$9$T,1=UIHP2E6(9H33*5$)9/A0.*+/)6AN2X=..%K
MAA*8QC8CF\8>GW#3&Z?"Q'0+>W=`1B:-E:,8FAZ/$':0!)1%2%-(,!2]"$>D
M`,(U@!7$#@AO1>S%-7U,"1K."TT/8M"7Y@^;STH]2I:CH@6BX"#9R]`2WJ()
MNU*D7<`$_`_$X-P"U%,FRW#H$2)-L4%/S>_*BH>0J.(';XD31&,'0Y51`')`
MDW]8^Z*'Y<^:;>-I&8%D/N'9OISBF#&#8;`J,H=ZH#`\*VJC5_V(6SFTMHS7
MVR+H+V-"Q1%7?M7DR`FQX#T`%[C,AL'W(205A1U0I!4UA&HCKKYPLY.XN+M)
MO>I,(K!D<%RP#5QNZ8&5.#$V'SGR%*=M\/)NB'>\\/F,BG%6,"E*#Q7`#*'"
M@D:"@"3GK:3DY$7S(J6[:'TLZLMR^+",E!X'9:&N0)@%RU:)HF.Z$^P`%C;X
MY^PIP'OJH*/V+)9ZIT*0R'\6)77(2RU7K#N2IY+<)DR`">PV@T@YS!TS!*.B
M;I[A-UDHB060EOD75E?1W5_<4*6_SR\M"W[##7JV%E[&ZB7GC<JXICB]S_TL
M+-FEV:MHKM7<_L+K-",]C-R#12ETE;"M",,_/X^>*_3D_HOI90(=<@$G<-X9
MPA!(8/W(B4_SN9";P)#5X"Q(!X7E0547*3,(%5D%+*N8#:OP%,(..*+?@5HK
M[#D1'?]+U`@SSG16%+L5Q!YDNE\NH:J)^TRB^-B"(F.Y(N&4)-#3Q:H#VG:K
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MR%MG117S84_",-$"VJ6&*9J(^^A[,$D)1%-@K31!*7C3+N`6-6!2A:6Z*450
MW[O7M/A"L^Z'V/#I%EW54(7R#8EL7;JPC*W('8)ZB>`$$3ZC&)<QF2=R6JB>
M/)ZDT='4"EM"]"`.8LM"D?FMP45U"?S,7LK9H%4`NNGJP80=__%"#<8#(%`M
M6"3&A#BF^42;,6^?%5UA-'O-M53DX*6`-X7Z41PUW-*C!?_A1@RJY;E]G;@2
M*-I(Y"<%DC$]/6F/P**:8:5(?*.UQPP1PX3B14-&88ZP9#?:K&)=(82Z;-\)
M,4K&2ZPA2@(:'N`*<0'/J)V%&;6T[R3L::ZK.7:@`M*-Z^A!N4=`?F13@B[4
M&$7NB10>.13P**V6<!D._Z&[KPPM*LF\=8.?.$JB`^]A/,Z/"?D7=!L^T#PQ
M#<0V;.$1%]B#%?J15]/#S5B#H*YQF=\2RCLM`^05.D(?,1>S6?#S1U9'1BR+
MN'_SN./'=[$&P8S0//70?&4#A0X.YCT_\NH\"TO\!-TQ7_-9AO`N[?81NK/'
M#P(QE<Q6BRD]5*OT$?;`P'2F8\V=:#IM@B;L:8OE'!I$<F&I)P:&2#M6DHP+
MC!Z8C6?PP[JRA64AC''"CFN)HY`\F8RK%%5)"],BV&'1E^W8+L&^'>P@.99>
M\$YOH#.PVA+5.,%3&_@0_0L`"X&J)#&C1[F%VK<*>+46:$T\0A4VN60[\<Y,
MLWQ^.)1NRXJ;_PJF0Y_#\VD"?6C+";9K-4$3,\4>&!;AY=F1*/#R9\Q>_H>9
MAM@E#QUJ6N3#)`4QQ]2C32T(;_]!&5UX>`8STM/S\UMM>(#4'EF$-HKDS4?X
M!@(U9<)^`E]4+U%CX*6K$%E0%.L*+HA8[N,$7HAQ\GR'Z;(M(A:+A-:)\4$J
M<HO&97W5*&`A%3D5HI'#9BZH&O@&N$[K.894+@:S!.BT9)"=`$(^9B6(X1`A
M;X;[?G&V<H!QA>A@:,GYQ)/',8>'!B(11++=#A.T)#H5(5:F%ZM@0U"]%-*0
M&FYL:.9T,%\X<$3XD"519K2R5E0O<0>5E#Y`/P#KMN<%-J(TK]B)GD`_=LAD
M@U8%QPULHM+49]Q2<8E(_0#KT\&=PT@V;(,PF6*W!''K(IXD]E03NUH"H&(M
M+&UG\^Q8>#SD7X'!FUV*!Q0RCC_%G,C?Y:D!@&UL@L7E.848ID1H3I5KPJGD
ME.-;P?`1[!_UT)W4=#RV14>>[E2A1[N(C.+LM$-.6!E@$%Y-R4J<(D)G;'(+
M\RG.P,)N'27)X(==G'GS#2;LK-T4/W`=VTFL5XR/\PH4T6*5NF3'>]%`42(B
M5CW</K%.#HPK1BX]+)?4.#R!%#E@B>&B=7-Y*RLRA!\H]]#",R/>G`NG0B7F
MN*R)#[A<5EQR)'08FU.SX=NH&;F;<:[,$Q;YWGBF/"*<X(D*FT(]++`2.QF5
MS85:RN5-4#BL($S1MPS\R/T5YLA$W4G"SD#4ZYK.D9;R"_.K2%2_2'MNLA"<
M>3^T(!AW1%F!9&@VZ6*`JV>%Q^_CE>5#POH0?6P[EC.*F@TE)2`^11`I+,I#
M-'W*^G/`LH1(Q2Z;*W0436HQIB9UIN#HC$*])J\),/A#P.&47Z)-S.@<&8,_
MMDGK!M4K8]YTB,P8\-(VKF/_]8:5>::V'EI%;BSZ*`8'`BH*QZ5<B;7'1:$.
M+=5-%=2#FN-EF%$KG4BO\.<7UNXJ"V>*VN*&+;[0=++>+U%?&9]NEO,Y4NU[
MA,?";77P[IU7$Z_W&\T$_XMWIZG0Z!ZK=*,AQ=-VE4@V,`AC!W)X'(9GY`(?
M?84(\3)HSJLD&2."AP%I]$6Z,CLB;+3,Z69)C_<?6,"#;AP[GTY5*/S`M5MH
M@,.\!XUW\`8F/%KKXJ(!^F/P.?\@O+J7VUVV\3'_OCE?8@VSB:Y#%$HY@9L(
M<CS<#(X[45=P;A,[DH6UZ2P)'!8/"CVKZ:\4QJ@5&CLYP"YBQ":DPL8SSDLI
M@'ML6C`B7/7R_`P)&[^+\*'7'6T.>M'N('<>]`5+2%/848YTT5.1JT/34.CR
MTE145(42FBW-^%<05V<L]-=F8>7H7WB9U/J&8Z4E8*9#MXS7BP<-BZWH";I%
M.=56D3OV,OC9$<!2608..#^RL5"M7_%88)I^W"7F9!"XWES*@B8[,W)TB?Q7
MF)/#5C,S<:R,>6(W?O6XD;L3MV:?.R&=V0DJ)Y.OX-G4/2MX6<EG5%8X.4#(
MKG6B.[1TEQ-;E($7B^<TTR<'6D5N@THO9SFCF"DB:J42@/1N`IZVI#V)SYA]
MT07$HKX#-+ZPK,2#VHN&[TZPPS2>AYM,+6<6NA;L6"^6,21J0C/WO<)D1\;@
MXJ8<-OL,#U72V)@=K>3=&4(=3S-)475#A6W>L>M5N,T!7(:$M6`X3RQC'FR7
M()H,U)?W#HE3*F$S#,2.M6U,Y'*.F:'H0[QRPV-+RE8:^X7$5$XPT'S=8'*4
MJ/VV2\ZB,ZD1L4,B4Z+'F\NHYZD[@!=34S[BS7Z=E8BLZR6\03>F&C<Z8#5&
M-KLK$E2PD/R']^F?EGBD*\.O*'0C1X:>$N*G"!B52LW>$7]IQ_E4:<.0XZV'
M>/LQWG-]S%>V7@?WPE_2)9?'^`M^KE7R]KSG,'GT`,P<NHE4WS+T0)!_JIVW
M8D#X*4JZY35W[O)O7C1:?/D5[9:'][.:T>4AX956T8%MX=C9@O&$1C%T%S;S
MLF*Q@E=?5_S?++USUTD"_?O:ZT(9+W(C,@:]`N"7+*LD6KH@[-@05R'%_1VY
MD:=-*=@Q<Q9Y4KQ]Q%M,087U7N&6(;TZ+>QKH;V*72L2WXM%LE&S29L=71?J
MJ?!1Y'W67)(VIH`X>A#XX6$S(R,^SP@6H@N@>!DOW2>.FCK@+*S]I!+=(Y[<
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M>>4JA6J=<*ST[1_</5ON7`H!#X*RS&EU%E]<E>DGQC!MTIXOOA^57N.0\<!&
MET240;WNZAAZ=(^E.!Z].H75KF%1"+MMDE38H3"P5I'-I_:>GU*EC$MO>-'H
MMIEPX]7JFZ)8O1FZ0K34FK?EU+,9-*H"XV8R1S#$\$/J1*>MF?+V6'_M^*IA
M:H!X$7=X\G71(5>LBF>'7)-&/3KDFN#M-QQYS;K?(9^23YJ&&\W%HAWO@;@T
M_[#0(A2Y;0L&U&@'%,!"H6B4RB+@!<1ZK/2GC&<G6,$VICYBF.BBS@HRU`O!
MK"$QSC3<4`3AL@/49[P]6/2FEV@K)!Q<8_)1X::"G[X&SU]G*A@7GIH3K$ZF
M^V8FO79<@<B`GA`#CI\!N,_T8#/NXED!OKE_%)2I%6""US#Y&:^Y8<4+N0R$
MDYZ(7V.&*)#@!]?Q""`?A]FO'#-P8HH[D6G'?S'MA"/2B1L30X#8Z?^XW![C
MO+,($+K)Z?'*?V_Y91"")#_</_7ZO?N[BZC@]Z/R<'E]W;O[>O;YOM^__W:A
MH(!'7][>?.GSK_[H7?=_NU#:U9_CGQ][7W\+?_]V^?BU=\??4)O"4_W[!_;,
M5G3#_SL[4Z[NOWV[O+O^!!/\V;_\?'M#@:N<J-7JSR?*V=E*%8&#?/>(>\8O
M%805ZU]^_7ISK=#A^!`Q_<`_&MF?3G1:L2^@P?RB`4TY?3K!<A]B61Y8"6"W
MZ.\I<C+_^\4T_/$G#B@G`:K?,SK#A46&$9GX#&[X&!_FHOHQ00L&\-7][?=O
M=VR1GI2GFWX"!=]81NX0.YP\&OH7W\C]?HA4;9.WVQ$<+@K[)D,UFQ*-XT5C
M&>/?W%V+XN^[PG19@D2;)2.6`\?WG8DHV>.U16:92Y%61@-7^24&<YQWWHRI
MU%53+1C^\_WC]<UCI/;_JTK_3U&G,#`&;A^53,1U!_4;H-XYR="*V;`AOOCA
MGQ"M*3>+@S4*[2!;>>^%1H=EFI50EI]I:NLS#88D!V>,8M"A)NE`Z:`>G`YK
M*@K?F9XH@Q$6\H*;^%]75S<W7[Z(>F.Y*5RH;R(ONG_S?_VSWMWUS1TXWV<J
M=<@SADHYZ9%/GFF]GL0ZBP7>]+I&/0.3=2UG>:;+]J#F)F]6VNUJI=EHE!C5
MHE*VWNA6.FJUQ*@6D[*-2J/9K53K1>'9C?3QR]CT2=&U\6,JE2<5\LZ8NU4!
M'Z;$:$JJ2JH65@DS1?C4^_]N0.6=-U'G+7*3A_3_,A7S;>_NYNRW&R']O`YN
MZ13RX_T?3[]=7M]<W=_>/U9._NL+_3\QD9Q^X^OW?O_F\>MC[[IR@E7>9V.Z
M0W%!=7CX7I)@V4NR`2)YAE\=G[T-@*P(3N!4B;G$?`^8;Q:%YU8OY^JZ"B;7
MQM46M0Z%,'OCB]*M4ZO6\Z_+FOB6?(9%K%Q>C"3-BCA#<6BVF=HL7O(R:1ID
M&+S%O&1+YB5WDY=L-F5><C=YR5:S;'E)&1++\$AB+C&7(;$,B0LQ0W%"E?+,
M(&E69IKM2VVVFX77F^WF5A7GFAB7?HHM\72A<))D*^H4!2*;#'5EJ"L#/HGY
M(4)=]A'/XD5_\9/4#`848&+3+@S!RE-_\Z_/'\M><<`Z>1K[CKQ<1@?R'US'
M=K!["#W?OJ)A1Y&O+GTD6+*OQ)@I2=0HX<IR6/L+O6W.G+"+-N#?"FT>(/11
MF":08UU^^/%IUEOF2W367R#)$^^^X"F?'6S"</KE\NGS!WKA+N_DS;LS>,3W
MV37NV-D[;OL1MGI(W9:CQ3TT(U9F!X?Q=#`VW3A7OML6;<_L\]O%:6.'`"_0
M3%VKF6BAA+^$?0[HQ7Z`+G;H8;AZ$3X1A.&Q\7CZJ)M2WOX)\VT2%'915$97
M!7K4/.S4L&XWA74E,27']"S[_?`^O-W\B8P8-T0"VSE1#%B/B69YGTYZ=U^R
MY)?>]43_YN^?_*H*("Z:)-W\AS:.9%1Y-+V_0!/A%]J(J#$X71&<C$:[M3^?
M\-J(;_0HWI]7@0<*E[AS8_/?OUK:J_,T,?WQ_Z+7\V#I[`<!HX?`)2>_5L^[
M+;&%Q6)0WX!4N[H"*75G2'5VAY2Z`JGZKI!JMM^"U`._>A2[EOJ7MG$3WC[Z
MG=X,?HOWE$>X9:+S)0`+BNWJX.TOYBOMSLN!_/6A^<\8J!Q3;0!;5FO4/V_9
MI5>..XO>/0!H61T=_T2E&8`ZG0>LOC?`LMJ(_?E-O,PB!=V?WTS;G`23"-;V
MWF#-:G"S`E;M-0&K6MT$V,NXL>H]&N*,?C[8XR:K32AK#G(9-4.Z(_[]L*^]
MQLBU1:5QEEJ67LK8?'^Z/OFUUJ+A0(S0#N#;(P$ZJPA0.SP!GO0Q,0*+W`\O
MP>T(.[@\1:W4;GAC-W1!F72S#M'#=(PQ'Q^TMW\);\(+3_^8R-ZLW=`EHTR+
MO5K2!C5+\9D_U<RC8=9(CPV=;OQ""^$N;WM?`7_Z18A3LZM.7R$T7K_1#+S)
M9U^<E)LG\.L\@5\SB/HZ1\)7V9MFQ5"RJ<LQH[&,\=?L3;-=J92-;F2C&V'X
M(^)`V35'=LV177-RT*$D77-VI'4*?XHERZ[*%CP;3B=;\!R<LK(%CVS!LU_E
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MHXK'Z;>!STY)I.8@45R<2XFP$/U6LI5`X7&OK<8]<Y&;S9(M<GTEHNI6Y:#1
M:':K]4:92-3(0:)CE8/F:MPS%[G5+-DBMU;W(]NN/6BWJ\U&J4C4SD&B8Y6#
M-=O5Q8O<VO4B`S,^$]<WP<]["K#MB6ECBYYK,A#`[ZYH_U/M_J/QYS>U6E?_
MO`I<[2NQKQQWZK#^9F$KM<43S2TS[2"DUIJI%D)+AD@BA=_T;&"E`-L%]?#H
M+C#6(SS\Y.,;<;NU",?N<H]N!TB&C>&JP@+G!SR)\".9:C/:O?!^F%BZKKIL
MZ:@"_H?ZY[=J;:L+UTDM7!J\A8V;\O6(ZF-4,M^EJ9O5_^Z]=VGJY.O25"U3
MEZ96N_G&+DWP)I]]7YLE8KY+=FF:&ZK;.@HTVO6C0*/>W2X:RQA?=FEZ-SU1
MOMLN@7?^0PSEJV;:(AU^_.$4+?H'Q4E]_4US_R(L_9CX/G9[L7,X[9WM:Z\4
MW\'\5NU[HC+OG)DD5]A'4^GY9.)),H%7X?B:=7!"')'.*T%?L.5,](:^<Z<]
M;*WO!)YF&]Z')=RT?]P+P%EO/PV4$7#LHB?(9\W2;)THFI_=-E")NIEMW"CD
M+4[".KY7OG,//^UA#K79VF26]T.H6J79Z4I2Y2-5N]$\$*D*I4C7:[6T)S5*
M<W1@1X4DG6+2+)UR:E&O?D"&X)7B[3:6YGGFT-2U+;;8V[$<%$/,3ML;'59;
M..Z'(R!-75)F$=.T]TN:0BG+@GJ=;/O-$[0A,90A7HCF+%2D4E'FYOFP'E>M
M%1D92:O"#%\:6NU<N:Y54SZO;C<N*P^1+%T9>>[AME9"O*^288G9$6%6+.]L
M"V>U%RO3W6J1?9W-+L.(NSX#6X81)0T.28-"J;5"9NCNB*_H=`O8/YL2UW0,
M&6O*I)Q,RLFDG(P;9=PHHRN)F8P;9=SX7N*%XHPH:2#CQF)O5N8ID<OP]`L8
M,1:HG*F3450HZ91=(2>+"7.2JM7J'(A4,KZ4\65A8A6)6?DP*Y8C)N-+&5=(
M&D@:'%E\N8VVS`?3:WMKPUR.(7?>Z+8<0THR')H,,O23H5]AP@B)6?DP$Q0(
M^WB(3L-O:3>6[%WV13/=WS4K()>>1WSO&]&\P(7A[$?L4^*"'ORL>::7T:RL
MOO5F95E;`SG71+8?R]%^["T-Q]1J]6<^X;Y"`=$.R8YC<T-U.D>!1E.5:!0'
MC?J6V]@MDU_9..W=]*JZ],#I$;'_\8<5F_&#^3S)>R+8+7DF5@RI*FDR1Y.:
MI,D<30XO.T>DRDO?#P[O))`-X79Q0^2:I6Z+.72GI6_?')O,E`EM0*H,`UA0
M!595T35OK)!_!R9`A:W,Y^G]EN*W+5XF_Y;I]E+)]+8YU4:GTFQLU"CMP,0M
MYEINJ9]%.9"5C%N"Z4K+N,4QK>N=/CZ488UZ>BM>U,9;FM$=:Z-ZO=+LJ`61
MF!),5UIM)!FW8,0MYEH6CW%W;D;7*B:1=V;+^Y,EYA)SB?D:MX4?.K.XA;,;
M^0W:;I7WOLYR+%[F\LZPZYI_2;,R8"1I5L09BD.S`MFMXNV(9112'F48?(B4
M1JU3JZCU:D'"[A),5]J4AF3<@A&WF&M9/,:5N3B9BSN.[(3$7&+^?C`O4$PC
M<W$EB,;?4[Q?GADDS23-WA?-2FFWEK3D*(KAVEOCG*TQ;Z&FV'EK%4FVLN`D
MR5;4*0I$-IDVDVFSXT@D2,PEYN\'<T%OLX\[:$.5VJ#/>;PW#A,21X:37OP1
M-7#*&R11*E/@*JR[4F:,DZ()#O)]Y:+%]./<(QM&R891Q](PJM&4:!0'#=DP
M2C:,.G##*-D(:"0;1LF&4;)AU*%5N6P8)1M&E:8\/LL+D0VC"E&DK'8JK<Y&
M=^%)VAXM;8NYE,6K_R[!=*6E;7$,JVP7508./H2B;W8KU5:S(`)3@NE*JXPD
MWQ:+ML5<RN+Q[<Z-J*RTD;4'$G.)N<1<'E"3!]3D(9@2821I5L09),W*3+,"
MV:WB[8;)9E&[F[/=KK2;]8)$W4=&V])O9Q68MC(3)S-Q,A,G,W$ERDU(S"7F
M[P?S`D4T,A-7@EC\/47[Y9E!TDS2['W1K)1V2[:*V@'S%FJ*`G6A*=,4DFR2
M;.^2;#)M)M-FQY%(D)A+S-\/YH+>9A]WUBHJ_.OOOP3>V4C3IA=?--/]7;,"
M<NEYQ/>^$<T+7&+<VX]X,,8%F_%9\TRO3U[]SY:C__7KCS\HRM_#MY_T,3$"
MB]P/+Y\UTT*XOSCNDV:1I^A<#0SDV+IIF9IO.G8?GXE&4TSCTTE?&]6Z#5P7
M&QL?/9+AIY/K6E6MG_R*,`M=IS!Z.,,`YD*MGB/=Z1=#;6):LXL^4EVY(R_*
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M/W\Z5T;.,W'M"02UM(WO)+!-W9QJEN(,`!NZ/RHM3XD8OP##2U))4KU?4A7*
M\APFNFFLBF[\`*MX%--6')LH,Z*YBN,J%O'*86KVTH\@9_^!9J595\LOMON@
M5:TMZ91GCM/&3NCTX4C(@R+7W`V)2F9=#A77Y+4OVM`G;FQB_+'K!*,Q_DO8
M5YY`\-U]*H-)*X9V4SN56OU0HE6`X?-JH%:!<2@&B8IHPXI!&92QSJ$8:.?F
M:ZWC8/,&;>,382&2I3L!EGNXK9V!V=>9%XF9Q*P$F!7+L]]"KZ+%9F*W^G%?
MO8G*,.*N^YF4841)`TF#P]*@4*K],%L"*[:B^XZO6<IQ;4@7*&79KE?:FW4I
M?C^TZFS4A?S]T.ETHX[BN\FP%(@\('*=1E6F662:Y;T'MA(SB5EQ,"N4+R[3
M+#*TE#20-)`T.+HT2T%K_J\<=^JXFD\4@PQ\>;JLE"7&!1A>DDJ2ZOV2JE"6
M1M;X'WFFM=ZI=-LR*YUKCJXD4Z[D_6[H="S)^X-*7*&,BRSQER7^6Q6M6K72
M;A7YP%HQR*36"HQ#,4ATNIN"AB,H\:<RMIOM^0*8+[GW+'?[)&82L_)A5BS/
M7NX]R_TV20-)`TF#8]M[+G")OU[J_><"I2B;W4J[T*T2"D2K6I'S306BTZE:
MP*X)!:(/RESC4+PD\RHRKU*82%9B)C$K#F:%<KYE7D7&DI(&D@:2!D>75SE4
M,<R*VV)89F52VCMC"A3AJ?5ZI=&5183YB%65^:=\>97:;JIYCB6O@E+7[,C$
MBDRLO/M05F(F,2L.9L7ROF5B10:3D@:2!I(&1Y=8R:_:V\W"Z78*TO:4^PH,
M"S_DEGA:DD&209)A"S#+_(;,;Q0FHI282<R*@YF@&ME'W#Z+_C+,YWA.5!7$
M-A1GJ`0><<^\*='-H4D,I7_Y]>O--?SS^?9&=`(3KT<;@&M[K@-7^66!8QEA
M,XTG@EG#J1[NGWK]WOW=A>(22_/-9Q)KYEC/^_-Z'K[ZHW?=_^U"Z51_SM#Y
M?FI_4A6?XCK?S]S^W-AOIU2FP%5.U&KUYVRW.T43'.3[RD6+Z<=Y42>V3US1
M,+'=58:*3U[],_KDA46&_D>ZLWMYV_L*]*9?A#1LM51J`0>.:Q`P>%5@?&(A
MY^M@>Z._N2VF?[^8AC_^=`)O\MGW%:*)9&>T`>/Y_=L=P^5)>;KI)ZB5;_L'
MR7$2"UG^[2-.![6VR=OM!=M0;QBJT3T*-)JJ1*,X:#2:VT5CF?S>W%V+"O.P
M^1]A[O'::F2=C=Z$"?7'>>?-F$I=O:><.?QJERFO@R08I6S8$%_\<#EQ7!]^
M,$0*_/C#E>/Y%-!!MME\+^3YZCJL$UU,FN^V2V"8.9)]U4Q^Y8RD65Z:W<*3
M1!(-/GS13#=)F]\U*R`')\T1&8"5*!_>`"QG*U5=GZ].>[;BCYW`TVS#^["$
MG?:/?`%8Z_!%N^KRHMUH':^)3B8#XL9DK:L5I5;E'<`6J(@"EO'N>/BR]`8N
MP/"25))4[Y=4A;(^AVG%L>+`R+?2'A61+%Z4X26I)*G>+ZD*96,*>M70<=WF
M+!F_*,-+4DE2O5]2%<KRR*N'COSDLMJL-%NM\HOM7KH,'JKC?LGH%%8IJ[4C
ML`?[$L+NH5HM%,K>',%M1&4P0,40+;5;:7?;!<:C&&0J=+>:8I#H=#>M18[@
MIB"0L4YW-_<H%<"TR(-)VSXP<;Q'021F$K/B8%8LKULV7I'-)B0-)`TD#8ZM
M\4J!;PK*OWT<&]#=?2I#VJ9`*<MZLU)O'>H"]9+12JT5.<E5($(5,8U3(/*`
MS#4ZATH&RER.S.44)GJ6F$G,BH-9H1Q^F<N1\:ND@:2!I,'1Y7(*>@S@JM0W
M/A<CNBX%+I)411E>DNKH2%4H2R/+_H\\TZJV*_6F3-_G*_N7=,J7O=]-!?NQ
M9.]1Y-J[N2:P9-9%%OF_(\>J55&[15:@Q:"26N2+5HM!HM/=<-$1U/BW*K6#
M7=2[<\,BMX7E1IS$3&)6/LR*Y7/+;6&Y%29I(&D@:7!LV\(%+O'72[TU7*#D
M8:U>:39DFYY\9=*RVCY?0F4W=#J6?#V*7/M0(B?3*C*M4IA`5F(F,2L.9H7R
MO65:18:2D@:2!I(&1Y=6.525RHJK75AB95+:"UX*%.$U.Y5NM<C-%0M$*[55
MY`J5`A'J=#=-HH\EJ]+L5JHMV8]29E7>?1PK,9.8%0>S8KG>,JLB(TE)`TD#
M28.CRZKD5^WM9N%T.P5I>\I]!8:%'W)+/"W)(,D@R;`%F&5^0^8W"A-12LPD
M9L7!3%"-["/NG45_&>9S/">J"F(;BC-4`H^X9]Z4Z.;0)(;2O_SZ]>8:_OE\
M>R,Z@?QU\?/??PF\LY&F32^>]#$Q`HO<#R^?-=/">;\X[I-FD:=HY^Z1Z(ZM
MFY9)&Y[W\9D^>?4_6X[^UZ\__J`H?P]'>W"=*7']V8.EV?ZE;=S\.S"GV#X]
M>EXQC4\G?6U4ZS:1[K8//SR2X:>3ZUI5K9_\BE`"D"%=T8$]0Q_Z0JV>(UWI
M%T-M8EJSBSY25;DC+\JC,]'LCPF2IW],6(=H$S.U)9IST:;QJP*L#_=/O7[O
M_NY"<8D%I'HFL0&*S9D_;\[@JS]ZU_W?+I1V]><,T^:G]F#5YL]SIFV;^'`1
MT&'=B"O:0[:CRX;&A3NC3UY89.A_I+O)E[>]KX`__2+$J553J>$=.*Y!P,Y6
M8=V)A0*G@\F/_N8N`/W[Q33\\:<3>)//OJ_(4+3'3([`9G__=L=P>5*>;OI<
MLM;9=$)RG,2RG7_3BM-!K6WR=GO!YM<;ANIT)!H9:"SCF)N[:U$7'S;1(<P]
M7IMQU]G1'+C*+S'.X[SS9DREKMX\S1Q^M6^0UQ,0U&`V;(@O?K@F.ID,B!L#
M6U<K"IHU"N=@/BLCJ0/4J1V<.D<DF2M1/KQD+N>LYOJ<==JS%7_L!)YF&]Z'
M)=RT?]P+P%F'+QE4EY<,WFH#/(3IN#,E"A?FZ2EK!9<>*JRT"GT/<Z%(=;AB
MP4*I@\,<S%ZA#+YI=C#4=-[JKESZH!@R5*NH]6J!T2@*E:K-HZWS/`*GX'XX
M-'6B?`E<VP1E0.CUBU(=O*$ROE+O%+DS0U&H5)-.06&=@ENB>63L6(;2FTQ=
MYYF@#BC'>:*"L'>CTI!M;G/<A%KIUF4/[.)Z!5>.[?ENH.,V)-ZS\.`Z([<L
M]RL4@\=KS2+W'RH&C53U:$,#62(EBU(D9L6RM?(XD3Q"(6EP3,=(#A-%YVK-
M$5;HR83:6QUHM=(]6(N``@R?UX?N5IH'VX<HE#(H:"Q]"W&S<JGKP22P-)\8
MRC69ND1G-;Y4.UQ.'-<W_T._D`HB?XL5%31$=S=II".X#NA4K57JM=THT(7D
MD7&UC*L+$WT>+V;%LKLRKI8QI:2!C*NWZ$AG')LJI1.VCT++;J7;+O*><X%(
MU:[4JG++2;K&[]Z!/%[,"F5'I6LLW4))@Z-RC67G,MFD29)A:S!+KUAZQ87Q
M'8\7,T',V,>]]3U:W:DHV=DH[I/4LWW-'ID`Z*7G$=^#E[\ZCO%B6E:R-5+<
MZJ@E6QW-M3IJ-G*U.JJ6JM51I_;65D>=&I]]7ZZDJ,Z/I=51L[.])D&%Z5;4
M:!X%&BWU*-`XDM4X$C0D4\F&9.^D(9E:E1W)EI"GLT7JR(YD[ZLCV1MY;UU^
MN_'@32RU%;'^\8=;<T@.SG#;%L<W-`B\<CQ?TL'_*-1D)QEEKA[[G1/JCDA^
MD7(CY::,<B,=G'TRV7M"*PZ8VNN+AFPEFRDQOC/=X$#;8L';Z0&W>)]&81LU
M%_.D?4L%;Q8ZF0!LJ4PUO0F<KZ1T-Y,?]W22M)*TY9M.DE:2MGS32=)*TJ:F
M*XZ'N]XYLUWYMROZN?0>'BE-\7_7[\FU[=D&&9HV+%%!&'>'N&YV^NQM<ZIJ
MI5/=J'6+I.URA#LUM584K7MD!);,*VE;1MI*Q?">F+<XKFY1DKDKG-W+R8C8
MRN6$V,;V^A660UC45CS]C&AN1K?STJ!<4`HW*LW"J(823)>WTUN]TE$WZH.7
M&\^-^N*5@YIJM=+J=$J,9T')*F5_)[)?JW0WNT5!RG["=VUV]D/-,OFNI4C3
M7CDN4?I$']L`]&CVKCQ757JN.Z9PI=;=Z'8_2=4LX]7=[#)`:;KBR>N;7:@F
M^5-*_;ZDOM/83WCU#J2^L2=2%L!;I?#G;>23RKUNW,5G$:%*U]4G$Y'=#;_3
M;C=OQF5K?7W2V.ZKSX_$7&(N,9>82\P+E"7;1K/?_`[9;IV/?37_7;S,NYIA
MUVUL]X^1I%D19Y`TDS23-"OF#))F9:99@3R^@M3TK3B@S2XDGCNF/9_).]X=
MTO>47S]$T6^M76F6>JNDP+0];53:[?W0=JL[)@4F::U6`:LBV56J@G+1]K1>
M:;<VNNM/JH(TN]8KG?I^2"HW4>4FJMQ$+=\6@\1<8BXQEY@?+^8%2JG)3529
M#)8)]%)@)&E6Q!DDS23-),V*.4-Q:%8<CZ\8ATM7;*&&%X_.)^Z.=\]4MO_;
M[9R=2K=5E+/F1T9:V>1+\JXDK22M5`OOEW=W[N'*O52YERIW&B3F$G.)N<1<
M8EZXS)K<2Y4Y89E'+P=&DF9%G$'23-),TJR8,Q2'9J7T^-K-PKM\%,3M^7QK
M8KS;*;;$O87"29*MJ%-(LDFR2;(5?`I)MK*3;>>.H-QRE%N.,B$O,9>82\PE
MYA+S>;^#?=0&%HG^,LSG&`8TO<0V%&>H!!YQS[PIT<VA20RE?_GUZ\TU_//Y
M]D;,N?#7Q<]__R7PSD::-KUXTL?$""QR/XS;B['N8I>V$1;-]Q&</GGU/UN.
M_M>O/_Z@*'\/![C4]6`26)I/C'M_3-PK9S)UR9C8GOE,>K;N3,BMXWEWQ+\?
M]K57Q30^G?2U4:W;/E$,`'VB6=ZGD[,ZKHKMPQR/9/CII%>KJK4_A;'A_>^V
M2X">_R%&SWXFGH_7FW[53!N'_T8F`^*>*(%ML@&^/UV?_*HV6\`P,;)KPKHE
M1#MK(=IW-=N#3Z9C7QK_"AB:V>C5FIUN`?#KKL*O/@=XJ]4Y..#U:G4EX!MS
M(`08A\=370O/]1APBP*V[(W/9.BXY)'HEN9YH.YT"E\&KK5EN%YG,>-9NYW`
M80,P=H!/?24^&_/H6;M18`(TUB+`&LQ[5M\-UI<3Q_7-_]!'YJUJC%AS;4Y5
MX;NDN"V=*O]BS%.]M5,Q6I]=YB%<ZC[L7S"V@=)21V%/K)Z-QY7FC<$?Q']N
M_AV8X-;"7-X7S71_UZR`7)N>;CE>X)(8F95>0>W/Z/UO1,.7$0$/I"QP7=,>
M,53BAWKV-/"]6_),+'6!N]=I=9)^16ZX-T57S>%+Y$+WQH/8`9;W?A@]GC'O
M`OP;G6:C>R`"K'0R<J[W1@0X(`,L=3S68(`L?J_M>KTOGS73PB#OB^,^P3M/
M")3IFR2V5^I23V1?'%ZO-SMJT@8N!'U]%)?Z&GOBX6:WVFKN#,.E3L>.N'2W
M:[;44]G0SBS`:(,EHH[94CVR,BVR!S&K=6K4TQ0Q7`3YV@CF2(?L',%VN]VL
M[P:_VDI/8!^.S_;0R9$\V+9\K<]^NF6\7D2_\OSEQ`ELGWK)0^)"#.>_$&(+
M(%(08DU26VW!TX`"@!O,O/92K+3`>U%UZZS$K:D-3(LJPK678Z4Q7KT<ZT^?
MU_Y<DX'_3?/Y7W^8_MBT[VWR3Z*Y/"@GQI7C^3$Z*RUO[<\KQYTZ+J@T'#V>
M:X',M^MI%;8QM+O#?J65KO_Y_>FK\TQ<&Q<#7-AO@*YN3C7K?F"9(Y9P6<"C
MS68]KW]Q>$KDL.]K\4&]TVWOA@^H+.4=['+H$Q?&ZH]=)QB-X1]"Q_46D"&'
M%_!FAE"[[2Y+1NT`A3W0)D?J9"T6::G=>GG)4<^16GD[JW1J]4:):9/#.UN+
M56K5=DO=+3W655,+,%_IK=7F[$2G6^V^25/N#HL<+MV;>1O\@];;+,/N\,V1
M85F/7^O-1JM@.*[.L62D2!K=HK'F+EVV=KV=.X.R+WRW[9@UP2]K;`O'M;1Q
MPK'[ZCJ>%^]]X8Y7C/,NO;!:9WT[L@KRG1)CVVY7[0U.UR$)T-BEHU5[@T-^
M4&)LV[/J%@+_A8[:4EJL]K7>SAC=-Q!F'2SV1J0<KMQZ"9YMQB6'),SJ1-X&
MN9_6/H@4&O`'UYD2UY\]6!J%$[=8I[2.!-^,,<Z1Z[O5!L@)CCN+!EG@Q:NM
MI!>Q'(@DP$^^H__5\[R`&-<!9H`?B&LZ!DV.WDRFEC,CA#[S$+CZ6/,(#AKC
ML;H*Z,]+PS!Q?33K03.-GGVE34U?LQ:L5J.:K(=\$WQ[8]QM>X1JK0`2G?&>
M4%34L^/B*(&A5_N)<[BV<JFO-:#9'78Y'+^W)YCR.3Y%H$,SQ\[E>JGI\J"^
MVMN;+\8L#8,W<]0FO9G!.[FBG$*0(4<%TWH!7JY,Z;91SQ\C8#VG4"K3W';R
M[0T.ZFIP=TR#'`50;Q:%,M(C1Y;OD&'NFVF0UV]*TR/'J;2W^P*[<__V3J<<
MF</U?(4CHLWJ`W%[U3%%I5,K1[YQO8Q[(6B3\>9*UZ2UNGI^SN]Z@^^Q#);=
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M5VC0*V`)TR`N,?K.9T([A_3'FMTG$R2R:UJSWF0*ZI,8,3+K;Z:NUN3YX7A3
MR4XG1Y+JFV8'0TU':V*/5E3MU*K-I#I?IVHG+\QYSH,&+L`5N`2&^6*^XJ>%
MA0H;U!GEA3B''W!+-(^,'<N`]71!6='P?1'(W7IMYS#G.KAI>[X;Z*A`>S8,
M/`(R+P):W3UCK.Z),.]8-E,GKG<!5P[+F[\NKI4Z,;$+@'.D-];2"NEC[;N`
M.<?NTQI:H9[J\+<#B+LY]H'6T0J-1K>^<YASE8?GUPJU9OO-(`LYSVLR=0$J
MZLG!9XO0[F"V(3:*6SATC-SZ9^O46KV6BE^V!-7;EF=UJ<^\;'9;;]?,VU^#
M]7=-5+7;7=AN=!]K<$<$^-<_!==-IWZ7390$*0]V,6CK-S=4TXY&G@F3((:]
ME&,P5EO#N0VA-(N&@R:GZMD&&9KP)KDUGW$C)-D7\N95MP*\RV(>I!PA)-5D
M.BBR1^(1S=6QW=@U]LYPEA@^5>U4DY9O71BWA6$.ZU@(#+\L?/.[1X:!=6L.
MH_Q:`SL99Y3F3T;$O@20#0'L7Q_4UC]C(/-,LPE@:A9@$*&3/M''MF,YHUD,
MF+HCP+R$<6@L[Q'<6TR[.4>CF5KR52"\%>!\A:OS-)V/EUI[@3='F%<L`N=K
MSG-``@N6/,NF-98W[,UTV>KM5'>`]:??'OCKV\)&NYV;UCL'/T><F(?AZQVU
M5AB<<EC*/#+13:65#HC2ZB:]^?12K9O*X1P2IQQ]=_,L4Z?1V1=*0IC0R-,V
M-Y>IJ*8[("X'X&W`;LD.U^NYI?S-H&[+!*O-3FY>?S.P6S*_C?P\/`=JIGE>
M&$<T<K2=G>^`T$QY!_GFW`S.]0WK;N`$@B^!<K7]G"\1I5>K+($R:\;\:E=0
M;#>O4V)[Y`[@Z;\0ZYE\`^#&L?>H)BUE,]?AP?R.;0Y0-D$+"R#Z+TZ$3:I_
M[1ZPX1!LC`26<\1HJ`=!`V'8%)$O3N#&>-36QJ.[,1H(P<98P+,Q%O5#8`'/
MBGO<NNX&Q'AT9IKESRYMX];4\=$O9&X_OK&Z^>Q\!CR,1_).EB1PV.W@D5#'
M2NA<.P?;^M5%W51N?N5D&63+S(5=P<RNIOO8J&H>T/5M9+O9ZLX3,??4<SEY
M?/W!=8;$\VB/BLRU7GWD;[XG1W*W9OE,&5?"\!>6K?+Z+1?J[8QK7A;.]%;)
M>,-M;\WJ7@0C1Z/0^;(F]1"2D:-M9T9^N9%!QMV*QNHFFW-P-N>O7-RV:*QN
MFIEAVM7.VK*10F$91&_8K&NK[;G+&_-`<TV&!+Z&I8>%AG]-`8SU]]S`>4WM
M:Z5'SS_[^NJ^D6J0F'?VOO8JD"F&8'U-WFBUU$P0DE,(4A\^P*[,^N(Z$RQ4
MHW=F?28V&9J^`-`;^N:HJE#TGF.R+39\:BQO@9BY,]IL5)-69X.63N$0MXYF
M>P_:#`L!(]A6=R><7]S4D1)QW`S-\Q38ACO+8JS5S0#GC7%W7M_,39`!1.;T
MZ]=CM-JUC+OK%DZ]0K!6][:;5RP[%:P</>7F&U+5JQL(5JR:GHD="&SYAFZ_
M:NKVV]38>;EB=:W^G'O=:6>8P=P,F39[.1JDS4<BRP%8[!<(#]TYMIX&9?T,
M4JO;K"Z%)9Y&X%*JQQ)\<CF"F)]6)3\YEA%#M#0KA+I4_8?ZYS?<(4_!517X
M=-5T;X&LN33#@Y#5LB'K[!RRI4D;:G]V`-FE_\?8U,?"\TF@EF9@EI"K/0=4
M]DSKPK,TE[*$L9H[@J>QM45;"0_S);XX+GWN,W@/]\/[*7'YT97`\S^3;YII
M^_`_(H"8!=3)KP_-?_+9UQLW5=C%[Y"]MYD)8:%%XK+?1JK-4A8/96<CA5*O
MQ=.\`9[VRC6;/]&P)CR4L%>.9;&*;O.97+JN9H]H[6YX>1MM<0YT%Z+7)^(^
MF[I@Z%*]AC(9K`X,UOT3HDPCT'UAL"C!`(XHU0*+M[H:"7[<`/`<Z$>@](D[
MB1'M;@NU7Q_J_UR!2`*$'"!_GPY=@`W<9_HVO4XK@KRUTJ1L98E8^?RJ)<J"
M5$"0>UGH\X6)$@]@^`KO"Q+26FV*-L2E(>*R%*@$\%.&UOWPUK%'N'9XMNL!
M`BUZD"^]+BMM5_T?-5B7YI_TI!66"0\6P-OI).'-`T?"NQ_X/5H/CV_U``B7
M>$BO!S<<"O-",>0KK5QNR!-V."<<<YN9]#&^N2!B'`.\T@S65H.JI@O>ELS\
M!A";*SV''""V=@KB2D-9S\&J;X7P21\3(T!K-I^,ZV/6H`^0?+8<_:\8X':F
M:_'?EO_1,)\5SY]9Y-/)$)XX\\S_D`NU>EZ=^A_I%T-M8EJSB[XY`<:_(R_*
MHS/1[(]?[N_Z9U\NO_5N_WFAI']4Z*]/O?_OYD)1<:23_Q[Y'W_\`2><AM,E
M1O!Q!/;8?VN3Z<?_@A7\B(__,HU?%6!]N'_J]7OW=Q>*BTEPT*T?E8?+Z^O>
MW=>SS_?]_OVW"P4GCKZ\O?G2YU_]T;ON_W:AM*L_QS\_]K[^%O[^[?+Q:^^.
MOZ$VA:?Z]P_LF>WAHUGFR/YT`NH8EE\8UJ=Y)3XT+MP9??+"(D/_8__F__IG
ME[>]KX`__2+$J=EJ3E\_GBA@<`SB?CK!DFMB6=Y4TT'91W]/-<,(_WXQ#7_\
MZ03>Y+/S^=UP<O[P1?7C/(%?YPG\FD'4USD2OG+:P$S_[^Q,Z5]^OKU1KNYO
MOW^[8[@\*4\W?>7L3*"(L8S2(2&1'-'0O_A&[O<Y'<#'W>#M=@2':X[&&P$"
MJEJB,8_&,HZYN;OF',-><(7I=L[.RC,GV<#Q?6<BBO)X;<9%S:N@*OYT4LM2
M(OA[^.S`57Z)<1[GG3=C*G755`N&_WS_>'WS&-'QOUB)BJ).86#',@UN#]*(
MZPXJ)AM1S%"#V;`AOOCAFNC4JL;`UM6*2(T??T`;1X$>1.#GP.6]DJIV<%(=
MD<RN1/GP,KN<S9KKL]EISU;\L1-XFFUX'Y9PT_YQ/R1G^<X4W+$14-8!?^R_
MKJYN;KY\$1EMN1U<R*"1VTE]P=[=]<T=0'-&O>TL'9+R:B,G-M/:\,!"X04P
M"BRIPDM@%`P\YPD]?8N1ST!N7>.WP739+L[<Y#\=8,Y:L[K-625APSG52KO=
M*@AIBZ.57L:F3\JBDQZTF>M8%M5)8:F&$N[$'(5B*J:XUBM-M5EB-(M)U6ZM
M*#0MCCHJFY/$RUNI1A*V691PCT2A):Y2->W.JJN53J/,'E,QR=JN-%O=@J!9
M'.U4+F=)J&@_GLBMF.+2;!8ELBC!='F=3K5=$"2+HX!*XA[14BLE5$1\5UOJ
MGUWF-JIJI\1H%I.J]7:]($CN7`.)11OG3;%X8K5.&M+_R]1)M[V[F[/?;H0"
MBW4(A7N]5_??OEW>77\":/Y\O/_CZ;?+ZYNK^]O[Q\K)?WVA_W<B[/NFW_CZ
MO=^_>?SZV+NNG%BF3<[&!)?\@JJO\+TD];/7=P-$\@R_>FOP;0!D;1X*3"\Q
MWR/F!?(B<DOLN;JNS,XKM]T*,H50?#-6GW01.K5J/?\BKXEOR6=8)!?EQ>@]
MT:PX^J1P:9&,JLNC=%`/LHW:KJCMHJ0&CXVVU4JW591DMHPY9,QQ')[W^\6\
M.#Z"C#G*X-V^)_^Y/#,4AV:EU"?M9N$5"@5Q>QIE38Q+/\66!*10.+TOLLE@
M0P8;Q^%ROU_,!1EF'_$8<_2783[',"`;$]M0G*$2>,0]\Z9$-X<F,93^Y=>O
M-]?\B*=@#_GKXF>AI5_N8_%"PX?X)=97BQ^ZSW&BOB-/U+^/$_7=^EM/U'?K
M?/9]N<FB@9`GZN>&ZG0D&O)$O3Q1O\8Q<44>HE]!'7EN7IZ;E^?F9<WS"=,2
MK$>R@KWAYZDJBQ"V.6=#E14(NR%LO5$0PA9'`16NO"F+H'A=8:2"^MJK$N8Q
M9BRFAV]]1^D]/%+*X_^NCT))%5-T&Y562RTQFI*JY5%/9?./V(T6RM!U)@IV
MYL8D,"HLV<=C#\?$6O6BE!>68+K<5%4+<_BN.&JI%%Z3$+31]N92]^Q22EI%
MD9(23)>3JF$UA5HK"K+%T4`E<8SPTC>%7_HF]<\[DI023)<W,&O7"H)D<;1/
M*?P?6ODBE8Y4.D6:+F]WCJ)L`>Q<Y\C:55G!*3'?*>;%\1OD0;DR',G:_0S%
M.?15GAF*0[,"Z9."9$%JRR.1ON-KEHQ$=N8MMRN=MDR_;INJK4J[)@MF2IGZ
MN"6>IUP%KHOMVA\<%R_2EOIG9Y)RVJWM1_U\>`>TK'<.3$N9\I`IC^,(_-\O
MYL7Q%V3*HPS!]7L*W\LS0W%H5B!]4I"4Q\K"#WMTABT'CBK\*/#AEE:E*R_7
MW!5IZ_6B7($C@Q,9G!R'B_Y^,2^0,R&#DQ*XP>_)T2[/#,6A62GUB6Q<N@/F
M+=04!>K`6:8I"D0V&6S(8.,X7.[WB[D@P^SCSAN7OJD!*>M=&O8\#8^N]K77
M2\\COG<_):[F@\*Y=3SO2G/=V=!Q7S37\.+.I=T3Q0"`)YKE?3HYJR?[F/9H
M'U,EL$WV]_>GZY-?V]UFLP/K'C=;76-BL=OJF%C#1S(R/1\?=NPG7_/)A-C^
MY<0)P&L)86Q7$S"VYF&L_J/VY[=JHUY-PZHV&8]60P*OF/--X*FKP*NEP:I5
MWP)6U-O6AZ7O>5Y`C.O`!2H_$-=TC*>QYA+OCKS0G^(E;M=$^'IW7^9[U=;^
MO()O7,>RB''S[\#T9_=#6%(<VG5&KC:Y!%@,8GRC7>\$;-B<)[\"/]1K78$E
M\L&X&5[UE7BIF^+5;#<3G/X6M&`JG1##^^(Z$_Q=LW40\"MG,L%U%ML(MQL)
M3FIN$2'&=C7.=+E!$^1AL4S?O$Y-/#$?H=%<A4;]SQ[VP[,UBY^R?R+NLZF3
MWN,3@_S/R]\O[_K\\P.0V.T[WX@[(FXV9J$@K00RN32L\0BHK4<"(.J@8ZGT
MP1=7\*SI>X_$(YJKCV/<6LOTY766OJS76FJ"ZKEG38D',MEGS2,&+!#>GTW?
MNG1=S1Y17?%Y%C_RH,VH^D#<OVBF^[MF!024<S"9XEM(#J+[Q/C=P>[.V!3J
M$33.-],V)\$DQK8M8EO+6LB;R=1R9H0`7WJ!Y6LPIVW<.7;X_3507?<=E[+3
M/9V<+^O3YRN!5`^!2V`=S]NJ(&U[PWC_E-9>DY3N[)_2M?U2FF&\0TH_FMY?
M7UQ"J&XAGI_)T0E_)TM\MTYG,*\[(O02A/=-YA0[=ZK[)W-M5YIC"<(;.3`=
M=;5CEN&3J+7J%KR2=6%=[436,V"MJ2VUWNC4-X/U4M?1"_:`06A<!':3F,\8
M"<$;?EBQ'8%:7SND:72Z"8+FFO"M7EYGI9?W9G><(5-5W^;FO0&5')[>)JBH
M[0U169?+6ZM#BBR)Y&'F9EP^%T5'#F%VZ-YIK\WG-8C<:\M#]^Q)5T,:?H?&
MW_9(#&5G;2A!9;2K*Z%,39AF83+5S/"W4(S9NW/Z8OT4"/!E.\66*^=+`BC\
M#C9/3X'4K:X/4B.9D\F<8(Y(C(246QEO7@;^V''-_PCA7'>YF:+0_`D!G$F\
MJ^20"\/J>G5.K)>!DFT->(.D]')V:^N+1:U1S]3_R2DV4BW=U=F*^C\:?W[+
M-/GMSA:L:`XA2CA+MA'VW\SVIJX<3Z!Z8VVJU[NUUKI2OC:`*T@`YF1*7'_V
M8#'_$TW4=))@I^;ZHMBJK\B/+ISV;0*ZW&HQ`;T*)@&[R"FOC#;7%U&:@[FR
M-,^['_ZAH;?MW[N/F,F_"W":^R']PP-N%4PV'2O&IKU:4/ZDKXP=RR`N'Q$H
MR<.#W)CV?#*!U>*IH[>!G5RPI6,\$=#"-(E_I:$[]'G&G_/X@X*RZ.11N=N@
M0;C:$#]5JT(`M2$FJ]@!G$)P,4!&[^V;5^+JID<$(N-M&=HHZ===ZB`C8I:Q
MVUV9,7D[A?[D8?0<O<)H4VTN8YNWH[<[PO7'KA.,QGUTM]V0BB#CQTC%!*X"
M24,&_A98OCF%:&[=>>^'X3</KJF3WRA5KC2;!8BD9]/<06_XQ1SZA-@<S'OW
MF^,F(>UY:89N5E>G`[:J^&J<]D4DRI;$@.]&NC>::Z.3Y+P0]PG`^^*XO\4T
M[#L<4@$4O#<208&WT*70[%F\3K6-1&:53#2K6Y");2*^5_D1(*%<LVP=<GC4
MRU;B@`*Q&DN!Z.*ZWL)PX`9_(>0:WK+OB/_HS#0+33$?7-`GC>7T4;O=YI]\
MP,N12VA>U`MUB6GKIFV#-KD:FY8!X8_WF^--35^SOA'#U#7KBEYIQ1]_='S-
M-5_QGV?3#;S?-1U>)PN9O!XR^9K(K1W1T#`X)LGZSGRK5E\W2*%S+EC`,(?<
M2Z"'HAD#N3()56W2>H?FGVR`6;1ZX8;IXY?T5^LN4#MK@18#GUP7#E8J%=2L
MME=E"W%[V[*T@>-2,R;DZT%Q79-G8CDT3(*0"44(94RSS/_0:.]^"%&5$>@A
MQE\M[=5YFIC^^'^QFNS!TM<D!5W^;CH!F<0M']Z=/`G?8N&M5CM;0+R;)SU<
M+,1K]37P7@3\M>GIEN.!+,W=%=U4JUN_*SKK>&I6^=O2FO`!?CA5&Q_PTM?;
MR\_WCY=X`;1R^?7QYN;;S5W_B1:L#>;+NJ-CJ1N!$)?A;>53?TR4T&,8:YY"
MK15:1]MW%(M9&D6+S)[R`CJ;#&:*GWK/#<TJ?\=3'%=QV,:@(@SE$WUL.Y8S
MFE64N`1PJOET='B'?52TZ11>H0SLG2L"E'_S^%C@!"B:;8#D1.R/!9(AHSFV
M"/:(V,2%('RF3%WGV32(,H2Y7,:S,.>,/4;^'6@6@BN`%BEV#VL7ITR6%$\#
MAZ<"`-CX1HC=1`.Z$1MW6Y0AP0>0A4T[0&`Y9C""1_2`0J@['LR*6$P=_!&D
M5AD&/@B$`AP,)L2Q20P=P.6/31?)Y:)%48*I8].5T/2Q"62@-``@=>+Z`(E(
M&LVJP!J-,/!QW!E.^0L00(^413P?D/O.L2$R"FR#7OX=(@<(*82KKA=8\I_`
M_,6,!.];@%(E^VN*XT_J>6/^%UP(Q&%&-!?YSP"B+[Y6EUT?2X=#0XA(X5JA
M8K%FY[L0./C2Q`_@SX&/_%J)8>K9^CFP@.(%`\\T3`WH"L3_[)I`1^OLVXP`
M/D_@KPX&RBE_F_4%,DNH')#B'`D0^&>2U!0:K+#GF2.;LB`^.Z<[@%+`ZFP;
MLP(KKOFA+'H1#PAC"&P<J@2L'F9^*DQM6;#J*'M3GB167)8<Q,>T6-\XT3`A
M]+$*$B_X\Q,JYO+A2NEK[HA@D9S2C][@1QD:G=I'-A%RMF^>@7FQ0:RI&ISZ
MJ,:8GCA7OM,\$HX.Y)I0'4(QC<DBJM*)-E,&.`Q/>@!@(/Y<4:'(FTS@+>?E
M##4@B*=ACDQ4G0C)3+&)G]!1.)^F\)#!4+B5/OL,PH:8<=<`%>\EXO&-XQ%^
M#_.'9`O@=XM-#C1S<>!3\T/,+/@+P>I!IGPYGA`2TE'H+R14ZZA6A%4]-=,#
MX4]CU*X@UZ[')0M_&)JNYXMZ*T32"_1QN.I&1/ZR"QEXA$Y*TE#CL6)+?%I/
MNWOY!$[DN1=P!2,AX4($$SD#^@5YU:W`@V40B1X9>>1/D#_7)#XN$D3K#GAT
M-CR"8C%P#.195S-Q3;01C(>+QZ?")\`N@QG#ZK?_(#LB6"'^WX'AOUT.1'&=
M`N>!JIA0?<%,NL_<@&@NQJ6A_4`;T=R2#,8&DIYAF.+W/[7/J_,6C9IE1CZ$
MCK$L<#X0'^U[TNY2_D5J\.=,V^!^#Q/=4)C1D>`#:C&?<\P9Y\RY,X*R\)VS
MB6DHN72&)XH]Y0YN9$,]*;I<"*0]"]_W1#B3(CFW2"53)4K/5IY`N4>,54VR
M#>&Y+&H4F.<+B(:,)_!:Z$*;?CP)O=,Q)#G$7=ABDQ.;RH&6D`/XA2_!G`X@
MRCB8<*O$J0U/7UW7VA5@!Q!E/%BG/&NN95KPX&"G+M,C!'1DB*;:!1FD],=K
M=4^%[\OE$`$+W#G/(0=4FTD.P+4044[I[3F/*')[8AW[XKB6\8+Q2:R(V8)>
MWUR=U:K-R,.H,,G$U^FC-&H)!I'?,Q9C+19!A;^-,#VKF)XP+WR"49F1$%%`
M71@@S#:-A";`L\P%LQT;!&.(?[LCS>;&A\(;\.FSX0Z%E>.')"`@7_1U:C:,
MV,!-`W<*WD@R`%Q+/]?/NWO2SW[D+?HQJ8T8[:TK:'&9TDI:5-#97@+7@=EK
MM%.E<!W\141M\-E%9Z`?3(!(5Q@YPS]4<I13?+1T"D*T$=76O(:@^*]4#502
M1^@")MYGEH$)R1!&P$0#MQ.Z!>RL`\<:FJ^%WA%,`9:&3HDOF=1`ASD2QZ4<
MZ+AHI$)=%$X%HX9CT-><%PC5P4\#!H\4SY?K2Q9"4;9W0*9M`X*QJ3D)_/5D
M5A#9S/3!MD1VE13F%S]*TS?)78)*NY2TVP!,R0C\%L\W_<!G.2\N8M&)K5/V
M5.G$[%[WG<5"QE&?RU',F5ZP8[$5C&UN&*/HC%H^U4Y,Q3.;A48.?W<F`]-F
M2QN)Q>HTPML-FKK+@&-[TL'I_V:[)#B[21^9#;Q3L;FT@&G`.X(E<K4I@>A4
M]U)9/^64/U1FL4EYK[`64XO0;!C-*`,S>J:X)AK=Q\6_./)B1($/W'S]\OC<
MZ_64B6,1/;!(+C8/R<T9O)F#P>/H;2F3+XJ?0SA%^/>FE`7/!^![<@*P]!-P
MNNR*\OU_E5/AB]+QEA@:=5+!\2I_AVH*`7DQQLV(:-D1#Q;6:O'FB051]63J
MN'A,CJMKRAGF9!+8-'#1II3N$`";3N!Q_?[V`(/RWZLY`2\)YL[>X"B>=A;I
M_"85O:?\P>4$7-`YS8M?EDXVOE%G"P2C^Q;!H#A3?F.%?ZFL0>RW7%W_WUF]
MJM*5N[IN5&'`$4V+X1^W'\[G'KA5:%$YR@<!O6T$W)L/5;C'(A%0E"[1>&!O
MT\(OOM."6V]<F?%1=(A)^6LZ.]06_H)LYM@;!?0E\7_8@FW?_:'CBG:+K^=.
MQ?"):+X/>'^%>##3&4H_4#KI!#ZU<1,YX<4'K@8(B9Y0*L[`H\_<79J7VP'Q
M7PB\'@T#ZYVF4Y0*3LSE\C%CJ1:W6,*,_YGA!B,$_%_!"&/TT\OKJP\BXX11
M2D98DC&>*>S"QK4(/@B]'VW'4EM)\^!?R,`-\.U:56TDJ8+G^Y2?:N?->3$%
M21)D&NU0FAZX884"$UA^*`K?;OJ/O2MX%U:`RLC;=4<>UW(GNF-B&NM8YSDN
M>:L:`99(%-S$:@-`F0PT"&O1ABO/Q'!\T^9&X?_.8%&7*Y2X']<;2KS$0FG'
M?HP*3>*ZUK@(3%U=$KB@-'>N'9?82&K!O.M`5EM=I)D3,K6Q9=#JJ\L)=T.T
M14S`JPYX`PEV!A-/IG]!(8H+%I\T*RYO-L(2A`BMQAJ(_,GWTL`^A5^P3A0<
MSU\?U.H_PP,$.X`Z!U'HO9T/H:K]%BJLATAWA'@O;1[0VX0*F:M=74&6%7!O
M$_/6VS$7=D?BB#L/$>K=@A%A:37X<B)@CCK&GFZTT'T6E@-.G$S(P1C%(<G2
M0O'E)&'YPR@E_N7_9^_:>AO'D?7[`/,?A.P9(`TH/;K+SFX/X$Z<M/>DXXSC
MGL8\#1293G3&EK*RG'3VUQ^2DBW)HNZ233EL8'<<7\BJC\5B%567#1B;^_`B
M<(BT[9/,^/%L/(+;M^A=9T%MH5*&@B141R'<).-YY'+DV_\6$@>%,B`RC:8<
M<4#^94$!:'`;;*S(2`77D)T*A2KTW>R$R,"[J0GQ%+-PVO+ED7:J(^T.O5.>
M8^:GQ4%PH,<TLB\,G#5&*!^D2N6+1FB:M%M[)7_"G605@'PB,`MR(U<#T_03
M9\'L$LPMTPI-,ZE\OMB9K*B:'@<L?\8F=TD-XR+PT`('+=PN@1M_X;C/00["
MGA7IMN[)MD`R\I/AUU#-@?FVH&:0I!.4!8G72@X!TAM/P(E=\^Q^&*O7ONW_
M5O2B*%Z=.N*J1FB]&]^/4*[.>1"T\`+"DO!A@7DO66`>OO5]=#G]<L[UA%\(
MQ>:]1/NZ7Q+%YIOD)ZC.;6(#+EJD'D=#!D.CA3O#WSQ?@+GW3]R(;W`SNH;\
MXS<V/.F"C$OA/^!`D$\G*/$*7>$^&R;<A=N_@Z+\^.]7:^8]?3J!OPQFWU=K
MD&A1?+]@^,7XYMO76Y^7>^Y^.`U*B!=JG18`B>#8#EVF]5J`@RC5^;6>TBJN
MPE"JP-@X7C:R!']X>QFMG7^@ACV)-J#>4^G]5Z9OX8/+_1KR_%1T7L)48GZ+
M1.+P^;T>B(QO.SGT3@C:G$S;(D@^_1,ZJMPP/4\.4YN2?[H7C(Y(`G-9[KX$
M2N4E$%F"!Y<R.G"0&`X8!_'@.#"MLT\I:_Q4.QVA9Z7.>F78LR"`@"Q-^^>=
M`LFJWJ*=X'2VT9+=OUO@/.,']^!?*W"G.-MT93GVA_.4I\DE3>,J)B(]PQ=L
M"-X)7AA4M`S?%:BH4J*O3Y8']JY"I6P5>@5FJ$9-)U1E0:G[GSW,(0M\7Y.Z
MOT/W@978Y^6^PK`JA)7&2\*AL*)*6Q[*Y,S1E[CY8R>T)1V;1N'[DD`Q&[2@
M),DZQ6S0@9+,B[+(=".MEJ3C`D@NTXTEW:.>)$HT,\.PHF;X@ECUF`%)KP$Y
MC)48NP4>M^V+S*'&R,!/<=R$!N_DCJ'_<9':R]S4^,$%G8F9YBV\0TY%26N%
MBP_'@`VO,'12T5'$=DS05&Q:5ZK1$,B/:C04L9":G>-_1#5[,[H=GGT91B(6
MLR!!4487XZ]?![>7GR`!?TW&W^^_#"Z'%^.;\80_^<<5_G<2B3C:_<7UM^ET
M.+F>C"[Y$U1F_NP)H-4\QQIY\[NXM)!7K@3A18;+?SI>;$+2\_*(O#+.&&>$
MX>BRR@JKBX]BGL)(G@3M:A%,4?27H;H.O!-!+KZ..?Q1/F*:*--+,</@N#"@
M2JT=YD8N$AY#2-V@R[ZFPWR755Y7VW%NC@DF2>(E0:68#SI@$ON\(/0.Q`=5
M^H_2`,%-\S\<(@B)7P=E<Q8+YQ5EX">Q99HS[>*C1=5Y#/="+:K,8X"G157)
M;L[8S1G]MS",L^YQ1I>)Q6[.V(T)PX!AP&[.&O4;J;\YHR@\O1M16`PP!EAU
MP)C7R+Q&:CP0QEGW.*/*O&)>(_,6&`8,@R/S&DNH-5VE3J]ADII3;#D<4C]D
M0S+-8&`PU*.9N7[,]:/&C6"<=8^SB`+Q7Z+:V-N_@OY5_IQH0P%[ACN%K8![
MAAIM67,+S+CIX/IZ>!D4W(W8",'/HZ_#,O8UBJ^G57$?SN>H/=T+V(XR,3PP
M`:9CF];"[XN65L:]Q\JXOXLR[EI/K5C&'?XRF'U?WD3T*&-EW!-#L?KGQ\Q&
MEN"S,N[OJ6@R*Z+]R(IH+U@1;59$FR1#K(CV>\N1N7/!&4J/63BK;I20H2A:
MY;0G\JK:3GW#6ED?-&&D]GE1DAE&F55E%%[O]_>+4>O*D=UVLYM3QMGQ<D:7
M=<4"G5B`"\.`8<`"G>C1:RS0B9;0%IJ&9#`<&@;F^C'7CQHW@G'6/<ZHLI$.
MGD),,JU0+7?.\#C4,&CM.>X;AZ*GNG'#WO+PA4LJZ;PNM=,6YQA**DD"+PKM
M]*`[!GA$E9?$/3]VH$HM4OJ\<=/9`K>YB+:R8&TL2LNXS$O:GML1=`>=PY<2
MH&#XXDT_='G/Q1VI4I94VI"XV21J\</LQE(/TUOK.7D$6O&TO5Z3QX!.>STF
MNZ$'*34:Q]X3<)D.+%[`G=6XSX-(/UCE=@J&+XB1UI)W04$5KLX;AZR1)`4;
MI*T^DD>%46O])(\)I;;Z2G9,U5)J?UX\&?8CX"R;^V/;163`NHB4EG+6?XGU
M7VKP9#GJ_DLLAH;%8S#.CI<SNNPNEC[!PN89!@R#XTJ?H/+FSJ^GAGM2GC[X
M%=D^<,^N\V*MH%_9"6^2HMSI;H1Y,,`88,S79+[F$?@MC+/N<4:54<9\3>9C
M,`P8!D?F:[)4?9:<S6`X/,W'!0-S_9CK1XT;P3CK'F<1!>*_/$!/DO*M1-*:
MDER".7!=,(-##%8KX*T&]NS&,A[@*)X%5FG]2/JL'TFB'XE>K!^)VJE^)$J_
M:C\2I1_,OB]/(GJ,L7XDB:$TA;'!&GFP1A[DHON7P`3+!^"&Q,HB'T7CYY]8
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M#$S374>\+UQWLL&*O6S'D/RP>BW5&:8D+:34JL'8)1U4*NI_1RO5#OE/`ZIS
M*0!$1O8:7KXKZ/L*-V><YW).D1W10,)U<>76[D;>5P)V^C)W=X:V$W499FUR
M1(\^H>,^)!+#1\@PZ9:!2J<]+.H2K_5K-0MBN))PE75>%FC!E1Z]0LM]1_GH
MX$@*(KOS:&W?'`6O#-J.:24ZK)V<.UA\W<H-S/^L+:231K9GV(_6PX+IHQ8W
MS:G"BV*M-@V%^:S56[$S:"J]_5S`4MF+D4Y;*$?OC.XF6&C0_RZ9VMG71JG9
MF(^I';K0;%WML,<][*$'X[Q5SBDR'=CCG@X\6&A_!GH>771G!GHPHT>?T'$!
MPA[WM&X)]WA=WT\4YGOP*_J\J.PGH9#Y%<RO.'+K^OUR3H\=P/R*+EBP[\E&
M[LX,]&!&D3[IQB..J>,9"U(Q.)SGPB(_]A(QI:%\7UJR,SHP75%<I1XO:OMY
MA,UB/MHJ>Q)127\8BS4N/<`-%@OGU;!-P-12>SZ^J/7V5HWI/=R9B++$]_94
MUX'=FK!;DR._.WB_G--C2K!;DR[XY^_I!J`[,]"#&47ZA));DYPD&52S.NF@
M<*>;^Y(W@OG50;^$XLK*-`0V,DB9=\*\$V:C,\Z9=\*\$XIGH,?2[LX,]&#6
M27V2T6Z=%H6"26Q.HY3DN/-3-+1!J.+I?<'&G`WF;!R'R?U^.8_L8?\EZJR^
M_6MFO80T(#$&]HQSYMQZ!=RSU3,PK;F%;O`&U]?#RZ#K=.0\#'X>??VO7]>K
MLT?#>#Z_-Y_`;+T`X_GF)G!J_/`#%0;V+!(Y-44D3<$/[_/",?_^[>>?..Y?
MFT&NP`RXQF)DF\X2P-\'588_`QO,+>\"GL>6O8:**&B0Y]@KSII].ID:CZHL
MG'`SR,'26*P^G9S):'%LU$M^`N:?3BY1U]\3;FU;_M_?[B]/?CL3^W)?@9(0
M<E&>@.88$/,8$),,:))`#P-2'@-R@@%9Z$,6FF3@WC,\@"3.,2NR(9<7)$62
M]1@75:EHFA>EO$S)HBQ2R8M:7KR4/A*NQGFY<EQXQ-N5N-#*KTAO9XN7GMVG
MWES,?IS#+UO^N^/Y+?"VG491HU&`-/4$K(#AFD_PY25X`0OG>0EL#T[CM_Z+
M<**7WB>B(FF8E69(:8>M7ND%4D21>J[ZI3>/V-9:I0CN9S"'@GWQ9-B/8&1O
M8QNWH8U;7I0*)[TD28(:LE.1A":9J'+:]P6A1Q4354Y\55>UAIC8:,3DY[LV
MZ&:DP=)9VU[(0(6S/A2EJM,W17R%PST4H4,37^$T#T6G&>)39"^D,?>L3M`8
MH2UE]#@)P_D<F)[U`K;?GD`#90+@1";TEWS>O,`F1L;+VG/<M]B70W)C!_+H
M]BJ;WKNU"R#!'V4EI+D!<E(@CH^1@DUA3G//:,*V%40A[FDT2MM>V,X]Q`D;
M7I5$N=MLJ[GG?5)52+HNZ0=F.S1^-L91R%+YTU_49:T(0\E9X\2&IALPH.EV
MM?:@'OAJV=9RO;PSWI#5MKI<@^D3<($Q]X`;$IUYVH^(-J067X32DQ<"FNS4
M@=#Z59MPZ4M.WA#E33CPAZ&\"7>]#<IQ]=S![/_6*P_+6TAQ[G&?D!)]QY@J
M.&5-.G,=[X1,:%HAB6B8SMQ3.B$!4B$51R8S[D[$?]&<(ZWFGL$YMQYM4;A/
M$+3<$SG[CN0H,,@]PK-O5-K%(&<';;RBQ*.:#&=?RW7V$Y*?=)7KT],>?[E&
M0M(F2WC3-/.7:THD!#;I<#?-7^(',8&_,%SW;>ZXKX8[B^R\3,MB1!)$#;H#
M\84J,7$.Q=NMET)MIE5!I%82M+Z432UYTGQ*-^\%WDY(9:9-0:12D:6=X[K`
MA!$-/8':RUZ#*]=9WKG.;&UZ$7V&'QF;\!=P00:/+@!QTT(K;UJ(FA`JWPIS
MDRE'3UM<P\3/N*]=(T9CA2MW3=2)1":GB2\U^5#8762]O".MZ8H0-QTSIRHM
M@!?.$OW75Q'V+/"^5_=/A@L^0Q=Q%OW"A;,*+^?TS/.7*+&RI"EE!;8T@7$(
MKN'W76,!?SF8+:&?N_*0DGD!B:4I?Y,N*KV=PS5GLIS%@1L!JD#O[6YAX#TP
M_,_:PFL;$IEY0I)5F:CFZ(C4:4O+DM\694MLYG%')E81RXH'GG/WR/:`"U:(
M%_RI?V2&=)7WBWO(SH@=PJ09<O#R&UEMJ2A_*HFR+@MZ-D!XDHBFC'PA$@'D
M^V]!^YJPC410U61+8H4C2>E%O(P*DS=%>N;Q1+PI@_Z1V@+I_F<C&^XR$ZQ6
M9.6=SD?F$49>@LU50R.4M,%4+_,4)"]."TSM[J&M91U9\)#F\H==7U3(-B1I
MHBHDE;\-[NDZ^3!()XD,>.1K<;76*W]"B5)/U,A;CSQ9-<)R3R.",2CWI2RQ
M(Q.6JILS7,->>8]*E*5>GOE?VOG+(C'WP"(`V(-26H_$`NYH+WY.J03*_L(G
MMFTL`I/^'K@OT,,83>Z_@N4#</^Z<RW'G3I?@?L(7/^]A/$J^U'+I(<I9(\5
M2TWZE_!-$YB%?/2R^,#W.[E\#/X8W$Z+\R1B>WPKX;FT%N(+W9K-PVLTY#)]
M\^`^^:]?*FW+;K_^LI5E%T)8C-]L'DJ+:%]HE->D+L!N:QG9+$.\6)_XB[5K
M0._HPG&?'1_2^*IAHVIEA1_LLJB*/;G9[3<!2\<#B[<;ZV_X_U/G,_!7.+(C
M^U*KRZ;AN\L"TIA.:B%.OUO>TXVUM#Q?EL?VMXCCVY=;Y5$1"FH8$I'E156I
MS\SX%3KQJR?K>7.G.C8]!WX`-8=.YE%J6C0'MKTV%B$:.Z%;??407"IJL84D
M$Q]?2N+MZ2Z76GTN-_Y`RKIM]U\!NBHP4,`NB3U(__?:M58SRXRHQVP&1$4I
MRP!>O(QOH6UXOWY808_)LZ++N*LV,HV5)E9'[,<T1W6:&V:\@-E2;U7[,H5\
M0T^C-M])<ZS7/*MW`%H4L_$</1][M"W_0>XWVP4&/C"O#<M&*FN`@IMVE&#(
MJTBX%,P3YY/?[M0_`TYJ$!'7,[=K-/1XCI%=C>SO3Y;Y-(08>&^^!@XO!#0A
M9JTDPD]W7;21!Y;0JPEU1X&YRA[(FM"`=;$#$*3LWVL;P(.JCZ]Y3/PM]&>*
ME:67M8UKG<Z:T+P-4IIEH;FC.DPKC04+3H#M&8M-R."5X^Y$%L:33$-P"%ZM
M?/(;RFB=62^;G%Q4]^$,E9XX%X6/*"<7OS$WEM;B[7R*,G*Y6_#*39RE8?^3
M5&./E,*;6M=B^@2XN8.N'R#UG/.PL!Y]U0+?=;D'R`WGHJ<PJ`'!Q>`KI'_E
MK2#B,^!R<\/$]?7PAPY^_F$[]IF)+C(6"`+.V>#"+3`PG+%"&;^;10R3B&61
MYQ`:W,R!8T!YLLW%>@8X."@'?@#7M"`A\)>0%O!J+#@H04LXE,O!HV3QAO^T
M;-_%?G:=%^A-(19.+1N.X*Q7D,#5A_.4,H`^?)$5N!O?CZ:C\>TYG&Z!GV&%
MM0+"R@->LO(`?.O[Z'+ZY9S3A5\(50B\W<*&ZB^)*@1>_34EE0G`Z=28./Y$
M%(1?R*5&=C!!@WS+S<X.\0O2Q$V`=GBT6@(6A@?'A5+SZ02>I5`^4.JZ"25C
M^W=0Y0'__6K-O*=/`:$!!&C;G.$9SA=@OH4IO5A$#`N?X(OQS;>OM_XBW7/W
MPVF,A9QZ>@%W:/*3,,6]>#V^#5-2G5_K*04$*PREJ,VRD07U\/8R*G!Y=3Z2
MM0XJ%R4E;*8VBI!"Y:6D[*62`*=OZV;*BNZCYF6Q.21>TVH5X*\!55TQ+->V
M8W]"2&BP0J$0TB'C$M_3Y([*'[UJD+"CF02F2F"?=&QT0@)IU8`ZD[_"\B?R
M>KV67$P#$B2PQR2PL`2J0JTBYTS_):YS@MQ5)H/%M:!&.#/HD<%DY<HLK5B[
M5.6&KLZ5IBP\7&,%&?=5@#%UN-IG:`,UV=/%OUTAVE<-]BZ,V'9]\/01C]2*
M\SLQ+_W'/?[#"^XY>-[3B9.5HFL^4>![.M7W?.R$92<L.V'9"7N<)VP3?3(.
M)H)[ZXO1C2%;;]A04P[92<I.TOR3U'_90G,`_^=9[0%JQ'%5JF1WL7;=2!:[
M)I3/)),T34L)X2LR=26R1_;TU?D3&&XDFC$W(SI)>4^3JU`>SEZ5^"<7@!WR
MRV=%2WU1J4C^=OZ*#%PY:W>'_MQLZ&0*HJZIU>C?3E^5?.ME!WZQ?-ZSNE/[
MH_SLE:@/2<Y->TXB+O3T2GLUD]))6.($]3K>TI>9H$4L&26IJ='`A)DJ$949
M\TRNT]4^49E1R>1:@.EQT[E$78(YM"!FN&R.];!&4:FHOLA7XP=:=3_N./KA
MZ@ZXP^7SPGD#`+XTH^>%&$MWDHH551;56-)Q76(*<1?\QOUJ>.83A"GVN3_.
M>(X_#'G3*O"F"KF\%2>E*<Y"EO0*+`E*$RP5X@75"`KR,B*YGIJ8GWV=S!^+
M[X]"$]:B,3/WB*SN]DVCE)DG1*YR5Y_&T+K]?6VX'G`7;U>6;=BFA>K3SAUW
M&=1F)F8E2*1\GWI9"3&_8/?#F(M8.MX][EET/WX_DY_L>/J4N'C\.&1P,[J&
M_.,W-CQI4A_W."P?AP]_&<R^KYZO43>=A>XGAE(%Q@9C@W(VLO9OR7R0EAI*
M1_I9!G,_9;)J.Z^N\?SIQ/]O4JTD3J+\V[M`-XMZY'")GE&DFW=Q^^8#>H'S
MYDAWFO<7D_'=W?!R\NUFR*,9HI`_)"_4(U=G_JH\%44FG<BL![3$X?,A*WJ]
M&3DVLP'\7<2YAUFPO!LH)`;%!@J90;&!0J$#BBZ=%223LPS+#R[WZV$%+5N,
MD+==5HY.1Y%\;)X#/TP`I?89P%5$%8TY`Z?@KSYD"-K^8:%`Z#H2+N?Z!1V2
M0++XN.PD,.5@26`=@ZI_J$#]KN'4$QA01>;0I$,!1=6Q0F4N$WJ"MW!6W8BW
MIF/+G(HZ+\M2*XQ\.`9X^CPQ09W!@^&19%Y4VE&(1P&/Q`O:GC<75<<$I=['
M9V-EF;@(V<Q:K#TPX^S@Z,"^I>DLEX[MNYCL+"DN[L)'J9WJ*,>@"R`X[?AL
M1P).GX&3#DX[7FR1,\1_V5KD=?5ZA;%[O7B*QQ%%>Z1Q3V&UQM+1);)8-;I$
M%H/9671)]5]3'`C`V&!LL.B2[D:72"RZI'9TB90%R[N!0F)0Q*)+&!2/F^B2
MPT/1I;."19<DY8A%EQSI_2Z++JD772(?JLAUYZ`2A';N+8\.*ID71295!:'2
M%*KKB[(@$Q9D4BZ*0N95%D61!8^NLR>GJ?"HO+#O)V!=@D?C>\+A'A`>_IB@
MU`EA02:MB/O^GX9W"QQVCF2`TT[KDB,!YPB#3**O2<7]2I0_B5=0"5K1AN7*
M)"FK]A<NB/-[LMR,(L?+W6V&S9M,SI^,5'^G7VDR)7^R9)$:Z.U7FDS-GTQ)
M3`;]Y4J39996Q&5M2&NV4^.OZ&29U1#]R1)KUJ_&5V;E0G^JQ(KU>T*EN3*K
M#/IS)19,DXK,!3WMD0W-)(";?[\8%FX1/'4NL.5T[\%-^>0L9L!=^:;6AB0Y
MLW)@RE8\$V7HHL:H*CE_0\1GUA!,V=J0>.A`4D!\`268$+PS414DG0+B"RC5
MA"2?B1ITOB@@/E=)$U39F:C+LD0!\;E*GZ`:S\2^0,6&+7"()&5>DO$I<G#B
M"QQ*29F7)$%K4&R&AFM;]B.J(WF/O&'\E8$]NPS<YBVQO9Q2B0FUOAD1THSL
MVY#>G"DKTM?/I4_*HD]NF3Y%R*5/SJ)/;9L^,9<^Y9#KJTAYI3JSY:_U]95S
MZ<N4/Z5M^I1<^C+EK]\V?;F5<]N1O]`=W7P75?-<HE+!V`_%ZG/\C&OM#DS/
M>K&\MY32G(K&2G,FDC5ZQ9(UA$Z5YE3DJLD34$WXL[/DB>J_;C+.73T*-A3]
M*-C0E6;9R!+\;F8=Y$22YEY>'SZ2]``AR_AD]V-&R(&D[P:)[[A-$IA%1>'G
MGP8OP#4>0?S-X0_@FM9JY]T[US)WWP(N=[]]D,H`+@KP!"P-"QFJ\;=Q*7G#
M]-;&(O[!%+A+#D5-XV8I67'1QQ\+[3G/-6(0TK5OJS$)@1?!C=?>RC-LA!!G
M>-PE,,'R`;@AXK+(ASD6M2,32-RV^<SSL-,5?.2J\K+2YWMBK?(YW6"U7M1L
M17@_]GL=1I;.A=0_TB*M]*C^<E'*!U+\UZYA!S8!4^>M;`V1EU24#T++!CDR
M=2YJ'Y5:]9.8T':!5WK4>D<L^HV/S%1[>[ODM"=JO"+4"AXMS&FM8-(.*73M
MHUHK5)E):A=XI4>?=\),OS!L$RR8,F]3F8L*W]-$ILL;U>7U^BPP0>T"KZWK
M\F@PR4<U&M21;ZW/\3^B?K\9W0[/O@PC@1]E@-JM8C89?[__,K@<7HQOQA/^
MY!]7^%^TWN;N+ZZ_3:?#R?5D=,F?+"P;G#WA)S3G^"C8_"Z./GE]:S!29/C\
M9U75""`]S8K(/@6<4SD\@ZIC4-%CZQ;7AA_%LOKP_]N[MM[&;2S\5XP`"_0A
MX^I^*;8!TEQF`XPG:2:=8IX"Q:83;64IU25-]M<O2<G6791L2J9LOLPD<DR>
M\Y$\/'>5+XY^A22FL+J=,5X$0Q+D]HO<D=^1SU!W+L;+$<>,Q1G8P8PA&3P.
M_W'7C)`*GQUW35#+"-%UX50==9R+82^%,16YEX)GA'#W!'=/</?$@=C<HQB>
M#:@84HVY>V($1MTQF8WCF8%C-F;,1BF#=95Y(8Q)I">%.W(\^BDH'1"F>.*P
ML3H%0[!QGP'W&7"?P9$9PJ,8G@VHV-%71Y&^NPZF?0<!:BR%>K]?O;^".?HE
M]/!C'ES;7W!-E$Y5<Z?7D(R#U3T%URJ:!8P&6387\HB":X>:5Y'4Y^$F;UST
M[^<8R:>2J9^*)BN'Z<!$OS:5QXPLFPNI3EE15-@1_:.P`>).;Y--$^S)TO,G
MN/W&)'(7P)^$+P`*?,&8W#F6RZ5^;R=(.A4%Z=14N%IZ\)5I(YANK-!FI'_\
MXQ[>TK1M6^RZ-MM?/?<->VCPP*26VCIOJ5UJJ:VW:ZFMCJFEMJJ;6[;4AM],
M9A]*05J?&MY2NW(HA7(3YSVQH?)>U+P7->]%S42KY-B"N[3"PO-KR_8GWRTG
M*CS_";WC%[_<E[=)'I_S-EL,!S7:*-$7>:_D/9E%&F^LV=><RE1E!5EVY-0H
M/(V\IV_?9T/D#7W[PU:=2JQ`RX[@&8F"%"<X<<G3V^GX:4#1<RQ="LVI,4P+
MWS$)G%%H.KPMZD"!)T,2I3$SR[%E1/[PNA=>]S*B:HN>AV<#*G:4#MX`8@QE
M\_W/P$YA_GAF8`<SAN3).+PF6X65>&$`#RN-T-ER5.Y=;NUP:V=$Y@BW=KBU
MPZV=(];<QS,#.YB-4I[PUFT];%ZFIF"HF=:8IF`(-FZ=<.N$6R?':YW$/^ZA
MK+)-&61=">75ZM7Q/@#X!OPW>PZJ*S3/'3@$_NEV>0_FWK,+]8K%'?!M#_Y=
M$`85U98&K[8\CFI+0]VVVM)0D]EYM>7VWZ98IBB;G(W#9:-IX_.BT:,IE=Q$
M(I_*=OJ1X2!Q'#`.XMYQ.""I0V1Y_U*G>0\9W??03S?N)'SQHL!R%T%3F?3P
MO.]S9XTRM^4>!,#RYR\XL64!WH#CO:[@1B@#/,+L%8;S+*1336$ES^+`H!5/
M%9&5@J$#A):5OGSLB/I1U&)]!B[P+0?+>6NQLET["'WLUSH(4<_F&15/3<$8
M,9MLHFH8%<FUHV&234Q-9GI!]R[7>5R5QU4YYYQSGK[*TU?WGBC9_PSLI&*.
M9P:.V9@Q8T@&C\,)_."%E@,G\.9_?7I"V4#P7DW3@2;@'?U\&'X"AIUKRJFJ
MC-E9P#"TTJED<FA[@E9FYE4MW'7`70>'849RSH^/<X;45NXZ&('!=4PFW7AF
MX)B-&;-1RF!>+<S+7L?'$X>-U2D8@HU;]-RB/PSKCG-^?)QGI%?\XQZJQ2E7
M?-<5EJ?CWED?J(#@_!_+7V3?]?O=<J)XLB"(5O&SNG?WFKR:O%1-;K2K)A?&
M5$VN">*6U>3PF\GL0]EIV:OV4*K)C=KJ+TY*`RE-VX#75H^JEK9ZG>MK'W\`
MRY]<N8OBRV<)?:"?RGX/CE0!J8.IS^X=J185W`PY,L>1`W7U#C5NU-0=IT%-
M7GVH+$_>/*2L.7;X4<9YQ,E/]3LSGET7T_D_I3_JTK]H4L,J\\(1,Z\9U<P+
MM<RS(VA&48:Y$3,>MH`G<#561R5;M*DP01=><`RGB?/*HJ`8B49R;P=_?5KZ
M`$QL!#T(PHEOA8>5ADW:5>)4JKR0I*EX#->Q,#4KV1>GRC&P#]FL67V3ZR.4
M]9&%_68O4`3BPP;.8;RQM^TV^^JY%5*5LWEX;&:$0_SC'@)R-")E^2C<A;=:
M>2X>X<)ZM4/+P7,$J+>7_P86UYY_'861#V[@>.B5W)M`FRJ<3!:0KY7E!+^>
MW'R]SL?=;I#_\G$30403S+!'ZF02N7;\-_%4)V<2]HVE#'<FJA!91'_\5(I3
M^K[E/@.$VF\?Z9]D@;R+_/D+?'B''#BWRPP9=\!'>R=E7LPR+U6$'`FLPZG`
MR9DP-=3,.O=&=P$?]`F"#BPN(Q_>:G&P-L8X1_9F8,=R@Y1YJ7'E$?M2RY57
M33D+P':$4>9.)G+7=E^+HB')M-FK#L*7-DE)2GR-$)6)#`G.WRS;07(!GJ7/
M\+N9K:U0.]>BIHB24MC@/=#>#T)1^.+Y*)<AA49M`4U&&I^[BQL7G3_[#2\E
ME'-&+5BZ4I""U/F@!!/^YSLT*3<[6$P1TJI.2RM('F?6N[V*5@E`9W?*#PI8
M5!`;PS!W%N_D88.Z<9/K%JK`MH^_]`#\50J#3@\&48`X]$%M?SC`<_D?SUD`
M/[A=SCP?/+Q8\+F;7$:WR^\>6@X,1PI9U5L@6AZFLSNU)XPZ<$+I="5D9-X;
M'!_G%"B3*(32V_<"#A4Y<*`0P@>UV_7S2]N'IIOG9_"MOZ-EQ31$&H*ICK>A
MH-.ZJ*Q4H--U055HW(##0(=OT^#&C27E9]\+4KU($SOH19W!>_SVVT65!B&I
M$IU+L9[##NICUM*Z>H="P`XRZH%&UHOI(V1`)4MHJT-7TD]W"T&)N00V,LXV
M**<`=5&MJ6TAQ=!$>ANH@C^Z`'['[V>"/*_=:P\>>M0@U;HH['2D&CR6ID8/
MT[8LTP4Z.0#(D"@BVD;/IXFH+)FZ:%(4<R7>!C8B-6U@!"51D$Q%&HVM6;[/
M_\15-O`8O`'?>@9K\8Q].BFN>H/?B9[J]\>W2RC:,.7PN$]-HQ<-IHGC/<-L
M$&"FLWES,!M346<=9I+QE->NVD%MMO:D[JH1Y.`6M6DGQ9P>ZY0Q7X_=#79=
MV`_LVE25*:+>B7G*P%=H@NV@;Q\[H`R]V47`4&9_:"6YW5)(>Y'S--04*D#T
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MB1H=S=":D*3J%CHY,ZOW8Q\,#N(`S5B3Y\_//GB&0KH.YT93CC;.HDD9YZT!
MR*]#JQ9GD..W>#I$0(`U[NSGJ,W95R_\`<*T`5HVU2;%W!@0<U$IBHA!F!T(
MWT1,>7[R"/U=1AQ7=8';V?<C_3!GHG$Y`*"5W%&2(%=_1W;X<>,&H1_A0,]M
M^`)\E-F:K."&X$):C$E.GY0>[^$W?1L=R.;:`(V.-.C*S-XQ;,ZBC$4`Q[#"
M!DDA;)-F60EA;9+I0#CF&1H*QKQBE\+8)AF321CS#`U^HMO[`DR%F*U%.NHY
M&U^9JL.>]Z%\+KV`KQ*CRYW`%]6I=*3H;^L+,S6B+ZR-@-G/,NS'^]A1^'58
MBZ;,T2W7PBR7+[/`<WXIDO[48%%-WU7\@M(4I[R))E>Y%E$=NN7/7Z#U<`G>
M@..](K*3D>J,,5'-78_MR-J-%9/,RF?@0A0=R,GY8F6[-EP#W&*ZD1G#D`?F
M11<$(B\E#YED&H.3*9+(%+?</=+@K$AD5K;:/68AYCP$+S*1E]+ND97A(5=(
M9,K;[!Y)4X9'7"6SLM7N$4UA^%.M$9DIDJFHRNYD;GVC;J["3!>8M9_T^Z8O
M[3TD9P9Q7T6KE%62FD`O'K1N@:+1J"[IS/'^D6ZJ,:$;PEPCK=-0G$>`=-Q!
M(46:5&)"?T\/C73,\=Z1%H=+^=D@32.9GD6D+Y.F>FC6%.#A:D?6`%/QZ;5E
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M2TTEY5U:2A;77:2X[KU`4&[K;8>8&,@D*B"%?P?<N0TR.P8:*.^!_8MK.[^>
MA'X$*O)3"EMF\O,6TZC$:8H[LSC-G9]L2\QI+JX-M_#.7#0.K^],_8X-J77)
M:)&H=9'V_*Y-%S0409*RSO8>VVUC%+^"?_`G&5Z((6GY\7RQP/FNEG-GV?"`
M)BW@:V);NJ$J8C[QK`U%NS`A$V/1)5&+R-3D7<D\7_PW"N+C]N#5P%3M%+@'
M?T=V8(?K3.5XKDQR<7[7R\0P=HN`5\_$YJ'!*2-H$!^\P'&@0(>2W5LA"0KL
M9_<B@N?;G7\\0"$=6/-$^./?G%A\;ZC]"J!@A???G>?C#\+0MY\B_+:'!^\.
MTINVN=-E8HR\A-.G_"X8E.YVD/WA^L!R4!8ZNGO@QOQLV>X7J`;<NM_`'&[5
M$(KW<Q^ND/N<W;EK`E)TB%'W,CJX"SH9GEUIS".QM@:*<5^9'(\O%Q3E%:K"
MT(7KT[$@Q<L_+:0[A+?^/4ILRFD'FP^#Y-.,%"+G-^+C]8(5B/C+2'XGEL%%
MM(KBM\GGK[^:),@_X*\G9[*:LQVVH9^97CBZW$M_$*9ZX5Q8`4H40?^A)+LW
MR\&J6G@!%^4#?KL@]?7N)H1F0J4B__*6-G/N1&9CAMY-53*/*!JF.3"5C9H.
MHE(H%QE+AKXKE5O;\RU;NT(!W:*"Y0(X4.J\KY.5UAF>>5M+1:Q%OO49)"^K
MB1_KM0IL#R_':&[OBJZ9=4D6O#5^`RY8VAD9K#3J294G)L-#S>@9:[MDCM^^
M`I0CY3ZCNP[O@J7GX[*RN(+L#Q2ISKRR1%?R&DIEQ6&R!A>>_^K%KSZHUK77
M!O#65!5*`RT?2;!@G4\,E\J>H[0VVXG"+`M$F[XN/_F3.!4RZ0&$"?/4%01N
M;MMDY'(MT9U4A_4&UTU=STN`[<AH(Q)24LFI>D1EOWJ*@O6R0IKI__`GM\M+
M\!1>VL'<B]P0:B`K.^-R5KKGVQ7\6,2YB@K@'.J3`;@$\?\W[OD<_S5R:V`=
M%%H?`,I?*"DRI[_QOJP&3E$+ZF&'B4DT0]9>H76U/IZ)RKD>*#ZJ*?'$//<2
M\;J@$8AO0T%;Y*'0QE7<[@(^\:&5_,6VGE`>3M:YI)#]"24N))G$1AL22&Q@
MCE/!6$&[VMV-(,IBT;QH/6_1Y^7-`5@$U[ZW^F9A'F=6B`RGC]ME[(%$K*?&
M5$IV=]^`;!AFWJ[K/'TS];=+^&01S9%R4=CG:G<371(;:2U/5D_<^@6%N9?R
MI;1U-Y`E4RWZ[(GS%:[=Y1(:,+?+J_?Y"U*64(SFUJW6-&./;@0W4K*C,LT,
M=+6[=5QP?NQ*2IXQ*"F1/6HO[3G^&.$!SVULYX)%G2LA=K&$-3X,M?OEF&&0
M)DE#,$N\=TM%-B-FEGA[E\S(09AM\@O7.N53KLC7>F.L8-.UL)VCNI:@-B(1
MJ64IX<36C,+ORN-,E!YG-I0-K]>V"T>Q+>?+EXNU`P;=%I!(.&P]7T(+V8E&
MZ,Q`_N5BE:VT?A<?9\*F[N7*@<+/M^>)+[QD?I'Y4;=E)S-R2K](LA03^F6Q
M!=(ETC)?R1BXQ82!1..Z<9'_.P``F^;X5;\IG=T#W6O#M?UL!4]YK7V;4M78
MD:Z2*JT(4?TT&<0N/,>QGKRX4BKC[YC9T$((/1<DSHY@9BT@9_#:=`&.&_QI
MAR\W*'Z2&$4S@#8?8<LJ<,FE6:V'`&X$*PP=@'9T:,^AC%L_CYX"\'>$*M/>
M$''QTR_V'-L#SSZ(`^4U,3TU`:8/AB&4__[Y_<EW[%_0O_#7_P-02P,$%```
M``@`E5QC1`W2K%.3&@``Y,X!`!4`'`!C;&1X+3(P,3,Q,C,Q7V-A;"YX;6Q5
M5`D``YJO%%.:KQ13=7@+``$$)0X```0Y`0``[5U;4^0XLGX_$><_L.PS3=-]
M=L_.Q/39**#I)0(:`IB]/&T8EZI*VRZ;L5U<YM<?R657V65=4K)LI8&7Z0&4
MJ<S4EZF4G))^^>OS,MI[)&E&D_C+_M&'C_M[)`Z3*8WG7_97V4&0A93N__7_
M_ON_?OG#P<'>24J"G$SW[E_V+DF:TBC:.TG2AR0-<L9@[^"@;/B-Q"2M6I[?
MG-_N_?/XYF*O_#5O^C6>TYBL"2(:__B9_^<^R,C><T9_SL(%608725@T_K*_
MR/.'GP\/GYZ>/CS?I]&'))T??OKX\?/AADK:@O]T4#4[X+\Z./IT\/GHPW,V
MW=]CZL=9T3>@DZHYD[#1^NESU?;H\)^7%[>%\`<TSO(@#K=4K5Y*NJ.??OKI
ML/CKIBGKGBH$VK!FUMO;6]LO32)R0V9[_-]?;\X;U"&)HBEYSA?,^@]DE=,P
M^Q`FRT/>]O"49F&49*N4G+.17Y*[X)EDIR0/:)2=!%'XB4E5])"_/)`O^QE=
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MN_.4BF69<\HZG&09R3,V+7]+DND32_M=YH?`3@97KF^]AH1?;\ASKL190-._
M!]&*7)*`_\R#O1LMU)S=9S1+FA==L)$_2>*<+:G9TMK5D$#XUU4*F1.MHF(Y
M?<%^;O3-M"'QE$RKWKDJ+M>/A1B5(%$2-CJ/^"(_29N:EWT7J]Y9D-T72]]5
M=C`/@H=#;I%#$N59]9O"1@<?C\I5_1_+7_][(T^9C1^3F,SH9MJ(@GL2%;L<
MD-8YS;E5I*T.S;5LCR__C4R08S)+V+@O6%1AEN9`+D9S$K$LLMQGJ*OE@I5:
M9SV7IDUJ$)RD3?,$:5CUR?ZWA;_F[D?9XC!;+9<%MP/*<L**?I8F2_B@)DX-
M5=/PYSV-"'MYLM>MZR1ER_PO^T?[>T^$SA=Y\;^KC,F1//"F062%2C>^=T:8
M<$$D46X=KU8L9%T]E#N"F<0M[1F5@V+#P!]PG:`Q<6B^!J:[2,<!WT4JU'`O
MUJ5L(N9;U@Y`WY5=.7;V;%Z/`S@R92]N8"];Z0R?4#I#6^E3,B-I2J9,NV(U
M5)EGLDQ6L2PALV53CI@Y^2C2%4?6,4U5[+MM0_4`$5;/F+/2>>P@3[%F5.4I
M%@Q>3YCN;+Y^\A0+J4J\?W8<FB6+128177=]-?M.\E*0>,X_=Q"^-7!#,L(&
M=,'^]Y0\DB@IOJHQ74Z8S])\%\YNF99CXX#?^)'>BV6=HMZ5A*4'_(_>`WXY
M%&U.>=^V>M^Q&D;+&Q(F<4@C6@RP1-!)7JX6>;:\8B*];.E9^JRSC<L^=BWJ
MAO>HTLX^[6J;DSJ6"?5&0RW;KGUHE3B!NG%I=5DC=SG*[@HAJ_7S+67SBB@'
M`1.UU9"U]^]HF@%)+'47.HZXK\T\#^BC[0B85FXM!410@C660<@[;@S1D!@J
MW,X>M7W5XZZLC[$$T+70C0SW)$C3%Y8I/P7I%(PE/0<9P%24J**5"$,JM(%-
MH@M=M8Z5T%-U.`H\;I(0^+2N(ME!G+AI+U-\K8>B+FP2_K:BA0C-@AC-I&_*
M1IG-:#C@<37ED`K2`TLK*;U.)(,H;8#WC=H!):N'[89&M>%AMM*4TZM7D2(Z
M__CLOD+4VL/QZD_4'^Y/$:TY;:."55:BII9E)#(J_Q#LD(V`3.$J$Y%U9O[)
M=EPK#4`VXFB](>ZI+^>&;FJ<Q]=I$I(L$V^0&Z8_G7C*G-N8'1ZO-TV,7-C/
M299D*0CJ`H^6>MIJ5`M*&8AQ%IKJ=_;L36"XO6?4$6J<25([<=F4=+ELR46=
MILNI_6.Q>[(.M(WCE%W>:T\U%?WE[=7O2AL8Y.P22D6^WJ+PC\!NN;K:!`[S
M]%9'J'$F\9KUWLOT/ZML?1S(+`K*J-71KTWE'W/=HY[&%HZC7;LW>-T,SBC'
MS]NS?]?#'D]+4V2WBR`EQT%&IO4&)TDFJVOILRMX'+7HPK\3.`V\78W<7Z2V
MD*PGY]*=X6OZ?"_5FGWWI9X*1EW;:7U,L%]3=SM'Z%RVTG7^-(YYJ;I$Z#H*
MXKQ^DQ!TMM$RD,TA"D+_$.\P,T`-XBK>*_I##46)!U9%U_:[9NX8JV.Y$4/_
MD.Z>\=M;T/%BP$B0T@G^C-()`-E;L?*QS_T;Y/!\OB3S#UNG.;K(&/WEW65O
M<`!Z/."AOA;1WT'Q75&N24H3_CDI)6SE<DK6_TK<PY1\<Q`<2N;Q!#T3\3S+
M5F1ZNDI9@KJ6L+BPY^OR(4I>""G:7*]8LLIDY=F!RDJVO.HF,^?A/[P80R1Q
M:SAA]($*U3P=;R4,ZF(SB4[%QD5F'@GL.*D1KN:`TW)2.,@OV.C$#6)!%1<D
M4<(2/OJ`86A'><@PDQ`0/?22C3%^%#%1E5:#Z0"S'YI$NJ^9#IQ3NY[5FNDU
MSIH,I5]90%!`"(FNN$#8<R`U`V1/,7/$X"R<ZSMY*OYBF!*(:0%ALD:#!*4]
MA$J9808)E[7.41=N*-W*$I828DCHQ`?,GL.G.4A["J%C`6RM*N4NF4RG="W1
M=4"9[B?!`\V#J-#H?O=;^PUA?IVQX;XEZ2,-R5I[OM<]CPLNA>-*H#Y4M^7P
M]]\=$O>RC/L##X>S*:-_N5$7:A5YVDG]Z9/U-Z?R+K.359J2.'RY2]EJ-PC+
M"IKBIQ*;&_/Q<H'97?!\G:3%'_(\I?>KXA[XN^2:&5#Z3=V+#"6.!NY[W#[N
M<Z"<.?S`2J"N09#9XM>8F2VBOY/IWYAQ65[R+:`QKP&ZBK=O.DQ2%OWB>3UQ
MJ2QBZ.BNNM/X=/=N7J?[.C9_[Y[:75[4-1%,S+6>7*7)8T"C=41AEECR8R];
M0QX'&0TEOF;)I1Q#8^IQ>T8W8SD#O+$8)8[_%W5I!?C%1E\.)ZT@_$YD*2N$
MI$2'NJFW*",52W4Q&HQ(I[CWB]*,1C&Q5%\8%50]UB.!KB?4GQTG8;A:<M7)
M])2PR3M<5RVR_X](F4]/ECQG_KWXO6D)MFOVU0:/,[;C`W9/)NWD`NYD,KCK
M`\4T*7D5V*,[<W%J]P:LU\@*_U2WWSJ<K)V[HU5E)S?)2Q`5B<<%#;E5SXA,
M#5.RIC9J"O^103\XB;4)A.XN[7!S%`G4$>H)KRH0NB%%N`)["IBN>AE!WWXD
M"+.U@#G$#'KJJ5A!$YF$!^KX8R%I$.;\-"HD3ADSV8E:!O0C09@3\W2,:`;=
MXO["N]:'I5@SDF6%-/+YTXRHB4-IXY&`SDIW^YBFZP;_ET?3W!)&5/\.`,XR
MT8/*2'=[4.FZ@7_00K&8*M2Y2.+Y'4F7-7W*5=5G;\NJBR2(L^O@A6_Q2M`N
M:E*.;_-/WIRX,NPIN<\O@[S\]G)#'H*7HJ3B:G:=TCBD#_R*KN]LM.Z>2/1(
M+MD<N)!M,CKAN3%3)U[^(X00`DD_QA+&C+H`]3#1L6/4ZSDCW?[%<KR[I\0%
MF'=8V6!XP^*505=LFOX0N^D/=06[N4JL=_ELTX69-5C73%XC7`7FZ1FPZQY1
MKR6-E3I+5K)#0IUXV0)VS>,5XE5@G'[ANNX0]2+57"?ZZ"R^UGE9H[7@\1K1
MVC9.SV@M.D1=SFF@TV26D]0=8(7LS#&[P^95P59EHKZ0N]/G*&[BV6[=-$H_
M>4F<[R_ALH)4+IMEZ;.(5%/&W"1!5SO.Q5N_'WY#PBC(,CJC80&4+C8"<@28
M3LO)?]0Q`@N@P-O<@,*`!!$+4K\-$@?U!M&NW&=L^&KU2C+%RSUTT%F)/KHH
M!]<MZ_&Z2X\F=N(_;N4;1Q7<29`MSJ+DR=\DSRS&A;A.DT?*U#A^^37C[S?Q
MS_8T7M%X7EZ*G$BOB[+@L#UV`:?T>4!%).7FLNA)F-/']4?#SD8S9*JV(YB9
M_YAF@Z&D)VL*@YF!@#M'7#H)ACHM>#^YY1+KIF#M]SQ7-R%=G/)"BWF17<[C
M1Y*YG@P,F:HG`S`SGT>T0D*F&<_[;H.(/W96[O>\7,TN@_0'*<Z:;\^\2JQI
MS6=[D,N4'FU0,850XLZ,)F$%*.;.D3%3\<886,YH',2AX\!BR%0=6,#,4`06
M?L44?RC@:E:;?P"!1$DG"!R2]F@#A2DD)($"8B:3P``42Q88).*@#@20TW\2
MP)J0;MZ&@)"@A6V'I-G"6#UGRC")S"NT$(U7QP6]748\P((>+!CJ^KKK\I/J
M73()?UO1E)ADW2:TU80)HT&+YB[9M86Y^LZH82(9;*S[7D06%]@K'CI0-Q8M
M!VN-T*+242HG-<B`^5M=!M21LSY%7\W.XSR(YY0YSOJM*`G\8$35D4%-8[1P
M[)"B&1FHY^1,)POJ*N16:#>]A,:<@6R*1WV1S`#S?*?+9'J<[/47RGPVF/$1
M#5[')8?=7MD`2PZP8+@CDW"WIE[S:;0Y)R)4[LXU"=""V/GVG,)07O;GFO*@
MABP_++[>FFFD!+R0-UFQD,J"YW5*EG2US-:!N0BTLARP$[/:=1(V3-#"O4O.
MZ,*@?>>2EC*VSPZA77H'$>&%^<ETQ:VB7@?!"25?:$4$:+'M\).LUE`#?X,5
MR8/ZO%O]%`E3]I$EP'Q-IT@[`!2;LF-%2[3H[)!HP$W3<X:A%`1W#/TZFY$P
MOYI]?0Z+1^]O@IQ<Q=PN;$[@__!EV2-S-::<01V`*[;5Q7R=V:'%/Q3LCBWJ
M<KW87334,5OT5:)Z$4$"?PA).1#JIFAAVR%A-C!.SVFQ6I+V461,@;L^YS3N
MX`+F$E(:038A:(L6F([R"9UY!LPH!*+@AF;MN9@J1]_N].HV_LV(R]&`$J%%
M;8=P:F6PG@,K5*;V@7E,."Z>)3S>?990@EMUX^HE6$FCUXA+D$%ZQJ%,!OB[
M/MX_[?.`7^W3E7MTH*_["CKA!WYA^]>(2U,S#?J97RA.B=:_H$3K[GM;Y_$D
MW&PJ%ZG+#0D)6_ZQ+%NV7++B40Z/(>UK1'07\_6,;D/12J3_A#,?:"O#7/0A
MH--3,B-INGE1IE)-^0VB&S,I^&%,WH876!AT<'>`R5B='_DX%L<HI-\:R,P1
M5,12X(N)W@;0`08;'-ABF2H@'XT%R-5T5=X3QP_'M*[N-\YJ(,RTZ8V:R=L`
MOH5!O24\:ADKQ\!9;:YS;QMGT'(`AOHW"'NHZ3P'?2'``25V'J_'NLT#-K(D
MSGG%/;]#Q.<U66._ZV;(RS(KS&WEE5A$T;*ZW%+4`D5@L1K*Q$1W6<0PZ;EQ
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MN,,-]34,YW%.4I+EU0>;<M-`M@>F:KS9[A(W\@\%!PM0D`5<KT%EG:(&5ND%
MY1RACB4[C9JQ9/-'_P`2S:T@5;3SJ8R+\%BOO[I8$K,)+N)?`*9+&M,LY]/=
M(U%/&$"JJA)6U]H_#"!3BIG2QG.,ECWJ\^!50%/C1M)J9YI!A`N'\XL!3!Q,
M+`K48/JX_7YE%"SV=+\$2A5Z@-<Z`8["8?I,=L*Z^N3M6YG@D1[-ZT\`BLU&
MG:+E^TL8XWH)`S+L_3YSH9#`_1L6Z-XN/$M2)EV\?D$K?+E+@S@+P@("\;3X
MJ03$]#^K]24DE7&N>=1D?\CSE-ZO\K4UKH-4?I#,BPR:]Q%[ZGMTCN5S;+JX
MY<!RH]ZAD-GBUS@E041_)]._L0A%XWGM,.#FE/4DI?PKWRG[,9Y?0]YK[+L[
MC>=V[^;5.*ECB_?AC]U%5.P<H7B[N7$HO%9HA^()9WTYJ*Q9W0L5A9T>%2I?
M_P3JM=-:HMZFE?\8(1V8W<"@55+^1&N-M.7,(K8(<]N:F-^3.#3"1)M``HMZ
MPW$B0ZIJ9W#4.2N^E(\A5OO=.WEU`;LZ2G?#L''"_J4ROY0WW#Q5U&XP#C_4
MJF;L?R*.J.MX*X%9-J='M[KQ#AQV&XT+$DH5K6&QR[6GE:ND9*V2HER,;RX'
M95(=DYC,J+APS8!L!P)*"MQXL-0<C`PX?]3?6+?Q3E6`(6G5FC_0E&"831[@
M6@S8S-$LRL!YV>-%$L3544W)H(N:E,9I_FD<PZU0QWBLF[S:M]0A&NA"C=M5
M/$U?@-FOM'$]!Q8T&@<,0"K:+=L$7-L7OR'\RGT<1/RMB-L%(;FW]9FZ.D-8
MA2&LMAA<9/5&F;!-0P%$FV([9DY@:@B=94W0*`AILL"UV26^Q'F2GP1I^D+C
M^=^#2)H<&=%6U18P&BR0V!WXI)OV"L24/37.0\!ZP`6HVBS`9*\7,G`=\A=9
MS@4DJ_(P;7,,!M#K*E<+@P^`!R6!*"<$OZZ+1O(INFX"'>K5TZ+VJPK.KT:Z
M)8;5MR+9&@/]%Z*=&W\TB9"R\?:]+6$C5".OF`Q!2NI`()@"97QQX0$\RVGG
M-50SV75:[NP44JDR047+S0-;@A;^T0V;T_3J":&MGLV$3''A>E.7>I:D?']W
M6UK#KS'>_J0)@'9<JLAH2NT?5-JE0S>+F"TBC/M"79,H?5/X.U$\ZZHEV;X"
MJ&B*!5CB"`56$KAKH>8(N+M@X/=3F_<M:E,R=?O:*ZB2=O[!`$[,0*K:Y68R
MUKC@400Y)JC^_21%RRI!$[5`!081"O1ZF2S0A-R0WF9BLX6AS=([[V2(>L#E
M,[5S2,HM8$FS[=FZG3_[1P0,`QK%+/+]-D=<(ZYXMX'?*`O:XP#1[FQY:&C\
M`T:?SEMH;YC$PWK`=1O&[M%G)NG7YS!:%<<UDF3Z1*-(@B<3TNU]!P`2+&@2
MP<A":6`N#^.,"SUO[%@&+)OO<#!#G<OKCF8@!<5;.9K1ZZD,^P,92%`QF4[I
M>F?J.J#\.>O@@>9!5$NX9&D+F+#*60`$_M$"RW"-E;?(>2%]X,)2^5R3\)DF
M]11D0+G])J*G\`\G;?YKKKE9]@OB+RPZ]CM1E<D6:(Z2M:U/3^TV6,`AG90T
M:@'S5PDK7$->[HKQW3!UH)`W;.XQ-AKX'VE8AJI5SB(Y%?'$-?9L?;Y:<JW(
M5'9C`;^<0',#AB67[7Z*&;5_2`$3E4YFL<E:3#O$!4;-WHID*V$<>R3=]D%:
M>QU_PC%B-_R<>$RF7X,TIO$\JP'PE,QH*#WA#"?<7,^O)_`__K"X8*R\12B`
M]*'`$HK;"2Z#]`<I+IZJUWX@N)G@%907H;'699!7MQZM[Q\E4WY)J97--+Q`
MEI/R\!]=;`$#+N""V4\\9YG)!B_TDLJ$^HX'J$[_H/F"QE<Q^1<)TK.`IJIO
MUFZ8&GJ!C-FX3.LRMN@9=S'QR*(.&'4600AL:(N(I)/;)D"IY!WVI2QP2)WE
M)&4"WRW29#5?L']((7PF"T4]<3>=F0&,$1E3%7QZ[,&54=%$I+[`EPPQ#(T8
MY5B3S>TVKC7`$K6^I4F6;:].Y7>FUA:TY_%Y_$C6MQ<+KU-RRECK5D8\L<_O
MRE5%;\9UM<1P*>"P%X=9Y1P"?;I,-U#>7=)=(5OL3F&2]/9I\9[R7L<BXW0<
MZ13HV(EL^G&5N2%S+O3YFZ''H<WB4+OACG#%,S)]Y'(0QJ:YG)HG]FG+82YG
M8%P_N9Q:P+Z>P^LQF>,*M2[FZ8F[PX2N8HS=-[RD=$*K8T_J*J&1^A!T4NSN
M3W8]]93;^?>SL65W>N<;2WYGX9$HZCMV3W=-XFE5Z(2BS`/_.<!!C3$E,QHS
MO[^@CSRA:DH+-XP=FXV13,G])QY&6$B<F4J81T!D:1[`-)4!=5G&KOQ%(+7U
M:36QQ*ME1/A@JE%O8*"*I>D!JMZP>2:777Y'%(RH-+2N,3X,0D.ED1F<!$9=
MCZ@O(U,(7_B9.=@:9'JXE<WQ`0X>]`R-X2C(Z7O%_N2</NGWEN]CB\`X5']C
M$0$XGHXC@;I7JPB`)*UY7T2_KS]Z7B9;F,71XAC6,^HEL2*>U+Z?E76!A<',
MYP(-(_WL(&7@'[9.YPN8H?J;0:3]M[-*[<>>,<60?H;$X9K2Q<"@2/\59SJ1
M'N<<Z0%%A/9[/Y$U;"6#V!)H#V(U&+_6\U=OY22#[W*I]]IWUP4<-@`;LO[=
MG?C]U<!C"S^OMOC6=_AYK]8<)`B!8#9LQ:8[!?JLVL2Y%_5^K\[['2/R.T;P
M+;6<7KD#LJBONW=DPF'):]YO8D#H'H"=B('O7>B\)='G+0O>3^:]'Y!]7X$/
M=#:VS]7X.(_%OI]B>E]_#GR`J<^UJ.79I;&XX6N['PU?\MCEL'I',P]T8MU<
M2KB3H/C6OY'\D@3\YR*2>/_87]13;$3;2BO;$-&UKWQ3WL[?6ZA!MIC$4_X/
MOR'\D<$O-M'=F+YZ/15.AR`,:0<XZ6X1Q3W_`N+&ZZOP'D>ZMVN\$PF>%4<'
M+[#.]GA2=3&R^86_QD;7^2GWD"3.:3PG<8B@I.SJ@8G.Q;E@4Q_)SE8YKWVC
M,5VNEM?!RWHFE&["&U)73VU!J?P]+@:34/UYQXZ)F8TD'W=\Q`]3+"2.+"6,
M,$".C2?0#(5`/8D!E3F/[YZ2(GGOAN$V'S,8U^G?`I*E]AH8S'4Y4!\$ANNS
M68YV1G2+DS&F:QS>"*IE-AL>US5)A._?C@[99\DJ=0+L%B-37-<8O`U8RRPV
M.*IK@@A?1!P?J.FCFVC=8F0,ZBV#-P)JB<6&!_56$.%#?R,#]=V"I"3@F^3=
M,-WF8P;I.OU;0+347@,#NBY'B><_=]BG*O_`_W//NF6_^7]02P,$%`````@`
ME5QC1'12@=',2@``*6D%`!4`'`!C;&1X+3(P,3,Q,C,Q7V1E9BYX;6Q55`D`
M`YJO%%.:KQ13=7@+``$$)0X```0Y`0``[7W;=MNXLN#[K#7_D.GSG,ZE=^_;
MVCUG.8Z=]CFVY64[W6<_9=$4)'-"$6I>'+N_?@"*E$02EP*(&Q6])+($H"ZH
M*A0*A<*__O-YE;YZ0GF1X.R7'][]^/:'5RB+\3S)EK_\4!6OHR).DA_^\__^
M[__UK__S^O6KTQQ%)9J_>GAY=87R/$G35Z<X7^,\*LD`KUZ_;AI^0AG*VY87
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M@)\IZ_^C'NW->*S(9Y11\7T]QZLHR0RB.!S:!+[U4*]7:/6`<I/(=L<U@.DC
M02J/JP?T>LL(@_@R1S<K#V@156EI1R#:L?<Q;M'MXTH'CE&:SM%S^4@,X!I5
M91(7/\9X]:;&^6-2Q"DNJAS=E3C^^H'8FODI7JT)L-H`?D1EE*3%>SDI<3I_
M)OB^^^G=^XV)^P_XV(9)N2#KR`K=1\^H,(,_<T"7_+?(?N.$S&B#2YPM[U&^
MNDRBAR1-RL345,A'-TQ.#0='9F9B,)AA9&_1$\HJ9`37_EB&43W%:1H]-/[;
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M1/\VY_.)1S;NO*[6.7JD6_(G1$VM(;>5-ZIY]%=)67.(Z.(IKBT+RLRY"2``
MIO<^Q+5$"](6Y9^SI(XL&_):Q2,;(>.NC,I:9(G9'_C(.MA+!G1DI>ZID1S)
M?=G8^Z3,T2+)$KKKNR1_=L`2(E`V1_,6,*7`0IRL1J9%)\5Q!X>4'BO@O$O[
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MBW%[KGSRG(A,+*!7(P;"EJ%1_;%S3`JGN]M/3/G'SGFI$9/".^<=VA?(O&%]
MDKDZ+X#;UU\8/(`>>A.NDV]1/K\G4"1*Q&S7<++WFS\?@6TT\SPBVZ5Z^_3A
M9=?F)GJAW]7([RC(YC=IE%U'*R35+YO@6@_!"@@OVLP6H/Y:;Y^E7+7O(#A8
MJ&TB%K)]N$4%(J@]$NP_HB>4XCK.>/9,>8"N.LDO#!51Z-U,#ZB'20%FI?&`
MUZ+>1.*QU*NN21OX?6%5@6M']H81"/K-UIL^Q5E1I24-Q6?S:YRUWW],<A23
MP>JHP*Q&A2MB9@;L[9,UQG$OBU9M$;;`7:Y4VZ"D509#%(1LFZ7LXW%O&]T_
M*8IJ59-$(\M7J'S$<YSBY<O)0U'F45R.<7_,08=Z0R8@'L9L4F,?EVC^&T[)
M,&E2OMR2I>.*J.&J6KF:5!`2-N96`CA`DVU05U1=:ELSJF_UQS-#V7TWSP3E
MA6.4'`IRO!G2:#7J"`O),,((?(&Q@2\PE-/!,V1G0"5**&S[Y9U*;/"+63GF
M9OUKAP?5:`TG*/C>HRQM[G>EQ+:>S%>$']2HELD3@F[[E?HWG`?VF<C67X<#
M9C;_:I!#EL+&CJ,YV\PW!(EBUDH#M,%L8"?W@NCHO%6+:[X.4!61#5G<7?BH
MT7,`^[\N$@[W?RW@X_[/Q8Q^;_N_'A.43<V![O]$!\=^=WQLS-S.6UA+O_N0
MKK?$*X>4RB3J)]].QX.<#P\JAI&F%K^3.1E6@>X[%98`?7].A(L9"\YIL$MT
MR*;AEI(IR0H;M&FS.';??Q=.#H\/?AV<(58ARYM1#;]-BJ_G.:)7D%&.BM+#
MZ2<`!1M[7R'8[V_1<C^;P2UA+ED@,S!_.6@#XS:\!D#!F8$YAM;<S>;W96`4
MPVH_'XJ!:3<,'Y.G9(ZR.66&Z\`]"[;->'T7WM&66)R_@S4B0MIEUN.OOO?;
M\AL5PU;[>VX;:1+@*S[#_29KFZR6^[`=D[FY5<QF^/O;MV\/;7WHGD+Y/=IU
M?Z9[7"4LS^'!KQ,<Z@,W)<V^6[I<,-LU4]O[S;TBL4PXAN,O7C,V7?HBQ!XO
M\,FVOLGR&;%P':HXKAA6Y^]@UPLA[0`#XO-N0!-$D:\6K';M:M']+<S50H"_
MUFK!'$]ELO_UIL>?2_*GVQ)KK'+[QFYTS];U0S#9DA98)%I)P)SF:)Z4IU&>
MORQP3M5)6`AMS##-U"KW-G>C'0::5VQ,=P@ENAU5!1LUC]@(/P8JKH-3Y_ZX
M#BX'6G6+D'Y2D24W)SLE4,$M7H?.K;)AHX#(!%;8XG?ADAI`72WN]##O;TII
ME%Q>ZD-CWYD30`GYZN7V)8GXCRHI-A,HUA!)CX:GW%9!44H_$K]8JBS@O@+J
M>^V]J(]L[O`XLKF*Q(';UR0X/*>E?^CMQ:J8+:Y0OD0YO9TH51:E?FWX0-K<
M#4E<;5#L"2#+BS*HS0T>0SO;JY/![KAQ"C"=*L7L6X;RXC%9GSX*DFUE3=O=
M`*N%-5S%`BYLS,;7GQB+6(L5B>)L0880NML,X<@ANS[,#9'$^9'V:7@I:!<6
MO:!JH<">(MJ]U_"4SQP>0S37]>'"[3L_4'@AJU0=8";(-"\&-O<"+F[OI.%;
M8,_MKE32VE>I#<$N<+`W52%888O*+JT!!>?4ASBM\N@3RO:>[Q:7S)2U;YC%
M;^9>+.!;&JQ.J-)^JP.ULX1+H?ET+"^R65QB@LW[MV__)A8/>$^V&\?LX$YD
M`.Z4P*634POR[QCBH0`HY+6IK2P,+OPLK/'LSZ)`_01.06<U0R(!QJO>/%8L
M[%^UU#XBD8:8(5<I5:'+0\X3J_4G/:K@->-4^&,W]%G<3W1&`2;.]\F$SYI2
MJO%Z:?LO[WO<!?7P(T.`0+TZO>&$Y_7DRE0L6][ART\]UL&ZN)45Y3BV!MUA
M!;"-B@TD*,QL\^4O/29Q6WF0!TE`&$:0CTBPSZ5&+3(J:?WE9[5XZ)?!M4]7
MBPPH)*I*;3B!4*\%,6G!6V+K+@F(]+^J/"GF22P,<"GVW%N7A*W##X2J$3PZ
M$`H%YW,M*BZR_ZHR]/[MVW_4[R#%-6KT3Z4`&'08]C(F[SV5T)@B'PS%R<!0
M0[9CG1A%)RXA,&'R3JPDX%Y#U\(U+OM7F72C^;X*T`,L[6HJ%`=+3#0>BY.!
M=;N0<"7@&I6SQ=GS.MF<\%`B/].[HW_6?W)7E)'C215=-LRTS(!)GEF^$:"#
MF'()OO"-ATZBIC$3H@;<3@%$94-2B\GN:A?<8O0Z2DW#MOU!V0`V%UPJ>Q\#
MY;IW$]%J>=JI6446P;-36U!9=W]/RL?+9)64&S,_RSXS'Z$9,8I4J]F=#TK%
M`?QQJ>]"=)1KTH6O_*JYNL9W!'+`=BH!<LP!H0_E!!\:&RL*5!8"/Q"7_T;E
MQO7C+_&C!]PQ7G><"=H+@UPS;#K&8V:G-IWR\G:+5KA$Z<ME\I7\>X\_()DH
MCQE+NM2)AIB@`!O@E<ME#X"43&S_YD9L3[*LBM+=$GVRPE7&>KY\U#A2<>5U
M/RA1!?'(I9A*$)(6;#$IHIM'&;;/-%!0L\7G+$=1K3>?R-S5M"]*E/=V.SQI
M-3!D,RFC1IJ@#)OCG'EQ-H&;3++_$5I""-<L*_027@^<I+U5)][*T1<$O#0M
M6J]0(L>8"C"B._*[ZJ$HHZQ,]HV_."(S?D2Y^$D'FI9TFN6;>4-J`#6I5/O,
M]K^NZ-S.%G7637&1_?Z8Q(]GA*#R9<,V)$HD4.C=S!"HQ[1$6)\95@RM"AI2
MT?29VD+=E?8U,L*##R@C["I%XBCIT7"=VVJ:8@<CVHJHR4!+Q<OHB>C);R?7
M]^+\.T:3AC^=7Z9R"YE/CJ&+QRP`UNI9\_:\9">3W^/-Z;MX>@5-VSTJJX5C
MO5>X;X&5B%._"\*8<A$83U._AS!H_KGMNT+`:#8I29"1:5(<^+`F5K#XKL3Q
MUT'9[J9VL4;I8L]%^`?>@<DJ^T/78V09_;T!_5W\V#Z.*R6CX-'!*[EL#4;+
M>'/CVJ[8;$'X^M=2+#'9_",#7/_9/`D'5Q]Z0R.!(JG[QFS7^O;=W\)]:H4[
MR3L*LOE-&F6@HG`VP4%7`BT07LK/L05(]<&3\2SEFI\.@LJOD8Q!+.1J)8-G
M`7G/&C+LPM[WQX<9#_=A1I_BV6J41$)9S=K-:N<G[X1(5QVA<0O"TC.9C16H
MX(KM_LA]R75J6SGQE+/5.L4O")WBK*A2>FY%C/XUSMKO/R8YBLE@]29YMI8'
M7$8/V'!TQ#@!/K@V9JW%%KBKOZ/1H*03/1I/0<C&_?CRF<N7S\P6MMU$"]MR
MB&=_5$GY<I'%1+Z3)T0E^OW;MS\386U*K]8"VGPM*7)J<.BV7*Z)$=U+%L#"
MF>>5=&UFE=<UB$7(]DH[@+6QS,6L*FFRRSS)EK<X3<\WQ\,V(L\@@&.CT1(@
MAS!-FUP0-S/4A65^<MKQ`W3XQHFQJ4=U@5-B/KXM)-/8N[E2\KX3T_L[2I:/
M)9J?/*$\6J*S9Y3'28%N\B1&E.\+EV99$1GS5@&,P*%/O?_Y]C/)$U\05!7(
MWF*A,+4NEA`@8RPN+R"&N'WG<"1Q/8IN$95V0NDISNHW[JLHO4?YJGWRGK?#
M]82&(;NB#-WORO$@I_1!699Y1+^7K2)^L-F?>=<8N$X)]*1;K'7%ZV1SLA?=
MLH>YNGABRT%N;T[F\V1#QR>4$4:DNTS-0K`,.84[=MV!P9K>W#4RW?I%Q46V
MN75\C\LHO2!2G&1%$O\6I97-S8D*>$,>!`SDA+8E2MI@>`>B,7_FMQ\0!IC>
M:2@1?I#&OSUH(?RMZM/F&<W>OW^,LH9%USA[0@59)"T?-XQ"9*Q1T01^R--M
M[]A"%P=WDSS!8XYQZF-J/1DYM>87%2VV&%MEM-GQG2\UO7W9)S)T^3$JT7F4
MY/6:',Q:I(.I.SNFAMUW+5&!BU&`LG.@RZ.61KM?/U4EQN?2JL)2#VLOG)4!
M/M%L[QHC)QL?4AO:.%*\1/[)/.AL,U^]?;#5`HC!6\NV@/AYVY%[W]`)+R=X
MR]!G*2JA\/=8W3_(&O[L1^!XUYXDZ+N\[.1SBO5ENUG3Z[5[&\RUE:IE'HO1
MUE4#\H2\=_<I6]:F>,II6Q:8$K(UNB6[`X(L(:&^;"*_("YJWUX59[<)4!<-
M7*!488R7^Y$P!$.6T?82)TQ"!:U[EX`]2R=,KN3D*-Y$@PP<LC00#5GAS=6X
MTVB=E%%::T9!;]7E3VA^CO/SJJQR=%$4590)O2#ML=H+D^K]`[2"VI6QQK+/
M804L?51#UH6Q_E37F?F4X\)*?3\Y-$,)4TP($](X+_?XY-,R\9M\(@*#U^X1
M2<"_U9%_XAB>/:\1=?SN,?VJV:30D#,P-_B=S"@$A:2A)'Z3B!US^WW/P.&G
M_%O@5O#&T=BBX"5U8APF5ERFPTJ(\)EN/FY6#R/S7)<'!VEWI+D:76YYR=5B
MHV`]'ZL/=D(F9B(IR<*)_>XRDCG<.)H=3XZ0+1P=&Z[#<IX.)9LT-$=LZBFE
MSIRZ`\HK9>?@^4HL96-C9_7C%9C9U>$]R>;]$IA_%Q<^5>K<K@&P/J&=`FO3
MJU.>5`V.3%[TGEST'#F_J?+X,6H2>&:+O5-#8NXH/VQ$PL%`QT:V`8`FY*!(
MCZ>=38C+EYSLTQ2T8E.$Z1$]FG^L\B1;;KR0S5G^GOW:%CT0QE&T!]M?5!0'
MF)""Z9U&CV6J[\-F??R#5IRQ>:^#*B*^$L^U$#&5>ZX(?-+*[CO]?,Q$'W(&
MNAY?@C=.(XZ^P\IH\9^Z<LQ1<9:C<DQ&,<Z60[94FR2=UG!O@Z3V$^SX((VF
MR['`3,@)&ITP8G^>`LH,L4EL\$;`RME*ERU>CEK9*%@_2>V#G9#1F$@*B'!B
MO[L4$`XWCF8GU!0031P=&ZYC"DB(*2#C9.>8`F**G\K6]8!20&YI]R#2/X:8
M3'K5DX5+B78L4$*O]GH_NM!$Q=3AA3+X"2U5X1U?C)OL0S[`T.6,S$S])=3$
MA$ZIC6TB1AIEPMOVXT:$I"B(1IF0[LL3@8RPTF66STB$@]:4D0:,83TL7LX4
M0#-T`9,)84+:YZ5FA7Q:?*<1623PD+5[C[O.7O:2PC3_T/#Q#2^K,Q70(9E5
M:@_2$FR>B6G"'L7)4Y2D-(Q!+&(=6K)A"(`@Q]H!*9@)F0&YT^UF,ESGWMND
M2*;./T]1G<7E:?9LG+W'V#11,+3LP\%.2/V]>/V:$SCQK8`RU=^W&;$5W'>"
MF#.3<PS\^S-2W\DQ@!L^?8?&;B^Y^F2YS-$R*I&S8,EHG.R:.`@>$[)N/H,M
MIF;Z,((QX[EQR):*?]_#E?^EB($A*P2&.B&;$YQ'I3>U!^PZJ3)$9GG^.D7+
MTPNJ5>4CSI,_Q04?;,$R'!C>&W]"=L-91)C'_@F&@H>D'*2N#NV6]6`O%Y;Y
ME?\8OC4S)1./T_+)"UFGM]ED*'\B/@.;"=O["#6]Q3TNHW3_]U-<E->X_#<J
M;U&,EQFU:/NU<@1Z[A1^_P$XNS`G9`_&Q!E\S&`8,06WE(=L1?393O^A@91M
MDJNT%H)A,&/]`>;0$U)]>VZ[G.E3\-A%5,A4\F^'N+`W-1MPWGQ%VXF4U@\B
MMI=Z#O`)*7Z0:SYD3@]\\1>SP([)X97IEC%47JMNG>1U)UKCB6$D;((Q5_2Q
M._J$=)R[N#O@NX/%W2H5,DW[>\":1JS'KS@E:!:SQ17.$;V\?X^RIM3S;/$;
MINY,O<UPI)0:&-G17R5$CJIN>C8G:A5T")89D'\$94#NR?#%(Z&QH2E:(C=V
M`@K8E#F0PSMJO>;<3$:YP73)=/C=VZ"4N'/^?U+L4T?+\5Q%^5=4UFE)87@(
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MUJ@JD[CX,<:K-[5H[0)JM;VZQ-F21F(OD^@A20E`5'Q$992DQ?L??-F?4V*M
MHP=,D[.>T/[9ZDDV)R8]YOQ\3SX545S;WH&`,TR.#3"-6)L=VM]"L'VBR`!!
MG=>36"N`-6"MZ;<`P*#-C]*4;^FMR&K?YMN>`*ZQ-TG=P.S;HTH:GR,MR6S/
MRW]2BXOFO_Q`7$6T^Q)G);'29VD-YI<?"K2D'SSJ^ST!,%OLT;[_BAA#987M
MFTGGM/%&XW#B(_9<7R%)!0O-D1J^*/<VZ5ZV[^6]WCB:?+LCGF%LDB%<Z\#$
MH:_FNK`!.FPN_?,FQ_,J+C^B)Y3B=4U*1AS6F$Y&MCQ9YJA&ERMY^H,T/%;L
MZWY'HSN-V!"#N$*HB%@GF4(/(67)]/&8IO$U%:NO,(`7-DVAV;<Z8O2<VA8>
MB6=%F:RBDNYZB_(<YWM2V-QL9:WPIH:4[(=`([FW0C:];<.<=>I3&\-=IAF#
M/%0;FK$UO**KRTJ=)=+>Z_,=R;6(6^%(,!M+.X\G*\KJYS69S:QLPY(K7#$?
M2M(>0R*Y[*[?D0`#>!>.'`N1M?.D&$><;\D:D%7HG$QDF_E+J:[/Z+EN!ZA3
MPW1)VP.44!7NN!=)&'8[&>R71@_@6*0^#<%1UAR#>#L%^8@>RMWI,N1`0])C
M*Q2<5MY"<EV,9.<$@M9,"AU'ZF63@-6IX2@Q!U)_CRJ"<'`1;'J<61(%ID33
MS;DD@"UJWK"?W208`C]V`K@`$KL=.$2VC;S$G(63@C6HXVH0"U)??200G,9X
M>AI/E[N<(^&@]NP58:^97=2YL@OL(4#?BP##>([U:.R)L!!6QR4#P+`CQ(9R
M$%!,G+(YI4)Z(L=MVV8`#']WOT.0&)3^H;R$)+!MVX`9G(YSAW=JV*Z2^6FT
M/D^R*(N3*+V\/!6?@<G:-\SA-W,W[5`=Q.KDP8U"=_)A,`(^?Q*YM#+SJG*`
MQ(`C-:T.3H`<>I+L1E_Z%5OYS>PLP&@156D)M[']!1A(ED_'T>@1"-C[XC?\
M\A[L=GTQ7$9$/N]@STN)/I\NE]'I;^[2DWUZ7.9)3.Q^4M<ISM=X4P%1O-HJ
M=F_X!^X5]EJL1_RHI5D5I!U9,K/*W.0X1FA>T(CP15%4Q-M`LP5EA,"/EW?:
MY3-Q&[KW[!5#?V`JQT8``8"412@H9T\AG*?CZX&&#UD)]W9YL-TS?]\\`;WB
MTS%6D5@CVTD/,#/OM_3@3A("'[1I3U9WWT]`\WE4C%'WX9A.4T%NT7IS@#];
MM)>T*-(W>4(V[.LH%2>!J/7>GJ;#.@5K`O1)US4-.A"=IF!T\;_(R`*&"IJ`
M?).W6)\C?@ZH8G?FWE#0*VQ)TB5^A"BI@@SYT?D6^[-G>MT6[:N&8$$"]&H8
M+6P9K&2ITSG6;8%`"OGQP7HAEA[^,%KMNS)>KU$-70F6_Z)VP+,=D^FW*(8(
M/%><N"(DKJJ5=(Z9[;:'/9W?W.L_B^\8CK]XHKO7BL3C!3[97:OU(2J2XFZ=
MHV@^RWZ+\H2ZXK=1B41/#JH.P71+1-V"7SVT.6`RF0P`UIHL@MS=S^MSF@E-
M/*:/%?J\QMG64S_'^1E-&*7F>[:XBLHJ3\J739T>;GS2$@2F=(X;.%CYM<U"
M8ZZW$:P`TF\Q06Q73'E#Q<R\^!L!P93_D2-/20',,M&8!IA!"Z`"%H^Z3_$3
MRJ*LI(O2;+';0Y-/JZ1:763_1E%.'XMB99P;&8\IW"K#3$F21[#'F-AJX`"0
M4:.A70V$SW'%/9\?.9R^A&Y&.3@!93+'K7QV4`"(I\60\<TVZD@^40=_;QV`
M221D!*80BCM.2>Z46&!,U$!0`=*E%T16.I"89>G6?]BZ%FJ'$L(AA`<3G)Y3
M$C`U)A@_H!"#!8B87GP9)&)MX<ZS/RJ:1945**[HQ=8KLKU[3.L*OE&:TI;`
M4S"-`9GBIS3.E(1Q#(.,B:8.$@!!]?GFQO[)S8>7=MO5?Q>)<PE0WG$OF5O4
M.%A)U*)V;$04"`P@67\/)B;_$15QGM0HSA;[<=TZX`N.R\.&89I&6=?@97`4
M)TS&Z(&@`?*Y?<X^@"(-39T)WS4:CI6JCY6JCY6JG17`<38!QTK5@=?Y.%:J
M'I2<%5!_K%1]K%1MV0^J:"!H'>7ERW6TDMTY$#7?^B6L)OY2$-&ZRN/'J$#;
M(I%]#*65>)3'V&7E0_MYT3SA;/;S'#5Y(%B0A\`'"9'*0$/6M:::^"QOJNI*
M=$W4O%L5OM?$-X'4.+:%@Z6Z)>W3)975SHON"&=G>%\41"-75UC`&'=%)4""
MJ&K>K2]-D#W%JQ7*:263Y,]H$^QH2!'?;3<.0+*OUAAWFJ\PV&*LE1<:S"/K
M5$L^I=$SOELEY>-_D\;H)HTE!1TD[=L*#MQF'I+KE==PK$XP/P4?"KU;QT$&
MU:F0W.(RRI-G^M]3DE?%;U$<$ZS$D@+JU/JIXK;N94:^EF%-4F5+[!!D][XH
M"%3`!;B.#\"`T`MY&S$NNJ38>U!92Z._GTIBTK#26$Z$&4SR6:U$-]8"[C<H
M]:74TX\<RH(L^L0'%EKQ7*P*%'G@MOOR$S3>\&604.Y*DF0A!SAQG@,-1J^-
M;)[CVTDQ_U`%TKS-I.*UFN:6'D:TE0VZ#+3;!\5H69<L(\[BZ6.2SG."V:^X
MJ(OT7:%Y$D?I*:(F4!)YTAJE#2\I=I[:AGT4<PQOXS5Q<2J2-V3O1I"(EL1E
M;'2EO;1WC<I;_!*E98**6Q0CLL.9\V12<YAVL5/M?8#/,XWCH/L'FW3Q#;A@
MI+O@!.`<VV-L0HB=4^NT$:,7X`/7XM;;8".[T30]*Q#)5APK"62G%0]O;L^A
M;Z!S6[9+$:/!U'P@*9&&_1P!/+=BL+<DM??++CJKT1U.02Z,O#?#<Q%U.G"'
M!<POOWX*`$UE@3U$]P20^N/1/1%B%W15Y<V2V513%"7\,1MV'9CMCX=E6D`L
M\))ES\'(3DU>0Y=;JH<"_5$1"L^>*)DOTG<M)3W::R:\5H=O&F$,\F@=90A.
M3%ZE"9S2/GR9]9K`*9LGN=RIY7!RX`'$1_%TQ71AQIM%\B?*+S)):AJG6>NG
M]W^=W)Y.2)[I#1T'F.NIOTVR.5ZC=;*J9*$?;LO6:V(T"#ZQ3$;4V&PR_OB!
M5P+N62GY^ZZB]NP%PI^0R$VP>&U0$Q4N-,G*X-DT;&H&G>/\-ED^EO?X&BUQ
MF40EZE:8W%H]6FGC,WTV[13E):'N-"'.Y:HHZ9-6W.H]5H#L(D<FQSZL7:!U
M[GN)0UF@QGF5[.HK^IP1VO."%JO)YO>/1%J*_T*+!?D*9[O?Q.NU[CCM]"EW
MGYJ_-Y9!9AU";6Q<U['>/)C4'CKOM.V&$)?0)Y5*=)'Q=)PGK$8&;?.7QXUU
M@&;>)'?=FW4SV+M6D[L2QU_IBYYH_K'*DVRY69U^B](*;;XFE*BJB9%!6V=\
MW%@'J"8FN>M>3<Q@;ZTDO*EB%D4Y6]RB9/50Y04-SLJ/>J1]MM>"N>T.2]A5
M&>/E+$B.G+7*\(8*@FXR]B@=HN,@5K-NBGKSTV'*H(!\+V+'Q$>ER'L`!1CW
M^$/$8YN6?RS(>"S(:/DH]UB0\5B0\5B0,;2"C+>49M-/S;O&__C&K,TW9GU6
M._A0%43+B^(D_J-*BLUDB(55TJ/A'+=54)32C\1#DR;A@/L*J.^U]Z(*LKG#
MX\CFJ@L';E]YX/!"5JEC"=Z<=[?G6(+W6(+7_<[W6(+W6(+W6(+727##;T+^
M,97[F,H]%56YBIZ35;62^D?,=@T'>[]YR`%B['8Q''_Q]KI[*5L\GMO:RU4>
M?4+9*<[739Q?4M!&TKYU*[C-W$\L?">&U0E5VB9VH';+S\B@.16*8YVL@ZZ3
M9516KM`\RM&S],X/KUUK_@<_3RT+5$*@X2Q/+K20_83C51!5ZGQ?!3F6G_9_
M2]A'^6F.L2=DW*)%E<TIGKM*8CR;+VG>L);;ZK`2E10XXC[G4X:7XTIB\5>T
M0&F*<N@=%4"7;4D.0<NI^1QPL@V['Q#`Q^J!L!#\L7K@X-;2AYP(W'VUPODI
MO4.70TKMJH_`O*`F[C@U`Z'/%)N7TD!X."U'QU.PII#03?1"_VKNA9(Y.D_R
MHMR]$W47I;O2JO/F1C\WA&81EB2_=!R(`_3'',R%>V?.*E''HGO@O#&/"[L,
M0:?&];*:?TN6%UE!^%+5E^@W9O\6%8C@\"B)+BOU;H/-P$Y36\^UF&%X+5?$
MP4X1,\5U_!Z747J#2_*16+BK)$5%B3/4F$)N49&1PTE68^DHW]&"J\;1<-94
M*-[*6G"(RR;O;H#'A7*(DE-[=9(28YL4]WL7\:0G:9`^;4JIL.G4%C\%P@TO
M>2#(,L'YV<5"-[!`5]&\KFJ19:A6@]^3\O&"LJ;.,I@MKE"9)['J`C@2C&1A
MU![].UHPS<Q`.`OI6'J4M>\0%]B#KWCLQ(9VZKJI6D9F9XF]Z_7YCJR8B%OA
MV"8VEC)9_:M)6=T%SV>+.UR5C]%J3:SEY_\6^XK`;@W'I:VGYC&JD6_8:80"
M=RI')ZLERN1;#&:K;5F\[H]3$PHA<:8W#FQ8LBG_F]$"<B@J"6V?4(;(QD4Z
M]Y+F;=H=K]74I`%&KF&QD`&5U@ERX09=5Q2GO3*WRF%2_@@2AXC5\3ORBJ1\
M"\<U$J#JNMZQ9GECM6*]!U>\V&NM8H.EB;>B%$#=M.NH)/_.%MM3V&P^>Z)O
M.Z!O^K73>"FY?%@#XS/(SU7HVR;K@KH8=%ZV(0D!9%[I,,T1!O7`Y!UMU_E2
MGRYL@@4#=0?CT75WU.$?7.VL@W_?37>FS80P%:&;CDOZO%5UD3VAHFR]O-.H
M>!0(%;]QPUE6`W<^C;:=`],WWJ0!0-E)G38C+M>H)!M.O$*7F-#Y1+P1JA#W
MF"8`XJPN_OV(B9>3%Q^B@GDR.'*DUI-0[3TA*1S'&7,BJHN'G?1`8_)+=>TF
MQT\)\=4_O'PFR_]%-B-+%-F<9LL3LHU]2NACT:?$"4BRBGS7_$AVMV)Q-C#P
M3KI'#38M83?'-Z.R;P(M.^E`Q\(]Q\(]EL)@O^/\*Q'ETVB=E%'*D`1!JX8I
M_1\G8(SD1!G:RW)@6)OE8^6%[[/R0E@"PUU:N.V^O(,N*%_,%IG86U+0(JK2
M<M2:`J<OB)7D74!1\/WMQ=D?55*^&`]^#T%(8]Z`+OOOFO%:&G[?K0-&',X6
M-^?B[C)0#>'QX+TT*4V<F!\?UO!5,P&,@PLX#VXV'!]K.#[68")J+7^G\L/+
MIF81V7LO\VC%$4*%7L.7)IF-71##W6`K]9,2Y&6OK3(CG/<N(50+##D7+N^%
M2C&\D(]M[LJHW.1)I%%1S!8U4;(C05F?K5QQV_FK7;^'BC1*Q6_<9HXQ&OB)
M2TFGI%\12$8:?R/!`S4HZ\,'$;)&7!&R066D6>W:.J+=W\(L(RW`7ZN,-',\
MMV6DB?M+N)2B^<:WGM&,+OIT\,8L2VI*JW3>9HZ"^CB.7((7)CR2?-4EE%5R
M6@ELR';CCN"-BM,;,B3*<S2OV2`/<<I[;7/=!2T]I"7SK7L_S@DFD9]0/``V
MB%L!@(0L/:?5JDKKM&9%`8)UW!;$%S?V$#4'S%O?=5&AF._&\`$/'!D8P)#%
MZ_>ZKGN=(G2;+!_+XAJ7:!<D/7DHRCQB%HO3'*$]PX/V,N@$;&Q%`WF6UW#;
M"P(;)&Y0OI=[<O<8Y=Q`Y[C1NML$Y4'<JZ/J+&/3K.+J*Q"SKG,Q#J,`RY*#
M@LBPH`@\GY4-#A@+F4P"*S_2N_?+X+RM]YN?$T1FB%>$M9O`KEY^J9E8J*SY
ME_>*0=`O`VILSZYB'%29XG`"H#X3D:4!P6&#+S])PX!?S!8@5<DF@$0"`31Y
MC?\9M1R2$,/)JLXS&!4<8HX!BQ'UNAY`J$C$#/L1(S9TMTO5(TH7MVB94)>4
M`MJJS,F*WD;E'ML!^[4KEK2Y#V%22;A0HW=DY@44V`06*_:&Y@[%5;Y))8^H
M>GQX:?=,34/A(\UF1H9L>"&C36;G:X=_IG;!IK%3UHVP=L2J!]A:^V$X$,>+
M4I2C#=9-Y".-)*^L`KILER)!RRFX-'!2#7@P$&`AWWUC6I.S9_IN0X%N\B1&
MVQ^UEQ[@<*+U1CK$82PR:IQRLK)`40I9R/<T^F-5[R_JETIJW2VNT;?Z)W&6
ME,H`PRB4L%.XGOTH\K5=?$VHR@(8IC_#2Z`>Y;\,![6CKBK'>&3O/Z_IF66M
MC=D[R(F)LQ4MZ[K!VQ.=YK7S.<_'L01&M"Z-&7TR2Y8#YMH_*C2`:L@7MXF'
M&B,T+^CK6]0PTO=S.M0(5C=PWV:R`.W#7]-4B1Z]G,$!ABQGWTG1*<48Q)@*
M4\`(Q,AR4F;?Q#)K8.\?<UPM'^]IL)]_:N,`IIV5O@?JNU[V16P/V0=@XRU3
M.KVW):SN>7^+T@J-V/*R^XMWO/T^X3L'.L3;VN]R@-J1/5Y)V.9XX:I*RV2=
MHD)5O6:+3ASIUYHAIU%VBV*4/*&+K*;R8G&>+$J$LD8;9_D5SKL*>5'(=H$A
MX]J6\@H2Q6DM3&'RT-Z"%C2],F.D]^"(J9WQ?I[_)GIX4I6/.$_^9%H1M8[;
M/;&X<?AKGA*Y!G;#(&AV!,O"MN:D*!`]%3F+\HPNW?@;RN\()\YQ_NON=/`>
M-]JVITZD;ZU.M`087JVC[,7&%L@&?@:V2V;1FM8*%@[?PMR&6:%19E`&[R2%
M:*KU[F^-MMFJ8)5Y'?8694_`:E<);KA#PLW9%@2"TK0,=A@\F_(60X$^:6G"
ML`Y!CE62U<@,HK:ET2K)>[*]TXOS*DUI]=^3-,7UPPZS&HU[?-.^;37?*%.4
M;O9`'UX^TQ#SMSPI13=8K(':7G2Q`"%<Q\H15\?=>K")7^"U@Z^B9U@=)U:[
MMHY3][<PZS@)\->JX\0<+_#)/E865Z5NLI7%Y4MI$QEL'YHA>_^[B%_*&-QQ
MN,SQVD]GT0)1;&P)DD!3J2QN6&1VR57]M>]DN<S1,BK1[IXIV:8`A$EWR*&8
MJ8\T'0$<R25CHJF-!T!HC=[C.D^>T?RV1H>BGQ1%O:VFBM3<,>/))KQGPUQ(
MA\`E39GF<0*E``X@-T;SZ:]Q2<1VDQY"#.\]RE=)5E^$WGLVFQN,5.G<1@MA
M?0(7(!W*Q\F0&D2`&)E-X]S+<^NMXY?DN\_K#>+W^`/Z/4J>ZA?/=GM';@%V
M0\,.UTZ]T0(72K/<,K:&CL(%(,C;]+00GI6I5JLH?R%6/5EFR2*)HZP\B6-:
M2:(^=TR3.$%%\]3,3QIOS9C9%V\?%*,A\Z)E"?=M&I5NC?2(F_H+"&P?868@
M6'QXV?N+]]#-V*$&#[A#N]M^'4=IEONAA7',X$8=1+@,`@^Z.!S<ZSH,^B4W
M:R0]^$KM^=T&%D:;C$+Y,1JXKX#Z7GLOQVJRN</CR%;13=;Q&AQ>R&5`/Z*'
M\B(KB.+7M:'$VL1OO.7IL$$@I%U'*[GJR+HPR=QOYD51!-."->GCJ,804E\K
MI!#<OI!1Y=$GE)WB?(TW9=`D=0\E[;=UY7G-W)^6P,T05B=4R49VH'8W33)H
M(5O(4YP]H;Q,B&=U5ST0A&AX`LVIH,M?*X#VW17/E+5W+V%2E>Z7[5$D&FAM
M=H`'17G```,L<3[:RP>X08"+UKIH0+RBJ91$!SH,O&:,LN/\AGZJ)8L]!07"
M_/D'7NN1\@V-WB(`-_^!N!;2@`F<6".Q$0BX`*MXFC;Z@(V9)7LO@!RR)G?1
MOLA*E*.BI$>9=1W3^>Z2#7BW"!F$N3"(.TY#[4>PPH`5T(`><BW&6[2.7B@E
MQ6PA65MX3=OG6@8_3T.<)&09$1HNC)!K2W4E?6_U:R^F;,XN=TW@X3R5P9AV
M##;`-`30`&N,VS4E+`)/8.92MOE(O:9;&BAZIR.^O#%D4COL-W%AE3+"IHQR
M@;O.>^UB>),G69RLHW3S#L9'E.$VX>@<YSNDB1>!Q;4AS0_.%%#M,<,67HO<
M&R'5%K"REC'KS!+7&<`C+7%W#+@E;ON%+<SC&>'&$O>`6TO*-2.:[4;N['F-
ML@))MD*"U@V7F2VF(5ARXHR(D`B,2NKMU#(6WWO+6+S)\9JHZ0M]$Z4\R>I'
MWM94?P<BP:Y*#>R\*TLM[1!`#B,737CN(FR(0<ZBK)NK7$6%F>5F+"JQ@&L^
MY)CP\Q6!&!Q<GN+@+0E6Y([SB,7>]P&^#3V@@'FBW_G%2TH4\XEH&/)N'HOV
M><[-5<O-6UX2P57H+5MU]GN$QPU0S1J%WC)N>*]CHS*SPZ<B%-F@ON#LL&"\
M&P&&'K)B7A&.@&IXL-JU-3RZOX59PT.`OU8-#^9X3C--+Z,'FMJ(\Y>M\(E3
M3:4=&GX(VKF?6Q5%PQK$JAN%8;T.(,!)I`("'6BH,>:NT(#T$#$J8(O,0"%D
MBZSN'`!Z#/+I@'W\Y`PJ>@4Z](?J"_B,RQ_K>;FLY^5SIL^KG!!)*XYF\_/D
MF7XJI-,N[]16-1$TG(0#H4RQ"2="`6C(HL6E^'.!%E5ZF2Q$T52%WK*%;+]'
M0%(GC::JL\!@(%4%^"22G/7<6?!SOV.=5O4G@/U>1EBMJQ+E\OTFL,>NF@R[
M54!Z*U\M8+2:7"ID$.UD''/"$5=15BVBN*P?20-&)"!]MHZEJ.DD!$659&.A
M"1#,D'.0;]$3RBITBV*\;":V]R0`,U%=UFF;LLYO&)!@23T',,$&'08`3/=U
M:M-T$XM+GM`)?21A61_37B4I*DJ<H9LF";]Y`('_<KWN0-ME3;F_A_VR?`*Q
M09[P]]=</'K%T'3A!YZ>/J/91=<XHPH8T7RABRS&*]%>2=*C83BW5<BBID;B
M")F"`E))(`\@$^TB*XEBT$3,S7-=Q)1_PGC^+4G3)OU,(_N,6RZ7$(,NJ:X1
M,!=90][FFSXB'UZNHO^'\_H)F\%Z-BRG:VKD;;G=\0.:K#.LB0TO)<W@J&,9
MYBAWS;288%N,9%<`'8]YKS:R$8P/+C=.@1.21"3-D;;)X(J]0^78#D]0B;,1
MH\$XQQ[!2T*3KH0,DN_'LHSK%"EB.,S7U\<LY&/W<R,&0F.4X5(;L&$08*EH
M%#1'DG,K(&.@(PW](T@[1D`!L\'YY`$J_T5VD^,8%<4M*A#!\9'X3Q_)YC'%
ML&,.I?[;-0W4Q_TV?8R%'RQCZGS17;A8>`T7+Q5\G&9SGJR6*#LA6,SEQR:B
MM@T7V4W<"Y.NM<!JY.H8.I'`R.&&;<Z$FG+V'*?5/,F6;4P(<)@R=DB8(R\8
M9C+,-,C$D<P+</&0RXG:1DC&,MW%A(NGXG:(CU_(]D-@-*]1";`6:@/(??I.
MIP#9`LIM4^DN98G?[#;%^07O:=13W&"8P/<P&GEN?E?Z`<UZJ[OZ,+L*%PI=
M@V'4IQP7BFNWR@`<YO`Z^5BG-69\6"%$G26"%1F.$:.(B`HF(6NTP*"=5W5:
M^`KG9?)G70VJ*9HR;D4&#RM?IP%#A<A8!L+7Z+F\_X;2)W2%L_)1,^:K,+"<
MN:#!@O(%X)(%CWJJLU3'=Y!BKA`55<$XP"NB)H^6U39WDA,3PV?JS/Q\70Q#
M7F'&'^YJC#"X@*DYAI\+J2-.=4WP:HIGN5ZO-XZ2;L7>7]Z/.YO\8O:>E()4
M:QY/CN7/E`XE]:28FYB>HWL4/V8XQ<L7R;-P@K;;]')6DZ`<0/`1#X!<*T<\
M0K@AFSA`Q(*S`?<1=;"4IRFAU';2)1=\R((CT)8Z:J*WT>UTE:^#3?.@;-6H
MP#63`<Z"UCWH(8L?),HW,E"M$:`^E`@L@!U.XJ]"/$(63[4PSK]1E-]_P\9B
M@[WQM$*"VS&",JZ.(H%L!@88`.PC&F`M#8MQ/_TL:1<Q/QWLW,Z?7V_;4"J8
M*^]\-+HAO]LGLCIQ7*VJE#Y&N&^`-!<K\6"`E8HW0%#+U+@]`(Q)[G8%,GRF
M*MB<Y92`UTN_`HVH[XQM1@E*SEVZ8PPFANJ0=5`-63NLO/8P:9<27+'-@L.H
M7L1M(#L3=@>U<GU=.7^*R(5<`TM,BG8RME(2=F#+V#AW;4B\.]=L'_9$A8ZS
MB)[C2EA$>-2`VD[89I"@A->A#\9@8:`N6`=39<68\"HZ(@/?72!%`T79'/X\
M+>-&VIHU;GL#ZANW>I#OUK@-61BJ<=O'-&3%V,=_MNA3)U``6,?M%75QXX.Q
M[4I<<67-@4C)Q/2O!S1/1NQ9,/M;.,JR.?Z;[TC7\5U0F^^">BY\>WR!T.4+
MA+XG^_C$E,,GI@*K2DPVC)>X*&Y0?O<8Y4B_$K$A+S<KDWF25K22^!V*JYQ0
MCYI\`#0_)].^>5^C<9'.HCPC.]TM^@-W@N4/&P;1>L[&AO5F"'8/YHPDAE<,
MV2Z@9B),#VZ[7K(UN<0.F<ZUGZ:HZAM?2]0<7)WED=SY\,(>0'+.[0"J&;,K
MAA38K(%JN$*["OGGO4JK"P'J1X34&&?+XHE0'\2+H"@[K9IYMEJG^`6A4YP5
M55IN7BVZQEG[_<<D1S$9[*[$\==9C8KXWN7H`9LI&S&.^PT->&ZQ!4XI"C?G
M(N=X;`(LO6'9`0$9)1L+*7?*S1(*,V%F"0RY\(?B2B]K/BA3`>G@I]*!HR5>
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MQ5=(K%[>::<BW(8^;407*5E<7-R!1ZKC.#5@3H8J+R>+J^=\>`P-%\$YN-CN
M@-X/+Q]0%C\2:_!5$J"%=N7)W*!Y0$QH$9.&2J%=N4SH-_<2*@5/I4PKQ=3#
M];,'7ZJE/+@A;]L91-\3F.I:U^_%5[A=RW"HICBIJ]FP%W=IVVL9BG(-9DRZ
MVO'(55&I%JI\S1M""UF1-M?!JZ+$*Y3+CA7YC;>W*(<-O)%&MR*S10<EJ:Y(
M^S2$"MIYT1/!S&`]"KG*,035UPDYB)`UXBY*42&-(3!:M?DO^[^XCPN`E_=^
M>@J7(`4SV04UR!EA@`A9$EKA'=`ICS#!>K;+KJQU`%+$6-;ZZZX2S7"AVD$>
MK+U`B$Y/WS^ET3.^6R7EXW^3QN@FC<6'Z[+V[0-;W&;NA4-NW[$Z@5R!X$+K
MG'5+H01\E"V)FTCWC<+0@8*BL<Z'P=""-N1J,0I9\\&-"T@'/W=45((3RF2'
M%Y+P?"(%W)P+6@[>-96T#4:J6+MR%3I#V8O[E"#HAI7;[LM/T&WJ%\/%XN&R
M(]ZIPDGSNC\-RL[<$$^#?!$MT3N&DZG2C6=S.DT#V(Q<*I]X\8FU<>[%@A;@
M8VS&_$].$-V\ZSD`=#!<E8961S)3,+Z=-VDXV^.;1?(GRB\RR:Z8TZSAQ>#7
MT/?`8G)&;GUY@T\LC>8FQT2[RI>3;'[V1Y6LZ>'^-2I]Y\VT:-VDF_SY+6Z#
M18BQZ,([MY(-Z!#`_50NFO";I[`A!G=*9=U<9>$HS"SW'J@2"[A&0HX)_^XF
M$(.#R]SAT@U*(U#H+5/K(-(*^%(`22]0Z"WCAO=T`Y69Q6/9H*[1_-"'"G2G
MQR&7T0/.:>N7+4IBST_:H>&>H)U[;U"%_5B#6'51&9Z:`0$&?$ZBO&Y!551]
M!PM%!:RG&GM;HWIZ%675(HK+*D^R)5!5(7VVB4&BIM-16`62C>DL"&;($4LN
MP9]R7&@Y6IV.,J^B:1R0D$GW"$J$&]P9`.&&+&SG54Z801^IR>;GR3/]),_F
MDG=JWU$3-`Q(P.39.F"*39@Q!:!V@I&&[OO&<;6JTLVMM76.XJ2.N9+/*:HG
M.IOOOXS$99!`$$V#:&_]&ALV("&76E%+S#1H;XUC&++Z7**H0(\XG5^LUCE^
MJH-!<M,,Z-7N"$4M`Y);N7&&TVS2.D.@RN3+Y[/27)+%+YE#NLE<3$^OF%MP
M,!7>+S?H7D[EY7):2:G,JYBB=$'-\9)X,'(;!NFVR[T0-`U(Q``)X7"J39HQ
M$%B9D/E\*!?B"0B$3:7[EOV0+@$)G]2^:3'!F)U3@@X6Q0#.Z*^B_"LJ:6!S
M5_'#]P']7GVT)X((1>X<Y_2NT0['@;R(BR+#QQG6/(;T#>`$GX^G0O%HV!@*
M/')\B*\WY?RZSDK\@!3\DV,EJ,L,Q.;@#O?K?"GJ'Q2S!:TNU)CL\@5</EEQ
MA/W+SY!>(7-&>MRO/`:<._YO4"O,.2M_4X,MXC1V.3[,/$\E/)P>,WZ^^X2?
M4)Y1$T%0NZJR)$[643I[2)-E[1?Q=U-Z`S1\5NCGWL]5GS1L@"5C1(]Q3*F.
M1LA7!OFK9UVP+BI;'=RX]&A^BHORY('L/*-8&.`W,6X;U1\W5O"\_3TI'Y-L
MEJ%_HRCO$&&`P?+!%;DL&M!#>4@C<M8_4#'-6WYQR3'H#TY9S*$]39-5G]Y_
MSG(4I92B3T2`1IDJP'A2Y1&.8<[AT)I[!FX\?\3T^&.,#G/8D$P/1&ZP?>9J
M6!T!YATGR#C&3KUS,/V7Y"]B?/DVQ,1PJB:D/TI81F2#G4TSTH5@T)"T`[LS
M)4;$Q[0E8?)W8$O&H&[<E/10GJ;WTB7W/$KRWZ*T0@8W6]PQ%96(,4[P_.R(
MSY8`TQNLP<!CS-/>8"%Y-U"9,K&IXO%S](9J@+:1S=00W4E<,X$>H:C'@C4?
M@!+CHQ$+GDP)+]VC"W"_074KI9X>:^FHG5GH\R/\DPJ_57GR-;U9AR@I.PH`
MJ6&`?MO<,&';"9U;Z%!O[KA"#;K;$C-`SAO)7#!Y%F$GF\$,AG;LQLA8P<FB
M1#EQC^X?<UPM'\E_J':5"ME!AT4HJN=*P,'#==)!IQ_V&6[W&,0F_M-2+0MQ
M?1U8IM3LNXWWCV!Z`+%_+>PGK6AF8M]ZT"PIVW<4$Q_%=__Q<4WTIZ5PHL"M
M)0BF%.LPHKEVF6POK&L+[Y!C-5I>M>F</A.Y?"%KC)7$LNGDDNEMEPQ790\B
ME@1/%G,=0X)@YK0XLAJJN]H1%]E%]H2*LKZQ/SH;!S*X5GH?=\R0K)BY/:L^
M6[UL4G70#5,[J"=O33L@@^MDKH6@'0ZWF/I<];&CU,$VY%(\8B]F]]=IE>>2
M@E5Z(X&\7D;OD%8**_D^,H[Y3O#AXW=XOJW!)&:SKJT1Q)3K[`0_7Z;3/OV>
M:?.QLU.\1MGKHH5V$@(0S>_Q!S2CM4/N'Z/L'JUH5D6>I"\7JS4A8E=V!.YT
MJ8\M75%4AIR8X-MBIE.KI8&E3!'^&E#IG)J@2YPM[U&^NDRBAR1ME+XNG_.3
MM_HYU.I<U"6SH*_:2'ILA8?3RF-AK7V,9'5N!*V9%#JN72.;A$%!+#DU'&7G
M0!H6O>)#.+@:,U212Z+(E&C`BS&BYFWU4F:38`B4UH41=^`0Z;7BBW!2^A59
M(=1Q-8@%:5!]50PAY-S\2QQEQ4WT0E5>7L^7VW@K(\,&[OTQR70,Q$-"%%@T
M.*5Y^>.'+1@;=X<2]^&EV=J\`"[NP3KN&151XR#(W^WK;M$Z>JE#A?3QF"2K
MB^1<9-=D@;O_AM(G=$56NT?9:C)Z7`;S-,;RHY@`T6#8;U,L$^HR'S66P1^/
M4L#WZ$0.H61Y5;D>QP`C6ULG<^M-249H)L[]-VS*</2&T[$7VR$.TDRP&>3#
M.O0Q<9J[V-6_SG,5*$\P-_@'[<?<;+.:NQ<RX!Y<CUR]W;@:K)"S]-0U@*8C
M&K5^^P-JV[_-((=K`1E,\F8#.[B$?`#?U="+C'@GJ"AOHQ*=E!L=/<M8EE.K
M/]."<OL$:T;'T6XRN"F#&>11N"*7E;;@8]D+!!;RTS#*QNH<5^(XV8CQ=!>K
MS1@'NU8Q6.1KJ>J@<EARG3P9]<+VQ].6ZWJ,PY7K(8N\R?4^*B&_LJ1`67WM
MR:QH,X=4E^[>,`<HX")&N9=Q-C932D/99I5=H8C^75/H^PFG7:I;4:"R.,GF
M>PDR#:+S679+<X7H(^BDP37.\O;/#U&1@)YXL@*G?1G:[-C^WL\V0(<LM<8X
M#(-SX#B-QXY(]A_[ML1OK@$V2M7@%7'CU!Q<>M*6163UV]GY\QS]4:$L?I%D
M*RGT[BN>J(=_;K!PDR8V*?3N<T/4PTO*D\K,\FP(F`URZ\#'@JOS`.@A'^CN
MD;[]^&M"7+8\?GRY1$\HA>LF8("A>@H[^6?+OE<Z1%5+5Z7C"+16T->W_D)F
M'Z#"4.Y`E%F`$D2?Y:A,0K/W*=KZ(-*T2)7N(H$=='$?$U"QU1`)%7-!+IA\
M-$!2R0,?LC">%66RBDHT6VQ)VG[8>\U9)I0ZPS33HM8U#"&5&R!LC#]*8LM%
MK"_`6@@%G$)H?JO',SC@K8[5/2\S>U$%QY"-DOHV#-!C4*8>V,=/P7[%_9<.
M_:'NNGRFDHW97BCU_?)^S*;BB^%2\EIR"=Q7C&/+)'8304CL1;:NRJ*F_!U\
M$\'OU9=+5LN)>F-PZNTX7Q#X(<O<:50\$J>$_D??SWB*T@[U._]1(('*8[1/
MF\#[>91.FV<TNISS<P:CCJW;9U2"W67`@[9>-QH0-$.V92Q;_%YK_7P/7C_?
M'^#ZR:;>W?K9AQ]R3C^_M(U`Y.2=I(6-#G9)!//&SQH(0"]H<:U9HN;>2?NT
MPLIO=ZBR"N2,)U&58F<G!9US9;1/ZPI767F?1UFQ0'GQ`97?$,KVEI!Z*>"6
M[ATW&B=U##K(@8FS.8:Z%703>#LMJ[C%=8]X4WJ@/V1?&71&.FB-&,U:GVHQ
M`ODII;B?XM4Z1X]TU_^$:/%;W^GM>Z7"ZRJ0'00O,D)"C>9`!%D.F.90K5^F
MW-V?>PI#599JKC.,&K,<)XQK2T#?8=5G#+\&N2)N`S=5!Z>#2]Z^*PD#*`Z;
M5ZPI$W!&`RF2U%!0OV8*)6W])2YUT9$F?`K;MZE([#9>$CAA<]1/,P(0R2_5
M+((XR!\20@HYN63/=%RC<E?\?O<R!WW0AEH/:118=ZCAL@'L[MYC%L\S?Z70
MX0=7,IE(")8$->!VA)57)!^V<-WB-#W'^;<HYY?$UQY)S6OI#!""UHJ0)3,_
M6]Q'S^/]O/Y(:DS;]7;])I.^5.BY?1P^<=Y>4L9.T_$;8!5PZJJ6+XOU/;JQ
M3CGS1!B&0,A^`<2A9+89)%9R6_E)V0-[DC#J0O`?O;X)O-.2.BJ6UN423^;_
MK]IX&2I>(V"`X;HC[#0=#Q%.NS&_$`+2;?81]&FYD:$<,PZC\6C.6+1"-A,B
M6CZ@!<[1+8K3J"B211+7(@EQ7@V,VDSFJ)$FZ]2:XY\M!]<$AE/5BY$*H"'I
M!R[2`<FNLI#^%-9!X2K9O-I+<YEQ5B;9$F7Q[E6V]][.#&=DJQE1?"Y15*#Y
MYE`8<D((Z]@JD:2QOS.0[0.#3!1EIWXJW=L3$5`75Z=\P%GLQPO4R>9Z?V(,
M!H$"%<@[&S'9([KJH:BO099G3^0?P`MPDAZM$/):^8IB*<UK7QI!)`/>&.6#
M'HBA!&3(D:J3'$6SQ2V*TK."QEQN<DSH+E]$,0=)ES;*P&WF?L^K9]B`A!HR
M9E)H3M]7Z>)>T$JELT7]F7>&)._!7/Z[#4,7#35*1TH&%)B=?'^88%!OECBO
M]1JY>9*`RG!61NGL(4V6FTTE4&24QF(+$W"(*8J9#G<L"*`:&DX3_'N87E=T
M2FKLT#>"WEI%%L6=V<+'ZS-%:0/1;T&\)'!E\O0WB_*T)^WJ\B3NS)8G7I\I
MRA.(?@OR)($KDZ>_A[7=DV8F2OOPMWQ^,Q0E6RCY)D\Q/Y$-#["S4SQ=_OO;
MMV_#D2'I>;*P/5MV_)T6RV='+#9J!\1<:!*A43P3WA>8`*+5MSC^BA:D+<H_
M9\D3RHND?/%]M>44IT1V,;7S3^@DSZ-LB=J`^C7.8L[/]9%]%-<K`"2H;0-,
M6WG&Z-`!!,P-$`0/KYL&-@C&FP/@*G1O15:Y@7Y+$\"UO2:IXQ\B&*?JX"X)
MT45OMMBC77+^(&S?3#JGC<>(>'_B(_9<RY/S]$;:QL\5>WMQW,4S/`BHCV$(
MUSHP<1B&U_5@.[W1<9/C>167'^DU:+RN2:$WLF,Z&=GR9)DC)$P+U1^DX;%B
M7P_9BYK3B`TQB)^WJ(98)V:AAU#`UQ`LKJE8?84!'/::0K-O=<3H.;4M/!+;
MB.M)5B:_7OQ&_WO`<W;]L'$#2?8^@O[N[8Q-?]H(%YWZRB,Q!I]<>PMX;.^;
MS!9W)8Z_/F+2-B\VEP*\Q3FV6$&B%?S&_=OW040.6F2DNWYFPSY)CG?;`E[S
M+M,I[7>'XW/OR"GN.-].;<MYK$MQK$LQS;H47L]]Z")V4105FG^L:*6NS3EH
M79#K&GVK?Q%KCT+_K1:!^H3&D[O'*$?%"*9P!A!S9=#)P_&9TAP/UC4-7@C4
M$H#*<`E40B%H?:5953BK*9*&%;EMM_NKP>^!W^25433NTBY_]*!%XB*+<YK"
M\A%M_K_(ACL3<6F7D2,US%?N[=?`=W=N$F/.;+QON'L-W.N1[MRQS+6(6JZ*
M*2+`--)LP$%KGVA%.ENM4_R"4-WFILKC1\*7FS02)F:-&0_@8`G&"(V'FP6:
MB["V!R8?$>*2B48)RT>3BXV*SP;FGI83QQU=R:D#X#A9HU+?=]8T()V^`&/1
MM`^-#YM)UF0$HS-$W9FL\*W972I4M)A%OY;"U@,I*6<7=/AZV'%*-H3T?1TE
M]U$\!->IY'4+4SGU^*0W&D1]8=QSIL\J`J&BUB!&B?4<@)J2NDM04M=_A]D)
M[+,3&V40NZ`L%3KT:4I/YO-D@\]-E!!Q.(W621FE\MPX2+\V$T[<-O#@E@JE
M(ZO3@2!)#^/-:B;8?$)/5,=%LT8<N>H"5F>XG\#SQJYO[#TL_,SJ,0Q"=UM-
M-H0&H]M6'$T&/6@A`U0#4ZET"AL#7F1[*@N))@>,E3P%0I66H_"RP)@,I(^,
MXUJ-M6OCICYM#BW(+;UQF*'Y691GA##YW0MQAV8B>(T"-P0@VL9IO02$M*S'
MH:JX4GS-HCJK!=L.=CJ4$TTL3HEZQLG/?C?N;='RXAYS=HZUI_E`*VY0<T&6
M_+JZSRTB;"J2$MVA_"F)T88'MRC&RPW/:W8(]_YN0&_#![;!35:W',^$+;5T
M1H;T05*?&LUSSPG34++,3JL\1UG\LG?1XR1C/V/0UE>^P7G]0UGFR4-5TA#F
M/;XA?,Q*@7I[P4-2G]L2[,DJOL\YLF4%_-`DK4@6HDG8O6CW*V$N\6/:Y^QF
MV1U]VWGS6G.>T.NG^X[.B*+ZID!*%'T\F(/3:<.<=ZV^QM"75U[RJ*D$V]W[
M!B=/49)NK,U>W+=A)'US/18HH.9(S>PJ]YZLNHSCDRTMT,5*)MS_F'P(0#W9
MQEU.\^AD"._94)R@QDF\V1\E[$JGND,`<A2[W:8MNNJ<\1'`8J(3>GU+48K2
M..'ECP%)3/,MOLH3K9*.IB.X4(24DM!&BVP`%39KO_<29TM:VO\RB1Z2M'9I
MZXPQ?S4V/Z('XHD495Y!"U!(>FP%A-/*FPWI8B2K1R%HS:30<64*V21@=6HX
M"LV!U-=?$028IDZK7@75Y))H,J4;\$*3J'DS`^PFP1`HK4HA[L`ATFM="N&D
M8`WJN$K$@M37(`F$P#VT2QQEQ4WT0A5?FK7!;[P5DV$#]\Z59$8&$B(A"BP=
M[%P-P?@ZLN$N#U^T-$BT3"4'GP%&IF)*^?>^MT#;(H974=F$0V>+UJ&L*:I#
M2&29_$#0^"K:"6D.-:B?#>WN7G45_:.1'!GK/&F#!\CL.]D>J/F>_D//S<DW
M_Q]02P,$%`````@`E5QC1*!O_BF*%P$`@P,3`!4`'`!C;&1X+3(P,3,Q,C,Q
M7VQA8BYX;6Q55`D``YJO%%.:KQ13=7@+``$$)0X```0Y`0``[/UM<^2XE2V,
M?K\1]S_@^CSGN#I"U>U6>UX\<TX^D:62VII121I)U1Y'Q0D'E8F4Z&:2V213
M5?*OOP#X3N*5W"#!5'ZPNY0$]MZ97&OM#1`$_O?_^VT;H!<<)WX4_I_?_?C]
M'WZ'<+B*UG[X]']^MT_>>\G*]W_W_R[^O_^?__W_>_\>G<782_$:/;ZB3SB.
M_2!`9U&\BV(O)0;0^_=YPY]QB..BY>7=Y3WZ[P]W5RC_F#8]#Y_\$&<=`C_\
M]=_H_SUZ"4;?$O_?DM4SWGI7T8HU_C^_>T[3W;_]\,/7KU^___88!]]'\=,/
MIW_XPT\_E+V$+>A?[XMF[^E'[W\\??_3C]]_2]:_0^3KAPGSK>&D:$XB;+3^
M^E/1]L<?_OO3U3T+_KT?)JD7KJI>'2]YOQ__]*<__<"NEDV)>U\24&F:_'H(
M9;]?'`7X#F\0_>_GNTMA[S_]0%O\$.(G>G^NO$<<$+?,1/JZP__G=XF_W06X
M^.PYQAN^K2".&Z;H;_LG^MO^^,_TM_T?30\_#`[U(4J]P'Z\=3?UH`/ZT17Y
M5\,Y_I;B<(W7A7OJ0'+CF']VIYGETG:T:E@-*/"CN/F=5L'Z&XGYQY]^/,W0
M^S_H)W^[\\-UM,,[?[M//^'M(RZ[L8BS?I)6J9_2D'D-?F@&2<TUPHQQ$NWC
M%6XY9/_YF\*MU@_5N-E9G"KCVX"$0<4+A^\_W_\.^6M5GT7],_0E^_3__N\?
MJJ_4_1F6<?.&>?&JB)/\4_'=\A8_K")"X5WZOO$U-W&T5=^S2/-7KO]H_X:Z
M[5`:(84A&R#XVX\F,$A)>L)78V"!Q-5`P[Q!4/W*KL+@U`0&ZVBUW^(P926!
M=22<$B3@'?E6Q&."TF>,_'`3Q=NL>HEQP*H;\KO5^WX_<\"<V@/,@`QW>W>Q
M?(HQIC=?G.'$K?(OPVLP'-5BMP`9CFM<@65.GP7Y#)4?NI3B)#<MTOR9FU#M
MMFM!=2P4P*<X&##0%$<^G?>]%V4V=^Z^C<P&!`"2V3[BU/.#!.UP3/X1DL$^
M_9UHDO-*E?CJI\_HUML'Z"YZ]8+T%5WLPS6ZO#Q!5]_??H_>$=/?N9#PAN!(
MD/`@<#1D2$>&H+'_C?[GQ8_WR2_>:N6'6#*ZT^E0#/3D;0'J/)U@((9_"C^J
MFD_:?9%?1N5UE#=P*7WJW??(_/:TZC]9EW8I."F\+`PL+:*,#3>S!H<()N'X
M<SYPLC)`M8DH[6$KO;2+H_5^E18W!,6EUKUD1EU([_"P%(URK<%R0"FPW$;[
M,+W#*^R_X/5%%-_Y3\_I0W3KQ:F_\G?D=EZ&9U%`8F,/85[P,HX)>EAEPBL5
M0`SF/]Q`6\/)"_)E`$J1H7$H*#_,_"+KCHK^B.@!8A8HJ&LVB%2@AA54,^.`
M$L!`-X)'4%-'!IELZ<R\&09?C;E,-%K-?=X1O)*[N,&8)-O,S)$Y,F0<N2/X
MA6R4GD[3IUNZ>EGB*HA$UY+0C\EU/WUE:8S^&1>I;-=,91Y:-9*95_ERH:YU
MCY."NMA=3@ZHJ^_3:/7K99+L\?KC/O;#IUL<^]'Z%R_8X^QC$IQ)70UB,/_A
M!]H:KEP@7P:@KAX:AT*OAIE?L.XH:X@R`RBS@)B)XA(5*I?K:ACH1O`(:NK0
M(),M'9HWP^#K:I>)1NOJ\]_V-.7[X0M.TB-MS(KJ(W&L%M5.<Z=;5+^PU!1M
M4,+25Q(%:^0ER`L1;I.,WOOHD3XAGG.A[1Y/!86VNSP=LG@+$SH3#CWAF\V5
M3_Z9X`N,/^[Q37B-TVQI@8^38DC`7=G5ST2Q[,NT-\!ZD'X!0RP8,_:L6C]B
M:'!1=:`:DW=!I`^ID,E'(2+=4-FOG)1V0"?ZPBR"N/>M]2=F1MJ+4YQ'O(7%
M<1,#GRVK:T`_R*%/IX)WWJOW&##XAP3^<0E_A^:()X&_<"'?H1/`ROK`J3EP
MJL,!MO;`C]>LBGP54\*%TG$:3H@6)4[*":`2\#(D:DZ&%Y<-K_=D$**J_-0]
M.06?K!,LZ=7A`9=W4H<&Q);8:;&Y:$G'?,TJCK9VC*X:<!&S5!MK'&J*^TH8
MZ0).[19E]N':+<'\&F";229Y,X#5J;#F"UG;9=0(J.W.T.T,0.Q:E60+Q1HU
MD6T4#ZN`_*CVN/L:/T6I[Z68?'1.=Q"@VV_<;,I72AYPO/T<KG%\EKV@<^;'
M!+K9G@^)H%""=U#54Y"V0;0!_LO"5&>@<:GU!=#=(G]RW5@<6IID'Y=&J2Q5
MKY-2NVA/#:/<,FJ8=D.A+-"C(V36*%BI'9R+KB@>,,NMU+:S)7M>*1=T+Y_K
MA27=R1_9SC:MET+)+[,]\GD(_HZ,!OI%+97^\R4U=R`AX3C]&-=3>I?J>5I?
MY6E]5??GR,AC9CH@'L?,5`<&C(JN]_1MN9O-IST9=.T"G)P%7I+<;/["%I"D
M-UG`9U&X]BEM;\+S;V3DYB=DV,:ND*;%)[>QO\)_)J,V$K47YI/8="7Q=AN%
M;"T$6_E`ON7JM[U/UT.02SLO?.4-IER**X>)&R$-3P%N?`^P$9\C7T>19IR(
M<I%%0?-,&0=B@="/\E!0.?@LHZ$/"`OOM&46$?U7^2D+"F51(1)6L:@D>Y^1
M1I8MK<I79=/!:Q$=RL-S()<Y<9?X*="IT!IYTX7(6NG6A9`.1:KAA^TN?*MY
M*#:=)*@T>UMJ=CY0P(7Z[ICZIL]>RC[/Y/LY$^-GNK"X&GO$E2Z7JY#9H*.4
MXU7F^_<)_1<5;K9(^:C.KJNS:'[#A=B.^FSOMMN8A''AB\U$HKM3/J&Y8L=M
MQ6Z\ZZ'6[.QU[)9DNS`[Y,(M<EFS!7-1+L0V!\T>^O;YS8[&N@S7ER%=CD#"
MN"6"0Q#^K^*-'HTZUM\F5_<!>C5/-SBHM\,U_.F\8*<TD[_MG;5#'MT)M6B)
M:%-$V[JT-Z095#BOMQG"+%</K:Z\E]6<0:BEMZM'`BH=MC$HTH_?`@RE;SW/
M&XC6WE8>"XO-^K2^$V5WYVD&6H7(NE!5V@>T[/7@40"M4]GDOR/[#1.\^OXI
M>OEAC?T?:+%#_\&JGO=_^#$_:>M_D(_^MB3X7%.,?L3)*O9W=:3F'%$U*W>>
MY#49Q$N5YV$%B\2ZF&G"3HOR4U3[>%IR*.]<I/M+M[>?ZK:L4"ZV!5BM/WLQ
M_N`E>$V'`CA,F(35WI=//KQ6;6Z]5_K9\JL7KS/F)>??=GYV[!U]MLZMZ^VX
M*$8`T-8!$J"=+PQ6L8&'I\JGP`X7]/_9U$^477<A<UH">30&LEJY&-9).VM#
M?X5]0D+/@.`%#M+7;,BE6^G.G,-T)/=0K>*C\Z[^%I\@RBA6,3^Q)1-KNI9O
M3\JZ@'U(VR`O15^?_=4S^R2A+M_3\TO7N1@@CSI%F+IS8R'?+*5!./(\B@/H
MSVPT#%;-&<Y=%,B0FC5'K#VJ&SVI[RN9T-URZRUSTZ01-7Z2#[*3$U0Y8*_R
M'-5@*$P/6`VLSPQ<!-Z3;$J@?KT]%Y!=@YL$J/L"'/WG9C6'_:QU;;Q/_W9H
MH-^X'_P1/N>6M8?VM(E@3)_U'H[*<<;V%U&</5M,;C:?HA@_/'OD\S!_X_AF
M\TN4^N$3FY4;81J@1S1V9@R,`G&N`.GQ,[I7J9A]B7&+&I/8A-6/3O&CJGW8
M.U%Y*&RE.@F&+I2A5\-BLP%Z(8LHFY(_O(*ICVY8K:WZ"YF=(LP@'KOUFM$/
MX_I`S^#+6'A&?Y1;_N_<F4G.YIVJ4P2?*[W<EGKYXQ_^9[%2\"732E=6<CL@
M3:YHY4@36$>UG/H^6UE(<A1,_D_=7I+-7J0WEL]B%S#Z>5U!R]7<;-7U`<[=
MSUI0QYD#/$1!G7(.YX&83R@/ZSO#V9ZJT74*-2.C]N=`BM/]49RI^C4"MIVK
ME"$LRA:MK24/K3+7IA1POC"D,E124+F%UG[UUW2O9E;%[.;*DQFH"IT9:!>Z
M&C)S$`6KJSIC;3Q_5!J`F^/4,I8Y*`S\4I>J$&IN%']HCW.<%2A;X^.Y"=2T
M*Q9J;T(OD_HWN/#\^),7_XI3]A+T]*L9+$8*M]+!2I`.9#2K/[\+2=#6%[0_
M.VTC;NB5%8W=^;RDE7)IH"B+--^7[^VNO;"I<N!3X_8E&6[2W$*L\!/J5GY0
M]\9'5KZHD^M`CDFE,4MTWMQWBFT)V)P@VM!<L,URP4N9"X[+38[IP?8RE6."
M./0$X>C2EV..D"V9P<J405O5TX9>PGB+:VO>?/:PMR;GF#W`9S?SHZG+PT@2
M\5Z(BJ;YW1:V&I[Q%`$`S'")/2B47M1QD5^HCN]+7-JS4'5+(Y/?OTEW0>,6
MWX0FP<LE@2?X`2TTANB0KD!1>5J4"]O+@(!'--:8"WQLE+O@""(%WT><>GZ0
M</8!##K8<J$0@P&7H!2Q"JX!R?@37I/2XMMEN!)G85&;_!MV+P_'OL@E0,+E
MF%9@O--CD7]"MZYT*;<*;U2D]>,V$=MNU8)JUPBX`+9=P"?.X5B@J3+_;+X`
M$&5$!R%@(_D!H$"\"VZ,`R^?J<A[G5#9<"'A]46+(,4!HV5`4KLC`UB\P4&`
MX\^A_T*$P$]?Q?E-HWG^3:4MAZ-=(Q"`!"CWHD"^K/.B=A%55UW*D#JW.C*]
M)TT:2#JT&"$U#2ZE$F_PB=46QMB2].KRH2%*E(CGB"D;F=H:K+3R-U_>7,CD
ML"`4Y/<Y@O`G$Q"2KH_1=-+VDRB!'AS`?IH08`/*RMLX6N]7Z4?\@H-HQQ[#
MA.MLRL8/G\I)&W&AV<M`_AL9]AU.JU[!`I2GIGX5C#,SM\B;HUI[=DA)V:-Z
MK.)27=L/6='P&]YDL)&)%J<-W8.G$2/_5MXIG1+YM+"N/7-&^Y`>%5GM,)ZM
MET"[.'KQUSBA_V`\6==XDN#XA9A/3O)^6^^5E%*K8+_&Y-_A?N.MTCT];N^$
M'C498_)'R%9UK.HKT0G;?B"?Q=&K%Z0^<467AM!@U^@1IU\Q#EE`.R^F5UVH
MOD8GGVB8\';H9S2XT!FP3LJ]TV;E5\\]]SFGJK3S)@$O&)(X`_@!5>7'_:^X
M*F(_Q)X?/NRW$3VZ=(7C,Q("CL4EI7GO_!<TZ3B<W>9A`E221DX5A#:PM:!M
MZ_.?K#5BS5'6'F4=7*H@>P`I&GB+FUS6[]\BLHEC\+2E[QQ^DG4:?--*D;9^
M6Y@5E5P'CUH;T[@3`5=KDE=;O%T8>8Q)`$$)Y@`!!A1?UQX9A.*;S8<]*?IP
MDI`2\.:%EMSXZQ7YX#+%VX17=IGTRW\OO2[#N6T2&D"1I>E.P6(M*XNL%7V%
MHVC'YN:*EN@+;8M88Q=**B.01+UO8I./.CU;3-1S!IZ$=-S"%TWCX9462M?+
MA\]WY^CF`GWX?']Y?7Y_CY;7']'-+^=WOUR>_^7P02JJFR:"Z9"G/Z1""-.S
M*$F3VRCP5Z\/^%OZ(1!LC*-N73S7D30$F%53A@'QQ$;F1#51)NZ[R*XA=A%E
M5]$7>AVQ!BY(O,9MC@QO2&N&2]B^/9TE,0P_62MT!B_8=M!%Q;F.K\/"DO`!
MP=S09&/T:0E0](T7/UD%49+7J-YJ%=%#>\,GM,O$BS[KVF6@6U$3+@PA(5$G
MFJ6WCSK30RLW7O+(?JM]\O[)\W;9R94X2)/BD_81EOG'?UO&V+O9W&$O.$\(
MTO!M'-$7G%Y;\-9M7AQP*6PVB%ZZ40!HM88K,;>4G1?T"CMA8[.AVP4D.X_\
M_SL_1,EO>[I3V0;C]+MIZ:1]RR/3V],Z4E/0NB*3VBZDAJN\F94$XEK3*L*R
M]0\9QNA5E%U&Q?5#@Y:H0K`/K@%#L)OT&<>7X2K:8HTAF+IU_M5E#8=7-^HP
M`(9@4B>*FD;2=\&NH>PB^I*/P=P:@FG<YLCPAC0I(6[?*E]DAL&+9K$S^"&8
M'711R:WCZ["P)!+8V:')QA#,$J`TAV`Q7D5/H<^>_)%&?J9NZSUF^Q/$7IAX
MJVR;J?392Q$M+\,H92L.60D:OG^*J$F:[]@7=6(@!XE=P4!N!.P.J`X^>(F?
MW&QNLP>\V2Y*CPFYGZN45QYH-,^_O;3E<.YI!`)0(<B]*#@GZ[Q@%RDQZI?1
MEZ*!"S6"SKV.3&]*DQN2#BUR2$V#*[O$&WRA8`MDM%3@PNS0L"6J&D9!UP#M
M_3GPOD7W6S]]_D_2&-\&DNUD5&WS;RYN-IP4JA"@^"#QHR"#L.>"77$`]\K;
M&!G]Y$V\BUJWP"XV"JZC(E=6W@2"QTWK+#?!XC?6&U7=T2YP8J<2(*R)U'5&
M:(,\8<P"RDYS?<HPA#(0D<LNK72'`I-@D&093$-6L&S\?[!AF>0-97Z38JU*
M^RK`LU^^0XA5*1W+JF>[K0Z+[`/7-GD3W:)(YW=M/9AM-FH_C6V;@'_PW_1@
M8>W(0`RP52+LH[G>>.%*$,=NO96%'D/OOM8+`Y5*N%`I]0.):.$&)$B&[!CN
M/48Q;?UZ_MO>W\DWV5`V+G8-%[<#V+M7%01`@I/Y4.W:*^RZJ"ZA\II+Z4]]
M>R.S.]':IU?4O+U3K]@L_$;0(E\6=A*W@"FVFWB%*EQ</20P"?<4GQ6<;"1A
M*X@2[BX><'#F0EJ&`YH@5<\+:!:V9;."LY_X^?"@`"78C,TZH(9L6E_?3$BC
M)-1I7VQF+VT*L*&U1B@`M:'"C6I[:UGO1>.JFT6BU@V/C&],:[]K28_VWM=2
MX_"[IDO<6=A$WQK6V.;Z#;2Y5#P"@TRX"?\\86:CEK2(-&%%N>7CSX6B$AJ`
M@M)RI@"T4&-:Q-]/PKQZ@$`3E)PC`<WT7;$$K[Y_BEY^6&,_>TV,_*/]=ACY
MZ&]G^S@F05SXR<H+_HJ]^#Q<?_32-GYUFN:_B[C9(.[H1#"L!E5X$!-%VG&1
M7T'9)42O(7(1T:O3TD3KID8F-Z!)#5'KBA9RF\Z\/4G/+7T@7I;?_/;&.M(V
MQ7N2S6LP[ZWQ_`&]JM8RK?%^6J/'@OV)Z-_H"_UDXL&5_!9U7SZ3W,D<V(TF
MG)?,FA:LS2@0YG@_X_`LBG=1MJ9?/)N@:EN)MZ#9\,)'%0+`#(+$A:+.$?:D
M^NTA<@G5KKDT;:"\LY'17>A(.+=UJ[(1&P4OGT6NX*<(X,%$IP;R:X<#'-$4
MP(R@8V/8;P$]XI4=S=%_;J`N6"Z,_*'P)ACQ6\;;D,VR\6-Z&29IS'!S2T9_
M*W_G!<LM?<WO(PZCK1^R2"ZB^"P*V>:247@9IM%9M-U&87ZV?3>I@QHNMMB&
ML0FPW2ODEP.H+:#B46T-"^)F0<V@RLX)*BVAS!2JVV)OF%;6B+90&6'V$#/H
M@'S`@CVRA[765K,0IMN[T,*$"[]#,T1<%K8<GQ%SV>+=DJI>1M5H0]_EQ@F]
M8VO&U36EMU\Z0ZN*NRRI'?EJ`K0C8X?]D%:V6Y\3:4EE_D"/=Y(3UTL(;W.+
MA,-L8[T]*4,3S%X1I@=*[=FV#_2HJ#:CLQ;TL]1_##!3`!>J>O=I+MH#?JXT
M'S`26:Y6\1ZO[]@Q9:_ET4'X`N,DGX?GC3,,NA53WCH]ALN706``(P`];PK!
MT3&RR!NAO%7M,$>,:,/BT8H#_#?!1M3WYK6FW]4=6[S4<@6>7#6\6GD1>RR<
MLNE,+XY?:<YZ\8(]IBF.Y"F:OQZ]@)Z)@9)GC%.TIH_]Z#9$CX'_E&T_1+<P
MHG;6I'D<[9^>LXV+6$N*]YWWZM%$MVF>JTBN!%DDR??H<Y*]SD0T+\!T5PF:
M.',$[**XV"R)?ASXWJ,?^,S(.[IMTE<_??;)Y1"C5_I,EKC)/Z+-0SJW%A2[
M)9'OMWI=D6#\#0JB\`G'W[F0>ZUR3[C9X@&Q#_Q$QM&H=ZI.$@</4$%A-PE`
M`8HRG!`96CT3][7C'4F5R+;!8?M+:Y1HQD9:!9M!?SB*&@<-6,R9^-;DK;[)
MBL-Y'T;B^E&J1;=LP_\3!PL_<\3QF=X7N2W6:YL1:(!!&-92EG8,\'.E+M""
M;6MM1HRWS`=5H?:V&&%C+M()4IR.-MBJ4VY=H]RJH%QV#LAQ]#45X16%KS.$
M!ULSL=Q2./V#8?D6QWZT5B^'$/?AKG3@-8=^OB(."7Q]`M>5T;,0CH7NJH)Z
M(Y2U<H"9VD"0/6Y0XH?['*';2_J(@.?$\D.^KDO;3]QM8)'5B'7P[0X<?'I/
MJV<)/_N/CZT@L+D<DY8M7A>010'46K#A0OUB"ZA:SUNM`W5([9%#C!1`YR'Y
M$J^7U5);V>;\)OV*&D2K"P`'#4*#J$7TW*D8J&-E4;1BPY6L':HU=(%H)KB(
M>M^W%MTT>K8II^7,&NWNR&`CW.,+\L/=QM%ZOTIKPX]R4IZ,!I=/,<;T0^XI
M]P/,Y+]@+PO#.3H@<*BZK5\("AKW,;K(6S:F_*H'7'1*H&KM`,6'@"Z"0D%3
M`'H8:NE!KU#`R\<>44`=WN@4)[+-\%DW1)&'CA3I@X@C28J?Q,:PRQFRL!6Y
M?H)PP#Y`<352B^LDVN4D6K=(%)0D\DJC+@S:IF618&CWEEED8<<>9TCT4Y5Q
M:GN'T^F,NVCU*][@(,!Q19`W3P_!%D%.T@-FH%8\%4I($#_'GGI()N[0'7SQ
MVH*27!R,A0$5UYD^:3G=%^5G+&5EG[I%0LGM%M)-"9$NK;I=Q`3BF;>92;K^
M;`U/P!'6&7*\%<!I#!=F!CG+Q3X\]#0*>.S%(2E)UMG>@[0LR9^Y>+'/2O=Z
MA9^@)`K6=)U)@N,7DB\3>N7%7Q,+^W!-]XD@!HBF;]FJ&J]<[?(]6@9)1!?0
M!/LU5CMG3L,H?$\BSE?5)/LMM;F-0OR*/+H[5%9)>2'"V80U^6-%%_>@:$_&
M'RC9X96_\5?%^X%TJ4\9K1^B)_H;N3LR`2*A>K0Q,Q+:'2O`<W#6]3\0"-4U
MO5T0#JC3[_VGD*H(<9.'L(R)SZ=,,ZI#YV7/-/O:R'\M\^[#.=@W9(!BK(=K
M!4&-+2[NSG\YO_Y\[@`9>V,G`KF?3<*:6FEQV#R(R6G]@+^E'P+!UE&]C1@2
MN]9_/&9W@AZ1VG7?0-RN3"YJ78H4A.J=4-4+?:']$.OHPCZ5_1'73PY$R#74
M@]),3T&HA0%>;1K'8.5U<Q>806<J&L/%K?>*'G&V[PH;7.U2RHEL9Y7M+L`I
M1NN**\T-%,MQV>_)J+'&N&+LMVI,@WBUT%P8B$U&--&LR=ND&OB[Y4[P['2.
M!28\T@53$\XA?<CNXE$09,>D^2_U,/3&C>:]BQW(#3H";`EL'";$+N4F3E6;
M!>O;6IS=7%TM/]S<+1\N;Z[1\N>[\_-/Y]</]PXPN0=<HH$WLK5[L';_]G["
M!HZG.>*E6-:;K9L7G^\B;==:K]YJ,_AD%ZGOX<>ZB,S+SW3A]ZH6G.?O+;AS
MF(O\#D;:/SA_)7FC:?,,%X$U:[GI+U'\*ZG5S[R=GWH!+__P6^1?K'UQ>![A
MNP/(%1W#BGS0:K_(_T;Y!PY(O>#.1!J_9Q.7S38M66X;`!\0-!W`OT(Y[,;3
M\7!QZU=SOO6B,:53-]_&P_6!][_[<N+7)AR*%Q.SB0X7YBWZH$,P#@-$QX`L
M=>&'?HJO2%VX7H;KRW"--]4GEP0!X1/=RG>9)#A-/KQ^\OX>Q6>!ER0/=-4`
M+ZO!6,Q_JZ'&AM,(YNL`9-G!@2C(.=#^(NN/6',VYUB9R#^LC*#,"GI\1<P.
M8H;0%V;*A0<!0"".+$"IJ2+#;+949VB`X#EL6$!6GB2X34-:4]4>K^7Y<]7<
MDXE\NB._^[/'-GS/WUIG.RLQ3^\#QE:_8JO'G)WDZ\NHH;6&#[^,7621;CR/
MDOWCWW$V95'?F^`$X6^%MZ<H6G_U@X!&0-K1=$D%AJC'EJG'BGY_%\H#!V5#
M5)S.2#B&[%NZ?<+ADM!Z3:DM/GI2UJ[8?93;!&#[.(EKB#U$^>956[_Q>BW8
MIZC\V*43)J4W,-+^P5N;E7%:MO<CXQJ#WV.0X\;"QII@6,FV/FJ@9?X@$6YB
MZ39,K.PV"8<4W1,CO9#4!X7RY$M\\UWVJ^6])ZB%.A>J@J&P$VVE:`=V@Q['
MTL>^J^<P"J*G5\E!SY)VY2-67A.(AZEBUR"/3;GFE0](.;T6]%-4?>Q2MI7>
MP/9#3^6]+A]O=EMV'F3RC,$?PLMQ8^'L9C"LL$-.FFB9/TB$9S:[#1,KYS3#
M(44WVV:+$.EJQ$J`G)N-'XHPT2G-=A`&MM/P%:;O`GZ,MN1V\=*KNC5W=^%F
M0^@]-7EA6-M+L^7,:!?-1M_%Y9K"G2YW:VP5SMJ<H*_/4;&*UT/T=<Z@H`=Z
M1[<IQ]\\NH[WA%Q]],)?3PC)0G9<XF8?LO<\7TAK.HE6//#:^/'V.WK!0T]Q
MM-]1A\P@W93\Z[._>D8[+TY]>F1?BE&^%;GS&W=R,2C;LE,"VIRDXO;233J;
MABWO(UMW!OI"O1VTL\GC]N[960/T)6OB0O$)""V]#8NM@&M`-OCDK\^\W84?
M>N'*]X*KJS/Q4$O5-O_>XF;#.:$*`8`/$A<*-@A[+K(KJ+R$R#67QF#*.QL9
MW84F`42M6_`7&P575I$K^'$9/)BHL&;7#@<W(NF<$7)L#-4L@$=WR-86K!.J
M6"[4@E"($PS7+"-NR%O0]*CLRR39X_6'UP?2_69S&T=/L;<5#]YT^Q3O."N;
M`[Q7IAD2Q!O,:E>JU\54%A;9H>A9$[J&@#:BXZR\F4NEKC88HEXWK/5BF*)7
M^STPI1/X%QP5+NV\.FP=DNQA:37>7_N;#<X.*,M:)71"8$<\)/DN4-E$0,)P
MW)B40SY)$,R1"[IO";W"5WC'Q>^@YV1A2G[!`*_/?]N3VW9#;SC)XKE_V8,S
M@X[EDS2M/A#3X0;!@3QKT_.GG";7,;.HFJ&L'2H:5HG#G<&A&5#:4^7F("MG
MSC6Z=J;2M=Q9>'JCX=?&4[_Q4,N>"WHAD:5JF_VW`$[QH\-#@Z>=IXTC(K3[
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M&!O/_2K+L?`\Y%$1E<YG(H8XOO.?GM/DEB!'7%9J-"\>$,E:`DS)JP.!>"PD
M]:*:?I=T7M0NHNPJHI==*O=T[G5D>E-:4^?B#NU9<YEI^`<^8F]VGO58PAFG
M[A(!3S:W$6?M_/+19:TE^T]`#T%8^3L?YSO\1X]T@4"M,",Q$'VCU1?O\1%]
ME[I>N=%#1D+DK8@RLHJ0;DOKA4ZL_09EA?"1T@QY`;^GJRU2G`KE]^#P)=J+
M=0Q\#:A*?L8A'8>=!WB5QOXJWX[H+(IW;#/)2%*A&';-?Q?M7L,Y9!@@0!6C
M[U%!*EU#B[PA*EH66^RA6EN72AU3T$1#[FB3BIJ=6[34=@F>`C0]PS_`'!O%
MM';Z^?SL[*W`4U2+'"I`;3S"'!VCNFMT=039A>IZ'*0+JJ))D3[%7HI7?H@O
M4[SE'DP,9W7HGHHU@Q-N[=;Y6@"5&4@PMC9VJWR`[+%(S2%FSX6*#Q#=0+NF
MB6B3B]-PNU![I]4"=6?CQ3(H^,)S'B2EY6J7A.PHZGP7PR/K]'`S>]Z9'I:Q
M\9)'=B_WR?LGS]ME)V;@($V*3]I'9^0?_ZU^`@_Y,M<DG.J3A]HS<.Y\S4`K
MQ?Z(IKT'J=3`F(?5#/V=B^6GK\U%XVA%JC.DR_M:'U3OY,C+34,1%P'!H+6A
MFIF12D]Z1V'O<?+J&:_W`;[9W*3/.+Z*PJ<''&^O?._1#]AN(FSG5?GQJSUM
M%`^>C;L#/!?I&3+D(T3S$%2/4$PM+LC?^\"+6[LT1[0W"DCW]Z3<VJ*@,G"2
M[<2,=UZ<K:O*>Y(!191M,?/HD1!7&"7/&#NQP4QO=$8@B&D]QS&TTGZX8QP$
M_!-%PQ!`M[.9GC.T:B_Z4*ZP7HAV0[0?JG7,3RE`CIU</`T=A`_.WQXAX)^[
M3\^*4QXKN!GD#5-`]&S?+0H,VGTP6S)T&:ZB+;X@O_B]1P-[\+Y]P"$9-J?<
MB6N#;N5^A!H](#9ITPX,(+GI>5-NVJ8VLB@:H:P5HMQ`M!WE+FF)BJ8.D-4$
M'.W=W$QAE1-2HV-G=S<-5Q;V$%1ZA9]<'0NEV1Z#1YRV;N/A(M7&X_W1P-I]
M.WE=8->O89=>2'+\I@2_CUE_%X;)=O$K*'TFP>^``N<7>F15PQG;+F']$'W`
M]U&PYE4WNGWR7T;=?#@==4."RAD:_A0<5%I8++?1/DR1E^9+X*_Q5_0?-+;7
M.M.R`T#6%%2/F+U3Z`#UM!$2];J+3<JI>K7XIG8"GBQ4+JV\T&$?HIQ7.\H3
M\&H(3;H0;;W`L=ZS5RSH)S'>T8/PR%\[=EBY"XG$$II%)=`!X-FH\E$,(D?`
M,:EU?BF`6R_"LZV#"N#>'[2VB@J:D=$XH)2Y98)Q$<5_H>GR@Y?0"22B(E[V
MW'&?I!_P)X^>Q.F'F%O8]+.0_UZFG8?3L%^X4"60L7<%2PWM+;+VB)XUD=5'
MCZ0+>]A7=D);THM2=UOV<X#`/5$6`=S[)K7-;+2(;AH`>!(R"\!*B34M!5KE
MUZX7'^B>(M7`PH5J:P)ZB"JQ-T40R)IM8F*<<K+#AYP-53?T*6?#IS>>'42E
MGT/P!SY`;/G-%SRWD[>5'!Z6-;-SC%(]!)#'<D(7/0Y08CW%AR?1RRZL$E'>
M6O7!21PDE+.^_-8:1R9E1D<YC8NZLE('P0.*UC8/SUAQ2F/K\#<ZJY0=3^="
M'0,$.)-SN@`A9^7H#Y'LZO50'OL!)<%ZX4`L_E,YZGVZ0B;*RN,^7!%G30#H
M'I8@%FIY'^UC$BR)MMSAR$=\0$`P.]Z#2`=^BF+_'^5!HB\>*0[W27ZR!SWB
MHSCNXT!.^>@-6_,3/L"!"U9K7X8I)J!/;\+@-1L.W&S.OZ79.;#J\ENK.[<B
M5_2$KJZT`@6OVU5>C2HON;%N=5^T1[1#/E"D3"W[.,#./FB2U60F>.06:5(#
MTKI-X=KRZ$'JW<9ZO&E@3I-5=3L(F/V\]?N(@CR;7WUKN-8;?APFLNVLWYL(
MW*?9@'I72C5603VOPKYZ2=:6'@50;,J)O^%XY6<SJG3G3G:'4';N>V%V5FL\
MQB65</&@`Z0"*_\^[R[B*$PO,/ZXQY]W47B'=]XKO7(1Q64X-YM/7DJPD9:1
M4BOJZA#".K=X'&886J$@OJ:=Q#PP,B-I&^1K\7FWH;W1!F,B0QCMB0$J0IF%
M8H"9O>P8$37SB9+MG=BLQ`+D9:(%R"FNH@VQ+Q6\88%;+C*&!#?"=/U<>,Q9
M;;KG$=LKSHB@B,D*%]9XF]NLE4`E[0-">_>J$*?YKC<P.#+>^'>%7(<Q4Z:?
M<F:<<H.(6$0?"ZZ71MG0HS%X+PS7)J>HS2/)^X'QX$@.-LQ9KM=^YB.+\P9V
MG`-BGCO0&6@96C1!OBBX9@Z-RD@TASGK:F9EKY3-PQ!-&%+(5!.2=ES1'.1`
MJIH#0[=<&PV*SO;#AOFPG3U9K]';I_]_F_/Z8N83'8[36V_H<R1XGY_6_C.7
M&7&\NP>#5U%>=S:3)GGV'*:>Z`43(G1!I7OS(*[+@=8@::9R`#9,RG,3"9'\
MBV[?50M3/0K2Z<T=Y,@[0FN?3IC@0Q2%4R.]DMKJ#C#J!4?>H3'"<$Y*M'`D
M4PH#(')E0-9?RG*Y8\LY7>;<=DT^%KQI17T3^T^=2GJ7`YN3:(MG!\Y6TE;Q
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MMOY^>QG^%7OQ`S'89C:(+6[-;&(&6I;,OP)XQ6P4@I$4&5CNULM%9T1[9Z_I
MEV/#W``=7%,3B-EP3F=ZP%,F,[W1SM48?6M2B3$)RG*&UP_%=JWL`J/8^O"<
M.;N*.;N*.:^4.2F[P^^\!'GTP>>*M/GN2*0N4(Y4$OQ"]FME)]C4K91SMGA/
M(HIUIH)KL\8-^KE7(4]'.*WZV#G"#:B.KZ/47^%R>T"*%C]D_+C9L+VBZ_/Q
M]5+8J&/^:VKV&2XG1L$!5+2Z_A3RH&=FD34K5@73%46UEI3W95L'F&V&DZC_
M;6PR5JMKBYZ:[L"3GY9?^*)Q3-"RB=,,MK6=D=,F;+VW!%M1;7=XP+51HHV*
MW6;Q%6K#V(7"RCZ.!2739#@>4`R=1=MM%++]VL[S+55N-A?[(+AYP?$R"**4
M!G##/#]$MX0<SUZ"JQ6?]\\>0<F'U\]TV[ROL4^`P2N=++K)[X$5#\/UPN(7
M!RCB[$2G4"`;3A>9T6R70G1>VQR(&LX>F92F46:;,K&P7G]3+;-/=P^J>7!`
MUVQR*!H+M$W%M."HI:]6O@IX56$A2OCB^5#$@A;F.<>SG5SIBO'Z?F)4+=Y[
MI5KD>XL1/=A71A+TS@]1PLRX,'T[:W$0#0R.\F#O)[<Q1#D8A>#,/1>%`AWM
M5+7"*BL[V$;1+HQ]YBT#@G'50<K`D/,-J#=ZH,V:Q+W#8<)HN8QCPA(V7OSP
M6C7)%VXOOWKQ.OL"R5^P__2<XO62?#GO"=_A;7:JQ5D4IK&W2O=>0,>AR\>$
M_<D;STT40G$"P]C>`7;6G^8'@S@C8O3(53O^CQQ05BRR\[O6J.X2U7S2\K#>
MKGA_BSD^R4><R0DJG*/<.RK=HYK_[!'FER($)T[(F(CQD0LT:AV%,&X0[;,5
MQOX)X$\9&?<;P(^$W[HDTA&T@9`=U6MJX!_UR]HY8\]10&K^Y/RWO9^^/M`W
M([GULKQI_60Q7BN@DYW$`4"=)<;UH'."$Z?CHGX!95?0%W;-B8)(<4LYARXI
M`5`0E-^8=\@2SZ2=8\&ZGNR=!P8((YJK/OK)*HB2?8RSHR9$1SJ243W1H(2N
M%4QJUGY/W\QI'2'ASL$1(#B4GOIE"XF@TGOEA_@RQ5OQ^8[RYD()KK6TP:1.
M(%:DN.[%F$=59[XDT^N(-7!3E[OW6L4)$3J$K"@[*)E1,SV"3I?>+`R"+(&,
M/9YKJ&_6X-"@I2^Y[H/+QL,D:_@Z_=V"*9;/?M*X>,Z#-G[HA2L_>P67XH`6
M`JM@3X^=(A6!AU*:U+Y'#\^D?=6&SOGMD^SX^756:!0G3+%462\WO"2)B`<Z
M;/[JI\]H'='!"]IB^M9H@M9XPPZR)Q]%(=T(!VV]\!5YWW!2G#B=Q7!P7!`\
M^1F%"P/*D,_W/]/%`B$;HX;K3_O07_D[+[AY#/PG=LN33^S>\HH2X\[Y;V/0
M;SCKC8,$5``3WPH]T#=5?_!+W]Z._=2O5HK016'WZ*FTA;PG3#2#-/#"-=H6
M9FLM$A?(:@ZU:!@*FC36[MXBM8%;\'2G[1N^LIH"][3J^OS]_?<-;#<@'55=
MWA*B167:86,:\@R@2>!,BCPBU#\WP5RV1[4.Z$O6Q86QZWBH%A1<DZ-Z0#&V
M?/'\@);'%U%\[P7XOLS>]"74?.]I\M=R0T3X)L0/V5&R['53^MYILMS24V'_
M01],)-Q5+W8\Y'<`VOAPN;#S=0$+1/``%?(#[&]!_MQG.YAZA>7W9+#X/B&V
MV5;X]0K42\F8,TE/4(BS+NN_[Q.V+BTYR;?2#Y_HT)$.$TF_B`C>AHQ'B=H5
M+[ZSDY/9*/+9CYM7-U$01%^+V>V`#%&3M-[`A2K6$OVB$4#?5%E8'RTIAOX"
MX%4(;(!FY;>B5)FWH+`C>0J+B)A$U":JC)ZP71U091=YU#`BEE%N.MO8B>WQ
M1)J7YA&U?Y2`80`]BH"UW]AHO*(S!I^Y$I#ASZ>B),@X3B>46W4`)3K]R(7Q
M_!R)+1A#'1"Q1QB-_<4GQ6A((J71_1Q'2?(YC+$7T!!_]OQPR#A,U[;A"$QM
M=CQ]U/V*(Q9'&B$!B:'2DVDY])499/40V^62V425442MSD@MM0G03R<-^66H
MCRKK/951'?1DQ8XJ-/A'#?/C-!WDE*5-_J"<U36$WP%.YE3+3,S.H0.3(S\[
MOZB-=3`SI&CW]>DGEDCW52)](NT2NO%"4DO'7DKWQ(W\,&7SF/X6G^2GA](U
M-;6YT&SW>[KR!G_;X56:K;YADZ"X2.*5,&2[@CYZY+NOB)EGC%.T]E)BG#X4
MJFR1XA8_13&++\3$"ADV>0EZQL'Z?1J]+X\K#2/V>1I[:RI"55QSFB2=6GP&
M#IX<%9\I'U\!#Y[Z^(%ZE#7QH*K/5W=A]MFJZAMY!9Z'GOLXK!>7@.>NP,=G
M)IZ@9['<J@M-PK3RTM3A*`<[1&&ZVK$U5T[K0\Y\.:(2<"PJ9Z-SUA[!'95.
M]JN[]U#.'9E[>P_H)I8`6P_KW)0`*^/05AQ7Y"\2M627L(&FE*-)A16;LJCU
M!>SKGBJ,WM(F-[SH#,BR!D[KE![F=*7(!,%*K9$:TY8314@C%@W22$9:L3<-
M-336X`FXX]9V;T[0R+QN=X!($Z^9R8*UM6JF:1UPW4QAV(V'><VO*:74GS*9
M"O$3?:T;:`"C%=L(3_-R7V_A@7L+V?!/O;C4`7SJE6<1^.=>1>!./G;/@IMT
M4M4MLNI,H`895#1F4(\/V@]!=&RN]'G3L@/YFO1,Y>9TZ");X8#HR/%^6#PX
MCCNTJ&;XZ*J?)TL+:\8?=?7[^N./P(SC'/DA4F=D]B8?(H%HZR!&6GJ,-$AQ
M3;^0\T^3'1CDS4,/1AS\'5?*'*K"C;5:YJAQCHPH9Z)MYB--TU7%LQMWNJPB
M(RVX<4A%IARG7GA^_(L7[+FGC\!;AQJ/U@P[(,F=K^F""->#LBV\E2]@J:6&
M$;-\".K:I0.PHHKX!J6AI7UHW:P%[E[%508WW7OT;K&\\2[]VYA`&H^ZUH91
M;YV\4[YD[QA_3\WW$-W03/S"X+.MK>HY;AKJ@&+8&C)-KQ@#AD87_C>\OB/8
MNMG08]K])"$N;D(:[\V&'?O!&_+H]\I_:YT.PV50/RR`H8>6,X58:=A8L#:(
M-J(R5#6C<\QLX$`^94T=D`,#7$0][UR3O.I^+5+J.`)/SVJG\#7S./"D-6X&
MT%4%S)AB]9V7T&<>F/PP8?K=86-35(P>##IM%(4C`;2[6]*&BU?\C3:B)XW5
M@4N/WLX77F:/^FCAEZ!=[*_8*:4HH8<ITR;47I2?;(J2*&"G&=%^Q(J?OKI0
MK-ED@*"XFH`!`XJA,W8/F9?+)-G3)ZHWF^5Z[6>NV,'9R?+I*6:+86XV&TP+
M_%L*!EZ5!&`N_S4'61JN$`!?!"JM#0M%(2=#C"_*SXD:9!=RF6"G210V,L$H
M]LFH]`&MO#`[!HWJ#U46CV@H/1S1(V;9R>T.*`@$HB-H:#459X#!EA0-"@T\
M2P^(QLK2'E>)R%FDX]EFI@O)W2EJB@KB(SF[/Q7DFA1G24FJ\*Q[-E6!"@.4
M@I4)E-E`52HMK"!FYD@S$79F2+,!=?K]ZAFO]W1$<,V62]YL/NP3/R3#MV6X
MOGG!\8N/OS[0J5=>66[>._]U33H"G`AN'":`@!@Y59T2KF]K4;2E>I"UIO\J
MVK.EK$4/](7U<6$;AQY(B@;>X]8)WMK]VP=Z&SB&/^M>V[F5RG4:C-.ZM$3Y
M&J>>']"\]AO15!(B"?FE>9@]PUX<%H__PI(4CW521`4I\DFJA-2F+E2C(S)#
M5&LZP(T!*>Y\NPNB5XS/HC#9!ZG'#GZ]CL+B\X]^C%?$&$O--RR`YMFU]8PW
MV%C^RPZP,UPU!G\)@/0X)`:%DO0WO2B:H*HO$P?2&Y77BOYY`9Y9<.ETYN$@
MC6#QTI23WN9:ZC(@+/!$W#L6*WG917*Q#<="Y,4QL<[F>M#79QSCQU?",(3S
M[B<T6Q?,(Q0+H_!]<0VM"^+Y23:C%&1O>I%/<9;TLZ=2>YIK3E"R?_P[SG;3
M>L%)RM8.TD3/7M@BMS0E8RMVXO<)\E"X9P@CR3^?O,J-Y3-7[+6S9(=7_L8G
M3MFDUPF=Q5KC#4EHZZ)Y-9&%ED'Z7*Q)HN^AD?^]>+'OY2Y#6I\$P>M)OJ`Q
M#Y&^S89#^I-D\&3?]1N.5WZ"UR?,QW,4K$F'G?>:3<K1+_(KSM=*D3A67O),
MOS2]1F?;Z!<OO@;Y_OFO1<S^MJ>?9=_W>_1`OVW](S9=]XBS1W!^F%O<>O&O
M.&5;5C-'Y)>A'Z_V<4SO:7XYFQ6D.RA$^[3^8W^?ZV5"6KY2Z_LDNXE>RG8M
M.R&-4[HW*0W5#^F30__%_P>F8?L[/SM%FE[.1\ZT:W9'5]%VA\,DJ_FJ&_V(
M0W*+6*\-^=B)QX?."+2HXCM*=/U'`M\?VDE]/B6C*E;09#^Z"ZNHW>&)8'K0
M>9X,F1I\QL'F#C_Y=#M):OZ>E!TLMV5+>;D3@II]BFE`97.`*1+-D""F_-2N
M5),@*@L+U@+5FZ"R#<H:.4!<;1Q$O>Y5:WI"T:L]*:%T`C]-IW`)OV;1/A2S
M=W*^^=O]-B\]:>U<+>&G!6+G`?#&IR6[1S=7("B.ZRA."O.'"U_A_-K\`6QC
M6>,(&.XN:=S:@+0+8PY;F!941B-C>LA2Q<!+DIO-7]C,1'H3W_E/S^DUFPZX
MV;`_DEL<UQ[?LD>UW%6*@RP5"Q1[&@%8>C$H?(@U%WT#4"VWZ&=WP?I1#<A[
MT@DIUOP$79?315E_1`R@QKH,9L,!W@\$900(D=;2BEZVVJLJ>@8$OVZI5R#P
MA9];'*)%8D45DF@W.(Y)NLS6]N_(3_KL)1C%&8=H?L4>2:_1/B6Y,\RVS>*]
M%G#D51,]1V9U?AL;%:ECY.I6K]53C)Q2Z;.7HJ_T^<.:EE;^XY[NCJ=/-!<J
M5Q>8)EH>Z"[3H"OBLRC,GKC<A.?Y\ZA:=/D;7MFK1GF8R]5O>Y^HO7:I/-R%
MK(8>8MV2B@W_PK:J[D&1]5&[`0[%=3HJK=)7O`N[S:J]]FYBHWXOS+LJ@`!D
MT5!&,$K*!+._$QTE'?(5QBEF^D<XTOAA1FI`1QQ-5C=>)R9X><3(*^!#"Z&B
M4F)7\J46=$GBD?A#,7FDOLV?>;0!SIS8WQT2=;<?R";N?Y\T1C]-E:"CINT^
M2:5B0;HT!,/9L9+SBF$RNIJK8K@S'BMVQZ*OWG(7N8_AS\Y(K>7*.='F_A3N
MC>':88XKXDWO=D=WY<:!F;?#4W`^^:S*N8SO=I2]X=&NS+>^G.M58B-<YT>+
M#NF.V3B2+DA':08_MC/&&QM93JTR(XTYCSJC=S=F,#1U26IL#EK5RO0&AK&3
MR],X`UQ7Y6G`T+=X#/II'Z3^+L")Z?>XV12?L*U4_LS>G3OSPKOL+;C+D&T+
M?;FY\#<IQF'^M6_B3U'<_.:7B>QYILMQYIAS,\3AF<S-[P6>_QS]FHJ\Z634
MXE4SVR+,,NT6LPK9"ZTLQ]+/60(MWL1]]I+:A\T7DMDZ<O;NZ8__5*1U.H.Q
MC>(RMPM3NI^4B=R%K.SDS>1G<Z=#;=0`+D;:JAU<#-'"D,C%KVDV9:.8)7;Q
M"\XSA337-9>1H?YSU>1?Y:?9]H%9G(@$BNZJ?)(=CT+221YM,<E-/7W*<TIC
MIIOD$(>6,KEX,V>40D3S7"[&>DPBKGQ-^`TL7/R6,\TDI_5,HCW^N&N//X1C
MCVSH\3_[C#F.^6+V^4(P\>ABK`>0+R9:X[-,$DR^;WSNL5U.;Z.O.+XG7_<B
MBK-OS;H\1/DWKWTUTI=]-=*+?+KSPE?H]4`V8@-8.P0;UK2/XVS\Q!.O20+^
M2A8?[H%&"K;6*8N*]L[C0BPP1"-C#P#SP>5=4344(\S&T)$:*D)$>8P.U`3.
MW"[X!XD6U1+@D2-D=("/)V%_-*=66D!^-;=6?[U-A>^N*O-*I<:Y4N^84K--
M5[WZL=6-(9_7'?`U1G'Y*,\KY7MUE.]YR;>-)6U'`9^U@+NVK.Z-:KAJN9Y4
MTK/]X[Y&^T+>N\L)N$L)V![;4H7/]Z.C>VZ3])#-_;'Y0I\$^36;/<P-_SYI
M32RZL+K`E?OK>EZPL);PF!>&3-U=[==?_:?+,"$W9)]B$MT9/=TMOB,*0<#_
M+#Y-QJQG?K]U.PU/?&;A`4P9:3M4I`I-.XNL'2H;LJF1K"DJVKITL(LA7J(!
M=[,I+GI]6]37=0A>L.DYAA\/CPM?.I;,6KX-9(H&1`>)31NE_LCP;);)]0/Y
M8AQX:?;`3T>!72A.Q\"WH+";$-\#BJ)E0!333QZ><>SM\#[U5\EEN!*70CKM
M\]]%WG0X175"`:2EPIV"C-+>&@3,^Z.Z@1/"QY4+K-,"161\\YK\DO5HL4IN
M'#Q7R-R!+@RV!T%VZAL'8A1A+E76P$@3U2HSQ1KX^D&+@#LM`7>`L!*4""/!
M:D`Y\/`<;;WD/S!]`SF)PL^A_T+^X:>OXHI`LTO^2RA;#Z>(9D!0'%&[4]!$
M96#Q\!^?'>"([GV.^MR,)D\4G5I44;H`%V&%1RMGQ=J&&:T`U&5H9@255E!E
MQH5"U`I&147"W%%J5"TH*E/KZ"3E@@1[+I6H=C`HJ"A&Q>"`NJ)R=;.YC_;I
ML[?=I22"_Q37%9I=\M]#V7HXGS0#`F"3VI."32H#BQIUH@VJ-4&?_],E,NF"
M(.ISIYI44G1J44GI`ES.%1[A'Y/81B&M.&H?'RK:1.7#W/%FX]&'=<AI/>P0
MBN,)44<7REP[.!64&*/B=,B3C.T3#N7/+K@MBJ<5K8L`4W5<=Q#3P&W#JGFX
M9OL%^]NYF5W^S8DT?M+6)%NC37M:K64`?GZVX0`^*0^[]VR:GWXRSQLNG*YW
MZ9;;R(L#[[I6UBM5P84,UP<<HDEW.'`,R$[WV$M)5#_C$*?^2IJF%$WS;R=L
M!7"*N#P`R*/#A9Y4)X8+.FK@/.^*\K[N/$57W??(Y":U3OGF-VX?[BTR"7].
M/=\3Z,-R:&RQX6H3.Z[54"`($B79N6`(_"$X.)!..T!RX1DX#'@$2=@J>'32
M<O[SL)\FP:OOGZ*7'];8_X%F:OH/EK+?_^'']WG2)A_][9R]J?,7'`3_&49?
M0Q)=$H5X?9DD^T[FUFZ?_RZ*MH/HH1W+,)75<2-FB+KW(KN,Z/7WO](&J&B!
MLB;3LD;_ED?&=Z;)'FF7BD,:UNUM`!Z%=WBS#]=T:_HK?X7#!%_@-CYUFA;;
M8(M:`>S])@\`8@=/H0?5UF>"C@MR`5574'X)D6L.I`[5'8U,?O[6#EC\QNU-
MJ$0FX?<-Y'N"G^B!AA#;"C4*XPI#08ZA#:;[U^WHOP\%2\+]-V>")AMS2."`
MZKY?[6VC/=T,:8-"%=)<&'##0$VT=9]-J-FM>'^)`G(;O?CUP@^(4@DK74&[
M1H7;:0-4V0I\0U6T7?,ZE6R[5U'!EI^C[((K=:OH!G+J5?F];M2IK::\^K1C
MS=Y^C5%`G$<Q$<<7O*0OMS]A*I9WT:L7I*^WWBO]ZQ;'?K2^(#_/A1\G*7U#
MG;[N[@7W7H!O-CDQU[=QM-ZO4EY1:]-/L8^B%1<`^ZY8_.H0^QO:"4^U"XH-
MKXN&550SBW*[*#>,,LN(,AXQVZ@RCJAUFJ4+^RAWX$!.MLJC:#3<MO;\L."I
MO7^'E2\#OT>3A3`M;)AW,)*1;V172@&MTC=,#E:5'"2Y'`2%'.QRB+$C"'-A
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M%Y[1.L$/TW'T6V/(F`/>R4C2';:F+,%43Z)W9:K9MMG$[ODC1EMOC='C:W:0
M7U:`/GIT0!N%B$C'MCSE;Y9#UW%):3@`=8*4=H>1[!'GF9?BIRAN']NF:-48
M-+9:`(T5N7ZAAHAMXSHCPV:?8D#(/D7%QZX,`_DWC3/ZD]W=QJ"OT9`WUFM9
M&GV(MWR*<<8Y(HPF`SIN1\7PK=7'7B[E!F>[LFP[[9DBFV86]/_+0R>*2PZG
M)SXN])*1#%.*Q-/HJIEF6NY&J_0:?JUL+C8F1%L;C;&:K8;96=988"`V'=3,
M%\:0NX^-"M]3V3*<LBFB;=\$8@TK?NN(M5O-W^X?`W]U$41>>QF@M$VCDF]<
M!ZKC.3ZAJOBF:9T:OMZCJ."SSQ#[T)7ZG7>C.-6[^'XV:O=:,U[EWK`R>MU>
M'-->4LGH:8RXMZ*"YW6TEV'$85I,,ERG/3,-QY;L84K6G)W_7'9P..=(4*27
M>)0P5.2>;G_-!,1S/%K=U'4^WM,/N^!F[Z25&,;?5L$^H2`OWA?RWBBJ34<!
M!X/K,9]96(9V]\E$J(7TN:^4LT$'PR'&B'2P.]BXPT]^DM(#.:^];9MAJF:-
M(4>["="H@^\9:N#1L:XS]FAU*H8?U<>(?N[*"$1PZSB#$.E-;HQ#FBUY0Y&V
M+6NCD<MP%6WQ@_?M#M.?PP]\)M;GWW9^S/YUL[G&Z<T.T[_"IZLH27"R#-?%
M\6?DGQ_Q"PZB'1O]>]_.8KSV^6,7V[[RG]J>F^&9UO9/`#"*LABB(G=;\[S(
M+"/R$6K:1I5QFO:)>53:1YD#Y(7KZ@Q;^D?-"3.9NW$@Y5MG6#0JFIO::<M;
MJ_2P]Z7`ZW9;H<*/7@]/5.C(V%0\_I>WW?W[43[&@^]10"82$!O3!`>H(>S,
M)(S86R&9B-!9A;5/C__!A*OH$:=?,0[S-9-^5L:D1#3R37I0%),V(=[X*?(2
M%+,73/":M&26\KJ'OFZ2/?.D<L0649+NJZRAS"2YMMO39H^OR-OM@E>J;"Q$
MTBFA^ZMN\)I\ZP`E](V6E"Z)JEDD/P=F[-C%F/Z=7V(O+)(?DOQ6>VHPRGZX
M*"1RF::Q_[A/V:9$I"-N*&Q(%#8J%3:H%#:NEV?KFKY2KZN<I=FT#0X]]L7I
ME<#[FJ#U/BZ^5?9"I0MS-X>BQ()YH0-78LMO/9)8".4N"9R__2<6+U@5M&N^
MY]AN`_6"(]\WV)N-'?-:KS2V>I7O,F:?(W8!D2NNS#V)[B#O[47IS6[,/K6:
M<M]7;%NS-O_T$9-41UA%R'7E>X^$HJF/DQNBQO%R]=O>)Y<N2640/ODD(RP)
M/_E32P/,Y#]1+PO#*[`!@0.65OVB4%1-?8PNEN5K(>N\>Y:I<P.OG0J!7,W^
MB;>D]J$[N%7E4Y*5&A%UB;S<)ZE""J>D9*)>74CX0P`<02&JJ18]#+7R;Z]0
MP`<Y/:(`/>;`%7+1&8NB&YMXJ'4\0:PK*OJBJC/*>K]UCH@F%=XR2_1&^7_*
M6!+B)WK`BV*BT!FRD*&YD!)',@C&=4Z2`;PZ+3[-]\(YBY*4CAI9D.?9)(I^
MC6I@3%JI:MFQ)1,&7\):0M6+H9=2Z)B6I-;R2G$F`#/`YJHRB3EW9F_WX1C5
MT19SS$OU1<.<ELIHA352XM6(1;-(!4B_TU*K4;<**'2D#@\71_*(?R0;3ZB<
M9,^IG4F58EWLJB1B-LWBDSYT-:V7(B_&*(Q2E."=1Q\%!=1,L@JB!#OQD,4=
MQAJ5TPXQ%J:TSLKX6F0_QU&BFN:5=^J6RJ+VH!HD#\J.T@A]ZBN*P$2A&X]X
M$Q$J>P&[O_FSV!<OV&=_T,^_>DP9V@K#YE<[ZK+&=.M07RPP5$U67AR_$K]?
MO7A-:FCVZ!=&OQR3'@60A1*C18"ND/"[B05#Y,9F*N?[M#4I:XU`G0G7?,;C
M7:WA=X@U/61(:M2C,P:EV6&V=!F/_A#,'C+IPB.VI(B'3RJ_M1X'C4UUY34.
M-B$KJ<OP-HY(HDOXZU@,GZ</LBFJPXS-6:!RSZ]DLXHS#\E4"4P]6!D[^N'[
M71:%>.6>ZT_IA]%"(5/#V";2,$.K*HDS#M)^=C8,R6Y%Z1R91?6H'Z+<CO@]
M)\?7`[C$1NUZ]\C'<1<4N$I+4HQ?WMZQEX,^NKO*P"F*Z9;M;E/,\CKQ:+N-
MPOLT6OUZ_^P1]M[LTX0$N/;#)_&B<8U.S17DT@Y0R\DUH@);6R[WI;707&:B
M7'7.&B'6Z@1E[5"MH3.+T'40P5N1KH^DG+WJ?MRUZE(_HV_CUMG;_`ZO,&FR
MY@VS>QM1;.HFZ6]OMR!ET!:W>)/Y[KECD-BD9'?1[F$YJ.CF0#;O#S>]C8%T
M89OSW=B,YB9!DC!&VSI+&,-X.\.-R0DZM,S6LN7O>,8X\-+LCG5.]2`7CY0P
MW4'NL$DQYK9RH_*"<VIKBP3D_K%GW+5S<&I'N'*.Q*E1:[-/]W21#4[96:_L
M`?P'3'Z/B+Z/[<*,Z73\,MR2;C)^#:A!E[\LKQ\^8;HE'J^ZY%S.?XO&E>%\
MYSB"2FY-TPIZUALOV!\.,(!W%R+5S]?$;*U!"XV-KN`Z7K,..E7>]Z;2*H/]
MB;YD'_S?N=U?4=9WX0[;R,&][W0S;_KA)HJWV7*S'8Y3SP_SV8`,#I?;[3YD
MZT^]'=ZG_BHYH7M,N)``S>`A2%H@\!B0:!I;9"S#=;D5QEE]E=Z5'^)+NOR7
MEXQZFLA_!^/>PZG1,V"HQ&?N7L$N4X.+Z\YN.]GV0>66.LTUF@YPK2_&(H@;
MWV2LH9$6JXU#`$\,AA&`E@=30Y]-9C0V\F/`?RCWZD.-?N@+[8E85Q<*DDE8
M("ILG.(!5`9L>%^&X=X+KORMGQ5#V8(I90HTL,'+@5K=@67`(&3`$K)'""9R
MH&.Q/87CL68H*-O1<XA;J;*1&UTH1'NC3Z(+YB#FR8*&%9DN:`5A-T%JA&`O
M0T[""4Z.;";%K!NJ^J&LX]ME@E:*?!M<,'MIPG2T-`TAZ'NV[;SPAL$NF,EP
M#.Q6*D*VORA_P8=V)V7-5[:W2=]64%8S5^6K-S,+$_+,E+=RFIMM-.B2D8\B
M)??R;MID*]V,F$IRGU9.UQX#E9Q3M65#AFP+A:\XQMDFV.3N.+E3M34,FY=+
M<T+QB!40((1)C7-]<Y44B#QH^!D7,);@9Z5$H=N>;ZI]T.G<VN?4#_Q_-(12
MKW+1LZ4L:%1F;+)2[RM8+7^4(?0FK\*RO%BZSO;=J'5G<^$U`TZ+@"8V=;7!
M".I*P9!;T]8155`C9C=Y*".7;E,QBA9Z]%279+]EKTWG1Z6<(+J+CO\4,@+1
M]7F8_8L*>B`M!<O=;W"+A?L:6A[WY48]]`DMWFSP*B5=O1?/#XIWLV.Z\PXN
ME@T6;VKG2W;YYZ.X76..RF_SBO3-,7S$LG8R>F=%L`XIC]3I`F-6U+%2>__%
M3Y^K><KD)OS,WR^ZGP5EG<WO;%,S9.%:K:D%CGL+`]>>O'[^2KK4'H(E]$GQ
M9R>V>NX)+UT]T,"H4@-X-K29SP]@Q%3)"V#D$G@,`IC.:S)&!$U&D+OB=IUI
MC1+F->4!DF+$JG$41I`*\4H;^&\4]\8%X>BXMU+\W>%M1'?"OO)_)?__$'W`
M63EJ^KA8;4=9",I,V)0`=>A6BT*I^]XZ(+$J+Q"+CBCK21']B%'1V6EQT,"@
MKD1HPUDI$V)+VF(A"V;$5"D.8^0J<FS&]'I23@\;B`LN!74N[8O[[X?%S&?V
M^-SQN<U1Z&5>?[X)@HU8D8[.+GYU:LJ=(W7,2]A)J3.DG/T:$H@_^[NS9[K=
MP?*;SW_%4]RL*$9Y+0`H+G8,44IRK:N8R>FT*#]$V:?H"_W<B7?&)+<NTOVM
M6S3H-FRCG&<*7O^[7NS43T`PR7;I33T_2%KONJ>Q%R;>*IL\8$4/^?;[@.Z5
MC:(26JL,6EY"-^SV0Z(MCZ_H'K-NZ*=_/:7/K&A)=1F2O$5^8S("><'AGAZI
MMG9C%FX(%H7UC`TTPDGJQVA+[K.&J#8;\F6U:`/.G:9S>]PI_9BQ)^^V>'B3
M/&DA0\H4+HKX3,F:RKE2F+.MW9D?V#?I`)''WHGKI/CLFH-)WAPPFN(*!QDX
M@;T,;U9I](AC\HO]BWC++/U>?.GE=@#G@20L>$KPG9GQ@V>C2Q6"F5HSE_9X
M,H"%E$9J//$9Q>DGIQ?7D6UYYC@=H]*V!%!Q'=ZI(2K@(MK?P>(`$K&:66"^
MF(6?_!L'L*=U3>5#\\"1*9J1&Q^9<)5+<AG^QS[$]-P3=MK$BOFG?VJ7,;HF
M^#6-NC<X*W4#AJ]V-#R;$55IL%,'L0.9:!_*V#_E)S%EW;)/W"V,M($F9;8A
M7/DD5QF1,UX=@NW$I(I@C,IJ=#+HUUR)C"$.%F#C,$.S-#MX;MBNX,8G!J>V
M4^6)-TL"O2IP6A(,J`]OV0/XF\T=7D5/H4\=W&P^AS'VV'/@GXEHTL?&RPT!
M=BMJ7JT(8"[_G0=9&BX2`%\$H)X<%H5"-8887V2=Z6.-6G?Z9V4`40OH'5UC
M]1WRJ!74KDX=4!4(Q$;0T&EJS0"#+=T9%!IX(AX0C96"U56V<98P[DKZQ4WZ
M[2OZ/77HUZY[72AMG>*?J.0],K#[4X&7Q<[2[[2>[L1\8XN)HSCC748XMMJX
M1;HCYT1`FB'GAE3>)*CX(5JN?MO["0M*/`6K:EO4S,)F`%*A"`&BVA6[4+%;
MU'/!KK"S7:IK+LUY*N]L9'076A02M&[S0V@4/N$(7-FIY\#QU)A2+)#E5:V<
M**A@$"4LA>:#*?@*!1Y0IS6)J@'I@'`D2N]V<30\,7_"\1..E3F9UZR9CILM
MP/#.<PR7A%O6]>#=Z%3A.OO8P:S+O7=<6$ON<A//]89\*#=-V5+#NA>;R74P
M3K@I=<L:.)1-^R%%D4.=Q(JMI#D<*/54F0%D]OB0YT98?`S(B/=$#/;)S29S
MMPS7M70L>G]/MT_^S=7-A\-=-R2`+*KA2L$`I85%UH).0N4)ECZT;0QS77DA
M4!L+4:_[U22/JE>+26HGX+*K<FDE7]M'),WDE\*S=9,2K=L*K8X-G2WA5%0&
MC(Q42PE`_+:A?B^-)`#W'J)^6)83@>[[81HV-)*!.Z^.&>!"GVBRMQ#5_0RH
M9NW]1+73T1,#'$+KPSP"TKEG@X$P[9,1+`%5)ROD/R7[&1.\^OXI>OEAC?T?
M:**@_V`9X_T??GR?YPSRT=\^YNB[\).5%_P5>_$%^:0]5-!HF?]"PE:#B*?A
M?U@2D#L0TTK6;U%<0-D51"\A=FU:VNC<S<C@IV^20]"X8H34HK7:B'N,='9@
M(-TH\G[_2,0N3/WZ>8+B?;J'6\M_M"&&AN>RX5\#H/8:%(0BXPVPO1"<_9Z?
M:9MM[5HSX.:.WP!`C8`ATY2+_O9:.79(8.!%8O]@K!2/;E*L.#3'RPB5[[U"
M#Z%99;2K[U9WDA$NJ1&NNZ_RP9Z&XQ"-147QD<BV=SAWE,6G6:KD<#;1X>R1
M73I[I,^`7>,,4;-5HGJ#5$Y;[C"UT0YXH,J)`7JHVG1A,EBM]^P,5_/%U$X.
M6'EW5C)D%0.!.VBM-9<-6QM6QSE78!FNN01.'F@=PQNI]NC..T5`U1-XSV:]
M0*'/#%!Z-=F:66&L?4(`G5D5C#@3](7U<>&A0!\X2;9=-@)DSE4#`[(MEE6N
M[6Y*+O=N?[/_$:%.AWGWJV<R\`KH=OV;@.ZW26!/'SS[(4TX?O4X^H14BZMG
MND,G'7YY^_0YBOWT]20?)-+A'"%*=?XB6GLI)I^2P2,[F[%Y9@!M*QA/DCYD
MU!?LU[2Q%Q*/"4X2EO_R@2C;%-U_CK(7BFI'/+HP(!R5AUH'!DS%Q`&I]2P*
M2$P1C>0%+^.8ODK$TGL4?\0O.(AV]"\2WEFTW>)XY7L%!&XVMW&TWJ]2\<)C
M<./Y;P]H=[BF@7])@)0.&9-"!>%<+1JF4,T6/4(:U:PQ4>O8HQ*56W1I!3<\
M"2*[^&L*')CYEOP!A@U>IH#%9E;$Z$R`S9'9M/JI&2-,]5K<7K>XO>)QFW0.
M4!REWHL?DU%IDL:>[\+K1[,AN*B&.5)\R(]J-,>M.4Z9)<M/19O8K89S?Y=Y
M<F'8,1^Z"^;19T_W`<.=N^C5"]+7Y5.,66SBL8N\9?Z+BAH-UR>Y>X`A@M"!
M0B\$_1;YYZB\X%(-KKB9D<%/W^02OVV+&"*#X$F-[PB^"(7%#MLTJHV>PP"-
MJ.*:!6QL%#;`R!&6''&.)Z_HX$+E``$H04ZW"*@ADXM^N/+#D&#B[-D/UC$.
MDS]'R<Y/O>`37OLK+SC#])@IR0QB+PO%-*%A9X!11:]PP>8&3+VKA@9F]A95
M>U1T^'V"BBXH[X.R3@[PL2>X(H!;WJK(C6RTRV[#`."'TD8!6'FN-RWR6[M>
MUA[EH1@'7IJ=<VO$#A?2U03T$,Y0O26"&-5=J@=!TQ+CU#`IN#1FG`+^HAD;
M=^`_H!K\N/\5?P[]%U+)^*0*#=</S]'62_Z#KE*/DRBLKHGKP;XVBC6/QMV'
ML[]OR(#IL4<("ATPMJB1(*E-5'7,EH,QLZBT6[ON0HKL#<<(!"*M!9R&5EHZ
M81X$>*(T#0'T2-SI2<+>/#<C@4L)<R(RB&K&-T@'\-=M'.#$J3$GWC`5!/6C
M8U08M%QQNXW"^S1:_7K_[!$*+8LW&R^B^-[CK__7[E0N+U2VAUB`H!D4W,HA
MM4/E6@&5B476!"6T3>VU4_J@/R$-T#N?7&1]OW.`I_K(:#^C-T-4,8Y3=>L\
M45>ZL;`P1N$3M.@:`Y39\C,&2]8*9<U0V0Z1AHBV/&1$BA=_'0(F[2S"&@&;
MIYT#DU9R!75AV&L/I,(E2R.#=$")<EZ^F'.SN<9IXS4/3%_TN",WF_S2S^P`
MQ7)=5/GZ!W>/6C"C^>\*8&\XK<&^%$`B@HA%(0;#72PJ$W11)#&"FJ]0XNQ]
MK\)0?CAJM;ZR>KMRXM>9@4$=V<%54X0&FVV)%$"8X)EV<$Q6'N_.@9S90V#V
M9F>6Q_.W-?FO9>9$C>M$K2^$KM[83+(W/3&YOH_9ZJ;R4$472@%G.2RJ=X\L
MUOGQ].KI/V4L#O$3?8:CF'^8!8E/S7/L__*VNW\_9MDA()LY0V'F,]M#E"OR
MV>==ML'*0_0!_\7S7_#ZP^MGND/;U]BG<WZ*V<XA)KMSH?VL@8[^AWPAV-FJ
MGI'HSQ?T<M"<Y^I.<"%J!>UWQ<9&A"B/&&6FT.,KJAMS0+J@H"R<A0`@2'>&
MHH]1\?Q%OQ!M3L'UB<C&B]!N<Y&.!VB[]X1MNSK;OI9LVQ_99@"<(]],?C;+
M$^)N4JX[F1[H,Y#-L,=XF[]$Y#T]Q6Q<0T8!&\Q&WKO87^'F7KK4!W%&5R70
M[O1//TGV'F$:'3TTY_+92TKYW``FGM=NO9[D)O_53P3<Y_^``<(O7K#'R_0O
MS_[JF8Q(/N`0;\B0Y#X*UKSB7Z-Y_CM*6P[7+XU``)5)[DVA.K+.;3UYH6V1
MEZ*OM#6;IGO,VJ.$M*>:4I.$VHQ=C'=17.SYYLC<G0Y8(M.[VJ2II$.+@E+3
MX.E5X@UT?8,M8-+J\I<F%NFL4]$$T3:'AC!1*3A'C(&OU+0&-%)3+<O#"=@2
M+C8K^A7]!XWJM2Z!!P<X0>TQ"N`&U`P7GA]GGI,$ITEV^QYB+TSH>LT/./V*
M<?@)>\D^9L7G%9WTY,XE#K.4_VI]C0QGX+#PH:C9.PH%:WO:763-49JWI(\6
M'[/&K%+9$+-YG;.M.J-5X"6)O_%7K!1S8;YB(#@C0*@T]:&?K99T]`T(/(WU
M"\3*.@"WF-1Z[3MM'N.3]Z;_]C+"Y6Q:TT,_/#(@6.UC-CQX]!(_*2G(;*,?
M3_)_G+*'C=F_?RJV9:Y1]-G',7UVY<3K<`XP4E0D'CD9&$X**D8VCG&1E*FT
M9U:;H3S%Y85KV;LD6:U_QJUC/FLA9#;L@:B3KWSOT0_\U,<@Q7)_<^V*N8\E
M0'7I_T4@!:97%+HJT\-X76AJW>>J-@/0*I"<P?AOJXZY09'T]`G-7O8VCP;^
M.;JK-&//SVOL.ISAJ@N$4Y;)1\KUJYI-1[*NL:[[")T_I@UJU'Q#`ULGN*LJ
MTEWF[H!RO?UD_IX"C<5V1A3>7V,"0?J$_H8@*7YX]L('O-U%!$1^\'JYW7GT
M)0I>W0YI-[\C,":'RQ[D5X,J.(!B4F@@B)?%)R_^%:=LL4]2&D"KTD*^H"BB
M1MZGQ,K[M#*#_-R.`P(&BO'(&L::@@9AN:5L,,&"ER<085F9<9\/6:6S\7[X
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M%]UE;[Z@JCO*^],*FEI`U(0#>7$H,"-(E+3XW\]8>_O-OB'!;TC;+Q+XAU:N
M,8D-/G/&["K&["K&O%+&;.C-?4=&AQY]"V1%FKBP":83!!+NXGRD$/MY;#R$
M<HY%W8=/.4V\)Q&UHNPI,!&-+0HB,GK+AG.DR%\W:.?"G(L;1!/M$>TRT4Q'
M8QLO>63W9Y^\?_*\738DPT&:%)^TQV;YQW];KE9TTM`/GVZCP%_1!U^/]*3Q
M5=KBM'Z'XIF0I.$@7=&/9%@-J^5'K`P:W1?WGS]]6M[]%=U<H/O+GZ\O+R[/
MEM</:'EV=O/Y^N'R^F=T>W-U>79Y?C\MG0UN?F1^FUH3*,+V%?=T;-M[+KLB
MV6;/CG%A,RYGT9:H\S,.$_\%7X:K:(OI5DMW41!<1/%7+^8_A>UMI>*7L0&`
M:=K>84-,R?9QKIJ`-;>YJ/7))U(;O5#6#;VC';]#7VA?E'=VX>"2`="+@,#0
MH;RAG?8,:8]`X)]@&`<!/U!T@R%L!_IG8A+3PZ^05Z,+>[Y(]PFIT<7/Z1(P
MNCR^LLM1B)TX%7M"L@@?"KI'EP'IM-J?$'L)3A[(R.9FP_[-2YOJUOEO)6LX
MG.OJ,`#2G=2)@K22OHO:_I[L(J)7Z7B3_>D`YS1N<F1X.YH,$K=O,45F&#R!
MB)W!)PH[V*+"7X`I.#PPB01Y=G"R,;MF"5'=.;*T#K!L2[-L[S/VMU-;C$%B
M3S"/-0+VX))[MJW8S>8.A_BK%]PPC]R7"XTZ\E.^J`\XL^3!P1<"0G]F+!.8
MZ98'^>:YA')Y4Y2W=8]A"IQ(R::%,3[K^%WE!!2YLYT'^'ZM5QA604OKC@JE
MV%L]HSB':O9+O@6D:E8G!X#5$<H7NW#E/O@3HW=618X%8.N5/N,!&ZX@HANQ
M8O+SLJ>$52PI">4Q\)\\W?K(R`Z_7-(T`<YQH]#ABRE=]V:\U[/:+;7J_9IU
M5TK+KJJO>[PW@Z!4!OJ@F:\)6I;D$J$9C.U4J!6&]2IN0K;4:CP*PEHV7-5)
MLZ;+TKP-^6[%GL6D'9W@]L+7WR<H*@W2N[[S7FFJ34L31U[IEI%OC5DCU)Q3
MDDM8D1IS#;.]P#6HYF#M.CK7]"I;5[@&5_=>[[>/..XQ$2COR*]L17W`E40>
M''SM*O1GIA`",]WJ-&LXBXE`!4ZDU-7"&)^I_*YR:HK<V<Y[?+_62TBKH*5%
M8H72YBS*FT"I9O5V`#@=H2"S"]5NR16*D#NK"4`+H-8KD\8#]8!"Z*YX*>!F
M<Q6%3_0Q+'V)X#;VPY6_\X)LWRE>)636,_^E=#L-9ZU9>`#%D+9#!5LU[2S*
M=FRI%&F9K9MB[Y26C?-=41U@I2%<H@$WL\E*O;XM6NHZ!$\V>H[AJZ)QT9OO
M%E3A=U<"UGM#@!551P<)61L%TLBHE>W.62&8OF?GM\ZB<Z$N&@/0@LIH0D"#
M;=]Q&1(=Q4FZ#-?5JY07&'.GB0R[<K?GD/2"?A%:&:"UUYYEGHU><Q8;DNU+
ME_4YJ;_:3'>FV_@$2JCX9$.L(#<Y;8HSV3O,NBC-.:W96?J&LL2EY5?_A9Y!
MSY\<&^NTKNIL*E.T9LBN;2A#.[P5".OM;W$X(`8_X')T)#<.OC00ZC>#:*V-
M)$9&M)7MQ7^.HR3Y',;8"^@VKS][?EA[8_`RO"QWE^668J"&E1N,&]FTN4UI
MCR]G=9=2LWAZ;U-JXD:U2RFSA2ICB%JKO^Y*WR:N&71`>F#!KKM-:7\BY:(%
M8EI[FU*C<$?<6=@@KI%W&W>/O+32K>J#^BO]^XJO3Y2OCW@3Q1BM\7J_8JL'
M:@WH*_YT#RN_AB*Z0T`1X7O2]3T[=;NV23G=?#RS5.OFPF#0>?*;;RM^I#__
MAS2K[Z/4"Q3U_:RX3\8&W-Q\S,!&V#D0$HXQZ*#[CU@9=.@8-AUTR&V.*&$Z
M7V[,08<B'BCMDKHQ'G10:P<RZ-`">T_),R"2J>#)3/<5/'FXTU4=LKBF'70X
M0%ZM00<;4\@&'6Q4\O8&'5.1?_"@XTA_HT''GS+ZA_B)6GB`''NX(`&\L0?M
MX,23!_?).'3PX1H9!PP^LIT-'[QOY]]V.$SP!QSBC9]^8*DCVZ_R,J3GP+(,
MN@R"Z*L7=E@.82J_%[VM#!>H@5\`8!#1/P*%[/0UO,BW[24]4=X5O<L[?U<4
M&%E_6CZ4%E!IP@%!&@K,"!(E3<GI::PE,KU#`L_Q/2.Q4M2[1J9FX4X/2,?L
M+%)&L)00#!<$>RP(1E<7K/$&QS$;<DM:[G"<DI*>UN8$&X01I$S?T[^B[-T.
M^M)'3E>V>&RSP:NT.')]E1%XO6='MM=>=/:SDS5>2EI[)0*)*>2A9(=7_L;'
MM3!I?!XI19QX#<<)ZHN*_R/YLY_'5DGOG`"<EOF4DB3G+GJWBZ,7/R$MRXS*
M(=R13&VTS(A,`PKTLR@@\454PU_P,HYI"#3Y%2_I+8G2__GR%_J?QVCM\U>"
M]S:2_\8]^@^7D]Y!`]80?6)0B(>Y2?$KL1YI])XT9O_(6N>[CGA$19+]X]]Q
M=D0,6W+NTONQ_1$9P8"DJ1[&9EJZT2,,\/1K'`/H*G,7F,+.V*AW0K5>M9TZ
M:`]$:5-U?<N4$-6G;Y,4X*O6G6#&:7T/$$[:>-/X%Y24SN'?0AEYGJ3^E@ZH
MSJ(DO8CBC_@%!]&.7KK'\8N_,BLH#<PI2DLM2_;TP>"+6$R>>E'T%`L=XY)T
M6G9'M#^;#ZI90(4)AX7%!*QZ$F,.?X74:!C4%!VMT$9+OQK16)D3=I5H^5X4
M]5$>+OFU*OA%/U[7.)84$*BV0IK%(&\2XIE6N6^9>J/5P)/SCK[AN:,3L(1G
MY#]LOF1'G$GY=J26""\SI):%HOKSCMRI,+W-WED5[U[6I[^B;.9WM:<FLE`M
M%L8"MSV%@FM-4OKF[5'>P9W]S7H!2D\&-#"I8#W/@B;-^<Y'2YD\]_"[GTV'
M=5I]%I@NMC&(\2IZ"MG*0B\A?[W@<(\1R9-QX\#!1LWY]AA@6E0>&`=L;*<V
M(0UD6ZOM6_R@]2&O-CS)'\#Y":-0O,:M'9OTZ>3R$,X6GPPKR9'Y-*16Q$&P
MQM_N"+C(;_]\_MN>8.&2_/@AC>N68)C<EW]:ANNS?>S]C,/[-%K]FG_\+Y\P
MG3'FEI!P9HO*$L(B@`[!?3&(.A0D&I56`3A9Y$90805E9E!I!]$>B%IBRPMS
M6X@9*Z_]"_J2&?R_+F@0(,8C6R!KZ=5PPVT9@P@5OEH8'I6%0GHF9&7+%=IT
M9<1D-*RSDU&2?GJDHRZ:CH3L^Q-:J>KGPLGF&,`/29V_S9;B-I?8MXG[^R2C
M+C_==KA<2[=YV8^=V<_5;8*+1@AS)/B@?:&S]RT>O&]+^K9%4AWB$27)F1?'
MKP2Z7[UXG5Q'Z5]Q^CGUV8N&O%'$8&/EWM&][4!L2SKP2X#LM=L_!N6>I7U-
M+XJN[#6^K/,)JIUD1M\D;AA`892B5YRBPH8#JC0<H^TM3F$PG^M/;W.=35![
MAV5AH]^>L<#7]"X2B[W0QWI44WUT6C`DQ(E*=@7LO?R24?LCHR1P.7)*_"/9
M*,N=I%6S!*^FX+NOF)*K:1K[C_N4[65%[GJ^V0W]JTE!M.(FN(*.+M3=[O!1
MN*VWXWRTL);CDQ_@)(U"G#\H2#YY:WP9GD5AB%<TC+_XZ?-EZ*<^H]K-YA,F
MB%SQJFQ++A0K0GI;M_<L<>`7MKBNI']D/9]#]G4H69U2FBS6IR2(&J4O\U=F
MT5=B%U6&J;YFIAT00EM$T7LN"4-'Q8/+GDXTGVWV_@JC+2?H&>%XJV[FH@1T
M$%*L0]OF-%^U:.XW:7[^<'=Y=J3Y4`0>B6[S9QYS:=%LN"X]^U$A`K0U3PA.
MT*.7D!(]"LN52$FY,5"CR/"J+^#"<&F>\F&XP&F6\C%@&$;W75FE>/W1?_'7
M.%R3P.C0_C*\B"CL,=M*<9_N8^X6A.:]\[M@TG&X5IJ'"57M&'E6B)N!K471
M%JWSQE2NV)R-SUZU*=JC#>O@@+KT@%(T\"8W%4&_?XOL)H[!RP!]YU;>[YP&
MWYRW-ZN\C,V@[T)F'1'[HG+ZX-%O5-\J9K,F0OUI3=>+YNBV`G>M![IX@[HN
MJO4<P+9.A9;_U.QGWGC)(_NM]\G[)\_;_4`KMQ]PD";%)ZR6>_^'']_GU5S^
M\=^6JQ55PF09KF^(,,9W>(7]%QII<HW3LVP7U!:C>O4M#JC1ZS.(Z[WB`RCA
M3/V*J6YF:5$T8^O86$-4:SDMJ_N!)1IT+UO[QNMTK:ALZ!$R21FYAMH>;B+4
MLM494MR>(-+Z!.7MWPZ*A8>13(CC\1-2GCS)G_$>KZ]\[]$/V,$,Q?>H??31
M3U9!E)#$FG^=!_PM_4""_%61N6"=M%(<E'%028']QK#*`Q:;OD0!N:R4+#=X
M@G*3J&;@I*9SM8]19;A4._2%&D?,^L3O>%GFC%`CK7"S):4P/L2:"_4=;!89
M,#&"/OD]&&%@1<[9V=WG\X_H_+]OSZ_OS^^/;(9`V2'S>;)B2V^XSV_,+W[L
M#.CY$=@3GCZ#GU;73H7@I`QH#V"D&."34CE`:=L<(>E9'DJ#P:<Q6"Y+3"='
MQL.0I"GPP%@:57!CS,XFV49QZO\C?VY/<T4Q2+^-\=;?;Q/QZ>$PQBK![F4$
MBHX#OH'!>41:DM\O%"U.]S&]J#=G0\>\%5L<Y,6_XNRUBNK,2F>48`@L>4HQ
M'.:5CO2PQ=697C%9RFD]8K&0\]SB3YXSLY[H7;WO=Y1!9?<ZM9(35#-QY)/&
M$=E.,VK<S-X<$RI'4_+VM?PL:`>F'M(X8(=50E]Z,L#OO2@F6_-CX1PBKOP6
M<[FI@XH:^;C-^?P26+:5E+CN#"<*Y>=(6@96D4(.&UHR99\;N("6;=G&U6F%
MJ\;S(==&]'`8$ZRU&@-CH]<`MW&TP4G"HKG`FH6`HE.S&A`VAJ27(B)0AHE]
M:=-,9*)D6KT!HBW<Y)L*""+2Z0&HR3M!'R'YA#XLJKS`IZT'CG;16*\H.G@\
M9!@JBHR1@#AJ*MAO]P&=>_Q(7SU89:]HD7\'V2@W7-<'NN3[T/T+7^G^="FY
M1G>S8QN7BY,&J/DJO0"9A5(`T&\)/6$,%9R6JL`X6UP1VJ":.52WQZ;"ZH:<
MD218M//$RP:?*I$#L<Z50Z"X+65PD.@LS%7/C[IYZ<#E[0DJS74H?((*DR=L
M0]LT6X98VCU2O"\8#XWDDU1'USC]',;88QN(53/[/WM^2'<;XQZM,=1,M]K1
M[`ZMBD91PXYS3$,P$CH]HXNJ#:*7T#MZ\3NZU07W\?9)MG7GAFXPZ)QJF0%0
MIDY]H-S5("TK4JW1C,-RX:`5A<4"83I^M!/^-=WPN6),U:U!'C<.AIF>(!II
MVA&*3))VV6KELVA+RHEG'";^"[X,5]$6T[#)M[K9/'C?U%G7Q$HWZ>KUAA84
MDYCMI%S-"(P41<MF0TZR]Y`:75#6QSGI,(*93#EZX+4K&SI&I*JA%X7EO*H3
MA%E:)8,./UK?IUZ<SH(.-+]^\(C-%49>RK:%><1/?LB.D,EW6,N^T]LFA$8F
M?4.4,%IAD,'G/#2;3IZ,$*<=0M`M8XY4X-S](Q6^_>TG:X.NR1CPDVZ-E`^W
MV!X5E"$/#DY)C$N-G^9!#:=&6[JSFWK]]4=8MN8S]>(<=U35;X9&8>W01E(&
MLR]&6-07`8W9%I7GB7*B]2G(,9'=GG149D!W)QRM8WW`P,@ZVIU*<Q0H=`]$
M_RG,%FJM7A]B+TP"]KQRN?[[/ILWA9EX[./);'+2S,.8M7F?[S[^)*=AE&!E
MOI'?!:WL]]7SEB?ZD"7&F2P2XFXR8VB56T-I90[YX2K8TP,'21^O)J<1D]-5
M0T[]>94*O2G6=X0Q@,]F8Q`31[W'*6;?9L)AODF@$Q0_<]$1XX+J!.7F46$?
MU1R@RL-LYQZ<58^!,]VSTP_GBL0K/\27*=Y*=CSI9<:LO*MU'U-P.U&/7YC5
M0P!3R\KH8M9S)'QD]=4E$4;-)*>TTEM/:G%,6&R444Q42=@%?H])%=H7L<[S
MF5BQ1)"!67E$BCB73Q_H"MIAN;1APBR/YEW'U)%&M*,J2.$93#TR@Z:ZP7K-
M2S*:".LK%SR<F@G%0W%(_1#_#@H$=XB@^^11HW-7%*2=H.5`(T([A;3<L9$.
MR$PM.M,!+!<Y1W$=I,C(K8^T+JTE?:6$EOJT7`Y+?%LL@L<!;;O@Y4]@N?OH
MT"*6-:K9"=`\8F):K_TLB%O/7U^&9][.3[V`9-5M%-ZGDC-;M#L6"4FC`PRI
MM2.#3$0Z3C7XK#:SJ-H@VNC])<E%63-'B*N/C"YI35%5T%79CT-5#5]6DH[2
M+WC"&0N<+-$TX4D?N>8-3U#6%+&V;P&LPNPR"5PGSRKR48Y.'WDN@1W3Z,1C
M/X.8%(-2"W/-&\HZSP`W<OH):SJYAQ%SA*7QB%WD<9+"^RHIN#;JL`!"PRQ@
M!89C:G\QUDD>HCM,?W,_P-<XK4W.16=>\GP;1_1@YO6'U\\)?5W[9H=C,EH*
MGY:KU'_)SG%Z3-+86PFW7;/HJLPT-EP`:82];P^:UZR$J2-*%APO:E8I14N[
M;/4/M4D_I581-4:KW](<JNS]FRMJ9Y%`')&T3M=26>$]\039QO>Q4T[`1PI?
MA1R03F0UCT0IFL\)"\DH/*#'5_0NUX_ON`*"OA2NG"F<YBXEXC+M4,5DHJ)0
M4,C>/WLQ?O3(EZ+/='&8L*GS._S;WD_\%-_C^,5?X5OVWCO]@9Y"9N47+]@+
M%U6,Y)97+%IQ!Y\-+/XJMHI(.R$;)@H;02Q8[_<?:'=4[^^@Q-MDDUSN[?.8
M)_P6O"J2@)7O:;VZM!"UU4KS4,6$4X'*GLQDRO/849X35+I#N3^4.40UCT=]
M&HL!;UVA1BQ9`V8<K]G7^=#^.OD!9*+"TZAS43YJ=H(1;:,((4LY7<<:&JIG
M:O%`CZU#"7U&FDO<JM8,X:P=>D<$<1T%@1<GWSFB:&8PZNI2'Q@6VJ+5EZ,0
MFCZM5"):OL'KB;$1S7)[T5*8NHLS$M\2E(6)<E(PCYBT&J?U7H8I@9O_&.!E
MDF#QP?5:G8HDI6@,PV.MB""3DLJA!G7E)IK'QT<;M%R1>BAF.X<735'6UA'"
MZJ&B2U03-!7TE/;AT%+APTIND?HTRRDO.'Z,G,`E2R4M9+XI0`HSQOPA:;8W
M;D3&9OZ+$Y@\;6&R*-`W48S\"IS>X8-3M,'M_,$)O5NM=5#^]-:%4K2C[*A8
MG*J4_H@?TX]^LHKV87H;XZV_WVI5TY)^W(*:V]X"'R5Q62NK^3Y-B<FSLKB.
MPO=L!07!$R8_1^K8X%<;$PI2JN'$926GFXJ87$_V\P3'+?ATS3B@Y%76M!DJ
MVJ%W>4M7)ALM@E2ORAX'IB.FD##UUWZPIW5U=6[>^;=L,\H+\NO3R:1]FG^7
M<R^FAYTDMSC.IIM>^0:6WWSA5(Y]CT7:LND)1ECL_Q9`@F0U4`TIL^A_4;]6
M.SP2?:&775F[.`)KNIHY&E4+K;7GD*/2-K_=@>C[E6I[16#S,,I]!;T=(_"W
MA!R^P(5F784K9TQRWY>:FY2V#D)LNZB&5E81;V!D]$JR_QU8W%;&:4#1V7I2
M,D>NTC$B?1LDH.^-[7",$GKYR-.^B#HR%?1W-7J`9'V<,Q%%3\5CF,(:HLQ!
M-7MTKJ>P2)?+9FMT7-Q&=CXD%ST*FSW)IQZO7'M;_#':>GYH-`[I=I..+^K-
M+:I<-RJ;VM7PUE>3:D9$2G.":"/T)6OFM'9P8*&I"4)`29E>]=)E<-V/V\S4
MUIKEELY_VYE&:-J&F4,H;+I0[C2_GSNS!V5<UFN=W-/B-DHQL>0%P2LJ16B5
M;=G&!B8D23Y[*7KVR.=AE*)'C)MG:]&#J</Z>*;>&ZV\8+7/-L1,2-^5MZ=+
M;NFQUIL-7J7H:[0/UIEU9MFKSV.XK'E]N01=+'&I"E,G9:;!BZ0B8@>'05EH
MX`^?YR4*["$VS.CG!&4FCT0VQ][A4'G$DDKZR@/WU0;05QC,7U6@;ZEIE!4&
M*QKS5P^R]]^<6J*H6HHH>UE`M+#0YF+6'HO\-9*!Z:UD<CR[VRC4L4$W<FPE
MR<Y[2%5;$LK:-G2FTP80J`+_D(,;@1]=)+=[+O(/<E"XLC^>]&X*X"Z_^0WL
MMYJ*J-"Q:$_B6J[L*!X8;"H]/$$%@)S;&`T`0W(%M8.BL?552UBEBFI%2JUK
M:`\6U'8CO;\_?[AW">BZ"->11Q6BQQ!$NTHXX.97VN>HY)DB02YR4%B8J&S4
M*1=E9:*-)&]M<%K9-\SKQ5"U60RZ!.KVK9+G;XVLK<C6(]1Z5FL\<PQP:KKY
M`D"K<!L(@;$5[<+S8[97%WWO)HB2?2S<!4O5OJ%TW':`<)?$`:Z`?%^Z3.#U
MSI5QXX=>N/+)O[*WWY&7H@UICEYH>Y>((KOM`M*HD=*@#Z>YB$I<R_:4E>/.
MCLJ"XZRNOO0RRO8!K!H<'L3D&FT79"-J]XOG!_10Y(LHOO>"VA.>G^,H23Z'
M,?8"_Q]X_;/GAZJQ^!!;A>;WLP%#TB'Q0TX`](Q#@]^]+"_8151=1?2R*_7W
M(-!UY0``PX50]#'%$9%^$5G)8GU"`<]P;K&#9<:BX_M-%+]/2-?&(DTN?=R;
MG7&`2,*<ZS"57,C5=+N#3UY:K&3%W]*[*"#^GQZ^XN`%?XK"]+FJ0XS3=S_S
MRHQN:M:RAO7[EJ/D?>/0AHB=H;-%UC9\HBL]HQ"C5^S%*(I1@!/G:X2>R#90
MNT'<4<J?F743132->VXBF>\70S?N392K-R!L&LJAP-:H&BC]/A,(GR@>.+7C
M>UB4'R/Z^;Q$30[*WDJF@W5#^>*:[*]9@@C''1AIA#3>`,D)-FD,F-A^:)69
M$]3D'_K@)3Z=B/23E1>@O])Z(V_].J-AU70T-1]FN4=4]RJ*O_CILQ_>A)@"
M$FJP)3=J6%.(C(VJ@?)O-*X$"F.!TT"!"V,)I!4XRFIOE!7?]2<Q\](Z!:A[
MBYT660RUCF^SO]B)8IRR+.''9%:7`)?ZDS&3EB>',Z,Q+M.&UA5N<,WQRJ)1
M+4%6%US#0RJ,EL'I)(W[S:86M790EH2MZ>90I8V/71AYD_%BB,`U[`*)7"M6
M9XJ*1EQ337A,3K\^4Q^\NI\W'7(DKPGP#H&^+M0IQO6'=EUA7:U&K0,&"@S-
MV_&O.*47W=NY5WVS#;ALRE`3YHV=$,=+=`/QI4Q,AX@T\VP`B347U%LR#0_Y
M)!SB"?B4#^ILO`[2,PY+S^;J3[A7\W["#?S(#/!!&=`#,H>>8#OQY-H>*Z">
M5!_9!#4`FX)/KB3JZJ\S^;OC_:QH)6=.[Q'41QCS:%.XO`B&BD[79GV0-Y_2
M6XXJ0]U0P5-++SI&3)6"$\7X.;<3A.'S6(A"=!3<TS0[KY4,]N#>+T$>*N"A
M#QIQ`.NG>B5E_8,SIW:[F(H8HG,^'".&*]5B5>R6ZQZ`7G(0VC.<WN'8&74D
M*_P>$RP,X,4"-ZCM6I]9OM4!7^\!J@K/AD/4CKG^PU1.9%-._73"F6KZ9V2V
M])D&JOAU8*\IC$'`H;-$4U+0X?R?O[]90!"Z'%"8[UL=",U.HWV*;SEE[2`.
MS8(XBIPMZLH79XW0-F\U4ZE3(7NX\NEQIZ\,"JP#J*(P[KF)I.#]]L:#`O8L
M9Z!:&ON!V42#9]^%W33$W]N=;36X,5K?7X/C]8#6;IO3`'K'#27C#,56VPWX
M'AR\;S(W^>U^!SO%JK&?(4N6Y/:G6[6A\[VGWMQ#$:.E!1]2KZU-0.9>W9I3
M`68)B`'K#"58VPW0PA'Y-W%%@EF4-YOE:D7/X2.AWD:!OWK-_O^!I)0/Q/FO
M`ETUZYS?-MU.(`IH%B&@K&D[5FN5IJE%5C]$&W1+?AH<9B<NNJ$ZAD#I2$DO
MH.7ZH->W2WI=GS;FW/5\0T^PCXY9.G5>HK9J>X*R=NA+_E_:`;$>CDR'CX-G
MT43WM(B>,#?IIB%5QK'%TC'R2#_Z_6YQO7SX?'>.;B[0A\_WE]?G]_=H>?T1
MW?QR?O?+Y?E?'.65`84TN:)!BY$TW;I\]X.*0)31%_=5V``MVMH*@)<1%7.?
M^"%.DN7JM[V?^#2>Y3?AK+2B=:&>HE8PK)#'`,0,H1,-?@CZ+HH+J'8%?:'7
M7*&'XO9V2:*%AX(H_,8<NHBL.DR:*_+!98JW!LSI=!'3I];4%H<ZT4"6)')W
MO2A5&5C4Z40RT-D^]G[&(3J+XET4NS2FU<&`#L=$R!$3K>RAQ;::?2MUC<0C
M>(EC$WJL\.&*.FV"6!MWI7T@]H3UT&CHF[9*HO^,,?X8;3T_-*B7N/TDE5.K
MO;4:BAN7O6JJ[:Y?7=6TPB7C"2I:H2]9.W<I*0"'5MTEPY6D`FMTTZO%6IY<
M(^E9M'WT0Y;WDVRF2L%.<8<6+7D-0?DHCL1"-<9UID]#3O>*?_6+;K%-<K.%
M-%,"I,6O;GLQL7BV;19=77^V2BYP?#7*K?IE]V?_0<&GJKSLPF\\03^CLV4X
MWGEQ^GKM;;%D8DK6-/^1^$U`N"7S#L,I@0<UF[@=%_5/$?W8J6DHZ<WL\$3C
MUN?\X+7L,H-OSQE.>,GS,ES3_YR3,NS%"W"8)LOTS(OC5S]\DAT18=2W8(U>
M'Q@:F<0'6!#I^M5@FY:E!;V.O'"-V#]J+1WAGQ%.NH3L`;."H3I=.935\VBC
MK-)R;59A[7#L1^O[E`B0<]BE)9@0O<@C51=^\L.0/@6CRXK8-WD[H!859H<*
M:Z/M-#)8GX=K]T!]J@`U"?I-PEFP1<:APODGX)I]9!3_)$'Q"85QT=RE?1I&
MP?%/[N%XZA&#WG)MH[[2$8.=Q=I&\5D?,?19]JIG:9XC!NW%K7U@)N6P<F&K
MIL?Q<I'EA=HC`U8Z3'!_L?88<#8;*XP#Z)&34O8<<7U!?OO:XT59*I+WJ"<@
M44LX"LMC@4XV0F^:C!7TSUA:7*7O@:?/N%Q!Y54M'2*F`@1\.FHAITY!?@<!
M\436K>4/OD,K6<,.\LH,46*/WNGZNHW#1)Q4]D?`W-3CCG*GEX]^L@JB9!^;
M/:V0])>./[C]+-9SDCBMCT/XOON6=CQKBT]1B%_1EFTOCC;[<)VP4F]%&8WG
M,3J1(4FSI%.#45K4<;KK%G9<S^.-5CCNQQFQ6(>V8N12;4:&JCYO#^5F@Y=Q
M<3YNAKL(HJ_7Y.:0?UZ&+SBA;W>1KW'AAUZXHO]>I?Y+MO%#^0T4>\]`F:WE
MPV'FP(0$XEL!9\^!(>DISR`GB_O];A?@+=V?(:BI#GTB18R^9R)%/:#+<!/%
M6X=>>`%#,E>I`#E2DZ\A5OFJ-BQ.6TE]2%0V<KWS1"PK`VKD!.5F4&F'50RE
M)529JG/6M5V:W66HK,28%T='+$@"+TEN-G_QXM@+TYOXSG]Z3J_WVT<<WVQJ
M)T]X08#7'U[S=DG>4+BV%L9J48X,M0:C@##?";(8&1R1A@0.]+'(VM+*(WGV
MR`]-!OQ!P(X7>WQ%,6ODB*X!8;8K:Z!D*#1MF%&.I`V-TDK5,2PH\*+#?<*Q
MDH.:H(S++]+]>=E54H*4;*Q,H<P6Y6-AK>QQY*8FP.;-SHGKC?-O.%[Y";Z-
M_14N+_8J,C1-R2H+I0E[TJ89O>T:0AU&3QU3&5X4#=".MD#O_!"M(U(OQ`G:
M$=W:AW[ZG<.2I(L^/1TRP[),>A26-/5&&<]H)8`BDE'R_E0D463XDD&L>ZW-
M/)+ZJ`PR2M].<&CT1'V?1JM?I1N6B!LVDVRC`:0T<#R#TKYI7YO4]6X58=FG
MCNTJ(KF#(IJ)[W:30K5V0H(T;#D#?UIU/+*]P%[PDI+TB3U/29;AFL[Z"2X_
MD'\EWHJ]&W^EV-_-AHORQ75(TT`OO,-_6\@Z&#8\G;?L`1TN&M;0\BG&F3%'
M!,8&TCEO]5OC4R%J@!YXNPA`QF^E%@>,T*Q&?\'Q8W3P/*:E_=WY+^?7G\^/
MQ!T*JR-UK?W&1B]Q:]39L^;L:2?[U@RR)_QTR<U*U`35K3JX"^@,)4#T#OI1
M`N!^8Z,7WW<1?=/@Y>#3]T^_6]RDSSA&5U'X]/X!QUMTY7N/?L`>SASY/!1K
MA\KGZ:<UJB5*RO?[S2TH)B6X/:TJGB36$:84^-[[2Q7/WN+LYNIJ^>'F;OEP
M>7.-EC_?G9]_.K]^N'=;A&0@TM88-1(5`L(QH*\/7.]CIG-.`.#/PZ9#-GOZ
M):REZ\MFW=LB8&30FPZ%QX;]F%EON_73(GN?1>Q`)1RNC%ZQZ6.CS'Q&?8'D
MH4>\4/)@YEI'($PLDN3WZ=/E`\MW[/RYLYOKA\OKG\^OSR[/G<F`?>#$D8/^
MJ"SEP,`$3Q",(IB!))@+@#[=[9/;2B$K\S:(O329EQ>S%VB+RVE][(S>74<I
M^<^/?V2-?OQG5U:!:8#"A+3&%#4BI*U"5.@0OO"TAL2LL!1@D3;X_C`1)ZX2
MQ\&<$Y)O,OW1QXA)'0@_"=(GXG'21_\!HY')@RD(M0:(`P!J4A)*!XEF,8R<
ME4:9(9D8\\ITYOI<R11LZ)$+)^##N!DS"MGZS%LOOHGO4R_%:[:YRBV.[^G[
MG)(TJ=FSEAN5/<"403,VX"RH]JHG`RH[BZQ1MMCX!)%V^09$[?=IV"NY#@VE
M="'#Y;D9WFK45G3D\UGIS5924SBVD<E&PFV1LYK(C6*4M<TQ3%HCUOQMP%:6
MDZ8`[B39YQ.F;[JJ<TVS73>S%->AR=CT:R=KE#Z,N);W:O#*.>*T;IN,)MP[
MW*5$UDQ*@,*299W.W%A4Y2&X:"LN^I)][M`HH"]$-'03#"23:&+CF!.Q)/*.
M3NM>AD9]PROP`O^.$R/@_Y*?I]>H,_Z?[__PAQ^K.OG?T>F?_N7D#W_X`_U?
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M\`VL.:'*Z!6G/N,7,$S]5.;!A(WB_>QG/5Q\"=\(FA.^_FAMR`$&K#_R"RQG
M1R##4/7':5`UX>BDFM/0':%T>XA&*?66=GC4C<7F:*7AK0>E:OWYHY:J@:.\
MXMQ[-;>$@!&QJ^J@P;"Z]5&TNW)H<<H(&G#=B:0W`CGMX8TET$TB[6?>SD^]
M((OU#B<X?L'KBRB^V*?[&-.<1$<?:L$WL]--`[K]H8EJ%K>=E*$=@Q&O-:TV
M!P-QW@YMHIB-#)P?>QH"3R8(O3#<%0D],U+IT(W$<A;3"\-B;IN2&=T\F/<K
M\N%=G2M97U1T/M)$(YLZ0Y0)!U6U![ZZHRI.%]&PJM'43HW+B<;FP*KIKD>A
M6S?`KW-K+9RCL1@!ZDI7C!M1H5M?C:"N=!OV1QE?U3Q:'V!!`D\TQ#IY"]C3
M'F990]^H<K_#8<*.S%R&ZSN<^G%K!PSU3A*F%JIDH-\3BI^FL8*1U<"Q%G>U
M[2WNSA\N[]A^2>A^^<OE]<_WZ/9J>>T,?8WAPV-S3PQ6U-8UP&6ZOG>7B!^%
M]!VNF\U'O,%QC-</WK=EDF#V6E=MMP(-`>AIJ28$QA;`!*%G[+`U9(\H]%3"
MU.[B-O;#E;\CH\A5V9T>]9`^8[3.C:#4^X8\9H:M]PS<VQ:R/R:YZC(,X#65
M,33$5QOC:"P5NZ:!6*B!72%.7C'7"%-T1*0G6E9DJ>\#X]QIR!/S1E)Z.\F<
M<?-UC)])G>&_X,N0:#.^QNG-AGX!=7[6[%G+Q\H>8!JB&1MPOE5[U9,)E1VZ
M6<?MW?F?SZ_O+W\Y1U<W]_?_Y@[7=7'!Y;89J&I,5G3D,U?IS5:.4SBVD=-&
M`B?+61UXO@UTRC+-%/B<-)/<1H&_>LW^7V/+**/NXIPBZ&:+N-(H[687D>M>
M+.8;6S1:HJLH<6@H9H07'3;K($Y,:&YO+58+_(Z4>KC>1\@_]N%;C)XJ`&>-
M3U#6$'W)_^OBUDXCP=L@8XT,<"=&0>:C'_U1C_UJTB@/1:D7#!KE#"T@9Y5M
M.K?;I%PT+A*-BL/1!RUFR6+X<'HHT+IYX7"AUF-$XCC8P`_6LX>S4W[]@=Y1
MO'UW@DA#.J=+FIZ@99K&_N,^]1X#MO;KUHMQF!XH*,7O/HX"RFE+BRC5V4%9
MJYNDR&@VM\9*7E26LT#+93^*-HS,:KZ*BP,M]DD0)"%@O9<>"YM^QLH/=:]C
M3)^"PU`T7,W3!:*-W=R&V!)&36H7NR@=-V'LB3B>_[;W=W2YCVI;1UGK6GK@
MM@+CHB0&X&3`]Z1'/E[?17$!X>**.[22W5HNF]18J%&(TYC/'*Y56[+.<69#
MS8%Q5&@W0U)YS;VM(D$@)=-EFZ`:4X7)CQFF,5M]>><GOSX0CQ^CK>>'0B56
M]BC56-(2B$;*6*"()'.D0R9Q_T7C(J)7$;V,OF0-G.&4^KYS>*4+EI)9P@X\
M=DFL.\NPJ_:!V2J"=3J(^%5K:(=>G4A`:QZ)LQX,J[JW"!:3BXY2JGNGU8P2
MH4-$J"O9*>=BVW:J()$_^$+($KBR<JBCWU]H`\1:N"K?@[`F+HS&0-N$XOT!
MAZOGK1?_:E8C";J)A+S3W`[=!%%9HES76P_BM8WPR%>V<;V"$J%"340YGD1D
M;/72H&3'C[/$/(OQVD_IOW0YV>TAHF.]I1TF=F.Q65DUO/4@8:U_BW_1!F47
M,R;2]S7(1_?^4^AO_)47INALGZ31E@3.+M[O=[O`)W\YRE`.1M3D%`)+Q,NJ
M@P8EZ]9'*<HJA]:K,CA@\NNRDSHZY[`X#A:.VE6;)4!.6;>]TKF!Y3=?>]3=
M[2&LUFHM+15JG5ALU6AU1WW*LZJ_>%J+7G:589R[KE&-B:`B+,3*#CHU6,VZ
ML_QZH*MYM&>,ZXV%D\59(TOSQ/4(;$T1YS[ZS`ZSKMR)!7;)5?8T;ZS&;#`'
M",*)X&*]F)Y-9YGRX;4<5)FE(VXW<4YJ-;>5F+A16<M.;6^]4E33B&(&P>UD
MQ<>$3L:2H4F<MAJ]M')7RX^SM+S%,?W`>\(_ZE*2TT5$QT93.U3D1&-S#J'I
MK@</ZP8X3VC0.R]!'CV7FEYP9EM:#0BHV2<&CHAYM1X:K&O8'V6.H.;1^B0!
M)/)$TP15DT,%GO9<@#7HC2KV21KO5S20R_`VCIX(RA/%>D-UETKL)4VA^*:,
M!E;L9>ZT*"<VL*A?17Z(BNO.4$U]YWE4T\5+131A#R[1)/8M:;S0HP6-MP>X
M7..YD'-NW2(T]B0R/Q+Z1I7Y%QRG/AG_W^\?HWCMAUZ*UQ_Q8WJVC^E+9F*Q
MU^Q82;ZR`Q0)-2.#E7^U4RU.JLPL:FU0O1&BK9SAI"XX>,PT`U;%3D4_+D>5
MOBSE"85?"]EB''SFF4.,T!.4MWP+4)6DD@G`ZD1:N2;WI&]FZ?95)Y=Z']OD
M[<8W3HII^!W$XIJEF2<:#E9,""R$FIK!55<C$M<]CIQT*M<CYAT;H-7(/E7C
MMP/A'FG(.HB=2$:J^2R]?NHD!#VSI1?7.,G';,I!8:7!WJ3.WO4<DH[&M(,1
MI-0\E4P_J#R-G&3Z3(,9'`H_"CYI?OGC_T2KMPW2'NED=C`%WTAJ''R>*NH?
M]R9O[:%4N(_4^"AUHM@Q+W/T"QS[O!RWJ!E*1V$A,X\4T8MVQG0S(MKHB6#$
MH?!0M"F'O8<)N!YU""CDQE3U>!?%)"X:UCTF0VQV9HQB^*K1IU1V:5L@JFG$
M`ZKN<G\ZC)-96)27F::CI&S@"MMT[C^';_JP*?DFZ<)CG-2#'9F7N(07>JO`
MR\2^@!X3M:J)<_4]/`;%JC\>"L=4_B2]V=QA?_NXCQ/ZGL;Y-WKTI_C%(47[
M4O&%[8`8IX@#5.G%OG3()NJ]J'^(5J2=,]*NNLD<2NGAHB23H#F/2$++=J1<
MX`Y>QJV@*I/OA.WMW<!7?OWP$"86;/L8&U>HZ9&.>6#J(XSES6LRS6\&1B99
M%,`B+7"EQR9NY\7-[?G=\N'R^F=T_M^WY]?WY\X<=:BXOUS^:""B1AY>:SYW
M^'9MR3//FPUU!H=3H<W91BO%50>/S(7"EDR:[:)K.F'6%&2%$%NBBY'PZA[*
MU'%ASI#?+1ZH-W2SP_3%I?#)O7*%>_.43-##OQKWXZBI;17MA0V^:LX=&+K2
M.!P:(TKA?KL/"'U?\&V<GT9^GT:K7^7SR%J="IE4-(9AA59$D+6KRJ$&:>0F
M%O<XIM-W9^]_1&4#Q%HX0B0]%'1I98*>@F+2/AS"*7Q846:I3W"=M@U`IN%E
MBS8$79M5MH)%H>"/BL8QDT&VJV3G?71%-M#J5:8#16L@+FK%!)H05!YU""FW
ML2@:H%6]A2L4U(,!AX,F^"DI*.W$XZ#"BYV4('4*GQ.L8S#+"CD*&VWRG=4<
M2PMV,"E.#..B<KS40!^)7K+7U^GY.Q]QLHI]%M7-YA<O]NG\^YV7X@]>(MR,
MK8^)_.<UZPI"W3[1`J830_=J7AL97+#_T.=1?D@"QDF*Z'-Q-TC="T<=A@]`
M8TYV$PM=YIOYMY&<3"*`SE23PIOF,+9(INIP@FI=*.Z+3HCV0JS;6T6_*-FY
M@_^ITN"5X@PJ16MN<KL"/GU*$8.UE'5E=#20J._B`<=;=!5YC@QR5'=40301
M!+B,NA(?^B.T:C]/7/4[7$K[M3T+**)Z?Y,^D_K[*@J?WF>0(@KC!PZMS85"
MEIY:NXXMX'?M;(#JM%-$.'A>&1BJ!&_.V4;55)E=MA&_I"4WHT-NP2_Q;8,I
M^IOO\_HM[E?/>+TG130IJ)GTIE1Z6ZQ)W-J-7W9W%6R1[,//::CBB&,[\#>#
MJ[TB=;VG,U4W&WHX<_I:NZ]:]#$QQ&67G@$+Y#.)W%J5K1F$*7^US"ZR2Y3<
MR;-'?D'ZKU6TW9(1=,*>$?HAP?C79W_UG+T/]=5+ZALEN$AX(SPJ]*`'MKER
MH6-'I29ZL=@O\73BL#O9-"%EN!-/M8XGJ*)4UKF>)X]T235'-ZX09JKLS";-
M[G<Q]M8W87TV370HAVEW;B:6=;.@).HHK65=J6M3X9`86US6G[Z@K1<_^:&3
M1WH8`TBA!=H0Y/)?W%O%>IE?^\E1[-UN2AP)S]STEST>R-HC4CDV'KR\-7#K
MI;<IX#UN*OOH)ZL@2O8Q5KPS)V]<2U.\1F`,%D<`QU:N#SUN<KHN'L[O/J&K
MF^6U.Q23W$<NH93WO4:>;EL^57@V72(&MS[-_IG0E4-T_9!>D:?17S7?TNUG
M=\`HBG.,V16.[P$CQ(ZU!5MFX*6"V1*\SN92!/,L[TA5F%URLAS4@9K^V%"!
M5M6`L-W=8!S8]3SJ?$G;_6C3)':QKYX4J7H@UN7M8=QXVF-$E$^5`"7'_HH;
M<E,:X-&^8L\V.*I]?"^G6_?AM4-G]$INH()$XG-XN^U4I'#KK%T-PM[&_DIS
MCD^COW[Y5_0;*_\UXQRW_"M]@Z3`W-JBEN)V]"-6TJVC(/#BA$[U9>7=?*J[
M%I+Z9#XN&/7S7M:]5]XK/$]4W67N)ZCN;$#;J+IC7=X>Q@=4=]91/E5^N_:V
M^&.T]?Q0*YUUFW.S5[V9!3IWH[#!W8874ZK6.G=Y22^B+]EE)RM!SFU6T$X(
M#"['JM8J2M7MNLF@XMDAG5FZ3^D&UM6IXEJ<TC'`99F\HP7>Z41JK4I4.#<E
MJ-3<XL+_AM?("\.]%S3?S9O!8V$M0"GX;`!*+L-E_56<E_NV7RW*_(_R-L:(
M4/];9_7#$=]Z=>+!(MSJ.R%C0KO[YL@)*K%.>YR@K`^J.KU)O&N]=#(5WEVH
MZY8IB=>/UN?AVKBDX_155G.-/I;YSXEOE!JNZ7<(\>N69IW,>%`QX+48:4I"
MU[J:<+GA<=RT57-M=PK/.F:Y4W>-/$47+&3-$6G_=E!L7HC9Q_&8Z2C;PN[!
M^[9,$IPFMW%$E"Q]O26H2^DNI[_M_1W]*L*<9&J@3$SZ'8%H;AHI:(HR<*[#
M>6US^31#ULP56AMCAL/MGK@KZ:W;G\=Q?=]V$I:N?_BL-1&,L_R5;UI*FN=X
M/D%%#_(OVB?;H[KH]1;A+LYG+@!^_,QV&:ZB+2:1UW8)4>0R69=6]N(W!66Y
M+!HI2/^4L3K$3W0P_*!WG(#"JSZGN086/\=1DJ`&DQW<O44#!D*&:H"GQ4A>
M#S$'^?9MIAF>1UN)Q0KL.LFC=NT$,4@>*O)4V<`^]L97_`L_],A/S<YIN,:J
M@8N@=4OG.ZU`&2:(P<+XH^M)GUKMOHLS;^>3I.+_@]!J7?!KPUK1(V0<.E%1
M=;.%G)*CHT6F5F,QCSI67:/0'7[!X5Z\M(#;JD69\BHH55H^+5"D\J!/C:)/
ME6;R3]R"?_N&"6'/O[,MN.>-Q#`OK=BL3G(GM@J2`6AHE!T'@0=5-0&%B,D$
M[VQ/_E#.=?(;\^6O;&0#]*T([(EAY<B8!4771?X/=!O%Q<;,LV!'^S:K2,*'
M!9\IQ6^B(DQI<P0ES7U9%M3AB.+)ZPG*+QX2DC15%QA+$SZ#8B-RY681.IU$
MSYI:C>W,RG,CLOE,J>VPQP1\TP1ONL[I!TE\$*AGTV7@$<V?-_IHS)FW?(SR
M8*CAT_K#(&C\"1_Z9+!T[=QF.VC4?IYC%8]35.1A>D;^ZZNK\7;#3B5>-0`N
MF-J>K53@-2<FM5+9K5XEN5<9=6Z>I"H2W.A./52TD]5"E2V[-77AQUX]/1`?
MK3J:5)#9YX<`%'7I#`F5R:8MKLGO:#)ST6W/G[RHM[,QU.S&86\*H^'+>,Q9
MZSV/.3W.+58--X6HX(\WJ^;*(6?=\@@S&)4[RY,84)CB3V54UP\/89IS&E8P
M-O7,AM&,AM9,AM7AHY$TFRTRZCCJ.V*<Z4R%Z9C09"2H.P(<<R9BG!F(`3B2
MSS@<$I3,IA6@P#2A]))_%)^=?]OA,,%GT9;^EQW3O`S7'W"(-WZ:W-/=F3YX
M"5[7&]"U&KK"#>A*)/L@+NPP'?#;VYPLAPFSA]!`.%[<T[UBWS_2BZA^U5&)
M@F2$6N#@^2<21P!/&M(*\GU&R?(`D5JO$>9,?&%]0O]=7LBMGS24@;T94W@X
M0<P'1T`0=7-4$6@LOQ4=<:K`8^<$]R_:&MWU"[&\VU@"VXARW(*I<`VBA9FQ
MQ7*UBO>5AB5,MMBUV8A2$S=]A(:'/'WIR(['[B,'N=^)2@7F?8+T#P]CPS3]
M)N$](#=:!KA3.:Q_^C+/7.-1?9I\!<7Q&KF+-#4;]@XB;F_&]B+K9(EH@AP$
M!4VCS/,V0#L@T5B![83IY6:'8S*4"Y^NHB0Y\^+X=1/%7[UXK?U,4FU!E&YD
M/>T06QVKS?0C]=Z#ZQ)["_JR:7D=T0:HT<)1HFN`24UX;42*:"\VH$%_F?=1
MLI<X`.M9;#R$"[/:$?3BN^XF[*<=7&7K.'ME/GEOR2"+V\M:*2N)T?)@B^^Y
M7U7+L[6@Q,\7Z\Z!Z`K`:)6R:L1)BEE.9[V"ENMUK+$8Q_D8XS'+Z)6.RXZ@
M-AFCC0GK";/5+UZPSY[+!4'TE6X7HYNIQ#U%68K7PP[!Q;$9;&77(S]Q_?9@
M-\<.C]>H;(?*AHXR6H(6-9N54!/QN-M1@\,\;Z.DI:YCZRG)'F"%J>C-8E8[
M^XR$VDFRCO[VJ/S&W=QB;TM4?@1VQC=]-Z)L=65S=`W:%5=?48P#=D(,P=+E
M[=W_\K:[?__H'/.,MJ*40J3++JW-)]LV+2N_^6:G@_;;!4,:E?<.UI@2H7<E
MY)PYI00"7AKR[3K`P(_#@@;5J6P'70*W@\*3\*@JFWB:.NGK[[<DZ20M`NSM
MMR2)R'I1T'>_&YZ)66V/KD"")MFT-UWB]-&EWFB;+G%\6APHV@&AQF;I+N^\
M!`A)L[K"%BA'S0M^2)?\AVGL/^YI//1\CT_>-W^[WR[9.<7UB\DMCL^WNR!Z
MQ3@_:E&</*`L5QEFN$4H^D-]-]A<!1"5EI8,]K/(6Z-5K2%Z?$4[+T[]E;_S
MPC1Q])1%.%SSQ`F8-)5^#37,%;GAT5I*ST,#LY##YT+.O!J@9E"]*3MMZP05
MS,UL-5HD]#1)5)@[*8X_/A+7#'&'0=W)BY@\WOB3EZZ>_?"I<3W[#C<;=M&L
MA#&W*R]@3.S9E$?S[V6_>#&*J;<Z&GA9%&W1EOX]IQ*E!VYU=:XW)>0:IV]6
M6^%,(AVQ--$/:Z3"Q#7B*8J2DI6%I4:CLA*A!U"P%D>BZN-L_E2=0RD"7H.`
M%1^3*Y]3Y89EN:MF1O*:PGO"5+5P7GPGOT=/;#YVY[VB9/_X=YQ-/^)&63)W
M>;.A:]!R!JECKM4:[A09END&5U:<5P3-'IC<>J]'&LJ@-4<B3EY)T`V9[O`J
M>@KI$:QF10._K[P^:/>Q*4S\^.QG_8[?WHK3LK3(-]=".'^W?!/%*'W&Z(]_
M^/'=K]\QD7%:(P2(T94#*>#DO&]VU:9XV^.(:;7I>J0,:@NZBKS(-I^K6K\=
M#!MFKU%0/&9.VL5XY;.5[>3?`:;_6(;KY9:>[_D/]KDP)>EW+3.23A<@2NM'
M!YJ/M-SJ<%K#T*+>BNVQ5[_L"H<-8,*AL#'(2OZJ>_+HJ^//3@Y2>S9+02\X
M?HR<`VV6AUJP]>HW!;NUKY%M^(H3T`$"&'R)_)C(/6TB]P25+=^L]HI7V4\%
MWA%K)S]9!5&RC_'-IK[#\EWV(A@M^6I[,-]ZKUL<ILD#_I9^(%']*BJK8*P6
M%==0:S#2`/.=(.NTP1%I:,I`'XO[AYNS_WS_87E__A&=W7RZ/;^^7SY<WEP[
M(BY`0.WJ#B@#"D$:9I2C54.CM)*#AP4%/L7A/LM8.5J:H-/^C7,4<BML>J1U
MWD)A"GVAQA"SYLJ;%(Y24UCJSHR<#M88C_4OHGH+$,2H:84A,#:N[DF_T<BB
M)XH%4//X+@ZEL)##L[]XZ<#>5+FX-@<(ER!&5W3KW(M#/WRBB\P+G?579"3W
MT0_VJ?`IIV:O_!8H6X-(BV9,@&,3M4>U0JAL+-@';-HB_XB^_Y_MOTK?^"#8
MVY+RA_5%[ZZC%*/3[]`[/T3K*`B\.*&+F5!"+SNR1%H7.QU9,`-=SGM%IRZQ
ME5YL#`<43J'+_1&`2\OUH@D#*FMT@CIP/FQ0B@KIPX"ET22Q]E..,=!Y6A?6
M=?ZCAT18`[;`D^!UE0EKD@GK&]13T8SQV-"=KA92S0`KVPOJ'^A96V4<%FL>
MLSD@<>]%HZIA%]VDE\;DBRXN!(223)=(+(^A_];F'RVABE^$.#@/"`DRW9+#
M!LRFT^K;*/!7KZ:*+>@ET.U.:RLD$\1D4<.['LTYU[8Q&ST704!).#EV!*1K
M=5)3K^-E#)UO.;6M]A;P)QI^9LW0E_R_SB<"*'3J)@7;^)QX8M-D.E-G$M/F
M.'NL"<O^X^EB#$W'S>_HP/D[Y(=DW(P/8`!M.&PV&"IK#I!'G-$997JQ/\RD
M4XF'`R&CJ4(@$$TGQV;/E_2>*]E]GC3><Z0A$YWE<Z./M4G-`Q)GXUE-HZ=#
MVG.8HTZ[C_04"`!V(JEV^EE/7TCI"C8TJ*83;<5R)55S@6P#+S%216&'/$;+
M@H2=9S-KHE[$HPD&`6?$"V_$=IUAS6:#5^G-YOS;ZIG@`-]Y*;X)S[SD>1FN
MZ7_.?]O[+UY`%P31UT_]<$^^4'[&:Q2*S@.",ENP<+`Y&+8"?2O(<FQX2!H2
M,-3)(K/`]C_);2!J!)VQ?R>(E'?4#GO"S?Y1L^B(J$`ANBL^L%PI1&J@58Z8
M#8[32OTY,"KP0G4.A&2EKX"2,BJ>H,H:JLP=&:J+L;ES=.S"Q'_!EVPBX,'[
M1K\+W>TB7/E!]C;G,KW`:Q)Z<)]ZZ9X$\MIH+*U-0"PWRI.!%@'5$.2[@1<I
M0Z/2E<5A?A:?O[__'I4744PUT<7=FR%A+%`\2(XT)&^089'J#8S67G$R*#`[
M]<DLN%A5*<0,RBZQ8Z<8"IJF3I"7HMQ:C;VM3HX=->$ZA>5UR_Q(/&+UDN_R
MF;]A53O;ZVP?Q^)MG+7[%96'NCV,D.G&!5DU:/C4T"&EE<5RM8KWV;O7)+Z`
MC7R*;BC?FM&5,8XV/KIZ8`BM@NNJ;APFJSU92;8JM^"I=!R`LC28-WI?G`?>
M.'DQ;WCX$!4FI`E`.GXRN<?QB[_"Q8H)^N)N]2[O,F`1D'_=;*H](4FYXT?9
M"[Y7?H@O4[P53MG;\=)*5&#6024#^#M;2()P$>HK$I3/Q2]>L*^VY3O/=N)+
M2'&^B>*M0SN;V:*`4.CL<*TEBD!.Q!(*]BUL5@5`0=JJ(6;,[WI]@G*;C3V-
MZF9/4&68/GNH[7J<V<XV14)?J'G$[+NRVGVFXJ"JF0Y%'B:HQ])H]>LGO'W$
ML:JFZK9LUT7U%K#"U_5MHSYI>#'0H%J_!?'^1W1^?WOKT(D'LELHIJ[P?K?)
M5S64$*ANS6J.K!Q9RW/#<=+,-_1S]"6[XEJFZ`D9I6(#@\:QD>QU%+[@A(S)
MEU^]>)T\1"D]8[BZ3M/"=93^%:?MA'$1Q?E'M-V/*E$>-0B3<3"@\_%J:/!?
M;.Q1-.07`"K"X4):_`7[3\]TYM![P3$]+'"7E=L1^1-]??97S_0]BVJ/TA4]
MNL5/V+[YJWQ%^"-&<56O>XE;F^I/Q.M^];LM?3$I[L%BZ%G[`_X&D\T<@'V'
M2286#EGR#*<E2K\H<WS2W+*9G61%_*)77#_1ZJ28M:`GMM6\'Q71!28=-?&@
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MVOX(+,AL8('#<2/_5@I\@PC`Z_0I(<VJYKP]7?K&`,Y:HD_8H^VV+"FYM99A
M=-0+:U!G<#]>RBM#_/!:@\A%C'_;XW#UNOSFBR8^#7KF/[-6#Q`%,(@-AO9Z
M#M5LU[&SJ'.YO(2^T(N.<-H$&QTJFP,KYZ]&QRYMM;PYQ]9EDN`T68;UMXKR
M\-<W(1F&[N/8#Y](`S)XC8L_Z2:HR8/W&(@VK@"WWV;^<+NP^@#U/8%5!"`L
M`ZT9[&W!+S22$U1V9N_EU+NC+ZRO:X(%!GRQK`%SJRU^0\U+)')XY,X)Z8?7
M\I]_]G%,(//\>H5?"/*T*A^-SMWB1]H)NO[1B!"\!)+[-*J"9*9JLG."RNNN
M%D(Z4)'50OI0ZY9#DK[2BDCJTSDNUU-/*4;2V3J3KFT>2[O`LE@C.L!9.4VW
M!C26&1+5#H[Q5P<@8O;JPZO-74E/"7.E_FQ,N>EXAIYJ&Q6G=&JMGFY$9:Y;
M<VOVX2N:2YL.P-,FGG+B0/ILU:"G).UT>EBCLB`V>SSN.NQ'X[8=$8?K\VA.
M/;(U08H6@>4PD["WU5&/O!UO+G,W.[Q-[^A,X_X2'@OZ66.S-$[+A:3(=S]Z
M\ZW-KZ24(T>+USK@D[";VUV/XP+/8Y697/=CU)HC0+E9==;![/[9G6/BW*0*
M'1OI\WHZ=*78P\V*#\"G1%?`^[=9^;XV<BQ0?.,\-JH\UA9AH:V[N1H4[58>
M#8E(!?AXZ$J\$Q/P-[!:.T"$:*V^F">-V[-CF4WVS+=FM:A?UO0$&,F386;;
MP?W9YJ@&RLKH`/1@@@JK6M"7*$Z!U.G2KG^X36%%4!(-L*+Q/1D(%,_`XF)Y
M>8=^65Y]/D>?SI?WG^_./YU?/]P[)A2R>R[FO1HI;1)S>D@XR;7O',7J,S?=
MY]#&T^M*&[+GN^*^]IZ>J>*U^!!-XKKGTS2AQ?KT1FT)A_-S\&HXZ3U.TT2E
M[*F:R(3FXS5Q!,Y)0E9,<,J';(F9[I2]H1G^[(1&=QO#%NVH[<TQZ(1@//Y0
M&UW<KY[Q>A^P-ULV?NB%*]\+D)<--9+]X]]QEO4V,YI1T`>A:IA@"F?^.$!I
M15GJ:\0QPNA>&87E`?PT'!$,P_G#[GR4G:WY=??IP>@\T1PQ.\"4:<>]VNE6
MUD<R\K662&7QV,B:`G_]1L#UI]QS&P*;D%4#-))!L`X)^1ZLYB:>2VN)R`[L
M6D^D:TU(*G$VB0""4)D>1H#A!,)_&>[V:<)6__^DMZ1>W*,M^KR6L,03QV)#
M\+G>#'C'Z;]@?Z&?'..5Y!Z+6:4$1IM1W0X2/O&LN\RF'XW9]*,VFWZTSJ8?
M1V73CP/9]&.333^ZRZ;V/=9B$Q\8$C;]:,*F'T=Y?Z3KT%J!!`^L]O@[:W&"
M<KBY^G(($.Z4E9%EY$VKXZ?&.GZJK>.GUG7\=%0=/QU(M].FCI^ZRZ?V/=;B
M$Q\8$C:=FK#I=&P=/QU/QX&`)=?QTQGH^!#<F>BX#>2-J.-XC6,ON`Q7T18_
M>-_R<X,_X!!O_/0L"E,_W/OAT\V.-),=`M#?4*'Z/0S`$+9WY%(`_REC<8B?
MV-'G:C+W"4.#X^9F%WD?1[C='UA=R@\%::$#QG8X\M`C%BOYRC@.\#3F"O)9
MTLMZH:P;(OV*L]31N[SK=W1O]:(WJKH?^2+>W-Q-QHR89_W03_&5_X+7EV%*
M@.L_!ME#T,\)WNR#*W\CW)'.H&N12[6ZP,B'07208RH]MQHJH6.HW%*6+N;?
M.+)7LA$NNM0V1U5!98V>'/)J^;.2X#0\@Z>T,>')TA9K]YXU1%7+;/W+"<H:
MORGP"C/19/!U(=LD/\=1(AS#:7939IFBN67^-J,:);N4+H=0-S>RH*>FN$['
MUITWH"(7,TH29KU,"%CX&3=W9%['RQN`P%/FB^0$L8:'CDWS%&$+G4ZDAN4V
MBE/_'VSHE(^M_HJ]^(*T-4\8&L;4:41JQ#;!-;[!."E''L@@/9"97A`$_:OS
M$J"#,Q-AT,>M6BPDMHPD1!K3R&E/$LN(R7`:2N@DSGKW8N;P!%$+B)HX\HF'
MESDQRN54_4#<P^7JAK7>R3JW,I$N-;[#I.FZB,2&.&6V:<+^Y[D*3!-L``K#
M0V]O@6'&(!0FC\J-I,V"F3YK6V?&P+S-;!QYQ0?-O)CE1/*^V*?[&'.^AFH?
M'0"3ZC2N8<JV7&E_FW$2NDXX@[1+[:#V`'+#&B.OKE<X7Z$0;9!?25NV+X#S
MPJ6/71/U,F6$6L"4%HU43".^D8L$940C5@K34TZG9KBFCU;YA<.%GZR\(*L?
M/GG$%ST4_4MAW)5EL\Z1LD==X1@MG:@PEJO5?KL/:+ZH?Y4>,P-R0QJ3`B(#
MUH<\\LAAE^[V"6/8:$=@=E&[T%`FYP5'A32CD8L6:C6&+'P[9J,542QC3P'P
MXQAS]#\J%;3&_$>R:`!C#G1Q(NN2<M`\P]8ZJ;,I:VQ;*6H1:8VOH]0+!N7(
MS.$@$:`F%N3_G&=N_7:;L+0+$S4?21\C[C$?(Z<EXG/$%`2#-,VAX2%CL4=V
ML(!&)U3_D_?W*#X+O"2Y]K98OBES/ROJO,#O;9N[LIBM4UG@?!"WN3:55&>]
M$.N&:#_7MF[N"3H31=!`KUH@>$:,%(,?Q0PDY,-K%7K],'-]^1!94$M'MZ=M
MV1#%:ETR.(X'R47'GD(JT.-K0RR^T$[NJX006R8*H0"H6AW:!HR4H>M]!JI`
M"J#^#X0YG;6&E^,]Y.5$.,[CW*;CH8.!VGDL&?D#1O[V8UCG6<X#C.&@H/>3
MU5I?TR'"9$]+:[[''<!:P*[F@'9.SR\!X=QOK&L;T$ZD*,YSTFO\+7WXBH,7
M_"D*T^<>M:R!T5Z+DKO&)EA^*?I&DRU1Y@0$O1ZSXX(N6/ZC\U)B@L>!ZRL5
M.-=X!*.V.72M93?&Z1<SMV.:=DWS!%3JO\*96D*9*939.A)2!UASIJ2KM0-[
M!8MH`TC-T#;6_VUC9F2J]RIKWV#:MXVS0*R\6DE-TUK@7^8H/1V<0;P=V<5M
M+Z$I;(&\&\EBFC[7%[%,_]Z294H,?=N8F#CRB8>7.3'*Y53]\#4"R]0U6_W?
M-*8VIGJ5LHI_VK>,61Q6WJ0DEFF2_J>YBDH=8A#O0780VUM0B"F0-R!I1&XD
M:!+*]/G9*A>&OE/\-3KRJ`N5^3!IQ,0<Q=A_"L_V<8S#U>M#[(6)MZ)A)<MP
MS?X,V!=(;J/`)PU4IY(.M5<DZ/YV8%1IZ/>`3-0#8M$0J-[6%WE75/1%M=:.
M"-!@.'9%"`CAA0SU-<>1HOZ164GL?<,!3^YN\H<E>2Z#\N[("]=U2B4HLX"^
MY/]U[T!8A^@FS/LS(-SH^1_@B)[>AIH9?X(C>GI'#ON>;Y\PM.7)[(B>K(]3
MF@)SY,A0D#8U9-B!(SUBL9BFISRBQQ7DUS/R?(_HF90OBJSK&&.F'6=GM8%J
M&;9V1\G(N=W!6GW/C\SR6+CCM%_1WC(ST]&M`!M:=;445Y+RN=E/KTYN^QIK
M!-KT.\90TPH\Q8/'K)U[RZFM8M5DL&<?K2.FE7T<^FQ3J7!]X7^C_TKD!V4K
M.Q1I1-(0AIS*2"#3ALR9!A_%W1<WFXV_PFA3-&&S-OBWO;_;XM"55W/4=[U+
M.EVD%%03MN=03&+;2B(0^C-+`"\X?HPFQ1O5_1QQ%PW$G1\RXH3R/D_,G0(7
M'=;`=DJ*C`;*BNNN'=$.B[;3*=$V7O'PL^>'5U&2W(0?_607)3Z-Z&:3/;P6
MU`]:??*?3=$6A&5:\8#.TZH\J@DGM["@EQ&IX.^]@&VZG'WN!M'T;G^':R:H
MR<DF[=+EF\*##8&7NH0>6%I&'2TK&.[>T2;?4?C56E$4WL;1#L?I*[HE?M*J
MW#A!Y]]6P7[-ID+]@&6)G[VD:L\>8OI,)8O/#A?+HD)E3#1/D4"H5MUL;M)G
M'&NF#V&/3O+@M`3FKS`6:.[R')DPM]M?P5K6U-$,(D:`A',JV'3XUND@8QO'
MNMW,T7%HEC<T9S\L`I"-1QG(_.R!68RS+6_)KYSD!4SJ?4./V4.:`P6A6O;M
MPG`ZR2]2.JL*RJ)`4_WEG06)0-3)"C/E$5H:5RA<F_-58*HUTHCSY.$%[HXZ
MM'"C9*X6[@04YO=5LUGD<XS\PO=M;X@R$H#[#UK>$JQU<].XP!XQ8Y'*(_:"
M9;A>KK=^Z--'>*G_@O/5(Z)4I=>KR%&JUC"TUHL)LG!4>M3@LL+&(F_`)@J:
M31RAJ284NOPTPE!!2WDG#A]57JQD&+E3\-1B'X<LF0B16*P!/&Q$"E/%R)AT
M)CE(EU(8]=5+%*`++(SB&R]I&#R9U+/4H*TWOP2B>E#9!V=ZQ!4]O-3T.$%B
MZ;-H8W!Z@4:L7JIQ[!'[&"#NF7^LPGC$7!1%ZZ]^0.-MOTG>_CM[G4R4E_K:
M*7*4>7\8ZO>-&S)W]8A!0Q6,K2XZ&SXXH@*]L=55A($P+;3!U`Q')\PCL9+Z
M3,,`3X-N@)^EQ[P3RX^<S4\X'[G^;O24U!$F5@?),W["5>1107H$9KW%9&9$
MTXI[;M%&S08YQ,7(M:OFMD3:Z*;6)75NMU6E7?UOK!.E_4<_6051LH^Q:FNE
M?D;413VWL^V*1A+Q..4\/X!!Y0S/Y.+R^F%Y_?/EAZMSM+R_/W^X1\OKC^CG
MFYN/?[F\NG*+C(;(,JE+U`A5ER0<&T;U"#>&D2MY3@PCEO'C@%Y=P*.J%_HR
MITK=(AUZU.@3$,*QG*G8/*&7#9.,";RE0J]X1U0-HY?8S2P>3J)4O\\^!)8F
MJB!^Q]TP@AEH0G&I[]0XO[]:"]K];.L`/\YQ:N:.[T$BT++FZ`!5'RHF-)>B
M34WQ9G<C>K<]CUS_-MV/6/K:Q*[.C'5Q?=83U>#([U'TCH;]\=+:Y7;G^3%=
M-GL3%VOP;S974?C$]A4O9M/SURSYT^IZVW-;])3?0"L>0%3)XG<'3+]VHE2+
MG0V_B\HH78U/C>7G&;CT3-LF)SK*:)^`N8):<-356BO?QD9%8B%0Z-KE@(A/
MZZ$Z]9MOEG5D@#[.+[80F.&#_;GKAZ@&.U0%&;&N"V_C:(63Y`XGF"#JF=2D
M'_$+#B+VCI1T=;E1WZ+VTNL#HZ@F\4'61YI^-81/R]+B\O;N?WG;W;]_=$1M
MC'#1U8\>L"KT0*<KA^%Z'JUD?1W7X'E\7("R7!NBO"4JFK)IB%ICQU:3CX%B
M85Z;$,=CYAZZ'<=]ZJ68AJ=X4*9H7>8702L@MDIC@&*GR(D.'_E]%V<WU_<W
M5Y<?EP_G']']`_G/I_/KAWMT<X%N;L_OE@^7I`%[G'5V\^GV[OS/Y]?WE[^<
MHZN;^WM7^"B__QP&Z@"F9!RW,8]C`JN.LNJ*>J(;0W_S13M>:?3@LZO9T@;#
M>+%885G+D3'3&OT7^<D<Y5547$9?:`-G,ISZOJM8)0$+GUGU#DIV-:V[Q;`'
M[YOV(@^-'@V&"5H",DP:"R3#1(YT&<;OO[B\)GGJ'#TL__O<J?PDO\<"-ND`
MH\$F;@<1FP36G6/3<I\^1[&?OGZ,MIX?JJ@D:-[F4:<9+(D$40`SJ.O%@#[M
MSD5VHN=&E=?0E^RJ4ZE)<I?%3)+CHDVC5FL)ASIVW260LM83-1:2![S"$T5@
MBSB&=5VGJX`TSE5SPCNK01A5#==NJT,6YRLWY7($C2[BV@U\@8!&-*`SV5)W
MO6JXQHLG,RCB=)YXZ6-$7,;)GD!)[=N9EA9[A)^-M@BR;.ZYE&ZG7^J`!Y]X
M?GDL^$T^[Z4QF%#TD<]]61A6*.*Q.O]E/,`069#-@3DXU%!A0'<>3#WH$'31
MG@MS=OBA/NM6=Y;,W%*[`C.Q`)LPS6.W4:\916&080WL%@)0VUH?O=O%T8N?
MD';?_9M+[.^'.7$J[@W@=G[6-R1)VR;16"TF]0.Q5F-.3XQ61:I[<KMSI^5.
MS1QE;>L8=R;/R&995R^SVE4(HPP9I5[0.T,.(;LJTSE-5V-*&I%.FUBC)IZ1
MDLL03*F2Q&%ARE#*P5`U@23?8?J[^H'/DL?9,T$'O@P_X@V.8[RF,^=LU?@O
M7K#/5CX$0?35"SM`AS?<%OH!!F')._B;V1A@#0G*0!7ZNUEDC9$?HO(J*B\[
MIA_#P2N6&BABM#6IMUV)?`V(U6K^[!V7M53K.O]H`C_?;/"*[9=>2^5W7HI1
MTRP9\95<+4QG#YJSG:@X_#U!RVVT=^64*+=YK*PN9L7DR8>1O#&PX&O#S?=J
M.C"?!E8:'GL&3/.;3C-IK`X.=,I,Y6[1_)P,OM.O&(<H?<;(8_I(7^:-\2Z*
MZ7FO?C5,IZ\>U5J1SW=[VF2?T%FWS]_??\\>7.T)M5X1B<:U@@F.,4.FXLQ8
M:3X_I[`_:-I.&?O$,^&*^":<('=+!,P*K:QJFO-<N@.\!IAY=YC9DT\*";[J
M,KW`:WI84)F8JOX$ZF;S0\-\R*>*^MJV.60=]GWM3R#UCJ_W6+:GQP4]5Q=Y
M::T\HI^[LD^2%;3KCDE!2"4?G/9SH3U.[?L-1IQ\ZA?B2/-0<Z&Q2=%$R9X;
MJY&^U6<6\U%.RX#A+-4LA6""TDISSTE%\W;!8VGW1T44-LJ07MNQB3K7'ED[
M5Q'H;U^FAX4V/=7;B`GM6LV>MK<$M`&DYNJ'&6RO!P8R91:P!K/)A[ULH?LR
M7--U[D'9!BM?9#6S(A^ZBGO;+&E5,=L??DHBZ%V9"FTNV!4GDX0AEG0K0DU0
MRBL^D1'MFDX<Q8C#-U$0(PW0Q@2ZV<QT1@KZ7(K9J;7'R2Q&5];98CA"FHPO
MDV?2F_09Q\OUW_=)2E\<,\R@HM[RS-GM95-%1#':SY0<S[V%HV-KP3YQFN5"
M=.BR6P$O.:?;G;6YW/4Z8LYK.Q\IU]F$JEEN8[U1K?LL$AHXU`T3V&A@GSQA
MD0_.8KSVTW+C6K.4)>XO3UJ\?C:%0!RG%,Q_RH0@Q$^$7.O>J8OKO;<B<*PM
MA#L[YRV=IKL$1+J$5^)03OAN=VW*\SR/F.&Z[D?*<;8Q;9;GZ(7,P$FYR_DL
M4IT5[!NFNU'1/VK*B[&7X(\X^^]EN%RM*""26^_5H\>$A&OR2;PGRNY[C^0K
MI;YLTG.`L2H9]C(")2`#O@'L^*Y?(%KJTL?THFB%\F8LC>8-BU=`W<FA0X#(
M$Y7AP*[TI8<MKMCTBLE2WNT1BX4D[!9G\@>%K`=Z5_3]CKY()253S<213SR\
MS(E1+N1R$C@;=9.Z!/LO]*N8IW")#67FYO:UK#R2>*&'LT81#!$;GL4J+U,)
MR>:R:M==%Q`9K`QT0XU.I5AP3)AH!#>"<9,M)X3Q<NPH:-?)J$<:"!#@+A&F
MS)'%2\]W^`6'>\F+*GK]A+FPT]Z2&`CBLCHV[?KLP_NVE46YVT#^B:LD%D%!
M@[AR%`FIVNJF0\^.IW%R4\NM_7QD!8N2O//V0*J?4>S#=,K,P;)<_F(G/6W9
M?'I4:4&8320]+1%9&:O5#"/SWH??8GO9*I<YS,&HT:/!;5T("CDN-*##=HGW
M<=*3,`#[B6HT2$N25X;ULM,1]?JY;1K<3YKOBGC/O)V?>H%Z_R1#`^)L)^QH
M2Q84D=K-=6+GO71!9"[?@S%A0E!*0+ZK&UOJ7>'2G?WP33&EHP9ZN!1+@:"_
MEA((?8^4``7^1\A_X\!<EOU*T.=]7-QY9T2\&R2_"1#OSE`OD\B>H[QF9\T!
M7M%IE"JX&:'EAV4"U\,+X-Q4/IS+_G*6U#*$&)>S7(1IUK%Y]C<N80N?4XS:
M,M]C#]C`H6HP3'M[:.X[+K.+YRE3TFV,=YZ_+N9+\P5XQ<,WPQ1E8DR8LO2,
M6)($DV]@.:5IAM)'-[1,+_)6M2?A9WO2/$P=%PXC%&H(20]4"V5%QY:.S.C%
M-$X:U8G%?EJ=F"Z2M%OPJ#C?IN+3D4=BG,R)25,F\/LT6OWZ'`5K'"?GO^W]
M]/4N"H*+*/[JQ6OMS*UE19BR%;TMZ8Y6S%:G6%41]!$;N4V1QM1[_1YE_5S5
M%3VL:0B*"6B%.B(UHB,@BBC&R<'2(.PGW]&)($FW/"J@+[0ORCL[.RL[#C/T
M<^RTW!@SJZ[QQ@_]%%_Y+WA]&:8$K#Y]58.E_P^OG[R_1_%9X"7)\ILO'@_W
MLE)F5</>0$K2*V8H'3%UKJ,C9C8758?W`>V!JB[%0\POM*4SHM$/9!S1&(+6
M4C*,C/`DPS"*F4C&^;=5L%_[X=//4;3^Z@=!/\T0FM$3#4[W,51#&#5H,6X<
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M-^D*I$/FT8*F;R/W.I)C8'#Q$*7LG(F6LKBB'#V`Q%&+WG`L]4'?`D\33/S;
M2;7Z$<"GUPGQG:71SDB8=)E+ZAR;`.(4Z0H%IDN%/\=18O#DRJ2S(/V).EE1
M!7F$6BF/)A/SE"=T;"X&`E.+LRA)4;1!+$)W'T(904;)<RW("?C-[ZMFMLCG
M&&F-[]MV0K..7D$28XV=?F@T!IIU\]6X>'9KN#9@F-9C>#9BS3K1<`RL3!45
MIVX26(J/7D5G_U*S7XDYW>C*+`F]X/@Q<@ZM-`_1D=.L:BAXT`X9(<T.MJ<C
ME/]V07MJ-`/P9D!\^H9`_-/X,UIP^/WIB%_I/74%OZ.6_)B0(\U?Q117][Q6
M52'?O`K%1IY/X(T`VCZTB-;HLR@^*-XY=H8VW%O&8XCDWE94J#?BHKYIQ9)`
MUYU8F(P9BH9\>N6`\""I4$$1,;[D%:^=7[(C`!7*QV_<$L!V(U#0\R.`G:W@
M.])G0:LKH<(+SHX,KFW$D%UT:VY"=H^%#)%BHD639ELQ6]HV;<IHTY<M-06#
M4T-;VW`Z)"2I)-<.EB:K.3_B1\GB'U%+?NV9M;!1;-1]6Q#=IA?CNH/UJ]B!
M\Z0<A6A-KKA%#M[-5%4AG#O/KT-H0V4MDED;H4*ECBQ7J4,0PZM63]#'@T&,
M9NT*AIG))/0J"I\><+S5EU)>#[ZD-EO:8`DO%GL2V_)F3)Q&?Z[DDIR+R*=;
M%$1>Z"23N'=?Q2@)9/B\JG=0\JMI?01MKCNTK-&0D.-K-FWQGF'.6?4>C#E-
M-;>&NO'5_=;SQ;O*=9NT]#N[!$J=NC<+"IV;U^<'Z[`X\Y)G1/^)-E%<PL$M
M$C3NDQ#UG+O9`CG[FD)49_UMBB?U8$LM>]W^AA[2#^9ZWU7R-OS.CRQ@)(3\
M1,!['+_X*WQY=_\);Q]Q+-,T=:^ZS,E:P^%>'1.T&$H]:A)$8F-Q@=<X]@*'
MN*)QW_GTT09,G4_B3@**R;Q8TUNQ4RL2;!=TI5"3)L7!JRAOA-Z19M^A+UE+
M=]Z7L0)+J="/",PQTT'Q&(B>-$[+-6$&$#4L1;_;`(AO(L^@TLYQHD.L3C=6
M\YZ@%:U\\6][_\4+Z&7V6&3KQ;_BE![BCA*\VL=.'0TIO+\<%BFP4-*FW8['
ME*XM.ZK=]@,OU$`0RN2X_)0AAWY^"$`1*ZP-J$RBHW3"@L27[?-[7])<^3*]
MJ8&N[BH[0C-),U)P?JG]&O%.96[Q:7GWG^</RP]7Y^C^_.SSW>7#Y?F]<W34
MQ8V,IF;8ZY)7T5]*:J5O!\E^&>91?RI3>R=^HE4X3CT_?(B]=7D:UD<_6051
MLH_Q`_Z6?B#A_JJ6!BONND("[`9:=JS\"G:*2>A0C70-UOE,5-`.162::9.4
M784%]2;58^#O9;FJ!XW6XMC@<!2A/4[Q0_:(DXU7*OO%T2.5!_2.C6@R)RCW
MDK_R\AVJ'*$OU!5BOIR9>#H4G=$8B!VHTHQ7)])'V&G^"/N!.),<FB)KFM\@
M?A,0&95YAQ%`@0>U>'$[+IJ+*DX0O>+4^232^]DAN<;=S^G):]FE%M^>J[20
M[ETN;RR@!N@.Y/(([-##8!]Q05<!19S:"EQQ;Y4TD6WHS6^KIHIKVW)?T1/$
MZ-%AE]M='+U@EB^ES^HU>A2TD;6$X8XZ%L!QM]R;!I4D_1?E152_Z@B1-&YY
METW:."DH)>[`X97,NHVAH,0A]&C.(L[HF(J/-,<>P4-#3C0>&0MT(RJZ[SWZ
M`1O4Y`?)BX1<V+#0;TX#&"X)/0/N#\-UHD&>;K=\=^/\3U1KX0A7Q#>R2Q'5
M32]XT6G'H0/'EA7I[?@!5UPHK#!]K3X]*4!S"$`12J@5J$PBF,MPW3U+5RV?
MTFY=,14TA^:*-"H[0BMR:40EOI%<A&OMV$2PNR>R:^-#1CT=9'5IR.TE):7`
MCV4UYWJUJ.WVX-G2?0;-MP%&C:PP$ARG++$5JZ_4'80E-_#J*G4DD!,F,F=]
MRJMJR12G&'?D(#"->ZU1;,E71(G;ZY1>=D\)$?NS7[4#P4M4Q3MWL`<LUO0+
M?!MHFT2^U7HM%FAXOM@MSDU)P2FYG4.]%LR5J);"V+I*6I1%TUO>$KYYWFX-
M&1MTP]V9F="O.K6Z:\Y4V*M(M:*T4Y^J7`\?(E:UZ]7E\L/E%5O>BI;7']']
MP\W9?_[YYNKC^=W][]'Y?WV^?/BK<]330Y#Q\%&[SI7V-A],CE8#2[V//==A
M!=#BN0^7ZV7+>.X[+6(?T6.FKQ7=:8<>FB8NM+M-RC14OP1$RZXWT'32,*_#
ML%J'Q?W^,<@^0!M,>+3+M_WXN/\5H\^A_T*BH*2B_'IXCK9>@OX#;S;DTRBL
M77>%:9P;RV&3\/:7?*E:\#A1[V]'R2L/\&H]`"^9ZF9P81_,];Z+E1+JSH^Y
M]-0+DUOOE:XPER^B$S8LEYQV&P`M-Q5YAE1"GA.=M::=;@OZ&<H_<P3BXGO'
M65*JN,\%V#OM>$M)N[:L2%['#[CP0<&#B2#]M$"(:ZO8!D%%J(Q6P#*-2FKH
MHT09+2#>LAH:`]UU!=0#M!K(<@C;5SHSC=.=?1]RYZFXL1GXN=YT'?V:_+8;
M'4UHEMK,[_AI*YW-]LX+S@6$N_/CODY6;!2LVDI#VK;V,AFG#=B[9$+_H!F-
M[T?O=;)NS\7#^=TG='6SO'8%\;+[R'UQ3'7;2P9PFO)?&^-8M*.&'%?P%3\H
M8+*ZO_X"HH,O\T.`2)Q"[<%H&FG]Y*7YJ_AW>.>]LE=K;C:WL1^N_)T77(9_
MQ5[\\#724%Y34QQAUC<!SD'3Z"W)ND$89B36-KP@J/DG]ZALC"XITWMBE2,#
MNI;D*J$?C^U<I!N)S50U.0FZB>X$57U/4-4;11M4]J=[Y5`+B)@X,JB-D[EP
MR.%$?$&X#)6)Z[;ZIN+,QC0:5(]_RF2<QV%!B)AEFH[_9:9BTH#8<#7A(+:O
MF%!3`&J21>1$2J:A3)Z3[7)A:%:F-HY,ZH)E/EQR.37[+^*G:@-L]4[-S,9$
M6E2+?]+4G,5A0XZH99J:_W6N@E*'&("@=!';6TZ(*0@Y81&YD9I)*-.G9JM<
M&)R:B8TCD[I@F0^7G$S-RPW!(UQVYIHS3]`M,V.+$O=;3).FVZ&`JE/3^.+A
M&<?8HY_-3FCXN!NB-3(DFXM-P]H@O6G%-7'Z;D0S808?CR9]\SCCU8Q3N66&
M`23TB3CF9%K/I_*)=[`A=\-8[R?3F9&)GLG5O\&D3Z?S0&P\FF.FZ;C[GV<G
M,3R<`3QAX^"V]Q,V:@OB&5L6DQ-C;Q;+Y(-OVY08_+R:&CDRBH>8.7%JFF3]
MX37_!LJ-,;0Z<9(OKS&XG(@CLI1,N0[-%()C8E$KRK?1GE)^$\4H?<8HH&^T
M?'WV5\_L3X(S^EZS3S3A,?"?O!2S]YYC"D+WM$`"&"GGE4#C,+O;1\Y@G@_;
MV:_KTRS+O>#X,7("LC1YW60()#]64F(0[81(9FF.P?D=:1+LV5%CMYEVH@N,
MOSMD_.KDIIDB&/RM(-O0/>W671=^LB*09755T=Z]'5GL(%/X_M&8R'1TRN(:
M?TL?ON+@!7^*PO19=F3<8)M])C"ZML8?L8F^SU33&9QX@(=P'0]T<N./[HE$
M?R@.&Y$I$-YG6-8V.7!TUHUP\HF/=DB3SG^,SZ$!LR'4%,ILH<S8D8IJ5,V7
MC./5"I^\OT<Q/8J0!$R_RC)<=P[#%1\D:]@[OR':O4`DRC!&&"G2=ZH6'5U;
M"]:0';W)%(2VK6^_6#L3VZ7#:TTQU%&+?B#,54&S<Y?_VEYGQ'3IV;C&_?79
M#GJ"KG&<HS'>X)Q=?6LFK'?J/%YS//5AONS47NWNO=COVMF^+.2S?9)&6S(D
M525U;L,ZHUL-X*C+]0S(T;9]33(VNRV*/]U+I?P[Q^>.["[72=)H)V!#RY8[
ML(]_Q2G=1*BBYFT4^"O127[J#B4-Q`V!Z*"*!'`"2NI,AR/"[HOJ6BT;N<(8
MY<WF,$<3("6#1.UY3!+;MC%_(_8'/3EC#5]T6H6+L!.4_\I?\O\ZMR<0+/I$
M$Q_CX&]:1?^9E%I742(N:=1=)*I>-;5&NG8T4I#]*2-=B-GJB'[:7G/8CWVE
M@<4=]@+_'WB-WM'/OD/T4Q2%Z-X+\@,@J@DR.D2963[H`$6+DP)X23A9]-!C
M965_K+Q0>!PC,X"A4Y(=:!/TCC9R9%T&//A,4H(=^(V9%K[YV_U6NM$^MTTI
M_(UK0#3B^`,MVIOV=;A2[['(_W0%_[R[PP&\^":6^*XUX0&Z8<&.@-9<P"OF
MH-N>:2+[P+$=\OL@0*QQ<!@84<7\4*UBO#:%BC6OP6"9YP]2Q5KV->#<Z+'(
M_W0$P]R[T\6PY"86"*XWX2"X:<&*BM5=@*O8L-O.5"S[P#45ZX$`H8H!8F`\
M%;OVMOAFTY@6ECY;5+;/?Q1).Q"\*^.`0;[,C9H%XMZUIQ)./>I3W]X..701
MD=-$V+Q+&8EE9^B#TS,O>;Z-HQ=_C=<?7C\G>'T97OBA%Z[\\&FY2OT7-@P[
MB\+4#_?DLYL=CK,W%12O.\$:+X@)9!2&Q:#?$+#0`0M,0R1@7"VH$7011%\3
M=$$XC4H#J++P;XZH#"RPNY)D@SB%?H'8YH@=4,PVBDN8V*"KTMEQE-;!Q!)B
M3"ULH<=7](Z:0W1"GD?:$U091955YUX)F@>K1>7[O'D]><63AVRGXNEI7%[Q
M&!NU*:4]OZ']BL<\L-YJ:NJJ4_&4!F93\?0%MJXV#B..7!D-;6LKHW',(U8\
MAK&-5/&XRU&-BH='VIE7/(ZQVK#BF0FO)Z]X>,&;E34R"_+:A=_3IO+)8M6J
M0O0.WC7SWEO&N/:84EV&JQA["4;O/N+L7]_1USJ9@-'U4>P?]`6"%R^@+P\Z
M+412@.FJC09*Y8+",Z"M&GSO(Z9\7@`CY?4Q4*^1H;FY^&WBWC"5CH[\49,B
MD<IHB^G2LN6+YP=TU=E#=!9MMU%XGT:K7Y^C8$W&GA^\Q%^)$V,?*U5R-.L-
MI1-]8H9-DH81:$F&D4TF&K2M,T+0"T@\,1B`R$H.3(QP)<$L"DL)T20(LZ2H
M/RLU-=2+#'D$NR3[O4&X&VTUI[U9H@N`/\T`_RZ@"^Y)"4B[OG'D"_:E>YO(
M_\D$^;LH\5/_92;0_XEN?XO?I]XW%!SU_J<CZJL?XX_@8_[)T?['<LZ+],E?
ML$)E/WK?LIZHWO4$L<YOG!I_G`<U)I\EUYSUM[(>`'0=@!,/%L>;<=</R/:S
MQ-K\9#XER7UFZ(P>00`6^$F@C>=_T,_]7'R.;VM*PVW"%1,>*TJY?4ZY:!XS
M_Q,3S<ZC]C=!->"=^]UGV2GDTI@C*76@-6=23E[):ZY8MO(N$^@[3$Z\%#%>
M):\?D.WW(`2"QWOGP6D],P4M\)L,-MY?@'YOP<7WD-QZ_V@$OL&^;W2D)%C=
M[R@I)R\Q+L,7G$!/%AH:E9<8VL9LZIWA-[)?8N@'U%OR=%UT)PO+GG,I+TP!
MJZME_8@@5S)-F]I*IAWCB.6%9DPCE1?N<$VCO.!Q;X[EQ<24-"PO'"7E7,J+
M?N\H]S0.4FZ,\XYRSV]H_]&)>6"VI5'\CC)/$=U^1[DOL($UL-<[RH:VH15Q
MDG>4#6-SJVR9@*.P9<Q<WE%VC-5V*IRI>3UFQ?-UN5K1,^Y)H.1;A>2?*\R.
MM\P.A<C^GYZKP8[5$-8V_<R458QI=R`A[!<U:&5B'(*.OAD:7=SA%;F*JEZH
MV<T52>J),H[X#,)K*3)F5GAR8AJ'G8+`+`KXU.\`";)T_E7,`?</&YJ.'^(T
M[!I#1DRM>[IC\\WF/O52G%R&?WGV5\_GY'NDKUE%@(4/)/1[%@E4IP>,5NC'
M!IDFM;QJB(*&G476B!YCE+!F]&'`5]H0I<\88=8:[6)_Z\5^\)JO<*3G'L7H
MV4N*O]=LVP_Z0?8B'*+O!H7XV]Z59&H`LJX^&".T$`1U1XX&Z'BSDAC5CL%S
MX7A(9QFOQ/I]"^M96U0T?AN@%>:QB6`[?K8J5QW>XR>6914Y2MB^E9DX[4`I
M*HS#0A;B^=)G9+=WC851N70WR:^Z13SQ[1;23860%L4ZS<7$XEBVF04Z[FQI
M/S"^FCI?+0Z_/UB$J63<)L;&D^PRM"NZW5QRL4_W,<Z/B[GU7EFT'_?XX1G'
MV-NDPL.F>MO)?]P>_4%XV3MNP)30)P8UE<VM+JI_NT'G_J#JT'PH/G/R&YOI
MBD*/2&PD).,PH!.5(ZBGB:U*9UFO$Y3U*X[50D7/$T3ZHB-->*APGRC.957%
M8I^>5LPR*O#RG9XQCY]-C1[VF]I<W#P&_E/^4'X3Q>B1[NH;T\=C;!_?Y2>T
MBA)2,N[#-8'^QEOY`9THH1>CE``:A5'X?N41Z@=L-Y1J2!>P"&8E/.KG^,.0
M;B8YXN?RQE%,F)=MK:!Q@#U&&9DF9'+13U9>@/Z*O1A]\E)Z^/BK<XMAIF++
MP!0]&E^<2\^7X07A*P65:`*SOR&S)-TP,*;,<"(?/U4W@P#3F[K9!4'*O\Q*
M)GB8ZJL48GR:247-3F^U:,0R88*MQ3%1CK4/^QYC7S]$M#M+M?.J0BT19F!V
M'9DR+N98_P7#Y-BV(>,<6QD866G:D4^28VM!0(I-:9;FV'^=FV1T,#5`,@3X
M-!:,PLX0P:ABF3;'%G&8Y5CM'<V=03]-M<LPW)-1*IT&(O^):E-$]`#Z9XPV
M_B9]1J^D_9$F$)GU((D"O%>=.PPY[56,DN[S+$:M4$:PVYR;E'&P&'T@7F&J
MT:XETW*T;F%<L>G&/D5!VH@"4'%J=FE)^L\S$PX.L/HKAQ"EIL)1&1J@'/5H
M)LVV52"3S?W81W^_V1_6?Y89UQ)Q!I>I(U-GLJQ[1X(]_[;#88*OL>::!WX?
M?B9MM[4A&?QX[&7'CC]C)6A96#S0S=::2Q%P=ME).@L`H"*N%#=\@C:[**G8
M]C!"OFJZM)R9H)''SS:T#<H;G=`-%PX7A)IYPBH,G1MQG>UC*D7#!ELM(V;C
MK++SF!5F*^+Q1U=5`&"E96&2CJG^Z"2-=?'3MRKDX]"L',QM]*X$RQ@F'#_E
M,4P[I6\/X9I3^7&2SF\J'Y@*`\=&AT2&::;M+;+`9+H^6Z5Y3?<Z>?B*@Q?2
M(@K3YWG-($!S8]A<_4C<F*!BK(Z@5)6%W9;MVJ_>`I;U7=^`6YWSO1A0N-:O
MSE)G3A66W4(QKX3WNTV=JJ&$'W5K5A-$Y<C:F'TX3IKC\\:IO(<!&64M`@P:
MY\;:E^'#UPCFV6;+CO&3S;+_R(]U6G%/\E2SB@'RJ4YAE8Z^_\DQPAK#:<!C
M&3XRC1_)Y&:&/)`I(YGV268>QG3/,:WBO><SS*_1/)]@PA-E^-/+\:@R549=
M+Y,$I\F5'^++%&_UTJ>H$S=7=AM;4`E11-:R(,>AJ01T3"S8QR[R5GC#%215
M`(7+QW8?%?FZ/NPGI;9/NQG(`M8XN66-LC;H"VV%6#,GWRZ&`J->>K`-1^>&
M4L,&4/V&3>-6CC8GM92>P0K%8KG+-J\$`]H:[?(&+A)7#9J^-=^@.J]W=3?I
M\&>B00\D@HTWPWA;H!XX?+$&ZRDR5I0D9UX<OVZB^*L7K]7#%%&'3E[J-@1F
ML2@2*T,3CC,3NG:ZLP.<HI*C`9U`7M5;N$9)X7V7L%"!E0[MVNUE3.O:MILS
MVO[LI0E@J+62`07:V:$#3:WP-J$VHH['3U[H_X.M(CJ+PB0*_#7[8QFN;PG`
MZ4HC^N?-)C]PW0O8GO`L(ZDV$H2T760'&)LPU(;\?D`:`!22AER`>%I<+Q\^
MWYVCFPOTX?/]Y?7Y_3U:7G]$-[^<W_UR>?X71Z0%%,A=%;+`DT*N($QSE`TF
M8F=$D.Y]>19M=S%^QF'BO^#J>3NILFXV#]XWD<89="TD3*L+C$(91`<YY:+G
M5D-D=`RQ0GB5K2M[3U*N'Q6[F:[J/?.SC!Q1%!/8=`7#''2%'FCTY-!=RY^5
MZEG#,W@=/29Z66W-P-IHV%P)Q5Y1H@=@D`YO!;_"`GPR!+N1CSY@,HC`=W@5
M>$GB;_P52[1#TI2F18WLI;1D71,TOPOD!,^@:(:)B,I^KBR\-(C>T0FC[]`C
M,X'BM@WW9487MD;J8\8%#4E2&#13*F5T8Z=@14!C9N:)N::9QW.Z=<S,*\-/
M0;T^]8!+Y!NY>LB6.ER3^RQ_U5G6MI[QNVW@Q$7D'SI+<_QH:D*G9\[U['.'
M""N\E7PJ*NY\G6+MI@+R="U:RTEM5U:R#1QFJ@R172&27UX['`1)9=H2AD:6
MUBO?>Z3GYO@X^>@G*U)'[V/EF4K:'>NBJ^@`1R6MR`!9I?*G23&YF<7-PY_/
M[]#5S?7/[Q_.[SZAJ\OEA\NKRX?+\WN'"*>'"C[[3!!5)Z*TGX"5"E].4?1^
M'Z[CUUK$,EH*&]>IR&D$1S]A!-`5$,^1)M>Z7;-LYA"3Q#>2SQ[5C:\SIM-6
MP!*.36L%4,>7E0H($C-5#91=0K5KAP0D:15D#4K33U!_#F/L!?X_\/K/4;#V
MPZ>?/3^D@^>;\!ZOZ/EHY&LL8S\AESZ2/\.G6_:\KN?L-90[Q=3V<#=6)^*@
M?H41)L4!0NT_BS?8^:*RD$_H(6H"12'ZY,6_XI2=F5G9<DC1;))'>Y8/F*Z*
M"<"AWO1G!X=_KS'G[8=&:VM_M4.4#%KOU$2#]DXRZ<!$/(ZZ,39BC\HQJ7)`
M;T9WD))QJO4@L:8JN9^L%LGK$B(ME3>4NT.9/Y0YG,\CQQDJCFB3O8-7G)''
MH-=16+X"E7U!V1!2W+H^`N2U@M-5<0S0XR^N)TUAX_3-52E?/A3CP$N)^!#@
M7=[=H__:$U!M7JFZ/)!6W@[O4W^%Z$1Q1$K`5_1S[+GSZK,""WR94(*GSO%N
M8P%%>5:MY?2N,RLSAK#`J^8,Z]?R?'A8@)(6JA8A-=T#5+T%*M(.@@>F=I:J
M2".!%G"1,_.GH]V5*U=1^/3^`<=;1Z?@Y;=<^314:TD+M[WZZ><HBUNX_FQ.
MO=@`&Y7N"FBW44Q_IT,$F52XYP<SHW&ZR3MA5D!V^E9`)AM4S@]D/]E=5P2'
MKY_*G%E==G3Q'AS6?IH2:]/5HXJ#H>2M!94H\%%/\A@LUJ!&AWH(^BZ*\R-R
MG:;SCS,J1=5G<6@A1$`F\=D:(JMC2+;9L4I_RB`6XB<Z/30)R%C5B>DF-4VL
M'1:D=$M.MT%EXXD0,)I.N>G_S.7<WQM3FA4F-*9<6,#_@+^E'XCG7S5SOZ2G
M<@E_K8?E-?R=V"S6!WRO0Y;R5W;FO):_BP^#Q?PB<`F8R>EHLIR_YFV,+,!Q
M;.6!Q#@@K1Y4U-?V5@W1%]H4L;:N[-YM&;2Z1<I8L)TNT6AF%44*L<3#$:;[
M>I$LWT?;3:[H$T./`VK`CR/*MA6X%Q*XVCIW7.BJXW!DC+\J9^4ES]G#YP?O
M6WY2O&)ICJQ+:WT.ORGH0@E9-!96Z@C<Z:^:X!I8D`OOS\@5NL@/?<`AWO@N
MC5E5=UVX<$(#*W4R"7J(%U#P[=M<F,/S:&MUCA6P-=;IT`;%DE4*O;S-H4)/
MM7#'/OC&WEYFM8KW>&WVY$39J;'AC+@QX!8BJHC`MZ"1.-3=5T1HHMA>)&M0
M<,ZE,DF-`,$N(YK(J=-.V$>TZXC8A[TM;$0^[>QE8Q%\M=UM<O@Y/ET.#D7Y
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M3CY&6\\/!86VLGU^4R7M0+*`,@X8O9:Y46NKN/>BN,3DK+B(OF27'1G"J^]U
M1TETX9%S7MB\RT^)96>XY+U2DM,0V9,++U"=#:S1H^"3K"4,H]2Q`'%*ZDB#
M59+^B^79V=WG\X_H_+]OSZ_O75D6KW.?NUS2!D?!)G$'#I]DUAUB%!O%/D3+
MU6][/\;53I'5/EUB;NGWK5BFTP>*;_KQ@;YMJ.M9BXH:EA:WY,=X]A*2X$AQ
M[O!FGV:0X1'6&'$5==5=N236\6AC&*[E&GKX/#)RZ7"U:$A__+SI6X>P:`0W
M)8@GS$FD,MWA.'V])9!+23H])Y_NMN)G%>8&1-E)TM$.QY61VLU3,O<]*"\V
MMV`M$K_8G*%HR49K93-'&:^&DYKVNI`4,5_87X/^$M^C)#*A?^O9;"Q\B_):
MT>$$L2XG1[AKI[I)`#]BTJ-3HFS*D\V3WD9DI(A3$CL-,W^CQF`;@:'FBH38
MVPR,<@S\%H#/PP>$HB$L?8TO[LX?+N_./YU?/Z#[Y2^7US_?H]NKY;4C2C(4
MA%U=@8%UH3$]K7$4IW=<5A)NSVC`TZ^+G&&I.>O+LF_VM+39'17]W=Y6P1U^
M";.X\PP;,<,30%][6RQ_^L=M5&3CUD48L>!Z!!*`MFT-6C>[+.C?B'[@VJ,[
M_HWJ,DIV0PN6--IPL-^RX1JBE]]\X3,"3I,6FK-+H%BN>X-%<FY9'\>L0QW%
M]`/',-RX.4($<VYA"[^TA1B]67]GL$MLX3C&Z_N49(E;+[Z)[U,Z:_:+%^SQ
M+8[OG[U8M)6$6>=RP89>)Z#5&R810HZ3=!WK+.[0,K4XB\(7,KKWZ=."L@]B
MG4[H8C3$VJ-W1%K741!X<8)VI.1+:._O'&&B&:`XJT)Z`+)<(J+3E[=>1,^G
ME1&.EF_P\<S8V&9C%1ZBHQAES7-LW]*CKFF/MP1GX:!C4D!/E<)8D%KYJM&2
MFYSR%A:HVO`->KH(WX\I$[-^\I3R_WS_AQ^KO/+OZ*>3/_SA#_1_&043M-RG
MSU%,#[_[=W0=%9]>)@G=KX#-.>S3)"7_H`=,>2GZB%=X^T@H_-./)XC>;-:(
M_./413HWX:/@+@]K7)IF.J;@9&[-?D9ACNRFCT$(Y28&=N4DQ]EA($=/XN&P
M,Y5X9Q*1W3DM#>=UX$IYLZ$%JO`BL3:>:#DSY4ZCNUSD&Z+M(IFX"%!P2H(:
M+K'J[57\:MJV+]%U?W:5&A!T7-T^>*CIJ;@ML$VKZ54M:*#KW4X2;:\WML:S
M;D26-;[AL!_E:B:TM+YJ[RX).<C0(J(041(J5GWTZ%CW,9;^5SXM'5II'9O-
ME)!DB$PR1'IO`I$FZ6%FF`0^=\@^&$_%]<G;D$?1V43C@G':FJ4V/650M'!Z
M2:J61FMK5.3$9+EN:7KLQ\>Z#:W*I=;!76[R\*%%3C&P)-RL3[%JD;/A9:Q4
M47,ZQA@6&)RRT>R;@:1)]6(3E*.FC)WGK_-]OXL5><LDP:EB>W:#GE7J4/>`
MHJ=N;+`I1,.K%E.5=A9YH]JRUV)WZ*RA,T35!@F/K(8(J^BJZLBEK-J;I5RB
M<FPAGXR%U#RO,*P6IUA4F,V:.K;7NVW02K+,)+`==?^D%<;KY(+\WG3"UR/W
MXF;S$3^*DXRJ0[6#DK`AU!9*BDA`,XG$F=9.2J+NB^4VVA,</49Q''UU9_BO
MO,V\S9/TH%&R2]2>NWV2T+:=%"#R!Z_\EI"5Z7QV%=&[BXKK])5PVN(0H2:6
M\C'`-K5P7T7ATP..M\8"SNLH%?)F!XN<XT5F7=A;3OO2L&%F\:YX<_J[!A-I
M`W05>:'+=.3B0Y.6$FQ)R5GOITO2IJ_Q,D/=[S@9P@)$Y1F#MGR?4K"ZGCN@
MP&J62VS#=>K<<A9MMU'(IL^,4@NGGS2S--I;I"PG+NMYI>FS+V?K5A9TS^A=
M@[2)%S#"KEBS[*&WRW3E`423K6)L2:E:ZZ;+U(:G\?)*S:VU)1BC`)7F%@K5
M9G[);D'1P9DI4GLH-4LI\\0I^+*,<0!Z*BM^LH897M\`2H7+-,9'Z31ESSW)
MH<MP_<E+Z0:.KS<;DYU[^]KAE$6:_<&9;12WI;))-P8S\NM97=!FV>[V>4O?
M_>U_>^-.JA!](,S1"RTS<OW0C,1VUM,*P^8DP(3$Z$X1T&YUGKP>6:(!"O=Y
M,EW>O=GDAV7X+SA[;*J9:,4=!9F5U\&*7(@CLY@[N4[--8%CAB<!44RW<]M%
MB1=0!7!KS8LV3I0<5V),0.EN/S6'>;[&2&Y=O[:SF36H"O)5MB=VWO(-854W
M`8V#UHE2#-M_A"!+*ZUT&O-22:T1/"$[$=A*&75'AMRKNDKF4+(9`O;Q^787
M1*\8HWQO2;;)F8L,[-Y^.>M$<.'QK&RKX%;-IG7U+WU957P(I'&4G>'KX)"D
MI=G@6!K]",>;.#\73[;?I:1I\^#&5A/(,QNYWL%(PO.@?5)CLZ/HD$:7]LB4
MW5#1Z8RRVU]QH]-2>"9CRYY#O.`?J_`YP9M]<.5OQ!N2:?>L6*/N`44BW=A@
MZQP-KUH\4]I9G">IOV7;!^[9IR@@%;$[*4D;&CS^&>*JHJ.J(Y>=:F^6"B*5
M8PO5T5CXS.NF^D$YS7-R3E#6&-'6;P.UDA)K$MPZD&1^CJ-$4H9I=%*EEKRQ
M7<HV(AHCH10.!W`U,[%XB%(O</OH-CT<Z#.2AQ\5%5D?`Q;F/D9-',SG:#D#
M"H(:F8*U.V0P&F<&*W!T(!_<1H&_>E4>C&;8794C.MWL\E00Y1AYH^MZ`'W;
MQA:SS"(BS.A36(XZ%95;O0U(W?$[:K9I>1\M[]B$L$8NRGJ@+_E_W3M/;#2<
M&R>MT9#N0"*[QI(W(Y5=5`F+-;5+[UHT8R2FS-T`)E,#@@1T@LA%Q]E9O_GZ
MC.Q"1L5!^G*$/N^8_5&S"O%HEDE2.GZ=&'CUM/&&H&><`.8`/OC72BSB[E19
MKAPR_,2OCXP$/P?JC.5CDL;>RKC8:/=351Q5>[L4;,=EF84U=P.H6%I9W-[=
MW)[?/?P5+:\_HO/_^GQY2X_U)C0\?W"<AAU`Z'-1@"45'8MN!IRL/#E/S-YS
M6,:S5Z/-6TTR8P4TT*_-4MVOGO%ZGRW/W=6K-CR3&:LA8_B^LU1]1NU3S4R-
M/R<%#5+E/!3Z\L!>>YK/]!,(:(U''%9AZT*6(9[E9]'K]U3FF5H/RP3NQ&:;
MOW6'0PA<V5$-S&A3]"5K[#QWNU@Q(*\(:$KNEAU-R%OSYCQ[/[S2<.4KD75[
MJMA;[V&7O=W8++.WX7``>VMV]-CKUA)G;:3H<U<(,Q5WJXX&W*U[<YZ['_UD
M%43)/L:]1WH2$RHV<[O:I;4DVC'&@7SW`]C.,SCC^1L9F/0)KX:DBOD<"P82
MP/4_ZN"1$\%HP\@Q,*X>6E:=R"AS-N-+:_@W'G..S@`'LN&5'^++%&^-"]E.
M1U7FJW6P*P2=R,;(<G6G`WA?F6D^EY[+#&<7%?H4%B%*1=NRGP%9:[Y&35*E
MW]%2$S0P-68X:5O$&KN>>T#@:IQGK`)VO)SR7WLO)K(9O%[XH1>N?"^X##=1
MO/5H9*JQE5GG_(?5[03"8;,(`7.,MF,UG35-+>[/K\[/'LX_HO_ZO+Q[.+^[
M^BNZN+Q>7I]=+J_0Q^7#$KW[''K[M9_B]7=N<-H00!U>]P)@SFR]OEUVZ_JT
MD9+T?$.GI=&Q3--3V1*535&MK8.#HW'`+$I4T\+9D815#=\4*[-Z6M%)8;S>
M]LDOCGD$#>`Z'R@&')L'E^$D0#-3!R5B=42B:\10+7A1N"(;=P2*LF=]G>OY
M#U?['(3$'3\P]*R;51.O:KU@_W3J65KW3G2X(+I9.<K+RUW\UGHZA<Q/>/N(
M8QDVFRWJZ"RNP.&SZ0L0H:5A38SF[0N4.K5>@W=7^$CEWKHZ5K,&`K06O9W!
M*UX%7I+X&W_%5)]N.;=<K?;;?4#W0V('X9Y%VUV,GW&8^"_X,EQ%6YR?BGN+
M8S]:7^/T9O/@?1,!WH*+@C&@IF$H9^';`LYD`(>GP7Q(A_G)NPF*2ZMXG6TE
M&;&SL%=U2\AGIAP1&!LLZ"J4/:X5$@?H@:.1H/';F+2!C!!Z:F?6Y*;31&U[
M&;5K%O,C[QLV46;T!!7GNV=VV?MZ[+16[]M1`H8"]%!%8,Q*:Y<?)GRS86=Z
MX+7DS&=%Z[+^$;0"DCII#%)B_"G3K!`_T5NF4Y>(?.FH$+_OHCB]V<$SFU7W
MET-K'4"4_.0VYE%-8-5.ZN0Z@\^"X%#*<M.N!J?\HD,'*T,A2JSY=C$UD1+O
M'Z-X[8=4I73E6-"%I\F=IO!$$D1C3YV[#@UYU39`J)45=[<>75Q%11I]W+-]
M6C_AM1=C9^HW#1#(:2:'#H]IK1X*NG7L6]?QED>K8@Z-/(ZLUUJXJNT@R--2
M>:O8FT;O-35>H>N6M%Q;OTWG_#HNS'C3J*8I3:)]FJ1>2.[V$]K%?KCR=U[`
MUAQZJU6\)]SQ0Q(<3ASDCSYG]!1:S8QQE-BV^O9&3E=EW116,V#H""@,-*81
M2C;+<A6%3W3@K*F:PCX<">6T!:>$,!YKQ3'/HQECNA;JPIM-?U[YWJ,?.'1"
MKQX(I)Q288=#KTX7.=<X'FQK<L>E38&V@+VN=.<`)&W>IW1&S4TIA\*@CLC;
M1N$T\G\6A2\X3OW'`&N*OZ`'1_H[+<%Y)XC%FNQW_9D1K]V_+OFU:W,8GHI@
M("6>'#L<TK4ZR"G7L6Y;]EL.;8H^,/*Z@E^'W^$B3D?H;6)N5)$G6'[V$KQ\
MBC&FX9[1-34XWM'9UVMO*]\$R[A_E0!T^T'QT2Q.,&YJN]5BJJ:U1?US1"^X
MML#2&#<\_O:"7L5EO>Y<9NMZ=H?G"2:WYWD9KC_B%QQ$[)W5\V\['":B4TBU
M^I1\EK8%XK!&/*`3I7)_.H2565@4E]E4::V!*Q35N?T<6NJCIJ2BI`N/?E(/
M=LHYB4OX@LXJ[K*BCH\\E+<Y7`2*2[OQ,.B([,O?2]'OJ9,"8-]CT8]MK'1@
M\O*+AITF0=>S2@W*UV:,D:5#4>%K-CK>1D\9F>-1$P<L0G62"/J2M75FR&$7
MM+TRBT78.I)EL@/F^F299D^=+%/TL$_@9FQC99G2ZT`.YW:4#';F>:(^2LR8
MRX68#F_S,RK->%MX&SW=9(Y'33>P4-5)-^X?(&H;Q[TRD$4DCY^!M(8TTM&+
ME8&*]3%)C^*N'&G\+V^[^_>/:!7CM>_8^$*W*M,9-:@JK3'&`G;+_MX@:*@K
M?0?OC&$!G7EQ_+J)XJ]>O':TF#=#B$H@83`RJNREL;]*\?H^)6E.I7[BMI4(
M\MI`<4#L'U82N7ZT2,'IN:@^1@G]W!D"2&XGCP?*NU^1H=N4RPF>14ORV75E
M044A<9-K:H$<=L4]#1T,(8FB6@/1%/IZYB6T$J;_H3O^OG@!7=AQ37[D[#5S
MI>CJ&N@HL;HC,,=T([6BV1K.30BI-%?GZ(JT0G'^\B&!:D+?5O735[3&NRAQ
MJ#8VA92$RH:P[+!;U5]&>;5ON\E$Y=]>AAD9Y:U<1-NQ213VCUJ/$U3U>8M@
M5R>S*>$^9MI+/3_$ZW,O#OWP*5&,*V2-RW3&;P3$:%D$H&E*X$B'K-RNB_IF
M1A_QQE^YDV:DMY7#,@T8E'SBM>5QAV_33EK@^8)/`<`(RJ0]NX**2\Z-,R"@
M)!9GFV":3G1KRI`+@Z8`BSL*Q)C7P0JGQ)%9%&FN4W.Z<<S,1[PED%"R3PDG
M`0^[_=2<Y/D:0^R[?FT+OS54\A/".PY4'=E$WRY6=;/&.&@=,YN\X'"/[_`J
M>@I]&H[BT`QUAS)[B!L"D5,5"6BVD#C3X:.P^R)[-_K2J4V'E?>80S%-7)3$
M$K7G$4ILVX[LB_S!R[TE6&7RSJZBVF7TI6C@3,T/"36QBH\!MBE5.UMHHSJK
M3[N?4,,[[2T13A"7547O^NS#P+85'@U=Y9X(#1H4E`-)R,-6-QTZ=CR-DP):
M;NUG`BMP%.2%.:R)M`=6_;1A'ZZC)Q'A85BMR\V4`'845LL+O,!KGH95-%X\
M1*D7H#C[VRGLRP[#XM^L)HYY1V&5_2R*J.$1V2F]`99N+Y6_[`;?S?,&*Z1J
MNEM\:B4=&M[=TS*Y.?-&BO:-/;5U8\?/*'I32)UFK0QC9[JHX]5"QNDSAJ\Z
M+>[.?SF__GS^;VY!6'M<+KJO+4`K1^#)*),\B>6IG6%@J)7KB:MS-SV0H<IB
M<-@84?RB5R](7Q5;Y7`;%<+7N@@#<ZY'2-%K.]!`>;/+(O_;$53S;U$7T[);
M6>"YT8:#YI8-*SK7\&&F<B\X?HQ&`0$5NMLX6N\)Z>/L"L).[3'3"Q9"H7,/
M&-`%_&!$G);"X-AN0_V0(*KO09$P>KK+\[$\W;4:-=-=>1$2U"V/\.FN<J"-
MZZ)+J7/9Y^[LQLZ_62)<\V]J$]7%3+,(U:4-B_J6^[";^/K#@9?XW)I\[`4+
M1>)S"1AV$M\`1-02GUNSE/V0($]\0$@8+_'=/WLQ?O02O*:'R9*DS`Z;7<8Q
MN<=LB]</KU63?$/V)7TS_H;%GOR"DQ2O+\/LP-D+SX]_\8(]_E&00FV[RV^*
M/3<@E+7]*P`6"!9#52N)-><+^F_T0O^@V[NS%]Q1QL8$O;!>Z)T?HG44!%Z<
M.+)FU#IY.MHW$EUS#;7EK:O&]KZ7C0QO*UKH.>*#U`I:T;*.[UE/5+>.:N;1
MXRNJMRL.+V$^3E#NY01E?A`1E\S3"6):Q)P=9<86P-^:T,R@@"R_S#))]MOL
MZ])Y(?K2,#T6"KR$U'8XM(C4<#1M7M#^)5PH)'6"M9@>U.X7Q9]Y!8GHF7`S
MEW)]KL")N2D_AXJYTA^@G&M\-Z<J1V6\SM2.KLL#4/U8%8FHYND$E=KS<!0=
MRT!_B[(S@SKR-C^4ZC;V5YB>.;?=1B';5XT4S2OQ)F7V'0ZM(S4<39LEM'\)
M%^I(G6`M)@JU^T71!.UH&^0ER$.[[*+WQ"8JTV>,@N@KCHL_-C0M;+WX5YQ6
MTYGTPHK9SV<VO11AG[V72R\]XB<_I*]R%VVCS88,+\G?.S;*1%'6SMOM`G_E
MT3,O\3<2AD\B6WOIW&<I].D+EV5,)6-HCE'Z`\PQ&M_-J=)6&:\SI:WKB@54
MVI:RQQQEQ^TR\6*^3E#N[2@[-J'^%H5G!L7M35&SL_Q+<_%?L/_T3,KWY0N.
M255PA^F)JR1YGT4A6T*^]P(KLZ?#(P%Z-M\K`B>>PPWX[5PHH`=]"_L/\/K$
MM<C[HEIG6BW3\A>'ZZ)`SNKBF2<@``*#/[@;KB9`3_1Z!`+_L*_7K^%4;=W_
MBSA3=!^>RD&O8*B%<(**(%`>!2K#0+4X#F%V^D#TT]::B$-5T/D,$K*U(LMP
M7<[P1_0C=\8.\`&"+O>%"<R)!`S_2SLT``']<F,M+`0)MQRNY(L(Z6D6Y0-@
M(J;TXP,?OEC0$$O+$2WH'.CR18CX;"UXA/GM7!P:P7T_UT9,;U:6+:T0YXG[
M6Q]\O2WUM[M\_:WK_WP&=C?[-$F)')`OJ?GE3RV-X`9$`C14ZQ6!$YE_P&^G
MD^"S(O\^]>+4_A"LWW>QG]3[Q%4.JFJ=Z2"JLTSJD(910X@,GC&'JPI08NP1
M"'P&[/5KN#C4Z?%%S,8T&2'/P_51\,Q^8Y'D'?"\T=P%S]98X"AY4]]8X`U[
MCDI7_VE!)V9J(;S!N9?9*^BQ:#12T!'G1[P`RT_;YK0HYA/J5V!R0-<7Y,//
MAG4-V:RU7SBU?QKOGG1Y+KQQ!?NJ!AQ6U'M;R?>5`_#'*?UO-'N@0/]T[$1K
MTSLNK%F![OF("K5ZQNM]@&\VRQ?/#^@T]$44TU#O\6H?^W3;TP?ZJ4B_3/L7
MZJ;?#X8/IG$"<<7`K0:3M*TMBJ9TQ%LV?K^)XO<):8ZJ]N@+Z^$*$8WAU*5I
M3T06%-;MSB&XOF<'Z1^F_MH/]JG_4@OW_-LJV*_Q^H+<)5J_[5-6OMULBC.3
M;W',RC?5B9;V''4%!<P!M/(`?W/(XLU&D$:"!N6VH7R[*"7#"=\+@E=46"]?
M(*?]$I0^>REZ]LCG840?C>`0^6'FE6YE1V<+0YRB($H2.FW8Z(U67K"B!X:S
M*<='O/+V=&MX.M>XV>!5BKY&^V"=66>6/1+,^R(0YQ07FI@R:;8C`ET-!_(C
M%7NP[V)E(``>)_AXXE"TAXUNZG57S6Z]XBHL(\I$5+--.Q76Z<OAV0Q.7J&Y
M=]3KO*5#.(8[2/&88TFI-^P$=`)>2MH9P`)^8]<4O,]0&,*E1=T^.+'6'G[#
M,Q-<HI4#>9#OX)XT7T=A=A@`"W.Y(M_/3U]9N/HC>1,C'6G5ZPPLG2816QE=
M:P9@HG]:)A?W^^W6BU^I4I'?+(U]MO@^WT0M[^.:4!GA2R)$/7#:$1H=&S(A
MT8O![@!0)P9[@[N)H-\>E)5]\B1=])K!*&M,/JA'1RXP8HK4R<+]T%[0P';G
MRI<L]$RG0PUW4FQ_@\#",_2;64G%`X(RT:C>;NHINWZ,D[/I>C!^)9(%Q(V.
MB/6U*Q.V_K':3?]]X[)7$CA.P7;I(%IQ>9+MYUDMIYQ13>$B:=6UQYQH.VV-
M4E]16?\N=._\;"5FM7]^[WIEN!-)[3+$N#4%'?Z-[6GIH-CZZ>H`ET*%;:U5
M;TEL:;E^:,BL]!:`-%K:"T9.B0KW]Z&GR$.^PUA%5?\8S0JL`0.=62E#N_KR
M:CS?4X'8Y*<Y;,H3;Q/:#F]W0?2*<>OLVZ?8"U/LRCM_L]0#D[ILOHHP1;U&
M*\XH)-\GN=E<AJMHBQ^\;W2?D##!'W"(-WYJ6)SUMMBIQ'I8`M;8WM\%NL;J
M$XB);)K;;RADU9W^E1E`Q`+*3:!WN9'O9E`H]0>P1`6'LJ(C>,8&9>K6(SJ[
MQ8UQ0)8K&>?XUZY15@T&^AD#4\)`G#/02]/8?]RGQ;H#0HG4#_=L+Y8=CK.5
MQ$<JRK$U3S).45=\\M)\R<K-YBH*G^CKL1_QHVDQ86:F4T'H=@=6+[.HK0B6
M=@@F*J5IM/DB1$S$R-]Y`?*VT9[J4S%Z"B(O1%^?_=4S^Y/"W@M?D4\4[#'P
MG[Q\C\88[SSGGC@9XE*B1KT0WA$@/2LRU=&-PV[>UXO"WG.A"6G3SNA5+_H7
M[?>>'H*.:,\95-%C,T2=I%WAR!3I^#),"5I]$N8R27":+,/USU&T_NH'@6%&
M-K;42<H&%H#5Q3AV*ZG9)`H3F=&WV]`9O^Q&)SI)OQ/VVB&=]URM]EOZDB'=
M.7D;Q:G_C_RI,]U'^2FW[9KPF`-4HCU]T=X1'VU#,OTQB,9NFM8.Q%ZFGIQ%
M[7Q==4193\:2HN\,,O8TQ%'G;;>H,T7V/F?O=/LON)P.N".B?(?I[?4#GXFR
M81KO;[*3S_N8`M:C_M_&2H;O%8Z)2/5PT-"JN-$2/>+T*]TD@)U0ST;I6:,=
MR?EL,X)R-I%*6JW5BKV"1)KL$SJ12*]\_O[^>W2?DDJ9T.(5Q>X<;@^!?8GB
M#6941_C,+<H4L$]\=JL(\XCLE1,.4K9=8)06Z@_8J!'4M#*#4L,5!JJ+#]<Y
M.$4Y\A%O<!SC-0F_+*:N?.^1?(-RHRG]2J27M4X18F@%6,EZ?0<KI8=I)"82
M9F9;\!2@^:"25@SKW&Q68%1#IZ`R[9I^]<.L1+J&D*"C64;&9')E&)7=:L$H
M&'N%@C,$:Y<'16=6%M1F(&H&9E`93,LL=3W@)K<FV6-GM8KW>$#BUS70W1M'
MV1%ZWQO-2.ULBZAV;K1IC<I<<^ESUKI81>1<(M;&D&RW&#,<=B1!U5^ZRXO2
MM^6=^13^+>ZX-RZL.SODY<">5W8<`^X:N]--"/@I,MW%/MW'^),?^MO]]HX,
M7;P@?PD@N8CBFVSU9/ATA;W$.`D"V.[DQT$V@04&X/M9R:K#XC)1IB&>&I*5
MKXIC[Q31-73T9444TQ<5:9E_MOQ$QM8)*?KWX1K':./1&:7TE5V,R#@[1F$4
MOE]Y1&X"IG-1X1H%S+=K8@=!#8D.PC&O(Y`#3,NT<U#$=NN(`:'9*S%FP?%V
M89*90KDME!DK7DG.B%_:0YG!&10N[G)97>[,C\U3%$G_M?=BDH6#UPL_)#G&
M]X++D(!UVV=Q0@];G2+(R`:P&O:(WTJ18Q:'B>"96&[(6X(#=@0]^JVP@#:%
M";3V4@^]VX?>?NV3-M^YIF)]<"E1K?XP[VB4@2F9)AE%9+>B,`C%7@7A!(':
M%4+9%95]4:WS#*J!Z7BDSO;N,<FM(]FN_!!?IGB;J.?W]6T8',U6ZSO:\6R=
M>.U,]&OYASFKK;*X^/^W=S7-C>-(]J\@]C+5$>[#5L]A9P^*4/FCVCLNNZ;L
MZHD)QQQH";89+9-NDG*7Y]<O`9(2)0(@`";`!*5+MTL$D`DRW\O$5^)+E/U.
M"TX9V^?8&,/$EJSN99.99'?RL[\)N_O96AHXGO/O5\'AM/\81MZ9_%=?2\CJ
M$5X1G>?TAP.-98#1D3"&9_S$MCK3/)\O_EC'><RG8S^]M_[%G7NO<S1KIN,?
M=:L#4X>9UM#<H2W=A#XT&]WACZ8.:5<Z85?>MW[`>@F+H>4I6,3*ACLTHM>*
MBDET]<!')G(.''2X9UBS!L&XUT,^PWKE.60'/#E@*:2=Q?UE&^/G`<;X0P\&
M@.#!(/ZQ/1Y@J^=8XX5QCNH@!IW90".X8SO8$#IDC((+H^.D_ER5'4G9,N,;
MG6=9"0W*EQ_GR?*Z[(GD\5WY5\YN`FGRF_:&(]""!(E"H02`IS&$[3E\6E$P
M_<RR'0*)W4M"VJI&VLWR/5#7;/>3K`AIMXUUY`:.(V621">8[1`TE!QU0D6H
MON`C\?DV1\\-V^3'LNAE])DF^>:4Z56:6QS-L&]5=%[#IC7XK>[V?7)ULL-*
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MJ;6:F[OJEA47KFZ;9Q6W`D@E@7`16%G2!;I4";F<@;G#PX"BE`F\('LT6:;7
MST+J1IXKQG>7O]3->W"3W!1<UQ%<@.1P$KO.KV;]1:N])OW)1.G<*,>B4\2Z
MHG6MW(S0/7.</!5678>95:?$%YV<K&X"1\S3<^&3CD;6U\G2SAA1Y=>,I1HI
MWK^6J"WFR?+\CW7\RE=8M:8$]*IW8KZ^:L!\K*<E-+GV2C7ARI[&9LWS$\)+
M\%T5FS)8A[R:UJ-@'R/[ZU")NK:*&?KDX@.ZA+Q:.RX^O8LOTM9C`J#V.U0Q
MN%U@+@'J)S39#%?+A(V&2MN)TV1AV>XVL8?WG8)UFX0WBI7?H#"A($!8V'48
M<F#S*@H=K#D:CF6[C.FR?>F@C"WE)1O>$Y6`83"Y;,BI**$4#6H1U)NQO\A5
M&I4#M!4[T7>ZSGA*O:_LNKLT08)VQ3?MXK;7`!H$=@L*L"1JS<G,1E<0^)P$
MG.'P>8#JY[VK64_81N-%9473L![I<-F1_7AG5:94C7LUJ0H*[G+J3@%(6`@D
MPS/JKA!M7+2KS?;XD\5>&XI%!0?1MY2A0?[==Z'0*B=%PDY;#HFT)<<1CPXW
MES:+5MQYBI`X+2VEAS:!;644TOQ"7QYHUL^9N^6ZE-D\A[;_7;EN"',CPP@`
M=:T97F[<^V8J@Q=^WJZU5\64QMZTY)@7*S$.:7&(4>R3(KFO?L<R\S#`1#0H
M$<Q(1B'$?BJ4DR"\F;LE/E/KQDQV6C;<:[M*JW5.:F9T]D:SA]3Q%V=,-J^O
M$_Z371+,+R9@5_[QT?(J6$O0X+&1;>&C,]=F;`0?=]U9H%_\H]LO[M-;93'-
M3[]F]?USMVS/6T\@WUMCX\T4)8%LO%<74&^GDJ8#`WG]V>DJ8O/-9/.4\,=8
M\-'_S05XT364#7JD%41H4K3NAD^E`N&'#LX,K1I.L,==6T,WM(`U.KF;]F-V
M'DF];YU3MLPY7R[C2OO/-*%9M#J+\\4JS4N_E<\?\B*+%M)!C0^9C6-Q*PN&
M+GR\#TCGYEA?#=9RJL%L6XK$V]S[2*C."WBZ9.D1LPW9NA0IH&NW/7029[A4
M&3Q2F39K\&A)8Z^8<JO8"6E13RV+M(21^T8<EL!K@FPD#?X.B(\""$#9IN;B
M_3(I.[3F&_)XQI.[YRBYX;W*K]/DC>8%77Y+5ZN+-&.5H"/204H,#5$MA8_K
M>@:],0Q!K&T''/HG.Y4J=X4EF?<X"(3S+!!,,-316.D`Z'DLWP&JT-BJ#VAB
MY:F0$U`T7<DF+>%UGKNB%$]J^7S?;:5!^>>:3^8U!S_*B)MI16JU0H^Z@R9+
M\+A\DG090.1>]^YF7>1%E"SCY.F?-'YZ+OLY?RO'*T_T_`?-%G%.OV;Q@K*^
M/[J)W@<K,C2"'Z#`N%YR\)O#$,D/Z81#AVFOUJPI2.J2I"E*>%F6,**BR\#]
MV'#@PODR*!(9ZLVL]0#T:`/>!:I!@'4_T`P$IL9M0`."3<C?TN"$]-'F9&;=
M)\&;X..`23-G`..!WG'0Y[*)(K],JK1%WN?PQ>*=S][OBT4^+R9^2QCB?'/5
MQYP.VU-FQO]=^J8/<4)R/B?U4^!>R!9P'N>?E)!W/N^T*]WGC--^OU%%Y8;:
MHXG%0^8?OQ/QE6QV850E_4AT8T'F2'53#Z/WQA?\X5E4T(LHSGZ+5FMI4CUL
M^GD.Q#7T"LI-:K_G`$-YG;[A\;7]VNX,!I;L]M$L)Z^E&^4#@P,;%^@3Q&C^
MU)3#/+O;7O7&\\<:;R[DL4EO]T(=O$R,<<<=_@A6)G@1PG0D3$G"M3SR?FB\
M/_9`:\K,CVBH)DT2K-/SG14?V\$8O`:ZPRU(R7Y\._R[\CED`M4>P$4#ZC.-
M88\#*)H[.&=\H.O`X!2P<%&0O1]E^`'7`>\#C.GRD^X@07U-Q(G1.&!WA]*1
M`<>%T)$#`P_$+]+LD<8%.R(]9C1NJ0942&XL'H?3LWQKF()S\RYX\("F2LU.
MH])'K*8>I]N"%-Y5#:,+*&]EJ(4#EV7\'E#&[H:]0!?`3X'#P$/YEOS#B^>#
M94IGD?WDN!)1C#_\F'5U^'^\'$&[\OVE!VKD(E]"E[PG[`OD7;519-NHM1DS
MS48@;@X<V&,DTA!RB_-5YSWQHR3/:'H>UGZA/?7-HOU7[M=OBR@KQMR,B9KY
M6*C?.F[)[Z1?UR5(5/#;1A[H4YPD[&GZR'^H7NPAG<7"QV$CY@$ZLMC`3V=T
MNTP%MO-D>>0P^?OLY3!:_G9D+SSL);L/Z,A>(4PF;'8ASO-\_5+U\OS'*UV4
MG?PM797-K,I7\BTJZ)?H1_RR?H&>3;!68.AT@H7@<9V3]9O"<-#)1GF'CLE<
MG5GSF.3\PJ!7/I_YMBE[0EZJDN1#E).(^:9%*2UTCV0/3SB7-)0BAGHD8_F`
M+LFB[Z@B:F/]T1P4"IVQ@([Z;$_ED);D$[*APZUPPJ2?D%K^D?C&!,^1^J8>
MCL?)R.'XK@(>P_%&<#">;?=-!1:.;Y3'X=QJ=33"\:KDP8;C>_`<Q2L)*<*C
M3ZI-8!2?U/0]U'"\TC_$<!PE8XT7CE?RC\0W)GB.U!=D.-Z[(/`;7PT8+9.O
M6+SSC7;[8I$OVHK?DI+4_E;YLX0^E?8\ZGIM1_DQEVOWE)E5_SZD!5@)XCRN
MORHQ[WSQ=5>ZS[77_7ZCBJL-M4<358=,/WYS6=54=S"I?+$1G?]=<J%0W=AQ
MM%'4JQ6C.F5S;].P`\BR)#8VJ_GSIRZQL2%7DJ,^46=*%B;`UH6AS_C`CS<?
M8$XJ3SDE0S+S$5"F-#;_:GB<>H&TVK5X\\@+Y:5W.7]Y7:7O%#PUNJZ\H3,5
M_7+&'1;HO@<,2X(:NCJ,_7NESYH-!LGF1NMJRH']M4A?7DI`5TN!9=Q>D$49
MNS]0\EI^VV?.>>4@@$:+9_(:946\B%]+Q9(G0NOF>5:/=QJ%?H1/&WAP<;PA
MUH>&[7WB`./T_IZAFH/H4Q?-I`-NI@&:5FCHZGI#5Y4D?F=Q(^O(-NZ,_/#X
M)H!`5+2(^"W.?[_(*+U,RA"'YH7GPR8:XEWL;5.*Q;=)1.,M80ABS57WO$=$
MI<R,/?SYL7Q*XOHQR?@>CH,Y6J(#1K<;.O3IP,5F#H5TQULYE/U&%><::H\F
M[`V9FQSO7F.2"1--&MF3/TN"FNF\;%P+DNL"B+'Y?]@28IP\52N(_PT=1RM$
M#(V5A4V/ZW`4O<40\XK5<^@[1`)G];_KG!R!$[;*ON%(N1]%0VE7(`&06H7Z
MHPH5!1JB"0<QP!8HK./_(PT#3&)_U&@,`!YZH>.``$(H_41`O;?[?4M7JXLT
M8ZUZ/QXP2$M_Z7K-M$.^T7?0.\<03CKK(8H\<T8ZS_2NJR4?@KL39"1*&2--
MW0#N<[[%V$K)41+>F;U%5(,`-YU$,XXX\G7KDXR3_5W33=S/'\HFHT7Q[Z.7
M"-E+C)BP^:#\1``#1>$=DY^S-,^A!WO]DH8.V%02QO7@_7W','!2:NG0F2KD
M[EPTS@<HP9_0UL`!G/_0!MU0#R`7!,CBJMZ@BMCEBJ*)NO&!'2CZ55S:S<4<
MZ0/6C@^#0`((Y:[BA%X6]`4\<NLT/#10:S4X+D]W>H8A#&LKY9"(MV*D9[4#
MI\JNW<(QHPP30VEPTRX@Z[5T114E;?1"$Q3YAAY(R$/N67N$-QCZQ)P7R(+'
M+J."-H#(!'#V#?$6!(3[#L9F>`=O-\3;-G4Z%\9BU;`;.I?I:A5E.3GN-E"P
M!\K%([SK13@7B9!%VH`]0Q.K'R+](M\@<&3S,-@<\_K_D<\]VT+`-T!/B-BM
M[XT^QM3!LO!X%T]/E(6G,!5VD6:/-"[6I0/!-QEFHYSSZ3`SI9`[;ILWC&'1
M$KIC8[IM(U5GIU'I"U?T4+VQ%25X],<#*,NY/S;1S:='-GMG88V,3/H6SES7
M1-G5[WQ72[/CC-?TV-W_K-<A\/N$QEPCWH,HU<#7Z"F@VQ"E[RH0)XWF-K*N
M/OZ=[2'=2"8'N7^/.=X%C!T%1O!\X5[#V.F`YA@%SWVPZ%F0#3IV)G7X1$[P
MYPX#I:?1HO9`""J`^%L[@^WNQ?=0P;>E>&]W)C1B`TE*OON6,*P]F*N.(2]Y
MK8SBSH2JQ('>F;`'QA$RB0OI8*CW,90^1A[QIM^H`F-#[=',W(?,3:/=F5")
M/S+=6)@Y<AW:&#OO26UP_J.,$^*<;K(;[$WP-\^_9G&'JL=50C?>!A;NQZTY
M>6,^8V_H#@!X.5B59LT_`]_(XP:;YD[))4?H.B90'2S<$_`[&"4@!^V#][!\
MZK2E&Z+GNDFS-M+;>;,Z>V&:4H0K<61&#(@Z<F,0`;Q>MZ.'%741N<-*!TK8
MJBT515)'PW>$88+<6'/W^1]U=9G5Y4FKPH$=B+/$)G@62#MR&#J)9"8</E>D
M=J]139>;*8]FMCQ<HH).7ML2.Y7X>R+\YBKS;>@,%T",+5H6./_Q2A=EE\_B
MMWA91A1L6<#'#A257!=;3\3R\"WJJMX+PK5<B;J>%W&%6KA<NVT$DD8B7[H-
MW!$9P]3M4JT&0[A8H16)=;PT*^XIJH!:5VVS4'J,G7%X&8O%T!MB63;$\A[3
MU7+ZF^"0$8V7S2"!4$T`D6WW8*>KHXS]DH!FA8424,RJ*/J.XPR.4D_W4R8B
MN5,\4:,!!?!)BG[<`4U'"`3!3ST(>X,J[I,KBFW2%!':H2=#6R(F<UH8"7FX
MFLW$2A\!Q'*]9P1_X]D2)?LB$&0)M-3/>:H+8[V0GP6W?,\8)B8<]&W,,^2F
MVLZJ"M/<K^",'SP>0Q]&84-]*+1Z/@^P&[\Y5.$^=/?0#!(.FW#]YA&LR5VU
M@?H@DPE.C_?])R<Y'.8/8*36W4!SO7YYH!GTB*M/#OP^[*9]%)-OTGYC&,DH
M=/2Z.;&6:KY?>E)S\7*(N-PN*$0C_+;`2HS3#8!-3U`%Y3(UT037N#C`Z5;D
M2L21+.!L=_IT$4`D5W7DYI$_S>=O4;QB_;M(,QZX0@=TFN*&QG6]8L;E=<VW
M@"'*ZU?5(='W":_8/B>;)^0QS>HIAG6RY/,3E)0OZW_(UU+'"45]NCB"XW,S
MY`XE]1YI@-S>VR]4$6&/MF:!X1O-'M*#98]-M)B3:(<_XCQ?LSU;1XIP99Q'
MDAB5)(PNOG4X>D3-#A]!QI+U4"1])/)0Y<@SKNS[T'@F@/&F+,G-75I$J\ND
MR.(DCQ=.MF]9B(9=7^@1B6FN4>OM8!B?FJGM;5)2K<B,_\C2GE>_DC>^9%EZ
MB;Q(%[^3M%[*H*+,C*$/76U@Z&I:TH0$8.<IE9*=35WV]!=5%&N@.=+UD##8
MR-&JR6XBQ8W(26SX"8;"'"^V!$AB`83(JM.[OZ6KLIE57+S[3M<BENPR8<N^
M1+QY$,3O!G'2EH["(R5!V-/#2^*6K<RIIVZ10-9/3@4E7PQU0_J"/655V.\M
MJDA:7_%PDKC@9+"=1"[56/Z5YZY[VY+.P21T040_7I.Z!$!``43!>U/AZ^(Y
MS>+_4/"T+GUR@+<BM=I'M4C8Z3<&!Z#0T=_*X%;J[$OT@]_7E5=K>>DC6:0O
M+V5X6E%]B?0'RK</E.S/EO>>V*)-/MUM1UVP.%ODD^$2>&UO(\;=HEZK)ZBB
M1)F::"97<;$!T+1I=X/`1L*1*^!,=_IL$4!(IWLYI8]I395<7Q>@C\WXIN\%
M0TAHH#."^X2EEYQ/?Q9`"3#_5_UZ&/^+Q(YPM2^RL%)7;31A9E@,,\Y5Y4>^
M\@>'(V,%&MK.D^476H;ORW25/KW/'_(BBQ;@)RK-);L(;V42\?D>];O!&N)*
MM?;L@B1ZS%I%&)BKZ<]'YE3XUE8^5TI?7E?I>^E*HH3=<I#118GBO1VO?,8T
M^*D/"TRZ]3!:A.#"PX@%._8QLMZBCXO%BJ..C'$3D]/HF/-82RBY;\3^^\A?
M?H%Q9+!`XN1Z)R\_S2:[X-Q](N]A6@`="C.6CN(XAN4[PQ!76_?`_3D-4YUF
MF[RJ49U7E0?./R_9`'X;=D\SS?9`]((?Q!A&(T`G,@R5@#^<8?P64$7C=IU`
M$YE/A]J@3Z-5X@\N)77@'.GJW-K46#*<B/]F7>1%.6".DR>=2^Z!(WU#Z4`1
MOK94%+[/\!WI>+PJV?)M$66%^[A>7W_W3D]7ETW2ZE8%EK3Z@3[%2<+^T4U;
M/=5XWA2CX#[*CB2`/).F<'B/I-UKC/&ZIO)F<7J%M?/$PT6U`7(6"]`EK"5/
MM7_DK'$YRU4\?60MEQ\-2Y[&@,D*)HOC9C:A)58PD="()ESVD>'&`<N1X<*<
M(:ANT9HGR^9(\UW*?FI=NC!_>LKH4U10+WDB!^L#-(LP0`\4WF[P>T2T=CBD
M+^Z=HKUVL\V#_J24;]4ECVSS"VU2793LQWZ>8)K*X2P`[A&AB`G(0UJK`^\S
M![P9C.,$Z^Y@6Y><*&U"KU7^MF76\Q:SLI_W+B/;TO4D$VM.B71=3;T<`NV.
M/7BI^E=V[#)AQW3C-\JND<J_IJMX\6XT[-!J23E@Z&G!H</2TMUYD-ZGA:V?
M4+<[NV6Q[\^?.OR.F6CUC$V3(DTL5TEMRH9T2:E'&W]1G%(1/_'7*(A0Q3Q-
M*,,CF$UE?O5>3NKO?%___X[^*,BGDM%_1WU8PA^4S.*$\<$TMF^VFDEU>DN]
M5`[\=B)4M]1+^XUWL=WC+=5=J>;+YWS)?"HS:G*8N%P[<GE3?4>,T]4@S#?5
M=]3$-A.%A`.@9XYVUJ6G=%/]F&3A8=/,D2[V7KG1EI>QMA>/RAP?K38-'R,(
M<`N=/BF$,\23S$#[&OF9BG>[,P3K.-'T+>'?]S&.3]!69N,H%`N+!S3P-$:I
MKT5$3\-47>G>%@@#B5)UM<<VU@V2M+SNJ9CLL#D<JO.\/2(@L@LG^FYUS<O.
M[%YY\`LN*'=6][X'1!&T2E>OTR@#=CZGK?F6Z>UT[D>5R]D5'SN5I>*<SK6$
ML--8JBZVF!8IC3A=SYGD%E],;.-AH0<MWP0997XK'>]%FK&'[D-,@3#X^')'
M"#:7('@#."/+746]^H.VZ,H5Y),C:A$27+*T''GP!-V2Y92==_J$/!1LZ8HX
M#L0!>H<1(+EG<D@M"/5VZ=!HQ4/DAY!8$,5\N:R#_#]WI7[S9,EVI5]'+_0L
M?8GBQ#;B&R!*-]ZS$N&']0?TWA/CVVD(P/<V@F?G?ZSCXKVB;7)?_1H*-0]!
M@CDQ#\>=+BE;2+*@9*O^!$/(@Q>W1LCN"Z.4MTU9`>0"AGFCB"8)!G<(PPX)
MO53"UIN]IIJD$X@>1M@BX3\-\3"=QMA,$5[ZSV%]PC83,WEF'6]'VD$D&)TF
M.X^WK6U*_.QQ7!0_)?%CO(C*[BT6Z3HI2M5Y(H28YBQ7!4]5(1N_&%5NQAF:
ME6!<EI&&0(Y%5Z:&`]!K:M8J1[8%25.2W./+.F)F.EV6LS&]AHNTZ@HX0U.F
MD]A+2[99C*0[!/5MSSSP^/[ER_S;O\C-!;F]_'Q]>7%Y.K^^(_/3TYOOUW>7
MUY_)UYNKR]/+\]M#LF>I=QW5HCUZJR(JV"SC52EB=9DLTA=Z%_U@+CC)Z2>:
MT,>X.$U9+]9E1V[*`3UWZ[G,?PULKO%HULW`4,/`7BA!\+>**A*^4U@G5XV]
M,AKT8=OXC-=$PA1#C:[+'3!FW'")96L"=K'6RXD'M=0&?-X!(T*XRV5U^?"<
MUR95=5+6)W4#Y$/=Q$\G9-L*V39S1)C,=D+#V$@^_?_669POXP73Z@M592[0
MJR7RT*+2\`PCUPDR-.^5:$@9@C;0^D[%5U<#N-=<1"CM5NH!HTB*<[_6%>K4
M?;DQ.9$S:I<B]U4Y+%,9CHQ2RWEX,$O/KH#-M-ZQW.DJYN\4:A-]ZR$<PCH2
M`>'4;EL3/=LJL\V_R3W_!1,LNM])C`+9]VR;_*:,Q,);;:`SZ*LXH9?EG\J9
M"&'!?<-N%8`U[HYDZ#AE7XB!I6^K;:T=F95W/YS<TF4?>=_:-^44%M]JRUET
ML2/'24`!81N;L*'B0O8[X0^P$:*5J2BC`7!C&8$B;Q[YE1//Z6I9DDJUS7C^
MD!=9M"CZ6%.G[CZ1JNO`@D='/V`T]8@T`)BRI=GIS?7MS=7EV?SN_(S<WI7_
M^W)^?7?+%V[N;D[__NO-U=GYM]N_D/-_?+^\^Q<R*&H9CAR=!G:W#U=5506"
MU1(1@OHTRI\O5NF?N3Z6I56Z$!84A4:N5!MPP(HD&>&TVX`*GJ?SVU_)Q=7-
M/[$LH>I8@`J+?7;3A6"GAA)Y@O;1`:YB!+:G*4W8F8WYC[AWS*&JLP\Y<5E8
MS*GT`0:=1)0!ZH0M-*>DMC^3>_8`6R2J_/)RJ&D8S#[61%448!-+0(>VF\>+
M.(F211RMOJ9YS+<0:KNYWJI==Z>H`NWV>K4#=W\JB49N4-[0KCO\-+^:7Y^>
MD]M?S\_O\#G!?OM0.4-=Z^HZ16E-I7-4R$,'V]-5E.=U)*WC(&7E]P':+0>+
M2ID>P%`4B#'`7Z?VC/_"SEWQWW!Z0NDGEF.LQRKV@;5?7(&F;LMX(%2J=)GG
M:[H\6V=LLV!U%0G/^U/]?9DL,AKE](Q6_Y>"R[JE#>PL6@`"I+7NH)/J-EKH
M(-F\W>JZ6%+5(E4U4I4]J<Y^Y"?UOTE3F7QHJF,Y;SG`)`4T,=2^-P1BW)"(
M6BRT<;.>8*P(_((#&MQ42Q9'Y,"92!C80>*PYXMRF%U%Z_(8V+"^CG/>K>>>
M5T1Z^G+$>[('TLA.:W6ZQ88[XH1MRDUHM4?JS[AXYHD.3M=9])DF)-I617C%
MC;&9F=&&PE)UJ*)=W9`@=B5[=ZEM\5X=J3N[UW6:[3J'9^56+M&3G8_N_GB&
M:'OO)ZVN=GZ":BX)0*JE>]<G$FW-`-W&K!T?:AJ06Y4N"_39I9H".K6U&4`@
MUZ.CZTCWY.?<&GF?E^,5`G)R#JS;T,5YM._1'5Q%D#<E#<H/4.E6U!G1U17<
MQ[,[FNG`^XUF#^G@45PC=F`86S73N*_TD2S2EY?29U77+>7I:DG6R9*=X6#^
M*TI*HR'SIXRBVO"L;3=FP:O(YG1B5E[/,%BM97D?C7&Y;I)T^++>358P5?BU
M;[J!33@,-F.KP5=XAOS12YSEP(8_ZLT@\,('8:\?,=FKY^CI<U:RE2#@XQH_
M[*>(4X53=BVUXRO3%N"0;J<[M`<SUD*3#@S;W?-PI8V?_Z"+=1&_47+S^!@O
MRBXAX@5+NQ,3Q2`C;O.&64,2(C'5QIDG-%/$R10$#G!L)R;J>INY"%FRV!-R
M30LVVKE(LT<:%VL\=X2-C!YEG(@0/Z//:W#=SU]>5^D[I;S,UQ*^SV4_V,43
M%K/XO6UI3.DKVG`^[]FKOZ?)?I4>PR9%Y2WO>>EJYJ2BIBI+;Y5KNJY?/VE:
M(*P)3#1D;:!&\Z>Z]JXQE2IMRFQ>5:&1[T4$J2H^5Q1&0)+F6H,*24<@=6TE
M'"B-[M<K)N</ZP3K3;YTZ47'U@WIK&=(&G`_L:;4'#A3JX4:`V??Q,W.-G\&
M-D^L-C.S>3@=D]69E1.V8SA+)]'%^RRS4`^ON]A\X@#ZOI6FX9RMT%32CYBB
M\JMO4:(*B6>61A96^\;[6]/QT:I6W'-3?Q]\K>XJ-1E(5(JV`4;?@;E[#;,U
MXR=M'.A0E+PQ0YY2:>4]!)`K8Q8'P&P#&@=JK2T7<1ML_!I+[&-O[]"Q\N\'
M!QZ?6S=&0HWF)H]PYX?]0\MFFP@":"$)HJ_IG_R15<S<J:P3(K<JN6>;CH;^
M_');]$!"V38U.VUOSJT];U@1:]=HS*A`9G0ZN-_4-81Y2Z9WA[F1[7^/K@L3
M%N[5_<YBQS^SN"AHPC8S4>X5#]2NK8+%L"W;9^3GQ*@UX[JR0E4BA"`.SJ!M
M0C3G!CUZ`,:71RV.0W7K:>P'\G`8JJN7IWT^@[?AMUHQ/T>"&LD"6S':46!^
M`&I;S6R?@/]3(UNQ/K?2`!JKYA89_"=&0*S49H^+*SO%X5LLQ_;BNAH^QM/(
M7JR?)U\#$CWNM:0Y'L(/8?N(46ES&D`VCQ;W)?IV/);#^J%S4ZZ,F/DB=J+B
M-4L7E"YSPJR&Y-&*LD,6]7056WZMUHD:VWY=/ZSB15GDT$S<QEN%;.1&(_Q7
MGJ[[#:&5E^/\^4NZ3@J217R[367F.PNA\='&K<;]P=OX+_Y&$2YL^Q>MT40@
M4UBPAOP+/D/V/,0PNP*OKT)[,.'VLKL^3:"'#4/NMI-6G[6?_8543_\7$?Z,
M[ZK3-)`VSK1OI9.W[<PU".4YF55R85^;>:0]"R/SHLCBAW717'#\M0QSV#6F
M344T%V9`FJ`R,G=NA&/2>N6&3.[*,*@NI7Q9-4?H5&OIU!U(1=N`5]*8$,B!
M).LWL28-0&O9HQ3<XMHZ4)?)]>-]Q-+=^R(/QBWS4T?SUKQU8E0#'].S:?NP
M7F_E#+=&'B@MHI6-![*$XW_-[IA$(@(?5H"90$D7,CK@\,7S9HS^6NV0*:*L
M\&@WC+`_166U!9V"F>AS*RI#,9MZYX9RGN@>U@<QDX_3,A/5M#=>,S&:O;8>
M`]F:R"_3,A'5A#)>$_FKZT&$K77\U6@":Q(6]%>?%C1F['Z=%M1XP4%421K3
M[Q9V!!Z11JY@M"?+!E([3<QN[VY.__[KS=79^;?;$ES_^'YY]R^L*!)^>@U$
M*4Q&BJUV'1V<[<K`C;FS.%^LTGR=T3OZH_A4RO_="'Z*^DHD"NLY!*5"3Z>1
MD%RV+5Y%K04'7979:**XW_*4@!94U\6V4+*?X$PBWOW$KQ<[EBY1LO)D6X'<
MLRJ$UT&[.NG.S/5G*/P;ND=_MG[(Z1_K,M(_?RO_\X6^/,C/6*G*-GY*7`8&
MR"KYD/Y'(D<#H\*:L^W/A+[A&50I/V<76!I?OX&0J*@`+N(6G?@`D2APOH>U
M&\[C6\OA3\A]]0P+7P.8D)2''1K1:/QZ5\H[2U^B6)KKOJ^\F&?;Y5P`IJN'
M$\CLB#&&3:MV%SCL(;FO'N-$C^!;]R%(:AYB#&V+]^*HW3)B+,U_Q-(3>^K2
M<AQ5I5RAJ*V#,PS50JP0Q.O*\,,>XD7/SO?5P8[`(.3(886U<%.UB@<UKZ\K
M?OH^6IU&^?/%*OWS,GE,LQ>>F;AONMBL]@95FK6`4&:D(^A(05>R#A3UVIJU
M"[:'\^DC8?4(JTA:-;'`U<R0!/"UL<0-G+4JB^"M*=7-J$5+./PXQKM55V.=
MEET++1G?;GI/1BT?(XUKUOZ\V%WTXS2CR[@XC;+LO524)<NOCI=*/)=&C?IE
M*DN"`%E#%T"OI);6CUE5_5GYD"SX4[)H/49RPE'GHW=`J&\I->P4%;I04[;N
MPFLH!$)["H>6QCP"L[7J.6D7."%5D6F:G(SK?1G=R)Q^';VH9\@T:ZFXO5W:
M'>2Z.CD$W8XP2^"UVI!#CQ5"-H^F:Q%Z*)2:D@J'VTJ:6&Q+08U'Q0Q;;WEE
M?`4WR]:KATMGISO3)J\MPQJJV;;^;ZWIXZ0S;M+BNMX-U:P;FP>\>6S=^J7"
MD:IL@R%Q&1C\J.0#84<B0@,WPIHS/AV=/N[<J\;N*[I.DY^CUF]WY9]YQ%.2
MYK@`I?SH73!IV$@#)%%1`8C$+6(!T/<DHXOT*8G_0Y<EWC_1A#[&A0Q"/:7K
M%R0M!0*C'AT`!_AR2?UXDM6=M1^0HG1)#_4C''CI^\(=Q.B91(T92>$N:J2M
MNAC)2X1!C^(=F!,;O>\8%(MQ/DW2H&3C==<FY9&*\])1G.=%_!(5T@2YXD(-
M\>X]A$&'4"(DS>X+T(##;I59^6\6I6Q^06+ZXF_5M7C5-VW,?*>,P+KWVG#"
MDSLRP.EQJ!EP,MPSA!/R-5W%BW=R7_\?W5YL.R.1LB&HF?CC/I9HL%H26ZW2
M/]F9VC/Z2+.,4_4\SVEQ^LP"Z,M$N1AEVTS]$LVK@^#*5FM`#K90H1^>QHW.
MFN<\,'YKJI.HJ8\#LM96U@'U0'NM06_:2I<6S/5PX5],M8#V0"A`P+S8I@[9
M5#HA&VRP&)]7/"%559;>&=-2W7CXD+E%?`CQYUK_R>?IBGR>++_%3\]%OGM8
MJF=CHF'M^K5KUP+A#4,=`=VFON1^HM!MJ[J:HSK^1JJ2_!)>'-@WM9<.Y.T,
MKL:Y9N4NO+6ENO![FL*AW=T(QLN<6U.4KR/4]MLY,HML`Z(OJY;YK['MVJ.W
MHDQ-NIR_T2QZHM=K=L[LYI%SWLVZR(O2:N+DZ5.4QXNR4V?Q:EV6ECFO08TU
MOLRR$1AJ&-0#()ZPU4&#-NR:GC7U2%V15#79U$]]<56K]@GA]3G?U"T@895A
MYMDE&0AS;QC'JBT!`5GJY,3/6NGBY(YK=)AJW8']/:]O&8U6B_6J'/0D3UT$
M$7:SUE6:Y^2UQ!VO23YP-_[Q)WRW9.-`FM2[8\1:^\-=E7^5/S8_E?]YB'):
M_O+_4$L#!!0````(`)5<8T1B:&[#,7L``+[B"``5`!P`8VQD>"TR,#$S,3(S
M,5]P<F4N>&UL550)``.:KQ13FJ\44W5X"P`!!"4.```$.0$``.V]6W?DN)$N
M^G[6.O^AC_=SN[O:'ML]:^;LI4NIK!F54B.IVMM/O2@F,D47DU#SHI+ZUV^`
M26;R@L`=!$CII4H2`40@\"$0"`0"__&_7W;I=\\H+Q*<_><?/OSQQS]\A[(8
MKY-L^Y]_J(KOHR).DC_\[_____U__N/_^_[[[\YR%)5H_=W#ZW>?49XG:?K=
M&<Z?<!Z5I('OOO^^*?@)92AO2U[>7MY]]W].;Z^^:_Y,BW[,MDF&]A72)/OZ
M[_2?AZA`W[T4R;\7\2/:15<XK@O_YQ\>R_+IWW_XX=NW;W]\><C3/^)\^\-/
M/_[XIQ\.M<`2]+?OVV+?TS]]_^&G[__TX8\OQ?H/WY'N9T5-6X)(6YQPV"O]
M[4]MV0\__)_/5W<U\]\G65%&67RL-:+2U/OP\\\__U!_/10EY!,.0X>FB?2^
M^VXOOQRGZ!9MOJ/_?[F]!&O__`,M\4.&MG1\KJ('E!*R=1/EZQ/ZSS\4R>XI
M1>W?'G.T8;>5YGFO*2K;GZEL/_R%RO9_]2G\8,SJ/2ZCU#V_73*R3,<H3=?H
MI7PDZ'Y"59G$Q1]CO-N3.T^*.,5%E:-+,K-VZ#YZ0<4Y*J,D+<0]B=/U"^'T
MPY\^_+3'[/_BMV>9Y3.<IM%#,[]/MCE".Y25=M@7M6VY*W<ECK^>DFF\/L.[
M)Y05-=V&VD]F71&U[0Y(]]%#BNSAJ&UN2MD[%+WUCERC\@H7Q0W*[QZC'%GI
M`=3F)&-@`S_\EFUWH]KMHOQUM;E+MEFR2>(H*T_B&%=928R6&YPF<8**]G_#
MCBG2\M+5!B]_FJ*K1UJ6NWJ3XR>4EZ\GV?KC;U7R1%<",B]LH%/0M.6.$)GE
M%5I_?*'SP(YZ!IITR[@5S0:UZ66>6-%T2I1\JH,_3Z@._NS`[-SMDK(V!\FT
M/<,U5;(QM32,$LU/UR%+MK2X?=MP1"F*R8;I?ZHH+U&>OEXD&=F4)E%Z'I61
M'=M.CH3ECMVB,LGKO<A=]$S$6-RDD1U;E=_RI.-C11M*4;#<K8LHR7^)T@I]
M1A']O<:\C=YP&[;<B<]1_I4,.VG[#L55GI26%!NO7>M[T#+*M@EI^Z0H4*UV
M/F&\_I:DJ9T]J;!Y^RKZ*4>/Q%))GA'=D%E::=B-3KZ^&'HXI`A,,$NLZ&%N
MPY8[L:(%KG"VO4?Y[BJ)'I+47D>$C5M?&I]15MEQ>PS;<CV=;=E90*N6V:\'
M%%NR.T:-3;<66')TB]NW[>B+2CJ_-J=5D62HH"17SRA_3M`W.TX_B?9=.``?
M,2F:%]034K[:<\"RFW5^?F*XJ#$;G,:S947THK8G6LIL&$JBMGWZ4DP/AQ1I
M36N`&/J-Q:W['+D)!VZ:C:Z5?O%;MFTRDM4!;4A9E'_)DCK4Q-+"PV]YVEED
MJ"+$K5OISET9E?5H$TB/5FV='@@:=+/[L++M<&F<6#-*)CH#=G'Z.Z5![LP2
M=QT^8#5NP--*.\42.Y51[L0:GV`?9WL#Y_IPV>JI\F1+O9LE?DI7L#,7\#1G
M<`X.WR8^=7-YWC;-!L3!SF.2<P/[!P93>E&=N4^=^:WM.*QML8?CBD*-KLQ$
M:Y6OE]D&YSM]XY?;GA663Z.41OC?/2)4WA#K+B/%2(E("PJ<QER?NE@^;K'$
M\%E4/%ZD^)L6>YW*MG?E^[V?X4Z\;<0Z#DVA-]7M!"?7$OK,$U06Y*]UF2OR
MAQY%PCC*UFC=TJ1<6[HO4K/0,I'BN$<WI?>E<-[O:D.VO@:SB8J'^BY,57R_
MC:*G'Z@(?D!I6;1_J87R_8\?F@M2_ZOY\Z\'5CIF^$-1YE%\0$5*[\S4E\9D
M:Q#-207#+?F#]QXW^XQ3E*%-4N[-WHK8CZNGYBY;(2L)]9:&$E)IH2^Y+F!/
M\KX4HSQN"9(?1VCMWSUK2OSP5*\CW\>/27H`^B;'.S4$8)MBNNGT\;M__TZ"
MC^]*/"ZF0K\J"%W\1/]*5U.<DTWT?_[APQ^^(_+>H#QO[K]QY%D+DUCS!>I=
M.O.`^`M$F(]2!3D`@-=OJ!E(G0;"@;L&?K%%X8EF@3Q[W=FAPY;IY&!>59W#
M@G`H>HMB3#;H:;('HK5U0I*`^O(A;-B;^#]N-B@NR3;@R")!Q8#-LH$IM88K
MPLAKKS`@=XLM-P*WTN*<%)HL'K%+J9LK/D$WNOK0"OM+LA[H5AUG=*>TVIPW
MW)..'CQ.'9>W0`\:M-0@0:L%;Y(;<?@IQX5(2'*5&GF("GM7-29#CC6%`J@+
M#5:Z>D'$PI*F_*BOC2;-MM15=Q;E^>L&Y]^B?`WM%#1:@"#-J^D=WY+`Y$%9
M6C(`KODL<"',([U0/,NO5G*5QJBUM0:-79GT+P!;]2'T2?Q;E9!/PV.A00=-
MF^%V6=!"2!-6L/98$I-XU@(+CS[]96W/ZP,0NCX3$A9\6*;--<.JWXSW*6#)
MGV5)D&Z\6OK,L2?/3S8GSZ)<]FH>J\D\^4*V3,<Y)/OF&I7[_E([[N0Y2E(:
MT7*/:6`7SKIA@*=1D<2`9M1LI1E9Y=KAS`DG;C`S:4[J\E)FU=+<><)%0CUM
MOJ?/:%]$?C@COQ/!ZFQU^;6A;2Y4R_LTL;#%E9*(_>TM1-:YZE^$HTV\Z77N
M:&.R$,;"+=Z=[_M[F=WD.$9%<4MD18;SD0C@'#VC%-?7"!2WZD9M0II'N3GO
M8-??Q-L0H+4=O28S$^Q0I@Q.P3E*MIF%X!3MAMK@%(T&O$\%6\$IIL)S%)RB
MP19[>OQIIM,#,.,!B>C%23BA,0Q1L=/VG.:;QJ;1Y4A,NJ6TW!'3.1VBQ:[H
MDC,/GC#SO6G1=SYNGKT$[=\:."MX"(":'._`J(9W!-OQ#/`EX<0K,"*Y4)PR
M[CA+'7)+G?0&`$"G3@^/S@[;1NSXZ1N/N#RL-_+HY%498)1=U#M2Y3T6&GW7
M=DC(T0H*B[)^MTX/ZJ5!RK$&58)6Y7'Y&0%-2P26?5]C:FRP_5EY)7:",F(O
M)/N]T&ISC<I>^!RBVI[MPCN<0S!1:*W1]HZ">7O>46SHU7(B5[L>+ELLFLZ7
M67B[CAUN!:+FR8+K\[U4K'ISFAOV/%!""8;@76(QN:SY(;&9/>ODZB-JHQ%X
M46>2&R7S.\.%]#T4BZ3DO1P:)+Q/4"=N$5-93^%'T>#1EKGGY#`?4%ZG:(-S
M=/8895MTF=&L5_L>IRG^UKP+/#+R#)OBW_<5M^)]3M@PZ.S(T($9I\T8&_W_
M-F<O#[`TL^.Q0<>/9BM\:PZN/:?I8<^FDY1F")8=S*KI%`K4<[]?8H5KBT9-
MR/8*<MG0=YO*2\*:]Y1+TJZJ#PZI;8IDFGJU[.9)E@6LL`$(MYR*(<%7=R<@
M*Q?[]CV'\I*4[GBR#B716G`G.YJ]'`"T;C/-\*E7]PYN2Y&'AH)S$W>HSA1[
M2OQEEE,",,+VMX[7_ZJ*LI>-4\YVAVKS;?9QK3GAWIZM+I!>"#;ZF,4ES0D)
M]U<M`'UO:J^ZO(>TJ>9]6CCQ>K)D,H4GLZ$[:\0"DU^DM=FE^0[(`.!GR1J1
M$X,;HP.DS=:C?PTC)@)8#9R$2KBFQ;=%WEA@A8+Q,N7@3&+J..Z0K0D=PC+#
M7G=ES2"I,+L`8^MT31R]F#I5@X8;2S?UNN%T3]INP_5=Y_8:YJ\>2@UZA[J7
M3:Z^S$/8_RIQSYZ:?UO&A3:WF'%LF>L`0<Y@_SD,@YU]L-7^]2J)]Z$\17U]
MI=X(LV^WV6F,>\5(JAWON+>24E)=9"X22TIQ`>BN'W_\T<9IYG_\,!K'*_*'
MJ9]H`AZ+\OU<TRUZJLC6(BK0@:<S>@"!<H+3\O4ZVJ%SO(N2#+!VE.LW8%.H
M9T]3?49K,OE>B)K]C'8/(]\JMTS#]_BS=W6A/@18KJ^`0I"F=]`-8SI+2@9]
M>`Z<YL^E">C(R+\DT(Y54+H1/5@JJ%[N$P;S%81T/4[/!^6]SSC1&&+][@-S
M#J#8-1XE*(&SSIZ*/:ORZ!/*SG#^U*QUL*H5E6W?Z`"+!0D$]NABM3XKP*!'
M[Z!R83I+4KVW=(?,4;:C[ZWU<?R[7]Z9DX-3HLM_,+-@+&4LTPG(O&A;ZRJW
M7BLVU9B=L?P<O22[:L<=36:9UJKL?PMC1`><8KFN\$9U7Z$[KH.6PM!-T-)V
MW,$]HY,\ISVBQJ_PH5O-VH<GJN0K^GM3(7Y$ZRI%JPW$+MWV7^,L!C[?DY\*
MT@?J,;NGV:*!6>2.4/L.@P,"WN:S+O+PA`(?*`Q%EGMO-#A@-;RUYIX06&TZ
M7'/L'V[91OY`&>]KD$/@834)`4N:?0:[8`88"P^/X_Y&["YRK2/-5IH14J[M
M'=U\W&%;@@&@RZ3>19\RU0E<"\T9PM%W#GL6!$4;X8"EO*-#=]"Q4O\!<"@2
M/[@<0*)A6/6V'J_M>[HYBR^OZ,&V9Q7Q#C\NY]C\\`=,?3@FVW,"R),+;YFT
M8"-<)1FZ+-$.!IQ]$H)-J%[3]M8$0OL6;:IL3<VG1@%=(&9D@:!H^^H45"J`
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MI@3VOK`5[SCV8M*K"3<$JUW(<1@/A$$GK=7Z6[*]S`HBT:I$%ZV:;A,1<`Y>
ME6JVY["2E;R#7W\!UI*+M<57EKKSY.F+77AO@4!S+TMMAQEP1-TOKB.E]SE:
MH\OL#&<9JAG_1U(^7F;$$JBEL]I\1F6>Q"J+KB$)P6*LW;IWS'M9I.T,1@B+
MMW9/@GY\`NKM81&Y1_E.9?8Q*PKFU*#.VYPI/,&%@/\!?V$D9P90?9*2=I/B
MOG/[GGN]6Z9\&U3*+>H=NOK&J((,K)F@?)K.(;98PU/N/-N+&0JR!HZV/;5P
M=#6N-G>X*A^CW1-9T;_\-ZP9)*LT$A66]HX_??V@)@EK*D)(UGGZY\5J"8>1
MH9Z.J6SV)XRTXI"!L]NBC&_2,$NT1LS@HW?`&Y@MO'[:,U0&5,)(K0J`XPY%
M)>G^)Y0A8E%Q42(HV@:^0:5FC!NYGEL#$$C.>8I&%]Z!ZXHRO]H<;_6HN`C@
MV@(_`:NB=PAZ<18(11B"QX#%I(6L?DX1?_](YFWQ7VA#."F(F2D1@299I;U8
M+2KM'=#Z.E5-$M9TJY"L2]`%DDCRKL3QU]'KQTT>R9^\)9(\,DA-_B-CMRBE
M*3GKS)_UP\T/E/76LPYD3+';:!OK9=A8`,E5/NZ>4OR*T!W*GY,8L1_"IEFA
MX^9D@N8<WF;)[Z0_=>1PW4FY_"H.:(U2K%BEX5V=6D(K,_F*N]&`TOX:=8:=
MEL5J)P*XT[O/UUV_)4Q[?]7PS;E^)%&CE_4?*.D=ZFZ!.<K2+B,PH2/*(J?C
MI.T`A^'=0P?8Y5X[E:K#QVTPN5ME`"7&G\I%.@Y%"1R%F]&`_2Q1D]6=G]A2
MON8A7;A$C5"Q!5__51>$&L;&%X*E*"[I>O#)MRA?"RX%,\NT#O3^-W^;`/9R
MU7'LG+X>RS3V6,W\L0?9FKZ]+<SI[Y)4NP5P0L*[`F`#"4\J6BBK4Y>UGGGN
MA"47%[Y;`^X,9T65EOM7Y*]QUO[]/,E13!JK/22K6GW!OCSCQAIQ&[3C':Y.
MT8@M"QJR[QWTX>!O-.!]UHNFG:W2Z+!CL,XXHC*8F-9:]V?"[)E$:W8?V*]I
MZ54^A#[*5?*NP5Q!"!L*$%!6EMGM9>R49'/6>DFH["%=?Q$E.7TV$9T41;6K
M%34]"/V,RD>\QBG>O@I.(B:D+&LBVZ"XC)&DX(X)]'_!*6DF3<K76S(3/B<9
M?5M@B@&58L#%N`H(>]?/4TX;E6V6J\'5-5+-Q:"TI;/8_27YBFC,5AZE1,`G
MZQWI()4LC721\6DJU6W0(EG'^RQ6]FOJ",/4LRE)<]DYBQR?QO$<I;[.WP8\
M2>8J6N9>97HK=?J-SB1]])0H;SZV]?[=+H^V=9^!"6WKEK!W?;)@VYHYN&_'
MMFZ['W3VSI;W\^0Y6:.,]I4NS9?9!:8#A>@O%U59Y<QL_.JU6[>N0D7O4]1>
M1*"9T)S%^"FS%0:D`WU]=LE;!^T,28ZV#<(D27H9""U:<`_B1>9!99&AV3P^
M\"PVIP2[%IHC0OXGDT>+;(K!"\@"<]3=9:>>=:SBW9[G^UHHK/<JC"QA`;H:
M;I/BZT6.B.%(^H:*<N)#/`GR+MP,7++^E<<"G`SR`QO0`C=)Y]]5D8K4IO-Y
M2I"?3!6]^SN]#.Q;445\7^?4628#5$5#[QJ5VI3G+BRZ+H];^O3>M<XT0[E`
M=</N=1C)W@+6,_VS*'\GO-,?[;YKF^F&<\'Z9MCO8!)A63SUXE_O'I?HGGP%
M$]8X/I(:GE<I9;-J6QN=,LDDI_(VG(TO@#N@S#*--`;?PAC4`:=8KBN\@=U7
MZ`[MH*6%S7+G&S]?;I2I_2<!3(DE&!420[E`DX+=:U#5S//61>,"XJ]`K#+M
M"M3_YGVZB58@3E<45Z!^2RYA$4CNR_UED/OH!>W/:0MOZ2X/G!R9$]P@E:C1
M2Z$%E`P@"R55;#BCH8"KS8'7YIK-*<K0)BGKT;DG`WI*./H*K?7F+8XR2FJT
MY%UAR""#F1325&S<*U=,?MAY'37X6-*UP4X(RF9#7XA[/BHJNF+3@)`L3M+]
M<W&*4T._R7&V58VFYCLYC`5G:W;H,+*D,.FC),X;WHD(B)&+ZEST5TGT0)UE
M2;.DR\\,K=9&DT*QE?G.!Q-QV9H*BCPXB\8,Q)SEIG+W9MIJ[V`__E8EY2M]
M9CJOZILB*RJ`^\<HVZ?&*JYQ]DQVL6A]B]/T`N>TDFT_D!$3IDXA3>+S\_+)
M=W3_-(B_4>[3GVZ`6[K>%PQ/,\F&(]!PE&T[!+4$8L4WJ"X(2_NKISJ"_:Z,
M\M*W&?F>R/<]D>][(M_)$_G:S#O_GM<WD"7_/:^O-N]+<EQ:O\#^'H8TVS`D
MGR^)O)\`NSP!GJ=N>G]/<`*'O/XB*_>&H*7V1TY[XW:]JPB7;P7:E?J$[P,:
M,Q[>TM8:H!PKBU6DE7WODW?0VH<8EA.#*/6#(3M=-/;9"!=07,</WZ\0FK.%
M.?(,9*AX2;IMLH9W0O?&V?XPL'UYK?7EQH3KY!E1AHB\_HUL0,^J//J$LGK3
MV?SYK["CPV*SC2BMM!@,F@"WA7VQ"1`X<#U8H;\D0U_[4.1*\+R0O89-3PVO
M`GA$B+"\PWLTG45/21FE-:\%!6+^C-87.-_G:+PLBBHB>`2DJMU.JV34ZWM7
M*1:1A.U)TO;QYA4KV[8&D^_*B0BS.9==56511MDZR;8.8UZDB)DJ,0&1)0R1
MFU@5$1W[`S/_V!,Y1-N(,9$<'=O*EMM!*S$C<,>6%QMB44C_0,GVL43KDV>4
M1UOT\07E<5*@FSR)$1VBS50J7)$1^UI$FH&E#[O?L?8SP,M:/%3GDIN%16&4
MW2\WDB)QM!3Q11'2`@4X]4QE,1#`+:).(B*8,YS5!R15E-*4U,!YID\6+.DA
M9>KS2\8OA#W4Z9]X*XX?3DS3]YMPX&TE\CK-;"3XMS;N@_7(AV"L/`%@(I"0
M5B7/]O/)>IWLY="\NGF,!A"%X$Q"TW2-DJ,UOW%;M9GJ]N96<9GMGRBXQV64
M7A+`)UF1Q'46&D>;'A72EBP-.9+SW>XH30R+.QN-H;2]K9'INLT=C%R7WP]`
ME*ZL#5;@3Z3I\CPJT2$A5A"WA76XG.ZVJ1IW;QI-`4,H0-S,>6%T/+FGO>&L
M"AY_EY]5A#GQ[6@)(;[!71X8'-N(KQ;3P>1Q<5)BGP/CZ\D:E.>K*:<],7$V
MVO,\-;$ICB7E#;LE*IOTBO2U#C_CW_7DE6UO?;++A#]K#6]KJ\AHXLO8`M:6
MA.;#,Z)"+'-*#G(3A(5C,0+%/9..I><VZ1PW2[M[Q<N;,^7EJP$?X#C.[RSX
MILKCQZA9I^L;DVU8-5G6Z>4/VT>^T@1-3W8E"/F?/+H6X!4O@'^RL9DDTM]E
M;Y:TD)ON)OKF_*<<%]8O,(DI63I:8U*8[VR?/.I</$*SC3MG=FUQ>L!K6)@'
M#G[]X#\@[-?1[>PW%!(6PIB_!X-9TV3[8X*/V3H(;69-W4]^"&O&A1-K:-%'
MJ[YBCLP&>.[A1\J]7YR]Y>1XN"_6R>-#V.2=QX`,R<Y7&<T@43UWC-]0GOJA
M'-X5E+K4PHMP\V1VV>?K+>C`<&/=PC+NYASP]FXHF@3<C*+\?82\:3%A*^I-
MD?A\U698@6\F8[[,V#=%B3A[,-!*RH#C8Q(GV7J8\O%O<*9/I8JM"I"KXWWF
M"K)UZG1=+1^G)`7GR%I:2-%M^PZ%QW"B#@_@^/DS4RCP:-9$M#ZO<J)?]PJN
M[EK1"VL[!%@03(*Q`F:M=;6&3BO^L>PFPL>*5*<)W]%EU9)F(^OQ`P[`^.>)
MH:/K#Y8%Z._5;DAF+@$-S'<:J8?.F,K77V2,!N>FD^SG_23+T)8^KN%]DAF>
MN/]2NTV(N?7QY0G1J/][3/_4R(NNXI('\1]XN^^@&+04+F.3L3<;0Q,\2A86
M8&-33F'L\$-2HZUGY.#-=:L487)651R+S'RM(Z-P&?=#%D1<C)-N+DY=.#DN
MZLMO\N-C-GGGI\-#LO-5+S,(@.&.\1L*@!G*88$;PPGD%EX(C"9_$RNY]Q"8
MP$-@S&#T'@)C(,DW92J*SMW)4&U00M_U\AH$H\F&K3`89?+S59YA!<*8C?LR
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ML60C&/`Q7VWBR_]A:]#G[A\QD,.[3A.*4;1Q\47>K<9BD)VO@IK\0%IS+&>[
M#Y+O+UOA_.5=X3"EYN)>WR1,3::<WN_\V;CS-R4F%ND6-I70NUJD=C/]AXKM
MD+>1&ZACF82IRF(V/5\%Y,9%))9_V-XA)O]+FKR';,0H?R::B2VHPR676AS%
M/2ZCM/O]#!?E-2[_B<I;%.-M1OUGW>2KP*R>E'8#MXEHSE</Z#IW?`RF;T?.
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MSU'^%95UB+E_H\,AI_8,$B=,OBLC3X"8@09S)`:VVOOPX]O<R+N)H9-S#\PA
MFD[0$P!,'][!Y!),JH$6\P2:="\!$/[T#D+%A=E1&K]@5ES;_0.`9_'1L]D#
M;]JSH3DH.KD.`="RF#;M'5IFCQ_-`6N:/03`9_'.^3OX'#]$LRQTJHD`@.\;
MB[X72K>3MSR\!Z%UF'/^2)8:4_/5>$MX"MH`0.^/9>F*$3A`_?%'B][%)>G>
MXPO;OA3LF(.IM&B7\EM0E;XU(3C2;^@A588H+*BL`-]JT9'>Y^@EV56[?D`>
M$5,;:&I;1<G2,U5(8CKS53]N]J:*(Q/V+E/<&9=6RW_\,,(4Z=[7_3?FIQ[>
MT$N)LO4Q/^L(<3%*TS4I1?1<](2J,HF+/\9XMV?GZ%F\1N45+FBWZ_Z?HS)*
MTN(/WBZ'1#EUK!_X&3IRA]<X!,7;"Q=@,7_*^/!$Z4E6)NLD)2/TC.Y07.5)
MF:#BXTN<5F1\+X@ZH+BN]CA8;89]Z3VV.M3`3HBT:M=RX]YUK1!,>"+)`FH3
MXJ^G#"WSU;K(/,X4PXZ<OK(;.'E)H%PV$U!L1MHI)>\3RM$DP3Y&2OC2M(TN
M=F>RTZX%.ZVOHQTZQ_1X76ENCJMQ)UBWN/=9,@6&A5,&%""`>X=,BR=!EUDC
M)`,AUNT&X`QG1966$=DO9.MKG+5_/T]R%)/&.IF=/B-&;A`[C0TN#6NT$RC$
M&9C#EH6FA-XC/X?`(0,^@+/&6;J[;Q&Q-!.:&K7N*!/L4F6;80'*S`JG*OTU
M@*&`3`,KBQ&-WDT`Z45DY.*R:\://6A6;/9.L][Q'KR!#HW!W*SQ3C_LS=A`
M/(BU/AKY7VL)^O,C'ME;;;ILW:*4'L70[!9%/3(/':_P*&QTH%#L--I`V+2Q
M`#R7;,][-]_I24PF3%*^UFBX)U@Z3<>7!>TW//)0ZC?H74=;`AW3=VE)SH`V
M-N.<[=74YWA)]OA1'H<3\[U'6&^ZJ30RFEIRE1<]C33D-^&4D>../3WFN:\X
M]ETJ%=9)6O-2&V[#9%>UQ.5GDB-ZHTEGG<ZBYZ?;49EP*EOO"'O66[RFYMDN
M[89[=(T$&I6Z%U915+LF+XBNC6I.A&.OFC2^Z$GM0/Y>[%@3[MG3U\)5P%!<
M"]5N%^6O1%P)T6*;)*8.^#C&55:_X8/3)$Y0T?[OS=DP9DG@2!!7:'V-G(+>
M%"V!;5*L-@/>7O?_BA2H6N5&#+*5O"L\B8'%AK*`SA)`RET%)$MQ29OE+P6U
MG(HRV1%M#9T5L`LU(A]^G!G,N'TS@M.PY25M(L^BXO$D6]/_Z.V!YRBEJ[J<
MDE.JVPR$9)V984]'$D:0E"2XI(W//M\7-0V/)U/[#@/P%%=H1H)7<&9`E.ZS
M$?IX5)P9ZSZ4(\YH`KE]-MW;I/AZ1MA/2OH3I!+%-5I%R"LY,]3)]]I,Z?'(
ML'%G,67'A+@[W"C^C"*Z0:0[9Y7=AW+]9G04ZLT,H;H2,<*K`M$EO9=YD^,G
ME)>O-^D^D)`:*$_'OHO`JUK],%*RU68&76UY&"!7GN:2GFPZK8HD0T5QAG</
M259+CF]ABBNTGAU.P9G!4;K/9AX<#I4P7BFP`[E/&*^_)6E*YM@ED56V38A1
M?5(4J"R&OW.1J-U.,U@:]6>&6U,)&<%9@W@8V?F=H[S]I(MN=GTQJH?UEH-F
MKD1<H7A(U'V2]0GA>[E[(I8\-7]6^7E2/.$B2E>;*YQMKY)GM&[G,0V2)A)D
M3V@YV]<AI08`3BC,;/*XE[+1-'/"GOM$]9->U'I&684Z[S/*32_I>H<+7,+R
M,X.^J@2,@"Q!S'WJ^FGO#R(R</1@YIQT/<7UEOGC"PVE05P#1Z'F\6ZAN,;L
MP*DJ!4-X2I!SG^+>Y`KW3502ENO0++X&E"S=BI53<":84NRP#HZ$)-SGL/>>
M5F\?Q5=O".C1#+%/J,N0[ZLP:(F;"D_0PDR`:T]*1LI1B[S[O/E3'L+A'"7;
M[*PB;&=D7N>DHT1(]>6K;%W_FG8=D\)#.=/VVD,Z_79F-@5L2<SL$$^?B47E
MX2<S'N_0??0BZ<D0%&_=$6"QF6%5LK]FC@&0!H"T>1[#T04G1X]DS2'KR[[/
M*CXTU>J'>!S9:C-#IJ8\#"-U9&D"R)WG:=XP'X8<8"5K`4E>YPY/M=X;H5)(
M"@#C/`_=KM&WCEARG)$?X_W#NRKJ5+>99L#4J\\,OX;R,0*T.FW@ZL+4YW*`
M.ZM^KJ"[7'#=6>+2C8QY!6>"-K4.Z[NS>"3>0)IXN9N83?;X/WF[B=E&1YW$
MOU5)49^L</(\"TH/0M1&I;R'XW4YHC_FB)\[5[H>I^>#\MZUA&@,&0%ZLMT'
ME`5`D16DQZ$$WK"TMVB<57GT"65G.'_"^ZL!<)9:4=EV+P@6"Q(([-'%:GU6
M@$&/WF'I@.DLZ9KM&[L$?TSEP`!"<?K:^4WNA0ZU9D890V2K>Y^GBH<]9O(Q
M.^E1IBVIU+UF>E64HV#]U'@H08X!T7):$[:YB%K*.XH>RN,S<QS;$R[8Y@=E
M%`BD6\)'&D3%F5T,ZE$&SO!@Y7Y">85&-+J@A]L.#_5G-,5@7M)8R[OJ@3!$
M;Z:@->T"-U>\=+WCU6!1^<"0P\\=K]I_*2"Q\\=+D+)DC1(R#]B_/<I8-*X$
M">-EJL!;XT[1$">B^A24GWP!3#NIL9.;>MK[OP-!R8FWK`T@*QYD'P`BV`C*
M5^0$^@PK^-P'5[NJS@Q8^XP9)[[TP4U.'];_JHJRUN2H7&WNHQ=X`^V*TG'G
M;9^"=U6A@#<\I;0!12-FM_=0A0LVG:NIF>Z(A9LX!YMA%DTP[UH@&\;+C`P]
M*LI;`LN[DF+S!N4T3C;:0HXQ]0:8FTI^1>\@5+5:M*5B:,2HT+64!)"WC0C>
M;:ELTEB/Q!U2<YZ:<:8J7&'/-XUGLT-]24D*;]%3DQA[M>%L1Z%BA\M]P\_>
M0:BJP@4]-%34X]:7!*+^,M3965]7U(6UVM!T3.7KL8B<]UVE(::5(=?`[*!J
M+"6K5H<<?9>Q6"$A?O]C0;IY2\7[017H4'T1OL?UE@-K@4Q<H7E,%@3QU)Y!
M(+*HWY6;/,GBY"E*3W;46#U'&=XUJ<F(97KL'=DVX#.\VS7OM;'"D*PVS(2R
M=INS@;DS06KBWR8_X,289UX,"95`1!4C`^W>KR^OW=MZLX&]J4S<:_>6+`CB
M>1KEK3>HR0_"V=QQ2AYNO3)*S`Z"XGX:@HU)`(35<MZ#:K/O=A/O7J/2\UO3
M8$Y@P;FG=#U1(N<`3CU!WK236BNGLP[I[I+\T,KDLU:\S20D+I70>HK7H`)1
M*R=QG%=HW6C3PK<ZB5YK!LA@U(Q%J2B27J+&(7\5IV0`L?3-2%PET4.2UJ^G
M*+[**=O`*'Y>7-&_4I$89F;HO*)0(+4"DV='S8O)OC'%TER/?-<L^IZG1J*W
M^#5*:SOPBNRIB&PO$"KVYY_#KJA6.X8^B6O,125HRD!/$<@36U+T8_LT=_,H
M<$?IL6&I7*_-<B(N/Q=4ZHK`;'V2H!;&,Y8"#<C,T7J&L[K#==I-"7VHW,A`
M.RK4GPLJK<C'@N94(+VD(_ZF^V1;ND%%4?<(7MO5*O6Q"Q:>"U"U.F^F.T6D
MEO3$91T]/=["\($H5ZF;?8=3>&Y`5.J\&1!%I);TYJ4J!F5'8$'(FP9TRGA3
MSV>+RR@-T9$AE_[)L^/TS68@.2&LK9.THFG'C^].?WRA#^&@]0696?064+7'
MR&HSS/:HX%VU3&CLA;5&P+L*T\USXDC&EC*AV.-NZ;Y?I8QY?_:F-.T-K526
M(YM$K&L/5H:D*=<O,_9/7]D-<)+03$"Q74%=4O*NZQWA&_L8*>$M)QM=[)G5
M+KL67JX<-K?"E$JRU;CS+:@42U-`6CB#5',V.61:/"=<)8$"3AK:DY(SG!55
M6N[C@ZYQUO[]/,E13!JK8[/W#R#!"4:-&QN<?VFT$RCBV2FBK`I-"<S]_%&F
M?"SIC-=P\E\)TD_9;MZ.Z=5I=JZ"W]\R<2/U?MMV1-ZV&:C",D"D/8N6*7<W
MB_85*P3?$ON+4H\!^%_?D*//7;IC.YR%M_6Z1:3725RB=6VH<%.3<LL>GYIF
ME?&/2`4[4Z6_!F:D@,RRL],$ZA2"#,:Y>8"N1!ESK.:>"B.;ZYM+JZRCTRRE
M5U;1;]IIEA?U6A2]LY_4.21I3`4-6B3S%64!Q`AP..M<V^";K5IM'!]35:D;
M0'#!1542ECXG6;*K=K<4.NE-DV+J`N>K)T2?M,FV5R@JE&]K66A[=`AHU*9W
M-:>'+>;^PIYP`;VHQ"M[IV'$X](C"'CR]7R3[%V-2@81]Q'<@WL+]/-*)"G-
M5MHP8]7:\U>"9@*SK>Z4N5F24U"R\X*P>JU&U/`?3O"S+GK5)X!2E+0B6QHS
M8)$70R7[?IG=?\/_1%$.G0YJMZ,V#;KUW]!,`,7F;3)T.0KC0NK4\X%0179F
MQ*@EY3G1:>%MS0I(=#[G18>G)5U]E1;`!:YR*Q-CU)#JO.@T\*:F!20XC[.B
MP]*BKN%*]S]YMK-:C!I2GA3'!M[6I``$YW-2'%E:TI5@R?[?/Z(<19L2/"C4
M;D=M2G3KOZ$9`8K-VX3H<F3KRO*,YH/9+-##_IM"?"@XA]#]5_,+^?[138_)
MFHR"UTC28\JNPT;RL.P"\<L5AW/4#JD#`2&SU,3'^+ZSJ*#)J^A_-*?P<Y12
M"5WC+.:Z^M4;&`5CBBMZA[3Q"9>VF&P?;JDP\@8BG^Y0BJ@P_J>*<L)D^GJ1
M9!$18Y2>1V7D^]A^S-5EML'YKI:)],&]9BL-`)5K>]1ESRBK$.10&'X^Z*'V
MS]ZUC.Y`86$G`2VB2+"O1UI"2SK\(^O[\<WMDV<R^>L8INZC1H^8Z)6\.(V*
M)`:0IME*,U;*M9>`6S.1V8>W,C_+BF0?W8.GG:2I36E8]7'5'>9&EJO5W@P7
ME5X"KM5$8A_'0OJ6#N1"QJT*6F4PNF!D^L'CXEZ!'?9236W*J<M%JTE?ZE&@
M%NV\Z!K(UO<6E4F.J`OA+GJNA9!&F>\=+[TXB+)B#]]L?>11)4Q=M85CD+I\
M38]OD&Z2#-4NGSQYJ"BS=.`^1R_4LWF29564=C]2;+=Y7\B/,>S*L]CRX=U2
M"RUZUV\ZB,(NQ0K[!&7Y[+^$:H&_)3D!`($T?<X_1R4!2[;M?=_+8;6I/ZK-
M+_5V^;-+I;V%SBUMD4XRLU2XFW7HL'[_K<\@:U/G+<^90"?+LJ**`3G0%X1N
M48RW6?([N)-4JLN?"L,Z"T4]5S23`'S(@;-@X$"VG?P35\_I)MX/7/623G!Y
M5DPRH='6**F$4AO>59L%!YH-\=EWKVERM?1$$1=1DO\2I17ZC"+Z>QW&XUGS
M'7@ZLBE*!RE3I8$6OZ@W!79@ZZ0H4%DTP[%>9;<T;51.S$UZ/E&(=)=N,T/A
M2%?WKK&DAAY;DQ"@F7A<=-60.O7%J9S/4?X5E53%'#.B>=8XE]DS*O8AC#3=
M&K&D:1AB^=K)LL_7/^H--'!2J1B`<74(/[G`^5W4'4&Z;R"+:9KHV%EFS8X?
M\]%LSKLNTX`1.S^P#7D"FDZ>1R!#L"9OB].#EX1`MJ7I'O=K`9'D)XS7WY(T
M]:P.6S8(1T,FI3>>6FTTR%.L&X!>%(VEO"I4;FFD_11:\*[P]%#"U'FZ@@/4
MG!)G;$VGP-'2MYG43YFC1Y05R7,=Q^H_E^N1GWUT[34J5YO[Z$4BID.R9B>6
M0U@C`!UV$L?5KDIISN'ZC6P&WX>14S#M3%H=6W9ZK7G7<RJH85MT%L3(.4,0
M\`98<GH\O0%=)\B]^M-[\M7`DZ\>0=Z_@+O>K^1R#]:*JX[T&Z]*"$K,5H)I
M:=&XRQ_-8R&`!V?NJH<"_5;1^][/Y)][0H_S&J^@=(LSJ)1W:"DA`ZOV6_@J
M"4RTAQV(6`!P8?;@2O!JH%PE9JJ'<6%_;X?E*%IM;E&4?BS(&*.;'!-6RU>@
MTZ+B[;MA8#'ODT5RV+!RGZ725PSI]5[C`>DX#\J=D=)2FG:6=)>(IJ?@3N#Y
MX.'K#2C?K3;USX-)+5F:G:VF5]`[FN1GM5JGM2>UD$P8J87E($0-1F(?UO$-
M-RA/\)KJ*?IHR.HA3;:U=(;+I'$[;-A)-C%S0.H(RBI4)1D((UY7#L37%7T&
MK.X&^D;Z\22+6GY%-DRA.C/'I90HK`(1HAA&%D4YY'4FD!KR^!79R(/JS!QY
M4J*PBCR(HJT,AR'<46!LRONO.HH])8-7($%?25O..PY%7@^^@X3976B;P:8D
M\(JT%'BI%$(!#/<U5&Y9-E"">?54//(P3%2>.`7I<$#RAMXS944[ZF<V`%9K
M.*;J4XZ+XDN6HRBE=WKH>1P8S&BCJ=9[IMN*/0L&9J%^43<JF]_^D92/2;;*
MZF3O3.[4Q*3;NE!RZ@U[TT%6D(1=BWJ@T$R8/EA@-IDU]9G^O-=%&=K2(WK?
MAMI[C+5QC+7<L;-D?86HZ5`.H-V'1RL<0;N+@P[G$/IS]"^<4XNN6&V@3L*'
MTHJU&W%+U_(.1W5`85/A"$^#!)QTH2C-P3R`R-WU*]>7!V,P7@%51*F!4<5K
M(,F)(AA;#HS@"&P6OMQ]PL\HSZ@Z)Z0_5UD2)T^]HP*FHT"O<B,]A7IS`-?8
MNV`D'7UL'=T/J@S,.E>8S"(P<E9K6)%CA[>\)7D50KR0Y!;M9(?SDN[':%H4
MP=[$2IN*'@"@+>^J0@]#V(TP#0RF*V:$DQEO2\I-J.7JZ,G%<#*)&S;QJ0T:
M]#ZM[,P*C6DF+69@KADQKC/W>`R_C0DX<"A^(N:0]@(FT9:JT[_?1E@N_T_C
M3:23MBVZ^S^%L?\T@Y!-;S]#SLJZB<.S56?_)\Y)^=+44E\JQU0X=FQKL#W%
MJ<9H)WA9]A!VZ(!-^VK4J(D"ZS06L-J2A9>I306)UM">&C%L;$MU&%V2PCK#
M^1/.HQ+1KA\%P8T,DJISN/3*+>M]!FCY]G0$8<.E)TG7_F6$0#TI\-5(`U>>
MS6,F13["ND4BO7?=$/I$2]X_YKC:/I+_4*TQ"YZ_PR$%55>B9./>9X0U)XA[
MV;ORACCAW/E5KD"UIZ8?6MXG,IW_F<M3T%?UC,%LV86C0\>6PGUW[1C)WZN;
M1XWO-S4ES0.I]2@YFI9O,\#::`A\!ENK,FXZ-6T%7KN:G)"#T%'KMB;AXKR&
M;N7MPGUHG>.9KH(,Q=')AGB9=8+#C2]9B1K6N7(%M[GT)4U?P-.N8$I\FB:Q
MZ"]8][B,4M].>2T_B<WH/!M1>3-:J*R'#<TA4DC*"Z:>"\9L_I@N1O4>UL5B
M)-.P5BA0>(O15(X/?0E/[.E08M3Y/)J3-]GBK7I;SF0SEL+(F#6%E7'\[:S*
M*4"T[`NP%2G+@E';^UR8,&1&)#Q_,3(,SM[UGH&]*`K?\W63@\&7LW>1W=J)
M9S@K$L(JW>&=HOK)AOO'*+M'.QI)DR?IZ^7NB?1V]*:W]7:%FD^ER?E.$5=R
MG<A.4.&//67^;3%IGNK>7^%L2S/D7B710Y(VND0WU9.EO/`U7QU^9%_YD*_8
M)G&4J.#-SCMO0$83P)Z1_Q.HVW#!IINL`MXUD,)@886^0LDHA=2ZZRR+RI*B
MA]O^W4<O'9D(X,4N/(#8L-#,8<;MLU6H#2D%?<C4,KU_,.N"")RNLO7S6Z<H
M0YN$[;53J#:`%;?&S#"F*0HCM,G37)*GY*C&GU$&7BT"2HW6SN;KS-`FUTO+
MJV9#(HP]IQTL7>$H*VZBU^[5A0&06$4:^?8_S11"G/Y9P4^_?6>[+U\[FKLJ
M6^>O8GN+7[B[<V$4FBFTI/IL!600I3!>-G"S@9;<+@LVQ_,&UQ2PD@"4^H,%
M(02V#'O'/UH2E`;@%<Y1D1V4*9W]F(%-<)CSMYEF7QYV\QIGL1+PQA4`['4+
M+@1^8-^=(+!+C0W"G\.(2*I/Q7I;WI-MCO:G`7<X99XBR=9I!"PN/C.(Z0C!
MW%LA)@AX9"V\PV$-:2?E/QZ3^+'3"2[(^,6[^()*SA9:4EVWA"J(%@"HJ7W\
M`*#V+V-=X+QF_C0JC@^ITG2P55&>HL]10L239.SC<+T66MDK5IXC$LT$9`Q.
M5?(`7J<^)+!C[='P3!JVM\KV7NE:;OM'XP!S3Z)&,S3<DC,#JGKOK5A\7'(`
M$"V<&@02*M&XM'U'1ARC8<YP2F8#32:4/*.3/(^R;?UJ;'&2K:DQ#GR^)S\5
M9&2I/I%[F<4VH5'B;7L$O*DNF@=JM>DPQWE@A%NV$0Y0QKNB<H@*K"8A8;28
M+0:[*A!@#`P,\1<A/NIOQ.XB-UV<9BMMG*1J;>_HYN,.VQ(,`%TF]5[LKRI5
MF[@$MB30+",F[#E9,5/\U#Q@43]LGL<)O9U1]WRUN<GQNHK9;YFZ:?R0VM!:
MN]XQJPM%[%C&T!4'-78/&R.+;"XIC.\,5QEAA,"D?+V.=HAC=O"*'N8%JXBW
MSMVBIRJ/'\DFN/;[T0$><LA]/DNY?B,&A7K>IS]W5+&Y+(!IS"+;7:H4R+E8
ME3ZET0N^VR7EXW^3PN@FC>%%1E2V=2"`Q;QC0'ULL5K?`1!(TSUH<9C>LI2R
M\<[C2O#BE0L2`N-(KVFKSN^8@G!+C.2KA/Q8H`N$SBNTRJY1>8M?HY3ZL&Y1
MC`AGD/=;IXFC^UNMMG?%X`0EV(XPH77%'L==I[H:ITM21HWQN\KO4/Y,.L^Q
M$'E%#\/&*N*[<Q0=#4/\!U6%Y?O=9)7S/JFYHX1U^LJ<B2PR70N/T_P$;H=;
M7$9Y\D+_>T[RJO@EBF,R[V$K3ZI":__SRX:"`,[(8HU>\W$P)G90KP(B82A3
M`$=WR39+-DD<965SP--==(373HW::,]!E*O[37:GW5WF*P^.#I=86>]4&6<_
M!V&/X0G49&/M'+9GG.>@!47;6RQ0*>]*T=0/*M=_RUY-D.BR7S9P>78HX>;T
M<G3(YNLXL!:/9)*,K+\9X>Z,#@89EN+ON'A*RBC]C-9$_Z5GB++".7?1:J'U
M'RA6]HY+??>9D9RL.=54N0CZ7GEWKWY)N49%>=G;ID/ALVHU&3X=7B7O()W,
ME2,O.D\>'!Z#04-[S^OK85KS-JN\DH==*KN0=ZB:6F)2O;=LB$$TP\B%`.G*
MVPL),,&E6E$R"G@'D?ZB+.ZOK86712D,P%@Z?]]/BH\O3W23`AVR,POU==3A
MHW=8N5I&I:0QT8H)\6()FL\H?\!O;5<I=33B85?)Y@L<:6^JY*YZ*-!O%>G.
MQV?:)T*/<Q`E*-TZ3J%2;P23<E+R`DN0-3`?T!L9,X=Q&YZ\6C;[8RGA#V^%
M\JOSN(?3PO*PW@OF<%JDD_CJ2^5\&J`DT$+\(^J__?CCC^$`AGLU@UN6#91@
M]G;BD8=AHK*C`^EP0,+?Q^T!$L3>?Y/\CO++C!/8"A1I93;\ZAT6!EM^?D^M
M[?>'9(('27N;_#;9/I;W^!IM<9E$)4V*_I'>BRWJ^Q&'_M,LX%\RTHDSE-,;
MYF=)'E>[HHRRF/T,KA,"PVP#=MKV#F_7'GQW`S&MH]]F/T*?H+=)ML9/Z"G9
M5;SC`+!4ZV9C%/".=X4H-5'_]$/3&"V'CHGSZBOZDI%)DQ=)^4KZ=O](.E7\
M%]H0U@J<';_!B-%MH\UXK%S=.]KTC0=#65FS+M3Y`)$<2'#ER8[VN`VK/RKU
M&R*!)$Z>B%J_S*!EA`5K*PVVM]/-VO(.>*?FA$U!3VD^&/(=^H2Z*W'\];(H
M*K0^K_(DV^[-I3JCV?[/I,LJ$\I*@ZVWP:RM94\HFX*><D(9\@U.J'DF**/O
M+:\VMRC9/51Y07WA_+-Q8?G#E4NPW&*GA:J,)CX\Y[`%@GJ>41Y-##KM,'0>
MRRK2OQ#0?%H\6CF2F!B@?4Y`3%IX:B60!'QG>$?H/%(7T#.B>0B]I^(C':['
MZN-O%=F54?YP5H\L)[)!IL[!H.*6]:8P!NQPSS2Y99M^`F6\ZQ*YL<)JG86.
MJGBTNM,>H!%@!KHXKG952E\1N$;E\5WVR^P9%27M:IM/E)^"3K.9=I>O7-T[
M[/@HPM9$`R"12;Z7A4Z9;!@W@*W#NLY_VUN5]L_JT:[S,JOJ-#&&LT15[U#6
MZBG66RVA"P$*+/3"`OBD@]:WO(Z.K%L]<(Z-9"6`7KE($"1)^Y98W!<X_Q;E
M[`?CM5M1$T&O@;G,5(['V%1L9O.7X0K68.@-+E1D":]?6#%3!\-6U*;"L;;?
MS!8&&&:;91HB8R6N4.<+L-?D^+$T"YYJ3S%91_/2]UQ@=+GM+I#81:/FP9<K
M4<-C2M4XC8JB3H-"!Y@^`2T!D.9YN;WS7Z`R7)`X)&:UV;3W15<%7'@2`8,^
M3"&C_>2O-AETOBC/9^0-=HYV1E:-`?`V?@A&4>U@3_>#OOY7M?=<R+JB)"J/
M32!N)>^0U'$[R8O!@K.)2VR)^9),O2>&6WG+#A5U;L)(YF'Q(5N@RZ=H@^G[
M4OU%4[0SL]!B]RE<W9:6L&.S)TK[NS<CWM[*##*8*AISXNV`/PB4B^"L'G5C
M]JQT".XYQ=J_?C!SS/TZ.MB8%]9-Q16L4TXYNF?OE/N8K4.,\*&7N:YPE/D.
M[+G"V9:L>;MS]"#*5,(KVD;(,8OX"_<;L,,-W^$7!CH83``/=W"P8B^![1"+
M1B],#V@[@!/C.Q232;>FG/%3#4#EVCBU\??@AIZ37T#0.\EQ9R06&#<\ZP-%
MVA%A0GRYPNTU0Z"0URY>9H2-J@[!Y<3P<$IV.C<JX7U>",8%J_00F!EL$MV9
MP6S:1?K[/J$K:J3DC,5<JBQS6+O%W++-7*8E2W-8][Y6R\D>J_:59;%#5(XW
M<#FM3_!8P^=D?18]7219E-'G2Z^NSN`+WJ*RC1C@8N$-.'`]6[*GL@,^N'0-
MM[ZD6*"!(`0A@(+2;&UB%-!G[3&P&*%U08^;Z=U$F@-DM:%\`AT55S@^!P86
M#&))YPT7UNHPN+0S2`T2DH(DEGB2SS.3>*N6?`0S@P)WQ5(*4`Y/8@J>%36!
M\1NV&:L`/4J,,I1'Z<<4Q66>Q&3=H4]TG.'\J;[^AS/.&\5J5=LGBV5KS<88
MT).#IFT@36Q)QVP=KX78'00[@H+3,]QU$>Z2_D+8:],20HP3VT)IR-!3]$I[
MLMI0[7C?:,>;G+XL]!2E^[0J+,6D5O,0QBE7:0X0TI>".K24:"WJ(0IZ*YYS
M"C/ZW@+M^/?`L`2:/5!7]&R=3FLVWP20\ENU[S2=9&O"?`/:"\1.)*I8E;D'
MY=0*;/1A3:(G!TU5(DW,TN'SG#9N:LX0O=D)MNU<WA/J[A963?J<[IH%:'.)
M&HW8N24#0QC7`)7OLKY!RJ5AZ>6%(!!7+WK<$VU&B:[%X'U;#!L#0TM!*25I
MV]K(0I!)C>MM.#\G6;*K=MP!998YG('TOH4QJ..G#V6ZPAO8XX.&0$O!Y#UV
M<:9Q&A5)<4>Z$:U7V2]1GM"U]C8JT0<`,:K5F18GKYIWG"DL/YK"T%^+Y`D&
M@UJI/<^7IXL<UU;S>86^/.'LL%OOYZ__')55GI2O^[N.S$,J1ZTS<6S6\!R0
M[E::5O9?9OR$GKJXW]>3]3K9L[KO[LKN1+'2/'.F&+8\TZEB4YY6YHHA0\&D
M)9::+&?X&6515M(5<;4Y^F;(3[NDVEUF_T11?D\:'`8K6FF+.0U4FIDIYK4E
M907@*M2#R4=L#\T7N&*_:V+6E#Z6]ZTL&<H,.4V'Y#UQETF,[0/YYN`A)S_1
M'4MG$1)C5Z8V$Z[\BC-%J((TK("23P_$X=3^4*5SME66'LR<@P4D?];&K<X]
M;P-JSA2**O*P>NX&$`3!^)<0P7A=46<CZ<!O%0V5R@H45S2S_6>RLWU,7VG!
M*$UI28EC8(W&F$!5:F>FL-67E140*Y$'(?W767JBNR=IIZ_MCE-P04ZN4N>&
M+:_P'#"KU7%]#[.(#(C!O\WTM?F^3,Y1$>=)W;W5INM2KWWM4F<B<DTP%:ZH
MZISP:B`46^<C(J(@EG]>S.,OQ$B*LFU"^GU2%*A^/.<3QNMO29KZSA;1\D%8
M&G(I?5U:JXTVRE^MKCW+[R+)DA)=T9<6:]IKM#G^9<@*U<'_POD9357%NEAM
ML<5&+J:->5=2>J#`+F0):#(E#@^6HREG`:3.4&":$[:LV<HA^$VQMM];/I;P
MB&V)CW4IR(S'?K"=(F_A@_K(\?@Q;35@\UJ2`S>[!>\:6Q>1\J"6$!V@JQ5Y
M4P`SFZ<@`%W?1BZ*6R(1,HJ/9%*?HV>4XB=J5G,C"I7J'D`K52=TF'(QALU$
MI`=.%D=]@$IQLJ24#A?&UH=&"V/+6M7J"$-""DN99BMB206ZA.F@`ML2%Z`=
M%'CJ:@5E7EPD]3G9;5%V0K30&EQRA.7:I*W,(B$C1K22R/9<'1?0BL&AZ&DY
ML.U<&3DSK3A8QBY20R=+IT%O*T3KOA`XY0!_VVPWU%QW-]!IJ[MEILO[2'A)
M9II`*A]?XK1:)]GVX$GC^XE-FY/;77.:F8T@+0G04'`!+,_&D)%W3HBDI[?Y
M`SE4<%$P.%N2EN$80M>H%.@4M<KBC4VO4H`B^5*@395>)1LHMZ]*5:$XNE6\
MZP+%H9;:UX$R43?:.SS([>.ZM&<]@1F24#<-U)LXIE%0J!J,D#[EN%!8^%4J
M`X*!*GF?V%J#CPVE`R[G\KP,\E-(\6!KX0[A%2".,KRH2GIXOL-YF?Q>R[A)
MW*&_G$LW*5[D)9H*4:@,AJ_12WG_#:5-K*J&MURA4;%@I1KSKF^L@$S.;:PN
M777#0\BSI%M9BM<E94%V%-FA?S3E-JI#B2\7*83/,'TE*W[,<(JWK_!I`J_<
MX9UZ5I&0-8O4:8)$SRV?)K`ISOH%8H?^94L>3/?^:'U&EY0.FC,I:OM<W5KJ
M51/;0TWQD/62MNN$*8L)W"8MW5DC4V:;:>`JT7"1!(!2VWX`"<DX]@*P.=!&
M;N";?L8&HD[T\0U;V98.VM+:C1[:\`YVOYM0MBR#VGL>6%R213+G7/".MLN2
M.>,M;X8[5*%D\K,1+7?+HG5`ZGZ#(LO6DAZ"X.F_XXOJ756HL6[R&Y)8-*$&
M0EXQ]3<Q<O*:8EL#<J*,^9_WF,_0EC86,NJ!59^1#=!2:_I&8R#I``,P&^6S
M!GHT''G)!2VN'K.Q$=AO.UJ/J'9CM%GC==9OD?!7&ZWX.*6XN+"UG[X),);#
M%,M]354;CZ`G:#8*27#.HAT.-L79B@IS2WH-27T=9J3"M=.8MB$72"Y<_W:<
M?,I<?V8<+[/N/*=0MZ.KS5`,P%21JW2X:,DOO,3U0DE`[E<($3N6WBM[PD5"
MTU3ZQK3&O"9E[2T+G<;TEX6ZD?=E@27-\):%FD?GK_XM0S=:#*GV>BP@P2P;
M$5.GFGY_!_+]'<CW=R#?WX&4@D7T(H8%JTP+B_ZWX&'!Z8HB+/HMN7Q`+I`D
MPM<T"SA:;4ZK@JR<!4TBO'I&^7."OOE.(KS*MU'6+,HT?3Y.D_4>=?5K[`?9
MK#9D?8^R.(G2._(75&?4%]P(L]IV`S5+;=J[&7$7/Z)UE9+1Y8PRF'A8O78C
M!Y6*WE6+72!@4]D!ZLH*EX<S+Q7NP)M9WA:WN^JA0+]5I&<?G\D_]X0>)_1-
M4+J%+%3*[]9-`T98M>NLW9<\W>[B"=*SB2%`U7'X'&UCNTI.I5XC,+DJ'N\`
M/*.BW$_\;'T6%8]@Q#]4\!#?/R[@=SXHC196Z"IK$L@0ZQ_@C8DL[EZKGD;2
MG6KFNDF!\I("PJ]1>9D1:Q]=8=+=9V+&4X'<XS.\V^'LKL3QUT=,M@=Y09]+
MB0$-H=E*JR=5:\]3MY@)R8;B4>9@84BGJO8FQ\\)V0Z?OGXIJ)-W]42VO662
M;4_B,GE.R@05Q&XF?ZC(WYJ/Q(Z&@6^AT>,\,&ILMM/"G@@MS1(CAL*X,@"8
MO__`^5?"[UGTE)31\(HGIT0CW^''>4%.W#\3_#!;7YB_F+%SXR:`%Y:'M]7!
M)'47[8[Y&VF55.T`)<'6N:40Y+G3@%_N00.W+!LHP1P\B$<>AHG*<01(AP.2
M*<ZN`CFDZ-JP'W^KDO+5]]F$]1NW[S$`LXT!\.D,?P\`<!D`,,_$N6-M>8U+
M48I,N4KM<BTH;/$(<T0)/J_D%P59#^4D4G($L%)W(7N#2^MX4`C1F.!$IZ9]
M6105W:M3@VBU(7OW;1[M&,NN0HTN#CB%/;O9!8.+=;K,]*:S"?41P"'@%0C,
M/:I2'2$8O&]75899C`J9;:L$10EXN'P_C#KHB-A2M-Y#=K4A2W22;1O2O!2@
M"A4/.4&EZH0*$#`EJ+HDU'`RR@@J17!9=E@3@5,'IJ\VM:QXH2JB\@=M!9;S
MUM<N*US7(5RPG6^,`@'89J*AP0I=!(TR@$AWW\)J/+QMZ1V9VZ@XNVDG;<TN
MWTLHKM'"GU?2.U(X@X]U>@M@94RFYRGD-;\D%7NVSVV4/",%J,E5:M61H+!W
MP,E`"6MV'E)4,,F>JA*0"@.(THZ'*UX<H41QT`%Q910U"/'_B-+-+=HF=$M/
M17Q874YVN,J&;B"E.FU/A,4#,(H%8X+UNBZWE;X:G2.+R80Q*>QHYW]$>1[M
MPR%OD^UC65`GT_%41^"15*S=AC+(UK*X'=VOQ0WE55[3O:ZHDEMM]DS<H+P3
MC77W2(#+W)\:M=0WH)4;\;Z2J0XXMBDU8*F3Y.FXS=7D)8QIK^=OJ5\-1VMM
MMPNSOISW95`U@/7&HA.&)Q>7OI@!7>?1HO[M`O@*C:1+1M&U+M$\*'7?+AZV
M:KM#<97OHR<C"JS3UU9S-@4AIY>E5F76/IG6YK@(NA&E^8)HC:\EQ:MWE/1Y
M52M=HGKQNC8#BFOTK?X$>XA5*H\/M[B50E/*S,V:D20T=FVJ]"Q!]1GE#]B%
M5X/RN^]M8XRF408;;A+%#[X`3LD`D*5BELGWVL@*XY)97(II!:-+Y>D."2.K
MTQPHU;",JH\O*(^3`MWD28P.'[4L*<FF>.:3L(G%V4QJ0G-L*`F9">-BDIWI
M0#1EC-"ZN"#C2W5HE-$^=]PE`/:EZQW&3%@^-'7)-8?4^Z]M"4F06A(BWU*V
M$06_B'YJ$0FOB%H>D3^'MYO[)4HKI+F98]?E[^6&=4+#D<Y6CBL'^SNY(3E+
MV<%=;>28IL(9SM9)G08J:ZV&SJ%#3`6V[>OJDY@(*C]>T!(>1IF3X)F:)JW/
MT0J=0,XNS[5,F'2>?=^_UN.$[$M%BFC'ZT.M.T]M'9!&NW_,<;5]O*='6>Q#
MR0GHN=%U`U+OBD\\`F%JP0''84Q/6QOY;L3?WDU^4I6/.$]^'YD;:I6.0\HM
M'-IJ(-B_J_5<?_/.IV,)@JZLWO;0\'.5ELE3B@K5";G:]-QI?Z\%=A9EMRA&
MR3.ZS.IMP.7F(MF4"&7-_%WEGW'>G\*7!<]T#IG/-BM5D"S.=BT+4YPNUL`P
M>^K\C8[`%Q"]8%F#E42:8!BOISC8=.S?CUGE'Z,\HVXD_`WE=T1N%SC_^_%4
M]QXWN.X`E]2M@4LSBN'=4Y2]VMZ@N.#-PF;&+ENS72S"$6%HFR2[O6.KGK^&
MH7K<KZ,=Z=1+JIS:"8FOR6Q5&99FJV["$-\\;5&9G@$)^,)0,YT.'#M_4:4I
M379ZDJ:XSEB_JKF_QS=5'C]&!3I9[R46I7L?P>GK%^JC^I8G)73%PQF9PTT0
M!Q1F8>-/)&#=.XU..%M8@MWW!]E$JA]*TR?Y(-L\8?&>=_D][[()8-[S+LMV
M=&9YERU;?LU!3_LT"-E-WT7L))K2E<96&51^EC:65.<M6$P0'9<OCUH&US$(
M>&C3G6RW.=I&)3I>,":;+`'L=)L;`U*]I5E"U5!@%D"LS@$([ZDO=0+PODA>
MT/JVYIOV,RF*VGU`YV9S2YN%8OE:C>QE*LP'D\K=UX6>#"$088&\V'.-2S(3
M]K''1.O?HWR79,T;KB=DTM1I`9C^696*K0-5KLY\H*8C!%VT2=("`6<QIM72
MBCTT-Z[(W[X\[7MXCT_1/Z+DN7XAZ^B1828]L]3D>.76:VT^\+4K.`LKN!X7
M(.0MQ"P&\O+,_F'%^^@%%<V3,S]Y>W/FP(MT"C6)&H>W?CDE[2FAPVM[]5.5
MV9H0/",82<JS*,]?-SC_%N7K`GSB0:-ZTS^EFM[='S+CAHUE`OA$.,0/JD.)
M:'CIB0]=;&)?RU?.G4Y^X>'\&13RNR;I8`,K]IRU^BC0[;^@S:8W!P!Q_?:B
MXB"(@O':"Z#`!8V*SYY-AP^2<-.@7V;$L"',W*)GE%7HCCXO&J/+VSNNXUZR
MU@$T@M(!8@?VY:OU71I$8Z>^D%`8&3GMX/#PQBV-72EJ#QUGP1.4;F0/E@JJ
ME_L`<?ZIJG0]3L\'Y;W/.=$88OWN`Y,.H-B=<Q*4)GA/ZJS*HT\H.\/Y$]XG
MX>9DKA64/3P2`!4+$@CLT<5J?5:`08_>T?T`T@E#]8(/`T1E5:PVGU&^13DQ
M;OE*5:E.YX$??O%INL-[7TVVED27O"M-M3'"NC)@^^GX5#L7^\74)E">JV\9
MF56/R=/9(_`"LJA8ZY!AE7#&)XQD;D$VKV'@E2=BK-`YYOY]W/;1]<-N<WKL
M76:KN,1DP2!2^RN\A,O78H\VLT)00P^LX\H=ET#"8`F7(1'&8FYGA\'T8W%V
M4L+RC>0YY<+JZW6TX^^E)&OQ^MTM[=U\%H\@UNT\8$"#%+L[*2&E\'QAMZ2W
M1.Z/7-<7NU`CL.'',,'!&&\LV4$51!S)]'(=#YH/0_D:'09>\9Y=TVQ"Z5"P
M4]O;Y.EQVN,.F$CB"BP9#`K.X?!J/+980PKZAUA7K.0(/+IA3$F++QP3T5P1
M$NE_57E2K),8]*@IUNJ^=LPK[7T94#G?4.N[P?F&D-#BGG4R/.R6._6P>-H-
M$K3Y])/<5KJXS/ZKRA"1]L^$_W,4UQBAOTKOJV6;8&^RQ;5GN.-6%(GQ]EM,
M+XR'E&3,P=[4N48EO:C_E.R/">@<^U(F:?)[_:O0+M1H2V@<B9J9@RIDFDXV
MQ6?)JC)DZ7VADSRT<+/<29*U^32/LH*IT<-.Y2A=2:@R#N7G@!X=W<`6R#1*
MX$![<0]GF<QV\3&<K0G.I&3SO0[E.?V/I'R\2G;)OF_%*OM2B&/*I5L0SG9V
MY3E`26?J2XAJ&CW`9F1QCPT8[G5ESZ4L[G8Y),&DT_;4Q'DSS-1GLD\Q")N3
MN/PG*O<6)-LD,&ZLD:Y!.W-`'ZQ';`G0IDHQX,EYWOXPQQ<P.8Q.9*R9(ZI<
M!)VE&(;B+=KA$J6O5\E7\B^]J<E37";M"`T>7A-S@+..V2,MMFF,'QX[,P7X
M299547JTZ$YVN&+G1=!M0PALJ/I202TEKFD`#;$2=&+G_:WYU>86Q7B;[1//
M;KYD.8KJJ?@I2K):0!M"?K!M9N':0G/MF)FT-&^T6Q2B1>`;<15&UF&7<94L
M5:]0@QM;.7<=KBX'RR$N7,)L;/X<AG[F<$Z]1S3;8QEE9=)=>&#WH7EK8IP*
M&YHMC.V*T*9N-F$*"/&:9X[B-L=^'5!47&;_>$SBQX^DY^7K7K;@`]<*-0</
M/7!KS!;L^G*QK+NE&`!`/,]`16I4U3;6[[6'[Q1E:).4$'`%I9M!`4O-'J!R
M_;<,2I`H`,1`HI9.?CFYOH>CY!B?&_'UOGB/856_)@[WS/AF>*_IT--LWY`]
M7'Z/]Y$M,!`XQ0YB8Y0(]TXT``N9?JI=@QZ`@TE@)B#I]$J(%+!L'RZ,8G/%
MC+C'-H##H.(RV7H@>2QO<DR6YO*52(BF`WVB.6NO4=GDM/26TO(N?D3KBJ9M
M;AF\2<FNJLLE*QFD;O7V2HET-8_OIP.,G;X.7TP9/:(N7?,PKR1J>+=0E,<:
MF\F$_5Z()!/]-]<EB(=W7Q?NH.B5(H6:(@0&]7*1"HIDP*?ZGI$$?2G<B5\Y
MLIJV@RR'-+\3SE\/',#&C[!P(R).N7!QPG[&2*G?JM#HOV@D(F7I;NHSRA^P
M?Z</*)21\T-6@8V])@+]U:D0GA@^Y;A0%D&ODJC[3>%P9R37#:8H`[6)R?2!
MB2@NZ>XXV%=!3GOI>B)P0OGM0\(G*^N[X>9'%:C=W._JI">P+SY'6;4A#%;T
M?2D)$T.F_.'955[1<&'#,304>F_!UN!3LW0SDV=N+&6C"EL>[O>I5Z(PZ:F/
M8NPL0"=Q7.VJ-"K1^AP1_N.DEB+Y.44U7#)ZWI^7S45B4#S`.F6[^?;8R%JS
MWB>*GE7F2*Y6[#=[O)E.M)_W$RVK'U]<^YYJ%U6>)25]2"9;7R0O]*>"FR)(
M7*%]09%3,%R`\]\SENZ\V0(M0\[2;>K0'0+72'FWT:DBVFC41<,%H]X>F-5_
MESO@FIZMR_VXC%+?8+Q"48'H"WV7NZ<</]>O2/*5HD2-UCO**QDN$OEJ4;[[
M=O0BEY[S&^43(E'&5`$@J5+U<.M9IDJX(.6J2PUY6%&;<G0M@3:0U?P,9T69
M5W52PTMJ2V^))/D:5*;*X35:7M%PX<G7H0H"L*-$^02=W9P/).IF10M<X6Q+
M'XV^2J*')$W*!.TOJ_N+NMFS=61'^CU9^8KMK5J)"A;?LCEXO;B"OR<#=YIV
MGJ/OO6RCV<8HM$BVNG=5HC"HV(Z0`-4B9N283TZ9@24=G9VCA_*RUJNB`#E.
MR8,YQB@Q,TS*]]8(>5PR-I/V6MI@DDE!X+JC[`IB!GE%VRTELXAWH/"&'"MU
M$(`&@T!OD\ALF!>.'@P>N#%\_,(`)H*)U.,.-P<6*M%X+!H\9/`C[KQC(\J*
MF^B5PIOO@P(+'C`Q+A`<'CA.)E'_)-'`<"<Q6@[FVHH+NV3D*.':)F.W"LL^
MN0H@GNYH>WZ.:&`#-1A6F]8$K0'`VV68-C/::,A6]SX+10/.C&W2$H[46LYT
MI*D3GF(.>Q\LT+"2F\1ZMA78MKW[6BQ79B"^H[MJMXORU]7F+MEFR2:)J;\M
MCFD"BB3;WN`TB>E.97^!ZR=OOJ1;X!E8\'O[F)O1JZ\6>>>_1S<NT>4_&`-G
M+&4LTPE@7MYV'WUEMA+>=:7/29;LJAUW-)EEVE#/_K<P1G3`*9;K"F]4]Q6Z
MXSIH:4E^LK&Z%/BWQ16.47A@P0`,TSE<IO4PIR2&UUE\/4S;?V#]^Y7E&46"
MOU]9?K^R_'YE^?W*LO>;1(NZLAR$O?I^89G?FR\%VE3I5;*!3%B%FB)!=&N$
M.SVY3E0=:;@,X>Z27=*T_1R]B%T/K#*'6Z8OLW(]<+JBZ'KHM[2DRX7O-YX6
M=>-IGJ_%VMB'0OY[B[O-6]&+D3ZCJ,[P[JDBH\G?"$B6/L26`Z6\(T4[K%RF
MV[8BR@%:2WKYU:D'"=X4!)!+P.)XO2<5>4\J,N^;>;?H&645ZKP/)#C`$E=H
MCZ\Y!<.%('>[*]UW*[M<'K5@POH`Y7:&TW3O44N>T4F>4_NKGD))BHH29^@F
M>JUONY+>(5*$^9BD=B,'(TBYOG=@2D`,6Q(/M),&.3BH1PW*P0#6XOVV:YSA
M]C6*RRS&.\AI*"C=O<G&*C434*KU5@M]0A)O(,\Z=!VMB=/[T_N=3[\Q,N]7
MY^9R=<YG(,'[U;G`KLZ%!(;W>W,!W9OS"XSW2W-R_9O@TMP\CXZ[%XM.7YLK
M1Z\"BTRN4D?7\`H'T?7C7:M;]-3L3JF[.<GBY"E*+[-K8GG??T/I,_J,L_*1
MMQ@;M\D0G$9;04Q?"91@-]+CS'B8J>$R8,#,DI1$Z-=J`2]CGT0O[VW][CW+
MJ2A;A]D+5G'OTU#BTJM.S]5ON$I2<3YQO(_!'.ZRSC/H24EG_Q-%^?TW;&,E
M'S2ELX`?FO`.5L?K-EM6TR[7!QZ6!/[^#+_,"%.H*&^C$IV4>^7Z,1NN>5IU
MF6L?6,<[GA6R/NB(03_5@R2U)08$*HR)TF93?S!$9,((%O*U3!+JT#&%66/:
M2^6^$>]`GF*Q9,C+PW*YY^)-3X,+7,$>5H.V="?!OHVW,`<8TII^"NR96%)X
MG[H(DF=KZT"W+>T94+?Q)F;`6%H>9D#-A+.DZ6'/@),-X=C>)&`VISX/!LTL
M>RKP9#;E;!CPP9X0?UE,3)E2)CAO`6:S2;8$'%><1D52@ZPS9]D=D"W>L,\M
MZ5UAR.5$4NRR5@XD,8TE'>I=5S2:8;59M4&R=VA;ZSE@M@C+-Z+GE/.&-6GT
M8/7^#J`F(M5=<3@DEH2T,YS%I%=Y+8?;I/C*BWKE%SZ^C<0L%$X73U]/418_
MDF7S*R=V4[8:U.U1<>_:7#!\6+OO@$9GTQL\`"6@$UY@WYCGEF-N[*=L-1!.
MP^+AP0D""1=87"G(`FM`F0^Q(<7P('87I8*$((P2;<;-[I<`,0*,-Y;IFS0<
M^D1Z.32[C2]Z(1<FUI2H`:]MT%4%KZ:+*/Y>H@9HQ(04B2\S<CREJQJ5SZ''
M5;5A1^B?546)=R@?L<U/XB)7J\61J'1X6!(D<U'JOK1AR$[F(J*U)/W].?H7
MSML>%QRU#1<\I!`9%_#GR8AV]7,I'9:X*EI8OO5DP.6\3RG."&'UG@)S:$RD
MY[V`&Y\@0^ZG-'K!=[ND?/QO4AC=I#&<&T=4MI$"7,S[<(L'$JOU%1AQD,[!
M/PJWOR1-.5H.K@27'L05(*OO*H"$MR.F;E!._Q!MT0?9#C.J0%WN%?4^MR2&
MCF?HPOV6M4RN6/&(?#I+O"2A]CB&E)_8Z"D,B()DBL@0D*SB?%6[6J_E=Q5=
MLI^7#(5&LK;H6"V#@9<SDICT(FD/=%>BBTY3!^X!YNS-)OD=Y9<9QXH%BK0B
M&W[UC@MYFU70,UU3==2LRRQC@83J7$1)_DN45N@SBNCO]7&R[\B<`U-'/D6Q
M.3)5VGSDW*+^$K"W;)T4!2J+DVS=25+4C,YZE=VBN,II'E%2X!IG>?MK'4+`
M.RBWWOY0G.;M>E=!4BC"[F4*J#`>>[UT\?;8"L`G?NC-Z6M'25WDZ+<*9?$K
MQRVI4',(9EZ-<&!J#78L3$L+38164RZ9T.9Q%Q)H65QRO<T*-8>@Y=4(![02
MN&+!45H<(CC"])E`X]$-%&C%84[Q7W!1J,J!VKA*.%B3`(T`:P*!B,`&,R`"
MVYCPK#WDG>EW^/'O"=F<Y/'CZQ5Z1JG<0BY1>;R6<ROY%TEWU,>L*J\6PC9X
MDQFN&\ZLED.!:&)+2DF\G'"8$4YRF(D`UI:/19GLHA*M-@<V&5L0[AJCTT0C
M>+6JX:!3"6/8BJ@45B&0I2Y4U5A9QKIDL$L9N:4=N%X@U[?EMOT=*4?%(^&-
M_D??,7F.TAY8CZB#SI=5Z[>'S?+UPE$Q5G&$S87HT`-PQ3SLEN=SB2??4_E_
MY&UM3RX@+H,!O,5XX.\R>ZK*HF;N@]R>'*XQ5/RLDN%`5-<:DA>$;>.'2WE)
M"0!/GJ,DI;/K`N?T#LH=G7?UU`3`*:[07H#G%`P'FJY646DQ3;UL\AA;$K!9
M,_@G9;7[D[3:_6G9:I<MB"G4[D^#+>:\W\:=QFQSL,?T8MW9Z<>L$P[N12"_
M!Q:6;Y=GN-PB)@E_=984TN2+,\R7K22:N(Q2ZY&(0X'L:*CT?1YE!6&M.$7E
M-X2RSF)0*_:AA6FA)<`?)MO(<H%O3[9330DCCH,.VSUTJB,A&S-&O[GAM-%I
MZ:W,'6,I^YE`.FP[R]D92-SS+8Z_DHZD*<J_9,DS83,I7_7CGA7?+1>^9:M9
M6_!2>5`/V][%CVA=I6BU@=@M]CB/@<\UBDD?"$RX@<_N"+7I;1P0\)OZ3@-Y
M>$*!LU+HR;/<2[WC@-7PLHK0>W2K38=K3J@5MVPC?Z",=S/`(?"PFH2`A=X^
M@UTP`XR%A\=Q?R-V%[D^6\U66A^(:FWOZ.;C#ML2#`!=)O6>_T*5Z@1)/VYR
MO*[B\IP:M?BIYIK:UC'*"FI&;W-4<\>Y0ZG3P$&02G6]XTL7-MB*K-@7[]58
M.M[D5&-E69E(C!>6T4YXE,K#/@G!SD6O:7N*!.*KS<A\DI7)WR]_H?\]X/7X
M!-VL$8%P./6]*Q4G6,&6!`JF#;#'\T$E:?"ZQ-"U:4QTAQK*BV5OMS_.0CT"
M\>VM:('V=9:.\[-Q[_WD+:_!N\M+WN7U[AZ9J>Y]=X^\NT?>W2/O[I%W]\B[
M>^3=/?*VW2/M/=+U&2[*"YQW$'>'\F>"."5'B4)S`H%)M>1=Y7AQGJ@+.00W
MBA372U)D^TUN9W,K"BE1K]@,KTP%[U-%H5<>(Q7DN0TD2&&QN]1W#^$$'L(G
M7"24H/4P6JBW!].5>OY4+`MF18$-,:CC?>)XL19X@@O!+ACP%\8M1T54?WDB
M`YV5-_MWQ?<AO"K@YM478)Q=]6U"74*,(2">S::M*T1.@']+C/6L0A=DC,]P
M5ML_5#2?2)]&STO+5VC&1%!VV5A6$=24X!7PY>P.C]<3RCO2:BV;U>:NQ/'7
M1TS*Y@7-8%.^^CN4I*Q<%D6%UN<5O4YR@_($K^N;(]?H6_T%<G4IU6V/#N7J
M^+N7P.;O[I',Y$)3($!EOD1&E;RK*K7AQH9B@?91,DSTML^2Q($ML86W'KR@
MF*-K!!XBI;H'#$O5\2\/;M@$L]"PA[YOZ.@-$Y;L)CCK)(CU9UV?"#R[_&-B
MWXLSO'O"66W9P/$?4G6&B&&7#0=`H)=,I;<BX(Q<5H+&`P3,@%%N8F9NV3;#
M+;M,.,#@#CM6ZZP('RQ:O9RT;!H!PH3PN,-9K2;YSW9#Y0Y.F=%W[]#@CS26
M[QP`!V;[?4?WJ-UE&FZC33VT$D'G$*P"WKIUF<4YB@ITCO;_7V9C,^(6I^D%
MSK]%^1KHLV8KC4"4:WN?;9PQQK:D(M++5ZQD1<HD%S9'1]X;CCN`6;"[]1\4
M\(XZ73P--_R\C@.H4R0]VN8/2-I"W=/>8U!&>1D$]@#WQ\?=4XI?$:K+W%1Y
M_$A$>)-&D(UJU):$.X_31FCRVWN#0(:U_'WBUF0<@+Q6O*L*,P3)>@BE!:GA
M,@3;EG8A\KA;WK('B+&.:-)0,[UZ$BJE*1^:#/9(T!`"HZ*,4F"*(;#YW^^4
M[%QGB4)C6M?-2$_AAN@"IF?/`-IW<6A32=NJ_.J@!0M5"W/.JLM(KR6962TG
M.5_37`4;LK-=2F:\Z2_!E+06@)@)T,5XLEXG>WYNHH2P?!8])664\B\$RM1I
MK__QRWH'I+0;4J73NBY)`0T@YM#B(A/VV1'DG]0_,+H21BK/<P7O^+;W&FFO
MJ<3'!ZS2XT.$?BGO$++@9I(3@7U?$TC7%AP#<CB=Q'&UJU)ZMZHVDZDBS-$C
MO2OZ3&06XQW_!5#E^NT2)%_/.Y3EER--86@O3?+T@`CA>2]3MES9ADY21]YN
M=:[<#_*$FNF6YO/)T/ICE&=$`OQT&/S"AUAQ=B'O.)96,%+=U-4F4.-`N/:[
MZE!T?$ZK)AH.W@=/??`40Y8=#:`P=OG?YJG73];_JHJROF-RCX'-=6UV/Q!9
MKJF^(O9,+?-;1&19)"5J[OSOA76+8KS-ZE9JN8'^D6G('EPLKLDM819./"CV
M)[#[#K#G_E_F.?>A70J1+$JVV5E%NI/%KYW;92?9NOXMW2/[(.YK5*XV]]'+
M#<[K#V69)P]529U*]_BFQBZ@"+SPT$VV,1WM):@(G\-E7U],W!NV\OCKLI3'
MEXR,0IK\CM9_)R-`C*A/9!MSA8MBE1V?0#[)$YK]K&MEM1)4U!.VR`E4@CF9
M)<]^RX,PW40W9YP]I_^F/*>?4?Z`_<]JTK&]9*@0#D^8W^..$[Z1-WT(+P8F
MJV8KS?`KUU["U#(3F?T9H\P/>R+\/,_%31AT/B[PZP=AL,ZO(:3\,L"J1*?]
MAIIK'OU]S-:^`2=W&@V4^O4GN7-H6F[.^)/MOO<SZ`^ZMQX@),YKG`RC'*?0
M(8KA9S_YO3H/NZ5/XKW?BF;^T8@(9U67"`SO5UL,5-6%-.T91)\1:.>AO@J&
M8W)!T:+Z,(?KRP0)!P9T993*A@:K0UR6%>F`X.G`'<C+24U:-GL/H-\EVRS9
M)'&4E4W;W0QR<L^@Z[;13B;EZO82&\K2OB=#<TH:_FK2_U$CB@+HU/?[^KCV
M@&-+$AOH%RVF#JD.-9AQ=VLP$#VS=^/<1R^H\);W\,"#=.9\B1K'3!-P29\Y
M.(9<08I'I0K<YQ`TBLK@8:V.PP8W1'"028-#:/&:H+:_3H>A#]Z40N<1R4T_
M%B-M'Q<ICM$:38[E0J`W[#3:H,VT,6_:1YKQTR[C(@5EJ555X4*M>5=SEK"&
M74D84)9F;'?UJ3&[BU>YUU%92^>T*I(,%33O]NJ9AIBA;][T[BK?1EGR>]WQ
M,[+;QFFRCIK@EBYD5IN+)(NR.(G2PVU`D?JUVG8;DV&G36_*F!Z0%JO-21S3
MYP&2;`O(#BS7R('QW;L*M#O>6%X8T&-/-OCIJC@&'\M76JBDI_XW**^5MS=%
MU5Y]:1D1Z!Y1\381+%C,7Z[;`4LB0TQ8'NAJ2,:3<+2P>G^ANU8`J5[&6YC$
MXN?[7;7;1?GK:M-QGQT5W@W1H7'BT7DT9D6@",05CM>>P8+^#L)X@R#2#&J5
MQTYK;B7O.D-B8+&A+``5`E/N'7!)4ER>"KG)\1/*RU=B9M'C[:<F)MZ;SFCY
MH3>QRRY3`M4A7>_XL+JHO#=%`O(F[Y+6:4(DF3!=UO(#CRV)AZEGA&QTU8T:
M^>6;,>-(T7#BAZ]Q*=J_R%4"HXO[A0,*G::,R:L<Y?I<@82I;"1'FAM**2<5
MZ71^70;XH9,@X<4K&&+3Y15:?WRACFZ/&Z*;Z)5>QJ#.Y)JE*!7MB"1JM(#A
ME?29%XM:TT7#73,0G4?=J5\=?.=]?X^S%&D>-T3Z6TUKC7O783*0PA,)%S*F
M8!8'>;NLLK9X/;@7!LZV])WOCE#\G6B!HR,ZKI*NV+T?+*C@]THVDSF1ZE.H
M*11$2$I*87R'UYR5I`&=1@G)CRXIB\@N7KG0JU9)V3YZ31^L3K(MRKQZH#D\
M2:L:K38Z]_D4ZGJ]Q2CD4Z2+]!I1D51(&DH/%MB2N`"]I<34\)ZD"C.+UV:W
MJ$SR.KK@+GJNSQ=I:E"/\_,0HT7&Y\B<BA93;>$X,^5K^O.9T^P@-8/U:GR#
M"4<'3D]1AC:)S%T26\VUTU2[F1#TFS)@L'T!@GI.EKF>WUV;J<7KNSN4HKA$
MZ_^IHIPPF;X>PJS.HS+RIOC&[%QF&YSO:F%(*S_-5AH,*M?VI@2YG(I4GEIE
M&=F$I,YT(8`-!00H,$5VNDI,EHW%JZR+*,GK:\N?441_KZU7;YKJP,V109%S
M7Z9*`R-^46\*A\662,](U>%T.R2M(C6"6*_O@.;@D>RJ"0&IQ6N'SU'^%=5Y
M/(\)`3U>HWU&37[C<_30AGR4KYU<A:);M:H-'"Z<RE?T>.?VP.1EUK!Y'+\1
MP]GZ#.7TD87[/**Y'T^*`JEL[ER3&XO>,AGO>D\#CGAR^8-7CF5Y[]]`=L7S
M\E3O)2&0;1-Z)%MWFTCC$\;K;TF:>M/`+0.$ER%[TMM(K38:,"K6]::*I?@4
M*5B]1E0D%9(RU(,%MB0N0,LI,=55=*K,+-Z0K&,EL$?G/UUMI'44OW![@Q\H
MY$WKM#$IE#&1<N&6;3H(E/&N*@2C@]5Z":4)8!+ISG&@\:5.91Q7=20^L?0R
M(KK7CK_,7A(W'A5>XC:5>NWTE:IB.)D+%/]QBY]_6*-D/X_)#\/I2_[TZYZ#
M6[1-*.&LO(YVP[>C1,7:2Z_,(GZSK"F-#I;N*BMWF@PI.HEA$LZ>8%?#PAGI
M1$Z]TF1&_C<:)F`7ENNA851FKG#@=]8.'D8TX(>6)P)$VX=[TBP#!ZS/`QVW
M_S2_4>=TS72P^TW#C]5./,8W;2+T\ZCD#3:SW&#4!V7F._R\SMK"P8`&_%3I
M1(`X(4RM*6,7:31,F0-^;V];]+_-;^!YG3,=\$';\'.F4P_T.2KB/*DYX8TW
MH]APV'M%9CSZ<%>M@:!'`G[><B(L-+=I+LB^,TK_B:(<7@A$1=NX0[#8_'`A
MV653;,!DX!<,)]T:_(/LT_\[P]^R.Q05.$/K.JG\\#5ZZ?*]K0)8=GYP4>F\
MG:T#2`M^)F]2X/R"TXIT,G^]2%*4#Y^2$);K`6549JX`X7?6#C!&-.#GXJ9U
M,NQ5W2UZH@^W9EN:#+""<<$OWG<Y`$7GBA*IKEMR0`"D.,^^30J:&L-G9$'<
MXASV2S%+]2`R*#%79/`Z:@<0`PJ<1]<FQ<%-]9`F\46*HZ%+GENFAX'>][DB
M`.ZDG?'OM>_NB3;%I6/X)N"J*HLRRM;C#+]JE?K+"+?"7`&C(`9+2PJ7(``I
M#][/XY[K@OR%98@(2@X\H*-2\T.,7(=M>4%'5`!L3.@([;.V=]/*H8-1EHF/
M7KFY(P3NM%V,].@`*#EZ4;V&+IQ&:93%Z.X1H?*FEO\C(B4B?W&4AZ3KG43L
M-WC__)\P39Y\U;+-#2=3Q6.BSB8LIEZ?R`"M\IKC_6N*AS3L;'&H53[.!*E*
MWB.=E`8;FTN%G2Q/S$,_+:<<;7=Q4MXQW#SI696/.$]^'[UCKE:)B=EQX85@
M52P%^Q@=TX1#/A:"S?8!=VE<]BMP,-D67!0>H=Z[PF)+#PY+60@.8:>!8BT.
M(L-P&;B`I;3;P"8V)5P'?YXG0#M>$D4K5*%F>RXO4V.V8%67AR7`2A&&0W[F
M#5I)LU.BQABD"S(XY?MO'Y2RIN9?%@)&KITI*`V!</86IER_78&/;UO^=2'`
M$QN6"H<P@9Y"6<>A<WM2YQSJ;[._.==-[DOH/-+\><^(OC'I-17F@9/]N_#7
MB(SB??0BD0)3LN9Q]HAK^-0<(^YP*9.F5ZH:1P;]XMZUB,K`8FU!<%)1"H@/
M](B`Z$)OX9Y%Q>-%BK_YTQP=E7]@1O[("JPR/JIB%/6F)`@6*3LW.7Y.R-B=
MOGXIT/HR6SV1,:(A>B=QF3S7.6OV29\K\K?F(\Y$XK';>"-(6XUZ5TM2X,&.
MI2DV?T:\==65+9X6=61&A++7W-00.GF.DI3F@+K''1NQ>7B+/D(>PY-'IY7C
M+%&K[7TZ6(8WMB5)8(;887<PE]387-2D.5G_JVH2J-WC6Q1CLN5*44\F1!1R
M$A<L2RY)M1<6G9#P-CCGB""*;($IU,C/*:KU0K8^V=%`_M\CQLU.G:IM#)M4
M%>\*RRF,L)$$`9WE@N.N!I/C=%%JBT@N1U&!SM'^_XZLSJ*GI(Q28>96U0;*
M-GVH?,6`Q-,^RM<^LD!@B)+G^CD_:0E)M`$*B5O7NT[10`.V(RDP&ZHL0_UL
MJ$J,&&N$G_<:(4-;>BCJ6R<`IN$^1:RC/;5FX_P]M7*C'B-P<(S0NK@@L^DN
M2E&=?;>DV79?5QMFJF\H)D>SG<,L4J[O7>=81A2V*4V5K9<BP_UH(&5&%V7%
M`!)M3K[<:"S-QOD:2[G1(#06/;BF]SA6F\Y>7T)#<>LQ-!)0/E0-I(L00`/)
M24M%XR@R"&D<@#%;&N89Y0_8OXZYJY[(CI!N/J.T]2F+<Z!JUFX/761K>=P@
MD06`+%LW40(%$[&*'+8WW4_>Y['J(&&I3D)'%'+$^MN2+A'W*W@XJM2"%WT"
MK^EDKG8W?5G4W9JNSVZU&:;ZASSK4I4.2?WXA;W/I:D<O$I2\^3:%?%H"_N!
M&"MC!Q:1^Q-9-LZ;SGQ\H0_,HM:=Q9T59HV!GDRY1KS/(MLN30W9.?9MRG%D
M/$,DG)SSC6(Q\U^ZB6)1YFE1!L!-]-HL)R?Q;U4"O)@(."E4ZK9C*%?'.^`=
MNDMUI#:9BU2.N2FTG*]SA?KN71IE4H<'H\*L$X).H5!Q;=D)QY&+!\];EYM%
M*>^3F!@G-7AZ=CN]L-$>PQ*![Y)J5W1>KH1V=4:-M;L]S4:\SXO)=H$VI.QK
M=ZC)NW$6B+!6"\:&@NX`CD)4VR7R*L-!0,Q*WF>1[5V@A&P<[_K8'"P,T6:N
M5R?70JQ>!PE@9CB->[<GYRG#X(VXMI99"!-5X'O^C79=1"RDK^4K-5K;M\F?
M:!'9G;BP`6@[SJD8ZAQRL2>7EI^WC3F'PRE6I_GZ(,TBDMSX()5Y6EAB-5:4
M3/=Y8J4H*59%;IA4OX)WG$\=)\65E]=`J3YGB\(\RZ_Z*4JR.JL&&^TR59IQ
MXQ?UCO"IG"T*$O/D4N%S:)R=,*QM)GQ?A%@W5`;T$ED<YQ5A-8D>DI1W^&36
MF/#B$+\1[S/(U0TB!=E-=)6(S]&B\G<.[R>L-N0OZXHJ$'Y`EGQ%X`(+JX)W
MC$]W8T5"7IZNJ+`X6Q3F;]%3L[.E<?%$<'E)`\XX1K]$C6;4N"5#A;<%,U]>
M0I/9]UR6%F;F?-QL4%RN-A]?XL<HVZ);PM0JHP(EBQC]C[IJGLGD)M)0\*?;
M:K9]G\RX.>\S2-4A9%F"AJX@<VX6M1"TNYY5=ECWCOY-D?];K7(S?K*5O.-\
MJNVREA0];9QE>37.E1[6VB(ZH-;9-PM;D(Q"6/8.659*D\8C2.R%9_HL@-G6
M2BTD0;%1*]DT`I@A[O;75N4\V=[;E&MK\R^$D(3NAJW6.1+'<5)U&'MS1ME0
M)X?EW;E(2E[VYPRF%F9%`?(S7TGTEXU`UPA+,1?N=]-*A!>EJ>N'*$Z)<;BF
M6>515M2]!'#++]SFTP`*>4?C5!MA*2EYVOA"O"WJ'2:S!4Y-9RLV:B4S50!S
MR9V!8U7.DUE`IEQ;FW\AK"EL+_0)D5">OY*.UP\2`M-,J6[[O(Q<'>^31M4<
MTI&%H2$D2=(67,D,2/":,)>7OD$[N)5&-B[MS;3F5AH`6.EZS(PVS/+>@>HG
MJ8U8=D'DM6&RN:SG!#7TMU2=7S_H:&Y:R_N4D-7=>G+PJ;750;K7VA^S8.YV
M3*6OM//P>U)<*ORZ>WYR!K/V4%XK@ZCA[)4FZGZ(O)Y%M[FQ;M$SRL`-@G0]
M\-QY5-X[3&V?-O,EXOB,>40<@NV/\P1N?<!Q350UF:I[/7T?O33YW`#,RE1I
M!H=?U#M2IUII%23F:6WE<[@PS-<&YO[F\)H&E]<_[Q^ZYOEQ^#6Z>P"HI'?`
MNPMSD)?09#$,7)86!NGNF?5=]4"ZDV3T=%DR0@&JP@A0&!<-%=66XQ,$,O(2
MGC#FR0*NPXI/:/<0A\6IU0?9FB%$ZLI*<5'E2/"Z@JUF.VK?K#GOLTC'GV]1
M@A:<1F;<+&Q%J!,]?LJCC*J&*B?=OZD=7;7WK#XX?Y"-D]!OZ?`2O$8+WB>$
M-8!CF[($YHDILST7C@Z3"YL^O566IB.0MZ7&I5EF5+>4=ZA/9$&!DO%C/'79
M@>!KYTG.__AA-+)7Y`_[;\Q/O5%'+R7*B`!:J8W&/49INB:ER"8^>D)5F<3%
M'\DF?L]09PG=;^W_X-%+2L@?^!&_$\PK??2(LDMY5!VUJU#T2"!4[*`LAI^]
M:PG1@&#ISL%.6Q:!_@0>-AS(LY1QNGZI$?'AIP8/]"\MO]3_T&0O."=_27%]
M)8\LSE=)3-90JLNV.4*LG-2FS?3QI-:"=\B!.,+6!`-@<4B9@E"?8B`@M;0E
MQT6=X+KQ#XL4G:AXNX4&BWG4Y`4B6*71")TQYI^.2-4YS$EN6>^S3SAR6*_?
MT!X&(-?7_UPR"YMG.\+U(]4FSVB_-A*+>+6YCUZ$4TZZYF'V2=3P&0-_/.@Z
M>8Z2E.;!NL>=UV,?,;&`\^(T*I(8D(IF*\<H=[7:`4Q?>11@6V("Y[:0ET$$
MNAH/BYKX]6DL0V)4&*W4;F@4)X%26>;)0U7NQ7-38T*@'"RWWCWJM]%J<%*_
MP#E*MME914"4Q:_W>905A%/:D6Q=_Y;N9_7AC%ZBOXICXY0'P0@ZHNU=/=J>
M!\.`#T_#""A@2[T=!8U,U\M`5+QXHT^=D516U):MW>BB+3U<8;QY9Y7U/I54
MMNG"SAILR%EMNW_E+&Q7G.3V6]\E!Q-8U`-SM_@U2LM7P>Z?6:B=Q8./WE&D
MM+_G]<QD0S]H=Y'357,GYL92M[-#L\;;HI0$))4O68ZB-/D=K?].MJU)MNWD
M[#LDNS_)$^HW[AZYMY)4W"[8(B?8&9B3\3XS/6P"+`^.?WO?O$/SGO3-$L:_
MZ<,NU+<,PKG#PS/HI7JD8,1#[2WJC9M/*$-YE-*G&]:[)$MH]VDB>[XY*5FK
M3>(K*NT=5BH&IUK?#2Q0(:%%`?%P(>BX'$#&!5RRM0M8);R#3&%O+.ZB_K:8
MV?:BGNKD[!C4SR7ESR,#@)CF?DZ^^W;V:%QZBX)B:U<(8NV`&+L`$"5E<+%[
MH6-J'5JR]FY"""CHI[:Y)#+)MO1I%>Z#47*5F/F.QH6]XTC%PE+JN8&!):*S
MJ+<[2/<0$16-!*SWRTW(-1M[_,*'"&=V(>]84S"TI#JJ;VM!S<\;2L.Y)1E?
M*8BK#``X*DI*T#L#M31N>5&YD-LYP?<P`*4&JB<<#X*&SE%R&"@H&X%_P&Y&
M^+!%[21D4&(H+(4)SC0S[<<HSY)L6]R@O,V$G<0T,#I)J_)X6VSX=IY<K?9I
M/%'I.<%4K>OZL!32652"S7^@9/M(NG7RC/)HBZZKW0/*5YNZYZNJ+(BY3P^%
MY-!IUE@S<KJ-S`G+5@2E#W%=\HM,S*@4C:5Z,\,D,$N"%GM`?IZG*CH>/)\G
MQ1/>)WM:;;C^'ZDZHV<RF66]`U'I?$VAWR:G:WPR;O,5>;UW?QJE41:CNT>$
M2F]7[CN7_YNT"5%ZTXR"X)Z(2M5#HA>9*O[\PS7H!-UF%VK]OX./WF>\TB!A
MR5Z*<S&!M'I^WP&-0`+X;6)I?\=!=..*6[:'K%$9[P`#@#*"$K]W`*+ZC8^Q
M,VIT41!Z?UF&!SD(4&Z>E&'2M/8JP4P!VGE2F72]ZTZC(BA?!6I/M7HS0O+5
M0A",W`H@KC#N?'AK@?*`8@T)`!-4EG9WSO)H+FJBGL3U`S[%3?1*'>!-9R%K
MA%NX-4>`0B%A4&*%D.JK&'&<=0&BL"A\*:M^:64?I'J_:4>HYHYGAG%*'L$U
M+N%]%JGI;JE>LG>,,FJ:V;RM^?.,\@?L?P8=#B<O<'Y';,?CQ1B:?_+XFT!U
MZ[72ZG35VMYA*KT3,!.,[IY`F>J\[SG=Y/@)Y>7K31K5F>[HC'YJTC>`^E%<
MY3`(O**!0)&O)17ZJN@.X;>]R#O3NIY-S5VG)9^G//5%W7LF5G!>$89')C.\
M!^&7/VY#H'+>`:J\$Y'JL>EF!"*R*+@UJ;NO<+:]1_F.DYF=4[+=@;!*A`0N
M95>+N,\6?2Q,8HL"6R>8D.N1!XH=+[0-/GO'F!JJ!/TSV@&.V[:%H%"V?XV7
MJ+V@<(MBE#S3K0--QB#GKY.J.W#?">IXAZ#\!D]#"-K;.CE:B[H6/KR513KZ
M\25.JSJ=!\;K;TF:`OA4J7J\5R!1)1!T"NX8J/9=>>\G1V-1:*RGG?1F0E"Z
MF\1H`1L)N=X:;2-`$HL&&7TZ2PEGXPH`U+H%0T*;\LY"6@(6-Q@\FHO"X\EZ
MG>Q[<A,EZ\NL>:>\8QM#!J)TQ=8ZE*C@':=JR%26@=%^18;:HK!)I/5$>MH$
M>K>&<<^2AD](96L>1T9<PSL\I7<N6@+0VK=(45I4LH5.!^56;ZAL=^$>EPD$
M;,*56=`[Y9T'T.BB(-1Y!9*OR.""?4=RKX!WY*CM+81]--I6L%I?%)8Z8A#'
M@<*!GV'!QB32<Y+0SJ4EL8KC:E>E]"Z;3`Y?V&FLT\K1?:Q6VSM@%7<+1M(Q
MVSJHDEZ4AI39,?!,X]GN`ES8^U*6_4RS%PG.'`#?^JS.#FR=#XC.`#00$(*J
MD';_"WWA"W#ZN_7WR[OZ9ZI-J&,NJ5\:HQ8F?24JR;8HBV%#7:)&)[`#+!D2
MS)0->7D96#3LN407I>!N41DE&5JWV:(ZEN$YVB1Q`BD\^8J'/,?B"MZ1JH9-
M91D8&>TRU!:%37[&9&9FY%!RX,@F+#`UN_@9;&RF%)S9LF$:<J\5A:H<:*\Q
M0"%,S'%'(7<U6!"\>1D`[DR19E/ILUI?5/Y0T403[[>XU233.02`.DO>;AEI
MN'&!`Y2MI1D-`:WG#<?-VQ5\GP"_<#,64*&0\"CA&Y#JJY%_`*)@(7E?2&OK
MH)O"B`)A>3;.@HHL,%%]LOVWJ/,X)!<&QC.</:.\I&'?=]4#Z4V2[;>;HC@%
M^8H'!Y:X0D@XE4D,IBH#(_4H0PU"YTP3PG"Z+%2;2G7%&%V,.M61BU7'JQ1Y
MET#VFJ[W/"GB%!=5CLYP2B"+\SUPMCFJ$P`4&CE\XW3]4D^A#S\U$XC^Y=<.
M@6=TDN=1MJU)'%D`TBMIUCY,(OF*'C6+B,E[,H*G*1P.K]&"M(`Z-;WI&ET0
M8!LB&B@<15[Z^D:!!W?9U&"=TWRA_SQ$!2)_^;]02P,$%`````@`E5QC1).;
M?\]?&0``ER<!`!$`'`!C;&1X+3(P,3,Q,C,Q+GAS9%54"0`#FJ\44YJO%%-U
M>`L``00E#@``!#D!``#L7=USH[B6?]^J_1_8O.QLU::=C^ZYTUW3<XLX3MIW
M_#6VTSWS=$L!V=8V%AX!23Q__9XCP`8#`@SIQE/<ASL=.!(Z^NE(YTO'/__S
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M>$&<1_FA\(UL<GYQ>;YO).@B]K&71V&%@_NQ`V]W/,`+T]W11NG>=?R7(2FW
M.??6Z=V:KNBXVPWM`-$Y4%'!C`@#^"J=`?DFA8$7*W/\UYW?!XQ_C72_)&23
MVCN^2.G<@N:*[O'U(W'HCG'J9E*_[R`$'2#94>?/47Q^7A+#"1;2Y?OW[SOR
M[7XD2Q27_-%(LK"525D<8(<:;Y;V4P=>I,Q.`>D)US_+7__GC#LNX0:-KCBF
MF/T=/<B\IDFI)YS;KMP0Y+/PZ6;#^,(.'L%#G*D/(7A3NM#DW'W`.?]XYK#U
MQL)!R&<K*2`HD^>AO/W;(-8;&&)(@C.I&*:<:&AB>)8<V6#_W;`'(HQ$)PEH
M.QMA;ZAP&8C!?N%U:N/*I(NR7$$3QEF3F;+(8UFFH`FUFLK/1M"R_$`3!X[`
M;[#VL)\Y,*+A/QZF_4*GF!SCK6UX>$[KW.QQE[G;/LBK6,LQGVD,]C$EQ6X<
MX4CV"_.7"_B?=JZ%[:/_)-S4_,ZT2&\_=PZ[..S=<Z@YYK_(?Q_.;M`Z(%&U
M/-@2BC>,2UUZN^!IB$AM0-T0"[?<V8KB.8;`Q)ZH@;A$(&8P5S1`HCL>S<:#
M_JT^[]UJ-_I`'W5[VNQ3KS>?M2@41&%"!'"^HD!!K"0D\=<Y^+PKCH_V0ZSG
M_VGQ4N"UF]/QH@_6T)KZ."4?J_&Y4LK/;`[_&?9&@,WX3AM/>E-]W@<"31_=
M`N5P,NU]ZHUF_<\];3">M0)6"K`N<'&5@9K_+@>ZRQJATW[`3VI7K=`5Q'#F
MVL;7E0VTPNG]Z<&!GX`RA42-Z'4)89S-Q]U?/XT'M[WI[+^UWF\/_?D?+78*
M[+K$6=U9]K/CX[3_4XW)VQ*8=/79)^UN,/[2[H1*S9PYAF4[GJ`CXL+_CQ<W
MGL,X=1S0Q,=/5#PQ^ARHZ(5(50A>^BKBOB/X8Z3/'Z8]1.SF8=8?]6;^KCC^
MW)M^[O>^M.`5`F_FK==$;&&?8TO.%J"R@2EE&+8'Y@]?3FR+&6#;'>)8L)4:
MTJL$I+.'X5"?_B%WQO[]J'_7[^JCN:9WN^.'T;P_NM<F(+3=?J\5S6+H=NTU
M\+ZBW&%/=&`["2"3!&K,KA.8M0KDD=C<$28^$\NC0TKP;SR9$OBD$ZDQ>IO`
MZ$[O3[7/^N"AIPU[^@RV37G:M4`5`FI(Q%?JDD>+SJCA">:F;(BI-&J8WB5@
M@KWOU]Y<OQF`+=WKPFCG[4Y7%*2)[X?<HAL0M/0-"LHH=$7EDZFA^C$!U62*
MQMC\#ZERH-X^08GZ7VW4F[>`%0*L#TSS)0.)T1V'NJ@*WMNV^<PLZQ`T%:D:
MN'\D@.N/YOKHOH\RIL]FZ*]"!._'X]LO_<&@Q:X0=J#J"8^:O9<-*`[)S?#P
MM1JCGQ(8@;XW?0"[K/?[!-2*=@LLB,H8"08V7\ZI6`\8>616ZEF52:?&Z7T"
MI_'\4V\**M_H_GS>FPZU05^_Z0_:4ZLX9!(!F_!#B';/E9!<7B0@\7$8ZZ,6
M@&+F;X8#4$FA!B7IJ6B]?-7PN2'P6;14X3B)1G[SJ-0XI;@?$*?S&WW6\YWK
M</A(=WN+52&LIO2)<H\>@A,^5J.1="Q,>Y][HX=>._D%/3V611Z#_$A]*6BZ
M/R&+3`U.TJ/0'0\&^LW8#T=I^OVTU[H42AD_&!^<DY>D=A9]I48EZ4#HCV#;
MZFES_?=6`RON(5TS5PH!F)5=6SJP*4]S>JM(U4@E_0>`T[`_]V-.?BQ7^K=[
MH]:Y7>*\<9GO$9V1)X#"F5A)33J=2`U7TFLP[<W[OM-4F^F?`:B9-AFT2G91
M)8Y:U'"I^9M'A$N%M;UCG(#<$.N6N"2AS*FIU=`EG0FSWJ#7Q2CO;P_Z%,RC
MP1_:77^D@Z#I`^U6G^O:#P^<>":#3[9Y$W4&#:L%#PL%$:\J!1&U'\*/M,#7
M"?P<XR!'PAZT58%^71%T_Q,MY$>&D-/1S2)3`UDDG-P"5D-<.1TT%:D:N,(Q
MYA:]ZL'F=/`4E&KL"@:>6^1JB4"G@Z<F5N-7*AK=HEA;6#H=R?P&:C3+AJA;
M0"O%JM-!3"=2`Y<?MVZAJB>`G8Y9#K4:O%+![!;'.H)V&5:ABE:)88D`7@O@
MT>&)K$/OD$`-E3I4T<)36\PBTSC/::"&KV3\XD@\7Q65XQ?0]_:/9^R;1=JH
M4:WH*V^EMK9K4K=@QS,K@7&!%BJ$WY:_-*7]$'3<@EJG0SP#WW*-U5!7<XFW
MJ+\>ZE>58%??'W_KWQ^OBGM[8_Q5D+^NA/QU'O)7=2!_W2+_"LB_K83\VSSD
MK^M`_FV+_)$1T(SC/)-.C6:Q&&A[0E</@F;@IJ158U<B#-H"6#D.FH&?BE0-
M7^%(:`M>7>!%ZB65H,^!,:$#Y\#8UDFJ);2=(8\YU&HL2P:W6\&L*[J=`6:!
M%FI`R\>W6TQKQC1USRW:+`?=Q-9;%-UV#ZZ4QY`AKAE4:A"+9#*T0EE+*D,&
M;'GD:OQ*)C.T4-8)96)CS:7/`3.QHQ8!L]U':X(S]:PLU"8'UH2WMI",MJ?D
M<04U,O;9P]=*S%3E-=I=M'*AC:R@:":A&JQB93=:W&K)Y5-AETFLQJ],-E^+
M87T8)L/3:NH<%)/AZ#P4V\.M9(&5#.$[>*O&*;/<2BM<]11>R8P1*JG5H!4O
MP]*B>'S&<Z8C-$&A1BLOY[E%J")"*2[-)$D.1BGNRQ2,VB/J>)0RG,_I9#EH
M)6SH=(EJC>;:[A-DI[KDM5!#6?I&0;M;5J^-E*DX*FC5,!:NE-0"6.N=D"S[
MNU`C-:25;X6T0)<".KS<`5OJ(Z"%PTG@FDJC@O&GBZ3O<G?A`W;:&\!/_I!8
M"U(Q:=QG[09FMBX$@2,OM<AF#K4:N!0_9B2C-[32]>E4A\.QK;E9XDBTC:]T
M`;14/'`F?XH^TPFMI%7CE_1C1CK3]KVU&V4=^!4"+@>Q%%]8*F(M3C59$PES
ML$@3-89IKK$B]D1K)!:^ODI=O-,PH6*V(B)1Y?OPM1JNI&\,VFO8@08]:+*+
M%I=C<$F_+9Y.I,8H::(G,6KO@%<"*^O>=SJ5&JZD*9X&5ZMSU)DLE+C@F4NO
MQC!I>Q?*_?I;W^'\N?/BF!_(9L/XPI;/@B><VSX+_D-\QM8;6[@:)VOJ;(A!
M8Y"_/`KKC2V6'=,5'1<^T.$V/^?>F@IFG&F.L:)K,K`-V6=^RY'?\/SJXN+]
M^>75^>6/;V`(9UJG['"P`W_=<;HD+C6+C<42(M;JJ('(WAQJO%G:3QV3,AC,
MY?7YQ>7Y]67F*%+;X#_.]XV+CV!!G$?)C^><+PG9%!Y!:L,.M5PG?'+4>#+P
M/FZ55%@B4?809J>FB9%]548*V:MK1+*OZEA%Q<@M+4)N+7)\W6'<<0DW:+$!
MR";XUWG8#H=QC<,H,P_1_M[)O\R",Q!I@%]^E_@FM?Q?3,>/?CR;,F[:&[IA
M:\\=TO4C%?X!:%CFR[_37B*V'\]@MP11^&#::\)XWZ5KW-YA@-ZCXS+7P^'=
M"]O;?#S#H;`/#$C.-`)O!3'<CV>NP%\5X@Q3)RP:_NW3;D#";',NOV-Z?EZ%
M@H/)]&Z7=9'@(.UEXSB8PJDGV`O^YXD)S_E,#(-QFH1#3=<XOO0U%D.84H.R
M)VK>V6+*EBMW;D^(`.V,;>",Z_-(^LQ3U*D:X;MB/_Z\^!RL;=@8B-@>,3$+
M8CF9,_-(+)1U&+"@)G./G#"9I]=W'(^:MY[`*A*RO;S)[C\&Y@M,6,5^3F?"
M@"\#U=XE'2\&S,`+4G>4WGITS,%4FMI;8J&N'BZ=Z,90MF4@72!:&[]IW3-2
M@?4^=RD8`&X_-O:9;65QK&K00$:!?"_U([JT708R#X]Z+R[6YK#Y>+';YM%.
M>^`F%5TJP)CB728,;^V?Q4Y\/NKL-RHT(5??>>;`GH&#8;P8>@#O!I3$KD4<
M9[SX0E#:W;'/>=?FIC3CQKSW`H@S!Q:(?`.DX9,)*+WTDTSA[Q(>2`5NNFO8
M(.1V(S<7F"[C3X_AEH.9QH1O(Q/>C.%$<6(@!DLJOC-,<KSCC4P?Y6:?H\P!
M.YBR`0K<3PDUH"!]X]0!Z:]*9*%'XZ@WVSW-A&SQF?Y,A.DSZ_1>-LS_"LIB
M=$;J[KF!PEPSC[#)^?(#4C6T!9VO"#SGP2$Q7GRV,6`CE]KK372I0?P=,9FO
MX!3&FU'1P_F5IC[_6]_TY/?-8_=U5WSDM-"=*-]8(,HO42,/BN\F#:\RP*9I
M<(%^O;\;D3C2,BD:=X@-J0F`OL"IFV`B^:IQHT_-I4CQ,RBH&L?31-BF9[BW
M](E:MJQ,!%J1OZ!`)!2NH7+M&L?WK?>5[N&Y$3"@N;>V42$VT$A!$R_!=)E&
MC>-843Q[``]P<%$#KQAY5*V`,0/TWWDY@P7*P0IR7/_W,K=S^N+>6/&31T44
M@\T-GW_G(T!&4?TK(ME<J8@J<E4+$W",,SA_)Y%8JQ[,5H0+)5735MN]15[L
MV9JYJU\MD(F)E3S6LDD:MT%,%NPON8*2F_WAF\:-?>#[8FVQW5782ZI)V32-
MXV=(N+>`3J7_.9LE-5GCN.H"R3WE75ML@AN_"8ZR21K'S2U]=/M@APD/'X(5
MPC&:8OGQEEO*[75P-4&&"[C4&L#HYJX=\;1%M8MZ^FM(_"'?0@U*L_D.].U.
M?<1(@@/+0!R$L8I0GQSO<,H18:R`G8@FC?F^.!"IH63/1(FV)S,O<1F`I2]<
M]I=<]'[`(5-<TD@;Z/.ZM0TO,)9Z'+Z^[?.%+=99VE`Q\J:I1<$=GSMAKPN:
MB5'#XZC6#5G@Y28GE%59:A2#.!G3D$9W.@RK+W]%*G4FEW_YIDT3A:(<I!ET
M1[1M@IV7E1FA1+I,HZ9A_,467S%&2C;,)5:$J<,7E63V%0_=.\Q$I@/,U)`A
MT2`WV7]R6!;Y9CLD_P<**$:?Y5V'",-5.SH"6=/]L-JBH]Y[E#ZI5TO&6E*N
MPP,SU0Y+?]TXBZ6+L0]JK+AMV<NDYSK]=>.XB"M^`XI9);=R7)G:89RH<1P-
MF0F;Q*XVP6#035KZF22-XR:2/W>SQ5;HSK.7@JP3*.63-HX[J8S!:45-OQCG
M>+&@,DG0'W>*4!6B/S4^Y69'S;+L'C1K'-<RX.P76_6SIC`O*)E#I*)J'$_W
ME%-!K!Z60A',"-01E1.N<(O&\7JT!I(6`JNCLZ8IJS-C14W/@HTVZVJ>U,52
M[9'239M@CMQ2V(`$XH61,32G9P1YF).7&UCF"Q:SN@M1-U6/#[(V(V.5+A)S
M;M_0@W3F?-+OPV29C.8O*V:L,#D(%B3TX5<!&GJ.>T.'L!%AEO%ATGJIAI7<
MAZ^FZ>HOS,G1<WV2XXPIDZW]W.U7-*:RM;X#YO((F\MB');PPL"86UM_%6(R
M=I`DGPEF3JNF+<^'#6R7W/7O@3QL;#ZE&S]I+WXE8(B)):`9ABQA+YES4*W3
MU]S#3/IX]!9V$+HP_91]8H5W:.J8N8J]GL;4!5FAP"'\"[\8X3([LJIL=!J,
MA[=!P,A"Q9P[U/#0=3H$85E96R0DEG486JG01W1:RE[\>(7-IFL_48Z.<>+*
M0R'$#_ZU9MZZS_^@1&#.-LUDOTP7@2)[1$YP/:E[MLL,NM-?4.L.4@$B-ZRB
MN7O%Z+__"1))7-A?5[KS+`M3#77+LF4-+#_?>VY//&&L0&W;;VW2$`?32]XL
M>X9=[,`7\0J]QW0.2?!MIRPW;3XG:_X+18\%6+0P!V1)IQ2-=GG%RP\RPEZ`
MZR4M&O>MO]PXVSGQ2SR'`9!,BN9&-I)#3G.%**F:AM/#[![V=L&#A(&AQ^4]
M=VO\:+%E8.T=NKQ*M&F<TTM_(DSV`GL]NBNBOQG]Z`;Z'?RE+V`'&W,*AYKM
M+5?R;,-#S@F29U"PG5BF4<T=?Q?=JD`R5D$VOS!WQ3CPB;S!"!WG@0M*+&3P
M/A[8J*_+$Y^SS*51S_R5Z_[DYO*`"RQ>!SPGC^:C>VC:UEV'W/@\UBR,8:=-
M]?W6+3!'3V+9#_QM)Q3OH$HW>YV3&.FTH9O9'7NAIF]3RRK&CO0R<3^,<ICR
M7H3X>-O[=5)X(U8ENJ9QPL"J/C`:]268V4O)6!C_9@9-MTW+]U()^F^;_+F+
M&2KN$R:LJ!*-FFM8]=8;R]Y2BIXUST*I@=&/;!X^OV6"&B[L`_N")`FKI$(?
MC;-29BMJ+:9TR;!OI)VYL+*#W'TO7H$KE[0A$I"_':96Z0D]KT'R"!61W2!2
M3-S?*([L(.;<HP9;$^M[;YPE"Q9%"SI$^/.+$L4BN[7WW+@SIUX&0[5"1HM?
M;QX//M.T27W]BEI^R<#%'0-U;E]N1&`)DMB$]9V41=W,X56)`S5/-OS4K;'H
M$8&>Z(G]3`6FO^P*Q@35[8(IB\R)LE9;<X;4-)D;>.8S6V(0#K^,9I!?.R.\
MS)B\M%VP0>/4'=T"$XXY\TA!_;2K]6JRQG$U7\$@G']1M$<<FRO*X.12-HZW
M_1#!]K0]=T76&Q=&_FLR6)!'V3C>Y`65U/5W\*)Q(Y]1XKH6Q91D$(XT%C(I
M&L?+"/.7%AXWL:?]_?58Y#Z#XIL:/%7R5+)N\@47]X.X<)";(.SU'1..BZ<8
M'HG$\ET_`>=F<`&XP$7!:MU7RH1X+3=3.J-SVR76Q,8*1L#/D(%B"%L/#1AW
M"DQ5;@^G8UQG<!BK.EQ@1@[H3V@UA$9"ZDWZ,HV:I]?O?A(=-%V;&\QBLL6^
M!NIX,:)ND,#-ET%DBV?4Q8!^NG*E12?H]3YQ,MMU>.$!!A^YR"$O>(1&W^%-
MEY3K$J5:G\SVDLY=^#0X1&2A%?1+(].P<O!9[@P5ZN,4Y\G'.,*IC/JEST<6
M;3-DYPBV^QP4"H,Z3OK^4$R.CNSJ9!9+UJ&4T$-2?G;BB+;-6$Q%++3/^FB>
M-,^B3QMGS\1.1EBANQ.P2X38+FR!V9].6CYAZ99-2U2),1`;M`[P$&O`UBPH
M7WD8W2K?M!F+.%^VLSF3*E5,E@O0-F1/J[0:4']<[!5*7.L/+IQW?P5=%IB/
MO"Y.?W5@XM5^U3MC_A#3H<HV//T)F=(UV.?6=L"^PO_CI5P?\8(2I&I^,I/S
MS*EP5FS37>$Q?W`S-/7M<;D@W^(ZZ,%P$W50,MXW[\"/C[//QX9K@VYR=7'Q
MCX3N4H2XZ1R"(OXOCU/\+4RI@1MRW/AG'KOY+1O'>W@#%+TA2__'B<>+>`ZU
M5-=D<F*<V\0U^R-[::#K;0+48FY+?X;#4M.TLDF:A[$_U"$5RY0?.$A]VS@>
M,!O,PY]RD<,$Z8I,?**"0!YI<P\-U=A3*FGE$S<.R%2KSS=Z4+.;X9"(C%(H
MM,,JG9R,,E3(7#[,HRW5JKF)M%E>GSM;Q"L#[\-\@6TDRX5@A"^E3%EM?39.
MJL(2Z9F_W9-%T#A.NE@"G^/-]>Z*6::`+?>3[<AB9$-8QP:Q,GZHIVS#QG$>
M_Z4AE-W"B3?EFS:.^\-L9N?PWDSZ18HLVMC65O>5_?S-N\Z(Y?<.3;YJXL@^
M@?@`P@$\>]CXA@5Z,[X0=.['"C,XZ4OBN)X::(7(7%W=E:7+(E7;TLJZ95&=
MCCMU=\O-CV[YRMP<#FD'M[`;ZCY3"B86P;K@V&R`*SU6N?'(#DY%']SQ%XF>
M5IBE8WIIR&JJ<I$3;U4QD'N_[*$,OON_#+K&.J>"6=O^>D,.XA;U='<J"^V(
MDDEWMA=31X[M(=!*&I.ZKAN&M_8L&+B?IX$Y]H*NT`V`ERDPDPA/X2E8%G>^
M:17_S9[2C9L;\H3=@#J8*S=>R'^GVIQ)HDK'ZFNPL'=5<OI,K*!.438W6?2-
M8TQ:K2#[^UQ8.6@W5L\FF\^"S1O']NY:9$$\L^BK)$/683'LRA&"Z`15EG$;
M/?A)N-B/!15KT)!#^^@"JF#5[,\,_.6WW.*I*2U.9Q(*EW7!H$KDB.GS/G\"
MY@\3@FOJ[U24EU)5<>J</G5_#5E_^?.W2X\.4E(#<_*&+FQ!PZ`N&A!^LI)E
MV<_XT;0$Z[(]--=)D9-2SUWVJ?\9__-HFXPZ!7S.BK95#J)O>Q&A!T-9XV+'
M7.:X%WV&!3N,0E-1J)=F;#\5YNIAL\"BUF&)S,/#O%RSANPF1::#6I9)7T(/
MI5]&$G8(O(?T1/$G5*XN+MYAS,7_#6#IP`L>)[-+:NFM<9[O1"*X(BW0=O^@
M;DI>6(4^FB%:-2:1#XD))TP7`*8&#ALCPGU,2@E\Z,/_7RKH@AMREI@3:S)&
MJ!`(17S)!D=N1`]G_+&(;YX"Z)74%)?,LLR4U+P4Z.GHGJ#[IH&Y+!7<\BD%
M'<B$.B%!M";*@P*>,J@6$C;ZH(`H3LY(S4T$<@%02P$"'@,4````"`"57&-$
MIG1"HV$>`0!7&A(`$0`8```````!````I($`````8VQD>"TR,#$S,3(S,2YX
M;6Q55`4``YJO%%-U>`L``00E#@``!#D!``!02P$"'@,4````"`"57&-$#=*L
M4Y,:``#DS@$`%0`8```````!````I(&L'@$`8VQD>"TR,#$S,3(S,5]C86PN
M>&UL550%``.:KQ13=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`E5QC1'12
M@=',2@``*6D%`!4`&````````0```*2!CCD!`&-L9'@M,C`Q,S$R,S%?9&5F
M+GAM;%54!0`#FJ\44W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`)5<8T2@
M;_XIBA<!`(,#$P`5`!@```````$```"D@:F$`0!C;&1X+3(P,3,Q,C,Q7VQA
M8BYX;6Q55`4``YJO%%-U>`L``00E#@``!#D!``!02P$"'@,4````"`"57&-$
M8FANPS%[``"^X@@`%0`8```````!````I(&"G`(`8VQD>"TR,#$S,3(S,5]P
M<F4N>&UL550%``.:KQ13=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`E5QC
M1).;?\]?&0``ER<!`!$`&````````0```*2!`A@#`&-L9'@M,C`Q,S$R,S$N
M>'-D550%``.:KQ13=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``*PQ
$`P``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELTAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>NATURE OF BUSINESS AND OVERVIEW (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_NatureOfBusinessAndOverviewLineItems', window );"><strong>NATURE OF BUSINESS AND OVERVIEW</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash, cash equivalents and marketable securities</a></td>
        <td class="nump">$ 303,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 303,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
        <td class="num">(22,062,000)<span></span></td>
        <td class="num">(23,140,000)<span></span></td>
        <td class="num">(19,016,000)<span></span></td>
        <td class="num">(17,332,000)<span></span></td>
        <td class="num">(16,807,000)<span></span></td>
        <td class="num">(15,027,000)<span></span></td>
        <td class="num">(13,773,000)<span></span></td>
        <td class="num">(13,516,000)<span></span></td>
        <td class="num">(81,550,000)<span></span></td>
        <td class="num">(59,123,000)<span></span></td>
        <td class="num">(44,799,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (67,669,000)<span></span></td>
        <td class="num">$ (49,782,000)<span></span></td>
        <td class="num">$ (35,658,000)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_NatureOfBusinessAndOverviewLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_NatureOfBusinessAndOverviewLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of investments and unrestricted cash as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.1,2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsAndCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COLLABORATION AGREEMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementDisclosureAbstract', window );"><strong>COLLABORATION AGREEMENTS</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">COLLABORATION AGREEMENTS</a></td>
        <td class="text"><div style="font-size:10.0pt;font-family:Times New Roman;">
<p style="FONT-FAMILY: times;"><font size="2"><b>(14) COLLABORATION AGREEMENTS</b></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has entered into license agreements whereby the Company has received licenses or options to license technology, specified patents or patent applications. The Company's licensing and development collaboration agreements generally provide for royalty payments equal to specified percentages of product sales, annual license maintenance fees, continuing patent prosecution costs and potential future milestone payments to third parties upon the achievement of certain developmental, regulatory and/or commercial milestones. Nonrefundable license fee expense was $0.7&#160;million, $0.7&#160;million and $1.4&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Medarex,&#160;Inc., a subsidiary of Bristol-Myers Squibb (Medarex)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and Medarex have entered into an assignment and license agreement, as amended, that provides for the assignment of certain patent and other intellectual property rights and a license to certain Medarex technology related to the Company's APC Targeting Technology&#8482; and an anti-mannose receptor product. Under the terms of the agreement, the Company may be required to pay royalties in the low-single digits on any net product sale of a Licensed Royalty-Bearing Product or Anti-Mannose Product to Medarex until the later of (i)&#160;the expiration of the last to expire applicable patent and (ii)&#160;the tenth anniversary of the first commercial sale of such licensed product.</font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and Medarex have also entered into a research and commercialization agreement, as amended, that provides the Company with certain rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform for generating antibodies until December 2015. Under the terms of the agreement, the Company may be required to pay milestones of up to $7.0&#160;million upon obtaining first approval for commercial sale in a first indication of a product containing a licensed antibody and royalty payments in the low-to-mid single digits on any net product sales to Medarex with respect to the development of any products containing such licensed antibodies until the later of (i)&#160;the expiration of the last to expire applicable patent and (ii)&#160;the tenth anniversary of the first commercial sale of such licensed product. In September 2010, the Company exercised an option under the agreement, whereby it licensed from Medarex access to the UltiMab technology to develop and commercialize human antibodies to CD27, including varlilumab.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Rockefeller University (Rockefeller)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In November 2005, the Company and Rockefeller entered into a license agreement for the exclusive worldwide rights to human DEC-205 receptor, with the right to sublicense the technology. The license grant is exclusive except that Rockefeller may use and permit other nonprofit organizations to use the human DEC-205 receptor patent rights for educational and research purposes. The Company may be required to pay milestones of up to $3.9&#160;million upon obtaining first approval for commercial sale in a first indication of a product targeting the licensed receptor and royalty payments in the low-to-mid single digits on any net product sales to Rockefeller with respect to development and commercialization of the human DEC-205 receptor.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Duke University Brain Tumor Cancer Center (Duke)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In September 2006, the Company and Duke entered into a license agreement that gave the Company access and reference to the clinical data generated by Duke and its collaborators in order for the Company to generate its own filing with the FDA relating to rindopepimut. The Company may be required to pay milestone of up to $0.7&#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Duke with respect to development and commercialization of rindopepimut.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Ludwig Institute for Cancer Research (Ludwig)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In October 2006, the Company and Ludwig entered into an agreement for the nonexclusive rights to certain cancer tumor targets for use in combination with the Company's APC Targeting Technology. The Company may be required to pay milestones of up to $1.0&#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Ludwig with respect to development and commercialization of the technology licensed from Ludwig.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Alteris Therapeutics,&#160;Inc. (Alteris)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In October 2005, the Company completed the acquisition of the assets of Alteris, including the EGFRvIII molecule. The Company may be required to pay Alteris up to $5.0&#160;million upon obtaining the first approval for commercial sale of a product containing EGFRvIII, including rindopepimut.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>University of Southampton, UK (Southampton)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In November 2008, the Company entered into a license agreement with Southampton to develop human antibodies towards CD27, a potentially important target for immunotherapy of various cancers. The Company may be required to pay milestones of up to approximately $1.4&#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Southampton with respect to development and commercialization of varlilumab.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Amgen&#160;Inc. (Amgen)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In March 2009, the Company entered into a license agreement with Amgen to acquire the exclusive rights to CDX-301 and CD40 ligand (CD40L). CDX-301 and CD40L are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. The Company may be required to pay milestones of up to $1.0&#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the low-single digits on any net product sales to Amgen with respect to development and commercialization of the technology licensed from Amgen, including CDX-301.</font></p>
<p style="FONT-FAMILY: times;"><font size="2"><i>Seattle Genetics,&#160;Inc. (Seattle Genetics)</i></font></p>
<p style="FONT-FAMILY: times;"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In connection with the CuraGen acquisition, the Company assumed the license agreement between CuraGen and Seattle Genetics whereby CuraGen acquired the rights to proprietary antibody-drug conjugate (ADC) technology for use with the Company's proprietary antibodies for the potential treatment of cancer. In February 2014, the Company paid $2.5&#160;million in milestones to Seattle Genetics as a result of the METRIC initiation. The Company may be required to pay milestones of up to $5.0&#160;million upon obtaining first approval for commercial sale in a first indication and royalty payments in the mid-single digits on any net product sales to Seattle Genetics with respect to development and commercialization of the ADC technology, including glembatumumab vedotin and CDX-014.</font></p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>cldx_CollaborativeArrangementDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>cldx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 808<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
